data_1a57_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a57 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CZ ' HD12 ' A' ' 93' ' ' ILE . 23.1 m-85 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 103.735 -2.691 . . . . 0.0 103.735 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -148.96 62.72 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 115.791 -2.364 . . . . 0.0 114.913 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 176.78 21.13 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 115.192 -3.385 . . . . 0.0 107.449 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.274 16.9 p -72.84 168.47 18.8 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 128.253 2.972 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CG ' ' HG3' ' A' ' 115' ' ' LYS 0.287 7.8 m95 -145.81 146.69 31.27 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 111.732 -3.985 . . . . 0.0 112.485 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 61.49 -179.43 0.12 Allowed 'General case' 0 C--O 1.196 -1.752 1 O-C-N 133.297 6.623 . . . . 0.0 118.142 175.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.256 1.0 OUTLIER . . . . . 0 CA--C 1.482 -1.664 3 O-C-N 135.793 8.183 . . . . 0.0 119.938 174.897 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.454 ' CA ' ' HE2' ' A' ' 7' ' ' LYS 0.314 0.4 OUTLIER 150.76 142.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.509 1 O-C-N 133.083 6.49 . . . . 0.0 104.805 179.935 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -110.84 165.77 11.57 Favored 'General case' 0 CA--C 1.561 1.399 1 O-C-N 133.098 6.499 . . . . 0.0 100.441 179.589 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.478 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 4.2 m 175.95 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 1 O-C-N 132.316 6.01 . . . . 0.0 107.123 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 23' ' ' LEU . 2.6 mp -133.41 140.67 46.34 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 109.007 -3.724 . . . . 0.0 109.422 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 m -159.2 81.15 0.77 Allowed 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 113.214 -3.395 . . . . 0.0 107.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.27 151.41 1.45 Allowed 'General case' 0 N--CA 1.433 -1.289 1 O-C-N 132.849 6.343 . . . . 0.0 111.271 179.631 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.28 56.09 0.88 Allowed 'General case' 0 C--N 1.352 0.71 1 O-C-N 129.903 4.502 . . . . 0.0 106.873 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.77 87.36 0.61 Allowed Glycine 0 CA--C 1.547 2.031 2 C-N-CA 110.846 -5.454 . . . . 0.0 101.746 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 p30 34.13 55.13 0.61 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 133.029 5.782 . . . . 0.0 109.048 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 88.82 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 3 O-C-N 131.392 5.432 . . . . 0.0 96.533 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 69' ' ' MET . 21.7 p90 -121.82 131.19 53.92 Favored 'General case' 0 C--O 1.209 -1.056 2 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.84 156.36 22.13 Favored 'General case' 0 N--CA 1.478 0.934 4 O-C-N 136.984 8.928 . . . . 0.0 98.656 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.291 2.7 t -127.54 143.14 41.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 126.932 3.253 . . . . 0.0 104.425 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.2 tttm -93.12 77.65 4.61 Favored 'General case' 0 N--CA 1.421 -1.881 2 CA-C-O 133.808 6.527 . . . . 0.0 114.072 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -86.45 62.1 7.22 Favored 'General case' 0 N--CA 1.42 -1.974 1 CA-C-N 108.019 -4.173 . . . . 0.0 107.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -74.0 119.37 18.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 112.924 -3.51 . . . . 0.0 109.574 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.03 -142.02 0.16 Allowed 'General case' 0 C--N 1.353 0.724 0 C-N-CA 114.574 -2.85 . . . . 0.0 114.385 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -96.48 38.53 1.2 Allowed 'General case' 0 C--N 1.355 0.845 0 O-C-N 124.16 0.912 . . . . 0.0 111.07 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -152.42 54.63 0.8 Allowed 'General case' 0 C--O 1.2 -1.508 1 O-C-N 129.937 4.523 . . . . 0.0 105.182 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.26 -161.78 0.2 Allowed 'General case' 0 C--O 1.246 0.889 1 O-C-N 132.387 6.054 . . . . 0.0 110.621 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.63 -68.99 0.46 Allowed 'General case' 0 CA--C 1.548 0.892 1 C-N-CA 111.661 -4.016 . . . . 0.0 102.599 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 67.14 134.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.776 2 CA-C-O 131.505 5.431 . . . . 0.0 107.79 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.38 165.17 18.87 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 110.027 -3.26 . . . . 0.0 108.787 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.91 101.15 7.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.091 1 O-C-N 132.234 5.959 . . . . 0.0 101.663 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 5.8 p -111.48 154.75 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 129.054 3.971 . . . . 0.0 112.867 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL 0.27 3.3 p90 170.5 -172.55 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 132.098 5.874 . . . . 0.0 110.739 -179.606 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -115.29 81.32 1.56 Allowed 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 115.66 -2.416 . . . . 0.0 114.73 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 1.0 OUTLIER 48.73 -115.78 0.78 Allowed 'General case' 0 C--N 1.324 -0.524 1 O-C-N 129.573 4.295 . . . . 0.0 110.041 -179.987 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 49' ' ' LEU . . . -71.81 76.15 0.7 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 104.664 -3.374 . . . . 0.0 104.664 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.3 t -129.93 97.22 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 1 O-C-N 131.659 4.976 . . . . 0.0 111.014 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.75 157.37 36.59 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 128.129 3.393 . . . . 0.0 110.844 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 13.3 p90 172.33 159.98 0.11 Allowed 'General case' 0 C--N 1.373 1.605 1 O-C-N 131.072 5.233 . . . . 0.0 114.869 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.34 96.83 6.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 101.047 -3.686 . . . . 0.0 101.047 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.514 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -121.42 128.33 52.06 Favored 'General case' 0 C--O 1.209 -1.067 1 O-C-N 129.169 4.043 . . . . 0.0 114.665 -179.928 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.84 168.25 13.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 112.76 -3.576 . . . . 0.0 107.738 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.12 -41.85 0.38 Allowed 'General case' 0 CA--C 1.509 -0.597 1 O-C-N 131.32 5.387 . . . . 0.0 112.774 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.62 45.42 2.46 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 125.065 1.478 . . . . 0.0 114.487 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 42.64 28.38 0.12 Allowed 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.9 41.4 0.06 OUTLIER Glycine 0 C--N 1.364 2.138 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.1 p -137.32 177.74 7.64 Favored 'General case' 0 C--N 1.315 -0.893 1 O-C-N 130.849 4.5 . . . . 0.0 112.054 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -161.77 37.5 0.13 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 114.888 -2.725 . . . . 0.0 106.084 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.18 99.6 0.03 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-N 108.839 -3.8 . . . . 0.0 109.644 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -107.69 108.39 19.6 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 110.329 -3.123 . . . . 0.0 108.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -162.77 -161.09 11.79 Favored Glycine 0 C--O 1.21 -1.382 1 C-N-CA 110.93 -5.414 . . . . 0.0 107.57 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.413 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 9.9 t -154.19 99.36 2.22 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 129.004 3.414 . . . . 0.0 116.737 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.702 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 25.2 m95 -81.89 127.72 33.31 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 118.11 -2.869 . . . . 0.0 104.461 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.457 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 75.9 p -120.3 69.16 0.86 Allowed 'General case' 0 N--CA 1.433 -1.293 1 O-C-N 135.695 8.122 . . . . 0.0 110.647 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.517 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 59.6 ttp -43.7 118.53 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 1 O-C-N 131.712 5.632 . . . . 0.0 104.058 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -119.5 59.71 0.85 Allowed 'General case' 0 CA--C 1.506 -0.742 1 O-C-N 130.693 4.996 . . . . 0.0 110.509 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.86 -85.89 1.37 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 117.46 -2.305 . . . . 0.0 110.682 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.01 23.94 11.83 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 114.531 -2.652 . . . . 0.0 114.025 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -123.77 -172.36 2.51 Favored 'General case' 0 N--CA 1.476 0.866 1 O-C-N 130.172 4.67 . . . . 0.0 109.705 -179.883 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.1 mt -157.97 37.94 0.26 Allowed 'General case' 0 C--O 1.214 -0.766 0 O-C-N 126.641 2.463 . . . . 0.0 114.028 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -62.04 135.69 26.28 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 1 CA-C-N 106.905 -4.679 . . . . 0.0 114.841 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.472 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 159.24 -161.14 31.85 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 104.549 -3.42 . . . . 0.0 104.549 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HG3' HG12 ' A' ' 88' ' ' ILE . 8.5 ttmt -174.59 122.97 0.27 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 113.675 -3.21 . . . . 0.0 112.344 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -124.35 146.37 48.88 Favored 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.066 4.604 . . . . 0.0 102.039 179.913 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.718 ' CG ' ' C ' ' A' ' 85' ' ' LYS 0.348 16.9 ttmt -139.23 152.3 47.21 Favored 'General case' 0 N--CA 1.424 -1.735 1 CA-C-N 105.448 -5.342 . . . . 0.0 117.845 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HG3' ' CA ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -113.33 63.02 0.64 Allowed 'General case' 0 CA--C 1.558 1.284 0 O-C-N 126.246 2.216 . . . . 0.0 108.929 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 t -17.34 -44.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 131.949 5.781 . . . . 0.0 115.425 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 9.9 t0 -65.4 -3.42 4.24 Favored 'General case' 0 N--CA 1.436 -1.161 1 O-C-N 129.97 4.544 . . . . 0.0 113.773 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER 168.23 -30.41 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 115.705 -2.398 . . . . 0.0 114.688 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.476 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -88.64 -30.63 14.96 Favored Glycine 0 CA--C 1.56 2.844 1 C-N-CA 112.729 -4.557 . . . . 0.0 103.268 -179.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.718 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 50.25 17.25 0.32 Allowed 'General case' 0 N--CA 1.441 -0.887 1 O-C-N 133.356 5.974 . . . . 0.0 118.896 178.69 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 79' ' ' LYS . 1.7 mt-10 161.06 116.22 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 1 O-C-N 129.459 4.224 . . . . 0.0 109.172 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 HD12 ' CD ' ' A' ' 80' ' ' ARG . 4.8 mp -152.76 58.95 0.8 Allowed 'General case' 0 C--O 1.207 -1.145 1 O-C-N 139.654 10.597 . . . . 0.0 112.301 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 90' ' ' VAL . 92.5 mt -67.25 -177.49 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.235 1 CA-C-N 108.032 -4.167 . . . . 0.0 104.893 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.21 63.1 0.97 Allowed 'General case' 0 C--O 1.194 -1.82 0 O-C-N 128.425 3.578 . . . . 0.0 106.255 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 88' ' ' ILE . 9.0 t -67.29 112.06 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 110.735 -2.939 . . . . 0.0 106.469 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 91' ' ' ARG . 1.2 tpm_? -172.55 157.38 3.9 Favored 'General case' 0 C--O 1.191 -1.998 1 C-N-CA 110.738 -4.385 . . . . 0.0 116.779 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -137.21 148.17 46.34 Favored 'General case' 0 N--CA 1.439 -1.011 1 O-C-N 129.707 4.38 . . . . 0.0 104.971 179.522 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.518 HD12 ' CZ ' ' A' ' 2' ' ' PHE . 16.3 mm -55.55 96.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.913 1 O-C-N 131.632 5.582 . . . . 0.0 109.304 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 t -38.51 -57.17 1.19 Allowed 'General case' 0 CA--C 1.509 -0.619 1 O-C-N 130.885 5.116 . . . . 0.0 113.621 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.68 98.48 0.15 Allowed Glycine 0 CA--C 1.559 2.824 1 N-CA-C 103.051 -4.02 . . . . 0.0 103.051 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m120 79.48 15.43 0.94 Allowed 'General case' 0 CA--C 1.553 1.063 1 O-C-N 132.466 5.451 . . . . 0.0 108.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.286 0.1 OUTLIER 174.68 170.73 0.25 Allowed 'General case' 0 C--O 1.2 -1.533 0 O-C-N 127.256 2.847 . . . . 0.0 108.928 178.696 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD11 ' CD1' ' A' ' 93' ' ' ILE . 16.5 tp -123.36 158.45 31.06 Favored 'General case' 0 N--CA 1.434 -1.237 2 O-C-N 132.475 6.109 . . . . 0.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 91' ' ' ARG 0.255 7.8 mt -110.01 -89.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.101 4.626 . . . . 0.0 103.807 179.835 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 111.1 90.23 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.729 1 O-C-N 133.188 6.555 . . . . 0.0 105.473 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.1 m -87.71 92.45 9.11 Favored 'General case' 0 C--O 1.197 -1.7 2 O-C-N 132.623 6.202 . . . . 0.0 112.28 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -70.39 113.38 7.47 Favored 'General case' 0 C--O 1.211 -0.968 2 CA-C-N 107.073 -4.603 . . . . 0.0 106.192 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -88.64 116.1 26.65 Favored 'General case' 0 C--N 1.364 1.209 1 O-C-N 129.105 4.003 . . . . 0.0 102.419 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -131.52 118.13 19.73 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.888 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 36.06 30.87 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.25 -19.91 9.18 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.779 -2.153 . . . . 0.0 114.188 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.94 162.34 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 116.41 -1.757 . . . . 0.0 115.298 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.25 85.07 2.35 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 126.456 2.348 . . . . 0.0 105.288 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.438 . . -89.27 104.6 17.13 Favored 'General case' 0 C--O 1.2 -1.548 1 O-C-N 129.112 4.007 . . . . 0.0 110.507 179.959 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -97.84 134.57 40.81 Favored 'General case' 0 C--N 1.315 -0.9 1 O-C-N 135.3 7.875 . . . . 0.0 110.425 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -99.28 141.21 32.34 Favored 'General case' 0 CA--C 1.562 1.411 1 N-CA-C 99.395 -4.298 . . . . 0.0 99.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.8 mt -112.94 105.84 19.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 1 O-C-N 130.175 4.672 . . . . 0.0 113.824 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 29.1 m-85 -137.88 -156.19 0.67 Allowed 'General case' 0 N--CA 1.436 -1.156 2 CA-C-N 108.124 -4.125 . . . . 0.0 104.993 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.82 -138.9 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.173 1 O-C-N 131.041 5.213 . . . . 0.0 110.483 -179.785 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HG3' ' CG ' ' A' ' 6' ' ' TRP . 15.7 tttt -135.83 166.71 22.67 Favored 'General case' 0 C--O 1.202 -1.409 0 O-C-N 127.503 3.002 . . . . 0.0 109.434 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.434 -1.268 0 CA-C-N 113.579 -1.646 . . . . 0.0 106.699 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.509 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 2.8 m-85 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 124.006 1.86 . . . . 0.0 108.384 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -169.83 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 116.632 -2.027 . . . . 0.0 114.887 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.24 -147.02 4.87 Favored Glycine 0 N--CA 1.48 1.62 1 C-N-CA 111.067 -5.349 . . . . 0.0 103.502 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 24' ' ' THR 0.254 7.5 p -97.63 166.18 11.62 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 129.333 3.608 . . . . 0.0 104.266 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.588 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.26 10.4 m95 -141.61 169.91 16.71 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 113.058 -3.354 . . . . 0.0 112.07 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 51.5 179.06 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 178.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.258 0.5 OUTLIER . . . . . 0 CA--C 1.487 -1.454 3 CA-C-O 135.591 7.377 . . . . 0.0 120.263 175.015 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 21' ' ' LEU 0.359 0.0 OUTLIER 171.13 165.91 0.08 Allowed 'General case' 0 CA--C 1.566 1.56 1 O-C-N 130.573 4.921 . . . . 0.0 104.268 179.805 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -131.93 151.48 51.69 Favored 'General case' 0 CA--C 1.558 1.26 4 O-C-N 134.494 7.371 . . . . 0.0 97.022 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.554 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 3.2 m 178.15 71.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 1 O-C-N 131.293 5.371 . . . . 0.0 104.215 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.445 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 2.7 mp -86.37 157.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 109.87 -3.332 . . . . 0.0 108.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 m -172.77 77.3 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 128.056 3.347 . . . . 0.0 104.673 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -45.75 145.09 1.47 Allowed 'General case' 0 N--CA 1.449 -0.524 2 O-C-N 132.556 6.16 . . . . 0.0 112.032 179.925 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -105.0 -7.48 19.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.98 63.86 0.24 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 103.21 -3.956 . . . . 0.0 103.21 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 p30 105.52 -20.9 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.277 1 O-C-N 131.944 5.143 . . . . 0.0 111.559 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.67 84.69 7.46 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 129.091 3.994 . . . . 0.0 103.27 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 17.1 m-85 -91.76 129.44 37.73 Favored 'General case' 0 C--O 1.19 -2.056 1 N-CA-C 96.177 -5.49 . . . . 0.0 96.177 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . 0.255 0.4 OUTLIER -132.88 114.1 13.66 Favored 'General case' 0 N--CA 1.483 1.213 2 O-C-N 135.895 8.247 . . . . 0.0 97.454 -179.741 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.442 14.7 t -85.48 154.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 2 C-N-CA 109.64 -4.824 . . . . 0.0 102.935 -179.839 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 2.8 tttm -88.56 16.8 6.05 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 118.848 2.907 . . . . 0.0 118.848 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HG3' HG11 ' A' ' 34' ' ' VAL 0.327 26.3 mt-10 -44.25 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 109.624 -3.443 . . . . 0.0 107.934 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 46.0 m -100.08 141.74 32.5 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 125.764 1.915 . . . . 0.0 113.322 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.08 -151.3 0.48 Allowed 'General case' 0 C--N 1.352 0.696 0 O-C-N 128.231 3.457 . . . . 0.0 110.054 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -111.08 30.01 7.27 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.432 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 20.2 m-85 -110.6 -78.13 0.59 Allowed 'General case' 0 CA--C 1.55 0.956 2 O-C-N 130.448 4.843 . . . . 0.0 110.366 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 2.1 mpt_? -139.04 8.63 2.51 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.563 2.415 . . . . 0.0 112.391 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.1 18.97 2.39 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 127.2 2.813 . . . . 0.0 104.204 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 57' ' ' LEU 0.298 9.7 tt -35.71 101.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.722 3 O-C-N 132.218 5.949 . . . . 0.0 110.24 179.429 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.42 144.64 27.21 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 109.643 -3.435 . . . . 0.0 105.944 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.85 128.22 50.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 1 O-C-N 129.38 4.175 . . . . 0.0 101.344 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.345 14.0 p -138.85 159.42 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 115.912 -2.315 . . . . 0.0 112.945 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.3 OUTLIER 170.73 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.928 1 O-C-N 134.977 7.673 . . . . 0.0 111.193 179.959 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.71 76.9 1.46 Allowed 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 127.212 2.82 . . . . 0.0 110.175 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 38.87 -80.48 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.962 1 O-C-N 131.71 5.631 . . . . 0.0 115.813 179.692 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.63 72.88 2.75 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.2 110.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.104 1 O-C-N 131.666 4.98 . . . . 0.0 116.958 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.08 163.04 15.66 Favored 'General case' 0 C--O 1.205 -1.257 1 O-C-N 129.87 4.481 . . . . 0.0 106.277 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 10.7 p90 178.38 167.24 0.82 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 112.36 -3.736 . . . . 0.0 114.495 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.69 83.92 1.93 Allowed 'General case' 0 CA--C 1.562 1.412 1 N-CA-C 100.104 -4.036 . . . . 0.0 100.104 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -93.65 150.07 20.71 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 129.049 3.968 . . . . 0.0 114.997 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 88.22 2.71 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 128.362 3.539 . . . . 0.0 105.144 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HB3' HD13 ' A' ' 43' ' ' ILE . 3.6 mm? -62.38 -75.63 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 128.796 3.81 . . . . 0.0 112.455 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.33 -138.98 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 114.797 -2.525 . . . . 0.0 109.045 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.75 6.68 23.79 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 127.26 2.85 . . . . 0.0 111.734 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 66.19 0.19 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-O 115.712 -2.716 . . . . 0.0 107.323 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -123.14 -76.61 0.59 Allowed 'General case' 0 C--O 1.213 -0.863 1 O-C-N 130.786 4.463 . . . . 0.0 112.869 179.939 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER 65.03 32.47 10.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.632 1.208 . . . . 0.0 109.438 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.417 HD11 ' HB ' ' A' ' 61' ' ' THR . 3.7 mp -71.35 84.06 0.79 Allowed 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 128.371 3.545 . . . . 0.0 108.334 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -72.28 115.73 11.87 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.29 -155.36 6.82 Favored Glycine 0 C--O 1.199 -2.041 1 C-N-CA 110.423 -5.656 . . . . 0.0 107.801 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.653 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.28 1.1 t -179.73 130.17 0.1 Allowed 'General case' 0 CA--C 1.499 -0.994 1 O-C-N 134.394 6.585 . . . . 0.0 110.969 -177.391 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.675 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 71.7 m95 -140.86 113.12 7.92 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 118.307 -2.745 . . . . 0.0 106.509 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 p -96.57 54.83 1.38 Allowed 'General case' 0 N--CA 1.428 -1.528 2 O-C-N 132.16 5.912 . . . . 0.0 116.316 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.509 ' HE2' ' CE2' ' A' ' 2' ' ' PHE . 21.6 tpp -40.13 107.69 0.07 Allowed 'General case' 0 C--O 1.212 -0.908 1 O-C-N 134.398 7.311 . . . . 0.0 104.833 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -130.48 115.95 17.53 Favored 'General case' 0 C--O 1.21 -0.979 0 O-C-N 128.526 3.641 . . . . 0.0 106.85 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.89 -132.05 46.22 Favored Glycine 0 CA--C 1.55 2.225 0 C-N-CA 117.01 -2.519 . . . . 0.0 107.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.422 ' HB3' HG21 ' A' ' 93' ' ' ILE . 11.9 m120 -97.95 52.78 1.07 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 115.679 -2.105 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -132.99 171.65 13.68 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 125.108 1.505 . . . . 0.0 113.753 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -153.11 46.06 0.67 Allowed 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.939 1.352 . . . . 0.0 113.146 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.4 134.12 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 110.27 -3.15 . . . . 0.0 115.679 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' CH2' ' A' ' 67' ' ' TRP . . . 157.87 -157.49 28.27 Favored Glycine 0 CA--C 1.554 2.495 1 N-CA-C 102.863 -4.095 . . . . 0.0 102.863 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.563 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.314 0.0 OUTLIER -173.14 131.6 0.49 Allowed 'General case' 0 C--N 1.363 1.153 0 O-C-N 129.326 3.603 . . . . 0.0 116.319 179.604 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.675 ' CE1' ' CZ2' ' A' ' 67' ' ' TRP . 1.2 m-85 -112.07 163.29 14.46 Favored 'General case' 0 C--O 1.193 -1.878 1 CA-C-O 129.117 4.294 . . . . 0.0 101.706 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' CG ' ' C ' ' A' ' 85' ' ' LYS . 11.0 ttmt -171.2 146.69 2.41 Favored 'General case' 0 N--CA 1.441 -0.908 1 CA-C-N 104.39 -5.823 . . . . 0.0 117.087 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.411 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -94.91 104.81 16.7 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 115.041 -2.409 . . . . 0.0 107.287 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 35.6 m -78.5 76.38 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 1 O-C-N 131.53 5.519 . . . . 0.0 111.933 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.13 -47.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 O-C-N 129.095 3.997 . . . . 0.0 108.538 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -179.05 5.17 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 127.271 2.857 . . . . 0.0 116.408 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.17 -44.09 3.89 Favored Glycine 0 CA--C 1.545 1.947 1 N-CA-C 102.139 -4.384 . . . . 0.0 102.139 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 86.69 -156.92 0.01 OUTLIER 'General case' 0 C--O 1.252 1.227 1 O-C-N 132.357 5.386 . . . . 0.0 113.372 179.991 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.24 148.83 49.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.836 2.562 . . . . 0.0 117.425 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.7 36.37 1.62 Allowed 'General case' 0 C--O 1.206 -1.21 1 O-C-N 132.619 6.199 . . . . 0.0 110.388 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.466 ' CG1' ' HG3' ' A' ' 77' ' ' LYS . 36.7 mt -53.65 163.95 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.558 1 CA-C-N 107.223 -4.535 . . . . 0.0 106.062 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.408 ' N ' HG21 ' A' ' 88' ' ' ILE . . . -135.13 59.95 1.71 Allowed 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 128.585 3.678 . . . . 0.0 106.047 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.7 118.13 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 1 O-C-N 129.327 4.142 . . . . 0.0 104.057 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -178.74 160.82 1.2 Allowed 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 113.302 -3.359 . . . . 0.0 114.352 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HG3' ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -144.52 134.61 24.07 Favored 'General case' 0 N--CA 1.424 -1.748 2 O-C-N 132.583 6.177 . . . . 0.0 108.129 179.642 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 72' ' ' ASN . 0.4 OUTLIER -63.34 108.77 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 1 O-C-N 130.974 5.172 . . . . 0.0 110.085 179.909 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.99 91.05 3.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 126.895 2.622 . . . . 0.0 115.647 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.75 -122.42 6.59 Favored Glycine 0 C--O 1.208 -1.479 0 N-CA-C 103.692 -3.763 . . . . 0.0 103.692 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -130.96 53.51 1.97 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 109.157 -3.521 . . . . 0.0 106.012 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.272 0.2 OUTLIER 174.15 137.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 1 O-C-N 130.434 4.834 . . . . 0.0 108.837 179.957 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 93' ' ' ILE . 2.5 tt -111.63 120.09 40.9 Favored 'General case' 0 C--O 1.203 -1.343 1 O-C-N 130.795 5.06 . . . . 0.0 109.067 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 11.6 mt -54.07 -84.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.316 3 O-C-N 131.526 5.516 . . . . 0.0 108.852 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 107.06 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.107 1 O-C-N 133.856 6.972 . . . . 0.0 104.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.465 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 18.5 m -96.48 84.34 3.68 Favored 'General case' 0 C--O 1.193 -1.892 2 O-C-N 133.571 6.794 . . . . 0.0 112.749 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.31 121.28 14.46 Favored 'General case' 0 C--O 1.218 -0.555 1 CA-C-N 107.862 -4.245 . . . . 0.0 106.871 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 HD11 ' A' ' 88' ' ' ILE . 1.8 m -98.1 70.8 2.1 Favored 'General case' 0 C--N 1.36 1.061 1 O-C-N 130.704 5.002 . . . . 0.0 101.536 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -97.15 130.98 44.34 Favored 'General case' 0 C--N 1.362 1.127 1 CA-C-N 107.347 -4.479 . . . . 0.0 109.422 -179.994 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 34.8 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.12 31.68 25.14 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 114.941 -3.504 . . . . 0.0 116.229 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.0 -49.12 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 117.934 -1.507 . . . . 0.0 110.83 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 8.1 tt0 79.07 31.83 0.28 Allowed 'General case' 0 C--N 1.35 0.604 0 O-C-N 127.431 2.957 . . . . 0.0 107.902 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.447 . . -62.42 166.71 4.85 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 113.296 -3.362 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 7.5 mttm -140.49 -48.45 0.43 Allowed 'General case' 0 N--CA 1.438 -1.043 1 O-C-N 131.909 5.756 . . . . 0.0 111.25 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.46 -158.38 0.19 Allowed 'General case' 0 C--O 1.202 -1.4 1 O-C-N 131.766 5.666 . . . . 0.0 104.446 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.78 115.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.47 1 C-N-CA 111.098 -4.241 . . . . 0.0 112.24 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.543 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 21.1 m-30 -109.97 174.34 5.91 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 131.102 5.251 . . . . 0.0 106.314 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.547 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.03 130.26 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.531 2 O-C-N 131.381 5.425 . . . . 0.0 114.109 -179.382 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.588 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.3 tttt -47.22 169.16 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 109.035 -3.712 . . . . 0.0 112.455 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.423 -1.805 0 CA-C-N 111.48 -2.6 . . . . 0.0 113.032 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 98' ' ' LEU . 75.4 m-85 . . . . . 0 CA--C 1.556 1.176 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -148.59 30.38 0.83 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 128.052 3.345 . . . . 0.0 117.324 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -151.53 8.0 Favored Glycine 0 C--N 1.349 1.293 2 C-N-CA 112.933 -4.46 . . . . 0.0 103.707 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.425 ' C ' ' CD1' ' A' ' 6' ' ' TRP 0.296 0.6 OUTLIER -89.85 -176.55 4.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 128.367 3.039 . . . . 0.0 105.627 179.616 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.539 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.334 19.1 m95 -162.63 153.17 16.83 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 113.147 -3.311 . . . . 0.0 113.581 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 15.2 mtmt 63.14 176.59 0.15 Allowed 'General case' 0 N--CA 1.426 -1.629 1 O-C-N 131.769 5.668 . . . . 0.0 119.086 176.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.255 0.5 OUTLIER . . . . . 0 CA--C 1.479 -1.786 3 CA-C-O 135.442 7.306 . . . . 0.0 120.869 174.88 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.035 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.447 0.0 OUTLIER 150.6 174.15 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.682 1 O-C-N 129.504 4.253 . . . . 0.0 102.383 -179.161 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 2.6 mt -119.12 163.62 16.76 Favored 'General case' 0 CA--C 1.557 1.249 3 O-C-N 132.515 6.134 . . . . 0.0 98.742 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.509 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 52.9 m 179.85 96.03 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.238 1 O-C-N 133.902 7.001 . . . . 0.0 108.278 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.567 ' CG2' ' CE1' ' A' ' 32' ' ' PHE . 4.7 mp -117.28 140.47 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.193 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -164.78 84.84 0.41 Allowed 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 128.494 3.621 . . . . 0.0 107.539 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -46.06 138.36 5.23 Favored 'General case' 0 N--CA 1.438 -1.052 2 O-C-N 132.943 6.402 . . . . 0.0 110.019 179.482 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -89.47 4.58 48.66 Favored 'General case' 0 C--N 1.343 0.286 1 O-C-N 130.068 4.605 . . . . 0.0 107.457 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.21 -58.46 0.61 Allowed Glycine 0 CA--C 1.55 2.246 2 N-CA-C 100.826 -4.91 . . . . 0.0 100.826 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -10.46 4.0 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 108.785 -3.708 . . . . 0.0 109.062 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -91.45 169.52 10.71 Favored 'General case' 0 C--N 1.306 -1.308 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CE1' ' CG2' ' A' ' 25' ' ' ILE . 31.6 t80 -165.91 71.97 0.15 Allowed 'General case' 0 C--O 1.192 -1.942 1 N-CA-C 95.501 -5.74 . . . . 0.0 95.501 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.89 137.01 47.13 Favored 'General case' 0 CA--C 1.503 -0.856 2 O-C-N 133.717 6.886 . . . . 0.0 102.831 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.372 0.5 OUTLIER -114.46 144.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 1 N-CA-C 99.774 -4.158 . . . . 0.0 99.774 179.248 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CB ' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -101.55 58.79 0.86 Allowed 'General case' 0 N--CA 1.422 -1.858 1 CA-C-O 133.491 6.377 . . . . 0.0 117.924 -179.953 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -73.34 47.19 0.21 Allowed 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 108.92 -3.764 . . . . 0.0 110.151 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.421 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 30.8 t -58.05 138.04 56.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 116.017 -2.273 . . . . 0.0 108.343 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.54 127.91 0.14 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 114.737 -2.785 . . . . 0.0 114.746 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.05 -65.7 0.25 Allowed 'General case' 0 C--O 1.223 -0.298 0 O-C-N 128.972 3.92 . . . . 0.0 111.418 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 40.3 m-85 -120.55 102.16 8.25 Favored 'General case' 0 C--O 1.203 -1.393 0 O-C-N 127.861 3.226 . . . . 0.0 112.619 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.1 OUTLIER 61.47 -173.01 0.14 Allowed 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 126.722 2.513 . . . . 0.0 117.248 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -90.23 -20.4 23.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 126.671 2.482 . . . . 0.0 109.159 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 ' CG1' HD22 ' A' ' 57' ' ' LEU 0.282 5.9 tp 6.84 77.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.427 2 O-C-N 133.312 6.633 . . . . 0.0 111.344 178.845 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.75 148.74 6.96 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 119.494 -2.004 . . . . 0.0 111.161 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.14 98.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 O-C-N 128.177 3.423 . . . . 0.0 104.267 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.285 8.1 p -106.64 164.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 113.662 -3.215 . . . . 0.0 116.072 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 1.7 p90 -171.74 -161.79 0.2 Allowed 'General case' 0 N--CA 1.442 -0.862 1 O-C-N 129.976 4.547 . . . . 0.0 110.722 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -142.76 85.16 1.87 Allowed 'General case' 0 C--N 1.363 1.17 0 O-C-N 127.056 2.722 . . . . 0.0 115.373 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 69' ' ' MET . 0.1 OUTLIER 18.22 94.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 131.261 5.351 . . . . 0.0 116.715 -179.941 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.41 46.72 3.44 Favored Glycine 0 C--O 1.207 -1.575 0 CA-C-O 114.209 -3.551 . . . . 0.0 104.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 t -134.89 118.53 25.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 1 O-C-N 130.315 4.185 . . . . 0.0 112.696 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.81 159.85 26.35 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 115.477 -2.489 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -173.23 165.57 4.84 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 130.625 4.953 . . . . 0.0 113.376 -179.822 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.57 89.98 3.13 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.13 144.57 28.12 Favored 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 116.082 -2.247 . . . . 0.0 113.341 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -106.51 71.38 0.86 Allowed 'General case' 0 CA--C 1.555 1.169 1 O-C-N 129.682 4.363 . . . . 0.0 103.018 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.48 HD22 ' CG1' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -38.06 -81.19 0.01 OUTLIER 'General case' 0 C--O 1.238 0.46 1 O-C-N 131.839 5.712 . . . . 0.0 114.239 -179.982 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.84 -101.45 0.03 OUTLIER 'General case' 0 C--O 1.247 0.972 0 CA-C-O 115.305 -2.284 . . . . 0.0 112.107 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.94 4.65 8.02 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 126.578 2.424 . . . . 0.0 111.844 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.59 53.65 0.03 OUTLIER Glycine 0 CA--C 1.549 2.203 0 CA-C-O 115.59 -2.784 . . . . 0.0 109.769 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 p -92.09 -64.93 1.05 Allowed 'General case' 0 CA--C 1.551 1.005 0 O-C-N 128.52 3.13 . . . . 0.0 107.352 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER 81.47 32.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.56 1 O-C-N 129.564 4.29 . . . . 0.0 111.076 177.619 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD21 ' CG ' ' A' ' 78' ' ' PHE . 2.7 mp -62.54 82.24 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.105 0 O-C-N 126.371 2.295 . . . . 0.0 110.807 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLU . 62.3 m -69.15 117.47 10.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.78 -154.1 6.15 Favored Glycine 0 C--O 1.209 -1.434 1 C-N-CA 109.99 -5.862 . . . . 0.0 108.136 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.671 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 11.5 t 172.09 129.44 0.02 OUTLIER 'General case' 0 C--O 1.248 1.024 1 O-C-N 134.498 6.646 . . . . 0.0 111.861 -178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 69.9 m95 -136.76 128.76 29.41 Favored 'General case' 0 C--O 1.203 -1.359 1 O-C-N 116.194 -4.066 . . . . 0.0 106.283 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.42 31.85 5.81 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.432 4.832 . . . . 0.0 117.197 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.414 ' HB2' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 2.29 101.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.916 1 O-C-N 133.388 6.68 . . . . 0.0 109.611 179.377 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' ASN . 1.1 mm-40 -108.45 95.2 5.5 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 129.092 3.995 . . . . 0.0 112.171 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.32 -91.74 0.09 OUTLIER Glycine 0 C--N 1.353 1.51 1 O-C-N 129.55 4.281 . . . . 0.0 108.979 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -136.69 46.57 2.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 129.153 3.502 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.2 mtpt -129.33 163.04 26.58 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 128.843 3.84 . . . . 0.0 110.785 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 2' ' ' PHE . 8.2 mt -141.74 68.38 1.33 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 127.226 2.829 . . . . 0.0 112.186 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.49 83.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 2 O-C-N 131.044 5.215 . . . . 0.0 111.01 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 67' ' ' TRP . . . -150.57 -177.66 24.7 Favored Glycine 0 CA--C 1.555 2.575 2 CA-C-N 106.994 -4.639 . . . . 0.0 102.695 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.308 0.3 OUTLIER -155.14 168.69 26.2 Favored 'General case' 0 C--O 1.204 -1.32 1 O-C-N 132.758 5.623 . . . . 0.0 112.083 -179.733 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 m-85 -148.18 166.85 26.66 Favored 'General case' 0 C--O 1.19 -2.033 1 CA-C-O 128.943 4.211 . . . . 0.0 104.052 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 5.0 ttpt -173.14 132.81 0.51 Allowed 'General case' 0 N--CA 1.418 -2.059 1 CA-C-N 104.428 -5.805 . . . . 0.0 117.992 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.484 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -100.88 38.21 1.59 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 126.512 2.383 . . . . 0.0 114.281 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 7.02 -67.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.999 1 O-C-N 131.772 5.67 . . . . 0.0 115.041 179.832 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.456 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 9.9 t0 -42.59 -26.01 0.11 Allowed 'General case' 0 N--CA 1.443 -0.808 1 O-C-N 130.248 4.717 . . . . 0.0 112.543 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.11 -16.45 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 113.954 -3.098 . . . . 0.0 117.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.425 ' HA3' ' HG3' ' A' ' 80' ' ' ARG . . . -97.79 -32.75 6.09 Favored Glycine 0 CA--C 1.548 2.147 1 C-N-CA 112.98 -4.438 . . . . 0.0 104.226 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.87 -157.85 0.06 Allowed 'General case' 0 C--O 1.25 1.089 1 O-C-N 131.672 4.983 . . . . 0.0 113.416 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.568 ' N ' ' HD3' ' A' ' 79' ' ' LYS 0.347 0.0 OUTLIER -61.88 133.46 55.46 Favored 'General case' 0 C--O 1.198 -1.638 1 O-C-N 129.534 4.271 . . . . 0.0 114.745 -177.598 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.484 ' CD1' ' HD3' ' A' ' 80' ' ' ARG 0.255 2.4 mt -136.68 38.45 2.63 Favored 'General case' 0 C--O 1.208 -1.132 1 O-C-N 136.145 8.403 . . . . 0.0 109.641 -179.697 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 HG12 ' HG3' ' A' ' 77' ' ' LYS . 90.7 mt -61.83 163.5 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.707 1 CA-C-N 107.239 -4.528 . . . . 0.0 102.608 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' ' 88' ' ' ILE . . . -141.99 67.98 1.33 Allowed 'General case' 0 C--O 1.211 -0.939 1 O-C-N 134.47 7.356 . . . . 0.0 105.45 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.64 131.34 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-N 111.824 -2.444 . . . . 0.0 108.962 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.457 ' C ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -152.4 -158.25 0.88 Allowed 'General case' 0 N--CA 1.435 -1.209 1 C-N-CA 110.856 -4.338 . . . . 0.0 112.311 179.771 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CG ' ' C ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 166.48 79.17 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.318 1 O-C-N 130.592 4.933 . . . . 0.0 105.265 -178.593 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 2' ' ' PHE 0.262 0.4 OUTLIER -24.08 92.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 1 O-C-N 132.383 6.052 . . . . 0.0 113.785 -179.419 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 p -53.07 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.102 1 O-C-N 129.261 4.101 . . . . 0.0 116.36 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -112.63 0.74 Allowed Glycine 0 CA--C 1.559 2.795 0 C-N-CA 115.633 -3.175 . . . . 0.0 106.46 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -117.38 46.19 1.76 Allowed 'General case' 0 C--N 1.362 1.133 1 CA-C-N 106.937 -4.632 . . . . 0.0 109.14 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -172.48 152.52 2.67 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 128.316 3.51 . . . . 0.0 106.863 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -104.32 107.37 18.25 Favored 'General case' 0 C--O 1.204 -1.306 2 O-C-N 132.321 6.013 . . . . 0.0 108.147 179.532 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -56.26 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.891 2 O-C-N 134.696 7.498 . . . . 0.0 103.287 -179.998 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 99' ' ' ILE . 7.7 mm-40 99.45 98.1 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.079 1 O-C-N 130.257 4.723 . . . . 0.0 103.263 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.8 m -100.96 95.46 6.61 Favored 'General case' 0 C--O 1.195 -1.812 2 O-C-N 130.529 4.893 . . . . 0.0 111.236 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -66.97 131.28 45.55 Favored 'General case' 0 C--O 1.202 -1.408 3 CA-C-N 106.411 -4.904 . . . . 0.0 106.481 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 90.5 m -111.94 80.1 1.29 Allowed 'General case' 0 C--O 1.199 -1.553 1 O-C-N 131.824 5.702 . . . . 0.0 107.021 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -101.09 154.73 18.48 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 108.705 -3.862 . . . . 0.0 110.649 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.3 mm-40 -32.65 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 10.15 67.19 Favored Glycine 0 C--N 1.357 1.727 0 C-N-CA 115.752 -3.118 . . . . 0.0 116.851 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.02 173.36 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 115.975 -1.964 . . . . 0.0 114.657 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.67 58.45 1.61 Allowed 'General case' 0 C--N 1.353 0.752 1 O-C-N 131.491 5.495 . . . . 0.0 107.067 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.321 . . -80.56 121.63 26.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 128.42 3.575 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -104.28 179.61 4.22 Favored 'General case' 0 N--CA 1.426 -1.666 1 O-C-N 133.718 6.886 . . . . 0.0 108.536 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -159.14 135.82 9.38 Favored 'General case' 0 CA--C 1.562 1.406 2 O-C-N 130.131 4.644 . . . . 0.0 99.014 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.2 pt -111.23 111.47 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 1 O-C-N 132.2 5.938 . . . . 0.0 114.039 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 93.0 m-85 -109.63 -142.18 0.38 Allowed 'General case' 0 CA--C 1.559 1.321 1 O-C-N 131.48 5.488 . . . . 0.0 101.901 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -149.94 0.06 Allowed 'General case' 0 C--O 1.205 -1.25 1 O-C-N 132.9 6.375 . . . . 0.0 111.417 179.56 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.2 tttt -131.63 -175.68 3.79 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 124.997 2.332 . . . . 0.0 112.616 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.204 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 CA--C 1.556 1.18 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -170.06 59.44 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 114.4 -2.92 . . . . 0.0 114.953 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 48.4 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 1 C-N-CA 111.366 -5.206 . . . . 0.0 107.24 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.401 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 34.8 p 59.22 162.85 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.814 1 O-C-N 132.269 5.334 . . . . 0.0 111.479 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.285 8.4 m95 -157.38 149.06 22.15 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 116.328 -1.796 . . . . 0.0 114.079 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 38.4 mtmt 59.71 178.96 0.09 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER . . . . . 0 CA--C 1.481 -1.674 3 O-C-N 134.061 7.101 . . . . 0.0 120.693 174.864 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 114.424 -2.703 . . . . 0.0 104.586 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.396 0.0 OUTLIER -147.12 140.2 25.23 Favored 'General case' 0 CA--C 1.566 1.569 1 O-C-N 131.029 5.205 . . . . 0.0 100.612 179.687 . . . . . . . . 5 4 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.0 mt -98.4 164.39 12.3 Favored 'General case' 0 C--N 1.318 -0.799 2 O-C-N 133.072 6.482 . . . . 0.0 98.811 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.537 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 20.8 m 174.04 89.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 O-C-N 128.882 3.864 . . . . 0.0 104.155 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 32' ' ' PHE 0.263 4.4 mp -111.05 152.86 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 108.533 -3.94 . . . . 0.0 110.809 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.0 m -162.34 80.22 0.52 Allowed 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 114.134 -3.026 . . . . 0.0 108.045 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.35 124.0 12.24 Favored 'General case' 0 C--O 1.214 -0.814 2 O-C-N 132.996 6.435 . . . . 0.0 110.992 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -116.84 111.0 19.08 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 128.608 3.692 . . . . 0.0 103.229 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 -114.17 4.43 Favored Glycine 0 CA--C 1.546 2.026 1 N-CA-C 101.69 -4.564 . . . . 0.0 101.69 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 62.99 1.07 Allowed 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 127.338 2.434 . . . . 0.0 107.38 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.05 161.87 33.22 Favored 'General case' 0 C--N 1.306 -1.312 1 N-CA-C 98.936 -4.468 . . . . 0.0 98.936 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 25' ' ' ILE . 69.1 t80 -158.0 72.9 0.66 Allowed 'General case' 0 C--O 1.193 -1.918 1 N-CA-C 99.439 -4.282 . . . . 0.0 99.439 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 139.43 47.07 Favored 'General case' 0 CA--C 1.505 -0.761 2 O-C-N 131.784 5.677 . . . . 0.0 103.827 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.479 ' CG1' ' HG2' ' A' ' 36' ' ' GLU 0.383 0.5 OUTLIER -120.13 137.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 128.782 3.802 . . . . 0.0 101.427 179.915 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 8.2 tttm -87.52 17.85 4.3 Favored 'General case' 0 N--CA 1.414 -2.228 1 N-CA-C 121.871 4.026 . . . . 0.0 121.871 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 7.3 pt-20 -49.68 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 124.727 2.204 . . . . 0.0 110.385 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 t -77.03 152.82 34.97 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 116.406 -2.117 . . . . 0.0 109.299 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.98 102.09 0.09 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 114.867 -2.733 . . . . 0.0 116.077 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 60.7 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 1 O-C-N 129.574 4.296 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 1.1 m-85 -78.18 91.45 4.35 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 115.59 -2.444 . . . . 0.0 110.695 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.29 -160.76 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 129.198 4.061 . . . . 0.0 115.757 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -7.69 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 127.034 2.709 . . . . 0.0 108.205 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.8 tp 11.8 91.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.42 2 O-C-N 132.885 6.366 . . . . 0.0 111.909 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.63 123.35 17.66 Favored 'General case' 0 C--N 1.369 1.433 0 O-C-N 118.219 -2.8 . . . . 0.0 111.071 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.07 106.29 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 2 O-C-N 130.08 4.613 . . . . 0.0 100.014 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.312 10.7 p -118.0 153.51 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 O-C-N 127.444 2.965 . . . . 0.0 114.149 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 2.2 p90 -179.32 -165.63 0.08 Allowed 'General case' 0 N--CA 1.429 -1.521 1 O-C-N 132.357 6.035 . . . . 0.0 111.132 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.75 73.53 1.41 Allowed 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 116.571 -2.052 . . . . 0.0 108.638 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 69' ' ' MET . 0.2 OUTLIER 69.59 -79.22 0.04 OUTLIER 'General case' 0 C--O 1.198 -1.615 2 O-C-N 132.499 6.125 . . . . 0.0 111.666 179.988 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.91 84.09 0.33 Allowed Glycine 0 CA--C 1.537 1.437 0 N-CA-C 104.665 -3.374 . . . . 0.0 104.665 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.12 -40.74 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 O-C-N 131.341 4.789 . . . . 0.0 111.641 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.86 125.22 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.935 2 O-C-N 133.013 6.446 . . . . 0.0 108.368 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 3.3 p90 -167.25 140.6 3.55 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 112.311 -3.756 . . . . 0.0 115.37 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.76 151.21 21.3 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 100.846 -3.761 . . . . 0.0 100.846 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.47 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -170.51 135.1 1.16 Allowed 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 112.236 -3.786 . . . . 0.0 109.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 91.21 8.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 114.456 -2.688 . . . . 0.0 105.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 55' ' ' TYR . 10.5 mp -68.87 -96.11 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 O-C-N 129.544 4.277 . . . . 0.0 114.24 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 40' ' ' PHE . . . -46.66 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 126.587 2.429 . . . . 0.0 116.185 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.0 14.17 4.75 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 124.939 1.399 . . . . 0.0 112.739 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.66 58.68 0.09 OUTLIER Glycine 0 CA--C 1.544 1.858 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.7 p -67.3 -60.57 2.48 Favored 'General case' 0 N--CA 1.425 -1.722 1 O-C-N 131.755 5.032 . . . . 0.0 110.126 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 65.73 46.71 2.29 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 125.487 1.742 . . . . 0.0 108.532 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' CD2' HD21 ' A' ' 87' ' ' LEU . 5.2 mp -99.84 84.12 2.85 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 127.66 3.1 . . . . 0.0 107.644 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -70.04 105.85 3.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 111.362 -2.654 . . . . 0.0 110.286 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.516 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -166.31 -156.42 9.48 Favored Glycine 0 CA--C 1.557 2.681 1 C-N-CA 111.954 -4.927 . . . . 0.0 104.314 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CE1' ' A' ' 78' ' ' PHE 0.26 8.8 t -161.27 135.54 7.02 Favored 'General case' 0 CA--C 1.491 -1.29 1 O-C-N 131.793 5.055 . . . . 0.0 114.481 179.525 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.744 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 9.4 m95 -115.03 97.66 6.35 Favored 'General case' 0 C--O 1.192 -1.96 0 O-C-N 117.839 -3.038 . . . . 0.0 104.553 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.16 97.36 7.9 Favored 'General case' 0 N--CA 1.447 -0.609 2 O-C-N 137.421 9.201 . . . . 0.0 114.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.437 ' CB ' HD23 ' A' ' 49' ' ' LEU . 3.6 ttp -56.69 109.53 0.64 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 128.974 3.922 . . . . 0.0 105.402 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 28.9 tt0 -101.68 65.12 1.01 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.158 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -105.78 0.79 Allowed Glycine 0 CA--C 1.551 2.327 0 O-C-N 128.817 3.823 . . . . 0.0 103.924 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.78 62.7 2.72 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 128.63 3.194 . . . . 0.0 109.041 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -172.23 179.14 2.67 Favored 'General case' 0 C--N 1.358 0.955 1 O-C-N 129.678 4.361 . . . . 0.0 109.95 179.934 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.5 mt -157.6 74.54 0.75 Allowed 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 127.272 2.857 . . . . 0.0 112.191 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.58 134.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.037 -2.347 . . . . 0.0 116.036 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.454 ' HA3' ' CZ3' ' A' ' 67' ' ' TRP . . . 173.78 -166.1 38.18 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 103.745 -3.742 . . . . 0.0 103.745 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.427 ' HG3' HG12 ' A' ' 88' ' ' ILE 0.251 12.5 tttm 176.65 117.67 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.348 1 O-C-N 133.822 6.248 . . . . 0.0 113.345 179.997 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.744 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.1 OUTLIER -114.59 171.5 7.6 Favored 'General case' 0 C--O 1.192 -1.932 0 O-C-N 128.768 3.793 . . . . 0.0 101.335 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HE2' ' HA2' ' A' ' 84' ' ' GLY 0.338 0.0 OUTLIER -170.43 142.1 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 108.922 -3.763 . . . . 0.0 115.061 -179.001 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.63 106.08 18.22 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 118.295 -1.362 . . . . 0.0 108.887 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.65 -16.82 17.59 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 1 O-C-N 130.777 5.048 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.04 -36.27 72.27 Favored 'General case' 0 C--O 1.252 1.206 0 O-C-N 129.091 3.994 . . . . 0.0 111.677 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -122.9 3.95 9.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 126.747 2.529 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.42 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 69.17 43.28 72.38 Favored Glycine 0 CA--C 1.558 2.746 2 N-CA-C 100.863 -4.895 . . . . 0.0 100.863 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -105.08 132.19 51.63 Favored 'General case' 0 N--CA 1.44 -0.946 2 CA-C-N 105.617 -5.291 . . . . 0.0 115.429 -179.539 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -110.16 139.6 45.14 Favored 'General case' 0 C--O 1.199 -1.554 0 CA-C-N 121.344 1.884 . . . . 0.0 107.844 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -130.7 45.44 2.81 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 133.031 6.457 . . . . 0.0 110.28 179.995 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' HG3' ' A' ' 77' ' ' LYS . 96.9 mt -68.81 168.03 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.949 1 CA-C-N 107.929 -4.214 . . . . 0.0 103.592 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . . . -143.22 107.7 4.81 Favored 'General case' 0 C--O 1.195 -1.803 1 O-C-N 130.83 5.081 . . . . 0.0 105.587 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 t -110.87 106.95 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 128.645 3.716 . . . . 0.0 102.519 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -156.08 162.5 40.27 Favored 'General case' 0 C--O 1.189 -2.111 1 C-N-CA 110.411 -4.516 . . . . 0.0 116.136 -179.535 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -149.16 136.86 20.4 Favored 'General case' 0 N--CA 1.439 -1.015 2 O-C-N 132.84 6.337 . . . . 0.0 109.8 179.725 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.47 ' CD1' HD13 ' A' ' 98' ' ' LEU . 6.2 mm -47.55 124.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 1 O-C-N 131.891 5.744 . . . . 0.0 110.177 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -126.43 101.43 6.69 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 128.526 3.641 . . . . 0.0 117.297 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.94 39.05 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 59.32 44.15 15.73 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 111.637 -2.282 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.554 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.265 0.1 OUTLIER -158.71 157.64 32.16 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 114.621 -2.609 . . . . 0.0 108.309 179.063 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -113.65 141.32 47.35 Favored 'General case' 0 C--O 1.208 -1.11 1 O-C-N 133.733 6.896 . . . . 0.0 109.187 179.894 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.29 5.0 mt -105.55 -46.35 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 1 O-C-N 129.302 4.126 . . . . 0.0 107.621 -179.863 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 63.2 100.5 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.142 1 O-C-N 129.58 4.3 . . . . 0.0 104.366 -179.367 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.411 HG22 ' CG ' ' A' ' 108' ' ' GLU . 1.4 m -98.55 96.76 8.19 Favored 'General case' 0 N--CA 1.427 -1.594 2 O-C-N 130.604 4.94 . . . . 0.0 111.949 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.28 126.15 28.86 Favored 'General case' 0 C--O 1.202 -1.438 1 CA-C-N 107.422 -4.445 . . . . 0.0 105.227 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -103.63 68.02 0.92 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -84.19 132.67 34.65 Favored 'General case' 0 CA--C 1.493 -1.213 1 CA-C-N 106.436 -4.893 . . . . 0.0 117.187 -179.63 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 44.58 31.72 0.66 Allowed 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.94 6.46 67.1 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.939 -2.077 . . . . 0.0 112.673 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.73 148.08 21.84 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-O 116.615 -1.66 . . . . 0.0 111.833 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.411 ' CG ' HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -107.12 107.76 18.89 Favored 'General case' 0 C--N 1.371 1.517 1 O-C-N 129.116 4.01 . . . . 0.0 107.441 -179.671 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.429 . . -135.52 137.29 41.93 Favored 'General case' 0 N--CA 1.417 -2.093 1 O-C-N 130.053 4.596 . . . . 0.0 112.446 179.846 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 175.98 8.86 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 130.612 4.945 . . . . 0.0 110.479 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 37.9 mtt85 -141.24 130.36 23.39 Favored 'General case' 0 N--CA 1.48 1.059 2 O-C-N 129.861 4.476 . . . . 0.0 99.627 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 134.28 28.03 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 C-N-CA 114.359 -2.936 . . . . 0.0 112.84 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 111' ' ' ARG . 2.6 m-85 -147.95 -157.13 0.78 Allowed 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 131.199 5.312 . . . . 0.0 107.37 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -166.94 -144.21 0.06 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 131.802 5.689 . . . . 0.0 112.061 -179.737 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 10.4 tttt -128.99 -171.74 2.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.462 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.21 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 O-C-N 127.163 2.789 . . . . 0.0 117.8 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.06 171.78 36.64 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 114.68 -3.628 . . . . 0.0 106.029 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -97.14 153.57 17.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 114.747 -2.781 . . . . 0.0 103.735 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.561 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 18.0 m95 -126.87 170.59 12.07 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 111.845 -3.931 . . . . 0.0 112.58 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 7.1 mtmt 43.58 -178.71 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.851 1 O-C-N 130.747 5.029 . . . . 0.0 117.366 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.277 1.2 t . . . . . 0 CA--C 1.484 -1.595 2 O-C-N 131.522 5.513 . . . . 0.0 118.013 174.982 . . . . . . . . 2 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.565 1.526 0 CA-C-O 111.767 -3.968 . . . . 0.0 101.413 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 61.22 149.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 134.048 7.092 . . . . 0.0 105.825 179.224 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -124.93 172.75 9.13 Favored 'General case' 0 N--CA 1.436 -1.146 3 CA-C-N 106.285 -4.961 . . . . 0.0 99.067 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.433 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 18.0 m -168.21 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 1 O-C-N 129.429 4.206 . . . . 0.0 108.553 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.447 HD12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mp 72.14 137.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 109.202 -3.635 . . . . 0.0 109.557 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 m -170.11 73.56 0.07 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.531 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -52.35 145.29 11.37 Favored 'General case' 0 C--O 1.207 -1.177 2 O-C-N 133.307 6.63 . . . . 0.0 114.662 179.678 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.07 62.07 1.34 Allowed 'General case' 0 C--N 1.358 0.962 1 O-C-N 131.921 5.763 . . . . 0.0 104.361 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.45 57.01 0.81 Allowed Glycine 0 CA--C 1.552 2.357 1 C-N-CA 112.21 -4.805 . . . . 0.0 103.873 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 53.17 14.09 0.46 Allowed 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 112.733 -3.508 . . . . 0.0 110.6 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 84.27 5.77 Favored 'General case' 0 CA--C 1.55 0.976 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 6.3 m-85 -82.12 142.38 32.3 Favored 'General case' 0 CA--C 1.562 1.415 1 N-CA-C 96.646 -5.316 . . . . 0.0 96.646 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.83 112.99 15.36 Favored 'General case' 0 N--CA 1.482 1.155 3 O-C-N 137.527 9.267 . . . . 0.0 97.421 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 36' ' ' GLU 0.383 1.2 t -80.32 149.87 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 C-N-CA 111.01 -4.276 . . . . 0.0 104.764 179.934 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.286 0.7 OUTLIER -85.15 2.86 41.76 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 109.275 -3.602 . . . . 0.0 120.317 179.622 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -47.98 109.07 0.19 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.25 -3.159 . . . . 0.0 108.359 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.442 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 5.8 m -103.57 126.87 50.98 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 127.202 2.814 . . . . 0.0 107.595 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -152.46 -160.61 1.16 Allowed 'General case' 0 C--O 1.24 0.595 0 O-C-N 126.889 2.618 . . . . 0.0 112.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.25 -89.05 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.351 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.34 45.18 0.07 Allowed 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 113.732 -3.187 . . . . 0.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER 170.71 -164.35 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.959 1 O-C-N 133.573 6.796 . . . . 0.0 111.834 -179.912 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.48 121.12 44.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 1.9 tt -148.65 91.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.137 2 O-C-N 130.093 4.62 . . . . 0.0 109.378 -179.16 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.3 142.85 54.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 108.9 -3.773 . . . . 0.0 110.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.8 t -105.05 99.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.264 2 O-C-N 131.413 5.446 . . . . 0.0 99.876 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 47' ' ' PHE 0.338 3.6 p -101.56 168.07 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 112.393 -3.723 . . . . 0.0 115.656 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -164.85 163.13 21.18 Favored 'General case' 0 N--CA 1.434 -1.266 1 O-C-N 130.861 5.101 . . . . 0.0 112.583 -179.506 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.09 28.91 6.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 115.546 -2.462 . . . . 0.0 114.699 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 61.7 86.61 0.11 Allowed 'General case' 0 N--CA 1.441 -0.899 1 O-C-N 130.483 4.864 . . . . 0.0 115.811 179.931 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.24 75.0 0.9 Allowed Glycine 0 C--O 1.199 -2.046 0 N-CA-C 104.496 -3.441 . . . . 0.0 104.496 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.61 -42.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 1 O-C-N 130.678 4.399 . . . . 0.0 116.378 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 78.44 126.85 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.132 1 O-C-N 129.408 4.193 . . . . 0.0 111.52 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -161.19 151.73 17.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 113.635 -3.226 . . . . 0.0 115.069 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.09 118.43 36.75 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 101.346 -3.575 . . . . 0.0 101.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.7 138.52 28.94 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 114.958 -2.697 . . . . 0.0 111.484 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.32 98.2 10.41 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 128.616 3.698 . . . . 0.0 106.822 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.4 mt -84.28 139.26 32.45 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 126.902 2.626 . . . . 0.0 112.378 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 55.97 5.02 0.14 Allowed 'General case' 0 C--O 1.247 0.954 0 O-C-N 127.252 2.845 . . . . 0.0 114.842 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.21 -39.48 0.36 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.42 -40.71 7.23 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 115.336 -2.924 . . . . 0.0 107.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.11 150.73 31.7 Favored 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 130.208 4.123 . . . . 0.0 110.546 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' HB2' HG11 ' A' ' 81' ' ' VAL . 17.7 mt-10 -153.49 68.26 0.78 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 113.278 -3.369 . . . . 0.0 106.418 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 9.4 mp -79.17 131.15 36.11 Favored 'General case' 0 C--O 1.201 -1.459 2 CA-C-N 107.076 -4.602 . . . . 0.0 113.961 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.6 m -119.82 105.97 11.63 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -168.4 -160.38 16.1 Favored Glycine 0 CA--C 1.542 1.723 1 C-N-CA 110.75 -5.5 . . . . 0.0 103.781 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 6.1 t -151.68 157.02 41.53 Favored 'General case' 0 N--CA 1.426 -1.639 1 O-C-N 133.35 5.971 . . . . 0.0 117.942 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 33.1 m95 -124.94 112.25 16.38 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 114.629 -2.605 . . . . 0.0 104.689 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 p -107.14 52.68 0.71 Allowed 'General case' 0 N--CA 1.435 -1.192 1 O-C-N 135.51 8.006 . . . . 0.0 116.028 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.82 111.37 0.34 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 134.124 7.14 . . . . 0.0 104.153 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -90.1 -43.28 10.58 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 109.443 -3.526 . . . . 0.0 110.507 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.81 101.86 0.21 Allowed Glycine 0 CA--C 1.532 1.151 0 O-C-N 128.292 3.495 . . . . 0.0 105.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 73.26 13.94 4.61 Favored 'General case' 0 N--CA 1.447 -0.595 1 O-C-N 130.683 4.402 . . . . 0.0 110.008 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -124.06 -169.37 1.95 Allowed 'General case' 0 N--CA 1.471 0.609 1 O-C-N 129.642 4.339 . . . . 0.0 108.35 -179.72 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 91' ' ' ARG . 0.8 OUTLIER -169.31 43.65 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 128.506 3.629 . . . . 0.0 111.896 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 t -77.51 136.5 24.18 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 3 O-C-N 131.316 5.385 . . . . 0.0 113.24 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.53 -159.96 32.63 Favored Glycine 0 CA--C 1.556 2.655 1 N-CA-C 101.652 -4.579 . . . . 0.0 101.652 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.509 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 178.0 141.26 0.09 Allowed 'General case' 0 C--O 1.201 -1.484 1 O-C-N 130.918 4.54 . . . . 0.0 113.53 -179.449 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -131.18 178.5 6.65 Favored 'General case' 0 C--N 1.367 1.349 3 O-C-N 130.61 4.944 . . . . 0.0 105.694 -179.552 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' HE2' ' CA ' ' A' ' 84' ' ' GLY 0.324 0.8 OUTLIER -163.74 131.24 3.44 Favored 'General case' 0 C--N 1.365 1.274 1 CA-C-N 106.257 -4.974 . . . . 0.0 113.64 179.906 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 72.7 ttt180 -85.92 94.87 9.29 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.32 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 62' ' ' GLU . 14.3 p -47.41 -26.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 O-C-N 133.175 6.547 . . . . 0.0 113.77 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.32 -0.712 1 O-C-N 130.121 4.638 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.82 -3.45 15.71 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 114.745 -2.782 . . . . 0.0 114.748 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.497 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 70.62 33.36 67.18 Favored Glycine 0 CA--C 1.557 2.674 2 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 3.9 tppt? -72.74 -78.26 0.09 Allowed 'General case' 0 N--CA 1.421 -1.904 1 CA-C-N 105.473 -5.364 . . . . 0.0 120.805 -178.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 52.8 mt-10 83.26 60.29 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.459 1 O-C-N 130.209 4.693 . . . . 0.0 107.906 -177.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 tp -91.48 69.23 5.84 Favored 'General case' 0 CA--C 1.49 -1.341 1 O-C-N 135.009 7.693 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 77' ' ' LYS 0.29 78.0 mt -76.81 -179.46 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 69.68 0.73 Allowed 'General case' 0 C--O 1.201 -1.469 0 O-C-N 128.627 3.705 . . . . 0.0 106.223 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.64 137.15 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 110.936 -2.847 . . . . 0.0 105.497 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG3' ' CD1' ' A' ' 98' ' ' LEU . 0.4 OUTLIER 179.51 162.48 0.89 Allowed 'General case' 0 N--CA 1.414 -2.272 1 C-N-CA 111.363 -4.135 . . . . 0.0 114.044 179.843 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.87 154.76 35.74 Favored 'General case' 0 N--CA 1.424 -1.746 1 O-C-N 131.441 5.463 . . . . 0.0 105.534 178.688 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 98' ' ' LEU . 4.9 mm -56.09 91.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 1 O-C-N 132.365 6.041 . . . . 0.0 109.694 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -31.31 -59.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 1 O-C-N 133.002 6.439 . . . . 0.0 115.258 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.14 -83.14 0.12 Allowed Glycine 0 CA--C 1.556 2.634 0 N-CA-C 103.24 -3.944 . . . . 0.0 103.24 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.3 26.52 5.41 Favored 'General case' 0 CA--C 1.551 1.007 1 CA-C-N 107.123 -4.538 . . . . 0.0 105.193 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -164.44 163.08 22.32 Favored 'General case' 0 CA--C 1.563 1.45 1 O-C-N 133.049 6.468 . . . . 0.0 106.706 -179.881 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' CD1' ' HG3' ' A' ' 91' ' ' ARG . 17.2 tp -115.89 136.53 52.95 Favored 'General case' 0 N--CA 1.437 -1.122 1 O-C-N 132.853 6.346 . . . . 0.0 110.484 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.277 4.2 mt -85.28 -60.79 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 2 CA-C-O 110.796 -4.43 . . . . 0.0 106.102 -179.588 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 86.09 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 1 O-C-N 134.064 7.103 . . . . 0.0 102.865 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.45 98.74 8.59 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.714 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.3 95.74 1.34 Allowed 'General case' 0 C--O 1.21 -1.022 2 CA-C-N 107.489 -4.414 . . . . 0.0 105.086 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.1 132.69 51.25 Favored 'General case' 0 N--CA 1.48 1.032 1 O-C-N 129.541 4.276 . . . . 0.0 100.812 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -160.13 147.43 16.3 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 110.448 -3.069 . . . . 0.0 115.888 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 43.28 28.91 0.19 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.184 -2.28 . . . . 0.0 116.043 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 C--N 1.358 1.796 0 C-N-CA 117.066 -2.492 . . . . 0.0 116.328 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.15 -159.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 118.801 -1.159 . . . . 0.0 112.765 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -138.13 93.67 2.79 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 116.435 -2.106 . . . . 0.0 106.448 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.47 . . -105.13 150.39 25.08 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 125.954 2.034 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 177.59 9.19 Favored 'General case' 0 N--CA 1.427 -1.603 1 O-C-N 131.52 5.513 . . . . 0.0 110.75 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -147.07 107.15 4.0 Favored 'General case' 0 CA--C 1.561 1.366 2 O-C-N 130.757 5.035 . . . . 0.0 99.834 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.31 132.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 O-C-N 128.872 3.857 . . . . 0.0 113.586 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 13.7 m-30 -140.15 175.73 9.35 Favored 'General case' 0 N--CA 1.423 -1.796 2 O-C-N 133.675 6.86 . . . . 0.0 104.083 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -159.95 -155.21 0.43 Allowed 'General case' 0 C--O 1.2 -1.52 1 O-C-N 131.367 5.417 . . . . 0.0 111.325 179.454 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.4 tttt -110.21 -173.04 2.16 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.747 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 109.422 -3.535 . . . . 0.0 111.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.251 4.2 p-10 -33.1 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.7 1 O-C-N 130.493 4.871 . . . . 0.0 118.541 179.803 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.76 -176.29 43.65 Favored Glycine 0 C--N 1.355 1.594 1 C-N-CA 113.169 -4.348 . . . . 0.0 105.221 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 24' ' ' THR . 46.5 p -97.76 165.93 11.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 112.486 -3.685 . . . . 0.0 103.576 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 13.1 m95 -136.67 172.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 112.589 -3.576 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 7.6 mtmt 38.92 -178.64 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.505 4.878 . . . . 0.0 118.502 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.329 1.0 OUTLIER . . . . . 0 CA--C 1.493 -1.231 3 CA-C-N 105.319 -5.401 . . . . 0.0 118.794 174.915 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.47 ' HG ' ' CB ' ' A' ' 38' ' ' SER . 1.2 mp . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 113.604 -3.093 . . . . 0.0 102.909 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' CG ' ' HB2' ' A' ' 37' ' ' SER 0.399 0.0 OUTLIER -150.29 168.62 23.53 Favored 'General case' 0 CA--C 1.566 1.586 1 O-C-N 131.682 5.614 . . . . 0.0 101.776 -179.912 . . . . . . . . 5 4 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 7.0 mt -139.95 153.55 46.95 Favored 'General case' 0 CA--C 1.562 1.423 4 O-C-N 132.805 6.315 . . . . 0.0 97.233 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.55 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 40.7 m 175.84 77.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 1 O-C-N 131.169 5.293 . . . . 0.0 106.499 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 23' ' ' LEU . 3.9 mp -89.13 157.48 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 C-N-CA 114.452 -2.899 . . . . 0.0 110.971 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.4 m -167.72 77.78 0.16 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 112.803 -3.559 . . . . 0.0 107.915 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.486 ' CA ' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -55.59 157.54 3.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 128.685 3.74 . . . . 0.0 115.555 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.8 61.56 1.67 Allowed 'General case' 0 C--N 1.356 0.87 0 O-C-N 128.787 3.804 . . . . 0.0 104.547 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.77 -95.39 0.43 Allowed Glycine 0 CA--C 1.555 2.566 2 O-C-N 130.551 4.907 . . . . 0.0 102.443 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -146.82 21.93 1.26 Allowed 'General case' 0 N--CA 1.415 -2.183 2 O-C-N 134.375 6.573 . . . . 0.0 106.392 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -125.46 126.39 44.85 Favored 'General case' 0 CA--C 1.552 1.02 1 O-C-N 129.729 4.393 . . . . 0.0 101.881 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -143.13 173.19 11.79 Favored 'General case' 0 C--O 1.193 -1.888 2 N-CA-C 96.162 -5.495 . . . . 0.0 96.162 179.736 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.07 124.66 20.85 Favored 'General case' 0 N--CA 1.473 0.708 2 O-C-N 137.945 9.528 . . . . 0.0 101.605 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.406 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.448 3.0 t -79.24 149.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 113.915 -3.114 . . . . 0.0 103.17 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.304 13.3 tttt -90.05 32.01 0.94 Allowed 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.438 27.8 tt0 -58.51 102.52 0.11 Allowed 'General case' 0 C--N 1.362 1.111 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB2' ' CG ' ' A' ' 22' ' ' LYS . 23.2 m -121.26 124.49 44.77 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 127.598 3.061 . . . . 0.0 112.147 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.47 ' CB ' ' HG ' ' A' ' 21' ' ' LEU . 1.5 t 159.34 -50.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 1 O-C-N 130.013 4.571 . . . . 0.0 115.317 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -38.8 -31.71 0.07 Allowed 'General case' 0 C--O 1.219 -0.545 0 O-C-N 128.416 3.572 . . . . 0.0 111.633 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.73 -48.85 0.06 Allowed 'General case' 0 C--N 1.356 0.876 1 C-N-CA 111.232 -4.187 . . . . 0.0 110.38 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.78 43.57 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.58 1.8 . . . . 0.0 114.953 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.481 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 84.47 6.18 0.59 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 128.891 3.87 . . . . 0.0 108.008 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.372 0.2 OUTLIER -25.69 92.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.069 3 O-C-N 133.55 6.781 . . . . 0.0 110.325 177.269 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.31 141.82 36.67 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 110.608 -2.996 . . . . 0.0 107.801 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.28 97.15 5.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 1 O-C-N 130.423 4.827 . . . . 0.0 103.86 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.308 1.2 p -95.47 155.64 3.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 C-N-CA 114.424 -2.91 . . . . 0.0 111.817 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.65 177.57 3.88 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 130.949 5.156 . . . . 0.0 111.8 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.19 78.37 1.83 Allowed 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 128.57 3.669 . . . . 0.0 116.144 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 15.58 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.524 1 O-C-N 129.173 4.046 . . . . 0.0 117.204 -179.819 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.9 53.46 1.39 Allowed Glycine 0 C--O 1.197 -2.165 0 N-CA-C 105.236 -3.146 . . . . 0.0 105.236 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.62 111.38 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 1 O-C-N 130.611 4.359 . . . . 0.0 112.195 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.24 151.1 28.29 Favored 'General case' 0 N--CA 1.473 0.717 1 O-C-N 130.97 5.169 . . . . 0.0 109.727 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -172.19 113.94 0.31 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 112.217 -3.793 . . . . 0.0 116.86 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.89 53.12 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 101.114 -3.661 . . . . 0.0 101.114 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 57' ' ' LEU . 6.9 t80 -154.53 97.22 1.98 Allowed 'General case' 0 C--O 1.206 -1.212 0 C-N-CA 112.113 -3.835 . . . . 0.0 113.427 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.1 t -64.38 91.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.929 1 O-C-N 130.343 4.777 . . . . 0.0 104.202 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -54.96 -76.11 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 129.022 3.951 . . . . 0.0 111.841 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.71 26.26 0.5 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.02 -24.8 0.15 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -33.47 2.0 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-O 115.072 -3.071 . . . . 0.0 109.033 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.5 p -58.23 -172.38 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 1 O-C-N 130.064 4.038 . . . . 0.0 115.01 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 tp10 -150.72 -60.86 0.19 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 117.109 -1.836 . . . . 0.0 107.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 mp 34.67 77.46 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.613 1 O-C-N 131.711 5.632 . . . . 0.0 113.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.0 m -87.69 99.66 12.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 112.169 -2.287 . . . . 0.0 107.988 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.559 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -159.38 -166.24 17.95 Favored Glycine 0 CA--C 1.536 1.401 1 C-N-CA 111.041 -5.361 . . . . 0.0 108.108 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.512 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 5.2 t -150.47 113.51 4.82 Favored 'General case' 0 N--CA 1.437 -1.122 2 O-C-N 132.376 5.397 . . . . 0.0 118.37 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.755 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 40.6 m95 -94.11 129.33 40.7 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 117.409 -3.307 . . . . 0.0 104.332 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.414 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 49.2 p -124.65 58.33 1.23 Allowed 'General case' 0 N--CA 1.433 -1.279 1 O-C-N 133.43 6.706 . . . . 0.0 116.301 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.406 ' HB3' ' CD2' ' A' ' 49' ' ' LEU 0.278 0.0 OUTLIER -42.26 112.43 0.34 Allowed 'General case' 0 N--CA 1.441 -0.896 1 O-C-N 131.116 5.26 . . . . 0.0 104.112 -179.923 . . . . . . . . 5 4 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.43 -78.45 0.22 Allowed 'General case' 0 C--O 1.212 -0.903 0 O-C-N 127.975 3.297 . . . . 0.0 108.529 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.05 -76.47 0.06 OUTLIER Glycine 0 CA--C 1.555 2.544 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 37.34 4.11 Favored 'General case' 0 CA--C 1.537 0.45 1 O-C-N 130.09 4.053 . . . . 0.0 108.258 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -130.32 177.48 7.3 Favored 'General case' 0 C--N 1.362 1.126 1 O-C-N 129.249 4.093 . . . . 0.0 112.432 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.3 mt -149.71 46.29 0.94 Allowed 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.54 2.4 . . . . 0.0 113.285 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.82 130.36 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 2 O-C-N 131.015 5.197 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.16 -164.58 36.11 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 103.902 -3.679 . . . . 0.0 103.902 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.488 ' CG ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -176.38 133.64 0.23 Allowed 'General case' 0 N--CA 1.423 -1.804 0 O-C-N 129.256 3.563 . . . . 0.0 114.149 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.6 OUTLIER -128.13 164.86 21.55 Favored 'General case' 0 C--O 1.203 -1.384 3 O-C-N 135.041 7.713 . . . . 0.0 105.272 179.765 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HG2' ' C ' ' A' ' 85' ' ' LYS . 3.8 tmtt? -154.0 153.17 31.49 Favored 'General case' 0 N--CA 1.417 -2.106 1 CA-C-N 106.744 -4.753 . . . . 0.0 117.734 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.426 ' HB3' ' HA3' ' A' ' 84' ' ' GLY . 44.0 ttt180 -104.13 85.84 2.46 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.942 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 ' HB ' ' HG2' ' A' ' 62' ' ' GLU . 1.2 t -42.68 -27.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 O-C-N 128.564 3.665 . . . . 0.0 113.338 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 30.9 t0 -72.99 0.55 10.99 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 128.787 3.804 . . . . 0.0 112.5 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER 102.09 12.0 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.284 1 O-C-N 132.772 6.295 . . . . 0.0 115.671 -179.489 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 80' ' ' ARG . . . -78.03 -39.69 23.04 Favored Glycine 0 CA--C 1.559 2.788 2 C-N-CA 111.27 -5.252 . . . . 0.0 100.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 2.1 tttt 83.86 -178.95 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.655 2 O-C-N 134.558 6.681 . . . . 0.0 115.534 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 79' ' ' LYS 0.257 1.4 mt-10 -38.23 135.92 0.68 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 132.448 6.092 . . . . 0.0 116.586 -178.434 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 39.75 2.59 Favored 'General case' 0 C--O 1.197 -1.696 1 O-C-N 130.816 5.073 . . . . 0.0 110.251 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.488 HG12 ' CG ' ' A' ' 77' ' ' LYS . 82.8 mt -64.15 149.54 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.445 2 N-CA-C 98.907 -4.479 . . . . 0.0 98.907 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.57 76.8 1.29 Allowed 'General case' 0 C--N 1.315 -0.914 1 O-C-N 134.545 7.403 . . . . 0.0 106.843 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.9 121.67 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 128.564 3.665 . . . . 0.0 102.305 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CD ' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -162.52 157.05 21.7 Favored 'General case' 0 C--O 1.192 -1.953 1 C-N-CA 110.343 -4.543 . . . . 0.0 113.483 -179.71 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -157.29 127.96 6.55 Favored 'General case' 0 C--O 1.209 -1.045 1 O-C-N 130.281 4.738 . . . . 0.0 103.663 179.819 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.432 HD11 ' HG ' ' A' ' 98' ' ' LEU . 1.5 mm -38.0 120.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 1 O-C-N 130.787 5.054 . . . . 0.0 111.793 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 -66.58 0.57 Allowed 'General case' 0 C--O 1.248 0.975 1 O-C-N 129.273 4.108 . . . . 0.0 114.584 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -128.93 -88.92 0.57 Allowed Glycine 0 CA--C 1.547 2.07 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -130.39 44.77 2.91 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 128.985 3.403 . . . . 0.0 106.401 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.2 172.06 7.6 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.462 4.226 . . . . 0.0 109.298 -179.653 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.559 ' CD2' ' CD ' ' A' ' 91' ' ' ARG . 1.9 mt -133.27 129.6 37.85 Favored 'General case' 0 C--O 1.205 -1.273 1 O-C-N 132.549 6.156 . . . . 0.0 112.16 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 34.4 mt -80.05 -82.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.932 2 O-C-N 129.796 4.435 . . . . 0.0 106.381 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 96.79 85.96 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 1 O-C-N 134.775 7.547 . . . . 0.0 105.026 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.414 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 4.6 m -82.57 92.26 7.08 Favored 'General case' 0 C--O 1.197 -1.688 2 O-C-N 131.18 5.3 . . . . 0.0 111.7 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.54 126.5 29.86 Favored 'General case' 0 C--O 1.207 -1.138 2 C-N-CA 110.484 -4.486 . . . . 0.0 106.158 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.9 m -101.08 87.01 3.15 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-O 127.62 3.581 . . . . 0.0 101.716 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -109.85 128.17 55.16 Favored 'General case' 0 C--N 1.359 1.001 1 CA-C-N 107.485 -4.416 . . . . 0.0 115.877 -179.978 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 30.3 mt-10 50.41 20.75 0.72 Allowed 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 120.058 -1.651 . . . . 0.0 114.951 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.1 -9.33 54.49 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 117.925 -2.083 . . . . 0.0 114.739 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.85 113.5 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.04 91.37 3.09 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.473 . . -125.77 122.54 36.52 Favored 'General case' 0 N--CA 1.414 -2.262 0 O-C-N 126.704 2.503 . . . . 0.0 116.25 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 22.9 mtmt -98.0 163.41 12.78 Favored 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 134.902 7.626 . . . . 0.0 108.893 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -107.85 -47.27 3.62 Favored 'General case' 0 CA--C 1.555 1.173 1 O-C-N 130.806 5.066 . . . . 0.0 105.276 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.302 11.6 mt 88.3 103.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 1 O-C-N 130.83 5.081 . . . . 0.0 109.283 179.992 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.537 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 16.8 m-85 -136.07 179.72 6.18 Favored 'General case' 0 N--CA 1.427 -1.601 1 O-C-N 132.695 6.247 . . . . 0.0 107.216 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -148.23 -152.48 0.44 Allowed 'General case' 0 C--O 1.203 -1.394 1 O-C-N 131.749 5.655 . . . . 0.0 112.369 179.125 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.6 tttt -115.55 -162.08 0.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 126.811 2.044 . . . . 0.0 111.575 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.431 -1.412 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.705 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -132.53 47.79 2.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.1 -171.68 38.67 Favored Glycine 0 N--CA 1.482 1.707 1 C-N-CA 110.731 -5.509 . . . . 0.0 105.446 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.371 4.4 p -82.85 -174.53 5.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 112.843 -3.543 . . . . 0.0 104.286 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.561 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.27 59.5 m95 -162.0 128.77 3.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 112.625 -3.56 . . . . 0.0 113.475 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.61 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 23.1 mtmt 73.91 177.4 0.24 Allowed 'General case' 0 C--O 1.193 -1.885 0 O-C-N 126.957 2.66 . . . . 0.0 117.229 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.482 -1.638 3 O-C-N 136.592 8.682 . . . . 0.0 120.812 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.21 -1.001 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.435 0.0 OUTLIER -152.83 142.66 22.07 Favored 'General case' 0 CA--C 1.565 1.556 1 O-C-N 129.226 4.079 . . . . 0.0 100.398 179.755 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.434 ' N ' ' HE2' ' A' ' 7' ' ' LYS . 7.5 mt -101.16 175.97 5.41 Favored 'General case' 0 C--N 1.311 -1.107 2 O-C-N 132.704 6.252 . . . . 0.0 97.859 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.584 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 m 164.38 76.7 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 1 CA-C-O 128.53 4.014 . . . . 0.0 102.223 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.456 HG23 ' CE2' ' A' ' 32' ' ' PHE . 3.3 mp -99.55 150.22 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 109.489 -3.505 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m -170.79 75.62 0.07 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 113.531 -3.267 . . . . 0.0 102.669 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 2.7 pm0 -51.67 141.42 16.67 Favored 'General case' 0 C--O 1.212 -0.903 1 O-C-N 130.318 4.761 . . . . 0.0 115.862 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.2 pm0 -116.57 103.9 10.87 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 128.857 3.848 . . . . 0.0 103.17 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.61 -121.48 6.05 Favored Glycine 0 N--CA 1.482 1.738 2 N-CA-C 100.747 -4.941 . . . . 0.0 100.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 19.3 m120 -110.49 3.65 19.76 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 114.431 -2.699 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 16.9 mttt -81.36 141.14 34.28 Favored 'General case' 0 CA--C 1.544 0.718 1 N-CA-C 97.421 -5.029 . . . . 0.0 97.421 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.456 ' CE2' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -148.93 101.2 3.15 Favored 'General case' 0 C--O 1.194 -1.856 1 N-CA-C 96.048 -5.538 . . . . 0.0 96.048 -179.683 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.14 143.87 30.73 Favored 'General case' 0 N--CA 1.454 -0.264 3 O-C-N 134.461 7.351 . . . . 0.0 101.956 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.333 1.3 t -111.75 149.5 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 2 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 179.718 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.584 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 3.0 tttm -87.32 45.02 1.23 Allowed 'General case' 0 C--O 1.195 -1.778 0 CA-C-O 126.585 3.088 . . . . 0.0 116.394 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 1.3 mm-40 -59.77 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.479 -2.146 . . . . 0.0 109.736 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 35' ' ' LYS . 4.3 t -97.2 117.65 31.87 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.485 2.366 . . . . 0.0 112.319 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.01 -156.45 0.57 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -78.4 -43.46 27.38 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 126.738 2.524 . . . . 0.0 108.763 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -45.58 -65.34 0.55 Allowed 'General case' 0 C--O 1.209 -1.04 1 O-C-N 132.341 6.026 . . . . 0.0 109.145 179.722 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -163.2 -163.39 0.84 Allowed 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 126.9 2.625 . . . . 0.0 111.135 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.426 ' C ' HG21 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.03 -16.08 57.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 114.546 -2.861 . . . . 0.0 104.748 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 42' ' ' ASN 0.259 0.1 OUTLIER 11.59 68.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.335 3 O-C-N 133.146 6.529 . . . . 0.0 111.575 179.279 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 150.33 28.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.454 -3.521 . . . . 0.0 108.473 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG22 ' CZ ' ' A' ' 78' ' ' PHE . 9.3 p -105.02 115.06 46.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.08 1 O-C-N 130.889 5.118 . . . . 0.0 104.126 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 47' ' ' PHE 0.256 9.7 p -131.05 161.65 40.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 C-N-CA 113.816 -3.154 . . . . 0.0 114.718 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 46' ' ' VAL . 2.9 p90 177.09 -168.82 0.06 Allowed 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 109.35 -3.568 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.252 0.9 OUTLIER -126.18 82.75 2.1 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 128.704 3.752 . . . . 0.0 115.029 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 68' ' ' THR . 4.8 tp -0.83 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 1 O-C-N 133.614 6.821 . . . . 0.0 116.344 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.4 36.14 5.23 Favored Glycine 0 C--O 1.204 -1.776 0 N-CA-C 104.048 -3.621 . . . . 0.0 104.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.81 114.71 22.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 1 O-C-N 130.486 4.286 . . . . 0.0 116.788 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.86 159.25 21.39 Favored 'General case' 0 CA--C 1.556 1.21 1 O-C-N 130.235 4.709 . . . . 0.0 107.882 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -172.83 164.4 5.15 Favored 'General case' 0 N--CA 1.439 -1.007 1 C-N-CA 111.318 -4.153 . . . . 0.0 113.271 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -127.9 80.88 1.99 Allowed 'General case' 0 CA--C 1.563 1.448 1 N-CA-C 100.149 -4.019 . . . . 0.0 100.149 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -102.48 126.19 49.44 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 127.976 3.297 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 t -78.9 171.45 15.17 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 112.209 -3.796 . . . . 0.0 106.643 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.12 179.55 8.18 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 127.27 2.856 . . . . 0.0 109.514 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB1' ' CG2' ' A' ' 61' ' ' THR . . . 39.48 -98.97 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 O-C-N 128.527 3.642 . . . . 0.0 112.302 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.25 27.37 3.47 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 124.272 0.982 . . . . 0.0 112.87 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.24 71.07 0.29 Allowed Glycine 0 C--N 1.361 1.92 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.466 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 25.8 p -104.83 -47.84 3.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.326 1.45 . . . . 0.0 108.559 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.94 58.1 4.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 126.434 2.334 . . . . 0.0 109.743 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' CD1' ' HB ' ' A' ' 61' ' ' THR . 5.8 mp -84.26 76.06 10.14 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.466 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 68.8 m -52.07 119.63 4.54 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.69 -158.16 7.46 Favored Glycine 0 C--O 1.205 -1.671 1 C-N-CA 111.422 -5.18 . . . . 0.0 109.066 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.623 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.296 0.6 OUTLIER 172.78 124.12 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.886 2 O-C-N 132.5 5.471 . . . . 0.0 113.878 -178.413 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 68.2 m95 -133.83 134.1 42.41 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 119.494 -2.004 . . . . 0.0 106.635 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.429 ' HA ' HD13 ' A' ' 49' ' ' LEU . 2.3 p -118.27 36.33 4.41 Favored 'General case' 0 N--CA 1.424 -1.751 2 O-C-N 131.245 5.341 . . . . 0.0 116.677 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.411 ' N ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -8.17 87.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 1 O-C-N 136.392 8.557 . . . . 0.0 109.145 -179.988 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.51 -168.05 1.58 Allowed 'General case' 0 C--N 1.356 0.885 1 CA-C-N 108.22 -4.082 . . . . 0.0 109.613 -179.499 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.11 92.45 0.14 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 116.894 -2.574 . . . . 0.0 110.734 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.41 ' HB3' HG23 ' A' ' 93' ' ' ILE . 28.3 m120 54.42 44.09 29.4 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.074 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 11.8 mtpt -132.42 173.64 11.08 Favored 'General case' 0 C--N 1.347 0.477 1 O-C-N 129.989 4.556 . . . . 0.0 108.576 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -148.81 58.26 1.05 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 128.245 3.466 . . . . 0.0 111.567 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.38 78.68 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.934 2 CA-C-O 129.475 4.464 . . . . 0.0 112.091 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.488 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -148.92 -167.32 13.74 Favored Glycine 0 CA--C 1.554 2.518 1 CA-C-N 106.304 -4.953 . . . . 0.0 104.35 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.547 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.265 0.7 OUTLIER -163.22 171.46 16.21 Favored 'General case' 0 C--N 1.37 1.477 2 O-C-N 131.483 4.873 . . . . 0.0 112.584 179.964 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 42.7 m-85 -149.72 151.88 34.38 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-O 127.738 3.637 . . . . 0.0 101.98 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.29 0.0 OUTLIER -169.04 127.01 0.99 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 109.81 -3.359 . . . . 0.0 117.668 -179.75 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HG3' ' HG2' ' A' ' 85' ' ' LYS . 69.7 mtt180 -76.6 113.02 13.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 126.588 2.43 . . . . 0.0 108.586 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.14 -24.94 25.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 1 O-C-N 131.478 5.486 . . . . 0.0 108.594 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -45.7 -51.65 12.12 Favored 'General case' 0 C--O 1.249 1.077 1 O-C-N 129.622 4.327 . . . . 0.0 112.294 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -141.93 3.97 1.65 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 113.496 -3.282 . . . . 0.0 117.621 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.481 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 98.01 36.3 4.77 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HE3' ' CZ ' ' A' ' 104' ' ' TYR . 3.2 tptm -70.96 -64.7 0.85 Allowed 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 120.131 3.382 . . . . 0.0 120.131 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 25.7 mt-10 71.14 87.99 0.11 Allowed 'General case' 0 C--O 1.199 -1.554 1 O-C-N 129.618 4.324 . . . . 0.0 110.926 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -110.94 48.41 0.93 Allowed 'General case' 0 C--O 1.193 -1.893 1 O-C-N 132.349 6.031 . . . . 0.0 109.281 179.483 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.416 ' CG2' HG22 ' A' ' 90' ' ' VAL 0.268 98.4 mt -65.2 164.32 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.58 0 CA-C-N 108.582 -3.917 . . . . 0.0 105.675 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.5 71.95 1.39 Allowed 'General case' 0 C--O 1.201 -1.476 1 O-C-N 133.763 6.914 . . . . 0.0 105.309 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.416 HG22 ' CG2' ' A' ' 88' ' ' ILE . 76.6 t -76.23 115.62 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 1 O-C-N 132.038 5.836 . . . . 0.0 105.614 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.454 ' CD ' ' HB ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -169.49 165.91 10.32 Favored 'General case' 0 C--O 1.187 -2.204 0 C-N-CA 114.669 -2.812 . . . . 0.0 114.714 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -156.91 118.84 3.84 Favored 'General case' 0 C--O 1.21 -1.005 1 O-C-N 130.479 4.862 . . . . 0.0 107.026 179.669 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.56 ' CD1' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -42.61 144.99 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.54 1 O-C-N 133.013 6.445 . . . . 0.0 113.577 179.876 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 t -150.89 123.01 8.25 Favored 'General case' 0 CA--C 1.506 -0.717 1 O-C-N 129.75 4.406 . . . . 0.0 115.996 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.57 13.86 74.85 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 t30 57.47 58.73 3.64 Favored 'General case' 0 CA--C 1.563 1.476 1 O-C-N 131.884 5.108 . . . . 0.0 104.603 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.665 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.323 0.4 OUTLIER -178.41 100.21 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.588 1 O-C-N 132.116 5.885 . . . . 0.0 108.66 179.204 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.6 151.78 43.8 Favored 'General case' 0 N--CA 1.423 -1.783 1 O-C-N 130.423 4.827 . . . . 0.0 114.978 179.872 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' ' CD ' ' A' ' 91' ' ' ARG . 26.9 mt -106.69 -106.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.337 3 O-C-N 133.447 6.717 . . . . 0.0 107.922 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 116.21 93.17 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.519 2 O-C-N 135.261 7.85 . . . . 0.0 98.348 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 1.3 m -72.39 -29.77 64.05 Favored 'General case' 0 N--CA 1.42 -1.944 1 O-C-N 133.333 6.646 . . . . 0.0 119.69 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 62.05 76.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 128.626 3.704 . . . . 0.0 105.74 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.6 m -76.35 78.4 3.1 Favored 'General case' 0 C--O 1.204 -1.325 0 O-C-N 128.439 3.587 . . . . 0.0 105.956 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.441 ' CZ ' ' HE3' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -104.6 118.02 35.56 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 109.773 -3.376 . . . . 0.0 112.936 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 17.71 63.07 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.19 6.61 61.45 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 117.552 -2.261 . . . . 0.0 116.216 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.83 110.4 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.27 78.74 7.22 Favored 'General case' 0 C--N 1.363 1.173 0 O-C-N 128.246 3.466 . . . . 0.0 105.125 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.416 . . -86.57 86.2 7.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.319 2.887 . . . . 0.0 116.275 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 5.6 mtmp? -90.61 148.58 22.57 Favored 'General case' 0 N--CA 1.425 -1.683 1 O-C-N 130.042 4.589 . . . . 0.0 108.879 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -147.6 111.04 4.93 Favored 'General case' 0 CA--C 1.558 1.275 1 O-C-N 130.544 4.902 . . . . 0.0 101.31 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.55 128.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 1 O-C-N 130.908 5.13 . . . . 0.0 111.595 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.61 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 m-85 -131.22 -154.77 0.65 Allowed 'General case' 0 C--N 1.318 -0.776 1 O-C-N 131.727 5.642 . . . . 0.0 104.865 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.665 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.31 -138.0 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.595 1 O-C-N 131.336 5.398 . . . . 0.0 113.4 -177.627 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.1 tttt -137.34 158.53 44.22 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.417 -2.105 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.361 179.656 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.457 ' CZ ' HD12 ' A' ' 93' ' ' ILE . 9.9 m-85 . . . . . 0 CA--C 1.561 1.365 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -33.86 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.996 1 O-C-N 130.716 5.01 . . . . 0.0 118.465 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.24 27.09 0.03 OUTLIER Glycine 0 C--N 1.353 1.48 2 C-N-CA 110.485 -5.626 . . . . 0.0 109.683 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.26 157.21 0.16 Allowed 'General case' 0 C--O 1.248 0.983 0 O-C-N 127.696 2.645 . . . . 0.0 110.028 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 23' ' ' LEU 0.3 21.0 m95 -156.16 169.83 23.6 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 111.967 -3.873 . . . . 0.0 112.063 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.509 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 4.4 mtmt 44.72 -179.63 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.789 1 O-C-N 133.555 6.784 . . . . 0.0 118.34 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.271 0.4 OUTLIER . . . . . 0 CA--C 1.481 -1.706 3 CA-C-O 135.05 7.119 . . . . 0.0 120.848 174.852 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.381 0.0 OUTLIER -178.45 178.85 0.82 Allowed 'General case' 0 C--O 1.198 -1.653 1 O-C-N 132.456 6.097 . . . . 0.0 103.386 179.848 . . . . . . . . 5 4 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 4.0 mt -136.46 166.02 24.47 Favored 'General case' 0 CA--C 1.563 1.446 2 O-C-N 130.74 5.025 . . . . 0.0 97.504 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.474 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 86.3 m 175.67 73.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 1 O-C-N 129.715 4.385 . . . . 0.0 107.277 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 23' ' ' LEU . 3.7 mp -86.18 144.88 8.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 113.876 -3.13 . . . . 0.0 109.248 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.7 m -162.75 79.41 0.49 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 116.43 -2.108 . . . . 0.0 105.97 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -53.57 154.63 3.49 Favored 'General case' 0 N--CA 1.441 -0.892 2 O-C-N 132.031 5.832 . . . . 0.0 114.711 179.881 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -124.82 81.85 1.99 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.24 -87.45 1.56 Allowed Glycine 0 CA--C 1.558 2.766 1 N-CA-C 103.086 -4.006 . . . . 0.0 103.086 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -128.27 3.06 5.74 Favored 'General case' 0 N--CA 1.409 -2.506 2 O-C-N 133.212 5.889 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -79.79 160.3 26.21 Favored 'General case' 0 C--N 1.326 -0.432 2 N-CA-C 98.922 -4.473 . . . . 0.0 98.922 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -170.68 86.52 0.11 Allowed 'General case' 0 C--O 1.201 -1.465 2 N-CA-C 96.418 -5.401 . . . . 0.0 96.418 179.862 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.39 129.85 42.4 Favored 'General case' 0 CA--C 1.507 -0.702 2 O-C-N 132.829 6.331 . . . . 0.0 103.279 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 32' ' ' PHE 0.323 69.3 t -102.29 134.32 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 1 N-CA-C 99.325 -4.324 . . . . 0.0 99.325 179.61 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -81.68 63.04 5.78 Favored 'General case' 0 CA--C 1.49 -1.361 1 CA-C-O 132.495 5.903 . . . . 0.0 116.233 -179.748 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.291 4.8 mt-10 -80.52 71.41 7.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 O-C-N 117.032 -3.543 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 m -77.31 126.48 30.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 112.454 -3.698 . . . . 0.0 107.058 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 -165.92 0.33 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 116.075 -2.25 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 69.38 -96.03 0.03 OUTLIER 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.031 0.832 . . . . 0.0 111.415 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -141.26 20.28 2.25 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 127.228 2.83 . . . . 0.0 111.468 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -176.71 -176.55 0.72 Allowed 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 127.595 3.06 . . . . 0.0 111.38 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 122.47 36.79 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.335 0.7 OUTLIER -140.98 146.48 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 2 O-C-N 131.091 5.244 . . . . 0.0 105.204 -179.32 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -116.66 173.62 6.52 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 110.26 -3.155 . . . . 0.0 108.571 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.19 91.41 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.328 1 O-C-N 131.561 5.538 . . . . 0.0 101.115 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -103.38 158.0 5.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 1 O-C-N 130.722 5.014 . . . . 0.0 112.685 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.0 p90 169.23 -158.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.738 1 O-C-N 133.462 6.726 . . . . 0.0 111.006 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 51' ' ' VAL . 23.7 mt-10 -138.05 83.74 1.99 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 116.118 -2.233 . . . . 0.0 114.034 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 32' ' ' PHE . 1.5 mp 43.44 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 1 O-C-N 130.96 5.163 . . . . 0.0 116.08 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 68' ' ' THR . . . -92.27 71.72 1.61 Allowed Glycine 0 C--O 1.203 -1.843 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 48' ' ' GLU . 74.5 t -144.84 92.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 1 O-C-N 131.182 4.695 . . . . 0.0 112.363 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.32 147.17 34.35 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 113.531 -3.268 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -154.42 161.07 41.91 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 132.392 6.058 . . . . 0.0 115.896 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.71 109.79 20.18 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -179.78 4.54 Favored 'General case' 0 CA--C 1.509 -0.604 1 O-C-N 130.095 4.622 . . . . 0.0 110.294 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.88 99.05 3.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 114.542 -2.863 . . . . 0.0 105.311 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.47 -74.02 0.05 Allowed 'General case' 0 C--O 1.247 0.936 0 O-C-N 126.769 2.543 . . . . 0.0 114.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 18.06 3.16 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 126.358 2.286 . . . . 0.0 115.232 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 73.3 0.49 3.68 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 126.417 2.323 . . . . 0.0 114.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.86 25.18 2.26 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 128.566 3.666 . . . . 0.0 108.161 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 p -118.37 170.87 8.56 Favored 'General case' 0 C--O 1.218 -0.567 1 O-C-N 130.479 4.282 . . . . 0.0 110.173 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -157.38 38.53 0.29 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 113.861 -3.136 . . . . 0.0 106.989 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.0 98.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 108.736 -3.847 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -99.53 101.6 12.88 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.227 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -168.21 -168.12 29.85 Favored Glycine 0 CA--C 1.541 1.702 1 C-N-CA 112.4 -4.714 . . . . 0.0 106.885 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.25 147.62 43.88 Favored 'General case' 0 CA--C 1.499 -0.998 1 O-C-N 133.709 6.182 . . . . 0.0 113.286 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.62 ' NE1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 m95 -124.97 104.87 8.81 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 50' ' ' GLY . 21.0 p -101.79 73.44 1.42 Allowed 'General case' 0 C--O 1.2 -1.548 1 O-C-N 134.437 7.335 . . . . 0.0 116.008 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.17 98.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 2 O-C-N 132.406 6.066 . . . . 0.0 103.813 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.11 -22.51 28.85 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 117.361 -1.736 . . . . 0.0 110.688 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.81 101.73 0.7 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 104.524 -3.43 . . . . 0.0 104.524 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 61.16 26.9 16.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 110.911 -2.645 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -133.76 -170.7 2.55 Favored 'General case' 0 C--N 1.358 0.951 1 O-C-N 130.606 4.941 . . . . 0.0 111.393 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -165.76 39.17 0.06 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 114.682 -2.807 . . . . 0.0 112.683 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 76' ' ' GLY . 48.7 t -69.98 146.66 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 110.228 -3.169 . . . . 0.0 116.002 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' N ' HG11 ' A' ' 75' ' ' VAL . . . 151.17 -145.68 13.78 Favored Glycine 0 CA--C 1.559 2.813 1 N-CA-C 100.008 -5.237 . . . . 0.0 100.008 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.49 ' CB ' HG12 ' A' ' 88' ' ' ILE . 9.4 tttm 171.05 123.04 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 134.861 6.859 . . . . 0.0 114.049 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CZ ' ' NE1' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -113.04 166.53 11.33 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.276 16.1 ttmt -162.84 149.95 13.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 109.666 -3.425 . . . . 0.0 113.41 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.464 ' CD ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -98.98 72.48 1.91 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 117.242 -1.783 . . . . 0.0 106.306 178.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.435 HG13 ' N ' ' A' ' 82' ' ' ASP . 1.4 t -29.74 -52.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 O-C-N 130.74 5.025 . . . . 0.0 115.351 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' N ' HG13 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -52.66 -31.07 35.26 Favored 'General case' 0 N--CA 1.435 -1.197 1 O-C-N 129.322 4.139 . . . . 0.0 112.516 -179.219 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.63 -3.31 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.243 4.09 . . . . 0.0 115.479 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' CD ' ' A' ' 80' ' ' ARG . . . -91.0 -30.02 11.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 104.229 -3.548 . . . . 0.0 104.229 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER 76.62 -169.69 0.07 Allowed 'General case' 0 N--CA 1.425 -1.686 1 O-C-N 132.377 5.398 . . . . 0.0 118.455 179.667 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 2.0 mp0 -45.45 139.27 3.8 Favored 'General case' 0 N--CA 1.429 -1.525 1 O-C-N 132.627 6.205 . . . . 0.0 116.111 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD13 ' CD ' ' A' ' 80' ' ' ARG . 30.3 mt -148.16 47.43 1.06 Allowed 'General case' 0 C--O 1.201 -1.487 1 O-C-N 137.151 9.032 . . . . 0.0 109.806 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.49 HG12 ' CB ' ' A' ' 77' ' ' LYS . 89.5 mt -64.72 172.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.123 1 CA-C-N 108.342 -4.027 . . . . 0.0 104.097 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.1 66.71 1.49 Allowed 'General case' 0 C--O 1.205 -1.265 1 O-C-N 130.824 5.077 . . . . 0.0 107.903 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.16 110.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 1 O-C-N 131.137 5.273 . . . . 0.0 102.129 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 1.1 tpm_? -164.5 156.41 16.11 Favored 'General case' 0 C--O 1.188 -2.161 1 C-N-CA 111.219 -4.192 . . . . 0.0 113.182 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 4.2 pt-20 -158.79 134.91 9.07 Favored 'General case' 0 N--CA 1.424 -1.728 2 O-C-N 129.975 4.547 . . . . 0.0 105.149 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.457 HD12 ' CZ ' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -39.75 106.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.844 1 O-C-N 132.876 6.36 . . . . 0.0 111.01 179.89 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.11 67.11 Favored 'General case' 0 C--O 1.241 0.625 1 O-C-N 129.255 4.097 . . . . 0.0 114.355 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.46 96.23 0.1 Allowed Glycine 0 CA--C 1.545 1.964 0 C-N-CA 116.181 -2.914 . . . . 0.0 106.961 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 58.05 37.13 26.51 Favored 'General case' 0 N--CA 1.437 -1.121 2 CA-C-N 107.063 -4.569 . . . . 0.0 109.495 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.304 0.0 OUTLIER 179.44 179.46 0.47 Allowed 'General case' 0 CA--C 1.564 1.499 0 O-C-N 128.047 3.342 . . . . 0.0 106.579 179.403 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 ' CD2' ' CG ' ' A' ' 100' ' ' GLN . 8.1 tt -140.54 130.78 25.02 Favored 'General case' 0 C--O 1.211 -0.963 2 O-C-N 134.646 7.466 . . . . 0.0 109.349 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 112' ' ' ILE . 66.7 mt -76.13 -101.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.417 -2.111 1 O-C-N 130.046 4.591 . . . . 0.0 102.717 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.472 ' CG ' ' CD2' ' A' ' 98' ' ' LEU . 6.8 mt-30 130.34 75.1 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.486 1 O-C-N 131.801 5.688 . . . . 0.0 102.043 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m -81.27 93.34 6.51 Favored 'General case' 0 N--CA 1.428 -1.557 1 O-C-N 131.067 5.23 . . . . 0.0 112.006 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.37 125.1 25.39 Favored 'General case' 0 C--O 1.201 -1.465 2 CA-C-N 106.82 -4.718 . . . . 0.0 105.283 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.41 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 m -101.76 76.99 1.69 Allowed 'General case' 0 C--O 1.206 -1.236 1 O-C-N 130.613 4.945 . . . . 0.0 101.747 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.33 109.16 21.34 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 108.702 -3.863 . . . . 0.0 115.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 48.88 37.0 9.12 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.548 -2.114 . . . . 0.0 113.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.65 -12.39 61.21 Favored Glycine 0 C--N 1.346 1.094 1 C-N-CA 113.762 -4.066 . . . . 0.0 113.942 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.47 131.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 117.539 -1.22 . . . . 0.0 112.958 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -90.81 71.92 6.61 Favored 'General case' 0 C--N 1.358 0.936 1 O-C-N 129.359 4.162 . . . . 0.0 107.96 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.395 . . -89.97 103.84 16.46 Favored 'General case' 0 C--O 1.196 -1.723 0 C-N-CA 112.839 -3.545 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 145.14 30.93 Favored 'General case' 0 N--CA 1.417 -2.086 1 O-C-N 133.031 6.457 . . . . 0.0 110.475 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -128.7 119.25 24.28 Favored 'General case' 0 CA--C 1.559 1.311 2 O-C-N 132.029 5.83 . . . . 0.0 99.296 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 10.2 pt -79.22 137.08 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 1 O-C-N 130.11 4.631 . . . . 0.0 113.378 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 12.6 m-30 -125.68 -177.87 4.06 Favored 'General case' 0 N--CA 1.435 -1.196 2 O-C-N 135.94 8.275 . . . . 0.0 106.402 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.94 127.0 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.233 2 CA-C-O 131.872 5.606 . . . . 0.0 113.329 -179.405 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 10.2 ttmt -41.34 -62.92 0.77 Allowed 'General case' 0 C--O 1.203 -1.381 0 CA-C-O 128.166 3.841 . . . . 0.0 117.193 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.366 1.319 0 CA-C-N 109.363 -3.562 . . . . 0.0 113.171 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.43 98.24 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 O-C-N 127.61 3.069 . . . . 0.0 116.513 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 153.58 6.66 Favored Glycine 0 N--CA 1.464 0.52 0 C-N-CA 114.594 -3.67 . . . . 0.0 104.417 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' CG2' HG22 ' A' ' 24' ' ' THR . 10.8 p -66.11 167.94 9.22 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 114.923 -2.711 . . . . 0.0 108.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.281 35.7 m95 -142.68 149.07 38.37 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 115.471 -2.204 . . . . 0.0 112.724 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 8.5 mtmt 56.7 -179.33 0.05 OUTLIER 'General case' 0 C--O 1.197 -1.663 1 O-C-N 129.488 4.242 . . . . 0.0 117.269 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.265 1.0 OUTLIER . . . . . 0 CA--C 1.485 -1.534 3 O-C-N 135.793 8.183 . . . . 0.0 120.086 174.769 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.371 0.0 OUTLIER -179.24 123.49 0.08 Allowed 'General case' 0 C--O 1.195 -1.787 0 O-C-N 128.878 3.861 . . . . 0.0 105.529 179.956 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' TRP . 8.8 mt -87.91 162.0 17.15 Favored 'General case' 0 CA--C 1.552 1.036 2 O-C-N 129.862 4.476 . . . . 0.0 101.654 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.499 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 87.7 m -178.53 64.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.195 1 O-C-N 130.117 4.636 . . . . 0.0 105.439 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.473 ' CG2' ' HB3' ' A' ' 32' ' ' PHE . 3.4 mp -82.48 146.45 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 113.339 -3.344 . . . . 0.0 109.209 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -172.37 79.18 0.05 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 113.546 -3.261 . . . . 0.0 103.273 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.511 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -31.0 139.51 0.03 OUTLIER 'General case' 0 C--O 1.208 -1.099 2 O-C-N 134.834 7.584 . . . . 0.0 116.742 179.734 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -104.18 -99.61 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 128.815 3.822 . . . . 0.0 104.177 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.07 80.99 0.36 Allowed Glycine 0 CA--C 1.564 3.123 1 N-CA-C 99.699 -5.361 . . . . 0.0 99.699 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 68.66 28.33 5.71 Favored 'General case' 0 N--CA 1.433 -1.295 2 O-C-N 131.875 5.103 . . . . 0.0 106.646 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.5 ttpp -131.91 110.1 10.55 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 128.925 3.89 . . . . 0.0 101.315 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -101.36 166.37 10.78 Favored 'General case' 0 C--O 1.197 -1.687 2 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 -179.434 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 98.17 4.38 Favored 'General case' 0 N--CA 1.478 0.96 3 O-C-N 137.692 9.37 . . . . 0.0 97.356 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.409 0.9 OUTLIER -72.42 127.33 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 2 C-N-CA 109.643 -4.823 . . . . 0.0 98.984 179.705 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.429 25.1 tttt -76.18 8.43 3.3 Favored 'General case' 0 C--N 1.368 1.387 0 CA-C-N 109.978 -3.283 . . . . 0.0 119.581 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.421 2.6 mt-10 -47.76 106.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 111.038 -2.801 . . . . 0.0 103.502 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 p -138.36 145.84 41.57 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 128.282 3.489 . . . . 0.0 106.57 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.3 p -140.28 -175.25 4.19 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 116.217 -2.193 . . . . 0.0 112.373 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -15.98 60.81 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 127.408 2.943 . . . . 0.0 105.02 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -97.26 -109.8 0.16 Allowed 'General case' 0 N--CA 1.435 -1.215 1 CA-C-N 108.194 -4.093 . . . . 0.0 108.934 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HG2' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -135.75 44.97 2.46 Favored 'General case' 0 CA--C 1.496 -1.114 1 O-C-N 129.161 4.038 . . . . 0.0 117.785 -179.076 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -72.62 -35.68 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' HD22 ' A' ' 57' ' ' LEU 0.267 5.1 tt 11.96 60.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 2 O-C-N 133.944 7.027 . . . . 0.0 112.036 178.318 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.93 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.831 -2.44 . . . . 0.0 111.436 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.31 50.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 47' ' ' PHE 0.275 3.0 p -61.53 167.22 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 O-C-N 129.065 3.978 . . . . 0.0 112.782 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -166.44 -157.1 0.26 Allowed 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.926 3.891 . . . . 0.0 111.064 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 1.2 mt-10 -138.42 52.79 1.81 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 126.472 2.357 . . . . 0.0 114.802 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.462 HD21 ' CE1' ' A' ' 32' ' ' PHE . 2.3 tp 18.11 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.533 1 CA-C-O 130.004 4.716 . . . . 0.0 117.461 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.32 51.4 8.62 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 103.375 -3.89 . . . . 0.0 103.375 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.52 121.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 1 O-C-N 134.53 6.664 . . . . 0.0 115.177 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.54 16.22 Favored 'General case' 0 C--O 1.21 -1.002 1 O-C-N 131.58 5.55 . . . . 0.0 110.167 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 9.5 p90 -176.99 169.47 2.37 Favored 'General case' 0 N--CA 1.421 -1.879 0 O-C-N 128.554 3.659 . . . . 0.0 114.457 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 136.67 52.77 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.23 101.62 4.06 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 128.923 3.889 . . . . 0.0 113.409 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 t -69.92 155.98 39.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 113.296 -3.361 . . . . 0.0 102.844 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' A' ' 43' ' ' ILE . 5.5 tp -147.21 -92.66 0.09 Allowed 'General case' 0 C--O 1.245 0.85 1 O-C-N 129.269 4.106 . . . . 0.0 110.745 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' CB ' ' HG2' ' A' ' 41' ' ' ARG . . . -60.06 -5.45 1.03 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 112.921 -3.418 . . . . 0.0 115.999 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t70 106.49 -15.65 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.595 1 O-C-N 129.531 4.269 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.11 -55.6 0.26 Allowed Glycine 0 CA--C 1.558 2.74 0 N-CA-C 104.202 -3.559 . . . . 0.0 104.202 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 p -39.56 137.87 0.78 Allowed 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 128.968 3.393 . . . . 0.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.94 37.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 114.551 -2.86 . . . . 0.0 109.023 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 mp -42.02 97.91 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.687 1 O-C-N 130.658 4.974 . . . . 0.0 112.225 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.4 m -93.84 99.39 11.77 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 111.602 -2.544 . . . . 0.0 106.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.69 -175.71 34.0 Favored Glycine 0 C--O 1.201 -1.937 1 C-N-CA 111.617 -5.087 . . . . 0.0 108.556 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 t -140.85 143.81 34.97 Favored 'General case' 0 CA--C 1.5 -0.978 2 O-C-N 132.509 5.476 . . . . 0.0 111.883 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.616 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.3 m95 -124.25 111.64 16.08 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -99.98 41.88 1.14 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 135.485 7.991 . . . . 0.0 113.613 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -37.52 107.43 0.06 Allowed 'General case' 0 C--N 1.317 -0.806 1 O-C-N 134.434 7.334 . . . . 0.0 107.917 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -82.99 -74.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.305 0 O-C-N 129.055 3.972 . . . . 0.0 108.525 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.56 -79.85 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.117 1 O-C-N 129.435 4.21 . . . . 0.0 107.993 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.58 44.21 2.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 127.991 2.818 . . . . 0.0 108.865 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -141.08 178.73 7.18 Favored 'General case' 0 C--N 1.356 0.865 1 O-C-N 129.147 4.029 . . . . 0.0 112.451 -179.96 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.447 ' HB2' ' CB ' ' A' ' 91' ' ' ARG . 4.8 mt -148.28 91.87 1.96 Allowed 'General case' 0 C--N 1.321 -0.649 0 O-C-N 126.584 2.428 . . . . 0.0 110.596 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.28 119.68 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 O-C-N 128.321 3.513 . . . . 0.0 117.444 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.55 -141.33 5.82 Favored Glycine 0 CA--C 1.557 2.673 1 CA-C-N 108.082 -4.145 . . . . 0.0 103.772 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.474 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -178.79 131.68 0.12 Allowed 'General case' 0 C--O 1.204 -1.334 1 O-C-N 131.772 5.042 . . . . 0.0 113.966 -179.972 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.4 OUTLIER -127.13 167.9 15.38 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-O 127.417 3.484 . . . . 0.0 101.672 179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 6.8 ttmt -170.48 144.14 2.39 Favored 'General case' 0 N--CA 1.427 -1.617 1 CA-C-N 106.857 -4.702 . . . . 0.0 114.138 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 69.64 0.8 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 125.105 1.503 . . . . 0.0 107.175 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -31.64 -40.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.39 1 O-C-N 131.184 5.302 . . . . 0.0 115.472 -179.828 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 11.6 p-10 -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.442 -0.832 1 O-C-N 131.03 5.206 . . . . 0.0 112.549 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 172.08 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 O-C-N 128.903 3.877 . . . . 0.0 115.998 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.5 -34.38 6.08 Favored Glycine 0 CA--C 1.543 1.79 0 N-CA-C 104.092 -3.603 . . . . 0.0 104.092 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 78.0 -171.19 0.06 Allowed 'General case' 0 N--CA 1.436 -1.158 1 O-C-N 132.153 5.266 . . . . 0.0 117.272 -179.804 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 77.6 mt-10 -48.6 149.48 1.67 Allowed 'General case' 0 N--CA 1.432 -1.334 1 O-C-N 132.355 6.034 . . . . 0.0 113.456 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -158.18 35.38 0.24 Allowed 'General case' 0 C--O 1.196 -1.751 1 O-C-N 135.255 7.847 . . . . 0.0 109.343 178.772 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' THR 0.251 42.7 mt -50.28 127.49 6.1 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.639 1 O-C-N 132.98 6.425 . . . . 0.0 100.479 -179.794 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 67' ' ' TRP . . . -87.62 68.88 9.64 Favored 'General case' 0 C--O 1.205 -1.244 1 O-C-N 132.878 6.361 . . . . 0.0 110.958 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 t -66.92 108.36 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 1 C-N-CA 111.567 -4.053 . . . . 0.0 102.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.447 ' CB ' ' HB2' ' A' ' 74' ' ' LEU . 8.9 ttm180 -139.05 168.73 19.19 Favored 'General case' 0 C--O 1.195 -1.778 0 O-C-N 128.479 3.612 . . . . 0.0 111.674 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.12 94.09 0.05 Allowed 'General case' 0 C--N 1.363 1.184 2 O-C-N 132.458 6.099 . . . . 0.0 108.438 179.829 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.429 ' HB ' HD11 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -28.28 105.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.749 1 O-C-N 133.424 6.702 . . . . 0.0 112.115 -179.938 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.9 m -94.55 130.73 40.85 Favored 'General case' 0 N--CA 1.439 -0.976 1 O-C-N 129.117 4.01 . . . . 0.0 113.541 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.1 -116.27 7.07 Favored Glycine 0 CA--C 1.561 2.91 1 N-CA-C 100.653 -4.979 . . . . 0.0 100.653 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.69 57.69 1.05 Allowed 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 129.609 3.77 . . . . 0.0 107.999 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.269 0.0 OUTLIER 176.77 115.55 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.53 1 O-C-N 130.694 4.996 . . . . 0.0 107.312 179.375 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.429 HD11 ' HB ' ' A' ' 93' ' ' ILE . 1.5 tp -65.3 148.34 51.87 Favored 'General case' 0 N--CA 1.416 -2.158 2 O-C-N 133.366 6.667 . . . . 0.0 111.686 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.411 HG22 ' HD2' ' A' ' 110' ' ' LYS . 2.2 mt -130.27 128.92 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 3 O-C-N 131.6 5.563 . . . . 0.0 102.571 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HB3' ' NE ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.75 129.09 54.33 Favored 'General case' 0 C--O 1.21 -1.003 1 O-C-N 135.395 7.935 . . . . 0.0 101.796 179.891 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -82.34 -43.96 16.79 Favored 'General case' 0 N--CA 1.41 -2.467 2 O-C-N 131.184 5.303 . . . . 0.0 116.457 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 59.95 61.03 1.98 Allowed 'General case' 0 C--O 1.205 -1.281 1 O-C-N 129.331 4.144 . . . . 0.0 104.406 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' ILE . 54.7 m -55.2 101.85 0.06 Allowed 'General case' 0 N--CA 1.479 1.002 1 N-CA-C 100.119 -4.03 . . . . 0.0 100.119 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 113.1 20.86 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 109.165 -3.652 . . . . 0.0 110.561 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -4.79 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.92 -3.8 67.64 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 116.618 -2.706 . . . . 0.0 112.536 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 108' ' ' GLU . 1.4 t -162.56 154.12 3.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' N ' HG11 ' A' ' 107' ' ' VAL . 1.2 mt-10 -119.15 114.14 21.99 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 128.206 3.441 . . . . 0.0 102.334 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.378 . . -102.96 81.64 2.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 116.314 -2.155 . . . . 0.0 114.295 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HD2' HG22 ' A' ' 99' ' ' ILE . 1.6 mtmm -72.25 150.72 43.39 Favored 'General case' 0 N--CA 1.435 -1.18 1 O-C-N 129.993 4.558 . . . . 0.0 108.859 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -131.91 -164.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 1 O-C-N 131.381 5.426 . . . . 0.0 103.234 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -162.0 79.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.044 1 C-N-CA 111.45 -4.1 . . . . 0.0 109.85 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 41.6 m-85 -100.2 -145.08 0.34 Allowed 'General case' 0 C--N 1.319 -0.757 1 O-C-N 130.552 4.907 . . . . 0.0 105.704 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.47 -154.45 0.16 Allowed 'General case' 0 C--O 1.197 -1.699 1 O-C-N 131.979 5.799 . . . . 0.0 111.462 -179.856 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 21.5 tttt -115.21 -141.71 0.38 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 111.842 -2.436 . . . . 0.0 111.605 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.222 -179.512 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 98' ' ' LEU . 98.3 m-85 . . . . . 0 CA--C 1.554 1.133 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 24.4 p-10 -169.32 32.55 0.02 OUTLIER 'General case' 0 C--N 1.364 1.202 0 CA-C-N 110.137 -3.211 . . . . 0.0 115.914 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.53 159.62 21.18 Favored Glycine 0 C--N 1.346 1.105 1 C-N-CA 113.38 -4.248 . . . . 0.0 106.777 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.26 134.21 56.34 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 115.382 -2.527 . . . . 0.0 109.723 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.539 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.301 70.8 m95 -114.89 140.71 48.76 Favored 'General case' 0 N--CA 1.412 -2.342 1 CA-C-O 111.087 -4.292 . . . . 0.0 111.983 -179.807 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.612 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 11.4 mtmt 67.13 177.81 0.23 Allowed 'General case' 0 N--CA 1.424 -1.736 1 O-C-N 131.547 5.529 . . . . 0.0 118.164 176.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.486 -1.51 3 O-C-N 136.329 8.518 . . . . 0.0 120.802 174.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.437 0 CA-C-O 114.663 -2.589 . . . . 0.0 104.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.323 1.4 ptmt 163.52 150.39 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.466 1 O-C-N 134.967 7.667 . . . . 0.0 103.661 179.85 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 ' N ' ' HE2' ' A' ' 7' ' ' LYS . 2.9 mt -114.04 176.35 5.08 Favored 'General case' 0 CA--C 1.56 1.354 2 O-C-N 131.778 5.673 . . . . 0.0 98.486 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.477 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 77.8 m -162.03 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 128.729 3.768 . . . . 0.0 107.668 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.458 HG23 ' CE2' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 63.9 145.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-O 124.784 2.231 . . . . 0.0 115.947 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 169.27 67.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -26.15 124.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.28 2 O-C-N 135.804 8.19 . . . . 0.0 114.173 179.794 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -9.02 53.29 Favored 'General case' 0 N--CA 1.482 1.128 1 O-C-N 130.918 5.136 . . . . 0.0 106.371 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.87 -40.83 0.35 Allowed Glycine 0 CA--C 1.55 2.279 1 N-CA-C 102.171 -4.372 . . . . 0.0 102.171 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.79 -12.13 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.926 1 O-C-N 131.461 4.859 . . . . 0.0 112.817 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -78.95 120.21 23.22 Favored 'General case' 0 N--CA 1.48 1.062 1 N-CA-C 96.253 -5.462 . . . . 0.0 96.253 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -126.45 105.33 8.69 Favored 'General case' 0 C--O 1.208 -1.118 1 N-CA-C 98.73 -4.545 . . . . 0.0 98.73 -179.263 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.21 127.07 53.93 Favored 'General case' 0 CA--C 1.492 -1.267 2 O-C-N 135.603 8.064 . . . . 0.0 104.435 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 32' ' ' PHE 0.324 2.2 t -93.95 143.8 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-O 126.659 3.123 . . . . 0.0 103.248 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -86.59 70.03 10.4 Favored 'General case' 0 C--O 1.196 -1.718 2 CA-C-O 133.405 6.336 . . . . 0.0 112.902 179.114 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' CG ' HG13 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -78.34 44.8 0.52 Allowed 'General case' 0 N--CA 1.42 -1.95 1 CA-C-N 107.49 -4.414 . . . . 0.0 109.672 -179.697 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 t -67.78 119.81 13.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 114.023 -3.071 . . . . 0.0 104.803 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.32 100.07 0.94 Allowed 'General case' 0 C--O 1.244 0.791 0 O-C-N 127.442 2.964 . . . . 0.0 109.934 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 62.47 -173.32 0.15 Allowed 'General case' 0 C--N 1.361 1.094 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 12.6 m-85 57.2 -95.56 0.06 Allowed 'General case' 0 C--N 1.357 0.915 1 O-C-N 129.371 4.169 . . . . 0.0 106.667 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' ASN 0.291 1.4 mpt_? -153.58 -161.5 1.27 Allowed 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 128.249 2.62 . . . . 0.0 111.316 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -103.91 98.93 8.7 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 128.022 3.326 . . . . 0.0 103.12 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 41' ' ' ARG 0.263 0.1 OUTLIER -131.17 151.02 35.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 2 CA-C-O 130.784 5.088 . . . . 0.0 110.051 -178.894 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.67 173.18 6.88 Favored 'General case' 0 N--CA 1.427 -1.62 1 CA-C-N 107.189 -4.55 . . . . 0.0 109.588 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.03 105.86 19.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 1 O-C-N 132.825 6.328 . . . . 0.0 101.0 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.313 6.3 p -112.27 158.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 113.671 -3.212 . . . . 0.0 116.187 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 67' ' ' TRP . 5.2 p90 -171.52 -132.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.647 1 O-C-N 131.761 5.663 . . . . 0.0 111.026 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.48 58.87 0.22 Allowed 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 112.924 -3.511 . . . . 0.0 114.898 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 31.53 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 127.345 2.903 . . . . 0.0 116.637 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 58.4 2.36 Favored Glycine 0 CA--C 1.547 2.09 1 N-CA-C 102.73 -4.148 . . . . 0.0 102.73 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -156.52 118.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.779 1 O-C-N 131.858 5.093 . . . . 0.0 113.43 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.17 160.58 27.91 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 129.403 4.19 . . . . 0.0 107.625 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CE1' ' C ' ' A' ' 65' ' ' GLY . 15.2 p90 -175.85 149.2 0.91 Allowed 'General case' 0 C--N 1.36 1.048 2 O-C-N 132.328 6.018 . . . . 0.0 115.576 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -110.92 90.58 3.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 115.556 -2.164 . . . . 0.0 106.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.24 135.61 38.92 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 127.568 3.042 . . . . 0.0 111.897 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -96.43 85.08 3.83 Favored 'General case' 0 CA--C 1.551 1.007 1 O-C-N 130.857 5.098 . . . . 0.0 105.759 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' HB3' HD13 ' A' ' 43' ' ' ILE . 3.7 mp -71.05 -173.03 0.76 Allowed 'General case' 0 C--O 1.243 0.721 1 O-C-N 132.394 6.059 . . . . 0.0 110.264 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.05 -146.86 0.32 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-O 115.033 -2.413 . . . . 0.0 111.178 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.54 -6.09 55.17 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 128.027 3.329 . . . . 0.0 108.935 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.16 49.83 0.02 OUTLIER Glycine 0 CA--C 1.549 2.181 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.497 ' CG2' ' CD1' ' A' ' 63' ' ' LEU . 21.9 m -102.39 116.61 32.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 126.585 1.991 . . . . 0.0 109.18 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.5 119.21 36.8 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 115.574 -2.45 . . . . 0.0 109.115 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.497 ' CD1' ' CG2' ' A' ' 61' ' ' THR . 0.6 OUTLIER -127.14 60.82 1.38 Allowed 'General case' 0 C--O 1.202 -1.415 0 CA-C-N 110.726 -2.943 . . . . 0.0 107.215 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 54.4 m -41.7 117.03 0.86 Allowed 'General case' 0 N--CA 1.436 -1.142 1 O-C-N 129.23 4.081 . . . . 0.0 104.175 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' C ' ' CE1' ' A' ' 53' ' ' PHE . . . -149.1 -159.74 8.74 Favored Glycine 0 C--O 1.209 -1.436 1 C-N-CA 110.175 -5.774 . . . . 0.0 108.65 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 ' C ' ' CG ' ' A' ' 67' ' ' TRP 0.287 0.7 OUTLIER 175.25 130.94 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.136 2 O-C-N 131.992 5.172 . . . . 0.0 111.808 -178.252 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.75 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 33.4 m95 -136.31 121.01 18.43 Favored 'General case' 0 C--O 1.203 -1.351 0 O-C-N 119.044 -2.285 . . . . 0.0 106.46 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -98.76 22.49 9.99 Favored 'General case' 0 N--CA 1.426 -1.63 2 O-C-N 130.651 4.969 . . . . 0.0 116.988 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 4.22 88.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 1 O-C-N 136.567 8.667 . . . . 0.0 108.322 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -94.99 95.2 8.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 128.047 3.342 . . . . 0.0 111.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.45 -102.2 0.3 Allowed Glycine 0 CA--C 1.541 1.66 1 O-C-N 129.268 4.105 . . . . 0.0 105.565 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.459 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . 74.9 m-20 -120.24 53.37 1.09 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 115.31 -2.281 . . . . 0.0 113.103 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 2.4 mtpt -135.92 171.47 14.42 Favored 'General case' 0 C--N 1.343 0.308 1 O-C-N 130.978 5.174 . . . . 0.0 109.185 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -142.08 54.74 1.46 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 127.874 3.234 . . . . 0.0 111.797 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.88 102.0 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.862 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.554 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -171.33 -161.62 22.27 Favored Glycine 0 C--O 1.2 -2.021 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.288 0.0 OUTLIER -156.89 165.39 36.32 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 129.028 3.428 . . . . 0.0 113.713 -179.508 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.75 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 33.7 m-85 -145.54 153.84 41.54 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 101.248 -3.612 . . . . 0.0 101.248 176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.325 0.0 OUTLIER -171.45 130.99 0.72 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 110.255 -3.157 . . . . 0.0 116.86 -179.633 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 85' ' ' LYS . 94.0 mtt180 -81.39 100.58 9.33 Favored 'General case' 0 N--CA 1.439 -0.989 1 O-C-N 129.374 4.171 . . . . 0.0 108.977 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.91 -26.85 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 1 O-C-N 132.208 5.943 . . . . 0.0 108.757 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -57.0 -39.52 74.85 Favored 'General case' 0 N--CA 1.442 -0.837 1 O-C-N 132.215 5.947 . . . . 0.0 110.466 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -126.15 -2.47 7.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 127.513 3.008 . . . . 0.0 117.073 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.438 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 77.61 38.01 29.17 Favored Glycine 0 C--O 1.2 -2.025 2 C-N-CA 112.224 -4.798 . . . . 0.0 101.889 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 80' ' ' ARG 0.26 15.4 tptp -81.05 -71.92 0.45 Allowed 'General case' 0 N--CA 1.424 -1.755 2 O-C-N 132.695 5.585 . . . . 0.0 120.935 -178.87 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.496 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 12.3 mm-40 73.93 108.38 0.07 Allowed 'General case' 0 N--CA 1.429 -1.506 1 O-C-N 129.206 4.067 . . . . 0.0 113.464 -178.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -139.56 49.21 1.81 Allowed 'General case' 0 C--O 1.198 -1.635 1 O-C-N 132.255 5.972 . . . . 0.0 109.985 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 103' ' ' THR 0.255 30.6 mt -61.99 139.71 20.36 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 1 CA-C-N 107.849 -4.251 . . . . 0.0 101.357 -179.812 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.68 97.83 7.61 Favored 'General case' 0 C--O 1.2 -1.54 1 O-C-N 134.73 7.519 . . . . 0.0 103.254 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.34 115.6 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 O-C-N 128.941 3.901 . . . . 0.0 110.541 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.485 ' CG ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -163.72 -168.54 1.67 Allowed 'General case' 0 C--O 1.192 -1.94 0 C-N-CA 112.923 -3.511 . . . . 0.0 115.933 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 91' ' ' ARG 0.296 0.1 OUTLIER -177.12 110.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 1 O-C-N 130.419 4.824 . . . . 0.0 106.127 -179.535 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 72' ' ' ASN . 2.4 tp -33.25 98.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 1 O-C-N 133.46 6.725 . . . . 0.0 113.317 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -84.03 75.17 10.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 116.152 -2.219 . . . . 0.0 115.076 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.26 -123.41 5.94 Favored Glycine 0 CA--C 1.563 3.077 1 N-CA-C 102.585 -4.206 . . . . 0.0 102.585 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -130.52 44.25 2.99 Favored 'General case' 0 N--CA 1.437 -1.112 1 CA-C-N 108.055 -4.072 . . . . 0.0 106.073 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.592 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.278 0.0 OUTLIER -173.4 97.92 0.12 Allowed 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.416 4.823 . . . . 0.0 108.777 179.725 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 2' ' ' PHE . 3.2 tt -72.99 148.64 44.03 Favored 'General case' 0 N--CA 1.424 -1.727 1 O-C-N 130.321 4.763 . . . . 0.0 115.209 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.61 167.26 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 2 CA-C-N 106.345 -4.934 . . . . 0.0 103.429 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.25 98.93 0.83 Allowed 'General case' 0 C--O 1.204 -1.294 1 O-C-N 131.13 5.269 . . . . 0.0 103.895 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' THR . 8.9 t -85.49 112.34 20.82 Favored 'General case' 0 N--CA 1.428 -1.574 2 O-C-N 131.177 5.298 . . . . 0.0 112.461 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.18 88.97 2.49 Favored 'General case' 0 C--O 1.208 -1.118 2 C-N-CA 110.772 -4.371 . . . . 0.0 105.773 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.8 m -65.4 93.72 0.15 Allowed 'General case' 0 C--O 1.209 -1.076 0 O-C-N 128.659 3.725 . . . . 0.0 101.37 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 1.8 t80 -110.57 114.5 27.96 Favored 'General case' 0 CA--C 1.498 -1.038 1 CA-C-N 107.512 -4.404 . . . . 0.0 111.426 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 47.45 17.59 0.08 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 112.428 -2.169 . . . . 0.0 116.547 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.31 16.91 19.36 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 116.306 -2.854 . . . . 0.0 114.59 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.15 -38.29 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 120.225 2.013 . . . . 0.0 113.357 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 68.16 97.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 1 O-C-N 130.071 4.607 . . . . 0.0 108.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.363 . . -132.07 113.64 13.59 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 128.398 3.561 . . . . 0.0 109.116 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -174.34 2.53 Favored 'General case' 0 N--CA 1.421 -1.878 1 O-C-N 133.694 6.871 . . . . 0.0 111.381 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -156.5 119.8 4.22 Favored 'General case' 0 C--O 1.204 -1.331 2 O-C-N 130.418 4.824 . . . . 0.0 101.511 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.06 125.36 45.63 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 O-C-N 127.763 3.164 . . . . 0.0 112.903 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.612 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 65.6 m-85 -120.58 -141.96 0.34 Allowed 'General case' 0 N--CA 1.446 -0.673 1 O-C-N 131.013 5.196 . . . . 0.0 104.949 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.592 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -164.16 -149.89 0.14 Allowed 'General case' 0 C--O 1.199 -1.579 1 O-C-N 131.538 5.524 . . . . 0.0 112.526 179.903 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 24.0 tttt -128.56 154.79 45.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 127.211 2.204 . . . . 0.0 111.185 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 N--CA 1.434 -1.228 0 O-C-N 127.767 3.167 . . . . 0.0 113.678 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.554 1.116 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -144.33 57.49 1.32 Allowed 'General case' 0 C--N 1.358 0.938 0 CA-C-N 110.126 -3.215 . . . . 0.0 111.192 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.429 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . -165.53 177.31 40.85 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 114.113 -3.899 . . . . 0.0 105.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.327 23.8 p -80.26 177.81 8.71 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 113.858 -3.137 . . . . 0.0 104.087 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.556 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 75.3 m95 -150.69 167.86 26.08 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 115.506 -2.187 . . . . 0.0 112.189 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 8.5 mtmt 51.03 179.19 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 O-C-N 127.83 3.207 . . . . 0.0 118.814 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.486 -1.512 3 O-C-N 133.492 6.745 . . . . 0.0 121.414 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 114.216 -2.802 . . . . 0.0 106.506 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.407 0.0 OUTLIER -179.14 175.45 0.96 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 133.237 6.586 . . . . 0.0 103.342 -179.7 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -136.96 157.55 46.49 Favored 'General case' 0 CA--C 1.565 1.547 3 O-C-N 133.895 6.997 . . . . 0.0 97.7 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.595 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 2.9 m 177.78 80.44 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 1 O-C-N 131.913 5.758 . . . . 0.0 106.514 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.498 ' CG2' ' HB2' ' A' ' 32' ' ' PHE . 2.2 mp -95.81 118.76 42.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 CA-C-N 109.451 -3.522 . . . . 0.0 109.079 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.5 m -172.63 68.62 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 128.895 3.872 . . . . 0.0 108.905 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 32' ' ' PHE 0.297 1.5 tp60 -73.89 -95.26 0.02 OUTLIER 'General case' 0 C--N 1.354 0.786 1 C-N-CA 110.74 -4.384 . . . . 0.0 115.504 -179.888 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 170.86 144.94 0.03 OUTLIER 'General case' 0 C--O 1.244 0.771 0 O-C-N 128.555 3.659 . . . . 0.0 106.427 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 30' ' ' ASN . . . 74.88 -97.32 1.0 Allowed Glycine 0 CA--C 1.559 2.792 3 O-C-N 130.902 5.127 . . . . 0.0 102.361 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 12.2 m120 -152.74 47.64 0.72 Allowed 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.62 6.129 . . . . 0.0 112.317 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 6.1 mttp -118.33 161.85 19.26 Favored 'General case' 0 CA--C 1.552 1.048 1 N-CA-C 96.579 -5.341 . . . . 0.0 96.579 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB2' ' CG2' ' A' ' 25' ' ' ILE . 23.0 p90 -167.8 76.96 0.15 Allowed 'General case' 0 C--O 1.197 -1.706 2 C-N-CA 110.383 -4.527 . . . . 0.0 99.656 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 138.12 58.43 Favored 'General case' 0 CA--C 1.505 -0.755 2 O-C-N 130.907 5.129 . . . . 0.0 100.529 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.369 6.8 t -91.05 132.66 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 179.688 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.595 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.25 19.8 tttt -73.74 52.61 0.41 Allowed 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 126.732 3.158 . . . . 0.0 117.28 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG3' ' CG1' ' A' ' 34' ' ' VAL 0.265 50.3 mt-10 -72.28 68.24 0.74 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.869 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -84.49 91.42 7.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 114.257 -2.977 . . . . 0.0 108.85 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 m -87.54 -178.78 6.2 Favored 'General case' 0 C--N 1.367 1.34 0 O-C-N 126.622 2.451 . . . . 0.0 116.549 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.6 -9.16 59.79 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 126.102 2.126 . . . . 0.0 108.351 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 19.7 m-85 -69.3 -55.32 10.82 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 113.341 -3.343 . . . . 0.0 106.978 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -158.95 6.63 0.11 Allowed 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 114.394 -2.717 . . . . 0.0 117.367 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.81 62.97 0.87 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 101.927 -3.361 . . . . 0.0 101.927 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 0.0 OUTLIER -134.88 113.47 16.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 3 CA-C-O 130.994 5.188 . . . . 0.0 111.249 -178.301 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.98 -172.95 4.21 Favored 'General case' 0 C--N 1.372 1.586 1 CA-C-N 107.259 -4.519 . . . . 0.0 109.59 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.26 118.36 31.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 O-C-N 128.839 3.837 . . . . 0.0 101.525 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.33 160.64 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 C-N-CA 113.035 -3.466 . . . . 0.0 111.758 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER 177.09 -176.89 0.15 Allowed 'General case' 0 N--CA 1.435 -1.183 1 O-C-N 129.818 4.449 . . . . 0.0 111.649 -179.819 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HB2' ' HD3' ' A' ' 31' ' ' LYS 0.315 3.7 tm-20 -141.97 86.51 1.99 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 114.676 -2.809 . . . . 0.0 113.388 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 36.87 91.64 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.282 1 O-C-N 131.236 5.335 . . . . 0.0 115.743 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.46 65.22 3.71 Favored Glycine 0 C--O 1.203 -1.842 0 CA-C-O 114.248 -3.529 . . . . 0.0 105.713 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.23 -33.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 1 O-C-N 131.511 4.889 . . . . 0.0 113.637 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.8 126.02 0.03 OUTLIER 'General case' 0 C--O 1.2 -1.551 2 O-C-N 132.047 5.842 . . . . 0.0 108.368 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 9.6 p90 -173.7 149.33 1.59 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 112.5 -3.68 . . . . 0.0 117.479 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 64' ' ' THR . . . -104.56 138.44 40.91 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 100.698 -3.816 . . . . 0.0 100.698 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 56' ' ' SER . 4.4 t80 -150.78 26.96 0.73 Allowed 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 111.757 -3.977 . . . . 0.0 115.082 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 55' ' ' TYR . 7.4 t 23.52 78.68 0.02 OUTLIER 'General case' 0 C--O 1.249 1.061 1 O-C-N 134.693 7.496 . . . . 0.0 110.121 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 57' ' ' LEU . 13.3 mt -81.44 167.37 19.46 Favored 'General case' 0 C--N 1.317 -0.83 1 O-C-N 129.854 4.472 . . . . 0.0 114.991 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB2' HG22 ' A' ' 61' ' ' THR . . . 45.99 25.12 0.29 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 126.014 2.071 . . . . 0.0 115.388 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.74 42.13 19.18 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 126.926 2.641 . . . . 0.0 115.276 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.86 -48.3 0.06 OUTLIER Glycine 0 C--N 1.367 2.261 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 58' ' ' ALA . 3.5 p -63.61 173.61 1.63 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 127.72 2.659 . . . . 0.0 114.242 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -164.27 36.85 0.08 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 112.436 -3.706 . . . . 0.0 108.794 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.82 106.65 0.51 Allowed 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 126.558 2.411 . . . . 0.0 108.485 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 54' ' ' ALA . 58.3 m -103.7 107.26 18.04 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 112.102 -2.317 . . . . 0.0 107.688 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -161.0 -163.35 13.88 Favored Glycine 0 C--O 1.203 -1.837 1 C-N-CA 111.16 -5.305 . . . . 0.0 107.499 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.441 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 1.5 t -142.33 114.67 8.37 Favored 'General case' 0 CA--C 1.495 -1.17 2 O-C-N 135.426 7.192 . . . . 0.0 118.735 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.719 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.5 m95 -99.54 112.58 24.77 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.7 p -106.03 66.26 0.71 Allowed 'General case' 0 N--CA 1.427 -1.594 1 O-C-N 132.618 6.199 . . . . 0.0 115.022 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -40.05 109.25 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 1 O-C-N 133.839 6.962 . . . . 0.0 103.207 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -66.89 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 127.563 3.04 . . . . 0.0 106.405 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.67 -63.06 0.04 OUTLIER Glycine 0 CA--C 1.556 2.654 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.38 16.94 2.39 Favored 'General case' 0 N--CA 1.444 -0.727 1 O-C-N 131.44 4.847 . . . . 0.0 108.647 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -99.4 176.71 5.42 Favored 'General case' 0 N--CA 1.476 0.826 1 O-C-N 131.307 5.379 . . . . 0.0 108.737 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.4 mt -148.17 45.16 1.07 Allowed 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 126.804 2.565 . . . . 0.0 111.951 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.68 137.75 23.05 Favored 'Isoleucine or valine' 0 C--N 1.364 1.227 1 CA-C-N 106.853 -4.703 . . . . 0.0 114.025 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.88 -149.65 20.5 Favored Glycine 0 CA--C 1.547 2.063 1 N-CA-C 100.649 -4.98 . . . . 0.0 100.649 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 176.5 137.82 0.06 Allowed 'General case' 0 C--O 1.208 -1.083 1 O-C-N 134.046 6.38 . . . . 0.0 112.632 -179.986 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.719 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -124.73 168.02 13.76 Favored 'General case' 0 C--O 1.195 -1.782 2 O-C-N 132.526 6.141 . . . . 0.0 104.814 179.783 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 86' ' ' GLU 0.28 0.0 OUTLIER -163.94 140.54 6.7 Favored 'General case' 0 N--CA 1.427 -1.609 1 CA-C-N 106.227 -4.988 . . . . 0.0 113.398 179.975 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' CG ' ' HB2' ' A' ' 82' ' ' ASP . 32.8 ttt180 -93.46 112.09 23.92 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 127.623 3.077 . . . . 0.0 107.164 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 21.2 t -66.02 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 1 O-C-N 130.714 5.009 . . . . 0.0 109.217 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.478 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . 32.6 m-20 -87.58 19.85 3.19 Favored 'General case' 0 N--CA 1.44 -0.957 1 O-C-N 134.024 7.078 . . . . 0.0 107.86 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.611 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 83.45 18.03 0.24 Allowed 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 128.502 3.626 . . . . 0.0 117.475 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 80' ' ' ARG . . . -82.49 -11.69 81.55 Favored Glycine 0 CA--C 1.562 2.993 1 C-N-CA 110.335 -5.698 . . . . 0.0 104.116 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.7 ttmm 41.55 82.83 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 2 O-C-N 132.672 5.572 . . . . 0.0 121.38 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 18.3 mt-10 82.79 71.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.667 1 O-C-N 129.754 4.409 . . . . 0.0 117.071 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mp -99.83 64.58 1.27 Allowed 'General case' 0 C--O 1.197 -1.697 1 O-C-N 132.198 5.936 . . . . 0.0 113.646 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 77' ' ' LYS 0.305 93.8 mt -77.84 -174.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 108.563 -3.926 . . . . 0.0 101.647 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.31 73.47 0.92 Allowed 'General case' 0 C--O 1.196 -1.745 0 O-C-N 128.051 3.345 . . . . 0.0 106.242 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.87 110.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 110.597 -3.001 . . . . 0.0 105.427 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.674 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -162.82 162.67 26.63 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 111.854 -3.938 . . . . 0.0 113.438 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.674 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -153.69 121.05 5.82 Favored 'General case' 0 CA--C 1.543 0.679 2 CA-C-N 107.326 -4.488 . . . . 0.0 103.806 179.554 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.296 5.0 tt -48.4 108.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 1 O-C-N 131.265 5.353 . . . . 0.0 112.99 -179.766 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -74.74 69.33 1.79 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 130.025 4.578 . . . . 0.0 115.479 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.05 -113.4 2.63 Favored Glycine 0 CA--C 1.558 2.76 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -138.6 47.32 1.96 Allowed 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 129.461 3.683 . . . . 0.0 107.456 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 179.04 127.64 0.07 Allowed 'General case' 0 CA--C 1.56 1.354 0 O-C-N 128.577 3.673 . . . . 0.0 106.966 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.474 ' CA ' HG13 ' A' ' 93' ' ' ILE . 11.9 tp -90.94 162.52 14.72 Favored 'General case' 0 C--O 1.206 -1.231 1 O-C-N 134.209 7.193 . . . . 0.0 111.863 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.474 ' CG2' ' CB ' ' A' ' 110' ' ' LYS . 1.4 mp -107.77 -85.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 2 CA-C-O 110.707 -4.473 . . . . 0.0 103.294 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 13.3 mm-40 93.82 93.41 0.01 OUTLIER 'General case' 0 C--O 1.202 -1.415 1 O-C-N 133.593 6.808 . . . . 0.0 104.824 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.8 p -83.93 -166.37 1.39 Allowed 'General case' 0 N--CA 1.416 -2.174 1 O-C-N 129.273 4.108 . . . . 0.0 113.177 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -156.22 89.33 1.13 Allowed 'General case' 0 C--O 1.2 -1.552 1 C-N-CA 110.752 -4.379 . . . . 0.0 103.293 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.63 79.11 0.42 Allowed 'General case' 0 C--O 1.213 -0.835 1 O-C-N 129.804 4.44 . . . . 0.0 107.532 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -104.58 100.96 10.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 108.661 -3.881 . . . . 0.0 111.295 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 46.88 17.09 0.05 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.61 -18.57 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 116.388 -2.815 . . . . 0.0 116.41 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.12 142.5 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 119.72 1.76 . . . . 0.0 112.933 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -109.09 87.16 2.43 Favored 'General case' 0 C--N 1.364 1.238 1 O-C-N 129.3 4.125 . . . . 0.0 108.119 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.425 . . -106.71 142.41 36.39 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 116.109 -2.236 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' CB ' ' CG2' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -148.64 171.01 16.86 Favored 'General case' 0 N--CA 1.435 -1.184 1 O-C-N 130.875 5.109 . . . . 0.0 109.904 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.49 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -123.96 137.55 54.6 Favored 'General case' 0 CA--C 1.558 1.256 3 O-C-N 129.562 4.289 . . . . 0.0 99.921 179.541 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.09 110.0 15.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 C-N-CA 113.714 -3.194 . . . . 0.0 112.22 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 111' ' ' ARG . 6.4 m-30 -108.56 175.43 5.47 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 128.84 3.838 . . . . 0.0 103.981 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.36 -159.19 0.31 Allowed 'General case' 0 C--O 1.198 -1.652 2 O-C-N 131.639 5.587 . . . . 0.0 111.616 179.404 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.556 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 21.6 tttt -112.59 -127.98 0.29 Allowed 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.782 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 . . . . . 0 CA--C 1.561 1.399 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 22.5 p-10 -32.79 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 130.75 5.031 . . . . 0.0 118.294 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.79 -169.7 38.09 Favored Glycine 0 C--N 1.345 1.05 1 C-N-CA 112.006 -4.902 . . . . 0.0 105.496 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.309 0.4 OUTLIER -100.34 167.68 10.25 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 114.074 -3.051 . . . . 0.0 104.929 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.558 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.264 34.4 m95 -143.21 140.15 30.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 O-C-N 128.672 3.733 . . . . 0.0 111.109 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.554 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 19.3 mtmt 58.2 178.58 0.06 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.306 0.6 OUTLIER . . . . . 0 CA--C 1.484 -1.588 3 O-C-N 136.404 8.565 . . . . 0.0 113.964 174.815 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.136 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.345 0.0 OUTLIER -159.94 149.79 18.27 Favored 'General case' 0 C--O 1.205 -1.259 1 O-C-N 130.856 5.098 . . . . 0.0 104.115 -179.811 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 6.6 mt -116.57 177.68 4.61 Favored 'General case' 0 CA--C 1.562 1.422 2 O-C-N 132.964 6.415 . . . . 0.0 97.937 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 21.9 m -167.91 -85.31 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 1 O-C-N 130.921 5.138 . . . . 0.0 106.508 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 23' ' ' LEU . 1.0 OUTLIER 72.68 162.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 109.163 -3.653 . . . . 0.0 108.853 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 27' ' ' GLN . 90.9 m -138.31 -48.93 0.54 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 112.781 -3.568 . . . . 0.0 108.661 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR 0.316 3.9 pt20 65.97 123.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.027 2 O-C-N 132.503 6.127 . . . . 0.0 115.778 178.762 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 7.1 tt0 -98.97 -130.81 0.22 Allowed 'General case' 0 C--O 1.248 1.022 0 O-C-N 128.795 3.81 . . . . 0.0 104.829 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.14 -53.43 3.91 Favored Glycine 0 CA--C 1.546 2.002 2 N-CA-C 99.594 -5.402 . . . . 0.0 99.594 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' ND2' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -136.17 75.81 1.57 Allowed 'General case' 0 N--CA 1.44 -0.956 1 CA-C-N 107.589 -4.305 . . . . 0.0 105.862 -179.9 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' CD ' ' C ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -168.28 102.88 0.44 Allowed 'General case' 0 C--O 1.246 0.917 1 C-N-CA 111.418 -4.113 . . . . 0.0 102.337 -179.893 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 39.7 p90 -140.09 165.25 27.87 Favored 'General case' 0 CA--C 1.562 1.426 1 N-CA-C 99.402 -4.295 . . . . 0.0 99.402 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.95 125.08 21.53 Favored 'General case' 0 N--CA 1.476 0.828 2 O-C-N 137.605 9.316 . . . . 0.0 101.468 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' A' ' 23' ' ' LEU 0.352 1.1 t -84.89 132.77 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 112.932 -3.507 . . . . 0.0 103.585 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.308 0.3 OUTLIER -71.94 -0.83 12.44 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 109.361 -3.563 . . . . 0.0 118.875 179.789 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.368 1.0 OUTLIER -37.76 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.106 -2.77 . . . . 0.0 109.192 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -91.93 133.45 35.68 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 115.327 -2.549 . . . . 0.0 109.395 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p 177.02 -169.13 0.06 Allowed 'General case' 0 C--N 1.353 0.746 0 O-C-N 127.65 3.094 . . . . 0.0 112.958 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.08 -91.76 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.624 0 O-C-N 125.276 1.61 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -117.58 -36.54 3.67 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 128.254 3.471 . . . . 0.0 111.609 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -143.14 0.15 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 127.222 2.826 . . . . 0.0 115.228 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.7 -22.31 34.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 116.289 -2.164 . . . . 0.0 107.387 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt 25.28 69.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.223 2 O-C-N 132.349 6.03 . . . . 0.0 111.1 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.56 155.3 36.16 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 109.639 -3.437 . . . . 0.0 105.148 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 78' ' ' PHE . 6.3 t -123.09 117.61 52.19 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 1 O-C-N 129.544 4.277 . . . . 0.0 101.462 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.271 0.3 OUTLIER -118.23 162.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 114.663 -2.815 . . . . 0.0 114.831 179.843 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -177.2 -159.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 130.095 4.622 . . . . 0.0 111.448 -179.961 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.1 49.5 1.85 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 117.757 -1.577 . . . . 0.0 114.582 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER 39.52 98.37 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 127.778 3.656 . . . . 0.0 115.28 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.01 52.93 1.56 Allowed Glycine 0 CA--C 1.545 1.957 1 N-CA-C 101.563 -4.615 . . . . 0.0 101.563 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -147.3 122.02 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 1 O-C-N 132.184 5.285 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.52 153.16 22.05 Favored 'General case' 0 CA--C 1.558 1.252 1 O-C-N 130.423 4.827 . . . . 0.0 106.968 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -168.42 124.33 0.99 Allowed 'General case' 0 N--CA 1.426 -1.664 1 O-C-N 129.136 4.023 . . . . 0.0 118.566 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.05 118.78 26.66 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -142.59 135.74 28.5 Favored 'General case' 0 C--O 1.21 -0.999 0 O-C-N 127.573 3.046 . . . . 0.0 112.558 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.35 141.88 28.15 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 128.354 3.534 . . . . 0.0 106.883 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.17 -67.47 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 128.758 3.786 . . . . 0.0 114.365 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.23 24.16 4.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 116.848 -1.549 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.12 16.01 5.64 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 125.867 1.979 . . . . 0.0 114.489 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.01 56.36 0.12 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 104.813 -3.315 . . . . 0.0 104.813 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.97 -87.82 0.56 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 129.876 3.927 . . . . 0.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.76 15.22 8.04 Favored 'General case' 0 CA--C 1.517 -0.317 1 O-C-N 129.465 4.228 . . . . 0.0 109.656 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.5 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 124.374 2.035 . . . . 0.0 108.525 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.0 m -85.95 113.35 21.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 77' ' ' LYS . . . -144.79 -155.47 6.47 Favored Glycine 0 C--O 1.209 -1.445 1 C-N-CA 111.673 -5.06 . . . . 0.0 109.213 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.629 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.27 8.8 t -179.78 135.96 0.12 Allowed 'General case' 0 CA--C 1.496 -1.131 2 O-C-N 133.524 6.073 . . . . 0.0 111.917 -178.154 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 67.7 m95 -141.45 119.63 12.13 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 116.692 -3.755 . . . . 0.0 106.209 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 1.1 p -106.43 34.72 3.25 Favored 'General case' 0 N--CA 1.434 -1.246 2 O-C-N 134.543 7.402 . . . . 0.0 116.154 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . 0.264 4.3 ttm -17.66 84.56 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 1 O-C-N 136.57 8.669 . . . . 0.0 108.058 -179.92 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.72 94.54 9.42 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 128.046 3.341 . . . . 0.0 107.074 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.11 -132.04 36.25 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -85.43 60.66 6.38 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 109.075 -3.563 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 158.83 44.18 Favored 'General case' 0 C--N 1.359 1.015 1 O-C-N 129.297 4.123 . . . . 0.0 111.149 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 91' ' ' ARG . 13.0 mt -141.93 59.59 1.48 Allowed 'General case' 0 C--O 1.209 -1.047 0 O-C-N 128.269 3.481 . . . . 0.0 111.459 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.15 101.66 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 1 CA-C-N 107.531 -4.395 . . . . 0.0 115.601 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.81 -144.99 4.36 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 103.3 -3.92 . . . . 0.0 103.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.3 0.1 OUTLIER -176.89 165.21 2.42 Favored 'General case' 0 C--O 1.201 -1.457 2 O-C-N 131.36 4.8 . . . . 0.0 112.092 -179.767 . . . . . . . . 5 4 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 19.9 m-85 -144.38 166.1 26.06 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HE2' ' CG ' ' A' ' 86' ' ' GLU 0.283 0.0 OUTLIER -174.28 152.43 1.8 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 108.966 -3.743 . . . . 0.0 117.221 179.327 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' CB ' ' A' ' 85' ' ' LYS . 5.8 ptm180 -104.11 78.29 1.5 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 126.299 2.25 . . . . 0.0 107.252 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 m -22.12 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 1 O-C-N 133.331 6.644 . . . . 0.0 114.047 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -41.88 -47.02 4.17 Favored 'General case' 0 N--CA 1.451 -0.425 1 O-C-N 134.751 7.532 . . . . 0.0 107.637 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -112.0 -0.28 15.78 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 128.544 3.653 . . . . 0.0 113.304 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.26 34.63 88.62 Favored Glycine 0 CA--C 1.559 2.782 1 N-CA-C 101.361 -4.696 . . . . 0.0 101.361 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -66.02 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 3 O-C-N 132.615 5.538 . . . . 0.0 118.264 179.983 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 46.3 mt-10 116.87 133.52 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 1 O-C-N 132.455 6.097 . . . . 0.0 109.136 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.64 42.4 0.48 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 133.289 6.618 . . . . 0.0 110.003 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 77' ' ' LYS 0.256 4.7 mt -67.71 171.52 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.591 1 O-C-N 131.42 5.45 . . . . 0.0 105.004 -179.567 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.68 73.95 1.25 Allowed 'General case' 0 C--O 1.219 -0.545 1 O-C-N 133.66 6.85 . . . . 0.0 107.592 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.69 125.71 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -166.58 153.88 9.46 Favored 'General case' 0 C--O 1.191 -1.982 1 C-N-CA 110.407 -4.517 . . . . 0.0 115.405 179.83 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 4.5 mt-10 -149.04 113.61 5.32 Favored 'General case' 0 N--CA 1.433 -1.324 1 O-C-N 131.018 5.199 . . . . 0.0 107.095 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' HB ' HD13 ' A' ' 98' ' ' LEU 0.26 0.1 OUTLIER -45.5 112.99 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.668 1 O-C-N 130.325 4.766 . . . . 0.0 109.296 179.823 . . . . . . . . 5 4 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -67.72 -89.58 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.097 0 O-C-N 128.734 3.771 . . . . 0.0 116.89 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -135.92 100.33 0.34 Allowed Glycine 0 C--O 1.206 -1.638 0 C-N-CA 115.464 -3.255 . . . . 0.0 107.662 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 52.51 22.73 2.25 Favored 'General case' 0 N--CA 1.443 -0.809 2 O-C-N 130.639 4.376 . . . . 0.0 109.663 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.459 ' CD ' ' HB2' ' A' ' 114' ' ' LYS 0.296 0.0 OUTLIER -168.8 134.1 1.65 Allowed 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 127.581 3.051 . . . . 0.0 109.022 179.283 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD13 ' HB ' ' A' ' 93' ' ' ILE . 2.6 tt -97.67 142.12 29.86 Favored 'General case' 0 N--CA 1.437 -1.095 1 O-C-N 133.598 6.811 . . . . 0.0 115.863 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 29.0 mt -83.19 -84.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.518 0 O-C-N 128.945 3.903 . . . . 0.0 106.284 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 92.95 107.67 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.274 1 O-C-N 131.024 5.203 . . . . 0.0 100.833 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.2 p -77.76 -38.7 46.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 128.406 3.566 . . . . 0.0 119.462 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 61.81 53.04 3.26 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 111.569 -2.56 . . . . 0.0 105.583 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 m -52.42 117.18 2.67 Favored 'General case' 0 C--N 1.36 1.023 1 O-C-N 133.038 6.461 . . . . 0.0 100.625 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 5.7 t80 -144.58 138.04 27.18 Favored 'General case' 0 CA--C 1.49 -1.349 1 O-C-N 130.13 4.644 . . . . 0.0 112.604 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 1.0 OUTLIER 37.41 35.13 0.05 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.841 -1.981 . . . . 0.0 115.952 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.58 79.64 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 116.76 -2.638 . . . . 0.0 117.305 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.81 -19.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 66.48 173.08 0.24 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 128.33 3.519 . . . . 0.0 106.951 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.328 . . -174.8 81.43 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 117.234 -1.787 . . . . 0.0 114.166 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -95.5 120.86 36.48 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 129.729 4.393 . . . . 0.0 109.084 -179.931 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -92.85 -34.12 13.96 Favored 'General case' 0 CA--C 1.555 1.16 1 O-C-N 129.974 4.546 . . . . 0.0 104.164 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 83.5 118.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.126 1 O-C-N 130.25 4.719 . . . . 0.0 108.03 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 37.0 m-85 -141.8 -146.67 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 1 O-C-N 129.549 4.28 . . . . 0.0 106.511 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -170.31 -145.31 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.024 1 O-C-N 131.104 5.253 . . . . 0.0 111.668 -179.739 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.558 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 17.4 tttt -129.03 -58.51 1.14 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.232 1.413 . . . . 0.0 111.979 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.411 -2.384 0 CA-C-N 111.027 -2.806 . . . . 0.0 113.837 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.473 ' CE1' HG23 ' A' ' 93' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.267 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.41 ' CB ' HG22 ' A' ' 26' ' ' THR 0.252 5.0 p-10 -34.48 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.874 1 O-C-N 130.443 4.839 . . . . 0.0 117.735 179.493 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 169.57 -179.2 42.2 Favored Glycine 0 N--CA 1.477 1.43 1 C-N-CA 112.231 -4.795 . . . . 0.0 104.169 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 3.3 p -88.4 173.08 8.92 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 113.712 -3.195 . . . . 0.0 108.168 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 64.6 m95 -152.14 117.69 5.35 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.631 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 89.3 171.58 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' CG1' ' HG3' ' A' ' 22' ' ' LYS 0.274 0.5 OUTLIER . . . . . 0 CA--C 1.479 -1.775 3 CA-C-O 135.886 7.517 . . . . 0.0 120.305 174.864 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.424 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HA ' ' CE ' ' A' ' 7' ' ' LYS 0.321 7.9 mttt 147.09 141.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.53 2 O-C-N 132.914 6.384 . . . . 0.0 106.576 177.423 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.9 mt -96.5 161.57 13.85 Favored 'General case' 0 CA--C 1.565 1.552 3 O-C-N 132.692 6.245 . . . . 0.0 96.686 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 2.7 m 172.09 83.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 1 O-C-N 129.308 4.13 . . . . 0.0 101.336 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.427 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 3.7 mp -106.13 116.34 49.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 108.688 -3.869 . . . . 0.0 112.833 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.41 HG22 ' CB ' ' A' ' 3' ' ' ASP . 2.9 m -162.14 77.2 0.49 Allowed 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 127.134 2.771 . . . . 0.0 108.506 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.472 ' HB2' ' C ' ' A' ' 31' ' ' LYS . 8.1 mm-40 -68.11 -93.07 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 1 C-N-CA 110.998 -4.281 . . . . 0.0 113.428 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -127.2 -7.86 5.9 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 113.396 -3.192 . . . . 0.0 106.725 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.82 -11.27 29.84 Favored Glycine 0 CA--C 1.538 1.493 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.9 -30.4 2.03 Favored 'General case' 0 N--CA 1.411 -2.418 1 CA-C-O 111.649 -4.024 . . . . 0.0 111.547 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 43.5 mttt -103.86 -165.94 1.21 Allowed 'General case' 0 C--O 1.246 0.897 1 N-CA-C 97.725 -4.917 . . . . 0.0 97.725 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 25.6 m-85 -167.86 156.63 9.38 Favored 'General case' 0 C--O 1.203 -1.389 1 N-CA-C 97.355 -5.054 . . . . 0.0 97.355 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.82 128.99 18.73 Favored 'General case' 0 N--CA 1.479 1.015 4 O-C-N 136.662 8.726 . . . . 0.0 98.079 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 23' ' ' LEU 0.431 4.0 t -88.15 121.46 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 1 N-CA-C 99.303 -4.332 . . . . 0.0 99.303 179.9 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.376 11.2 tttt -56.09 -18.99 11.29 Favored 'General case' 0 C--N 1.37 1.489 0 CA-C-N 110.281 -3.145 . . . . 0.0 119.252 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 3.58 67.87 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 109.774 -3.375 . . . . 0.0 111.342 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 21' ' ' LEU . 19.1 m -70.45 127.9 34.33 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 116.816 -1.954 . . . . 0.0 113.071 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -126.38 -168.49 1.87 Allowed 'General case' 0 C--N 1.369 1.417 0 O-C-N 125.707 1.879 . . . . 0.0 112.263 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.25 -25.52 58.13 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 125.507 2.575 . . . . 0.0 104.722 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -90.32 69.24 7.02 Favored 'General case' 0 N--CA 1.437 -1.093 1 CA-C-N 106.653 -4.794 . . . . 0.0 107.143 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.93 177.58 0.1 Allowed 'General case' 0 N--CA 1.436 -1.172 1 O-C-N 129.328 4.142 . . . . 0.0 114.677 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -71.5 -44.62 64.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 111.776 -3.969 . . . . 0.0 102.539 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 64.61 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.512 3 CA-C-O 130.08 4.752 . . . . 0.0 107.074 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.02 138.4 42.17 Favored 'General case' 0 C--N 1.373 1.611 1 CA-C-N 106.395 -4.911 . . . . 0.0 108.26 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.36 86.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 1 N-CA-C 99.782 -4.155 . . . . 0.0 99.782 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.8 163.04 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 1 C-N-CA 111.003 -4.279 . . . . 0.0 113.311 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.8 p90 -161.94 149.68 14.58 Favored 'General case' 0 N--CA 1.433 -1.311 1 O-C-N 132.888 6.367 . . . . 0.0 111.06 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.02 51.55 1.83 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 113.056 -3.458 . . . . 0.0 115.554 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 47.75 89.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 2 O-C-N 132.714 6.259 . . . . 0.0 114.585 -179.711 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.28 59.1 2.78 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.74 -32.2 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 1 O-C-N 133.915 6.303 . . . . 0.0 115.225 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.06 138.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 1 O-C-N 131.421 5.451 . . . . 0.0 109.049 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 p90 179.31 145.96 0.18 Allowed 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 108.668 -3.878 . . . . 0.0 116.505 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 137.31 47.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.474 -3.899 . . . . 0.0 100.474 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -147.69 100.79 3.27 Favored 'General case' 0 C--O 1.21 -1.001 1 O-C-N 129.295 4.122 . . . . 0.0 114.06 179.848 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 94.7 1.87 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 112.775 -3.57 . . . . 0.0 101.484 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' TYR . 5.7 tp -82.55 -86.35 0.1 Allowed 'General case' 0 CA--C 1.507 -0.709 1 O-C-N 131.735 5.647 . . . . 0.0 116.117 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.57 10.11 0.07 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 115.825 -2.036 . . . . 0.0 116.494 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 9.4 5.59 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 120.504 1.502 . . . . 0.0 111.122 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.09 46.26 0.27 Allowed Glycine 0 CA--C 1.548 2.128 0 N-CA-C 105.178 -3.169 . . . . 0.0 105.178 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -126.59 -88.93 0.56 Allowed 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 132.155 5.268 . . . . 0.0 114.537 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 62.14 71.95 0.52 Allowed 'General case' 0 C--O 1.217 -0.654 0 O-C-N 127.595 3.06 . . . . 0.0 106.784 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 78' ' ' PHE . 11.1 mp -120.57 76.08 1.17 Allowed 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 128.518 3.636 . . . . 0.0 113.92 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.9 m -48.44 111.84 0.51 Allowed 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.89 -171.38 12.32 Favored Glycine 0 CA--C 1.538 1.469 2 C-N-CA 111.026 -5.368 . . . . 0.0 107.029 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.603 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 5.9 t 176.53 128.96 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.218 2 O-C-N 133.611 6.124 . . . . 0.0 111.368 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 52.1 m95 -137.73 117.83 13.48 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 117.174 -3.454 . . . . 0.0 106.347 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -96.6 33.64 1.79 Allowed 'General case' 0 N--CA 1.422 -1.87 2 O-C-N 130.703 5.002 . . . . 0.0 116.706 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.448 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 2.2 ttt -18.93 106.19 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.814 1 O-C-N 136.821 8.825 . . . . 0.0 107.523 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.22 -44.72 87.38 Favored 'General case' 0 CA--C 1.505 -0.786 1 O-C-N 129.684 4.365 . . . . 0.0 108.673 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.83 -39.35 0.18 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 110.46 -3.064 . . . . 0.0 107.492 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.07 30.53 1.61 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 129.795 3.879 . . . . 0.0 108.748 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.3 mttt -135.61 157.38 47.02 Favored 'General case' 0 N--CA 1.453 -0.315 1 O-C-N 131.032 5.207 . . . . 0.0 111.604 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 mt -134.91 60.11 1.71 Allowed 'General case' 0 C--O 1.214 -0.775 0 O-C-N 127.879 3.237 . . . . 0.0 110.852 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -85.31 93.27 3.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 1 CA-C-N 106.544 -4.843 . . . . 0.0 114.044 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.538 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -159.08 -156.64 8.14 Favored Glycine 0 C--O 1.207 -1.585 2 CA-C-N 107.599 -4.364 . . . . 0.0 102.955 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.331 21.8 ttpt -170.54 123.98 0.68 Allowed 'General case' 0 C--N 1.37 1.476 1 C-N-CA 108.813 -5.155 . . . . 0.0 112.779 179.934 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 28.0 m-85 -106.09 162.46 13.6 Favored 'General case' 0 C--O 1.2 -1.504 2 N-CA-C 99.831 -4.137 . . . . 0.0 99.831 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE2' ' CA ' ' A' ' 84' ' ' GLY 0.366 0.2 OUTLIER -168.23 130.9 1.48 Allowed 'General case' 0 CA--C 1.495 -1.152 1 CA-C-N 105.594 -5.275 . . . . 0.0 113.737 -178.716 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 11.2 ttp180 -82.41 86.72 6.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 125.007 1.442 . . . . 0.0 110.775 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.39 -33.75 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 O-C-N 128.044 3.34 . . . . 0.0 110.274 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.91 -46.57 81.9 Favored 'General case' 0 C--O 1.248 1.002 1 O-C-N 132.36 6.038 . . . . 0.0 108.825 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.34 -5.7 17.63 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 113.403 -3.319 . . . . 0.0 112.559 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.48 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 75.91 41.54 27.67 Favored Glycine 0 CA--C 1.557 2.677 2 C-N-CA 110.843 -5.456 . . . . 0.0 100.485 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 8.6 tppt? -81.75 -81.44 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 2 CA-C-N 105.75 -5.225 . . . . 0.0 121.239 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 7.0 mm-40 91.04 121.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.576 4.922 . . . . 0.0 108.084 -177.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 87' ' ' LEU . 1.4 pt? -153.45 48.48 0.68 Allowed 'General case' 0 C--O 1.194 -1.836 1 O-C-N 132.435 6.084 . . . . 0.0 110.292 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.421 HG12 ' HG3' ' A' ' 77' ' ' LYS . 30.8 mt -52.33 141.99 5.5 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.552 2 O-C-N 130.248 4.717 . . . . 0.0 104.87 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.65 59.03 0.7 Allowed 'General case' 0 C--O 1.213 -0.832 1 O-C-N 130.75 5.032 . . . . 0.0 105.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.3 t -64.02 102.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 O-C-N 127.848 3.218 . . . . 0.0 110.842 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.559 ' C ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -140.63 -174.03 3.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 115.408 -2.517 . . . . 0.0 110.554 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.559 ' CG ' ' C ' ' A' ' 91' ' ' ARG 0.299 0.0 OUTLIER 176.9 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 132.386 6.054 . . . . 0.0 105.822 -178.858 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.473 HG23 ' CE1' ' A' ' 2' ' ' PHE . 0.1 OUTLIER -39.86 100.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.05 1 O-C-N 131.673 5.608 . . . . 0.0 110.001 179.247 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 m -85.59 -69.07 0.68 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 108.838 -3.801 . . . . 0.0 117.723 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.06 -106.44 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 CA-C-O 126.279 3.155 . . . . 0.0 105.705 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.33 52.61 1.55 Allowed 'General case' 0 CA--C 1.54 0.586 1 CA-C-N 108.009 -4.095 . . . . 0.0 105.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.318 0.0 OUTLIER -159.81 -118.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 1 O-C-N 130.399 4.812 . . . . 0.0 106.272 179.546 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' A' ' 100' ' ' GLN . 9.9 tt 155.88 103.56 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.196 1 O-C-N 129.849 4.468 . . . . 0.0 109.442 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -48.49 -72.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.41 -2.472 1 O-C-N 130.903 5.127 . . . . 0.0 107.483 -179.876 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 7.6 tp60 79.06 100.71 0.06 Allowed 'General case' 0 CA--C 1.562 1.428 1 O-C-N 134.737 7.523 . . . . 0.0 100.428 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.469 ' CG2' ' HG3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -105.94 119.77 40.04 Favored 'General case' 0 N--CA 1.411 -2.41 2 O-C-N 134.04 7.088 . . . . 0.0 114.346 179.752 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.66 81.93 8.65 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ILE . 1.5 m -65.94 98.65 0.43 Allowed 'General case' 0 C--N 1.361 1.067 1 O-C-N 132.359 6.037 . . . . 0.0 101.332 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -107.62 120.29 41.8 Favored 'General case' 0 N--CA 1.435 -1.19 2 O-C-N 129.718 4.386 . . . . 0.0 113.359 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 4.88 64.65 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 126.937 2.648 . . . . 0.0 117.601 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.89 13.29 29.88 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 118.39 -1.862 . . . . 0.0 116.347 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.61 148.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-O 116.618 -1.658 . . . . 0.0 115.197 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -117.59 67.46 0.75 Allowed 'General case' 0 C--N 1.362 1.129 1 O-C-N 129.724 4.39 . . . . 0.0 106.586 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.411 . . -99.94 97.16 8.07 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 127.672 3.108 . . . . 0.0 111.582 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HG3' ' CG2' ' A' ' 101' ' ' THR . 2.1 mtmt -89.98 176.51 6.77 Favored 'General case' 0 N--CA 1.419 -1.982 2 O-C-N 135.117 7.76 . . . . 0.0 110.074 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -135.24 117.32 15.38 Favored 'General case' 0 CA--C 1.561 1.39 3 O-C-N 131.975 5.797 . . . . 0.0 98.991 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.14 126.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 1 O-C-N 129.495 4.247 . . . . 0.0 112.468 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.631 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 31.1 m-85 -140.19 -149.24 0.27 Allowed 'General case' 0 N--CA 1.445 -0.72 1 O-C-N 129.851 4.469 . . . . 0.0 107.858 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.18 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 1 O-C-N 131.114 5.259 . . . . 0.0 112.257 -179.147 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.567 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 28.3 tttt -123.04 -130.53 0.27 Allowed 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.721 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.264 0.3 OUTLIER . . . . . 0 C--O 1.21 -0.985 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.966 0 CA-C-O 116.974 -1.489 . . . . 0.0 107.897 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.36 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 128.827 3.83 . . . . 0.0 116.8 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.97 176.35 36.56 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 114.853 -3.546 . . . . 0.0 105.79 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.392 0.2 OUTLIER -93.01 160.89 14.67 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 111.898 -3.921 . . . . 0.0 109.747 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.537 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 12.8 m95 -127.61 161.29 29.19 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-O 113.033 -3.365 . . . . 0.0 111.095 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.523 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 10.6 mtmt 46.41 -179.59 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.328 0.9 OUTLIER . . . . . 0 CA--C 1.487 -1.458 3 CA-C-O 133.024 6.154 . . . . 0.0 119.239 174.984 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.997 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' NZ ' ' A' ' 35' ' ' LYS 0.395 0.0 OUTLIER -174.86 134.55 0.36 Allowed 'General case' 0 CA--C 1.566 1.569 1 O-C-N 132.379 6.049 . . . . 0.0 103.891 -179.962 . . . . . . . . 5 4 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -97.29 158.22 15.57 Favored 'General case' 0 CA--C 1.555 1.147 3 O-C-N 130.705 5.003 . . . . 0.0 97.801 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.572 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.4 m 173.18 94.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 2 CA-C-O 130.402 4.906 . . . . 0.0 102.455 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.476 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 3.5 mp -106.89 138.41 32.82 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 109.429 -3.532 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -174.56 73.0 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.168 2.792 . . . . 0.0 108.468 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 32' ' ' PHE . 3.7 mm-40 -92.17 -95.0 0.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 113.367 -3.333 . . . . 0.0 112.295 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.47 1.82 0.53 Allowed 'General case' 0 C--O 1.251 1.138 0 O-C-N 127.982 3.302 . . . . 0.0 107.797 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.89 -33.15 5.76 Favored Glycine 0 CA--C 1.539 1.558 1 N-CA-C 101.552 -4.619 . . . . 0.0 101.552 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.48 -36.99 9.76 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-O 112.723 -3.513 . . . . 0.0 112.188 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HG2' ' CG ' ' A' ' 48' ' ' GLU . 72.5 mttt -111.37 173.92 6.11 Favored 'General case' 0 C--O 1.247 0.923 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 32' ' ' PHE 0.265 2.0 p90 -167.8 68.66 0.08 Allowed 'General case' 0 C--O 1.187 -2.222 1 C-N-CA 110.836 -4.346 . . . . 0.0 100.757 178.638 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.01 123.3 13.13 Favored 'General case' 0 CA--C 1.502 -0.894 2 CA-C-N 105.777 -5.192 . . . . 0.0 103.947 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.413 0.5 OUTLIER -91.41 142.74 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 101.584 -3.487 . . . . 0.0 101.584 -179.753 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.572 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.279 6.2 tttt -77.68 1.54 19.58 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 110.629 -2.987 . . . . 0.0 118.603 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' CB ' HG12 ' A' ' 34' ' ' VAL 0.252 0.0 OUTLIER -36.43 99.42 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 110.597 -3.002 . . . . 0.0 109.516 -179.962 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.49 164.43 12.22 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 128.29 3.494 . . . . 0.0 110.095 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -171.19 3.04 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 125.237 1.586 . . . . 0.0 112.694 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -76.05 -7.75 55.4 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.962 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 33.9 m-85 -80.94 -71.66 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.18 -2.736 . . . . 0.0 110.396 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -150.78 -172.31 4.16 Favored 'General case' 0 N--CA 1.433 -1.286 1 O-C-N 131.891 5.744 . . . . 0.0 112.443 179.871 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.41 ' C ' HG21 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.87 -23.46 59.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 113.753 -3.179 . . . . 0.0 104.25 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.439 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 7.4 tp 28.18 80.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.122 2 O-C-N 132.839 6.337 . . . . 0.0 110.676 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.35 120.52 21.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 109.701 -3.408 . . . . 0.0 105.828 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 47' ' ' PHE . 98.2 t -91.12 97.9 7.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 1 O-C-N 132.254 5.971 . . . . 0.0 102.779 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.316 8.9 p -99.98 158.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 1 O-C-N 129.161 4.038 . . . . 0.0 115.226 -179.967 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CE2' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -178.8 -160.45 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 129.543 4.277 . . . . 0.0 112.055 -179.64 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.45 ' CG ' ' HG2' ' A' ' 31' ' ' LYS 0.294 22.9 mt-10 -142.77 63.03 1.4 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.278 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 32' ' ' PHE . 19.5 mt 54.15 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.217 0 O-C-N 128.159 3.412 . . . . 0.0 114.626 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 68' ' ' THR . . . -94.52 82.44 0.94 Allowed Glycine 0 C--O 1.197 -2.2 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.95 111.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 O-C-N 132.747 5.616 . . . . 0.0 112.897 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.87 163.34 14.07 Favored 'General case' 0 C--N 1.365 1.266 1 O-C-N 129.35 4.156 . . . . 0.0 106.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -173.32 143.64 1.11 Allowed 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 114.003 -3.079 . . . . 0.0 116.209 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.52 91.02 4.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.68 147.57 28.37 Favored 'General case' 0 C--O 1.208 -1.094 1 O-C-N 130.192 4.682 . . . . 0.0 112.772 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.61 92.98 4.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 128.16 3.413 . . . . 0.0 103.539 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 2.7 tp -47.36 -86.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 1 O-C-N 130.75 5.031 . . . . 0.0 109.998 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.27 -135.85 0.02 OUTLIER 'General case' 0 C--O 1.248 1.001 0 C-N-CA 116.875 -1.93 . . . . 0.0 109.723 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.46 -37.02 82.3 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.521 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.77 -81.71 0.82 Allowed Glycine 0 CA--C 1.545 1.909 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.41 HG23 HD11 ' A' ' 63' ' ' LEU . 1.4 m 35.7 77.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 1 O-C-N 131.089 4.641 . . . . 0.0 113.426 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -81.99 139.93 34.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 115.31 -2.556 . . . . 0.0 104.36 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -155.73 44.21 0.44 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 129.264 4.102 . . . . 0.0 111.695 -179.719 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -43.03 106.71 0.07 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 111.866 -2.424 . . . . 0.0 109.525 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -173.48 -161.98 24.63 Favored Glycine 0 N--CA 1.479 1.502 1 C-N-CA 111.133 -5.317 . . . . 0.0 107.474 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 8.3 t -154.36 142.04 19.92 Favored 'General case' 0 C--O 1.247 0.953 0 O-C-N 129.45 3.677 . . . . 0.0 116.585 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.732 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 6.1 m95 -122.28 96.76 5.17 Favored 'General case' 0 C--O 1.196 -1.713 0 CA-C-O 113.192 -3.289 . . . . 0.0 102.595 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.403 HG23 HG22 ' A' ' 66' ' ' THR . 1.2 t -105.72 75.58 1.14 Allowed 'General case' 0 N--CA 1.438 -1.058 2 O-C-N 139.426 10.454 . . . . 0.0 114.404 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.408 ' HB3' HD23 ' A' ' 49' ' ' LEU 0.262 30.7 ttp -46.33 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 2 O-C-N 132.991 6.432 . . . . 0.0 103.778 179.963 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -46.52 90.12 Favored 'General case' 0 C--O 1.211 -0.948 1 O-C-N 132.094 5.871 . . . . 0.0 104.831 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.17 -76.83 0.04 OUTLIER Glycine 0 CA--C 1.549 2.17 0 N-CA-C 105.326 -3.11 . . . . 0.0 105.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -114.34 9.98 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.166 2.921 . . . . 0.0 107.89 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.28 -178.97 3.8 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 128.945 3.903 . . . . 0.0 108.32 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.2 mt -152.69 43.06 0.64 Allowed 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 126.853 2.596 . . . . 0.0 112.772 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 76' ' ' GLY . 15.3 t -69.52 140.1 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 1 CA-C-N 107.85 -4.25 . . . . 0.0 117.525 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' HG11 ' A' ' 75' ' ' VAL . . . 165.8 -142.24 7.55 Favored Glycine 0 CA--C 1.547 2.059 3 CA-C-N 107.232 -4.531 . . . . 0.0 102.545 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HG3' HG12 ' A' ' 88' ' ' ILE 0.369 8.0 tttt 175.71 125.29 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.408 1 O-C-N 132.135 5.256 . . . . 0.0 112.517 -179.75 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.732 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -123.0 156.37 34.93 Favored 'General case' 0 C--O 1.204 -1.325 3 O-C-N 130.323 4.764 . . . . 0.0 102.073 -179.151 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' CE ' ' HB2' ' A' ' 86' ' ' GLU 0.335 0.0 OUTLIER -160.68 152.03 19.25 Favored 'General case' 0 N--CA 1.424 -1.766 1 CA-C-N 107.282 -4.508 . . . . 0.0 114.664 179.989 . . . . . . . . 5 4 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.593 ' NE ' ' HZ1' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -105.14 99.59 9.2 Favored 'General case' 0 CA--C 1.556 1.173 0 O-C-N 128.65 3.719 . . . . 0.0 108.344 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -43.46 -29.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 1 O-C-N 129.886 4.491 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -39.75 -56.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.505 1 O-C-N 133.537 6.773 . . . . 0.0 105.444 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -122.43 8.56 9.62 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 129.069 3.981 . . . . 0.0 113.438 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.78 50.84 56.43 Favored Glycine 0 CA--C 1.55 2.26 1 N-CA-C 101.83 -4.508 . . . . 0.0 101.83 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.593 ' HZ1' ' NE ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -82.78 -64.14 1.23 Allowed 'General case' 0 N--CA 1.413 -2.284 1 O-C-N 131.813 5.067 . . . . 0.0 120.188 -179.355 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB2' ' CE ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER 81.35 137.66 0.06 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 131.953 5.783 . . . . 0.0 113.415 -177.656 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.424 HD23 ' HG ' ' A' ' 63' ' ' LEU 0.314 0.2 OUTLIER -155.88 34.96 0.35 Allowed 'General case' 0 C--O 1.201 -1.481 1 O-C-N 133.542 6.776 . . . . 0.0 113.02 177.979 . . . . . . . . 5 4 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.421 HG12 ' HG3' ' A' ' 77' ' ' LYS . 75.6 mt -46.54 114.71 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.562 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.584 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HB1' ' CZ2' ' A' ' 67' ' ' TRP . . . -85.61 69.7 10.67 Favored 'General case' 0 C--O 1.196 -1.758 1 O-C-N 130.659 4.974 . . . . 0.0 106.611 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.54 127.23 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 1 O-C-N 133.109 6.506 . . . . 0.0 100.916 178.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HD3' ' CA ' ' A' ' 100' ' ' GLN . 2.3 ttp180 -158.17 161.75 37.88 Favored 'General case' 0 C--O 1.191 -2.02 1 C-N-CA 109.702 -4.799 . . . . 0.0 112.876 -177.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.6 145.99 2.11 Favored 'General case' 0 C--N 1.35 0.593 1 O-C-N 131.274 5.359 . . . . 0.0 106.411 179.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 1.1 mm -53.68 111.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 1 O-C-N 130.141 4.651 . . . . 0.0 110.695 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 t -51.97 -61.46 2.25 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 128.253 3.47 . . . . 0.0 116.025 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.48 -94.73 0.12 Allowed Glycine 0 C--O 1.206 -1.626 1 N-CA-C 102.987 -4.045 . . . . 0.0 102.987 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -102.35 32.85 3.36 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 111.027 -2.586 . . . . 0.0 107.905 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.84 175.05 0.87 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 128.669 3.731 . . . . 0.0 105.217 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.519 ' CD2' ' CG ' ' A' ' 100' ' ' GLN . 1.3 tt -109.41 157.48 18.88 Favored 'General case' 0 C--O 1.201 -1.457 1 O-C-N 132.326 6.016 . . . . 0.0 110.034 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 1.0 OUTLIER -116.09 -62.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 1 O-C-N 129.433 4.208 . . . . 0.0 109.608 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.519 ' CG ' ' CD2' ' A' ' 98' ' ' LEU . 23.7 mt-30 83.09 134.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.469 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.0 m -141.88 101.15 3.89 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.989 5.18 . . . . 0.0 112.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -88.49 95.33 10.18 Favored 'General case' 0 C--O 1.203 -1.348 1 O-C-N 129.673 4.358 . . . . 0.0 107.205 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.5 m -62.32 120.03 10.2 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 178.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -170.14 119.68 0.6 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 110.946 -2.843 . . . . 0.0 113.386 -179.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 40.66 -81.16 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.635 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -61.01 -18.52 54.81 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.941 -3.028 . . . . 0.0 110.94 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.22 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 46.18 79.86 0.05 Allowed 'General case' 0 C--N 1.358 0.946 1 O-C-N 129.354 4.159 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.346 . . -117.99 74.64 0.95 Allowed 'General case' 0 C--O 1.199 -1.568 0 O-C-N 126.595 2.434 . . . . 0.0 108.585 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -84.04 153.09 24.02 Favored 'General case' 0 N--CA 1.416 -2.153 1 O-C-N 131.64 5.588 . . . . 0.0 111.665 -179.104 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -179.88 4.12 Favored 'General case' 0 CA--C 1.558 1.274 1 CA-C-N 107.964 -4.198 . . . . 0.0 104.758 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 mp -131.08 108.45 15.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 1 O-C-N 129.498 4.249 . . . . 0.0 112.933 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -119.69 179.66 4.16 Favored 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.951 5.157 . . . . 0.0 106.676 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.7 126.02 0.08 Allowed 'General case' 0 N--CA 1.429 -1.477 2 O-C-N 132.3 6.0 . . . . 0.0 113.577 -179.758 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.537 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 18.0 tttt -38.09 -57.07 1.1 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 110.014 -3.266 . . . . 0.0 116.463 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.423 -1.797 0 O-C-N 127.902 3.251 . . . . 0.0 111.371 179.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' GLY . 2.6 m-85 . . . . . 0 CA--C 1.56 1.357 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.93 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.418 -2.035 1 O-C-N 129.633 4.333 . . . . 0.0 116.472 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' PHE . . . 164.46 147.43 5.1 Favored Glycine 0 C--N 1.339 0.701 1 C-N-CA 112.22 -4.8 . . . . 0.0 106.612 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.1 p -61.46 166.2 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 115.729 -2.389 . . . . 0.0 108.564 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 115' ' ' LYS 0.25 73.4 m95 -139.46 158.74 43.63 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 111.758 -3.972 . . . . 0.0 110.43 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.498 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 11.4 mtmt 51.02 -178.25 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.837 0 O-C-N 128.571 3.67 . . . . 0.0 117.141 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.308 1.2 t . . . . . 0 CA--C 1.485 -1.534 3 O-C-N 134.303 7.252 . . . . 0.0 114.78 174.931 . . . . . . . . 2 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.401 0.0 OUTLIER 167.98 153.97 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.626 1 O-C-N 132.317 6.01 . . . . 0.0 100.668 -179.66 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 8.0 mt -112.59 170.33 8.26 Favored 'General case' 0 CA--C 1.551 0.99 1 O-C-N 133.266 6.604 . . . . 0.0 101.028 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 25' ' ' ILE . 1.6 m -156.14 -81.6 0.07 Allowed 'General case' 0 C--O 1.199 -1.577 1 O-C-N 130.218 4.699 . . . . 0.0 106.264 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.451 ' N ' HG23 ' A' ' 24' ' ' THR . 2.6 mp 70.91 129.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.385 0 CA-C-N 109.142 -3.663 . . . . 0.0 109.733 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.0 m -162.55 80.19 0.51 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.1 148.34 36.23 Favored 'General case' 0 C--N 1.357 0.918 1 CA-C-N 106.08 -5.055 . . . . 0.0 115.246 -179.953 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.83 86.42 2.5 Favored 'General case' 0 CA--C 1.555 1.155 0 O-C-N 128.29 3.494 . . . . 0.0 103.412 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.13 -128.91 8.7 Favored Glycine 0 CA--C 1.552 2.365 2 C-N-CA 110.839 -5.458 . . . . 0.0 102.821 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.56 55.95 0.98 Allowed 'General case' 0 N--CA 1.437 -1.111 1 O-C-N 131.083 4.637 . . . . 0.0 109.252 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -146.84 122.56 10.54 Favored 'General case' 0 CA--C 1.552 1.041 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CE2' ' HG2' ' A' ' 69' ' ' MET . 3.8 m-85 -119.48 171.09 8.59 Favored 'General case' 0 C--O 1.211 -0.933 2 O-C-N 130.111 4.632 . . . . 0.0 99.061 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.68 127.88 5.57 Favored 'General case' 0 C--O 1.249 1.058 3 O-C-N 136.284 8.49 . . . . 0.0 98.674 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 36' ' ' GLU 0.369 2.4 t -101.56 146.89 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HD2' ' CB ' ' A' ' 24' ' ' THR 0.27 12.7 ttmt -91.67 48.57 1.47 Allowed 'General case' 0 C--O 1.195 -1.791 0 CA-C-O 127.491 3.52 . . . . 0.0 115.145 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG3' HG13 ' A' ' 34' ' ' VAL 0.284 7.3 mt-10 -69.01 88.53 0.4 Allowed 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 m -86.61 128.02 34.96 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 127.222 2.826 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.6 -161.98 0.92 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 114.683 -2.807 . . . . 0.0 115.128 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -96.26 -7.21 36.1 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 111.961 -2.382 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -92.28 -65.9 0.97 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 114.572 -2.851 . . . . 0.0 107.265 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 -155.69 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 128.654 3.721 . . . . 0.0 110.616 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -75.66 -67.44 0.67 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 112.263 -3.775 . . . . 0.0 103.604 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.251 0.4 OUTLIER 72.42 75.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.422 2 CA-C-O 134.919 7.057 . . . . 0.0 105.52 179.76 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.05 151.84 23.38 Favored 'General case' 0 C--N 1.373 1.619 1 CA-C-N 107.182 -4.554 . . . . 0.0 105.558 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.39 117.23 53.33 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 1 O-C-N 131.104 5.253 . . . . 0.0 102.734 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.325 9.4 p -115.11 155.42 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 115.798 -2.361 . . . . 0.0 110.977 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -166.79 177.88 6.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 127.667 3.104 . . . . 0.0 111.442 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -119.35 67.5 0.8 Allowed 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 115.326 -2.55 . . . . 0.0 115.169 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 tp 23.32 75.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.812 1 O-C-N 130.148 4.655 . . . . 0.0 116.237 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.87 57.56 0.49 Allowed Glycine 0 CA--C 1.561 2.911 1 CA-C-O 112.545 -4.475 . . . . 0.0 104.452 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -150.67 120.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 O-C-N 134.662 6.742 . . . . 0.0 114.932 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.82 151.99 24.86 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 128.065 3.353 . . . . 0.0 107.913 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 21.4 p90 -173.66 162.71 4.16 Favored 'General case' 0 C--N 1.37 1.492 1 O-C-N 131.74 5.65 . . . . 0.0 115.006 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.68 141.41 37.17 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -154.19 102.97 2.5 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 116.732 -1.987 . . . . 0.0 109.683 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.67 95.17 2.8 Favored 'General case' 0 CA--C 1.539 0.519 1 O-C-N 129.106 4.004 . . . . 0.0 104.066 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.13 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 1 O-C-N 132.56 6.163 . . . . 0.0 109.773 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.72 177.05 3.75 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 116.584 -2.046 . . . . 0.0 109.812 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.38 66.26 4.79 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 128.543 3.652 . . . . 0.0 111.607 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.23 -38.43 0.17 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 115.243 -2.976 . . . . 0.0 108.378 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.4 p -52.79 166.54 0.2 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 129.336 3.61 . . . . 0.0 114.021 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -165.02 49.14 0.1 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 125.413 2.53 . . . . 0.0 107.906 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 mp -69.37 125.72 27.56 Favored 'General case' 0 C--N 1.367 1.347 0 CA-C-N 110.237 -3.165 . . . . 0.0 107.994 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 m -126.82 98.75 5.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.538 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.44 -164.9 18.45 Favored Glycine 0 N--CA 1.478 1.449 1 C-N-CA 111.917 -4.944 . . . . 0.0 104.475 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.401 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 8.8 t -140.56 150.67 43.95 Favored 'General case' 0 N--CA 1.428 -1.56 1 O-C-N 131.073 4.631 . . . . 0.0 116.585 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.489 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 9.0 m95 -129.43 122.89 30.3 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-O 115.476 -2.202 . . . . 0.0 105.474 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.61 97.51 4.09 Favored 'General case' 0 C--O 1.203 -1.375 1 O-C-N 136.059 8.349 . . . . 0.0 110.626 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.551 ' HG2' ' CE2' ' A' ' 32' ' ' PHE 0.254 9.2 tpp -74.24 137.98 43.36 Favored 'General case' 0 CA--C 1.512 -0.49 1 O-C-N 132.181 5.926 . . . . 0.0 105.756 179.963 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -141.28 120.64 13.11 Favored 'General case' 0 C--O 1.218 -0.576 1 O-C-N 129.178 4.049 . . . . 0.0 105.427 -179.921 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.44 -98.11 0.02 OUTLIER Glycine 0 CA--C 1.557 2.682 1 O-C-N 129.521 4.263 . . . . 0.0 106.55 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 51.14 1.82 Allowed 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 129.703 3.825 . . . . 0.0 109.87 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 70' ' ' GLU . 1.5 mtpt -137.35 160.14 39.93 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 128.409 3.568 . . . . 0.0 108.65 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.6 mt -144.23 64.72 1.3 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.57 147.0 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 CA-C-O 129.778 4.608 . . . . 0.0 115.577 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.19 -147.3 15.71 Favored Glycine 0 CA--C 1.563 3.063 1 CA-C-N 107.183 -4.553 . . . . 0.0 103.641 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.473 ' CG ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.73 139.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.651 1 O-C-N 134.045 6.38 . . . . 0.0 112.86 -179.835 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.538 ' CG ' ' HA3' ' A' ' 65' ' ' GLY . 5.5 m-85 -123.52 -169.49 1.95 Allowed 'General case' 0 C--O 1.204 -1.339 2 O-C-N 134.324 7.265 . . . . 0.0 104.648 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.316 0.0 OUTLIER -169.96 -145.68 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 109.801 -3.363 . . . . 0.0 115.162 -179.281 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 47.0 ttt180 -168.12 90.29 0.29 Allowed 'General case' 0 C--N 1.352 0.679 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.884 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -32.51 -33.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 127.621 3.076 . . . . 0.0 113.014 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -53.44 -49.5 67.23 Favored 'General case' 0 CA--C 1.508 -0.636 1 O-C-N 129.727 4.392 . . . . 0.0 111.894 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.1 19.08 2.98 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-O 113.66 -3.067 . . . . 0.0 117.908 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 63.15 55.28 27.14 Favored Glycine 0 C--O 1.2 -1.976 1 N-CA-C 102.435 -4.266 . . . . 0.0 102.435 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 6.9 tppt? -80.94 -81.82 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 2 O-C-N 132.131 5.253 . . . . 0.0 118.603 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.49 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 78.2 mt-10 86.95 97.62 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.637 1 O-C-N 131.036 5.21 . . . . 0.0 109.832 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.9 tp -124.08 53.38 1.41 Allowed 'General case' 0 C--O 1.201 -1.478 1 O-C-N 138.185 9.678 . . . . 0.0 108.607 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.473 HG12 ' CG ' ' A' ' 77' ' ' LYS . 25.5 mt -78.61 -178.0 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.176 2 CA-C-N 107.247 -4.524 . . . . 0.0 103.691 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.54 88.94 0.66 Allowed 'General case' 0 C--O 1.195 -1.794 1 O-C-N 131.804 5.69 . . . . 0.0 108.732 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.65 121.0 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 O-C-N 126.396 2.31 . . . . 0.0 107.583 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.3 tpt180 -170.63 163.04 8.11 Favored 'General case' 0 C--O 1.186 -2.243 0 C-N-CA 111.892 -3.923 . . . . 0.0 112.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.419 ' HG2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -150.87 132.22 14.6 Favored 'General case' 0 N--CA 1.426 -1.626 1 O-C-N 132.035 5.835 . . . . 0.0 107.086 179.226 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -48.18 129.28 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 1 O-C-N 132.509 6.131 . . . . 0.0 109.149 179.976 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.9 p -78.92 -67.98 0.7 Allowed 'General case' 0 C--O 1.247 0.94 0 O-C-N 127.654 3.096 . . . . 0.0 116.13 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.17 -66.92 0.33 Allowed Glycine 0 CA--C 1.545 1.95 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.34 27.73 1.24 Allowed 'General case' 0 C--N 1.35 0.619 0 CA-C-N 110.501 -2.85 . . . . 0.0 107.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.73 119.28 2.9 Favored 'General case' 0 N--CA 1.433 -1.289 0 O-C-N 128.356 3.535 . . . . 0.0 109.642 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 121.67 28.62 Favored 'General case' 0 CA--C 1.557 1.231 1 O-C-N 129.771 4.42 . . . . 0.0 108.688 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.471 ' CG2' ' HB2' ' A' ' 110' ' ' LYS . 30.9 mt -74.04 -80.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.491 2 CA-C-O 111.285 -4.198 . . . . 0.0 108.206 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 99.75 112.6 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.394 2 O-C-N 136.054 8.346 . . . . 0.0 98.127 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 110' ' ' LYS . 30.9 p -82.95 -32.07 27.33 Favored 'General case' 0 N--CA 1.404 -2.74 1 O-C-N 130.306 4.754 . . . . 0.0 119.906 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 104' ' ' TYR . 62.9 m-85 60.24 70.22 0.64 Allowed 'General case' 0 CA--C 1.565 1.538 0 O-C-N 128.973 3.921 . . . . 0.0 103.558 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.6 m -69.22 73.7 0.32 Allowed 'General case' 0 C--O 1.215 -0.712 1 O-C-N 132.169 5.918 . . . . 0.0 106.206 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' TYR . 3.3 t80 -88.85 116.74 27.34 Favored 'General case' 0 CA--C 1.495 -1.144 1 CA-C-N 108.261 -4.063 . . . . 0.0 112.863 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 61.0 46.04 8.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 112.817 -1.992 . . . . 0.0 112.708 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.82 4.12 57.44 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-O 124.769 2.316 . . . . 0.0 117.528 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.15 137.2 53.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 119.558 -2.143 . . . . 0.0 115.051 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.93 132.17 43.12 Favored 'General case' 0 C--N 1.366 1.3 1 O-C-N 129.206 4.066 . . . . 0.0 105.661 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.354 . . -138.85 44.0 2.07 Favored 'General case' 0 N--CA 1.424 -1.764 0 O-C-N 128.368 3.542 . . . . 0.0 112.783 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 2.7 pttp -74.73 168.99 18.76 Favored 'General case' 0 N--CA 1.419 -1.989 1 O-C-N 133.308 6.63 . . . . 0.0 109.047 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -145.45 -90.62 0.1 Allowed 'General case' 0 CA--C 1.556 1.208 1 O-C-N 129.292 4.12 . . . . 0.0 100.632 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -174.63 179.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 111.377 -2.647 . . . . 0.0 108.974 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 8.8 m-85 166.49 178.55 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 1 O-C-N 136.157 8.411 . . . . 0.0 104.926 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.514 ' CB ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.72 -154.17 0.33 Allowed 'General case' 0 C--O 1.198 -1.607 1 O-C-N 131.795 5.684 . . . . 0.0 111.515 178.683 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HG3' ' CE3' ' A' ' 6' ' ' TRP 0.253 29.9 tttt -110.53 -138.39 0.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.255 7.7 tp10 . . . . . 0 N--CA 1.442 -0.841 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.441 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 . . . . . 0 CA--C 1.56 1.352 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -35.36 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 129.785 4.428 . . . . 0.0 117.878 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 153.13 175.56 24.68 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 115.413 -3.279 . . . . 0.0 105.297 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.285 3.6 p -90.78 176.8 6.51 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 113.274 -3.37 . . . . 0.0 103.844 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.54 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 28.4 m95 -147.21 160.37 42.55 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-O 112.592 -3.575 . . . . 0.0 112.435 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 2.5 mtmt 50.93 -178.89 0.02 OUTLIER 'General case' 0 C--O 1.195 -1.784 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.26 0.5 OUTLIER . . . . . 0 CA--C 1.483 -1.627 3 CA-C-O 135.409 7.29 . . . . 0.0 119.675 174.899 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.445 0 CA-C-O 114.266 -2.778 . . . . 0.0 104.793 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER -171.72 150.54 2.71 Favored 'General case' 0 CA--C 1.563 1.464 1 O-C-N 133.302 6.626 . . . . 0.0 102.228 179.843 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.4 mt -115.32 157.1 24.3 Favored 'General case' 0 CA--C 1.565 1.546 4 O-C-N 132.916 6.385 . . . . 0.0 97.666 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.56 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.9 m 172.09 96.46 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.249 1 O-C-N 132.768 6.292 . . . . 0.0 102.745 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' CD1' ' A' ' 32' ' ' PHE . 3.0 mp -114.66 112.35 39.72 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 108.96 -3.746 . . . . 0.0 109.962 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 35.9 m -155.07 79.68 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 127.74 3.15 . . . . 0.0 108.44 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.497 ' CB ' ' C ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -88.08 -98.62 0.09 Allowed 'General case' 0 C--N 1.355 0.845 3 CA-C-N 105.865 -5.152 . . . . 0.0 111.634 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.88 -6.17 4.51 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 128.088 3.367 . . . . 0.0 106.47 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.31 -27.4 8.11 Favored Glycine 0 CA--C 1.546 1.969 1 N-CA-C 99.189 -5.565 . . . . 0.0 99.189 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -25.67 6.0 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 111.737 -3.983 . . . . 0.0 111.627 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' C ' ' CB ' ' A' ' 27' ' ' GLN . 2.6 mttm -101.56 178.89 4.51 Favored 'General case' 0 C--O 1.25 1.085 1 N-CA-C 97.596 -4.964 . . . . 0.0 97.596 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -176.64 139.38 0.31 Allowed 'General case' 0 C--O 1.19 -2.076 1 N-CA-C 97.217 -5.105 . . . . 0.0 97.217 178.875 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.67 119.88 25.5 Favored 'General case' 0 C--O 1.249 1.028 3 O-C-N 136.446 8.591 . . . . 0.0 98.577 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.364 1.2 t -84.6 128.41 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 1 N-CA-C 99.747 -4.168 . . . . 0.0 99.747 -179.944 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.295 5.3 tttm -67.72 -8.88 38.92 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 120.775 3.62 . . . . 0.0 120.775 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HB2' ' CG1' ' A' ' 34' ' ' VAL 0.339 3.9 tt0 -29.37 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 108.499 -3.955 . . . . 0.0 109.965 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -80.45 155.65 26.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 114.228 -2.989 . . . . 0.0 111.035 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.6 t -121.57 -151.82 0.49 Allowed 'General case' 0 N--CA 1.442 -0.827 0 O-C-N 127.527 3.017 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.13 -29.56 11.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 126.198 2.186 . . . . 0.0 108.937 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.507 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 10.2 m-85 -66.5 -60.49 2.69 Favored 'General case' 0 CA--C 1.551 1.013 1 O-C-N 130.654 4.971 . . . . 0.0 105.162 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.507 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -151.58 -163.28 1.71 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 128.972 3.92 . . . . 0.0 113.54 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.39 -16.46 52.14 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 121.431 1.923 . . . . 0.0 109.939 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 41' ' ' ARG . 8.8 tt 20.05 94.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.266 2 O-C-N 132.336 6.022 . . . . 0.0 111.972 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 152.1 22.0 Favored 'General case' 0 C--N 1.366 1.304 0 O-C-N 117.001 -3.562 . . . . 0.0 104.198 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -126.79 91.64 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.93 1 O-C-N 130.469 4.855 . . . . 0.0 103.707 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.29 0.7 OUTLIER -92.18 158.89 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 1 C-N-CA 111.052 -4.259 . . . . 0.0 115.764 -179.993 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -154.66 -177.0 6.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 O-C-N 129.011 3.944 . . . . 0.0 111.303 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG3' ' CE ' ' A' ' 31' ' ' LYS 0.258 1.2 tt0 -130.22 31.54 4.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.267 3.48 . . . . 0.0 111.805 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.83 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 1 O-C-N 133.749 6.906 . . . . 0.0 113.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.51 52.14 3.28 Favored Glycine 0 CA--C 1.548 2.118 0 CA-C-O 113.797 -3.779 . . . . 0.0 104.085 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.31 104.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 1 O-C-N 134.851 6.853 . . . . 0.0 113.531 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 145.57 33.63 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 110.45 -3.068 . . . . 0.0 109.563 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.58 124.01 7.72 Favored 'General case' 0 C--N 1.372 1.577 2 O-C-N 129.733 4.396 . . . . 0.0 116.131 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.6 73.53 4.36 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 121.75 41.27 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 127.564 3.04 . . . . 0.0 112.375 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -74.47 114.84 13.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 111.853 -3.939 . . . . 0.0 106.54 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.43 155.92 20.7 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 127.229 2.831 . . . . 0.0 112.408 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.41 22.93 3.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 115.721 -2.085 . . . . 0.0 114.026 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t70 39.14 38.7 0.34 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 128.957 3.911 . . . . 0.0 112.16 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.81 -58.03 0.01 OUTLIER Glycine 0 CA--C 1.543 1.786 0 N-CA-C 105.725 -2.95 . . . . 0.0 105.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -77.07 149.48 35.77 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 127.8 2.706 . . . . 0.0 114.274 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -143.31 66.24 1.31 Allowed 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.27 117.67 5.05 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 129.093 3.996 . . . . 0.0 107.255 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -123.57 109.55 13.92 Favored 'General case' 0 C--O 1.205 -1.283 0 O-C-N 126.404 2.315 . . . . 0.0 108.65 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 178.13 -146.11 7.31 Favored Glycine 0 N--CA 1.479 1.558 1 C-N-CA 113.838 -4.03 . . . . 0.0 103.727 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.312 15.2 t -176.16 141.44 0.44 Allowed 'General case' 0 CA--C 1.486 -1.485 1 O-C-N 131.247 4.733 . . . . 0.0 119.58 -178.553 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.722 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.5 m95 -107.5 145.45 33.08 Favored 'General case' 0 C--O 1.195 -1.769 1 O-C-N 115.971 -4.206 . . . . 0.0 100.5 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 p -126.56 25.21 6.52 Favored 'General case' 0 N--CA 1.428 -1.526 2 O-C-N 135.278 7.861 . . . . 0.0 115.21 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 3.65 105.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.887 1 O-C-N 137.638 9.336 . . . . 0.0 108.611 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 4.5 mp0 -114.0 -170.74 1.77 Allowed 'General case' 0 C--O 1.215 -0.713 1 O-C-N 129.625 4.328 . . . . 0.0 110.391 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.41 105.83 0.81 Allowed Glycine 0 CA--C 1.541 1.707 0 O-C-N 127.354 2.909 . . . . 0.0 108.51 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 39.71 55.56 2.43 Favored 'General case' 0 C--O 1.238 0.491 1 O-C-N 131.496 4.88 . . . . 0.0 110.046 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -140.36 -174.27 3.9 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 127.021 2.701 . . . . 0.0 109.772 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.1 mt -161.01 30.69 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 O-C-N 126.391 2.307 . . . . 0.0 115.507 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 t -59.27 137.14 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 2 O-C-N 131.24 5.338 . . . . 0.0 114.42 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' HA3' ' CZ3' ' A' ' 67' ' ' TRP . . . 154.22 -139.94 7.14 Favored Glycine 0 C--O 1.197 -2.186 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 78' ' ' PHE 0.333 20.1 tttm -177.63 176.51 1.24 Allowed 'General case' 0 C--N 1.371 1.531 1 O-C-N 133.164 5.861 . . . . 0.0 110.145 -178.682 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 22.4 m-85 -176.06 172.62 2.36 Favored 'General case' 0 C--O 1.212 -0.92 2 O-C-N 134.178 7.174 . . . . 0.0 102.602 175.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG2' ' C ' ' A' ' 85' ' ' LYS 0.296 13.7 ttmt -160.22 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.825 1 CA-C-N 105.076 -5.511 . . . . 0.0 110.135 179.962 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' CA ' ' A' ' 84' ' ' GLY 0.272 5.9 ptt180 175.61 56.91 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 117.267 -1.349 . . . . 0.0 111.336 178.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.7 t -41.46 87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.558 2 O-C-N 134.769 7.543 . . . . 0.0 108.521 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 t70 170.31 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.107 1 O-C-N 130.597 4.935 . . . . 0.0 107.348 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.93 -0.38 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 129.017 3.948 . . . . 0.0 115.377 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -101.93 -35.01 4.12 Favored Glycine 0 CA--C 1.54 1.649 1 C-N-CA 113.036 -4.411 . . . . 0.0 105.546 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.48 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 75.43 -174.76 0.12 Allowed 'General case' 0 CA--C 1.495 -1.145 1 O-C-N 131.292 4.76 . . . . 0.0 114.063 179.837 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.258 6.6 mt-10 -34.41 142.01 0.05 OUTLIER 'General case' 0 C--O 1.198 -1.623 1 O-C-N 130.077 4.611 . . . . 0.0 116.334 -177.297 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.429 HD13 ' HD3' ' A' ' 80' ' ' ARG . 40.4 mt -150.65 37.22 0.65 Allowed 'General case' 0 C--O 1.194 -1.829 1 O-C-N 132.969 6.418 . . . . 0.0 110.074 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.437 HG12 ' HG3' ' A' ' 77' ' ' LYS . 21.5 mt -62.27 152.39 6.92 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 3 O-C-N 130.053 4.596 . . . . 0.0 99.54 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 67' ' ' TRP . . . -124.98 87.15 2.66 Favored 'General case' 0 C--O 1.197 -1.7 1 O-C-N 135.58 8.05 . . . . 0.0 110.363 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.23 107.85 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 114.892 -2.723 . . . . 0.0 105.232 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -168.53 164.27 12.49 Favored 'General case' 0 C--O 1.194 -1.868 1 C-N-CA 111.097 -4.241 . . . . 0.0 115.717 -179.519 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -151.77 143.65 23.76 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 128.6 3.687 . . . . 0.0 104.088 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 0.3 OUTLIER -58.35 81.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 1 O-C-N 133.176 6.548 . . . . 0.0 110.135 -179.985 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.62 -114.72 0.81 Allowed Glycine 0 CA--C 1.55 2.223 0 N-CA-C 104.528 -3.429 . . . . 0.0 104.528 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -113.86 24.74 11.8 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 109.688 -3.256 . . . . 0.0 108.893 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.91 165.21 32.61 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 110.963 -2.835 . . . . 0.0 106.756 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD13 ' CD1' ' A' ' 93' ' ' ILE . 5.3 tt -110.48 121.23 44.8 Favored 'General case' 0 N--CA 1.447 -0.582 1 O-C-N 130.162 4.664 . . . . 0.0 109.826 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 91' ' ' ARG . 1.7 mt -71.11 -55.79 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 109.47 -3.513 . . . . 0.0 107.724 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.425 ' N ' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 73.65 105.68 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 1 O-C-N 132.27 5.981 . . . . 0.0 103.97 -179.915 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.402 HG21 ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.21 91.03 3.48 Favored 'General case' 0 N--CA 1.424 -1.763 2 O-C-N 132.408 6.067 . . . . 0.0 113.141 179.671 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.77 125.5 27.01 Favored 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 109.309 -4.956 . . . . 0.0 105.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.9 m -96.53 68.01 2.47 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 127.811 3.672 . . . . 0.0 105.982 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 2.0 t80 -65.06 156.68 30.7 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 109.803 -3.362 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 5.0 tp10 -47.76 104.55 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 112.848 -1.978 . . . . 0.0 115.681 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.8 83.78 Favored Glycine 0 C--N 1.347 1.178 0 C-N-CA 117.799 -2.143 . . . . 0.0 116.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.269 2.5 t -136.93 169.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -143.15 58.1 1.4 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.422 . . -98.42 152.49 19.44 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 114.658 -2.817 . . . . 0.0 111.287 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.402 ' HG2' HG21 ' A' ' 101' ' ' THR . 0.2 OUTLIER -109.95 -163.21 0.84 Allowed 'General case' 0 N--CA 1.444 -0.747 1 O-C-N 134.029 7.081 . . . . 0.0 107.359 -179.771 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -57.63 0.74 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 110.469 -3.059 . . . . 0.0 105.801 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.284 4.5 mt 86.88 115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.027 1 O-C-N 129.386 4.179 . . . . 0.0 110.096 -179.847 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 9.1 m-85 -142.62 179.65 6.85 Favored 'General case' 0 N--CA 1.417 -2.081 1 O-C-N 130.091 4.619 . . . . 0.0 107.167 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -150.36 -160.92 1.24 Allowed 'General case' 0 C--O 1.196 -1.756 1 O-C-N 131.97 5.793 . . . . 0.0 111.836 179.501 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 11.7 tttt -123.17 152.61 41.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 111.812 -2.449 . . . . 0.0 112.549 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.419 -1.989 1 O-C-N 129.389 4.18 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.56 1.345 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.95 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.777 1 O-C-N 131.027 5.204 . . . . 0.0 117.415 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.8 148.16 5.04 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 114.893 -3.17 . . . . 0.0 106.265 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.295 36.0 p -68.28 167.88 13.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 112.361 -3.735 . . . . 0.0 110.094 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.546 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 73.1 m95 -141.27 167.69 21.57 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-O 111.116 -4.278 . . . . 0.0 113.487 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.554 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 5.3 mtmt 36.85 171.84 0.0 OUTLIER 'General case' 0 C--O 1.19 -2.057 1 O-C-N 133.813 6.946 . . . . 0.0 119.182 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.287 0.9 OUTLIER . . . . . 0 CA--C 1.491 -1.321 3 CA-C-N 105.262 -5.426 . . . . 0.0 119.331 174.941 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.566 1.589 0 CA-C-O 114.107 -2.854 . . . . 0.0 105.491 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.432 31.0 mttt 145.07 170.74 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.604 1 O-C-N 134.015 7.072 . . . . 0.0 101.018 -178.847 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' CA ' ' HB2' ' A' ' 6' ' ' TRP . 7.3 mt -141.83 -178.63 5.76 Favored 'General case' 0 CA--C 1.567 1.604 3 O-C-N 133.148 6.53 . . . . 0.0 96.985 177.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.481 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 18.7 m -166.65 -90.04 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 128.418 3.574 . . . . 0.0 106.173 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.408 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER 70.72 130.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-N 109.752 -3.385 . . . . 0.0 109.316 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.4 m -168.27 73.99 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 113.185 -3.406 . . . . 0.0 103.583 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -37.38 138.96 0.28 Allowed 'General case' 0 N--CA 1.436 -1.131 2 O-C-N 133.483 6.74 . . . . 0.0 115.576 -179.923 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -92.9 0.36 Allowed 'General case' 0 C--N 1.35 0.618 1 O-C-N 131.017 5.198 . . . . 0.0 106.505 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.55 66.5 0.24 Allowed Glycine 0 CA--C 1.55 2.266 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 68.2 14.47 9.25 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -93.88 132.7 38.05 Favored 'General case' 0 CA--C 1.552 1.047 1 CA-C-O 111.213 -4.232 . . . . 0.0 100.827 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' CD1' HD21 ' A' ' 49' ' ' LEU . 13.0 m-85 -110.59 142.17 42.8 Favored 'General case' 0 C--O 1.191 -2.004 2 N-CA-C 96.858 -5.238 . . . . 0.0 96.858 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.91 108.44 9.83 Favored 'General case' 0 CA--C 1.496 -1.116 2 O-C-N 134.575 7.422 . . . . 0.0 100.744 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.42 4.2 t -81.57 150.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 112.635 -3.626 . . . . 0.0 103.772 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.255 3.6 ttmt -98.99 36.88 1.61 Allowed 'General case' 0 N--CA 1.425 -1.711 1 CA-C-O 133.049 6.166 . . . . 0.0 116.949 179.792 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.335 28.1 tt0 -57.78 97.6 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 1 CA-C-N 107.455 -4.43 . . . . 0.0 107.512 -179.804 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.0 m -99.59 134.06 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.97 3.294 . . . . 0.0 106.767 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.23 -162.27 1.23 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 127.316 2.885 . . . . 0.0 112.807 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -57.46 -41.37 80.42 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -87.38 82.66 7.49 Favored 'General case' 0 N--CA 1.435 -1.198 2 O-C-N 131.35 5.406 . . . . 0.0 106.487 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 35.14 -143.7 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 131.284 5.365 . . . . 0.0 114.878 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -77.29 -70.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 113.109 -3.436 . . . . 0.0 106.073 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 57' ' ' LEU 0.25 0.2 OUTLIER 66.17 104.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 1 CA-C-O 132.302 5.81 . . . . 0.0 104.3 179.623 . . . . . . . . 5 4 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.83 154.23 18.17 Favored 'General case' 0 C--N 1.372 1.586 0 CA-C-N 109.673 -3.421 . . . . 0.0 106.863 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 107.61 17.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 1 O-C-N 131.157 5.286 . . . . 0.0 102.498 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.461 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.374 9.9 p -112.23 154.03 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 114.049 -3.06 . . . . 0.0 113.422 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -163.73 -163.05 0.76 Allowed 'General case' 0 N--CA 1.442 -0.829 1 O-C-N 131.657 5.598 . . . . 0.0 114.602 -179.946 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -136.28 53.38 1.93 Allowed 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.355 2.284 . . . . 0.0 114.02 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.517 HD21 ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER 52.3 19.52 1.14 Allowed 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 128.701 3.751 . . . . 0.0 115.736 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.55 71.75 0.02 OUTLIER Glycine 0 CA--C 1.546 1.978 0 N-CA-C 105.091 -3.203 . . . . 0.0 105.091 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.15 -49.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 130.159 4.094 . . . . 0.0 112.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.03 131.72 0.05 Allowed 'General case' 0 C--O 1.202 -1.441 1 O-C-N 129.426 4.204 . . . . 0.0 105.724 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -164.82 148.69 8.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 129.038 3.961 . . . . 0.0 117.09 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.54 115.77 30.92 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 100.468 -3.901 . . . . 0.0 100.468 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -139.23 128.14 23.57 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 127.972 3.295 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.49 112.6 15.71 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 115.417 -2.513 . . . . 0.0 105.692 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 HG22 ' A' ' 43' ' ' ILE . 3.5 mm? -66.49 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 O-C-N 126.501 2.376 . . . . 0.0 111.386 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.44 -142.5 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.662 -1.161 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.03 -14.25 19.52 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 124.827 1.329 . . . . 0.0 111.669 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.47 74.36 0.34 Allowed Glycine 0 CA--C 1.562 3.007 0 O-C-N 128.591 3.682 . . . . 0.0 104.67 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.8 p -150.61 148.63 28.87 Favored 'General case' 0 N--CA 1.433 -1.28 1 O-C-N 131.985 5.167 . . . . 0.0 112.81 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -147.97 48.81 1.06 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 127.12 2.763 . . . . 0.0 108.721 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.05 166.21 14.24 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 113.549 -3.26 . . . . 0.0 107.514 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -161.92 118.32 2.07 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 110.302 -3.135 . . . . 0.0 104.439 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.24 -130.26 1.39 Allowed Glycine 0 CA--C 1.529 0.936 1 C-N-CA 110.782 -5.485 . . . . 0.0 108.401 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.595 ' C ' ' CG ' ' A' ' 67' ' ' TRP . 3.3 t 170.6 139.01 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.708 1 O-C-N 132.665 5.568 . . . . 0.0 110.472 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 78' ' ' PHE . 46.6 m95 -139.2 107.54 5.81 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 122.187 2.267 . . . . 0.0 106.753 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -103.49 74.8 1.28 Allowed 'General case' 0 N--CA 1.429 -1.513 2 O-C-N 131.441 5.463 . . . . 0.0 114.143 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.432 ' HB3' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -46.29 134.09 9.05 Favored 'General case' 0 C--O 1.215 -0.724 1 O-C-N 130.804 5.065 . . . . 0.0 105.352 179.867 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -136.98 66.67 1.46 Allowed 'General case' 0 C--N 1.347 0.46 1 O-C-N 131.131 5.269 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.79 84.19 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.167 0 O-C-N 125.68 1.863 . . . . 0.0 110.719 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 63.07 28.11 16.02 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 114.899 -2.477 . . . . 0.0 114.622 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -129.69 156.96 43.41 Favored 'General case' 0 N--CA 1.476 0.869 1 O-C-N 129.877 4.485 . . . . 0.0 107.694 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ARG . 7.9 mt -141.6 47.78 1.65 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 126.571 2.419 . . . . 0.0 116.877 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 t -68.66 147.65 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 1 CA-C-N 107.85 -4.25 . . . . 0.0 112.138 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.99 27.56 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.481 ' CA ' ' CH2' ' A' ' 67' ' ' TRP 0.268 0.1 OUTLIER -174.53 128.55 0.33 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 111.951 -3.9 . . . . 0.0 117.676 -179.617 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 67' ' ' TRP . 25.6 m-85 -101.9 177.95 4.75 Favored 'General case' 0 C--O 1.204 -1.311 1 CA-C-O 129.288 4.375 . . . . 0.0 100.773 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' ' CA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.64 -129.89 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 1 CA-C-N 105.079 -5.509 . . . . 0.0 110.284 179.583 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 51.0 ttt180 168.65 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.685 0 O-C-N 128.138 3.399 . . . . 0.0 109.247 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.6 -1.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 1 O-C-N 131.93 5.768 . . . . 0.0 114.767 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.62 -26.79 12.66 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 128.493 3.621 . . . . 0.0 112.041 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.28 1.25 9.06 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 66.46 39.19 94.0 Favored Glycine 0 CA--C 1.558 2.749 1 N-CA-C 100.773 -4.931 . . . . 0.0 100.773 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.262 0.6 OUTLIER -74.44 -80.86 0.07 Allowed 'General case' 0 N--CA 1.411 -2.383 1 CA-C-N 106.145 -5.027 . . . . 0.0 120.994 -179.008 . . . . . . . . 5 4 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.539 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER 78.61 101.87 0.07 Allowed 'General case' 0 CA--C 1.561 1.396 0 O-C-N 127.621 3.076 . . . . 0.0 109.489 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.76 48.57 2.15 Favored 'General case' 0 C--O 1.195 -1.779 1 O-C-N 133.636 6.835 . . . . 0.0 108.884 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' HD3' ' A' ' 77' ' ' LYS . 57.0 mt -66.57 146.0 13.5 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.479 2 O-C-N 130.029 4.581 . . . . 0.0 103.937 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB1' ' CZ3' ' A' ' 67' ' ' TRP . . . -108.9 105.61 15.23 Favored 'General case' 0 C--O 1.213 -0.827 1 O-C-N 137.751 9.407 . . . . 0.0 105.077 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.85 100.43 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 128.917 3.886 . . . . 0.0 104.68 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -156.58 155.74 32.4 Favored 'General case' 0 C--O 1.19 -2.033 1 C-N-CA 110.615 -4.434 . . . . 0.0 113.756 179.76 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.5 108.34 3.34 Favored 'General case' 0 CA--C 1.558 1.279 2 CA-C-N 107.581 -4.372 . . . . 0.0 102.521 179.228 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 98' ' ' LEU . 11.5 tt -42.66 109.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 1 O-C-N 132.986 6.428 . . . . 0.0 112.287 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.0 m -105.19 95.25 5.71 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 128.387 3.555 . . . . 0.0 115.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.0 -118.31 3.77 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 103.256 -3.937 . . . . 0.0 103.256 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.67 47.29 1.56 Allowed 'General case' 0 CA--C 1.552 1.029 1 O-C-N 130.18 4.106 . . . . 0.0 106.146 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.303 0.0 OUTLIER -177.3 110.93 0.08 Allowed 'General case' 0 C--O 1.204 -1.32 2 O-C-N 130.801 5.063 . . . . 0.0 108.358 179.801 . . . . . . . . 5 4 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 3.0 tt -79.45 104.71 10.25 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 128.728 3.768 . . . . 0.0 108.815 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 26.1 mm -50.76 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.672 1 O-C-N 133.48 6.738 . . . . 0.0 108.434 -179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.413 ' HG2' HD22 ' A' ' 98' ' ' LEU . 23.2 mt-30 99.36 90.48 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 1 O-C-N 132.899 6.374 . . . . 0.0 103.915 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.8 m -102.64 96.75 7.09 Favored 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.683 6.864 . . . . 0.0 114.06 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -67.78 132.85 48.19 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 112.605 -3.638 . . . . 0.0 105.213 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -107.86 94.8 5.27 Favored 'General case' 0 C--O 1.206 -1.198 1 O-C-N 132.129 5.893 . . . . 0.0 101.631 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 1.4 t80 -109.64 117.36 33.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 109.792 -3.367 . . . . 0.0 117.6 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 27.42 31.51 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.77 -6.37 6.16 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 116.718 -2.658 . . . . 0.0 114.353 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.4 t -120.03 145.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.979 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 70.89 0.73 Allowed 'General case' 0 C--N 1.359 1.011 1 O-C-N 130.87 5.106 . . . . 0.0 103.388 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.436 . . -90.86 119.13 30.81 Favored 'General case' 0 N--CA 1.41 -2.447 1 O-C-N 130.921 5.138 . . . . 0.0 116.267 179.907 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.4 163.08 14.85 Favored 'General case' 0 N--CA 1.415 -2.199 1 O-C-N 132.663 6.227 . . . . 0.0 106.924 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.27 99.53 4.56 Favored 'General case' 0 CA--C 1.556 1.202 3 O-C-N 130.195 4.684 . . . . 0.0 99.437 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.23 123.02 7.53 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 O-C-N 128.862 3.851 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 14.2 m-30 -117.21 176.81 4.97 Favored 'General case' 0 N--CA 1.434 -1.24 2 O-C-N 132.544 6.152 . . . . 0.0 108.463 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 171.12 134.76 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.633 2 O-C-N 131.898 5.749 . . . . 0.0 113.843 -177.607 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 1.3 tttt -51.41 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.34 1 CA-C-O 128.649 4.071 . . . . 0.0 113.502 176.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.37 1.492 0 O-C-N 118.952 -2.342 . . . . 0.0 110.519 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 93' ' ' ILE . 4.8 m-30 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -50.3 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 127.737 3.148 . . . . 0.0 117.911 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.29 125.21 0.77 Allowed Glycine 0 C--N 1.353 1.488 1 C-N-CA 112.377 -4.725 . . . . 0.0 107.663 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.334 46.2 p -49.97 127.89 17.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 129.148 3.499 . . . . 0.0 110.123 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.562 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.324 55.7 m95 -100.58 161.47 13.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 128.565 3.666 . . . . 0.0 112.276 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 2.3 mtmt 50.99 -178.66 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.696 1 O-C-N 129.333 4.146 . . . . 0.0 117.325 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.326 0.9 OUTLIER . . . . . 0 CA--C 1.483 -1.603 2 O-C-N 134.538 7.399 . . . . 0.0 113.753 174.979 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.403 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.377 0.0 OUTLIER 174.56 134.18 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.5 1 O-C-N 131.733 5.646 . . . . 0.0 102.694 179.689 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.472 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 13.2 mt -93.55 167.69 11.52 Favored 'General case' 0 CA--C 1.559 1.291 2 O-C-N 131.533 5.52 . . . . 0.0 100.33 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 3.9 m 176.7 79.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 1 O-C-N 132.518 6.136 . . . . 0.0 105.993 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.547 HG23 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 mp -90.11 144.07 9.89 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 110.293 -3.14 . . . . 0.0 109.188 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.7 m -162.48 82.29 0.53 Allowed 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 112.491 -3.683 . . . . 0.0 109.092 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.433 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -51.65 148.05 5.85 Favored 'General case' 0 C--O 1.214 -0.797 2 O-C-N 130.373 4.795 . . . . 0.0 115.054 179.684 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -131.65 101.43 5.49 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 128.75 3.781 . . . . 0.0 103.76 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -104.08 2.26 Favored Glycine 0 CA--C 1.546 2.027 2 C-N-CA 110.909 -5.424 . . . . 0.0 99.934 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -131.36 14.21 5.06 Favored 'General case' 0 N--CA 1.435 -1.222 1 O-C-N 131.798 5.058 . . . . 0.0 109.241 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -82.8 155.29 24.27 Favored 'General case' 0 C--N 1.321 -0.662 1 N-CA-C 99.494 -4.261 . . . . 0.0 99.494 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.547 ' CZ ' HG23 ' A' ' 25' ' ' ILE . 9.3 t80 -155.67 106.76 2.52 Favored 'General case' 0 C--O 1.191 -1.995 2 N-CA-C 95.674 -5.676 . . . . 0.0 95.674 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.15 142.48 38.3 Favored 'General case' 0 N--CA 1.475 0.806 1 O-C-N 132.503 6.127 . . . . 0.0 102.797 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.356 24.7 t -111.48 140.04 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 1 O-C-N 129.144 4.027 . . . . 0.0 100.97 179.697 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 5.2 tttt -85.2 64.42 8.66 Favored 'General case' 0 CA--C 1.49 -1.355 1 CA-C-O 130.901 5.143 . . . . 0.0 115.029 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -81.76 61.8 5.29 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 109.64 -3.436 . . . . 0.0 104.323 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.57 130.81 35.35 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 113.228 -3.389 . . . . 0.0 109.454 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -146.61 -158.79 0.94 Allowed 'General case' 0 C--N 1.368 1.394 0 O-C-N 125.87 1.981 . . . . 0.0 113.066 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -14.53 60.34 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.05 52.97 0.97 Allowed 'General case' 0 N--CA 1.424 -1.772 0 O-C-N 128.22 3.45 . . . . 0.0 107.349 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 72.9 -164.26 0.11 Allowed 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 127.637 3.086 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -81.85 -30.52 32.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 127.657 3.098 . . . . 0.0 107.127 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 tp 37.14 70.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.104 2 O-C-N 132.107 5.879 . . . . 0.0 110.444 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -66.07 114.79 5.48 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.711 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.96 95.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 2 O-C-N 131.657 5.598 . . . . 0.0 99.802 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.282 2.8 p -114.68 151.67 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 1 O-C-N 129.536 4.272 . . . . 0.0 116.086 -179.691 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 3.4 p90 -174.17 -171.7 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 131.682 5.614 . . . . 0.0 111.7 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -124.8 76.47 1.52 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 128.201 3.438 . . . . 0.0 113.762 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 69' ' ' MET . 0.1 OUTLIER 24.36 78.48 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.738 1 O-C-N 133.744 6.903 . . . . 0.0 116.294 -179.876 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.62 64.28 1.83 Allowed Glycine 0 CA--C 1.537 1.407 0 N-CA-C 105.714 -2.955 . . . . 0.0 105.714 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.24 -38.01 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 1 O-C-N 130.588 4.346 . . . . 0.0 111.209 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.89 143.84 0.06 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 109.025 -3.716 . . . . 0.0 110.644 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.5 p90 178.3 -178.33 0.26 Allowed 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 129.279 4.112 . . . . 0.0 116.184 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.7 14.11 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.91 131.59 24.11 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 115.749 -2.38 . . . . 0.0 111.259 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.3 122.91 28.56 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.1 -62.12 1.64 Allowed 'General case' 0 C--O 1.247 0.968 1 O-C-N 130.547 4.905 . . . . 0.0 115.086 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.86 35.74 2.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 125.777 1.923 . . . . 0.0 111.383 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 68.25 26.28 6.98 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 126.9 2.625 . . . . 0.0 110.672 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.87 -60.78 0.04 OUTLIER Glycine 0 CA--C 1.557 2.712 1 CA-C-O 113.204 -4.109 . . . . 0.0 105.61 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 m -5.25 -77.53 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 1 O-C-N 135.278 7.105 . . . . 0.0 110.576 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 74.86 122.97 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.497 1 O-C-N 129.321 4.138 . . . . 0.0 103.865 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.39 69.85 0.77 Allowed 'General case' 0 C--O 1.205 -1.287 0 CA-C-N 109.285 -3.598 . . . . 0.0 106.843 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -67.92 96.83 0.62 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 111.176 -2.738 . . . . 0.0 106.273 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -165.39 172.11 40.86 Favored Glycine 0 C--O 1.207 -1.579 1 C-N-CA 111.175 -5.298 . . . . 0.0 107.843 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -133.89 143.13 48.08 Favored 'General case' 0 CA--C 1.507 -0.706 1 O-C-N 134.863 6.86 . . . . 0.0 113.241 179.874 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.615 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 22.9 m95 -113.82 122.17 46.24 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 101.338 -3.579 . . . . 0.0 101.338 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -117.02 48.92 1.24 Allowed 'General case' 0 C--N 1.316 -0.848 2 O-C-N 135.59 8.056 . . . . 0.0 115.873 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.515 ' HG3' ' CE2' ' A' ' 32' ' ' PHE . 2.6 tmm? -30.84 133.09 0.08 Allowed 'General case' 0 C--O 1.216 -0.7 1 O-C-N 134.376 7.298 . . . . 0.0 108.472 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.03 76.36 1.56 Allowed 'General case' 0 N--CA 1.48 1.048 1 O-C-N 129.12 4.012 . . . . 0.0 108.296 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.95 -113.11 5.57 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.71 28.18 1.59 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 114.172 -2.823 . . . . 0.0 114.432 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.294 0.1 OUTLIER -130.21 154.61 47.38 Favored 'General case' 0 C--N 1.342 0.255 1 O-C-N 129.273 4.108 . . . . 0.0 112.843 -179.834 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.3 mt -131.11 70.36 1.47 Allowed 'General case' 0 C--O 1.211 -0.939 0 O-C-N 129.081 3.988 . . . . 0.0 111.46 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.71 123.53 43.87 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 2 O-C-N 131.076 5.235 . . . . 0.0 110.512 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.19 -166.84 39.72 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-N 108.428 -3.987 . . . . 0.0 103.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 4.9 tttm -178.02 133.69 0.15 Allowed 'General case' 0 C--O 1.203 -1.387 1 O-C-N 132.304 5.355 . . . . 0.0 112.453 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -128.95 164.18 23.72 Favored 'General case' 0 N--CA 1.48 1.069 2 O-C-N 131.561 5.538 . . . . 0.0 102.386 -179.434 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.366 0.0 OUTLIER -157.65 143.18 17.18 Favored 'General case' 0 N--CA 1.432 -1.347 1 CA-C-N 107.21 -4.541 . . . . 0.0 113.491 -178.901 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.511 ' CG ' ' HG2' ' A' ' 85' ' ' LYS . 4.3 ptm180 -102.62 94.24 5.53 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 129.281 4.113 . . . . 0.0 109.185 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -33.46 -36.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.431 1 O-C-N 134.393 7.308 . . . . 0.0 112.114 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -38.96 -52.09 1.79 Allowed 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.99 5.181 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -121.76 5.23 9.99 Favored 'General case' 0 N--CA 1.422 -1.874 0 O-C-N 127.808 3.193 . . . . 0.0 118.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.476 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 75.43 36.01 45.69 Favored Glycine 0 CA--C 1.554 2.497 2 C-N-CA 112.019 -4.896 . . . . 0.0 100.866 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HG2' ' CG ' ' A' ' 80' ' ' ARG 0.274 14.3 tptp -76.94 -75.11 0.21 Allowed 'General case' 0 N--CA 1.422 -1.865 1 O-C-N 131.918 5.128 . . . . 0.0 120.088 -179.695 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.486 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 42.8 mt-10 84.4 88.95 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.499 1 O-C-N 129.766 4.416 . . . . 0.0 108.317 -178.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.94 56.05 0.65 Allowed 'General case' 0 C--O 1.196 -1.76 1 O-C-N 131.66 5.6 . . . . 0.0 111.031 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.414 HG12 ' HG3' ' A' ' 77' ' ' LYS . 64.7 mt -67.93 157.99 5.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 108.895 -3.775 . . . . 0.0 102.9 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 67' ' ' TRP . . . -129.35 74.12 1.56 Allowed 'General case' 0 C--O 1.213 -0.868 1 O-C-N 133.982 7.051 . . . . 0.0 109.425 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.56 133.48 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 1 O-C-N 129.41 4.194 . . . . 0.0 107.436 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -178.12 148.58 0.51 Allowed 'General case' 0 C--O 1.191 -1.997 0 O-C-N 128.479 3.612 . . . . 0.0 114.6 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 3.6 mt-10 -143.66 114.67 7.81 Favored 'General case' 0 CA--C 1.561 1.376 1 O-C-N 129.874 4.484 . . . . 0.0 107.327 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 98' ' ' LEU . 2.6 mm -18.43 80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.243 1 O-C-N 134.499 7.374 . . . . 0.0 110.661 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.21 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.733 1 O-C-N 132.648 6.217 . . . . 0.0 115.305 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.95 -131.21 10.23 Favored Glycine 0 CA--C 1.553 2.406 1 N-CA-C 102.061 -4.416 . . . . 0.0 102.061 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.16 29.3 8.01 Favored 'General case' 0 C--N 1.361 1.09 1 CA-C-N 107.189 -4.505 . . . . 0.0 109.587 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -156.28 151.62 26.71 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 114.635 -2.602 . . . . 0.0 108.253 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' CD1' HD11 ' A' ' 93' ' ' ILE . 2.5 tt -105.15 126.47 52.12 Favored 'General case' 0 N--CA 1.445 -0.705 1 O-C-N 132.215 5.947 . . . . 0.0 112.132 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -77.25 -82.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 1 CA-C-O 109.927 -4.844 . . . . 0.0 108.256 -179.994 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' N ' ' CG2' ' A' ' 99' ' ' ILE . 95.8 mt-30 103.43 111.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.35 1 O-C-N 133.363 6.664 . . . . 0.0 100.903 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -112.29 102.49 10.64 Favored 'General case' 0 N--CA 1.424 -1.74 1 O-C-N 130.464 4.853 . . . . 0.0 113.847 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -75.24 101.3 4.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 113.513 -3.275 . . . . 0.0 105.326 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -84.92 97.8 9.98 Favored 'General case' 0 C--O 1.217 -0.642 1 O-C-N 129.511 4.257 . . . . 0.0 104.211 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.451 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -120.18 119.3 32.85 Favored 'General case' 0 C--N 1.363 1.185 1 CA-C-N 108.182 -4.099 . . . . 0.0 117.517 -179.935 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 50.15 23.01 1.04 Allowed 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.8 -6.43 24.05 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 117.639 -2.22 . . . . 0.0 115.464 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.257 39.5 t -95.16 163.0 2.35 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 CA-C-N 113.039 -1.581 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.35 58.76 1.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 127.26 2.85 . . . . 0.0 106.647 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.508 . . -82.02 128.94 34.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.061 3.351 . . . . 0.0 112.11 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.12 171.86 11.99 Favored 'General case' 0 N--CA 1.418 -2.07 1 O-C-N 132.872 6.358 . . . . 0.0 106.912 179.836 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -134.11 133.52 41.19 Favored 'General case' 0 C--O 1.207 -1.173 2 O-C-N 130.501 4.876 . . . . 0.0 99.602 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 pt -85.52 85.04 2.23 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 1 O-C-N 130.376 4.798 . . . . 0.0 113.653 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.517 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 12.7 m-30 -91.64 179.25 5.7 Favored 'General case' 0 N--CA 1.441 -0.924 1 O-C-N 132.395 6.059 . . . . 0.0 104.836 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -154.61 -163.23 1.54 Allowed 'General case' 0 C--O 1.198 -1.644 1 O-C-N 130.766 5.041 . . . . 0.0 111.652 179.992 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 74.5 tttt -118.76 -119.59 0.31 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 CA--C 1.558 1.275 0 CA-C-O 117.429 -1.272 . . . . 0.0 111.285 -179.885 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -55.73 104.86 0.15 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 158.34 9.79 Favored Glycine 0 C--N 1.351 1.389 0 C-N-CA 114.15 -3.881 . . . . 0.0 104.488 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 p -78.72 163.42 25.43 Favored 'General case' 0 C--N 1.355 0.82 1 C-N-CA 110.566 -4.454 . . . . 0.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.507 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 23.0 m95 -132.81 162.27 31.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 112.319 -3.705 . . . . 0.0 111.043 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.8 OUTLIER 49.43 179.41 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 178.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.357 2.3 t . . . . . 0 CA--C 1.487 -1.471 3 O-C-N 132.769 6.293 . . . . 0.0 115.265 174.96 . . . . . . . . 2 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.249 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.368 0.0 OUTLIER -161.75 153.54 19.07 Favored 'General case' 0 C--O 1.2 -1.542 1 O-C-N 129.608 4.317 . . . . 0.0 104.354 -179.985 . . . . . . . . 5 4 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 34' ' ' VAL . 4.5 mt -114.01 175.88 5.28 Favored 'General case' 0 CA--C 1.565 1.53 3 O-C-N 134.57 7.419 . . . . 0.0 97.544 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.422 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 14.3 m -171.33 -79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 128.802 3.814 . . . . 0.0 104.939 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 73.88 151.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-N 109.277 -3.601 . . . . 0.0 110.346 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.9 m -166.66 71.91 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -48.94 125.36 10.25 Favored 'General case' 0 C--O 1.205 -1.268 1 O-C-N 131.589 5.555 . . . . 0.0 114.376 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -88.64 -112.36 0.06 Allowed 'General case' 0 C--N 1.365 1.249 1 O-C-N 130.389 4.806 . . . . 0.0 103.299 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.77 100.82 1.02 Allowed Glycine 0 CA--C 1.564 3.136 2 N-CA-C 100.526 -5.03 . . . . 0.0 100.526 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 m120 56.04 43.58 26.85 Favored 'General case' 0 N--CA 1.424 -1.745 0 O-C-N 128.04 2.847 . . . . 0.0 109.158 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -155.6 116.88 3.94 Favored 'General case' 0 CA--C 1.548 0.88 2 N-CA-C 98.618 -4.586 . . . . 0.0 98.618 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -127.95 169.82 13.55 Favored 'General case' 0 C--O 1.198 -1.628 2 N-CA-C 97.978 -4.823 . . . . 0.0 97.978 179.868 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.78 132.53 29.04 Favored 'General case' 0 CA--C 1.494 -1.185 2 O-C-N 133.921 7.013 . . . . 0.0 99.643 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 23' ' ' LEU 0.364 2.2 t -91.5 134.68 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 -179.998 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -68.78 -10.7 58.13 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 108.535 -3.939 . . . . 0.0 119.201 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' CB ' HG11 ' A' ' 34' ' ' VAL 0.27 2.3 tp10 -33.82 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 109.919 -3.31 . . . . 0.0 110.262 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -81.57 132.6 35.31 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 116.463 -2.095 . . . . 0.0 108.073 -179.27 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.63 -152.31 0.14 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 114.09 -3.044 . . . . 0.0 111.711 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.72 1.78 21.36 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 127.833 3.208 . . . . 0.0 108.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.412 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 82.8 m-85 -82.29 -56.58 3.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 109.451 -3.522 . . . . 0.0 105.424 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -175.09 -174.5 0.76 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 130.198 4.686 . . . . 0.0 112.334 -179.872 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.99 124.67 34.95 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.309 0.9 OUTLIER -142.09 106.66 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.039 2 CA-C-O 131.859 5.599 . . . . 0.0 109.483 -178.493 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 125.18 25.1 Favored 'General case' 0 C--N 1.373 1.587 1 CA-C-N 107.197 -4.547 . . . . 0.0 109.546 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -91.24 65.27 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.495 2 O-C-N 130.32 4.762 . . . . 0.0 100.128 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.08 161.11 5.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 1 C-N-CA 111.003 -4.279 . . . . 0.0 115.941 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CE1' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -174.77 -155.71 0.06 Allowed 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 128.1 3.375 . . . . 0.0 110.579 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.8 mt-10 -130.81 177.92 7.05 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 115.478 -2.201 . . . . 0.0 108.083 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 69' ' ' MET . 0.2 OUTLIER -99.34 94.7 6.59 Favored 'General case' 0 C--O 1.214 -0.795 1 O-C-N 131.64 5.587 . . . . 0.0 109.804 -179.903 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.99 53.17 1.95 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-O 114.04 -3.644 . . . . 0.0 104.868 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 25.5 t -141.44 123.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 1 O-C-N 130.714 4.42 . . . . 0.0 111.677 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.42 160.18 20.65 Favored 'General case' 0 C--N 1.356 0.883 1 O-C-N 130.053 4.595 . . . . 0.0 107.788 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 56.0 p90 -177.15 177.68 1.21 Allowed 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 130.676 4.985 . . . . 0.0 116.228 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.3 135.23 47.12 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.0 -154.1 0.6 Allowed 'General case' 0 C--O 1.204 -1.336 0 O-C-N 128.009 3.318 . . . . 0.0 113.745 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.27 89.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.3 mt -83.12 170.62 14.58 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.974 2.671 . . . . 0.0 110.508 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.47 -141.17 0.69 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 126.049 2.093 . . . . 0.0 113.521 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -26.06 60.46 Favored 'General case' 0 C--N 1.366 1.289 0 O-C-N 120.884 -1.135 . . . . 0.0 110.089 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.04 71.56 0.03 OUTLIER Glycine 0 CA--C 1.554 2.519 0 CA-C-O 116.337 -2.368 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 p -73.82 -134.06 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 1 O-C-N 132.636 5.551 . . . . 0.0 107.382 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -146.8 -61.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 112.38 -3.728 . . . . 0.0 104.022 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mp 42.86 70.48 0.29 Allowed 'General case' 0 C--O 1.214 -0.809 1 O-C-N 131.047 5.217 . . . . 0.0 111.449 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.7 m -88.28 117.31 27.1 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.921 1.688 . . . . 0.0 108.936 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.62 -138.78 4.18 Favored Glycine 0 N--CA 1.473 1.106 1 C-N-CA 110.108 -5.806 . . . . 0.0 107.62 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.382 5.9 t -173.07 166.69 4.99 Favored 'General case' 0 N--CA 1.446 -0.665 1 O-C-N 130.667 4.393 . . . . 0.0 116.889 -179.122 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.538 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 2.6 m95 -122.37 145.94 47.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -136.31 32.42 2.84 Favored 'General case' 0 C--N 1.321 -0.652 2 O-C-N 135.099 7.749 . . . . 0.0 111.649 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.427 ' HB3' HD22 ' A' ' 49' ' ' LEU . 16.7 ttp -32.17 132.99 0.11 Allowed 'General case' 0 C--N 1.317 -0.84 2 O-C-N 134.909 7.63 . . . . 0.0 108.873 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.45 139.83 33.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 111.331 -2.668 . . . . 0.0 108.809 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 30.02 -98.67 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.816 1 O-C-N 133.086 6.491 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -119.35 56.78 0.91 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 108.813 -3.693 . . . . 0.0 112.337 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -148.11 179.8 7.48 Favored 'General case' 0 C--O 1.249 1.069 1 O-C-N 129.335 4.147 . . . . 0.0 110.322 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.2 mt -147.13 46.14 1.16 Allowed 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 126.193 2.183 . . . . 0.0 112.755 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.63 130.16 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 1 O-C-N 129.294 4.121 . . . . 0.0 113.356 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.488 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 156.99 -142.49 8.73 Favored Glycine 0 CA--C 1.564 3.151 2 CA-C-N 106.647 -4.797 . . . . 0.0 103.917 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 170.59 168.69 0.07 Allowed 'General case' 0 N--CA 1.44 -0.942 1 O-C-N 133.789 6.229 . . . . 0.0 111.04 -179.289 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.538 ' CE2' ' CE2' ' A' ' 67' ' ' TRP . 11.9 m-85 -150.1 157.02 42.68 Favored 'General case' 0 C--O 1.197 -1.694 1 O-C-N 133.743 6.902 . . . . 0.0 101.615 176.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HG2' ' CG1' ' A' ' 81' ' ' VAL . 4.2 ttpt -155.4 135.69 13.14 Favored 'General case' 0 N--CA 1.422 -1.835 1 CA-C-N 107.612 -4.358 . . . . 0.0 112.407 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.488 ' CG ' ' HA3' ' A' ' 84' ' ' GLY . 14.9 ptm180 -106.38 47.57 0.87 Allowed 'General case' 0 CA--C 1.557 1.237 0 O-C-N 125.906 2.004 . . . . 0.0 107.18 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' CG1' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -6.16 -52.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.619 1 O-C-N 132.08 5.862 . . . . 0.0 115.658 -179.758 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 80' ' ' ARG . 2.1 t0 -39.23 -29.86 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 129.026 3.954 . . . . 0.0 113.059 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 174.79 -22.83 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.978 0 O-C-N 128.982 3.926 . . . . 0.0 114.132 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.488 ' HA3' ' CG ' ' A' ' 80' ' ' ARG . . . -69.59 -52.18 22.13 Favored Glycine 0 CA--C 1.536 1.36 1 N-CA-C 101.826 -4.51 . . . . 0.0 101.826 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.03 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.939 2 O-C-N 132.015 5.185 . . . . 0.0 120.303 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.424 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 10.1 mt-10 74.48 62.03 0.07 Allowed 'General case' 0 N--CA 1.432 -1.366 1 O-C-N 130.226 4.704 . . . . 0.0 117.75 177.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.481 ' CD1' ' HG2' ' A' ' 80' ' ' ARG . 23.2 mt -97.7 61.53 1.6 Allowed 'General case' 0 C--O 1.199 -1.588 1 O-C-N 130.175 4.672 . . . . 0.0 108.8 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.473 ' CG1' ' HB2' ' A' ' 77' ' ' LYS . 16.1 mt -69.98 -173.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 1 CA-C-N 107.226 -4.534 . . . . 0.0 104.487 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 54.12 0.75 Allowed 'General case' 0 C--O 1.196 -1.726 0 O-C-N 128.014 3.321 . . . . 0.0 105.449 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -57.66 113.12 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 1 O-C-N 131.014 5.196 . . . . 0.0 103.474 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.706 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -161.7 162.76 29.89 Favored 'General case' 0 C--O 1.189 -2.131 0 C-N-CA 113.599 -3.24 . . . . 0.0 113.27 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.706 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -162.76 100.78 1.01 Allowed 'General case' 0 N--CA 1.449 -0.522 2 O-C-N 131.187 5.304 . . . . 0.0 104.779 179.662 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 98' ' ' LEU . 1.8 mm 5.04 73.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.807 1 O-C-N 134.731 7.519 . . . . 0.0 111.453 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 t -15.21 -51.33 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.071 1 O-C-N 133.431 6.707 . . . . 0.0 117.092 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.17 -88.72 0.1 Allowed Glycine 0 CA--C 1.548 2.15 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -125.73 18.43 7.99 Favored 'General case' 0 CA--C 1.555 1.149 2 CA-C-N 105.785 -5.207 . . . . 0.0 103.52 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.508 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -153.49 168.79 24.97 Favored 'General case' 0 C--O 1.22 -0.486 0 O-C-N 127.892 3.245 . . . . 0.0 106.776 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -108.08 139.98 41.94 Favored 'General case' 0 N--CA 1.434 -1.27 1 O-C-N 130.525 4.891 . . . . 0.0 109.863 -179.885 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 91' ' ' ARG . 1.5 mt -102.96 -79.76 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.474 2 O-C-N 130.022 4.576 . . . . 0.0 105.639 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 2.6 mm100 105.52 82.27 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 1 O-C-N 132.776 6.298 . . . . 0.0 104.734 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.406 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 1.8 m -84.89 95.84 9.15 Favored 'General case' 0 N--CA 1.427 -1.619 2 O-C-N 130.983 5.177 . . . . 0.0 112.137 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -68.29 149.46 49.43 Favored 'General case' 0 N--CA 1.48 1.064 1 C-N-CA 110.094 -4.642 . . . . 0.0 105.085 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.3 m -118.53 72.0 0.86 Allowed 'General case' 0 C--O 1.206 -1.216 1 O-C-N 130.97 5.169 . . . . 0.0 107.75 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -88.55 108.68 19.54 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 109.118 -3.674 . . . . 0.0 110.372 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -17.25 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 126.96 2.663 . . . . 0.0 116.563 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.84 0.92 58.77 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 117.654 -2.213 . . . . 0.0 113.94 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.4 t -157.67 104.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -88.26 79.95 7.68 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-O 114.892 -2.48 . . . . 0.0 108.078 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.381 . . -93.91 148.47 22.11 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 129.41 4.194 . . . . 0.0 109.591 179.528 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 50.8 mtmt -119.31 163.56 16.98 Favored 'General case' 0 N--CA 1.421 -1.912 1 O-C-N 133.393 6.683 . . . . 0.0 110.825 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 133.22 46.92 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 129.059 3.975 . . . . 0.0 101.152 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.59 114.16 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 O-C-N 127.367 2.917 . . . . 0.0 112.153 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 10.1 m-30 -129.25 174.2 9.81 Favored 'General case' 0 N--CA 1.422 -1.85 2 O-C-N 131.773 5.671 . . . . 0.0 104.251 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -163.74 -165.35 1.02 Allowed 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 132.728 6.267 . . . . 0.0 111.915 179.976 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 16.3 tttt -117.13 142.93 46.38 Favored 'General case' 0 N--CA 1.427 -1.624 0 O-C-N 119.123 -2.236 . . . . 0.0 111.279 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.243 0 O-C-N 126.94 2.65 . . . . 0.0 112.478 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' A' ' 93' ' ' ILE . 2.1 m-30 . . . . . 0 CA--C 1.559 1.296 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.59 97.62 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.614 1 O-C-N 129.529 4.268 . . . . 0.0 115.795 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.17 142.7 3.46 Favored Glycine 0 N--CA 1.47 0.941 0 C-N-CA 114.295 -3.812 . . . . 0.0 105.949 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.319 60.2 p -67.41 164.2 19.16 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 115.558 -2.457 . . . . 0.0 107.537 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 71.1 m95 -141.19 135.34 30.68 Favored 'General case' 0 N--CA 1.411 -2.394 0 O-C-N 127.788 3.18 . . . . 0.0 113.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.588 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 26.5 mtmt 59.37 178.03 0.08 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.26 1.5 t . . . . . 0 CA--C 1.482 -1.64 3 O-C-N 135.122 7.764 . . . . 0.0 120.932 174.876 . . . . . . . . 2 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.558 1.281 0 CA-C-O 113.477 -3.154 . . . . 0.0 106.244 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.362 1.3 mttp 83.12 155.99 0.11 Allowed 'General case' 0 C--O 1.198 -1.616 1 O-C-N 134.931 7.644 . . . . 0.0 101.555 -178.54 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 34' ' ' VAL . 7.3 mt -118.14 174.02 6.45 Favored 'General case' 0 C--O 1.242 0.695 2 O-C-N 132.133 5.896 . . . . 0.0 99.275 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 4.3 m -156.06 -79.03 0.09 Allowed 'General case' 0 C--O 1.198 -1.633 0 O-C-N 127.615 3.072 . . . . 0.0 107.83 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 32' ' ' PHE . 1.2 mp 62.08 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-N 109.401 -3.545 . . . . 0.0 114.702 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 m -145.68 78.57 1.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 116.239 -2.184 . . . . 0.0 106.954 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 18.0 mm-40 -91.21 -111.73 0.09 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 114.112 -3.035 . . . . 0.0 109.879 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -122.2 3.65 9.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.55 -16.0 55.36 Favored Glycine 0 CA--C 1.56 2.9 0 N-CA-C 104.289 -3.525 . . . . 0.0 104.289 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -115.81 -38.18 3.75 Favored 'General case' 0 N--CA 1.435 -1.182 1 O-C-N 131.078 4.634 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -102.38 -170.33 1.79 Allowed 'General case' 0 CA--C 1.551 0.996 1 N-CA-C 97.856 -4.868 . . . . 0.0 97.856 179.198 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER 179.68 126.29 0.07 Allowed 'General case' 0 C--O 1.195 -1.791 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 179.154 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.87 112.25 25.3 Favored 'General case' 0 C--O 1.252 1.197 3 O-C-N 132.585 6.178 . . . . 0.0 97.208 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 HD23 ' A' ' 23' ' ' LEU 0.317 2.5 t -75.51 146.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 1 C-N-CA 111.026 -4.269 . . . . 0.0 105.152 179.799 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.263 2.4 ttmm -87.5 54.87 3.28 Favored 'General case' 0 C--O 1.195 -1.778 2 CA-C-O 128.523 4.011 . . . . 0.0 113.486 179.577 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.282 27.4 tt0 -72.68 68.55 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.854 -2.43 . . . . 0.0 107.668 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 132.87 36.64 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 116.341 -2.144 . . . . 0.0 108.088 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -137.13 -162.12 1.25 Allowed 'General case' 0 C--N 1.351 0.631 0 C-N-CA 114.126 -3.029 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.51 58.12 0.94 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 126.744 2.528 . . . . 0.0 106.659 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.409 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 15.9 m-85 -134.01 -71.81 0.5 Allowed 'General case' 0 C--N 1.358 0.962 1 CA-C-N 107.57 -4.377 . . . . 0.0 106.765 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -156.1 10.0 0.26 Allowed 'General case' 0 N--CA 1.428 -1.538 1 O-C-N 129.848 4.467 . . . . 0.0 116.206 179.691 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 75.63 8.41 3.73 Favored 'General case' 0 CA--C 1.548 0.897 1 O-C-N 129.407 4.192 . . . . 0.0 109.353 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 57' ' ' LEU 0.336 0.7 OUTLIER -28.45 138.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.319 3 O-C-N 133.288 6.618 . . . . 0.0 110.615 178.741 . . . . . . . . 5 4 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.87 137.64 50.91 Favored 'General case' 0 C--N 1.373 1.601 1 CA-C-N 108.176 -4.102 . . . . 0.0 109.373 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.99 107.47 22.9 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.128 1 O-C-N 131.696 5.623 . . . . 0.0 104.2 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.464 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.319 2.8 p -110.02 168.47 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 2 O-C-N 130.196 4.685 . . . . 0.0 116.148 -179.752 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.464 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 6.3 p90 -174.43 -177.93 1.31 Allowed 'General case' 0 N--CA 1.427 -1.59 1 O-C-N 131.601 5.563 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 51' ' ' VAL . 2.7 tt0 -138.3 40.75 2.26 Favored 'General case' 0 N--CA 1.426 -1.644 0 O-C-N 127.007 2.692 . . . . 0.0 114.445 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.17 115.02 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.098 1 O-C-N 132.795 6.31 . . . . 0.0 115.855 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.44 44.88 94.64 Favored Glycine 0 CA--C 1.545 1.933 1 CA-C-O 112.673 -4.404 . . . . 0.0 104.367 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 48' ' ' GLU . 37.9 t -115.12 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 1 O-C-N 133.672 6.16 . . . . 0.0 114.882 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -79.27 151.9 30.86 Favored 'General case' 0 C--N 1.354 0.775 1 O-C-N 129.577 4.298 . . . . 0.0 111.624 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -174.55 -174.62 0.86 Allowed 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.39 4.181 . . . . 0.0 115.581 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.35 97.04 4.6 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -106.31 130.88 54.07 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 128.135 3.397 . . . . 0.0 113.025 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.1 t -91.99 71.09 5.52 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 112.599 -3.64 . . . . 0.0 106.002 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.508 ' CD1' ' CD1' ' A' ' 43' ' ' ILE . 27.2 tp -36.17 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 O-C-N 131.164 5.29 . . . . 0.0 112.997 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -88.07 -136.11 0.09 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 114.984 -2.436 . . . . 0.0 109.169 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.11 58.25 0.63 Allowed 'General case' 0 C--O 1.21 -0.987 0 O-C-N 127.249 2.843 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.03 -81.05 0.11 Allowed Glycine 0 CA--C 1.556 2.642 1 CA-C-O 112.499 -4.5 . . . . 0.0 104.116 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.478 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . 0.2 OUTLIER 23.02 -94.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.717 1 O-C-N 133.316 5.95 . . . . 0.0 109.398 -179.704 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 74.91 29.2 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 126.827 2.579 . . . . 0.0 108.743 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 78' ' ' PHE . 7.2 mp -63.91 92.11 0.07 Allowed 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 128.868 3.855 . . . . 0.0 107.817 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 100.0 m -89.12 99.31 12.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.798 -2.91 . . . . 0.0 109.668 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -160.38 -152.72 6.66 Favored Glycine 0 CA--C 1.546 1.998 1 C-N-CA 113.635 -4.126 . . . . 0.0 105.843 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.496 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 6.0 t -163.5 118.48 1.64 Allowed 'General case' 0 CA--C 1.494 -1.179 1 O-C-N 131.184 4.696 . . . . 0.0 114.927 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.708 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m95 -96.31 124.74 40.41 Favored 'General case' 0 C--N 1.356 0.867 1 O-C-N 115.62 -4.425 . . . . 0.0 106.86 -179.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.51 94.88 5.07 Favored 'General case' 0 C--O 1.202 -1.402 2 O-C-N 135.106 7.754 . . . . 0.0 108.948 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.68 88.18 0.7 Allowed 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 109.943 -3.299 . . . . 0.0 103.965 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -94.93 81.82 3.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 126.422 2.327 . . . . 0.0 111.112 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.56 -92.85 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 O-C-N 128.647 3.717 . . . . 0.0 109.973 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -110.03 35.49 3.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.748 -2.726 . . . . 0.0 111.182 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 154.09 43.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 115.5 -2.48 . . . . 0.0 108.377 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 HD13 ' CZ ' ' A' ' 2' ' ' PHE . 4.9 mt -134.8 37.32 3.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 127.605 3.066 . . . . 0.0 115.098 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.63 149.61 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 1 CA-C-N 107.879 -4.237 . . . . 0.0 115.598 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.75 -150.07 21.33 Favored Glycine 0 CA--C 1.551 2.301 1 N-CA-C 102.754 -4.138 . . . . 0.0 102.754 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' A' ' 88' ' ' ILE . 8.4 tttt 178.84 115.5 0.04 OUTLIER 'General case' 0 C--N 1.368 1.403 1 O-C-N 131.6 4.941 . . . . 0.0 114.311 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -120.25 145.32 47.15 Favored 'General case' 0 C--O 1.203 -1.383 1 CA-C-O 129.87 4.652 . . . . 0.0 102.309 179.802 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HD2' ' CB ' ' A' ' 81' ' ' VAL . 18.1 ttmt -138.52 147.62 43.33 Favored 'General case' 0 N--CA 1.425 -1.707 1 CA-C-N 105.991 -5.095 . . . . 0.0 115.103 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.477 ' HG3' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -97.49 24.28 6.79 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 128.917 3.886 . . . . 0.0 111.908 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 82' ' ' ASP . 1.4 m 1.73 -57.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.777 1 O-C-N 134.891 7.619 . . . . 0.0 114.807 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 t0 -45.34 -27.18 0.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 128.989 3.931 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.78 -7.96 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 C-N-CA 114.218 -2.993 . . . . 0.0 118.358 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.21 -46.34 2.22 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 105.212 -3.155 . . . . 0.0 105.212 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 90.04 -150.49 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 134.351 6.56 . . . . 0.0 113.896 179.844 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.264 0.2 OUTLIER -63.58 133.44 53.76 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-O 112.77 -3.491 . . . . 0.0 114.965 -178.799 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.477 ' CD1' ' HG3' ' A' ' 80' ' ' ARG . 0.5 OUTLIER -137.24 49.21 2.03 Favored 'General case' 0 C--O 1.202 -1.412 1 O-C-N 137.99 9.556 . . . . 0.0 108.434 178.108 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 77' ' ' LYS . 88.5 mt -61.68 174.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.17 2 CA-C-N 107.153 -4.567 . . . . 0.0 104.235 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.99 55.15 1.72 Allowed 'General case' 0 N--CA 1.436 -1.132 1 O-C-N 130.856 5.098 . . . . 0.0 107.726 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 t -55.76 112.47 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 1 O-C-N 131.436 5.46 . . . . 0.0 100.865 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HD3' ' CD2' ' A' ' 98' ' ' LEU . 5.5 ttm180 -151.89 160.08 43.63 Favored 'General case' 0 CA--C 1.495 -1.144 1 C-N-CA 109.468 -4.893 . . . . 0.0 113.472 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -160.87 136.38 7.96 Favored 'General case' 0 C--N 1.356 0.869 1 O-C-N 131.464 5.477 . . . . 0.0 109.369 -179.429 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.51 HD12 ' CZ ' ' A' ' 2' ' ' PHE . 4.4 mm -67.45 124.47 22.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 1 O-C-N 133.336 6.647 . . . . 0.0 110.354 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -77.22 -65.58 0.93 Allowed 'General case' 0 CA--C 1.503 -0.845 1 O-C-N 129.716 4.385 . . . . 0.0 113.171 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' OE2' ' A' ' 97' ' ' GLU . . . -174.44 78.05 0.08 OUTLIER Glycine 0 CA--C 1.554 2.482 0 C-N-CA 115.358 -3.306 . . . . 0.0 106.711 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 79.44 27.79 0.37 Allowed 'General case' 0 CA--C 1.551 0.981 1 CA-C-N 106.599 -4.801 . . . . 0.0 108.445 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.325 0.0 OUTLIER -168.8 142.74 3.05 Favored 'General case' 0 CA--C 1.564 1.516 1 O-C-N 130.731 5.019 . . . . 0.0 107.938 179.252 . . . . . . . . 5 4 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' CD2' ' HD3' ' A' ' 91' ' ' ARG . 3.8 tt -106.2 133.14 51.37 Favored 'General case' 0 N--CA 1.439 -1.0 2 O-C-N 135.206 7.817 . . . . 0.0 112.853 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -75.08 -66.86 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-O 111.99 -3.862 . . . . 0.0 105.479 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 92.95 0.08 Allowed 'General case' 0 C--O 1.201 -1.483 1 O-C-N 134.712 7.508 . . . . 0.0 101.631 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.48 HG21 ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -111.24 124.04 51.42 Favored 'General case' 0 N--CA 1.425 -1.699 1 CA-C-N 107.844 -4.253 . . . . 0.0 113.44 179.929 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -91.95 151.81 20.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 113.297 -3.24 . . . . 0.0 104.279 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 m -134.95 70.34 1.44 Allowed 'General case' 0 C--O 1.214 -0.807 1 O-C-N 131.843 5.714 . . . . 0.0 105.571 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -88.96 121.4 31.28 Favored 'General case' 0 CA--C 1.497 -1.064 1 CA-C-N 106.813 -4.721 . . . . 0.0 111.302 -179.898 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 55.71 -85.31 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.441 0.696 . . . . 0.0 109.857 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -151.0 37.46 0.87 Allowed Glycine 0 C--N 1.363 2.05 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.696 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 108' ' ' GLU . 96.4 t -136.68 149.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 116.685 -1.626 . . . . 0.0 114.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' N ' HG11 ' A' ' 107' ' ' VAL . 18.2 mp0 -124.46 104.3 8.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 128.954 3.909 . . . . 0.0 105.183 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 110' ' ' LYS 0.435 . . -100.11 -32.13 11.07 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 128.526 3.641 . . . . 0.0 113.588 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' CG ' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER 46.73 -80.37 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.091 1 O-C-N 137.735 9.397 . . . . 0.0 111.462 179.961 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' ALA . 2.4 mtm180 77.34 88.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.42 1 N-CA-C 99.505 -4.258 . . . . 0.0 99.505 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.7 pt -65.36 159.28 4.15 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 1 O-C-N 130.372 4.795 . . . . 0.0 114.077 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 22.0 m-85 -144.81 -148.44 0.24 Allowed 'General case' 0 N--CA 1.442 -0.848 1 O-C-N 130.858 5.099 . . . . 0.0 105.124 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.56 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.24 -141.33 0.04 OUTLIER 'General case' 0 C--O 1.196 -1.744 1 O-C-N 131.678 5.611 . . . . 0.0 112.139 -179.446 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.549 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 7.0 tttt -132.43 154.04 50.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 125.891 1.676 . . . . 0.0 110.804 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.196 179.569 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CZ ' HD12 ' A' ' 93' ' ' ILE . 23.1 m-85 62.04 51.18 3.74 Favored 'General case' 0 N--CA 1.469 0.477 1 O-C-N 131.676 5.61 . . . . 0.0 103.735 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -148.96 62.72 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 115.791 -2.364 . . . . 0.0 114.913 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 176.78 21.13 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 115.192 -3.385 . . . . 0.0 107.449 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.274 16.9 p -72.84 168.47 18.8 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 128.253 2.972 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CG ' ' HG3' ' A' ' 115' ' ' LYS 0.287 7.8 m95 -145.81 146.69 31.27 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 111.732 -3.985 . . . . 0.0 112.485 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 61.49 -179.43 0.12 Allowed 'General case' 0 C--O 1.196 -1.752 1 O-C-N 133.297 6.623 . . . . 0.0 118.142 175.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.256 1.0 OUTLIER 29.56 133.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.664 3 O-C-N 135.793 8.183 . . . . 0.0 119.938 174.897 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.56 81.49 0.03 OUTLIER 'General case' 0 C--N 1.367 1.364 0 CA-C-N 110.598 -3.001 . . . . 0.0 108.303 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -90.82 92.63 8.88 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 123.016 1.388 . . . . 0.0 111.356 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 52.97 -160.68 0.12 Allowed 'General case' 0 C--N 1.363 1.196 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.308 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.4 -34.22 77.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.928 1.393 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 t30 75.73 137.23 0.06 Allowed 'General case' 0 C--N 1.36 1.046 0 O-C-N 129.002 3.939 . . . . 0.0 108.151 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -101.89 -155.85 0.54 Allowed 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 109.848 -3.342 . . . . 0.0 108.7 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -86.54 -158.88 0.44 Allowed 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 114.626 -2.83 . . . . 0.0 110.602 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.96 -58.99 0.5 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 117.92 -2.086 . . . . 0.0 113.301 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 71.89 85.5 0.12 Allowed 'General case' 0 C--O 1.248 0.975 0 O-C-N 126.589 1.994 . . . . 0.0 106.197 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -129.46 131.81 46.79 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 116.189 -1.862 . . . . 0.0 111.704 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 17.43 61.42 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.598 1 O-C-N 131.29 5.369 . . . . 0.0 113.814 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 97.36 8.23 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 110.714 -2.948 . . . . 0.0 111.594 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 37' ' ' SER . 0.6 OUTLIER -81.32 -173.26 4.24 Favored 'General case' 0 CA--C 1.55 0.972 1 CA-C-N 107.453 -4.43 . . . . 0.0 103.178 -179.995 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.454 ' CA ' ' HE2' ' A' ' 7' ' ' LYS 0.314 0.4 OUTLIER 150.76 142.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.509 1 O-C-N 133.083 6.49 . . . . 0.0 104.805 179.935 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -110.84 165.77 11.57 Favored 'General case' 0 CA--C 1.561 1.399 1 O-C-N 133.098 6.499 . . . . 0.0 100.441 179.589 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.478 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 4.2 m 175.95 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 1 O-C-N 132.316 6.01 . . . . 0.0 107.123 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 23' ' ' LEU . 2.6 mp -133.41 140.67 46.34 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 109.007 -3.724 . . . . 0.0 109.422 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 m -159.2 81.15 0.77 Allowed 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 113.214 -3.395 . . . . 0.0 107.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.27 151.41 1.45 Allowed 'General case' 0 N--CA 1.433 -1.289 1 O-C-N 132.849 6.343 . . . . 0.0 111.271 179.631 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.28 56.09 0.88 Allowed 'General case' 0 C--N 1.352 0.71 1 O-C-N 129.903 4.502 . . . . 0.0 106.873 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.77 87.36 0.61 Allowed Glycine 0 CA--C 1.547 2.031 2 C-N-CA 110.846 -5.454 . . . . 0.0 101.746 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 p30 34.13 55.13 0.61 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 133.029 5.782 . . . . 0.0 109.048 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 88.82 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 3 O-C-N 131.392 5.432 . . . . 0.0 96.533 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 69' ' ' MET . 21.7 p90 -121.82 131.19 53.92 Favored 'General case' 0 C--O 1.209 -1.056 2 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.84 156.36 22.13 Favored 'General case' 0 N--CA 1.478 0.934 4 O-C-N 136.984 8.928 . . . . 0.0 98.656 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.291 2.7 t -127.54 143.14 41.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 126.932 3.253 . . . . 0.0 104.425 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.2 tttm -93.12 77.65 4.61 Favored 'General case' 0 N--CA 1.421 -1.881 2 CA-C-O 133.808 6.527 . . . . 0.0 114.072 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -86.45 62.1 7.22 Favored 'General case' 0 N--CA 1.42 -1.974 1 CA-C-N 108.019 -4.173 . . . . 0.0 107.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -74.0 119.37 18.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 112.924 -3.51 . . . . 0.0 109.574 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.03 -142.02 0.16 Allowed 'General case' 0 C--N 1.353 0.724 0 C-N-CA 114.574 -2.85 . . . . 0.0 114.385 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -96.48 38.53 1.2 Allowed 'General case' 0 C--N 1.355 0.845 0 O-C-N 124.16 0.912 . . . . 0.0 111.07 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -152.42 54.63 0.8 Allowed 'General case' 0 C--O 1.2 -1.508 1 O-C-N 129.937 4.523 . . . . 0.0 105.182 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.26 -161.78 0.2 Allowed 'General case' 0 C--O 1.246 0.889 1 O-C-N 132.387 6.054 . . . . 0.0 110.621 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.63 -68.99 0.46 Allowed 'General case' 0 CA--C 1.548 0.892 1 C-N-CA 111.661 -4.016 . . . . 0.0 102.599 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 67.14 134.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.776 2 CA-C-O 131.505 5.431 . . . . 0.0 107.79 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.38 165.17 18.87 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 110.027 -3.26 . . . . 0.0 108.787 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.91 101.15 7.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.091 1 O-C-N 132.234 5.959 . . . . 0.0 101.663 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 5.8 p -111.48 154.75 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 129.054 3.971 . . . . 0.0 112.867 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL 0.27 3.3 p90 170.5 -172.55 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 132.098 5.874 . . . . 0.0 110.739 -179.606 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -115.29 81.32 1.56 Allowed 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 115.66 -2.416 . . . . 0.0 114.73 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 1.0 OUTLIER 48.73 -115.78 0.78 Allowed 'General case' 0 C--N 1.324 -0.524 1 O-C-N 129.573 4.295 . . . . 0.0 110.041 -179.987 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 49' ' ' LEU . . . -71.81 76.15 0.7 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 104.664 -3.374 . . . . 0.0 104.664 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' LEU . 2.3 t -129.93 97.22 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 1 O-C-N 131.659 4.976 . . . . 0.0 111.014 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.75 157.37 36.59 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 128.129 3.393 . . . . 0.0 110.844 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 13.3 p90 172.33 159.98 0.11 Allowed 'General case' 0 C--N 1.373 1.605 1 O-C-N 131.072 5.233 . . . . 0.0 114.869 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.34 96.83 6.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 101.047 -3.686 . . . . 0.0 101.047 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.514 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -121.42 128.33 52.06 Favored 'General case' 0 C--O 1.209 -1.067 1 O-C-N 129.169 4.043 . . . . 0.0 114.665 -179.928 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.84 168.25 13.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 112.76 -3.576 . . . . 0.0 107.738 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.12 -41.85 0.38 Allowed 'General case' 0 CA--C 1.509 -0.597 1 O-C-N 131.32 5.387 . . . . 0.0 112.774 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -123.62 45.42 2.46 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 125.065 1.478 . . . . 0.0 114.487 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 42.64 28.38 0.12 Allowed 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.9 41.4 0.06 OUTLIER Glycine 0 C--N 1.364 2.138 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.1 p -137.32 177.74 7.64 Favored 'General case' 0 C--N 1.315 -0.893 1 O-C-N 130.849 4.5 . . . . 0.0 112.054 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -161.77 37.5 0.13 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 114.888 -2.725 . . . . 0.0 106.084 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.18 99.6 0.03 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-N 108.839 -3.8 . . . . 0.0 109.644 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -107.69 108.39 19.6 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 110.329 -3.123 . . . . 0.0 108.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -162.77 -161.09 11.79 Favored Glycine 0 C--O 1.21 -1.382 1 C-N-CA 110.93 -5.414 . . . . 0.0 107.57 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.413 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 9.9 t -154.19 99.36 2.22 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 129.004 3.414 . . . . 0.0 116.737 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.702 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 25.2 m95 -81.89 127.72 33.31 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 118.11 -2.869 . . . . 0.0 104.461 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.457 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 75.9 p -120.3 69.16 0.86 Allowed 'General case' 0 N--CA 1.433 -1.293 1 O-C-N 135.695 8.122 . . . . 0.0 110.647 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.517 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 59.6 ttp -43.7 118.53 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 1 O-C-N 131.712 5.632 . . . . 0.0 104.058 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -119.5 59.71 0.85 Allowed 'General case' 0 CA--C 1.506 -0.742 1 O-C-N 130.693 4.996 . . . . 0.0 110.509 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.86 -85.89 1.37 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 117.46 -2.305 . . . . 0.0 110.682 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.01 23.94 11.83 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 114.531 -2.652 . . . . 0.0 114.025 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -123.77 -172.36 2.51 Favored 'General case' 0 N--CA 1.476 0.866 1 O-C-N 130.172 4.67 . . . . 0.0 109.705 -179.883 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.1 mt -157.97 37.94 0.26 Allowed 'General case' 0 C--O 1.214 -0.766 0 O-C-N 126.641 2.463 . . . . 0.0 114.028 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -62.04 135.69 26.28 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 1 CA-C-N 106.905 -4.679 . . . . 0.0 114.841 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.472 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 159.24 -161.14 31.85 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 104.549 -3.42 . . . . 0.0 104.549 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HG3' HG12 ' A' ' 88' ' ' ILE . 8.5 ttmt -174.59 122.97 0.27 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 113.675 -3.21 . . . . 0.0 112.344 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -124.35 146.37 48.88 Favored 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.066 4.604 . . . . 0.0 102.039 179.913 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.718 ' CG ' ' C ' ' A' ' 85' ' ' LYS 0.348 16.9 ttmt -139.23 152.3 47.21 Favored 'General case' 0 N--CA 1.424 -1.735 1 CA-C-N 105.448 -5.342 . . . . 0.0 117.845 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HG3' ' CA ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -113.33 63.02 0.64 Allowed 'General case' 0 CA--C 1.558 1.284 0 O-C-N 126.246 2.216 . . . . 0.0 108.929 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 t -17.34 -44.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 131.949 5.781 . . . . 0.0 115.425 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 9.9 t0 -65.4 -3.42 4.24 Favored 'General case' 0 N--CA 1.436 -1.161 1 O-C-N 129.97 4.544 . . . . 0.0 113.773 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER 168.23 -30.41 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 115.705 -2.398 . . . . 0.0 114.688 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.476 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -88.64 -30.63 14.96 Favored Glycine 0 CA--C 1.56 2.844 1 C-N-CA 112.729 -4.557 . . . . 0.0 103.268 -179.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.718 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 50.25 17.25 0.32 Allowed 'General case' 0 N--CA 1.441 -0.887 1 O-C-N 133.356 5.974 . . . . 0.0 118.896 178.69 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 79' ' ' LYS . 1.7 mt-10 161.06 116.22 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 1 O-C-N 129.459 4.224 . . . . 0.0 109.172 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD12 ' CD ' ' A' ' 80' ' ' ARG . 4.8 mp -152.76 58.95 0.8 Allowed 'General case' 0 C--O 1.207 -1.145 1 O-C-N 139.654 10.597 . . . . 0.0 112.301 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 90' ' ' VAL . 92.5 mt -67.25 -177.49 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.235 1 CA-C-N 108.032 -4.167 . . . . 0.0 104.893 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.21 63.1 0.97 Allowed 'General case' 0 C--O 1.194 -1.82 0 O-C-N 128.425 3.578 . . . . 0.0 106.255 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 88' ' ' ILE . 9.0 t -67.29 112.06 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 110.735 -2.939 . . . . 0.0 106.469 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 91' ' ' ARG . 1.2 tpm_? -172.55 157.38 3.9 Favored 'General case' 0 C--O 1.191 -1.998 1 C-N-CA 110.738 -4.385 . . . . 0.0 116.779 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -137.21 148.17 46.34 Favored 'General case' 0 N--CA 1.439 -1.011 1 O-C-N 129.707 4.38 . . . . 0.0 104.971 179.522 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.518 HD12 ' CZ ' ' A' ' 2' ' ' PHE . 16.3 mm -55.55 96.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.913 1 O-C-N 131.632 5.582 . . . . 0.0 109.304 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 t -38.51 -57.17 1.19 Allowed 'General case' 0 CA--C 1.509 -0.619 1 O-C-N 130.885 5.116 . . . . 0.0 113.621 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.68 98.48 0.15 Allowed Glycine 0 CA--C 1.559 2.824 1 N-CA-C 103.051 -4.02 . . . . 0.0 103.051 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m120 79.48 15.43 0.94 Allowed 'General case' 0 CA--C 1.553 1.063 1 O-C-N 132.466 5.451 . . . . 0.0 108.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.286 0.1 OUTLIER 174.68 170.73 0.25 Allowed 'General case' 0 C--O 1.2 -1.533 0 O-C-N 127.256 2.847 . . . . 0.0 108.928 178.696 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD11 ' CD1' ' A' ' 93' ' ' ILE . 16.5 tp -123.36 158.45 31.06 Favored 'General case' 0 N--CA 1.434 -1.237 2 O-C-N 132.475 6.109 . . . . 0.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 91' ' ' ARG 0.255 7.8 mt -110.01 -89.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.101 4.626 . . . . 0.0 103.807 179.835 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 111.1 90.23 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.729 1 O-C-N 133.188 6.555 . . . . 0.0 105.473 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.1 m -87.71 92.45 9.11 Favored 'General case' 0 C--O 1.197 -1.7 2 O-C-N 132.623 6.202 . . . . 0.0 112.28 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -70.39 113.38 7.47 Favored 'General case' 0 C--O 1.211 -0.968 2 CA-C-N 107.073 -4.603 . . . . 0.0 106.192 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -88.64 116.1 26.65 Favored 'General case' 0 C--N 1.364 1.209 1 O-C-N 129.105 4.003 . . . . 0.0 102.419 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -131.52 118.13 19.73 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.888 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 36.06 30.87 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.25 -19.91 9.18 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.779 -2.153 . . . . 0.0 114.188 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.94 162.34 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 116.41 -1.757 . . . . 0.0 115.298 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.25 85.07 2.35 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 126.456 2.348 . . . . 0.0 105.288 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.438 . . -89.27 104.6 17.13 Favored 'General case' 0 C--O 1.2 -1.548 1 O-C-N 129.112 4.007 . . . . 0.0 110.507 179.959 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -97.84 134.57 40.81 Favored 'General case' 0 C--N 1.315 -0.9 1 O-C-N 135.3 7.875 . . . . 0.0 110.425 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -99.28 141.21 32.34 Favored 'General case' 0 CA--C 1.562 1.411 1 N-CA-C 99.395 -4.298 . . . . 0.0 99.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.8 mt -112.94 105.84 19.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 1 O-C-N 130.175 4.672 . . . . 0.0 113.824 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.537 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 29.1 m-85 -137.88 -156.19 0.67 Allowed 'General case' 0 N--CA 1.436 -1.156 2 CA-C-N 108.124 -4.125 . . . . 0.0 104.993 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.82 -138.9 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.173 1 O-C-N 131.041 5.213 . . . . 0.0 110.483 -179.785 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HG3' ' CG ' ' A' ' 6' ' ' TRP . 15.7 tttt -135.83 166.71 22.67 Favored 'General case' 0 C--O 1.202 -1.409 0 O-C-N 127.503 3.002 . . . . 0.0 109.434 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.434 -1.268 0 CA-C-N 113.579 -1.646 . . . . 0.0 106.699 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.029 0.442 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.509 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 2.8 m-85 -92.34 71.94 5.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 116.659 -2.016 . . . . 0.0 108.384 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -169.83 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 116.632 -2.027 . . . . 0.0 114.887 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.24 -147.02 4.87 Favored Glycine 0 N--CA 1.48 1.62 1 C-N-CA 111.067 -5.349 . . . . 0.0 103.502 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 24' ' ' THR 0.254 7.5 p -97.63 166.18 11.62 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 129.333 3.608 . . . . 0.0 104.266 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.588 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.26 10.4 m95 -141.61 169.91 16.71 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 113.058 -3.354 . . . . 0.0 112.07 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 51.5 179.06 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 178.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.258 0.5 OUTLIER 22.75 146.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.454 3 CA-C-O 135.591 7.377 . . . . 0.0 120.263 175.015 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -104.7 -126.04 0.23 Allowed 'General case' 0 C--N 1.372 1.571 1 CA-C-N 107.479 -4.419 . . . . 0.0 102.483 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 33.47 79.24 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 O-C-N 126.229 2.206 . . . . 0.0 115.641 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 13' ' ' ASN . 1.7 m120 -64.1 174.68 1.47 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 116.266 -2.174 . . . . 0.0 111.585 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.61 79.79 0.01 OUTLIER 'General case' 0 C--O 1.242 0.704 0 O-C-N 126.668 2.48 . . . . 0.0 112.029 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' ASN . 5.3 t30 -154.13 45.39 0.58 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-O 123.436 1.589 . . . . 0.0 107.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -141.49 110.1 6.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.546 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.6 t -89.39 136.5 32.99 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 127.534 3.022 . . . . 0.0 108.755 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.48 27.01 73.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 114.44 -3.743 . . . . 0.0 113.247 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . . . -81.22 118.31 22.47 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 127.843 2.731 . . . . 0.0 109.175 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -102.3 35.98 2.26 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 125.173 1.546 . . . . 0.0 113.483 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -168.98 108.28 0.46 Allowed 'General case' 0 C--O 1.209 -1.072 0 O-C-N 124.821 1.326 . . . . 0.0 111.389 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -164.3 135.67 4.47 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 127.203 2.815 . . . . 0.0 110.174 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' C ' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -144.25 -173.15 3.94 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 129.056 3.972 . . . . 0.0 102.576 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 21' ' ' LEU 0.359 0.0 OUTLIER 171.13 165.91 0.08 Allowed 'General case' 0 CA--C 1.566 1.56 1 O-C-N 130.573 4.921 . . . . 0.0 104.268 179.805 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -131.93 151.48 51.69 Favored 'General case' 0 CA--C 1.558 1.26 4 O-C-N 134.494 7.371 . . . . 0.0 97.022 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.554 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 3.2 m 178.15 71.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 1 O-C-N 131.293 5.371 . . . . 0.0 104.215 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.445 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 2.7 mp -86.37 157.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 109.87 -3.332 . . . . 0.0 108.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 m -172.77 77.3 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 128.056 3.347 . . . . 0.0 104.673 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -45.75 145.09 1.47 Allowed 'General case' 0 N--CA 1.449 -0.524 2 O-C-N 132.556 6.16 . . . . 0.0 112.032 179.925 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -105.0 -7.48 19.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.98 63.86 0.24 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 103.21 -3.956 . . . . 0.0 103.21 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 p30 105.52 -20.9 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.277 1 O-C-N 131.944 5.143 . . . . 0.0 111.559 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.67 84.69 7.46 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 129.091 3.994 . . . . 0.0 103.27 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 17.1 m-85 -91.76 129.44 37.73 Favored 'General case' 0 C--O 1.19 -2.056 1 N-CA-C 96.177 -5.49 . . . . 0.0 96.177 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . 0.255 0.4 OUTLIER -132.88 114.1 13.66 Favored 'General case' 0 N--CA 1.483 1.213 2 O-C-N 135.895 8.247 . . . . 0.0 97.454 -179.741 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.442 14.7 t -85.48 154.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 2 C-N-CA 109.64 -4.824 . . . . 0.0 102.935 -179.839 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.554 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 2.8 tttm -88.56 16.8 6.05 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 118.848 2.907 . . . . 0.0 118.848 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HG3' HG11 ' A' ' 34' ' ' VAL 0.327 26.3 mt-10 -44.25 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 109.624 -3.443 . . . . 0.0 107.934 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 46.0 m -100.08 141.74 32.5 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 125.764 1.915 . . . . 0.0 113.322 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.08 -151.3 0.48 Allowed 'General case' 0 C--N 1.352 0.696 0 O-C-N 128.231 3.457 . . . . 0.0 110.054 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -111.08 30.01 7.27 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.432 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 20.2 m-85 -110.6 -78.13 0.59 Allowed 'General case' 0 CA--C 1.55 0.956 2 O-C-N 130.448 4.843 . . . . 0.0 110.366 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 2.1 mpt_? -139.04 8.63 2.51 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.563 2.415 . . . . 0.0 112.391 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.1 18.97 2.39 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 127.2 2.813 . . . . 0.0 104.204 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 57' ' ' LEU 0.298 9.7 tt -35.71 101.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.722 3 O-C-N 132.218 5.949 . . . . 0.0 110.24 179.429 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.42 144.64 27.21 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 109.643 -3.435 . . . . 0.0 105.944 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.85 128.22 50.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 1 O-C-N 129.38 4.175 . . . . 0.0 101.344 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.345 14.0 p -138.85 159.42 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 115.912 -2.315 . . . . 0.0 112.945 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.3 OUTLIER 170.73 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.928 1 O-C-N 134.977 7.673 . . . . 0.0 111.193 179.959 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.71 76.9 1.46 Allowed 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 127.212 2.82 . . . . 0.0 110.175 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 38.87 -80.48 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.962 1 O-C-N 131.71 5.631 . . . . 0.0 115.813 179.692 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.63 72.88 2.75 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.2 110.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.104 1 O-C-N 131.666 4.98 . . . . 0.0 116.958 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.08 163.04 15.66 Favored 'General case' 0 C--O 1.205 -1.257 1 O-C-N 129.87 4.481 . . . . 0.0 106.277 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 10.7 p90 178.38 167.24 0.82 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 112.36 -3.736 . . . . 0.0 114.495 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.69 83.92 1.93 Allowed 'General case' 0 CA--C 1.562 1.412 1 N-CA-C 100.104 -4.036 . . . . 0.0 100.104 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.439 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -93.65 150.07 20.71 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 129.049 3.968 . . . . 0.0 114.997 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 88.22 2.71 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 128.362 3.539 . . . . 0.0 105.144 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HB3' HD13 ' A' ' 43' ' ' ILE . 3.6 mm? -62.38 -75.63 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 128.796 3.81 . . . . 0.0 112.455 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.33 -138.98 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 114.797 -2.525 . . . . 0.0 109.045 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.75 6.68 23.79 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 127.26 2.85 . . . . 0.0 111.734 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 66.19 0.19 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-O 115.712 -2.716 . . . . 0.0 107.323 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.417 ' HB ' HD11 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -123.14 -76.61 0.59 Allowed 'General case' 0 C--O 1.213 -0.863 1 O-C-N 130.786 4.463 . . . . 0.0 112.869 179.939 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER 65.03 32.47 10.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.632 1.208 . . . . 0.0 109.438 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.417 HD11 ' HB ' ' A' ' 61' ' ' THR . 3.7 mp -71.35 84.06 0.79 Allowed 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 128.371 3.545 . . . . 0.0 108.334 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -72.28 115.73 11.87 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.29 -155.36 6.82 Favored Glycine 0 C--O 1.199 -2.041 1 C-N-CA 110.423 -5.656 . . . . 0.0 107.801 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.653 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.28 1.1 t -179.73 130.17 0.1 Allowed 'General case' 0 CA--C 1.499 -0.994 1 O-C-N 134.394 6.585 . . . . 0.0 110.969 -177.391 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.675 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 71.7 m95 -140.86 113.12 7.92 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 118.307 -2.745 . . . . 0.0 106.509 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 p -96.57 54.83 1.38 Allowed 'General case' 0 N--CA 1.428 -1.528 2 O-C-N 132.16 5.912 . . . . 0.0 116.316 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.509 ' HE2' ' CE2' ' A' ' 2' ' ' PHE . 21.6 tpp -40.13 107.69 0.07 Allowed 'General case' 0 C--O 1.212 -0.908 1 O-C-N 134.398 7.311 . . . . 0.0 104.833 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -130.48 115.95 17.53 Favored 'General case' 0 C--O 1.21 -0.979 0 O-C-N 128.526 3.641 . . . . 0.0 106.85 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.89 -132.05 46.22 Favored Glycine 0 CA--C 1.55 2.225 0 C-N-CA 117.01 -2.519 . . . . 0.0 107.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.422 ' HB3' HG21 ' A' ' 93' ' ' ILE . 11.9 m120 -97.95 52.78 1.07 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 115.679 -2.105 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -132.99 171.65 13.68 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 125.108 1.505 . . . . 0.0 113.753 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -153.11 46.06 0.67 Allowed 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.939 1.352 . . . . 0.0 113.146 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.4 134.12 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 110.27 -3.15 . . . . 0.0 115.679 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' CH2' ' A' ' 67' ' ' TRP . . . 157.87 -157.49 28.27 Favored Glycine 0 CA--C 1.554 2.495 1 N-CA-C 102.863 -4.095 . . . . 0.0 102.863 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.563 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.314 0.0 OUTLIER -173.14 131.6 0.49 Allowed 'General case' 0 C--N 1.363 1.153 0 O-C-N 129.326 3.603 . . . . 0.0 116.319 179.604 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.675 ' CE1' ' CZ2' ' A' ' 67' ' ' TRP . 1.2 m-85 -112.07 163.29 14.46 Favored 'General case' 0 C--O 1.193 -1.878 1 CA-C-O 129.117 4.294 . . . . 0.0 101.706 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' CG ' ' C ' ' A' ' 85' ' ' LYS . 11.0 ttmt -171.2 146.69 2.41 Favored 'General case' 0 N--CA 1.441 -0.908 1 CA-C-N 104.39 -5.823 . . . . 0.0 117.087 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.411 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -94.91 104.81 16.7 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 115.041 -2.409 . . . . 0.0 107.287 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 35.6 m -78.5 76.38 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 1 O-C-N 131.53 5.519 . . . . 0.0 111.933 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.13 -47.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 O-C-N 129.095 3.997 . . . . 0.0 108.538 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -179.05 5.17 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 127.271 2.857 . . . . 0.0 116.408 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.17 -44.09 3.89 Favored Glycine 0 CA--C 1.545 1.947 1 N-CA-C 102.139 -4.384 . . . . 0.0 102.139 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 86.69 -156.92 0.01 OUTLIER 'General case' 0 C--O 1.252 1.227 1 O-C-N 132.357 5.386 . . . . 0.0 113.372 179.991 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.24 148.83 49.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.836 2.562 . . . . 0.0 117.425 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.7 36.37 1.62 Allowed 'General case' 0 C--O 1.206 -1.21 1 O-C-N 132.619 6.199 . . . . 0.0 110.388 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.466 ' CG1' ' HG3' ' A' ' 77' ' ' LYS . 36.7 mt -53.65 163.95 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.558 1 CA-C-N 107.223 -4.535 . . . . 0.0 106.062 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.408 ' N ' HG21 ' A' ' 88' ' ' ILE . . . -135.13 59.95 1.71 Allowed 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 128.585 3.678 . . . . 0.0 106.047 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.7 118.13 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 1 O-C-N 129.327 4.142 . . . . 0.0 104.057 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.476 ' CZ ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -178.74 160.82 1.2 Allowed 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 113.302 -3.359 . . . . 0.0 114.352 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.476 ' HG3' ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -144.52 134.61 24.07 Favored 'General case' 0 N--CA 1.424 -1.748 2 O-C-N 132.583 6.177 . . . . 0.0 108.129 179.642 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 72' ' ' ASN . 0.4 OUTLIER -63.34 108.77 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 1 O-C-N 130.974 5.172 . . . . 0.0 110.085 179.909 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.99 91.05 3.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 126.895 2.622 . . . . 0.0 115.647 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.75 -122.42 6.59 Favored Glycine 0 C--O 1.208 -1.479 0 N-CA-C 103.692 -3.763 . . . . 0.0 103.692 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -130.96 53.51 1.97 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 109.157 -3.521 . . . . 0.0 106.012 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.272 0.2 OUTLIER 174.15 137.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 1 O-C-N 130.434 4.834 . . . . 0.0 108.837 179.957 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 93' ' ' ILE . 2.5 tt -111.63 120.09 40.9 Favored 'General case' 0 C--O 1.203 -1.343 1 O-C-N 130.795 5.06 . . . . 0.0 109.067 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 11.6 mt -54.07 -84.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.316 3 O-C-N 131.526 5.516 . . . . 0.0 108.852 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 107.06 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.107 1 O-C-N 133.856 6.972 . . . . 0.0 104.039 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.465 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 18.5 m -96.48 84.34 3.68 Favored 'General case' 0 C--O 1.193 -1.892 2 O-C-N 133.571 6.794 . . . . 0.0 112.749 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.31 121.28 14.46 Favored 'General case' 0 C--O 1.218 -0.555 1 CA-C-N 107.862 -4.245 . . . . 0.0 106.871 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 HD11 ' A' ' 88' ' ' ILE . 1.8 m -98.1 70.8 2.1 Favored 'General case' 0 C--N 1.36 1.061 1 O-C-N 130.704 5.002 . . . . 0.0 101.536 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -97.15 130.98 44.34 Favored 'General case' 0 C--N 1.362 1.127 1 CA-C-N 107.347 -4.479 . . . . 0.0 109.422 -179.994 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 34.8 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.12 31.68 25.14 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 114.941 -3.504 . . . . 0.0 116.229 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.0 -49.12 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 117.934 -1.507 . . . . 0.0 110.83 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 8.1 tt0 79.07 31.83 0.28 Allowed 'General case' 0 C--N 1.35 0.604 0 O-C-N 127.431 2.957 . . . . 0.0 107.902 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.447 . . -62.42 166.71 4.85 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 113.296 -3.362 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 7.5 mttm -140.49 -48.45 0.43 Allowed 'General case' 0 N--CA 1.438 -1.043 1 O-C-N 131.909 5.756 . . . . 0.0 111.25 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.46 -158.38 0.19 Allowed 'General case' 0 C--O 1.202 -1.4 1 O-C-N 131.766 5.666 . . . . 0.0 104.446 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.78 115.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.47 1 C-N-CA 111.098 -4.241 . . . . 0.0 112.24 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.543 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 21.1 m-30 -109.97 174.34 5.91 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 131.102 5.251 . . . . 0.0 106.314 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.547 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.03 130.26 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.531 2 O-C-N 131.381 5.425 . . . . 0.0 114.109 -179.382 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.588 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.3 tttt -47.22 169.16 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 109.035 -3.712 . . . . 0.0 112.455 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.423 -1.805 0 CA-C-N 111.48 -2.6 . . . . 0.0 113.032 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.021 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 98' ' ' LEU . 75.4 m-85 55.4 73.79 0.4 Allowed 'General case' 0 CA--C 1.556 1.176 1 O-C-N 129.507 4.254 . . . . 0.0 106.079 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -148.59 30.38 0.83 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 128.052 3.345 . . . . 0.0 117.324 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -151.53 8.0 Favored Glycine 0 C--N 1.349 1.293 2 C-N-CA 112.933 -4.46 . . . . 0.0 103.707 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.425 ' C ' ' CD1' ' A' ' 6' ' ' TRP 0.296 0.6 OUTLIER -89.85 -176.55 4.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 128.367 3.039 . . . . 0.0 105.627 179.616 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.539 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.334 19.1 m95 -162.63 153.17 16.83 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 113.147 -3.311 . . . . 0.0 113.581 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 15.2 mtmt 63.14 176.59 0.15 Allowed 'General case' 0 N--CA 1.426 -1.629 1 O-C-N 131.769 5.668 . . . . 0.0 119.086 176.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.255 0.5 OUTLIER 55.82 102.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.479 -1.786 3 CA-C-O 135.442 7.306 . . . . 0.0 120.869 174.88 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.41 138.92 43.73 Favored 'General case' 0 C--N 1.375 1.713 1 CA-C-N 107.631 -4.349 . . . . 0.0 103.626 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? 58.13 65.5 1.28 Allowed 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.324 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -44.88 137.9 3.83 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 110.833 -2.894 . . . . 0.0 112.781 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.08 93.7 6.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.896 2.622 . . . . 0.0 107.68 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.29 42.71 1.27 Allowed 'General case' 0 C--N 1.356 0.868 0 O-C-N 127.631 3.082 . . . . 0.0 106.054 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -127.22 35.06 4.62 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 126.314 2.259 . . . . 0.0 109.683 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -135.3 174.71 10.31 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 127.977 3.298 . . . . 0.0 106.813 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.41 67.1 0.45 Allowed Glycine 0 CA--C 1.552 2.38 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.22 80.15 0.1 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.456 -1.872 . . . . 0.0 108.52 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -81.56 101.92 10.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.628 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.44 -42.05 0.16 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 127.379 2.924 . . . . 0.0 113.324 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 70.99 162.28 0.24 Allowed 'General case' 0 C--N 1.358 0.96 0 O-C-N 125.111 1.507 . . . . 0.0 108.098 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -157.61 -163.93 1.45 Allowed 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 110.523 -3.035 . . . . 0.0 106.293 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.447 0.0 OUTLIER 150.6 174.15 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.682 1 O-C-N 129.504 4.253 . . . . 0.0 102.383 -179.161 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 2.6 mt -119.12 163.62 16.76 Favored 'General case' 0 CA--C 1.557 1.249 3 O-C-N 132.515 6.134 . . . . 0.0 98.742 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.509 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 52.9 m 179.85 96.03 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.238 1 O-C-N 133.902 7.001 . . . . 0.0 108.278 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.567 ' CG2' ' CE1' ' A' ' 32' ' ' PHE . 4.7 mp -117.28 140.47 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.193 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -164.78 84.84 0.41 Allowed 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 128.494 3.621 . . . . 0.0 107.539 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -46.06 138.36 5.23 Favored 'General case' 0 N--CA 1.438 -1.052 2 O-C-N 132.943 6.402 . . . . 0.0 110.019 179.482 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -89.47 4.58 48.66 Favored 'General case' 0 C--N 1.343 0.286 1 O-C-N 130.068 4.605 . . . . 0.0 107.457 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.21 -58.46 0.61 Allowed Glycine 0 CA--C 1.55 2.246 2 N-CA-C 100.826 -4.91 . . . . 0.0 100.826 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -10.46 4.0 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 108.785 -3.708 . . . . 0.0 109.062 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -91.45 169.52 10.71 Favored 'General case' 0 C--N 1.306 -1.308 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CE1' ' CG2' ' A' ' 25' ' ' ILE . 31.6 t80 -165.91 71.97 0.15 Allowed 'General case' 0 C--O 1.192 -1.942 1 N-CA-C 95.501 -5.74 . . . . 0.0 95.501 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.89 137.01 47.13 Favored 'General case' 0 CA--C 1.503 -0.856 2 O-C-N 133.717 6.886 . . . . 0.0 102.831 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.372 0.5 OUTLIER -114.46 144.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 1 N-CA-C 99.774 -4.158 . . . . 0.0 99.774 179.248 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CB ' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -101.55 58.79 0.86 Allowed 'General case' 0 N--CA 1.422 -1.858 1 CA-C-O 133.491 6.377 . . . . 0.0 117.924 -179.953 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -73.34 47.19 0.21 Allowed 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 108.92 -3.764 . . . . 0.0 110.151 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.421 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 30.8 t -58.05 138.04 56.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 116.017 -2.273 . . . . 0.0 108.343 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.54 127.91 0.14 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 114.737 -2.785 . . . . 0.0 114.746 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.05 -65.7 0.25 Allowed 'General case' 0 C--O 1.223 -0.298 0 O-C-N 128.972 3.92 . . . . 0.0 111.418 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 40.3 m-85 -120.55 102.16 8.25 Favored 'General case' 0 C--O 1.203 -1.393 0 O-C-N 127.861 3.226 . . . . 0.0 112.619 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.1 OUTLIER 61.47 -173.01 0.14 Allowed 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 126.722 2.513 . . . . 0.0 117.248 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -90.23 -20.4 23.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 126.671 2.482 . . . . 0.0 109.159 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 ' CG1' HD22 ' A' ' 57' ' ' LEU 0.282 5.9 tp 6.84 77.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.427 2 O-C-N 133.312 6.633 . . . . 0.0 111.344 178.845 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.75 148.74 6.96 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 119.494 -2.004 . . . . 0.0 111.161 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.14 98.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 O-C-N 128.177 3.423 . . . . 0.0 104.267 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.285 8.1 p -106.64 164.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 113.662 -3.215 . . . . 0.0 116.072 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 1.7 p90 -171.74 -161.79 0.2 Allowed 'General case' 0 N--CA 1.442 -0.862 1 O-C-N 129.976 4.547 . . . . 0.0 110.722 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -142.76 85.16 1.87 Allowed 'General case' 0 C--N 1.363 1.17 0 O-C-N 127.056 2.722 . . . . 0.0 115.373 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 69' ' ' MET . 0.1 OUTLIER 18.22 94.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 131.261 5.351 . . . . 0.0 116.715 -179.941 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.41 46.72 3.44 Favored Glycine 0 C--O 1.207 -1.575 0 CA-C-O 114.209 -3.551 . . . . 0.0 104.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 t -134.89 118.53 25.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 1 O-C-N 130.315 4.185 . . . . 0.0 112.696 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.81 159.85 26.35 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 115.477 -2.489 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -173.23 165.57 4.84 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 130.625 4.953 . . . . 0.0 113.376 -179.822 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -125.57 89.98 3.13 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.13 144.57 28.12 Favored 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 116.082 -2.247 . . . . 0.0 113.341 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -106.51 71.38 0.86 Allowed 'General case' 0 CA--C 1.555 1.169 1 O-C-N 129.682 4.363 . . . . 0.0 103.018 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.48 HD22 ' CG1' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -38.06 -81.19 0.01 OUTLIER 'General case' 0 C--O 1.238 0.46 1 O-C-N 131.839 5.712 . . . . 0.0 114.239 -179.982 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.84 -101.45 0.03 OUTLIER 'General case' 0 C--O 1.247 0.972 0 CA-C-O 115.305 -2.284 . . . . 0.0 112.107 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.94 4.65 8.02 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 126.578 2.424 . . . . 0.0 111.844 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.59 53.65 0.03 OUTLIER Glycine 0 CA--C 1.549 2.203 0 CA-C-O 115.59 -2.784 . . . . 0.0 109.769 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 p -92.09 -64.93 1.05 Allowed 'General case' 0 CA--C 1.551 1.005 0 O-C-N 128.52 3.13 . . . . 0.0 107.352 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 64' ' ' THR . 0.4 OUTLIER 81.47 32.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.56 1 O-C-N 129.564 4.29 . . . . 0.0 111.076 177.619 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD21 ' CG ' ' A' ' 78' ' ' PHE . 2.7 mp -62.54 82.24 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.105 0 O-C-N 126.371 2.295 . . . . 0.0 110.807 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLU . 62.3 m -69.15 117.47 10.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.78 -154.1 6.15 Favored Glycine 0 C--O 1.209 -1.434 1 C-N-CA 109.99 -5.862 . . . . 0.0 108.136 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.671 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 11.5 t 172.09 129.44 0.02 OUTLIER 'General case' 0 C--O 1.248 1.024 1 O-C-N 134.498 6.646 . . . . 0.0 111.861 -178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 69.9 m95 -136.76 128.76 29.41 Favored 'General case' 0 C--O 1.203 -1.359 1 O-C-N 116.194 -4.066 . . . . 0.0 106.283 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.42 31.85 5.81 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.432 4.832 . . . . 0.0 117.197 -177.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.414 ' HB2' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 2.29 101.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.916 1 O-C-N 133.388 6.68 . . . . 0.0 109.611 179.377 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' ASN . 1.1 mm-40 -108.45 95.2 5.5 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 129.092 3.995 . . . . 0.0 112.171 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.32 -91.74 0.09 OUTLIER Glycine 0 C--N 1.353 1.51 1 O-C-N 129.55 4.281 . . . . 0.0 108.979 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -136.69 46.57 2.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 129.153 3.502 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.2 mtpt -129.33 163.04 26.58 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 128.843 3.84 . . . . 0.0 110.785 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 2' ' ' PHE . 8.2 mt -141.74 68.38 1.33 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 127.226 2.829 . . . . 0.0 112.186 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.49 83.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 2 O-C-N 131.044 5.215 . . . . 0.0 111.01 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 67' ' ' TRP . . . -150.57 -177.66 24.7 Favored Glycine 0 CA--C 1.555 2.575 2 CA-C-N 106.994 -4.639 . . . . 0.0 102.695 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.308 0.3 OUTLIER -155.14 168.69 26.2 Favored 'General case' 0 C--O 1.204 -1.32 1 O-C-N 132.758 5.623 . . . . 0.0 112.083 -179.733 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 m-85 -148.18 166.85 26.66 Favored 'General case' 0 C--O 1.19 -2.033 1 CA-C-O 128.943 4.211 . . . . 0.0 104.052 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 5.0 ttpt -173.14 132.81 0.51 Allowed 'General case' 0 N--CA 1.418 -2.059 1 CA-C-N 104.428 -5.805 . . . . 0.0 117.992 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.484 ' HD3' ' CD1' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -100.88 38.21 1.59 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 126.512 2.383 . . . . 0.0 114.281 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 7.02 -67.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.999 1 O-C-N 131.772 5.67 . . . . 0.0 115.041 179.832 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.456 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 9.9 t0 -42.59 -26.01 0.11 Allowed 'General case' 0 N--CA 1.443 -0.808 1 O-C-N 130.248 4.717 . . . . 0.0 112.543 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.11 -16.45 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 113.954 -3.098 . . . . 0.0 117.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.425 ' HA3' ' HG3' ' A' ' 80' ' ' ARG . . . -97.79 -32.75 6.09 Favored Glycine 0 CA--C 1.548 2.147 1 C-N-CA 112.98 -4.438 . . . . 0.0 104.226 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.87 -157.85 0.06 Allowed 'General case' 0 C--O 1.25 1.089 1 O-C-N 131.672 4.983 . . . . 0.0 113.416 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.568 ' N ' ' HD3' ' A' ' 79' ' ' LYS 0.347 0.0 OUTLIER -61.88 133.46 55.46 Favored 'General case' 0 C--O 1.198 -1.638 1 O-C-N 129.534 4.271 . . . . 0.0 114.745 -177.598 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.484 ' CD1' ' HD3' ' A' ' 80' ' ' ARG 0.255 2.4 mt -136.68 38.45 2.63 Favored 'General case' 0 C--O 1.208 -1.132 1 O-C-N 136.145 8.403 . . . . 0.0 109.641 -179.697 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 HG12 ' HG3' ' A' ' 77' ' ' LYS . 90.7 mt -61.83 163.5 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.707 1 CA-C-N 107.239 -4.528 . . . . 0.0 102.608 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' ' 88' ' ' ILE . . . -141.99 67.98 1.33 Allowed 'General case' 0 C--O 1.211 -0.939 1 O-C-N 134.47 7.356 . . . . 0.0 105.45 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.64 131.34 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-N 111.824 -2.444 . . . . 0.0 108.962 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.457 ' C ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -152.4 -158.25 0.88 Allowed 'General case' 0 N--CA 1.435 -1.209 1 C-N-CA 110.856 -4.338 . . . . 0.0 112.311 179.771 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CG ' ' C ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 166.48 79.17 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.318 1 O-C-N 130.592 4.933 . . . . 0.0 105.265 -178.593 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 2' ' ' PHE 0.262 0.4 OUTLIER -24.08 92.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 1 O-C-N 132.383 6.052 . . . . 0.0 113.785 -179.419 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 p -53.07 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.102 1 O-C-N 129.261 4.101 . . . . 0.0 116.36 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -112.63 0.74 Allowed Glycine 0 CA--C 1.559 2.795 0 C-N-CA 115.633 -3.175 . . . . 0.0 106.46 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -117.38 46.19 1.76 Allowed 'General case' 0 C--N 1.362 1.133 1 CA-C-N 106.937 -4.632 . . . . 0.0 109.14 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -172.48 152.52 2.67 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 128.316 3.51 . . . . 0.0 106.863 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -104.32 107.37 18.25 Favored 'General case' 0 C--O 1.204 -1.306 2 O-C-N 132.321 6.013 . . . . 0.0 108.147 179.532 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -56.26 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.891 2 O-C-N 134.696 7.498 . . . . 0.0 103.287 -179.998 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 99' ' ' ILE . 7.7 mm-40 99.45 98.1 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.079 1 O-C-N 130.257 4.723 . . . . 0.0 103.263 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.8 m -100.96 95.46 6.61 Favored 'General case' 0 C--O 1.195 -1.812 2 O-C-N 130.529 4.893 . . . . 0.0 111.236 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -66.97 131.28 45.55 Favored 'General case' 0 C--O 1.202 -1.408 3 CA-C-N 106.411 -4.904 . . . . 0.0 106.481 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 90.5 m -111.94 80.1 1.29 Allowed 'General case' 0 C--O 1.199 -1.553 1 O-C-N 131.824 5.702 . . . . 0.0 107.021 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -101.09 154.73 18.48 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 108.705 -3.862 . . . . 0.0 110.649 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.3 mm-40 -32.65 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.88 10.15 67.19 Favored Glycine 0 C--N 1.357 1.727 0 C-N-CA 115.752 -3.118 . . . . 0.0 116.851 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -158.02 173.36 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 115.975 -1.964 . . . . 0.0 114.657 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.67 58.45 1.61 Allowed 'General case' 0 C--N 1.353 0.752 1 O-C-N 131.491 5.495 . . . . 0.0 107.067 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.321 . . -80.56 121.63 26.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 128.42 3.575 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -104.28 179.61 4.22 Favored 'General case' 0 N--CA 1.426 -1.666 1 O-C-N 133.718 6.886 . . . . 0.0 108.536 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -159.14 135.82 9.38 Favored 'General case' 0 CA--C 1.562 1.406 2 O-C-N 130.131 4.644 . . . . 0.0 99.014 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.2 pt -111.23 111.47 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 1 O-C-N 132.2 5.938 . . . . 0.0 114.039 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.507 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 93.0 m-85 -109.63 -142.18 0.38 Allowed 'General case' 0 CA--C 1.559 1.321 1 O-C-N 131.48 5.488 . . . . 0.0 101.901 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -149.94 0.06 Allowed 'General case' 0 C--O 1.205 -1.25 1 O-C-N 132.9 6.375 . . . . 0.0 111.417 179.56 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.2 tttt -131.63 -175.68 3.79 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 124.997 2.332 . . . . 0.0 112.616 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.204 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 122.098 0.952 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -169.72 79.24 0.11 Allowed 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 110.203 -3.18 . . . . 0.0 103.733 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -170.06 59.44 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 114.4 -2.92 . . . . 0.0 114.953 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 48.4 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 1 C-N-CA 111.366 -5.206 . . . . 0.0 107.24 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' C ' ' CD1' ' A' ' 6' ' ' TRP . 34.8 p 59.22 162.85 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.814 1 O-C-N 132.269 5.334 . . . . 0.0 111.479 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.577 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.285 8.4 m95 -157.38 149.06 22.15 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 116.328 -1.796 . . . . 0.0 114.079 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 38.4 mtmt 59.71 178.96 0.09 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.257 0.5 OUTLIER 39.07 148.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 3 O-C-N 134.061 7.101 . . . . 0.0 120.693 174.864 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.33 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 CA-C-N 107.644 -4.343 . . . . 0.0 108.141 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -43.1 132.64 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.9 152.01 11.02 Favored 'General case' 0 C--O 1.206 -1.188 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.812 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.83 -159.11 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -84.52 70.95 10.78 Favored 'General case' 0 CA--C 1.541 0.625 1 O-C-N 129.6 4.313 . . . . 0.0 102.688 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.36 167.68 0.31 Allowed 'General case' 0 C--O 1.215 -0.732 0 O-C-N 128.508 3.63 . . . . 0.0 105.283 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 t 65.91 -153.38 0.25 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.63 153.72 5.95 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 127.665 3.103 . . . . 0.0 112.36 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.56 53.2 0.75 Allowed 'General case' 0 C--O 1.242 0.692 0 CA-C-N 112.05 -2.075 . . . . 0.0 107.468 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.66 136.86 10.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 126.142 2.151 . . . . 0.0 111.529 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.47 94.17 9.33 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 116.166 -1.873 . . . . 0.0 109.617 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -108.21 161.76 14.69 Favored 'General case' 0 CA--C 1.561 1.403 1 O-C-N 130.153 4.658 . . . . 0.0 113.193 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -146.66 -178.72 6.33 Favored 'General case' 0 CA--C 1.553 1.088 1 O-C-N 129.511 4.257 . . . . 0.0 104.586 -179.976 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.396 0.0 OUTLIER -147.12 140.2 25.23 Favored 'General case' 0 CA--C 1.566 1.569 1 O-C-N 131.029 5.205 . . . . 0.0 100.612 179.687 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.0 mt -98.4 164.39 12.3 Favored 'General case' 0 C--N 1.318 -0.799 2 O-C-N 133.072 6.482 . . . . 0.0 98.811 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.537 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 20.8 m 174.04 89.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 O-C-N 128.882 3.864 . . . . 0.0 104.155 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 32' ' ' PHE 0.263 4.4 mp -111.05 152.86 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 108.533 -3.94 . . . . 0.0 110.809 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.0 m -162.34 80.22 0.52 Allowed 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 114.134 -3.026 . . . . 0.0 108.045 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.35 124.0 12.24 Favored 'General case' 0 C--O 1.214 -0.814 2 O-C-N 132.996 6.435 . . . . 0.0 110.992 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -116.84 111.0 19.08 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 128.608 3.692 . . . . 0.0 103.229 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 -114.17 4.43 Favored Glycine 0 CA--C 1.546 2.026 1 N-CA-C 101.69 -4.564 . . . . 0.0 101.69 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 62.99 1.07 Allowed 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 127.338 2.434 . . . . 0.0 107.38 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.05 161.87 33.22 Favored 'General case' 0 C--N 1.306 -1.312 1 N-CA-C 98.936 -4.468 . . . . 0.0 98.936 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 25' ' ' ILE . 69.1 t80 -158.0 72.9 0.66 Allowed 'General case' 0 C--O 1.193 -1.918 1 N-CA-C 99.439 -4.282 . . . . 0.0 99.439 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 139.43 47.07 Favored 'General case' 0 CA--C 1.505 -0.761 2 O-C-N 131.784 5.677 . . . . 0.0 103.827 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.479 ' CG1' ' HG2' ' A' ' 36' ' ' GLU 0.383 0.5 OUTLIER -120.13 137.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 128.782 3.802 . . . . 0.0 101.427 179.915 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 8.2 tttm -87.52 17.85 4.3 Favored 'General case' 0 N--CA 1.414 -2.228 1 N-CA-C 121.871 4.026 . . . . 0.0 121.871 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 7.3 pt-20 -49.68 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 124.727 2.204 . . . . 0.0 110.385 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 t -77.03 152.82 34.97 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 116.406 -2.117 . . . . 0.0 109.299 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.98 102.09 0.09 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 114.867 -2.733 . . . . 0.0 116.077 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 60.7 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 1 O-C-N 129.574 4.296 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 58' ' ' ALA . 1.1 m-85 -78.18 91.45 4.35 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 115.59 -2.444 . . . . 0.0 110.695 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.29 -160.76 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 129.198 4.061 . . . . 0.0 115.757 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -7.69 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 127.034 2.709 . . . . 0.0 108.205 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.8 tp 11.8 91.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.42 2 O-C-N 132.885 6.366 . . . . 0.0 111.909 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.63 123.35 17.66 Favored 'General case' 0 C--N 1.369 1.433 0 O-C-N 118.219 -2.8 . . . . 0.0 111.071 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.07 106.29 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 2 O-C-N 130.08 4.613 . . . . 0.0 100.014 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.312 10.7 p -118.0 153.51 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 O-C-N 127.444 2.965 . . . . 0.0 114.149 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 2.2 p90 -179.32 -165.63 0.08 Allowed 'General case' 0 N--CA 1.429 -1.521 1 O-C-N 132.357 6.035 . . . . 0.0 111.132 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.75 73.53 1.41 Allowed 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 116.571 -2.052 . . . . 0.0 108.638 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 69' ' ' MET . 0.2 OUTLIER 69.59 -79.22 0.04 OUTLIER 'General case' 0 C--O 1.198 -1.615 2 O-C-N 132.499 6.125 . . . . 0.0 111.666 179.988 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.91 84.09 0.33 Allowed Glycine 0 CA--C 1.537 1.437 0 N-CA-C 104.665 -3.374 . . . . 0.0 104.665 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.12 -40.74 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 O-C-N 131.341 4.789 . . . . 0.0 111.641 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.86 125.22 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.935 2 O-C-N 133.013 6.446 . . . . 0.0 108.368 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 3.3 p90 -167.25 140.6 3.55 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 112.311 -3.756 . . . . 0.0 115.37 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.76 151.21 21.3 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 100.846 -3.761 . . . . 0.0 100.846 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.47 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -170.51 135.1 1.16 Allowed 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 112.236 -3.786 . . . . 0.0 109.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 91.21 8.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 114.456 -2.688 . . . . 0.0 105.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 55' ' ' TYR . 10.5 mp -68.87 -96.11 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 O-C-N 129.544 4.277 . . . . 0.0 114.24 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 40' ' ' PHE . . . -46.66 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 126.587 2.429 . . . . 0.0 116.185 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.0 14.17 4.75 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 124.939 1.399 . . . . 0.0 112.739 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.66 58.68 0.09 OUTLIER Glycine 0 CA--C 1.544 1.858 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.7 p -67.3 -60.57 2.48 Favored 'General case' 0 N--CA 1.425 -1.722 1 O-C-N 131.755 5.032 . . . . 0.0 110.126 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 65.73 46.71 2.29 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 125.487 1.742 . . . . 0.0 108.532 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' CD2' HD21 ' A' ' 87' ' ' LEU . 5.2 mp -99.84 84.12 2.85 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 127.66 3.1 . . . . 0.0 107.644 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -70.04 105.85 3.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 111.362 -2.654 . . . . 0.0 110.286 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.516 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -166.31 -156.42 9.48 Favored Glycine 0 CA--C 1.557 2.681 1 C-N-CA 111.954 -4.927 . . . . 0.0 104.314 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CE1' ' A' ' 78' ' ' PHE 0.26 8.8 t -161.27 135.54 7.02 Favored 'General case' 0 CA--C 1.491 -1.29 1 O-C-N 131.793 5.055 . . . . 0.0 114.481 179.525 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.744 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 9.4 m95 -115.03 97.66 6.35 Favored 'General case' 0 C--O 1.192 -1.96 0 O-C-N 117.839 -3.038 . . . . 0.0 104.553 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.16 97.36 7.9 Favored 'General case' 0 N--CA 1.447 -0.609 2 O-C-N 137.421 9.201 . . . . 0.0 114.879 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.437 ' CB ' HD23 ' A' ' 49' ' ' LEU . 3.6 ttp -56.69 109.53 0.64 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 128.974 3.922 . . . . 0.0 105.402 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 28.9 tt0 -101.68 65.12 1.01 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.158 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -105.78 0.79 Allowed Glycine 0 CA--C 1.551 2.327 0 O-C-N 128.817 3.823 . . . . 0.0 103.924 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.78 62.7 2.72 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 128.63 3.194 . . . . 0.0 109.041 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -172.23 179.14 2.67 Favored 'General case' 0 C--N 1.358 0.955 1 O-C-N 129.678 4.361 . . . . 0.0 109.95 179.934 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.5 mt -157.6 74.54 0.75 Allowed 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 127.272 2.857 . . . . 0.0 112.191 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.58 134.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.037 -2.347 . . . . 0.0 116.036 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.454 ' HA3' ' CZ3' ' A' ' 67' ' ' TRP . . . 173.78 -166.1 38.18 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 103.745 -3.742 . . . . 0.0 103.745 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.427 ' HG3' HG12 ' A' ' 88' ' ' ILE 0.251 12.5 tttm 176.65 117.67 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.348 1 O-C-N 133.822 6.248 . . . . 0.0 113.345 179.997 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.744 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.1 OUTLIER -114.59 171.5 7.6 Favored 'General case' 0 C--O 1.192 -1.932 0 O-C-N 128.768 3.793 . . . . 0.0 101.335 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HE2' ' HA2' ' A' ' 84' ' ' GLY 0.338 0.0 OUTLIER -170.43 142.1 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 108.922 -3.763 . . . . 0.0 115.061 -179.001 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.63 106.08 18.22 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 118.295 -1.362 . . . . 0.0 108.887 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.65 -16.82 17.59 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 1 O-C-N 130.777 5.048 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.04 -36.27 72.27 Favored 'General case' 0 C--O 1.252 1.206 0 O-C-N 129.091 3.994 . . . . 0.0 111.677 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -122.9 3.95 9.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 126.747 2.529 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.42 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 69.17 43.28 72.38 Favored Glycine 0 CA--C 1.558 2.746 2 N-CA-C 100.863 -4.895 . . . . 0.0 100.863 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -105.08 132.19 51.63 Favored 'General case' 0 N--CA 1.44 -0.946 2 CA-C-N 105.617 -5.291 . . . . 0.0 115.429 -179.539 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -110.16 139.6 45.14 Favored 'General case' 0 C--O 1.199 -1.554 0 CA-C-N 121.344 1.884 . . . . 0.0 107.844 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -130.7 45.44 2.81 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 133.031 6.457 . . . . 0.0 110.28 179.995 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' HG3' ' A' ' 77' ' ' LYS . 96.9 mt -68.81 168.03 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.949 1 CA-C-N 107.929 -4.214 . . . . 0.0 103.592 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . . . -143.22 107.7 4.81 Favored 'General case' 0 C--O 1.195 -1.803 1 O-C-N 130.83 5.081 . . . . 0.0 105.587 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 t -110.87 106.95 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 128.645 3.716 . . . . 0.0 102.519 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -156.08 162.5 40.27 Favored 'General case' 0 C--O 1.189 -2.111 1 C-N-CA 110.411 -4.516 . . . . 0.0 116.136 -179.535 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -149.16 136.86 20.4 Favored 'General case' 0 N--CA 1.439 -1.015 2 O-C-N 132.84 6.337 . . . . 0.0 109.8 179.725 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.47 ' CD1' HD13 ' A' ' 98' ' ' LEU . 6.2 mm -47.55 124.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 1 O-C-N 131.891 5.744 . . . . 0.0 110.177 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -126.43 101.43 6.69 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 128.526 3.641 . . . . 0.0 117.297 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.94 39.05 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 59.32 44.15 15.73 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 111.637 -2.282 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.554 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.265 0.1 OUTLIER -158.71 157.64 32.16 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 114.621 -2.609 . . . . 0.0 108.309 179.063 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -113.65 141.32 47.35 Favored 'General case' 0 C--O 1.208 -1.11 1 O-C-N 133.733 6.896 . . . . 0.0 109.187 179.894 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.29 5.0 mt -105.55 -46.35 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 1 O-C-N 129.302 4.126 . . . . 0.0 107.621 -179.863 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 63.2 100.5 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.142 1 O-C-N 129.58 4.3 . . . . 0.0 104.366 -179.367 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.411 HG22 ' CG ' ' A' ' 108' ' ' GLU . 1.4 m -98.55 96.76 8.19 Favored 'General case' 0 N--CA 1.427 -1.594 2 O-C-N 130.604 4.94 . . . . 0.0 111.949 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.28 126.15 28.86 Favored 'General case' 0 C--O 1.202 -1.438 1 CA-C-N 107.422 -4.445 . . . . 0.0 105.227 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -103.63 68.02 0.92 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -84.19 132.67 34.65 Favored 'General case' 0 CA--C 1.493 -1.213 1 CA-C-N 106.436 -4.893 . . . . 0.0 117.187 -179.63 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 44.58 31.72 0.66 Allowed 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.94 6.46 67.1 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.939 -2.077 . . . . 0.0 112.673 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.73 148.08 21.84 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-O 116.615 -1.66 . . . . 0.0 111.833 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.411 ' CG ' HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -107.12 107.76 18.89 Favored 'General case' 0 C--N 1.371 1.517 1 O-C-N 129.116 4.01 . . . . 0.0 107.441 -179.671 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.429 . . -135.52 137.29 41.93 Favored 'General case' 0 N--CA 1.417 -2.093 1 O-C-N 130.053 4.596 . . . . 0.0 112.446 179.846 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 175.98 8.86 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 130.612 4.945 . . . . 0.0 110.479 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 37.9 mtt85 -141.24 130.36 23.39 Favored 'General case' 0 N--CA 1.48 1.059 2 O-C-N 129.861 4.476 . . . . 0.0 99.627 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 134.28 28.03 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 C-N-CA 114.359 -2.936 . . . . 0.0 112.84 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 111' ' ' ARG . 2.6 m-85 -147.95 -157.13 0.78 Allowed 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 131.199 5.312 . . . . 0.0 107.37 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -166.94 -144.21 0.06 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 131.802 5.689 . . . . 0.0 112.061 -179.737 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 10.4 tttt -128.99 -171.74 2.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -104.15 -31.35 9.68 Favored 'General case' 0 C--O 1.22 -0.462 1 O-C-N 130.221 4.701 . . . . 0.0 108.086 -179.831 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.21 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 O-C-N 127.163 2.789 . . . . 0.0 117.8 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.06 171.78 36.64 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 114.68 -3.628 . . . . 0.0 106.029 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -97.14 153.57 17.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 114.747 -2.781 . . . . 0.0 103.735 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.561 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 18.0 m95 -126.87 170.59 12.07 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 111.845 -3.931 . . . . 0.0 112.58 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 7.1 mtmt 43.58 -178.71 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.851 1 O-C-N 130.747 5.029 . . . . 0.0 117.366 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.277 1.2 t 26.51 114.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 2 O-C-N 131.522 5.513 . . . . 0.0 118.013 174.982 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.32 121.35 40.19 Favored 'General case' 0 C--N 1.373 1.588 0 O-C-N 118.577 -2.577 . . . . 0.0 110.345 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 10' ' ' ARG . 16.4 mmm180 56.85 -174.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.32 -64.03 0.22 Allowed 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.432 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 64.36 20.45 12.17 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 127.715 3.134 . . . . 0.0 110.782 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 p30 31.67 55.02 0.28 Allowed 'General case' 0 N--CA 1.452 -0.353 1 O-C-N 130.621 4.95 . . . . 0.0 109.133 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.47 -16.32 14.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 110.859 -2.882 . . . . 0.0 112.863 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.5 p -131.67 133.2 44.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.72 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.03 142.43 7.68 Favored Glycine 0 CA--C 1.543 1.844 0 O-C-N 128.308 3.505 . . . . 0.0 109.591 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.57 101.21 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 129.021 3.424 . . . . 0.0 107.54 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -43.1 -51.55 5.81 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 128.681 3.738 . . . . 0.0 108.747 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.37 86.62 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 112.389 -2.187 . . . . 0.0 113.019 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.0 m-20 -85.11 -57.9 2.9 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 127.67 3.106 . . . . 0.0 108.976 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HA ' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER 53.76 -89.76 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.526 1 O-C-N 130.667 4.979 . . . . 0.0 101.413 179.946 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER 61.22 149.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 134.048 7.092 . . . . 0.0 105.825 179.224 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 mt -124.93 172.75 9.13 Favored 'General case' 0 N--CA 1.436 -1.146 3 CA-C-N 106.285 -4.961 . . . . 0.0 99.067 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.433 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 18.0 m -168.21 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 1 O-C-N 129.429 4.206 . . . . 0.0 108.553 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.447 HD12 ' CE1' ' A' ' 2' ' ' PHE . 1.9 mp 72.14 137.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 109.202 -3.635 . . . . 0.0 109.557 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 m -170.11 73.56 0.07 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.531 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -52.35 145.29 11.37 Favored 'General case' 0 C--O 1.207 -1.177 2 O-C-N 133.307 6.63 . . . . 0.0 114.662 179.678 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.07 62.07 1.34 Allowed 'General case' 0 C--N 1.358 0.962 1 O-C-N 131.921 5.763 . . . . 0.0 104.361 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.45 57.01 0.81 Allowed Glycine 0 CA--C 1.552 2.357 1 C-N-CA 112.21 -4.805 . . . . 0.0 103.873 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 53.17 14.09 0.46 Allowed 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 112.733 -3.508 . . . . 0.0 110.6 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 84.27 5.77 Favored 'General case' 0 CA--C 1.55 0.976 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 6.3 m-85 -82.12 142.38 32.3 Favored 'General case' 0 CA--C 1.562 1.415 1 N-CA-C 96.646 -5.316 . . . . 0.0 96.646 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.83 112.99 15.36 Favored 'General case' 0 N--CA 1.482 1.155 3 O-C-N 137.527 9.267 . . . . 0.0 97.421 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 36' ' ' GLU 0.383 1.2 t -80.32 149.87 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 C-N-CA 111.01 -4.276 . . . . 0.0 104.764 179.934 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.286 0.7 OUTLIER -85.15 2.86 41.76 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 109.275 -3.602 . . . . 0.0 120.317 179.622 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -47.98 109.07 0.19 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.25 -3.159 . . . . 0.0 108.359 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.442 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 5.8 m -103.57 126.87 50.98 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 127.202 2.814 . . . . 0.0 107.595 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -152.46 -160.61 1.16 Allowed 'General case' 0 C--O 1.24 0.595 0 O-C-N 126.889 2.618 . . . . 0.0 112.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.25 -89.05 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.351 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.34 45.18 0.07 Allowed 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 113.732 -3.187 . . . . 0.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER 170.71 -164.35 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.959 1 O-C-N 133.573 6.796 . . . . 0.0 111.834 -179.912 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.48 121.12 44.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 1.9 tt -148.65 91.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.137 2 O-C-N 130.093 4.62 . . . . 0.0 109.378 -179.16 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.3 142.85 54.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 108.9 -3.773 . . . . 0.0 110.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.8 t -105.05 99.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.264 2 O-C-N 131.413 5.446 . . . . 0.0 99.876 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 47' ' ' PHE 0.338 3.6 p -101.56 168.07 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 112.393 -3.723 . . . . 0.0 115.656 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -164.85 163.13 21.18 Favored 'General case' 0 N--CA 1.434 -1.266 1 O-C-N 130.861 5.101 . . . . 0.0 112.583 -179.506 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.09 28.91 6.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 115.546 -2.462 . . . . 0.0 114.699 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 61.7 86.61 0.11 Allowed 'General case' 0 N--CA 1.441 -0.899 1 O-C-N 130.483 4.864 . . . . 0.0 115.811 179.931 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.24 75.0 0.9 Allowed Glycine 0 C--O 1.199 -2.046 0 N-CA-C 104.496 -3.441 . . . . 0.0 104.496 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.61 -42.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 1 O-C-N 130.678 4.399 . . . . 0.0 116.378 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 78.44 126.85 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.132 1 O-C-N 129.408 4.193 . . . . 0.0 111.52 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -161.19 151.73 17.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 113.635 -3.226 . . . . 0.0 115.069 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.09 118.43 36.75 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 101.346 -3.575 . . . . 0.0 101.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.7 138.52 28.94 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 114.958 -2.697 . . . . 0.0 111.484 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.32 98.2 10.41 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 128.616 3.698 . . . . 0.0 106.822 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.4 mt -84.28 139.26 32.45 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 126.902 2.626 . . . . 0.0 112.378 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 55.97 5.02 0.14 Allowed 'General case' 0 C--O 1.247 0.954 0 O-C-N 127.252 2.845 . . . . 0.0 114.842 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.21 -39.48 0.36 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.42 -40.71 7.23 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 115.336 -2.924 . . . . 0.0 107.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.11 150.73 31.7 Favored 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 130.208 4.123 . . . . 0.0 110.546 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' HB2' HG11 ' A' ' 81' ' ' VAL . 17.7 mt-10 -153.49 68.26 0.78 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 113.278 -3.369 . . . . 0.0 106.418 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 9.4 mp -79.17 131.15 36.11 Favored 'General case' 0 C--O 1.201 -1.459 2 CA-C-N 107.076 -4.602 . . . . 0.0 113.961 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.6 m -119.82 105.97 11.63 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -168.4 -160.38 16.1 Favored Glycine 0 CA--C 1.542 1.723 1 C-N-CA 110.75 -5.5 . . . . 0.0 103.781 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 6.1 t -151.68 157.02 41.53 Favored 'General case' 0 N--CA 1.426 -1.639 1 O-C-N 133.35 5.971 . . . . 0.0 117.942 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 33.1 m95 -124.94 112.25 16.38 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 114.629 -2.605 . . . . 0.0 104.689 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 p -107.14 52.68 0.71 Allowed 'General case' 0 N--CA 1.435 -1.192 1 O-C-N 135.51 8.006 . . . . 0.0 116.028 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.82 111.37 0.34 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 134.124 7.14 . . . . 0.0 104.153 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -90.1 -43.28 10.58 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 109.443 -3.526 . . . . 0.0 110.507 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.81 101.86 0.21 Allowed Glycine 0 CA--C 1.532 1.151 0 O-C-N 128.292 3.495 . . . . 0.0 105.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 73.26 13.94 4.61 Favored 'General case' 0 N--CA 1.447 -0.595 1 O-C-N 130.683 4.402 . . . . 0.0 110.008 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -124.06 -169.37 1.95 Allowed 'General case' 0 N--CA 1.471 0.609 1 O-C-N 129.642 4.339 . . . . 0.0 108.35 -179.72 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 91' ' ' ARG . 0.8 OUTLIER -169.31 43.65 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 128.506 3.629 . . . . 0.0 111.896 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 t -77.51 136.5 24.18 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 3 O-C-N 131.316 5.385 . . . . 0.0 113.24 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.53 -159.96 32.63 Favored Glycine 0 CA--C 1.556 2.655 1 N-CA-C 101.652 -4.579 . . . . 0.0 101.652 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.509 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 178.0 141.26 0.09 Allowed 'General case' 0 C--O 1.201 -1.484 1 O-C-N 130.918 4.54 . . . . 0.0 113.53 -179.449 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -131.18 178.5 6.65 Favored 'General case' 0 C--N 1.367 1.349 3 O-C-N 130.61 4.944 . . . . 0.0 105.694 -179.552 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' HE2' ' CA ' ' A' ' 84' ' ' GLY 0.324 0.8 OUTLIER -163.74 131.24 3.44 Favored 'General case' 0 C--N 1.365 1.274 1 CA-C-N 106.257 -4.974 . . . . 0.0 113.64 179.906 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.476 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 72.7 ttt180 -85.92 94.87 9.29 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.32 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 62' ' ' GLU . 14.3 p -47.41 -26.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 O-C-N 133.175 6.547 . . . . 0.0 113.77 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.32 -0.712 1 O-C-N 130.121 4.638 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.82 -3.45 15.71 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 114.745 -2.782 . . . . 0.0 114.748 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.497 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 70.62 33.36 67.18 Favored Glycine 0 CA--C 1.557 2.674 2 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 3.9 tppt? -72.74 -78.26 0.09 Allowed 'General case' 0 N--CA 1.421 -1.904 1 CA-C-N 105.473 -5.364 . . . . 0.0 120.805 -178.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 52.8 mt-10 83.26 60.29 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.459 1 O-C-N 130.209 4.693 . . . . 0.0 107.906 -177.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 tp -91.48 69.23 5.84 Favored 'General case' 0 CA--C 1.49 -1.341 1 O-C-N 135.009 7.693 . . . . 0.0 112.498 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 77' ' ' LYS 0.29 78.0 mt -76.81 -179.46 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 69.68 0.73 Allowed 'General case' 0 C--O 1.201 -1.469 0 O-C-N 128.627 3.705 . . . . 0.0 106.223 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.64 137.15 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 110.936 -2.847 . . . . 0.0 105.497 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.497 ' HG3' ' CD1' ' A' ' 98' ' ' LEU . 0.4 OUTLIER 179.51 162.48 0.89 Allowed 'General case' 0 N--CA 1.414 -2.272 1 C-N-CA 111.363 -4.135 . . . . 0.0 114.044 179.843 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.87 154.76 35.74 Favored 'General case' 0 N--CA 1.424 -1.746 1 O-C-N 131.441 5.463 . . . . 0.0 105.534 178.688 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.467 ' CD1' HD11 ' A' ' 98' ' ' LEU . 4.9 mm -56.09 91.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 1 O-C-N 132.365 6.041 . . . . 0.0 109.694 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -31.31 -59.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 1 O-C-N 133.002 6.439 . . . . 0.0 115.258 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.14 -83.14 0.12 Allowed Glycine 0 CA--C 1.556 2.634 0 N-CA-C 103.24 -3.944 . . . . 0.0 103.24 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.3 26.52 5.41 Favored 'General case' 0 CA--C 1.551 1.007 1 CA-C-N 107.123 -4.538 . . . . 0.0 105.193 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.458 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -164.44 163.08 22.32 Favored 'General case' 0 CA--C 1.563 1.45 1 O-C-N 133.049 6.468 . . . . 0.0 106.706 -179.881 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' CD1' ' HG3' ' A' ' 91' ' ' ARG . 17.2 tp -115.89 136.53 52.95 Favored 'General case' 0 N--CA 1.437 -1.122 1 O-C-N 132.853 6.346 . . . . 0.0 110.484 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.277 4.2 mt -85.28 -60.79 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 2 CA-C-O 110.796 -4.43 . . . . 0.0 106.102 -179.588 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 86.09 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 1 O-C-N 134.064 7.103 . . . . 0.0 102.865 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.45 98.74 8.59 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.714 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.3 95.74 1.34 Allowed 'General case' 0 C--O 1.21 -1.022 2 CA-C-N 107.489 -4.414 . . . . 0.0 105.086 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.1 132.69 51.25 Favored 'General case' 0 N--CA 1.48 1.032 1 O-C-N 129.541 4.276 . . . . 0.0 100.812 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -160.13 147.43 16.3 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 110.448 -3.069 . . . . 0.0 115.888 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 43.28 28.91 0.19 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.184 -2.28 . . . . 0.0 116.043 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 C--N 1.358 1.796 0 C-N-CA 117.066 -2.492 . . . . 0.0 116.328 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.15 -159.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 118.801 -1.159 . . . . 0.0 112.765 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -138.13 93.67 2.79 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 116.435 -2.106 . . . . 0.0 106.448 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.47 . . -105.13 150.39 25.08 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 125.954 2.034 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 177.59 9.19 Favored 'General case' 0 N--CA 1.427 -1.603 1 O-C-N 131.52 5.513 . . . . 0.0 110.75 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -147.07 107.15 4.0 Favored 'General case' 0 CA--C 1.561 1.366 2 O-C-N 130.757 5.035 . . . . 0.0 99.834 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.31 132.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 O-C-N 128.872 3.857 . . . . 0.0 113.586 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 13.7 m-30 -140.15 175.73 9.35 Favored 'General case' 0 N--CA 1.423 -1.796 2 O-C-N 133.675 6.86 . . . . 0.0 104.083 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -159.95 -155.21 0.43 Allowed 'General case' 0 C--O 1.2 -1.52 1 O-C-N 131.367 5.417 . . . . 0.0 111.325 179.454 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.4 tttt -110.21 -173.04 2.16 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.747 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 109.422 -3.535 . . . . 0.0 111.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.54 -60.77 0.17 Allowed 'General case' 0 C--N 1.358 0.955 0 O-C-N 128.2 3.438 . . . . 0.0 104.381 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.251 4.2 p-10 -33.1 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.7 1 O-C-N 130.493 4.871 . . . . 0.0 118.541 179.803 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.76 -176.29 43.65 Favored Glycine 0 C--N 1.355 1.594 1 C-N-CA 113.169 -4.348 . . . . 0.0 105.221 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 24' ' ' THR . 46.5 p -97.76 165.93 11.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 112.486 -3.685 . . . . 0.0 103.576 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 13.1 m95 -136.67 172.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 112.589 -3.576 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 7.6 mtmt 38.92 -178.64 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.505 4.878 . . . . 0.0 118.502 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 10' ' ' ARG 0.329 1.0 OUTLIER -2.86 125.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 3 CA-C-N 105.319 -5.401 . . . . 0.0 118.794 174.915 . . . . . . . . 5 4 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.97 -45.78 13.7 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 110.272 -3.149 . . . . 0.0 104.883 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HB2' HG11 ' A' ' 8' ' ' VAL . 38.7 ttt180 54.51 106.63 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.49 3.043 . . . . 0.0 115.355 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -67.47 -13.34 61.95 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.252 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 63.65 97.17 0.04 OUTLIER 'General case' 0 C--O 1.237 0.429 0 O-C-N 127.859 3.225 . . . . 0.0 107.114 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.14 128.85 14.21 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.38 139.2 51.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 127.541 3.026 . . . . 0.0 108.349 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -157.92 -162.03 1.1 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 116.461 -2.095 . . . . 0.0 105.598 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.07 -82.78 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 O-C-N 127.004 2.69 . . . . 0.0 109.701 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.35 116.97 9.2 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.38 118.55 31.47 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 117.996 -1.002 . . . . 0.0 108.851 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -104.68 90.43 3.49 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 127.483 2.989 . . . . 0.0 111.945 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -132.66 125.72 30.97 Favored 'General case' 0 CA--C 1.547 0.853 1 O-C-N 133.094 6.496 . . . . 0.0 110.681 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.47 ' HG ' ' CB ' ' A' ' 38' ' ' SER . 1.2 mp -112.21 -172.12 1.98 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 113.604 -3.093 . . . . 0.0 102.909 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' CG ' ' HB2' ' A' ' 37' ' ' SER 0.399 0.0 OUTLIER -150.29 168.62 23.53 Favored 'General case' 0 CA--C 1.566 1.586 1 O-C-N 131.682 5.614 . . . . 0.0 101.776 -179.912 . . . . . . . . 5 4 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 7.0 mt -139.95 153.55 46.95 Favored 'General case' 0 CA--C 1.562 1.423 4 O-C-N 132.805 6.315 . . . . 0.0 97.233 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.55 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 40.7 m 175.84 77.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 1 O-C-N 131.169 5.293 . . . . 0.0 106.499 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 23' ' ' LEU . 3.9 mp -89.13 157.48 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 C-N-CA 114.452 -2.899 . . . . 0.0 110.971 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.4 m -167.72 77.78 0.16 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 112.803 -3.559 . . . . 0.0 107.915 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.486 ' CA ' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -55.59 157.54 3.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 128.685 3.74 . . . . 0.0 115.555 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.8 61.56 1.67 Allowed 'General case' 0 C--N 1.356 0.87 0 O-C-N 128.787 3.804 . . . . 0.0 104.547 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.77 -95.39 0.43 Allowed Glycine 0 CA--C 1.555 2.566 2 O-C-N 130.551 4.907 . . . . 0.0 102.443 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -146.82 21.93 1.26 Allowed 'General case' 0 N--CA 1.415 -2.183 2 O-C-N 134.375 6.573 . . . . 0.0 106.392 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -125.46 126.39 44.85 Favored 'General case' 0 CA--C 1.552 1.02 1 O-C-N 129.729 4.393 . . . . 0.0 101.881 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -143.13 173.19 11.79 Favored 'General case' 0 C--O 1.193 -1.888 2 N-CA-C 96.162 -5.495 . . . . 0.0 96.162 179.736 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.07 124.66 20.85 Favored 'General case' 0 N--CA 1.473 0.708 2 O-C-N 137.945 9.528 . . . . 0.0 101.605 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.406 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.448 3.0 t -79.24 149.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 113.915 -3.114 . . . . 0.0 103.17 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.304 13.3 tttt -90.05 32.01 0.94 Allowed 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.438 27.8 tt0 -58.51 102.52 0.11 Allowed 'General case' 0 C--N 1.362 1.111 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB2' ' CG ' ' A' ' 22' ' ' LYS . 23.2 m -121.26 124.49 44.77 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 127.598 3.061 . . . . 0.0 112.147 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.47 ' CB ' ' HG ' ' A' ' 21' ' ' LEU . 1.5 t 159.34 -50.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 1 O-C-N 130.013 4.571 . . . . 0.0 115.317 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -38.8 -31.71 0.07 Allowed 'General case' 0 C--O 1.219 -0.545 0 O-C-N 128.416 3.572 . . . . 0.0 111.633 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.73 -48.85 0.06 Allowed 'General case' 0 C--N 1.356 0.876 1 C-N-CA 111.232 -4.187 . . . . 0.0 110.38 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.78 43.57 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.58 1.8 . . . . 0.0 114.953 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.481 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 84.47 6.18 0.59 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 128.891 3.87 . . . . 0.0 108.008 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.372 0.2 OUTLIER -25.69 92.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.069 3 O-C-N 133.55 6.781 . . . . 0.0 110.325 177.269 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.31 141.82 36.67 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 110.608 -2.996 . . . . 0.0 107.801 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.28 97.15 5.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 1 O-C-N 130.423 4.827 . . . . 0.0 103.86 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.308 1.2 p -95.47 155.64 3.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 C-N-CA 114.424 -2.91 . . . . 0.0 111.817 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.65 177.57 3.88 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 130.949 5.156 . . . . 0.0 111.8 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.19 78.37 1.83 Allowed 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 128.57 3.669 . . . . 0.0 116.144 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 15.58 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.524 1 O-C-N 129.173 4.046 . . . . 0.0 117.204 -179.819 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.9 53.46 1.39 Allowed Glycine 0 C--O 1.197 -2.165 0 N-CA-C 105.236 -3.146 . . . . 0.0 105.236 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.62 111.38 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 1 O-C-N 130.611 4.359 . . . . 0.0 112.195 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.24 151.1 28.29 Favored 'General case' 0 N--CA 1.473 0.717 1 O-C-N 130.97 5.169 . . . . 0.0 109.727 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -172.19 113.94 0.31 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 112.217 -3.793 . . . . 0.0 116.86 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.89 53.12 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 101.114 -3.661 . . . . 0.0 101.114 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 57' ' ' LEU . 6.9 t80 -154.53 97.22 1.98 Allowed 'General case' 0 C--O 1.206 -1.212 0 C-N-CA 112.113 -3.835 . . . . 0.0 113.427 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.1 t -64.38 91.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.929 1 O-C-N 130.343 4.777 . . . . 0.0 104.202 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -54.96 -76.11 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 129.022 3.951 . . . . 0.0 111.841 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.71 26.26 0.5 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.02 -24.8 0.15 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -33.47 2.0 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-O 115.072 -3.071 . . . . 0.0 109.033 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.5 p -58.23 -172.38 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 1 O-C-N 130.064 4.038 . . . . 0.0 115.01 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 tp10 -150.72 -60.86 0.19 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 117.109 -1.836 . . . . 0.0 107.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 mp 34.67 77.46 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.613 1 O-C-N 131.711 5.632 . . . . 0.0 113.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.0 m -87.69 99.66 12.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 112.169 -2.287 . . . . 0.0 107.988 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.559 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -159.38 -166.24 17.95 Favored Glycine 0 CA--C 1.536 1.401 1 C-N-CA 111.041 -5.361 . . . . 0.0 108.108 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.512 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 5.2 t -150.47 113.51 4.82 Favored 'General case' 0 N--CA 1.437 -1.122 2 O-C-N 132.376 5.397 . . . . 0.0 118.37 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.755 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 40.6 m95 -94.11 129.33 40.7 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 117.409 -3.307 . . . . 0.0 104.332 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.414 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 49.2 p -124.65 58.33 1.23 Allowed 'General case' 0 N--CA 1.433 -1.279 1 O-C-N 133.43 6.706 . . . . 0.0 116.301 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.406 ' HB3' ' CD2' ' A' ' 49' ' ' LEU 0.278 0.0 OUTLIER -42.26 112.43 0.34 Allowed 'General case' 0 N--CA 1.441 -0.896 1 O-C-N 131.116 5.26 . . . . 0.0 104.112 -179.923 . . . . . . . . 5 4 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.43 -78.45 0.22 Allowed 'General case' 0 C--O 1.212 -0.903 0 O-C-N 127.975 3.297 . . . . 0.0 108.529 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.05 -76.47 0.06 OUTLIER Glycine 0 CA--C 1.555 2.544 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 37.34 4.11 Favored 'General case' 0 CA--C 1.537 0.45 1 O-C-N 130.09 4.053 . . . . 0.0 108.258 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -130.32 177.48 7.3 Favored 'General case' 0 C--N 1.362 1.126 1 O-C-N 129.249 4.093 . . . . 0.0 112.432 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.3 mt -149.71 46.29 0.94 Allowed 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.54 2.4 . . . . 0.0 113.285 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.82 130.36 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 2 O-C-N 131.015 5.197 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.16 -164.58 36.11 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 103.902 -3.679 . . . . 0.0 103.902 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.488 ' CG ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -176.38 133.64 0.23 Allowed 'General case' 0 N--CA 1.423 -1.804 0 O-C-N 129.256 3.563 . . . . 0.0 114.149 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.6 OUTLIER -128.13 164.86 21.55 Favored 'General case' 0 C--O 1.203 -1.384 3 O-C-N 135.041 7.713 . . . . 0.0 105.272 179.765 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HG2' ' C ' ' A' ' 85' ' ' LYS . 3.8 tmtt? -154.0 153.17 31.49 Favored 'General case' 0 N--CA 1.417 -2.106 1 CA-C-N 106.744 -4.753 . . . . 0.0 117.734 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.426 ' HB3' ' HA3' ' A' ' 84' ' ' GLY . 44.0 ttt180 -104.13 85.84 2.46 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.942 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 ' HB ' ' HG2' ' A' ' 62' ' ' GLU . 1.2 t -42.68 -27.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 O-C-N 128.564 3.665 . . . . 0.0 113.338 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 30.9 t0 -72.99 0.55 10.99 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 128.787 3.804 . . . . 0.0 112.5 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER 102.09 12.0 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.284 1 O-C-N 132.772 6.295 . . . . 0.0 115.671 -179.489 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 80' ' ' ARG . . . -78.03 -39.69 23.04 Favored Glycine 0 CA--C 1.559 2.788 2 C-N-CA 111.27 -5.252 . . . . 0.0 100.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 2.1 tttt 83.86 -178.95 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.655 2 O-C-N 134.558 6.681 . . . . 0.0 115.534 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' N ' ' HG2' ' A' ' 79' ' ' LYS 0.257 1.4 mt-10 -38.23 135.92 0.68 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 132.448 6.092 . . . . 0.0 116.586 -178.434 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 39.75 2.59 Favored 'General case' 0 C--O 1.197 -1.696 1 O-C-N 130.816 5.073 . . . . 0.0 110.251 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.488 HG12 ' CG ' ' A' ' 77' ' ' LYS . 82.8 mt -64.15 149.54 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.445 2 N-CA-C 98.907 -4.479 . . . . 0.0 98.907 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.57 76.8 1.29 Allowed 'General case' 0 C--N 1.315 -0.914 1 O-C-N 134.545 7.403 . . . . 0.0 106.843 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.9 121.67 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 128.564 3.665 . . . . 0.0 102.305 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CD ' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -162.52 157.05 21.7 Favored 'General case' 0 C--O 1.192 -1.953 1 C-N-CA 110.343 -4.543 . . . . 0.0 113.483 -179.71 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -157.29 127.96 6.55 Favored 'General case' 0 C--O 1.209 -1.045 1 O-C-N 130.281 4.738 . . . . 0.0 103.663 179.819 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.432 HD11 ' HG ' ' A' ' 98' ' ' LEU . 1.5 mm -38.0 120.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 1 O-C-N 130.787 5.054 . . . . 0.0 111.793 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 -66.58 0.57 Allowed 'General case' 0 C--O 1.248 0.975 1 O-C-N 129.273 4.108 . . . . 0.0 114.584 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -128.93 -88.92 0.57 Allowed Glycine 0 CA--C 1.547 2.07 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -130.39 44.77 2.91 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 128.985 3.403 . . . . 0.0 106.401 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.2 172.06 7.6 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.462 4.226 . . . . 0.0 109.298 -179.653 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.559 ' CD2' ' CD ' ' A' ' 91' ' ' ARG . 1.9 mt -133.27 129.6 37.85 Favored 'General case' 0 C--O 1.205 -1.273 1 O-C-N 132.549 6.156 . . . . 0.0 112.16 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 34.4 mt -80.05 -82.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.932 2 O-C-N 129.796 4.435 . . . . 0.0 106.381 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 96.79 85.96 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 1 O-C-N 134.775 7.547 . . . . 0.0 105.026 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.414 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 4.6 m -82.57 92.26 7.08 Favored 'General case' 0 C--O 1.197 -1.688 2 O-C-N 131.18 5.3 . . . . 0.0 111.7 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.54 126.5 29.86 Favored 'General case' 0 C--O 1.207 -1.138 2 C-N-CA 110.484 -4.486 . . . . 0.0 106.158 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.9 m -101.08 87.01 3.15 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-O 127.62 3.581 . . . . 0.0 101.716 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -109.85 128.17 55.16 Favored 'General case' 0 C--N 1.359 1.001 1 CA-C-N 107.485 -4.416 . . . . 0.0 115.877 -179.978 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 30.3 mt-10 50.41 20.75 0.72 Allowed 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 120.058 -1.651 . . . . 0.0 114.951 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.1 -9.33 54.49 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 117.925 -2.083 . . . . 0.0 114.739 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.85 113.5 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.04 91.37 3.09 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.473 . . -125.77 122.54 36.52 Favored 'General case' 0 N--CA 1.414 -2.262 0 O-C-N 126.704 2.503 . . . . 0.0 116.25 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 22.9 mtmt -98.0 163.41 12.78 Favored 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 134.902 7.626 . . . . 0.0 108.893 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -107.85 -47.27 3.62 Favored 'General case' 0 CA--C 1.555 1.173 1 O-C-N 130.806 5.066 . . . . 0.0 105.276 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.302 11.6 mt 88.3 103.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 1 O-C-N 130.83 5.081 . . . . 0.0 109.283 179.992 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.537 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 16.8 m-85 -136.07 179.72 6.18 Favored 'General case' 0 N--CA 1.427 -1.601 1 O-C-N 132.695 6.247 . . . . 0.0 107.216 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -148.23 -152.48 0.44 Allowed 'General case' 0 C--O 1.203 -1.394 1 O-C-N 131.749 5.655 . . . . 0.0 112.369 179.125 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.6 tttt -115.55 -162.08 0.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 126.811 2.044 . . . . 0.0 111.575 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.431 -1.412 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.705 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 118.335 -0.84 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 53.62 33.98 17.66 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 128.772 3.795 . . . . 0.0 105.448 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -132.53 47.79 2.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.1 -171.68 38.67 Favored Glycine 0 N--CA 1.482 1.707 1 C-N-CA 110.731 -5.509 . . . . 0.0 105.446 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.371 4.4 p -82.85 -174.53 5.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 112.843 -3.543 . . . . 0.0 104.286 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.561 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.27 59.5 m95 -162.0 128.77 3.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 112.625 -3.56 . . . . 0.0 113.475 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.61 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 23.1 mtmt 73.91 177.4 0.24 Allowed 'General case' 0 C--O 1.193 -1.885 0 O-C-N 126.957 2.66 . . . . 0.0 117.229 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 t 32.05 118.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.638 3 O-C-N 136.592 8.682 . . . . 0.0 120.812 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.61 -171.33 3.9 Favored 'General case' 0 N--CA 1.421 -1.875 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.202 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.98 96.27 4.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.813 -1.54 . . . . 0.0 111.944 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.93 -19.4 7.27 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.182 0.927 . . . . 0.0 112.017 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 64.37 -93.7 0.04 OUTLIER 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.486 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 4.0 m120 53.19 -95.1 0.04 OUTLIER 'General case' 0 C--N 1.351 0.652 0 O-C-N 126.392 2.308 . . . . 0.0 106.885 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.486 ' CD1' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -148.9 95.71 2.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.226 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.4 p -165.2 156.83 14.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 114.054 -3.058 . . . . 0.0 107.739 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.38 62.05 0.01 OUTLIER Glycine 0 C--O 1.208 -1.514 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.731 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.39 -86.4 0.08 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 112.846 -1.677 . . . . 0.0 107.171 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -151.5 63.47 0.88 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 128.152 3.408 . . . . 0.0 112.605 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.82 76.22 1.53 Allowed 'General case' 0 C--N 1.365 1.268 0 O-C-N 125.262 1.601 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -122.21 23.38 9.85 Favored 'General case' 0 CA--C 1.554 1.096 1 O-C-N 130.441 4.838 . . . . 0.0 111.35 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.8 153.62 42.58 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 108.892 -3.776 . . . . 0.0 104.511 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.435 0.0 OUTLIER -152.83 142.66 22.07 Favored 'General case' 0 CA--C 1.565 1.556 1 O-C-N 129.226 4.079 . . . . 0.0 100.398 179.755 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.434 ' N ' ' HE2' ' A' ' 7' ' ' LYS . 7.5 mt -101.16 175.97 5.41 Favored 'General case' 0 C--N 1.311 -1.107 2 O-C-N 132.704 6.252 . . . . 0.0 97.859 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.584 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 m 164.38 76.7 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 1 CA-C-O 128.53 4.014 . . . . 0.0 102.223 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG23 ' CE2' ' A' ' 32' ' ' PHE . 3.3 mp -99.55 150.22 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 109.489 -3.505 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m -170.79 75.62 0.07 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 113.531 -3.267 . . . . 0.0 102.669 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 2.7 pm0 -51.67 141.42 16.67 Favored 'General case' 0 C--O 1.212 -0.903 1 O-C-N 130.318 4.761 . . . . 0.0 115.862 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.2 pm0 -116.57 103.9 10.87 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 128.857 3.848 . . . . 0.0 103.17 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.61 -121.48 6.05 Favored Glycine 0 N--CA 1.482 1.738 2 N-CA-C 100.747 -4.941 . . . . 0.0 100.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 19.3 m120 -110.49 3.65 19.76 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 114.431 -2.699 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 16.9 mttt -81.36 141.14 34.28 Favored 'General case' 0 CA--C 1.544 0.718 1 N-CA-C 97.421 -5.029 . . . . 0.0 97.421 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' CE2' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -148.93 101.2 3.15 Favored 'General case' 0 C--O 1.194 -1.856 1 N-CA-C 96.048 -5.538 . . . . 0.0 96.048 -179.683 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.14 143.87 30.73 Favored 'General case' 0 N--CA 1.454 -0.264 3 O-C-N 134.461 7.351 . . . . 0.0 101.956 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.333 1.3 t -111.75 149.5 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 2 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 179.718 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.584 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 3.0 tttm -87.32 45.02 1.23 Allowed 'General case' 0 C--O 1.195 -1.778 0 CA-C-O 126.585 3.088 . . . . 0.0 116.394 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 1.3 mm-40 -59.77 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.479 -2.146 . . . . 0.0 109.736 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 35' ' ' LYS . 4.3 t -97.2 117.65 31.87 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.485 2.366 . . . . 0.0 112.319 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.01 -156.45 0.57 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -78.4 -43.46 27.38 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 126.738 2.524 . . . . 0.0 108.763 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -45.58 -65.34 0.55 Allowed 'General case' 0 C--O 1.209 -1.04 1 O-C-N 132.341 6.026 . . . . 0.0 109.145 179.722 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -163.2 -163.39 0.84 Allowed 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 126.9 2.625 . . . . 0.0 111.135 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.426 ' C ' HG21 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.03 -16.08 57.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 114.546 -2.861 . . . . 0.0 104.748 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 42' ' ' ASN 0.259 0.1 OUTLIER 11.59 68.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.335 3 O-C-N 133.146 6.529 . . . . 0.0 111.575 179.279 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 150.33 28.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.454 -3.521 . . . . 0.0 108.473 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG22 ' CZ ' ' A' ' 78' ' ' PHE . 9.3 p -105.02 115.06 46.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.08 1 O-C-N 130.889 5.118 . . . . 0.0 104.126 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 47' ' ' PHE 0.256 9.7 p -131.05 161.65 40.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 C-N-CA 113.816 -3.154 . . . . 0.0 114.718 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CG2' ' A' ' 46' ' ' VAL . 2.9 p90 177.09 -168.82 0.06 Allowed 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 109.35 -3.568 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.252 0.9 OUTLIER -126.18 82.75 2.1 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 128.704 3.752 . . . . 0.0 115.029 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 68' ' ' THR . 4.8 tp -0.83 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 1 O-C-N 133.614 6.821 . . . . 0.0 116.344 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.4 36.14 5.23 Favored Glycine 0 C--O 1.204 -1.776 0 N-CA-C 104.048 -3.621 . . . . 0.0 104.048 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.81 114.71 22.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 1 O-C-N 130.486 4.286 . . . . 0.0 116.788 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.86 159.25 21.39 Favored 'General case' 0 CA--C 1.556 1.21 1 O-C-N 130.235 4.709 . . . . 0.0 107.882 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -172.83 164.4 5.15 Favored 'General case' 0 N--CA 1.439 -1.007 1 C-N-CA 111.318 -4.153 . . . . 0.0 113.271 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -127.9 80.88 1.99 Allowed 'General case' 0 CA--C 1.563 1.448 1 N-CA-C 100.149 -4.019 . . . . 0.0 100.149 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -102.48 126.19 49.44 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 127.976 3.297 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 t -78.9 171.45 15.17 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 112.209 -3.796 . . . . 0.0 106.643 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.12 179.55 8.18 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 127.27 2.856 . . . . 0.0 109.514 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB1' ' CG2' ' A' ' 61' ' ' THR . . . 39.48 -98.97 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 O-C-N 128.527 3.642 . . . . 0.0 112.302 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.25 27.37 3.47 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 124.272 0.982 . . . . 0.0 112.87 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.24 71.07 0.29 Allowed Glycine 0 C--N 1.361 1.92 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.466 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 25.8 p -104.83 -47.84 3.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.326 1.45 . . . . 0.0 108.559 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.94 58.1 4.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 126.434 2.334 . . . . 0.0 109.743 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' CD1' ' HB ' ' A' ' 61' ' ' THR . 5.8 mp -84.26 76.06 10.14 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.466 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 68.8 m -52.07 119.63 4.54 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.69 -158.16 7.46 Favored Glycine 0 C--O 1.205 -1.671 1 C-N-CA 111.422 -5.18 . . . . 0.0 109.066 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.623 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.296 0.6 OUTLIER 172.78 124.12 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.886 2 O-C-N 132.5 5.471 . . . . 0.0 113.878 -178.413 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 68.2 m95 -133.83 134.1 42.41 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 119.494 -2.004 . . . . 0.0 106.635 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.429 ' HA ' HD13 ' A' ' 49' ' ' LEU . 2.3 p -118.27 36.33 4.41 Favored 'General case' 0 N--CA 1.424 -1.751 2 O-C-N 131.245 5.341 . . . . 0.0 116.677 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.411 ' N ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -8.17 87.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 1 O-C-N 136.392 8.557 . . . . 0.0 109.145 -179.988 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.51 -168.05 1.58 Allowed 'General case' 0 C--N 1.356 0.885 1 CA-C-N 108.22 -4.082 . . . . 0.0 109.613 -179.499 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.11 92.45 0.14 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 116.894 -2.574 . . . . 0.0 110.734 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.41 ' HB3' HG23 ' A' ' 93' ' ' ILE . 28.3 m120 54.42 44.09 29.4 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.074 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 11.8 mtpt -132.42 173.64 11.08 Favored 'General case' 0 C--N 1.347 0.477 1 O-C-N 129.989 4.556 . . . . 0.0 108.576 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -148.81 58.26 1.05 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 128.245 3.466 . . . . 0.0 111.567 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.38 78.68 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.934 2 CA-C-O 129.475 4.464 . . . . 0.0 112.091 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.488 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -148.92 -167.32 13.74 Favored Glycine 0 CA--C 1.554 2.518 1 CA-C-N 106.304 -4.953 . . . . 0.0 104.35 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.265 0.7 OUTLIER -163.22 171.46 16.21 Favored 'General case' 0 C--N 1.37 1.477 2 O-C-N 131.483 4.873 . . . . 0.0 112.584 179.964 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 42.7 m-85 -149.72 151.88 34.38 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-O 127.738 3.637 . . . . 0.0 101.98 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.29 0.0 OUTLIER -169.04 127.01 0.99 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 109.81 -3.359 . . . . 0.0 117.668 -179.75 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HG3' ' HG2' ' A' ' 85' ' ' LYS . 69.7 mtt180 -76.6 113.02 13.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 126.588 2.43 . . . . 0.0 108.586 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.14 -24.94 25.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 1 O-C-N 131.478 5.486 . . . . 0.0 108.594 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -45.7 -51.65 12.12 Favored 'General case' 0 C--O 1.249 1.077 1 O-C-N 129.622 4.327 . . . . 0.0 112.294 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -141.93 3.97 1.65 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 113.496 -3.282 . . . . 0.0 117.621 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.481 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 98.01 36.3 4.77 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HE3' ' CZ ' ' A' ' 104' ' ' TYR . 3.2 tptm -70.96 -64.7 0.85 Allowed 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 120.131 3.382 . . . . 0.0 120.131 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 25.7 mt-10 71.14 87.99 0.11 Allowed 'General case' 0 C--O 1.199 -1.554 1 O-C-N 129.618 4.324 . . . . 0.0 110.926 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -110.94 48.41 0.93 Allowed 'General case' 0 C--O 1.193 -1.893 1 O-C-N 132.349 6.031 . . . . 0.0 109.281 179.483 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.416 ' CG2' HG22 ' A' ' 90' ' ' VAL 0.268 98.4 mt -65.2 164.32 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.58 0 CA-C-N 108.582 -3.917 . . . . 0.0 105.675 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.5 71.95 1.39 Allowed 'General case' 0 C--O 1.201 -1.476 1 O-C-N 133.763 6.914 . . . . 0.0 105.309 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.416 HG22 ' CG2' ' A' ' 88' ' ' ILE . 76.6 t -76.23 115.62 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 1 O-C-N 132.038 5.836 . . . . 0.0 105.614 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.454 ' CD ' ' HB ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -169.49 165.91 10.32 Favored 'General case' 0 C--O 1.187 -2.204 0 C-N-CA 114.669 -2.812 . . . . 0.0 114.714 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -156.91 118.84 3.84 Favored 'General case' 0 C--O 1.21 -1.005 1 O-C-N 130.479 4.862 . . . . 0.0 107.026 179.669 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.56 ' CD1' ' CH2' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -42.61 144.99 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.54 1 O-C-N 133.013 6.445 . . . . 0.0 113.577 179.876 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 t -150.89 123.01 8.25 Favored 'General case' 0 CA--C 1.506 -0.717 1 O-C-N 129.75 4.406 . . . . 0.0 115.996 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.57 13.86 74.85 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 t30 57.47 58.73 3.64 Favored 'General case' 0 CA--C 1.563 1.476 1 O-C-N 131.884 5.108 . . . . 0.0 104.603 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.665 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.323 0.4 OUTLIER -178.41 100.21 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.588 1 O-C-N 132.116 5.885 . . . . 0.0 108.66 179.204 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.6 151.78 43.8 Favored 'General case' 0 N--CA 1.423 -1.783 1 O-C-N 130.423 4.827 . . . . 0.0 114.978 179.872 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' ' CD ' ' A' ' 91' ' ' ARG . 26.9 mt -106.69 -106.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.337 3 O-C-N 133.447 6.717 . . . . 0.0 107.922 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 116.21 93.17 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.519 2 O-C-N 135.261 7.85 . . . . 0.0 98.348 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 1.3 m -72.39 -29.77 64.05 Favored 'General case' 0 N--CA 1.42 -1.944 1 O-C-N 133.333 6.646 . . . . 0.0 119.69 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 62.05 76.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 128.626 3.704 . . . . 0.0 105.74 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.6 m -76.35 78.4 3.1 Favored 'General case' 0 C--O 1.204 -1.325 0 O-C-N 128.439 3.587 . . . . 0.0 105.956 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.441 ' CZ ' ' HE3' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -104.6 118.02 35.56 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 109.773 -3.376 . . . . 0.0 112.936 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 17.71 63.07 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.19 6.61 61.45 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 117.552 -2.261 . . . . 0.0 116.216 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.83 110.4 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.27 78.74 7.22 Favored 'General case' 0 C--N 1.363 1.173 0 O-C-N 128.246 3.466 . . . . 0.0 105.125 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.416 . . -86.57 86.2 7.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.319 2.887 . . . . 0.0 116.275 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 5.6 mtmp? -90.61 148.58 22.57 Favored 'General case' 0 N--CA 1.425 -1.683 1 O-C-N 130.042 4.589 . . . . 0.0 108.879 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -147.6 111.04 4.93 Favored 'General case' 0 CA--C 1.558 1.275 1 O-C-N 130.544 4.902 . . . . 0.0 101.31 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.55 128.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 1 O-C-N 130.908 5.13 . . . . 0.0 111.595 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.61 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 m-85 -131.22 -154.77 0.65 Allowed 'General case' 0 C--N 1.318 -0.776 1 O-C-N 131.727 5.642 . . . . 0.0 104.865 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.665 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.31 -138.0 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.595 1 O-C-N 131.336 5.398 . . . . 0.0 113.4 -177.627 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.1 tttt -137.34 158.53 44.22 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.417 -2.105 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.361 179.656 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.457 ' CZ ' HD12 ' A' ' 93' ' ' ILE . 9.9 m-85 -140.81 -70.8 0.37 Allowed 'General case' 0 CA--C 1.561 1.365 1 O-C-N 130.336 4.772 . . . . 0.0 104.543 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -33.86 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.996 1 O-C-N 130.716 5.01 . . . . 0.0 118.465 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.24 27.09 0.03 OUTLIER Glycine 0 C--N 1.353 1.48 2 C-N-CA 110.485 -5.626 . . . . 0.0 109.683 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.26 157.21 0.16 Allowed 'General case' 0 C--O 1.248 0.983 0 O-C-N 127.696 2.645 . . . . 0.0 110.028 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.503 ' HB2' ' CB ' ' A' ' 23' ' ' LEU 0.3 21.0 m95 -156.16 169.83 23.6 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 111.967 -3.873 . . . . 0.0 112.063 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 4.4 mtmt 44.72 -179.63 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.789 1 O-C-N 133.555 6.784 . . . . 0.0 118.34 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.271 0.4 OUTLIER 40.33 51.27 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.706 3 CA-C-O 135.05 7.119 . . . . 0.0 120.848 174.852 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.15 -59.83 0.82 Allowed 'General case' 0 C--N 1.367 1.343 0 CA-C-N 108.455 -3.975 . . . . 0.0 103.151 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -90.05 140.25 29.83 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.033 0.921 . . . . 0.0 111.831 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.71 -21.84 0.28 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-N 112.922 -1.945 . . . . 0.0 114.338 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 61.05 41.39 13.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 116.332 -1.794 . . . . 0.0 110.627 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.07 111.55 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.955 1 O-C-N 129.958 4.536 . . . . 0.0 109.449 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -50.6 -45.05 57.18 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.4 m -92.31 123.11 35.4 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 115.11 -2.636 . . . . 0.0 107.693 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.1 98.14 2.34 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 127.27 2.856 . . . . 0.0 107.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.36 -75.32 0.08 Allowed 'General case' 0 C--N 1.361 1.069 0 CA-C-N 111.003 -2.599 . . . . 0.0 104.587 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -80.69 153.87 27.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 126.246 2.216 . . . . 0.0 107.575 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.42 36.31 0.65 Allowed 'General case' 0 C--O 1.207 -1.139 0 O-C-N 125.868 1.98 . . . . 0.0 110.803 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -161.16 87.12 0.71 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 128.801 3.813 . . . . 0.0 108.829 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.63 170.59 6.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.381 0.0 OUTLIER -178.45 178.85 0.82 Allowed 'General case' 0 C--O 1.198 -1.653 1 O-C-N 132.456 6.097 . . . . 0.0 103.386 179.848 . . . . . . . . 5 4 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 4.0 mt -136.46 166.02 24.47 Favored 'General case' 0 CA--C 1.563 1.446 2 O-C-N 130.74 5.025 . . . . 0.0 97.504 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.474 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 86.3 m 175.67 73.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 1 O-C-N 129.715 4.385 . . . . 0.0 107.277 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 23' ' ' LEU . 3.7 mp -86.18 144.88 8.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 113.876 -3.13 . . . . 0.0 109.248 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.7 m -162.75 79.41 0.49 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 116.43 -2.108 . . . . 0.0 105.97 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -53.57 154.63 3.49 Favored 'General case' 0 N--CA 1.441 -0.892 2 O-C-N 132.031 5.832 . . . . 0.0 114.711 179.881 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -124.82 81.85 1.99 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.24 -87.45 1.56 Allowed Glycine 0 CA--C 1.558 2.766 1 N-CA-C 103.086 -4.006 . . . . 0.0 103.086 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -128.27 3.06 5.74 Favored 'General case' 0 N--CA 1.409 -2.506 2 O-C-N 133.212 5.889 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -79.79 160.3 26.21 Favored 'General case' 0 C--N 1.326 -0.432 2 N-CA-C 98.922 -4.473 . . . . 0.0 98.922 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 34' ' ' VAL . 0.5 OUTLIER -170.68 86.52 0.11 Allowed 'General case' 0 C--O 1.201 -1.465 2 N-CA-C 96.418 -5.401 . . . . 0.0 96.418 179.862 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.39 129.85 42.4 Favored 'General case' 0 CA--C 1.507 -0.702 2 O-C-N 132.829 6.331 . . . . 0.0 103.279 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 32' ' ' PHE 0.323 69.3 t -102.29 134.32 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 1 N-CA-C 99.325 -4.324 . . . . 0.0 99.325 179.61 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -81.68 63.04 5.78 Favored 'General case' 0 CA--C 1.49 -1.361 1 CA-C-O 132.495 5.903 . . . . 0.0 116.233 -179.748 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.291 4.8 mt-10 -80.52 71.41 7.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 O-C-N 117.032 -3.543 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 m -77.31 126.48 30.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 112.454 -3.698 . . . . 0.0 107.058 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 -165.92 0.33 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 116.075 -2.25 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 69.38 -96.03 0.03 OUTLIER 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.031 0.832 . . . . 0.0 111.415 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -141.26 20.28 2.25 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 127.228 2.83 . . . . 0.0 111.468 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -176.71 -176.55 0.72 Allowed 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 127.595 3.06 . . . . 0.0 111.38 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 122.47 36.79 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.335 0.7 OUTLIER -140.98 146.48 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 2 O-C-N 131.091 5.244 . . . . 0.0 105.204 -179.32 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -116.66 173.62 6.52 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 110.26 -3.155 . . . . 0.0 108.571 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.19 91.41 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.328 1 O-C-N 131.561 5.538 . . . . 0.0 101.115 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -103.38 158.0 5.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 1 O-C-N 130.722 5.014 . . . . 0.0 112.685 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.0 p90 169.23 -158.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.738 1 O-C-N 133.462 6.726 . . . . 0.0 111.006 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 51' ' ' VAL . 23.7 mt-10 -138.05 83.74 1.99 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 116.118 -2.233 . . . . 0.0 114.034 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 32' ' ' PHE . 1.5 mp 43.44 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 1 O-C-N 130.96 5.163 . . . . 0.0 116.08 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 68' ' ' THR . . . -92.27 71.72 1.61 Allowed Glycine 0 C--O 1.203 -1.843 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 48' ' ' GLU . 74.5 t -144.84 92.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 1 O-C-N 131.182 4.695 . . . . 0.0 112.363 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.32 147.17 34.35 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 113.531 -3.268 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -154.42 161.07 41.91 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 132.392 6.058 . . . . 0.0 115.896 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.71 109.79 20.18 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -179.78 4.54 Favored 'General case' 0 CA--C 1.509 -0.604 1 O-C-N 130.095 4.622 . . . . 0.0 110.294 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.88 99.05 3.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 114.542 -2.863 . . . . 0.0 105.311 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.47 -74.02 0.05 Allowed 'General case' 0 C--O 1.247 0.936 0 O-C-N 126.769 2.543 . . . . 0.0 114.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 18.06 3.16 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 126.358 2.286 . . . . 0.0 115.232 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 73.3 0.49 3.68 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 126.417 2.323 . . . . 0.0 114.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.86 25.18 2.26 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 128.566 3.666 . . . . 0.0 108.161 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 p -118.37 170.87 8.56 Favored 'General case' 0 C--O 1.218 -0.567 1 O-C-N 130.479 4.282 . . . . 0.0 110.173 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -157.38 38.53 0.29 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 113.861 -3.136 . . . . 0.0 106.989 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.0 98.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 108.736 -3.847 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -99.53 101.6 12.88 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.227 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -168.21 -168.12 29.85 Favored Glycine 0 CA--C 1.541 1.702 1 C-N-CA 112.4 -4.714 . . . . 0.0 106.885 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.25 147.62 43.88 Favored 'General case' 0 CA--C 1.499 -0.998 1 O-C-N 133.709 6.182 . . . . 0.0 113.286 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.62 ' NE1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 m95 -124.97 104.87 8.81 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 50' ' ' GLY . 21.0 p -101.79 73.44 1.42 Allowed 'General case' 0 C--O 1.2 -1.548 1 O-C-N 134.437 7.335 . . . . 0.0 116.008 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.17 98.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 2 O-C-N 132.406 6.066 . . . . 0.0 103.813 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.11 -22.51 28.85 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 117.361 -1.736 . . . . 0.0 110.688 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.81 101.73 0.7 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 104.524 -3.43 . . . . 0.0 104.524 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 61.16 26.9 16.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 110.911 -2.645 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -133.76 -170.7 2.55 Favored 'General case' 0 C--N 1.358 0.951 1 O-C-N 130.606 4.941 . . . . 0.0 111.393 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -165.76 39.17 0.06 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 114.682 -2.807 . . . . 0.0 112.683 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 76' ' ' GLY . 48.7 t -69.98 146.66 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 110.228 -3.169 . . . . 0.0 116.002 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' N ' HG11 ' A' ' 75' ' ' VAL . . . 151.17 -145.68 13.78 Favored Glycine 0 CA--C 1.559 2.813 1 N-CA-C 100.008 -5.237 . . . . 0.0 100.008 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' CB ' HG12 ' A' ' 88' ' ' ILE . 9.4 tttm 171.05 123.04 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 134.861 6.859 . . . . 0.0 114.049 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CZ ' ' NE1' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -113.04 166.53 11.33 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.276 16.1 ttmt -162.84 149.95 13.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 109.666 -3.425 . . . . 0.0 113.41 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' CD ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -98.98 72.48 1.91 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 117.242 -1.783 . . . . 0.0 106.306 178.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.435 HG13 ' N ' ' A' ' 82' ' ' ASP . 1.4 t -29.74 -52.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 O-C-N 130.74 5.025 . . . . 0.0 115.351 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' N ' HG13 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -52.66 -31.07 35.26 Favored 'General case' 0 N--CA 1.435 -1.197 1 O-C-N 129.322 4.139 . . . . 0.0 112.516 -179.219 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 170.63 -3.31 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.243 4.09 . . . . 0.0 115.479 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' CD ' ' A' ' 80' ' ' ARG . . . -91.0 -30.02 11.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 104.229 -3.548 . . . . 0.0 104.229 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER 76.62 -169.69 0.07 Allowed 'General case' 0 N--CA 1.425 -1.686 1 O-C-N 132.377 5.398 . . . . 0.0 118.455 179.667 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 2.0 mp0 -45.45 139.27 3.8 Favored 'General case' 0 N--CA 1.429 -1.525 1 O-C-N 132.627 6.205 . . . . 0.0 116.111 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD13 ' CD ' ' A' ' 80' ' ' ARG . 30.3 mt -148.16 47.43 1.06 Allowed 'General case' 0 C--O 1.201 -1.487 1 O-C-N 137.151 9.032 . . . . 0.0 109.806 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.49 HG12 ' CB ' ' A' ' 77' ' ' LYS . 89.5 mt -64.72 172.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.123 1 CA-C-N 108.342 -4.027 . . . . 0.0 104.097 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.1 66.71 1.49 Allowed 'General case' 0 C--O 1.205 -1.265 1 O-C-N 130.824 5.077 . . . . 0.0 107.903 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.16 110.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 1 O-C-N 131.137 5.273 . . . . 0.0 102.129 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 1.1 tpm_? -164.5 156.41 16.11 Favored 'General case' 0 C--O 1.188 -2.161 1 C-N-CA 111.219 -4.192 . . . . 0.0 113.182 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 4.2 pt-20 -158.79 134.91 9.07 Favored 'General case' 0 N--CA 1.424 -1.728 2 O-C-N 129.975 4.547 . . . . 0.0 105.149 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.457 HD12 ' CZ ' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -39.75 106.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.844 1 O-C-N 132.876 6.36 . . . . 0.0 111.01 179.89 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.11 67.11 Favored 'General case' 0 C--O 1.241 0.625 1 O-C-N 129.255 4.097 . . . . 0.0 114.355 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.46 96.23 0.1 Allowed Glycine 0 CA--C 1.545 1.964 0 C-N-CA 116.181 -2.914 . . . . 0.0 106.961 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 58.05 37.13 26.51 Favored 'General case' 0 N--CA 1.437 -1.121 2 CA-C-N 107.063 -4.569 . . . . 0.0 109.495 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.523 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.304 0.0 OUTLIER 179.44 179.46 0.47 Allowed 'General case' 0 CA--C 1.564 1.499 0 O-C-N 128.047 3.342 . . . . 0.0 106.579 179.403 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 ' CD2' ' CG ' ' A' ' 100' ' ' GLN . 8.1 tt -140.54 130.78 25.02 Favored 'General case' 0 C--O 1.211 -0.963 2 O-C-N 134.646 7.466 . . . . 0.0 109.349 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 112' ' ' ILE . 66.7 mt -76.13 -101.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.417 -2.111 1 O-C-N 130.046 4.591 . . . . 0.0 102.717 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.472 ' CG ' ' CD2' ' A' ' 98' ' ' LEU . 6.8 mt-30 130.34 75.1 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.486 1 O-C-N 131.801 5.688 . . . . 0.0 102.043 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m -81.27 93.34 6.51 Favored 'General case' 0 N--CA 1.428 -1.557 1 O-C-N 131.067 5.23 . . . . 0.0 112.006 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.37 125.1 25.39 Favored 'General case' 0 C--O 1.201 -1.465 2 CA-C-N 106.82 -4.718 . . . . 0.0 105.283 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.41 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 m -101.76 76.99 1.69 Allowed 'General case' 0 C--O 1.206 -1.236 1 O-C-N 130.613 4.945 . . . . 0.0 101.747 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.33 109.16 21.34 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 108.702 -3.863 . . . . 0.0 115.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 48.88 37.0 9.12 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.548 -2.114 . . . . 0.0 113.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.65 -12.39 61.21 Favored Glycine 0 C--N 1.346 1.094 1 C-N-CA 113.762 -4.066 . . . . 0.0 113.942 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.47 131.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 117.539 -1.22 . . . . 0.0 112.958 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -90.81 71.92 6.61 Favored 'General case' 0 C--N 1.358 0.936 1 O-C-N 129.359 4.162 . . . . 0.0 107.96 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.395 . . -89.97 103.84 16.46 Favored 'General case' 0 C--O 1.196 -1.723 0 C-N-CA 112.839 -3.545 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 145.14 30.93 Favored 'General case' 0 N--CA 1.417 -2.086 1 O-C-N 133.031 6.457 . . . . 0.0 110.475 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -128.7 119.25 24.28 Favored 'General case' 0 CA--C 1.559 1.311 2 O-C-N 132.029 5.83 . . . . 0.0 99.296 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 10.2 pt -79.22 137.08 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 1 O-C-N 130.11 4.631 . . . . 0.0 113.378 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 12.6 m-30 -125.68 -177.87 4.06 Favored 'General case' 0 N--CA 1.435 -1.196 2 O-C-N 135.94 8.275 . . . . 0.0 106.402 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.523 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.94 127.0 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.233 2 CA-C-O 131.872 5.606 . . . . 0.0 113.329 -179.405 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 10.2 ttmt -41.34 -62.92 0.77 Allowed 'General case' 0 C--O 1.203 -1.381 0 CA-C-O 128.166 3.841 . . . . 0.0 117.193 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.366 1.319 0 CA-C-N 109.363 -3.562 . . . . 0.0 113.171 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.137 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -42.72 83.56 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 127.312 2.882 . . . . 0.0 105.178 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.43 98.24 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 O-C-N 127.61 3.069 . . . . 0.0 116.513 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 153.58 6.66 Favored Glycine 0 N--CA 1.464 0.52 0 C-N-CA 114.594 -3.67 . . . . 0.0 104.417 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' CG2' HG22 ' A' ' 24' ' ' THR . 10.8 p -66.11 167.94 9.22 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 114.923 -2.711 . . . . 0.0 108.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.281 35.7 m95 -142.68 149.07 38.37 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 115.471 -2.204 . . . . 0.0 112.724 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 8.5 mtmt 56.7 -179.33 0.05 OUTLIER 'General case' 0 C--O 1.197 -1.663 1 O-C-N 129.488 4.242 . . . . 0.0 117.269 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.265 1.0 OUTLIER 33.4 141.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.534 3 O-C-N 135.793 8.183 . . . . 0.0 120.086 174.769 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -169.61 50.48 0.03 OUTLIER 'General case' 0 C--N 1.374 1.664 0 O-C-N 117.312 -3.367 . . . . 0.0 107.659 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -137.25 150.4 47.81 Favored 'General case' 0 C--O 1.21 -1.021 0 O-C-N 120.695 -1.253 . . . . 0.0 114.17 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -115.74 94.15 4.56 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.682 1.864 . . . . 0.0 108.311 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.31 -64.18 1.19 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -144.98 165.08 29.18 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 127.297 2.873 . . . . 0.0 107.883 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 66.29 152.98 0.07 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 108.419 -3.991 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -157.99 30.29 0.26 Allowed 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.1 31.19 5.39 Favored Glycine 0 CA--C 1.55 2.255 0 O-C-N 126.42 2.325 . . . . 0.0 112.681 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.8 -104.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 111.281 -2.46 . . . . 0.0 109.793 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -153.78 -170.37 3.56 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.62 -169.6 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 117.566 -1.654 . . . . 0.0 111.013 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.26 -124.1 0.09 Allowed 'General case' 0 C--N 1.352 0.705 0 O-C-N 126.375 2.297 . . . . 0.0 113.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 155.02 22.67 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.371 0.0 OUTLIER -179.24 123.49 0.08 Allowed 'General case' 0 C--O 1.195 -1.787 0 O-C-N 128.878 3.861 . . . . 0.0 105.529 179.956 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' TRP . 8.8 mt -87.91 162.0 17.15 Favored 'General case' 0 CA--C 1.552 1.036 2 O-C-N 129.862 4.476 . . . . 0.0 101.654 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.499 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 87.7 m -178.53 64.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.195 1 O-C-N 130.117 4.636 . . . . 0.0 105.439 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.473 ' CG2' ' HB3' ' A' ' 32' ' ' PHE . 3.4 mp -82.48 146.45 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 113.339 -3.344 . . . . 0.0 109.209 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -172.37 79.18 0.05 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 113.546 -3.261 . . . . 0.0 103.273 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.511 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -31.0 139.51 0.03 OUTLIER 'General case' 0 C--O 1.208 -1.099 2 O-C-N 134.834 7.584 . . . . 0.0 116.742 179.734 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -104.18 -99.61 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 128.815 3.822 . . . . 0.0 104.177 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.07 80.99 0.36 Allowed Glycine 0 CA--C 1.564 3.123 1 N-CA-C 99.699 -5.361 . . . . 0.0 99.699 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 68.66 28.33 5.71 Favored 'General case' 0 N--CA 1.433 -1.295 2 O-C-N 131.875 5.103 . . . . 0.0 106.646 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.5 ttpp -131.91 110.1 10.55 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 128.925 3.89 . . . . 0.0 101.315 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -101.36 166.37 10.78 Favored 'General case' 0 C--O 1.197 -1.687 2 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 -179.434 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 98.17 4.38 Favored 'General case' 0 N--CA 1.478 0.96 3 O-C-N 137.692 9.37 . . . . 0.0 97.356 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.409 0.9 OUTLIER -72.42 127.33 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 2 C-N-CA 109.643 -4.823 . . . . 0.0 98.984 179.705 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.429 25.1 tttt -76.18 8.43 3.3 Favored 'General case' 0 C--N 1.368 1.387 0 CA-C-N 109.978 -3.283 . . . . 0.0 119.581 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.421 2.6 mt-10 -47.76 106.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 111.038 -2.801 . . . . 0.0 103.502 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 p -138.36 145.84 41.57 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 128.282 3.489 . . . . 0.0 106.57 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.3 p -140.28 -175.25 4.19 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 116.217 -2.193 . . . . 0.0 112.373 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -15.98 60.81 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 127.408 2.943 . . . . 0.0 105.02 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -97.26 -109.8 0.16 Allowed 'General case' 0 N--CA 1.435 -1.215 1 CA-C-N 108.194 -4.093 . . . . 0.0 108.934 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.446 ' HG2' ' CB ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -135.75 44.97 2.46 Favored 'General case' 0 CA--C 1.496 -1.114 1 O-C-N 129.161 4.038 . . . . 0.0 117.785 -179.076 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -72.62 -35.68 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' HD22 ' A' ' 57' ' ' LEU 0.267 5.1 tt 11.96 60.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 2 O-C-N 133.944 7.027 . . . . 0.0 112.036 178.318 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.93 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.831 -2.44 . . . . 0.0 111.436 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.31 50.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 47' ' ' PHE 0.275 3.0 p -61.53 167.22 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 O-C-N 129.065 3.978 . . . . 0.0 112.782 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -166.44 -157.1 0.26 Allowed 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.926 3.891 . . . . 0.0 111.064 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 1.2 mt-10 -138.42 52.79 1.81 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 126.472 2.357 . . . . 0.0 114.802 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.462 HD21 ' CE1' ' A' ' 32' ' ' PHE . 2.3 tp 18.11 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.533 1 CA-C-O 130.004 4.716 . . . . 0.0 117.461 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.32 51.4 8.62 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 103.375 -3.89 . . . . 0.0 103.375 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.52 121.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 1 O-C-N 134.53 6.664 . . . . 0.0 115.177 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.54 16.22 Favored 'General case' 0 C--O 1.21 -1.002 1 O-C-N 131.58 5.55 . . . . 0.0 110.167 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 9.5 p90 -176.99 169.47 2.37 Favored 'General case' 0 N--CA 1.421 -1.879 0 O-C-N 128.554 3.659 . . . . 0.0 114.457 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 136.67 52.77 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.23 101.62 4.06 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 128.923 3.889 . . . . 0.0 113.409 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 t -69.92 155.98 39.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 113.296 -3.361 . . . . 0.0 102.844 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.477 HD22 ' CG2' ' A' ' 43' ' ' ILE . 5.5 tp -147.21 -92.66 0.09 Allowed 'General case' 0 C--O 1.245 0.85 1 O-C-N 129.269 4.106 . . . . 0.0 110.745 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' CB ' ' HG2' ' A' ' 41' ' ' ARG . . . -60.06 -5.45 1.03 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 112.921 -3.418 . . . . 0.0 115.999 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t70 106.49 -15.65 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.595 1 O-C-N 129.531 4.269 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.11 -55.6 0.26 Allowed Glycine 0 CA--C 1.558 2.74 0 N-CA-C 104.202 -3.559 . . . . 0.0 104.202 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 p -39.56 137.87 0.78 Allowed 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 128.968 3.393 . . . . 0.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.94 37.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 114.551 -2.86 . . . . 0.0 109.023 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.2 mp -42.02 97.91 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.687 1 O-C-N 130.658 4.974 . . . . 0.0 112.225 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.4 m -93.84 99.39 11.77 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 111.602 -2.544 . . . . 0.0 106.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.69 -175.71 34.0 Favored Glycine 0 C--O 1.201 -1.937 1 C-N-CA 111.617 -5.087 . . . . 0.0 108.556 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 t -140.85 143.81 34.97 Favored 'General case' 0 CA--C 1.5 -0.978 2 O-C-N 132.509 5.476 . . . . 0.0 111.883 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.616 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.3 m95 -124.25 111.64 16.08 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -99.98 41.88 1.14 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 135.485 7.991 . . . . 0.0 113.613 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -37.52 107.43 0.06 Allowed 'General case' 0 C--N 1.317 -0.806 1 O-C-N 134.434 7.334 . . . . 0.0 107.917 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -82.99 -74.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.305 0 O-C-N 129.055 3.972 . . . . 0.0 108.525 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.56 -79.85 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.117 1 O-C-N 129.435 4.21 . . . . 0.0 107.993 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.58 44.21 2.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 127.991 2.818 . . . . 0.0 108.865 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -141.08 178.73 7.18 Favored 'General case' 0 C--N 1.356 0.865 1 O-C-N 129.147 4.029 . . . . 0.0 112.451 -179.96 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' HB2' ' CB ' ' A' ' 91' ' ' ARG . 4.8 mt -148.28 91.87 1.96 Allowed 'General case' 0 C--N 1.321 -0.649 0 O-C-N 126.584 2.428 . . . . 0.0 110.596 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.28 119.68 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 O-C-N 128.321 3.513 . . . . 0.0 117.444 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.55 -141.33 5.82 Favored Glycine 0 CA--C 1.557 2.673 1 CA-C-N 108.082 -4.145 . . . . 0.0 103.772 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -178.79 131.68 0.12 Allowed 'General case' 0 C--O 1.204 -1.334 1 O-C-N 131.772 5.042 . . . . 0.0 113.966 -179.972 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.4 OUTLIER -127.13 167.9 15.38 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-O 127.417 3.484 . . . . 0.0 101.672 179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 6.8 ttmt -170.48 144.14 2.39 Favored 'General case' 0 N--CA 1.427 -1.617 1 CA-C-N 106.857 -4.702 . . . . 0.0 114.138 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 69.64 0.8 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 125.105 1.503 . . . . 0.0 107.175 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -31.64 -40.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.39 1 O-C-N 131.184 5.302 . . . . 0.0 115.472 -179.828 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 11.6 p-10 -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.442 -0.832 1 O-C-N 131.03 5.206 . . . . 0.0 112.549 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 172.08 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 O-C-N 128.903 3.877 . . . . 0.0 115.998 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.5 -34.38 6.08 Favored Glycine 0 CA--C 1.543 1.79 0 N-CA-C 104.092 -3.603 . . . . 0.0 104.092 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 78.0 -171.19 0.06 Allowed 'General case' 0 N--CA 1.436 -1.158 1 O-C-N 132.153 5.266 . . . . 0.0 117.272 -179.804 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 77.6 mt-10 -48.6 149.48 1.67 Allowed 'General case' 0 N--CA 1.432 -1.334 1 O-C-N 132.355 6.034 . . . . 0.0 113.456 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.257 0.1 OUTLIER -158.18 35.38 0.24 Allowed 'General case' 0 C--O 1.196 -1.751 1 O-C-N 135.255 7.847 . . . . 0.0 109.343 178.772 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' THR 0.251 42.7 mt -50.28 127.49 6.1 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.639 1 O-C-N 132.98 6.425 . . . . 0.0 100.479 -179.794 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 67' ' ' TRP . . . -87.62 68.88 9.64 Favored 'General case' 0 C--O 1.205 -1.244 1 O-C-N 132.878 6.361 . . . . 0.0 110.958 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 t -66.92 108.36 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 1 C-N-CA 111.567 -4.053 . . . . 0.0 102.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' CB ' ' HB2' ' A' ' 74' ' ' LEU . 8.9 ttm180 -139.05 168.73 19.19 Favored 'General case' 0 C--O 1.195 -1.778 0 O-C-N 128.479 3.612 . . . . 0.0 111.674 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.12 94.09 0.05 Allowed 'General case' 0 C--N 1.363 1.184 2 O-C-N 132.458 6.099 . . . . 0.0 108.438 179.829 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.429 ' HB ' HD11 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -28.28 105.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.749 1 O-C-N 133.424 6.702 . . . . 0.0 112.115 -179.938 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.9 m -94.55 130.73 40.85 Favored 'General case' 0 N--CA 1.439 -0.976 1 O-C-N 129.117 4.01 . . . . 0.0 113.541 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.1 -116.27 7.07 Favored Glycine 0 CA--C 1.561 2.91 1 N-CA-C 100.653 -4.979 . . . . 0.0 100.653 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.69 57.69 1.05 Allowed 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 129.609 3.77 . . . . 0.0 107.999 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.269 0.0 OUTLIER 176.77 115.55 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.53 1 O-C-N 130.694 4.996 . . . . 0.0 107.312 179.375 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.429 HD11 ' HB ' ' A' ' 93' ' ' ILE . 1.5 tp -65.3 148.34 51.87 Favored 'General case' 0 N--CA 1.416 -2.158 2 O-C-N 133.366 6.667 . . . . 0.0 111.686 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.411 HG22 ' HD2' ' A' ' 110' ' ' LYS . 2.2 mt -130.27 128.92 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 3 O-C-N 131.6 5.563 . . . . 0.0 102.571 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HB3' ' NE ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.75 129.09 54.33 Favored 'General case' 0 C--O 1.21 -1.003 1 O-C-N 135.395 7.935 . . . . 0.0 101.796 179.891 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -82.34 -43.96 16.79 Favored 'General case' 0 N--CA 1.41 -2.467 2 O-C-N 131.184 5.303 . . . . 0.0 116.457 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 59.95 61.03 1.98 Allowed 'General case' 0 C--O 1.205 -1.281 1 O-C-N 129.331 4.144 . . . . 0.0 104.406 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' ILE . 54.7 m -55.2 101.85 0.06 Allowed 'General case' 0 N--CA 1.479 1.002 1 N-CA-C 100.119 -4.03 . . . . 0.0 100.119 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 113.1 20.86 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 109.165 -3.652 . . . . 0.0 110.561 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -4.79 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.92 -3.8 67.64 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 116.618 -2.706 . . . . 0.0 112.536 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 108' ' ' GLU . 1.4 t -162.56 154.12 3.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' N ' HG11 ' A' ' 107' ' ' VAL . 1.2 mt-10 -119.15 114.14 21.99 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 128.206 3.441 . . . . 0.0 102.334 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.378 . . -102.96 81.64 2.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 116.314 -2.155 . . . . 0.0 114.295 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HD2' HG22 ' A' ' 99' ' ' ILE . 1.6 mtmm -72.25 150.72 43.39 Favored 'General case' 0 N--CA 1.435 -1.18 1 O-C-N 129.993 4.558 . . . . 0.0 108.859 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -131.91 -164.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 1 O-C-N 131.381 5.426 . . . . 0.0 103.234 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -162.0 79.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.044 1 C-N-CA 111.45 -4.1 . . . . 0.0 109.85 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.59 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 41.6 m-85 -100.2 -145.08 0.34 Allowed 'General case' 0 C--N 1.319 -0.757 1 O-C-N 130.552 4.907 . . . . 0.0 105.704 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.47 -154.45 0.16 Allowed 'General case' 0 C--O 1.197 -1.699 1 O-C-N 131.979 5.799 . . . . 0.0 111.462 -179.856 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 21.5 tttt -115.21 -141.71 0.38 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 111.842 -2.436 . . . . 0.0 111.605 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.222 -179.512 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 116.222 -1.847 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 98' ' ' LEU . 98.3 m-85 54.01 81.97 0.09 Allowed 'General case' 0 CA--C 1.554 1.133 1 O-C-N 133.744 6.903 . . . . 0.0 101.753 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 24.4 p-10 -169.32 32.55 0.02 OUTLIER 'General case' 0 C--N 1.364 1.202 0 CA-C-N 110.137 -3.211 . . . . 0.0 115.914 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.53 159.62 21.18 Favored Glycine 0 C--N 1.346 1.105 1 C-N-CA 113.38 -4.248 . . . . 0.0 106.777 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.26 134.21 56.34 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 115.382 -2.527 . . . . 0.0 109.723 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.539 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.301 70.8 m95 -114.89 140.71 48.76 Favored 'General case' 0 N--CA 1.412 -2.342 1 CA-C-O 111.087 -4.292 . . . . 0.0 111.983 -179.807 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.612 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 11.4 mtmt 67.13 177.81 0.23 Allowed 'General case' 0 N--CA 1.424 -1.736 1 O-C-N 131.547 5.529 . . . . 0.0 118.164 176.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 41.79 149.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.51 3 O-C-N 136.329 8.518 . . . . 0.0 120.802 174.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.52 35.69 0.01 OUTLIER 'General case' 0 C--N 1.37 1.496 1 CA-C-N 108.144 -4.116 . . . . 0.0 105.42 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -122.96 72.85 1.11 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 123.238 1.494 . . . . 0.0 114.269 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -171.04 120.69 0.53 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 112.696 -2.047 . . . . 0.0 112.931 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.21 -41.33 1.26 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 116.469 -1.729 . . . . 0.0 109.081 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.445 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 2.0 p30 -115.81 14.21 16.25 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 128.084 3.365 . . . . 0.0 106.328 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 2.4 m-85 46.37 61.6 2.67 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 127.832 3.208 . . . . 0.0 111.262 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -81.27 138.46 35.73 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 116.741 -1.983 . . . . 0.0 107.004 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.34 -132.75 5.63 Favored Glycine 0 C--O 1.207 -1.561 0 O-C-N 126.067 2.104 . . . . 0.0 112.297 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.82 -51.54 3.85 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 110.728 -2.736 . . . . 0.0 106.305 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -98.59 0.06 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.649 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -124.79 139.47 53.82 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 127.062 2.726 . . . . 0.0 108.298 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -58.69 174.16 0.35 Allowed 'General case' 0 CA--C 1.561 1.399 1 O-C-N 129.287 4.117 . . . . 0.0 110.308 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.44 -175.46 5.84 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 110.394 -3.094 . . . . 0.0 104.885 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.323 1.4 ptmt 163.52 150.39 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.466 1 O-C-N 134.967 7.667 . . . . 0.0 103.661 179.85 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' N ' ' HE2' ' A' ' 7' ' ' LYS . 2.9 mt -114.04 176.35 5.08 Favored 'General case' 0 CA--C 1.56 1.354 2 O-C-N 131.778 5.673 . . . . 0.0 98.486 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.477 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 77.8 m -162.03 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 128.729 3.768 . . . . 0.0 107.668 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.458 HG23 ' CE2' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 63.9 145.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-O 124.784 2.231 . . . . 0.0 115.947 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 169.27 67.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -26.15 124.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.28 2 O-C-N 135.804 8.19 . . . . 0.0 114.173 179.794 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -9.02 53.29 Favored 'General case' 0 N--CA 1.482 1.128 1 O-C-N 130.918 5.136 . . . . 0.0 106.371 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.87 -40.83 0.35 Allowed Glycine 0 CA--C 1.55 2.279 1 N-CA-C 102.171 -4.372 . . . . 0.0 102.171 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.79 -12.13 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.926 1 O-C-N 131.461 4.859 . . . . 0.0 112.817 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -78.95 120.21 23.22 Favored 'General case' 0 N--CA 1.48 1.062 1 N-CA-C 96.253 -5.462 . . . . 0.0 96.253 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.526 ' CE1' HG22 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -126.45 105.33 8.69 Favored 'General case' 0 C--O 1.208 -1.118 1 N-CA-C 98.73 -4.545 . . . . 0.0 98.73 -179.263 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -109.21 127.07 53.93 Favored 'General case' 0 CA--C 1.492 -1.267 2 O-C-N 135.603 8.064 . . . . 0.0 104.435 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 32' ' ' PHE 0.324 2.2 t -93.95 143.8 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-O 126.659 3.123 . . . . 0.0 103.248 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -86.59 70.03 10.4 Favored 'General case' 0 C--O 1.196 -1.718 2 CA-C-O 133.405 6.336 . . . . 0.0 112.902 179.114 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' CG ' HG13 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -78.34 44.8 0.52 Allowed 'General case' 0 N--CA 1.42 -1.95 1 CA-C-N 107.49 -4.414 . . . . 0.0 109.672 -179.697 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 t -67.78 119.81 13.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 114.023 -3.071 . . . . 0.0 104.803 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.32 100.07 0.94 Allowed 'General case' 0 C--O 1.244 0.791 0 O-C-N 127.442 2.964 . . . . 0.0 109.934 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 62.47 -173.32 0.15 Allowed 'General case' 0 C--N 1.361 1.094 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 12.6 m-85 57.2 -95.56 0.06 Allowed 'General case' 0 C--N 1.357 0.915 1 O-C-N 129.371 4.169 . . . . 0.0 106.667 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' ASN 0.291 1.4 mpt_? -153.58 -161.5 1.27 Allowed 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 128.249 2.62 . . . . 0.0 111.316 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -103.91 98.93 8.7 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 128.022 3.326 . . . . 0.0 103.12 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 41' ' ' ARG 0.263 0.1 OUTLIER -131.17 151.02 35.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 2 CA-C-O 130.784 5.088 . . . . 0.0 110.051 -178.894 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.67 173.18 6.88 Favored 'General case' 0 N--CA 1.427 -1.62 1 CA-C-N 107.189 -4.55 . . . . 0.0 109.588 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.03 105.86 19.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 1 O-C-N 132.825 6.328 . . . . 0.0 101.0 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.313 6.3 p -112.27 158.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 113.671 -3.212 . . . . 0.0 116.187 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 67' ' ' TRP . 5.2 p90 -171.52 -132.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.647 1 O-C-N 131.761 5.663 . . . . 0.0 111.026 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.48 58.87 0.22 Allowed 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 112.924 -3.511 . . . . 0.0 114.898 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 31.53 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 127.345 2.903 . . . . 0.0 116.637 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 58.4 2.36 Favored Glycine 0 CA--C 1.547 2.09 1 N-CA-C 102.73 -4.148 . . . . 0.0 102.73 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -156.52 118.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.779 1 O-C-N 131.858 5.093 . . . . 0.0 113.43 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.17 160.58 27.91 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 129.403 4.19 . . . . 0.0 107.625 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CE1' ' C ' ' A' ' 65' ' ' GLY . 15.2 p90 -175.85 149.2 0.91 Allowed 'General case' 0 C--N 1.36 1.048 2 O-C-N 132.328 6.018 . . . . 0.0 115.576 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -110.92 90.58 3.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 115.556 -2.164 . . . . 0.0 106.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.24 135.61 38.92 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 127.568 3.042 . . . . 0.0 111.897 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -96.43 85.08 3.83 Favored 'General case' 0 CA--C 1.551 1.007 1 O-C-N 130.857 5.098 . . . . 0.0 105.759 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' HB3' HD13 ' A' ' 43' ' ' ILE . 3.7 mp -71.05 -173.03 0.76 Allowed 'General case' 0 C--O 1.243 0.721 1 O-C-N 132.394 6.059 . . . . 0.0 110.264 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.05 -146.86 0.32 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-O 115.033 -2.413 . . . . 0.0 111.178 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.54 -6.09 55.17 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 128.027 3.329 . . . . 0.0 108.935 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.16 49.83 0.02 OUTLIER Glycine 0 CA--C 1.549 2.181 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.497 ' CG2' ' CD1' ' A' ' 63' ' ' LEU . 21.9 m -102.39 116.61 32.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 126.585 1.991 . . . . 0.0 109.18 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.5 119.21 36.8 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 115.574 -2.45 . . . . 0.0 109.115 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' CD1' ' CG2' ' A' ' 61' ' ' THR . 0.6 OUTLIER -127.14 60.82 1.38 Allowed 'General case' 0 C--O 1.202 -1.415 0 CA-C-N 110.726 -2.943 . . . . 0.0 107.215 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 54.4 m -41.7 117.03 0.86 Allowed 'General case' 0 N--CA 1.436 -1.142 1 O-C-N 129.23 4.081 . . . . 0.0 104.175 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' C ' ' CE1' ' A' ' 53' ' ' PHE . . . -149.1 -159.74 8.74 Favored Glycine 0 C--O 1.209 -1.436 1 C-N-CA 110.175 -5.774 . . . . 0.0 108.65 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 ' C ' ' CG ' ' A' ' 67' ' ' TRP 0.287 0.7 OUTLIER 175.25 130.94 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.136 2 O-C-N 131.992 5.172 . . . . 0.0 111.808 -178.252 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.75 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 33.4 m95 -136.31 121.01 18.43 Favored 'General case' 0 C--O 1.203 -1.351 0 O-C-N 119.044 -2.285 . . . . 0.0 106.46 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -98.76 22.49 9.99 Favored 'General case' 0 N--CA 1.426 -1.63 2 O-C-N 130.651 4.969 . . . . 0.0 116.988 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 4.22 88.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 1 O-C-N 136.567 8.667 . . . . 0.0 108.322 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -94.99 95.2 8.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 128.047 3.342 . . . . 0.0 111.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.45 -102.2 0.3 Allowed Glycine 0 CA--C 1.541 1.66 1 O-C-N 129.268 4.105 . . . . 0.0 105.565 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.459 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . 74.9 m-20 -120.24 53.37 1.09 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 115.31 -2.281 . . . . 0.0 113.103 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 2.4 mtpt -135.92 171.47 14.42 Favored 'General case' 0 C--N 1.343 0.308 1 O-C-N 130.978 5.174 . . . . 0.0 109.185 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -142.08 54.74 1.46 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 127.874 3.234 . . . . 0.0 111.797 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.88 102.0 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.862 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.554 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -171.33 -161.62 22.27 Favored Glycine 0 C--O 1.2 -2.021 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.288 0.0 OUTLIER -156.89 165.39 36.32 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 129.028 3.428 . . . . 0.0 113.713 -179.508 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.75 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 33.7 m-85 -145.54 153.84 41.54 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 101.248 -3.612 . . . . 0.0 101.248 176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.325 0.0 OUTLIER -171.45 130.99 0.72 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 110.255 -3.157 . . . . 0.0 116.86 -179.633 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 85' ' ' LYS . 94.0 mtt180 -81.39 100.58 9.33 Favored 'General case' 0 N--CA 1.439 -0.989 1 O-C-N 129.374 4.171 . . . . 0.0 108.977 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.91 -26.85 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 1 O-C-N 132.208 5.943 . . . . 0.0 108.757 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -57.0 -39.52 74.85 Favored 'General case' 0 N--CA 1.442 -0.837 1 O-C-N 132.215 5.947 . . . . 0.0 110.466 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -126.15 -2.47 7.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 127.513 3.008 . . . . 0.0 117.073 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.438 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 77.61 38.01 29.17 Favored Glycine 0 C--O 1.2 -2.025 2 C-N-CA 112.224 -4.798 . . . . 0.0 101.889 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 80' ' ' ARG 0.26 15.4 tptp -81.05 -71.92 0.45 Allowed 'General case' 0 N--CA 1.424 -1.755 2 O-C-N 132.695 5.585 . . . . 0.0 120.935 -178.87 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.496 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 12.3 mm-40 73.93 108.38 0.07 Allowed 'General case' 0 N--CA 1.429 -1.506 1 O-C-N 129.206 4.067 . . . . 0.0 113.464 -178.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -139.56 49.21 1.81 Allowed 'General case' 0 C--O 1.198 -1.635 1 O-C-N 132.255 5.972 . . . . 0.0 109.985 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 103' ' ' THR 0.255 30.6 mt -61.99 139.71 20.36 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 1 CA-C-N 107.849 -4.251 . . . . 0.0 101.357 -179.812 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.68 97.83 7.61 Favored 'General case' 0 C--O 1.2 -1.54 1 O-C-N 134.73 7.519 . . . . 0.0 103.254 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.34 115.6 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 O-C-N 128.941 3.901 . . . . 0.0 110.541 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.485 ' CG ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -163.72 -168.54 1.67 Allowed 'General case' 0 C--O 1.192 -1.94 0 C-N-CA 112.923 -3.511 . . . . 0.0 115.933 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 91' ' ' ARG 0.296 0.1 OUTLIER -177.12 110.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 1 O-C-N 130.419 4.824 . . . . 0.0 106.127 -179.535 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 72' ' ' ASN . 2.4 tp -33.25 98.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 1 O-C-N 133.46 6.725 . . . . 0.0 113.317 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -84.03 75.17 10.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 116.152 -2.219 . . . . 0.0 115.076 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.26 -123.41 5.94 Favored Glycine 0 CA--C 1.563 3.077 1 N-CA-C 102.585 -4.206 . . . . 0.0 102.585 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -130.52 44.25 2.99 Favored 'General case' 0 N--CA 1.437 -1.112 1 CA-C-N 108.055 -4.072 . . . . 0.0 106.073 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.592 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.278 0.0 OUTLIER -173.4 97.92 0.12 Allowed 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.416 4.823 . . . . 0.0 108.777 179.725 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 2' ' ' PHE . 3.2 tt -72.99 148.64 44.03 Favored 'General case' 0 N--CA 1.424 -1.727 1 O-C-N 130.321 4.763 . . . . 0.0 115.209 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.61 167.26 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 2 CA-C-N 106.345 -4.934 . . . . 0.0 103.429 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.25 98.93 0.83 Allowed 'General case' 0 C--O 1.204 -1.294 1 O-C-N 131.13 5.269 . . . . 0.0 103.895 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' THR . 8.9 t -85.49 112.34 20.82 Favored 'General case' 0 N--CA 1.428 -1.574 2 O-C-N 131.177 5.298 . . . . 0.0 112.461 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.18 88.97 2.49 Favored 'General case' 0 C--O 1.208 -1.118 2 C-N-CA 110.772 -4.371 . . . . 0.0 105.773 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.8 m -65.4 93.72 0.15 Allowed 'General case' 0 C--O 1.209 -1.076 0 O-C-N 128.659 3.725 . . . . 0.0 101.37 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 1.8 t80 -110.57 114.5 27.96 Favored 'General case' 0 CA--C 1.498 -1.038 1 CA-C-N 107.512 -4.404 . . . . 0.0 111.426 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 47.45 17.59 0.08 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 112.428 -2.169 . . . . 0.0 116.547 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.31 16.91 19.36 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 116.306 -2.854 . . . . 0.0 114.59 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.15 -38.29 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 120.225 2.013 . . . . 0.0 113.357 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 68.16 97.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 1 O-C-N 130.071 4.607 . . . . 0.0 108.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.363 . . -132.07 113.64 13.59 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 128.398 3.561 . . . . 0.0 109.116 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -174.34 2.53 Favored 'General case' 0 N--CA 1.421 -1.878 1 O-C-N 133.694 6.871 . . . . 0.0 111.381 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -156.5 119.8 4.22 Favored 'General case' 0 C--O 1.204 -1.331 2 O-C-N 130.418 4.824 . . . . 0.0 101.511 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.06 125.36 45.63 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 O-C-N 127.763 3.164 . . . . 0.0 112.903 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.612 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 65.6 m-85 -120.58 -141.96 0.34 Allowed 'General case' 0 N--CA 1.446 -0.673 1 O-C-N 131.013 5.196 . . . . 0.0 104.949 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.592 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -164.16 -149.89 0.14 Allowed 'General case' 0 C--O 1.199 -1.579 1 O-C-N 131.538 5.524 . . . . 0.0 112.526 179.903 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 24.0 tttt -128.56 154.79 45.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 127.211 2.204 . . . . 0.0 111.185 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 N--CA 1.434 -1.228 0 O-C-N 127.767 3.167 . . . . 0.0 113.678 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.195 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.17 61.51 0.77 Allowed 'General case' 0 CA--C 1.554 1.116 1 O-C-N 129.9 4.5 . . . . 0.0 102.752 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -144.33 57.49 1.32 Allowed 'General case' 0 C--N 1.358 0.938 0 CA-C-N 110.126 -3.215 . . . . 0.0 111.192 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.429 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . -165.53 177.31 40.85 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 114.113 -3.899 . . . . 0.0 105.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.327 23.8 p -80.26 177.81 8.71 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 113.858 -3.137 . . . . 0.0 104.087 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.556 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 75.3 m95 -150.69 167.86 26.08 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 115.506 -2.187 . . . . 0.0 112.189 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HA ' ' CD ' ' A' ' 114' ' ' LYS . 8.5 mtmt 51.03 179.19 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 O-C-N 127.83 3.207 . . . . 0.0 118.814 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 32.22 112.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 3 O-C-N 133.492 6.745 . . . . 0.0 121.414 174.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -140.37 -148.81 0.26 Allowed 'General case' 0 N--CA 1.425 -1.723 1 CA-C-N 107.535 -4.393 . . . . 0.0 103.721 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -97.53 54.01 1.17 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 123.145 1.45 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -98.97 152.44 19.8 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.986 -1.086 . . . . 0.0 113.29 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -151.53 89.11 1.46 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 111.498 -2.592 . . . . 0.0 105.73 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -89.74 -12.27 39.85 Favored 'General case' 0 C--N 1.362 1.109 0 O-C-N 125.38 1.675 . . . . 0.0 109.277 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.46 -92.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 O-C-N 126.4 2.312 . . . . 0.0 112.116 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -179.52 -171.62 0.2 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 124.61 2.147 . . . . 0.0 107.041 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 41.62 4.89 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 111.349 -2.66 . . . . 0.0 110.779 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 131.49 47.64 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -156.27 -44.87 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 117.367 -1.302 . . . . 0.0 110.595 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.08 170.05 13.37 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 126.416 2.322 . . . . 0.0 112.082 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -133.11 115.72 15.43 Favored 'General case' 0 CA--C 1.538 0.495 1 O-C-N 129.846 4.466 . . . . 0.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -164.03 1.39 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 114.216 -2.802 . . . . 0.0 106.506 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.407 0.0 OUTLIER -179.14 175.45 0.96 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 133.237 6.586 . . . . 0.0 103.342 -179.7 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -136.96 157.55 46.49 Favored 'General case' 0 CA--C 1.565 1.547 3 O-C-N 133.895 6.997 . . . . 0.0 97.7 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.595 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 2.9 m 177.78 80.44 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 1 O-C-N 131.913 5.758 . . . . 0.0 106.514 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.498 ' CG2' ' HB2' ' A' ' 32' ' ' PHE . 2.2 mp -95.81 118.76 42.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 CA-C-N 109.451 -3.522 . . . . 0.0 109.079 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.5 m -172.63 68.62 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 128.895 3.872 . . . . 0.0 108.905 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 32' ' ' PHE 0.297 1.5 tp60 -73.89 -95.26 0.02 OUTLIER 'General case' 0 C--N 1.354 0.786 1 C-N-CA 110.74 -4.384 . . . . 0.0 115.504 -179.888 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 170.86 144.94 0.03 OUTLIER 'General case' 0 C--O 1.244 0.771 0 O-C-N 128.555 3.659 . . . . 0.0 106.427 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 30' ' ' ASN . . . 74.88 -97.32 1.0 Allowed Glycine 0 CA--C 1.559 2.792 3 O-C-N 130.902 5.127 . . . . 0.0 102.361 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 12.2 m120 -152.74 47.64 0.72 Allowed 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.62 6.129 . . . . 0.0 112.317 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 6.1 mttp -118.33 161.85 19.26 Favored 'General case' 0 CA--C 1.552 1.048 1 N-CA-C 96.579 -5.341 . . . . 0.0 96.579 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB2' ' CG2' ' A' ' 25' ' ' ILE . 23.0 p90 -167.8 76.96 0.15 Allowed 'General case' 0 C--O 1.197 -1.706 2 C-N-CA 110.383 -4.527 . . . . 0.0 99.656 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 138.12 58.43 Favored 'General case' 0 CA--C 1.505 -0.755 2 O-C-N 130.907 5.129 . . . . 0.0 100.529 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.369 6.8 t -91.05 132.66 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 179.688 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.595 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.25 19.8 tttt -73.74 52.61 0.41 Allowed 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 126.732 3.158 . . . . 0.0 117.28 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG3' ' CG1' ' A' ' 34' ' ' VAL 0.265 50.3 mt-10 -72.28 68.24 0.74 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.869 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -84.49 91.42 7.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 114.257 -2.977 . . . . 0.0 108.85 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 m -87.54 -178.78 6.2 Favored 'General case' 0 C--N 1.367 1.34 0 O-C-N 126.622 2.451 . . . . 0.0 116.549 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.6 -9.16 59.79 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 126.102 2.126 . . . . 0.0 108.351 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 19.7 m-85 -69.3 -55.32 10.82 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 113.341 -3.343 . . . . 0.0 106.978 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -158.95 6.63 0.11 Allowed 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 114.394 -2.717 . . . . 0.0 117.367 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.81 62.97 0.87 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 101.927 -3.361 . . . . 0.0 101.927 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 0.0 OUTLIER -134.88 113.47 16.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 3 CA-C-O 130.994 5.188 . . . . 0.0 111.249 -178.301 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.98 -172.95 4.21 Favored 'General case' 0 C--N 1.372 1.586 1 CA-C-N 107.259 -4.519 . . . . 0.0 109.59 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.26 118.36 31.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 O-C-N 128.839 3.837 . . . . 0.0 101.525 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.33 160.64 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 C-N-CA 113.035 -3.466 . . . . 0.0 111.758 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER 177.09 -176.89 0.15 Allowed 'General case' 0 N--CA 1.435 -1.183 1 O-C-N 129.818 4.449 . . . . 0.0 111.649 -179.819 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' HB2' ' HD3' ' A' ' 31' ' ' LYS 0.315 3.7 tm-20 -141.97 86.51 1.99 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 114.676 -2.809 . . . . 0.0 113.388 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 36.87 91.64 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.282 1 O-C-N 131.236 5.335 . . . . 0.0 115.743 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 57.46 65.22 3.71 Favored Glycine 0 C--O 1.203 -1.842 0 CA-C-O 114.248 -3.529 . . . . 0.0 105.713 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.23 -33.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 1 O-C-N 131.511 4.889 . . . . 0.0 113.637 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.8 126.02 0.03 OUTLIER 'General case' 0 C--O 1.2 -1.551 2 O-C-N 132.047 5.842 . . . . 0.0 108.368 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 9.6 p90 -173.7 149.33 1.59 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 112.5 -3.68 . . . . 0.0 117.479 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 64' ' ' THR . . . -104.56 138.44 40.91 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 100.698 -3.816 . . . . 0.0 100.698 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 56' ' ' SER . 4.4 t80 -150.78 26.96 0.73 Allowed 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 111.757 -3.977 . . . . 0.0 115.082 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 55' ' ' TYR . 7.4 t 23.52 78.68 0.02 OUTLIER 'General case' 0 C--O 1.249 1.061 1 O-C-N 134.693 7.496 . . . . 0.0 110.121 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 57' ' ' LEU . 13.3 mt -81.44 167.37 19.46 Favored 'General case' 0 C--N 1.317 -0.83 1 O-C-N 129.854 4.472 . . . . 0.0 114.991 -179.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB2' HG22 ' A' ' 61' ' ' THR . . . 45.99 25.12 0.29 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 126.014 2.071 . . . . 0.0 115.388 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.74 42.13 19.18 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 126.926 2.641 . . . . 0.0 115.276 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.86 -48.3 0.06 OUTLIER Glycine 0 C--N 1.367 2.261 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 58' ' ' ALA . 3.5 p -63.61 173.61 1.63 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 127.72 2.659 . . . . 0.0 114.242 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -164.27 36.85 0.08 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 112.436 -3.706 . . . . 0.0 108.794 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.82 106.65 0.51 Allowed 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 126.558 2.411 . . . . 0.0 108.485 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 54' ' ' ALA . 58.3 m -103.7 107.26 18.04 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 112.102 -2.317 . . . . 0.0 107.688 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -161.0 -163.35 13.88 Favored Glycine 0 C--O 1.203 -1.837 1 C-N-CA 111.16 -5.305 . . . . 0.0 107.499 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.441 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 1.5 t -142.33 114.67 8.37 Favored 'General case' 0 CA--C 1.495 -1.17 2 O-C-N 135.426 7.192 . . . . 0.0 118.735 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.719 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.5 m95 -99.54 112.58 24.77 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.7 p -106.03 66.26 0.71 Allowed 'General case' 0 N--CA 1.427 -1.594 1 O-C-N 132.618 6.199 . . . . 0.0 115.022 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -40.05 109.25 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 1 O-C-N 133.839 6.962 . . . . 0.0 103.207 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -66.89 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 127.563 3.04 . . . . 0.0 106.405 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.67 -63.06 0.04 OUTLIER Glycine 0 CA--C 1.556 2.654 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.38 16.94 2.39 Favored 'General case' 0 N--CA 1.444 -0.727 1 O-C-N 131.44 4.847 . . . . 0.0 108.647 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -99.4 176.71 5.42 Favored 'General case' 0 N--CA 1.476 0.826 1 O-C-N 131.307 5.379 . . . . 0.0 108.737 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.4 mt -148.17 45.16 1.07 Allowed 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 126.804 2.565 . . . . 0.0 111.951 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.68 137.75 23.05 Favored 'Isoleucine or valine' 0 C--N 1.364 1.227 1 CA-C-N 106.853 -4.703 . . . . 0.0 114.025 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.88 -149.65 20.5 Favored Glycine 0 CA--C 1.547 2.063 1 N-CA-C 100.649 -4.98 . . . . 0.0 100.649 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 176.5 137.82 0.06 Allowed 'General case' 0 C--O 1.208 -1.083 1 O-C-N 134.046 6.38 . . . . 0.0 112.632 -179.986 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.719 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -124.73 168.02 13.76 Favored 'General case' 0 C--O 1.195 -1.782 2 O-C-N 132.526 6.141 . . . . 0.0 104.814 179.783 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 86' ' ' GLU 0.28 0.0 OUTLIER -163.94 140.54 6.7 Favored 'General case' 0 N--CA 1.427 -1.609 1 CA-C-N 106.227 -4.988 . . . . 0.0 113.398 179.975 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' CG ' ' HB2' ' A' ' 82' ' ' ASP . 32.8 ttt180 -93.46 112.09 23.92 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 127.623 3.077 . . . . 0.0 107.164 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.415 ' HA ' ' NZ ' ' A' ' 79' ' ' LYS . 21.2 t -66.02 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 1 O-C-N 130.714 5.009 . . . . 0.0 109.217 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.478 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . 32.6 m-20 -87.58 19.85 3.19 Favored 'General case' 0 N--CA 1.44 -0.957 1 O-C-N 134.024 7.078 . . . . 0.0 107.86 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.611 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 83.45 18.03 0.24 Allowed 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 128.502 3.626 . . . . 0.0 117.475 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 80' ' ' ARG . . . -82.49 -11.69 81.55 Favored Glycine 0 CA--C 1.562 2.993 1 C-N-CA 110.335 -5.698 . . . . 0.0 104.116 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 1.7 ttmm 41.55 82.83 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 2 O-C-N 132.672 5.572 . . . . 0.0 121.38 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 18.3 mt-10 82.79 71.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.667 1 O-C-N 129.754 4.409 . . . . 0.0 117.071 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mp -99.83 64.58 1.27 Allowed 'General case' 0 C--O 1.197 -1.697 1 O-C-N 132.198 5.936 . . . . 0.0 113.646 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 77' ' ' LYS 0.305 93.8 mt -77.84 -174.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 108.563 -3.926 . . . . 0.0 101.647 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.31 73.47 0.92 Allowed 'General case' 0 C--O 1.196 -1.745 0 O-C-N 128.051 3.345 . . . . 0.0 106.242 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.87 110.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 110.597 -3.001 . . . . 0.0 105.427 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.674 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -162.82 162.67 26.63 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 111.854 -3.938 . . . . 0.0 113.438 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.674 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -153.69 121.05 5.82 Favored 'General case' 0 CA--C 1.543 0.679 2 CA-C-N 107.326 -4.488 . . . . 0.0 103.806 179.554 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CD1' ' CH2' ' A' ' 6' ' ' TRP 0.296 5.0 tt -48.4 108.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 1 O-C-N 131.265 5.353 . . . . 0.0 112.99 -179.766 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -74.74 69.33 1.79 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 130.025 4.578 . . . . 0.0 115.479 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.05 -113.4 2.63 Favored Glycine 0 CA--C 1.558 2.76 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -138.6 47.32 1.96 Allowed 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 129.461 3.683 . . . . 0.0 107.456 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 179.04 127.64 0.07 Allowed 'General case' 0 CA--C 1.56 1.354 0 O-C-N 128.577 3.673 . . . . 0.0 106.966 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.474 ' CA ' HG13 ' A' ' 93' ' ' ILE . 11.9 tp -90.94 162.52 14.72 Favored 'General case' 0 C--O 1.206 -1.231 1 O-C-N 134.209 7.193 . . . . 0.0 111.863 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.474 ' CG2' ' CB ' ' A' ' 110' ' ' LYS . 1.4 mp -107.77 -85.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 2 CA-C-O 110.707 -4.473 . . . . 0.0 103.294 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 13.3 mm-40 93.82 93.41 0.01 OUTLIER 'General case' 0 C--O 1.202 -1.415 1 O-C-N 133.593 6.808 . . . . 0.0 104.824 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.8 p -83.93 -166.37 1.39 Allowed 'General case' 0 N--CA 1.416 -2.174 1 O-C-N 129.273 4.108 . . . . 0.0 113.177 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -156.22 89.33 1.13 Allowed 'General case' 0 C--O 1.2 -1.552 1 C-N-CA 110.752 -4.379 . . . . 0.0 103.293 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.63 79.11 0.42 Allowed 'General case' 0 C--O 1.213 -0.835 1 O-C-N 129.804 4.44 . . . . 0.0 107.532 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -104.58 100.96 10.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 108.661 -3.881 . . . . 0.0 111.295 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 46.88 17.09 0.05 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.61 -18.57 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 116.388 -2.815 . . . . 0.0 116.41 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.12 142.5 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 119.72 1.76 . . . . 0.0 112.933 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -109.09 87.16 2.43 Favored 'General case' 0 C--N 1.364 1.238 1 O-C-N 129.3 4.125 . . . . 0.0 108.119 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.425 . . -106.71 142.41 36.39 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 116.109 -2.236 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' CB ' ' CG2' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -148.64 171.01 16.86 Favored 'General case' 0 N--CA 1.435 -1.184 1 O-C-N 130.875 5.109 . . . . 0.0 109.904 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.49 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -123.96 137.55 54.6 Favored 'General case' 0 CA--C 1.558 1.256 3 O-C-N 129.562 4.289 . . . . 0.0 99.921 179.541 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.09 110.0 15.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 C-N-CA 113.714 -3.194 . . . . 0.0 112.22 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 111' ' ' ARG . 6.4 m-30 -108.56 175.43 5.47 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 128.84 3.838 . . . . 0.0 103.981 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.36 -159.19 0.31 Allowed 'General case' 0 C--O 1.198 -1.652 2 O-C-N 131.639 5.587 . . . . 0.0 111.616 179.404 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.556 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 21.6 tttt -112.59 -127.98 0.29 Allowed 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.782 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.902 0 CA-C-O 121.952 0.882 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -103.3 -33.73 9.03 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 111.029 -2.805 . . . . 0.0 107.126 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 22.5 p-10 -32.79 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 130.75 5.031 . . . . 0.0 118.294 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.79 -169.7 38.09 Favored Glycine 0 C--N 1.345 1.05 1 C-N-CA 112.006 -4.902 . . . . 0.0 105.496 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.309 0.4 OUTLIER -100.34 167.68 10.25 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 114.074 -3.051 . . . . 0.0 104.929 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.558 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.264 34.4 m95 -143.21 140.15 30.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 O-C-N 128.672 3.733 . . . . 0.0 111.109 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.554 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 19.3 mtmt 58.2 178.58 0.06 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.306 0.6 OUTLIER 35.44 92.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.588 3 O-C-N 136.404 8.565 . . . . 0.0 113.964 174.815 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -139.74 29.14 2.13 Favored 'General case' 0 C--N 1.375 1.684 1 CA-C-N 107.717 -4.31 . . . . 0.0 108.59 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -142.84 -175.74 4.62 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.848 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 65.53 102.23 0.04 OUTLIER 'General case' 0 C--N 1.363 1.186 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.366 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -121.96 150.82 41.49 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 128.141 3.401 . . . . 0.0 107.598 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.08 59.03 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 128.518 3.636 . . . . 0.0 104.285 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -115.52 122.02 44.45 Favored 'General case' 0 N--CA 1.443 -0.82 2 O-C-N 129.435 4.209 . . . . 0.0 107.26 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.13 24.24 3.54 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.46 54.62 0.67 Allowed Glycine 0 CA--C 1.55 2.264 0 O-C-N 128.288 3.492 . . . . 0.0 111.325 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.23 -177.04 2.38 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 110.145 -3.027 . . . . 0.0 106.202 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -168.72 -40.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.805 0.812 . . . . 0.0 111.742 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.82 118.33 23.88 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 113.45 -1.705 . . . . 0.0 111.548 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -119.89 165.67 14.31 Favored 'General case' 0 C--N 1.362 1.112 1 O-C-N 130.5 4.875 . . . . 0.0 111.838 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.07 139.93 29.2 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 127.206 2.816 . . . . 0.0 105.417 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.345 0.0 OUTLIER -159.94 149.79 18.27 Favored 'General case' 0 C--O 1.205 -1.259 1 O-C-N 130.856 5.098 . . . . 0.0 104.115 -179.811 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 6.6 mt -116.57 177.68 4.61 Favored 'General case' 0 CA--C 1.562 1.422 2 O-C-N 132.964 6.415 . . . . 0.0 97.937 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 21.9 m -167.91 -85.31 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 1 O-C-N 130.921 5.138 . . . . 0.0 106.508 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 23' ' ' LEU . 1.0 OUTLIER 72.68 162.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 109.163 -3.653 . . . . 0.0 108.853 -179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 27' ' ' GLN . 90.9 m -138.31 -48.93 0.54 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 112.781 -3.568 . . . . 0.0 108.661 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR 0.316 3.9 pt20 65.97 123.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.027 2 O-C-N 132.503 6.127 . . . . 0.0 115.778 178.762 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 7.1 tt0 -98.97 -130.81 0.22 Allowed 'General case' 0 C--O 1.248 1.022 0 O-C-N 128.795 3.81 . . . . 0.0 104.829 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.14 -53.43 3.91 Favored Glycine 0 CA--C 1.546 2.002 2 N-CA-C 99.594 -5.402 . . . . 0.0 99.594 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' ND2' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -136.17 75.81 1.57 Allowed 'General case' 0 N--CA 1.44 -0.956 1 CA-C-N 107.589 -4.305 . . . . 0.0 105.862 -179.9 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' CD ' ' C ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -168.28 102.88 0.44 Allowed 'General case' 0 C--O 1.246 0.917 1 C-N-CA 111.418 -4.113 . . . . 0.0 102.337 -179.893 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 39.7 p90 -140.09 165.25 27.87 Favored 'General case' 0 CA--C 1.562 1.426 1 N-CA-C 99.402 -4.295 . . . . 0.0 99.402 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.95 125.08 21.53 Favored 'General case' 0 N--CA 1.476 0.828 2 O-C-N 137.605 9.316 . . . . 0.0 101.468 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' A' ' 23' ' ' LEU 0.352 1.1 t -84.89 132.77 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 112.932 -3.507 . . . . 0.0 103.585 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.308 0.3 OUTLIER -71.94 -0.83 12.44 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 109.361 -3.563 . . . . 0.0 118.875 179.789 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.368 1.0 OUTLIER -37.76 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.106 -2.77 . . . . 0.0 109.192 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -91.93 133.45 35.68 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 115.327 -2.549 . . . . 0.0 109.395 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p 177.02 -169.13 0.06 Allowed 'General case' 0 C--N 1.353 0.746 0 O-C-N 127.65 3.094 . . . . 0.0 112.958 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.08 -91.76 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.624 0 O-C-N 125.276 1.61 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -117.58 -36.54 3.67 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 128.254 3.471 . . . . 0.0 111.609 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -143.14 0.15 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 127.222 2.826 . . . . 0.0 115.228 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.7 -22.31 34.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 116.289 -2.164 . . . . 0.0 107.387 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt 25.28 69.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.223 2 O-C-N 132.349 6.03 . . . . 0.0 111.1 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -65.56 155.3 36.16 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 109.639 -3.437 . . . . 0.0 105.148 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 78' ' ' PHE . 6.3 t -123.09 117.61 52.19 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 1 O-C-N 129.544 4.277 . . . . 0.0 101.462 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.271 0.3 OUTLIER -118.23 162.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 114.663 -2.815 . . . . 0.0 114.831 179.843 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -177.2 -159.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 130.095 4.622 . . . . 0.0 111.448 -179.961 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.1 49.5 1.85 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 117.757 -1.577 . . . . 0.0 114.582 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 0.0 OUTLIER 39.52 98.37 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 127.778 3.656 . . . . 0.0 115.28 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.01 52.93 1.56 Allowed Glycine 0 CA--C 1.545 1.957 1 N-CA-C 101.563 -4.615 . . . . 0.0 101.563 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -147.3 122.02 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 1 O-C-N 132.184 5.285 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.52 153.16 22.05 Favored 'General case' 0 CA--C 1.558 1.252 1 O-C-N 130.423 4.827 . . . . 0.0 106.968 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -168.42 124.33 0.99 Allowed 'General case' 0 N--CA 1.426 -1.664 1 O-C-N 129.136 4.023 . . . . 0.0 118.566 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.05 118.78 26.66 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -142.59 135.74 28.5 Favored 'General case' 0 C--O 1.21 -0.999 0 O-C-N 127.573 3.046 . . . . 0.0 112.558 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.35 141.88 28.15 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 128.354 3.534 . . . . 0.0 106.883 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.17 -67.47 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 128.758 3.786 . . . . 0.0 114.365 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.23 24.16 4.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 116.848 -1.549 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.12 16.01 5.64 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 125.867 1.979 . . . . 0.0 114.489 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.01 56.36 0.12 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 104.813 -3.315 . . . . 0.0 104.813 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.97 -87.82 0.56 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 129.876 3.927 . . . . 0.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.76 15.22 8.04 Favored 'General case' 0 CA--C 1.517 -0.317 1 O-C-N 129.465 4.228 . . . . 0.0 109.656 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.5 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 124.374 2.035 . . . . 0.0 108.525 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.0 m -85.95 113.35 21.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 77' ' ' LYS . . . -144.79 -155.47 6.47 Favored Glycine 0 C--O 1.209 -1.445 1 C-N-CA 111.673 -5.06 . . . . 0.0 109.213 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.629 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.27 8.8 t -179.78 135.96 0.12 Allowed 'General case' 0 CA--C 1.496 -1.131 2 O-C-N 133.524 6.073 . . . . 0.0 111.917 -178.154 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 67.7 m95 -141.45 119.63 12.13 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 116.692 -3.755 . . . . 0.0 106.209 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.445 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 1.1 p -106.43 34.72 3.25 Favored 'General case' 0 N--CA 1.434 -1.246 2 O-C-N 134.543 7.402 . . . . 0.0 116.154 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . 0.264 4.3 ttm -17.66 84.56 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 1 O-C-N 136.57 8.669 . . . . 0.0 108.058 -179.92 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.72 94.54 9.42 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 128.046 3.341 . . . . 0.0 107.074 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.11 -132.04 36.25 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -85.43 60.66 6.38 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 109.075 -3.563 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 158.83 44.18 Favored 'General case' 0 C--N 1.359 1.015 1 O-C-N 129.297 4.123 . . . . 0.0 111.149 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 91' ' ' ARG . 13.0 mt -141.93 59.59 1.48 Allowed 'General case' 0 C--O 1.209 -1.047 0 O-C-N 128.269 3.481 . . . . 0.0 111.459 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.15 101.66 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 1 CA-C-N 107.531 -4.395 . . . . 0.0 115.601 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.81 -144.99 4.36 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 103.3 -3.92 . . . . 0.0 103.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.519 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.3 0.1 OUTLIER -176.89 165.21 2.42 Favored 'General case' 0 C--O 1.201 -1.457 2 O-C-N 131.36 4.8 . . . . 0.0 112.092 -179.767 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 19.9 m-85 -144.38 166.1 26.06 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HE2' ' CG ' ' A' ' 86' ' ' GLU 0.283 0.0 OUTLIER -174.28 152.43 1.8 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 108.966 -3.743 . . . . 0.0 117.221 179.327 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' CB ' ' A' ' 85' ' ' LYS . 5.8 ptm180 -104.11 78.29 1.5 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 126.299 2.25 . . . . 0.0 107.252 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.6 m -22.12 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 1 O-C-N 133.331 6.644 . . . . 0.0 114.047 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -41.88 -47.02 4.17 Favored 'General case' 0 N--CA 1.451 -0.425 1 O-C-N 134.751 7.532 . . . . 0.0 107.637 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -112.0 -0.28 15.78 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 128.544 3.653 . . . . 0.0 113.304 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.26 34.63 88.62 Favored Glycine 0 CA--C 1.559 2.782 1 N-CA-C 101.361 -4.696 . . . . 0.0 101.361 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -66.02 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 3 O-C-N 132.615 5.538 . . . . 0.0 118.264 179.983 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' ' 85' ' ' LYS . 46.3 mt-10 116.87 133.52 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 1 O-C-N 132.455 6.097 . . . . 0.0 109.136 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.64 42.4 0.48 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 133.289 6.618 . . . . 0.0 110.003 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 77' ' ' LYS 0.256 4.7 mt -67.71 171.52 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.591 1 O-C-N 131.42 5.45 . . . . 0.0 105.004 -179.567 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.68 73.95 1.25 Allowed 'General case' 0 C--O 1.219 -0.545 1 O-C-N 133.66 6.85 . . . . 0.0 107.592 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.69 125.71 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -166.58 153.88 9.46 Favored 'General case' 0 C--O 1.191 -1.982 1 C-N-CA 110.407 -4.517 . . . . 0.0 115.405 179.83 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 4.5 mt-10 -149.04 113.61 5.32 Favored 'General case' 0 N--CA 1.433 -1.324 1 O-C-N 131.018 5.199 . . . . 0.0 107.095 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' HB ' HD13 ' A' ' 98' ' ' LEU 0.26 0.1 OUTLIER -45.5 112.99 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.668 1 O-C-N 130.325 4.766 . . . . 0.0 109.296 179.823 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -67.72 -89.58 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.097 0 O-C-N 128.734 3.771 . . . . 0.0 116.89 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -135.92 100.33 0.34 Allowed Glycine 0 C--O 1.206 -1.638 0 C-N-CA 115.464 -3.255 . . . . 0.0 107.662 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 52.51 22.73 2.25 Favored 'General case' 0 N--CA 1.443 -0.809 2 O-C-N 130.639 4.376 . . . . 0.0 109.663 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.459 ' CD ' ' HB2' ' A' ' 114' ' ' LYS 0.296 0.0 OUTLIER -168.8 134.1 1.65 Allowed 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 127.581 3.051 . . . . 0.0 109.022 179.283 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD13 ' HB ' ' A' ' 93' ' ' ILE . 2.6 tt -97.67 142.12 29.86 Favored 'General case' 0 N--CA 1.437 -1.095 1 O-C-N 133.598 6.811 . . . . 0.0 115.863 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 29.0 mt -83.19 -84.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.518 0 O-C-N 128.945 3.903 . . . . 0.0 106.284 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 92.95 107.67 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.274 1 O-C-N 131.024 5.203 . . . . 0.0 100.833 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.2 p -77.76 -38.7 46.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 128.406 3.566 . . . . 0.0 119.462 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 61.81 53.04 3.26 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 111.569 -2.56 . . . . 0.0 105.583 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 m -52.42 117.18 2.67 Favored 'General case' 0 C--N 1.36 1.023 1 O-C-N 133.038 6.461 . . . . 0.0 100.625 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 5.7 t80 -144.58 138.04 27.18 Favored 'General case' 0 CA--C 1.49 -1.349 1 O-C-N 130.13 4.644 . . . . 0.0 112.604 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 1.0 OUTLIER 37.41 35.13 0.05 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.841 -1.981 . . . . 0.0 115.952 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.58 79.64 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 116.76 -2.638 . . . . 0.0 117.305 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.81 -19.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 66.48 173.08 0.24 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 128.33 3.519 . . . . 0.0 106.951 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.328 . . -174.8 81.43 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 117.234 -1.787 . . . . 0.0 114.166 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -95.5 120.86 36.48 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 129.729 4.393 . . . . 0.0 109.084 -179.931 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -92.85 -34.12 13.96 Favored 'General case' 0 CA--C 1.555 1.16 1 O-C-N 129.974 4.546 . . . . 0.0 104.164 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 83.5 118.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.126 1 O-C-N 130.25 4.719 . . . . 0.0 108.03 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 37.0 m-85 -141.8 -146.67 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 1 O-C-N 129.549 4.28 . . . . 0.0 106.511 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -170.31 -145.31 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.024 1 O-C-N 131.104 5.253 . . . . 0.0 111.668 -179.739 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.558 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 17.4 tttt -129.03 -58.51 1.14 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.232 1.413 . . . . 0.0 111.979 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.411 -2.384 0 CA-C-N 111.027 -2.806 . . . . 0.0 113.837 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' CE1' HG23 ' A' ' 93' ' ' ILE . 0.3 OUTLIER 159.97 -36.49 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 O-C-N 128.363 3.539 . . . . 0.0 105.051 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.41 ' CB ' HG22 ' A' ' 26' ' ' THR 0.252 5.0 p-10 -34.48 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.874 1 O-C-N 130.443 4.839 . . . . 0.0 117.735 179.493 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 169.57 -179.2 42.2 Favored Glycine 0 N--CA 1.477 1.43 1 C-N-CA 112.231 -4.795 . . . . 0.0 104.169 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 3.3 p -88.4 173.08 8.92 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 113.712 -3.195 . . . . 0.0 108.168 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 64.6 m95 -152.14 117.69 5.35 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.631 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 89.3 171.58 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' CG1' ' HG3' ' A' ' 22' ' ' LYS 0.274 0.5 OUTLIER 47.77 92.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.479 -1.775 3 CA-C-O 135.886 7.517 . . . . 0.0 120.305 174.864 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.37 -153.36 0.04 OUTLIER 'General case' 0 C--N 1.373 1.599 1 CA-C-N 107.656 -4.338 . . . . 0.0 108.352 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.14 154.41 40.08 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 119.69 -1.881 . . . . 0.0 111.996 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -96.9 -38.44 9.83 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 126.533 2.396 . . . . 0.0 111.459 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.63 -167.33 1.36 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.092 -1.432 . . . . 0.0 108.841 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -117.33 52.74 0.95 Allowed 'General case' 0 C--O 1.215 -0.739 1 O-C-N 130.222 4.702 . . . . 0.0 107.168 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' CG ' ' N ' ' A' ' 15' ' ' SER . 36.7 t80 -169.43 160.08 9.02 Favored 'General case' 0 C--O 1.217 -0.627 1 CA-C-N 108.355 -4.021 . . . . 0.0 106.477 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -133.56 125.45 28.86 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.279 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.8 -95.68 2.07 Favored Glycine 0 CA--C 1.547 2.075 0 O-C-N 127.058 2.724 . . . . 0.0 111.595 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.55 136.3 37.49 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 111.213 -2.493 . . . . 0.0 105.86 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -153.6 176.27 12.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 125.368 1.668 . . . . 0.0 109.063 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.84 76.43 0.8 Allowed 'General case' 0 C--O 1.207 -1.154 0 O-C-N 128.762 3.789 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -104.44 -155.41 0.53 Allowed 'General case' 0 C--N 1.357 0.91 1 O-C-N 129.543 4.277 . . . . 0.0 109.307 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -103.06 -169.87 1.71 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HA ' ' CE ' ' A' ' 7' ' ' LYS 0.321 7.9 mttt 147.09 141.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.53 2 O-C-N 132.914 6.384 . . . . 0.0 106.576 177.423 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.9 mt -96.5 161.57 13.85 Favored 'General case' 0 CA--C 1.565 1.552 3 O-C-N 132.692 6.245 . . . . 0.0 96.686 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 2.7 m 172.09 83.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 1 O-C-N 129.308 4.13 . . . . 0.0 101.336 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.427 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 3.7 mp -106.13 116.34 49.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 108.688 -3.869 . . . . 0.0 112.833 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.41 HG22 ' CB ' ' A' ' 3' ' ' ASP . 2.9 m -162.14 77.2 0.49 Allowed 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 127.134 2.771 . . . . 0.0 108.506 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.472 ' HB2' ' C ' ' A' ' 31' ' ' LYS . 8.1 mm-40 -68.11 -93.07 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 1 C-N-CA 110.998 -4.281 . . . . 0.0 113.428 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -127.2 -7.86 5.9 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 113.396 -3.192 . . . . 0.0 106.725 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.82 -11.27 29.84 Favored Glycine 0 CA--C 1.538 1.493 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.9 -30.4 2.03 Favored 'General case' 0 N--CA 1.411 -2.418 1 CA-C-O 111.649 -4.024 . . . . 0.0 111.547 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 43.5 mttt -103.86 -165.94 1.21 Allowed 'General case' 0 C--O 1.246 0.897 1 N-CA-C 97.725 -4.917 . . . . 0.0 97.725 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 27' ' ' GLN . 25.6 m-85 -167.86 156.63 9.38 Favored 'General case' 0 C--O 1.203 -1.389 1 N-CA-C 97.355 -5.054 . . . . 0.0 97.355 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.82 128.99 18.73 Favored 'General case' 0 N--CA 1.479 1.015 4 O-C-N 136.662 8.726 . . . . 0.0 98.079 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 23' ' ' LEU 0.431 4.0 t -88.15 121.46 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 1 N-CA-C 99.303 -4.332 . . . . 0.0 99.303 179.9 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.376 11.2 tttt -56.09 -18.99 11.29 Favored 'General case' 0 C--N 1.37 1.489 0 CA-C-N 110.281 -3.145 . . . . 0.0 119.252 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 3.58 67.87 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 109.774 -3.375 . . . . 0.0 111.342 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 21' ' ' LEU . 19.1 m -70.45 127.9 34.33 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 116.816 -1.954 . . . . 0.0 113.071 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -126.38 -168.49 1.87 Allowed 'General case' 0 C--N 1.369 1.417 0 O-C-N 125.707 1.879 . . . . 0.0 112.263 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.25 -25.52 58.13 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 125.507 2.575 . . . . 0.0 104.722 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -90.32 69.24 7.02 Favored 'General case' 0 N--CA 1.437 -1.093 1 CA-C-N 106.653 -4.794 . . . . 0.0 107.143 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.93 177.58 0.1 Allowed 'General case' 0 N--CA 1.436 -1.172 1 O-C-N 129.328 4.142 . . . . 0.0 114.677 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -71.5 -44.62 64.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 111.776 -3.969 . . . . 0.0 102.539 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 64.61 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.512 3 CA-C-O 130.08 4.752 . . . . 0.0 107.074 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.02 138.4 42.17 Favored 'General case' 0 C--N 1.373 1.611 1 CA-C-N 106.395 -4.911 . . . . 0.0 108.26 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.36 86.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 1 N-CA-C 99.782 -4.155 . . . . 0.0 99.782 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.8 163.04 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 1 C-N-CA 111.003 -4.279 . . . . 0.0 113.311 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.8 p90 -161.94 149.68 14.58 Favored 'General case' 0 N--CA 1.433 -1.311 1 O-C-N 132.888 6.367 . . . . 0.0 111.06 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.02 51.55 1.83 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 113.056 -3.458 . . . . 0.0 115.554 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 47.75 89.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 2 O-C-N 132.714 6.259 . . . . 0.0 114.585 -179.711 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.28 59.1 2.78 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.74 -32.2 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 1 O-C-N 133.915 6.303 . . . . 0.0 115.225 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.06 138.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 1 O-C-N 131.421 5.451 . . . . 0.0 109.049 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 p90 179.31 145.96 0.18 Allowed 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 108.668 -3.878 . . . . 0.0 116.505 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.45 137.31 47.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.474 -3.899 . . . . 0.0 100.474 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -147.69 100.79 3.27 Favored 'General case' 0 C--O 1.21 -1.001 1 O-C-N 129.295 4.122 . . . . 0.0 114.06 179.848 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 94.7 1.87 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 112.775 -3.57 . . . . 0.0 101.484 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' TYR . 5.7 tp -82.55 -86.35 0.1 Allowed 'General case' 0 CA--C 1.507 -0.709 1 O-C-N 131.735 5.647 . . . . 0.0 116.117 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.57 10.11 0.07 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 115.825 -2.036 . . . . 0.0 116.494 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 9.4 5.59 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 120.504 1.502 . . . . 0.0 111.122 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.09 46.26 0.27 Allowed Glycine 0 CA--C 1.548 2.128 0 N-CA-C 105.178 -3.169 . . . . 0.0 105.178 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -126.59 -88.93 0.56 Allowed 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 132.155 5.268 . . . . 0.0 114.537 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 62.14 71.95 0.52 Allowed 'General case' 0 C--O 1.217 -0.654 0 O-C-N 127.595 3.06 . . . . 0.0 106.784 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 78' ' ' PHE . 11.1 mp -120.57 76.08 1.17 Allowed 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 128.518 3.636 . . . . 0.0 113.92 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.9 m -48.44 111.84 0.51 Allowed 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.89 -171.38 12.32 Favored Glycine 0 CA--C 1.538 1.469 2 C-N-CA 111.026 -5.368 . . . . 0.0 107.029 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.603 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 5.9 t 176.53 128.96 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.218 2 O-C-N 133.611 6.124 . . . . 0.0 111.368 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 52.1 m95 -137.73 117.83 13.48 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 117.174 -3.454 . . . . 0.0 106.347 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.9 p -96.6 33.64 1.79 Allowed 'General case' 0 N--CA 1.422 -1.87 2 O-C-N 130.703 5.002 . . . . 0.0 116.706 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.448 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 2.2 ttt -18.93 106.19 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.814 1 O-C-N 136.821 8.825 . . . . 0.0 107.523 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.22 -44.72 87.38 Favored 'General case' 0 CA--C 1.505 -0.786 1 O-C-N 129.684 4.365 . . . . 0.0 108.673 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.83 -39.35 0.18 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 110.46 -3.064 . . . . 0.0 107.492 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.07 30.53 1.61 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 129.795 3.879 . . . . 0.0 108.748 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.3 mttt -135.61 157.38 47.02 Favored 'General case' 0 N--CA 1.453 -0.315 1 O-C-N 131.032 5.207 . . . . 0.0 111.604 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 mt -134.91 60.11 1.71 Allowed 'General case' 0 C--O 1.214 -0.775 0 O-C-N 127.879 3.237 . . . . 0.0 110.852 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -85.31 93.27 3.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 1 CA-C-N 106.544 -4.843 . . . . 0.0 114.044 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.538 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -159.08 -156.64 8.14 Favored Glycine 0 C--O 1.207 -1.585 2 CA-C-N 107.599 -4.364 . . . . 0.0 102.955 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.331 21.8 ttpt -170.54 123.98 0.68 Allowed 'General case' 0 C--N 1.37 1.476 1 C-N-CA 108.813 -5.155 . . . . 0.0 112.779 179.934 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 28.0 m-85 -106.09 162.46 13.6 Favored 'General case' 0 C--O 1.2 -1.504 2 N-CA-C 99.831 -4.137 . . . . 0.0 99.831 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE2' ' CA ' ' A' ' 84' ' ' GLY 0.366 0.2 OUTLIER -168.23 130.9 1.48 Allowed 'General case' 0 CA--C 1.495 -1.152 1 CA-C-N 105.594 -5.275 . . . . 0.0 113.737 -178.716 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 11.2 ttp180 -82.41 86.72 6.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 125.007 1.442 . . . . 0.0 110.775 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.39 -33.75 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 O-C-N 128.044 3.34 . . . . 0.0 110.274 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.91 -46.57 81.9 Favored 'General case' 0 C--O 1.248 1.002 1 O-C-N 132.36 6.038 . . . . 0.0 108.825 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.34 -5.7 17.63 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 113.403 -3.319 . . . . 0.0 112.559 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.48 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 75.91 41.54 27.67 Favored Glycine 0 CA--C 1.557 2.677 2 C-N-CA 110.843 -5.456 . . . . 0.0 100.485 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 8.6 tppt? -81.75 -81.44 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 2 CA-C-N 105.75 -5.225 . . . . 0.0 121.239 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 7.0 mm-40 91.04 121.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.576 4.922 . . . . 0.0 108.084 -177.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 87' ' ' LEU . 1.4 pt? -153.45 48.48 0.68 Allowed 'General case' 0 C--O 1.194 -1.836 1 O-C-N 132.435 6.084 . . . . 0.0 110.292 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.421 HG12 ' HG3' ' A' ' 77' ' ' LYS . 30.8 mt -52.33 141.99 5.5 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.552 2 O-C-N 130.248 4.717 . . . . 0.0 104.87 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.65 59.03 0.7 Allowed 'General case' 0 C--O 1.213 -0.832 1 O-C-N 130.75 5.032 . . . . 0.0 105.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.3 t -64.02 102.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 O-C-N 127.848 3.218 . . . . 0.0 110.842 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.559 ' C ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -140.63 -174.03 3.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 115.408 -2.517 . . . . 0.0 110.554 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.559 ' CG ' ' C ' ' A' ' 91' ' ' ARG 0.299 0.0 OUTLIER 176.9 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 132.386 6.054 . . . . 0.0 105.822 -178.858 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.473 HG23 ' CE1' ' A' ' 2' ' ' PHE . 0.1 OUTLIER -39.86 100.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.05 1 O-C-N 131.673 5.608 . . . . 0.0 110.001 179.247 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 m -85.59 -69.07 0.68 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 108.838 -3.801 . . . . 0.0 117.723 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.06 -106.44 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 CA-C-O 126.279 3.155 . . . . 0.0 105.705 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.33 52.61 1.55 Allowed 'General case' 0 CA--C 1.54 0.586 1 CA-C-N 108.009 -4.095 . . . . 0.0 105.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.318 0.0 OUTLIER -159.81 -118.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 1 O-C-N 130.399 4.812 . . . . 0.0 106.272 179.546 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' CD2' ' HB2' ' A' ' 100' ' ' GLN . 9.9 tt 155.88 103.56 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.196 1 O-C-N 129.849 4.468 . . . . 0.0 109.442 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -48.49 -72.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.41 -2.472 1 O-C-N 130.903 5.127 . . . . 0.0 107.483 -179.876 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' HB2' ' CD2' ' A' ' 98' ' ' LEU . 7.6 tp60 79.06 100.71 0.06 Allowed 'General case' 0 CA--C 1.562 1.428 1 O-C-N 134.737 7.523 . . . . 0.0 100.428 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.469 ' CG2' ' HG3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -105.94 119.77 40.04 Favored 'General case' 0 N--CA 1.411 -2.41 2 O-C-N 134.04 7.088 . . . . 0.0 114.346 179.752 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.66 81.93 8.65 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ILE . 1.5 m -65.94 98.65 0.43 Allowed 'General case' 0 C--N 1.361 1.067 1 O-C-N 132.359 6.037 . . . . 0.0 101.332 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -107.62 120.29 41.8 Favored 'General case' 0 N--CA 1.435 -1.19 2 O-C-N 129.718 4.386 . . . . 0.0 113.359 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 4.88 64.65 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 126.937 2.648 . . . . 0.0 117.601 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.89 13.29 29.88 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 118.39 -1.862 . . . . 0.0 116.347 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.61 148.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-O 116.618 -1.658 . . . . 0.0 115.197 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -117.59 67.46 0.75 Allowed 'General case' 0 C--N 1.362 1.129 1 O-C-N 129.724 4.39 . . . . 0.0 106.586 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.411 . . -99.94 97.16 8.07 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 127.672 3.108 . . . . 0.0 111.582 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HG3' ' CG2' ' A' ' 101' ' ' THR . 2.1 mtmt -89.98 176.51 6.77 Favored 'General case' 0 N--CA 1.419 -1.982 2 O-C-N 135.117 7.76 . . . . 0.0 110.074 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -135.24 117.32 15.38 Favored 'General case' 0 CA--C 1.561 1.39 3 O-C-N 131.975 5.797 . . . . 0.0 98.991 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.14 126.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 1 O-C-N 129.495 4.247 . . . . 0.0 112.468 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.631 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 31.1 m-85 -140.19 -149.24 0.27 Allowed 'General case' 0 N--CA 1.445 -0.72 1 O-C-N 129.851 4.469 . . . . 0.0 107.858 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.18 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 1 O-C-N 131.114 5.259 . . . . 0.0 112.257 -179.147 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.567 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 28.3 tttt -123.04 -130.53 0.27 Allowed 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.721 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.264 0.3 OUTLIER . . . . . 0 C--O 1.21 -0.985 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.069 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -31.71 14.85 Favored 'General case' 0 CA--C 1.55 0.966 1 O-C-N 129.331 4.145 . . . . 0.0 107.897 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.36 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 128.827 3.83 . . . . 0.0 116.8 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.97 176.35 36.56 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 114.853 -3.546 . . . . 0.0 105.79 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.392 0.2 OUTLIER -93.01 160.89 14.67 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 111.898 -3.921 . . . . 0.0 109.747 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.537 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 12.8 m95 -127.61 161.29 29.19 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-O 113.033 -3.365 . . . . 0.0 111.095 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 10.6 mtmt 46.41 -179.59 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.328 0.9 OUTLIER 1.09 117.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.458 3 CA-C-O 133.024 6.154 . . . . 0.0 119.239 174.984 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -145.38 35.55 1.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.941 -3.754 . . . . 0.0 109.427 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -171.75 0.71 Allowed 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.857 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.73 -147.76 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.923 1.389 . . . . 0.0 107.677 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.48 120.18 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 O-C-N 125.231 1.582 . . . . 0.0 110.345 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -111.65 -60.95 1.78 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-O 126.564 3.078 . . . . 0.0 108.061 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.97 160.37 30.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 110.531 -3.031 . . . . 0.0 110.729 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 59.87 30.85 20.37 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 126.129 2.143 . . . . 0.0 107.323 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.32 -63.57 1.13 Allowed Glycine 0 C--N 1.347 1.156 0 O-C-N 124.904 1.378 . . . . 0.0 111.981 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.9 -63.12 0.01 OUTLIER 'General case' 0 C--O 1.247 0.966 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.56 134.76 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.09 -172.22 2.51 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 127.026 2.704 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -120.97 -110.73 0.33 Allowed 'General case' 0 C--O 1.217 -0.626 0 O-C-N 128.617 3.698 . . . . 0.0 112.213 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.72 -169.3 2.68 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' NZ ' ' A' ' 35' ' ' LYS 0.395 0.0 OUTLIER -174.86 134.55 0.36 Allowed 'General case' 0 CA--C 1.566 1.569 1 O-C-N 132.379 6.049 . . . . 0.0 103.891 -179.962 . . . . . . . . 5 4 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -97.29 158.22 15.57 Favored 'General case' 0 CA--C 1.555 1.147 3 O-C-N 130.705 5.003 . . . . 0.0 97.801 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.572 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.4 m 173.18 94.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 2 CA-C-O 130.402 4.906 . . . . 0.0 102.455 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.476 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 3.5 mp -106.89 138.41 32.82 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 109.429 -3.532 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -174.56 73.0 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.168 2.792 . . . . 0.0 108.468 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 32' ' ' PHE . 3.7 mm-40 -92.17 -95.0 0.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 113.367 -3.333 . . . . 0.0 112.295 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.47 1.82 0.53 Allowed 'General case' 0 C--O 1.251 1.138 0 O-C-N 127.982 3.302 . . . . 0.0 107.797 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.89 -33.15 5.76 Favored Glycine 0 CA--C 1.539 1.558 1 N-CA-C 101.552 -4.619 . . . . 0.0 101.552 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.48 -36.99 9.76 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-O 112.723 -3.513 . . . . 0.0 112.188 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HG2' ' CG ' ' A' ' 48' ' ' GLU . 72.5 mttt -111.37 173.92 6.11 Favored 'General case' 0 C--O 1.247 0.923 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 32' ' ' PHE 0.265 2.0 p90 -167.8 68.66 0.08 Allowed 'General case' 0 C--O 1.187 -2.222 1 C-N-CA 110.836 -4.346 . . . . 0.0 100.757 178.638 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.01 123.3 13.13 Favored 'General case' 0 CA--C 1.502 -0.894 2 CA-C-N 105.777 -5.192 . . . . 0.0 103.947 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.413 0.5 OUTLIER -91.41 142.74 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 101.584 -3.487 . . . . 0.0 101.584 -179.753 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.572 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.279 6.2 tttt -77.68 1.54 19.58 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 110.629 -2.987 . . . . 0.0 118.603 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' CB ' HG12 ' A' ' 34' ' ' VAL 0.252 0.0 OUTLIER -36.43 99.42 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 110.597 -3.002 . . . . 0.0 109.516 -179.962 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.49 164.43 12.22 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 128.29 3.494 . . . . 0.0 110.095 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -171.19 3.04 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 125.237 1.586 . . . . 0.0 112.694 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -76.05 -7.75 55.4 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.962 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 33.9 m-85 -80.94 -71.66 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.18 -2.736 . . . . 0.0 110.396 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -150.78 -172.31 4.16 Favored 'General case' 0 N--CA 1.433 -1.286 1 O-C-N 131.891 5.744 . . . . 0.0 112.443 179.871 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' C ' HG21 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.87 -23.46 59.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 113.753 -3.179 . . . . 0.0 104.25 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.439 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 7.4 tp 28.18 80.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.122 2 O-C-N 132.839 6.337 . . . . 0.0 110.676 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.35 120.52 21.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 109.701 -3.408 . . . . 0.0 105.828 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 47' ' ' PHE . 98.2 t -91.12 97.9 7.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 1 O-C-N 132.254 5.971 . . . . 0.0 102.779 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.316 8.9 p -99.98 158.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 1 O-C-N 129.161 4.038 . . . . 0.0 115.226 -179.967 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CE2' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -178.8 -160.45 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 129.543 4.277 . . . . 0.0 112.055 -179.64 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.45 ' CG ' ' HG2' ' A' ' 31' ' ' LYS 0.294 22.9 mt-10 -142.77 63.03 1.4 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.278 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 32' ' ' PHE . 19.5 mt 54.15 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.217 0 O-C-N 128.159 3.412 . . . . 0.0 114.626 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 68' ' ' THR . . . -94.52 82.44 0.94 Allowed Glycine 0 C--O 1.197 -2.2 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.95 111.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 O-C-N 132.747 5.616 . . . . 0.0 112.897 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.87 163.34 14.07 Favored 'General case' 0 C--N 1.365 1.266 1 O-C-N 129.35 4.156 . . . . 0.0 106.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -173.32 143.64 1.11 Allowed 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 114.003 -3.079 . . . . 0.0 116.209 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.52 91.02 4.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.68 147.57 28.37 Favored 'General case' 0 C--O 1.208 -1.094 1 O-C-N 130.192 4.682 . . . . 0.0 112.772 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.61 92.98 4.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 128.16 3.413 . . . . 0.0 103.539 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 2.7 tp -47.36 -86.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 1 O-C-N 130.75 5.031 . . . . 0.0 109.998 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.27 -135.85 0.02 OUTLIER 'General case' 0 C--O 1.248 1.001 0 C-N-CA 116.875 -1.93 . . . . 0.0 109.723 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.46 -37.02 82.3 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.521 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.77 -81.71 0.82 Allowed Glycine 0 CA--C 1.545 1.909 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.41 HG23 HD11 ' A' ' 63' ' ' LEU . 1.4 m 35.7 77.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 1 O-C-N 131.089 4.641 . . . . 0.0 113.426 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -81.99 139.93 34.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 115.31 -2.556 . . . . 0.0 104.36 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HG ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -155.73 44.21 0.44 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 129.264 4.102 . . . . 0.0 111.695 -179.719 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -43.03 106.71 0.07 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 111.866 -2.424 . . . . 0.0 109.525 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -173.48 -161.98 24.63 Favored Glycine 0 N--CA 1.479 1.502 1 C-N-CA 111.133 -5.317 . . . . 0.0 107.474 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 8.3 t -154.36 142.04 19.92 Favored 'General case' 0 C--O 1.247 0.953 0 O-C-N 129.45 3.677 . . . . 0.0 116.585 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.732 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 6.1 m95 -122.28 96.76 5.17 Favored 'General case' 0 C--O 1.196 -1.713 0 CA-C-O 113.192 -3.289 . . . . 0.0 102.595 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.403 HG23 HG22 ' A' ' 66' ' ' THR . 1.2 t -105.72 75.58 1.14 Allowed 'General case' 0 N--CA 1.438 -1.058 2 O-C-N 139.426 10.454 . . . . 0.0 114.404 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.408 ' HB3' HD23 ' A' ' 49' ' ' LEU 0.262 30.7 ttp -46.33 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 2 O-C-N 132.991 6.432 . . . . 0.0 103.778 179.963 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -46.52 90.12 Favored 'General case' 0 C--O 1.211 -0.948 1 O-C-N 132.094 5.871 . . . . 0.0 104.831 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.17 -76.83 0.04 OUTLIER Glycine 0 CA--C 1.549 2.17 0 N-CA-C 105.326 -3.11 . . . . 0.0 105.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -114.34 9.98 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.166 2.921 . . . . 0.0 107.89 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.28 -178.97 3.8 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 128.945 3.903 . . . . 0.0 108.32 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.2 mt -152.69 43.06 0.64 Allowed 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 126.853 2.596 . . . . 0.0 112.772 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 76' ' ' GLY . 15.3 t -69.52 140.1 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 1 CA-C-N 107.85 -4.25 . . . . 0.0 117.525 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' HG11 ' A' ' 75' ' ' VAL . . . 165.8 -142.24 7.55 Favored Glycine 0 CA--C 1.547 2.059 3 CA-C-N 107.232 -4.531 . . . . 0.0 102.545 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.421 ' HG3' HG12 ' A' ' 88' ' ' ILE 0.369 8.0 tttt 175.71 125.29 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.408 1 O-C-N 132.135 5.256 . . . . 0.0 112.517 -179.75 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.732 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -123.0 156.37 34.93 Favored 'General case' 0 C--O 1.204 -1.325 3 O-C-N 130.323 4.764 . . . . 0.0 102.073 -179.151 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' CE ' ' HB2' ' A' ' 86' ' ' GLU 0.335 0.0 OUTLIER -160.68 152.03 19.25 Favored 'General case' 0 N--CA 1.424 -1.766 1 CA-C-N 107.282 -4.508 . . . . 0.0 114.664 179.989 . . . . . . . . 5 4 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.593 ' NE ' ' HZ1' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -105.14 99.59 9.2 Favored 'General case' 0 CA--C 1.556 1.173 0 O-C-N 128.65 3.719 . . . . 0.0 108.344 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -43.46 -29.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 1 O-C-N 129.886 4.491 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -39.75 -56.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.505 1 O-C-N 133.537 6.773 . . . . 0.0 105.444 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -122.43 8.56 9.62 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 129.069 3.981 . . . . 0.0 113.438 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.78 50.84 56.43 Favored Glycine 0 CA--C 1.55 2.26 1 N-CA-C 101.83 -4.508 . . . . 0.0 101.83 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.593 ' HZ1' ' NE ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -82.78 -64.14 1.23 Allowed 'General case' 0 N--CA 1.413 -2.284 1 O-C-N 131.813 5.067 . . . . 0.0 120.188 -179.355 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' HB2' ' CE ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER 81.35 137.66 0.06 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 131.953 5.783 . . . . 0.0 113.415 -177.656 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.424 HD23 ' HG ' ' A' ' 63' ' ' LEU 0.314 0.2 OUTLIER -155.88 34.96 0.35 Allowed 'General case' 0 C--O 1.201 -1.481 1 O-C-N 133.542 6.776 . . . . 0.0 113.02 177.979 . . . . . . . . 5 4 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.421 HG12 ' HG3' ' A' ' 77' ' ' LYS . 75.6 mt -46.54 114.71 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.562 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.584 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HB1' ' CZ2' ' A' ' 67' ' ' TRP . . . -85.61 69.7 10.67 Favored 'General case' 0 C--O 1.196 -1.758 1 O-C-N 130.659 4.974 . . . . 0.0 106.611 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.54 127.23 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 1 O-C-N 133.109 6.506 . . . . 0.0 100.916 178.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.473 ' HD3' ' CA ' ' A' ' 100' ' ' GLN . 2.3 ttp180 -158.17 161.75 37.88 Favored 'General case' 0 C--O 1.191 -2.02 1 C-N-CA 109.702 -4.799 . . . . 0.0 112.876 -177.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.6 145.99 2.11 Favored 'General case' 0 C--N 1.35 0.593 1 O-C-N 131.274 5.359 . . . . 0.0 106.411 179.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 1.1 mm -53.68 111.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 1 O-C-N 130.141 4.651 . . . . 0.0 110.695 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 t -51.97 -61.46 2.25 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 128.253 3.47 . . . . 0.0 116.025 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.48 -94.73 0.12 Allowed Glycine 0 C--O 1.206 -1.626 1 N-CA-C 102.987 -4.045 . . . . 0.0 102.987 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -102.35 32.85 3.36 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 111.027 -2.586 . . . . 0.0 107.905 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.84 175.05 0.87 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 128.669 3.731 . . . . 0.0 105.217 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.519 ' CD2' ' CG ' ' A' ' 100' ' ' GLN . 1.3 tt -109.41 157.48 18.88 Favored 'General case' 0 C--O 1.201 -1.457 1 O-C-N 132.326 6.016 . . . . 0.0 110.034 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 1.0 OUTLIER -116.09 -62.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 1 O-C-N 129.433 4.208 . . . . 0.0 109.608 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.519 ' CG ' ' CD2' ' A' ' 98' ' ' LEU . 23.7 mt-30 83.09 134.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.469 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.0 m -141.88 101.15 3.89 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.989 5.18 . . . . 0.0 112.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -88.49 95.33 10.18 Favored 'General case' 0 C--O 1.203 -1.348 1 O-C-N 129.673 4.358 . . . . 0.0 107.205 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.5 m -62.32 120.03 10.2 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 178.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -170.14 119.68 0.6 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 110.946 -2.843 . . . . 0.0 113.386 -179.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 40.66 -81.16 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.635 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -61.01 -18.52 54.81 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.941 -3.028 . . . . 0.0 110.94 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.2 t 68.22 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 46.18 79.86 0.05 Allowed 'General case' 0 C--N 1.358 0.946 1 O-C-N 129.354 4.159 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.346 . . -117.99 74.64 0.95 Allowed 'General case' 0 C--O 1.199 -1.568 0 O-C-N 126.595 2.434 . . . . 0.0 108.585 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -84.04 153.09 24.02 Favored 'General case' 0 N--CA 1.416 -2.153 1 O-C-N 131.64 5.588 . . . . 0.0 111.665 -179.104 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -179.88 4.12 Favored 'General case' 0 CA--C 1.558 1.274 1 CA-C-N 107.964 -4.198 . . . . 0.0 104.758 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.8 mp -131.08 108.45 15.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 1 O-C-N 129.498 4.249 . . . . 0.0 112.933 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -119.69 179.66 4.16 Favored 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.951 5.157 . . . . 0.0 106.676 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.7 126.02 0.08 Allowed 'General case' 0 N--CA 1.429 -1.477 2 O-C-N 132.3 6.0 . . . . 0.0 113.577 -179.758 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.537 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 18.0 tttt -38.09 -57.07 1.1 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 110.014 -3.266 . . . . 0.0 116.463 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.423 -1.797 0 O-C-N 127.902 3.251 . . . . 0.0 111.371 179.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.135 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' GLY . 2.6 m-85 -76.87 -32.87 57.78 Favored 'General case' 0 CA--C 1.56 1.357 1 O-C-N 131.012 5.195 . . . . 0.0 105.929 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.93 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.418 -2.035 1 O-C-N 129.633 4.333 . . . . 0.0 116.472 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' PHE . . . 164.46 147.43 5.1 Favored Glycine 0 C--N 1.339 0.701 1 C-N-CA 112.22 -4.8 . . . . 0.0 106.612 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.1 p -61.46 166.2 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 115.729 -2.389 . . . . 0.0 108.564 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.528 ' CE3' ' HG3' ' A' ' 115' ' ' LYS 0.25 73.4 m95 -139.46 158.74 43.63 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 111.758 -3.972 . . . . 0.0 110.43 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.498 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 11.4 mtmt 51.02 -178.25 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.837 0 O-C-N 128.571 3.67 . . . . 0.0 117.141 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.308 1.2 t 21.77 112.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.534 3 O-C-N 134.303 7.252 . . . . 0.0 114.78 174.931 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.16 75.92 2.62 Favored 'General case' 0 C--N 1.368 1.412 1 O-C-N 116.047 -4.158 . . . . 0.0 110.035 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -169.04 77.69 0.11 Allowed 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.993 -1.067 . . . . 0.0 111.57 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -121.2 -18.8 7.31 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 115.914 -1.994 . . . . 0.0 113.371 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 36.35 75.35 0.06 Allowed 'General case' 0 C--O 1.245 0.833 0 O-C-N 127.775 3.172 . . . . 0.0 112.205 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.41 -161.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 O-C-N 128.138 3.399 . . . . 0.0 108.538 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -86.92 85.87 7.29 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.706 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.1 22.89 0.25 Allowed 'General case' 0 C--N 1.363 1.168 0 C-N-CA 115.494 -2.482 . . . . 0.0 109.923 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.03 146.18 18.3 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.16 -42.94 2.45 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 116.445 -1.74 . . . . 0.0 108.897 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.26 -66.91 0.87 Allowed 'General case' 0 C--N 1.356 0.875 0 O-C-N 124.726 1.266 . . . . 0.0 111.65 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -179.47 0.15 Allowed 'General case' 0 C--O 1.221 -0.433 0 O-C-N 127.918 3.261 . . . . 0.0 110.521 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -98.42 -74.62 0.58 Allowed 'General case' 0 C--N 1.367 1.363 0 O-C-N 126.031 2.082 . . . . 0.0 112.098 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -167.65 170.68 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.401 0.0 OUTLIER 167.98 153.97 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.626 1 O-C-N 132.317 6.01 . . . . 0.0 100.668 -179.66 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 8.0 mt -112.59 170.33 8.26 Favored 'General case' 0 CA--C 1.551 0.99 1 O-C-N 133.266 6.604 . . . . 0.0 101.028 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 25' ' ' ILE . 1.6 m -156.14 -81.6 0.07 Allowed 'General case' 0 C--O 1.199 -1.577 1 O-C-N 130.218 4.699 . . . . 0.0 106.264 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.451 ' N ' HG23 ' A' ' 24' ' ' THR . 2.6 mp 70.91 129.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.385 0 CA-C-N 109.142 -3.663 . . . . 0.0 109.733 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.0 m -162.55 80.19 0.51 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.1 148.34 36.23 Favored 'General case' 0 C--N 1.357 0.918 1 CA-C-N 106.08 -5.055 . . . . 0.0 115.246 -179.953 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.83 86.42 2.5 Favored 'General case' 0 CA--C 1.555 1.155 0 O-C-N 128.29 3.494 . . . . 0.0 103.412 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.13 -128.91 8.7 Favored Glycine 0 CA--C 1.552 2.365 2 C-N-CA 110.839 -5.458 . . . . 0.0 102.821 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.56 55.95 0.98 Allowed 'General case' 0 N--CA 1.437 -1.111 1 O-C-N 131.083 4.637 . . . . 0.0 109.252 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -146.84 122.56 10.54 Favored 'General case' 0 CA--C 1.552 1.041 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.551 ' CE2' ' HG2' ' A' ' 69' ' ' MET . 3.8 m-85 -119.48 171.09 8.59 Favored 'General case' 0 C--O 1.211 -0.933 2 O-C-N 130.111 4.632 . . . . 0.0 99.061 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.68 127.88 5.57 Favored 'General case' 0 C--O 1.249 1.058 3 O-C-N 136.284 8.49 . . . . 0.0 98.674 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG13 ' HG3' ' A' ' 36' ' ' GLU 0.369 2.4 t -101.56 146.89 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HD2' ' CB ' ' A' ' 24' ' ' THR 0.27 12.7 ttmt -91.67 48.57 1.47 Allowed 'General case' 0 C--O 1.195 -1.791 0 CA-C-O 127.491 3.52 . . . . 0.0 115.145 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG3' HG13 ' A' ' 34' ' ' VAL 0.284 7.3 mt-10 -69.01 88.53 0.4 Allowed 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 m -86.61 128.02 34.96 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 127.222 2.826 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.6 -161.98 0.92 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 114.683 -2.807 . . . . 0.0 115.128 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -96.26 -7.21 36.1 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 111.961 -2.382 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -92.28 -65.9 0.97 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 114.572 -2.851 . . . . 0.0 107.265 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.98 -155.69 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 128.654 3.721 . . . . 0.0 110.616 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -75.66 -67.44 0.67 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 112.263 -3.775 . . . . 0.0 103.604 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.251 0.4 OUTLIER 72.42 75.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.422 2 CA-C-O 134.919 7.057 . . . . 0.0 105.52 179.76 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.05 151.84 23.38 Favored 'General case' 0 C--N 1.373 1.619 1 CA-C-N 107.182 -4.554 . . . . 0.0 105.558 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.39 117.23 53.33 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 1 O-C-N 131.104 5.253 . . . . 0.0 102.734 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.325 9.4 p -115.11 155.42 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 115.798 -2.361 . . . . 0.0 110.977 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -166.79 177.88 6.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 127.667 3.104 . . . . 0.0 111.442 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -119.35 67.5 0.8 Allowed 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 115.326 -2.55 . . . . 0.0 115.169 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 tp 23.32 75.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.812 1 O-C-N 130.148 4.655 . . . . 0.0 116.237 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.87 57.56 0.49 Allowed Glycine 0 CA--C 1.561 2.911 1 CA-C-O 112.545 -4.475 . . . . 0.0 104.452 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -150.67 120.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 O-C-N 134.662 6.742 . . . . 0.0 114.932 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.82 151.99 24.86 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 128.065 3.353 . . . . 0.0 107.913 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 21.4 p90 -173.66 162.71 4.16 Favored 'General case' 0 C--N 1.37 1.492 1 O-C-N 131.74 5.65 . . . . 0.0 115.006 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.68 141.41 37.17 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -154.19 102.97 2.5 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 116.732 -1.987 . . . . 0.0 109.683 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.67 95.17 2.8 Favored 'General case' 0 CA--C 1.539 0.519 1 O-C-N 129.106 4.004 . . . . 0.0 104.066 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.13 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 1 O-C-N 132.56 6.163 . . . . 0.0 109.773 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.72 177.05 3.75 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 116.584 -2.046 . . . . 0.0 109.812 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.38 66.26 4.79 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 128.543 3.652 . . . . 0.0 111.607 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.23 -38.43 0.17 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 115.243 -2.976 . . . . 0.0 108.378 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.4 p -52.79 166.54 0.2 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 129.336 3.61 . . . . 0.0 114.021 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -165.02 49.14 0.1 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 125.413 2.53 . . . . 0.0 107.906 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 mp -69.37 125.72 27.56 Favored 'General case' 0 C--N 1.367 1.347 0 CA-C-N 110.237 -3.165 . . . . 0.0 107.994 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 m -126.82 98.75 5.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.538 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.44 -164.9 18.45 Favored Glycine 0 N--CA 1.478 1.449 1 C-N-CA 111.917 -4.944 . . . . 0.0 104.475 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.401 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 8.8 t -140.56 150.67 43.95 Favored 'General case' 0 N--CA 1.428 -1.56 1 O-C-N 131.073 4.631 . . . . 0.0 116.585 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.489 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 9.0 m95 -129.43 122.89 30.3 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-O 115.476 -2.202 . . . . 0.0 105.474 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.61 97.51 4.09 Favored 'General case' 0 C--O 1.203 -1.375 1 O-C-N 136.059 8.349 . . . . 0.0 110.626 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.551 ' HG2' ' CE2' ' A' ' 32' ' ' PHE 0.254 9.2 tpp -74.24 137.98 43.36 Favored 'General case' 0 CA--C 1.512 -0.49 1 O-C-N 132.181 5.926 . . . . 0.0 105.756 179.963 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -141.28 120.64 13.11 Favored 'General case' 0 C--O 1.218 -0.576 1 O-C-N 129.178 4.049 . . . . 0.0 105.427 -179.921 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.44 -98.11 0.02 OUTLIER Glycine 0 CA--C 1.557 2.682 1 O-C-N 129.521 4.263 . . . . 0.0 106.55 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 51.14 1.82 Allowed 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 129.703 3.825 . . . . 0.0 109.87 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 70' ' ' GLU . 1.5 mtpt -137.35 160.14 39.93 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 128.409 3.568 . . . . 0.0 108.65 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.6 mt -144.23 64.72 1.3 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.57 147.0 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 CA-C-O 129.778 4.608 . . . . 0.0 115.577 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.19 -147.3 15.71 Favored Glycine 0 CA--C 1.563 3.063 1 CA-C-N 107.183 -4.553 . . . . 0.0 103.641 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.473 ' CG ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 163.73 139.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.651 1 O-C-N 134.045 6.38 . . . . 0.0 112.86 -179.835 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.538 ' CG ' ' HA3' ' A' ' 65' ' ' GLY . 5.5 m-85 -123.52 -169.49 1.95 Allowed 'General case' 0 C--O 1.204 -1.339 2 O-C-N 134.324 7.265 . . . . 0.0 104.648 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.316 0.0 OUTLIER -169.96 -145.68 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 109.801 -3.363 . . . . 0.0 115.162 -179.281 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 47.0 ttt180 -168.12 90.29 0.29 Allowed 'General case' 0 C--N 1.352 0.679 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.884 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -32.51 -33.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 127.621 3.076 . . . . 0.0 113.014 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -53.44 -49.5 67.23 Favored 'General case' 0 CA--C 1.508 -0.636 1 O-C-N 129.727 4.392 . . . . 0.0 111.894 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.1 19.08 2.98 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-O 113.66 -3.067 . . . . 0.0 117.908 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 63.15 55.28 27.14 Favored Glycine 0 C--O 1.2 -1.976 1 N-CA-C 102.435 -4.266 . . . . 0.0 102.435 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 6.9 tppt? -80.94 -81.82 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 2 O-C-N 132.131 5.253 . . . . 0.0 118.603 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.49 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 78.2 mt-10 86.95 97.62 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.637 1 O-C-N 131.036 5.21 . . . . 0.0 109.832 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.9 tp -124.08 53.38 1.41 Allowed 'General case' 0 C--O 1.201 -1.478 1 O-C-N 138.185 9.678 . . . . 0.0 108.607 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.473 HG12 ' CG ' ' A' ' 77' ' ' LYS . 25.5 mt -78.61 -178.0 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.176 2 CA-C-N 107.247 -4.524 . . . . 0.0 103.691 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.54 88.94 0.66 Allowed 'General case' 0 C--O 1.195 -1.794 1 O-C-N 131.804 5.69 . . . . 0.0 108.732 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.65 121.0 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 O-C-N 126.396 2.31 . . . . 0.0 107.583 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.3 tpt180 -170.63 163.04 8.11 Favored 'General case' 0 C--O 1.186 -2.243 0 C-N-CA 111.892 -3.923 . . . . 0.0 112.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.419 ' HG2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -150.87 132.22 14.6 Favored 'General case' 0 N--CA 1.426 -1.626 1 O-C-N 132.035 5.835 . . . . 0.0 107.086 179.226 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -48.18 129.28 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 1 O-C-N 132.509 6.131 . . . . 0.0 109.149 179.976 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.9 p -78.92 -67.98 0.7 Allowed 'General case' 0 C--O 1.247 0.94 0 O-C-N 127.654 3.096 . . . . 0.0 116.13 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.17 -66.92 0.33 Allowed Glycine 0 CA--C 1.545 1.95 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.34 27.73 1.24 Allowed 'General case' 0 C--N 1.35 0.619 0 CA-C-N 110.501 -2.85 . . . . 0.0 107.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.73 119.28 2.9 Favored 'General case' 0 N--CA 1.433 -1.289 0 O-C-N 128.356 3.535 . . . . 0.0 109.642 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 121.67 28.62 Favored 'General case' 0 CA--C 1.557 1.231 1 O-C-N 129.771 4.42 . . . . 0.0 108.688 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.471 ' CG2' ' HB2' ' A' ' 110' ' ' LYS . 30.9 mt -74.04 -80.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.491 2 CA-C-O 111.285 -4.198 . . . . 0.0 108.206 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 99.75 112.6 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.394 2 O-C-N 136.054 8.346 . . . . 0.0 98.127 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 110' ' ' LYS . 30.9 p -82.95 -32.07 27.33 Favored 'General case' 0 N--CA 1.404 -2.74 1 O-C-N 130.306 4.754 . . . . 0.0 119.906 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 104' ' ' TYR . 62.9 m-85 60.24 70.22 0.64 Allowed 'General case' 0 CA--C 1.565 1.538 0 O-C-N 128.973 3.921 . . . . 0.0 103.558 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.6 m -69.22 73.7 0.32 Allowed 'General case' 0 C--O 1.215 -0.712 1 O-C-N 132.169 5.918 . . . . 0.0 106.206 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' TYR . 3.3 t80 -88.85 116.74 27.34 Favored 'General case' 0 CA--C 1.495 -1.144 1 CA-C-N 108.261 -4.063 . . . . 0.0 112.863 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 61.0 46.04 8.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 112.817 -1.992 . . . . 0.0 112.708 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.82 4.12 57.44 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-O 124.769 2.316 . . . . 0.0 117.528 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.15 137.2 53.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 119.558 -2.143 . . . . 0.0 115.051 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.93 132.17 43.12 Favored 'General case' 0 C--N 1.366 1.3 1 O-C-N 129.206 4.066 . . . . 0.0 105.661 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.354 . . -138.85 44.0 2.07 Favored 'General case' 0 N--CA 1.424 -1.764 0 O-C-N 128.368 3.542 . . . . 0.0 112.783 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 2.7 pttp -74.73 168.99 18.76 Favored 'General case' 0 N--CA 1.419 -1.989 1 O-C-N 133.308 6.63 . . . . 0.0 109.047 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -145.45 -90.62 0.1 Allowed 'General case' 0 CA--C 1.556 1.208 1 O-C-N 129.292 4.12 . . . . 0.0 100.632 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -174.63 179.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 111.377 -2.647 . . . . 0.0 108.974 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.498 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 8.8 m-85 166.49 178.55 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 1 O-C-N 136.157 8.411 . . . . 0.0 104.926 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.514 ' CB ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.72 -154.17 0.33 Allowed 'General case' 0 C--O 1.198 -1.607 1 O-C-N 131.795 5.684 . . . . 0.0 111.515 178.683 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HG3' ' CE3' ' A' ' 6' ' ' TRP 0.253 29.9 tttt -110.53 -138.39 0.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.255 7.7 tp10 . . . . . 0 N--CA 1.442 -0.841 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.441 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -145.41 -48.74 0.23 Allowed 'General case' 0 CA--C 1.56 1.352 0 O-C-N 127.826 3.204 . . . . 0.0 105.304 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -35.36 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 129.785 4.428 . . . . 0.0 117.878 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 153.13 175.56 24.68 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 115.413 -3.279 . . . . 0.0 105.297 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.285 3.6 p -90.78 176.8 6.51 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 113.274 -3.37 . . . . 0.0 103.844 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.54 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 28.4 m95 -147.21 160.37 42.55 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-O 112.592 -3.575 . . . . 0.0 112.435 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 2.5 mtmt 50.93 -178.89 0.02 OUTLIER 'General case' 0 C--O 1.195 -1.784 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.26 0.5 OUTLIER 28.33 36.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 3 CA-C-O 135.409 7.29 . . . . 0.0 119.675 174.899 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.19 -53.18 15.32 Favored 'General case' 0 C--N 1.373 1.63 1 CA-C-N 107.873 -4.24 . . . . 0.0 103.792 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.0 103.44 15.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.188 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.21 113.0 25.65 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.074 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.86 44.91 0.83 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.49 -164.26 0.98 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 128.061 3.351 . . . . 0.0 105.009 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -92.68 19.94 6.94 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 111.567 -2.56 . . . . 0.0 110.833 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 t 67.45 101.82 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.719 1.247 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.29 155.59 18.53 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 115.861 -3.066 . . . . 0.0 107.559 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.83 -53.16 16.33 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -155.06 51.98 0.61 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 124.391 1.057 . . . . 0.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -106.83 21.04 18.15 Favored 'General case' 0 C--O 1.208 -1.091 0 O-C-N 128.504 3.627 . . . . 0.0 109.305 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -93.27 119.07 32.01 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 111.331 -2.668 . . . . 0.0 110.529 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 163.45 14.91 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 109.526 -3.488 . . . . 0.0 104.793 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER -171.72 150.54 2.71 Favored 'General case' 0 CA--C 1.563 1.464 1 O-C-N 133.302 6.626 . . . . 0.0 102.228 179.843 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.4 mt -115.32 157.1 24.3 Favored 'General case' 0 CA--C 1.565 1.546 4 O-C-N 132.916 6.385 . . . . 0.0 97.666 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.56 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.9 m 172.09 96.46 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.249 1 O-C-N 132.768 6.292 . . . . 0.0 102.745 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' CG2' ' CD1' ' A' ' 32' ' ' PHE . 3.0 mp -114.66 112.35 39.72 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 108.96 -3.746 . . . . 0.0 109.962 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 35.9 m -155.07 79.68 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 127.74 3.15 . . . . 0.0 108.44 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.497 ' CB ' ' C ' ' A' ' 31' ' ' LYS . 4.6 mm-40 -88.08 -98.62 0.09 Allowed 'General case' 0 C--N 1.355 0.845 3 CA-C-N 105.865 -5.152 . . . . 0.0 111.634 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.88 -6.17 4.51 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 128.088 3.367 . . . . 0.0 106.47 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.31 -27.4 8.11 Favored Glycine 0 CA--C 1.546 1.969 1 N-CA-C 99.189 -5.565 . . . . 0.0 99.189 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -25.67 6.0 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 111.737 -3.983 . . . . 0.0 111.627 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' C ' ' CB ' ' A' ' 27' ' ' GLN . 2.6 mttm -101.56 178.89 4.51 Favored 'General case' 0 C--O 1.25 1.085 1 N-CA-C 97.596 -4.964 . . . . 0.0 97.596 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -176.64 139.38 0.31 Allowed 'General case' 0 C--O 1.19 -2.076 1 N-CA-C 97.217 -5.105 . . . . 0.0 97.217 178.875 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.67 119.88 25.5 Favored 'General case' 0 C--O 1.249 1.028 3 O-C-N 136.446 8.591 . . . . 0.0 98.577 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.364 1.2 t -84.6 128.41 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 1 N-CA-C 99.747 -4.168 . . . . 0.0 99.747 -179.944 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.295 5.3 tttm -67.72 -8.88 38.92 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 120.775 3.62 . . . . 0.0 120.775 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HB2' ' CG1' ' A' ' 34' ' ' VAL 0.339 3.9 tt0 -29.37 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 108.499 -3.955 . . . . 0.0 109.965 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -80.45 155.65 26.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 114.228 -2.989 . . . . 0.0 111.035 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.6 t -121.57 -151.82 0.49 Allowed 'General case' 0 N--CA 1.442 -0.827 0 O-C-N 127.527 3.017 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.13 -29.56 11.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 126.198 2.186 . . . . 0.0 108.937 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.507 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 10.2 m-85 -66.5 -60.49 2.69 Favored 'General case' 0 CA--C 1.551 1.013 1 O-C-N 130.654 4.971 . . . . 0.0 105.162 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.507 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -151.58 -163.28 1.71 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 128.972 3.92 . . . . 0.0 113.54 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.39 -16.46 52.14 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 121.431 1.923 . . . . 0.0 109.939 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 41' ' ' ARG . 8.8 tt 20.05 94.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.266 2 O-C-N 132.336 6.022 . . . . 0.0 111.972 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 152.1 22.0 Favored 'General case' 0 C--N 1.366 1.304 0 O-C-N 117.001 -3.562 . . . . 0.0 104.198 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -126.79 91.64 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.93 1 O-C-N 130.469 4.855 . . . . 0.0 103.707 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.29 0.7 OUTLIER -92.18 158.89 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 1 C-N-CA 111.052 -4.259 . . . . 0.0 115.764 -179.993 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -154.66 -177.0 6.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 O-C-N 129.011 3.944 . . . . 0.0 111.303 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HG3' ' CE ' ' A' ' 31' ' ' LYS 0.258 1.2 tt0 -130.22 31.54 4.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.267 3.48 . . . . 0.0 111.805 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.83 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 1 O-C-N 133.749 6.906 . . . . 0.0 113.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.51 52.14 3.28 Favored Glycine 0 CA--C 1.548 2.118 0 CA-C-O 113.797 -3.779 . . . . 0.0 104.085 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.31 104.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 1 O-C-N 134.851 6.853 . . . . 0.0 113.531 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 145.57 33.63 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 110.45 -3.068 . . . . 0.0 109.563 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.58 124.01 7.72 Favored 'General case' 0 C--N 1.372 1.577 2 O-C-N 129.733 4.396 . . . . 0.0 116.131 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.6 73.53 4.36 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 121.75 41.27 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 127.564 3.04 . . . . 0.0 112.375 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -74.47 114.84 13.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 111.853 -3.939 . . . . 0.0 106.54 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.43 155.92 20.7 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 127.229 2.831 . . . . 0.0 112.408 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.41 22.93 3.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 115.721 -2.085 . . . . 0.0 114.026 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t70 39.14 38.7 0.34 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 128.957 3.911 . . . . 0.0 112.16 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.81 -58.03 0.01 OUTLIER Glycine 0 CA--C 1.543 1.786 0 N-CA-C 105.725 -2.95 . . . . 0.0 105.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -77.07 149.48 35.77 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 127.8 2.706 . . . . 0.0 114.274 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -143.31 66.24 1.31 Allowed 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.27 117.67 5.05 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 129.093 3.996 . . . . 0.0 107.255 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -123.57 109.55 13.92 Favored 'General case' 0 C--O 1.205 -1.283 0 O-C-N 126.404 2.315 . . . . 0.0 108.65 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 178.13 -146.11 7.31 Favored Glycine 0 N--CA 1.479 1.558 1 C-N-CA 113.838 -4.03 . . . . 0.0 103.727 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.312 15.2 t -176.16 141.44 0.44 Allowed 'General case' 0 CA--C 1.486 -1.485 1 O-C-N 131.247 4.733 . . . . 0.0 119.58 -178.553 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.722 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.5 m95 -107.5 145.45 33.08 Favored 'General case' 0 C--O 1.195 -1.769 1 O-C-N 115.971 -4.206 . . . . 0.0 100.5 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 p -126.56 25.21 6.52 Favored 'General case' 0 N--CA 1.428 -1.526 2 O-C-N 135.278 7.861 . . . . 0.0 115.21 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 3.65 105.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.887 1 O-C-N 137.638 9.336 . . . . 0.0 108.611 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 73' ' ' LYS . 4.5 mp0 -114.0 -170.74 1.77 Allowed 'General case' 0 C--O 1.215 -0.713 1 O-C-N 129.625 4.328 . . . . 0.0 110.391 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.41 105.83 0.81 Allowed Glycine 0 CA--C 1.541 1.707 0 O-C-N 127.354 2.909 . . . . 0.0 108.51 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 39.71 55.56 2.43 Favored 'General case' 0 C--O 1.238 0.491 1 O-C-N 131.496 4.88 . . . . 0.0 110.046 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -140.36 -174.27 3.9 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 127.021 2.701 . . . . 0.0 109.772 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ARG . 1.1 mt -161.01 30.69 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 O-C-N 126.391 2.307 . . . . 0.0 115.507 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 t -59.27 137.14 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 2 O-C-N 131.24 5.338 . . . . 0.0 114.42 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' HA3' ' CZ3' ' A' ' 67' ' ' TRP . . . 154.22 -139.94 7.14 Favored Glycine 0 C--O 1.197 -2.186 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 78' ' ' PHE 0.333 20.1 tttm -177.63 176.51 1.24 Allowed 'General case' 0 C--N 1.371 1.531 1 O-C-N 133.164 5.861 . . . . 0.0 110.145 -178.682 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 22.4 m-85 -176.06 172.62 2.36 Favored 'General case' 0 C--O 1.212 -0.92 2 O-C-N 134.178 7.174 . . . . 0.0 102.602 175.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG2' ' C ' ' A' ' 85' ' ' LYS 0.296 13.7 ttmt -160.22 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.825 1 CA-C-N 105.076 -5.511 . . . . 0.0 110.135 179.962 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' CA ' ' A' ' 84' ' ' GLY 0.272 5.9 ptt180 175.61 56.91 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 117.267 -1.349 . . . . 0.0 111.336 178.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.7 t -41.46 87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.558 2 O-C-N 134.769 7.543 . . . . 0.0 108.521 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 t70 170.31 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.107 1 O-C-N 130.597 4.935 . . . . 0.0 107.348 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.93 -0.38 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 129.017 3.948 . . . . 0.0 115.377 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -101.93 -35.01 4.12 Favored Glycine 0 CA--C 1.54 1.649 1 C-N-CA 113.036 -4.411 . . . . 0.0 105.546 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.48 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 75.43 -174.76 0.12 Allowed 'General case' 0 CA--C 1.495 -1.145 1 O-C-N 131.292 4.76 . . . . 0.0 114.063 179.837 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.258 6.6 mt-10 -34.41 142.01 0.05 OUTLIER 'General case' 0 C--O 1.198 -1.623 1 O-C-N 130.077 4.611 . . . . 0.0 116.334 -177.297 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 HD13 ' HD3' ' A' ' 80' ' ' ARG . 40.4 mt -150.65 37.22 0.65 Allowed 'General case' 0 C--O 1.194 -1.829 1 O-C-N 132.969 6.418 . . . . 0.0 110.074 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.437 HG12 ' HG3' ' A' ' 77' ' ' LYS . 21.5 mt -62.27 152.39 6.92 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 3 O-C-N 130.053 4.596 . . . . 0.0 99.54 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.464 ' HB1' ' CH2' ' A' ' 67' ' ' TRP . . . -124.98 87.15 2.66 Favored 'General case' 0 C--O 1.197 -1.7 1 O-C-N 135.58 8.05 . . . . 0.0 110.363 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.23 107.85 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 114.892 -2.723 . . . . 0.0 105.232 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -168.53 164.27 12.49 Favored 'General case' 0 C--O 1.194 -1.868 1 C-N-CA 111.097 -4.241 . . . . 0.0 115.717 -179.519 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -151.77 143.65 23.76 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 128.6 3.687 . . . . 0.0 104.088 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 0.3 OUTLIER -58.35 81.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 1 O-C-N 133.176 6.548 . . . . 0.0 110.135 -179.985 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.62 -114.72 0.81 Allowed Glycine 0 CA--C 1.55 2.223 0 N-CA-C 104.528 -3.429 . . . . 0.0 104.528 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -113.86 24.74 11.8 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 109.688 -3.256 . . . . 0.0 108.893 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.91 165.21 32.61 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 110.963 -2.835 . . . . 0.0 106.756 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD13 ' CD1' ' A' ' 93' ' ' ILE . 5.3 tt -110.48 121.23 44.8 Favored 'General case' 0 N--CA 1.447 -0.582 1 O-C-N 130.162 4.664 . . . . 0.0 109.826 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 91' ' ' ARG . 1.7 mt -71.11 -55.79 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 109.47 -3.513 . . . . 0.0 107.724 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' N ' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 73.65 105.68 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 1 O-C-N 132.27 5.981 . . . . 0.0 103.97 -179.915 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.402 HG21 ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.21 91.03 3.48 Favored 'General case' 0 N--CA 1.424 -1.763 2 O-C-N 132.408 6.067 . . . . 0.0 113.141 179.671 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -70.77 125.5 27.01 Favored 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 109.309 -4.956 . . . . 0.0 105.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.9 m -96.53 68.01 2.47 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 127.811 3.672 . . . . 0.0 105.982 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 2.0 t80 -65.06 156.68 30.7 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 109.803 -3.362 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 5.0 tp10 -47.76 104.55 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 112.848 -1.978 . . . . 0.0 115.681 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.8 83.78 Favored Glycine 0 C--N 1.347 1.178 0 C-N-CA 117.799 -2.143 . . . . 0.0 116.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.269 2.5 t -136.93 169.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -143.15 58.1 1.4 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.422 . . -98.42 152.49 19.44 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 114.658 -2.817 . . . . 0.0 111.287 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.402 ' HG2' HG21 ' A' ' 101' ' ' THR . 0.2 OUTLIER -109.95 -163.21 0.84 Allowed 'General case' 0 N--CA 1.444 -0.747 1 O-C-N 134.029 7.081 . . . . 0.0 107.359 -179.771 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -57.63 0.74 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 110.469 -3.059 . . . . 0.0 105.801 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.284 4.5 mt 86.88 115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.027 1 O-C-N 129.386 4.179 . . . . 0.0 110.096 -179.847 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 9.1 m-85 -142.62 179.65 6.85 Favored 'General case' 0 N--CA 1.417 -2.081 1 O-C-N 130.091 4.619 . . . . 0.0 107.167 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -150.36 -160.92 1.24 Allowed 'General case' 0 C--O 1.196 -1.756 1 O-C-N 131.97 5.793 . . . . 0.0 111.836 179.501 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 11.7 tttt -123.17 152.61 41.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 111.812 -2.449 . . . . 0.0 112.549 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.419 -1.989 1 O-C-N 129.389 4.18 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 116.289 -1.815 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 168.01 -40.55 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.345 1 O-C-N 131.819 5.7 . . . . 0.0 103.51 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.95 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.777 1 O-C-N 131.027 5.204 . . . . 0.0 117.415 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.8 148.16 5.04 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 114.893 -3.17 . . . . 0.0 106.265 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.295 36.0 p -68.28 167.88 13.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 112.361 -3.735 . . . . 0.0 110.094 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.546 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 73.1 m95 -141.27 167.69 21.57 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-O 111.116 -4.278 . . . . 0.0 113.487 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.554 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 5.3 mtmt 36.85 171.84 0.0 OUTLIER 'General case' 0 C--O 1.19 -2.057 1 O-C-N 133.813 6.946 . . . . 0.0 119.182 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' A' ' 20' ' ' ASN 0.287 0.9 OUTLIER -1.13 134.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.321 3 CA-C-N 105.262 -5.426 . . . . 0.0 119.331 174.941 . . . . . . . . 5 4 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.95 -159.31 0.74 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 108.52 -3.946 . . . . 0.0 102.496 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.2 119.34 5.88 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-O 124.015 1.864 . . . . 0.0 111.41 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -150.94 73.85 1.13 Allowed 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.495 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.35 75.87 1.68 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.827 -1.533 . . . . 0.0 107.795 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.68 68.85 0.13 Allowed 'General case' 0 C--N 1.359 1.018 0 O-C-N 127.47 2.981 . . . . 0.0 106.603 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.22 54.03 10.92 Favored 'General case' 0 C--O 1.214 -0.814 1 CA-C-N 108.16 -4.109 . . . . 0.0 110.294 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.69 -172.46 0.19 Allowed 'General case' 0 C--N 1.347 0.498 0 O-C-N 126.641 2.463 . . . . 0.0 108.225 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.26 -92.14 0.09 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 117.512 -2.28 . . . . 0.0 113.008 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.02 133.59 54.1 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 116.151 -1.88 . . . . 0.0 106.431 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -88.81 90.47 8.43 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 126.951 2.657 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.74 36.09 0.7 Allowed 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.027 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 5.8 p-10 -86.19 172.92 10.16 Favored 'General case' 0 C--O 1.214 -0.784 1 O-C-N 131.987 5.804 . . . . 0.0 112.377 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.23 -165.05 1.11 Allowed 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 110.731 -2.941 . . . . 0.0 105.491 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.432 31.0 mttt 145.07 170.74 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.604 1 O-C-N 134.015 7.072 . . . . 0.0 101.018 -178.847 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' CA ' ' HB2' ' A' ' 6' ' ' TRP . 7.3 mt -141.83 -178.63 5.76 Favored 'General case' 0 CA--C 1.567 1.604 3 O-C-N 133.148 6.53 . . . . 0.0 96.985 177.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.481 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 18.7 m -166.65 -90.04 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 128.418 3.574 . . . . 0.0 106.173 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.408 ' CG1' ' HA ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER 70.72 130.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-N 109.752 -3.385 . . . . 0.0 109.316 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.4 m -168.27 73.99 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 113.185 -3.406 . . . . 0.0 103.583 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -37.38 138.96 0.28 Allowed 'General case' 0 N--CA 1.436 -1.131 2 O-C-N 133.483 6.74 . . . . 0.0 115.576 -179.923 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -92.9 0.36 Allowed 'General case' 0 C--N 1.35 0.618 1 O-C-N 131.017 5.198 . . . . 0.0 106.505 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.55 66.5 0.24 Allowed Glycine 0 CA--C 1.55 2.266 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 68.2 14.47 9.25 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -93.88 132.7 38.05 Favored 'General case' 0 CA--C 1.552 1.047 1 CA-C-O 111.213 -4.232 . . . . 0.0 100.827 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.517 ' CD1' HD21 ' A' ' 49' ' ' LEU . 13.0 m-85 -110.59 142.17 42.8 Favored 'General case' 0 C--O 1.191 -2.004 2 N-CA-C 96.858 -5.238 . . . . 0.0 96.858 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.91 108.44 9.83 Favored 'General case' 0 CA--C 1.496 -1.116 2 O-C-N 134.575 7.422 . . . . 0.0 100.744 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' CG1' ' A' ' 25' ' ' ILE 0.42 4.2 t -81.57 150.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 112.635 -3.626 . . . . 0.0 103.772 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.255 3.6 ttmt -98.99 36.88 1.61 Allowed 'General case' 0 N--CA 1.425 -1.711 1 CA-C-O 133.049 6.166 . . . . 0.0 116.949 179.792 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.335 28.1 tt0 -57.78 97.6 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 1 CA-C-N 107.455 -4.43 . . . . 0.0 107.512 -179.804 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.0 m -99.59 134.06 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.97 3.294 . . . . 0.0 106.767 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.23 -162.27 1.23 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 127.316 2.885 . . . . 0.0 112.807 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -57.46 -41.37 80.42 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -87.38 82.66 7.49 Favored 'General case' 0 N--CA 1.435 -1.198 2 O-C-N 131.35 5.406 . . . . 0.0 106.487 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 35.14 -143.7 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 131.284 5.365 . . . . 0.0 114.878 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -77.29 -70.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 113.109 -3.436 . . . . 0.0 106.073 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 57' ' ' LEU 0.25 0.2 OUTLIER 66.17 104.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 1 CA-C-O 132.302 5.81 . . . . 0.0 104.3 179.623 . . . . . . . . 5 4 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.83 154.23 18.17 Favored 'General case' 0 C--N 1.372 1.586 0 CA-C-N 109.673 -3.421 . . . . 0.0 106.863 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 107.61 17.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 1 O-C-N 131.157 5.286 . . . . 0.0 102.498 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.461 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.374 9.9 p -112.23 154.03 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 114.049 -3.06 . . . . 0.0 113.422 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -163.73 -163.05 0.76 Allowed 'General case' 0 N--CA 1.442 -0.829 1 O-C-N 131.657 5.598 . . . . 0.0 114.602 -179.946 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -136.28 53.38 1.93 Allowed 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.355 2.284 . . . . 0.0 114.02 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.517 HD21 ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER 52.3 19.52 1.14 Allowed 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 128.701 3.751 . . . . 0.0 115.736 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.55 71.75 0.02 OUTLIER Glycine 0 CA--C 1.546 1.978 0 N-CA-C 105.091 -3.203 . . . . 0.0 105.091 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.15 -49.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 130.159 4.094 . . . . 0.0 112.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.03 131.72 0.05 Allowed 'General case' 0 C--O 1.202 -1.441 1 O-C-N 129.426 4.204 . . . . 0.0 105.724 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -164.82 148.69 8.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 129.038 3.961 . . . . 0.0 117.09 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.54 115.77 30.92 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 100.468 -3.901 . . . . 0.0 100.468 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -139.23 128.14 23.57 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 127.972 3.295 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.49 112.6 15.71 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 115.417 -2.513 . . . . 0.0 105.692 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 HG22 ' A' ' 43' ' ' ILE . 3.5 mm? -66.49 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 O-C-N 126.501 2.376 . . . . 0.0 111.386 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.44 -142.5 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.662 -1.161 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.03 -14.25 19.52 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 124.827 1.329 . . . . 0.0 111.669 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.47 74.36 0.34 Allowed Glycine 0 CA--C 1.562 3.007 0 O-C-N 128.591 3.682 . . . . 0.0 104.67 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.8 p -150.61 148.63 28.87 Favored 'General case' 0 N--CA 1.433 -1.28 1 O-C-N 131.985 5.167 . . . . 0.0 112.81 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -147.97 48.81 1.06 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 127.12 2.763 . . . . 0.0 108.721 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.05 166.21 14.24 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 113.549 -3.26 . . . . 0.0 107.514 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -161.92 118.32 2.07 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 110.302 -3.135 . . . . 0.0 104.439 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.24 -130.26 1.39 Allowed Glycine 0 CA--C 1.529 0.936 1 C-N-CA 110.782 -5.485 . . . . 0.0 108.401 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.595 ' C ' ' CG ' ' A' ' 67' ' ' TRP . 3.3 t 170.6 139.01 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.708 1 O-C-N 132.665 5.568 . . . . 0.0 110.472 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 78' ' ' PHE . 46.6 m95 -139.2 107.54 5.81 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 122.187 2.267 . . . . 0.0 106.753 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.0 p -103.49 74.8 1.28 Allowed 'General case' 0 N--CA 1.429 -1.513 2 O-C-N 131.441 5.463 . . . . 0.0 114.143 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.432 ' HB3' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -46.29 134.09 9.05 Favored 'General case' 0 C--O 1.215 -0.724 1 O-C-N 130.804 5.065 . . . . 0.0 105.352 179.867 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -136.98 66.67 1.46 Allowed 'General case' 0 C--N 1.347 0.46 1 O-C-N 131.131 5.269 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.79 84.19 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.167 0 O-C-N 125.68 1.863 . . . . 0.0 110.719 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 63.07 28.11 16.02 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 114.899 -2.477 . . . . 0.0 114.622 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -129.69 156.96 43.41 Favored 'General case' 0 N--CA 1.476 0.869 1 O-C-N 129.877 4.485 . . . . 0.0 107.694 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ARG . 7.9 mt -141.6 47.78 1.65 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 126.571 2.419 . . . . 0.0 116.877 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 t -68.66 147.65 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 1 CA-C-N 107.85 -4.25 . . . . 0.0 112.138 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.99 27.56 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.481 ' CA ' ' CH2' ' A' ' 67' ' ' TRP 0.268 0.1 OUTLIER -174.53 128.55 0.33 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 111.951 -3.9 . . . . 0.0 117.676 -179.617 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 67' ' ' TRP . 25.6 m-85 -101.9 177.95 4.75 Favored 'General case' 0 C--O 1.204 -1.311 1 CA-C-O 129.288 4.375 . . . . 0.0 100.773 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' ' CA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.64 -129.89 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 1 CA-C-N 105.079 -5.509 . . . . 0.0 110.284 179.583 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 51.0 ttt180 168.65 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.685 0 O-C-N 128.138 3.399 . . . . 0.0 109.247 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.6 -1.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 1 O-C-N 131.93 5.768 . . . . 0.0 114.767 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.62 -26.79 12.66 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 128.493 3.621 . . . . 0.0 112.041 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.28 1.25 9.06 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 66.46 39.19 94.0 Favored Glycine 0 CA--C 1.558 2.749 1 N-CA-C 100.773 -4.931 . . . . 0.0 100.773 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.262 0.6 OUTLIER -74.44 -80.86 0.07 Allowed 'General case' 0 N--CA 1.411 -2.383 1 CA-C-N 106.145 -5.027 . . . . 0.0 120.994 -179.008 . . . . . . . . 5 4 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.539 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER 78.61 101.87 0.07 Allowed 'General case' 0 CA--C 1.561 1.396 0 O-C-N 127.621 3.076 . . . . 0.0 109.489 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.76 48.57 2.15 Favored 'General case' 0 C--O 1.195 -1.779 1 O-C-N 133.636 6.835 . . . . 0.0 108.884 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' HD3' ' A' ' 77' ' ' LYS . 57.0 mt -66.57 146.0 13.5 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.479 2 O-C-N 130.029 4.581 . . . . 0.0 103.937 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB1' ' CZ3' ' A' ' 67' ' ' TRP . . . -108.9 105.61 15.23 Favored 'General case' 0 C--O 1.213 -0.827 1 O-C-N 137.751 9.407 . . . . 0.0 105.077 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.85 100.43 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 128.917 3.886 . . . . 0.0 104.68 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -156.58 155.74 32.4 Favored 'General case' 0 C--O 1.19 -2.033 1 C-N-CA 110.615 -4.434 . . . . 0.0 113.756 179.76 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.5 108.34 3.34 Favored 'General case' 0 CA--C 1.558 1.279 2 CA-C-N 107.581 -4.372 . . . . 0.0 102.521 179.228 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 98' ' ' LEU . 11.5 tt -42.66 109.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 1 O-C-N 132.986 6.428 . . . . 0.0 112.287 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.0 m -105.19 95.25 5.71 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 128.387 3.555 . . . . 0.0 115.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.0 -118.31 3.77 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 103.256 -3.937 . . . . 0.0 103.256 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.67 47.29 1.56 Allowed 'General case' 0 CA--C 1.552 1.029 1 O-C-N 130.18 4.106 . . . . 0.0 106.146 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.303 0.0 OUTLIER -177.3 110.93 0.08 Allowed 'General case' 0 C--O 1.204 -1.32 2 O-C-N 130.801 5.063 . . . . 0.0 108.358 179.801 . . . . . . . . 5 4 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 3.0 tt -79.45 104.71 10.25 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 128.728 3.768 . . . . 0.0 108.815 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 26.1 mm -50.76 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.672 1 O-C-N 133.48 6.738 . . . . 0.0 108.434 -179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.413 ' HG2' HD22 ' A' ' 98' ' ' LEU . 23.2 mt-30 99.36 90.48 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 1 O-C-N 132.899 6.374 . . . . 0.0 103.915 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.8 m -102.64 96.75 7.09 Favored 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.683 6.864 . . . . 0.0 114.06 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -67.78 132.85 48.19 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 112.605 -3.638 . . . . 0.0 105.213 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -107.86 94.8 5.27 Favored 'General case' 0 C--O 1.206 -1.198 1 O-C-N 132.129 5.893 . . . . 0.0 101.631 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 1.4 t80 -109.64 117.36 33.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 109.792 -3.367 . . . . 0.0 117.6 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 27.42 31.51 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.77 -6.37 6.16 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 116.718 -2.658 . . . . 0.0 114.353 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.4 t -120.03 145.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.979 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 70.89 0.73 Allowed 'General case' 0 C--N 1.359 1.011 1 O-C-N 130.87 5.106 . . . . 0.0 103.388 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.436 . . -90.86 119.13 30.81 Favored 'General case' 0 N--CA 1.41 -2.447 1 O-C-N 130.921 5.138 . . . . 0.0 116.267 179.907 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.4 163.08 14.85 Favored 'General case' 0 N--CA 1.415 -2.199 1 O-C-N 132.663 6.227 . . . . 0.0 106.924 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.27 99.53 4.56 Favored 'General case' 0 CA--C 1.556 1.202 3 O-C-N 130.195 4.684 . . . . 0.0 99.437 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.23 123.02 7.53 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 O-C-N 128.862 3.851 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 14.2 m-30 -117.21 176.81 4.97 Favored 'General case' 0 N--CA 1.434 -1.24 2 O-C-N 132.544 6.152 . . . . 0.0 108.463 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.528 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 171.12 134.76 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.633 2 O-C-N 131.898 5.749 . . . . 0.0 113.843 -177.607 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 1.3 tttt -51.41 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.34 1 CA-C-O 128.649 4.071 . . . . 0.0 113.502 176.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.37 1.492 0 O-C-N 118.952 -2.342 . . . . 0.0 110.519 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.117 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 93' ' ' ILE . 4.8 m-30 -111.93 11.49 20.69 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -50.3 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 127.737 3.148 . . . . 0.0 117.911 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.29 125.21 0.77 Allowed Glycine 0 C--N 1.353 1.488 1 C-N-CA 112.377 -4.725 . . . . 0.0 107.663 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.334 46.2 p -49.97 127.89 17.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 129.148 3.499 . . . . 0.0 110.123 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.562 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.324 55.7 m95 -100.58 161.47 13.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 128.565 3.666 . . . . 0.0 112.276 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 2.3 mtmt 50.99 -178.66 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.696 1 O-C-N 129.333 4.146 . . . . 0.0 117.325 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.326 0.9 OUTLIER 15.21 104.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.603 2 O-C-N 134.538 7.399 . . . . 0.0 113.753 174.979 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -128.9 31.86 4.86 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 110.834 -2.894 . . . . 0.0 106.105 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -63.34 124.26 20.81 Favored 'General case' 0 C--O 1.203 -1.346 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.771 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -50.03 136.76 18.34 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 127.032 2.708 . . . . 0.0 108.283 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -28.7 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.416 3.573 . . . . 0.0 112.863 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -91.31 127.56 36.79 Favored 'General case' 0 C--N 1.367 1.367 0 O-C-N 127.3 2.875 . . . . 0.0 106.187 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -116.28 81.74 1.66 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 128.315 3.51 . . . . 0.0 106.58 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 t -121.65 -81.94 0.64 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 125.686 1.866 . . . . 0.0 106.735 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.32 -88.39 0.45 Allowed Glycine 0 CA--C 1.533 1.178 0 O-C-N 128.606 3.691 . . . . 0.0 110.062 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 129.3 40.79 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 111.986 -2.107 . . . . 0.0 107.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -122.68 -44.1 2.23 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 117.097 -1.841 . . . . 0.0 110.318 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -81.0 107.27 13.67 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.865 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' HB3' ' CD2' ' A' ' 21' ' ' LEU . 3.3 m-20 -110.6 -87.6 0.52 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 127.822 3.201 . . . . 0.0 111.352 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' CD2' ' HB3' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -144.84 174.08 11.31 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 127.679 3.112 . . . . 0.0 105.736 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.377 0.0 OUTLIER 174.56 134.18 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.5 1 O-C-N 131.733 5.646 . . . . 0.0 102.694 179.689 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.472 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 13.2 mt -93.55 167.69 11.52 Favored 'General case' 0 CA--C 1.559 1.291 2 O-C-N 131.533 5.52 . . . . 0.0 100.33 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 3.9 m 176.7 79.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 1 O-C-N 132.518 6.136 . . . . 0.0 105.993 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.547 HG23 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 mp -90.11 144.07 9.89 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 110.293 -3.14 . . . . 0.0 109.188 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.7 m -162.48 82.29 0.53 Allowed 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 112.491 -3.683 . . . . 0.0 109.092 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.433 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -51.65 148.05 5.85 Favored 'General case' 0 C--O 1.214 -0.797 2 O-C-N 130.373 4.795 . . . . 0.0 115.054 179.684 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -131.65 101.43 5.49 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 128.75 3.781 . . . . 0.0 103.76 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -104.08 2.26 Favored Glycine 0 CA--C 1.546 2.027 2 C-N-CA 110.909 -5.424 . . . . 0.0 99.934 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -131.36 14.21 5.06 Favored 'General case' 0 N--CA 1.435 -1.222 1 O-C-N 131.798 5.058 . . . . 0.0 109.241 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -82.8 155.29 24.27 Favored 'General case' 0 C--N 1.321 -0.662 1 N-CA-C 99.494 -4.261 . . . . 0.0 99.494 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.547 ' CZ ' HG23 ' A' ' 25' ' ' ILE . 9.3 t80 -155.67 106.76 2.52 Favored 'General case' 0 C--O 1.191 -1.995 2 N-CA-C 95.674 -5.676 . . . . 0.0 95.674 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.15 142.48 38.3 Favored 'General case' 0 N--CA 1.475 0.806 1 O-C-N 132.503 6.127 . . . . 0.0 102.797 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.356 24.7 t -111.48 140.04 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 1 O-C-N 129.144 4.027 . . . . 0.0 100.97 179.697 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 5.2 tttt -85.2 64.42 8.66 Favored 'General case' 0 CA--C 1.49 -1.355 1 CA-C-O 130.901 5.143 . . . . 0.0 115.029 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -81.76 61.8 5.29 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 109.64 -3.436 . . . . 0.0 104.323 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.57 130.81 35.35 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 113.228 -3.389 . . . . 0.0 109.454 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -146.61 -158.79 0.94 Allowed 'General case' 0 C--N 1.368 1.394 0 O-C-N 125.87 1.981 . . . . 0.0 113.066 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -14.53 60.34 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.05 52.97 0.97 Allowed 'General case' 0 N--CA 1.424 -1.772 0 O-C-N 128.22 3.45 . . . . 0.0 107.349 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 72.9 -164.26 0.11 Allowed 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 127.637 3.086 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -81.85 -30.52 32.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 127.657 3.098 . . . . 0.0 107.127 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.8 tp 37.14 70.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.104 2 O-C-N 132.107 5.879 . . . . 0.0 110.444 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -66.07 114.79 5.48 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.711 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.96 95.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 2 O-C-N 131.657 5.598 . . . . 0.0 99.802 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.282 2.8 p -114.68 151.67 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 1 O-C-N 129.536 4.272 . . . . 0.0 116.086 -179.691 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 3.4 p90 -174.17 -171.7 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 131.682 5.614 . . . . 0.0 111.7 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -124.8 76.47 1.52 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 128.201 3.438 . . . . 0.0 113.762 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD12 ' HB2' ' A' ' 69' ' ' MET . 0.1 OUTLIER 24.36 78.48 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.738 1 O-C-N 133.744 6.903 . . . . 0.0 116.294 -179.876 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.62 64.28 1.83 Allowed Glycine 0 CA--C 1.537 1.407 0 N-CA-C 105.714 -2.955 . . . . 0.0 105.714 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.24 -38.01 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 1 O-C-N 130.588 4.346 . . . . 0.0 111.209 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.89 143.84 0.06 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 109.025 -3.716 . . . . 0.0 110.644 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.5 p90 178.3 -178.33 0.26 Allowed 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 129.279 4.112 . . . . 0.0 116.184 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.7 14.11 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.91 131.59 24.11 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 115.749 -2.38 . . . . 0.0 111.259 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.3 122.91 28.56 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.1 -62.12 1.64 Allowed 'General case' 0 C--O 1.247 0.968 1 O-C-N 130.547 4.905 . . . . 0.0 115.086 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.86 35.74 2.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 125.777 1.923 . . . . 0.0 111.383 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 68.25 26.28 6.98 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 126.9 2.625 . . . . 0.0 110.672 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.87 -60.78 0.04 OUTLIER Glycine 0 CA--C 1.557 2.712 1 CA-C-O 113.204 -4.109 . . . . 0.0 105.61 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 m -5.25 -77.53 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 1 O-C-N 135.278 7.105 . . . . 0.0 110.576 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 74.86 122.97 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.497 1 O-C-N 129.321 4.138 . . . . 0.0 103.865 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.39 69.85 0.77 Allowed 'General case' 0 C--O 1.205 -1.287 0 CA-C-N 109.285 -3.598 . . . . 0.0 106.843 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -67.92 96.83 0.62 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 111.176 -2.738 . . . . 0.0 106.273 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -165.39 172.11 40.86 Favored Glycine 0 C--O 1.207 -1.579 1 C-N-CA 111.175 -5.298 . . . . 0.0 107.843 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -133.89 143.13 48.08 Favored 'General case' 0 CA--C 1.507 -0.706 1 O-C-N 134.863 6.86 . . . . 0.0 113.241 179.874 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.615 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 22.9 m95 -113.82 122.17 46.24 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 101.338 -3.579 . . . . 0.0 101.338 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.6 p -117.02 48.92 1.24 Allowed 'General case' 0 C--N 1.316 -0.848 2 O-C-N 135.59 8.056 . . . . 0.0 115.873 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.515 ' HG3' ' CE2' ' A' ' 32' ' ' PHE . 2.6 tmm? -30.84 133.09 0.08 Allowed 'General case' 0 C--O 1.216 -0.7 1 O-C-N 134.376 7.298 . . . . 0.0 108.472 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.03 76.36 1.56 Allowed 'General case' 0 N--CA 1.48 1.048 1 O-C-N 129.12 4.012 . . . . 0.0 108.296 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.95 -113.11 5.57 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.71 28.18 1.59 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 114.172 -2.823 . . . . 0.0 114.432 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.294 0.1 OUTLIER -130.21 154.61 47.38 Favored 'General case' 0 C--N 1.342 0.255 1 O-C-N 129.273 4.108 . . . . 0.0 112.843 -179.834 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.3 mt -131.11 70.36 1.47 Allowed 'General case' 0 C--O 1.211 -0.939 0 O-C-N 129.081 3.988 . . . . 0.0 111.46 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.71 123.53 43.87 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 2 O-C-N 131.076 5.235 . . . . 0.0 110.512 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.19 -166.84 39.72 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-N 108.428 -3.987 . . . . 0.0 103.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 4.9 tttm -178.02 133.69 0.15 Allowed 'General case' 0 C--O 1.203 -1.387 1 O-C-N 132.304 5.355 . . . . 0.0 112.453 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -128.95 164.18 23.72 Favored 'General case' 0 N--CA 1.48 1.069 2 O-C-N 131.561 5.538 . . . . 0.0 102.386 -179.434 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG2' ' CA ' ' A' ' 86' ' ' GLU 0.366 0.0 OUTLIER -157.65 143.18 17.18 Favored 'General case' 0 N--CA 1.432 -1.347 1 CA-C-N 107.21 -4.541 . . . . 0.0 113.491 -178.901 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.511 ' CG ' ' HG2' ' A' ' 85' ' ' LYS . 4.3 ptm180 -102.62 94.24 5.53 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 129.281 4.113 . . . . 0.0 109.185 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -33.46 -36.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.431 1 O-C-N 134.393 7.308 . . . . 0.0 112.114 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -38.96 -52.09 1.79 Allowed 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.99 5.181 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -121.76 5.23 9.99 Favored 'General case' 0 N--CA 1.422 -1.874 0 O-C-N 127.808 3.193 . . . . 0.0 118.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.476 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 75.43 36.01 45.69 Favored Glycine 0 CA--C 1.554 2.497 2 C-N-CA 112.019 -4.896 . . . . 0.0 100.866 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' HG2' ' CG ' ' A' ' 80' ' ' ARG 0.274 14.3 tptp -76.94 -75.11 0.21 Allowed 'General case' 0 N--CA 1.422 -1.865 1 O-C-N 131.918 5.128 . . . . 0.0 120.088 -179.695 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.486 ' CA ' ' HG2' ' A' ' 79' ' ' LYS . 42.8 mt-10 84.4 88.95 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.499 1 O-C-N 129.766 4.416 . . . . 0.0 108.317 -178.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.94 56.05 0.65 Allowed 'General case' 0 C--O 1.196 -1.76 1 O-C-N 131.66 5.6 . . . . 0.0 111.031 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.414 HG12 ' HG3' ' A' ' 77' ' ' LYS . 64.7 mt -67.93 157.99 5.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 108.895 -3.775 . . . . 0.0 102.9 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 67' ' ' TRP . . . -129.35 74.12 1.56 Allowed 'General case' 0 C--O 1.213 -0.868 1 O-C-N 133.982 7.051 . . . . 0.0 109.425 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.56 133.48 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 1 O-C-N 129.41 4.194 . . . . 0.0 107.436 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -178.12 148.58 0.51 Allowed 'General case' 0 C--O 1.191 -1.997 0 O-C-N 128.479 3.612 . . . . 0.0 114.6 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 3.6 mt-10 -143.66 114.67 7.81 Favored 'General case' 0 CA--C 1.561 1.376 1 O-C-N 129.874 4.484 . . . . 0.0 107.327 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 98' ' ' LEU . 2.6 mm -18.43 80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.243 1 O-C-N 134.499 7.374 . . . . 0.0 110.661 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.21 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.733 1 O-C-N 132.648 6.217 . . . . 0.0 115.305 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.95 -131.21 10.23 Favored Glycine 0 CA--C 1.553 2.406 1 N-CA-C 102.061 -4.416 . . . . 0.0 102.061 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.16 29.3 8.01 Favored 'General case' 0 C--N 1.361 1.09 1 CA-C-N 107.189 -4.505 . . . . 0.0 109.587 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.481 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -156.28 151.62 26.71 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 114.635 -2.602 . . . . 0.0 108.253 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' CD1' HD11 ' A' ' 93' ' ' ILE . 2.5 tt -105.15 126.47 52.12 Favored 'General case' 0 N--CA 1.445 -0.705 1 O-C-N 132.215 5.947 . . . . 0.0 112.132 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -77.25 -82.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 1 CA-C-O 109.927 -4.844 . . . . 0.0 108.256 -179.994 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.442 ' N ' ' CG2' ' A' ' 99' ' ' ILE . 95.8 mt-30 103.43 111.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.35 1 O-C-N 133.363 6.664 . . . . 0.0 100.903 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -112.29 102.49 10.64 Favored 'General case' 0 N--CA 1.424 -1.74 1 O-C-N 130.464 4.853 . . . . 0.0 113.847 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -75.24 101.3 4.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 113.513 -3.275 . . . . 0.0 105.326 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -84.92 97.8 9.98 Favored 'General case' 0 C--O 1.217 -0.642 1 O-C-N 129.511 4.257 . . . . 0.0 104.211 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.451 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -120.18 119.3 32.85 Favored 'General case' 0 C--N 1.363 1.185 1 CA-C-N 108.182 -4.099 . . . . 0.0 117.517 -179.935 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 50.15 23.01 1.04 Allowed 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.8 -6.43 24.05 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 117.639 -2.22 . . . . 0.0 115.464 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.257 39.5 t -95.16 163.0 2.35 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 CA-C-N 113.039 -1.581 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.35 58.76 1.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 127.26 2.85 . . . . 0.0 106.647 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.508 . . -82.02 128.94 34.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.061 3.351 . . . . 0.0 112.11 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.12 171.86 11.99 Favored 'General case' 0 N--CA 1.418 -2.07 1 O-C-N 132.872 6.358 . . . . 0.0 106.912 179.836 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -134.11 133.52 41.19 Favored 'General case' 0 C--O 1.207 -1.173 2 O-C-N 130.501 4.876 . . . . 0.0 99.602 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 pt -85.52 85.04 2.23 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 1 O-C-N 130.376 4.798 . . . . 0.0 113.653 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.517 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 12.7 m-30 -91.64 179.25 5.7 Favored 'General case' 0 N--CA 1.441 -0.924 1 O-C-N 132.395 6.059 . . . . 0.0 104.836 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -154.61 -163.23 1.54 Allowed 'General case' 0 C--O 1.198 -1.644 1 O-C-N 130.766 5.041 . . . . 0.0 111.652 179.992 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 74.5 tttt -118.76 -119.59 0.31 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 CA--C 1.558 1.275 0 CA-C-O 117.429 -1.272 . . . . 0.0 111.285 -179.885 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.109 0.48 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -87.72 -5.2 58.78 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 127.275 2.859 . . . . 0.0 106.661 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -55.73 104.86 0.15 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 158.34 9.79 Favored Glycine 0 C--N 1.351 1.389 0 C-N-CA 114.15 -3.881 . . . . 0.0 104.488 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 p -78.72 163.42 25.43 Favored 'General case' 0 C--N 1.355 0.82 1 C-N-CA 110.566 -4.454 . . . . 0.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.507 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 23.0 m95 -132.81 162.27 31.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 112.319 -3.705 . . . . 0.0 111.043 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.8 OUTLIER 49.43 179.41 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 178.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.357 2.3 t -8.51 100.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.471 3 O-C-N 132.769 6.293 . . . . 0.0 115.265 174.96 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -161.76 97.45 1.06 Allowed 'General case' 0 C--N 1.362 1.136 0 CA-C-N 110.942 -2.844 . . . . 0.0 107.773 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -178.52 147.94 0.43 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.535 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 70.5 156.82 0.16 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 126.737 2.523 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -105.38 92.84 4.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 127.305 2.878 . . . . 0.0 107.378 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -92.77 134.06 35.42 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 127.54 3.025 . . . . 0.0 109.385 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 15' ' ' SER . 11.2 p90 -87.77 -10.93 49.57 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.171 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.486 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 3.9 p -162.23 142.4 9.97 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 116.997 -1.881 . . . . 0.0 106.509 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 18.88 6.42 Favored Glycine 0 C--O 1.207 -1.541 0 O-C-N 127.824 3.202 . . . . 0.0 110.987 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.02 18.15 11.04 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 111.707 -2.247 . . . . 0.0 106.754 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 18' ' ' HIS . 5.6 m170 58.13 58.53 3.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 126.454 2.346 . . . . 0.0 112.05 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.61 -54.82 2.47 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.875 3.234 . . . . 0.0 109.769 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 p30 10.24 111.64 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 133.627 6.829 . . . . 0.0 115.376 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.93 140.76 36.46 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.368 0.0 OUTLIER -161.75 153.54 19.07 Favored 'General case' 0 C--O 1.2 -1.542 1 O-C-N 129.608 4.317 . . . . 0.0 104.354 -179.985 . . . . . . . . 5 4 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 34' ' ' VAL . 4.5 mt -114.01 175.88 5.28 Favored 'General case' 0 CA--C 1.565 1.53 3 O-C-N 134.57 7.419 . . . . 0.0 97.544 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.422 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 14.3 m -171.33 -79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 128.802 3.814 . . . . 0.0 104.939 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 73.88 151.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-N 109.277 -3.601 . . . . 0.0 110.346 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.9 m -166.66 71.91 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -48.94 125.36 10.25 Favored 'General case' 0 C--O 1.205 -1.268 1 O-C-N 131.589 5.555 . . . . 0.0 114.376 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -88.64 -112.36 0.06 Allowed 'General case' 0 C--N 1.365 1.249 1 O-C-N 130.389 4.806 . . . . 0.0 103.299 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.77 100.82 1.02 Allowed Glycine 0 CA--C 1.564 3.136 2 N-CA-C 100.526 -5.03 . . . . 0.0 100.526 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 m120 56.04 43.58 26.85 Favored 'General case' 0 N--CA 1.424 -1.745 0 O-C-N 128.04 2.847 . . . . 0.0 109.158 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -155.6 116.88 3.94 Favored 'General case' 0 CA--C 1.548 0.88 2 N-CA-C 98.618 -4.586 . . . . 0.0 98.618 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -127.95 169.82 13.55 Favored 'General case' 0 C--O 1.198 -1.628 2 N-CA-C 97.978 -4.823 . . . . 0.0 97.978 179.868 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.78 132.53 29.04 Favored 'General case' 0 CA--C 1.494 -1.185 2 O-C-N 133.921 7.013 . . . . 0.0 99.643 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 23' ' ' LEU 0.364 2.2 t -91.5 134.68 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 -179.998 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -68.78 -10.7 58.13 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 108.535 -3.939 . . . . 0.0 119.201 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' CB ' HG11 ' A' ' 34' ' ' VAL 0.27 2.3 tp10 -33.82 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 109.919 -3.31 . . . . 0.0 110.262 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -81.57 132.6 35.31 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 116.463 -2.095 . . . . 0.0 108.073 -179.27 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.63 -152.31 0.14 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 114.09 -3.044 . . . . 0.0 111.711 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.72 1.78 21.36 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 127.833 3.208 . . . . 0.0 108.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.412 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 82.8 m-85 -82.29 -56.58 3.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 109.451 -3.522 . . . . 0.0 105.424 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -175.09 -174.5 0.76 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 130.198 4.686 . . . . 0.0 112.334 -179.872 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.99 124.67 34.95 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.309 0.9 OUTLIER -142.09 106.66 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.039 2 CA-C-O 131.859 5.599 . . . . 0.0 109.483 -178.493 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 125.18 25.1 Favored 'General case' 0 C--N 1.373 1.587 1 CA-C-N 107.197 -4.547 . . . . 0.0 109.546 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 p -91.24 65.27 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.495 2 O-C-N 130.32 4.762 . . . . 0.0 100.128 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.08 161.11 5.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 1 C-N-CA 111.003 -4.279 . . . . 0.0 115.941 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CE1' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -174.77 -155.71 0.06 Allowed 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 128.1 3.375 . . . . 0.0 110.579 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.8 mt-10 -130.81 177.92 7.05 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 115.478 -2.201 . . . . 0.0 108.083 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 69' ' ' MET . 0.2 OUTLIER -99.34 94.7 6.59 Favored 'General case' 0 C--O 1.214 -0.795 1 O-C-N 131.64 5.587 . . . . 0.0 109.804 -179.903 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.99 53.17 1.95 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-O 114.04 -3.644 . . . . 0.0 104.868 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 25.5 t -141.44 123.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 1 O-C-N 130.714 4.42 . . . . 0.0 111.677 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.42 160.18 20.65 Favored 'General case' 0 C--N 1.356 0.883 1 O-C-N 130.053 4.595 . . . . 0.0 107.788 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 56.0 p90 -177.15 177.68 1.21 Allowed 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 130.676 4.985 . . . . 0.0 116.228 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.3 135.23 47.12 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.0 -154.1 0.6 Allowed 'General case' 0 C--O 1.204 -1.336 0 O-C-N 128.009 3.318 . . . . 0.0 113.745 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.27 89.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.3 mt -83.12 170.62 14.58 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.974 2.671 . . . . 0.0 110.508 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.47 -141.17 0.69 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 126.049 2.093 . . . . 0.0 113.521 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -26.06 60.46 Favored 'General case' 0 C--N 1.366 1.289 0 O-C-N 120.884 -1.135 . . . . 0.0 110.089 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.04 71.56 0.03 OUTLIER Glycine 0 CA--C 1.554 2.519 0 CA-C-O 116.337 -2.368 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 p -73.82 -134.06 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 1 O-C-N 132.636 5.551 . . . . 0.0 107.382 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -146.8 -61.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 112.38 -3.728 . . . . 0.0 104.022 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 mp 42.86 70.48 0.29 Allowed 'General case' 0 C--O 1.214 -0.809 1 O-C-N 131.047 5.217 . . . . 0.0 111.449 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.7 m -88.28 117.31 27.1 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.921 1.688 . . . . 0.0 108.936 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.62 -138.78 4.18 Favored Glycine 0 N--CA 1.473 1.106 1 C-N-CA 110.108 -5.806 . . . . 0.0 107.62 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.382 5.9 t -173.07 166.69 4.99 Favored 'General case' 0 N--CA 1.446 -0.665 1 O-C-N 130.667 4.393 . . . . 0.0 116.889 -179.122 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.538 ' CE2' ' CE2' ' A' ' 78' ' ' PHE . 2.6 m95 -122.37 145.94 47.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -136.31 32.42 2.84 Favored 'General case' 0 C--N 1.321 -0.652 2 O-C-N 135.099 7.749 . . . . 0.0 111.649 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.427 ' HB3' HD22 ' A' ' 49' ' ' LEU . 16.7 ttp -32.17 132.99 0.11 Allowed 'General case' 0 C--N 1.317 -0.84 2 O-C-N 134.909 7.63 . . . . 0.0 108.873 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.45 139.83 33.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 111.331 -2.668 . . . . 0.0 108.809 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 30.02 -98.67 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.816 1 O-C-N 133.086 6.491 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -119.35 56.78 0.91 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 108.813 -3.693 . . . . 0.0 112.337 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -148.11 179.8 7.48 Favored 'General case' 0 C--O 1.249 1.069 1 O-C-N 129.335 4.147 . . . . 0.0 110.322 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.2 mt -147.13 46.14 1.16 Allowed 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 126.193 2.183 . . . . 0.0 112.755 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.63 130.16 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 1 O-C-N 129.294 4.121 . . . . 0.0 113.356 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.488 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 156.99 -142.49 8.73 Favored Glycine 0 CA--C 1.564 3.151 2 CA-C-N 106.647 -4.797 . . . . 0.0 103.917 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 170.59 168.69 0.07 Allowed 'General case' 0 N--CA 1.44 -0.942 1 O-C-N 133.789 6.229 . . . . 0.0 111.04 -179.289 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.538 ' CE2' ' CE2' ' A' ' 67' ' ' TRP . 11.9 m-85 -150.1 157.02 42.68 Favored 'General case' 0 C--O 1.197 -1.694 1 O-C-N 133.743 6.902 . . . . 0.0 101.615 176.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HG2' ' CG1' ' A' ' 81' ' ' VAL . 4.2 ttpt -155.4 135.69 13.14 Favored 'General case' 0 N--CA 1.422 -1.835 1 CA-C-N 107.612 -4.358 . . . . 0.0 112.407 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.488 ' CG ' ' HA3' ' A' ' 84' ' ' GLY . 14.9 ptm180 -106.38 47.57 0.87 Allowed 'General case' 0 CA--C 1.557 1.237 0 O-C-N 125.906 2.004 . . . . 0.0 107.18 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.451 ' CG1' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -6.16 -52.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.619 1 O-C-N 132.08 5.862 . . . . 0.0 115.658 -179.758 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 80' ' ' ARG . 2.1 t0 -39.23 -29.86 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 129.026 3.954 . . . . 0.0 113.059 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 174.79 -22.83 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.978 0 O-C-N 128.982 3.926 . . . . 0.0 114.132 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.488 ' HA3' ' CG ' ' A' ' 80' ' ' ARG . . . -69.59 -52.18 22.13 Favored Glycine 0 CA--C 1.536 1.36 1 N-CA-C 101.826 -4.51 . . . . 0.0 101.826 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.03 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.939 2 O-C-N 132.015 5.185 . . . . 0.0 120.303 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.424 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 10.1 mt-10 74.48 62.03 0.07 Allowed 'General case' 0 N--CA 1.432 -1.366 1 O-C-N 130.226 4.704 . . . . 0.0 117.75 177.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.481 ' CD1' ' HG2' ' A' ' 80' ' ' ARG . 23.2 mt -97.7 61.53 1.6 Allowed 'General case' 0 C--O 1.199 -1.588 1 O-C-N 130.175 4.672 . . . . 0.0 108.8 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.473 ' CG1' ' HB2' ' A' ' 77' ' ' LYS . 16.1 mt -69.98 -173.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 1 CA-C-N 107.226 -4.534 . . . . 0.0 104.487 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.28 54.12 0.75 Allowed 'General case' 0 C--O 1.196 -1.726 0 O-C-N 128.014 3.321 . . . . 0.0 105.449 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 t -57.66 113.12 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 1 O-C-N 131.014 5.196 . . . . 0.0 103.474 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.706 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -161.7 162.76 29.89 Favored 'General case' 0 C--O 1.189 -2.131 0 C-N-CA 113.599 -3.24 . . . . 0.0 113.27 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.706 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -162.76 100.78 1.01 Allowed 'General case' 0 N--CA 1.449 -0.522 2 O-C-N 131.187 5.304 . . . . 0.0 104.779 179.662 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.422 HD11 ' CD1' ' A' ' 98' ' ' LEU . 1.8 mm 5.04 73.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.807 1 O-C-N 134.731 7.519 . . . . 0.0 111.453 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 t -15.21 -51.33 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.071 1 O-C-N 133.431 6.707 . . . . 0.0 117.092 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.17 -88.72 0.1 Allowed Glycine 0 CA--C 1.548 2.15 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -125.73 18.43 7.99 Favored 'General case' 0 CA--C 1.555 1.149 2 CA-C-N 105.785 -5.207 . . . . 0.0 103.52 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.508 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -153.49 168.79 24.97 Favored 'General case' 0 C--O 1.22 -0.486 0 O-C-N 127.892 3.245 . . . . 0.0 106.776 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 ' CD2' ' HG2' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -108.08 139.98 41.94 Favored 'General case' 0 N--CA 1.434 -1.27 1 O-C-N 130.525 4.891 . . . . 0.0 109.863 -179.885 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.446 ' HB ' ' HD3' ' A' ' 91' ' ' ARG . 1.5 mt -102.96 -79.76 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.474 2 O-C-N 130.022 4.576 . . . . 0.0 105.639 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 2.6 mm100 105.52 82.27 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 1 O-C-N 132.776 6.298 . . . . 0.0 104.734 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.406 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 1.8 m -84.89 95.84 9.15 Favored 'General case' 0 N--CA 1.427 -1.619 2 O-C-N 130.983 5.177 . . . . 0.0 112.137 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -68.29 149.46 49.43 Favored 'General case' 0 N--CA 1.48 1.064 1 C-N-CA 110.094 -4.642 . . . . 0.0 105.085 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.3 m -118.53 72.0 0.86 Allowed 'General case' 0 C--O 1.206 -1.216 1 O-C-N 130.97 5.169 . . . . 0.0 107.75 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -88.55 108.68 19.54 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 109.118 -3.674 . . . . 0.0 110.372 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -17.25 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 126.96 2.663 . . . . 0.0 116.563 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.84 0.92 58.77 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 117.654 -2.213 . . . . 0.0 113.94 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.4 t -157.67 104.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -88.26 79.95 7.68 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-O 114.892 -2.48 . . . . 0.0 108.078 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.381 . . -93.91 148.47 22.11 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 129.41 4.194 . . . . 0.0 109.591 179.528 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 50.8 mtmt -119.31 163.56 16.98 Favored 'General case' 0 N--CA 1.421 -1.912 1 O-C-N 133.393 6.683 . . . . 0.0 110.825 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 133.22 46.92 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 129.059 3.975 . . . . 0.0 101.152 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.59 114.16 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 O-C-N 127.367 2.917 . . . . 0.0 112.153 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 10.1 m-30 -129.25 174.2 9.81 Favored 'General case' 0 N--CA 1.422 -1.85 2 O-C-N 131.773 5.671 . . . . 0.0 104.251 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -163.74 -165.35 1.02 Allowed 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 132.728 6.267 . . . . 0.0 111.915 179.976 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 16.3 tttt -117.13 142.93 46.38 Favored 'General case' 0 N--CA 1.427 -1.624 0 O-C-N 119.123 -2.236 . . . . 0.0 111.279 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.243 0 O-C-N 126.94 2.65 . . . . 0.0 112.478 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 117.391 -1.29 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' A' ' 93' ' ' ILE . 2.1 m-30 -91.86 -22.64 19.98 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 128.727 3.767 . . . . 0.0 105.624 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.59 97.62 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.614 1 O-C-N 129.529 4.268 . . . . 0.0 115.795 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.17 142.7 3.46 Favored Glycine 0 N--CA 1.47 0.941 0 C-N-CA 114.295 -3.812 . . . . 0.0 105.949 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.319 60.2 p -67.41 164.2 19.16 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 115.558 -2.457 . . . . 0.0 107.537 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 71.1 m95 -141.19 135.34 30.68 Favored 'General case' 0 N--CA 1.411 -2.394 0 O-C-N 127.788 3.18 . . . . 0.0 113.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.588 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 26.5 mtmt 59.37 178.03 0.08 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.26 1.5 t 16.87 99.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.64 3 O-C-N 135.122 7.764 . . . . 0.0 120.932 174.876 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -121.18 -47.91 2.24 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.615 -3.803 . . . . 0.0 108.38 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -31.28 84.62 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 125.138 2.399 . . . . 0.0 115.738 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -66.93 129.66 40.62 Favored 'General case' 0 C--N 1.37 1.491 0 CA-C-N 111.197 -2.729 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 21.79 3.91 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.446 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 66.33 33.01 7.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 71.47 136.07 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.821 1 O-C-N 131.593 5.558 . . . . 0.0 108.769 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.87 9.14 6.89 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-N 113.055 -1.884 . . . . 0.0 108.793 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.45 -87.52 0.5 Allowed Glycine 0 CA--C 1.541 1.669 0 O-C-N 128.125 3.39 . . . . 0.0 112.668 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.62 31.14 0.23 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 117.216 -1.794 . . . . 0.0 108.979 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -120.11 156.76 30.38 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 126.019 2.074 . . . . 0.0 109.271 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 46.33 82.21 0.03 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 125.908 2.005 . . . . 0.0 113.941 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -163.31 114.92 1.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.955 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.38 -97.78 0.06 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 113.477 -3.154 . . . . 0.0 106.244 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.362 1.3 mttp 83.12 155.99 0.11 Allowed 'General case' 0 C--O 1.198 -1.616 1 O-C-N 134.931 7.644 . . . . 0.0 101.555 -178.54 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 34' ' ' VAL . 7.3 mt -118.14 174.02 6.45 Favored 'General case' 0 C--O 1.242 0.695 2 O-C-N 132.133 5.896 . . . . 0.0 99.275 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 4.3 m -156.06 -79.03 0.09 Allowed 'General case' 0 C--O 1.198 -1.633 0 O-C-N 127.615 3.072 . . . . 0.0 107.83 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.509 ' CG2' ' CD1' ' A' ' 32' ' ' PHE . 1.2 mp 62.08 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-N 109.401 -3.545 . . . . 0.0 114.702 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 m -145.68 78.57 1.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 116.239 -2.184 . . . . 0.0 106.954 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 18.0 mm-40 -91.21 -111.73 0.09 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 114.112 -3.035 . . . . 0.0 109.879 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -122.2 3.65 9.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.55 -16.0 55.36 Favored Glycine 0 CA--C 1.56 2.9 0 N-CA-C 104.289 -3.525 . . . . 0.0 104.289 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -115.81 -38.18 3.75 Favored 'General case' 0 N--CA 1.435 -1.182 1 O-C-N 131.078 4.634 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -102.38 -170.33 1.79 Allowed 'General case' 0 CA--C 1.551 0.996 1 N-CA-C 97.856 -4.868 . . . . 0.0 97.856 179.198 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER 179.68 126.29 0.07 Allowed 'General case' 0 C--O 1.195 -1.791 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 179.154 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.87 112.25 25.3 Favored 'General case' 0 C--O 1.252 1.197 3 O-C-N 132.585 6.178 . . . . 0.0 97.208 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 HD23 ' A' ' 23' ' ' LEU 0.317 2.5 t -75.51 146.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 1 C-N-CA 111.026 -4.269 . . . . 0.0 105.152 179.799 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.263 2.4 ttmm -87.5 54.87 3.28 Favored 'General case' 0 C--O 1.195 -1.778 2 CA-C-O 128.523 4.011 . . . . 0.0 113.486 179.577 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.282 27.4 tt0 -72.68 68.55 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.854 -2.43 . . . . 0.0 107.668 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 132.87 36.64 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 116.341 -2.144 . . . . 0.0 108.088 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -137.13 -162.12 1.25 Allowed 'General case' 0 C--N 1.351 0.631 0 C-N-CA 114.126 -3.029 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.51 58.12 0.94 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 126.744 2.528 . . . . 0.0 106.659 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.409 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 15.9 m-85 -134.01 -71.81 0.5 Allowed 'General case' 0 C--N 1.358 0.962 1 CA-C-N 107.57 -4.377 . . . . 0.0 106.765 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -156.1 10.0 0.26 Allowed 'General case' 0 N--CA 1.428 -1.538 1 O-C-N 129.848 4.467 . . . . 0.0 116.206 179.691 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 75.63 8.41 3.73 Favored 'General case' 0 CA--C 1.548 0.897 1 O-C-N 129.407 4.192 . . . . 0.0 109.353 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 57' ' ' LEU 0.336 0.7 OUTLIER -28.45 138.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.319 3 O-C-N 133.288 6.618 . . . . 0.0 110.615 178.741 . . . . . . . . 5 4 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.87 137.64 50.91 Favored 'General case' 0 C--N 1.373 1.601 1 CA-C-N 108.176 -4.102 . . . . 0.0 109.373 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.99 107.47 22.9 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.128 1 O-C-N 131.696 5.623 . . . . 0.0 104.2 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.464 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.319 2.8 p -110.02 168.47 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 2 O-C-N 130.196 4.685 . . . . 0.0 116.148 -179.752 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.464 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 6.3 p90 -174.43 -177.93 1.31 Allowed 'General case' 0 N--CA 1.427 -1.59 1 O-C-N 131.601 5.563 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 51' ' ' VAL . 2.7 tt0 -138.3 40.75 2.26 Favored 'General case' 0 N--CA 1.426 -1.644 0 O-C-N 127.007 2.692 . . . . 0.0 114.445 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.17 115.02 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.098 1 O-C-N 132.795 6.31 . . . . 0.0 115.855 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.44 44.88 94.64 Favored Glycine 0 CA--C 1.545 1.933 1 CA-C-O 112.673 -4.404 . . . . 0.0 104.367 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 48' ' ' GLU . 37.9 t -115.12 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 1 O-C-N 133.672 6.16 . . . . 0.0 114.882 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -79.27 151.9 30.86 Favored 'General case' 0 C--N 1.354 0.775 1 O-C-N 129.577 4.298 . . . . 0.0 111.624 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -174.55 -174.62 0.86 Allowed 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.39 4.181 . . . . 0.0 115.581 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.35 97.04 4.6 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -106.31 130.88 54.07 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 128.135 3.397 . . . . 0.0 113.025 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.1 t -91.99 71.09 5.52 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 112.599 -3.64 . . . . 0.0 106.002 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.508 ' CD1' ' CD1' ' A' ' 43' ' ' ILE . 27.2 tp -36.17 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 O-C-N 131.164 5.29 . . . . 0.0 112.997 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -88.07 -136.11 0.09 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 114.984 -2.436 . . . . 0.0 109.169 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.11 58.25 0.63 Allowed 'General case' 0 C--O 1.21 -0.987 0 O-C-N 127.249 2.843 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.03 -81.05 0.11 Allowed Glycine 0 CA--C 1.556 2.642 1 CA-C-O 112.499 -4.5 . . . . 0.0 104.116 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.478 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . 0.2 OUTLIER 23.02 -94.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.717 1 O-C-N 133.316 5.95 . . . . 0.0 109.398 -179.704 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 74.91 29.2 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 126.827 2.579 . . . . 0.0 108.743 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 78' ' ' PHE . 7.2 mp -63.91 92.11 0.07 Allowed 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 128.868 3.855 . . . . 0.0 107.817 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 100.0 m -89.12 99.31 12.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.798 -2.91 . . . . 0.0 109.668 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -160.38 -152.72 6.66 Favored Glycine 0 CA--C 1.546 1.998 1 C-N-CA 113.635 -4.126 . . . . 0.0 105.843 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.496 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 6.0 t -163.5 118.48 1.64 Allowed 'General case' 0 CA--C 1.494 -1.179 1 O-C-N 131.184 4.696 . . . . 0.0 114.927 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.708 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m95 -96.31 124.74 40.41 Favored 'General case' 0 C--N 1.356 0.867 1 O-C-N 115.62 -4.425 . . . . 0.0 106.86 -179.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.51 94.88 5.07 Favored 'General case' 0 C--O 1.202 -1.402 2 O-C-N 135.106 7.754 . . . . 0.0 108.948 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.68 88.18 0.7 Allowed 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 109.943 -3.299 . . . . 0.0 103.965 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -94.93 81.82 3.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 126.422 2.327 . . . . 0.0 111.112 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.56 -92.85 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 O-C-N 128.647 3.717 . . . . 0.0 109.973 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -110.03 35.49 3.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.748 -2.726 . . . . 0.0 111.182 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 154.09 43.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 115.5 -2.48 . . . . 0.0 108.377 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 HD13 ' CZ ' ' A' ' 2' ' ' PHE . 4.9 mt -134.8 37.32 3.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 127.605 3.066 . . . . 0.0 115.098 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.63 149.61 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 1 CA-C-N 107.879 -4.237 . . . . 0.0 115.598 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.75 -150.07 21.33 Favored Glycine 0 CA--C 1.551 2.301 1 N-CA-C 102.754 -4.138 . . . . 0.0 102.754 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' A' ' 88' ' ' ILE . 8.4 tttt 178.84 115.5 0.04 OUTLIER 'General case' 0 C--N 1.368 1.403 1 O-C-N 131.6 4.941 . . . . 0.0 114.311 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -120.25 145.32 47.15 Favored 'General case' 0 C--O 1.203 -1.383 1 CA-C-O 129.87 4.652 . . . . 0.0 102.309 179.802 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.454 ' HD2' ' CB ' ' A' ' 81' ' ' VAL . 18.1 ttmt -138.52 147.62 43.33 Favored 'General case' 0 N--CA 1.425 -1.707 1 CA-C-N 105.991 -5.095 . . . . 0.0 115.103 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' HG3' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -97.49 24.28 6.79 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 128.917 3.886 . . . . 0.0 111.908 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 82' ' ' ASP . 1.4 m 1.73 -57.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.777 1 O-C-N 134.891 7.619 . . . . 0.0 114.807 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 t0 -45.34 -27.18 0.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 128.989 3.931 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.78 -7.96 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 C-N-CA 114.218 -2.993 . . . . 0.0 118.358 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.21 -46.34 2.22 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 105.212 -3.155 . . . . 0.0 105.212 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 90.04 -150.49 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 134.351 6.56 . . . . 0.0 113.896 179.844 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.264 0.2 OUTLIER -63.58 133.44 53.76 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-O 112.77 -3.491 . . . . 0.0 114.965 -178.799 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.477 ' CD1' ' HG3' ' A' ' 80' ' ' ARG . 0.5 OUTLIER -137.24 49.21 2.03 Favored 'General case' 0 C--O 1.202 -1.412 1 O-C-N 137.99 9.556 . . . . 0.0 108.434 178.108 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 77' ' ' LYS . 88.5 mt -61.68 174.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.17 2 CA-C-N 107.153 -4.567 . . . . 0.0 104.235 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.99 55.15 1.72 Allowed 'General case' 0 N--CA 1.436 -1.132 1 O-C-N 130.856 5.098 . . . . 0.0 107.726 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 t -55.76 112.47 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 1 O-C-N 131.436 5.46 . . . . 0.0 100.865 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HD3' ' CD2' ' A' ' 98' ' ' LEU . 5.5 ttm180 -151.89 160.08 43.63 Favored 'General case' 0 CA--C 1.495 -1.144 1 C-N-CA 109.468 -4.893 . . . . 0.0 113.472 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -160.87 136.38 7.96 Favored 'General case' 0 C--N 1.356 0.869 1 O-C-N 131.464 5.477 . . . . 0.0 109.369 -179.429 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.51 HD12 ' CZ ' ' A' ' 2' ' ' PHE . 4.4 mm -67.45 124.47 22.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 1 O-C-N 133.336 6.647 . . . . 0.0 110.354 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -77.22 -65.58 0.93 Allowed 'General case' 0 CA--C 1.503 -0.845 1 O-C-N 129.716 4.385 . . . . 0.0 113.171 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' OE2' ' A' ' 97' ' ' GLU . . . -174.44 78.05 0.08 OUTLIER Glycine 0 CA--C 1.554 2.482 0 C-N-CA 115.358 -3.306 . . . . 0.0 106.711 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 79.44 27.79 0.37 Allowed 'General case' 0 CA--C 1.551 0.981 1 CA-C-N 106.599 -4.801 . . . . 0.0 108.445 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.325 0.0 OUTLIER -168.8 142.74 3.05 Favored 'General case' 0 CA--C 1.564 1.516 1 O-C-N 130.731 5.019 . . . . 0.0 107.938 179.252 . . . . . . . . 5 4 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' CD2' ' HD3' ' A' ' 91' ' ' ARG . 3.8 tt -106.2 133.14 51.37 Favored 'General case' 0 N--CA 1.439 -1.0 2 O-C-N 135.206 7.817 . . . . 0.0 112.853 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mt -75.08 -66.86 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-O 111.99 -3.862 . . . . 0.0 105.479 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.95 92.95 0.08 Allowed 'General case' 0 C--O 1.201 -1.483 1 O-C-N 134.712 7.508 . . . . 0.0 101.631 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.48 HG21 ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -111.24 124.04 51.42 Favored 'General case' 0 N--CA 1.425 -1.699 1 CA-C-N 107.844 -4.253 . . . . 0.0 113.44 179.929 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -91.95 151.81 20.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 113.297 -3.24 . . . . 0.0 104.279 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 m -134.95 70.34 1.44 Allowed 'General case' 0 C--O 1.214 -0.807 1 O-C-N 131.843 5.714 . . . . 0.0 105.571 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER -88.96 121.4 31.28 Favored 'General case' 0 CA--C 1.497 -1.064 1 CA-C-N 106.813 -4.721 . . . . 0.0 111.302 -179.898 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 55.71 -85.31 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.441 0.696 . . . . 0.0 109.857 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -151.0 37.46 0.87 Allowed Glycine 0 C--N 1.363 2.05 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.696 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 108' ' ' GLU . 96.4 t -136.68 149.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 116.685 -1.626 . . . . 0.0 114.767 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' N ' HG11 ' A' ' 107' ' ' VAL . 18.2 mp0 -124.46 104.3 8.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 128.954 3.909 . . . . 0.0 105.183 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 110' ' ' LYS 0.435 . . -100.11 -32.13 11.07 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 128.526 3.641 . . . . 0.0 113.588 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' CG ' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER 46.73 -80.37 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.091 1 O-C-N 137.735 9.397 . . . . 0.0 111.462 179.961 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' ALA . 2.4 mtm180 77.34 88.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.42 1 N-CA-C 99.505 -4.258 . . . . 0.0 99.505 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.7 pt -65.36 159.28 4.15 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 1 O-C-N 130.372 4.795 . . . . 0.0 114.077 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.588 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 22.0 m-85 -144.81 -148.44 0.24 Allowed 'General case' 0 N--CA 1.442 -0.848 1 O-C-N 130.858 5.099 . . . . 0.0 105.124 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.56 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.24 -141.33 0.04 OUTLIER 'General case' 0 C--O 1.196 -1.744 1 O-C-N 131.678 5.611 . . . . 0.0 112.139 -179.446 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.549 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 7.0 tttt -132.43 154.04 50.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 125.891 1.676 . . . . 0.0 110.804 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.196 179.569 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.978 ' CE1' HD11 ' A' ' 93' ' ' ILE . 23.1 m-85 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 103.735 -2.691 . . . . 0.0 103.735 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -148.96 62.72 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 115.791 -2.364 . . . . 0.0 114.913 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 176.78 21.13 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 115.192 -3.385 . . . . 0.0 107.449 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.274 16.9 p -72.84 168.47 18.8 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 128.253 2.972 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.599 ' CG ' ' HG3' ' A' ' 115' ' ' LYS 0.287 7.8 m95 -145.81 146.69 31.27 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 111.732 -3.985 . . . . 0.0 112.485 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.681 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 1.3 mtmt 61.49 -179.43 0.12 Allowed 'General case' 0 C--O 1.196 -1.752 1 O-C-N 133.297 6.623 . . . . 0.0 118.142 175.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 21' ' ' LEU 0.256 1.0 OUTLIER . . . . . 0 CA--C 1.482 -1.664 3 O-C-N 135.793 8.183 . . . . 0.0 119.938 174.897 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.725 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.314 0.4 OUTLIER 150.76 142.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.509 1 O-C-N 133.083 6.49 . . . . 0.0 104.805 179.935 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -110.84 165.77 11.57 Favored 'General case' 0 CA--C 1.561 1.399 1 O-C-N 133.098 6.499 . . . . 0.0 100.441 179.589 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.664 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 4.2 m 175.95 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 1 O-C-N 132.316 6.01 . . . . 0.0 107.123 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.768 HG12 HG22 ' A' ' 34' ' ' VAL . 2.6 mp -133.41 140.67 46.34 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 109.007 -3.724 . . . . 0.0 109.422 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 m -159.2 81.15 0.77 Allowed 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 113.214 -3.395 . . . . 0.0 107.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.27 151.41 1.45 Allowed 'General case' 0 N--CA 1.433 -1.289 1 O-C-N 132.849 6.343 . . . . 0.0 111.271 179.631 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.28 56.09 0.88 Allowed 'General case' 0 C--N 1.352 0.71 1 O-C-N 129.903 4.502 . . . . 0.0 106.873 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.77 87.36 0.61 Allowed Glycine 0 CA--C 1.547 2.031 2 C-N-CA 110.846 -5.454 . . . . 0.0 101.746 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 p30 34.13 55.13 0.61 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 133.029 5.782 . . . . 0.0 109.048 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 88.82 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 3 O-C-N 131.392 5.432 . . . . 0.0 96.533 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 69' ' ' MET . 21.7 p90 -121.82 131.19 53.92 Favored 'General case' 0 C--O 1.209 -1.056 2 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.84 156.36 22.13 Favored 'General case' 0 N--CA 1.478 0.934 4 O-C-N 136.984 8.928 . . . . 0.0 98.656 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 25' ' ' ILE 0.291 2.7 t -127.54 143.14 41.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 126.932 3.253 . . . . 0.0 104.425 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.2 tttm -93.12 77.65 4.61 Favored 'General case' 0 N--CA 1.421 -1.881 2 CA-C-O 133.808 6.527 . . . . 0.0 114.072 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -86.45 62.1 7.22 Favored 'General case' 0 N--CA 1.42 -1.974 1 CA-C-N 108.019 -4.173 . . . . 0.0 107.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -74.0 119.37 18.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 112.924 -3.51 . . . . 0.0 109.574 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.03 -142.02 0.16 Allowed 'General case' 0 C--N 1.353 0.724 0 C-N-CA 114.574 -2.85 . . . . 0.0 114.385 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -96.48 38.53 1.2 Allowed 'General case' 0 C--N 1.355 0.845 0 O-C-N 124.16 0.912 . . . . 0.0 111.07 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -152.42 54.63 0.8 Allowed 'General case' 0 C--O 1.2 -1.508 1 O-C-N 129.937 4.523 . . . . 0.0 105.182 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.26 -161.78 0.2 Allowed 'General case' 0 C--O 1.246 0.889 1 O-C-N 132.387 6.054 . . . . 0.0 110.621 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.63 -68.99 0.46 Allowed 'General case' 0 CA--C 1.548 0.892 1 C-N-CA 111.661 -4.016 . . . . 0.0 102.599 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER 67.14 134.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.776 2 CA-C-O 131.505 5.431 . . . . 0.0 107.79 179.886 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.38 165.17 18.87 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 110.027 -3.26 . . . . 0.0 108.787 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.91 101.15 7.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.091 1 O-C-N 132.234 5.959 . . . . 0.0 101.663 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 5.8 p -111.48 154.75 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 129.054 3.971 . . . . 0.0 112.867 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL 0.27 3.3 p90 170.5 -172.55 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 132.098 5.874 . . . . 0.0 110.739 -179.606 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 51' ' ' VAL . 19.4 mt-10 -115.29 81.32 1.56 Allowed 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 115.66 -2.416 . . . . 0.0 114.73 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 69' ' ' MET . 1.0 OUTLIER 48.73 -115.78 0.78 Allowed 'General case' 0 C--N 1.324 -0.524 1 O-C-N 129.573 4.295 . . . . 0.0 110.041 -179.987 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 49' ' ' LEU . . . -71.81 76.15 0.7 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 104.664 -3.374 . . . . 0.0 104.664 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' HD2' ' A' ' 53' ' ' PHE . 2.3 t -129.93 97.22 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 1 O-C-N 131.659 4.976 . . . . 0.0 111.014 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.75 157.37 36.59 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 128.129 3.393 . . . . 0.0 110.844 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 13.3 p90 172.33 159.98 0.11 Allowed 'General case' 0 C--N 1.373 1.605 1 O-C-N 131.072 5.233 . . . . 0.0 114.869 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' OE2' ' A' ' 62' ' ' GLU . . . -105.34 96.83 6.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 101.047 -3.686 . . . . 0.0 101.047 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.569 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -121.42 128.33 52.06 Favored 'General case' 0 C--O 1.209 -1.067 1 O-C-N 129.169 4.043 . . . . 0.0 114.665 -179.928 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.84 168.25 13.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 112.76 -3.576 . . . . 0.0 107.738 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.464 HD23 HG13 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.12 -41.85 0.38 Allowed 'General case' 0 CA--C 1.509 -0.597 1 O-C-N 131.32 5.387 . . . . 0.0 112.774 -179.957 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -123.62 45.42 2.46 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 125.065 1.478 . . . . 0.0 114.487 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 42.64 28.38 0.12 Allowed 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.9 41.4 0.06 OUTLIER Glycine 0 C--N 1.364 2.138 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.62 HG23 ' HB3' ' A' ' 58' ' ' ALA . 30.1 p -137.32 177.74 7.64 Favored 'General case' 0 C--N 1.315 -0.893 1 O-C-N 130.849 4.5 . . . . 0.0 112.054 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 5.5 tp10 -161.77 37.5 0.13 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 114.888 -2.725 . . . . 0.0 106.084 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.18 99.6 0.03 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-N 108.839 -3.8 . . . . 0.0 109.644 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -107.69 108.39 19.6 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 110.329 -3.123 . . . . 0.0 108.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.537 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -162.77 -161.09 11.79 Favored Glycine 0 C--O 1.21 -1.382 1 C-N-CA 110.93 -5.414 . . . . 0.0 107.57 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 66' ' ' THR . 9.9 t -154.19 99.36 2.22 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 129.004 3.414 . . . . 0.0 116.737 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.702 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 25.2 m95 -81.89 127.72 33.31 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 118.11 -2.869 . . . . 0.0 104.461 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.9 p -120.3 69.16 0.86 Allowed 'General case' 0 N--CA 1.433 -1.293 1 O-C-N 135.695 8.122 . . . . 0.0 110.647 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 59.6 ttp -43.7 118.53 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 1 O-C-N 131.712 5.632 . . . . 0.0 104.058 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -119.5 59.71 0.85 Allowed 'General case' 0 CA--C 1.506 -0.742 1 O-C-N 130.693 4.996 . . . . 0.0 110.509 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.86 -85.89 1.37 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 117.46 -2.305 . . . . 0.0 110.682 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.01 23.94 11.83 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 114.531 -2.652 . . . . 0.0 114.025 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.77 -172.36 2.51 Favored 'General case' 0 N--CA 1.476 0.866 1 O-C-N 130.172 4.67 . . . . 0.0 109.705 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 74' ' ' LEU . 1.1 mt -157.97 37.94 0.26 Allowed 'General case' 0 C--O 1.214 -0.766 0 O-C-N 126.641 2.463 . . . . 0.0 114.028 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -62.04 135.69 26.28 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 1 CA-C-N 106.905 -4.679 . . . . 0.0 114.841 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.472 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 159.24 -161.14 31.85 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 104.549 -3.42 . . . . 0.0 104.549 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -174.59 122.97 0.27 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 113.675 -3.21 . . . . 0.0 112.344 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -124.35 146.37 48.88 Favored 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.066 4.604 . . . . 0.0 102.039 179.913 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.718 ' CG ' ' C ' ' A' ' 85' ' ' LYS 0.348 16.9 ttmt -139.23 152.3 47.21 Favored 'General case' 0 N--CA 1.424 -1.735 1 CA-C-N 105.448 -5.342 . . . . 0.0 117.845 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.823 ' HG2' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -113.33 63.02 0.64 Allowed 'General case' 0 CA--C 1.558 1.284 0 O-C-N 126.246 2.216 . . . . 0.0 108.929 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 t -17.34 -44.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 131.949 5.781 . . . . 0.0 115.425 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 9.9 t0 -65.4 -3.42 4.24 Favored 'General case' 0 N--CA 1.436 -1.161 1 O-C-N 129.97 4.544 . . . . 0.0 113.773 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER 168.23 -30.41 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 115.705 -2.398 . . . . 0.0 114.688 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.568 ' HA3' ' HD3' ' A' ' 80' ' ' ARG . . . -88.64 -30.63 14.96 Favored Glycine 0 CA--C 1.56 2.844 1 C-N-CA 112.729 -4.557 . . . . 0.0 103.268 -179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.718 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 50.25 17.25 0.32 Allowed 'General case' 0 N--CA 1.441 -0.887 1 O-C-N 133.356 5.974 . . . . 0.0 118.896 178.69 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' C ' HD12 ' A' ' 87' ' ' LEU . 1.7 mt-10 161.06 116.22 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 1 O-C-N 129.459 4.224 . . . . 0.0 109.172 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' A' ' 80' ' ' ARG . 4.8 mp -152.76 58.95 0.8 Allowed 'General case' 0 C--O 1.207 -1.145 1 O-C-N 139.654 10.597 . . . . 0.0 112.301 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.5 mt -67.25 -177.49 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.235 1 CA-C-N 108.032 -4.167 . . . . 0.0 104.893 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.21 63.1 0.97 Allowed 'General case' 0 C--O 1.194 -1.82 0 O-C-N 128.425 3.578 . . . . 0.0 106.255 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -67.29 112.06 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 110.735 -2.939 . . . . 0.0 106.469 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD3' ' HB ' ' A' ' 99' ' ' ILE . 1.2 tpm_? -172.55 157.38 3.9 Favored 'General case' 0 C--O 1.191 -1.998 1 C-N-CA 110.738 -4.385 . . . . 0.0 116.779 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -137.21 148.17 46.34 Favored 'General case' 0 N--CA 1.439 -1.011 1 O-C-N 129.707 4.38 . . . . 0.0 104.971 179.522 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 98' ' ' LEU . 16.3 mm -55.55 96.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.913 1 O-C-N 131.632 5.582 . . . . 0.0 109.304 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 t -38.51 -57.17 1.19 Allowed 'General case' 0 CA--C 1.509 -0.619 1 O-C-N 130.885 5.116 . . . . 0.0 113.621 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.68 98.48 0.15 Allowed Glycine 0 CA--C 1.559 2.824 1 N-CA-C 103.051 -4.02 . . . . 0.0 103.051 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m120 79.48 15.43 0.94 Allowed 'General case' 0 CA--C 1.553 1.063 1 O-C-N 132.466 5.451 . . . . 0.0 108.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.286 0.1 OUTLIER 174.68 170.73 0.25 Allowed 'General case' 0 C--O 1.2 -1.533 0 O-C-N 127.256 2.847 . . . . 0.0 108.928 178.696 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 93' ' ' ILE . 16.5 tp -123.36 158.45 31.06 Favored 'General case' 0 N--CA 1.434 -1.237 2 O-C-N 132.475 6.109 . . . . 0.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 100' ' ' GLN 0.255 7.8 mt -110.01 -89.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.101 4.626 . . . . 0.0 103.807 179.835 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 99' ' ' ILE . 9.8 mm100 111.1 90.23 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.729 1 O-C-N 133.188 6.555 . . . . 0.0 105.473 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.1 m -87.71 92.45 9.11 Favored 'General case' 0 C--O 1.197 -1.7 2 O-C-N 132.623 6.202 . . . . 0.0 112.28 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -70.39 113.38 7.47 Favored 'General case' 0 C--O 1.211 -0.968 2 CA-C-N 107.073 -4.603 . . . . 0.0 106.192 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -88.64 116.1 26.65 Favored 'General case' 0 C--N 1.364 1.209 1 O-C-N 129.105 4.003 . . . . 0.0 102.419 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.1 t80 -131.52 118.13 19.73 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.888 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 36.06 30.87 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.25 -19.91 9.18 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.779 -2.153 . . . . 0.0 114.188 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -94.94 162.34 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 116.41 -1.757 . . . . 0.0 115.298 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.25 85.07 2.35 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 126.456 2.348 . . . . 0.0 105.288 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.438 . . -89.27 104.6 17.13 Favored 'General case' 0 C--O 1.2 -1.548 1 O-C-N 129.112 4.007 . . . . 0.0 110.507 179.959 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 101' ' ' THR . 7.3 mttp -97.84 134.57 40.81 Favored 'General case' 0 C--N 1.315 -0.9 1 O-C-N 135.3 7.875 . . . . 0.0 110.425 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 99' ' ' ILE . 8.8 mtt180 -99.28 141.21 32.34 Favored 'General case' 0 CA--C 1.562 1.411 1 N-CA-C 99.395 -4.298 . . . . 0.0 99.395 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.8 mt -112.94 105.84 19.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 1 O-C-N 130.175 4.672 . . . . 0.0 113.824 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 29.1 m-85 -137.88 -156.19 0.67 Allowed 'General case' 0 N--CA 1.436 -1.156 2 CA-C-N 108.124 -4.125 . . . . 0.0 104.993 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -169.82 -138.9 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.173 1 O-C-N 131.041 5.213 . . . . 0.0 110.483 -179.785 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.599 ' HG3' ' CG ' ' A' ' 6' ' ' TRP . 15.7 tttt -135.83 166.71 22.67 Favored 'General case' 0 C--O 1.202 -1.409 0 O-C-N 127.503 3.002 . . . . 0.0 109.434 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.434 -1.268 0 CA-C-N 113.579 -1.646 . . . . 0.0 106.699 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 124.006 1.86 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 9.8 p-10 -169.83 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 116.632 -2.027 . . . . 0.0 114.887 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.24 -147.02 4.87 Favored Glycine 0 N--CA 1.48 1.62 1 C-N-CA 111.067 -5.349 . . . . 0.0 103.502 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 24' ' ' THR 0.254 7.5 p -97.63 166.18 11.62 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 129.333 3.608 . . . . 0.0 104.266 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.26 10.4 m95 -141.61 169.91 16.71 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 113.058 -3.354 . . . . 0.0 112.07 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.737 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 51.5 179.06 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 178.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.258 0.5 OUTLIER . . . . . 0 CA--C 1.487 -1.454 3 CA-C-O 135.591 7.377 . . . . 0.0 120.263 175.015 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HG2' ' C ' ' A' ' 21' ' ' LEU 0.359 0.0 OUTLIER 171.13 165.91 0.08 Allowed 'General case' 0 CA--C 1.566 1.56 1 O-C-N 130.573 4.921 . . . . 0.0 104.268 179.805 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -131.93 151.48 51.69 Favored 'General case' 0 CA--C 1.558 1.26 4 O-C-N 134.494 7.371 . . . . 0.0 97.022 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.661 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.2 m 178.15 71.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 1 O-C-N 131.293 5.371 . . . . 0.0 104.215 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 34' ' ' VAL . 2.7 mp -86.37 157.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 109.87 -3.332 . . . . 0.0 108.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 27.9 m -172.77 77.3 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 128.056 3.347 . . . . 0.0 104.673 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 1.4 pt20 -45.75 145.09 1.47 Allowed 'General case' 0 N--CA 1.449 -0.524 2 O-C-N 132.556 6.16 . . . . 0.0 112.032 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -105.0 -7.48 19.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.98 63.86 0.24 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 103.21 -3.956 . . . . 0.0 103.21 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 p30 105.52 -20.9 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.277 1 O-C-N 131.944 5.143 . . . . 0.0 111.559 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.67 84.69 7.46 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 129.091 3.994 . . . . 0.0 103.27 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 17.1 m-85 -91.76 129.44 37.73 Favored 'General case' 0 C--O 1.19 -2.056 1 N-CA-C 96.177 -5.49 . . . . 0.0 96.177 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 33' ' ' THR 0.255 0.4 OUTLIER -132.88 114.1 13.66 Favored 'General case' 0 N--CA 1.483 1.213 2 O-C-N 135.895 8.247 . . . . 0.0 97.454 -179.741 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.442 14.7 t -85.48 154.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 2 C-N-CA 109.64 -4.824 . . . . 0.0 102.935 -179.839 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.8 tttm -88.56 16.8 6.05 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 118.848 2.907 . . . . 0.0 118.848 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.327 26.3 mt-10 -44.25 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 109.624 -3.443 . . . . 0.0 107.934 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 46.0 m -100.08 141.74 32.5 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 125.764 1.915 . . . . 0.0 113.322 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.08 -151.3 0.48 Allowed 'General case' 0 C--N 1.352 0.696 0 O-C-N 128.231 3.457 . . . . 0.0 110.054 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -111.08 30.01 7.27 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 20.2 m-85 -110.6 -78.13 0.59 Allowed 'General case' 0 CA--C 1.55 0.956 2 O-C-N 130.448 4.843 . . . . 0.0 110.366 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 2.1 mpt_? -139.04 8.63 2.51 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.563 2.415 . . . . 0.0 112.391 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.1 18.97 2.39 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 127.2 2.813 . . . . 0.0 104.204 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' ILE 0.298 9.7 tt -35.71 101.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.722 3 O-C-N 132.218 5.949 . . . . 0.0 110.24 179.429 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.42 144.64 27.21 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 109.643 -3.435 . . . . 0.0 105.944 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.85 128.22 50.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 1 O-C-N 129.38 4.175 . . . . 0.0 101.344 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.345 14.0 p -138.85 159.42 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 115.912 -2.315 . . . . 0.0 112.945 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.3 OUTLIER 170.73 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.928 1 O-C-N 134.977 7.673 . . . . 0.0 111.193 179.959 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.71 76.9 1.46 Allowed 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 127.212 2.82 . . . . 0.0 110.175 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 38.87 -80.48 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.962 1 O-C-N 131.71 5.631 . . . . 0.0 115.813 179.692 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.63 72.88 2.75 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 53' ' ' PHE . 4.5 t -148.2 110.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.104 1 O-C-N 131.666 4.98 . . . . 0.0 116.958 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.08 163.04 15.66 Favored 'General case' 0 C--O 1.205 -1.257 1 O-C-N 129.87 4.481 . . . . 0.0 106.277 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' HD2' HG12 ' A' ' 51' ' ' VAL . 10.7 p90 178.38 167.24 0.82 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 112.36 -3.736 . . . . 0.0 114.495 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.69 83.92 1.93 Allowed 'General case' 0 CA--C 1.562 1.412 1 N-CA-C 100.104 -4.036 . . . . 0.0 100.104 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.469 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -93.65 150.07 20.71 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 129.049 3.968 . . . . 0.0 114.997 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 88.22 2.71 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 128.362 3.539 . . . . 0.0 105.144 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.6 mm? -62.38 -75.63 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 128.796 3.81 . . . . 0.0 112.455 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 43' ' ' ILE . . . -84.33 -138.98 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 114.797 -2.525 . . . . 0.0 109.045 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.75 6.68 23.79 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 127.26 2.85 . . . . 0.0 111.734 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 66.19 0.19 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-O 115.712 -2.716 . . . . 0.0 107.323 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.531 ' HB ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -123.14 -76.61 0.59 Allowed 'General case' 0 C--O 1.213 -0.863 1 O-C-N 130.786 4.463 . . . . 0.0 112.869 179.939 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER 65.03 32.47 10.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.632 1.208 . . . . 0.0 109.438 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 61' ' ' THR . 3.7 mp -71.35 84.06 0.79 Allowed 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 128.371 3.545 . . . . 0.0 108.334 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -72.28 115.73 11.87 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 77' ' ' LYS . . . -150.29 -155.36 6.82 Favored Glycine 0 C--O 1.199 -2.041 1 C-N-CA 110.423 -5.656 . . . . 0.0 107.801 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.653 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.28 1.1 t -179.73 130.17 0.1 Allowed 'General case' 0 CA--C 1.499 -0.994 1 O-C-N 134.394 6.585 . . . . 0.0 110.969 -177.391 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.675 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 71.7 m95 -140.86 113.12 7.92 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 118.307 -2.745 . . . . 0.0 106.509 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 p -96.57 54.83 1.38 Allowed 'General case' 0 N--CA 1.428 -1.528 2 O-C-N 132.16 5.912 . . . . 0.0 116.316 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.6 tpp -40.13 107.69 0.07 Allowed 'General case' 0 C--O 1.212 -0.908 1 O-C-N 134.398 7.311 . . . . 0.0 104.833 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -130.48 115.95 17.53 Favored 'General case' 0 C--O 1.21 -0.979 0 O-C-N 128.526 3.641 . . . . 0.0 106.85 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.89 -132.05 46.22 Favored Glycine 0 CA--C 1.55 2.225 0 C-N-CA 117.01 -2.519 . . . . 0.0 107.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 11.9 m120 -97.95 52.78 1.07 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 115.679 -2.105 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -132.99 171.65 13.68 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 125.108 1.505 . . . . 0.0 113.753 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.1 mt -153.11 46.06 0.67 Allowed 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.939 1.352 . . . . 0.0 113.146 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.4 134.12 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 110.27 -3.15 . . . . 0.0 115.679 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' CH2' ' A' ' 67' ' ' TRP . . . 157.87 -157.49 28.27 Favored Glycine 0 CA--C 1.554 2.495 1 N-CA-C 102.863 -4.095 . . . . 0.0 102.863 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.563 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.314 0.0 OUTLIER -173.14 131.6 0.49 Allowed 'General case' 0 C--N 1.363 1.153 0 O-C-N 129.326 3.603 . . . . 0.0 116.319 179.604 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.675 ' CE1' ' CZ2' ' A' ' 67' ' ' TRP . 1.2 m-85 -112.07 163.29 14.46 Favored 'General case' 0 C--O 1.193 -1.878 1 CA-C-O 129.117 4.294 . . . . 0.0 101.706 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 ttmt -171.2 146.69 2.41 Favored 'General case' 0 N--CA 1.441 -0.908 1 CA-C-N 104.39 -5.823 . . . . 0.0 117.087 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.418 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -94.91 104.81 16.7 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 115.041 -2.409 . . . . 0.0 107.287 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 35.6 m -78.5 76.38 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 1 O-C-N 131.53 5.519 . . . . 0.0 111.933 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.13 -47.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 O-C-N 129.095 3.997 . . . . 0.0 108.538 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -179.05 5.17 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 127.271 2.857 . . . . 0.0 116.408 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.17 -44.09 3.89 Favored Glycine 0 CA--C 1.545 1.947 1 N-CA-C 102.139 -4.384 . . . . 0.0 102.139 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 86.69 -156.92 0.01 OUTLIER 'General case' 0 C--O 1.252 1.227 1 O-C-N 132.357 5.386 . . . . 0.0 113.372 179.991 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.24 148.83 49.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.836 2.562 . . . . 0.0 117.425 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD11 ' CG ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -141.7 36.37 1.62 Allowed 'General case' 0 C--O 1.206 -1.21 1 O-C-N 132.619 6.199 . . . . 0.0 110.388 179.589 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.489 HD11 ' HD3' ' A' ' 77' ' ' LYS . 36.7 mt -53.65 163.95 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.558 1 CA-C-N 107.223 -4.535 . . . . 0.0 106.062 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.13 59.95 1.71 Allowed 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 128.585 3.678 . . . . 0.0 106.047 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.7 118.13 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 1 O-C-N 129.327 4.142 . . . . 0.0 104.057 179.866 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -178.74 160.82 1.2 Allowed 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 113.302 -3.359 . . . . 0.0 114.352 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HG3' ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -144.52 134.61 24.07 Favored 'General case' 0 N--CA 1.424 -1.748 2 O-C-N 132.583 6.177 . . . . 0.0 108.129 179.642 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.34 108.77 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 1 O-C-N 130.974 5.172 . . . . 0.0 110.085 179.909 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.99 91.05 3.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 126.895 2.622 . . . . 0.0 115.647 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.75 -122.42 6.59 Favored Glycine 0 C--O 1.208 -1.479 0 N-CA-C 103.692 -3.763 . . . . 0.0 103.692 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -130.96 53.51 1.97 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 109.157 -3.521 . . . . 0.0 106.012 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.272 0.2 OUTLIER 174.15 137.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 1 O-C-N 130.434 4.834 . . . . 0.0 108.837 179.957 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.683 HD23 ' HG2' ' A' ' 100' ' ' GLN . 2.5 tt -111.63 120.09 40.9 Favored 'General case' 0 C--O 1.203 -1.343 1 O-C-N 130.795 5.06 . . . . 0.0 109.067 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 100' ' ' GLN . 11.6 mt -54.07 -84.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.316 3 O-C-N 131.526 5.516 . . . . 0.0 108.852 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER 107.06 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.107 1 O-C-N 133.856 6.972 . . . . 0.0 104.039 179.824 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.482 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 18.5 m -96.48 84.34 3.68 Favored 'General case' 0 C--O 1.193 -1.892 2 O-C-N 133.571 6.794 . . . . 0.0 112.749 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.31 121.28 14.46 Favored 'General case' 0 C--O 1.218 -0.555 1 CA-C-N 107.862 -4.245 . . . . 0.0 106.871 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HD12 ' A' ' 88' ' ' ILE . 1.8 m -98.1 70.8 2.1 Favored 'General case' 0 C--N 1.36 1.061 1 O-C-N 130.704 5.002 . . . . 0.0 101.536 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -97.15 130.98 44.34 Favored 'General case' 0 C--N 1.362 1.127 1 CA-C-N 107.347 -4.479 . . . . 0.0 109.422 -179.994 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 34.8 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.12 31.68 25.14 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 114.941 -3.504 . . . . 0.0 116.229 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 104' ' ' TYR . 63.4 t -109.0 -49.12 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 117.934 -1.507 . . . . 0.0 110.83 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.482 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 8.1 tt0 79.07 31.83 0.28 Allowed 'General case' 0 C--N 1.35 0.604 0 O-C-N 127.431 2.957 . . . . 0.0 107.902 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.447 . . -62.42 166.71 4.85 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 113.296 -3.362 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 7.5 mttm -140.49 -48.45 0.43 Allowed 'General case' 0 N--CA 1.438 -1.043 1 O-C-N 131.909 5.756 . . . . 0.0 111.25 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.46 -158.38 0.19 Allowed 'General case' 0 C--O 1.202 -1.4 1 O-C-N 131.766 5.666 . . . . 0.0 104.446 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.78 115.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.47 1 C-N-CA 111.098 -4.241 . . . . 0.0 112.24 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 21.1 m-30 -109.97 174.34 5.91 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 131.102 5.251 . . . . 0.0 106.314 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.03 130.26 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.531 2 O-C-N 131.381 5.425 . . . . 0.0 114.109 -179.382 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.3 tttt -47.22 169.16 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 109.035 -3.712 . . . . 0.0 112.455 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.423 -1.805 0 CA-C-N 111.48 -2.6 . . . . 0.0 113.032 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 98' ' ' LEU . 75.4 m-85 . . . . . 0 CA--C 1.556 1.176 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -148.59 30.38 0.83 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 128.052 3.345 . . . . 0.0 117.324 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -151.53 8.0 Favored Glycine 0 C--N 1.349 1.293 2 C-N-CA 112.933 -4.46 . . . . 0.0 103.707 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.595 HG22 ' OG1' ' A' ' 24' ' ' THR 0.296 0.6 OUTLIER -89.85 -176.55 4.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 128.367 3.039 . . . . 0.0 105.627 179.616 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.334 19.1 m95 -162.63 153.17 16.83 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 113.147 -3.311 . . . . 0.0 113.581 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 15.2 mtmt 63.14 176.59 0.15 Allowed 'General case' 0 N--CA 1.426 -1.629 1 O-C-N 131.769 5.668 . . . . 0.0 119.086 176.389 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.255 0.5 OUTLIER . . . . . 0 CA--C 1.479 -1.786 3 CA-C-O 135.442 7.306 . . . . 0.0 120.869 174.88 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.035 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HG3' ' HD3' ' A' ' 35' ' ' LYS 0.447 0.0 OUTLIER 150.6 174.15 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.682 1 O-C-N 129.504 4.253 . . . . 0.0 102.383 -179.161 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HD11 ' A' ' 25' ' ' ILE . 2.6 mt -119.12 163.62 16.76 Favored 'General case' 0 CA--C 1.557 1.249 3 O-C-N 132.515 6.134 . . . . 0.0 98.742 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.9 m 179.85 96.03 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.238 1 O-C-N 133.902 7.001 . . . . 0.0 108.278 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.839 HD11 HD22 ' A' ' 23' ' ' LEU . 4.7 mp -117.28 140.47 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.193 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -164.78 84.84 0.41 Allowed 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 128.494 3.621 . . . . 0.0 107.539 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -46.06 138.36 5.23 Favored 'General case' 0 N--CA 1.438 -1.052 2 O-C-N 132.943 6.402 . . . . 0.0 110.019 179.482 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -89.47 4.58 48.66 Favored 'General case' 0 C--N 1.343 0.286 1 O-C-N 130.068 4.605 . . . . 0.0 107.457 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.21 -58.46 0.61 Allowed Glycine 0 CA--C 1.55 2.246 2 N-CA-C 100.826 -4.91 . . . . 0.0 100.826 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 -10.46 4.0 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 108.785 -3.708 . . . . 0.0 109.062 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -91.45 169.52 10.71 Favored 'General case' 0 C--N 1.306 -1.308 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 25' ' ' ILE . 31.6 t80 -165.91 71.97 0.15 Allowed 'General case' 0 C--O 1.192 -1.942 1 N-CA-C 95.501 -5.74 . . . . 0.0 95.501 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -71.89 137.01 47.13 Favored 'General case' 0 CA--C 1.503 -0.856 2 O-C-N 133.717 6.886 . . . . 0.0 102.831 -179.883 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.372 0.5 OUTLIER -114.46 144.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 1 N-CA-C 99.774 -4.158 . . . . 0.0 99.774 179.248 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -101.55 58.79 0.86 Allowed 'General case' 0 N--CA 1.422 -1.858 1 CA-C-O 133.491 6.377 . . . . 0.0 117.924 -179.953 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.34 47.19 0.21 Allowed 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 108.92 -3.764 . . . . 0.0 110.151 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 30.8 t -58.05 138.04 56.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 116.017 -2.273 . . . . 0.0 108.343 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.54 127.91 0.14 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 114.737 -2.785 . . . . 0.0 114.746 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.05 -65.7 0.25 Allowed 'General case' 0 C--O 1.223 -0.298 0 O-C-N 128.972 3.92 . . . . 0.0 111.418 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 40.3 m-85 -120.55 102.16 8.25 Favored 'General case' 0 C--O 1.203 -1.393 0 O-C-N 127.861 3.226 . . . . 0.0 112.619 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.1 OUTLIER 61.47 -173.01 0.14 Allowed 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 126.722 2.513 . . . . 0.0 117.248 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -90.23 -20.4 23.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 126.671 2.482 . . . . 0.0 109.159 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 43' ' ' ILE 0.282 5.9 tp 6.84 77.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.427 2 O-C-N 133.312 6.633 . . . . 0.0 111.344 178.845 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.75 148.74 6.96 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 119.494 -2.004 . . . . 0.0 111.161 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.14 98.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 O-C-N 128.177 3.423 . . . . 0.0 104.267 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 47' ' ' PHE 0.285 8.1 p -106.64 164.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 113.662 -3.215 . . . . 0.0 116.072 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' N ' HG22 ' A' ' 46' ' ' VAL . 1.7 p90 -171.74 -161.79 0.2 Allowed 'General case' 0 N--CA 1.442 -0.862 1 O-C-N 129.976 4.547 . . . . 0.0 110.722 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -142.76 85.16 1.87 Allowed 'General case' 0 C--N 1.363 1.17 0 O-C-N 127.056 2.722 . . . . 0.0 115.373 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 18.22 94.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 131.261 5.351 . . . . 0.0 116.715 -179.941 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 92.41 46.72 3.44 Favored Glycine 0 C--O 1.207 -1.575 0 CA-C-O 114.209 -3.551 . . . . 0.0 104.95 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 t -134.89 118.53 25.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 1 O-C-N 130.315 4.185 . . . . 0.0 112.696 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.81 159.85 26.35 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 115.477 -2.489 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -173.23 165.57 4.84 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 130.625 4.953 . . . . 0.0 113.376 -179.822 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -125.57 89.98 3.13 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.13 144.57 28.12 Favored 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 116.082 -2.247 . . . . 0.0 113.341 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -106.51 71.38 0.86 Allowed 'General case' 0 CA--C 1.555 1.169 1 O-C-N 129.682 4.363 . . . . 0.0 103.018 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -38.06 -81.19 0.01 OUTLIER 'General case' 0 C--O 1.238 0.46 1 O-C-N 131.839 5.712 . . . . 0.0 114.239 -179.982 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.84 -101.45 0.03 OUTLIER 'General case' 0 C--O 1.247 0.972 0 CA-C-O 115.305 -2.284 . . . . 0.0 112.107 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.94 4.65 8.02 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 126.578 2.424 . . . . 0.0 111.844 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.59 53.65 0.03 OUTLIER Glycine 0 CA--C 1.549 2.203 0 CA-C-O 115.59 -2.784 . . . . 0.0 109.769 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 p -92.09 -64.93 1.05 Allowed 'General case' 0 CA--C 1.551 1.005 0 O-C-N 128.52 3.13 . . . . 0.0 107.352 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER 81.47 32.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.56 1 O-C-N 129.564 4.29 . . . . 0.0 111.076 177.619 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD23 ' CG ' ' A' ' 78' ' ' PHE . 2.7 mp -62.54 82.24 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.105 0 O-C-N 126.371 2.295 . . . . 0.0 110.807 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 62.3 m -69.15 117.47 10.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.78 -154.1 6.15 Favored Glycine 0 C--O 1.209 -1.434 1 C-N-CA 109.99 -5.862 . . . . 0.0 108.136 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.671 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 11.5 t 172.09 129.44 0.02 OUTLIER 'General case' 0 C--O 1.248 1.024 1 O-C-N 134.498 6.646 . . . . 0.0 111.861 -178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 69.9 m95 -136.76 128.76 29.41 Favored 'General case' 0 C--O 1.203 -1.359 1 O-C-N 116.194 -4.066 . . . . 0.0 106.283 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.456 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -111.42 31.85 5.81 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.432 4.832 . . . . 0.0 117.197 -177.988 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.73 ' CB ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 2.29 101.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.916 1 O-C-N 133.388 6.68 . . . . 0.0 109.611 179.377 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' ASN . 1.1 mm-40 -108.45 95.2 5.5 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 129.092 3.995 . . . . 0.0 112.171 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.32 -91.74 0.09 OUTLIER Glycine 0 C--N 1.353 1.51 1 O-C-N 129.55 4.281 . . . . 0.0 108.979 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -136.69 46.57 2.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 129.153 3.502 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.2 mtpt -129.33 163.04 26.58 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 128.843 3.84 . . . . 0.0 110.785 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 98' ' ' LEU . 8.2 mt -141.74 68.38 1.33 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 127.226 2.829 . . . . 0.0 112.186 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.49 83.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 2 O-C-N 131.044 5.215 . . . . 0.0 111.01 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 67' ' ' TRP . . . -150.57 -177.66 24.7 Favored Glycine 0 CA--C 1.555 2.575 2 CA-C-N 106.994 -4.639 . . . . 0.0 102.695 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.308 0.3 OUTLIER -155.14 168.69 26.2 Favored 'General case' 0 C--O 1.204 -1.32 1 O-C-N 132.758 5.623 . . . . 0.0 112.083 -179.733 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 m-85 -148.18 166.85 26.66 Favored 'General case' 0 C--O 1.19 -2.033 1 CA-C-O 128.943 4.211 . . . . 0.0 104.052 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 5.0 ttpt -173.14 132.81 0.51 Allowed 'General case' 0 N--CA 1.418 -2.059 1 CA-C-N 104.428 -5.805 . . . . 0.0 117.992 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -100.88 38.21 1.59 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 126.512 2.383 . . . . 0.0 114.281 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.606 HG22 ' N ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 7.02 -67.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.999 1 O-C-N 131.772 5.67 . . . . 0.0 115.041 179.832 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.606 ' N ' HG22 ' A' ' 81' ' ' VAL . 9.9 t0 -42.59 -26.01 0.11 Allowed 'General case' 0 N--CA 1.443 -0.808 1 O-C-N 130.248 4.717 . . . . 0.0 112.543 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.11 -16.45 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 113.954 -3.098 . . . . 0.0 117.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.446 ' HA3' ' HG3' ' A' ' 80' ' ' ARG . . . -97.79 -32.75 6.09 Favored Glycine 0 CA--C 1.548 2.147 1 C-N-CA 112.98 -4.438 . . . . 0.0 104.226 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.87 -157.85 0.06 Allowed 'General case' 0 C--O 1.25 1.089 1 O-C-N 131.672 4.983 . . . . 0.0 113.416 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.621 ' N ' ' HD3' ' A' ' 79' ' ' LYS 0.347 0.0 OUTLIER -61.88 133.46 55.46 Favored 'General case' 0 C--O 1.198 -1.638 1 O-C-N 129.534 4.271 . . . . 0.0 114.745 -177.598 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 80' ' ' ARG 0.255 2.4 mt -136.68 38.45 2.63 Favored 'General case' 0 C--O 1.208 -1.132 1 O-C-N 136.145 8.403 . . . . 0.0 109.641 -179.697 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 103' ' ' THR . 90.7 mt -61.83 163.5 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.707 1 CA-C-N 107.239 -4.528 . . . . 0.0 102.608 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.99 67.98 1.33 Allowed 'General case' 0 C--O 1.211 -0.939 1 O-C-N 134.47 7.356 . . . . 0.0 105.45 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.64 131.34 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-N 111.824 -2.444 . . . . 0.0 108.962 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -152.4 -158.25 0.88 Allowed 'General case' 0 N--CA 1.435 -1.209 1 C-N-CA 110.856 -4.338 . . . . 0.0 112.311 179.771 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 166.48 79.17 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.318 1 O-C-N 130.592 4.933 . . . . 0.0 105.265 -178.593 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 0.4 OUTLIER -24.08 92.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 1 O-C-N 132.383 6.052 . . . . 0.0 113.785 -179.419 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 p -53.07 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.102 1 O-C-N 129.261 4.101 . . . . 0.0 116.36 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -112.63 0.74 Allowed Glycine 0 CA--C 1.559 2.795 0 C-N-CA 115.633 -3.175 . . . . 0.0 106.46 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -117.38 46.19 1.76 Allowed 'General case' 0 C--N 1.362 1.133 1 CA-C-N 106.937 -4.632 . . . . 0.0 109.14 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.568 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -172.48 152.52 2.67 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 128.316 3.51 . . . . 0.0 106.863 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.552 HD22 ' HG2' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -104.32 107.37 18.25 Favored 'General case' 0 C--O 1.204 -1.306 2 O-C-N 132.321 6.013 . . . . 0.0 108.147 179.532 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -56.26 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.891 2 O-C-N 134.696 7.498 . . . . 0.0 103.287 -179.998 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.552 ' HG2' HD22 ' A' ' 98' ' ' LEU . 7.7 mm-40 99.45 98.1 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.079 1 O-C-N 130.257 4.723 . . . . 0.0 103.263 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.715 HG23 ' HG2' ' A' ' 110' ' ' LYS . 20.8 m -100.96 95.46 6.61 Favored 'General case' 0 C--O 1.195 -1.812 2 O-C-N 130.529 4.893 . . . . 0.0 111.236 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.2 m-85 -66.97 131.28 45.55 Favored 'General case' 0 C--O 1.202 -1.408 3 CA-C-N 106.411 -4.904 . . . . 0.0 106.481 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 88' ' ' ILE . 90.5 m -111.94 80.1 1.29 Allowed 'General case' 0 C--O 1.199 -1.553 1 O-C-N 131.824 5.702 . . . . 0.0 107.021 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -101.09 154.73 18.48 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 108.705 -3.862 . . . . 0.0 110.649 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.3 mm-40 -32.65 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.559 ' O ' HG13 ' A' ' 107' ' ' VAL . . . 88.88 10.15 67.19 Favored Glycine 0 C--N 1.357 1.727 0 C-N-CA 115.752 -3.118 . . . . 0.0 116.851 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -158.02 173.36 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 115.975 -1.964 . . . . 0.0 114.657 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.67 58.45 1.61 Allowed 'General case' 0 C--N 1.353 0.752 1 O-C-N 131.491 5.495 . . . . 0.0 107.067 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.321 . . -80.56 121.63 26.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 128.42 3.575 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG2' HG23 ' A' ' 101' ' ' THR . 11.4 mttt -104.28 179.61 4.22 Favored 'General case' 0 N--CA 1.426 -1.666 1 O-C-N 133.718 6.886 . . . . 0.0 108.536 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -159.14 135.82 9.38 Favored 'General case' 0 CA--C 1.562 1.406 2 O-C-N 130.131 4.644 . . . . 0.0 99.014 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 99' ' ' ILE . 1.2 pt -111.23 111.47 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 1 O-C-N 132.2 5.938 . . . . 0.0 114.039 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 93.0 m-85 -109.63 -142.18 0.38 Allowed 'General case' 0 CA--C 1.559 1.321 1 O-C-N 131.48 5.488 . . . . 0.0 101.901 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -149.94 0.06 Allowed 'General case' 0 C--O 1.205 -1.25 1 O-C-N 132.9 6.375 . . . . 0.0 111.417 179.56 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.674 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.2 tttt -131.63 -175.68 3.79 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 124.997 2.332 . . . . 0.0 112.616 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.204 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 CA--C 1.556 1.18 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -170.06 59.44 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 114.4 -2.92 . . . . 0.0 114.953 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 48.4 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 1 C-N-CA 111.366 -5.206 . . . . 0.0 107.24 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 34.8 p 59.22 162.85 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.814 1 O-C-N 132.269 5.334 . . . . 0.0 111.479 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.285 8.4 m95 -157.38 149.06 22.15 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 116.328 -1.796 . . . . 0.0 114.079 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 38.4 mtmt 59.71 178.96 0.09 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 21' ' ' LEU 0.257 0.5 OUTLIER . . . . . 0 CA--C 1.481 -1.674 3 O-C-N 134.061 7.101 . . . . 0.0 120.693 174.864 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 114.424 -2.703 . . . . 0.0 104.586 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.396 0.0 OUTLIER -147.12 140.2 25.23 Favored 'General case' 0 CA--C 1.566 1.569 1 O-C-N 131.029 5.205 . . . . 0.0 100.612 179.687 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.0 mt -98.4 164.39 12.3 Favored 'General case' 0 C--N 1.318 -0.799 2 O-C-N 133.072 6.482 . . . . 0.0 98.811 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.61 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 20.8 m 174.04 89.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 O-C-N 128.882 3.864 . . . . 0.0 104.155 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.829 HG21 ' CE1' ' A' ' 32' ' ' PHE 0.263 4.4 mp -111.05 152.86 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 108.533 -3.94 . . . . 0.0 110.809 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.0 m -162.34 80.22 0.52 Allowed 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 114.134 -3.026 . . . . 0.0 108.045 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -52.35 124.0 12.24 Favored 'General case' 0 C--O 1.214 -0.814 2 O-C-N 132.996 6.435 . . . . 0.0 110.992 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -116.84 111.0 19.08 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 128.608 3.692 . . . . 0.0 103.229 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 -114.17 4.43 Favored Glycine 0 CA--C 1.546 2.026 1 N-CA-C 101.69 -4.564 . . . . 0.0 101.69 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 62.99 1.07 Allowed 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 127.338 2.434 . . . . 0.0 107.38 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.05 161.87 33.22 Favored 'General case' 0 C--N 1.306 -1.312 1 N-CA-C 98.936 -4.468 . . . . 0.0 98.936 -179.842 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.829 ' CE1' HG21 ' A' ' 25' ' ' ILE . 69.1 t80 -158.0 72.9 0.66 Allowed 'General case' 0 C--O 1.193 -1.918 1 N-CA-C 99.439 -4.282 . . . . 0.0 99.439 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -72.78 139.43 47.07 Favored 'General case' 0 CA--C 1.505 -0.761 2 O-C-N 131.784 5.677 . . . . 0.0 103.827 179.933 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.383 0.5 OUTLIER -120.13 137.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 128.782 3.802 . . . . 0.0 101.427 179.915 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 8.2 tttm -87.52 17.85 4.3 Favored 'General case' 0 N--CA 1.414 -2.228 1 N-CA-C 121.871 4.026 . . . . 0.0 121.871 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG2' HG12 ' A' ' 34' ' ' VAL . 7.3 pt-20 -49.68 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 124.727 2.204 . . . . 0.0 110.385 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.601 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 t -77.03 152.82 34.97 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 116.406 -2.117 . . . . 0.0 109.299 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.98 102.09 0.09 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 114.867 -2.733 . . . . 0.0 116.077 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 60.7 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 1 O-C-N 129.574 4.296 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 58' ' ' ALA . 1.1 m-85 -78.18 91.45 4.35 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 115.59 -2.444 . . . . 0.0 110.695 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.29 -160.76 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 129.198 4.061 . . . . 0.0 115.757 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -7.69 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 127.034 2.709 . . . . 0.0 108.205 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.8 tp 11.8 91.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.42 2 O-C-N 132.885 6.366 . . . . 0.0 111.909 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.63 123.35 17.66 Favored 'General case' 0 C--N 1.369 1.433 0 O-C-N 118.219 -2.8 . . . . 0.0 111.071 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' HE1' ' A' ' 47' ' ' PHE . 46.1 t -88.07 106.29 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 2 O-C-N 130.08 4.613 . . . . 0.0 100.014 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.312 10.7 p -118.0 153.51 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 O-C-N 127.444 2.965 . . . . 0.0 114.149 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HG12 ' A' ' 45' ' ' VAL . 2.2 p90 -179.32 -165.63 0.08 Allowed 'General case' 0 N--CA 1.429 -1.521 1 O-C-N 132.357 6.035 . . . . 0.0 111.132 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.75 73.53 1.41 Allowed 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 116.571 -2.052 . . . . 0.0 108.638 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.2 OUTLIER 69.59 -79.22 0.04 OUTLIER 'General case' 0 C--O 1.198 -1.615 2 O-C-N 132.499 6.125 . . . . 0.0 111.666 179.988 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.666 ' HA2' HG22 ' A' ' 68' ' ' THR . . . -127.91 84.09 0.33 Allowed Glycine 0 CA--C 1.537 1.437 0 N-CA-C 104.665 -3.374 . . . . 0.0 104.665 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.12 -40.74 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 O-C-N 131.341 4.789 . . . . 0.0 111.641 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.86 125.22 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.935 2 O-C-N 133.013 6.446 . . . . 0.0 108.368 179.906 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 3.3 p90 -167.25 140.6 3.55 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 112.311 -3.756 . . . . 0.0 115.37 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -90.76 151.21 21.3 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 100.846 -3.761 . . . . 0.0 100.846 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.472 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -170.51 135.1 1.16 Allowed 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 112.236 -3.786 . . . . 0.0 109.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 91.21 8.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 114.456 -2.688 . . . . 0.0 105.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 55' ' ' TYR . 10.5 mp -68.87 -96.11 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 O-C-N 129.544 4.277 . . . . 0.0 114.24 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 40' ' ' PHE . . . -46.66 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 126.587 2.429 . . . . 0.0 116.185 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.0 14.17 4.75 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 124.939 1.399 . . . . 0.0 112.739 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.66 58.68 0.09 OUTLIER Glycine 0 CA--C 1.544 1.858 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.82 ' HB ' HD13 ' A' ' 63' ' ' LEU . 71.7 p -67.3 -60.57 2.48 Favored 'General case' 0 N--CA 1.425 -1.722 1 O-C-N 131.755 5.032 . . . . 0.0 110.126 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 65.73 46.71 2.29 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 125.487 1.742 . . . . 0.0 108.532 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.82 HD13 ' HB ' ' A' ' 61' ' ' THR . 5.2 mp -99.84 84.12 2.85 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 127.66 3.1 . . . . 0.0 107.644 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 22.8 m -70.04 105.85 3.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 111.362 -2.654 . . . . 0.0 110.286 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -166.31 -156.42 9.48 Favored Glycine 0 CA--C 1.557 2.681 1 C-N-CA 111.954 -4.927 . . . . 0.0 104.314 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CE1' ' A' ' 78' ' ' PHE 0.26 8.8 t -161.27 135.54 7.02 Favored 'General case' 0 CA--C 1.491 -1.29 1 O-C-N 131.793 5.055 . . . . 0.0 114.481 179.525 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.744 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 9.4 m95 -115.03 97.66 6.35 Favored 'General case' 0 C--O 1.192 -1.96 0 O-C-N 117.839 -3.038 . . . . 0.0 104.553 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.666 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -101.16 97.36 7.9 Favored 'General case' 0 N--CA 1.447 -0.609 2 O-C-N 137.421 9.201 . . . . 0.0 114.879 179.952 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.596 ' HB3' HD21 ' A' ' 49' ' ' LEU . 3.6 ttp -56.69 109.53 0.64 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 128.974 3.922 . . . . 0.0 105.402 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 28.9 tt0 -101.68 65.12 1.01 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.158 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -105.78 0.79 Allowed Glycine 0 CA--C 1.551 2.327 0 O-C-N 128.817 3.823 . . . . 0.0 103.924 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.78 62.7 2.72 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 128.63 3.194 . . . . 0.0 109.041 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -172.23 179.14 2.67 Favored 'General case' 0 C--N 1.358 0.955 1 O-C-N 129.678 4.361 . . . . 0.0 109.95 179.934 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 74' ' ' LEU . 2.5 mt -157.6 74.54 0.75 Allowed 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 127.272 2.857 . . . . 0.0 112.191 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.58 134.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.037 -2.347 . . . . 0.0 116.036 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 173.78 -166.1 38.18 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 103.745 -3.742 . . . . 0.0 103.745 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 88' ' ' ILE 0.251 12.5 tttm 176.65 117.67 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.348 1 O-C-N 133.822 6.248 . . . . 0.0 113.345 179.997 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.744 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.1 OUTLIER -114.59 171.5 7.6 Favored 'General case' 0 C--O 1.192 -1.932 0 O-C-N 128.768 3.793 . . . . 0.0 101.335 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.338 0.0 OUTLIER -170.43 142.1 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 108.922 -3.763 . . . . 0.0 115.061 -179.001 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.513 ' CB ' ' HB3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.63 106.08 18.22 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 118.295 -1.362 . . . . 0.0 108.887 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.65 -16.82 17.59 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 1 O-C-N 130.777 5.048 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.04 -36.27 72.27 Favored 'General case' 0 C--O 1.252 1.206 0 O-C-N 129.091 3.994 . . . . 0.0 111.677 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -122.9 3.95 9.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 126.747 2.529 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 69.17 43.28 72.38 Favored Glycine 0 CA--C 1.558 2.746 2 N-CA-C 100.863 -4.895 . . . . 0.0 100.863 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -105.08 132.19 51.63 Favored 'General case' 0 N--CA 1.44 -0.946 2 CA-C-N 105.617 -5.291 . . . . 0.0 115.429 -179.539 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 6.2 mt-10 -110.16 139.6 45.14 Favored 'General case' 0 C--O 1.199 -1.554 0 CA-C-N 121.344 1.884 . . . . 0.0 107.844 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.7 45.44 2.81 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 133.031 6.457 . . . . 0.0 110.28 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 77' ' ' LYS . 96.9 mt -68.81 168.03 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.949 1 CA-C-N 107.929 -4.214 . . . . 0.0 103.592 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB3' ' CZ3' ' A' ' 67' ' ' TRP . . . -143.22 107.7 4.81 Favored 'General case' 0 C--O 1.195 -1.803 1 O-C-N 130.83 5.081 . . . . 0.0 105.587 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 t -110.87 106.95 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 128.645 3.716 . . . . 0.0 102.519 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -156.08 162.5 40.27 Favored 'General case' 0 C--O 1.189 -2.111 1 C-N-CA 110.411 -4.516 . . . . 0.0 116.136 -179.535 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.16 136.86 20.4 Favored 'General case' 0 N--CA 1.439 -1.015 2 O-C-N 132.84 6.337 . . . . 0.0 109.8 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.2 mm -47.55 124.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 1 O-C-N 131.891 5.744 . . . . 0.0 110.177 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -126.43 101.43 6.69 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 128.526 3.641 . . . . 0.0 117.297 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.94 39.05 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 59.32 44.15 15.73 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 111.637 -2.282 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.672 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.265 0.1 OUTLIER -158.71 157.64 32.16 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 114.621 -2.609 . . . . 0.0 108.309 179.063 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.469 ' CD2' ' HG2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -113.65 141.32 47.35 Favored 'General case' 0 C--O 1.208 -1.11 1 O-C-N 133.733 6.896 . . . . 0.0 109.187 179.894 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.29 5.0 mt -105.55 -46.35 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 1 O-C-N 129.302 4.126 . . . . 0.0 107.621 -179.863 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 63.2 100.5 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.142 1 O-C-N 129.58 4.3 . . . . 0.0 104.366 -179.367 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 m -98.55 96.76 8.19 Favored 'General case' 0 N--CA 1.427 -1.594 2 O-C-N 130.604 4.94 . . . . 0.0 111.949 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.28 126.15 28.86 Favored 'General case' 0 C--O 1.202 -1.438 1 CA-C-N 107.422 -4.445 . . . . 0.0 105.227 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -103.63 68.02 0.92 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -84.19 132.67 34.65 Favored 'General case' 0 CA--C 1.493 -1.213 1 CA-C-N 106.436 -4.893 . . . . 0.0 117.187 -179.63 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 44.58 31.72 0.66 Allowed 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.94 6.46 67.1 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.939 -2.077 . . . . 0.0 112.673 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.73 148.08 21.84 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-O 116.615 -1.66 . . . . 0.0 111.833 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -107.12 107.76 18.89 Favored 'General case' 0 C--N 1.371 1.517 1 O-C-N 129.116 4.01 . . . . 0.0 107.441 -179.671 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.429 . . -135.52 137.29 41.93 Favored 'General case' 0 N--CA 1.417 -2.093 1 O-C-N 130.053 4.596 . . . . 0.0 112.446 179.846 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 175.98 8.86 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 130.612 4.945 . . . . 0.0 110.479 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 37.9 mtt85 -141.24 130.36 23.39 Favored 'General case' 0 N--CA 1.48 1.059 2 O-C-N 129.861 4.476 . . . . 0.0 99.627 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 134.28 28.03 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 C-N-CA 114.359 -2.936 . . . . 0.0 112.84 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 2.6 m-85 -147.95 -157.13 0.78 Allowed 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 131.199 5.312 . . . . 0.0 107.37 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -166.94 -144.21 0.06 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 131.802 5.689 . . . . 0.0 112.061 -179.737 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 10.4 tttt -128.99 -171.74 2.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.462 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.21 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 O-C-N 127.163 2.789 . . . . 0.0 117.8 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 24' ' ' THR . . . 171.06 171.78 36.64 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 114.68 -3.628 . . . . 0.0 106.029 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -97.14 153.57 17.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 114.747 -2.781 . . . . 0.0 103.735 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.661 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 18.0 m95 -126.87 170.59 12.07 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 111.845 -3.931 . . . . 0.0 112.58 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.1 mtmt 43.58 -178.71 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.851 1 O-C-N 130.747 5.029 . . . . 0.0 117.366 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.277 1.2 t . . . . . 0 CA--C 1.484 -1.595 2 O-C-N 131.522 5.513 . . . . 0.0 118.013 174.982 . . . . . . . . 2 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.565 1.526 0 CA-C-O 111.767 -3.968 . . . . 0.0 101.413 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 61.22 149.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 134.048 7.092 . . . . 0.0 105.825 179.224 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.534 HD11 HE21 ' A' ' 100' ' ' GLN . 5.6 mt -124.93 172.75 9.13 Favored 'General case' 0 N--CA 1.436 -1.146 3 CA-C-N 106.285 -4.961 . . . . 0.0 99.067 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 18.0 m -168.21 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 1 O-C-N 129.429 4.206 . . . . 0.0 108.553 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 2' ' ' PHE . 1.9 mp 72.14 137.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 109.202 -3.635 . . . . 0.0 109.557 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 m -170.11 73.56 0.07 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -52.35 145.29 11.37 Favored 'General case' 0 C--O 1.207 -1.177 2 O-C-N 133.307 6.63 . . . . 0.0 114.662 179.678 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.07 62.07 1.34 Allowed 'General case' 0 C--N 1.358 0.962 1 O-C-N 131.921 5.763 . . . . 0.0 104.361 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.45 57.01 0.81 Allowed Glycine 0 CA--C 1.552 2.357 1 C-N-CA 112.21 -4.805 . . . . 0.0 103.873 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 53.17 14.09 0.46 Allowed 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 112.733 -3.508 . . . . 0.0 110.6 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 84.27 5.77 Favored 'General case' 0 CA--C 1.55 0.976 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.601 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 6.3 m-85 -82.12 142.38 32.3 Favored 'General case' 0 CA--C 1.562 1.415 1 N-CA-C 96.646 -5.316 . . . . 0.0 96.646 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.83 112.99 15.36 Favored 'General case' 0 N--CA 1.482 1.155 3 O-C-N 137.527 9.267 . . . . 0.0 97.421 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 36' ' ' GLU 0.383 1.2 t -80.32 149.87 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 C-N-CA 111.01 -4.276 . . . . 0.0 104.764 179.934 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.286 0.7 OUTLIER -85.15 2.86 41.76 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 109.275 -3.602 . . . . 0.0 120.317 179.622 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -47.98 109.07 0.19 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.25 -3.159 . . . . 0.0 108.359 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -103.57 126.87 50.98 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 127.202 2.814 . . . . 0.0 107.595 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -152.46 -160.61 1.16 Allowed 'General case' 0 C--O 1.24 0.595 0 O-C-N 126.889 2.618 . . . . 0.0 112.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.25 -89.05 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.351 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.34 45.18 0.07 Allowed 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 113.732 -3.187 . . . . 0.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER 170.71 -164.35 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.959 1 O-C-N 133.573 6.796 . . . . 0.0 111.834 -179.912 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.48 121.12 44.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 1.9 tt -148.65 91.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.137 2 O-C-N 130.093 4.62 . . . . 0.0 109.378 -179.16 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.3 142.85 54.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 108.9 -3.773 . . . . 0.0 110.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 HD13 ' A' ' 57' ' ' LEU . 20.8 t -105.05 99.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.264 2 O-C-N 131.413 5.446 . . . . 0.0 99.876 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.338 3.6 p -101.56 168.07 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 112.393 -3.723 . . . . 0.0 115.656 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -164.85 163.13 21.18 Favored 'General case' 0 N--CA 1.434 -1.266 1 O-C-N 130.861 5.101 . . . . 0.0 112.583 -179.506 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.09 28.91 6.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 115.546 -2.462 . . . . 0.0 114.699 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 61.7 86.61 0.11 Allowed 'General case' 0 N--CA 1.441 -0.899 1 O-C-N 130.483 4.864 . . . . 0.0 115.811 179.931 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 76.24 75.0 0.9 Allowed Glycine 0 C--O 1.199 -2.046 0 N-CA-C 104.496 -3.441 . . . . 0.0 104.496 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.61 -42.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 1 O-C-N 130.678 4.399 . . . . 0.0 116.378 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.7 OUTLIER 78.44 126.85 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.132 1 O-C-N 129.408 4.193 . . . . 0.0 111.52 179.939 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -161.19 151.73 17.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 113.635 -3.226 . . . . 0.0 115.069 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.09 118.43 36.75 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 101.346 -3.575 . . . . 0.0 101.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.7 138.52 28.94 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 114.958 -2.697 . . . . 0.0 111.484 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.32 98.2 10.41 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 128.616 3.698 . . . . 0.0 106.822 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 10.4 mt -84.28 139.26 32.45 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 126.902 2.626 . . . . 0.0 112.378 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . 55.97 5.02 0.14 Allowed 'General case' 0 C--O 1.247 0.954 0 O-C-N 127.252 2.845 . . . . 0.0 114.842 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.21 -39.48 0.36 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.42 -40.71 7.23 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 115.336 -2.924 . . . . 0.0 107.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -79.11 150.73 31.7 Favored 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 130.208 4.123 . . . . 0.0 110.546 -179.88 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' HB2' HG12 ' A' ' 81' ' ' VAL . 17.7 mt-10 -153.49 68.26 0.78 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 113.278 -3.369 . . . . 0.0 106.418 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 87' ' ' LEU . 9.4 mp -79.17 131.15 36.11 Favored 'General case' 0 C--O 1.201 -1.459 2 CA-C-N 107.076 -4.602 . . . . 0.0 113.961 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.6 m -119.82 105.97 11.63 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . -168.4 -160.38 16.1 Favored Glycine 0 CA--C 1.542 1.723 1 C-N-CA 110.75 -5.5 . . . . 0.0 103.781 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 6.1 t -151.68 157.02 41.53 Favored 'General case' 0 N--CA 1.426 -1.639 1 O-C-N 133.35 5.971 . . . . 0.0 117.942 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 33.1 m95 -124.94 112.25 16.38 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 114.629 -2.605 . . . . 0.0 104.689 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 50' ' ' GLY . 9.1 p -107.14 52.68 0.71 Allowed 'General case' 0 N--CA 1.435 -1.192 1 O-C-N 135.51 8.006 . . . . 0.0 116.028 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.82 111.37 0.34 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 134.124 7.14 . . . . 0.0 104.153 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -90.1 -43.28 10.58 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 109.443 -3.526 . . . . 0.0 110.507 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.81 101.86 0.21 Allowed Glycine 0 CA--C 1.532 1.151 0 O-C-N 128.292 3.495 . . . . 0.0 105.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 73' ' ' LYS . 8.0 m120 73.26 13.94 4.61 Favored 'General case' 0 N--CA 1.447 -0.595 1 O-C-N 130.683 4.402 . . . . 0.0 110.008 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 92' ' ' GLU 0.259 0.0 OUTLIER -124.06 -169.37 1.95 Allowed 'General case' 0 N--CA 1.471 0.609 1 O-C-N 129.642 4.339 . . . . 0.0 108.35 -179.72 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 91' ' ' ARG . 0.8 OUTLIER -169.31 43.65 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 128.506 3.629 . . . . 0.0 111.896 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 t -77.51 136.5 24.18 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 3 O-C-N 131.316 5.385 . . . . 0.0 113.24 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.53 -159.96 32.63 Favored Glycine 0 CA--C 1.556 2.655 1 N-CA-C 101.652 -4.579 . . . . 0.0 101.652 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.509 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 178.0 141.26 0.09 Allowed 'General case' 0 C--O 1.201 -1.484 1 O-C-N 130.918 4.54 . . . . 0.0 113.53 -179.449 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -131.18 178.5 6.65 Favored 'General case' 0 C--N 1.367 1.349 3 O-C-N 130.61 4.944 . . . . 0.0 105.694 -179.552 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.324 0.8 OUTLIER -163.74 131.24 3.44 Favored 'General case' 0 C--N 1.365 1.274 1 CA-C-N 106.257 -4.974 . . . . 0.0 113.64 179.906 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 72.7 ttt180 -85.92 94.87 9.29 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.32 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' GLU . 14.3 p -47.41 -26.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 O-C-N 133.175 6.547 . . . . 0.0 113.77 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.32 -0.712 1 O-C-N 130.121 4.638 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.82 -3.45 15.71 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 114.745 -2.782 . . . . 0.0 114.748 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.526 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 70.62 33.36 67.18 Favored Glycine 0 CA--C 1.557 2.674 2 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 3.9 tppt? -72.74 -78.26 0.09 Allowed 'General case' 0 N--CA 1.421 -1.904 1 CA-C-N 105.473 -5.364 . . . . 0.0 120.805 -178.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 52.8 mt-10 83.26 60.29 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.459 1 O-C-N 130.209 4.693 . . . . 0.0 107.906 -177.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 63' ' ' LEU . 5.2 tp -91.48 69.23 5.84 Favored 'General case' 0 CA--C 1.49 -1.341 1 O-C-N 135.009 7.693 . . . . 0.0 112.498 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.677 HD12 HG22 ' A' ' 103' ' ' THR 0.29 78.0 mt -76.81 -179.46 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 69.68 0.73 Allowed 'General case' 0 C--O 1.201 -1.469 0 O-C-N 128.627 3.705 . . . . 0.0 106.223 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.64 137.15 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 110.936 -2.847 . . . . 0.0 105.497 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.622 ' HG3' HD11 ' A' ' 98' ' ' LEU . 0.4 OUTLIER 179.51 162.48 0.89 Allowed 'General case' 0 N--CA 1.414 -2.272 1 C-N-CA 111.363 -4.135 . . . . 0.0 114.044 179.843 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -152.87 154.76 35.74 Favored 'General case' 0 N--CA 1.424 -1.746 1 O-C-N 131.441 5.463 . . . . 0.0 105.534 178.688 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.918 HD13 HD13 ' A' ' 98' ' ' LEU . 4.9 mm -56.09 91.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 1 O-C-N 132.365 6.041 . . . . 0.0 109.694 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB2' HG13 ' A' ' 99' ' ' ILE . 13.9 t -31.31 -59.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 1 O-C-N 133.002 6.439 . . . . 0.0 115.258 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.14 -83.14 0.12 Allowed Glycine 0 CA--C 1.556 2.634 0 N-CA-C 103.24 -3.944 . . . . 0.0 103.24 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.3 26.52 5.41 Favored 'General case' 0 CA--C 1.551 1.007 1 CA-C-N 107.123 -4.538 . . . . 0.0 105.193 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -164.44 163.08 22.32 Favored 'General case' 0 CA--C 1.563 1.45 1 O-C-N 133.049 6.468 . . . . 0.0 106.706 -179.881 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 93' ' ' ILE . 17.2 tp -115.89 136.53 52.95 Favored 'General case' 0 N--CA 1.437 -1.122 1 O-C-N 132.853 6.346 . . . . 0.0 110.484 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 ' HD2' ' A' ' 110' ' ' LYS 0.277 4.2 mt -85.28 -60.79 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 2 CA-C-O 110.796 -4.43 . . . . 0.0 106.102 -179.588 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.534 HE21 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER 86.09 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 1 O-C-N 134.064 7.103 . . . . 0.0 102.865 179.933 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -103.45 98.74 8.59 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.714 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.3 95.74 1.34 Allowed 'General case' 0 C--O 1.21 -1.022 2 CA-C-N 107.489 -4.414 . . . . 0.0 105.086 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.677 HG22 HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -64.1 132.69 51.25 Favored 'General case' 0 N--CA 1.48 1.032 1 O-C-N 129.541 4.276 . . . . 0.0 100.812 179.988 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -160.13 147.43 16.3 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 110.448 -3.069 . . . . 0.0 115.888 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 43.28 28.91 0.19 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.184 -2.28 . . . . 0.0 116.043 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 C--N 1.358 1.796 0 C-N-CA 117.066 -2.492 . . . . 0.0 116.328 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER -131.15 -159.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 118.801 -1.159 . . . . 0.0 112.765 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 107' ' ' VAL . 27.5 mt-10 -138.13 93.67 2.79 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 116.435 -2.106 . . . . 0.0 106.448 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.47 . . -105.13 150.39 25.08 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 125.954 2.034 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -147.78 177.59 9.19 Favored 'General case' 0 N--CA 1.427 -1.603 1 O-C-N 131.52 5.513 . . . . 0.0 110.75 -179.987 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -147.07 107.15 4.0 Favored 'General case' 0 CA--C 1.561 1.366 2 O-C-N 130.757 5.035 . . . . 0.0 99.834 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.31 132.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 O-C-N 128.872 3.857 . . . . 0.0 113.586 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.639 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 13.7 m-30 -140.15 175.73 9.35 Favored 'General case' 0 N--CA 1.423 -1.796 2 O-C-N 133.675 6.86 . . . . 0.0 104.083 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -159.95 -155.21 0.43 Allowed 'General case' 0 C--O 1.2 -1.52 1 O-C-N 131.367 5.417 . . . . 0.0 111.325 179.454 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.661 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.4 tttt -110.21 -173.04 2.16 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.747 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 109.422 -3.535 . . . . 0.0 111.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' THR 0.251 4.2 p-10 -33.1 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.7 1 O-C-N 130.493 4.871 . . . . 0.0 118.541 179.803 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.76 -176.29 43.65 Favored Glycine 0 C--N 1.355 1.594 1 C-N-CA 113.169 -4.348 . . . . 0.0 105.221 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 24' ' ' THR . 46.5 p -97.76 165.93 11.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 112.486 -3.685 . . . . 0.0 103.576 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.658 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 13.1 m95 -136.67 172.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 112.589 -3.576 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.651 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.6 mtmt 38.92 -178.64 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.505 4.878 . . . . 0.0 118.502 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.329 1.0 OUTLIER . . . . . 0 CA--C 1.493 -1.231 3 CA-C-N 105.319 -5.401 . . . . 0.0 118.794 174.915 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 21' ' ' LEU . 1.2 mp . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 113.604 -3.093 . . . . 0.0 102.909 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 37' ' ' SER 0.399 0.0 OUTLIER -150.29 168.62 23.53 Favored 'General case' 0 CA--C 1.566 1.586 1 O-C-N 131.682 5.614 . . . . 0.0 101.776 -179.912 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 7.0 mt -139.95 153.55 46.95 Favored 'General case' 0 CA--C 1.562 1.423 4 O-C-N 132.805 6.315 . . . . 0.0 97.233 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 40.7 m 175.84 77.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 1 O-C-N 131.169 5.293 . . . . 0.0 106.499 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.9 mp -89.13 157.48 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 C-N-CA 114.452 -2.899 . . . . 0.0 110.971 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 86.4 m -167.72 77.78 0.16 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 112.803 -3.559 . . . . 0.0 107.915 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.531 ' CA ' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -55.59 157.54 3.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 128.685 3.74 . . . . 0.0 115.555 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.8 61.56 1.67 Allowed 'General case' 0 C--N 1.356 0.87 0 O-C-N 128.787 3.804 . . . . 0.0 104.547 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.77 -95.39 0.43 Allowed Glycine 0 CA--C 1.555 2.566 2 O-C-N 130.551 4.907 . . . . 0.0 102.443 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -146.82 21.93 1.26 Allowed 'General case' 0 N--CA 1.415 -2.183 2 O-C-N 134.375 6.573 . . . . 0.0 106.392 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -125.46 126.39 44.85 Favored 'General case' 0 CA--C 1.552 1.02 1 O-C-N 129.729 4.393 . . . . 0.0 101.881 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.531 ' HB3' ' CA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -143.13 173.19 11.79 Favored 'General case' 0 C--O 1.193 -1.888 2 N-CA-C 96.162 -5.495 . . . . 0.0 96.162 179.736 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.07 124.66 20.85 Favored 'General case' 0 N--CA 1.473 0.708 2 O-C-N 137.945 9.528 . . . . 0.0 101.605 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.589 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.448 3.0 t -79.24 149.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 113.915 -3.114 . . . . 0.0 103.17 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.304 13.3 tttt -90.05 32.01 0.94 Allowed 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.438 27.8 tt0 -58.51 102.52 0.11 Allowed 'General case' 0 C--N 1.362 1.111 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.506 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 23.2 m -121.26 124.49 44.77 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 127.598 3.061 . . . . 0.0 112.147 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.529 ' CB ' ' HG ' ' A' ' 21' ' ' LEU . 1.5 t 159.34 -50.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 1 O-C-N 130.013 4.571 . . . . 0.0 115.317 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -38.8 -31.71 0.07 Allowed 'General case' 0 C--O 1.219 -0.545 0 O-C-N 128.416 3.572 . . . . 0.0 111.633 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.73 -48.85 0.06 Allowed 'General case' 0 C--N 1.356 0.876 1 C-N-CA 111.232 -4.187 . . . . 0.0 110.38 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.78 43.57 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.58 1.8 . . . . 0.0 114.953 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 84.47 6.18 0.59 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 128.891 3.87 . . . . 0.0 108.008 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 43' ' ' ILE 0.372 0.2 OUTLIER -25.69 92.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.069 3 O-C-N 133.55 6.781 . . . . 0.0 110.325 177.269 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.31 141.82 36.67 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 110.608 -2.996 . . . . 0.0 107.801 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.28 97.15 5.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 1 O-C-N 130.423 4.827 . . . . 0.0 103.86 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.308 1.2 p -95.47 155.64 3.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 C-N-CA 114.424 -2.91 . . . . 0.0 111.817 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.65 177.57 3.88 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 130.949 5.156 . . . . 0.0 111.8 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.19 78.37 1.83 Allowed 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 128.57 3.669 . . . . 0.0 116.144 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.1 OUTLIER 15.58 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.524 1 O-C-N 129.173 4.046 . . . . 0.0 117.204 -179.819 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 96.9 53.46 1.39 Allowed Glycine 0 C--O 1.197 -2.165 0 N-CA-C 105.236 -3.146 . . . . 0.0 105.236 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.62 111.38 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 1 O-C-N 130.611 4.359 . . . . 0.0 112.195 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.24 151.1 28.29 Favored 'General case' 0 N--CA 1.473 0.717 1 O-C-N 130.97 5.169 . . . . 0.0 109.727 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -172.19 113.94 0.31 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 112.217 -3.793 . . . . 0.0 116.86 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.89 53.12 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 101.114 -3.661 . . . . 0.0 101.114 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 57' ' ' LEU . 6.9 t80 -154.53 97.22 1.98 Allowed 'General case' 0 C--O 1.206 -1.212 0 C-N-CA 112.113 -3.835 . . . . 0.0 113.427 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.1 t -64.38 91.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.929 1 O-C-N 130.343 4.777 . . . . 0.0 104.202 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -54.96 -76.11 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 129.022 3.951 . . . . 0.0 111.841 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.71 26.26 0.5 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.02 -24.8 0.15 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -33.47 2.0 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-O 115.072 -3.071 . . . . 0.0 109.033 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.5 p -58.23 -172.38 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 1 O-C-N 130.064 4.038 . . . . 0.0 115.01 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -150.72 -60.86 0.19 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 117.109 -1.836 . . . . 0.0 107.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 mp 34.67 77.46 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.613 1 O-C-N 131.711 5.632 . . . . 0.0 113.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.0 m -87.69 99.66 12.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 112.169 -2.287 . . . . 0.0 107.988 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -159.38 -166.24 17.95 Favored Glycine 0 CA--C 1.536 1.401 1 C-N-CA 111.041 -5.361 . . . . 0.0 108.108 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 5.2 t -150.47 113.51 4.82 Favored 'General case' 0 N--CA 1.437 -1.122 2 O-C-N 132.376 5.397 . . . . 0.0 118.37 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.755 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 40.6 m95 -94.11 129.33 40.7 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 117.409 -3.307 . . . . 0.0 104.332 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.481 HG22 ' HA2' ' A' ' 50' ' ' GLY . 49.2 p -124.65 58.33 1.23 Allowed 'General case' 0 N--CA 1.433 -1.279 1 O-C-N 133.43 6.706 . . . . 0.0 116.301 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.775 ' HB3' HD21 ' A' ' 49' ' ' LEU 0.278 0.0 OUTLIER -42.26 112.43 0.34 Allowed 'General case' 0 N--CA 1.441 -0.896 1 O-C-N 131.116 5.26 . . . . 0.0 104.112 -179.923 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.43 -78.45 0.22 Allowed 'General case' 0 C--O 1.212 -0.903 0 O-C-N 127.975 3.297 . . . . 0.0 108.529 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.05 -76.47 0.06 OUTLIER Glycine 0 CA--C 1.555 2.544 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 37.34 4.11 Favored 'General case' 0 CA--C 1.537 0.45 1 O-C-N 130.09 4.053 . . . . 0.0 108.258 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -130.32 177.48 7.3 Favored 'General case' 0 C--N 1.362 1.126 1 O-C-N 129.249 4.093 . . . . 0.0 112.432 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.3 mt -149.71 46.29 0.94 Allowed 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.54 2.4 . . . . 0.0 113.285 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.82 130.36 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 2 O-C-N 131.015 5.197 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.16 -164.58 36.11 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 103.902 -3.679 . . . . 0.0 103.902 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.568 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -176.38 133.64 0.23 Allowed 'General case' 0 N--CA 1.423 -1.804 0 O-C-N 129.256 3.563 . . . . 0.0 114.149 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.6 OUTLIER -128.13 164.86 21.55 Favored 'General case' 0 C--O 1.203 -1.384 3 O-C-N 135.041 7.713 . . . . 0.0 105.272 179.765 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 85' ' ' LYS . 3.8 tmtt? -154.0 153.17 31.49 Favored 'General case' 0 N--CA 1.417 -2.106 1 CA-C-N 106.744 -4.753 . . . . 0.0 117.734 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 79' ' ' LYS . 44.0 ttt180 -104.13 85.84 2.46 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.942 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -42.68 -27.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 O-C-N 128.564 3.665 . . . . 0.0 113.338 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 30.9 t0 -72.99 0.55 10.99 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 128.787 3.804 . . . . 0.0 112.5 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.6 OUTLIER 102.09 12.0 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.284 1 O-C-N 132.772 6.295 . . . . 0.0 115.671 -179.489 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.03 -39.69 23.04 Favored Glycine 0 CA--C 1.559 2.788 2 C-N-CA 111.27 -5.252 . . . . 0.0 100.87 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 2.1 tttt 83.86 -178.95 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.655 2 O-C-N 134.558 6.681 . . . . 0.0 115.534 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' N ' ' HG2' ' A' ' 79' ' ' LYS 0.257 1.4 mt-10 -38.23 135.92 0.68 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 132.448 6.092 . . . . 0.0 116.586 -178.434 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 39.75 2.59 Favored 'General case' 0 C--O 1.197 -1.696 1 O-C-N 130.816 5.073 . . . . 0.0 110.251 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' A' ' 77' ' ' LYS . 82.8 mt -64.15 149.54 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.445 2 N-CA-C 98.907 -4.479 . . . . 0.0 98.907 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.57 76.8 1.29 Allowed 'General case' 0 C--N 1.315 -0.914 1 O-C-N 134.545 7.403 . . . . 0.0 106.843 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.9 121.67 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 128.564 3.665 . . . . 0.0 102.305 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CD ' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -162.52 157.05 21.7 Favored 'General case' 0 C--O 1.192 -1.953 1 C-N-CA 110.343 -4.543 . . . . 0.0 113.483 -179.71 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -157.29 127.96 6.55 Favored 'General case' 0 C--O 1.209 -1.045 1 O-C-N 130.281 4.738 . . . . 0.0 103.663 179.819 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.569 HD12 ' HG ' ' A' ' 98' ' ' LEU . 1.5 mm -38.0 120.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 1 O-C-N 130.787 5.054 . . . . 0.0 111.793 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 -66.58 0.57 Allowed 'General case' 0 C--O 1.248 0.975 1 O-C-N 129.273 4.108 . . . . 0.0 114.584 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -128.93 -88.92 0.57 Allowed Glycine 0 CA--C 1.547 2.07 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -130.39 44.77 2.91 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 128.985 3.403 . . . . 0.0 106.401 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.573 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.2 172.06 7.6 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.462 4.226 . . . . 0.0 109.298 -179.653 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 93' ' ' ILE . 1.9 mt -133.27 129.6 37.85 Favored 'General case' 0 C--O 1.205 -1.273 1 O-C-N 132.549 6.156 . . . . 0.0 112.16 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 34.4 mt -80.05 -82.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.932 2 O-C-N 129.796 4.435 . . . . 0.0 106.381 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 96.79 85.96 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 1 O-C-N 134.775 7.547 . . . . 0.0 105.026 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.6 m -82.57 92.26 7.08 Favored 'General case' 0 C--O 1.197 -1.688 2 O-C-N 131.18 5.3 . . . . 0.0 111.7 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 16.5 m-85 -68.54 126.5 29.86 Favored 'General case' 0 C--O 1.207 -1.138 2 C-N-CA 110.484 -4.486 . . . . 0.0 106.158 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.52 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 47.9 m -101.08 87.01 3.15 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-O 127.62 3.581 . . . . 0.0 101.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.524 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -109.85 128.17 55.16 Favored 'General case' 0 C--N 1.359 1.001 1 CA-C-N 107.485 -4.416 . . . . 0.0 115.877 -179.978 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 30.3 mt-10 50.41 20.75 0.72 Allowed 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 120.058 -1.651 . . . . 0.0 114.951 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.1 -9.33 54.49 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 117.925 -2.083 . . . . 0.0 114.739 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.739 HG12 ' HB2' ' A' ' 109' ' ' ALA . 21.4 t -100.85 113.5 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.04 91.37 3.09 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.739 ' HB2' HG12 ' A' ' 107' ' ' VAL 0.473 . . -125.77 122.54 36.52 Favored 'General case' 0 N--CA 1.414 -2.262 0 O-C-N 126.704 2.503 . . . . 0.0 116.25 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 101' ' ' THR . 22.9 mtmt -98.0 163.41 12.78 Favored 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 134.902 7.626 . . . . 0.0 108.893 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -107.85 -47.27 3.62 Favored 'General case' 0 CA--C 1.555 1.173 1 O-C-N 130.806 5.066 . . . . 0.0 105.276 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.302 11.6 mt 88.3 103.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 1 O-C-N 130.83 5.081 . . . . 0.0 109.283 179.992 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.651 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 16.8 m-85 -136.07 179.72 6.18 Favored 'General case' 0 N--CA 1.427 -1.601 1 O-C-N 132.695 6.247 . . . . 0.0 107.216 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.573 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -148.23 -152.48 0.44 Allowed 'General case' 0 C--O 1.203 -1.394 1 O-C-N 131.749 5.655 . . . . 0.0 112.369 179.125 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.6 tttt -115.55 -162.08 0.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 126.811 2.044 . . . . 0.0 111.575 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.431 -1.412 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.705 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 57.1 p30 -132.53 47.79 2.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.1 -171.68 38.67 Favored Glycine 0 N--CA 1.482 1.707 1 C-N-CA 110.731 -5.509 . . . . 0.0 105.446 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.371 4.4 p -82.85 -174.53 5.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 112.843 -3.543 . . . . 0.0 104.286 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 93' ' ' ILE 0.27 59.5 m95 -162.0 128.77 3.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 112.625 -3.56 . . . . 0.0 113.475 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.554 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 23.1 mtmt 73.91 177.4 0.24 Allowed 'General case' 0 C--O 1.193 -1.885 0 O-C-N 126.957 2.66 . . . . 0.0 117.229 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.482 -1.638 3 O-C-N 136.592 8.682 . . . . 0.0 120.812 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.21 -1.001 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.435 0.0 OUTLIER -152.83 142.66 22.07 Favored 'General case' 0 CA--C 1.565 1.556 1 O-C-N 129.226 4.079 . . . . 0.0 100.398 179.755 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 7.5 mt -101.16 175.97 5.41 Favored 'General case' 0 C--N 1.311 -1.107 2 O-C-N 132.704 6.252 . . . . 0.0 97.859 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 m 164.38 76.7 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 1 CA-C-O 128.53 4.014 . . . . 0.0 102.223 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 32' ' ' PHE . 3.3 mp -99.55 150.22 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 109.489 -3.505 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 6.2 m -170.79 75.62 0.07 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 113.531 -3.267 . . . . 0.0 102.669 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 2.7 pm0 -51.67 141.42 16.67 Favored 'General case' 0 C--O 1.212 -0.903 1 O-C-N 130.318 4.761 . . . . 0.0 115.862 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.2 pm0 -116.57 103.9 10.87 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 128.857 3.848 . . . . 0.0 103.17 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.61 -121.48 6.05 Favored Glycine 0 N--CA 1.482 1.738 2 N-CA-C 100.747 -4.941 . . . . 0.0 100.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 19.3 m120 -110.49 3.65 19.76 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 114.431 -2.699 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 16.9 mttt -81.36 141.14 34.28 Favored 'General case' 0 CA--C 1.544 0.718 1 N-CA-C 97.421 -5.029 . . . . 0.0 97.421 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -148.93 101.2 3.15 Favored 'General case' 0 C--O 1.194 -1.856 1 N-CA-C 96.048 -5.538 . . . . 0.0 96.048 -179.683 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -101.14 143.87 30.73 Favored 'General case' 0 N--CA 1.454 -0.264 3 O-C-N 134.461 7.351 . . . . 0.0 101.956 -179.718 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 32' ' ' PHE 0.333 1.3 t -111.75 149.5 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 2 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 179.718 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 3.0 tttm -87.32 45.02 1.23 Allowed 'General case' 0 C--O 1.195 -1.778 0 CA-C-O 126.585 3.088 . . . . 0.0 116.394 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 1.3 mm-40 -59.77 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.479 -2.146 . . . . 0.0 109.736 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 35' ' ' LYS . 4.3 t -97.2 117.65 31.87 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.485 2.366 . . . . 0.0 112.319 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.01 -156.45 0.57 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -78.4 -43.46 27.38 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 126.738 2.524 . . . . 0.0 108.763 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -45.58 -65.34 0.55 Allowed 'General case' 0 C--O 1.209 -1.04 1 O-C-N 132.341 6.026 . . . . 0.0 109.145 179.722 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -163.2 -163.39 0.84 Allowed 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 126.9 2.625 . . . . 0.0 111.135 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -16.08 57.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 114.546 -2.861 . . . . 0.0 104.748 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.598 HG13 HD22 ' A' ' 57' ' ' LEU 0.259 0.1 OUTLIER 11.59 68.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.335 3 O-C-N 133.146 6.529 . . . . 0.0 111.575 179.279 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 150.33 28.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.454 -3.521 . . . . 0.0 108.473 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 9.3 p -105.02 115.06 46.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.08 1 O-C-N 130.889 5.118 . . . . 0.0 104.126 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 47' ' ' PHE 0.256 9.7 p -131.05 161.65 40.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 C-N-CA 113.816 -3.154 . . . . 0.0 114.718 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 2.9 p90 177.09 -168.82 0.06 Allowed 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 109.35 -3.568 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.252 0.9 OUTLIER -126.18 82.75 2.1 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 128.704 3.752 . . . . 0.0 115.029 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 69' ' ' MET . 4.8 tp -0.83 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 1 O-C-N 133.614 6.821 . . . . 0.0 116.344 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 49' ' ' LEU . . . 96.4 36.14 5.23 Favored Glycine 0 C--O 1.204 -1.776 0 N-CA-C 104.048 -3.621 . . . . 0.0 104.048 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.81 114.71 22.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 1 O-C-N 130.486 4.286 . . . . 0.0 116.788 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.86 159.25 21.39 Favored 'General case' 0 CA--C 1.556 1.21 1 O-C-N 130.235 4.709 . . . . 0.0 107.882 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -172.83 164.4 5.15 Favored 'General case' 0 N--CA 1.439 -1.007 1 C-N-CA 111.318 -4.153 . . . . 0.0 113.271 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -127.9 80.88 1.99 Allowed 'General case' 0 CA--C 1.563 1.448 1 N-CA-C 100.149 -4.019 . . . . 0.0 100.149 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -102.48 126.19 49.44 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 127.976 3.297 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 t -78.9 171.45 15.17 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 112.209 -3.796 . . . . 0.0 106.643 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.598 HD22 HG13 ' A' ' 43' ' ' ILE . 5.8 mt -151.12 179.55 8.18 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 127.27 2.856 . . . . 0.0 109.514 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' ' 61' ' ' THR . . . 39.48 -98.97 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 O-C-N 128.527 3.642 . . . . 0.0 112.302 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.25 27.37 3.47 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 124.272 0.982 . . . . 0.0 112.87 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.24 71.07 0.29 Allowed Glycine 0 C--N 1.361 1.92 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 25.8 p -104.83 -47.84 3.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.326 1.45 . . . . 0.0 108.559 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.94 58.1 4.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 126.434 2.334 . . . . 0.0 109.743 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 87' ' ' LEU . 5.8 mp -84.26 76.06 10.14 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.466 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 68.8 m -52.07 119.63 4.54 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' C ' HG22 ' A' ' 66' ' ' THR . . . -143.69 -158.16 7.46 Favored Glycine 0 C--O 1.205 -1.671 1 C-N-CA 111.422 -5.18 . . . . 0.0 109.066 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.623 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.296 0.6 OUTLIER 172.78 124.12 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.886 2 O-C-N 132.5 5.471 . . . . 0.0 113.878 -178.413 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 68.2 m95 -133.83 134.1 42.41 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 119.494 -2.004 . . . . 0.0 106.635 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 2.3 p -118.27 36.33 4.41 Favored 'General case' 0 N--CA 1.424 -1.751 2 O-C-N 131.245 5.341 . . . . 0.0 116.677 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.551 ' CB ' HD22 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -8.17 87.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 1 O-C-N 136.392 8.557 . . . . 0.0 109.145 -179.988 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -168.05 1.58 Allowed 'General case' 0 C--N 1.356 0.885 1 CA-C-N 108.22 -4.082 . . . . 0.0 109.613 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.11 92.45 0.14 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 116.894 -2.574 . . . . 0.0 110.734 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 m120 54.42 44.09 29.4 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.074 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -132.42 173.64 11.08 Favored 'General case' 0 C--N 1.347 0.477 1 O-C-N 129.989 4.556 . . . . 0.0 108.576 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -148.81 58.26 1.05 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 128.245 3.466 . . . . 0.0 111.567 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.38 78.68 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.934 2 CA-C-O 129.475 4.464 . . . . 0.0 112.091 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -148.92 -167.32 13.74 Favored Glycine 0 CA--C 1.554 2.518 1 CA-C-N 106.304 -4.953 . . . . 0.0 104.35 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.566 ' HG3' ' N ' ' A' ' 78' ' ' PHE 0.265 0.7 OUTLIER -163.22 171.46 16.21 Favored 'General case' 0 C--N 1.37 1.477 2 O-C-N 131.483 4.873 . . . . 0.0 112.584 179.964 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 42.7 m-85 -149.72 151.88 34.38 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-O 127.738 3.637 . . . . 0.0 101.98 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.57 ' CE ' ' HA2' ' A' ' 84' ' ' GLY 0.29 0.0 OUTLIER -169.04 127.01 0.99 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 109.81 -3.359 . . . . 0.0 117.668 -179.75 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 69.7 mtt180 -76.6 113.02 13.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 126.588 2.43 . . . . 0.0 108.586 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.14 -24.94 25.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 1 O-C-N 131.478 5.486 . . . . 0.0 108.594 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -45.7 -51.65 12.12 Favored 'General case' 0 C--O 1.249 1.077 1 O-C-N 129.622 4.327 . . . . 0.0 112.294 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -141.93 3.97 1.65 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 113.496 -3.282 . . . . 0.0 117.621 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.57 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 98.01 36.3 4.77 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 3.2 tptm -70.96 -64.7 0.85 Allowed 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 120.131 3.382 . . . . 0.0 120.131 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 25.7 mt-10 71.14 87.99 0.11 Allowed 'General case' 0 C--O 1.199 -1.554 1 O-C-N 129.618 4.324 . . . . 0.0 110.926 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' CD2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -110.94 48.41 0.93 Allowed 'General case' 0 C--O 1.193 -1.893 1 O-C-N 132.349 6.031 . . . . 0.0 109.281 179.483 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.469 ' CG2' HG23 ' A' ' 90' ' ' VAL 0.268 98.4 mt -65.2 164.32 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.58 0 CA-C-N 108.582 -3.917 . . . . 0.0 105.675 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.5 71.95 1.39 Allowed 'General case' 0 C--O 1.201 -1.476 1 O-C-N 133.763 6.914 . . . . 0.0 105.309 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 88' ' ' ILE . 76.6 t -76.23 115.62 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 1 O-C-N 132.038 5.836 . . . . 0.0 105.614 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.482 ' CD ' ' HB ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -169.49 165.91 10.32 Favored 'General case' 0 C--O 1.187 -2.204 0 C-N-CA 114.669 -2.812 . . . . 0.0 114.714 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -156.91 118.84 3.84 Favored 'General case' 0 C--O 1.21 -1.005 1 O-C-N 130.479 4.862 . . . . 0.0 107.026 179.669 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.779 HD12 HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -42.61 144.99 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.54 1 O-C-N 133.013 6.445 . . . . 0.0 113.577 179.876 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 t -150.89 123.01 8.25 Favored 'General case' 0 CA--C 1.506 -0.717 1 O-C-N 129.75 4.406 . . . . 0.0 115.996 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.57 13.86 74.85 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 t30 57.47 58.73 3.64 Favored 'General case' 0 CA--C 1.563 1.476 1 O-C-N 131.884 5.108 . . . . 0.0 104.603 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.323 0.4 OUTLIER -178.41 100.21 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.588 1 O-C-N 132.116 5.885 . . . . 0.0 108.66 179.204 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 HD12 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.6 151.78 43.8 Favored 'General case' 0 N--CA 1.423 -1.783 1 O-C-N 130.423 4.827 . . . . 0.0 114.978 179.872 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLN . 26.9 mt -106.69 -106.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.337 3 O-C-N 133.447 6.717 . . . . 0.0 107.922 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.6 mt-30 116.21 93.17 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.519 2 O-C-N 135.261 7.85 . . . . 0.0 98.348 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 110' ' ' LYS . 1.3 m -72.39 -29.77 64.05 Favored 'General case' 0 N--CA 1.42 -1.944 1 O-C-N 133.333 6.646 . . . . 0.0 119.69 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 62.05 76.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 128.626 3.704 . . . . 0.0 105.74 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.6 m -76.35 78.4 3.1 Favored 'General case' 0 C--O 1.204 -1.325 0 O-C-N 128.439 3.587 . . . . 0.0 105.956 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.6 118.02 35.56 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 109.773 -3.376 . . . . 0.0 112.936 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 17.71 63.07 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.19 6.61 61.45 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 117.552 -2.261 . . . . 0.0 116.216 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.83 110.4 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 101' ' ' THR . 2.0 mt-10 -89.27 78.74 7.22 Favored 'General case' 0 C--N 1.363 1.173 0 O-C-N 128.246 3.466 . . . . 0.0 105.125 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.416 . . -86.57 86.2 7.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.319 2.887 . . . . 0.0 116.275 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HG2' HG23 ' A' ' 101' ' ' THR . 5.6 mtmp? -90.61 148.58 22.57 Favored 'General case' 0 N--CA 1.425 -1.683 1 O-C-N 130.042 4.589 . . . . 0.0 108.879 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 14.4 mmt180 -147.6 111.04 4.93 Favored 'General case' 0 CA--C 1.558 1.275 1 O-C-N 130.544 4.902 . . . . 0.0 101.31 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.55 128.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 1 O-C-N 130.908 5.13 . . . . 0.0 111.595 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 m-85 -131.22 -154.77 0.65 Allowed 'General case' 0 C--N 1.318 -0.776 1 O-C-N 131.727 5.642 . . . . 0.0 104.865 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.765 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.31 -138.0 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.595 1 O-C-N 131.336 5.398 . . . . 0.0 113.4 -177.627 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 3.1 tttt -137.34 158.53 44.22 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.417 -2.105 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.361 179.656 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 93' ' ' ILE . 9.9 m-85 . . . . . 0 CA--C 1.561 1.365 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 1.5 m-20 -33.86 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.996 1 O-C-N 130.716 5.01 . . . . 0.0 118.465 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.24 27.09 0.03 OUTLIER Glycine 0 C--N 1.353 1.48 2 C-N-CA 110.485 -5.626 . . . . 0.0 109.683 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.26 157.21 0.16 Allowed 'General case' 0 C--O 1.248 0.983 0 O-C-N 127.696 2.645 . . . . 0.0 110.028 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 23' ' ' LEU 0.3 21.0 m95 -156.16 169.83 23.6 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 111.967 -3.873 . . . . 0.0 112.063 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 4.4 mtmt 44.72 -179.63 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.789 1 O-C-N 133.555 6.784 . . . . 0.0 118.34 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 21' ' ' LEU 0.271 0.4 OUTLIER . . . . . 0 CA--C 1.481 -1.706 3 CA-C-O 135.05 7.119 . . . . 0.0 120.848 174.852 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.642 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.381 0.0 OUTLIER -178.45 178.85 0.82 Allowed 'General case' 0 C--O 1.198 -1.653 1 O-C-N 132.456 6.097 . . . . 0.0 103.386 179.848 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 25' ' ' ILE . 4.0 mt -136.46 166.02 24.47 Favored 'General case' 0 CA--C 1.563 1.446 2 O-C-N 130.74 5.025 . . . . 0.0 97.504 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 86.3 m 175.67 73.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 1 O-C-N 129.715 4.385 . . . . 0.0 107.277 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 23' ' ' LEU . 3.7 mp -86.18 144.88 8.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 113.876 -3.13 . . . . 0.0 109.248 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.7 m -162.75 79.41 0.49 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 116.43 -2.108 . . . . 0.0 105.97 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -53.57 154.63 3.49 Favored 'General case' 0 N--CA 1.441 -0.892 2 O-C-N 132.031 5.832 . . . . 0.0 114.711 179.881 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -124.82 81.85 1.99 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.24 -87.45 1.56 Allowed Glycine 0 CA--C 1.558 2.766 1 N-CA-C 103.086 -4.006 . . . . 0.0 103.086 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -128.27 3.06 5.74 Favored 'General case' 0 N--CA 1.409 -2.506 2 O-C-N 133.212 5.889 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -79.79 160.3 26.21 Favored 'General case' 0 C--N 1.326 -0.432 2 N-CA-C 98.922 -4.473 . . . . 0.0 98.922 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HZ ' HD21 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -170.68 86.52 0.11 Allowed 'General case' 0 C--O 1.201 -1.465 2 N-CA-C 96.418 -5.401 . . . . 0.0 96.418 179.862 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.39 129.85 42.4 Favored 'General case' 0 CA--C 1.507 -0.702 2 O-C-N 132.829 6.331 . . . . 0.0 103.279 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG22 ' CE1' ' A' ' 32' ' ' PHE 0.323 69.3 t -102.29 134.32 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 1 N-CA-C 99.325 -4.324 . . . . 0.0 99.325 179.61 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -81.68 63.04 5.78 Favored 'General case' 0 CA--C 1.49 -1.361 1 CA-C-O 132.495 5.903 . . . . 0.0 116.233 -179.748 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.291 4.8 mt-10 -80.52 71.41 7.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 O-C-N 117.032 -3.543 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 m -77.31 126.48 30.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 112.454 -3.698 . . . . 0.0 107.058 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 -165.92 0.33 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 116.075 -2.25 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.5 m120 69.38 -96.03 0.03 OUTLIER 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.031 0.832 . . . . 0.0 111.415 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -141.26 20.28 2.25 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 127.228 2.83 . . . . 0.0 111.468 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -176.71 -176.55 0.72 Allowed 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 127.595 3.06 . . . . 0.0 111.38 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 122.47 36.79 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.335 0.7 OUTLIER -140.98 146.48 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 2 O-C-N 131.091 5.244 . . . . 0.0 105.204 -179.32 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -116.66 173.62 6.52 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 110.26 -3.155 . . . . 0.0 108.571 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.19 91.41 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.328 1 O-C-N 131.561 5.538 . . . . 0.0 101.115 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -103.38 158.0 5.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 1 O-C-N 130.722 5.014 . . . . 0.0 112.685 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.0 p90 169.23 -158.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.738 1 O-C-N 133.462 6.726 . . . . 0.0 111.006 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 83.74 1.99 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 116.118 -2.233 . . . . 0.0 114.034 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 69' ' ' MET . 1.5 mp 43.44 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 1 O-C-N 130.96 5.163 . . . . 0.0 116.08 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.27 71.72 1.61 Allowed Glycine 0 C--O 1.203 -1.843 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.5 t -144.84 92.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 1 O-C-N 131.182 4.695 . . . . 0.0 112.363 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.32 147.17 34.35 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 113.531 -3.268 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -154.42 161.07 41.91 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 132.392 6.058 . . . . 0.0 115.896 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.71 109.79 20.18 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -179.78 4.54 Favored 'General case' 0 CA--C 1.509 -0.604 1 O-C-N 130.095 4.622 . . . . 0.0 110.294 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.88 99.05 3.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 114.542 -2.863 . . . . 0.0 105.311 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.47 -74.02 0.05 Allowed 'General case' 0 C--O 1.247 0.936 0 O-C-N 126.769 2.543 . . . . 0.0 114.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 18.06 3.16 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 126.358 2.286 . . . . 0.0 115.232 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 73.3 0.49 3.68 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 126.417 2.323 . . . . 0.0 114.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.86 25.18 2.26 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 128.566 3.666 . . . . 0.0 108.161 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 p -118.37 170.87 8.56 Favored 'General case' 0 C--O 1.218 -0.567 1 O-C-N 130.479 4.282 . . . . 0.0 110.173 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -157.38 38.53 0.29 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 113.861 -3.136 . . . . 0.0 106.989 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.0 98.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 108.736 -3.847 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 64' ' ' THR . 2.9 m -99.53 101.6 12.88 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -168.21 -168.12 29.85 Favored Glycine 0 CA--C 1.541 1.702 1 C-N-CA 112.4 -4.714 . . . . 0.0 106.885 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.25 147.62 43.88 Favored 'General case' 0 CA--C 1.499 -0.998 1 O-C-N 133.709 6.182 . . . . 0.0 113.286 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 m95 -124.97 104.87 8.81 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.0 p -101.79 73.44 1.42 Allowed 'General case' 0 C--O 1.2 -1.548 1 O-C-N 134.437 7.335 . . . . 0.0 116.008 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.508 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.17 98.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 2 O-C-N 132.406 6.066 . . . . 0.0 103.813 179.891 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.11 -22.51 28.85 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 117.361 -1.736 . . . . 0.0 110.688 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.81 101.73 0.7 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 104.524 -3.43 . . . . 0.0 104.524 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 61.16 26.9 16.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 110.911 -2.645 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 4.1 mtpt -133.76 -170.7 2.55 Favored 'General case' 0 C--N 1.358 0.951 1 O-C-N 130.606 4.941 . . . . 0.0 111.393 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.665 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -165.76 39.17 0.06 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 114.682 -2.807 . . . . 0.0 112.683 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.98 146.66 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 110.228 -3.169 . . . . 0.0 116.002 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.17 -145.68 13.78 Favored Glycine 0 CA--C 1.559 2.813 1 N-CA-C 100.008 -5.237 . . . . 0.0 100.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.475 ' CB ' HG12 ' A' ' 88' ' ' ILE . 9.4 tttm 171.05 123.04 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 134.861 6.859 . . . . 0.0 114.049 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -113.04 166.53 11.33 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.664 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.276 16.1 ttmt -162.84 149.95 13.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 109.666 -3.425 . . . . 0.0 113.41 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.473 ' NE ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -98.98 72.48 1.91 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 117.242 -1.783 . . . . 0.0 106.306 178.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.4 t -29.74 -52.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 O-C-N 130.74 5.025 . . . . 0.0 115.351 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -52.66 -31.07 35.26 Favored 'General case' 0 N--CA 1.435 -1.197 1 O-C-N 129.322 4.139 . . . . 0.0 112.516 -179.219 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER 170.63 -3.31 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.243 4.09 . . . . 0.0 115.479 -178.83 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.451 ' HA3' ' CD ' ' A' ' 80' ' ' ARG . . . -91.0 -30.02 11.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 104.229 -3.548 . . . . 0.0 104.229 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 76.62 -169.69 0.07 Allowed 'General case' 0 N--CA 1.425 -1.686 1 O-C-N 132.377 5.398 . . . . 0.0 118.455 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.664 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 2.0 mp0 -45.45 139.27 3.8 Favored 'General case' 0 N--CA 1.429 -1.525 1 O-C-N 132.627 6.205 . . . . 0.0 116.111 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.473 HD11 ' NE ' ' A' ' 80' ' ' ARG . 30.3 mt -148.16 47.43 1.06 Allowed 'General case' 0 C--O 1.201 -1.487 1 O-C-N 137.151 9.032 . . . . 0.0 109.806 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' A' ' 77' ' ' LYS . 89.5 mt -64.72 172.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.123 1 CA-C-N 108.342 -4.027 . . . . 0.0 104.097 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.1 66.71 1.49 Allowed 'General case' 0 C--O 1.205 -1.265 1 O-C-N 130.824 5.077 . . . . 0.0 107.903 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.16 110.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 1 O-C-N 131.137 5.273 . . . . 0.0 102.129 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 1.1 tpm_? -164.5 156.41 16.11 Favored 'General case' 0 C--O 1.188 -2.161 1 C-N-CA 111.219 -4.192 . . . . 0.0 113.182 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.572 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 4.2 pt-20 -158.79 134.91 9.07 Favored 'General case' 0 N--CA 1.424 -1.728 2 O-C-N 129.975 4.547 . . . . 0.0 105.149 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.832 ' CD1' HD12 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -39.75 106.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.844 1 O-C-N 132.876 6.36 . . . . 0.0 111.01 179.89 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.11 67.11 Favored 'General case' 0 C--O 1.241 0.625 1 O-C-N 129.255 4.097 . . . . 0.0 114.355 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.46 96.23 0.1 Allowed Glycine 0 CA--C 1.545 1.964 0 C-N-CA 116.181 -2.914 . . . . 0.0 106.961 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 58.05 37.13 26.51 Favored 'General case' 0 N--CA 1.437 -1.121 2 CA-C-N 107.063 -4.569 . . . . 0.0 109.495 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 93' ' ' ILE 0.304 0.0 OUTLIER 179.44 179.46 0.47 Allowed 'General case' 0 CA--C 1.564 1.499 0 O-C-N 128.047 3.342 . . . . 0.0 106.579 179.403 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.832 HD12 ' CD1' ' A' ' 93' ' ' ILE . 8.1 tt -140.54 130.78 25.02 Favored 'General case' 0 C--O 1.211 -0.963 2 O-C-N 134.646 7.466 . . . . 0.0 109.349 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' GLN . 66.7 mt -76.13 -101.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.417 -2.111 1 O-C-N 130.046 4.591 . . . . 0.0 102.717 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.655 ' HG2' HD21 ' A' ' 98' ' ' LEU . 18.0 mt-30 130.34 75.1 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.486 1 O-C-N 131.801 5.688 . . . . 0.0 102.043 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m -81.27 93.34 6.51 Favored 'General case' 0 N--CA 1.428 -1.557 1 O-C-N 131.067 5.23 . . . . 0.0 112.006 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.37 125.1 25.39 Favored 'General case' 0 C--O 1.201 -1.465 2 CA-C-N 106.82 -4.718 . . . . 0.0 105.283 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 m -101.76 76.99 1.69 Allowed 'General case' 0 C--O 1.206 -1.236 1 O-C-N 130.613 4.945 . . . . 0.0 101.747 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.33 109.16 21.34 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 108.702 -3.863 . . . . 0.0 115.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 48.88 37.0 9.12 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.548 -2.114 . . . . 0.0 113.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.65 -12.39 61.21 Favored Glycine 0 C--N 1.346 1.094 1 C-N-CA 113.762 -4.066 . . . . 0.0 113.942 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.47 131.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 117.539 -1.22 . . . . 0.0 112.958 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -90.81 71.92 6.61 Favored 'General case' 0 C--N 1.358 0.936 1 O-C-N 129.359 4.162 . . . . 0.0 107.96 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.395 . . -89.97 103.84 16.46 Favored 'General case' 0 C--O 1.196 -1.723 0 C-N-CA 112.839 -3.545 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 145.14 30.93 Favored 'General case' 0 N--CA 1.417 -2.086 1 O-C-N 133.031 6.457 . . . . 0.0 110.475 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -128.7 119.25 24.28 Favored 'General case' 0 CA--C 1.559 1.311 2 O-C-N 132.029 5.83 . . . . 0.0 99.296 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 10.2 pt -79.22 137.08 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 1 O-C-N 130.11 4.631 . . . . 0.0 113.378 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.637 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.6 m-30 -125.68 -177.87 4.06 Favored 'General case' 0 N--CA 1.435 -1.196 2 O-C-N 135.94 8.275 . . . . 0.0 106.402 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 176.94 127.0 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.233 2 CA-C-O 131.872 5.606 . . . . 0.0 113.329 -179.405 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 10.2 ttmt -41.34 -62.92 0.77 Allowed 'General case' 0 C--O 1.203 -1.381 0 CA-C-O 128.166 3.841 . . . . 0.0 117.193 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.366 1.319 0 CA-C-N 109.363 -3.562 . . . . 0.0 113.171 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.43 98.24 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 O-C-N 127.61 3.069 . . . . 0.0 116.513 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 153.58 6.66 Favored Glycine 0 N--CA 1.464 0.52 0 C-N-CA 114.594 -3.67 . . . . 0.0 104.417 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 10.8 p -66.11 167.94 9.22 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 114.923 -2.711 . . . . 0.0 108.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.616 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.281 35.7 m95 -142.68 149.07 38.37 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 115.471 -2.204 . . . . 0.0 112.724 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 8.5 mtmt 56.7 -179.33 0.05 OUTLIER 'General case' 0 C--O 1.197 -1.663 1 O-C-N 129.488 4.242 . . . . 0.0 117.269 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.265 1.0 OUTLIER . . . . . 0 CA--C 1.485 -1.534 3 O-C-N 135.793 8.183 . . . . 0.0 120.086 174.769 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.371 0.0 OUTLIER -179.24 123.49 0.08 Allowed 'General case' 0 C--O 1.195 -1.787 0 O-C-N 128.878 3.861 . . . . 0.0 105.529 179.956 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 8.8 mt -87.91 162.0 17.15 Favored 'General case' 0 CA--C 1.552 1.036 2 O-C-N 129.862 4.476 . . . . 0.0 101.654 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 87.7 m -178.53 64.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.195 1 O-C-N 130.117 4.636 . . . . 0.0 105.439 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.4 mp -82.48 146.45 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 113.339 -3.344 . . . . 0.0 109.209 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -172.37 79.18 0.05 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 113.546 -3.261 . . . . 0.0 103.273 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -31.0 139.51 0.03 OUTLIER 'General case' 0 C--O 1.208 -1.099 2 O-C-N 134.834 7.584 . . . . 0.0 116.742 179.734 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -104.18 -99.61 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 128.815 3.822 . . . . 0.0 104.177 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.07 80.99 0.36 Allowed Glycine 0 CA--C 1.564 3.123 1 N-CA-C 99.699 -5.361 . . . . 0.0 99.699 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 68.66 28.33 5.71 Favored 'General case' 0 N--CA 1.433 -1.295 2 O-C-N 131.875 5.103 . . . . 0.0 106.646 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.5 ttpp -131.91 110.1 10.55 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 128.925 3.89 . . . . 0.0 101.315 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -101.36 166.37 10.78 Favored 'General case' 0 C--O 1.197 -1.687 2 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 -179.434 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 98.17 4.38 Favored 'General case' 0 N--CA 1.478 0.96 3 O-C-N 137.692 9.37 . . . . 0.0 97.356 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.409 0.9 OUTLIER -72.42 127.33 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 2 C-N-CA 109.643 -4.823 . . . . 0.0 98.984 179.705 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.429 25.1 tttt -76.18 8.43 3.3 Favored 'General case' 0 C--N 1.368 1.387 0 CA-C-N 109.978 -3.283 . . . . 0.0 119.581 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.421 2.6 mt-10 -47.76 106.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 111.038 -2.801 . . . . 0.0 103.502 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 p -138.36 145.84 41.57 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 128.282 3.489 . . . . 0.0 106.57 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.3 p -140.28 -175.25 4.19 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 116.217 -2.193 . . . . 0.0 112.373 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -15.98 60.81 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 127.408 2.943 . . . . 0.0 105.02 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -97.26 -109.8 0.16 Allowed 'General case' 0 N--CA 1.435 -1.215 1 CA-C-N 108.194 -4.093 . . . . 0.0 108.934 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.717 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -135.75 44.97 2.46 Favored 'General case' 0 CA--C 1.496 -1.114 1 O-C-N 129.161 4.038 . . . . 0.0 117.785 -179.076 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -72.62 -35.68 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.901 ' CG2' HD21 ' A' ' 57' ' ' LEU 0.267 5.1 tt 11.96 60.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 2 O-C-N 133.944 7.027 . . . . 0.0 112.036 178.318 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.93 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.831 -2.44 . . . . 0.0 111.436 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.31 50.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.275 3.0 p -61.53 167.22 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 O-C-N 129.065 3.978 . . . . 0.0 112.782 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -166.44 -157.1 0.26 Allowed 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.926 3.891 . . . . 0.0 111.064 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 1.2 mt-10 -138.42 52.79 1.81 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 126.472 2.357 . . . . 0.0 114.802 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 2.3 tp 18.11 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.533 1 CA-C-O 130.004 4.716 . . . . 0.0 117.461 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.32 51.4 8.62 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 103.375 -3.89 . . . . 0.0 103.375 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.52 121.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 1 O-C-N 134.53 6.664 . . . . 0.0 115.177 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.54 16.22 Favored 'General case' 0 C--O 1.21 -1.002 1 O-C-N 131.58 5.55 . . . . 0.0 110.167 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 9.5 p90 -176.99 169.47 2.37 Favored 'General case' 0 N--CA 1.421 -1.879 0 O-C-N 128.554 3.659 . . . . 0.0 114.457 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 136.67 52.77 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.23 101.62 4.06 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 128.923 3.889 . . . . 0.0 113.409 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 t -69.92 155.98 39.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 113.296 -3.361 . . . . 0.0 102.844 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.901 HD21 ' CG2' ' A' ' 43' ' ' ILE . 5.5 tp -147.21 -92.66 0.09 Allowed 'General case' 0 C--O 1.245 0.85 1 O-C-N 129.269 4.106 . . . . 0.0 110.745 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.717 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . . . -60.06 -5.45 1.03 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 112.921 -3.418 . . . . 0.0 115.999 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t70 106.49 -15.65 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.595 1 O-C-N 129.531 4.269 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.11 -55.6 0.26 Allowed Glycine 0 CA--C 1.558 2.74 0 N-CA-C 104.202 -3.559 . . . . 0.0 104.202 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 p -39.56 137.87 0.78 Allowed 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 128.968 3.393 . . . . 0.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.94 37.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 114.551 -2.86 . . . . 0.0 109.023 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' HD21 ' A' ' 87' ' ' LEU . 10.2 mp -42.02 97.91 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.687 1 O-C-N 130.658 4.974 . . . . 0.0 112.225 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.4 m -93.84 99.39 11.77 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 111.602 -2.544 . . . . 0.0 106.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.69 -175.71 34.0 Favored Glycine 0 C--O 1.201 -1.937 1 C-N-CA 111.617 -5.087 . . . . 0.0 108.556 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' THR . 15.0 t -140.85 143.81 34.97 Favored 'General case' 0 CA--C 1.5 -0.978 2 O-C-N 132.509 5.476 . . . . 0.0 111.883 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.691 ' CZ2' ' HB3' ' A' ' 89' ' ' ALA . 15.3 m95 -124.25 111.64 16.08 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -99.98 41.88 1.14 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 135.485 7.991 . . . . 0.0 113.613 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.431 ' HB2' HD13 ' A' ' 49' ' ' LEU . 4.6 tmm? -37.52 107.43 0.06 Allowed 'General case' 0 C--N 1.317 -0.806 1 O-C-N 134.434 7.334 . . . . 0.0 107.917 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -82.99 -74.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.305 0 O-C-N 129.055 3.972 . . . . 0.0 108.525 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.56 -79.85 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.117 1 O-C-N 129.435 4.21 . . . . 0.0 107.993 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.58 44.21 2.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 127.991 2.818 . . . . 0.0 108.865 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -141.08 178.73 7.18 Favored 'General case' 0 C--N 1.356 0.865 1 O-C-N 129.147 4.029 . . . . 0.0 112.451 -179.96 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 4.8 mt -148.28 91.87 1.96 Allowed 'General case' 0 C--N 1.321 -0.649 0 O-C-N 126.584 2.428 . . . . 0.0 110.596 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.28 119.68 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 O-C-N 128.321 3.513 . . . . 0.0 117.444 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.55 -141.33 5.82 Favored Glycine 0 CA--C 1.557 2.673 1 CA-C-N 108.082 -4.145 . . . . 0.0 103.772 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.474 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -178.79 131.68 0.12 Allowed 'General case' 0 C--O 1.204 -1.334 1 O-C-N 131.772 5.042 . . . . 0.0 113.966 -179.972 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.4 OUTLIER -127.13 167.9 15.38 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-O 127.417 3.484 . . . . 0.0 101.672 179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 6.8 ttmt -170.48 144.14 2.39 Favored 'General case' 0 N--CA 1.427 -1.617 1 CA-C-N 106.857 -4.702 . . . . 0.0 114.138 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 69.64 0.8 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 125.105 1.503 . . . . 0.0 107.175 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -31.64 -40.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.39 1 O-C-N 131.184 5.302 . . . . 0.0 115.472 -179.828 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 11.6 p-10 -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.442 -0.832 1 O-C-N 131.03 5.206 . . . . 0.0 112.549 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 172.08 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 O-C-N 128.903 3.877 . . . . 0.0 115.998 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.5 -34.38 6.08 Favored Glycine 0 CA--C 1.543 1.79 0 N-CA-C 104.092 -3.603 . . . . 0.0 104.092 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.492 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 78.0 -171.19 0.06 Allowed 'General case' 0 N--CA 1.436 -1.158 1 O-C-N 132.153 5.266 . . . . 0.0 117.272 -179.804 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 77.6 mt-10 -48.6 149.48 1.67 Allowed 'General case' 0 N--CA 1.432 -1.334 1 O-C-N 132.355 6.034 . . . . 0.0 113.456 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 63' ' ' LEU 0.257 0.1 OUTLIER -158.18 35.38 0.24 Allowed 'General case' 0 C--O 1.196 -1.751 1 O-C-N 135.255 7.847 . . . . 0.0 109.343 178.772 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' THR 0.251 42.7 mt -50.28 127.49 6.1 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.639 1 O-C-N 132.98 6.425 . . . . 0.0 100.479 -179.794 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -87.62 68.88 9.64 Favored 'General case' 0 C--O 1.205 -1.244 1 O-C-N 132.878 6.361 . . . . 0.0 110.958 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 t -66.92 108.36 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 1 C-N-CA 111.567 -4.053 . . . . 0.0 102.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 98' ' ' LEU . 8.9 ttm180 -139.05 168.73 19.19 Favored 'General case' 0 C--O 1.195 -1.778 0 O-C-N 128.479 3.612 . . . . 0.0 111.674 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.12 94.09 0.05 Allowed 'General case' 0 C--N 1.363 1.184 2 O-C-N 132.458 6.099 . . . . 0.0 108.438 179.829 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -28.28 105.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.749 1 O-C-N 133.424 6.702 . . . . 0.0 112.115 -179.938 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.9 m -94.55 130.73 40.85 Favored 'General case' 0 N--CA 1.439 -0.976 1 O-C-N 129.117 4.01 . . . . 0.0 113.541 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.1 -116.27 7.07 Favored Glycine 0 CA--C 1.561 2.91 1 N-CA-C 100.653 -4.979 . . . . 0.0 100.653 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.69 57.69 1.05 Allowed 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 129.609 3.77 . . . . 0.0 107.999 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.705 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.269 0.0 OUTLIER 176.77 115.55 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.53 1 O-C-N 130.694 4.996 . . . . 0.0 107.312 179.375 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 93' ' ' ILE . 1.5 tp -65.3 148.34 51.87 Favored 'General case' 0 N--CA 1.416 -2.158 2 O-C-N 133.366 6.667 . . . . 0.0 111.686 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.519 HG21 ' HD2' ' A' ' 110' ' ' LYS . 2.2 mt -130.27 128.92 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 3 O-C-N 131.6 5.563 . . . . 0.0 102.571 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' NE ' ' A' ' 91' ' ' ARG . 1.8 mt-30 -119.75 129.09 54.33 Favored 'General case' 0 C--O 1.21 -1.003 1 O-C-N 135.395 7.935 . . . . 0.0 101.796 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 110' ' ' LYS . 68.6 p -82.34 -43.96 16.79 Favored 'General case' 0 N--CA 1.41 -2.467 2 O-C-N 131.184 5.303 . . . . 0.0 116.457 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 59.95 61.03 1.98 Allowed 'General case' 0 C--O 1.205 -1.281 1 O-C-N 129.331 4.144 . . . . 0.0 104.406 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' ILE . 54.7 m -55.2 101.85 0.06 Allowed 'General case' 0 N--CA 1.479 1.002 1 N-CA-C 100.119 -4.03 . . . . 0.0 100.119 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 113.1 20.86 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 109.165 -3.652 . . . . 0.0 110.561 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -4.79 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 107' ' ' VAL . . . 94.92 -3.8 67.64 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 116.618 -2.706 . . . . 0.0 112.536 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 106' ' ' GLY . 1.4 t -162.56 154.12 3.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -119.15 114.14 21.99 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 128.206 3.441 . . . . 0.0 102.334 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.378 . . -102.96 81.64 2.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 116.314 -2.155 . . . . 0.0 114.295 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD2' HG21 ' A' ' 99' ' ' ILE . 1.6 mtmm -72.25 150.72 43.39 Favored 'General case' 0 N--CA 1.435 -1.18 1 O-C-N 129.993 4.558 . . . . 0.0 108.859 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.8 mtp180 -131.91 -164.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 1 O-C-N 131.381 5.426 . . . . 0.0 103.234 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -162.0 79.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.044 1 C-N-CA 111.45 -4.1 . . . . 0.0 109.85 179.993 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 41.6 m-85 -100.2 -145.08 0.34 Allowed 'General case' 0 C--N 1.319 -0.757 1 O-C-N 130.552 4.907 . . . . 0.0 105.704 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.705 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.47 -154.45 0.16 Allowed 'General case' 0 C--O 1.197 -1.699 1 O-C-N 131.979 5.799 . . . . 0.0 111.462 -179.856 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 21.5 tttt -115.21 -141.71 0.38 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 111.842 -2.436 . . . . 0.0 111.605 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.222 -179.512 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 98' ' ' LEU . 98.3 m-85 . . . . . 0 CA--C 1.554 1.133 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 24.4 p-10 -169.32 32.55 0.02 OUTLIER 'General case' 0 C--N 1.364 1.202 0 CA-C-N 110.137 -3.211 . . . . 0.0 115.914 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.53 159.62 21.18 Favored Glycine 0 C--N 1.346 1.105 1 C-N-CA 113.38 -4.248 . . . . 0.0 106.777 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -58.26 134.21 56.34 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 115.382 -2.527 . . . . 0.0 109.723 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.301 70.8 m95 -114.89 140.71 48.76 Favored 'General case' 0 N--CA 1.412 -2.342 1 CA-C-O 111.087 -4.292 . . . . 0.0 111.983 -179.807 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 11.4 mtmt 67.13 177.81 0.23 Allowed 'General case' 0 N--CA 1.424 -1.736 1 O-C-N 131.547 5.529 . . . . 0.0 118.164 176.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.486 -1.51 3 O-C-N 136.329 8.518 . . . . 0.0 120.802 174.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.437 0 CA-C-O 114.663 -2.589 . . . . 0.0 104.885 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.323 1.4 ptmt 163.52 150.39 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.466 1 O-C-N 134.967 7.667 . . . . 0.0 103.661 179.85 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 2.9 mt -114.04 176.35 5.08 Favored 'General case' 0 CA--C 1.56 1.354 2 O-C-N 131.778 5.673 . . . . 0.0 98.486 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.646 ' O ' HD12 ' A' ' 25' ' ' ILE . 77.8 m -162.03 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 128.729 3.768 . . . . 0.0 107.668 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.673 HG21 ' CE2' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 63.9 145.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-O 124.784 2.231 . . . . 0.0 115.947 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 169.27 67.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -26.15 124.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.28 2 O-C-N 135.804 8.19 . . . . 0.0 114.173 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -9.02 53.29 Favored 'General case' 0 N--CA 1.482 1.128 1 O-C-N 130.918 5.136 . . . . 0.0 106.371 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.87 -40.83 0.35 Allowed Glycine 0 CA--C 1.55 2.279 1 N-CA-C 102.171 -4.372 . . . . 0.0 102.171 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.79 -12.13 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.926 1 O-C-N 131.461 4.859 . . . . 0.0 112.817 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -78.95 120.21 23.22 Favored 'General case' 0 N--CA 1.48 1.062 1 N-CA-C 96.253 -5.462 . . . . 0.0 96.253 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.673 ' CE2' HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -126.45 105.33 8.69 Favored 'General case' 0 C--O 1.208 -1.118 1 N-CA-C 98.73 -4.545 . . . . 0.0 98.73 -179.263 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -109.21 127.07 53.93 Favored 'General case' 0 CA--C 1.492 -1.267 2 O-C-N 135.603 8.064 . . . . 0.0 104.435 -179.814 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.324 2.2 t -93.95 143.8 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-O 126.659 3.123 . . . . 0.0 103.248 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -86.59 70.03 10.4 Favored 'General case' 0 C--O 1.196 -1.718 2 CA-C-O 133.405 6.336 . . . . 0.0 112.902 179.114 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -78.34 44.8 0.52 Allowed 'General case' 0 N--CA 1.42 -1.95 1 CA-C-N 107.49 -4.414 . . . . 0.0 109.672 -179.697 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 t -67.78 119.81 13.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 114.023 -3.071 . . . . 0.0 104.803 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.32 100.07 0.94 Allowed 'General case' 0 C--O 1.244 0.791 0 O-C-N 127.442 2.964 . . . . 0.0 109.934 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 62.47 -173.32 0.15 Allowed 'General case' 0 C--N 1.361 1.094 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 12.6 m-85 57.2 -95.56 0.06 Allowed 'General case' 0 C--N 1.357 0.915 1 O-C-N 129.371 4.169 . . . . 0.0 106.667 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD2' ' HB3' ' A' ' 40' ' ' PHE 0.291 1.4 mpt_? -153.58 -161.5 1.27 Allowed 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 128.249 2.62 . . . . 0.0 111.316 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -103.91 98.93 8.7 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 128.022 3.326 . . . . 0.0 103.12 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.263 0.1 OUTLIER -131.17 151.02 35.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 2 CA-C-O 130.784 5.088 . . . . 0.0 110.051 -178.894 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.1 m-20 -117.67 173.18 6.88 Favored 'General case' 0 N--CA 1.427 -1.62 1 CA-C-N 107.189 -4.55 . . . . 0.0 109.588 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.03 105.86 19.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 1 O-C-N 132.825 6.328 . . . . 0.0 101.0 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.313 6.3 p -112.27 158.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 113.671 -3.212 . . . . 0.0 116.187 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.455 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.2 p90 -171.52 -132.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.647 1 O-C-N 131.761 5.663 . . . . 0.0 111.026 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.48 58.87 0.22 Allowed 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 112.924 -3.511 . . . . 0.0 114.898 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 31.53 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 127.345 2.903 . . . . 0.0 116.637 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 58.4 2.36 Favored Glycine 0 CA--C 1.547 2.09 1 N-CA-C 102.73 -4.148 . . . . 0.0 102.73 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -156.52 118.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.779 1 O-C-N 131.858 5.093 . . . . 0.0 113.43 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 1.0 OUTLIER -78.17 160.58 27.91 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 129.403 4.19 . . . . 0.0 107.625 179.723 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CE1' ' C ' ' A' ' 65' ' ' GLY . 15.2 p90 -175.85 149.2 0.91 Allowed 'General case' 0 C--N 1.36 1.048 2 O-C-N 132.328 6.018 . . . . 0.0 115.576 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -110.92 90.58 3.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 115.556 -2.164 . . . . 0.0 106.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.24 135.61 38.92 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 127.568 3.042 . . . . 0.0 111.897 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -96.43 85.08 3.83 Favored 'General case' 0 CA--C 1.551 1.007 1 O-C-N 130.857 5.098 . . . . 0.0 105.759 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' THR . 3.7 mp -71.05 -173.03 0.76 Allowed 'General case' 0 C--O 1.243 0.721 1 O-C-N 132.394 6.059 . . . . 0.0 110.264 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . 49.05 -146.86 0.32 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-O 115.033 -2.413 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.54 -6.09 55.17 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 128.027 3.329 . . . . 0.0 108.935 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.16 49.83 0.02 OUTLIER Glycine 0 CA--C 1.549 2.181 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.9 m -102.39 116.61 32.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 126.585 1.991 . . . . 0.0 109.18 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.5 119.21 36.8 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 115.574 -2.45 . . . . 0.0 109.115 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.14 60.82 1.38 Allowed 'General case' 0 C--O 1.202 -1.415 0 CA-C-N 110.726 -2.943 . . . . 0.0 107.215 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 54.4 m -41.7 117.03 0.86 Allowed 'General case' 0 N--CA 1.436 -1.142 1 O-C-N 129.23 4.081 . . . . 0.0 104.175 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' C ' ' CE1' ' A' ' 53' ' ' PHE . . . -149.1 -159.74 8.74 Favored Glycine 0 C--O 1.209 -1.436 1 C-N-CA 110.175 -5.774 . . . . 0.0 108.65 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 52' ' ' ASP 0.287 0.7 OUTLIER 175.25 130.94 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.136 2 O-C-N 131.992 5.172 . . . . 0.0 111.808 -178.252 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.75 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 33.4 m95 -136.31 121.01 18.43 Favored 'General case' 0 C--O 1.203 -1.351 0 O-C-N 119.044 -2.285 . . . . 0.0 106.46 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -98.76 22.49 9.99 Favored 'General case' 0 N--CA 1.426 -1.63 2 O-C-N 130.651 4.969 . . . . 0.0 116.988 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 4.22 88.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 1 O-C-N 136.567 8.667 . . . . 0.0 108.322 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -94.99 95.2 8.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 128.047 3.342 . . . . 0.0 111.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.45 -102.2 0.3 Allowed Glycine 0 CA--C 1.541 1.66 1 O-C-N 129.268 4.105 . . . . 0.0 105.565 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . 74.9 m-20 -120.24 53.37 1.09 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 115.31 -2.281 . . . . 0.0 113.103 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 2.4 mtpt -135.92 171.47 14.42 Favored 'General case' 0 C--N 1.343 0.308 1 O-C-N 130.978 5.174 . . . . 0.0 109.185 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -142.08 54.74 1.46 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 127.874 3.234 . . . . 0.0 111.797 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.88 102.0 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.862 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -171.33 -161.62 22.27 Favored Glycine 0 C--O 1.2 -2.021 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.288 0.0 OUTLIER -156.89 165.39 36.32 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 129.028 3.428 . . . . 0.0 113.713 -179.508 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.75 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 33.7 m-85 -145.54 153.84 41.54 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 101.248 -3.612 . . . . 0.0 101.248 176.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.325 0.0 OUTLIER -171.45 130.99 0.72 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 110.255 -3.157 . . . . 0.0 116.86 -179.633 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 85' ' ' LYS . 94.0 mtt180 -81.39 100.58 9.33 Favored 'General case' 0 N--CA 1.439 -0.989 1 O-C-N 129.374 4.171 . . . . 0.0 108.977 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.91 -26.85 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 1 O-C-N 132.208 5.943 . . . . 0.0 108.757 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -57.0 -39.52 74.85 Favored 'General case' 0 N--CA 1.442 -0.837 1 O-C-N 132.215 5.947 . . . . 0.0 110.466 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -126.15 -2.47 7.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 127.513 3.008 . . . . 0.0 117.073 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.503 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 77.61 38.01 29.17 Favored Glycine 0 C--O 1.2 -2.025 2 C-N-CA 112.224 -4.798 . . . . 0.0 101.889 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.26 15.4 tptp -81.05 -71.92 0.45 Allowed 'General case' 0 N--CA 1.424 -1.755 2 O-C-N 132.695 5.585 . . . . 0.0 120.935 -178.87 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 12.3 mm-40 73.93 108.38 0.07 Allowed 'General case' 0 N--CA 1.429 -1.506 1 O-C-N 129.206 4.067 . . . . 0.0 113.464 -178.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 63' ' ' LEU . 2.5 pt? -139.56 49.21 1.81 Allowed 'General case' 0 C--O 1.198 -1.635 1 O-C-N 132.255 5.972 . . . . 0.0 109.985 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 76' ' ' GLY 0.255 30.6 mt -61.99 139.71 20.36 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 1 CA-C-N 107.849 -4.251 . . . . 0.0 101.357 -179.812 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.68 97.83 7.61 Favored 'General case' 0 C--O 1.2 -1.54 1 O-C-N 134.73 7.519 . . . . 0.0 103.254 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 101' ' ' THR . 2.8 t -95.34 115.6 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 O-C-N 128.941 3.901 . . . . 0.0 110.541 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CG ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -163.72 -168.54 1.67 Allowed 'General case' 0 C--O 1.192 -1.94 0 C-N-CA 112.923 -3.511 . . . . 0.0 115.933 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.559 ' H ' ' CG ' ' A' ' 91' ' ' ARG 0.296 0.1 OUTLIER -177.12 110.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 1 O-C-N 130.419 4.824 . . . . 0.0 106.127 -179.535 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.6 HD11 ' H ' ' A' ' 97' ' ' GLU . 2.4 tp -33.25 98.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 1 O-C-N 133.46 6.725 . . . . 0.0 113.317 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -84.03 75.17 10.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 116.152 -2.219 . . . . 0.0 115.076 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.26 -123.41 5.94 Favored Glycine 0 CA--C 1.563 3.077 1 N-CA-C 102.585 -4.206 . . . . 0.0 102.585 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -130.52 44.25 2.99 Favored 'General case' 0 N--CA 1.437 -1.112 1 CA-C-N 108.055 -4.072 . . . . 0.0 106.073 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.694 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.278 0.0 OUTLIER -173.4 97.92 0.12 Allowed 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.416 4.823 . . . . 0.0 108.777 179.725 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 2' ' ' PHE . 3.2 tt -72.99 148.64 44.03 Favored 'General case' 0 N--CA 1.424 -1.727 1 O-C-N 130.321 4.763 . . . . 0.0 115.209 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.61 167.26 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 2 CA-C-N 106.345 -4.934 . . . . 0.0 103.429 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.25 98.93 0.83 Allowed 'General case' 0 C--O 1.204 -1.294 1 O-C-N 131.13 5.269 . . . . 0.0 103.895 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 90' ' ' VAL . 8.9 t -85.49 112.34 20.82 Favored 'General case' 0 N--CA 1.428 -1.574 2 O-C-N 131.177 5.298 . . . . 0.0 112.461 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.18 88.97 2.49 Favored 'General case' 0 C--O 1.208 -1.118 2 C-N-CA 110.772 -4.371 . . . . 0.0 105.773 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.8 m -65.4 93.72 0.15 Allowed 'General case' 0 C--O 1.209 -1.076 0 O-C-N 128.659 3.725 . . . . 0.0 101.37 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 1.8 t80 -110.57 114.5 27.96 Favored 'General case' 0 CA--C 1.498 -1.038 1 CA-C-N 107.512 -4.404 . . . . 0.0 111.426 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 47.45 17.59 0.08 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 112.428 -2.169 . . . . 0.0 116.547 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.31 16.91 19.36 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 116.306 -2.854 . . . . 0.0 114.59 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.15 -38.29 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 120.225 2.013 . . . . 0.0 113.357 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 68.16 97.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 1 O-C-N 130.071 4.607 . . . . 0.0 108.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.363 . . -132.07 113.64 13.59 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 128.398 3.561 . . . . 0.0 109.116 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -116.25 -174.34 2.53 Favored 'General case' 0 N--CA 1.421 -1.878 1 O-C-N 133.694 6.871 . . . . 0.0 111.381 -179.422 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -156.5 119.8 4.22 Favored 'General case' 0 C--O 1.204 -1.331 2 O-C-N 130.418 4.824 . . . . 0.0 101.511 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.06 125.36 45.63 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 O-C-N 127.763 3.164 . . . . 0.0 112.903 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 65.6 m-85 -120.58 -141.96 0.34 Allowed 'General case' 0 N--CA 1.446 -0.673 1 O-C-N 131.013 5.196 . . . . 0.0 104.949 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.694 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -164.16 -149.89 0.14 Allowed 'General case' 0 C--O 1.199 -1.579 1 O-C-N 131.538 5.524 . . . . 0.0 112.526 179.903 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.645 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 24.0 tttt -128.56 154.79 45.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 127.211 2.204 . . . . 0.0 111.185 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 N--CA 1.434 -1.228 0 O-C-N 127.767 3.167 . . . . 0.0 113.678 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.554 1.116 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -144.33 57.49 1.32 Allowed 'General case' 0 C--N 1.358 0.938 0 CA-C-N 110.126 -3.215 . . . . 0.0 111.192 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.429 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . -165.53 177.31 40.85 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 114.113 -3.899 . . . . 0.0 105.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.327 23.8 p -80.26 177.81 8.71 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 113.858 -3.137 . . . . 0.0 104.087 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.662 ' CE3' ' HG3' ' A' ' 115' ' ' LYS . 75.3 m95 -150.69 167.86 26.08 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 115.506 -2.187 . . . . 0.0 112.189 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 8.5 mtmt 51.03 179.19 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 O-C-N 127.83 3.207 . . . . 0.0 118.814 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.486 -1.512 3 O-C-N 133.492 6.745 . . . . 0.0 121.414 174.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 114.216 -2.802 . . . . 0.0 106.506 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.407 0.0 OUTLIER -179.14 175.45 0.96 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 133.237 6.586 . . . . 0.0 103.342 -179.7 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -136.96 157.55 46.49 Favored 'General case' 0 CA--C 1.565 1.547 3 O-C-N 133.895 6.997 . . . . 0.0 97.7 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 24' ' ' THR . 2.9 m 177.78 80.44 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 1 O-C-N 131.913 5.758 . . . . 0.0 106.514 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.703 HG22 ' HB2' ' A' ' 32' ' ' PHE . 2.2 mp -95.81 118.76 42.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 CA-C-N 109.451 -3.522 . . . . 0.0 109.079 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.5 m -172.63 68.62 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 128.895 3.872 . . . . 0.0 108.905 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.477 ' HB2' ' C ' ' A' ' 31' ' ' LYS 0.297 1.5 tp60 -73.89 -95.26 0.02 OUTLIER 'General case' 0 C--N 1.354 0.786 1 C-N-CA 110.74 -4.384 . . . . 0.0 115.504 -179.888 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 170.86 144.94 0.03 OUTLIER 'General case' 0 C--O 1.244 0.771 0 O-C-N 128.555 3.659 . . . . 0.0 106.427 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.32 1.0 Allowed Glycine 0 CA--C 1.559 2.792 3 O-C-N 130.902 5.127 . . . . 0.0 102.361 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -152.74 47.64 0.72 Allowed 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.62 6.129 . . . . 0.0 112.317 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 6.1 mttp -118.33 161.85 19.26 Favored 'General case' 0 CA--C 1.552 1.048 1 N-CA-C 96.579 -5.341 . . . . 0.0 96.579 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 25' ' ' ILE . 23.0 p90 -167.8 76.96 0.15 Allowed 'General case' 0 C--O 1.197 -1.706 2 C-N-CA 110.383 -4.527 . . . . 0.0 99.656 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 138.12 58.43 Favored 'General case' 0 CA--C 1.505 -0.755 2 O-C-N 130.907 5.129 . . . . 0.0 100.529 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.853 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 6.8 t -91.05 132.66 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 179.688 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.25 19.8 tttt -73.74 52.61 0.41 Allowed 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 126.732 3.158 . . . . 0.0 117.28 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.853 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.265 50.3 mt-10 -72.28 68.24 0.74 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.869 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -84.49 91.42 7.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 114.257 -2.977 . . . . 0.0 108.85 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 m -87.54 -178.78 6.2 Favored 'General case' 0 C--N 1.367 1.34 0 O-C-N 126.622 2.451 . . . . 0.0 116.549 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.6 -9.16 59.79 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 126.102 2.126 . . . . 0.0 108.351 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 19.7 m-85 -69.3 -55.32 10.82 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 113.341 -3.343 . . . . 0.0 106.978 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -158.95 6.63 0.11 Allowed 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 114.394 -2.717 . . . . 0.0 117.367 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.81 62.97 0.87 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 101.927 -3.361 . . . . 0.0 101.927 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 0.0 OUTLIER -134.88 113.47 16.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 3 CA-C-O 130.994 5.188 . . . . 0.0 111.249 -178.301 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.98 -172.95 4.21 Favored 'General case' 0 C--N 1.372 1.586 1 CA-C-N 107.259 -4.519 . . . . 0.0 109.59 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.26 118.36 31.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 O-C-N 128.839 3.837 . . . . 0.0 101.525 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.33 160.64 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 C-N-CA 113.035 -3.466 . . . . 0.0 111.758 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER 177.09 -176.89 0.15 Allowed 'General case' 0 N--CA 1.435 -1.183 1 O-C-N 129.818 4.449 . . . . 0.0 111.649 -179.819 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.315 3.7 tm-20 -141.97 86.51 1.99 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 114.676 -2.809 . . . . 0.0 113.388 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 36.87 91.64 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.282 1 O-C-N 131.236 5.335 . . . . 0.0 115.743 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.823 ' HA3' HG22 ' A' ' 68' ' ' THR . . . 57.46 65.22 3.71 Favored Glycine 0 C--O 1.203 -1.842 0 CA-C-O 114.248 -3.529 . . . . 0.0 105.713 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.23 -33.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 1 O-C-N 131.511 4.889 . . . . 0.0 113.637 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.8 126.02 0.03 OUTLIER 'General case' 0 C--O 1.2 -1.551 2 O-C-N 132.047 5.842 . . . . 0.0 108.368 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 9.6 p90 -173.7 149.33 1.59 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 112.5 -3.68 . . . . 0.0 117.479 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.56 138.44 40.91 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 100.698 -3.816 . . . . 0.0 100.698 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 56' ' ' SER . 4.4 t80 -150.78 26.96 0.73 Allowed 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 111.757 -3.977 . . . . 0.0 115.082 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 55' ' ' TYR . 7.4 t 23.52 78.68 0.02 OUTLIER 'General case' 0 C--O 1.249 1.061 1 O-C-N 134.693 7.496 . . . . 0.0 110.121 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.44 167.37 19.46 Favored 'General case' 0 C--N 1.317 -0.83 1 O-C-N 129.854 4.472 . . . . 0.0 114.991 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB3' HG23 ' A' ' 61' ' ' THR . . . 45.99 25.12 0.29 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 126.014 2.071 . . . . 0.0 115.388 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.74 42.13 19.18 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 126.926 2.641 . . . . 0.0 115.276 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.86 -48.3 0.06 OUTLIER Glycine 0 C--N 1.367 2.261 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 58' ' ' ALA . 3.5 p -63.61 173.61 1.63 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 127.72 2.659 . . . . 0.0 114.242 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -164.27 36.85 0.08 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 112.436 -3.706 . . . . 0.0 108.794 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 87' ' ' LEU . 8.0 mp -59.82 106.65 0.51 Allowed 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 126.558 2.411 . . . . 0.0 108.485 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.3 m -103.7 107.26 18.04 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 112.102 -2.317 . . . . 0.0 107.688 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -161.0 -163.35 13.88 Favored Glycine 0 C--O 1.203 -1.837 1 C-N-CA 111.16 -5.305 . . . . 0.0 107.499 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.441 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 1.5 t -142.33 114.67 8.37 Favored 'General case' 0 CA--C 1.495 -1.17 2 O-C-N 135.426 7.192 . . . . 0.0 118.735 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.719 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.5 m95 -99.54 112.58 24.77 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.823 HG22 ' HA3' ' A' ' 50' ' ' GLY . 73.7 p -106.03 66.26 0.71 Allowed 'General case' 0 N--CA 1.427 -1.594 1 O-C-N 132.618 6.199 . . . . 0.0 115.022 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -40.05 109.25 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 1 O-C-N 133.839 6.962 . . . . 0.0 103.207 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -66.89 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 127.563 3.04 . . . . 0.0 106.405 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.67 -63.06 0.04 OUTLIER Glycine 0 CA--C 1.556 2.654 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -140.38 16.94 2.39 Favored 'General case' 0 N--CA 1.444 -0.727 1 O-C-N 131.44 4.847 . . . . 0.0 108.647 179.543 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -99.4 176.71 5.42 Favored 'General case' 0 N--CA 1.476 0.826 1 O-C-N 131.307 5.379 . . . . 0.0 108.737 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.4 mt -148.17 45.16 1.07 Allowed 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 126.804 2.565 . . . . 0.0 111.951 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.68 137.75 23.05 Favored 'Isoleucine or valine' 0 C--N 1.364 1.227 1 CA-C-N 106.853 -4.703 . . . . 0.0 114.025 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.88 -149.65 20.5 Favored Glycine 0 CA--C 1.547 2.063 1 N-CA-C 100.649 -4.98 . . . . 0.0 100.649 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 176.5 137.82 0.06 Allowed 'General case' 0 C--O 1.208 -1.083 1 O-C-N 134.046 6.38 . . . . 0.0 112.632 -179.986 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.719 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -124.73 168.02 13.76 Favored 'General case' 0 C--O 1.195 -1.782 2 O-C-N 132.526 6.141 . . . . 0.0 104.814 179.783 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 86' ' ' GLU 0.28 0.0 OUTLIER -163.94 140.54 6.7 Favored 'General case' 0 N--CA 1.427 -1.609 1 CA-C-N 106.227 -4.988 . . . . 0.0 113.398 179.975 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.499 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 32.8 ttt180 -93.46 112.09 23.92 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 127.623 3.077 . . . . 0.0 107.164 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.02 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 1 O-C-N 130.714 5.009 . . . . 0.0 109.217 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.461 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . 32.6 m-20 -87.58 19.85 3.19 Favored 'General case' 0 N--CA 1.44 -0.957 1 O-C-N 134.024 7.078 . . . . 0.0 107.86 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 83' ' ' ASN . 0.3 OUTLIER 83.45 18.03 0.24 Allowed 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 128.502 3.626 . . . . 0.0 117.475 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 80' ' ' ARG . . . -82.49 -11.69 81.55 Favored Glycine 0 CA--C 1.562 2.993 1 C-N-CA 110.335 -5.698 . . . . 0.0 104.116 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 1.7 ttmm 41.55 82.83 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 2 O-C-N 132.672 5.572 . . . . 0.0 121.38 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 18.3 mt-10 82.79 71.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.667 1 O-C-N 129.754 4.409 . . . . 0.0 117.071 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 HD11 ' A' ' 63' ' ' LEU . 1.5 mp -99.83 64.58 1.27 Allowed 'General case' 0 C--O 1.197 -1.697 1 O-C-N 132.198 5.936 . . . . 0.0 113.646 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' A' ' 77' ' ' LYS 0.305 93.8 mt -77.84 -174.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 108.563 -3.926 . . . . 0.0 101.647 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.31 73.47 0.92 Allowed 'General case' 0 C--O 1.196 -1.745 0 O-C-N 128.051 3.345 . . . . 0.0 106.242 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 90' ' ' VAL . 2.4 t -61.87 110.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 110.597 -3.001 . . . . 0.0 105.427 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.686 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -162.82 162.67 26.63 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 111.854 -3.938 . . . . 0.0 113.438 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.686 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -153.69 121.05 5.82 Favored 'General case' 0 CA--C 1.543 0.679 2 CA-C-N 107.326 -4.488 . . . . 0.0 103.806 179.554 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 98' ' ' LEU 0.296 5.0 tt -48.4 108.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 1 O-C-N 131.265 5.353 . . . . 0.0 112.99 -179.766 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -74.74 69.33 1.79 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 130.025 4.578 . . . . 0.0 115.479 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.05 -113.4 2.63 Favored Glycine 0 CA--C 1.558 2.76 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -138.6 47.32 1.96 Allowed 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 129.461 3.683 . . . . 0.0 107.456 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.647 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 179.04 127.64 0.07 Allowed 'General case' 0 CA--C 1.56 1.354 0 O-C-N 128.577 3.673 . . . . 0.0 106.966 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 93' ' ' ILE . 11.9 tp -90.94 162.52 14.72 Favored 'General case' 0 C--O 1.206 -1.231 1 O-C-N 134.209 7.193 . . . . 0.0 111.863 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 110' ' ' LYS . 1.4 mp -107.77 -85.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 2 CA-C-O 110.707 -4.473 . . . . 0.0 103.294 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.3 mm-40 93.82 93.41 0.01 OUTLIER 'General case' 0 C--O 1.202 -1.415 1 O-C-N 133.593 6.808 . . . . 0.0 104.824 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.8 p -83.93 -166.37 1.39 Allowed 'General case' 0 N--CA 1.416 -2.174 1 O-C-N 129.273 4.108 . . . . 0.0 113.177 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -156.22 89.33 1.13 Allowed 'General case' 0 C--O 1.2 -1.552 1 C-N-CA 110.752 -4.379 . . . . 0.0 103.293 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.63 79.11 0.42 Allowed 'General case' 0 C--O 1.213 -0.835 1 O-C-N 129.804 4.44 . . . . 0.0 107.532 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -104.58 100.96 10.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 108.661 -3.881 . . . . 0.0 111.295 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 46.88 17.09 0.05 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.61 -18.57 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 116.388 -2.815 . . . . 0.0 116.41 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.12 142.5 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 119.72 1.76 . . . . 0.0 112.933 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -109.09 87.16 2.43 Favored 'General case' 0 C--N 1.364 1.238 1 O-C-N 129.3 4.125 . . . . 0.0 108.119 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.425 . . -106.71 142.41 36.39 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 116.109 -2.236 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.76 ' HB2' HG23 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -148.64 171.01 16.86 Favored 'General case' 0 N--CA 1.435 -1.184 1 O-C-N 130.875 5.109 . . . . 0.0 109.904 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.503 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -123.96 137.55 54.6 Favored 'General case' 0 CA--C 1.558 1.256 3 O-C-N 129.562 4.289 . . . . 0.0 99.921 179.541 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.09 110.0 15.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 C-N-CA 113.714 -3.194 . . . . 0.0 112.22 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 6.4 m-30 -108.56 175.43 5.47 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 128.84 3.838 . . . . 0.0 103.981 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.647 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.36 -159.19 0.31 Allowed 'General case' 0 C--O 1.198 -1.652 2 O-C-N 131.639 5.587 . . . . 0.0 111.616 179.404 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.662 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 21.6 tttt -112.59 -127.98 0.29 Allowed 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.782 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 . . . . . 0 CA--C 1.561 1.399 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -32.79 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 130.75 5.031 . . . . 0.0 118.294 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.79 -169.7 38.09 Favored Glycine 0 C--N 1.345 1.05 1 C-N-CA 112.006 -4.902 . . . . 0.0 105.496 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.309 0.4 OUTLIER -100.34 167.68 10.25 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 114.074 -3.051 . . . . 0.0 104.929 -179.964 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.656 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.264 34.4 m95 -143.21 140.15 30.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 O-C-N 128.672 3.733 . . . . 0.0 111.109 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' ' HD2' ' A' ' 114' ' ' LYS . 19.3 mtmt 58.2 178.58 0.06 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.306 0.6 OUTLIER . . . . . 0 CA--C 1.484 -1.588 3 O-C-N 136.404 8.565 . . . . 0.0 113.964 174.815 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.136 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.345 0.0 OUTLIER -159.94 149.79 18.27 Favored 'General case' 0 C--O 1.205 -1.259 1 O-C-N 130.856 5.098 . . . . 0.0 104.115 -179.811 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 6.6 mt -116.57 177.68 4.61 Favored 'General case' 0 CA--C 1.562 1.422 2 O-C-N 132.964 6.415 . . . . 0.0 97.937 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.526 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 21.9 m -167.91 -85.31 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 1 O-C-N 130.921 5.138 . . . . 0.0 106.508 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 72.68 162.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 109.163 -3.653 . . . . 0.0 108.853 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 27' ' ' GLN . 90.9 m -138.31 -48.93 0.54 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 112.781 -3.568 . . . . 0.0 108.661 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR 0.316 11.7 pt20 65.97 123.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.027 2 O-C-N 132.503 6.127 . . . . 0.0 115.778 178.762 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 7.1 tt0 -98.97 -130.81 0.22 Allowed 'General case' 0 C--O 1.248 1.022 0 O-C-N 128.795 3.81 . . . . 0.0 104.829 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.14 -53.43 3.91 Favored Glycine 0 CA--C 1.546 2.002 2 N-CA-C 99.594 -5.402 . . . . 0.0 99.594 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.17 75.81 1.57 Allowed 'General case' 0 N--CA 1.44 -0.956 1 CA-C-N 107.589 -4.305 . . . . 0.0 105.862 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -168.28 102.88 0.44 Allowed 'General case' 0 C--O 1.246 0.917 1 C-N-CA 111.418 -4.113 . . . . 0.0 102.337 -179.893 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -140.09 165.25 27.87 Favored 'General case' 0 CA--C 1.562 1.426 1 N-CA-C 99.402 -4.295 . . . . 0.0 99.402 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.95 125.08 21.53 Favored 'General case' 0 N--CA 1.476 0.828 2 O-C-N 137.605 9.316 . . . . 0.0 101.468 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.404 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.352 1.1 t -84.89 132.77 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 112.932 -3.507 . . . . 0.0 103.585 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.308 0.3 OUTLIER -71.94 -0.83 12.44 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 109.361 -3.563 . . . . 0.0 118.875 179.789 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.368 1.0 OUTLIER -37.76 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.106 -2.77 . . . . 0.0 109.192 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -91.93 133.45 35.68 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 115.327 -2.549 . . . . 0.0 109.395 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p 177.02 -169.13 0.06 Allowed 'General case' 0 C--N 1.353 0.746 0 O-C-N 127.65 3.094 . . . . 0.0 112.958 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.08 -91.76 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.624 0 O-C-N 125.276 1.61 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -117.58 -36.54 3.67 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 128.254 3.471 . . . . 0.0 111.609 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -143.14 0.15 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 127.222 2.826 . . . . 0.0 115.228 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.7 -22.31 34.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 116.289 -2.164 . . . . 0.0 107.387 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.666 HG13 HD13 ' A' ' 57' ' ' LEU . 13.9 tt 25.28 69.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.223 2 O-C-N 132.349 6.03 . . . . 0.0 111.1 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 57' ' ' LEU . 11.4 p-10 -65.56 155.3 36.16 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 109.639 -3.437 . . . . 0.0 105.148 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 6.3 t -123.09 117.61 52.19 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 1 O-C-N 129.544 4.277 . . . . 0.0 101.462 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.271 0.3 OUTLIER -118.23 162.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 114.663 -2.815 . . . . 0.0 114.831 179.843 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -177.2 -159.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 130.095 4.622 . . . . 0.0 111.448 -179.961 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.1 49.5 1.85 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 117.757 -1.577 . . . . 0.0 114.582 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 39.52 98.37 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 127.778 3.656 . . . . 0.0 115.28 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.01 52.93 1.56 Allowed Glycine 0 CA--C 1.545 1.957 1 N-CA-C 101.563 -4.615 . . . . 0.0 101.563 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -147.3 122.02 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 1 O-C-N 132.184 5.285 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.52 153.16 22.05 Favored 'General case' 0 CA--C 1.558 1.252 1 O-C-N 130.423 4.827 . . . . 0.0 106.968 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -168.42 124.33 0.99 Allowed 'General case' 0 N--CA 1.426 -1.664 1 O-C-N 129.136 4.023 . . . . 0.0 118.566 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.05 118.78 26.66 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -142.59 135.74 28.5 Favored 'General case' 0 C--O 1.21 -0.999 0 O-C-N 127.573 3.046 . . . . 0.0 112.558 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.35 141.88 28.15 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 128.354 3.534 . . . . 0.0 106.883 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -133.17 -67.47 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 128.758 3.786 . . . . 0.0 114.365 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.23 24.16 4.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 116.848 -1.549 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.12 16.01 5.64 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 125.867 1.979 . . . . 0.0 114.489 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.01 56.36 0.12 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 104.813 -3.315 . . . . 0.0 104.813 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -127.97 -87.82 0.56 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 129.876 3.927 . . . . 0.0 110.393 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 69.76 15.22 8.04 Favored 'General case' 0 CA--C 1.517 -0.317 1 O-C-N 129.465 4.228 . . . . 0.0 109.656 179.927 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.453 HD13 HG22 ' A' ' 61' ' ' THR . 10.9 mp -58.5 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 124.374 2.035 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.0 m -85.95 113.35 21.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 77' ' ' LYS . . . -144.79 -155.47 6.47 Favored Glycine 0 C--O 1.209 -1.445 1 C-N-CA 111.673 -5.06 . . . . 0.0 109.213 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.629 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.27 8.8 t -179.78 135.96 0.12 Allowed 'General case' 0 CA--C 1.496 -1.131 2 O-C-N 133.524 6.073 . . . . 0.0 111.917 -178.154 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 67.7 m95 -141.45 119.63 12.13 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 116.692 -3.755 . . . . 0.0 106.209 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 1.1 p -106.43 34.72 3.25 Favored 'General case' 0 N--CA 1.434 -1.246 2 O-C-N 134.543 7.402 . . . . 0.0 116.154 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.469 ' N ' HD21 ' A' ' 49' ' ' LEU 0.264 4.3 ttm -17.66 84.56 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 1 O-C-N 136.57 8.669 . . . . 0.0 108.058 -179.92 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.72 94.54 9.42 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 128.046 3.341 . . . . 0.0 107.074 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.11 -132.04 36.25 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -85.43 60.66 6.38 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 109.075 -3.563 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 158.83 44.18 Favored 'General case' 0 C--N 1.359 1.015 1 O-C-N 129.297 4.123 . . . . 0.0 111.149 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 74' ' ' LEU . 13.0 mt -141.93 59.59 1.48 Allowed 'General case' 0 C--O 1.209 -1.047 0 O-C-N 128.269 3.481 . . . . 0.0 111.459 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.15 101.66 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 1 CA-C-N 107.531 -4.395 . . . . 0.0 115.601 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.81 -144.99 4.36 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 103.3 -3.92 . . . . 0.0 103.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.3 0.1 OUTLIER -176.89 165.21 2.42 Favored 'General case' 0 C--O 1.201 -1.457 2 O-C-N 131.36 4.8 . . . . 0.0 112.092 -179.767 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 19.9 m-85 -144.38 166.1 26.06 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.572 ' HE2' ' CG ' ' A' ' 86' ' ' GLU 0.283 0.0 OUTLIER -174.28 152.43 1.8 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 108.966 -3.743 . . . . 0.0 117.221 179.327 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HG3' ' CB ' ' A' ' 85' ' ' LYS . 5.8 ptm180 -104.11 78.29 1.5 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 126.299 2.25 . . . . 0.0 107.252 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.473 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 5.6 m -22.12 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 1 O-C-N 133.331 6.644 . . . . 0.0 114.047 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -41.88 -47.02 4.17 Favored 'General case' 0 N--CA 1.451 -0.425 1 O-C-N 134.751 7.532 . . . . 0.0 107.637 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -112.0 -0.28 15.78 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 128.544 3.653 . . . . 0.0 113.304 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.26 34.63 88.62 Favored Glycine 0 CA--C 1.559 2.782 1 N-CA-C 101.361 -4.696 . . . . 0.0 101.361 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -66.02 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 3 O-C-N 132.615 5.538 . . . . 0.0 118.264 179.983 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.572 ' CG ' ' HE2' ' A' ' 79' ' ' LYS . 46.3 mt-10 116.87 133.52 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 1 O-C-N 132.455 6.097 . . . . 0.0 109.136 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.64 42.4 0.48 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 133.289 6.618 . . . . 0.0 110.003 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 86' ' ' GLU 0.256 4.7 mt -67.71 171.52 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.591 1 O-C-N 131.42 5.45 . . . . 0.0 105.004 -179.567 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.68 73.95 1.25 Allowed 'General case' 0 C--O 1.219 -0.545 1 O-C-N 133.66 6.85 . . . . 0.0 107.592 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.69 125.71 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.581 ' HG2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -166.58 153.88 9.46 Favored 'General case' 0 C--O 1.191 -1.982 1 C-N-CA 110.407 -4.517 . . . . 0.0 115.405 179.83 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 4.5 mt-10 -149.04 113.61 5.32 Favored 'General case' 0 N--CA 1.433 -1.324 1 O-C-N 131.018 5.199 . . . . 0.0 107.095 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 98' ' ' LEU 0.26 0.1 OUTLIER -45.5 112.99 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.668 1 O-C-N 130.325 4.766 . . . . 0.0 109.296 179.823 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -67.72 -89.58 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.097 0 O-C-N 128.734 3.771 . . . . 0.0 116.89 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 97' ' ' GLU . . . -135.92 100.33 0.34 Allowed Glycine 0 C--O 1.206 -1.638 0 C-N-CA 115.464 -3.255 . . . . 0.0 107.662 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 52.51 22.73 2.25 Favored 'General case' 0 N--CA 1.443 -0.809 2 O-C-N 130.639 4.376 . . . . 0.0 109.663 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.296 0.0 OUTLIER -168.8 134.1 1.65 Allowed 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 127.581 3.051 . . . . 0.0 109.022 179.283 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 91' ' ' ARG . 2.6 tt -97.67 142.12 29.86 Favored 'General case' 0 N--CA 1.437 -1.095 1 O-C-N 133.598 6.811 . . . . 0.0 115.863 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 100' ' ' GLN . 29.0 mt -83.19 -84.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.518 0 O-C-N 128.945 3.903 . . . . 0.0 106.284 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.476 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.4 tt0 92.95 107.67 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.274 1 O-C-N 131.024 5.203 . . . . 0.0 100.833 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.518 HG21 ' OE2' ' A' ' 108' ' ' GLU . 17.2 p -77.76 -38.7 46.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 128.406 3.566 . . . . 0.0 119.462 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 61.81 53.04 3.26 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 111.569 -2.56 . . . . 0.0 105.583 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 m -52.42 117.18 2.67 Favored 'General case' 0 C--N 1.36 1.023 1 O-C-N 133.038 6.461 . . . . 0.0 100.625 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 5.7 t80 -144.58 138.04 27.18 Favored 'General case' 0 CA--C 1.49 -1.349 1 O-C-N 130.13 4.644 . . . . 0.0 112.604 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.51 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 1.0 OUTLIER 37.41 35.13 0.05 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.841 -1.981 . . . . 0.0 115.952 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.58 79.64 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 116.76 -2.638 . . . . 0.0 117.305 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.81 -19.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.518 ' OE2' HG21 ' A' ' 101' ' ' THR . 9.4 mt-10 66.48 173.08 0.24 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 128.33 3.519 . . . . 0.0 106.951 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.328 . . -174.8 81.43 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 117.234 -1.787 . . . . 0.0 114.166 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -95.5 120.86 36.48 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 129.729 4.393 . . . . 0.0 109.084 -179.931 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -92.85 -34.12 13.96 Favored 'General case' 0 CA--C 1.555 1.16 1 O-C-N 129.974 4.546 . . . . 0.0 104.164 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 83.5 118.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.126 1 O-C-N 130.25 4.719 . . . . 0.0 108.03 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 21' ' ' LEU . 37.0 m-85 -141.8 -146.67 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 1 O-C-N 129.549 4.28 . . . . 0.0 106.511 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -170.31 -145.31 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.024 1 O-C-N 131.104 5.253 . . . . 0.0 111.668 -179.739 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 17.4 tttt -129.03 -58.51 1.14 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.232 1.413 . . . . 0.0 111.979 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.411 -2.384 0 CA-C-N 111.027 -2.806 . . . . 0.0 113.837 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.588 ' HZ ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.267 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' ILE 0.252 5.0 p-10 -34.48 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.874 1 O-C-N 130.443 4.839 . . . . 0.0 117.735 179.493 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 169.57 -179.2 42.2 Favored Glycine 0 N--CA 1.477 1.43 1 C-N-CA 112.231 -4.795 . . . . 0.0 104.169 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 24' ' ' THR 0.305 3.3 p -88.4 173.08 8.92 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 113.712 -3.195 . . . . 0.0 108.168 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.633 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 64.6 m95 -152.14 117.69 5.35 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 89.3 171.58 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 22' ' ' LYS 0.274 0.5 OUTLIER . . . . . 0 CA--C 1.479 -1.775 3 CA-C-O 135.886 7.517 . . . . 0.0 120.305 174.864 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.424 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.321 7.9 mttt 147.09 141.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.53 2 O-C-N 132.914 6.384 . . . . 0.0 106.576 177.423 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 25' ' ' ILE . 5.9 mt -96.5 161.57 13.85 Favored 'General case' 0 CA--C 1.565 1.552 3 O-C-N 132.692 6.245 . . . . 0.0 96.686 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.561 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 2.7 m 172.09 83.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 1 O-C-N 129.308 4.13 . . . . 0.0 101.336 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.663 HG23 ' H ' ' A' ' 33' ' ' THR . 3.7 mp -106.13 116.34 49.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 108.688 -3.869 . . . . 0.0 112.833 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.9 m -162.14 77.2 0.49 Allowed 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 127.134 2.771 . . . . 0.0 108.506 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.618 ' HB2' ' C ' ' A' ' 31' ' ' LYS . 8.1 mm-40 -68.11 -93.07 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 1 C-N-CA 110.998 -4.281 . . . . 0.0 113.428 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -127.2 -7.86 5.9 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 113.396 -3.192 . . . . 0.0 106.725 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.82 -11.27 29.84 Favored Glycine 0 CA--C 1.538 1.493 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.9 -30.4 2.03 Favored 'General case' 0 N--CA 1.411 -2.418 1 CA-C-O 111.649 -4.024 . . . . 0.0 111.547 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.618 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 43.5 mttt -103.86 -165.94 1.21 Allowed 'General case' 0 C--O 1.246 0.897 1 N-CA-C 97.725 -4.917 . . . . 0.0 97.725 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.631 ' HD1' HG22 ' A' ' 25' ' ' ILE . 25.6 m-85 -167.86 156.63 9.38 Favored 'General case' 0 C--O 1.203 -1.389 1 N-CA-C 97.355 -5.054 . . . . 0.0 97.355 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.663 ' H ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -143.82 128.99 18.73 Favored 'General case' 0 N--CA 1.479 1.015 4 O-C-N 136.662 8.726 . . . . 0.0 98.079 179.836 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.431 4.0 t -88.15 121.46 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 1 N-CA-C 99.303 -4.332 . . . . 0.0 99.303 179.9 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.376 11.2 tttt -56.09 -18.99 11.29 Favored 'General case' 0 C--N 1.37 1.489 0 CA-C-N 110.281 -3.145 . . . . 0.0 119.252 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HB2' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER 3.58 67.87 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 109.774 -3.375 . . . . 0.0 111.342 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' HA ' ' A' ' 21' ' ' LEU . 19.1 m -70.45 127.9 34.33 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 116.816 -1.954 . . . . 0.0 113.071 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -126.38 -168.49 1.87 Allowed 'General case' 0 C--N 1.369 1.417 0 O-C-N 125.707 1.879 . . . . 0.0 112.263 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.25 -25.52 58.13 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 125.507 2.575 . . . . 0.0 104.722 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' O ' HD12 ' A' ' 43' ' ' ILE . 13.3 m-85 -90.32 69.24 7.02 Favored 'General case' 0 N--CA 1.437 -1.093 1 CA-C-N 106.653 -4.794 . . . . 0.0 107.143 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.93 177.58 0.1 Allowed 'General case' 0 N--CA 1.436 -1.172 1 O-C-N 129.328 4.142 . . . . 0.0 114.677 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 43' ' ' ILE . 12.7 m-80 -71.5 -44.62 64.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 111.776 -3.969 . . . . 0.0 102.539 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER 64.61 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.512 3 CA-C-O 130.08 4.752 . . . . 0.0 107.074 -179.798 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.02 138.4 42.17 Favored 'General case' 0 C--N 1.373 1.611 1 CA-C-N 106.395 -4.911 . . . . 0.0 108.26 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.36 86.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 1 N-CA-C 99.782 -4.155 . . . . 0.0 99.782 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.8 163.04 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 1 C-N-CA 111.003 -4.279 . . . . 0.0 113.311 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.8 p90 -161.94 149.68 14.58 Favored 'General case' 0 N--CA 1.433 -1.311 1 O-C-N 132.888 6.367 . . . . 0.0 111.06 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.02 51.55 1.83 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 113.056 -3.458 . . . . 0.0 115.554 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.711 HD21 ' CB ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 47.75 89.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 2 O-C-N 132.714 6.259 . . . . 0.0 114.585 -179.711 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.28 59.1 2.78 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.74 -32.2 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 1 O-C-N 133.915 6.303 . . . . 0.0 115.225 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.06 138.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 1 O-C-N 131.421 5.451 . . . . 0.0 109.049 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 p90 179.31 145.96 0.18 Allowed 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 108.668 -3.878 . . . . 0.0 116.505 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -109.45 137.31 47.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.474 -3.899 . . . . 0.0 100.474 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -147.69 100.79 3.27 Favored 'General case' 0 C--O 1.21 -1.001 1 O-C-N 129.295 4.122 . . . . 0.0 114.06 179.848 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 94.7 1.87 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 112.775 -3.57 . . . . 0.0 101.484 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' TYR . 5.7 tp -82.55 -86.35 0.1 Allowed 'General case' 0 CA--C 1.507 -0.709 1 O-C-N 131.735 5.647 . . . . 0.0 116.117 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -64.57 10.11 0.07 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 115.825 -2.036 . . . . 0.0 116.494 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 9.4 5.59 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 120.504 1.502 . . . . 0.0 111.122 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.09 46.26 0.27 Allowed Glycine 0 CA--C 1.548 2.128 0 N-CA-C 105.178 -3.169 . . . . 0.0 105.178 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HD13 ' A' ' 63' ' ' LEU . 1.7 p -126.59 -88.93 0.56 Allowed 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 132.155 5.268 . . . . 0.0 114.537 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 62.14 71.95 0.52 Allowed 'General case' 0 C--O 1.217 -0.654 0 O-C-N 127.595 3.06 . . . . 0.0 106.784 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.562 HD13 ' HB ' ' A' ' 61' ' ' THR . 11.1 mp -120.57 76.08 1.17 Allowed 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 128.518 3.636 . . . . 0.0 113.92 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 92.9 m -48.44 111.84 0.51 Allowed 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.89 -171.38 12.32 Favored Glycine 0 CA--C 1.538 1.469 2 C-N-CA 111.026 -5.368 . . . . 0.0 107.029 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.603 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 5.9 t 176.53 128.96 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.218 2 O-C-N 133.611 6.124 . . . . 0.0 111.368 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 52.1 m95 -137.73 117.83 13.48 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 117.174 -3.454 . . . . 0.0 106.347 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD22 ' A' ' 49' ' ' LEU . 6.9 p -96.6 33.64 1.79 Allowed 'General case' 0 N--CA 1.422 -1.87 2 O-C-N 130.703 5.002 . . . . 0.0 116.706 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.711 ' CB ' HD21 ' A' ' 49' ' ' LEU . 2.2 ttt -18.93 106.19 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.814 1 O-C-N 136.821 8.825 . . . . 0.0 107.523 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.22 -44.72 87.38 Favored 'General case' 0 CA--C 1.505 -0.786 1 O-C-N 129.684 4.365 . . . . 0.0 108.673 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.83 -39.35 0.18 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 110.46 -3.064 . . . . 0.0 107.492 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.7 p30 -142.07 30.53 1.61 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 129.795 3.879 . . . . 0.0 108.748 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 5.3 mttt -135.61 157.38 47.02 Favored 'General case' 0 N--CA 1.453 -0.315 1 O-C-N 131.032 5.207 . . . . 0.0 111.604 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 74' ' ' LEU . 7.3 mt -134.91 60.11 1.71 Allowed 'General case' 0 C--O 1.214 -0.775 0 O-C-N 127.879 3.237 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -85.31 93.27 3.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 1 CA-C-N 106.544 -4.843 . . . . 0.0 114.044 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -159.08 -156.64 8.14 Favored Glycine 0 C--O 1.207 -1.585 2 CA-C-N 107.599 -4.364 . . . . 0.0 102.955 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.331 21.8 ttpt -170.54 123.98 0.68 Allowed 'General case' 0 C--N 1.37 1.476 1 C-N-CA 108.813 -5.155 . . . . 0.0 112.779 179.934 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 28.0 m-85 -106.09 162.46 13.6 Favored 'General case' 0 C--O 1.2 -1.504 2 N-CA-C 99.831 -4.137 . . . . 0.0 99.831 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.2 OUTLIER -168.23 130.9 1.48 Allowed 'General case' 0 CA--C 1.495 -1.152 1 CA-C-N 105.594 -5.275 . . . . 0.0 113.737 -178.716 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 11.2 ttp180 -82.41 86.72 6.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 125.007 1.442 . . . . 0.0 110.775 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.39 -33.75 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 O-C-N 128.044 3.34 . . . . 0.0 110.274 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -56.91 -46.57 81.9 Favored 'General case' 0 C--O 1.248 1.002 1 O-C-N 132.36 6.038 . . . . 0.0 108.825 -179.754 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.34 -5.7 17.63 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 113.403 -3.319 . . . . 0.0 112.559 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.552 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 75.91 41.54 27.67 Favored Glycine 0 CA--C 1.557 2.677 2 C-N-CA 110.843 -5.456 . . . . 0.0 100.485 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 8.6 tppt? -81.75 -81.44 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 2 CA-C-N 105.75 -5.225 . . . . 0.0 121.239 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 7.0 mm-40 91.04 121.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.576 4.922 . . . . 0.0 108.084 -177.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 63' ' ' LEU . 1.4 pt? -153.45 48.48 0.68 Allowed 'General case' 0 C--O 1.194 -1.836 1 O-C-N 132.435 6.084 . . . . 0.0 110.292 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.712 HG22 HG23 ' A' ' 90' ' ' VAL . 30.8 mt -52.33 141.99 5.5 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.552 2 O-C-N 130.248 4.717 . . . . 0.0 104.87 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.65 59.03 0.7 Allowed 'General case' 0 C--O 1.213 -0.832 1 O-C-N 130.75 5.032 . . . . 0.0 105.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 88' ' ' ILE . 13.3 t -64.02 102.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 O-C-N 127.848 3.218 . . . . 0.0 110.842 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.575 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -140.63 -174.03 3.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 115.408 -2.517 . . . . 0.0 110.554 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 91' ' ' ARG 0.299 0.0 OUTLIER 176.9 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 132.386 6.054 . . . . 0.0 105.822 -178.858 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -39.86 100.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.05 1 O-C-N 131.673 5.608 . . . . 0.0 110.001 179.247 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 m -85.59 -69.07 0.68 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 108.838 -3.801 . . . . 0.0 117.723 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.06 -106.44 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 CA-C-O 126.279 3.155 . . . . 0.0 105.705 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.33 52.61 1.55 Allowed 'General case' 0 CA--C 1.54 0.586 1 CA-C-N 108.009 -4.095 . . . . 0.0 105.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.88 ' O ' HD13 ' A' ' 93' ' ' ILE 0.318 0.0 OUTLIER -159.81 -118.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 1 O-C-N 130.399 4.812 . . . . 0.0 106.272 179.546 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 100' ' ' GLN . 9.9 tt 155.88 103.56 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.196 1 O-C-N 129.849 4.468 . . . . 0.0 109.442 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -48.49 -72.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.41 -2.472 1 O-C-N 130.903 5.127 . . . . 0.0 107.483 -179.876 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.721 ' HB2' HD21 ' A' ' 98' ' ' LEU . 7.6 tp60 79.06 100.71 0.06 Allowed 'General case' 0 CA--C 1.562 1.428 1 O-C-N 134.737 7.523 . . . . 0.0 100.428 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.031 HG23 ' HG3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -105.94 119.77 40.04 Favored 'General case' 0 N--CA 1.411 -2.41 2 O-C-N 134.04 7.088 . . . . 0.0 114.346 179.752 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.66 81.93 8.65 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ILE . 1.5 m -65.94 98.65 0.43 Allowed 'General case' 0 C--N 1.361 1.067 1 O-C-N 132.359 6.037 . . . . 0.0 101.332 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -107.62 120.29 41.8 Favored 'General case' 0 N--CA 1.435 -1.19 2 O-C-N 129.718 4.386 . . . . 0.0 113.359 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 4.88 64.65 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 126.937 2.648 . . . . 0.0 117.601 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.89 13.29 29.88 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 118.39 -1.862 . . . . 0.0 116.347 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.61 148.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-O 116.618 -1.658 . . . . 0.0 115.197 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -117.59 67.46 0.75 Allowed 'General case' 0 C--N 1.362 1.129 1 O-C-N 129.724 4.39 . . . . 0.0 106.586 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.411 . . -99.94 97.16 8.07 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 127.672 3.108 . . . . 0.0 111.582 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 1.031 ' HG3' HG23 ' A' ' 101' ' ' THR . 2.1 mtmt -89.98 176.51 6.77 Favored 'General case' 0 N--CA 1.419 -1.982 2 O-C-N 135.117 7.76 . . . . 0.0 110.074 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -135.24 117.32 15.38 Favored 'General case' 0 CA--C 1.561 1.39 3 O-C-N 131.975 5.797 . . . . 0.0 98.991 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.14 126.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 1 O-C-N 129.495 4.247 . . . . 0.0 112.468 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 31.1 m-85 -140.19 -149.24 0.27 Allowed 'General case' 0 N--CA 1.445 -0.72 1 O-C-N 129.851 4.469 . . . . 0.0 107.858 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.18 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 1 O-C-N 131.114 5.259 . . . . 0.0 112.257 -179.147 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.633 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 28.3 tttt -123.04 -130.53 0.27 Allowed 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.721 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.264 0.3 OUTLIER . . . . . 0 C--O 1.21 -0.985 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.966 0 CA-C-O 116.974 -1.489 . . . . 0.0 107.897 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.36 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 128.827 3.83 . . . . 0.0 116.8 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.97 176.35 36.56 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 114.853 -3.546 . . . . 0.0 105.79 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.538 HG22 ' OG1' ' A' ' 24' ' ' THR 0.392 0.2 OUTLIER -93.01 160.89 14.67 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 111.898 -3.921 . . . . 0.0 109.747 -179.605 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.643 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 12.8 m95 -127.61 161.29 29.19 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-O 113.033 -3.365 . . . . 0.0 111.095 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 10.6 mtmt 46.41 -179.59 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 8' ' ' VAL 0.328 0.9 OUTLIER . . . . . 0 CA--C 1.487 -1.458 3 CA-C-O 133.024 6.154 . . . . 0.0 119.239 174.984 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.997 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.395 0.0 OUTLIER -174.86 134.55 0.36 Allowed 'General case' 0 CA--C 1.566 1.569 1 O-C-N 132.379 6.049 . . . . 0.0 103.891 -179.962 . . . . . . . . 5 4 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 9.1 mt -97.29 158.22 15.57 Favored 'General case' 0 CA--C 1.555 1.147 3 O-C-N 130.705 5.003 . . . . 0.0 97.801 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.4 m 173.18 94.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 2 CA-C-O 130.402 4.906 . . . . 0.0 102.455 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 32' ' ' PHE . 3.5 mp -106.89 138.41 32.82 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 109.429 -3.532 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -174.56 73.0 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.168 2.792 . . . . 0.0 108.468 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.7 mm-40 -92.17 -95.0 0.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 113.367 -3.333 . . . . 0.0 112.295 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.47 1.82 0.53 Allowed 'General case' 0 C--O 1.251 1.138 0 O-C-N 127.982 3.302 . . . . 0.0 107.797 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.89 -33.15 5.76 Favored Glycine 0 CA--C 1.539 1.558 1 N-CA-C 101.552 -4.619 . . . . 0.0 101.552 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -98.48 -36.99 9.76 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-O 112.723 -3.513 . . . . 0.0 112.188 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' GLN . 72.5 mttt -111.37 173.92 6.11 Favored 'General case' 0 C--O 1.247 0.923 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.815 ' HD2' HG21 ' A' ' 25' ' ' ILE 0.265 2.0 p90 -167.8 68.66 0.08 Allowed 'General case' 0 C--O 1.187 -2.222 1 C-N-CA 110.836 -4.346 . . . . 0.0 100.757 178.638 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.01 123.3 13.13 Favored 'General case' 0 CA--C 1.502 -0.894 2 CA-C-N 105.777 -5.192 . . . . 0.0 103.947 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.413 0.5 OUTLIER -91.41 142.74 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 101.584 -3.487 . . . . 0.0 101.584 -179.753 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.279 6.2 tttt -77.68 1.54 19.58 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 110.629 -2.987 . . . . 0.0 118.603 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 34' ' ' VAL 0.252 0.0 OUTLIER -36.43 99.42 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 110.597 -3.002 . . . . 0.0 109.516 -179.962 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.49 164.43 12.22 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 128.29 3.494 . . . . 0.0 110.095 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -171.19 3.04 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 125.237 1.586 . . . . 0.0 112.694 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -76.05 -7.75 55.4 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.962 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 33.9 m-85 -80.94 -71.66 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.18 -2.736 . . . . 0.0 110.396 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -150.78 -172.31 4.16 Favored 'General case' 0 N--CA 1.433 -1.286 1 O-C-N 131.891 5.744 . . . . 0.0 112.443 179.871 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -23.46 59.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 113.753 -3.179 . . . . 0.0 104.25 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 57' ' ' LEU . 7.4 tp 28.18 80.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.122 2 O-C-N 132.839 6.337 . . . . 0.0 110.676 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.35 120.52 21.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 109.701 -3.408 . . . . 0.0 105.828 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 57' ' ' LEU . 98.2 t -91.12 97.9 7.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 1 O-C-N 132.254 5.971 . . . . 0.0 102.779 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.316 8.9 p -99.98 158.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 1 O-C-N 129.161 4.038 . . . . 0.0 115.226 -179.967 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -178.8 -160.45 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 129.543 4.277 . . . . 0.0 112.055 -179.64 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' CG ' ' HG2' ' A' ' 31' ' ' LYS 0.294 22.9 mt-10 -142.77 63.03 1.4 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.278 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 69' ' ' MET . 19.5 mt 54.15 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.217 0 O-C-N 128.159 3.412 . . . . 0.0 114.626 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.52 82.44 0.94 Allowed Glycine 0 C--O 1.197 -2.2 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.95 111.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 O-C-N 132.747 5.616 . . . . 0.0 112.897 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 6.5 t70 -91.87 163.34 14.07 Favored 'General case' 0 C--N 1.365 1.266 1 O-C-N 129.35 4.156 . . . . 0.0 106.797 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -173.32 143.64 1.11 Allowed 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 114.003 -3.079 . . . . 0.0 116.209 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.52 91.02 4.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.68 147.57 28.37 Favored 'General case' 0 C--O 1.208 -1.094 1 O-C-N 130.192 4.682 . . . . 0.0 112.772 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.61 92.98 4.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 128.16 3.413 . . . . 0.0 103.539 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.68 HD11 HG22 ' A' ' 45' ' ' VAL . 2.7 tp -47.36 -86.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 1 O-C-N 130.75 5.031 . . . . 0.0 109.998 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 -135.85 0.02 OUTLIER 'General case' 0 C--O 1.248 1.001 0 C-N-CA 116.875 -1.93 . . . . 0.0 109.723 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.46 -37.02 82.3 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.521 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.77 -81.71 0.82 Allowed Glycine 0 CA--C 1.545 1.909 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HD13 ' A' ' 63' ' ' LEU . 1.4 m 35.7 77.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 1 O-C-N 131.089 4.641 . . . . 0.0 113.426 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 63' ' ' LEU . 1.9 tm-20 -81.99 139.93 34.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 115.31 -2.556 . . . . 0.0 104.36 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -155.73 44.21 0.44 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 129.264 4.102 . . . . 0.0 111.695 -179.719 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -43.03 106.71 0.07 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 111.866 -2.424 . . . . 0.0 109.525 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -173.48 -161.98 24.63 Favored Glycine 0 N--CA 1.479 1.502 1 C-N-CA 111.133 -5.317 . . . . 0.0 107.474 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.49 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 8.3 t -154.36 142.04 19.92 Favored 'General case' 0 C--O 1.247 0.953 0 O-C-N 129.45 3.677 . . . . 0.0 116.585 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.732 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 6.1 m95 -122.28 96.76 5.17 Favored 'General case' 0 C--O 1.196 -1.713 0 CA-C-O 113.192 -3.289 . . . . 0.0 102.595 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -105.72 75.58 1.14 Allowed 'General case' 0 N--CA 1.438 -1.058 2 O-C-N 139.426 10.454 . . . . 0.0 114.404 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.77 ' HB3' HD22 ' A' ' 49' ' ' LEU 0.262 30.7 ttp -46.33 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 2 O-C-N 132.991 6.432 . . . . 0.0 103.778 179.963 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.74 -46.52 90.12 Favored 'General case' 0 C--O 1.211 -0.948 1 O-C-N 132.094 5.871 . . . . 0.0 104.831 -179.874 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.17 -76.83 0.04 OUTLIER Glycine 0 CA--C 1.549 2.17 0 N-CA-C 105.326 -3.11 . . . . 0.0 105.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -114.34 9.98 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.166 2.921 . . . . 0.0 107.89 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HB3' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.28 -178.97 3.8 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 128.945 3.903 . . . . 0.0 108.32 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.751 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.2 mt -152.69 43.06 0.64 Allowed 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 126.853 2.596 . . . . 0.0 112.772 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 73' ' ' LYS . 15.3 t -69.52 140.1 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 1 CA-C-N 107.85 -4.25 . . . . 0.0 117.525 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.8 -142.24 7.55 Favored Glycine 0 CA--C 1.547 2.059 3 CA-C-N 107.232 -4.531 . . . . 0.0 102.545 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' CB ' HG12 ' A' ' 88' ' ' ILE 0.369 8.0 tttt 175.71 125.29 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.408 1 O-C-N 132.135 5.256 . . . . 0.0 112.517 -179.75 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.732 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -123.0 156.37 34.93 Favored 'General case' 0 C--O 1.204 -1.325 3 O-C-N 130.323 4.764 . . . . 0.0 102.073 -179.151 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CE ' ' HB2' ' A' ' 86' ' ' GLU 0.335 0.0 OUTLIER -160.68 152.03 19.25 Favored 'General case' 0 N--CA 1.424 -1.766 1 CA-C-N 107.282 -4.508 . . . . 0.0 114.664 179.989 . . . . . . . . 5 4 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -105.14 99.59 9.2 Favored 'General case' 0 CA--C 1.556 1.173 0 O-C-N 128.65 3.719 . . . . 0.0 108.344 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -43.46 -29.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 1 O-C-N 129.886 4.491 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -39.75 -56.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.505 1 O-C-N 133.537 6.773 . . . . 0.0 105.444 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -122.43 8.56 9.62 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 129.069 3.981 . . . . 0.0 113.438 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.78 50.84 56.43 Favored Glycine 0 CA--C 1.55 2.26 1 N-CA-C 101.83 -4.508 . . . . 0.0 101.83 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' NZ ' ' NE ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -82.78 -64.14 1.23 Allowed 'General case' 0 N--CA 1.413 -2.284 1 O-C-N 131.813 5.067 . . . . 0.0 120.188 -179.355 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.605 ' OE2' HG22 ' A' ' 103' ' ' THR . 0.6 OUTLIER 81.35 137.66 0.06 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 131.953 5.783 . . . . 0.0 113.415 -177.656 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 87' ' ' LEU 0.314 0.2 OUTLIER -155.88 34.96 0.35 Allowed 'General case' 0 C--O 1.201 -1.481 1 O-C-N 133.542 6.776 . . . . 0.0 113.02 177.979 . . . . . . . . 5 4 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 103' ' ' THR . 75.6 mt -46.54 114.71 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.562 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.584 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 69.7 10.67 Favored 'General case' 0 C--O 1.196 -1.758 1 O-C-N 130.659 4.974 . . . . 0.0 106.611 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.54 127.23 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 1 O-C-N 133.109 6.506 . . . . 0.0 100.916 178.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.893 ' CD ' HD21 ' A' ' 98' ' ' LEU . 2.3 ttp180 -158.17 161.75 37.88 Favored 'General case' 0 C--O 1.191 -2.02 1 C-N-CA 109.702 -4.799 . . . . 0.0 112.876 -177.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.6 145.99 2.11 Favored 'General case' 0 C--N 1.35 0.593 1 O-C-N 131.274 5.359 . . . . 0.0 106.411 179.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 98' ' ' LEU . 1.1 mm -53.68 111.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 1 O-C-N 130.141 4.651 . . . . 0.0 110.695 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.6 ' CB ' HD13 ' A' ' 99' ' ' ILE . 1.5 t -51.97 -61.46 2.25 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 128.253 3.47 . . . . 0.0 116.025 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.48 -94.73 0.12 Allowed Glycine 0 C--O 1.206 -1.626 1 N-CA-C 102.987 -4.045 . . . . 0.0 102.987 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -102.35 32.85 3.36 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 111.027 -2.586 . . . . 0.0 107.905 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.84 175.05 0.87 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 128.669 3.731 . . . . 0.0 105.217 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 ' CD ' ' A' ' 91' ' ' ARG . 1.3 tt -109.41 157.48 18.88 Favored 'General case' 0 C--O 1.201 -1.457 1 O-C-N 132.326 6.016 . . . . 0.0 110.034 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.717 HG22 ' N ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -116.09 -62.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 1 O-C-N 129.433 4.208 . . . . 0.0 109.608 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.717 ' N ' HG22 ' A' ' 99' ' ' ILE . 23.7 mt-30 83.09 134.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.469 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.0 m -141.88 101.15 3.89 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.989 5.18 . . . . 0.0 112.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -88.49 95.33 10.18 Favored 'General case' 0 C--O 1.203 -1.348 1 O-C-N 129.673 4.358 . . . . 0.0 107.205 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.605 HG22 ' OE2' ' A' ' 86' ' ' GLU . 2.5 m -62.32 120.03 10.2 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 178.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -170.14 119.68 0.6 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 110.946 -2.843 . . . . 0.0 113.386 -179.083 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 107' ' ' VAL . 5.8 mt-10 40.66 -81.16 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.635 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.497 ' C ' HG23 ' A' ' 107' ' ' VAL . . . -61.01 -18.52 54.81 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.941 -3.028 . . . . 0.0 110.94 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 105' ' ' GLU . 2.2 t 68.22 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 46.18 79.86 0.05 Allowed 'General case' 0 C--N 1.358 0.946 1 O-C-N 129.354 4.159 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.346 . . -117.99 74.64 0.95 Allowed 'General case' 0 C--O 1.199 -1.568 0 O-C-N 126.595 2.434 . . . . 0.0 108.585 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -84.04 153.09 24.02 Favored 'General case' 0 N--CA 1.416 -2.153 1 O-C-N 131.64 5.588 . . . . 0.0 111.665 -179.104 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -120.64 -179.88 4.12 Favored 'General case' 0 CA--C 1.558 1.274 1 CA-C-N 107.964 -4.198 . . . . 0.0 104.758 -179.895 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.461 HD12 ' C ' ' A' ' 111' ' ' ARG . 1.8 mp -131.08 108.45 15.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 1 O-C-N 129.498 4.249 . . . . 0.0 112.933 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.707 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -119.69 179.66 4.16 Favored 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.951 5.157 . . . . 0.0 106.676 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.7 126.02 0.08 Allowed 'General case' 0 N--CA 1.429 -1.477 2 O-C-N 132.3 6.0 . . . . 0.0 113.577 -179.758 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 18.0 tttt -38.09 -57.07 1.1 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 110.014 -3.266 . . . . 0.0 116.463 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.423 -1.797 0 O-C-N 127.902 3.251 . . . . 0.0 111.371 179.872 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.432 ' HE1' HG21 ' A' ' 93' ' ' ILE . 2.6 m-85 . . . . . 0 CA--C 1.56 1.357 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -40.93 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.418 -2.035 1 O-C-N 129.633 4.333 . . . . 0.0 116.472 -179.897 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' PHE . . . 164.46 147.43 5.1 Favored Glycine 0 C--N 1.339 0.701 1 C-N-CA 112.22 -4.8 . . . . 0.0 106.612 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 11.1 p -61.46 166.2 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 115.729 -2.389 . . . . 0.0 108.564 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 115' ' ' LYS 0.25 73.4 m95 -139.46 158.74 43.63 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 111.758 -3.972 . . . . 0.0 110.43 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 11.4 mtmt 51.02 -178.25 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.837 0 O-C-N 128.571 3.67 . . . . 0.0 117.141 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 21' ' ' LEU 0.308 1.2 t . . . . . 0 CA--C 1.485 -1.534 3 O-C-N 134.303 7.252 . . . . 0.0 114.78 174.931 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.401 0.0 OUTLIER 167.98 153.97 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.626 1 O-C-N 132.317 6.01 . . . . 0.0 100.668 -179.66 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD23 ' C ' ' A' ' 35' ' ' LYS . 8.0 mt -112.59 170.33 8.26 Favored 'General case' 0 CA--C 1.551 0.99 1 O-C-N 133.266 6.604 . . . . 0.0 101.028 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 25' ' ' ILE . 1.6 m -156.14 -81.6 0.07 Allowed 'General case' 0 C--O 1.199 -1.577 1 O-C-N 130.218 4.699 . . . . 0.0 106.264 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.626 ' N ' HG22 ' A' ' 24' ' ' THR . 2.6 mp 70.91 129.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.385 0 CA-C-N 109.142 -3.663 . . . . 0.0 109.733 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.0 m -162.55 80.19 0.51 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 32' ' ' PHE . 8.6 pm0 -60.1 148.34 36.23 Favored 'General case' 0 C--N 1.357 0.918 1 CA-C-N 106.08 -5.055 . . . . 0.0 115.246 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.83 86.42 2.5 Favored 'General case' 0 CA--C 1.555 1.155 0 O-C-N 128.29 3.494 . . . . 0.0 103.412 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.13 -128.91 8.7 Favored Glycine 0 CA--C 1.552 2.365 2 C-N-CA 110.839 -5.458 . . . . 0.0 102.821 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -99.56 55.95 0.98 Allowed 'General case' 0 N--CA 1.437 -1.111 1 O-C-N 131.083 4.637 . . . . 0.0 109.252 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -146.84 122.56 10.54 Favored 'General case' 0 CA--C 1.552 1.041 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 49' ' ' LEU . 3.8 m-85 -119.48 171.09 8.59 Favored 'General case' 0 C--O 1.211 -0.933 2 O-C-N 130.111 4.632 . . . . 0.0 99.061 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -158.68 127.88 5.57 Favored 'General case' 0 C--O 1.249 1.058 3 O-C-N 136.284 8.49 . . . . 0.0 98.674 179.814 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 2.4 t -101.56 146.89 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' C ' HD23 ' A' ' 23' ' ' LEU 0.27 12.7 ttmt -91.67 48.57 1.47 Allowed 'General case' 0 C--O 1.195 -1.791 0 CA-C-O 127.491 3.52 . . . . 0.0 115.145 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.284 7.3 mt-10 -69.01 88.53 0.4 Allowed 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 m -86.61 128.02 34.96 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 127.222 2.826 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.6 -161.98 0.92 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 114.683 -2.807 . . . . 0.0 115.128 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -96.26 -7.21 36.1 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 111.961 -2.382 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -92.28 -65.9 0.97 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 114.572 -2.851 . . . . 0.0 107.265 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HD3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -141.98 -155.69 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 128.654 3.721 . . . . 0.0 110.616 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -75.66 -67.44 0.67 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 112.263 -3.775 . . . . 0.0 103.604 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD12 ' HD3' ' A' ' 41' ' ' ARG 0.251 0.4 OUTLIER 72.42 75.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.422 2 CA-C-O 134.919 7.057 . . . . 0.0 105.52 179.76 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.05 151.84 23.38 Favored 'General case' 0 C--N 1.373 1.619 1 CA-C-N 107.182 -4.554 . . . . 0.0 105.558 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.39 117.23 53.33 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 1 O-C-N 131.104 5.253 . . . . 0.0 102.734 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.325 9.4 p -115.11 155.42 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 115.798 -2.361 . . . . 0.0 110.977 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 67' ' ' TRP . 0.3 OUTLIER -166.79 177.88 6.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 127.667 3.104 . . . . 0.0 111.442 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -119.35 67.5 0.8 Allowed 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 115.326 -2.55 . . . . 0.0 115.169 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 32' ' ' PHE . 11.2 tp 23.32 75.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.812 1 O-C-N 130.148 4.655 . . . . 0.0 116.237 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.87 57.56 0.49 Allowed Glycine 0 CA--C 1.561 2.911 1 CA-C-O 112.545 -4.475 . . . . 0.0 104.452 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -150.67 120.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 O-C-N 134.662 6.742 . . . . 0.0 114.932 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 3.9 p30 -83.82 151.99 24.86 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 128.065 3.353 . . . . 0.0 107.913 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 21.4 p90 -173.66 162.71 4.16 Favored 'General case' 0 C--N 1.37 1.492 1 O-C-N 131.74 5.65 . . . . 0.0 115.006 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.68 141.41 37.17 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -154.19 102.97 2.5 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 116.732 -1.987 . . . . 0.0 109.683 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.67 95.17 2.8 Favored 'General case' 0 CA--C 1.539 0.519 1 O-C-N 129.106 4.004 . . . . 0.0 104.066 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.13 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 1 O-C-N 132.56 6.163 . . . . 0.0 109.773 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -70.72 177.05 3.75 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 116.584 -2.046 . . . . 0.0 109.812 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.38 66.26 4.79 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 128.543 3.652 . . . . 0.0 111.607 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.23 -38.43 0.17 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 115.243 -2.976 . . . . 0.0 108.378 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 58' ' ' ALA . 28.4 p -52.79 166.54 0.2 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 129.336 3.61 . . . . 0.0 114.021 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -165.02 49.14 0.1 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 125.413 2.53 . . . . 0.0 107.906 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 HD23 ' A' ' 87' ' ' LEU . 8.4 mp -69.37 125.72 27.56 Favored 'General case' 0 C--N 1.367 1.347 0 CA-C-N 110.237 -3.165 . . . . 0.0 107.994 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 m -126.82 98.75 5.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.44 -164.9 18.45 Favored Glycine 0 N--CA 1.478 1.449 1 C-N-CA 111.917 -4.944 . . . . 0.0 104.475 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.8 t -140.56 150.67 43.95 Favored 'General case' 0 N--CA 1.428 -1.56 1 O-C-N 131.073 4.631 . . . . 0.0 116.585 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.582 ' HB2' ' CD2' ' A' ' 47' ' ' PHE . 9.0 m95 -129.43 122.89 30.3 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-O 115.476 -2.202 . . . . 0.0 105.474 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.61 97.51 4.09 Favored 'General case' 0 C--O 1.203 -1.375 1 O-C-N 136.059 8.349 . . . . 0.0 110.626 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.572 ' HG2' ' CE2' ' A' ' 32' ' ' PHE 0.254 9.2 tpp -74.24 137.98 43.36 Favored 'General case' 0 CA--C 1.512 -0.49 1 O-C-N 132.181 5.926 . . . . 0.0 105.756 179.963 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -141.28 120.64 13.11 Favored 'General case' 0 C--O 1.218 -0.576 1 O-C-N 129.178 4.049 . . . . 0.0 105.427 -179.921 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.44 -98.11 0.02 OUTLIER Glycine 0 CA--C 1.557 2.682 1 O-C-N 129.521 4.263 . . . . 0.0 106.55 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 51.14 1.82 Allowed 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 129.703 3.825 . . . . 0.0 109.87 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 70' ' ' GLU . 1.5 mtpt -137.35 160.14 39.93 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 128.409 3.568 . . . . 0.0 108.65 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.6 mt -144.23 64.72 1.3 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.57 147.0 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 CA-C-O 129.778 4.608 . . . . 0.0 115.577 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.19 -147.3 15.71 Favored Glycine 0 CA--C 1.563 3.063 1 CA-C-N 107.183 -4.553 . . . . 0.0 103.641 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 163.73 139.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.651 1 O-C-N 134.045 6.38 . . . . 0.0 112.86 -179.835 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.61 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 5.5 m-85 -123.52 -169.49 1.95 Allowed 'General case' 0 C--O 1.204 -1.339 2 O-C-N 134.324 7.265 . . . . 0.0 104.648 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.671 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.316 0.0 OUTLIER -169.96 -145.68 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 109.801 -3.363 . . . . 0.0 115.162 -179.281 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 47.0 ttt180 -168.12 90.29 0.29 Allowed 'General case' 0 C--N 1.352 0.679 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.884 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -32.51 -33.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 127.621 3.076 . . . . 0.0 113.014 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 81' ' ' VAL . 1.2 t70 -53.44 -49.5 67.23 Favored 'General case' 0 CA--C 1.508 -0.636 1 O-C-N 129.727 4.392 . . . . 0.0 111.894 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.1 19.08 2.98 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-O 113.66 -3.067 . . . . 0.0 117.908 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 63.15 55.28 27.14 Favored Glycine 0 C--O 1.2 -1.976 1 N-CA-C 102.435 -4.266 . . . . 0.0 102.435 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 6.9 tppt? -80.94 -81.82 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 2 O-C-N 132.131 5.253 . . . . 0.0 118.603 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 78.2 mt-10 86.95 97.62 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.637 1 O-C-N 131.036 5.21 . . . . 0.0 109.832 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 HD21 ' A' ' 63' ' ' LEU . 12.9 tp -124.08 53.38 1.41 Allowed 'General case' 0 C--O 1.201 -1.478 1 O-C-N 138.185 9.678 . . . . 0.0 108.607 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 77' ' ' LYS . 25.5 mt -78.61 -178.0 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.176 2 CA-C-N 107.247 -4.524 . . . . 0.0 103.691 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.54 88.94 0.66 Allowed 'General case' 0 C--O 1.195 -1.794 1 O-C-N 131.804 5.69 . . . . 0.0 108.732 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.65 121.0 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 O-C-N 126.396 2.31 . . . . 0.0 107.583 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.3 tpt180 -170.63 163.04 8.11 Favored 'General case' 0 C--O 1.186 -2.243 0 C-N-CA 111.892 -3.923 . . . . 0.0 112.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -150.87 132.22 14.6 Favored 'General case' 0 N--CA 1.426 -1.626 1 O-C-N 132.035 5.835 . . . . 0.0 107.086 179.226 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -48.18 129.28 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 1 O-C-N 132.509 6.131 . . . . 0.0 109.149 179.976 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.9 p -78.92 -67.98 0.7 Allowed 'General case' 0 C--O 1.247 0.94 0 O-C-N 127.654 3.096 . . . . 0.0 116.13 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.17 -66.92 0.33 Allowed Glycine 0 CA--C 1.545 1.95 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.34 27.73 1.24 Allowed 'General case' 0 C--N 1.35 0.619 0 CA-C-N 110.501 -2.85 . . . . 0.0 107.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.73 119.28 2.9 Favored 'General case' 0 N--CA 1.433 -1.289 0 O-C-N 128.356 3.535 . . . . 0.0 109.642 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 121.67 28.62 Favored 'General case' 0 CA--C 1.557 1.231 1 O-C-N 129.771 4.42 . . . . 0.0 108.688 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' CG2' ' HB2' ' A' ' 110' ' ' LYS . 30.9 mt -74.04 -80.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.491 2 CA-C-O 111.285 -4.198 . . . . 0.0 108.206 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' N ' HG22 ' A' ' 99' ' ' ILE . 5.3 mt-30 99.75 112.6 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.394 2 O-C-N 136.054 8.346 . . . . 0.0 98.127 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 110' ' ' LYS . 30.9 p -82.95 -32.07 27.33 Favored 'General case' 0 N--CA 1.404 -2.74 1 O-C-N 130.306 4.754 . . . . 0.0 119.906 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 104' ' ' TYR . 62.9 m-85 60.24 70.22 0.64 Allowed 'General case' 0 CA--C 1.565 1.538 0 O-C-N 128.973 3.921 . . . . 0.0 103.558 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.6 m -69.22 73.7 0.32 Allowed 'General case' 0 C--O 1.215 -0.712 1 O-C-N 132.169 5.918 . . . . 0.0 106.206 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' TYR . 3.3 t80 -88.85 116.74 27.34 Favored 'General case' 0 CA--C 1.495 -1.144 1 CA-C-N 108.261 -4.063 . . . . 0.0 112.863 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 61.0 46.04 8.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 112.817 -1.992 . . . . 0.0 112.708 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.82 4.12 57.44 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-O 124.769 2.316 . . . . 0.0 117.528 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.15 137.2 53.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 119.558 -2.143 . . . . 0.0 115.051 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.93 132.17 43.12 Favored 'General case' 0 C--N 1.366 1.3 1 O-C-N 129.206 4.066 . . . . 0.0 105.661 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.354 . . -138.85 44.0 2.07 Favored 'General case' 0 N--CA 1.424 -1.764 0 O-C-N 128.368 3.542 . . . . 0.0 112.783 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 2.7 pttp -74.73 168.99 18.76 Favored 'General case' 0 N--CA 1.419 -1.989 1 O-C-N 133.308 6.63 . . . . 0.0 109.047 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -145.45 -90.62 0.1 Allowed 'General case' 0 CA--C 1.556 1.208 1 O-C-N 129.292 4.12 . . . . 0.0 100.632 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -174.63 179.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 111.377 -2.647 . . . . 0.0 108.974 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.517 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 8.8 m-85 166.49 178.55 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 1 O-C-N 136.157 8.411 . . . . 0.0 104.926 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.72 -154.17 0.33 Allowed 'General case' 0 C--O 1.198 -1.607 1 O-C-N 131.795 5.684 . . . . 0.0 111.515 178.683 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.62 ' HG3' ' CE3' ' A' ' 6' ' ' TRP 0.253 29.9 tttt -110.53 -138.39 0.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.255 7.7 tp10 . . . . . 0 N--CA 1.442 -0.841 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.441 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 . . . . . 0 CA--C 1.56 1.352 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 9.6 t0 -35.36 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 129.785 4.428 . . . . 0.0 117.878 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 153.13 175.56 24.68 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 115.413 -3.279 . . . . 0.0 105.297 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.285 3.6 p -90.78 176.8 6.51 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 113.274 -3.37 . . . . 0.0 103.844 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.585 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 28.4 m95 -147.21 160.37 42.55 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-O 112.592 -3.575 . . . . 0.0 112.435 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.5 mtmt 50.93 -178.89 0.02 OUTLIER 'General case' 0 C--O 1.195 -1.784 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 21' ' ' LEU 0.26 0.5 OUTLIER . . . . . 0 CA--C 1.483 -1.627 3 CA-C-O 135.409 7.29 . . . . 0.0 119.675 174.899 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.445 0 CA-C-O 114.266 -2.778 . . . . 0.0 104.793 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER -171.72 150.54 2.71 Favored 'General case' 0 CA--C 1.563 1.464 1 O-C-N 133.302 6.626 . . . . 0.0 102.228 179.843 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.4 mt -115.32 157.1 24.3 Favored 'General case' 0 CA--C 1.565 1.546 4 O-C-N 132.916 6.385 . . . . 0.0 97.666 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 1.9 m 172.09 96.46 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.249 1 O-C-N 132.768 6.292 . . . . 0.0 102.745 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.92 HG22 ' CD1' ' A' ' 32' ' ' PHE . 3.0 mp -114.66 112.35 39.72 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 108.96 -3.746 . . . . 0.0 109.962 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 35.9 m -155.07 79.68 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 127.74 3.15 . . . . 0.0 108.44 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.6 mm-40 -88.08 -98.62 0.09 Allowed 'General case' 0 C--N 1.355 0.845 3 CA-C-N 105.865 -5.152 . . . . 0.0 111.634 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.88 -6.17 4.51 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 128.088 3.367 . . . . 0.0 106.47 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.31 -27.4 8.11 Favored Glycine 0 CA--C 1.546 1.969 1 N-CA-C 99.189 -5.565 . . . . 0.0 99.189 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -25.67 6.0 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 111.737 -3.983 . . . . 0.0 111.627 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 2.6 mttm -101.56 178.89 4.51 Favored 'General case' 0 C--O 1.25 1.085 1 N-CA-C 97.596 -4.964 . . . . 0.0 97.596 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -176.64 139.38 0.31 Allowed 'General case' 0 C--O 1.19 -2.076 1 N-CA-C 97.217 -5.105 . . . . 0.0 97.217 178.875 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.565 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -128.67 119.88 25.5 Favored 'General case' 0 C--O 1.249 1.028 3 O-C-N 136.446 8.591 . . . . 0.0 98.577 -179.957 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.364 1.2 t -84.6 128.41 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 1 N-CA-C 99.747 -4.168 . . . . 0.0 99.747 -179.944 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.295 5.3 tttm -67.72 -8.88 38.92 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 120.775 3.62 . . . . 0.0 120.775 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.339 3.9 tt0 -29.37 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 108.499 -3.955 . . . . 0.0 109.965 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -80.45 155.65 26.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 114.228 -2.989 . . . . 0.0 111.035 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.6 t -121.57 -151.82 0.49 Allowed 'General case' 0 N--CA 1.442 -0.827 0 O-C-N 127.527 3.017 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.13 -29.56 11.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 126.198 2.186 . . . . 0.0 108.937 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 10.2 m-85 -66.5 -60.49 2.69 Favored 'General case' 0 CA--C 1.551 1.013 1 O-C-N 130.654 4.971 . . . . 0.0 105.162 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.58 -163.28 1.71 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 128.972 3.92 . . . . 0.0 113.54 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.39 -16.46 52.14 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 121.431 1.923 . . . . 0.0 109.939 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' HB ' ' CZ ' ' A' ' 41' ' ' ARG . 8.8 tt 20.05 94.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.266 2 O-C-N 132.336 6.022 . . . . 0.0 111.972 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 152.1 22.0 Favored 'General case' 0 C--N 1.366 1.304 0 O-C-N 117.001 -3.562 . . . . 0.0 104.198 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -126.79 91.64 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.93 1 O-C-N 130.469 4.855 . . . . 0.0 103.707 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 ' OG1' ' A' ' 33' ' ' THR 0.29 0.7 OUTLIER -92.18 158.89 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 1 C-N-CA 111.052 -4.259 . . . . 0.0 115.764 -179.993 . . . . . . . . 5 4 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -154.66 -177.0 6.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 O-C-N 129.011 3.944 . . . . 0.0 111.303 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.571 ' HB3' HG21 ' A' ' 51' ' ' VAL 0.258 1.2 tt0 -130.22 31.54 4.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.267 3.48 . . . . 0.0 111.805 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.83 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 1 O-C-N 133.749 6.906 . . . . 0.0 113.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 86.51 52.14 3.28 Favored Glycine 0 CA--C 1.548 2.118 0 CA-C-O 113.797 -3.779 . . . . 0.0 104.085 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 48' ' ' GLU . 21.7 t -134.31 104.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 1 O-C-N 134.851 6.853 . . . . 0.0 113.531 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 145.57 33.63 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 110.45 -3.068 . . . . 0.0 109.563 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.58 124.01 7.72 Favored 'General case' 0 C--N 1.372 1.577 2 O-C-N 129.733 4.396 . . . . 0.0 116.131 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.6 73.53 4.36 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 121.75 41.27 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 127.564 3.04 . . . . 0.0 112.375 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -74.47 114.84 13.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 111.853 -3.939 . . . . 0.0 106.54 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.43 155.92 20.7 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 127.229 2.831 . . . . 0.0 112.408 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.41 22.93 3.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 115.721 -2.085 . . . . 0.0 114.026 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t70 39.14 38.7 0.34 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 128.957 3.911 . . . . 0.0 112.16 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.81 -58.03 0.01 OUTLIER Glycine 0 CA--C 1.543 1.786 0 N-CA-C 105.725 -2.95 . . . . 0.0 105.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.402 ' C ' ' HG2' ' A' ' 62' ' ' GLU . 1.1 p -77.07 149.48 35.77 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 127.8 2.706 . . . . 0.0 114.274 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HG2' ' C ' ' A' ' 61' ' ' THR . 2.9 mt-10 -143.31 66.24 1.31 Allowed 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.27 117.67 5.05 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 129.093 3.996 . . . . 0.0 107.255 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -123.57 109.55 13.92 Favored 'General case' 0 C--O 1.205 -1.283 0 O-C-N 126.404 2.315 . . . . 0.0 108.65 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 178.13 -146.11 7.31 Favored Glycine 0 N--CA 1.479 1.558 1 C-N-CA 113.838 -4.03 . . . . 0.0 103.727 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 66' ' ' THR 0.312 15.2 t -176.16 141.44 0.44 Allowed 'General case' 0 CA--C 1.486 -1.485 1 O-C-N 131.247 4.733 . . . . 0.0 119.58 -178.553 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.722 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.5 m95 -107.5 145.45 33.08 Favored 'General case' 0 C--O 1.195 -1.769 1 O-C-N 115.971 -4.206 . . . . 0.0 100.5 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.404 HG22 ' HA2' ' A' ' 50' ' ' GLY . 25.8 p -126.56 25.21 6.52 Favored 'General case' 0 N--CA 1.428 -1.526 2 O-C-N 135.278 7.861 . . . . 0.0 115.21 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 3.65 105.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.887 1 O-C-N 137.638 9.336 . . . . 0.0 108.611 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -114.0 -170.74 1.77 Allowed 'General case' 0 C--O 1.215 -0.713 1 O-C-N 129.625 4.328 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.41 105.83 0.81 Allowed Glycine 0 CA--C 1.541 1.707 0 O-C-N 127.354 2.909 . . . . 0.0 108.51 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 39.71 55.56 2.43 Favored 'General case' 0 C--O 1.238 0.491 1 O-C-N 131.496 4.88 . . . . 0.0 110.046 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -174.27 3.9 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 127.021 2.701 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 98' ' ' LEU . 1.1 mt -161.01 30.69 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 O-C-N 126.391 2.307 . . . . 0.0 115.507 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 t -59.27 137.14 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 2 O-C-N 131.24 5.338 . . . . 0.0 114.42 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 154.22 -139.94 7.14 Favored Glycine 0 C--O 1.197 -2.186 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 78' ' ' PHE 0.333 20.1 tttm -177.63 176.51 1.24 Allowed 'General case' 0 C--N 1.371 1.531 1 O-C-N 133.164 5.861 . . . . 0.0 110.145 -178.682 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 22.4 m-85 -176.06 172.62 2.36 Favored 'General case' 0 C--O 1.212 -0.92 2 O-C-N 134.178 7.174 . . . . 0.0 102.602 175.481 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' C ' ' A' ' 85' ' ' LYS 0.296 13.7 ttmt -160.22 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.825 1 CA-C-N 105.076 -5.511 . . . . 0.0 110.135 179.962 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.695 ' NE ' HD11 ' A' ' 87' ' ' LEU 0.272 5.9 ptt180 175.61 56.91 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 117.267 -1.349 . . . . 0.0 111.336 178.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 31.7 t -41.46 87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.558 2 O-C-N 134.769 7.543 . . . . 0.0 108.521 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 t70 170.31 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.107 1 O-C-N 130.597 4.935 . . . . 0.0 107.348 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 175.93 -0.38 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 129.017 3.948 . . . . 0.0 115.377 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -101.93 -35.01 4.12 Favored Glycine 0 CA--C 1.54 1.649 1 C-N-CA 113.036 -4.411 . . . . 0.0 105.546 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.569 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 75.43 -174.76 0.12 Allowed 'General case' 0 CA--C 1.495 -1.145 1 O-C-N 131.292 4.76 . . . . 0.0 114.063 179.837 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.258 6.6 mt-10 -34.41 142.01 0.05 OUTLIER 'General case' 0 C--O 1.198 -1.623 1 O-C-N 130.077 4.611 . . . . 0.0 116.334 -177.297 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.695 HD11 ' NE ' ' A' ' 80' ' ' ARG . 40.4 mt -150.65 37.22 0.65 Allowed 'General case' 0 C--O 1.194 -1.829 1 O-C-N 132.969 6.418 . . . . 0.0 110.074 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 21.5 mt -62.27 152.39 6.92 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 3 O-C-N 130.053 4.596 . . . . 0.0 99.54 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' CH2' ' A' ' 67' ' ' TRP . . . -124.98 87.15 2.66 Favored 'General case' 0 C--O 1.197 -1.7 1 O-C-N 135.58 8.05 . . . . 0.0 110.363 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 90' ' ' VAL . 3.7 t -84.23 107.85 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 114.892 -2.723 . . . . 0.0 105.232 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD2' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -168.53 164.27 12.49 Favored 'General case' 0 C--O 1.194 -1.868 1 C-N-CA 111.097 -4.241 . . . . 0.0 115.717 -179.519 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -151.77 143.65 23.76 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 128.6 3.687 . . . . 0.0 104.088 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -58.35 81.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 1 O-C-N 133.176 6.548 . . . . 0.0 110.135 -179.985 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.62 -114.72 0.81 Allowed Glycine 0 CA--C 1.55 2.223 0 N-CA-C 104.528 -3.429 . . . . 0.0 104.528 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -113.86 24.74 11.8 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 109.688 -3.256 . . . . 0.0 108.893 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.572 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.91 165.21 32.61 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 110.963 -2.835 . . . . 0.0 106.756 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 74' ' ' LEU . 5.3 tt -110.48 121.23 44.8 Favored 'General case' 0 N--CA 1.447 -0.582 1 O-C-N 130.162 4.664 . . . . 0.0 109.826 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HB ' ' HD2' ' A' ' 91' ' ' ARG . 1.7 mt -71.11 -55.79 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 109.47 -3.513 . . . . 0.0 107.724 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' OE1' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER 73.65 105.68 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 1 O-C-N 132.27 5.981 . . . . 0.0 103.97 -179.915 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.21 91.03 3.48 Favored 'General case' 0 N--CA 1.424 -1.763 2 O-C-N 132.408 6.067 . . . . 0.0 113.141 179.671 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 50.4 m-85 -70.77 125.5 27.01 Favored 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 109.309 -4.956 . . . . 0.0 105.669 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.9 m -96.53 68.01 2.47 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 127.811 3.672 . . . . 0.0 105.982 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 2.0 t80 -65.06 156.68 30.7 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 109.803 -3.362 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 5.0 tp10 -47.76 104.55 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 112.848 -1.978 . . . . 0.0 115.681 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.8 83.78 Favored Glycine 0 C--N 1.347 1.178 0 C-N-CA 117.799 -2.143 . . . . 0.0 116.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.269 2.5 t -136.93 169.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -143.15 58.1 1.4 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.422 . . -98.42 152.49 19.44 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 114.658 -2.817 . . . . 0.0 111.287 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.667 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.2 OUTLIER -109.95 -163.21 0.84 Allowed 'General case' 0 N--CA 1.444 -0.747 1 O-C-N 134.029 7.081 . . . . 0.0 107.359 -179.771 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -57.63 0.74 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 110.469 -3.059 . . . . 0.0 105.801 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.284 4.5 mt 86.88 115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.027 1 O-C-N 129.386 4.179 . . . . 0.0 110.096 -179.847 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 9.1 m-85 -142.62 179.65 6.85 Favored 'General case' 0 N--CA 1.417 -2.081 1 O-C-N 130.091 4.619 . . . . 0.0 107.167 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.572 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -150.36 -160.92 1.24 Allowed 'General case' 0 C--O 1.196 -1.756 1 O-C-N 131.97 5.793 . . . . 0.0 111.836 179.501 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 11.7 tttt -123.17 152.61 41.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 111.812 -2.449 . . . . 0.0 112.549 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.419 -1.989 1 O-C-N 129.389 4.18 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.56 1.345 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.95 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.777 1 O-C-N 131.027 5.204 . . . . 0.0 117.415 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.8 148.16 5.04 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 114.893 -3.17 . . . . 0.0 106.265 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.295 36.0 p -68.28 167.88 13.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 112.361 -3.735 . . . . 0.0 110.094 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 73.1 m95 -141.27 167.69 21.57 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-O 111.116 -4.278 . . . . 0.0 113.487 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 5.3 mtmt 36.85 171.84 0.0 OUTLIER 'General case' 0 C--O 1.19 -2.057 1 O-C-N 133.813 6.946 . . . . 0.0 119.182 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.287 0.9 OUTLIER . . . . . 0 CA--C 1.491 -1.321 3 CA-C-N 105.262 -5.426 . . . . 0.0 119.331 174.941 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.566 1.589 0 CA-C-O 114.107 -2.854 . . . . 0.0 105.491 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.432 31.0 mttt 145.07 170.74 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.604 1 O-C-N 134.015 7.072 . . . . 0.0 101.018 -178.847 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 7.3 mt -141.83 -178.63 5.76 Favored 'General case' 0 CA--C 1.567 1.604 3 O-C-N 133.148 6.53 . . . . 0.0 96.985 177.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 25' ' ' ILE . 18.7 m -166.65 -90.04 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 128.418 3.574 . . . . 0.0 106.173 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 24' ' ' THR . 0.8 OUTLIER 70.72 130.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-N 109.752 -3.385 . . . . 0.0 109.316 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.4 m -168.27 73.99 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 113.185 -3.406 . . . . 0.0 103.583 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -37.38 138.96 0.28 Allowed 'General case' 0 N--CA 1.436 -1.131 2 O-C-N 133.483 6.74 . . . . 0.0 115.576 -179.923 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -92.9 0.36 Allowed 'General case' 0 C--N 1.35 0.618 1 O-C-N 131.017 5.198 . . . . 0.0 106.505 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.55 66.5 0.24 Allowed Glycine 0 CA--C 1.55 2.266 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 68.2 14.47 9.25 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -93.88 132.7 38.05 Favored 'General case' 0 CA--C 1.552 1.047 1 CA-C-O 111.213 -4.232 . . . . 0.0 100.827 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.693 ' CD1' HD23 ' A' ' 49' ' ' LEU . 13.0 m-85 -110.59 142.17 42.8 Favored 'General case' 0 C--O 1.191 -2.004 2 N-CA-C 96.858 -5.238 . . . . 0.0 96.858 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -130.91 108.44 9.83 Favored 'General case' 0 CA--C 1.496 -1.116 2 O-C-N 134.575 7.422 . . . . 0.0 100.744 -179.92 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 25' ' ' ILE 0.42 4.2 t -81.57 150.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 112.635 -3.626 . . . . 0.0 103.772 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.255 3.6 ttmt -98.99 36.88 1.61 Allowed 'General case' 0 N--CA 1.425 -1.711 1 CA-C-O 133.049 6.166 . . . . 0.0 116.949 179.792 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.335 28.1 tt0 -57.78 97.6 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 1 CA-C-N 107.455 -4.43 . . . . 0.0 107.512 -179.804 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.0 m -99.59 134.06 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.97 3.294 . . . . 0.0 106.767 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.23 -162.27 1.23 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 127.316 2.885 . . . . 0.0 112.807 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -57.46 -41.37 80.42 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -87.38 82.66 7.49 Favored 'General case' 0 N--CA 1.435 -1.198 2 O-C-N 131.35 5.406 . . . . 0.0 106.487 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER 35.14 -143.7 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 131.284 5.365 . . . . 0.0 114.878 -179.991 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 46.6 m-20 -77.29 -70.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 113.109 -3.436 . . . . 0.0 106.073 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.75 HG13 HD12 ' A' ' 57' ' ' LEU 0.25 0.2 OUTLIER 66.17 104.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 1 CA-C-O 132.302 5.81 . . . . 0.0 104.3 179.623 . . . . . . . . 5 4 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.83 154.23 18.17 Favored 'General case' 0 C--N 1.372 1.586 0 CA-C-N 109.673 -3.421 . . . . 0.0 106.863 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 107.61 17.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 1 O-C-N 131.157 5.286 . . . . 0.0 102.498 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' OG1' ' A' ' 33' ' ' THR 0.374 9.9 p -112.23 154.03 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 114.049 -3.06 . . . . 0.0 113.422 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -163.73 -163.05 0.76 Allowed 'General case' 0 N--CA 1.442 -0.829 1 O-C-N 131.657 5.598 . . . . 0.0 114.602 -179.946 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -136.28 53.38 1.93 Allowed 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.355 2.284 . . . . 0.0 114.02 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD23 ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER 52.3 19.52 1.14 Allowed 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 128.701 3.751 . . . . 0.0 115.736 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.563 ' CA ' HG22 ' A' ' 68' ' ' THR . . . 143.55 71.75 0.02 OUTLIER Glycine 0 CA--C 1.546 1.978 0 N-CA-C 105.091 -3.203 . . . . 0.0 105.091 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.15 -49.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 130.159 4.094 . . . . 0.0 112.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.03 131.72 0.05 Allowed 'General case' 0 C--O 1.202 -1.441 1 O-C-N 129.426 4.204 . . . . 0.0 105.724 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -164.82 148.69 8.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 129.038 3.961 . . . . 0.0 117.09 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.54 115.77 30.92 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 100.468 -3.901 . . . . 0.0 100.468 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -139.23 128.14 23.57 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 127.972 3.295 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.49 112.6 15.71 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 115.417 -2.513 . . . . 0.0 105.692 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 43' ' ' ILE . 3.5 mm? -66.49 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 O-C-N 126.501 2.376 . . . . 0.0 111.386 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.44 -142.5 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.662 -1.161 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.03 -14.25 19.52 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 124.827 1.329 . . . . 0.0 111.669 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.47 74.36 0.34 Allowed Glycine 0 CA--C 1.562 3.007 0 O-C-N 128.591 3.682 . . . . 0.0 104.67 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.8 p -150.61 148.63 28.87 Favored 'General case' 0 N--CA 1.433 -1.28 1 O-C-N 131.985 5.167 . . . . 0.0 112.81 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -147.97 48.81 1.06 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 127.12 2.763 . . . . 0.0 108.721 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.05 166.21 14.24 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 113.549 -3.26 . . . . 0.0 107.514 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -161.92 118.32 2.07 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 110.302 -3.135 . . . . 0.0 104.439 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.24 -130.26 1.39 Allowed Glycine 0 CA--C 1.529 0.936 1 C-N-CA 110.782 -5.485 . . . . 0.0 108.401 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.595 ' C ' ' CG ' ' A' ' 67' ' ' TRP . 3.3 t 170.6 139.01 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.708 1 O-C-N 132.665 5.568 . . . . 0.0 110.472 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 78' ' ' PHE . 46.6 m95 -139.2 107.54 5.81 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 122.187 2.267 . . . . 0.0 106.753 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.563 HG22 ' CA ' ' A' ' 50' ' ' GLY . 43.0 p -103.49 74.8 1.28 Allowed 'General case' 0 N--CA 1.429 -1.513 2 O-C-N 131.441 5.463 . . . . 0.0 114.143 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.482 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -46.29 134.09 9.05 Favored 'General case' 0 C--O 1.215 -0.724 1 O-C-N 130.804 5.065 . . . . 0.0 105.352 179.867 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -136.98 66.67 1.46 Allowed 'General case' 0 C--N 1.347 0.46 1 O-C-N 131.131 5.269 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.79 84.19 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.167 0 O-C-N 125.68 1.863 . . . . 0.0 110.719 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 6.4 m-20 63.07 28.11 16.02 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 114.899 -2.477 . . . . 0.0 114.622 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -129.69 156.96 43.41 Favored 'General case' 0 N--CA 1.476 0.869 1 O-C-N 129.877 4.485 . . . . 0.0 107.694 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ARG . 7.9 mt -141.6 47.78 1.65 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 126.571 2.419 . . . . 0.0 116.877 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 t -68.66 147.65 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 1 CA-C-N 107.85 -4.25 . . . . 0.0 112.138 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.99 27.56 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HA ' ' HH2' ' A' ' 67' ' ' TRP 0.268 0.1 OUTLIER -174.53 128.55 0.33 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 111.951 -3.9 . . . . 0.0 117.676 -179.617 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 67' ' ' TRP . 25.6 m-85 -101.9 177.95 4.75 Favored 'General case' 0 C--O 1.204 -1.311 1 CA-C-O 129.288 4.375 . . . . 0.0 100.773 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.64 -129.89 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 1 CA-C-N 105.079 -5.509 . . . . 0.0 110.284 179.583 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 51.0 ttt180 168.65 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.685 0 O-C-N 128.138 3.399 . . . . 0.0 109.247 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.6 -1.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 1 O-C-N 131.93 5.768 . . . . 0.0 114.767 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.62 -26.79 12.66 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 128.493 3.621 . . . . 0.0 112.041 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.28 1.25 9.06 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 66.46 39.19 94.0 Favored Glycine 0 CA--C 1.558 2.749 1 N-CA-C 100.773 -4.931 . . . . 0.0 100.773 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.262 0.6 OUTLIER -74.44 -80.86 0.07 Allowed 'General case' 0 N--CA 1.411 -2.383 1 CA-C-N 106.145 -5.027 . . . . 0.0 120.994 -179.008 . . . . . . . . 5 4 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER 78.61 101.87 0.07 Allowed 'General case' 0 CA--C 1.561 1.396 0 O-C-N 127.621 3.076 . . . . 0.0 109.489 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.76 48.57 2.15 Favored 'General case' 0 C--O 1.195 -1.779 1 O-C-N 133.636 6.835 . . . . 0.0 108.884 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 77' ' ' LYS . 57.0 mt -66.57 146.0 13.5 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.479 2 O-C-N 130.029 4.581 . . . . 0.0 103.937 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.9 105.61 15.23 Favored 'General case' 0 C--O 1.213 -0.827 1 O-C-N 137.751 9.407 . . . . 0.0 105.077 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 90' ' ' VAL . 4.0 t -101.85 100.43 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 128.917 3.886 . . . . 0.0 104.68 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -156.58 155.74 32.4 Favored 'General case' 0 C--O 1.19 -2.033 1 C-N-CA 110.615 -4.434 . . . . 0.0 113.756 179.76 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.5 108.34 3.34 Favored 'General case' 0 CA--C 1.558 1.279 2 CA-C-N 107.581 -4.372 . . . . 0.0 102.521 179.228 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.877 ' HB ' HD12 ' A' ' 98' ' ' LEU . 11.5 tt -42.66 109.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 1 O-C-N 132.986 6.428 . . . . 0.0 112.287 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.0 m -105.19 95.25 5.71 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 128.387 3.555 . . . . 0.0 115.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.0 -118.31 3.77 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 103.256 -3.937 . . . . 0.0 103.256 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.67 47.29 1.56 Allowed 'General case' 0 CA--C 1.552 1.029 1 O-C-N 130.18 4.106 . . . . 0.0 106.146 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.303 0.0 OUTLIER -177.3 110.93 0.08 Allowed 'General case' 0 C--O 1.204 -1.32 2 O-C-N 130.801 5.063 . . . . 0.0 108.358 179.801 . . . . . . . . 5 4 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.877 HD12 ' HB ' ' A' ' 93' ' ' ILE . 3.0 tt -79.45 104.71 10.25 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 128.728 3.768 . . . . 0.0 108.815 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 26.1 mm -50.76 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.672 1 O-C-N 133.48 6.738 . . . . 0.0 108.434 -179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.565 ' CG ' HD23 ' A' ' 98' ' ' LEU . 23.2 mt-30 99.36 90.48 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 1 O-C-N 132.899 6.374 . . . . 0.0 103.915 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.8 m -102.64 96.75 7.09 Favored 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.683 6.864 . . . . 0.0 114.06 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 73.6 m-85 -67.78 132.85 48.19 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 112.605 -3.638 . . . . 0.0 105.213 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -107.86 94.8 5.27 Favored 'General case' 0 C--O 1.206 -1.198 1 O-C-N 132.129 5.893 . . . . 0.0 101.631 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 1.4 t80 -109.64 117.36 33.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 109.792 -3.367 . . . . 0.0 117.6 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 27.42 31.51 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.77 -6.37 6.16 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 116.718 -2.658 . . . . 0.0 114.353 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.4 t -120.03 145.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.979 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 70.89 0.73 Allowed 'General case' 0 C--N 1.359 1.011 1 O-C-N 130.87 5.106 . . . . 0.0 103.388 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.436 . . -90.86 119.13 30.81 Favored 'General case' 0 N--CA 1.41 -2.447 1 O-C-N 130.921 5.138 . . . . 0.0 116.267 179.907 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.4 163.08 14.85 Favored 'General case' 0 N--CA 1.415 -2.199 1 O-C-N 132.663 6.227 . . . . 0.0 106.924 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.27 99.53 4.56 Favored 'General case' 0 CA--C 1.556 1.202 3 O-C-N 130.195 4.684 . . . . 0.0 99.437 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -57.23 123.02 7.53 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 O-C-N 128.862 3.851 . . . . 0.0 111.194 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.771 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 14.2 m-30 -117.21 176.81 4.97 Favored 'General case' 0 N--CA 1.434 -1.24 2 O-C-N 132.544 6.152 . . . . 0.0 108.463 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 171.12 134.76 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.633 2 O-C-N 131.898 5.749 . . . . 0.0 113.843 -177.607 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 1.3 tttt -51.41 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.34 1 CA-C-O 128.649 4.071 . . . . 0.0 113.502 176.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.37 1.492 0 O-C-N 118.952 -2.342 . . . . 0.0 110.519 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 4.8 m-30 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -50.3 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 127.737 3.148 . . . . 0.0 117.911 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.29 125.21 0.77 Allowed Glycine 0 C--N 1.353 1.488 1 C-N-CA 112.377 -4.725 . . . . 0.0 107.663 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.334 46.2 p -49.97 127.89 17.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 129.148 3.499 . . . . 0.0 110.123 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.324 55.7 m95 -100.58 161.47 13.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 128.565 3.666 . . . . 0.0 112.276 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.3 mtmt 50.99 -178.66 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.696 1 O-C-N 129.333 4.146 . . . . 0.0 117.325 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 21' ' ' LEU 0.326 0.9 OUTLIER . . . . . 0 CA--C 1.483 -1.603 2 O-C-N 134.538 7.399 . . . . 0.0 113.753 174.979 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.403 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.377 0.0 OUTLIER 174.56 134.18 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.5 1 O-C-N 131.733 5.646 . . . . 0.0 102.694 179.689 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 13.2 mt -93.55 167.69 11.52 Favored 'General case' 0 CA--C 1.559 1.291 2 O-C-N 131.533 5.52 . . . . 0.0 100.33 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.9 m 176.7 79.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 1 O-C-N 132.518 6.136 . . . . 0.0 105.993 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 mp -90.11 144.07 9.89 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 110.293 -3.14 . . . . 0.0 109.188 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.7 m -162.48 82.29 0.53 Allowed 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 112.491 -3.683 . . . . 0.0 109.092 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.405 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -51.65 148.05 5.85 Favored 'General case' 0 C--O 1.214 -0.797 2 O-C-N 130.373 4.795 . . . . 0.0 115.054 179.684 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -131.65 101.43 5.49 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 128.75 3.781 . . . . 0.0 103.76 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -104.08 2.26 Favored Glycine 0 CA--C 1.546 2.027 2 C-N-CA 110.909 -5.424 . . . . 0.0 99.934 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -131.36 14.21 5.06 Favored 'General case' 0 N--CA 1.435 -1.222 1 O-C-N 131.798 5.058 . . . . 0.0 109.241 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -82.8 155.29 24.27 Favored 'General case' 0 C--N 1.321 -0.662 1 N-CA-C 99.494 -4.261 . . . . 0.0 99.494 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 25' ' ' ILE . 9.3 t80 -155.67 106.76 2.52 Favored 'General case' 0 C--O 1.191 -1.995 2 N-CA-C 95.674 -5.676 . . . . 0.0 95.674 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.15 142.48 38.3 Favored 'General case' 0 N--CA 1.475 0.806 1 O-C-N 132.503 6.127 . . . . 0.0 102.797 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.356 24.7 t -111.48 140.04 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 1 O-C-N 129.144 4.027 . . . . 0.0 100.97 179.697 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB3' ' N ' ' A' ' 24' ' ' THR . 5.2 tttt -85.2 64.42 8.66 Favored 'General case' 0 CA--C 1.49 -1.355 1 CA-C-O 130.901 5.143 . . . . 0.0 115.029 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' OE1' HG23 ' A' ' 43' ' ' ILE . 9.9 tt0 -81.76 61.8 5.29 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 109.64 -3.436 . . . . 0.0 104.323 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.57 130.81 35.35 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 113.228 -3.389 . . . . 0.0 109.454 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -146.61 -158.79 0.94 Allowed 'General case' 0 C--N 1.368 1.394 0 O-C-N 125.87 1.981 . . . . 0.0 113.066 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -14.53 60.34 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.05 52.97 0.97 Allowed 'General case' 0 N--CA 1.424 -1.772 0 O-C-N 128.22 3.45 . . . . 0.0 107.349 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 72.9 -164.26 0.11 Allowed 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 127.637 3.086 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.504 ' C ' HG22 ' A' ' 43' ' ' ILE . 31.7 m-20 -81.85 -30.52 32.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 127.657 3.098 . . . . 0.0 107.127 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.691 HD11 HD22 ' A' ' 57' ' ' LEU . 3.8 tp 37.14 70.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.104 2 O-C-N 132.107 5.879 . . . . 0.0 110.444 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -66.07 114.79 5.48 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.711 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.96 95.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 2 O-C-N 131.657 5.598 . . . . 0.0 99.802 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.282 2.8 p -114.68 151.67 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 1 O-C-N 129.536 4.272 . . . . 0.0 116.086 -179.691 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 67' ' ' TRP . 3.4 p90 -174.17 -171.7 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 131.682 5.614 . . . . 0.0 111.7 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -124.8 76.47 1.52 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 128.201 3.438 . . . . 0.0 113.762 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 24.36 78.48 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.738 1 O-C-N 133.744 6.903 . . . . 0.0 116.294 -179.876 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.62 64.28 1.83 Allowed Glycine 0 CA--C 1.537 1.407 0 N-CA-C 105.714 -2.955 . . . . 0.0 105.714 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.24 -38.01 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 1 O-C-N 130.588 4.346 . . . . 0.0 111.209 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.89 143.84 0.06 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 109.025 -3.716 . . . . 0.0 110.644 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 28.5 p90 178.3 -178.33 0.26 Allowed 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 129.279 4.112 . . . . 0.0 116.184 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.7 14.11 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.91 131.59 24.11 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 115.749 -2.38 . . . . 0.0 111.259 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.3 122.91 28.56 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.691 HD22 HD11 ' A' ' 43' ' ' ILE . 94.8 mt -84.1 -62.12 1.64 Allowed 'General case' 0 C--O 1.247 0.968 1 O-C-N 130.547 4.905 . . . . 0.0 115.086 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -101.86 35.74 2.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 125.777 1.923 . . . . 0.0 111.383 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 68.25 26.28 6.98 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 126.9 2.625 . . . . 0.0 110.672 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.87 -60.78 0.04 OUTLIER Glycine 0 CA--C 1.557 2.712 1 CA-C-O 113.204 -4.109 . . . . 0.0 105.61 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 58' ' ' ALA . 8.8 m -5.25 -77.53 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 1 O-C-N 135.278 7.105 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 63' ' ' LEU . 5.6 tp10 74.86 122.97 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.497 1 O-C-N 129.321 4.138 . . . . 0.0 103.865 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -154.39 69.85 0.77 Allowed 'General case' 0 C--O 1.205 -1.287 0 CA-C-N 109.285 -3.598 . . . . 0.0 106.843 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -67.92 96.83 0.62 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 111.176 -2.738 . . . . 0.0 106.273 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -165.39 172.11 40.86 Favored Glycine 0 C--O 1.207 -1.579 1 C-N-CA 111.175 -5.298 . . . . 0.0 107.843 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -133.89 143.13 48.08 Favored 'General case' 0 CA--C 1.507 -0.706 1 O-C-N 134.863 6.86 . . . . 0.0 113.241 179.874 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.639 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 22.9 m95 -113.82 122.17 46.24 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 101.338 -3.579 . . . . 0.0 101.338 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 66' ' ' THR . 18.6 p -117.02 48.92 1.24 Allowed 'General case' 0 C--N 1.316 -0.848 2 O-C-N 135.59 8.056 . . . . 0.0 115.873 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.803 ' CB ' HD11 ' A' ' 49' ' ' LEU . 2.6 tmm? -30.84 133.09 0.08 Allowed 'General case' 0 C--O 1.216 -0.7 1 O-C-N 134.376 7.298 . . . . 0.0 108.472 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.03 76.36 1.56 Allowed 'General case' 0 N--CA 1.48 1.048 1 O-C-N 129.12 4.012 . . . . 0.0 108.296 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.95 -113.11 5.57 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.71 28.18 1.59 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 114.172 -2.823 . . . . 0.0 114.432 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.294 0.1 OUTLIER -130.21 154.61 47.38 Favored 'General case' 0 C--N 1.342 0.255 1 O-C-N 129.273 4.108 . . . . 0.0 112.843 -179.834 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.597 ' CD1' HD11 ' A' ' 98' ' ' LEU . 4.3 mt -131.11 70.36 1.47 Allowed 'General case' 0 C--O 1.211 -0.939 0 O-C-N 129.081 3.988 . . . . 0.0 111.46 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.71 123.53 43.87 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 2 O-C-N 131.076 5.235 . . . . 0.0 110.512 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.19 -166.84 39.72 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-N 108.428 -3.987 . . . . 0.0 103.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 4.9 tttm -178.02 133.69 0.15 Allowed 'General case' 0 C--O 1.203 -1.387 1 O-C-N 132.304 5.355 . . . . 0.0 112.453 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -128.95 164.18 23.72 Favored 'General case' 0 N--CA 1.48 1.069 2 O-C-N 131.561 5.538 . . . . 0.0 102.386 -179.434 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.0 OUTLIER -157.65 143.18 17.18 Favored 'General case' 0 N--CA 1.432 -1.347 1 CA-C-N 107.21 -4.541 . . . . 0.0 113.491 -178.901 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 85' ' ' LYS . 4.3 ptm180 -102.62 94.24 5.53 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 129.281 4.113 . . . . 0.0 109.185 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -33.46 -36.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.431 1 O-C-N 134.393 7.308 . . . . 0.0 112.114 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -38.96 -52.09 1.79 Allowed 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.99 5.181 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -121.76 5.23 9.99 Favored 'General case' 0 N--CA 1.422 -1.874 0 O-C-N 127.808 3.193 . . . . 0.0 118.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.513 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 75.43 36.01 45.69 Favored Glycine 0 CA--C 1.554 2.497 2 C-N-CA 112.019 -4.896 . . . . 0.0 100.866 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HG2' ' CG ' ' A' ' 80' ' ' ARG 0.274 14.3 tptp -76.94 -75.11 0.21 Allowed 'General case' 0 N--CA 1.422 -1.865 1 O-C-N 131.918 5.128 . . . . 0.0 120.088 -179.695 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 42.8 mt-10 84.4 88.95 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.499 1 O-C-N 129.766 4.416 . . . . 0.0 108.317 -178.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.94 56.05 0.65 Allowed 'General case' 0 C--O 1.196 -1.76 1 O-C-N 131.66 5.6 . . . . 0.0 111.031 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -67.93 157.99 5.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 108.895 -3.775 . . . . 0.0 102.9 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -129.35 74.12 1.56 Allowed 'General case' 0 C--O 1.213 -0.868 1 O-C-N 133.982 7.051 . . . . 0.0 109.425 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.56 133.48 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 1 O-C-N 129.41 4.194 . . . . 0.0 107.436 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -178.12 148.58 0.51 Allowed 'General case' 0 C--O 1.191 -1.997 0 O-C-N 128.479 3.612 . . . . 0.0 114.6 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 3.6 mt-10 -143.66 114.67 7.81 Favored 'General case' 0 CA--C 1.561 1.376 1 O-C-N 129.874 4.484 . . . . 0.0 107.327 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.864 ' CD1' HD12 ' A' ' 98' ' ' LEU . 2.6 mm -18.43 80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.243 1 O-C-N 134.499 7.374 . . . . 0.0 110.661 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.21 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.733 1 O-C-N 132.648 6.217 . . . . 0.0 115.305 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.95 -131.21 10.23 Favored Glycine 0 CA--C 1.553 2.406 1 N-CA-C 102.061 -4.416 . . . . 0.0 102.061 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.16 29.3 8.01 Favored 'General case' 0 C--N 1.361 1.09 1 CA-C-N 107.189 -4.505 . . . . 0.0 109.587 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.565 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -156.28 151.62 26.71 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 114.635 -2.602 . . . . 0.0 108.253 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 93' ' ' ILE . 2.5 tt -105.15 126.47 52.12 Favored 'General case' 0 N--CA 1.445 -0.705 1 O-C-N 132.215 5.947 . . . . 0.0 112.132 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -77.25 -82.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 1 CA-C-O 109.927 -4.844 . . . . 0.0 108.256 -179.994 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 99' ' ' ILE . 95.8 mt-30 103.43 111.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.35 1 O-C-N 133.363 6.664 . . . . 0.0 100.903 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -112.29 102.49 10.64 Favored 'General case' 0 N--CA 1.424 -1.74 1 O-C-N 130.464 4.853 . . . . 0.0 113.847 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -75.24 101.3 4.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 113.513 -3.275 . . . . 0.0 105.326 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -84.92 97.8 9.98 Favored 'General case' 0 C--O 1.217 -0.642 1 O-C-N 129.511 4.257 . . . . 0.0 104.211 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -120.18 119.3 32.85 Favored 'General case' 0 C--N 1.363 1.185 1 CA-C-N 108.182 -4.099 . . . . 0.0 117.517 -179.935 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 50.15 23.01 1.04 Allowed 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.8 -6.43 24.05 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 117.639 -2.22 . . . . 0.0 115.464 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 108' ' ' GLU 0.257 39.5 t -95.16 163.0 2.35 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 CA-C-N 113.039 -1.581 . . . . 0.0 111.013 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 107' ' ' VAL . 6.0 mt-10 -126.35 58.76 1.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 127.26 2.85 . . . . 0.0 106.647 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.508 . . -82.02 128.94 34.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.061 3.351 . . . . 0.0 112.11 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD2' HG21 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.12 171.86 11.99 Favored 'General case' 0 N--CA 1.418 -2.07 1 O-C-N 132.872 6.358 . . . . 0.0 106.912 179.836 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -134.11 133.52 41.19 Favored 'General case' 0 C--O 1.207 -1.173 2 O-C-N 130.501 4.876 . . . . 0.0 99.602 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 pt -85.52 85.04 2.23 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 1 O-C-N 130.376 4.798 . . . . 0.0 113.653 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -91.64 179.25 5.7 Favored 'General case' 0 N--CA 1.441 -0.924 1 O-C-N 132.395 6.059 . . . . 0.0 104.836 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -154.61 -163.23 1.54 Allowed 'General case' 0 C--O 1.198 -1.644 1 O-C-N 130.766 5.041 . . . . 0.0 111.652 179.992 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.63 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 74.5 tttt -118.76 -119.59 0.31 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 115' ' ' LYS . 1.3 tp10 . . . . . 0 CA--C 1.558 1.275 0 CA-C-O 117.429 -1.272 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.426 ' HZ ' HD11 ' A' ' 93' ' ' ILE . 1.8 m-30 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -55.73 104.86 0.15 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 158.34 9.79 Favored Glycine 0 C--N 1.351 1.389 0 C-N-CA 114.15 -3.881 . . . . 0.0 104.488 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 58.1 p -78.72 163.42 25.43 Favored 'General case' 0 C--N 1.355 0.82 1 C-N-CA 110.566 -4.454 . . . . 0.0 110.307 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.553 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 23.0 m95 -132.81 162.27 31.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 112.319 -3.705 . . . . 0.0 111.043 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.8 OUTLIER 49.43 179.41 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 178.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 8' ' ' VAL 0.357 2.3 t . . . . . 0 CA--C 1.487 -1.471 3 O-C-N 132.769 6.293 . . . . 0.0 115.265 174.96 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.249 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER -161.75 153.54 19.07 Favored 'General case' 0 C--O 1.2 -1.542 1 O-C-N 129.608 4.317 . . . . 0.0 104.354 -179.985 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD2' HG13 ' A' ' 34' ' ' VAL . 4.5 mt -114.01 175.88 5.28 Favored 'General case' 0 CA--C 1.565 1.53 3 O-C-N 134.57 7.419 . . . . 0.0 97.544 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.628 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.3 m -171.33 -79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 128.802 3.814 . . . . 0.0 104.939 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 24' ' ' THR . 0.9 OUTLIER 73.88 151.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-N 109.277 -3.601 . . . . 0.0 110.346 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.9 m -166.66 71.91 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -48.94 125.36 10.25 Favored 'General case' 0 C--O 1.205 -1.268 1 O-C-N 131.589 5.555 . . . . 0.0 114.376 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -88.64 -112.36 0.06 Allowed 'General case' 0 C--N 1.365 1.249 1 O-C-N 130.389 4.806 . . . . 0.0 103.299 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.77 100.82 1.02 Allowed Glycine 0 CA--C 1.564 3.136 2 N-CA-C 100.526 -5.03 . . . . 0.0 100.526 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 m120 56.04 43.58 26.85 Favored 'General case' 0 N--CA 1.424 -1.745 0 O-C-N 128.04 2.847 . . . . 0.0 109.158 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -155.6 116.88 3.94 Favored 'General case' 0 CA--C 1.548 0.88 2 N-CA-C 98.618 -4.586 . . . . 0.0 98.618 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -127.95 169.82 13.55 Favored 'General case' 0 C--O 1.198 -1.628 2 N-CA-C 97.978 -4.823 . . . . 0.0 97.978 179.868 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.78 132.53 29.04 Favored 'General case' 0 CA--C 1.494 -1.185 2 O-C-N 133.921 7.013 . . . . 0.0 99.643 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.597 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.364 2.2 t -91.5 134.68 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 -179.998 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -68.78 -10.7 58.13 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 108.535 -3.939 . . . . 0.0 119.201 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.44 ' CB ' HG12 ' A' ' 34' ' ' VAL 0.27 2.3 tp10 -33.82 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 109.919 -3.31 . . . . 0.0 110.262 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -81.57 132.6 35.31 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 116.463 -2.095 . . . . 0.0 108.073 -179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.63 -152.31 0.14 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 114.09 -3.044 . . . . 0.0 111.711 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.72 1.78 21.36 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 127.833 3.208 . . . . 0.0 108.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 82.8 m-85 -82.29 -56.58 3.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 109.451 -3.522 . . . . 0.0 105.424 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -175.09 -174.5 0.76 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 130.198 4.686 . . . . 0.0 112.334 -179.872 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.99 124.67 34.95 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.309 0.9 OUTLIER -142.09 106.66 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.039 2 CA-C-O 131.859 5.599 . . . . 0.0 109.483 -178.493 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 125.18 25.1 Favored 'General case' 0 C--N 1.373 1.587 1 CA-C-N 107.197 -4.547 . . . . 0.0 109.546 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.3 p -91.24 65.27 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.495 2 O-C-N 130.32 4.762 . . . . 0.0 100.128 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.08 161.11 5.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 1 C-N-CA 111.003 -4.279 . . . . 0.0 115.941 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CE1' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -174.77 -155.71 0.06 Allowed 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 128.1 3.375 . . . . 0.0 110.579 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.8 mt-10 -130.81 177.92 7.05 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 115.478 -2.201 . . . . 0.0 108.083 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 94.7 6.59 Favored 'General case' 0 C--O 1.214 -0.795 1 O-C-N 131.64 5.587 . . . . 0.0 109.804 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.99 53.17 1.95 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-O 114.04 -3.644 . . . . 0.0 104.868 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 25.5 t -141.44 123.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 1 O-C-N 130.714 4.42 . . . . 0.0 111.677 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.42 160.18 20.65 Favored 'General case' 0 C--N 1.356 0.883 1 O-C-N 130.053 4.595 . . . . 0.0 107.788 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 56.0 p90 -177.15 177.68 1.21 Allowed 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 130.676 4.985 . . . . 0.0 116.228 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.3 135.23 47.12 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.0 -154.1 0.6 Allowed 'General case' 0 C--O 1.204 -1.336 0 O-C-N 128.009 3.318 . . . . 0.0 113.745 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.27 89.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.52 HD12 HD22 ' A' ' 63' ' ' LEU . 10.3 mt -83.12 170.62 14.58 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.974 2.671 . . . . 0.0 110.508 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.47 -141.17 0.69 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 126.049 2.093 . . . . 0.0 113.521 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -26.06 60.46 Favored 'General case' 0 C--N 1.366 1.289 0 O-C-N 120.884 -1.135 . . . . 0.0 110.089 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.04 71.56 0.03 OUTLIER Glycine 0 CA--C 1.554 2.519 0 CA-C-O 116.337 -2.368 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 p -73.82 -134.06 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 1 O-C-N 132.636 5.551 . . . . 0.0 107.382 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -146.8 -61.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 112.38 -3.728 . . . . 0.0 104.022 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.52 HD22 HD12 ' A' ' 57' ' ' LEU . 1.8 mp 42.86 70.48 0.29 Allowed 'General case' 0 C--O 1.214 -0.809 1 O-C-N 131.047 5.217 . . . . 0.0 111.449 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.7 m -88.28 117.31 27.1 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.921 1.688 . . . . 0.0 108.936 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 176.62 -138.78 4.18 Favored Glycine 0 N--CA 1.473 1.106 1 C-N-CA 110.108 -5.806 . . . . 0.0 107.62 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.382 5.9 t -173.07 166.69 4.99 Favored 'General case' 0 N--CA 1.446 -0.665 1 O-C-N 130.667 4.393 . . . . 0.0 116.889 -179.122 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.569 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 2.6 m95 -122.37 145.94 47.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -136.31 32.42 2.84 Favored 'General case' 0 C--N 1.321 -0.652 2 O-C-N 135.099 7.749 . . . . 0.0 111.649 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 16.7 ttp -32.17 132.99 0.11 Allowed 'General case' 0 C--N 1.317 -0.84 2 O-C-N 134.909 7.63 . . . . 0.0 108.873 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.45 139.83 33.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 111.331 -2.668 . . . . 0.0 108.809 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 30.02 -98.67 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.816 1 O-C-N 133.086 6.491 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -119.35 56.78 0.91 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 108.813 -3.693 . . . . 0.0 112.337 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.4 mtpt -148.11 179.8 7.48 Favored 'General case' 0 C--O 1.249 1.069 1 O-C-N 129.335 4.147 . . . . 0.0 110.322 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.2 mt -147.13 46.14 1.16 Allowed 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 126.193 2.183 . . . . 0.0 112.755 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.63 130.16 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 1 O-C-N 129.294 4.121 . . . . 0.0 113.356 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.488 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 156.99 -142.49 8.73 Favored Glycine 0 CA--C 1.564 3.151 2 CA-C-N 106.647 -4.797 . . . . 0.0 103.917 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 170.59 168.69 0.07 Allowed 'General case' 0 N--CA 1.44 -0.942 1 O-C-N 133.789 6.229 . . . . 0.0 111.04 -179.289 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.599 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 11.9 m-85 -150.1 157.02 42.68 Favored 'General case' 0 C--O 1.197 -1.694 1 O-C-N 133.743 6.902 . . . . 0.0 101.615 176.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.946 ' HG2' HG13 ' A' ' 81' ' ' VAL . 4.2 ttpt -155.4 135.69 13.14 Favored 'General case' 0 N--CA 1.422 -1.835 1 CA-C-N 107.612 -4.358 . . . . 0.0 112.407 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.652 ' CD ' HD11 ' A' ' 87' ' ' LEU . 14.9 ptm180 -106.38 47.57 0.87 Allowed 'General case' 0 CA--C 1.557 1.237 0 O-C-N 125.906 2.004 . . . . 0.0 107.18 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.946 HG13 ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -6.16 -52.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.619 1 O-C-N 132.08 5.862 . . . . 0.0 115.658 -179.758 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 80' ' ' ARG . 2.1 t0 -39.23 -29.86 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 129.026 3.954 . . . . 0.0 113.059 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 174.79 -22.83 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.978 0 O-C-N 128.982 3.926 . . . . 0.0 114.132 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 80' ' ' ARG . . . -69.59 -52.18 22.13 Favored Glycine 0 CA--C 1.536 1.36 1 N-CA-C 101.826 -4.51 . . . . 0.0 101.826 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.03 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.939 2 O-C-N 132.015 5.185 . . . . 0.0 120.303 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 10.1 mt-10 74.48 62.03 0.07 Allowed 'General case' 0 N--CA 1.432 -1.366 1 O-C-N 130.226 4.704 . . . . 0.0 117.75 177.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' A' ' 80' ' ' ARG . 23.2 mt -97.7 61.53 1.6 Allowed 'General case' 0 C--O 1.199 -1.588 1 O-C-N 130.175 4.672 . . . . 0.0 108.8 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 77' ' ' LYS . 16.1 mt -69.98 -173.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 1 CA-C-N 107.226 -4.534 . . . . 0.0 104.487 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -153.28 54.12 0.75 Allowed 'General case' 0 C--O 1.196 -1.726 0 O-C-N 128.014 3.321 . . . . 0.0 105.449 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.9 t -57.66 113.12 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 1 O-C-N 131.014 5.196 . . . . 0.0 103.474 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.721 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -161.7 162.76 29.89 Favored 'General case' 0 C--O 1.189 -2.131 0 C-N-CA 113.599 -3.24 . . . . 0.0 113.27 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.721 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -162.76 100.78 1.01 Allowed 'General case' 0 N--CA 1.449 -0.522 2 O-C-N 131.187 5.304 . . . . 0.0 104.779 179.662 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 98' ' ' LEU . 1.8 mm 5.04 73.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.807 1 O-C-N 134.731 7.519 . . . . 0.0 111.453 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 t -15.21 -51.33 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.071 1 O-C-N 133.431 6.707 . . . . 0.0 117.092 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.17 -88.72 0.1 Allowed Glycine 0 CA--C 1.548 2.15 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -125.73 18.43 7.99 Favored 'General case' 0 CA--C 1.555 1.149 2 CA-C-N 105.785 -5.207 . . . . 0.0 103.52 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.618 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -153.49 168.79 24.97 Favored 'General case' 0 C--O 1.22 -0.486 0 O-C-N 127.892 3.245 . . . . 0.0 106.776 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -108.08 139.98 41.94 Favored 'General case' 0 N--CA 1.434 -1.27 1 O-C-N 130.525 4.891 . . . . 0.0 109.863 -179.885 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HB ' ' HD3' ' A' ' 91' ' ' ARG . 1.5 mt -102.96 -79.76 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.474 2 O-C-N 130.022 4.576 . . . . 0.0 105.639 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.522 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.6 mm100 105.52 82.27 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 1 O-C-N 132.776 6.298 . . . . 0.0 104.734 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.503 HG23 ' CG ' ' A' ' 110' ' ' LYS . 1.8 m -84.89 95.84 9.15 Favored 'General case' 0 N--CA 1.427 -1.619 2 O-C-N 130.983 5.177 . . . . 0.0 112.137 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -68.29 149.46 49.43 Favored 'General case' 0 N--CA 1.48 1.064 1 C-N-CA 110.094 -4.642 . . . . 0.0 105.085 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.3 m -118.53 72.0 0.86 Allowed 'General case' 0 C--O 1.206 -1.216 1 O-C-N 130.97 5.169 . . . . 0.0 107.75 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -88.55 108.68 19.54 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 109.118 -3.674 . . . . 0.0 110.372 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -17.25 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 126.96 2.663 . . . . 0.0 116.563 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.84 0.92 58.77 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 117.654 -2.213 . . . . 0.0 113.94 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.4 t -157.67 104.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -88.26 79.95 7.68 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-O 114.892 -2.48 . . . . 0.0 108.078 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.381 . . -93.91 148.47 22.11 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 129.41 4.194 . . . . 0.0 109.591 179.528 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' CG ' HG23 ' A' ' 101' ' ' THR . 50.8 mtmt -119.31 163.56 16.98 Favored 'General case' 0 N--CA 1.421 -1.912 1 O-C-N 133.393 6.683 . . . . 0.0 110.825 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.72 133.22 46.92 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 129.059 3.975 . . . . 0.0 101.152 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.59 114.16 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 O-C-N 127.367 2.917 . . . . 0.0 112.153 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 10.1 m-30 -129.25 174.2 9.81 Favored 'General case' 0 N--CA 1.422 -1.85 2 O-C-N 131.773 5.671 . . . . 0.0 104.251 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -163.74 -165.35 1.02 Allowed 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 132.728 6.267 . . . . 0.0 111.915 179.976 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.553 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 16.3 tttt -117.13 142.93 46.38 Favored 'General case' 0 N--CA 1.427 -1.624 0 O-C-N 119.123 -2.236 . . . . 0.0 111.279 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.243 0 O-C-N 126.94 2.65 . . . . 0.0 112.478 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 2.1 m-30 . . . . . 0 CA--C 1.559 1.296 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.59 97.62 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.614 1 O-C-N 129.529 4.268 . . . . 0.0 115.795 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.17 142.7 3.46 Favored Glycine 0 N--CA 1.47 0.941 0 C-N-CA 114.295 -3.812 . . . . 0.0 105.949 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.319 60.2 p -67.41 164.2 19.16 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 115.558 -2.457 . . . . 0.0 107.537 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 71.1 m95 -141.19 135.34 30.68 Favored 'General case' 0 N--CA 1.411 -2.394 0 O-C-N 127.788 3.18 . . . . 0.0 113.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 26.5 mtmt 59.37 178.03 0.08 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.81 HG11 HD22 ' A' ' 21' ' ' LEU 0.26 1.5 t . . . . . 0 CA--C 1.482 -1.64 3 O-C-N 135.122 7.764 . . . . 0.0 120.932 174.876 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.558 1.281 0 CA-C-O 113.477 -3.154 . . . . 0.0 106.244 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' H ' HD23 ' A' ' 21' ' ' LEU 0.362 1.3 mttp 83.12 155.99 0.11 Allowed 'General case' 0 C--O 1.198 -1.616 1 O-C-N 134.931 7.644 . . . . 0.0 101.555 -178.54 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 7.3 mt -118.14 174.02 6.45 Favored 'General case' 0 C--O 1.242 0.695 2 O-C-N 132.133 5.896 . . . . 0.0 99.275 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.3 m -156.06 -79.03 0.09 Allowed 'General case' 0 C--O 1.198 -1.633 0 O-C-N 127.615 3.072 . . . . 0.0 107.83 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.952 HG22 ' CD1' ' A' ' 32' ' ' PHE . 1.2 mp 62.08 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-N 109.401 -3.545 . . . . 0.0 114.702 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 m -145.68 78.57 1.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 116.239 -2.184 . . . . 0.0 106.954 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 18.0 mm-40 -91.21 -111.73 0.09 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 114.112 -3.035 . . . . 0.0 109.879 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -122.2 3.65 9.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.55 -16.0 55.36 Favored Glycine 0 CA--C 1.56 2.9 0 N-CA-C 104.289 -3.525 . . . . 0.0 104.289 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -115.81 -38.18 3.75 Favored 'General case' 0 N--CA 1.435 -1.182 1 O-C-N 131.078 4.634 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -102.38 -170.33 1.79 Allowed 'General case' 0 CA--C 1.551 0.996 1 N-CA-C 97.856 -4.868 . . . . 0.0 97.856 179.198 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.952 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER 179.68 126.29 0.07 Allowed 'General case' 0 C--O 1.195 -1.791 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 179.154 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.87 112.25 25.3 Favored 'General case' 0 C--O 1.252 1.197 3 O-C-N 132.585 6.178 . . . . 0.0 97.208 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.317 2.5 t -75.51 146.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 1 C-N-CA 111.026 -4.269 . . . . 0.0 105.152 179.799 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.263 2.4 ttmm -87.5 54.87 3.28 Favored 'General case' 0 C--O 1.195 -1.778 2 CA-C-O 128.523 4.011 . . . . 0.0 113.486 179.577 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.282 27.4 tt0 -72.68 68.55 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.854 -2.43 . . . . 0.0 107.668 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 132.87 36.64 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 116.341 -2.144 . . . . 0.0 108.088 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -137.13 -162.12 1.25 Allowed 'General case' 0 C--N 1.351 0.631 0 C-N-CA 114.126 -3.029 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.51 58.12 0.94 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 126.744 2.528 . . . . 0.0 106.659 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 15.9 m-85 -134.01 -71.81 0.5 Allowed 'General case' 0 C--N 1.358 0.962 1 CA-C-N 107.57 -4.377 . . . . 0.0 106.765 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -156.1 10.0 0.26 Allowed 'General case' 0 N--CA 1.428 -1.538 1 O-C-N 129.848 4.467 . . . . 0.0 116.206 179.691 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 75.63 8.41 3.73 Favored 'General case' 0 CA--C 1.548 0.897 1 O-C-N 129.407 4.192 . . . . 0.0 109.353 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.938 HD11 ' CD1' ' A' ' 57' ' ' LEU 0.336 0.7 OUTLIER -28.45 138.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.319 3 O-C-N 133.288 6.618 . . . . 0.0 110.615 178.741 . . . . . . . . 5 4 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.87 137.64 50.91 Favored 'General case' 0 C--N 1.373 1.601 1 CA-C-N 108.176 -4.102 . . . . 0.0 109.373 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.99 107.47 22.9 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.128 1 O-C-N 131.696 5.623 . . . . 0.0 104.2 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 47' ' ' PHE 0.319 2.8 p -110.02 168.47 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 2 O-C-N 130.196 4.685 . . . . 0.0 116.148 -179.752 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' N ' HG22 ' A' ' 46' ' ' VAL . 6.3 p90 -174.43 -177.93 1.31 Allowed 'General case' 0 N--CA 1.427 -1.59 1 O-C-N 131.601 5.563 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 2.7 tt0 -138.3 40.75 2.26 Favored 'General case' 0 N--CA 1.426 -1.644 0 O-C-N 127.007 2.692 . . . . 0.0 114.445 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.17 115.02 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.098 1 O-C-N 132.795 6.31 . . . . 0.0 115.855 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.44 44.88 94.64 Favored Glycine 0 CA--C 1.545 1.933 1 CA-C-O 112.673 -4.404 . . . . 0.0 104.367 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -115.12 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 1 O-C-N 133.672 6.16 . . . . 0.0 114.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 66' ' ' THR . 53.7 p-10 -79.27 151.9 30.86 Favored 'General case' 0 C--N 1.354 0.775 1 O-C-N 129.577 4.298 . . . . 0.0 111.624 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -174.55 -174.62 0.86 Allowed 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.39 4.181 . . . . 0.0 115.581 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.35 97.04 4.6 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -106.31 130.88 54.07 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 128.135 3.397 . . . . 0.0 113.025 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.1 t -91.99 71.09 5.52 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 112.599 -3.64 . . . . 0.0 106.002 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.938 ' CD1' HD11 ' A' ' 43' ' ' ILE . 27.2 tp -36.17 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 O-C-N 131.164 5.29 . . . . 0.0 112.997 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -88.07 -136.11 0.09 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 114.984 -2.436 . . . . 0.0 109.169 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.11 58.25 0.63 Allowed 'General case' 0 C--O 1.21 -0.987 0 O-C-N 127.249 2.843 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.03 -81.05 0.11 Allowed Glycine 0 CA--C 1.556 2.642 1 CA-C-O 112.499 -4.5 . . . . 0.0 104.116 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.844 HG21 HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER 23.02 -94.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.717 1 O-C-N 133.316 5.95 . . . . 0.0 109.398 -179.704 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 74.91 29.2 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 126.827 2.579 . . . . 0.0 108.743 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 61' ' ' THR . 7.2 mp -63.91 92.11 0.07 Allowed 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 128.868 3.855 . . . . 0.0 107.817 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 100.0 m -89.12 99.31 12.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.798 -2.91 . . . . 0.0 109.668 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -160.38 -152.72 6.66 Favored Glycine 0 CA--C 1.546 1.998 1 C-N-CA 113.635 -4.126 . . . . 0.0 105.843 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 66' ' ' THR . 6.0 t -163.5 118.48 1.64 Allowed 'General case' 0 CA--C 1.494 -1.179 1 O-C-N 131.184 4.696 . . . . 0.0 114.927 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.708 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m95 -96.31 124.74 40.41 Favored 'General case' 0 C--N 1.356 0.867 1 O-C-N 115.62 -4.425 . . . . 0.0 106.86 -179.031 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.51 94.88 5.07 Favored 'General case' 0 C--O 1.202 -1.402 2 O-C-N 135.106 7.754 . . . . 0.0 108.948 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.68 88.18 0.7 Allowed 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 109.943 -3.299 . . . . 0.0 103.965 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -94.93 81.82 3.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 126.422 2.327 . . . . 0.0 111.112 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.56 -92.85 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 O-C-N 128.647 3.717 . . . . 0.0 109.973 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -110.03 35.49 3.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.748 -2.726 . . . . 0.0 111.182 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 154.09 43.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 115.5 -2.48 . . . . 0.0 108.377 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.532 HD13 HH11 ' A' ' 91' ' ' ARG . 4.9 mt -134.8 37.32 3.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 127.605 3.066 . . . . 0.0 115.098 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.63 149.61 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 1 CA-C-N 107.879 -4.237 . . . . 0.0 115.598 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 155.75 -150.07 21.33 Favored Glycine 0 CA--C 1.551 2.301 1 N-CA-C 102.754 -4.138 . . . . 0.0 102.754 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 8.4 tttt 178.84 115.5 0.04 OUTLIER 'General case' 0 C--N 1.368 1.403 1 O-C-N 131.6 4.941 . . . . 0.0 114.311 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -120.25 145.32 47.15 Favored 'General case' 0 C--O 1.203 -1.383 1 CA-C-O 129.87 4.652 . . . . 0.0 102.309 179.802 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG2' ' C ' ' A' ' 85' ' ' LYS . 18.1 ttmt -138.52 147.62 43.33 Favored 'General case' 0 N--CA 1.425 -1.707 1 CA-C-N 105.991 -5.095 . . . . 0.0 115.103 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.656 ' CG ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -97.49 24.28 6.79 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 128.917 3.886 . . . . 0.0 111.908 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' CB ' ' HD2' ' A' ' 79' ' ' LYS . 1.4 m 1.73 -57.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.777 1 O-C-N 134.891 7.619 . . . . 0.0 114.807 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 t0 -45.34 -27.18 0.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 128.989 3.931 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.78 -7.96 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 C-N-CA 114.218 -2.993 . . . . 0.0 118.358 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.21 -46.34 2.22 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 105.212 -3.155 . . . . 0.0 105.212 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 90.04 -150.49 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 134.351 6.56 . . . . 0.0 113.896 179.844 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.492 ' HA ' ' HG3' ' A' ' 79' ' ' LYS 0.264 0.2 OUTLIER -63.58 133.44 53.76 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-O 112.77 -3.491 . . . . 0.0 114.965 -178.799 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.656 HD13 ' CG ' ' A' ' 80' ' ' ARG . 0.5 OUTLIER -137.24 49.21 2.03 Favored 'General case' 0 C--O 1.202 -1.412 1 O-C-N 137.99 9.556 . . . . 0.0 108.434 178.108 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.68 174.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.17 2 CA-C-N 107.153 -4.567 . . . . 0.0 104.235 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.99 55.15 1.72 Allowed 'General case' 0 N--CA 1.436 -1.132 1 O-C-N 130.856 5.098 . . . . 0.0 107.726 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.1 t -55.76 112.47 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 1 O-C-N 131.436 5.46 . . . . 0.0 100.865 178.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.754 ' HD3' HD21 ' A' ' 98' ' ' LEU . 5.5 ttm180 -151.89 160.08 43.63 Favored 'General case' 0 CA--C 1.495 -1.144 1 C-N-CA 109.468 -4.893 . . . . 0.0 113.472 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -160.87 136.38 7.96 Favored 'General case' 0 C--N 1.356 0.869 1 O-C-N 131.464 5.477 . . . . 0.0 109.369 -179.429 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 98' ' ' LEU . 4.4 mm -67.45 124.47 22.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 1 O-C-N 133.336 6.647 . . . . 0.0 110.354 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -77.22 -65.58 0.93 Allowed 'General case' 0 CA--C 1.503 -0.845 1 O-C-N 129.716 4.385 . . . . 0.0 113.171 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' OE2' ' A' ' 97' ' ' GLU . . . -174.44 78.05 0.08 OUTLIER Glycine 0 CA--C 1.554 2.482 0 C-N-CA 115.358 -3.306 . . . . 0.0 106.711 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 79.44 27.79 0.37 Allowed 'General case' 0 CA--C 1.551 0.981 1 CA-C-N 106.599 -4.801 . . . . 0.0 108.445 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.663 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.325 0.0 OUTLIER -168.8 142.74 3.05 Favored 'General case' 0 CA--C 1.564 1.516 1 O-C-N 130.731 5.019 . . . . 0.0 107.938 179.252 . . . . . . . . 5 4 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.894 HD12 ' CD1' ' A' ' 93' ' ' ILE . 3.8 tt -106.2 133.14 51.37 Favored 'General case' 0 N--CA 1.439 -1.0 2 O-C-N 135.206 7.817 . . . . 0.0 112.853 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 112' ' ' ILE . 3.3 mt -75.08 -66.86 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-O 111.99 -3.862 . . . . 0.0 105.479 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 73.95 92.95 0.08 Allowed 'General case' 0 C--O 1.201 -1.483 1 O-C-N 134.712 7.508 . . . . 0.0 101.631 -179.664 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -111.24 124.04 51.42 Favored 'General case' 0 N--CA 1.425 -1.699 1 CA-C-N 107.844 -4.253 . . . . 0.0 113.44 179.929 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -91.95 151.81 20.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 113.297 -3.24 . . . . 0.0 104.279 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 103' ' ' THR . 1.1 m -134.95 70.34 1.44 Allowed 'General case' 0 C--O 1.214 -0.807 1 O-C-N 131.843 5.714 . . . . 0.0 105.571 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -88.96 121.4 31.28 Favored 'General case' 0 CA--C 1.497 -1.064 1 CA-C-N 106.813 -4.721 . . . . 0.0 111.302 -179.898 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 5.9 mt-10 55.71 -85.31 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.441 0.696 . . . . 0.0 109.857 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -151.0 37.46 0.87 Allowed Glycine 0 C--N 1.363 2.05 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.696 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.4 t -136.68 149.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 116.685 -1.626 . . . . 0.0 114.767 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -124.46 104.3 8.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 128.954 3.909 . . . . 0.0 105.183 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 110' ' ' LYS 0.435 . . -100.11 -32.13 11.07 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 128.526 3.641 . . . . 0.0 113.588 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' CG ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER 46.73 -80.37 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.091 1 O-C-N 137.735 9.397 . . . . 0.0 111.462 179.961 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' ALA . 2.4 mtm180 77.34 88.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.42 1 N-CA-C 99.505 -4.258 . . . . 0.0 99.505 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 99' ' ' ILE . 3.7 pt -65.36 159.28 4.15 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 1 O-C-N 130.372 4.795 . . . . 0.0 114.077 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 22.0 m-85 -144.81 -148.44 0.24 Allowed 'General case' 0 N--CA 1.442 -0.848 1 O-C-N 130.858 5.099 . . . . 0.0 105.124 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.67 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -168.24 -141.33 0.04 OUTLIER 'General case' 0 C--O 1.196 -1.744 1 O-C-N 131.678 5.611 . . . . 0.0 112.139 -179.446 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 7.0 tttt -132.43 154.04 50.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 125.891 1.676 . . . . 0.0 110.804 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.196 179.569 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.978 ' CE1' HD11 ' A' ' 93' ' ' ILE . 23.1 m-85 62.04 51.18 3.74 Favored 'General case' 0 N--CA 1.469 0.477 1 O-C-N 131.676 5.61 . . . . 0.0 103.735 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -148.96 62.72 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 115.791 -2.364 . . . . 0.0 114.913 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 176.78 21.13 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 115.192 -3.385 . . . . 0.0 107.449 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.274 16.9 p -72.84 168.47 18.8 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 128.253 2.972 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.599 ' CG ' ' HG3' ' A' ' 115' ' ' LYS 0.287 7.8 m95 -145.81 146.69 31.27 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 111.732 -3.985 . . . . 0.0 112.485 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.681 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 1.3 mtmt 61.49 -179.43 0.12 Allowed 'General case' 0 C--O 1.196 -1.752 1 O-C-N 133.297 6.623 . . . . 0.0 118.142 175.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 21' ' ' LEU 0.256 1.0 OUTLIER 29.56 133.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.664 3 O-C-N 135.793 8.183 . . . . 0.0 119.938 174.897 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.56 81.49 0.03 OUTLIER 'General case' 0 C--N 1.367 1.364 0 CA-C-N 110.598 -3.001 . . . . 0.0 108.303 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -90.82 92.63 8.88 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 123.016 1.388 . . . . 0.0 111.356 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 52.97 -160.68 0.12 Allowed 'General case' 0 C--N 1.363 1.196 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.308 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.4 -34.22 77.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.928 1.393 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 t30 75.73 137.23 0.06 Allowed 'General case' 0 C--N 1.36 1.046 0 O-C-N 129.002 3.939 . . . . 0.0 108.151 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -101.89 -155.85 0.54 Allowed 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 109.848 -3.342 . . . . 0.0 108.7 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -86.54 -158.88 0.44 Allowed 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 114.626 -2.83 . . . . 0.0 110.602 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . 103.96 -58.99 0.5 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 117.92 -2.086 . . . . 0.0 113.301 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . 71.89 85.5 0.12 Allowed 'General case' 0 C--O 1.248 0.975 0 O-C-N 126.589 1.994 . . . . 0.0 106.197 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -129.46 131.81 46.79 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 116.189 -1.862 . . . . 0.0 111.704 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 17.43 61.42 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.598 1 O-C-N 131.29 5.369 . . . . 0.0 113.814 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 97.36 8.23 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 110.714 -2.948 . . . . 0.0 111.594 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.725 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -81.32 -173.26 4.24 Favored 'General case' 0 CA--C 1.55 0.972 1 CA-C-N 107.453 -4.43 . . . . 0.0 103.178 -179.995 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.314 0.4 OUTLIER 150.76 142.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.509 1 O-C-N 133.083 6.49 . . . . 0.0 104.805 179.935 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -110.84 165.77 11.57 Favored 'General case' 0 CA--C 1.561 1.399 1 O-C-N 133.098 6.499 . . . . 0.0 100.441 179.589 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.664 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 4.2 m 175.95 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 1 O-C-N 132.316 6.01 . . . . 0.0 107.123 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.768 HG12 HG22 ' A' ' 34' ' ' VAL . 2.6 mp -133.41 140.67 46.34 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 109.007 -3.724 . . . . 0.0 109.422 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 m -159.2 81.15 0.77 Allowed 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 113.214 -3.395 . . . . 0.0 107.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.27 151.41 1.45 Allowed 'General case' 0 N--CA 1.433 -1.289 1 O-C-N 132.849 6.343 . . . . 0.0 111.271 179.631 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.28 56.09 0.88 Allowed 'General case' 0 C--N 1.352 0.71 1 O-C-N 129.903 4.502 . . . . 0.0 106.873 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.77 87.36 0.61 Allowed Glycine 0 CA--C 1.547 2.031 2 C-N-CA 110.846 -5.454 . . . . 0.0 101.746 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 p30 34.13 55.13 0.61 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 133.029 5.782 . . . . 0.0 109.048 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 88.82 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 3 O-C-N 131.392 5.432 . . . . 0.0 96.533 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 69' ' ' MET . 21.7 p90 -121.82 131.19 53.92 Favored 'General case' 0 C--O 1.209 -1.056 2 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.84 156.36 22.13 Favored 'General case' 0 N--CA 1.478 0.934 4 O-C-N 136.984 8.928 . . . . 0.0 98.656 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 25' ' ' ILE 0.291 2.7 t -127.54 143.14 41.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 126.932 3.253 . . . . 0.0 104.425 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.2 tttm -93.12 77.65 4.61 Favored 'General case' 0 N--CA 1.421 -1.881 2 CA-C-O 133.808 6.527 . . . . 0.0 114.072 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -86.45 62.1 7.22 Favored 'General case' 0 N--CA 1.42 -1.974 1 CA-C-N 108.019 -4.173 . . . . 0.0 107.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -74.0 119.37 18.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 112.924 -3.51 . . . . 0.0 109.574 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.03 -142.02 0.16 Allowed 'General case' 0 C--N 1.353 0.724 0 C-N-CA 114.574 -2.85 . . . . 0.0 114.385 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -96.48 38.53 1.2 Allowed 'General case' 0 C--N 1.355 0.845 0 O-C-N 124.16 0.912 . . . . 0.0 111.07 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -152.42 54.63 0.8 Allowed 'General case' 0 C--O 1.2 -1.508 1 O-C-N 129.937 4.523 . . . . 0.0 105.182 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.26 -161.78 0.2 Allowed 'General case' 0 C--O 1.246 0.889 1 O-C-N 132.387 6.054 . . . . 0.0 110.621 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.63 -68.99 0.46 Allowed 'General case' 0 CA--C 1.548 0.892 1 C-N-CA 111.661 -4.016 . . . . 0.0 102.599 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER 67.14 134.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.776 2 CA-C-O 131.505 5.431 . . . . 0.0 107.79 179.886 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.38 165.17 18.87 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 110.027 -3.26 . . . . 0.0 108.787 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.91 101.15 7.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.091 1 O-C-N 132.234 5.959 . . . . 0.0 101.663 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 5.8 p -111.48 154.75 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 129.054 3.971 . . . . 0.0 112.867 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL 0.27 3.3 p90 170.5 -172.55 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 132.098 5.874 . . . . 0.0 110.739 -179.606 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 51' ' ' VAL . 19.4 mt-10 -115.29 81.32 1.56 Allowed 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 115.66 -2.416 . . . . 0.0 114.73 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 69' ' ' MET . 1.0 OUTLIER 48.73 -115.78 0.78 Allowed 'General case' 0 C--N 1.324 -0.524 1 O-C-N 129.573 4.295 . . . . 0.0 110.041 -179.987 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 49' ' ' LEU . . . -71.81 76.15 0.7 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 104.664 -3.374 . . . . 0.0 104.664 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' HD2' ' A' ' 53' ' ' PHE . 2.3 t -129.93 97.22 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 1 O-C-N 131.659 4.976 . . . . 0.0 111.014 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.75 157.37 36.59 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 128.129 3.393 . . . . 0.0 110.844 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 13.3 p90 172.33 159.98 0.11 Allowed 'General case' 0 C--N 1.373 1.605 1 O-C-N 131.072 5.233 . . . . 0.0 114.869 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' OE2' ' A' ' 62' ' ' GLU . . . -105.34 96.83 6.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 101.047 -3.686 . . . . 0.0 101.047 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.569 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -121.42 128.33 52.06 Favored 'General case' 0 C--O 1.209 -1.067 1 O-C-N 129.169 4.043 . . . . 0.0 114.665 -179.928 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.84 168.25 13.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 112.76 -3.576 . . . . 0.0 107.738 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.464 HD23 HG13 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.12 -41.85 0.38 Allowed 'General case' 0 CA--C 1.509 -0.597 1 O-C-N 131.32 5.387 . . . . 0.0 112.774 -179.957 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -123.62 45.42 2.46 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 125.065 1.478 . . . . 0.0 114.487 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 42.64 28.38 0.12 Allowed 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.9 41.4 0.06 OUTLIER Glycine 0 C--N 1.364 2.138 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.62 HG23 ' HB3' ' A' ' 58' ' ' ALA . 30.1 p -137.32 177.74 7.64 Favored 'General case' 0 C--N 1.315 -0.893 1 O-C-N 130.849 4.5 . . . . 0.0 112.054 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 5.5 tp10 -161.77 37.5 0.13 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 114.888 -2.725 . . . . 0.0 106.084 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.18 99.6 0.03 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-N 108.839 -3.8 . . . . 0.0 109.644 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -107.69 108.39 19.6 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 110.329 -3.123 . . . . 0.0 108.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.537 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -162.77 -161.09 11.79 Favored Glycine 0 C--O 1.21 -1.382 1 C-N-CA 110.93 -5.414 . . . . 0.0 107.57 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 66' ' ' THR . 9.9 t -154.19 99.36 2.22 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 129.004 3.414 . . . . 0.0 116.737 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.702 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 25.2 m95 -81.89 127.72 33.31 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 118.11 -2.869 . . . . 0.0 104.461 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.9 p -120.3 69.16 0.86 Allowed 'General case' 0 N--CA 1.433 -1.293 1 O-C-N 135.695 8.122 . . . . 0.0 110.647 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 59.6 ttp -43.7 118.53 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 1 O-C-N 131.712 5.632 . . . . 0.0 104.058 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -119.5 59.71 0.85 Allowed 'General case' 0 CA--C 1.506 -0.742 1 O-C-N 130.693 4.996 . . . . 0.0 110.509 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.86 -85.89 1.37 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 117.46 -2.305 . . . . 0.0 110.682 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.01 23.94 11.83 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 114.531 -2.652 . . . . 0.0 114.025 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.77 -172.36 2.51 Favored 'General case' 0 N--CA 1.476 0.866 1 O-C-N 130.172 4.67 . . . . 0.0 109.705 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 74' ' ' LEU . 1.1 mt -157.97 37.94 0.26 Allowed 'General case' 0 C--O 1.214 -0.766 0 O-C-N 126.641 2.463 . . . . 0.0 114.028 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -62.04 135.69 26.28 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 1 CA-C-N 106.905 -4.679 . . . . 0.0 114.841 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.472 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 159.24 -161.14 31.85 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 104.549 -3.42 . . . . 0.0 104.549 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -174.59 122.97 0.27 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 113.675 -3.21 . . . . 0.0 112.344 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -124.35 146.37 48.88 Favored 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.066 4.604 . . . . 0.0 102.039 179.913 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.718 ' CG ' ' C ' ' A' ' 85' ' ' LYS 0.348 16.9 ttmt -139.23 152.3 47.21 Favored 'General case' 0 N--CA 1.424 -1.735 1 CA-C-N 105.448 -5.342 . . . . 0.0 117.845 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.823 ' HG2' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -113.33 63.02 0.64 Allowed 'General case' 0 CA--C 1.558 1.284 0 O-C-N 126.246 2.216 . . . . 0.0 108.929 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 t -17.34 -44.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 131.949 5.781 . . . . 0.0 115.425 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 9.9 t0 -65.4 -3.42 4.24 Favored 'General case' 0 N--CA 1.436 -1.161 1 O-C-N 129.97 4.544 . . . . 0.0 113.773 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER 168.23 -30.41 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 115.705 -2.398 . . . . 0.0 114.688 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.568 ' HA3' ' HD3' ' A' ' 80' ' ' ARG . . . -88.64 -30.63 14.96 Favored Glycine 0 CA--C 1.56 2.844 1 C-N-CA 112.729 -4.557 . . . . 0.0 103.268 -179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.718 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 50.25 17.25 0.32 Allowed 'General case' 0 N--CA 1.441 -0.887 1 O-C-N 133.356 5.974 . . . . 0.0 118.896 178.69 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' C ' HD12 ' A' ' 87' ' ' LEU . 1.7 mt-10 161.06 116.22 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 1 O-C-N 129.459 4.224 . . . . 0.0 109.172 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' A' ' 80' ' ' ARG . 4.8 mp -152.76 58.95 0.8 Allowed 'General case' 0 C--O 1.207 -1.145 1 O-C-N 139.654 10.597 . . . . 0.0 112.301 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.5 mt -67.25 -177.49 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.235 1 CA-C-N 108.032 -4.167 . . . . 0.0 104.893 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.21 63.1 0.97 Allowed 'General case' 0 C--O 1.194 -1.82 0 O-C-N 128.425 3.578 . . . . 0.0 106.255 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -67.29 112.06 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 110.735 -2.939 . . . . 0.0 106.469 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD3' ' HB ' ' A' ' 99' ' ' ILE . 1.2 tpm_? -172.55 157.38 3.9 Favored 'General case' 0 C--O 1.191 -1.998 1 C-N-CA 110.738 -4.385 . . . . 0.0 116.779 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -137.21 148.17 46.34 Favored 'General case' 0 N--CA 1.439 -1.011 1 O-C-N 129.707 4.38 . . . . 0.0 104.971 179.522 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 98' ' ' LEU . 16.3 mm -55.55 96.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.913 1 O-C-N 131.632 5.582 . . . . 0.0 109.304 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 t -38.51 -57.17 1.19 Allowed 'General case' 0 CA--C 1.509 -0.619 1 O-C-N 130.885 5.116 . . . . 0.0 113.621 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.68 98.48 0.15 Allowed Glycine 0 CA--C 1.559 2.824 1 N-CA-C 103.051 -4.02 . . . . 0.0 103.051 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m120 79.48 15.43 0.94 Allowed 'General case' 0 CA--C 1.553 1.063 1 O-C-N 132.466 5.451 . . . . 0.0 108.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.286 0.1 OUTLIER 174.68 170.73 0.25 Allowed 'General case' 0 C--O 1.2 -1.533 0 O-C-N 127.256 2.847 . . . . 0.0 108.928 178.696 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 93' ' ' ILE . 16.5 tp -123.36 158.45 31.06 Favored 'General case' 0 N--CA 1.434 -1.237 2 O-C-N 132.475 6.109 . . . . 0.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 100' ' ' GLN 0.255 7.8 mt -110.01 -89.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.101 4.626 . . . . 0.0 103.807 179.835 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 99' ' ' ILE . 9.8 mm100 111.1 90.23 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.729 1 O-C-N 133.188 6.555 . . . . 0.0 105.473 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.1 m -87.71 92.45 9.11 Favored 'General case' 0 C--O 1.197 -1.7 2 O-C-N 132.623 6.202 . . . . 0.0 112.28 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -70.39 113.38 7.47 Favored 'General case' 0 C--O 1.211 -0.968 2 CA-C-N 107.073 -4.603 . . . . 0.0 106.192 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -88.64 116.1 26.65 Favored 'General case' 0 C--N 1.364 1.209 1 O-C-N 129.105 4.003 . . . . 0.0 102.419 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.1 t80 -131.52 118.13 19.73 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.888 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 36.06 30.87 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.25 -19.91 9.18 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.779 -2.153 . . . . 0.0 114.188 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -94.94 162.34 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 116.41 -1.757 . . . . 0.0 115.298 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.25 85.07 2.35 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 126.456 2.348 . . . . 0.0 105.288 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.438 . . -89.27 104.6 17.13 Favored 'General case' 0 C--O 1.2 -1.548 1 O-C-N 129.112 4.007 . . . . 0.0 110.507 179.959 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 101' ' ' THR . 7.3 mttp -97.84 134.57 40.81 Favored 'General case' 0 C--N 1.315 -0.9 1 O-C-N 135.3 7.875 . . . . 0.0 110.425 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 99' ' ' ILE . 8.8 mtt180 -99.28 141.21 32.34 Favored 'General case' 0 CA--C 1.562 1.411 1 N-CA-C 99.395 -4.298 . . . . 0.0 99.395 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.8 mt -112.94 105.84 19.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 1 O-C-N 130.175 4.672 . . . . 0.0 113.824 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 29.1 m-85 -137.88 -156.19 0.67 Allowed 'General case' 0 N--CA 1.436 -1.156 2 CA-C-N 108.124 -4.125 . . . . 0.0 104.993 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -169.82 -138.9 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.173 1 O-C-N 131.041 5.213 . . . . 0.0 110.483 -179.785 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.599 ' HG3' ' CG ' ' A' ' 6' ' ' TRP . 15.7 tttt -135.83 166.71 22.67 Favored 'General case' 0 C--O 1.202 -1.409 0 O-C-N 127.503 3.002 . . . . 0.0 109.434 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.434 -1.268 0 CA-C-N 113.579 -1.646 . . . . 0.0 106.699 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.604 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.029 0.442 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.34 71.94 5.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 116.659 -2.016 . . . . 0.0 108.384 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 9.8 p-10 -169.83 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 116.632 -2.027 . . . . 0.0 114.887 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.24 -147.02 4.87 Favored Glycine 0 N--CA 1.48 1.62 1 C-N-CA 111.067 -5.349 . . . . 0.0 103.502 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 24' ' ' THR 0.254 7.5 p -97.63 166.18 11.62 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 129.333 3.608 . . . . 0.0 104.266 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.26 10.4 m95 -141.61 169.91 16.71 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 113.058 -3.354 . . . . 0.0 112.07 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.737 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 51.5 179.06 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 178.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.258 0.5 OUTLIER 22.75 146.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.454 3 CA-C-O 135.591 7.377 . . . . 0.0 120.263 175.015 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -104.7 -126.04 0.23 Allowed 'General case' 0 C--N 1.372 1.571 1 CA-C-N 107.479 -4.419 . . . . 0.0 102.483 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 33.47 79.24 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 O-C-N 126.229 2.206 . . . . 0.0 115.641 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 13' ' ' ASN . 1.7 m120 -64.1 174.68 1.47 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 116.266 -2.174 . . . . 0.0 111.585 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.61 79.79 0.01 OUTLIER 'General case' 0 C--O 1.242 0.704 0 O-C-N 126.668 2.48 . . . . 0.0 112.029 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' ASN . 5.3 t30 -154.13 45.39 0.58 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-O 123.436 1.589 . . . . 0.0 107.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.556 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -141.49 110.1 6.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.546 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.6 t -89.39 136.5 32.99 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 127.534 3.022 . . . . 0.0 108.755 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.48 27.01 73.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 114.44 -3.743 . . . . 0.0 113.247 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 14' ' ' TYR . . . -81.22 118.31 22.47 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 127.843 2.731 . . . . 0.0 109.175 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -102.3 35.98 2.26 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 125.173 1.546 . . . . 0.0 113.483 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -168.98 108.28 0.46 Allowed 'General case' 0 C--O 1.209 -1.072 0 O-C-N 124.821 1.326 . . . . 0.0 111.389 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -164.3 135.67 4.47 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 127.203 2.815 . . . . 0.0 110.174 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -144.25 -173.15 3.94 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 129.056 3.972 . . . . 0.0 102.576 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HG2' ' C ' ' A' ' 21' ' ' LEU 0.359 0.0 OUTLIER 171.13 165.91 0.08 Allowed 'General case' 0 CA--C 1.566 1.56 1 O-C-N 130.573 4.921 . . . . 0.0 104.268 179.805 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -131.93 151.48 51.69 Favored 'General case' 0 CA--C 1.558 1.26 4 O-C-N 134.494 7.371 . . . . 0.0 97.022 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.661 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.2 m 178.15 71.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 1 O-C-N 131.293 5.371 . . . . 0.0 104.215 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 34' ' ' VAL . 2.7 mp -86.37 157.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 109.87 -3.332 . . . . 0.0 108.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 27.9 m -172.77 77.3 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 128.056 3.347 . . . . 0.0 104.673 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 1.4 pt20 -45.75 145.09 1.47 Allowed 'General case' 0 N--CA 1.449 -0.524 2 O-C-N 132.556 6.16 . . . . 0.0 112.032 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -105.0 -7.48 19.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.98 63.86 0.24 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 103.21 -3.956 . . . . 0.0 103.21 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 p30 105.52 -20.9 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.277 1 O-C-N 131.944 5.143 . . . . 0.0 111.559 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.67 84.69 7.46 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 129.091 3.994 . . . . 0.0 103.27 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 17.1 m-85 -91.76 129.44 37.73 Favored 'General case' 0 C--O 1.19 -2.056 1 N-CA-C 96.177 -5.49 . . . . 0.0 96.177 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 33' ' ' THR 0.255 0.4 OUTLIER -132.88 114.1 13.66 Favored 'General case' 0 N--CA 1.483 1.213 2 O-C-N 135.895 8.247 . . . . 0.0 97.454 -179.741 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.442 14.7 t -85.48 154.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 2 C-N-CA 109.64 -4.824 . . . . 0.0 102.935 -179.839 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.8 tttm -88.56 16.8 6.05 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 118.848 2.907 . . . . 0.0 118.848 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.327 26.3 mt-10 -44.25 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 109.624 -3.443 . . . . 0.0 107.934 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 46.0 m -100.08 141.74 32.5 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 125.764 1.915 . . . . 0.0 113.322 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.08 -151.3 0.48 Allowed 'General case' 0 C--N 1.352 0.696 0 O-C-N 128.231 3.457 . . . . 0.0 110.054 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -111.08 30.01 7.27 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 20.2 m-85 -110.6 -78.13 0.59 Allowed 'General case' 0 CA--C 1.55 0.956 2 O-C-N 130.448 4.843 . . . . 0.0 110.366 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 2.1 mpt_? -139.04 8.63 2.51 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.563 2.415 . . . . 0.0 112.391 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.1 18.97 2.39 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 127.2 2.813 . . . . 0.0 104.204 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' ILE 0.298 9.7 tt -35.71 101.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.722 3 O-C-N 132.218 5.949 . . . . 0.0 110.24 179.429 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.42 144.64 27.21 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 109.643 -3.435 . . . . 0.0 105.944 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.85 128.22 50.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 1 O-C-N 129.38 4.175 . . . . 0.0 101.344 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.345 14.0 p -138.85 159.42 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 115.912 -2.315 . . . . 0.0 112.945 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.3 OUTLIER 170.73 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.928 1 O-C-N 134.977 7.673 . . . . 0.0 111.193 179.959 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.71 76.9 1.46 Allowed 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 127.212 2.82 . . . . 0.0 110.175 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 38.87 -80.48 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.962 1 O-C-N 131.71 5.631 . . . . 0.0 115.813 179.692 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.63 72.88 2.75 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 53' ' ' PHE . 4.5 t -148.2 110.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.104 1 O-C-N 131.666 4.98 . . . . 0.0 116.958 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.08 163.04 15.66 Favored 'General case' 0 C--O 1.205 -1.257 1 O-C-N 129.87 4.481 . . . . 0.0 106.277 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' HD2' HG12 ' A' ' 51' ' ' VAL . 10.7 p90 178.38 167.24 0.82 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 112.36 -3.736 . . . . 0.0 114.495 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.69 83.92 1.93 Allowed 'General case' 0 CA--C 1.562 1.412 1 N-CA-C 100.104 -4.036 . . . . 0.0 100.104 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.469 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -93.65 150.07 20.71 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 129.049 3.968 . . . . 0.0 114.997 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 88.22 2.71 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 128.362 3.539 . . . . 0.0 105.144 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.6 mm? -62.38 -75.63 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 128.796 3.81 . . . . 0.0 112.455 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 43' ' ' ILE . . . -84.33 -138.98 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 114.797 -2.525 . . . . 0.0 109.045 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.75 6.68 23.79 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 127.26 2.85 . . . . 0.0 111.734 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 66.19 0.19 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-O 115.712 -2.716 . . . . 0.0 107.323 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.531 ' HB ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -123.14 -76.61 0.59 Allowed 'General case' 0 C--O 1.213 -0.863 1 O-C-N 130.786 4.463 . . . . 0.0 112.869 179.939 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER 65.03 32.47 10.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.632 1.208 . . . . 0.0 109.438 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 61' ' ' THR . 3.7 mp -71.35 84.06 0.79 Allowed 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 128.371 3.545 . . . . 0.0 108.334 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -72.28 115.73 11.87 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 77' ' ' LYS . . . -150.29 -155.36 6.82 Favored Glycine 0 C--O 1.199 -2.041 1 C-N-CA 110.423 -5.656 . . . . 0.0 107.801 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.653 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.28 1.1 t -179.73 130.17 0.1 Allowed 'General case' 0 CA--C 1.499 -0.994 1 O-C-N 134.394 6.585 . . . . 0.0 110.969 -177.391 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.675 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 71.7 m95 -140.86 113.12 7.92 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 118.307 -2.745 . . . . 0.0 106.509 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 p -96.57 54.83 1.38 Allowed 'General case' 0 N--CA 1.428 -1.528 2 O-C-N 132.16 5.912 . . . . 0.0 116.316 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.6 tpp -40.13 107.69 0.07 Allowed 'General case' 0 C--O 1.212 -0.908 1 O-C-N 134.398 7.311 . . . . 0.0 104.833 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -130.48 115.95 17.53 Favored 'General case' 0 C--O 1.21 -0.979 0 O-C-N 128.526 3.641 . . . . 0.0 106.85 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.89 -132.05 46.22 Favored Glycine 0 CA--C 1.55 2.225 0 C-N-CA 117.01 -2.519 . . . . 0.0 107.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 11.9 m120 -97.95 52.78 1.07 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 115.679 -2.105 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -132.99 171.65 13.68 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 125.108 1.505 . . . . 0.0 113.753 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.1 mt -153.11 46.06 0.67 Allowed 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.939 1.352 . . . . 0.0 113.146 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.4 134.12 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 110.27 -3.15 . . . . 0.0 115.679 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' CH2' ' A' ' 67' ' ' TRP . . . 157.87 -157.49 28.27 Favored Glycine 0 CA--C 1.554 2.495 1 N-CA-C 102.863 -4.095 . . . . 0.0 102.863 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.563 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.314 0.0 OUTLIER -173.14 131.6 0.49 Allowed 'General case' 0 C--N 1.363 1.153 0 O-C-N 129.326 3.603 . . . . 0.0 116.319 179.604 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.675 ' CE1' ' CZ2' ' A' ' 67' ' ' TRP . 1.2 m-85 -112.07 163.29 14.46 Favored 'General case' 0 C--O 1.193 -1.878 1 CA-C-O 129.117 4.294 . . . . 0.0 101.706 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 ttmt -171.2 146.69 2.41 Favored 'General case' 0 N--CA 1.441 -0.908 1 CA-C-N 104.39 -5.823 . . . . 0.0 117.087 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.418 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -94.91 104.81 16.7 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 115.041 -2.409 . . . . 0.0 107.287 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 35.6 m -78.5 76.38 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 1 O-C-N 131.53 5.519 . . . . 0.0 111.933 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.13 -47.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 O-C-N 129.095 3.997 . . . . 0.0 108.538 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -179.05 5.17 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 127.271 2.857 . . . . 0.0 116.408 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.17 -44.09 3.89 Favored Glycine 0 CA--C 1.545 1.947 1 N-CA-C 102.139 -4.384 . . . . 0.0 102.139 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 86.69 -156.92 0.01 OUTLIER 'General case' 0 C--O 1.252 1.227 1 O-C-N 132.357 5.386 . . . . 0.0 113.372 179.991 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.24 148.83 49.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.836 2.562 . . . . 0.0 117.425 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD11 ' CG ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -141.7 36.37 1.62 Allowed 'General case' 0 C--O 1.206 -1.21 1 O-C-N 132.619 6.199 . . . . 0.0 110.388 179.589 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.489 HD11 ' HD3' ' A' ' 77' ' ' LYS . 36.7 mt -53.65 163.95 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.558 1 CA-C-N 107.223 -4.535 . . . . 0.0 106.062 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.13 59.95 1.71 Allowed 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 128.585 3.678 . . . . 0.0 106.047 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.7 118.13 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 1 O-C-N 129.327 4.142 . . . . 0.0 104.057 179.866 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -178.74 160.82 1.2 Allowed 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 113.302 -3.359 . . . . 0.0 114.352 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HG3' ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -144.52 134.61 24.07 Favored 'General case' 0 N--CA 1.424 -1.748 2 O-C-N 132.583 6.177 . . . . 0.0 108.129 179.642 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.34 108.77 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 1 O-C-N 130.974 5.172 . . . . 0.0 110.085 179.909 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.99 91.05 3.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 126.895 2.622 . . . . 0.0 115.647 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.75 -122.42 6.59 Favored Glycine 0 C--O 1.208 -1.479 0 N-CA-C 103.692 -3.763 . . . . 0.0 103.692 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -130.96 53.51 1.97 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 109.157 -3.521 . . . . 0.0 106.012 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.272 0.2 OUTLIER 174.15 137.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 1 O-C-N 130.434 4.834 . . . . 0.0 108.837 179.957 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.683 HD23 ' HG2' ' A' ' 100' ' ' GLN . 2.5 tt -111.63 120.09 40.9 Favored 'General case' 0 C--O 1.203 -1.343 1 O-C-N 130.795 5.06 . . . . 0.0 109.067 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 100' ' ' GLN . 11.6 mt -54.07 -84.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.316 3 O-C-N 131.526 5.516 . . . . 0.0 108.852 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER 107.06 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.107 1 O-C-N 133.856 6.972 . . . . 0.0 104.039 179.824 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.482 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 18.5 m -96.48 84.34 3.68 Favored 'General case' 0 C--O 1.193 -1.892 2 O-C-N 133.571 6.794 . . . . 0.0 112.749 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.31 121.28 14.46 Favored 'General case' 0 C--O 1.218 -0.555 1 CA-C-N 107.862 -4.245 . . . . 0.0 106.871 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HD12 ' A' ' 88' ' ' ILE . 1.8 m -98.1 70.8 2.1 Favored 'General case' 0 C--N 1.36 1.061 1 O-C-N 130.704 5.002 . . . . 0.0 101.536 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -97.15 130.98 44.34 Favored 'General case' 0 C--N 1.362 1.127 1 CA-C-N 107.347 -4.479 . . . . 0.0 109.422 -179.994 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 34.8 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.12 31.68 25.14 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 114.941 -3.504 . . . . 0.0 116.229 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 104' ' ' TYR . 63.4 t -109.0 -49.12 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 117.934 -1.507 . . . . 0.0 110.83 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.482 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 8.1 tt0 79.07 31.83 0.28 Allowed 'General case' 0 C--N 1.35 0.604 0 O-C-N 127.431 2.957 . . . . 0.0 107.902 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.447 . . -62.42 166.71 4.85 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 113.296 -3.362 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 7.5 mttm -140.49 -48.45 0.43 Allowed 'General case' 0 N--CA 1.438 -1.043 1 O-C-N 131.909 5.756 . . . . 0.0 111.25 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.46 -158.38 0.19 Allowed 'General case' 0 C--O 1.202 -1.4 1 O-C-N 131.766 5.666 . . . . 0.0 104.446 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.78 115.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.47 1 C-N-CA 111.098 -4.241 . . . . 0.0 112.24 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 21.1 m-30 -109.97 174.34 5.91 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 131.102 5.251 . . . . 0.0 106.314 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.03 130.26 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.531 2 O-C-N 131.381 5.425 . . . . 0.0 114.109 -179.382 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.3 tttt -47.22 169.16 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 109.035 -3.712 . . . . 0.0 112.455 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.423 -1.805 0 CA-C-N 111.48 -2.6 . . . . 0.0 113.032 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.021 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 98' ' ' LEU . 75.4 m-85 55.4 73.79 0.4 Allowed 'General case' 0 CA--C 1.556 1.176 1 O-C-N 129.507 4.254 . . . . 0.0 106.079 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -148.59 30.38 0.83 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 128.052 3.345 . . . . 0.0 117.324 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -151.53 8.0 Favored Glycine 0 C--N 1.349 1.293 2 C-N-CA 112.933 -4.46 . . . . 0.0 103.707 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.595 HG22 ' OG1' ' A' ' 24' ' ' THR 0.296 0.6 OUTLIER -89.85 -176.55 4.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 128.367 3.039 . . . . 0.0 105.627 179.616 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.334 19.1 m95 -162.63 153.17 16.83 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 113.147 -3.311 . . . . 0.0 113.581 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 15.2 mtmt 63.14 176.59 0.15 Allowed 'General case' 0 N--CA 1.426 -1.629 1 O-C-N 131.769 5.668 . . . . 0.0 119.086 176.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.255 0.5 OUTLIER 55.82 102.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.479 -1.786 3 CA-C-O 135.442 7.306 . . . . 0.0 120.869 174.88 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.41 138.92 43.73 Favored 'General case' 0 C--N 1.375 1.713 1 CA-C-N 107.631 -4.349 . . . . 0.0 103.626 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? 58.13 65.5 1.28 Allowed 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.324 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -44.88 137.9 3.83 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 110.833 -2.894 . . . . 0.0 112.781 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.08 93.7 6.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.896 2.622 . . . . 0.0 107.68 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.29 42.71 1.27 Allowed 'General case' 0 C--N 1.356 0.868 0 O-C-N 127.631 3.082 . . . . 0.0 106.054 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -127.22 35.06 4.62 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 126.314 2.259 . . . . 0.0 109.683 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -135.3 174.71 10.31 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 127.977 3.298 . . . . 0.0 106.813 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.41 67.1 0.45 Allowed Glycine 0 CA--C 1.552 2.38 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.22 80.15 0.1 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.456 -1.872 . . . . 0.0 108.52 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -81.56 101.92 10.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.628 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.44 -42.05 0.16 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 127.379 2.924 . . . . 0.0 113.324 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.43 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 70.99 162.28 0.24 Allowed 'General case' 0 C--N 1.358 0.96 0 O-C-N 125.111 1.507 . . . . 0.0 108.098 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -157.61 -163.93 1.45 Allowed 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 110.523 -3.035 . . . . 0.0 106.293 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HG3' ' HD3' ' A' ' 35' ' ' LYS 0.447 0.0 OUTLIER 150.6 174.15 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.682 1 O-C-N 129.504 4.253 . . . . 0.0 102.383 -179.161 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HD11 ' A' ' 25' ' ' ILE . 2.6 mt -119.12 163.62 16.76 Favored 'General case' 0 CA--C 1.557 1.249 3 O-C-N 132.515 6.134 . . . . 0.0 98.742 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.9 m 179.85 96.03 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.238 1 O-C-N 133.902 7.001 . . . . 0.0 108.278 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.839 HD11 HD22 ' A' ' 23' ' ' LEU . 4.7 mp -117.28 140.47 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.193 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -164.78 84.84 0.41 Allowed 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 128.494 3.621 . . . . 0.0 107.539 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -46.06 138.36 5.23 Favored 'General case' 0 N--CA 1.438 -1.052 2 O-C-N 132.943 6.402 . . . . 0.0 110.019 179.482 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -89.47 4.58 48.66 Favored 'General case' 0 C--N 1.343 0.286 1 O-C-N 130.068 4.605 . . . . 0.0 107.457 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.21 -58.46 0.61 Allowed Glycine 0 CA--C 1.55 2.246 2 N-CA-C 100.826 -4.91 . . . . 0.0 100.826 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.61 -10.46 4.0 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 108.785 -3.708 . . . . 0.0 109.062 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -91.45 169.52 10.71 Favored 'General case' 0 C--N 1.306 -1.308 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 25' ' ' ILE . 31.6 t80 -165.91 71.97 0.15 Allowed 'General case' 0 C--O 1.192 -1.942 1 N-CA-C 95.501 -5.74 . . . . 0.0 95.501 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -71.89 137.01 47.13 Favored 'General case' 0 CA--C 1.503 -0.856 2 O-C-N 133.717 6.886 . . . . 0.0 102.831 -179.883 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.372 0.5 OUTLIER -114.46 144.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 1 N-CA-C 99.774 -4.158 . . . . 0.0 99.774 179.248 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -101.55 58.79 0.86 Allowed 'General case' 0 N--CA 1.422 -1.858 1 CA-C-O 133.491 6.377 . . . . 0.0 117.924 -179.953 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.34 47.19 0.21 Allowed 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 108.92 -3.764 . . . . 0.0 110.151 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 30.8 t -58.05 138.04 56.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 116.017 -2.273 . . . . 0.0 108.343 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.54 127.91 0.14 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 114.737 -2.785 . . . . 0.0 114.746 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.05 -65.7 0.25 Allowed 'General case' 0 C--O 1.223 -0.298 0 O-C-N 128.972 3.92 . . . . 0.0 111.418 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 40.3 m-85 -120.55 102.16 8.25 Favored 'General case' 0 C--O 1.203 -1.393 0 O-C-N 127.861 3.226 . . . . 0.0 112.619 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.1 OUTLIER 61.47 -173.01 0.14 Allowed 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 126.722 2.513 . . . . 0.0 117.248 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -90.23 -20.4 23.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 126.671 2.482 . . . . 0.0 109.159 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 43' ' ' ILE 0.282 5.9 tp 6.84 77.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.427 2 O-C-N 133.312 6.633 . . . . 0.0 111.344 178.845 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.75 148.74 6.96 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 119.494 -2.004 . . . . 0.0 111.161 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.14 98.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 O-C-N 128.177 3.423 . . . . 0.0 104.267 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 47' ' ' PHE 0.285 8.1 p -106.64 164.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 113.662 -3.215 . . . . 0.0 116.072 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' N ' HG22 ' A' ' 46' ' ' VAL . 1.7 p90 -171.74 -161.79 0.2 Allowed 'General case' 0 N--CA 1.442 -0.862 1 O-C-N 129.976 4.547 . . . . 0.0 110.722 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -142.76 85.16 1.87 Allowed 'General case' 0 C--N 1.363 1.17 0 O-C-N 127.056 2.722 . . . . 0.0 115.373 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 18.22 94.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 131.261 5.351 . . . . 0.0 116.715 -179.941 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 92.41 46.72 3.44 Favored Glycine 0 C--O 1.207 -1.575 0 CA-C-O 114.209 -3.551 . . . . 0.0 104.95 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 t -134.89 118.53 25.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 1 O-C-N 130.315 4.185 . . . . 0.0 112.696 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.81 159.85 26.35 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 115.477 -2.489 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -173.23 165.57 4.84 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 130.625 4.953 . . . . 0.0 113.376 -179.822 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -125.57 89.98 3.13 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.13 144.57 28.12 Favored 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 116.082 -2.247 . . . . 0.0 113.341 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -106.51 71.38 0.86 Allowed 'General case' 0 CA--C 1.555 1.169 1 O-C-N 129.682 4.363 . . . . 0.0 103.018 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -38.06 -81.19 0.01 OUTLIER 'General case' 0 C--O 1.238 0.46 1 O-C-N 131.839 5.712 . . . . 0.0 114.239 -179.982 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.84 -101.45 0.03 OUTLIER 'General case' 0 C--O 1.247 0.972 0 CA-C-O 115.305 -2.284 . . . . 0.0 112.107 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.94 4.65 8.02 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 126.578 2.424 . . . . 0.0 111.844 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.59 53.65 0.03 OUTLIER Glycine 0 CA--C 1.549 2.203 0 CA-C-O 115.59 -2.784 . . . . 0.0 109.769 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 p -92.09 -64.93 1.05 Allowed 'General case' 0 CA--C 1.551 1.005 0 O-C-N 128.52 3.13 . . . . 0.0 107.352 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER 81.47 32.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.56 1 O-C-N 129.564 4.29 . . . . 0.0 111.076 177.619 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD23 ' CG ' ' A' ' 78' ' ' PHE . 2.7 mp -62.54 82.24 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.105 0 O-C-N 126.371 2.295 . . . . 0.0 110.807 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 62.3 m -69.15 117.47 10.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.78 -154.1 6.15 Favored Glycine 0 C--O 1.209 -1.434 1 C-N-CA 109.99 -5.862 . . . . 0.0 108.136 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.671 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 11.5 t 172.09 129.44 0.02 OUTLIER 'General case' 0 C--O 1.248 1.024 1 O-C-N 134.498 6.646 . . . . 0.0 111.861 -178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 69.9 m95 -136.76 128.76 29.41 Favored 'General case' 0 C--O 1.203 -1.359 1 O-C-N 116.194 -4.066 . . . . 0.0 106.283 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.456 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -111.42 31.85 5.81 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.432 4.832 . . . . 0.0 117.197 -177.988 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.73 ' CB ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 2.29 101.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.916 1 O-C-N 133.388 6.68 . . . . 0.0 109.611 179.377 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' ASN . 1.1 mm-40 -108.45 95.2 5.5 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 129.092 3.995 . . . . 0.0 112.171 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.32 -91.74 0.09 OUTLIER Glycine 0 C--N 1.353 1.51 1 O-C-N 129.55 4.281 . . . . 0.0 108.979 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -136.69 46.57 2.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 129.153 3.502 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.2 mtpt -129.33 163.04 26.58 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 128.843 3.84 . . . . 0.0 110.785 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 98' ' ' LEU . 8.2 mt -141.74 68.38 1.33 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 127.226 2.829 . . . . 0.0 112.186 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.49 83.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 2 O-C-N 131.044 5.215 . . . . 0.0 111.01 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 67' ' ' TRP . . . -150.57 -177.66 24.7 Favored Glycine 0 CA--C 1.555 2.575 2 CA-C-N 106.994 -4.639 . . . . 0.0 102.695 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.308 0.3 OUTLIER -155.14 168.69 26.2 Favored 'General case' 0 C--O 1.204 -1.32 1 O-C-N 132.758 5.623 . . . . 0.0 112.083 -179.733 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 m-85 -148.18 166.85 26.66 Favored 'General case' 0 C--O 1.19 -2.033 1 CA-C-O 128.943 4.211 . . . . 0.0 104.052 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 5.0 ttpt -173.14 132.81 0.51 Allowed 'General case' 0 N--CA 1.418 -2.059 1 CA-C-N 104.428 -5.805 . . . . 0.0 117.992 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -100.88 38.21 1.59 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 126.512 2.383 . . . . 0.0 114.281 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.606 HG22 ' N ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 7.02 -67.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.999 1 O-C-N 131.772 5.67 . . . . 0.0 115.041 179.832 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.606 ' N ' HG22 ' A' ' 81' ' ' VAL . 9.9 t0 -42.59 -26.01 0.11 Allowed 'General case' 0 N--CA 1.443 -0.808 1 O-C-N 130.248 4.717 . . . . 0.0 112.543 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.11 -16.45 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 113.954 -3.098 . . . . 0.0 117.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' HA3' ' HG3' ' A' ' 80' ' ' ARG . . . -97.79 -32.75 6.09 Favored Glycine 0 CA--C 1.548 2.147 1 C-N-CA 112.98 -4.438 . . . . 0.0 104.226 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.87 -157.85 0.06 Allowed 'General case' 0 C--O 1.25 1.089 1 O-C-N 131.672 4.983 . . . . 0.0 113.416 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.621 ' N ' ' HD3' ' A' ' 79' ' ' LYS 0.347 0.0 OUTLIER -61.88 133.46 55.46 Favored 'General case' 0 C--O 1.198 -1.638 1 O-C-N 129.534 4.271 . . . . 0.0 114.745 -177.598 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 80' ' ' ARG 0.255 2.4 mt -136.68 38.45 2.63 Favored 'General case' 0 C--O 1.208 -1.132 1 O-C-N 136.145 8.403 . . . . 0.0 109.641 -179.697 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 103' ' ' THR . 90.7 mt -61.83 163.5 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.707 1 CA-C-N 107.239 -4.528 . . . . 0.0 102.608 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.99 67.98 1.33 Allowed 'General case' 0 C--O 1.211 -0.939 1 O-C-N 134.47 7.356 . . . . 0.0 105.45 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.64 131.34 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-N 111.824 -2.444 . . . . 0.0 108.962 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -152.4 -158.25 0.88 Allowed 'General case' 0 N--CA 1.435 -1.209 1 C-N-CA 110.856 -4.338 . . . . 0.0 112.311 179.771 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 166.48 79.17 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.318 1 O-C-N 130.592 4.933 . . . . 0.0 105.265 -178.593 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 0.4 OUTLIER -24.08 92.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 1 O-C-N 132.383 6.052 . . . . 0.0 113.785 -179.419 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 p -53.07 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.102 1 O-C-N 129.261 4.101 . . . . 0.0 116.36 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -112.63 0.74 Allowed Glycine 0 CA--C 1.559 2.795 0 C-N-CA 115.633 -3.175 . . . . 0.0 106.46 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -117.38 46.19 1.76 Allowed 'General case' 0 C--N 1.362 1.133 1 CA-C-N 106.937 -4.632 . . . . 0.0 109.14 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.568 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -172.48 152.52 2.67 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 128.316 3.51 . . . . 0.0 106.863 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD22 ' HG2' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -104.32 107.37 18.25 Favored 'General case' 0 C--O 1.204 -1.306 2 O-C-N 132.321 6.013 . . . . 0.0 108.147 179.532 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -56.26 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.891 2 O-C-N 134.696 7.498 . . . . 0.0 103.287 -179.998 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.552 ' HG2' HD22 ' A' ' 98' ' ' LEU . 7.7 mm-40 99.45 98.1 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.079 1 O-C-N 130.257 4.723 . . . . 0.0 103.263 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.715 HG23 ' HG2' ' A' ' 110' ' ' LYS . 20.8 m -100.96 95.46 6.61 Favored 'General case' 0 C--O 1.195 -1.812 2 O-C-N 130.529 4.893 . . . . 0.0 111.236 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.2 m-85 -66.97 131.28 45.55 Favored 'General case' 0 C--O 1.202 -1.408 3 CA-C-N 106.411 -4.904 . . . . 0.0 106.481 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 88' ' ' ILE . 90.5 m -111.94 80.1 1.29 Allowed 'General case' 0 C--O 1.199 -1.553 1 O-C-N 131.824 5.702 . . . . 0.0 107.021 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -101.09 154.73 18.48 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 108.705 -3.862 . . . . 0.0 110.649 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.3 mm-40 -32.65 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.559 ' O ' HG13 ' A' ' 107' ' ' VAL . . . 88.88 10.15 67.19 Favored Glycine 0 C--N 1.357 1.727 0 C-N-CA 115.752 -3.118 . . . . 0.0 116.851 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -158.02 173.36 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 115.975 -1.964 . . . . 0.0 114.657 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.67 58.45 1.61 Allowed 'General case' 0 C--N 1.353 0.752 1 O-C-N 131.491 5.495 . . . . 0.0 107.067 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.321 . . -80.56 121.63 26.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 128.42 3.575 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG2' HG23 ' A' ' 101' ' ' THR . 11.4 mttt -104.28 179.61 4.22 Favored 'General case' 0 N--CA 1.426 -1.666 1 O-C-N 133.718 6.886 . . . . 0.0 108.536 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -159.14 135.82 9.38 Favored 'General case' 0 CA--C 1.562 1.406 2 O-C-N 130.131 4.644 . . . . 0.0 99.014 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 99' ' ' ILE . 1.2 pt -111.23 111.47 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 1 O-C-N 132.2 5.938 . . . . 0.0 114.039 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 93.0 m-85 -109.63 -142.18 0.38 Allowed 'General case' 0 CA--C 1.559 1.321 1 O-C-N 131.48 5.488 . . . . 0.0 101.901 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -149.94 0.06 Allowed 'General case' 0 C--O 1.205 -1.25 1 O-C-N 132.9 6.375 . . . . 0.0 111.417 179.56 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.674 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.2 tttt -131.63 -175.68 3.79 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 124.997 2.332 . . . . 0.0 112.616 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.204 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 122.098 0.952 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -169.72 79.24 0.11 Allowed 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 110.203 -3.18 . . . . 0.0 103.733 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -170.06 59.44 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 114.4 -2.92 . . . . 0.0 114.953 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 48.4 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 1 C-N-CA 111.366 -5.206 . . . . 0.0 107.24 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 34.8 p 59.22 162.85 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.814 1 O-C-N 132.269 5.334 . . . . 0.0 111.479 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.285 8.4 m95 -157.38 149.06 22.15 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 116.328 -1.796 . . . . 0.0 114.079 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 38.4 mtmt 59.71 178.96 0.09 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 21' ' ' LEU 0.257 0.5 OUTLIER 39.07 148.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 3 O-C-N 134.061 7.101 . . . . 0.0 120.693 174.864 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.33 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 CA-C-N 107.644 -4.343 . . . . 0.0 108.141 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -43.1 132.64 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.9 152.01 11.02 Favored 'General case' 0 C--O 1.206 -1.188 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.812 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.83 -159.11 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -84.52 70.95 10.78 Favored 'General case' 0 CA--C 1.541 0.625 1 O-C-N 129.6 4.313 . . . . 0.0 102.688 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.36 167.68 0.31 Allowed 'General case' 0 C--O 1.215 -0.732 0 O-C-N 128.508 3.63 . . . . 0.0 105.283 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 t 65.91 -153.38 0.25 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.63 153.72 5.95 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 127.665 3.103 . . . . 0.0 112.36 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.56 53.2 0.75 Allowed 'General case' 0 C--O 1.242 0.692 0 CA-C-N 112.05 -2.075 . . . . 0.0 107.468 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.66 136.86 10.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 126.142 2.151 . . . . 0.0 111.529 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.47 94.17 9.33 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 116.166 -1.873 . . . . 0.0 109.617 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.761 ' C ' HD23 ' A' ' 21' ' ' LEU . 25.5 p-10 -108.21 161.76 14.69 Favored 'General case' 0 CA--C 1.561 1.403 1 O-C-N 130.153 4.658 . . . . 0.0 113.193 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -146.66 -178.72 6.33 Favored 'General case' 0 CA--C 1.553 1.088 1 O-C-N 129.511 4.257 . . . . 0.0 104.586 -179.976 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.396 0.0 OUTLIER -147.12 140.2 25.23 Favored 'General case' 0 CA--C 1.566 1.569 1 O-C-N 131.029 5.205 . . . . 0.0 100.612 179.687 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.0 mt -98.4 164.39 12.3 Favored 'General case' 0 C--N 1.318 -0.799 2 O-C-N 133.072 6.482 . . . . 0.0 98.811 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.61 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 20.8 m 174.04 89.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 O-C-N 128.882 3.864 . . . . 0.0 104.155 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.829 HG21 ' CE1' ' A' ' 32' ' ' PHE 0.263 4.4 mp -111.05 152.86 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 108.533 -3.94 . . . . 0.0 110.809 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.0 m -162.34 80.22 0.52 Allowed 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 114.134 -3.026 . . . . 0.0 108.045 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -52.35 124.0 12.24 Favored 'General case' 0 C--O 1.214 -0.814 2 O-C-N 132.996 6.435 . . . . 0.0 110.992 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -116.84 111.0 19.08 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 128.608 3.692 . . . . 0.0 103.229 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 -114.17 4.43 Favored Glycine 0 CA--C 1.546 2.026 1 N-CA-C 101.69 -4.564 . . . . 0.0 101.69 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 62.99 1.07 Allowed 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 127.338 2.434 . . . . 0.0 107.38 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.05 161.87 33.22 Favored 'General case' 0 C--N 1.306 -1.312 1 N-CA-C 98.936 -4.468 . . . . 0.0 98.936 -179.842 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.829 ' CE1' HG21 ' A' ' 25' ' ' ILE . 69.1 t80 -158.0 72.9 0.66 Allowed 'General case' 0 C--O 1.193 -1.918 1 N-CA-C 99.439 -4.282 . . . . 0.0 99.439 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -72.78 139.43 47.07 Favored 'General case' 0 CA--C 1.505 -0.761 2 O-C-N 131.784 5.677 . . . . 0.0 103.827 179.933 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.383 0.5 OUTLIER -120.13 137.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 128.782 3.802 . . . . 0.0 101.427 179.915 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 8.2 tttm -87.52 17.85 4.3 Favored 'General case' 0 N--CA 1.414 -2.228 1 N-CA-C 121.871 4.026 . . . . 0.0 121.871 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG2' HG12 ' A' ' 34' ' ' VAL . 7.3 pt-20 -49.68 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 124.727 2.204 . . . . 0.0 110.385 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.601 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 t -77.03 152.82 34.97 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 116.406 -2.117 . . . . 0.0 109.299 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.98 102.09 0.09 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 114.867 -2.733 . . . . 0.0 116.077 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 60.7 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 1 O-C-N 129.574 4.296 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 58' ' ' ALA . 1.1 m-85 -78.18 91.45 4.35 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 115.59 -2.444 . . . . 0.0 110.695 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.29 -160.76 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 129.198 4.061 . . . . 0.0 115.757 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -7.69 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 127.034 2.709 . . . . 0.0 108.205 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.8 tp 11.8 91.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.42 2 O-C-N 132.885 6.366 . . . . 0.0 111.909 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.63 123.35 17.66 Favored 'General case' 0 C--N 1.369 1.433 0 O-C-N 118.219 -2.8 . . . . 0.0 111.071 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' HE1' ' A' ' 47' ' ' PHE . 46.1 t -88.07 106.29 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 2 O-C-N 130.08 4.613 . . . . 0.0 100.014 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.312 10.7 p -118.0 153.51 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 O-C-N 127.444 2.965 . . . . 0.0 114.149 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HG12 ' A' ' 45' ' ' VAL . 2.2 p90 -179.32 -165.63 0.08 Allowed 'General case' 0 N--CA 1.429 -1.521 1 O-C-N 132.357 6.035 . . . . 0.0 111.132 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.75 73.53 1.41 Allowed 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 116.571 -2.052 . . . . 0.0 108.638 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.2 OUTLIER 69.59 -79.22 0.04 OUTLIER 'General case' 0 C--O 1.198 -1.615 2 O-C-N 132.499 6.125 . . . . 0.0 111.666 179.988 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.666 ' HA2' HG22 ' A' ' 68' ' ' THR . . . -127.91 84.09 0.33 Allowed Glycine 0 CA--C 1.537 1.437 0 N-CA-C 104.665 -3.374 . . . . 0.0 104.665 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.12 -40.74 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 O-C-N 131.341 4.789 . . . . 0.0 111.641 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.86 125.22 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.935 2 O-C-N 133.013 6.446 . . . . 0.0 108.368 179.906 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 3.3 p90 -167.25 140.6 3.55 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 112.311 -3.756 . . . . 0.0 115.37 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -90.76 151.21 21.3 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 100.846 -3.761 . . . . 0.0 100.846 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.472 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -170.51 135.1 1.16 Allowed 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 112.236 -3.786 . . . . 0.0 109.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 91.21 8.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 114.456 -2.688 . . . . 0.0 105.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 55' ' ' TYR . 10.5 mp -68.87 -96.11 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 O-C-N 129.544 4.277 . . . . 0.0 114.24 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 40' ' ' PHE . . . -46.66 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 126.587 2.429 . . . . 0.0 116.185 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.0 14.17 4.75 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 124.939 1.399 . . . . 0.0 112.739 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.66 58.68 0.09 OUTLIER Glycine 0 CA--C 1.544 1.858 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.82 ' HB ' HD13 ' A' ' 63' ' ' LEU . 71.7 p -67.3 -60.57 2.48 Favored 'General case' 0 N--CA 1.425 -1.722 1 O-C-N 131.755 5.032 . . . . 0.0 110.126 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 65.73 46.71 2.29 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 125.487 1.742 . . . . 0.0 108.532 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.82 HD13 ' HB ' ' A' ' 61' ' ' THR . 5.2 mp -99.84 84.12 2.85 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 127.66 3.1 . . . . 0.0 107.644 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 22.8 m -70.04 105.85 3.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 111.362 -2.654 . . . . 0.0 110.286 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -166.31 -156.42 9.48 Favored Glycine 0 CA--C 1.557 2.681 1 C-N-CA 111.954 -4.927 . . . . 0.0 104.314 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CE1' ' A' ' 78' ' ' PHE 0.26 8.8 t -161.27 135.54 7.02 Favored 'General case' 0 CA--C 1.491 -1.29 1 O-C-N 131.793 5.055 . . . . 0.0 114.481 179.525 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.744 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 9.4 m95 -115.03 97.66 6.35 Favored 'General case' 0 C--O 1.192 -1.96 0 O-C-N 117.839 -3.038 . . . . 0.0 104.553 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.666 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -101.16 97.36 7.9 Favored 'General case' 0 N--CA 1.447 -0.609 2 O-C-N 137.421 9.201 . . . . 0.0 114.879 179.952 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.596 ' HB3' HD21 ' A' ' 49' ' ' LEU . 3.6 ttp -56.69 109.53 0.64 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 128.974 3.922 . . . . 0.0 105.402 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 28.9 tt0 -101.68 65.12 1.01 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.158 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -105.78 0.79 Allowed Glycine 0 CA--C 1.551 2.327 0 O-C-N 128.817 3.823 . . . . 0.0 103.924 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.78 62.7 2.72 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 128.63 3.194 . . . . 0.0 109.041 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -172.23 179.14 2.67 Favored 'General case' 0 C--N 1.358 0.955 1 O-C-N 129.678 4.361 . . . . 0.0 109.95 179.934 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 74' ' ' LEU . 2.5 mt -157.6 74.54 0.75 Allowed 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 127.272 2.857 . . . . 0.0 112.191 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.58 134.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.037 -2.347 . . . . 0.0 116.036 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 173.78 -166.1 38.18 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 103.745 -3.742 . . . . 0.0 103.745 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 88' ' ' ILE 0.251 12.5 tttm 176.65 117.67 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.348 1 O-C-N 133.822 6.248 . . . . 0.0 113.345 179.997 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.744 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.1 OUTLIER -114.59 171.5 7.6 Favored 'General case' 0 C--O 1.192 -1.932 0 O-C-N 128.768 3.793 . . . . 0.0 101.335 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.338 0.0 OUTLIER -170.43 142.1 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 108.922 -3.763 . . . . 0.0 115.061 -179.001 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.513 ' CB ' ' HB3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.63 106.08 18.22 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 118.295 -1.362 . . . . 0.0 108.887 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.65 -16.82 17.59 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 1 O-C-N 130.777 5.048 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.04 -36.27 72.27 Favored 'General case' 0 C--O 1.252 1.206 0 O-C-N 129.091 3.994 . . . . 0.0 111.677 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -122.9 3.95 9.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 126.747 2.529 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 69.17 43.28 72.38 Favored Glycine 0 CA--C 1.558 2.746 2 N-CA-C 100.863 -4.895 . . . . 0.0 100.863 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -105.08 132.19 51.63 Favored 'General case' 0 N--CA 1.44 -0.946 2 CA-C-N 105.617 -5.291 . . . . 0.0 115.429 -179.539 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 6.2 mt-10 -110.16 139.6 45.14 Favored 'General case' 0 C--O 1.199 -1.554 0 CA-C-N 121.344 1.884 . . . . 0.0 107.844 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.7 45.44 2.81 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 133.031 6.457 . . . . 0.0 110.28 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 77' ' ' LYS . 96.9 mt -68.81 168.03 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.949 1 CA-C-N 107.929 -4.214 . . . . 0.0 103.592 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB3' ' CZ3' ' A' ' 67' ' ' TRP . . . -143.22 107.7 4.81 Favored 'General case' 0 C--O 1.195 -1.803 1 O-C-N 130.83 5.081 . . . . 0.0 105.587 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 t -110.87 106.95 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 128.645 3.716 . . . . 0.0 102.519 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -156.08 162.5 40.27 Favored 'General case' 0 C--O 1.189 -2.111 1 C-N-CA 110.411 -4.516 . . . . 0.0 116.136 -179.535 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.16 136.86 20.4 Favored 'General case' 0 N--CA 1.439 -1.015 2 O-C-N 132.84 6.337 . . . . 0.0 109.8 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.2 mm -47.55 124.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 1 O-C-N 131.891 5.744 . . . . 0.0 110.177 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -126.43 101.43 6.69 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 128.526 3.641 . . . . 0.0 117.297 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.94 39.05 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 59.32 44.15 15.73 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 111.637 -2.282 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.672 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.265 0.1 OUTLIER -158.71 157.64 32.16 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 114.621 -2.609 . . . . 0.0 108.309 179.063 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.469 ' CD2' ' HG2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -113.65 141.32 47.35 Favored 'General case' 0 C--O 1.208 -1.11 1 O-C-N 133.733 6.896 . . . . 0.0 109.187 179.894 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.29 5.0 mt -105.55 -46.35 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 1 O-C-N 129.302 4.126 . . . . 0.0 107.621 -179.863 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 63.2 100.5 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.142 1 O-C-N 129.58 4.3 . . . . 0.0 104.366 -179.367 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 m -98.55 96.76 8.19 Favored 'General case' 0 N--CA 1.427 -1.594 2 O-C-N 130.604 4.94 . . . . 0.0 111.949 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.28 126.15 28.86 Favored 'General case' 0 C--O 1.202 -1.438 1 CA-C-N 107.422 -4.445 . . . . 0.0 105.227 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -103.63 68.02 0.92 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -84.19 132.67 34.65 Favored 'General case' 0 CA--C 1.493 -1.213 1 CA-C-N 106.436 -4.893 . . . . 0.0 117.187 -179.63 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 44.58 31.72 0.66 Allowed 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.94 6.46 67.1 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.939 -2.077 . . . . 0.0 112.673 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.73 148.08 21.84 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-O 116.615 -1.66 . . . . 0.0 111.833 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -107.12 107.76 18.89 Favored 'General case' 0 C--N 1.371 1.517 1 O-C-N 129.116 4.01 . . . . 0.0 107.441 -179.671 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.429 . . -135.52 137.29 41.93 Favored 'General case' 0 N--CA 1.417 -2.093 1 O-C-N 130.053 4.596 . . . . 0.0 112.446 179.846 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 175.98 8.86 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 130.612 4.945 . . . . 0.0 110.479 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 37.9 mtt85 -141.24 130.36 23.39 Favored 'General case' 0 N--CA 1.48 1.059 2 O-C-N 129.861 4.476 . . . . 0.0 99.627 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 134.28 28.03 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 C-N-CA 114.359 -2.936 . . . . 0.0 112.84 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 2.6 m-85 -147.95 -157.13 0.78 Allowed 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 131.199 5.312 . . . . 0.0 107.37 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -166.94 -144.21 0.06 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 131.802 5.689 . . . . 0.0 112.061 -179.737 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 10.4 tttt -128.99 -171.74 2.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -104.15 -31.35 9.68 Favored 'General case' 0 C--O 1.22 -0.462 1 O-C-N 130.221 4.701 . . . . 0.0 108.086 -179.831 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.21 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 O-C-N 127.163 2.789 . . . . 0.0 117.8 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 24' ' ' THR . . . 171.06 171.78 36.64 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 114.68 -3.628 . . . . 0.0 106.029 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -97.14 153.57 17.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 114.747 -2.781 . . . . 0.0 103.735 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.661 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 18.0 m95 -126.87 170.59 12.07 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 111.845 -3.931 . . . . 0.0 112.58 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.1 mtmt 43.58 -178.71 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.851 1 O-C-N 130.747 5.029 . . . . 0.0 117.366 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.277 1.2 t 26.51 114.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 2 O-C-N 131.522 5.513 . . . . 0.0 118.013 174.982 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.32 121.35 40.19 Favored 'General case' 0 C--N 1.373 1.588 0 O-C-N 118.577 -2.577 . . . . 0.0 110.345 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 56.85 -174.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.32 -64.03 0.22 Allowed 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.432 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 64.36 20.45 12.17 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 127.715 3.134 . . . . 0.0 110.782 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 31.67 55.02 0.28 Allowed 'General case' 0 N--CA 1.452 -0.353 1 O-C-N 130.621 4.95 . . . . 0.0 109.133 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.47 -16.32 14.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 110.859 -2.882 . . . . 0.0 112.863 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.5 p -131.67 133.2 44.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.72 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.03 142.43 7.68 Favored Glycine 0 CA--C 1.543 1.844 0 O-C-N 128.308 3.505 . . . . 0.0 109.591 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.57 101.21 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 129.021 3.424 . . . . 0.0 107.54 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -43.1 -51.55 5.81 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 128.681 3.738 . . . . 0.0 108.747 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.37 86.62 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 112.389 -2.187 . . . . 0.0 113.019 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.0 m-20 -85.11 -57.9 2.9 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 127.67 3.106 . . . . 0.0 108.976 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 53.76 -89.76 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.526 1 O-C-N 130.667 4.979 . . . . 0.0 101.413 179.946 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 61.22 149.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 134.048 7.092 . . . . 0.0 105.825 179.224 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.534 HD11 HE21 ' A' ' 100' ' ' GLN . 5.6 mt -124.93 172.75 9.13 Favored 'General case' 0 N--CA 1.436 -1.146 3 CA-C-N 106.285 -4.961 . . . . 0.0 99.067 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 18.0 m -168.21 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 1 O-C-N 129.429 4.206 . . . . 0.0 108.553 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 2' ' ' PHE . 1.9 mp 72.14 137.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 109.202 -3.635 . . . . 0.0 109.557 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 m -170.11 73.56 0.07 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 0.7 OUTLIER -52.35 145.29 11.37 Favored 'General case' 0 C--O 1.207 -1.177 2 O-C-N 133.307 6.63 . . . . 0.0 114.662 179.678 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.07 62.07 1.34 Allowed 'General case' 0 C--N 1.358 0.962 1 O-C-N 131.921 5.763 . . . . 0.0 104.361 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.45 57.01 0.81 Allowed Glycine 0 CA--C 1.552 2.357 1 C-N-CA 112.21 -4.805 . . . . 0.0 103.873 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 53.17 14.09 0.46 Allowed 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 112.733 -3.508 . . . . 0.0 110.6 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 84.27 5.77 Favored 'General case' 0 CA--C 1.55 0.976 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.601 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 6.3 m-85 -82.12 142.38 32.3 Favored 'General case' 0 CA--C 1.562 1.415 1 N-CA-C 96.646 -5.316 . . . . 0.0 96.646 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.83 112.99 15.36 Favored 'General case' 0 N--CA 1.482 1.155 3 O-C-N 137.527 9.267 . . . . 0.0 97.421 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 36' ' ' GLU 0.383 1.2 t -80.32 149.87 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 C-N-CA 111.01 -4.276 . . . . 0.0 104.764 179.934 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.286 0.7 OUTLIER -85.15 2.86 41.76 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 109.275 -3.602 . . . . 0.0 120.317 179.622 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -47.98 109.07 0.19 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.25 -3.159 . . . . 0.0 108.359 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -103.57 126.87 50.98 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 127.202 2.814 . . . . 0.0 107.595 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -152.46 -160.61 1.16 Allowed 'General case' 0 C--O 1.24 0.595 0 O-C-N 126.889 2.618 . . . . 0.0 112.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.25 -89.05 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.351 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.34 45.18 0.07 Allowed 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 113.732 -3.187 . . . . 0.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER 170.71 -164.35 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.959 1 O-C-N 133.573 6.796 . . . . 0.0 111.834 -179.912 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.48 121.12 44.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 1.9 tt -148.65 91.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.137 2 O-C-N 130.093 4.62 . . . . 0.0 109.378 -179.16 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.3 142.85 54.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 108.9 -3.773 . . . . 0.0 110.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 HD13 ' A' ' 57' ' ' LEU . 20.8 t -105.05 99.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.264 2 O-C-N 131.413 5.446 . . . . 0.0 99.876 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.338 3.6 p -101.56 168.07 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 112.393 -3.723 . . . . 0.0 115.656 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -164.85 163.13 21.18 Favored 'General case' 0 N--CA 1.434 -1.266 1 O-C-N 130.861 5.101 . . . . 0.0 112.583 -179.506 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.09 28.91 6.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 115.546 -2.462 . . . . 0.0 114.699 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 61.7 86.61 0.11 Allowed 'General case' 0 N--CA 1.441 -0.899 1 O-C-N 130.483 4.864 . . . . 0.0 115.811 179.931 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 76.24 75.0 0.9 Allowed Glycine 0 C--O 1.199 -2.046 0 N-CA-C 104.496 -3.441 . . . . 0.0 104.496 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.61 -42.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 1 O-C-N 130.678 4.399 . . . . 0.0 116.378 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.7 OUTLIER 78.44 126.85 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.132 1 O-C-N 129.408 4.193 . . . . 0.0 111.52 179.939 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -161.19 151.73 17.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 113.635 -3.226 . . . . 0.0 115.069 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.09 118.43 36.75 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 101.346 -3.575 . . . . 0.0 101.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.7 138.52 28.94 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 114.958 -2.697 . . . . 0.0 111.484 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.32 98.2 10.41 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 128.616 3.698 . . . . 0.0 106.822 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 10.4 mt -84.28 139.26 32.45 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 126.902 2.626 . . . . 0.0 112.378 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . 55.97 5.02 0.14 Allowed 'General case' 0 C--O 1.247 0.954 0 O-C-N 127.252 2.845 . . . . 0.0 114.842 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.21 -39.48 0.36 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.42 -40.71 7.23 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 115.336 -2.924 . . . . 0.0 107.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -79.11 150.73 31.7 Favored 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 130.208 4.123 . . . . 0.0 110.546 -179.88 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' HB2' HG12 ' A' ' 81' ' ' VAL . 17.7 mt-10 -153.49 68.26 0.78 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 113.278 -3.369 . . . . 0.0 106.418 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 87' ' ' LEU . 9.4 mp -79.17 131.15 36.11 Favored 'General case' 0 C--O 1.201 -1.459 2 CA-C-N 107.076 -4.602 . . . . 0.0 113.961 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.6 m -119.82 105.97 11.63 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . -168.4 -160.38 16.1 Favored Glycine 0 CA--C 1.542 1.723 1 C-N-CA 110.75 -5.5 . . . . 0.0 103.781 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 6.1 t -151.68 157.02 41.53 Favored 'General case' 0 N--CA 1.426 -1.639 1 O-C-N 133.35 5.971 . . . . 0.0 117.942 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 33.1 m95 -124.94 112.25 16.38 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 114.629 -2.605 . . . . 0.0 104.689 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 50' ' ' GLY . 9.1 p -107.14 52.68 0.71 Allowed 'General case' 0 N--CA 1.435 -1.192 1 O-C-N 135.51 8.006 . . . . 0.0 116.028 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.82 111.37 0.34 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 134.124 7.14 . . . . 0.0 104.153 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -90.1 -43.28 10.58 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 109.443 -3.526 . . . . 0.0 110.507 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.81 101.86 0.21 Allowed Glycine 0 CA--C 1.532 1.151 0 O-C-N 128.292 3.495 . . . . 0.0 105.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 73' ' ' LYS . 8.0 m120 73.26 13.94 4.61 Favored 'General case' 0 N--CA 1.447 -0.595 1 O-C-N 130.683 4.402 . . . . 0.0 110.008 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 92' ' ' GLU 0.259 0.0 OUTLIER -124.06 -169.37 1.95 Allowed 'General case' 0 N--CA 1.471 0.609 1 O-C-N 129.642 4.339 . . . . 0.0 108.35 -179.72 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 91' ' ' ARG . 0.8 OUTLIER -169.31 43.65 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 128.506 3.629 . . . . 0.0 111.896 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 t -77.51 136.5 24.18 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 3 O-C-N 131.316 5.385 . . . . 0.0 113.24 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.53 -159.96 32.63 Favored Glycine 0 CA--C 1.556 2.655 1 N-CA-C 101.652 -4.579 . . . . 0.0 101.652 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.509 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 178.0 141.26 0.09 Allowed 'General case' 0 C--O 1.201 -1.484 1 O-C-N 130.918 4.54 . . . . 0.0 113.53 -179.449 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -131.18 178.5 6.65 Favored 'General case' 0 C--N 1.367 1.349 3 O-C-N 130.61 4.944 . . . . 0.0 105.694 -179.552 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.324 0.8 OUTLIER -163.74 131.24 3.44 Favored 'General case' 0 C--N 1.365 1.274 1 CA-C-N 106.257 -4.974 . . . . 0.0 113.64 179.906 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 72.7 ttt180 -85.92 94.87 9.29 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.32 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' GLU . 14.3 p -47.41 -26.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 O-C-N 133.175 6.547 . . . . 0.0 113.77 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.32 -0.712 1 O-C-N 130.121 4.638 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.82 -3.45 15.71 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 114.745 -2.782 . . . . 0.0 114.748 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.526 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 70.62 33.36 67.18 Favored Glycine 0 CA--C 1.557 2.674 2 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 3.9 tppt? -72.74 -78.26 0.09 Allowed 'General case' 0 N--CA 1.421 -1.904 1 CA-C-N 105.473 -5.364 . . . . 0.0 120.805 -178.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 52.8 mt-10 83.26 60.29 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.459 1 O-C-N 130.209 4.693 . . . . 0.0 107.906 -177.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 63' ' ' LEU . 5.2 tp -91.48 69.23 5.84 Favored 'General case' 0 CA--C 1.49 -1.341 1 O-C-N 135.009 7.693 . . . . 0.0 112.498 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.677 HD12 HG22 ' A' ' 103' ' ' THR 0.29 78.0 mt -76.81 -179.46 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 69.68 0.73 Allowed 'General case' 0 C--O 1.201 -1.469 0 O-C-N 128.627 3.705 . . . . 0.0 106.223 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.64 137.15 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 110.936 -2.847 . . . . 0.0 105.497 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.622 ' HG3' HD11 ' A' ' 98' ' ' LEU . 0.4 OUTLIER 179.51 162.48 0.89 Allowed 'General case' 0 N--CA 1.414 -2.272 1 C-N-CA 111.363 -4.135 . . . . 0.0 114.044 179.843 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -152.87 154.76 35.74 Favored 'General case' 0 N--CA 1.424 -1.746 1 O-C-N 131.441 5.463 . . . . 0.0 105.534 178.688 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.918 HD13 HD13 ' A' ' 98' ' ' LEU . 4.9 mm -56.09 91.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 1 O-C-N 132.365 6.041 . . . . 0.0 109.694 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB2' HG13 ' A' ' 99' ' ' ILE . 13.9 t -31.31 -59.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 1 O-C-N 133.002 6.439 . . . . 0.0 115.258 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.14 -83.14 0.12 Allowed Glycine 0 CA--C 1.556 2.634 0 N-CA-C 103.24 -3.944 . . . . 0.0 103.24 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.3 26.52 5.41 Favored 'General case' 0 CA--C 1.551 1.007 1 CA-C-N 107.123 -4.538 . . . . 0.0 105.193 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -164.44 163.08 22.32 Favored 'General case' 0 CA--C 1.563 1.45 1 O-C-N 133.049 6.468 . . . . 0.0 106.706 -179.881 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 93' ' ' ILE . 17.2 tp -115.89 136.53 52.95 Favored 'General case' 0 N--CA 1.437 -1.122 1 O-C-N 132.853 6.346 . . . . 0.0 110.484 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 ' HD2' ' A' ' 110' ' ' LYS 0.277 4.2 mt -85.28 -60.79 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 2 CA-C-O 110.796 -4.43 . . . . 0.0 106.102 -179.588 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.534 HE21 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER 86.09 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 1 O-C-N 134.064 7.103 . . . . 0.0 102.865 179.933 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -103.45 98.74 8.59 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.714 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.3 95.74 1.34 Allowed 'General case' 0 C--O 1.21 -1.022 2 CA-C-N 107.489 -4.414 . . . . 0.0 105.086 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.677 HG22 HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -64.1 132.69 51.25 Favored 'General case' 0 N--CA 1.48 1.032 1 O-C-N 129.541 4.276 . . . . 0.0 100.812 179.988 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -160.13 147.43 16.3 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 110.448 -3.069 . . . . 0.0 115.888 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 43.28 28.91 0.19 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.184 -2.28 . . . . 0.0 116.043 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 C--N 1.358 1.796 0 C-N-CA 117.066 -2.492 . . . . 0.0 116.328 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER -131.15 -159.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 118.801 -1.159 . . . . 0.0 112.765 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 107' ' ' VAL . 27.5 mt-10 -138.13 93.67 2.79 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 116.435 -2.106 . . . . 0.0 106.448 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.47 . . -105.13 150.39 25.08 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 125.954 2.034 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -147.78 177.59 9.19 Favored 'General case' 0 N--CA 1.427 -1.603 1 O-C-N 131.52 5.513 . . . . 0.0 110.75 -179.987 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -147.07 107.15 4.0 Favored 'General case' 0 CA--C 1.561 1.366 2 O-C-N 130.757 5.035 . . . . 0.0 99.834 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.31 132.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 O-C-N 128.872 3.857 . . . . 0.0 113.586 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.639 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 13.7 m-30 -140.15 175.73 9.35 Favored 'General case' 0 N--CA 1.423 -1.796 2 O-C-N 133.675 6.86 . . . . 0.0 104.083 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -159.95 -155.21 0.43 Allowed 'General case' 0 C--O 1.2 -1.52 1 O-C-N 131.367 5.417 . . . . 0.0 111.325 179.454 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.661 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.4 tttt -110.21 -173.04 2.16 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.747 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 109.422 -3.535 . . . . 0.0 111.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.54 -60.77 0.17 Allowed 'General case' 0 C--N 1.358 0.955 0 O-C-N 128.2 3.438 . . . . 0.0 104.381 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' THR 0.251 4.2 p-10 -33.1 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.7 1 O-C-N 130.493 4.871 . . . . 0.0 118.541 179.803 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.76 -176.29 43.65 Favored Glycine 0 C--N 1.355 1.594 1 C-N-CA 113.169 -4.348 . . . . 0.0 105.221 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 24' ' ' THR . 46.5 p -97.76 165.93 11.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 112.486 -3.685 . . . . 0.0 103.576 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.658 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 13.1 m95 -136.67 172.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 112.589 -3.576 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.651 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.6 mtmt 38.92 -178.64 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.505 4.878 . . . . 0.0 118.502 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 10' ' ' ARG 0.329 1.0 OUTLIER -2.86 125.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 3 CA-C-N 105.319 -5.401 . . . . 0.0 118.794 174.915 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.97 -45.78 13.7 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 110.272 -3.149 . . . . 0.0 104.883 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 8' ' ' VAL . 38.7 ttt180 54.51 106.63 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.49 3.043 . . . . 0.0 115.355 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -67.47 -13.34 61.95 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.252 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 63.65 97.17 0.04 OUTLIER 'General case' 0 C--O 1.237 0.429 0 O-C-N 127.859 3.225 . . . . 0.0 107.114 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.14 128.85 14.21 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.38 139.2 51.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 127.541 3.026 . . . . 0.0 108.349 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -157.92 -162.03 1.1 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 116.461 -2.095 . . . . 0.0 105.598 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.07 -82.78 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 O-C-N 127.004 2.69 . . . . 0.0 109.701 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.35 116.97 9.2 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.38 118.55 31.47 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 117.996 -1.002 . . . . 0.0 108.851 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -104.68 90.43 3.49 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 127.483 2.989 . . . . 0.0 111.945 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' HD2' ' A' ' 10' ' ' ARG . 4.1 m120 -132.66 125.72 30.97 Favored 'General case' 0 CA--C 1.547 0.853 1 O-C-N 133.094 6.496 . . . . 0.0 110.681 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 21' ' ' LEU . 1.2 mp -112.21 -172.12 1.98 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 113.604 -3.093 . . . . 0.0 102.909 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 37' ' ' SER 0.399 0.0 OUTLIER -150.29 168.62 23.53 Favored 'General case' 0 CA--C 1.566 1.586 1 O-C-N 131.682 5.614 . . . . 0.0 101.776 -179.912 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 7.0 mt -139.95 153.55 46.95 Favored 'General case' 0 CA--C 1.562 1.423 4 O-C-N 132.805 6.315 . . . . 0.0 97.233 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 40.7 m 175.84 77.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 1 O-C-N 131.169 5.293 . . . . 0.0 106.499 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.9 mp -89.13 157.48 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 C-N-CA 114.452 -2.899 . . . . 0.0 110.971 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 86.4 m -167.72 77.78 0.16 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 112.803 -3.559 . . . . 0.0 107.915 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.531 ' CA ' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -55.59 157.54 3.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 128.685 3.74 . . . . 0.0 115.555 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.8 61.56 1.67 Allowed 'General case' 0 C--N 1.356 0.87 0 O-C-N 128.787 3.804 . . . . 0.0 104.547 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.77 -95.39 0.43 Allowed Glycine 0 CA--C 1.555 2.566 2 O-C-N 130.551 4.907 . . . . 0.0 102.443 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -146.82 21.93 1.26 Allowed 'General case' 0 N--CA 1.415 -2.183 2 O-C-N 134.375 6.573 . . . . 0.0 106.392 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -125.46 126.39 44.85 Favored 'General case' 0 CA--C 1.552 1.02 1 O-C-N 129.729 4.393 . . . . 0.0 101.881 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.531 ' HB3' ' CA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -143.13 173.19 11.79 Favored 'General case' 0 C--O 1.193 -1.888 2 N-CA-C 96.162 -5.495 . . . . 0.0 96.162 179.736 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.07 124.66 20.85 Favored 'General case' 0 N--CA 1.473 0.708 2 O-C-N 137.945 9.528 . . . . 0.0 101.605 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.448 3.0 t -79.24 149.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 113.915 -3.114 . . . . 0.0 103.17 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.304 13.3 tttt -90.05 32.01 0.94 Allowed 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.438 27.8 tt0 -58.51 102.52 0.11 Allowed 'General case' 0 C--N 1.362 1.111 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.506 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 23.2 m -121.26 124.49 44.77 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 127.598 3.061 . . . . 0.0 112.147 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.529 ' CB ' ' HG ' ' A' ' 21' ' ' LEU . 1.5 t 159.34 -50.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 1 O-C-N 130.013 4.571 . . . . 0.0 115.317 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -38.8 -31.71 0.07 Allowed 'General case' 0 C--O 1.219 -0.545 0 O-C-N 128.416 3.572 . . . . 0.0 111.633 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.73 -48.85 0.06 Allowed 'General case' 0 C--N 1.356 0.876 1 C-N-CA 111.232 -4.187 . . . . 0.0 110.38 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.78 43.57 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.58 1.8 . . . . 0.0 114.953 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 84.47 6.18 0.59 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 128.891 3.87 . . . . 0.0 108.008 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 43' ' ' ILE 0.372 0.2 OUTLIER -25.69 92.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.069 3 O-C-N 133.55 6.781 . . . . 0.0 110.325 177.269 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.31 141.82 36.67 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 110.608 -2.996 . . . . 0.0 107.801 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.28 97.15 5.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 1 O-C-N 130.423 4.827 . . . . 0.0 103.86 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.308 1.2 p -95.47 155.64 3.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 C-N-CA 114.424 -2.91 . . . . 0.0 111.817 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.65 177.57 3.88 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 130.949 5.156 . . . . 0.0 111.8 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.19 78.37 1.83 Allowed 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 128.57 3.669 . . . . 0.0 116.144 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.1 OUTLIER 15.58 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.524 1 O-C-N 129.173 4.046 . . . . 0.0 117.204 -179.819 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 96.9 53.46 1.39 Allowed Glycine 0 C--O 1.197 -2.165 0 N-CA-C 105.236 -3.146 . . . . 0.0 105.236 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.62 111.38 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 1 O-C-N 130.611 4.359 . . . . 0.0 112.195 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.24 151.1 28.29 Favored 'General case' 0 N--CA 1.473 0.717 1 O-C-N 130.97 5.169 . . . . 0.0 109.727 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -172.19 113.94 0.31 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 112.217 -3.793 . . . . 0.0 116.86 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.89 53.12 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 101.114 -3.661 . . . . 0.0 101.114 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 57' ' ' LEU . 6.9 t80 -154.53 97.22 1.98 Allowed 'General case' 0 C--O 1.206 -1.212 0 C-N-CA 112.113 -3.835 . . . . 0.0 113.427 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.1 t -64.38 91.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.929 1 O-C-N 130.343 4.777 . . . . 0.0 104.202 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -54.96 -76.11 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 129.022 3.951 . . . . 0.0 111.841 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.71 26.26 0.5 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.02 -24.8 0.15 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -33.47 2.0 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-O 115.072 -3.071 . . . . 0.0 109.033 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.5 p -58.23 -172.38 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 1 O-C-N 130.064 4.038 . . . . 0.0 115.01 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -150.72 -60.86 0.19 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 117.109 -1.836 . . . . 0.0 107.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 mp 34.67 77.46 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.613 1 O-C-N 131.711 5.632 . . . . 0.0 113.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.0 m -87.69 99.66 12.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 112.169 -2.287 . . . . 0.0 107.988 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -159.38 -166.24 17.95 Favored Glycine 0 CA--C 1.536 1.401 1 C-N-CA 111.041 -5.361 . . . . 0.0 108.108 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 5.2 t -150.47 113.51 4.82 Favored 'General case' 0 N--CA 1.437 -1.122 2 O-C-N 132.376 5.397 . . . . 0.0 118.37 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.755 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 40.6 m95 -94.11 129.33 40.7 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 117.409 -3.307 . . . . 0.0 104.332 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.481 HG22 ' HA2' ' A' ' 50' ' ' GLY . 49.2 p -124.65 58.33 1.23 Allowed 'General case' 0 N--CA 1.433 -1.279 1 O-C-N 133.43 6.706 . . . . 0.0 116.301 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.775 ' HB3' HD21 ' A' ' 49' ' ' LEU 0.278 0.0 OUTLIER -42.26 112.43 0.34 Allowed 'General case' 0 N--CA 1.441 -0.896 1 O-C-N 131.116 5.26 . . . . 0.0 104.112 -179.923 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.43 -78.45 0.22 Allowed 'General case' 0 C--O 1.212 -0.903 0 O-C-N 127.975 3.297 . . . . 0.0 108.529 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.05 -76.47 0.06 OUTLIER Glycine 0 CA--C 1.555 2.544 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 37.34 4.11 Favored 'General case' 0 CA--C 1.537 0.45 1 O-C-N 130.09 4.053 . . . . 0.0 108.258 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -130.32 177.48 7.3 Favored 'General case' 0 C--N 1.362 1.126 1 O-C-N 129.249 4.093 . . . . 0.0 112.432 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.3 mt -149.71 46.29 0.94 Allowed 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.54 2.4 . . . . 0.0 113.285 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.82 130.36 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 2 O-C-N 131.015 5.197 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.16 -164.58 36.11 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 103.902 -3.679 . . . . 0.0 103.902 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.568 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -176.38 133.64 0.23 Allowed 'General case' 0 N--CA 1.423 -1.804 0 O-C-N 129.256 3.563 . . . . 0.0 114.149 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.6 OUTLIER -128.13 164.86 21.55 Favored 'General case' 0 C--O 1.203 -1.384 3 O-C-N 135.041 7.713 . . . . 0.0 105.272 179.765 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 85' ' ' LYS . 3.8 tmtt? -154.0 153.17 31.49 Favored 'General case' 0 N--CA 1.417 -2.106 1 CA-C-N 106.744 -4.753 . . . . 0.0 117.734 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 79' ' ' LYS . 44.0 ttt180 -104.13 85.84 2.46 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.942 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -42.68 -27.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 O-C-N 128.564 3.665 . . . . 0.0 113.338 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 30.9 t0 -72.99 0.55 10.99 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 128.787 3.804 . . . . 0.0 112.5 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.6 OUTLIER 102.09 12.0 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.284 1 O-C-N 132.772 6.295 . . . . 0.0 115.671 -179.489 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.03 -39.69 23.04 Favored Glycine 0 CA--C 1.559 2.788 2 C-N-CA 111.27 -5.252 . . . . 0.0 100.87 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 2.1 tttt 83.86 -178.95 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.655 2 O-C-N 134.558 6.681 . . . . 0.0 115.534 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' N ' ' HG2' ' A' ' 79' ' ' LYS 0.257 1.4 mt-10 -38.23 135.92 0.68 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 132.448 6.092 . . . . 0.0 116.586 -178.434 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 39.75 2.59 Favored 'General case' 0 C--O 1.197 -1.696 1 O-C-N 130.816 5.073 . . . . 0.0 110.251 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' A' ' 77' ' ' LYS . 82.8 mt -64.15 149.54 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.445 2 N-CA-C 98.907 -4.479 . . . . 0.0 98.907 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.57 76.8 1.29 Allowed 'General case' 0 C--N 1.315 -0.914 1 O-C-N 134.545 7.403 . . . . 0.0 106.843 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.9 121.67 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 128.564 3.665 . . . . 0.0 102.305 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CD ' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -162.52 157.05 21.7 Favored 'General case' 0 C--O 1.192 -1.953 1 C-N-CA 110.343 -4.543 . . . . 0.0 113.483 -179.71 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -157.29 127.96 6.55 Favored 'General case' 0 C--O 1.209 -1.045 1 O-C-N 130.281 4.738 . . . . 0.0 103.663 179.819 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.569 HD12 ' HG ' ' A' ' 98' ' ' LEU . 1.5 mm -38.0 120.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 1 O-C-N 130.787 5.054 . . . . 0.0 111.793 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 -66.58 0.57 Allowed 'General case' 0 C--O 1.248 0.975 1 O-C-N 129.273 4.108 . . . . 0.0 114.584 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -128.93 -88.92 0.57 Allowed Glycine 0 CA--C 1.547 2.07 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -130.39 44.77 2.91 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 128.985 3.403 . . . . 0.0 106.401 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.573 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.2 172.06 7.6 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.462 4.226 . . . . 0.0 109.298 -179.653 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 93' ' ' ILE . 1.9 mt -133.27 129.6 37.85 Favored 'General case' 0 C--O 1.205 -1.273 1 O-C-N 132.549 6.156 . . . . 0.0 112.16 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 34.4 mt -80.05 -82.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.932 2 O-C-N 129.796 4.435 . . . . 0.0 106.381 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 96.79 85.96 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 1 O-C-N 134.775 7.547 . . . . 0.0 105.026 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.6 m -82.57 92.26 7.08 Favored 'General case' 0 C--O 1.197 -1.688 2 O-C-N 131.18 5.3 . . . . 0.0 111.7 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 16.5 m-85 -68.54 126.5 29.86 Favored 'General case' 0 C--O 1.207 -1.138 2 C-N-CA 110.484 -4.486 . . . . 0.0 106.158 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.52 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 47.9 m -101.08 87.01 3.15 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-O 127.62 3.581 . . . . 0.0 101.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.524 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -109.85 128.17 55.16 Favored 'General case' 0 C--N 1.359 1.001 1 CA-C-N 107.485 -4.416 . . . . 0.0 115.877 -179.978 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 30.3 mt-10 50.41 20.75 0.72 Allowed 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 120.058 -1.651 . . . . 0.0 114.951 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.1 -9.33 54.49 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 117.925 -2.083 . . . . 0.0 114.739 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.739 HG12 ' HB2' ' A' ' 109' ' ' ALA . 21.4 t -100.85 113.5 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.04 91.37 3.09 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.739 ' HB2' HG12 ' A' ' 107' ' ' VAL 0.473 . . -125.77 122.54 36.52 Favored 'General case' 0 N--CA 1.414 -2.262 0 O-C-N 126.704 2.503 . . . . 0.0 116.25 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 101' ' ' THR . 22.9 mtmt -98.0 163.41 12.78 Favored 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 134.902 7.626 . . . . 0.0 108.893 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -107.85 -47.27 3.62 Favored 'General case' 0 CA--C 1.555 1.173 1 O-C-N 130.806 5.066 . . . . 0.0 105.276 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.302 11.6 mt 88.3 103.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 1 O-C-N 130.83 5.081 . . . . 0.0 109.283 179.992 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.651 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 16.8 m-85 -136.07 179.72 6.18 Favored 'General case' 0 N--CA 1.427 -1.601 1 O-C-N 132.695 6.247 . . . . 0.0 107.216 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.573 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -148.23 -152.48 0.44 Allowed 'General case' 0 C--O 1.203 -1.394 1 O-C-N 131.749 5.655 . . . . 0.0 112.369 179.125 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.6 tttt -115.55 -162.08 0.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 126.811 2.044 . . . . 0.0 111.575 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.431 -1.412 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.705 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 118.335 -0.84 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 53.62 33.98 17.66 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 128.772 3.795 . . . . 0.0 105.448 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 57.1 p30 -132.53 47.79 2.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.1 -171.68 38.67 Favored Glycine 0 N--CA 1.482 1.707 1 C-N-CA 110.731 -5.509 . . . . 0.0 105.446 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.371 4.4 p -82.85 -174.53 5.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 112.843 -3.543 . . . . 0.0 104.286 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 93' ' ' ILE 0.27 59.5 m95 -162.0 128.77 3.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 112.625 -3.56 . . . . 0.0 113.475 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.554 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 23.1 mtmt 73.91 177.4 0.24 Allowed 'General case' 0 C--O 1.193 -1.885 0 O-C-N 126.957 2.66 . . . . 0.0 117.229 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 t 32.05 118.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.638 3 O-C-N 136.592 8.682 . . . . 0.0 120.812 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.61 -171.33 3.9 Favored 'General case' 0 N--CA 1.421 -1.875 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.202 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.98 96.27 4.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.813 -1.54 . . . . 0.0 111.944 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.93 -19.4 7.27 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.182 0.927 . . . . 0.0 112.017 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 64.37 -93.7 0.04 OUTLIER 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 4.0 m120 53.19 -95.1 0.04 OUTLIER 'General case' 0 C--N 1.351 0.652 0 O-C-N 126.392 2.308 . . . . 0.0 106.885 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -148.9 95.71 2.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.226 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.4 p -165.2 156.83 14.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 114.054 -3.058 . . . . 0.0 107.739 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.38 62.05 0.01 OUTLIER Glycine 0 C--O 1.208 -1.514 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.731 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.39 -86.4 0.08 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 112.846 -1.677 . . . . 0.0 107.171 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -151.5 63.47 0.88 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 128.152 3.408 . . . . 0.0 112.605 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.82 76.22 1.53 Allowed 'General case' 0 C--N 1.365 1.268 0 O-C-N 125.262 1.601 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -122.21 23.38 9.85 Favored 'General case' 0 CA--C 1.554 1.096 1 O-C-N 130.441 4.838 . . . . 0.0 111.35 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.8 153.62 42.58 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 108.892 -3.776 . . . . 0.0 104.511 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.435 0.0 OUTLIER -152.83 142.66 22.07 Favored 'General case' 0 CA--C 1.565 1.556 1 O-C-N 129.226 4.079 . . . . 0.0 100.398 179.755 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 7.5 mt -101.16 175.97 5.41 Favored 'General case' 0 C--N 1.311 -1.107 2 O-C-N 132.704 6.252 . . . . 0.0 97.859 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 m 164.38 76.7 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 1 CA-C-O 128.53 4.014 . . . . 0.0 102.223 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 32' ' ' PHE . 3.3 mp -99.55 150.22 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 109.489 -3.505 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 6.2 m -170.79 75.62 0.07 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 113.531 -3.267 . . . . 0.0 102.669 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 2.7 pm0 -51.67 141.42 16.67 Favored 'General case' 0 C--O 1.212 -0.903 1 O-C-N 130.318 4.761 . . . . 0.0 115.862 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.2 pm0 -116.57 103.9 10.87 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 128.857 3.848 . . . . 0.0 103.17 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.61 -121.48 6.05 Favored Glycine 0 N--CA 1.482 1.738 2 N-CA-C 100.747 -4.941 . . . . 0.0 100.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 19.3 m120 -110.49 3.65 19.76 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 114.431 -2.699 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 16.9 mttt -81.36 141.14 34.28 Favored 'General case' 0 CA--C 1.544 0.718 1 N-CA-C 97.421 -5.029 . . . . 0.0 97.421 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -148.93 101.2 3.15 Favored 'General case' 0 C--O 1.194 -1.856 1 N-CA-C 96.048 -5.538 . . . . 0.0 96.048 -179.683 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -101.14 143.87 30.73 Favored 'General case' 0 N--CA 1.454 -0.264 3 O-C-N 134.461 7.351 . . . . 0.0 101.956 -179.718 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 32' ' ' PHE 0.333 1.3 t -111.75 149.5 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 2 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 179.718 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 3.0 tttm -87.32 45.02 1.23 Allowed 'General case' 0 C--O 1.195 -1.778 0 CA-C-O 126.585 3.088 . . . . 0.0 116.394 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 1.3 mm-40 -59.77 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.479 -2.146 . . . . 0.0 109.736 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 35' ' ' LYS . 4.3 t -97.2 117.65 31.87 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.485 2.366 . . . . 0.0 112.319 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.01 -156.45 0.57 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -78.4 -43.46 27.38 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 126.738 2.524 . . . . 0.0 108.763 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -45.58 -65.34 0.55 Allowed 'General case' 0 C--O 1.209 -1.04 1 O-C-N 132.341 6.026 . . . . 0.0 109.145 179.722 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -163.2 -163.39 0.84 Allowed 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 126.9 2.625 . . . . 0.0 111.135 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -16.08 57.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 114.546 -2.861 . . . . 0.0 104.748 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.598 HG13 HD22 ' A' ' 57' ' ' LEU 0.259 0.1 OUTLIER 11.59 68.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.335 3 O-C-N 133.146 6.529 . . . . 0.0 111.575 179.279 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 150.33 28.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.454 -3.521 . . . . 0.0 108.473 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 9.3 p -105.02 115.06 46.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.08 1 O-C-N 130.889 5.118 . . . . 0.0 104.126 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 47' ' ' PHE 0.256 9.7 p -131.05 161.65 40.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 C-N-CA 113.816 -3.154 . . . . 0.0 114.718 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 2.9 p90 177.09 -168.82 0.06 Allowed 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 109.35 -3.568 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.252 0.9 OUTLIER -126.18 82.75 2.1 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 128.704 3.752 . . . . 0.0 115.029 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 69' ' ' MET . 4.8 tp -0.83 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 1 O-C-N 133.614 6.821 . . . . 0.0 116.344 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 49' ' ' LEU . . . 96.4 36.14 5.23 Favored Glycine 0 C--O 1.204 -1.776 0 N-CA-C 104.048 -3.621 . . . . 0.0 104.048 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.81 114.71 22.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 1 O-C-N 130.486 4.286 . . . . 0.0 116.788 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.86 159.25 21.39 Favored 'General case' 0 CA--C 1.556 1.21 1 O-C-N 130.235 4.709 . . . . 0.0 107.882 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -172.83 164.4 5.15 Favored 'General case' 0 N--CA 1.439 -1.007 1 C-N-CA 111.318 -4.153 . . . . 0.0 113.271 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -127.9 80.88 1.99 Allowed 'General case' 0 CA--C 1.563 1.448 1 N-CA-C 100.149 -4.019 . . . . 0.0 100.149 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -102.48 126.19 49.44 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 127.976 3.297 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 t -78.9 171.45 15.17 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 112.209 -3.796 . . . . 0.0 106.643 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.598 HD22 HG13 ' A' ' 43' ' ' ILE . 5.8 mt -151.12 179.55 8.18 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 127.27 2.856 . . . . 0.0 109.514 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' ' 61' ' ' THR . . . 39.48 -98.97 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 O-C-N 128.527 3.642 . . . . 0.0 112.302 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.25 27.37 3.47 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 124.272 0.982 . . . . 0.0 112.87 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.24 71.07 0.29 Allowed Glycine 0 C--N 1.361 1.92 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 25.8 p -104.83 -47.84 3.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.326 1.45 . . . . 0.0 108.559 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.94 58.1 4.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 126.434 2.334 . . . . 0.0 109.743 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 87' ' ' LEU . 5.8 mp -84.26 76.06 10.14 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.466 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 68.8 m -52.07 119.63 4.54 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' C ' HG22 ' A' ' 66' ' ' THR . . . -143.69 -158.16 7.46 Favored Glycine 0 C--O 1.205 -1.671 1 C-N-CA 111.422 -5.18 . . . . 0.0 109.066 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.623 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.296 0.6 OUTLIER 172.78 124.12 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.886 2 O-C-N 132.5 5.471 . . . . 0.0 113.878 -178.413 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 68.2 m95 -133.83 134.1 42.41 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 119.494 -2.004 . . . . 0.0 106.635 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 2.3 p -118.27 36.33 4.41 Favored 'General case' 0 N--CA 1.424 -1.751 2 O-C-N 131.245 5.341 . . . . 0.0 116.677 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.551 ' CB ' HD22 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -8.17 87.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 1 O-C-N 136.392 8.557 . . . . 0.0 109.145 -179.988 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -168.05 1.58 Allowed 'General case' 0 C--N 1.356 0.885 1 CA-C-N 108.22 -4.082 . . . . 0.0 109.613 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.11 92.45 0.14 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 116.894 -2.574 . . . . 0.0 110.734 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 54.42 44.09 29.4 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.074 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -132.42 173.64 11.08 Favored 'General case' 0 C--N 1.347 0.477 1 O-C-N 129.989 4.556 . . . . 0.0 108.576 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -148.81 58.26 1.05 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 128.245 3.466 . . . . 0.0 111.567 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.38 78.68 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.934 2 CA-C-O 129.475 4.464 . . . . 0.0 112.091 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -148.92 -167.32 13.74 Favored Glycine 0 CA--C 1.554 2.518 1 CA-C-N 106.304 -4.953 . . . . 0.0 104.35 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.566 ' HG3' ' N ' ' A' ' 78' ' ' PHE 0.265 0.7 OUTLIER -163.22 171.46 16.21 Favored 'General case' 0 C--N 1.37 1.477 2 O-C-N 131.483 4.873 . . . . 0.0 112.584 179.964 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 42.7 m-85 -149.72 151.88 34.38 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-O 127.738 3.637 . . . . 0.0 101.98 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.57 ' CE ' ' HA2' ' A' ' 84' ' ' GLY 0.29 0.0 OUTLIER -169.04 127.01 0.99 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 109.81 -3.359 . . . . 0.0 117.668 -179.75 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 69.7 mtt180 -76.6 113.02 13.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 126.588 2.43 . . . . 0.0 108.586 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.14 -24.94 25.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 1 O-C-N 131.478 5.486 . . . . 0.0 108.594 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -45.7 -51.65 12.12 Favored 'General case' 0 C--O 1.249 1.077 1 O-C-N 129.622 4.327 . . . . 0.0 112.294 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -141.93 3.97 1.65 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 113.496 -3.282 . . . . 0.0 117.621 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.57 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 98.01 36.3 4.77 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 3.2 tptm -70.96 -64.7 0.85 Allowed 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 120.131 3.382 . . . . 0.0 120.131 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 25.7 mt-10 71.14 87.99 0.11 Allowed 'General case' 0 C--O 1.199 -1.554 1 O-C-N 129.618 4.324 . . . . 0.0 110.926 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' CD2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -110.94 48.41 0.93 Allowed 'General case' 0 C--O 1.193 -1.893 1 O-C-N 132.349 6.031 . . . . 0.0 109.281 179.483 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.469 ' CG2' HG23 ' A' ' 90' ' ' VAL 0.268 98.4 mt -65.2 164.32 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.58 0 CA-C-N 108.582 -3.917 . . . . 0.0 105.675 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.5 71.95 1.39 Allowed 'General case' 0 C--O 1.201 -1.476 1 O-C-N 133.763 6.914 . . . . 0.0 105.309 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 88' ' ' ILE . 76.6 t -76.23 115.62 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 1 O-C-N 132.038 5.836 . . . . 0.0 105.614 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.482 ' CD ' ' HB ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -169.49 165.91 10.32 Favored 'General case' 0 C--O 1.187 -2.204 0 C-N-CA 114.669 -2.812 . . . . 0.0 114.714 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -156.91 118.84 3.84 Favored 'General case' 0 C--O 1.21 -1.005 1 O-C-N 130.479 4.862 . . . . 0.0 107.026 179.669 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.779 HD12 HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -42.61 144.99 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.54 1 O-C-N 133.013 6.445 . . . . 0.0 113.577 179.876 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 t -150.89 123.01 8.25 Favored 'General case' 0 CA--C 1.506 -0.717 1 O-C-N 129.75 4.406 . . . . 0.0 115.996 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.57 13.86 74.85 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 t30 57.47 58.73 3.64 Favored 'General case' 0 CA--C 1.563 1.476 1 O-C-N 131.884 5.108 . . . . 0.0 104.603 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.323 0.4 OUTLIER -178.41 100.21 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.588 1 O-C-N 132.116 5.885 . . . . 0.0 108.66 179.204 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 HD12 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.6 151.78 43.8 Favored 'General case' 0 N--CA 1.423 -1.783 1 O-C-N 130.423 4.827 . . . . 0.0 114.978 179.872 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLN . 26.9 mt -106.69 -106.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.337 3 O-C-N 133.447 6.717 . . . . 0.0 107.922 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.6 mt-30 116.21 93.17 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.519 2 O-C-N 135.261 7.85 . . . . 0.0 98.348 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 110' ' ' LYS . 1.3 m -72.39 -29.77 64.05 Favored 'General case' 0 N--CA 1.42 -1.944 1 O-C-N 133.333 6.646 . . . . 0.0 119.69 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 62.05 76.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 128.626 3.704 . . . . 0.0 105.74 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.6 m -76.35 78.4 3.1 Favored 'General case' 0 C--O 1.204 -1.325 0 O-C-N 128.439 3.587 . . . . 0.0 105.956 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.6 118.02 35.56 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 109.773 -3.376 . . . . 0.0 112.936 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 17.71 63.07 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.19 6.61 61.45 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 117.552 -2.261 . . . . 0.0 116.216 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.83 110.4 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 101' ' ' THR . 2.0 mt-10 -89.27 78.74 7.22 Favored 'General case' 0 C--N 1.363 1.173 0 O-C-N 128.246 3.466 . . . . 0.0 105.125 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.416 . . -86.57 86.2 7.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.319 2.887 . . . . 0.0 116.275 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HG2' HG23 ' A' ' 101' ' ' THR . 5.6 mtmp? -90.61 148.58 22.57 Favored 'General case' 0 N--CA 1.425 -1.683 1 O-C-N 130.042 4.589 . . . . 0.0 108.879 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 14.4 mmt180 -147.6 111.04 4.93 Favored 'General case' 0 CA--C 1.558 1.275 1 O-C-N 130.544 4.902 . . . . 0.0 101.31 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.55 128.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 1 O-C-N 130.908 5.13 . . . . 0.0 111.595 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 m-85 -131.22 -154.77 0.65 Allowed 'General case' 0 C--N 1.318 -0.776 1 O-C-N 131.727 5.642 . . . . 0.0 104.865 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.765 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.31 -138.0 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.595 1 O-C-N 131.336 5.398 . . . . 0.0 113.4 -177.627 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 3.1 tttt -137.34 158.53 44.22 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.417 -2.105 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.361 179.656 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 93' ' ' ILE . 9.9 m-85 -140.81 -70.8 0.37 Allowed 'General case' 0 CA--C 1.561 1.365 1 O-C-N 130.336 4.772 . . . . 0.0 104.543 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 1.5 m-20 -33.86 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.996 1 O-C-N 130.716 5.01 . . . . 0.0 118.465 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.24 27.09 0.03 OUTLIER Glycine 0 C--N 1.353 1.48 2 C-N-CA 110.485 -5.626 . . . . 0.0 109.683 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.26 157.21 0.16 Allowed 'General case' 0 C--O 1.248 0.983 0 O-C-N 127.696 2.645 . . . . 0.0 110.028 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 23' ' ' LEU 0.3 21.0 m95 -156.16 169.83 23.6 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 111.967 -3.873 . . . . 0.0 112.063 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 4.4 mtmt 44.72 -179.63 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.789 1 O-C-N 133.555 6.784 . . . . 0.0 118.34 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 21' ' ' LEU 0.271 0.4 OUTLIER 40.33 51.27 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.706 3 CA-C-O 135.05 7.119 . . . . 0.0 120.848 174.852 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.15 -59.83 0.82 Allowed 'General case' 0 C--N 1.367 1.343 0 CA-C-N 108.455 -3.975 . . . . 0.0 103.151 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -90.05 140.25 29.83 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.033 0.921 . . . . 0.0 111.831 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.71 -21.84 0.28 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-N 112.922 -1.945 . . . . 0.0 114.338 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 61.05 41.39 13.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 116.332 -1.794 . . . . 0.0 110.627 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.07 111.55 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.955 1 O-C-N 129.958 4.536 . . . . 0.0 109.449 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -50.6 -45.05 57.18 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.4 m -92.31 123.11 35.4 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 115.11 -2.636 . . . . 0.0 107.693 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.1 98.14 2.34 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 127.27 2.856 . . . . 0.0 107.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.36 -75.32 0.08 Allowed 'General case' 0 C--N 1.361 1.069 0 CA-C-N 111.003 -2.599 . . . . 0.0 104.587 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -80.69 153.87 27.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 126.246 2.216 . . . . 0.0 107.575 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.42 36.31 0.65 Allowed 'General case' 0 C--O 1.207 -1.139 0 O-C-N 125.868 1.98 . . . . 0.0 110.803 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.411 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 24.2 t-20 -161.16 87.12 0.71 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 128.801 3.813 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.642 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -170.63 170.59 6.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.381 0.0 OUTLIER -178.45 178.85 0.82 Allowed 'General case' 0 C--O 1.198 -1.653 1 O-C-N 132.456 6.097 . . . . 0.0 103.386 179.848 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 25' ' ' ILE . 4.0 mt -136.46 166.02 24.47 Favored 'General case' 0 CA--C 1.563 1.446 2 O-C-N 130.74 5.025 . . . . 0.0 97.504 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 86.3 m 175.67 73.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 1 O-C-N 129.715 4.385 . . . . 0.0 107.277 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 23' ' ' LEU . 3.7 mp -86.18 144.88 8.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 113.876 -3.13 . . . . 0.0 109.248 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.7 m -162.75 79.41 0.49 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 116.43 -2.108 . . . . 0.0 105.97 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -53.57 154.63 3.49 Favored 'General case' 0 N--CA 1.441 -0.892 2 O-C-N 132.031 5.832 . . . . 0.0 114.711 179.881 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -124.82 81.85 1.99 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.24 -87.45 1.56 Allowed Glycine 0 CA--C 1.558 2.766 1 N-CA-C 103.086 -4.006 . . . . 0.0 103.086 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -128.27 3.06 5.74 Favored 'General case' 0 N--CA 1.409 -2.506 2 O-C-N 133.212 5.889 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -79.79 160.3 26.21 Favored 'General case' 0 C--N 1.326 -0.432 2 N-CA-C 98.922 -4.473 . . . . 0.0 98.922 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HZ ' HD21 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -170.68 86.52 0.11 Allowed 'General case' 0 C--O 1.201 -1.465 2 N-CA-C 96.418 -5.401 . . . . 0.0 96.418 179.862 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.39 129.85 42.4 Favored 'General case' 0 CA--C 1.507 -0.702 2 O-C-N 132.829 6.331 . . . . 0.0 103.279 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG22 ' CE1' ' A' ' 32' ' ' PHE 0.323 69.3 t -102.29 134.32 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 1 N-CA-C 99.325 -4.324 . . . . 0.0 99.325 179.61 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -81.68 63.04 5.78 Favored 'General case' 0 CA--C 1.49 -1.361 1 CA-C-O 132.495 5.903 . . . . 0.0 116.233 -179.748 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.291 4.8 mt-10 -80.52 71.41 7.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 O-C-N 117.032 -3.543 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 m -77.31 126.48 30.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 112.454 -3.698 . . . . 0.0 107.058 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 -165.92 0.33 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 116.075 -2.25 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.5 m120 69.38 -96.03 0.03 OUTLIER 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.031 0.832 . . . . 0.0 111.415 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -141.26 20.28 2.25 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 127.228 2.83 . . . . 0.0 111.468 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -176.71 -176.55 0.72 Allowed 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 127.595 3.06 . . . . 0.0 111.38 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 122.47 36.79 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.335 0.7 OUTLIER -140.98 146.48 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 2 O-C-N 131.091 5.244 . . . . 0.0 105.204 -179.32 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -116.66 173.62 6.52 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 110.26 -3.155 . . . . 0.0 108.571 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.19 91.41 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.328 1 O-C-N 131.561 5.538 . . . . 0.0 101.115 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -103.38 158.0 5.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 1 O-C-N 130.722 5.014 . . . . 0.0 112.685 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.0 p90 169.23 -158.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.738 1 O-C-N 133.462 6.726 . . . . 0.0 111.006 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 83.74 1.99 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 116.118 -2.233 . . . . 0.0 114.034 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 69' ' ' MET . 1.5 mp 43.44 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 1 O-C-N 130.96 5.163 . . . . 0.0 116.08 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.27 71.72 1.61 Allowed Glycine 0 C--O 1.203 -1.843 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.5 t -144.84 92.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 1 O-C-N 131.182 4.695 . . . . 0.0 112.363 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.32 147.17 34.35 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 113.531 -3.268 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -154.42 161.07 41.91 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 132.392 6.058 . . . . 0.0 115.896 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.71 109.79 20.18 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -179.78 4.54 Favored 'General case' 0 CA--C 1.509 -0.604 1 O-C-N 130.095 4.622 . . . . 0.0 110.294 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.88 99.05 3.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 114.542 -2.863 . . . . 0.0 105.311 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.47 -74.02 0.05 Allowed 'General case' 0 C--O 1.247 0.936 0 O-C-N 126.769 2.543 . . . . 0.0 114.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 18.06 3.16 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 126.358 2.286 . . . . 0.0 115.232 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 73.3 0.49 3.68 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 126.417 2.323 . . . . 0.0 114.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.86 25.18 2.26 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 128.566 3.666 . . . . 0.0 108.161 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 p -118.37 170.87 8.56 Favored 'General case' 0 C--O 1.218 -0.567 1 O-C-N 130.479 4.282 . . . . 0.0 110.173 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -157.38 38.53 0.29 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 113.861 -3.136 . . . . 0.0 106.989 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.0 98.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 108.736 -3.847 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 64' ' ' THR . 2.9 m -99.53 101.6 12.88 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -168.21 -168.12 29.85 Favored Glycine 0 CA--C 1.541 1.702 1 C-N-CA 112.4 -4.714 . . . . 0.0 106.885 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.25 147.62 43.88 Favored 'General case' 0 CA--C 1.499 -0.998 1 O-C-N 133.709 6.182 . . . . 0.0 113.286 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 m95 -124.97 104.87 8.81 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.0 p -101.79 73.44 1.42 Allowed 'General case' 0 C--O 1.2 -1.548 1 O-C-N 134.437 7.335 . . . . 0.0 116.008 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.508 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.17 98.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 2 O-C-N 132.406 6.066 . . . . 0.0 103.813 179.891 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.11 -22.51 28.85 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 117.361 -1.736 . . . . 0.0 110.688 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.81 101.73 0.7 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 104.524 -3.43 . . . . 0.0 104.524 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 61.16 26.9 16.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 110.911 -2.645 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 4.1 mtpt -133.76 -170.7 2.55 Favored 'General case' 0 C--N 1.358 0.951 1 O-C-N 130.606 4.941 . . . . 0.0 111.393 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.665 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -165.76 39.17 0.06 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 114.682 -2.807 . . . . 0.0 112.683 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.98 146.66 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 110.228 -3.169 . . . . 0.0 116.002 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.17 -145.68 13.78 Favored Glycine 0 CA--C 1.559 2.813 1 N-CA-C 100.008 -5.237 . . . . 0.0 100.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.475 ' CB ' HG12 ' A' ' 88' ' ' ILE . 9.4 tttm 171.05 123.04 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 134.861 6.859 . . . . 0.0 114.049 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -113.04 166.53 11.33 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.664 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.276 16.1 ttmt -162.84 149.95 13.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 109.666 -3.425 . . . . 0.0 113.41 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.473 ' NE ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -98.98 72.48 1.91 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 117.242 -1.783 . . . . 0.0 106.306 178.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.4 t -29.74 -52.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 O-C-N 130.74 5.025 . . . . 0.0 115.351 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -52.66 -31.07 35.26 Favored 'General case' 0 N--CA 1.435 -1.197 1 O-C-N 129.322 4.139 . . . . 0.0 112.516 -179.219 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 0.7 OUTLIER 170.63 -3.31 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.243 4.09 . . . . 0.0 115.479 -178.83 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' HA3' ' CD ' ' A' ' 80' ' ' ARG . . . -91.0 -30.02 11.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 104.229 -3.548 . . . . 0.0 104.229 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 76.62 -169.69 0.07 Allowed 'General case' 0 N--CA 1.425 -1.686 1 O-C-N 132.377 5.398 . . . . 0.0 118.455 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.664 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 2.0 mp0 -45.45 139.27 3.8 Favored 'General case' 0 N--CA 1.429 -1.525 1 O-C-N 132.627 6.205 . . . . 0.0 116.111 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.473 HD11 ' NE ' ' A' ' 80' ' ' ARG . 30.3 mt -148.16 47.43 1.06 Allowed 'General case' 0 C--O 1.201 -1.487 1 O-C-N 137.151 9.032 . . . . 0.0 109.806 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' A' ' 77' ' ' LYS . 89.5 mt -64.72 172.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.123 1 CA-C-N 108.342 -4.027 . . . . 0.0 104.097 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.1 66.71 1.49 Allowed 'General case' 0 C--O 1.205 -1.265 1 O-C-N 130.824 5.077 . . . . 0.0 107.903 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.16 110.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 1 O-C-N 131.137 5.273 . . . . 0.0 102.129 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 1.1 tpm_? -164.5 156.41 16.11 Favored 'General case' 0 C--O 1.188 -2.161 1 C-N-CA 111.219 -4.192 . . . . 0.0 113.182 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.572 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 4.2 pt-20 -158.79 134.91 9.07 Favored 'General case' 0 N--CA 1.424 -1.728 2 O-C-N 129.975 4.547 . . . . 0.0 105.149 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.832 ' CD1' HD12 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -39.75 106.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.844 1 O-C-N 132.876 6.36 . . . . 0.0 111.01 179.89 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.11 67.11 Favored 'General case' 0 C--O 1.241 0.625 1 O-C-N 129.255 4.097 . . . . 0.0 114.355 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.46 96.23 0.1 Allowed Glycine 0 CA--C 1.545 1.964 0 C-N-CA 116.181 -2.914 . . . . 0.0 106.961 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 58.05 37.13 26.51 Favored 'General case' 0 N--CA 1.437 -1.121 2 CA-C-N 107.063 -4.569 . . . . 0.0 109.495 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 93' ' ' ILE 0.304 0.0 OUTLIER 179.44 179.46 0.47 Allowed 'General case' 0 CA--C 1.564 1.499 0 O-C-N 128.047 3.342 . . . . 0.0 106.579 179.403 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.832 HD12 ' CD1' ' A' ' 93' ' ' ILE . 8.1 tt -140.54 130.78 25.02 Favored 'General case' 0 C--O 1.211 -0.963 2 O-C-N 134.646 7.466 . . . . 0.0 109.349 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' GLN . 66.7 mt -76.13 -101.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.417 -2.111 1 O-C-N 130.046 4.591 . . . . 0.0 102.717 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.655 ' HG2' HD21 ' A' ' 98' ' ' LEU . 18.0 mt-30 130.34 75.1 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.486 1 O-C-N 131.801 5.688 . . . . 0.0 102.043 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m -81.27 93.34 6.51 Favored 'General case' 0 N--CA 1.428 -1.557 1 O-C-N 131.067 5.23 . . . . 0.0 112.006 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.37 125.1 25.39 Favored 'General case' 0 C--O 1.201 -1.465 2 CA-C-N 106.82 -4.718 . . . . 0.0 105.283 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 m -101.76 76.99 1.69 Allowed 'General case' 0 C--O 1.206 -1.236 1 O-C-N 130.613 4.945 . . . . 0.0 101.747 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.33 109.16 21.34 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 108.702 -3.863 . . . . 0.0 115.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 48.88 37.0 9.12 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.548 -2.114 . . . . 0.0 113.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.65 -12.39 61.21 Favored Glycine 0 C--N 1.346 1.094 1 C-N-CA 113.762 -4.066 . . . . 0.0 113.942 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.47 131.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 117.539 -1.22 . . . . 0.0 112.958 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -90.81 71.92 6.61 Favored 'General case' 0 C--N 1.358 0.936 1 O-C-N 129.359 4.162 . . . . 0.0 107.96 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.395 . . -89.97 103.84 16.46 Favored 'General case' 0 C--O 1.196 -1.723 0 C-N-CA 112.839 -3.545 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 145.14 30.93 Favored 'General case' 0 N--CA 1.417 -2.086 1 O-C-N 133.031 6.457 . . . . 0.0 110.475 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -128.7 119.25 24.28 Favored 'General case' 0 CA--C 1.559 1.311 2 O-C-N 132.029 5.83 . . . . 0.0 99.296 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 10.2 pt -79.22 137.08 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 1 O-C-N 130.11 4.631 . . . . 0.0 113.378 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.637 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.6 m-30 -125.68 -177.87 4.06 Favored 'General case' 0 N--CA 1.435 -1.196 2 O-C-N 135.94 8.275 . . . . 0.0 106.402 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 176.94 127.0 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.233 2 CA-C-O 131.872 5.606 . . . . 0.0 113.329 -179.405 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 10.2 ttmt -41.34 -62.92 0.77 Allowed 'General case' 0 C--O 1.203 -1.381 0 CA-C-O 128.166 3.841 . . . . 0.0 117.193 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.366 1.319 0 CA-C-N 109.363 -3.562 . . . . 0.0 113.171 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.137 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -42.72 83.56 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 127.312 2.882 . . . . 0.0 105.178 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.43 98.24 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 O-C-N 127.61 3.069 . . . . 0.0 116.513 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 153.58 6.66 Favored Glycine 0 N--CA 1.464 0.52 0 C-N-CA 114.594 -3.67 . . . . 0.0 104.417 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 10.8 p -66.11 167.94 9.22 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 114.923 -2.711 . . . . 0.0 108.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.616 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.281 35.7 m95 -142.68 149.07 38.37 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 115.471 -2.204 . . . . 0.0 112.724 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 8.5 mtmt 56.7 -179.33 0.05 OUTLIER 'General case' 0 C--O 1.197 -1.663 1 O-C-N 129.488 4.242 . . . . 0.0 117.269 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.265 1.0 OUTLIER 33.4 141.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.534 3 O-C-N 135.793 8.183 . . . . 0.0 120.086 174.769 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -169.61 50.48 0.03 OUTLIER 'General case' 0 C--N 1.374 1.664 0 O-C-N 117.312 -3.367 . . . . 0.0 107.659 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -137.25 150.4 47.81 Favored 'General case' 0 C--O 1.21 -1.021 0 O-C-N 120.695 -1.253 . . . . 0.0 114.17 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -115.74 94.15 4.56 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.682 1.864 . . . . 0.0 108.311 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.31 -64.18 1.19 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -144.98 165.08 29.18 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 127.297 2.873 . . . . 0.0 107.883 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 66.29 152.98 0.07 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 108.419 -3.991 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -157.99 30.29 0.26 Allowed 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.1 31.19 5.39 Favored Glycine 0 CA--C 1.55 2.255 0 O-C-N 126.42 2.325 . . . . 0.0 112.681 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.8 -104.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 111.281 -2.46 . . . . 0.0 109.793 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -153.78 -170.37 3.56 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.62 -169.6 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 117.566 -1.654 . . . . 0.0 111.013 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.26 -124.1 0.09 Allowed 'General case' 0 C--N 1.352 0.705 0 O-C-N 126.375 2.297 . . . . 0.0 113.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 155.02 22.67 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.371 0.0 OUTLIER -179.24 123.49 0.08 Allowed 'General case' 0 C--O 1.195 -1.787 0 O-C-N 128.878 3.861 . . . . 0.0 105.529 179.956 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 8.8 mt -87.91 162.0 17.15 Favored 'General case' 0 CA--C 1.552 1.036 2 O-C-N 129.862 4.476 . . . . 0.0 101.654 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 87.7 m -178.53 64.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.195 1 O-C-N 130.117 4.636 . . . . 0.0 105.439 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.4 mp -82.48 146.45 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 113.339 -3.344 . . . . 0.0 109.209 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -172.37 79.18 0.05 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 113.546 -3.261 . . . . 0.0 103.273 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -31.0 139.51 0.03 OUTLIER 'General case' 0 C--O 1.208 -1.099 2 O-C-N 134.834 7.584 . . . . 0.0 116.742 179.734 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -104.18 -99.61 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 128.815 3.822 . . . . 0.0 104.177 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.07 80.99 0.36 Allowed Glycine 0 CA--C 1.564 3.123 1 N-CA-C 99.699 -5.361 . . . . 0.0 99.699 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 68.66 28.33 5.71 Favored 'General case' 0 N--CA 1.433 -1.295 2 O-C-N 131.875 5.103 . . . . 0.0 106.646 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.5 ttpp -131.91 110.1 10.55 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 128.925 3.89 . . . . 0.0 101.315 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -101.36 166.37 10.78 Favored 'General case' 0 C--O 1.197 -1.687 2 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 -179.434 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 98.17 4.38 Favored 'General case' 0 N--CA 1.478 0.96 3 O-C-N 137.692 9.37 . . . . 0.0 97.356 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.409 0.9 OUTLIER -72.42 127.33 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 2 C-N-CA 109.643 -4.823 . . . . 0.0 98.984 179.705 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.429 25.1 tttt -76.18 8.43 3.3 Favored 'General case' 0 C--N 1.368 1.387 0 CA-C-N 109.978 -3.283 . . . . 0.0 119.581 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.421 2.6 mt-10 -47.76 106.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 111.038 -2.801 . . . . 0.0 103.502 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 p -138.36 145.84 41.57 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 128.282 3.489 . . . . 0.0 106.57 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.3 p -140.28 -175.25 4.19 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 116.217 -2.193 . . . . 0.0 112.373 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -15.98 60.81 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 127.408 2.943 . . . . 0.0 105.02 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -97.26 -109.8 0.16 Allowed 'General case' 0 N--CA 1.435 -1.215 1 CA-C-N 108.194 -4.093 . . . . 0.0 108.934 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.717 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -135.75 44.97 2.46 Favored 'General case' 0 CA--C 1.496 -1.114 1 O-C-N 129.161 4.038 . . . . 0.0 117.785 -179.076 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -72.62 -35.68 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.901 ' CG2' HD21 ' A' ' 57' ' ' LEU 0.267 5.1 tt 11.96 60.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 2 O-C-N 133.944 7.027 . . . . 0.0 112.036 178.318 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.93 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.831 -2.44 . . . . 0.0 111.436 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.31 50.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.275 3.0 p -61.53 167.22 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 O-C-N 129.065 3.978 . . . . 0.0 112.782 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -166.44 -157.1 0.26 Allowed 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.926 3.891 . . . . 0.0 111.064 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 1.2 mt-10 -138.42 52.79 1.81 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 126.472 2.357 . . . . 0.0 114.802 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 2.3 tp 18.11 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.533 1 CA-C-O 130.004 4.716 . . . . 0.0 117.461 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.32 51.4 8.62 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 103.375 -3.89 . . . . 0.0 103.375 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.52 121.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 1 O-C-N 134.53 6.664 . . . . 0.0 115.177 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.54 16.22 Favored 'General case' 0 C--O 1.21 -1.002 1 O-C-N 131.58 5.55 . . . . 0.0 110.167 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 9.5 p90 -176.99 169.47 2.37 Favored 'General case' 0 N--CA 1.421 -1.879 0 O-C-N 128.554 3.659 . . . . 0.0 114.457 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 136.67 52.77 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.23 101.62 4.06 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 128.923 3.889 . . . . 0.0 113.409 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 t -69.92 155.98 39.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 113.296 -3.361 . . . . 0.0 102.844 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.901 HD21 ' CG2' ' A' ' 43' ' ' ILE . 5.5 tp -147.21 -92.66 0.09 Allowed 'General case' 0 C--O 1.245 0.85 1 O-C-N 129.269 4.106 . . . . 0.0 110.745 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.717 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . . . -60.06 -5.45 1.03 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 112.921 -3.418 . . . . 0.0 115.999 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t70 106.49 -15.65 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.595 1 O-C-N 129.531 4.269 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.11 -55.6 0.26 Allowed Glycine 0 CA--C 1.558 2.74 0 N-CA-C 104.202 -3.559 . . . . 0.0 104.202 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 p -39.56 137.87 0.78 Allowed 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 128.968 3.393 . . . . 0.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.94 37.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 114.551 -2.86 . . . . 0.0 109.023 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' HD21 ' A' ' 87' ' ' LEU . 10.2 mp -42.02 97.91 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.687 1 O-C-N 130.658 4.974 . . . . 0.0 112.225 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.4 m -93.84 99.39 11.77 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 111.602 -2.544 . . . . 0.0 106.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.69 -175.71 34.0 Favored Glycine 0 C--O 1.201 -1.937 1 C-N-CA 111.617 -5.087 . . . . 0.0 108.556 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' THR . 15.0 t -140.85 143.81 34.97 Favored 'General case' 0 CA--C 1.5 -0.978 2 O-C-N 132.509 5.476 . . . . 0.0 111.883 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.691 ' CZ2' ' HB3' ' A' ' 89' ' ' ALA . 15.3 m95 -124.25 111.64 16.08 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -99.98 41.88 1.14 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 135.485 7.991 . . . . 0.0 113.613 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.431 ' HB2' HD13 ' A' ' 49' ' ' LEU . 4.6 tmm? -37.52 107.43 0.06 Allowed 'General case' 0 C--N 1.317 -0.806 1 O-C-N 134.434 7.334 . . . . 0.0 107.917 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -82.99 -74.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.305 0 O-C-N 129.055 3.972 . . . . 0.0 108.525 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.56 -79.85 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.117 1 O-C-N 129.435 4.21 . . . . 0.0 107.993 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.58 44.21 2.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 127.991 2.818 . . . . 0.0 108.865 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -141.08 178.73 7.18 Favored 'General case' 0 C--N 1.356 0.865 1 O-C-N 129.147 4.029 . . . . 0.0 112.451 -179.96 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 4.8 mt -148.28 91.87 1.96 Allowed 'General case' 0 C--N 1.321 -0.649 0 O-C-N 126.584 2.428 . . . . 0.0 110.596 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.28 119.68 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 O-C-N 128.321 3.513 . . . . 0.0 117.444 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.55 -141.33 5.82 Favored Glycine 0 CA--C 1.557 2.673 1 CA-C-N 108.082 -4.145 . . . . 0.0 103.772 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -178.79 131.68 0.12 Allowed 'General case' 0 C--O 1.204 -1.334 1 O-C-N 131.772 5.042 . . . . 0.0 113.966 -179.972 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.4 OUTLIER -127.13 167.9 15.38 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-O 127.417 3.484 . . . . 0.0 101.672 179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 6.8 ttmt -170.48 144.14 2.39 Favored 'General case' 0 N--CA 1.427 -1.617 1 CA-C-N 106.857 -4.702 . . . . 0.0 114.138 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 69.64 0.8 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 125.105 1.503 . . . . 0.0 107.175 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -31.64 -40.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.39 1 O-C-N 131.184 5.302 . . . . 0.0 115.472 -179.828 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 11.6 p-10 -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.442 -0.832 1 O-C-N 131.03 5.206 . . . . 0.0 112.549 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 172.08 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 O-C-N 128.903 3.877 . . . . 0.0 115.998 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.5 -34.38 6.08 Favored Glycine 0 CA--C 1.543 1.79 0 N-CA-C 104.092 -3.603 . . . . 0.0 104.092 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.492 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 78.0 -171.19 0.06 Allowed 'General case' 0 N--CA 1.436 -1.158 1 O-C-N 132.153 5.266 . . . . 0.0 117.272 -179.804 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 77.6 mt-10 -48.6 149.48 1.67 Allowed 'General case' 0 N--CA 1.432 -1.334 1 O-C-N 132.355 6.034 . . . . 0.0 113.456 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 63' ' ' LEU 0.257 0.1 OUTLIER -158.18 35.38 0.24 Allowed 'General case' 0 C--O 1.196 -1.751 1 O-C-N 135.255 7.847 . . . . 0.0 109.343 178.772 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' THR 0.251 42.7 mt -50.28 127.49 6.1 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.639 1 O-C-N 132.98 6.425 . . . . 0.0 100.479 -179.794 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -87.62 68.88 9.64 Favored 'General case' 0 C--O 1.205 -1.244 1 O-C-N 132.878 6.361 . . . . 0.0 110.958 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 t -66.92 108.36 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 1 C-N-CA 111.567 -4.053 . . . . 0.0 102.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 98' ' ' LEU . 8.9 ttm180 -139.05 168.73 19.19 Favored 'General case' 0 C--O 1.195 -1.778 0 O-C-N 128.479 3.612 . . . . 0.0 111.674 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.12 94.09 0.05 Allowed 'General case' 0 C--N 1.363 1.184 2 O-C-N 132.458 6.099 . . . . 0.0 108.438 179.829 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -28.28 105.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.749 1 O-C-N 133.424 6.702 . . . . 0.0 112.115 -179.938 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.9 m -94.55 130.73 40.85 Favored 'General case' 0 N--CA 1.439 -0.976 1 O-C-N 129.117 4.01 . . . . 0.0 113.541 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.1 -116.27 7.07 Favored Glycine 0 CA--C 1.561 2.91 1 N-CA-C 100.653 -4.979 . . . . 0.0 100.653 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.69 57.69 1.05 Allowed 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 129.609 3.77 . . . . 0.0 107.999 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.705 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.269 0.0 OUTLIER 176.77 115.55 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.53 1 O-C-N 130.694 4.996 . . . . 0.0 107.312 179.375 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 93' ' ' ILE . 1.5 tp -65.3 148.34 51.87 Favored 'General case' 0 N--CA 1.416 -2.158 2 O-C-N 133.366 6.667 . . . . 0.0 111.686 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.519 HG21 ' HD2' ' A' ' 110' ' ' LYS . 2.2 mt -130.27 128.92 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 3 O-C-N 131.6 5.563 . . . . 0.0 102.571 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' NE ' ' A' ' 91' ' ' ARG . 1.8 mt-30 -119.75 129.09 54.33 Favored 'General case' 0 C--O 1.21 -1.003 1 O-C-N 135.395 7.935 . . . . 0.0 101.796 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 110' ' ' LYS . 68.6 p -82.34 -43.96 16.79 Favored 'General case' 0 N--CA 1.41 -2.467 2 O-C-N 131.184 5.303 . . . . 0.0 116.457 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 59.95 61.03 1.98 Allowed 'General case' 0 C--O 1.205 -1.281 1 O-C-N 129.331 4.144 . . . . 0.0 104.406 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' ILE . 54.7 m -55.2 101.85 0.06 Allowed 'General case' 0 N--CA 1.479 1.002 1 N-CA-C 100.119 -4.03 . . . . 0.0 100.119 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 113.1 20.86 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 109.165 -3.652 . . . . 0.0 110.561 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -4.79 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 107' ' ' VAL . . . 94.92 -3.8 67.64 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 116.618 -2.706 . . . . 0.0 112.536 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 106' ' ' GLY . 1.4 t -162.56 154.12 3.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -119.15 114.14 21.99 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 128.206 3.441 . . . . 0.0 102.334 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.378 . . -102.96 81.64 2.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 116.314 -2.155 . . . . 0.0 114.295 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD2' HG21 ' A' ' 99' ' ' ILE . 1.6 mtmm -72.25 150.72 43.39 Favored 'General case' 0 N--CA 1.435 -1.18 1 O-C-N 129.993 4.558 . . . . 0.0 108.859 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.8 mtp180 -131.91 -164.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 1 O-C-N 131.381 5.426 . . . . 0.0 103.234 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -162.0 79.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.044 1 C-N-CA 111.45 -4.1 . . . . 0.0 109.85 179.993 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 41.6 m-85 -100.2 -145.08 0.34 Allowed 'General case' 0 C--N 1.319 -0.757 1 O-C-N 130.552 4.907 . . . . 0.0 105.704 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.705 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.47 -154.45 0.16 Allowed 'General case' 0 C--O 1.197 -1.699 1 O-C-N 131.979 5.799 . . . . 0.0 111.462 -179.856 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 21.5 tttt -115.21 -141.71 0.38 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 111.842 -2.436 . . . . 0.0 111.605 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.222 -179.512 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 116.222 -1.847 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 98' ' ' LEU . 98.3 m-85 54.01 81.97 0.09 Allowed 'General case' 0 CA--C 1.554 1.133 1 O-C-N 133.744 6.903 . . . . 0.0 101.753 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 24.4 p-10 -169.32 32.55 0.02 OUTLIER 'General case' 0 C--N 1.364 1.202 0 CA-C-N 110.137 -3.211 . . . . 0.0 115.914 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.53 159.62 21.18 Favored Glycine 0 C--N 1.346 1.105 1 C-N-CA 113.38 -4.248 . . . . 0.0 106.777 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -58.26 134.21 56.34 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 115.382 -2.527 . . . . 0.0 109.723 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.301 70.8 m95 -114.89 140.71 48.76 Favored 'General case' 0 N--CA 1.412 -2.342 1 CA-C-O 111.087 -4.292 . . . . 0.0 111.983 -179.807 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 11.4 mtmt 67.13 177.81 0.23 Allowed 'General case' 0 N--CA 1.424 -1.736 1 O-C-N 131.547 5.529 . . . . 0.0 118.164 176.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER 41.79 149.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.51 3 O-C-N 136.329 8.518 . . . . 0.0 120.802 174.893 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.52 35.69 0.01 OUTLIER 'General case' 0 C--N 1.37 1.496 1 CA-C-N 108.144 -4.116 . . . . 0.0 105.42 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -122.96 72.85 1.11 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 123.238 1.494 . . . . 0.0 114.269 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -171.04 120.69 0.53 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 112.696 -2.047 . . . . 0.0 112.931 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.21 -41.33 1.26 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 116.469 -1.729 . . . . 0.0 109.081 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.463 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 2.0 p30 -115.81 14.21 16.25 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 128.084 3.365 . . . . 0.0 106.328 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 2.4 m-85 46.37 61.6 2.67 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 127.832 3.208 . . . . 0.0 111.262 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -81.27 138.46 35.73 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 116.741 -1.983 . . . . 0.0 107.004 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.34 -132.75 5.63 Favored Glycine 0 C--O 1.207 -1.561 0 O-C-N 126.067 2.104 . . . . 0.0 112.297 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.82 -51.54 3.85 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 110.728 -2.736 . . . . 0.0 106.305 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -98.59 0.06 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.649 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -124.79 139.47 53.82 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 127.062 2.726 . . . . 0.0 108.298 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -58.69 174.16 0.35 Allowed 'General case' 0 CA--C 1.561 1.399 1 O-C-N 129.287 4.117 . . . . 0.0 110.308 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.44 -175.46 5.84 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 110.394 -3.094 . . . . 0.0 104.885 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.323 1.4 ptmt 163.52 150.39 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.466 1 O-C-N 134.967 7.667 . . . . 0.0 103.661 179.85 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 2.9 mt -114.04 176.35 5.08 Favored 'General case' 0 CA--C 1.56 1.354 2 O-C-N 131.778 5.673 . . . . 0.0 98.486 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.646 ' O ' HD12 ' A' ' 25' ' ' ILE . 77.8 m -162.03 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 128.729 3.768 . . . . 0.0 107.668 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.673 HG21 ' CE2' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 63.9 145.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-O 124.784 2.231 . . . . 0.0 115.947 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 169.27 67.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -26.15 124.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.28 2 O-C-N 135.804 8.19 . . . . 0.0 114.173 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -9.02 53.29 Favored 'General case' 0 N--CA 1.482 1.128 1 O-C-N 130.918 5.136 . . . . 0.0 106.371 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.87 -40.83 0.35 Allowed Glycine 0 CA--C 1.55 2.279 1 N-CA-C 102.171 -4.372 . . . . 0.0 102.171 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.79 -12.13 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.926 1 O-C-N 131.461 4.859 . . . . 0.0 112.817 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -78.95 120.21 23.22 Favored 'General case' 0 N--CA 1.48 1.062 1 N-CA-C 96.253 -5.462 . . . . 0.0 96.253 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.673 ' CE2' HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -126.45 105.33 8.69 Favored 'General case' 0 C--O 1.208 -1.118 1 N-CA-C 98.73 -4.545 . . . . 0.0 98.73 -179.263 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -109.21 127.07 53.93 Favored 'General case' 0 CA--C 1.492 -1.267 2 O-C-N 135.603 8.064 . . . . 0.0 104.435 -179.814 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.324 2.2 t -93.95 143.8 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-O 126.659 3.123 . . . . 0.0 103.248 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -86.59 70.03 10.4 Favored 'General case' 0 C--O 1.196 -1.718 2 CA-C-O 133.405 6.336 . . . . 0.0 112.902 179.114 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -78.34 44.8 0.52 Allowed 'General case' 0 N--CA 1.42 -1.95 1 CA-C-N 107.49 -4.414 . . . . 0.0 109.672 -179.697 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 t -67.78 119.81 13.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 114.023 -3.071 . . . . 0.0 104.803 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.32 100.07 0.94 Allowed 'General case' 0 C--O 1.244 0.791 0 O-C-N 127.442 2.964 . . . . 0.0 109.934 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 62.47 -173.32 0.15 Allowed 'General case' 0 C--N 1.361 1.094 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 12.6 m-85 57.2 -95.56 0.06 Allowed 'General case' 0 C--N 1.357 0.915 1 O-C-N 129.371 4.169 . . . . 0.0 106.667 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD2' ' HB3' ' A' ' 40' ' ' PHE 0.291 1.4 mpt_? -153.58 -161.5 1.27 Allowed 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 128.249 2.62 . . . . 0.0 111.316 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -103.91 98.93 8.7 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 128.022 3.326 . . . . 0.0 103.12 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.263 0.1 OUTLIER -131.17 151.02 35.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 2 CA-C-O 130.784 5.088 . . . . 0.0 110.051 -178.894 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.1 m-20 -117.67 173.18 6.88 Favored 'General case' 0 N--CA 1.427 -1.62 1 CA-C-N 107.189 -4.55 . . . . 0.0 109.588 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.03 105.86 19.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 1 O-C-N 132.825 6.328 . . . . 0.0 101.0 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.313 6.3 p -112.27 158.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 113.671 -3.212 . . . . 0.0 116.187 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.455 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.2 p90 -171.52 -132.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.647 1 O-C-N 131.761 5.663 . . . . 0.0 111.026 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.48 58.87 0.22 Allowed 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 112.924 -3.511 . . . . 0.0 114.898 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 31.53 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 127.345 2.903 . . . . 0.0 116.637 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 58.4 2.36 Favored Glycine 0 CA--C 1.547 2.09 1 N-CA-C 102.73 -4.148 . . . . 0.0 102.73 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -156.52 118.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.779 1 O-C-N 131.858 5.093 . . . . 0.0 113.43 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 1.0 OUTLIER -78.17 160.58 27.91 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 129.403 4.19 . . . . 0.0 107.625 179.723 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CE1' ' C ' ' A' ' 65' ' ' GLY . 15.2 p90 -175.85 149.2 0.91 Allowed 'General case' 0 C--N 1.36 1.048 2 O-C-N 132.328 6.018 . . . . 0.0 115.576 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -110.92 90.58 3.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 115.556 -2.164 . . . . 0.0 106.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.24 135.61 38.92 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 127.568 3.042 . . . . 0.0 111.897 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -96.43 85.08 3.83 Favored 'General case' 0 CA--C 1.551 1.007 1 O-C-N 130.857 5.098 . . . . 0.0 105.759 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' THR . 3.7 mp -71.05 -173.03 0.76 Allowed 'General case' 0 C--O 1.243 0.721 1 O-C-N 132.394 6.059 . . . . 0.0 110.264 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . 49.05 -146.86 0.32 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-O 115.033 -2.413 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.54 -6.09 55.17 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 128.027 3.329 . . . . 0.0 108.935 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.16 49.83 0.02 OUTLIER Glycine 0 CA--C 1.549 2.181 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.9 m -102.39 116.61 32.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 126.585 1.991 . . . . 0.0 109.18 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.5 119.21 36.8 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 115.574 -2.45 . . . . 0.0 109.115 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.14 60.82 1.38 Allowed 'General case' 0 C--O 1.202 -1.415 0 CA-C-N 110.726 -2.943 . . . . 0.0 107.215 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 54.4 m -41.7 117.03 0.86 Allowed 'General case' 0 N--CA 1.436 -1.142 1 O-C-N 129.23 4.081 . . . . 0.0 104.175 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' C ' ' CE1' ' A' ' 53' ' ' PHE . . . -149.1 -159.74 8.74 Favored Glycine 0 C--O 1.209 -1.436 1 C-N-CA 110.175 -5.774 . . . . 0.0 108.65 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 52' ' ' ASP 0.287 0.7 OUTLIER 175.25 130.94 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.136 2 O-C-N 131.992 5.172 . . . . 0.0 111.808 -178.252 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.75 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 33.4 m95 -136.31 121.01 18.43 Favored 'General case' 0 C--O 1.203 -1.351 0 O-C-N 119.044 -2.285 . . . . 0.0 106.46 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -98.76 22.49 9.99 Favored 'General case' 0 N--CA 1.426 -1.63 2 O-C-N 130.651 4.969 . . . . 0.0 116.988 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 4.22 88.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 1 O-C-N 136.567 8.667 . . . . 0.0 108.322 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -94.99 95.2 8.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 128.047 3.342 . . . . 0.0 111.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.45 -102.2 0.3 Allowed Glycine 0 CA--C 1.541 1.66 1 O-C-N 129.268 4.105 . . . . 0.0 105.565 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . 74.9 m-20 -120.24 53.37 1.09 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 115.31 -2.281 . . . . 0.0 113.103 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 2.4 mtpt -135.92 171.47 14.42 Favored 'General case' 0 C--N 1.343 0.308 1 O-C-N 130.978 5.174 . . . . 0.0 109.185 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -142.08 54.74 1.46 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 127.874 3.234 . . . . 0.0 111.797 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.88 102.0 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.862 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -171.33 -161.62 22.27 Favored Glycine 0 C--O 1.2 -2.021 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.288 0.0 OUTLIER -156.89 165.39 36.32 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 129.028 3.428 . . . . 0.0 113.713 -179.508 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.75 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 33.7 m-85 -145.54 153.84 41.54 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 101.248 -3.612 . . . . 0.0 101.248 176.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.325 0.0 OUTLIER -171.45 130.99 0.72 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 110.255 -3.157 . . . . 0.0 116.86 -179.633 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 85' ' ' LYS . 94.0 mtt180 -81.39 100.58 9.33 Favored 'General case' 0 N--CA 1.439 -0.989 1 O-C-N 129.374 4.171 . . . . 0.0 108.977 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.91 -26.85 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 1 O-C-N 132.208 5.943 . . . . 0.0 108.757 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -57.0 -39.52 74.85 Favored 'General case' 0 N--CA 1.442 -0.837 1 O-C-N 132.215 5.947 . . . . 0.0 110.466 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -126.15 -2.47 7.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 127.513 3.008 . . . . 0.0 117.073 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.503 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 77.61 38.01 29.17 Favored Glycine 0 C--O 1.2 -2.025 2 C-N-CA 112.224 -4.798 . . . . 0.0 101.889 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.26 15.4 tptp -81.05 -71.92 0.45 Allowed 'General case' 0 N--CA 1.424 -1.755 2 O-C-N 132.695 5.585 . . . . 0.0 120.935 -178.87 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 12.3 mm-40 73.93 108.38 0.07 Allowed 'General case' 0 N--CA 1.429 -1.506 1 O-C-N 129.206 4.067 . . . . 0.0 113.464 -178.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 63' ' ' LEU . 2.5 pt? -139.56 49.21 1.81 Allowed 'General case' 0 C--O 1.198 -1.635 1 O-C-N 132.255 5.972 . . . . 0.0 109.985 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 76' ' ' GLY 0.255 30.6 mt -61.99 139.71 20.36 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 1 CA-C-N 107.849 -4.251 . . . . 0.0 101.357 -179.812 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.68 97.83 7.61 Favored 'General case' 0 C--O 1.2 -1.54 1 O-C-N 134.73 7.519 . . . . 0.0 103.254 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 101' ' ' THR . 2.8 t -95.34 115.6 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 O-C-N 128.941 3.901 . . . . 0.0 110.541 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CG ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -163.72 -168.54 1.67 Allowed 'General case' 0 C--O 1.192 -1.94 0 C-N-CA 112.923 -3.511 . . . . 0.0 115.933 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.559 ' H ' ' CG ' ' A' ' 91' ' ' ARG 0.296 0.1 OUTLIER -177.12 110.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 1 O-C-N 130.419 4.824 . . . . 0.0 106.127 -179.535 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.6 HD11 ' H ' ' A' ' 97' ' ' GLU . 2.4 tp -33.25 98.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 1 O-C-N 133.46 6.725 . . . . 0.0 113.317 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -84.03 75.17 10.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 116.152 -2.219 . . . . 0.0 115.076 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.26 -123.41 5.94 Favored Glycine 0 CA--C 1.563 3.077 1 N-CA-C 102.585 -4.206 . . . . 0.0 102.585 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -130.52 44.25 2.99 Favored 'General case' 0 N--CA 1.437 -1.112 1 CA-C-N 108.055 -4.072 . . . . 0.0 106.073 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.694 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.278 0.0 OUTLIER -173.4 97.92 0.12 Allowed 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.416 4.823 . . . . 0.0 108.777 179.725 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 2' ' ' PHE . 3.2 tt -72.99 148.64 44.03 Favored 'General case' 0 N--CA 1.424 -1.727 1 O-C-N 130.321 4.763 . . . . 0.0 115.209 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.61 167.26 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 2 CA-C-N 106.345 -4.934 . . . . 0.0 103.429 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.25 98.93 0.83 Allowed 'General case' 0 C--O 1.204 -1.294 1 O-C-N 131.13 5.269 . . . . 0.0 103.895 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 90' ' ' VAL . 8.9 t -85.49 112.34 20.82 Favored 'General case' 0 N--CA 1.428 -1.574 2 O-C-N 131.177 5.298 . . . . 0.0 112.461 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.18 88.97 2.49 Favored 'General case' 0 C--O 1.208 -1.118 2 C-N-CA 110.772 -4.371 . . . . 0.0 105.773 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.8 m -65.4 93.72 0.15 Allowed 'General case' 0 C--O 1.209 -1.076 0 O-C-N 128.659 3.725 . . . . 0.0 101.37 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 1.8 t80 -110.57 114.5 27.96 Favored 'General case' 0 CA--C 1.498 -1.038 1 CA-C-N 107.512 -4.404 . . . . 0.0 111.426 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 47.45 17.59 0.08 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 112.428 -2.169 . . . . 0.0 116.547 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.31 16.91 19.36 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 116.306 -2.854 . . . . 0.0 114.59 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.15 -38.29 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 120.225 2.013 . . . . 0.0 113.357 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 68.16 97.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 1 O-C-N 130.071 4.607 . . . . 0.0 108.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.363 . . -132.07 113.64 13.59 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 128.398 3.561 . . . . 0.0 109.116 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -116.25 -174.34 2.53 Favored 'General case' 0 N--CA 1.421 -1.878 1 O-C-N 133.694 6.871 . . . . 0.0 111.381 -179.422 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -156.5 119.8 4.22 Favored 'General case' 0 C--O 1.204 -1.331 2 O-C-N 130.418 4.824 . . . . 0.0 101.511 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.06 125.36 45.63 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 O-C-N 127.763 3.164 . . . . 0.0 112.903 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 65.6 m-85 -120.58 -141.96 0.34 Allowed 'General case' 0 N--CA 1.446 -0.673 1 O-C-N 131.013 5.196 . . . . 0.0 104.949 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.694 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -164.16 -149.89 0.14 Allowed 'General case' 0 C--O 1.199 -1.579 1 O-C-N 131.538 5.524 . . . . 0.0 112.526 179.903 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.645 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 24.0 tttt -128.56 154.79 45.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 127.211 2.204 . . . . 0.0 111.185 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 N--CA 1.434 -1.228 0 O-C-N 127.767 3.167 . . . . 0.0 113.678 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.195 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.17 61.51 0.77 Allowed 'General case' 0 CA--C 1.554 1.116 1 O-C-N 129.9 4.5 . . . . 0.0 102.752 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -144.33 57.49 1.32 Allowed 'General case' 0 C--N 1.358 0.938 0 CA-C-N 110.126 -3.215 . . . . 0.0 111.192 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.429 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . -165.53 177.31 40.85 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 114.113 -3.899 . . . . 0.0 105.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.327 23.8 p -80.26 177.81 8.71 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 113.858 -3.137 . . . . 0.0 104.087 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.662 ' CE3' ' HG3' ' A' ' 115' ' ' LYS . 75.3 m95 -150.69 167.86 26.08 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 115.506 -2.187 . . . . 0.0 112.189 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 8.5 mtmt 51.03 179.19 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 O-C-N 127.83 3.207 . . . . 0.0 118.814 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 32.22 112.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 3 O-C-N 133.492 6.745 . . . . 0.0 121.414 174.879 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -140.37 -148.81 0.26 Allowed 'General case' 0 N--CA 1.425 -1.723 1 CA-C-N 107.535 -4.393 . . . . 0.0 103.721 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -97.53 54.01 1.17 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 123.145 1.45 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -98.97 152.44 19.8 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.986 -1.086 . . . . 0.0 113.29 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -151.53 89.11 1.46 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 111.498 -2.592 . . . . 0.0 105.73 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -89.74 -12.27 39.85 Favored 'General case' 0 C--N 1.362 1.109 0 O-C-N 125.38 1.675 . . . . 0.0 109.277 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.46 -92.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 O-C-N 126.4 2.312 . . . . 0.0 112.116 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -179.52 -171.62 0.2 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 124.61 2.147 . . . . 0.0 107.041 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 41.62 4.89 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 111.349 -2.66 . . . . 0.0 110.779 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 131.49 47.64 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -156.27 -44.87 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 117.367 -1.302 . . . . 0.0 110.595 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.08 170.05 13.37 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 126.416 2.322 . . . . 0.0 112.082 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -133.11 115.72 15.43 Favored 'General case' 0 CA--C 1.538 0.495 1 O-C-N 129.846 4.466 . . . . 0.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -130.95 -164.03 1.39 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 114.216 -2.802 . . . . 0.0 106.506 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.407 0.0 OUTLIER -179.14 175.45 0.96 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 133.237 6.586 . . . . 0.0 103.342 -179.7 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -136.96 157.55 46.49 Favored 'General case' 0 CA--C 1.565 1.547 3 O-C-N 133.895 6.997 . . . . 0.0 97.7 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 24' ' ' THR . 2.9 m 177.78 80.44 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 1 O-C-N 131.913 5.758 . . . . 0.0 106.514 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.703 HG22 ' HB2' ' A' ' 32' ' ' PHE . 2.2 mp -95.81 118.76 42.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 CA-C-N 109.451 -3.522 . . . . 0.0 109.079 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.5 m -172.63 68.62 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 128.895 3.872 . . . . 0.0 108.905 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' HB2' ' C ' ' A' ' 31' ' ' LYS 0.297 1.5 tp60 -73.89 -95.26 0.02 OUTLIER 'General case' 0 C--N 1.354 0.786 1 C-N-CA 110.74 -4.384 . . . . 0.0 115.504 -179.888 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 170.86 144.94 0.03 OUTLIER 'General case' 0 C--O 1.244 0.771 0 O-C-N 128.555 3.659 . . . . 0.0 106.427 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.88 -97.32 1.0 Allowed Glycine 0 CA--C 1.559 2.792 3 O-C-N 130.902 5.127 . . . . 0.0 102.361 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -152.74 47.64 0.72 Allowed 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.62 6.129 . . . . 0.0 112.317 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 6.1 mttp -118.33 161.85 19.26 Favored 'General case' 0 CA--C 1.552 1.048 1 N-CA-C 96.579 -5.341 . . . . 0.0 96.579 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 25' ' ' ILE . 23.0 p90 -167.8 76.96 0.15 Allowed 'General case' 0 C--O 1.197 -1.706 2 C-N-CA 110.383 -4.527 . . . . 0.0 99.656 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 138.12 58.43 Favored 'General case' 0 CA--C 1.505 -0.755 2 O-C-N 130.907 5.129 . . . . 0.0 100.529 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.853 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 6.8 t -91.05 132.66 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 179.688 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.25 19.8 tttt -73.74 52.61 0.41 Allowed 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 126.732 3.158 . . . . 0.0 117.28 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.853 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.265 50.3 mt-10 -72.28 68.24 0.74 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.869 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -84.49 91.42 7.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 114.257 -2.977 . . . . 0.0 108.85 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 m -87.54 -178.78 6.2 Favored 'General case' 0 C--N 1.367 1.34 0 O-C-N 126.622 2.451 . . . . 0.0 116.549 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.6 -9.16 59.79 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 126.102 2.126 . . . . 0.0 108.351 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 19.7 m-85 -69.3 -55.32 10.82 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 113.341 -3.343 . . . . 0.0 106.978 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -158.95 6.63 0.11 Allowed 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 114.394 -2.717 . . . . 0.0 117.367 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.81 62.97 0.87 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 101.927 -3.361 . . . . 0.0 101.927 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 0.0 OUTLIER -134.88 113.47 16.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 3 CA-C-O 130.994 5.188 . . . . 0.0 111.249 -178.301 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.98 -172.95 4.21 Favored 'General case' 0 C--N 1.372 1.586 1 CA-C-N 107.259 -4.519 . . . . 0.0 109.59 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.26 118.36 31.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 O-C-N 128.839 3.837 . . . . 0.0 101.525 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.33 160.64 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 C-N-CA 113.035 -3.466 . . . . 0.0 111.758 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER 177.09 -176.89 0.15 Allowed 'General case' 0 N--CA 1.435 -1.183 1 O-C-N 129.818 4.449 . . . . 0.0 111.649 -179.819 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.315 3.7 tm-20 -141.97 86.51 1.99 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 114.676 -2.809 . . . . 0.0 113.388 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 36.87 91.64 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.282 1 O-C-N 131.236 5.335 . . . . 0.0 115.743 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.823 ' HA3' HG22 ' A' ' 68' ' ' THR . . . 57.46 65.22 3.71 Favored Glycine 0 C--O 1.203 -1.842 0 CA-C-O 114.248 -3.529 . . . . 0.0 105.713 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.23 -33.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 1 O-C-N 131.511 4.889 . . . . 0.0 113.637 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.8 126.02 0.03 OUTLIER 'General case' 0 C--O 1.2 -1.551 2 O-C-N 132.047 5.842 . . . . 0.0 108.368 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 9.6 p90 -173.7 149.33 1.59 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 112.5 -3.68 . . . . 0.0 117.479 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.56 138.44 40.91 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 100.698 -3.816 . . . . 0.0 100.698 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 56' ' ' SER . 4.4 t80 -150.78 26.96 0.73 Allowed 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 111.757 -3.977 . . . . 0.0 115.082 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 55' ' ' TYR . 7.4 t 23.52 78.68 0.02 OUTLIER 'General case' 0 C--O 1.249 1.061 1 O-C-N 134.693 7.496 . . . . 0.0 110.121 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.44 167.37 19.46 Favored 'General case' 0 C--N 1.317 -0.83 1 O-C-N 129.854 4.472 . . . . 0.0 114.991 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB3' HG23 ' A' ' 61' ' ' THR . . . 45.99 25.12 0.29 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 126.014 2.071 . . . . 0.0 115.388 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.74 42.13 19.18 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 126.926 2.641 . . . . 0.0 115.276 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.86 -48.3 0.06 OUTLIER Glycine 0 C--N 1.367 2.261 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 58' ' ' ALA . 3.5 p -63.61 173.61 1.63 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 127.72 2.659 . . . . 0.0 114.242 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -164.27 36.85 0.08 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 112.436 -3.706 . . . . 0.0 108.794 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 87' ' ' LEU . 8.0 mp -59.82 106.65 0.51 Allowed 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 126.558 2.411 . . . . 0.0 108.485 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.3 m -103.7 107.26 18.04 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 112.102 -2.317 . . . . 0.0 107.688 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -161.0 -163.35 13.88 Favored Glycine 0 C--O 1.203 -1.837 1 C-N-CA 111.16 -5.305 . . . . 0.0 107.499 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.441 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 1.5 t -142.33 114.67 8.37 Favored 'General case' 0 CA--C 1.495 -1.17 2 O-C-N 135.426 7.192 . . . . 0.0 118.735 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.719 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.5 m95 -99.54 112.58 24.77 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.823 HG22 ' HA3' ' A' ' 50' ' ' GLY . 73.7 p -106.03 66.26 0.71 Allowed 'General case' 0 N--CA 1.427 -1.594 1 O-C-N 132.618 6.199 . . . . 0.0 115.022 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -40.05 109.25 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 1 O-C-N 133.839 6.962 . . . . 0.0 103.207 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -66.89 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 127.563 3.04 . . . . 0.0 106.405 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.67 -63.06 0.04 OUTLIER Glycine 0 CA--C 1.556 2.654 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -140.38 16.94 2.39 Favored 'General case' 0 N--CA 1.444 -0.727 1 O-C-N 131.44 4.847 . . . . 0.0 108.647 179.543 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -99.4 176.71 5.42 Favored 'General case' 0 N--CA 1.476 0.826 1 O-C-N 131.307 5.379 . . . . 0.0 108.737 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.4 mt -148.17 45.16 1.07 Allowed 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 126.804 2.565 . . . . 0.0 111.951 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.68 137.75 23.05 Favored 'Isoleucine or valine' 0 C--N 1.364 1.227 1 CA-C-N 106.853 -4.703 . . . . 0.0 114.025 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.88 -149.65 20.5 Favored Glycine 0 CA--C 1.547 2.063 1 N-CA-C 100.649 -4.98 . . . . 0.0 100.649 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 176.5 137.82 0.06 Allowed 'General case' 0 C--O 1.208 -1.083 1 O-C-N 134.046 6.38 . . . . 0.0 112.632 -179.986 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.719 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -124.73 168.02 13.76 Favored 'General case' 0 C--O 1.195 -1.782 2 O-C-N 132.526 6.141 . . . . 0.0 104.814 179.783 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 86' ' ' GLU 0.28 0.0 OUTLIER -163.94 140.54 6.7 Favored 'General case' 0 N--CA 1.427 -1.609 1 CA-C-N 106.227 -4.988 . . . . 0.0 113.398 179.975 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.499 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 32.8 ttt180 -93.46 112.09 23.92 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 127.623 3.077 . . . . 0.0 107.164 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.02 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 1 O-C-N 130.714 5.009 . . . . 0.0 109.217 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . 32.6 m-20 -87.58 19.85 3.19 Favored 'General case' 0 N--CA 1.44 -0.957 1 O-C-N 134.024 7.078 . . . . 0.0 107.86 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 83' ' ' ASN . 0.3 OUTLIER 83.45 18.03 0.24 Allowed 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 128.502 3.626 . . . . 0.0 117.475 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 80' ' ' ARG . . . -82.49 -11.69 81.55 Favored Glycine 0 CA--C 1.562 2.993 1 C-N-CA 110.335 -5.698 . . . . 0.0 104.116 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 1.7 ttmm 41.55 82.83 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 2 O-C-N 132.672 5.572 . . . . 0.0 121.38 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 18.3 mt-10 82.79 71.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.667 1 O-C-N 129.754 4.409 . . . . 0.0 117.071 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 HD11 ' A' ' 63' ' ' LEU . 1.5 mp -99.83 64.58 1.27 Allowed 'General case' 0 C--O 1.197 -1.697 1 O-C-N 132.198 5.936 . . . . 0.0 113.646 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' A' ' 77' ' ' LYS 0.305 93.8 mt -77.84 -174.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 108.563 -3.926 . . . . 0.0 101.647 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.31 73.47 0.92 Allowed 'General case' 0 C--O 1.196 -1.745 0 O-C-N 128.051 3.345 . . . . 0.0 106.242 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 90' ' ' VAL . 2.4 t -61.87 110.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 110.597 -3.001 . . . . 0.0 105.427 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.686 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -162.82 162.67 26.63 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 111.854 -3.938 . . . . 0.0 113.438 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.686 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -153.69 121.05 5.82 Favored 'General case' 0 CA--C 1.543 0.679 2 CA-C-N 107.326 -4.488 . . . . 0.0 103.806 179.554 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 98' ' ' LEU 0.296 5.0 tt -48.4 108.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 1 O-C-N 131.265 5.353 . . . . 0.0 112.99 -179.766 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -74.74 69.33 1.79 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 130.025 4.578 . . . . 0.0 115.479 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.05 -113.4 2.63 Favored Glycine 0 CA--C 1.558 2.76 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -138.6 47.32 1.96 Allowed 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 129.461 3.683 . . . . 0.0 107.456 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.647 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 179.04 127.64 0.07 Allowed 'General case' 0 CA--C 1.56 1.354 0 O-C-N 128.577 3.673 . . . . 0.0 106.966 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 93' ' ' ILE . 11.9 tp -90.94 162.52 14.72 Favored 'General case' 0 C--O 1.206 -1.231 1 O-C-N 134.209 7.193 . . . . 0.0 111.863 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 110' ' ' LYS . 1.4 mp -107.77 -85.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 2 CA-C-O 110.707 -4.473 . . . . 0.0 103.294 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.3 mm-40 93.82 93.41 0.01 OUTLIER 'General case' 0 C--O 1.202 -1.415 1 O-C-N 133.593 6.808 . . . . 0.0 104.824 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.8 p -83.93 -166.37 1.39 Allowed 'General case' 0 N--CA 1.416 -2.174 1 O-C-N 129.273 4.108 . . . . 0.0 113.177 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -156.22 89.33 1.13 Allowed 'General case' 0 C--O 1.2 -1.552 1 C-N-CA 110.752 -4.379 . . . . 0.0 103.293 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.63 79.11 0.42 Allowed 'General case' 0 C--O 1.213 -0.835 1 O-C-N 129.804 4.44 . . . . 0.0 107.532 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -104.58 100.96 10.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 108.661 -3.881 . . . . 0.0 111.295 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 46.88 17.09 0.05 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.61 -18.57 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 116.388 -2.815 . . . . 0.0 116.41 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.12 142.5 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 119.72 1.76 . . . . 0.0 112.933 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -109.09 87.16 2.43 Favored 'General case' 0 C--N 1.364 1.238 1 O-C-N 129.3 4.125 . . . . 0.0 108.119 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.425 . . -106.71 142.41 36.39 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 116.109 -2.236 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.76 ' HB2' HG23 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -148.64 171.01 16.86 Favored 'General case' 0 N--CA 1.435 -1.184 1 O-C-N 130.875 5.109 . . . . 0.0 109.904 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.503 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -123.96 137.55 54.6 Favored 'General case' 0 CA--C 1.558 1.256 3 O-C-N 129.562 4.289 . . . . 0.0 99.921 179.541 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.09 110.0 15.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 C-N-CA 113.714 -3.194 . . . . 0.0 112.22 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 6.4 m-30 -108.56 175.43 5.47 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 128.84 3.838 . . . . 0.0 103.981 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.647 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.36 -159.19 0.31 Allowed 'General case' 0 C--O 1.198 -1.652 2 O-C-N 131.639 5.587 . . . . 0.0 111.616 179.404 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.662 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 21.6 tttt -112.59 -127.98 0.29 Allowed 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.782 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.902 0 CA-C-O 121.952 0.882 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -103.3 -33.73 9.03 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 111.029 -2.805 . . . . 0.0 107.126 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -32.79 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 130.75 5.031 . . . . 0.0 118.294 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.79 -169.7 38.09 Favored Glycine 0 C--N 1.345 1.05 1 C-N-CA 112.006 -4.902 . . . . 0.0 105.496 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.309 0.4 OUTLIER -100.34 167.68 10.25 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 114.074 -3.051 . . . . 0.0 104.929 -179.964 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.656 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.264 34.4 m95 -143.21 140.15 30.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 O-C-N 128.672 3.733 . . . . 0.0 111.109 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' ' HD2' ' A' ' 114' ' ' LYS . 19.3 mtmt 58.2 178.58 0.06 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.306 0.6 OUTLIER 35.44 92.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.588 3 O-C-N 136.404 8.565 . . . . 0.0 113.964 174.815 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -139.74 29.14 2.13 Favored 'General case' 0 C--N 1.375 1.684 1 CA-C-N 107.717 -4.31 . . . . 0.0 108.59 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -142.84 -175.74 4.62 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.848 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 65.53 102.23 0.04 OUTLIER 'General case' 0 C--N 1.363 1.186 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.366 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -121.96 150.82 41.49 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 128.141 3.401 . . . . 0.0 107.598 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.08 59.03 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 128.518 3.636 . . . . 0.0 104.285 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -115.52 122.02 44.45 Favored 'General case' 0 N--CA 1.443 -0.82 2 O-C-N 129.435 4.209 . . . . 0.0 107.26 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.13 24.24 3.54 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.46 54.62 0.67 Allowed Glycine 0 CA--C 1.55 2.264 0 O-C-N 128.288 3.492 . . . . 0.0 111.325 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.23 -177.04 2.38 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 110.145 -3.027 . . . . 0.0 106.202 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -168.72 -40.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.805 0.812 . . . . 0.0 111.742 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.82 118.33 23.88 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 113.45 -1.705 . . . . 0.0 111.548 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -119.89 165.67 14.31 Favored 'General case' 0 C--N 1.362 1.112 1 O-C-N 130.5 4.875 . . . . 0.0 111.838 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -144.07 139.93 29.2 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 127.206 2.816 . . . . 0.0 105.417 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.345 0.0 OUTLIER -159.94 149.79 18.27 Favored 'General case' 0 C--O 1.205 -1.259 1 O-C-N 130.856 5.098 . . . . 0.0 104.115 -179.811 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 6.6 mt -116.57 177.68 4.61 Favored 'General case' 0 CA--C 1.562 1.422 2 O-C-N 132.964 6.415 . . . . 0.0 97.937 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.526 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 21.9 m -167.91 -85.31 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 1 O-C-N 130.921 5.138 . . . . 0.0 106.508 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 72.68 162.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 109.163 -3.653 . . . . 0.0 108.853 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 27' ' ' GLN . 90.9 m -138.31 -48.93 0.54 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 112.781 -3.568 . . . . 0.0 108.661 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR 0.316 11.7 pt20 65.97 123.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.027 2 O-C-N 132.503 6.127 . . . . 0.0 115.778 178.762 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 7.1 tt0 -98.97 -130.81 0.22 Allowed 'General case' 0 C--O 1.248 1.022 0 O-C-N 128.795 3.81 . . . . 0.0 104.829 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.14 -53.43 3.91 Favored Glycine 0 CA--C 1.546 2.002 2 N-CA-C 99.594 -5.402 . . . . 0.0 99.594 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.17 75.81 1.57 Allowed 'General case' 0 N--CA 1.44 -0.956 1 CA-C-N 107.589 -4.305 . . . . 0.0 105.862 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -168.28 102.88 0.44 Allowed 'General case' 0 C--O 1.246 0.917 1 C-N-CA 111.418 -4.113 . . . . 0.0 102.337 -179.893 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -140.09 165.25 27.87 Favored 'General case' 0 CA--C 1.562 1.426 1 N-CA-C 99.402 -4.295 . . . . 0.0 99.402 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.95 125.08 21.53 Favored 'General case' 0 N--CA 1.476 0.828 2 O-C-N 137.605 9.316 . . . . 0.0 101.468 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.404 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.352 1.1 t -84.89 132.77 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 112.932 -3.507 . . . . 0.0 103.585 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.308 0.3 OUTLIER -71.94 -0.83 12.44 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 109.361 -3.563 . . . . 0.0 118.875 179.789 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.368 1.0 OUTLIER -37.76 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.106 -2.77 . . . . 0.0 109.192 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -91.93 133.45 35.68 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 115.327 -2.549 . . . . 0.0 109.395 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p 177.02 -169.13 0.06 Allowed 'General case' 0 C--N 1.353 0.746 0 O-C-N 127.65 3.094 . . . . 0.0 112.958 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.08 -91.76 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.624 0 O-C-N 125.276 1.61 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -117.58 -36.54 3.67 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 128.254 3.471 . . . . 0.0 111.609 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -143.14 0.15 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 127.222 2.826 . . . . 0.0 115.228 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.7 -22.31 34.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 116.289 -2.164 . . . . 0.0 107.387 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.666 HG13 HD13 ' A' ' 57' ' ' LEU . 13.9 tt 25.28 69.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.223 2 O-C-N 132.349 6.03 . . . . 0.0 111.1 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 57' ' ' LEU . 11.4 p-10 -65.56 155.3 36.16 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 109.639 -3.437 . . . . 0.0 105.148 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 6.3 t -123.09 117.61 52.19 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 1 O-C-N 129.544 4.277 . . . . 0.0 101.462 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.271 0.3 OUTLIER -118.23 162.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 114.663 -2.815 . . . . 0.0 114.831 179.843 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -177.2 -159.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 130.095 4.622 . . . . 0.0 111.448 -179.961 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.1 49.5 1.85 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 117.757 -1.577 . . . . 0.0 114.582 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 39.52 98.37 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 127.778 3.656 . . . . 0.0 115.28 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.01 52.93 1.56 Allowed Glycine 0 CA--C 1.545 1.957 1 N-CA-C 101.563 -4.615 . . . . 0.0 101.563 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -147.3 122.02 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 1 O-C-N 132.184 5.285 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.52 153.16 22.05 Favored 'General case' 0 CA--C 1.558 1.252 1 O-C-N 130.423 4.827 . . . . 0.0 106.968 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -168.42 124.33 0.99 Allowed 'General case' 0 N--CA 1.426 -1.664 1 O-C-N 129.136 4.023 . . . . 0.0 118.566 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.05 118.78 26.66 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -142.59 135.74 28.5 Favored 'General case' 0 C--O 1.21 -0.999 0 O-C-N 127.573 3.046 . . . . 0.0 112.558 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.35 141.88 28.15 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 128.354 3.534 . . . . 0.0 106.883 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -133.17 -67.47 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 128.758 3.786 . . . . 0.0 114.365 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.23 24.16 4.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 116.848 -1.549 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.12 16.01 5.64 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 125.867 1.979 . . . . 0.0 114.489 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.01 56.36 0.12 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 104.813 -3.315 . . . . 0.0 104.813 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -127.97 -87.82 0.56 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 129.876 3.927 . . . . 0.0 110.393 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 69.76 15.22 8.04 Favored 'General case' 0 CA--C 1.517 -0.317 1 O-C-N 129.465 4.228 . . . . 0.0 109.656 179.927 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.453 HD13 HG22 ' A' ' 61' ' ' THR . 10.9 mp -58.5 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 124.374 2.035 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.0 m -85.95 113.35 21.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 77' ' ' LYS . . . -144.79 -155.47 6.47 Favored Glycine 0 C--O 1.209 -1.445 1 C-N-CA 111.673 -5.06 . . . . 0.0 109.213 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.629 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.27 8.8 t -179.78 135.96 0.12 Allowed 'General case' 0 CA--C 1.496 -1.131 2 O-C-N 133.524 6.073 . . . . 0.0 111.917 -178.154 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 67.7 m95 -141.45 119.63 12.13 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 116.692 -3.755 . . . . 0.0 106.209 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 1.1 p -106.43 34.72 3.25 Favored 'General case' 0 N--CA 1.434 -1.246 2 O-C-N 134.543 7.402 . . . . 0.0 116.154 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.469 ' N ' HD21 ' A' ' 49' ' ' LEU 0.264 4.3 ttm -17.66 84.56 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 1 O-C-N 136.57 8.669 . . . . 0.0 108.058 -179.92 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.72 94.54 9.42 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 128.046 3.341 . . . . 0.0 107.074 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.11 -132.04 36.25 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -85.43 60.66 6.38 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 109.075 -3.563 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 158.83 44.18 Favored 'General case' 0 C--N 1.359 1.015 1 O-C-N 129.297 4.123 . . . . 0.0 111.149 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 74' ' ' LEU . 13.0 mt -141.93 59.59 1.48 Allowed 'General case' 0 C--O 1.209 -1.047 0 O-C-N 128.269 3.481 . . . . 0.0 111.459 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.15 101.66 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 1 CA-C-N 107.531 -4.395 . . . . 0.0 115.601 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.81 -144.99 4.36 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 103.3 -3.92 . . . . 0.0 103.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.519 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.3 0.1 OUTLIER -176.89 165.21 2.42 Favored 'General case' 0 C--O 1.201 -1.457 2 O-C-N 131.36 4.8 . . . . 0.0 112.092 -179.767 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 19.9 m-85 -144.38 166.1 26.06 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.572 ' HE2' ' CG ' ' A' ' 86' ' ' GLU 0.283 0.0 OUTLIER -174.28 152.43 1.8 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 108.966 -3.743 . . . . 0.0 117.221 179.327 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HG3' ' CB ' ' A' ' 85' ' ' LYS . 5.8 ptm180 -104.11 78.29 1.5 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 126.299 2.25 . . . . 0.0 107.252 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.473 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 5.6 m -22.12 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 1 O-C-N 133.331 6.644 . . . . 0.0 114.047 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -41.88 -47.02 4.17 Favored 'General case' 0 N--CA 1.451 -0.425 1 O-C-N 134.751 7.532 . . . . 0.0 107.637 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -112.0 -0.28 15.78 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 128.544 3.653 . . . . 0.0 113.304 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.26 34.63 88.62 Favored Glycine 0 CA--C 1.559 2.782 1 N-CA-C 101.361 -4.696 . . . . 0.0 101.361 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -66.02 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 3 O-C-N 132.615 5.538 . . . . 0.0 118.264 179.983 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.572 ' CG ' ' HE2' ' A' ' 79' ' ' LYS . 46.3 mt-10 116.87 133.52 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 1 O-C-N 132.455 6.097 . . . . 0.0 109.136 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.64 42.4 0.48 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 133.289 6.618 . . . . 0.0 110.003 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 86' ' ' GLU 0.256 4.7 mt -67.71 171.52 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.591 1 O-C-N 131.42 5.45 . . . . 0.0 105.004 -179.567 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.68 73.95 1.25 Allowed 'General case' 0 C--O 1.219 -0.545 1 O-C-N 133.66 6.85 . . . . 0.0 107.592 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.69 125.71 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.581 ' HG2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -166.58 153.88 9.46 Favored 'General case' 0 C--O 1.191 -1.982 1 C-N-CA 110.407 -4.517 . . . . 0.0 115.405 179.83 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 4.5 mt-10 -149.04 113.61 5.32 Favored 'General case' 0 N--CA 1.433 -1.324 1 O-C-N 131.018 5.199 . . . . 0.0 107.095 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 98' ' ' LEU 0.26 0.1 OUTLIER -45.5 112.99 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.668 1 O-C-N 130.325 4.766 . . . . 0.0 109.296 179.823 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -67.72 -89.58 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.097 0 O-C-N 128.734 3.771 . . . . 0.0 116.89 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 97' ' ' GLU . . . -135.92 100.33 0.34 Allowed Glycine 0 C--O 1.206 -1.638 0 C-N-CA 115.464 -3.255 . . . . 0.0 107.662 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 52.51 22.73 2.25 Favored 'General case' 0 N--CA 1.443 -0.809 2 O-C-N 130.639 4.376 . . . . 0.0 109.663 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.296 0.0 OUTLIER -168.8 134.1 1.65 Allowed 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 127.581 3.051 . . . . 0.0 109.022 179.283 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 91' ' ' ARG . 2.6 tt -97.67 142.12 29.86 Favored 'General case' 0 N--CA 1.437 -1.095 1 O-C-N 133.598 6.811 . . . . 0.0 115.863 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 100' ' ' GLN . 29.0 mt -83.19 -84.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.518 0 O-C-N 128.945 3.903 . . . . 0.0 106.284 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.476 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.4 tt0 92.95 107.67 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.274 1 O-C-N 131.024 5.203 . . . . 0.0 100.833 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.518 HG21 ' OE2' ' A' ' 108' ' ' GLU . 17.2 p -77.76 -38.7 46.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 128.406 3.566 . . . . 0.0 119.462 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 61.81 53.04 3.26 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 111.569 -2.56 . . . . 0.0 105.583 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 m -52.42 117.18 2.67 Favored 'General case' 0 C--N 1.36 1.023 1 O-C-N 133.038 6.461 . . . . 0.0 100.625 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 5.7 t80 -144.58 138.04 27.18 Favored 'General case' 0 CA--C 1.49 -1.349 1 O-C-N 130.13 4.644 . . . . 0.0 112.604 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.51 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 1.0 OUTLIER 37.41 35.13 0.05 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.841 -1.981 . . . . 0.0 115.952 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.58 79.64 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 116.76 -2.638 . . . . 0.0 117.305 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.81 -19.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.518 ' OE2' HG21 ' A' ' 101' ' ' THR . 9.4 mt-10 66.48 173.08 0.24 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 128.33 3.519 . . . . 0.0 106.951 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.328 . . -174.8 81.43 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 117.234 -1.787 . . . . 0.0 114.166 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -95.5 120.86 36.48 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 129.729 4.393 . . . . 0.0 109.084 -179.931 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -92.85 -34.12 13.96 Favored 'General case' 0 CA--C 1.555 1.16 1 O-C-N 129.974 4.546 . . . . 0.0 104.164 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 83.5 118.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.126 1 O-C-N 130.25 4.719 . . . . 0.0 108.03 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 21' ' ' LEU . 37.0 m-85 -141.8 -146.67 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 1 O-C-N 129.549 4.28 . . . . 0.0 106.511 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -170.31 -145.31 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.024 1 O-C-N 131.104 5.253 . . . . 0.0 111.668 -179.739 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 17.4 tttt -129.03 -58.51 1.14 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.232 1.413 . . . . 0.0 111.979 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.411 -2.384 0 CA-C-N 111.027 -2.806 . . . . 0.0 113.837 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.588 ' HZ ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER 159.97 -36.49 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 O-C-N 128.363 3.539 . . . . 0.0 105.051 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' ILE 0.252 5.0 p-10 -34.48 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.874 1 O-C-N 130.443 4.839 . . . . 0.0 117.735 179.493 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 169.57 -179.2 42.2 Favored Glycine 0 N--CA 1.477 1.43 1 C-N-CA 112.231 -4.795 . . . . 0.0 104.169 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 24' ' ' THR 0.305 3.3 p -88.4 173.08 8.92 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 113.712 -3.195 . . . . 0.0 108.168 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.633 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 64.6 m95 -152.14 117.69 5.35 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 89.3 171.58 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 22' ' ' LYS 0.274 0.5 OUTLIER 47.77 92.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.479 -1.775 3 CA-C-O 135.886 7.517 . . . . 0.0 120.305 174.864 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.37 -153.36 0.04 OUTLIER 'General case' 0 C--N 1.373 1.599 1 CA-C-N 107.656 -4.338 . . . . 0.0 108.352 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.14 154.41 40.08 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 119.69 -1.881 . . . . 0.0 111.996 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -96.9 -38.44 9.83 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 126.533 2.396 . . . . 0.0 111.459 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.63 -167.33 1.36 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.092 -1.432 . . . . 0.0 108.841 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -117.33 52.74 0.95 Allowed 'General case' 0 C--O 1.215 -0.739 1 O-C-N 130.222 4.702 . . . . 0.0 107.168 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' CG ' ' N ' ' A' ' 15' ' ' SER . 36.7 t80 -169.43 160.08 9.02 Favored 'General case' 0 C--O 1.217 -0.627 1 CA-C-N 108.355 -4.021 . . . . 0.0 106.477 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -133.56 125.45 28.86 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.279 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.8 -95.68 2.07 Favored Glycine 0 CA--C 1.547 2.075 0 O-C-N 127.058 2.724 . . . . 0.0 111.595 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.55 136.3 37.49 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 111.213 -2.493 . . . . 0.0 105.86 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -153.6 176.27 12.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 125.368 1.668 . . . . 0.0 109.063 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.84 76.43 0.8 Allowed 'General case' 0 C--O 1.207 -1.154 0 O-C-N 128.762 3.789 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -104.44 -155.41 0.53 Allowed 'General case' 0 C--N 1.357 0.91 1 O-C-N 129.543 4.277 . . . . 0.0 109.307 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -103.06 -169.87 1.71 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.321 7.9 mttt 147.09 141.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.53 2 O-C-N 132.914 6.384 . . . . 0.0 106.576 177.423 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 25' ' ' ILE . 5.9 mt -96.5 161.57 13.85 Favored 'General case' 0 CA--C 1.565 1.552 3 O-C-N 132.692 6.245 . . . . 0.0 96.686 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.561 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 2.7 m 172.09 83.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 1 O-C-N 129.308 4.13 . . . . 0.0 101.336 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.663 HG23 ' H ' ' A' ' 33' ' ' THR . 3.7 mp -106.13 116.34 49.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 108.688 -3.869 . . . . 0.0 112.833 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.9 m -162.14 77.2 0.49 Allowed 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 127.134 2.771 . . . . 0.0 108.506 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.618 ' HB2' ' C ' ' A' ' 31' ' ' LYS . 8.1 mm-40 -68.11 -93.07 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 1 C-N-CA 110.998 -4.281 . . . . 0.0 113.428 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -127.2 -7.86 5.9 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 113.396 -3.192 . . . . 0.0 106.725 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.82 -11.27 29.84 Favored Glycine 0 CA--C 1.538 1.493 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.9 -30.4 2.03 Favored 'General case' 0 N--CA 1.411 -2.418 1 CA-C-O 111.649 -4.024 . . . . 0.0 111.547 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.618 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 43.5 mttt -103.86 -165.94 1.21 Allowed 'General case' 0 C--O 1.246 0.897 1 N-CA-C 97.725 -4.917 . . . . 0.0 97.725 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.631 ' HD1' HG22 ' A' ' 25' ' ' ILE . 25.6 m-85 -167.86 156.63 9.38 Favored 'General case' 0 C--O 1.203 -1.389 1 N-CA-C 97.355 -5.054 . . . . 0.0 97.355 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.663 ' H ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -143.82 128.99 18.73 Favored 'General case' 0 N--CA 1.479 1.015 4 O-C-N 136.662 8.726 . . . . 0.0 98.079 179.836 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.431 4.0 t -88.15 121.46 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 1 N-CA-C 99.303 -4.332 . . . . 0.0 99.303 179.9 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.376 11.2 tttt -56.09 -18.99 11.29 Favored 'General case' 0 C--N 1.37 1.489 0 CA-C-N 110.281 -3.145 . . . . 0.0 119.252 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HB2' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER 3.58 67.87 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 109.774 -3.375 . . . . 0.0 111.342 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' HA ' ' A' ' 21' ' ' LEU . 19.1 m -70.45 127.9 34.33 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 116.816 -1.954 . . . . 0.0 113.071 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -126.38 -168.49 1.87 Allowed 'General case' 0 C--N 1.369 1.417 0 O-C-N 125.707 1.879 . . . . 0.0 112.263 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.25 -25.52 58.13 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 125.507 2.575 . . . . 0.0 104.722 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' O ' HD12 ' A' ' 43' ' ' ILE . 13.3 m-85 -90.32 69.24 7.02 Favored 'General case' 0 N--CA 1.437 -1.093 1 CA-C-N 106.653 -4.794 . . . . 0.0 107.143 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.93 177.58 0.1 Allowed 'General case' 0 N--CA 1.436 -1.172 1 O-C-N 129.328 4.142 . . . . 0.0 114.677 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 43' ' ' ILE . 12.7 m-80 -71.5 -44.62 64.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 111.776 -3.969 . . . . 0.0 102.539 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER 64.61 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.512 3 CA-C-O 130.08 4.752 . . . . 0.0 107.074 -179.798 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.02 138.4 42.17 Favored 'General case' 0 C--N 1.373 1.611 1 CA-C-N 106.395 -4.911 . . . . 0.0 108.26 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.36 86.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 1 N-CA-C 99.782 -4.155 . . . . 0.0 99.782 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.8 163.04 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 1 C-N-CA 111.003 -4.279 . . . . 0.0 113.311 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.8 p90 -161.94 149.68 14.58 Favored 'General case' 0 N--CA 1.433 -1.311 1 O-C-N 132.888 6.367 . . . . 0.0 111.06 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.02 51.55 1.83 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 113.056 -3.458 . . . . 0.0 115.554 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.711 HD21 ' CB ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 47.75 89.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 2 O-C-N 132.714 6.259 . . . . 0.0 114.585 -179.711 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.28 59.1 2.78 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.74 -32.2 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 1 O-C-N 133.915 6.303 . . . . 0.0 115.225 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.06 138.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 1 O-C-N 131.421 5.451 . . . . 0.0 109.049 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 p90 179.31 145.96 0.18 Allowed 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 108.668 -3.878 . . . . 0.0 116.505 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -109.45 137.31 47.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.474 -3.899 . . . . 0.0 100.474 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -147.69 100.79 3.27 Favored 'General case' 0 C--O 1.21 -1.001 1 O-C-N 129.295 4.122 . . . . 0.0 114.06 179.848 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 94.7 1.87 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 112.775 -3.57 . . . . 0.0 101.484 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' TYR . 5.7 tp -82.55 -86.35 0.1 Allowed 'General case' 0 CA--C 1.507 -0.709 1 O-C-N 131.735 5.647 . . . . 0.0 116.117 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -64.57 10.11 0.07 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 115.825 -2.036 . . . . 0.0 116.494 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 9.4 5.59 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 120.504 1.502 . . . . 0.0 111.122 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.09 46.26 0.27 Allowed Glycine 0 CA--C 1.548 2.128 0 N-CA-C 105.178 -3.169 . . . . 0.0 105.178 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HD13 ' A' ' 63' ' ' LEU . 1.7 p -126.59 -88.93 0.56 Allowed 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 132.155 5.268 . . . . 0.0 114.537 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 62.14 71.95 0.52 Allowed 'General case' 0 C--O 1.217 -0.654 0 O-C-N 127.595 3.06 . . . . 0.0 106.784 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.562 HD13 ' HB ' ' A' ' 61' ' ' THR . 11.1 mp -120.57 76.08 1.17 Allowed 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 128.518 3.636 . . . . 0.0 113.92 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 92.9 m -48.44 111.84 0.51 Allowed 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.89 -171.38 12.32 Favored Glycine 0 CA--C 1.538 1.469 2 C-N-CA 111.026 -5.368 . . . . 0.0 107.029 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.603 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 5.9 t 176.53 128.96 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.218 2 O-C-N 133.611 6.124 . . . . 0.0 111.368 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 52.1 m95 -137.73 117.83 13.48 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 117.174 -3.454 . . . . 0.0 106.347 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD22 ' A' ' 49' ' ' LEU . 6.9 p -96.6 33.64 1.79 Allowed 'General case' 0 N--CA 1.422 -1.87 2 O-C-N 130.703 5.002 . . . . 0.0 116.706 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.711 ' CB ' HD21 ' A' ' 49' ' ' LEU . 2.2 ttt -18.93 106.19 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.814 1 O-C-N 136.821 8.825 . . . . 0.0 107.523 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.22 -44.72 87.38 Favored 'General case' 0 CA--C 1.505 -0.786 1 O-C-N 129.684 4.365 . . . . 0.0 108.673 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.83 -39.35 0.18 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 110.46 -3.064 . . . . 0.0 107.492 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.7 p30 -142.07 30.53 1.61 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 129.795 3.879 . . . . 0.0 108.748 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 5.3 mttt -135.61 157.38 47.02 Favored 'General case' 0 N--CA 1.453 -0.315 1 O-C-N 131.032 5.207 . . . . 0.0 111.604 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 74' ' ' LEU . 7.3 mt -134.91 60.11 1.71 Allowed 'General case' 0 C--O 1.214 -0.775 0 O-C-N 127.879 3.237 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -85.31 93.27 3.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 1 CA-C-N 106.544 -4.843 . . . . 0.0 114.044 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -159.08 -156.64 8.14 Favored Glycine 0 C--O 1.207 -1.585 2 CA-C-N 107.599 -4.364 . . . . 0.0 102.955 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.331 21.8 ttpt -170.54 123.98 0.68 Allowed 'General case' 0 C--N 1.37 1.476 1 C-N-CA 108.813 -5.155 . . . . 0.0 112.779 179.934 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 28.0 m-85 -106.09 162.46 13.6 Favored 'General case' 0 C--O 1.2 -1.504 2 N-CA-C 99.831 -4.137 . . . . 0.0 99.831 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.2 OUTLIER -168.23 130.9 1.48 Allowed 'General case' 0 CA--C 1.495 -1.152 1 CA-C-N 105.594 -5.275 . . . . 0.0 113.737 -178.716 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 11.2 ttp180 -82.41 86.72 6.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 125.007 1.442 . . . . 0.0 110.775 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.39 -33.75 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 O-C-N 128.044 3.34 . . . . 0.0 110.274 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -56.91 -46.57 81.9 Favored 'General case' 0 C--O 1.248 1.002 1 O-C-N 132.36 6.038 . . . . 0.0 108.825 -179.754 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.34 -5.7 17.63 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 113.403 -3.319 . . . . 0.0 112.559 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 75.91 41.54 27.67 Favored Glycine 0 CA--C 1.557 2.677 2 C-N-CA 110.843 -5.456 . . . . 0.0 100.485 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 8.6 tppt? -81.75 -81.44 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 2 CA-C-N 105.75 -5.225 . . . . 0.0 121.239 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 7.0 mm-40 91.04 121.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.576 4.922 . . . . 0.0 108.084 -177.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 63' ' ' LEU . 1.4 pt? -153.45 48.48 0.68 Allowed 'General case' 0 C--O 1.194 -1.836 1 O-C-N 132.435 6.084 . . . . 0.0 110.292 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.712 HG22 HG23 ' A' ' 90' ' ' VAL . 30.8 mt -52.33 141.99 5.5 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.552 2 O-C-N 130.248 4.717 . . . . 0.0 104.87 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.65 59.03 0.7 Allowed 'General case' 0 C--O 1.213 -0.832 1 O-C-N 130.75 5.032 . . . . 0.0 105.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 88' ' ' ILE . 13.3 t -64.02 102.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 O-C-N 127.848 3.218 . . . . 0.0 110.842 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.575 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -140.63 -174.03 3.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 115.408 -2.517 . . . . 0.0 110.554 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 91' ' ' ARG 0.299 0.0 OUTLIER 176.9 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 132.386 6.054 . . . . 0.0 105.822 -178.858 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -39.86 100.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.05 1 O-C-N 131.673 5.608 . . . . 0.0 110.001 179.247 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 m -85.59 -69.07 0.68 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 108.838 -3.801 . . . . 0.0 117.723 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.06 -106.44 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 CA-C-O 126.279 3.155 . . . . 0.0 105.705 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.33 52.61 1.55 Allowed 'General case' 0 CA--C 1.54 0.586 1 CA-C-N 108.009 -4.095 . . . . 0.0 105.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.88 ' O ' HD13 ' A' ' 93' ' ' ILE 0.318 0.0 OUTLIER -159.81 -118.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 1 O-C-N 130.399 4.812 . . . . 0.0 106.272 179.546 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 100' ' ' GLN . 9.9 tt 155.88 103.56 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.196 1 O-C-N 129.849 4.468 . . . . 0.0 109.442 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -48.49 -72.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.41 -2.472 1 O-C-N 130.903 5.127 . . . . 0.0 107.483 -179.876 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.721 ' HB2' HD21 ' A' ' 98' ' ' LEU . 7.6 tp60 79.06 100.71 0.06 Allowed 'General case' 0 CA--C 1.562 1.428 1 O-C-N 134.737 7.523 . . . . 0.0 100.428 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.031 HG23 ' HG3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -105.94 119.77 40.04 Favored 'General case' 0 N--CA 1.411 -2.41 2 O-C-N 134.04 7.088 . . . . 0.0 114.346 179.752 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.66 81.93 8.65 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ILE . 1.5 m -65.94 98.65 0.43 Allowed 'General case' 0 C--N 1.361 1.067 1 O-C-N 132.359 6.037 . . . . 0.0 101.332 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -107.62 120.29 41.8 Favored 'General case' 0 N--CA 1.435 -1.19 2 O-C-N 129.718 4.386 . . . . 0.0 113.359 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 4.88 64.65 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 126.937 2.648 . . . . 0.0 117.601 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.89 13.29 29.88 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 118.39 -1.862 . . . . 0.0 116.347 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.61 148.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-O 116.618 -1.658 . . . . 0.0 115.197 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -117.59 67.46 0.75 Allowed 'General case' 0 C--N 1.362 1.129 1 O-C-N 129.724 4.39 . . . . 0.0 106.586 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.411 . . -99.94 97.16 8.07 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 127.672 3.108 . . . . 0.0 111.582 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 1.031 ' HG3' HG23 ' A' ' 101' ' ' THR . 2.1 mtmt -89.98 176.51 6.77 Favored 'General case' 0 N--CA 1.419 -1.982 2 O-C-N 135.117 7.76 . . . . 0.0 110.074 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -135.24 117.32 15.38 Favored 'General case' 0 CA--C 1.561 1.39 3 O-C-N 131.975 5.797 . . . . 0.0 98.991 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.14 126.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 1 O-C-N 129.495 4.247 . . . . 0.0 112.468 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 31.1 m-85 -140.19 -149.24 0.27 Allowed 'General case' 0 N--CA 1.445 -0.72 1 O-C-N 129.851 4.469 . . . . 0.0 107.858 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.18 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 1 O-C-N 131.114 5.259 . . . . 0.0 112.257 -179.147 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.633 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 28.3 tttt -123.04 -130.53 0.27 Allowed 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.721 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.264 0.3 OUTLIER . . . . . 0 C--O 1.21 -0.985 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.069 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -31.71 14.85 Favored 'General case' 0 CA--C 1.55 0.966 1 O-C-N 129.331 4.145 . . . . 0.0 107.897 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.36 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 128.827 3.83 . . . . 0.0 116.8 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.97 176.35 36.56 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 114.853 -3.546 . . . . 0.0 105.79 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.538 HG22 ' OG1' ' A' ' 24' ' ' THR 0.392 0.2 OUTLIER -93.01 160.89 14.67 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 111.898 -3.921 . . . . 0.0 109.747 -179.605 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.643 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 12.8 m95 -127.61 161.29 29.19 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-O 113.033 -3.365 . . . . 0.0 111.095 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 10.6 mtmt 46.41 -179.59 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 8' ' ' VAL 0.328 0.9 OUTLIER 1.09 117.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.458 3 CA-C-O 133.024 6.154 . . . . 0.0 119.239 174.984 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -145.38 35.55 1.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.941 -3.754 . . . . 0.0 109.427 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -171.75 0.71 Allowed 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.857 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.73 -147.76 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.923 1.389 . . . . 0.0 107.677 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.48 120.18 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 O-C-N 125.231 1.582 . . . . 0.0 110.345 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -111.65 -60.95 1.78 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-O 126.564 3.078 . . . . 0.0 108.061 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.97 160.37 30.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 110.531 -3.031 . . . . 0.0 110.729 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 59.87 30.85 20.37 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 126.129 2.143 . . . . 0.0 107.323 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 17' ' ' ALA . . . -92.32 -63.57 1.13 Allowed Glycine 0 C--N 1.347 1.156 0 O-C-N 124.904 1.378 . . . . 0.0 111.981 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 16' ' ' GLY . . . 173.9 -63.12 0.01 OUTLIER 'General case' 0 C--O 1.247 0.966 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.56 134.76 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.09 -172.22 2.51 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 127.026 2.704 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.696 ' C ' HD23 ' A' ' 21' ' ' LEU . 20.2 m120 -120.97 -110.73 0.33 Allowed 'General case' 0 C--O 1.217 -0.626 0 O-C-N 128.617 3.698 . . . . 0.0 112.213 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -139.72 -169.3 2.68 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.395 0.0 OUTLIER -174.86 134.55 0.36 Allowed 'General case' 0 CA--C 1.566 1.569 1 O-C-N 132.379 6.049 . . . . 0.0 103.891 -179.962 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 9.1 mt -97.29 158.22 15.57 Favored 'General case' 0 CA--C 1.555 1.147 3 O-C-N 130.705 5.003 . . . . 0.0 97.801 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.4 m 173.18 94.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 2 CA-C-O 130.402 4.906 . . . . 0.0 102.455 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 32' ' ' PHE . 3.5 mp -106.89 138.41 32.82 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 109.429 -3.532 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -174.56 73.0 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.168 2.792 . . . . 0.0 108.468 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.7 mm-40 -92.17 -95.0 0.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 113.367 -3.333 . . . . 0.0 112.295 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.47 1.82 0.53 Allowed 'General case' 0 C--O 1.251 1.138 0 O-C-N 127.982 3.302 . . . . 0.0 107.797 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.89 -33.15 5.76 Favored Glycine 0 CA--C 1.539 1.558 1 N-CA-C 101.552 -4.619 . . . . 0.0 101.552 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -98.48 -36.99 9.76 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-O 112.723 -3.513 . . . . 0.0 112.188 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' GLN . 72.5 mttt -111.37 173.92 6.11 Favored 'General case' 0 C--O 1.247 0.923 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.815 ' HD2' HG21 ' A' ' 25' ' ' ILE 0.265 2.0 p90 -167.8 68.66 0.08 Allowed 'General case' 0 C--O 1.187 -2.222 1 C-N-CA 110.836 -4.346 . . . . 0.0 100.757 178.638 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.01 123.3 13.13 Favored 'General case' 0 CA--C 1.502 -0.894 2 CA-C-N 105.777 -5.192 . . . . 0.0 103.947 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.413 0.5 OUTLIER -91.41 142.74 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 101.584 -3.487 . . . . 0.0 101.584 -179.753 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.279 6.2 tttt -77.68 1.54 19.58 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 110.629 -2.987 . . . . 0.0 118.603 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 34' ' ' VAL 0.252 0.0 OUTLIER -36.43 99.42 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 110.597 -3.002 . . . . 0.0 109.516 -179.962 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.49 164.43 12.22 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 128.29 3.494 . . . . 0.0 110.095 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -171.19 3.04 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 125.237 1.586 . . . . 0.0 112.694 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -76.05 -7.75 55.4 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.962 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 33.9 m-85 -80.94 -71.66 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.18 -2.736 . . . . 0.0 110.396 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -150.78 -172.31 4.16 Favored 'General case' 0 N--CA 1.433 -1.286 1 O-C-N 131.891 5.744 . . . . 0.0 112.443 179.871 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -23.46 59.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 113.753 -3.179 . . . . 0.0 104.25 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 57' ' ' LEU . 7.4 tp 28.18 80.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.122 2 O-C-N 132.839 6.337 . . . . 0.0 110.676 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.35 120.52 21.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 109.701 -3.408 . . . . 0.0 105.828 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 57' ' ' LEU . 98.2 t -91.12 97.9 7.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 1 O-C-N 132.254 5.971 . . . . 0.0 102.779 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.316 8.9 p -99.98 158.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 1 O-C-N 129.161 4.038 . . . . 0.0 115.226 -179.967 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -178.8 -160.45 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 129.543 4.277 . . . . 0.0 112.055 -179.64 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' CG ' ' HG2' ' A' ' 31' ' ' LYS 0.294 22.9 mt-10 -142.77 63.03 1.4 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.278 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 69' ' ' MET . 19.5 mt 54.15 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.217 0 O-C-N 128.159 3.412 . . . . 0.0 114.626 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.52 82.44 0.94 Allowed Glycine 0 C--O 1.197 -2.2 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.95 111.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 O-C-N 132.747 5.616 . . . . 0.0 112.897 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 6.5 t70 -91.87 163.34 14.07 Favored 'General case' 0 C--N 1.365 1.266 1 O-C-N 129.35 4.156 . . . . 0.0 106.797 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -173.32 143.64 1.11 Allowed 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 114.003 -3.079 . . . . 0.0 116.209 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.52 91.02 4.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.68 147.57 28.37 Favored 'General case' 0 C--O 1.208 -1.094 1 O-C-N 130.192 4.682 . . . . 0.0 112.772 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.61 92.98 4.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 128.16 3.413 . . . . 0.0 103.539 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.68 HD11 HG22 ' A' ' 45' ' ' VAL . 2.7 tp -47.36 -86.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 1 O-C-N 130.75 5.031 . . . . 0.0 109.998 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 -135.85 0.02 OUTLIER 'General case' 0 C--O 1.248 1.001 0 C-N-CA 116.875 -1.93 . . . . 0.0 109.723 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.46 -37.02 82.3 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.521 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.77 -81.71 0.82 Allowed Glycine 0 CA--C 1.545 1.909 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HD13 ' A' ' 63' ' ' LEU . 1.4 m 35.7 77.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 1 O-C-N 131.089 4.641 . . . . 0.0 113.426 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 63' ' ' LEU . 1.9 tm-20 -81.99 139.93 34.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 115.31 -2.556 . . . . 0.0 104.36 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -155.73 44.21 0.44 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 129.264 4.102 . . . . 0.0 111.695 -179.719 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -43.03 106.71 0.07 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 111.866 -2.424 . . . . 0.0 109.525 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -173.48 -161.98 24.63 Favored Glycine 0 N--CA 1.479 1.502 1 C-N-CA 111.133 -5.317 . . . . 0.0 107.474 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.49 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 8.3 t -154.36 142.04 19.92 Favored 'General case' 0 C--O 1.247 0.953 0 O-C-N 129.45 3.677 . . . . 0.0 116.585 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.732 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 6.1 m95 -122.28 96.76 5.17 Favored 'General case' 0 C--O 1.196 -1.713 0 CA-C-O 113.192 -3.289 . . . . 0.0 102.595 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -105.72 75.58 1.14 Allowed 'General case' 0 N--CA 1.438 -1.058 2 O-C-N 139.426 10.454 . . . . 0.0 114.404 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.77 ' HB3' HD22 ' A' ' 49' ' ' LEU 0.262 30.7 ttp -46.33 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 2 O-C-N 132.991 6.432 . . . . 0.0 103.778 179.963 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.74 -46.52 90.12 Favored 'General case' 0 C--O 1.211 -0.948 1 O-C-N 132.094 5.871 . . . . 0.0 104.831 -179.874 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.17 -76.83 0.04 OUTLIER Glycine 0 CA--C 1.549 2.17 0 N-CA-C 105.326 -3.11 . . . . 0.0 105.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -114.34 9.98 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.166 2.921 . . . . 0.0 107.89 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HB3' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.28 -178.97 3.8 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 128.945 3.903 . . . . 0.0 108.32 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.751 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.2 mt -152.69 43.06 0.64 Allowed 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 126.853 2.596 . . . . 0.0 112.772 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 73' ' ' LYS . 15.3 t -69.52 140.1 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 1 CA-C-N 107.85 -4.25 . . . . 0.0 117.525 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.8 -142.24 7.55 Favored Glycine 0 CA--C 1.547 2.059 3 CA-C-N 107.232 -4.531 . . . . 0.0 102.545 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' CB ' HG12 ' A' ' 88' ' ' ILE 0.369 8.0 tttt 175.71 125.29 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.408 1 O-C-N 132.135 5.256 . . . . 0.0 112.517 -179.75 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.732 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -123.0 156.37 34.93 Favored 'General case' 0 C--O 1.204 -1.325 3 O-C-N 130.323 4.764 . . . . 0.0 102.073 -179.151 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CE ' ' HB2' ' A' ' 86' ' ' GLU 0.335 0.0 OUTLIER -160.68 152.03 19.25 Favored 'General case' 0 N--CA 1.424 -1.766 1 CA-C-N 107.282 -4.508 . . . . 0.0 114.664 179.989 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -105.14 99.59 9.2 Favored 'General case' 0 CA--C 1.556 1.173 0 O-C-N 128.65 3.719 . . . . 0.0 108.344 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -43.46 -29.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 1 O-C-N 129.886 4.491 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -39.75 -56.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.505 1 O-C-N 133.537 6.773 . . . . 0.0 105.444 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -122.43 8.56 9.62 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 129.069 3.981 . . . . 0.0 113.438 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.78 50.84 56.43 Favored Glycine 0 CA--C 1.55 2.26 1 N-CA-C 101.83 -4.508 . . . . 0.0 101.83 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' NZ ' ' NE ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -82.78 -64.14 1.23 Allowed 'General case' 0 N--CA 1.413 -2.284 1 O-C-N 131.813 5.067 . . . . 0.0 120.188 -179.355 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.605 ' OE2' HG22 ' A' ' 103' ' ' THR . 0.6 OUTLIER 81.35 137.66 0.06 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 131.953 5.783 . . . . 0.0 113.415 -177.656 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 87' ' ' LEU 0.314 0.2 OUTLIER -155.88 34.96 0.35 Allowed 'General case' 0 C--O 1.201 -1.481 1 O-C-N 133.542 6.776 . . . . 0.0 113.02 177.979 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 103' ' ' THR . 75.6 mt -46.54 114.71 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.562 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.584 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 69.7 10.67 Favored 'General case' 0 C--O 1.196 -1.758 1 O-C-N 130.659 4.974 . . . . 0.0 106.611 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.54 127.23 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 1 O-C-N 133.109 6.506 . . . . 0.0 100.916 178.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.893 ' CD ' HD21 ' A' ' 98' ' ' LEU . 2.3 ttp180 -158.17 161.75 37.88 Favored 'General case' 0 C--O 1.191 -2.02 1 C-N-CA 109.702 -4.799 . . . . 0.0 112.876 -177.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.6 145.99 2.11 Favored 'General case' 0 C--N 1.35 0.593 1 O-C-N 131.274 5.359 . . . . 0.0 106.411 179.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 98' ' ' LEU . 1.1 mm -53.68 111.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 1 O-C-N 130.141 4.651 . . . . 0.0 110.695 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.6 ' CB ' HD13 ' A' ' 99' ' ' ILE . 1.5 t -51.97 -61.46 2.25 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 128.253 3.47 . . . . 0.0 116.025 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.48 -94.73 0.12 Allowed Glycine 0 C--O 1.206 -1.626 1 N-CA-C 102.987 -4.045 . . . . 0.0 102.987 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -102.35 32.85 3.36 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 111.027 -2.586 . . . . 0.0 107.905 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.84 175.05 0.87 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 128.669 3.731 . . . . 0.0 105.217 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 ' CD ' ' A' ' 91' ' ' ARG . 1.3 tt -109.41 157.48 18.88 Favored 'General case' 0 C--O 1.201 -1.457 1 O-C-N 132.326 6.016 . . . . 0.0 110.034 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.717 HG22 ' N ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -116.09 -62.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 1 O-C-N 129.433 4.208 . . . . 0.0 109.608 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.717 ' N ' HG22 ' A' ' 99' ' ' ILE . 23.7 mt-30 83.09 134.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.469 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.0 m -141.88 101.15 3.89 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.989 5.18 . . . . 0.0 112.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -88.49 95.33 10.18 Favored 'General case' 0 C--O 1.203 -1.348 1 O-C-N 129.673 4.358 . . . . 0.0 107.205 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.605 HG22 ' OE2' ' A' ' 86' ' ' GLU . 2.5 m -62.32 120.03 10.2 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 178.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -170.14 119.68 0.6 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 110.946 -2.843 . . . . 0.0 113.386 -179.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 107' ' ' VAL . 5.8 mt-10 40.66 -81.16 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.635 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.497 ' C ' HG23 ' A' ' 107' ' ' VAL . . . -61.01 -18.52 54.81 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.941 -3.028 . . . . 0.0 110.94 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 105' ' ' GLU . 2.2 t 68.22 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 46.18 79.86 0.05 Allowed 'General case' 0 C--N 1.358 0.946 1 O-C-N 129.354 4.159 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.346 . . -117.99 74.64 0.95 Allowed 'General case' 0 C--O 1.199 -1.568 0 O-C-N 126.595 2.434 . . . . 0.0 108.585 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -84.04 153.09 24.02 Favored 'General case' 0 N--CA 1.416 -2.153 1 O-C-N 131.64 5.588 . . . . 0.0 111.665 -179.104 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -120.64 -179.88 4.12 Favored 'General case' 0 CA--C 1.558 1.274 1 CA-C-N 107.964 -4.198 . . . . 0.0 104.758 -179.895 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.461 HD12 ' C ' ' A' ' 111' ' ' ARG . 1.8 mp -131.08 108.45 15.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 1 O-C-N 129.498 4.249 . . . . 0.0 112.933 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.707 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -119.69 179.66 4.16 Favored 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.951 5.157 . . . . 0.0 106.676 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.7 126.02 0.08 Allowed 'General case' 0 N--CA 1.429 -1.477 2 O-C-N 132.3 6.0 . . . . 0.0 113.577 -179.758 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 18.0 tttt -38.09 -57.07 1.1 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 110.014 -3.266 . . . . 0.0 116.463 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.423 -1.797 0 O-C-N 127.902 3.251 . . . . 0.0 111.371 179.872 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.135 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.432 ' HE1' HG21 ' A' ' 93' ' ' ILE . 2.6 m-85 -76.87 -32.87 57.78 Favored 'General case' 0 CA--C 1.56 1.357 1 O-C-N 131.012 5.195 . . . . 0.0 105.929 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -40.93 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.418 -2.035 1 O-C-N 129.633 4.333 . . . . 0.0 116.472 -179.897 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' PHE . . . 164.46 147.43 5.1 Favored Glycine 0 C--N 1.339 0.701 1 C-N-CA 112.22 -4.8 . . . . 0.0 106.612 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 11.1 p -61.46 166.2 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 115.729 -2.389 . . . . 0.0 108.564 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 115' ' ' LYS 0.25 73.4 m95 -139.46 158.74 43.63 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 111.758 -3.972 . . . . 0.0 110.43 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 11.4 mtmt 51.02 -178.25 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.837 0 O-C-N 128.571 3.67 . . . . 0.0 117.141 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 21' ' ' LEU 0.308 1.2 t 21.77 112.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.534 3 O-C-N 134.303 7.252 . . . . 0.0 114.78 174.931 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.16 75.92 2.62 Favored 'General case' 0 C--N 1.368 1.412 1 O-C-N 116.047 -4.158 . . . . 0.0 110.035 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -169.04 77.69 0.11 Allowed 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.993 -1.067 . . . . 0.0 111.57 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.406 ' C ' ' HG3' ' A' ' 12' ' ' GLU . 3.5 p-10 -121.2 -18.8 7.31 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 115.914 -1.994 . . . . 0.0 113.371 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 36.35 75.35 0.06 Allowed 'General case' 0 C--O 1.245 0.833 0 O-C-N 127.775 3.172 . . . . 0.0 112.205 179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.41 -161.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 O-C-N 128.138 3.399 . . . . 0.0 108.538 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -86.92 85.87 7.29 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.706 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.1 22.89 0.25 Allowed 'General case' 0 C--N 1.363 1.168 0 C-N-CA 115.494 -2.482 . . . . 0.0 109.923 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.03 146.18 18.3 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.16 -42.94 2.45 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 116.445 -1.74 . . . . 0.0 108.897 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.26 -66.91 0.87 Allowed 'General case' 0 C--N 1.356 0.875 0 O-C-N 124.726 1.266 . . . . 0.0 111.65 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -179.47 0.15 Allowed 'General case' 0 C--O 1.221 -0.433 0 O-C-N 127.918 3.261 . . . . 0.0 110.521 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -98.42 -74.62 0.58 Allowed 'General case' 0 C--N 1.367 1.363 0 O-C-N 126.031 2.082 . . . . 0.0 112.098 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -167.65 170.68 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.401 0.0 OUTLIER 167.98 153.97 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.626 1 O-C-N 132.317 6.01 . . . . 0.0 100.668 -179.66 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD23 ' C ' ' A' ' 35' ' ' LYS . 8.0 mt -112.59 170.33 8.26 Favored 'General case' 0 CA--C 1.551 0.99 1 O-C-N 133.266 6.604 . . . . 0.0 101.028 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 25' ' ' ILE . 1.6 m -156.14 -81.6 0.07 Allowed 'General case' 0 C--O 1.199 -1.577 1 O-C-N 130.218 4.699 . . . . 0.0 106.264 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.626 ' N ' HG22 ' A' ' 24' ' ' THR . 2.6 mp 70.91 129.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.385 0 CA-C-N 109.142 -3.663 . . . . 0.0 109.733 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.0 m -162.55 80.19 0.51 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 32' ' ' PHE . 8.6 pm0 -60.1 148.34 36.23 Favored 'General case' 0 C--N 1.357 0.918 1 CA-C-N 106.08 -5.055 . . . . 0.0 115.246 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.83 86.42 2.5 Favored 'General case' 0 CA--C 1.555 1.155 0 O-C-N 128.29 3.494 . . . . 0.0 103.412 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.13 -128.91 8.7 Favored Glycine 0 CA--C 1.552 2.365 2 C-N-CA 110.839 -5.458 . . . . 0.0 102.821 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -99.56 55.95 0.98 Allowed 'General case' 0 N--CA 1.437 -1.111 1 O-C-N 131.083 4.637 . . . . 0.0 109.252 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -146.84 122.56 10.54 Favored 'General case' 0 CA--C 1.552 1.041 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 49' ' ' LEU . 3.8 m-85 -119.48 171.09 8.59 Favored 'General case' 0 C--O 1.211 -0.933 2 O-C-N 130.111 4.632 . . . . 0.0 99.061 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -158.68 127.88 5.57 Favored 'General case' 0 C--O 1.249 1.058 3 O-C-N 136.284 8.49 . . . . 0.0 98.674 179.814 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 2.4 t -101.56 146.89 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' C ' HD23 ' A' ' 23' ' ' LEU 0.27 12.7 ttmt -91.67 48.57 1.47 Allowed 'General case' 0 C--O 1.195 -1.791 0 CA-C-O 127.491 3.52 . . . . 0.0 115.145 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.284 7.3 mt-10 -69.01 88.53 0.4 Allowed 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 m -86.61 128.02 34.96 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 127.222 2.826 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.6 -161.98 0.92 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 114.683 -2.807 . . . . 0.0 115.128 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -96.26 -7.21 36.1 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 111.961 -2.382 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -92.28 -65.9 0.97 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 114.572 -2.851 . . . . 0.0 107.265 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HD3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -141.98 -155.69 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 128.654 3.721 . . . . 0.0 110.616 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -75.66 -67.44 0.67 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 112.263 -3.775 . . . . 0.0 103.604 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD12 ' HD3' ' A' ' 41' ' ' ARG 0.251 0.4 OUTLIER 72.42 75.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.422 2 CA-C-O 134.919 7.057 . . . . 0.0 105.52 179.76 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.05 151.84 23.38 Favored 'General case' 0 C--N 1.373 1.619 1 CA-C-N 107.182 -4.554 . . . . 0.0 105.558 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.39 117.23 53.33 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 1 O-C-N 131.104 5.253 . . . . 0.0 102.734 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.325 9.4 p -115.11 155.42 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 115.798 -2.361 . . . . 0.0 110.977 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 67' ' ' TRP . 0.3 OUTLIER -166.79 177.88 6.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 127.667 3.104 . . . . 0.0 111.442 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -119.35 67.5 0.8 Allowed 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 115.326 -2.55 . . . . 0.0 115.169 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 32' ' ' PHE . 11.2 tp 23.32 75.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.812 1 O-C-N 130.148 4.655 . . . . 0.0 116.237 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.87 57.56 0.49 Allowed Glycine 0 CA--C 1.561 2.911 1 CA-C-O 112.545 -4.475 . . . . 0.0 104.452 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -150.67 120.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 O-C-N 134.662 6.742 . . . . 0.0 114.932 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 3.9 p30 -83.82 151.99 24.86 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 128.065 3.353 . . . . 0.0 107.913 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 21.4 p90 -173.66 162.71 4.16 Favored 'General case' 0 C--N 1.37 1.492 1 O-C-N 131.74 5.65 . . . . 0.0 115.006 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.68 141.41 37.17 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -154.19 102.97 2.5 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 116.732 -1.987 . . . . 0.0 109.683 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.67 95.17 2.8 Favored 'General case' 0 CA--C 1.539 0.519 1 O-C-N 129.106 4.004 . . . . 0.0 104.066 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.13 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 1 O-C-N 132.56 6.163 . . . . 0.0 109.773 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -70.72 177.05 3.75 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 116.584 -2.046 . . . . 0.0 109.812 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.38 66.26 4.79 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 128.543 3.652 . . . . 0.0 111.607 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.23 -38.43 0.17 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 115.243 -2.976 . . . . 0.0 108.378 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 58' ' ' ALA . 28.4 p -52.79 166.54 0.2 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 129.336 3.61 . . . . 0.0 114.021 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -165.02 49.14 0.1 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 125.413 2.53 . . . . 0.0 107.906 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 HD23 ' A' ' 87' ' ' LEU . 8.4 mp -69.37 125.72 27.56 Favored 'General case' 0 C--N 1.367 1.347 0 CA-C-N 110.237 -3.165 . . . . 0.0 107.994 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 m -126.82 98.75 5.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.44 -164.9 18.45 Favored Glycine 0 N--CA 1.478 1.449 1 C-N-CA 111.917 -4.944 . . . . 0.0 104.475 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.8 t -140.56 150.67 43.95 Favored 'General case' 0 N--CA 1.428 -1.56 1 O-C-N 131.073 4.631 . . . . 0.0 116.585 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.582 ' HB2' ' CD2' ' A' ' 47' ' ' PHE . 9.0 m95 -129.43 122.89 30.3 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-O 115.476 -2.202 . . . . 0.0 105.474 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.61 97.51 4.09 Favored 'General case' 0 C--O 1.203 -1.375 1 O-C-N 136.059 8.349 . . . . 0.0 110.626 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.572 ' HG2' ' CE2' ' A' ' 32' ' ' PHE 0.254 9.2 tpp -74.24 137.98 43.36 Favored 'General case' 0 CA--C 1.512 -0.49 1 O-C-N 132.181 5.926 . . . . 0.0 105.756 179.963 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -141.28 120.64 13.11 Favored 'General case' 0 C--O 1.218 -0.576 1 O-C-N 129.178 4.049 . . . . 0.0 105.427 -179.921 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.44 -98.11 0.02 OUTLIER Glycine 0 CA--C 1.557 2.682 1 O-C-N 129.521 4.263 . . . . 0.0 106.55 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 51.14 1.82 Allowed 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 129.703 3.825 . . . . 0.0 109.87 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 70' ' ' GLU . 1.5 mtpt -137.35 160.14 39.93 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 128.409 3.568 . . . . 0.0 108.65 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.6 mt -144.23 64.72 1.3 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.57 147.0 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 CA-C-O 129.778 4.608 . . . . 0.0 115.577 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.19 -147.3 15.71 Favored Glycine 0 CA--C 1.563 3.063 1 CA-C-N 107.183 -4.553 . . . . 0.0 103.641 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 163.73 139.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.651 1 O-C-N 134.045 6.38 . . . . 0.0 112.86 -179.835 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.61 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 5.5 m-85 -123.52 -169.49 1.95 Allowed 'General case' 0 C--O 1.204 -1.339 2 O-C-N 134.324 7.265 . . . . 0.0 104.648 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.671 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.316 0.0 OUTLIER -169.96 -145.68 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 109.801 -3.363 . . . . 0.0 115.162 -179.281 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 47.0 ttt180 -168.12 90.29 0.29 Allowed 'General case' 0 C--N 1.352 0.679 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.884 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -32.51 -33.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 127.621 3.076 . . . . 0.0 113.014 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 81' ' ' VAL . 1.2 t70 -53.44 -49.5 67.23 Favored 'General case' 0 CA--C 1.508 -0.636 1 O-C-N 129.727 4.392 . . . . 0.0 111.894 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.1 19.08 2.98 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-O 113.66 -3.067 . . . . 0.0 117.908 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 63.15 55.28 27.14 Favored Glycine 0 C--O 1.2 -1.976 1 N-CA-C 102.435 -4.266 . . . . 0.0 102.435 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 6.9 tppt? -80.94 -81.82 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 2 O-C-N 132.131 5.253 . . . . 0.0 118.603 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 78.2 mt-10 86.95 97.62 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.637 1 O-C-N 131.036 5.21 . . . . 0.0 109.832 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 HD21 ' A' ' 63' ' ' LEU . 12.9 tp -124.08 53.38 1.41 Allowed 'General case' 0 C--O 1.201 -1.478 1 O-C-N 138.185 9.678 . . . . 0.0 108.607 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 77' ' ' LYS . 25.5 mt -78.61 -178.0 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.176 2 CA-C-N 107.247 -4.524 . . . . 0.0 103.691 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.54 88.94 0.66 Allowed 'General case' 0 C--O 1.195 -1.794 1 O-C-N 131.804 5.69 . . . . 0.0 108.732 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.65 121.0 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 O-C-N 126.396 2.31 . . . . 0.0 107.583 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.3 tpt180 -170.63 163.04 8.11 Favored 'General case' 0 C--O 1.186 -2.243 0 C-N-CA 111.892 -3.923 . . . . 0.0 112.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -150.87 132.22 14.6 Favored 'General case' 0 N--CA 1.426 -1.626 1 O-C-N 132.035 5.835 . . . . 0.0 107.086 179.226 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -48.18 129.28 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 1 O-C-N 132.509 6.131 . . . . 0.0 109.149 179.976 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.9 p -78.92 -67.98 0.7 Allowed 'General case' 0 C--O 1.247 0.94 0 O-C-N 127.654 3.096 . . . . 0.0 116.13 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.17 -66.92 0.33 Allowed Glycine 0 CA--C 1.545 1.95 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.34 27.73 1.24 Allowed 'General case' 0 C--N 1.35 0.619 0 CA-C-N 110.501 -2.85 . . . . 0.0 107.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.73 119.28 2.9 Favored 'General case' 0 N--CA 1.433 -1.289 0 O-C-N 128.356 3.535 . . . . 0.0 109.642 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 121.67 28.62 Favored 'General case' 0 CA--C 1.557 1.231 1 O-C-N 129.771 4.42 . . . . 0.0 108.688 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' CG2' ' HB2' ' A' ' 110' ' ' LYS . 30.9 mt -74.04 -80.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.491 2 CA-C-O 111.285 -4.198 . . . . 0.0 108.206 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' N ' HG22 ' A' ' 99' ' ' ILE . 5.3 mt-30 99.75 112.6 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.394 2 O-C-N 136.054 8.346 . . . . 0.0 98.127 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 110' ' ' LYS . 30.9 p -82.95 -32.07 27.33 Favored 'General case' 0 N--CA 1.404 -2.74 1 O-C-N 130.306 4.754 . . . . 0.0 119.906 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 104' ' ' TYR . 62.9 m-85 60.24 70.22 0.64 Allowed 'General case' 0 CA--C 1.565 1.538 0 O-C-N 128.973 3.921 . . . . 0.0 103.558 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.6 m -69.22 73.7 0.32 Allowed 'General case' 0 C--O 1.215 -0.712 1 O-C-N 132.169 5.918 . . . . 0.0 106.206 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' TYR . 3.3 t80 -88.85 116.74 27.34 Favored 'General case' 0 CA--C 1.495 -1.144 1 CA-C-N 108.261 -4.063 . . . . 0.0 112.863 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 61.0 46.04 8.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 112.817 -1.992 . . . . 0.0 112.708 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.82 4.12 57.44 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-O 124.769 2.316 . . . . 0.0 117.528 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.15 137.2 53.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 119.558 -2.143 . . . . 0.0 115.051 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.93 132.17 43.12 Favored 'General case' 0 C--N 1.366 1.3 1 O-C-N 129.206 4.066 . . . . 0.0 105.661 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.354 . . -138.85 44.0 2.07 Favored 'General case' 0 N--CA 1.424 -1.764 0 O-C-N 128.368 3.542 . . . . 0.0 112.783 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 2.7 pttp -74.73 168.99 18.76 Favored 'General case' 0 N--CA 1.419 -1.989 1 O-C-N 133.308 6.63 . . . . 0.0 109.047 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -145.45 -90.62 0.1 Allowed 'General case' 0 CA--C 1.556 1.208 1 O-C-N 129.292 4.12 . . . . 0.0 100.632 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -174.63 179.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 111.377 -2.647 . . . . 0.0 108.974 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.517 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 8.8 m-85 166.49 178.55 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 1 O-C-N 136.157 8.411 . . . . 0.0 104.926 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.72 -154.17 0.33 Allowed 'General case' 0 C--O 1.198 -1.607 1 O-C-N 131.795 5.684 . . . . 0.0 111.515 178.683 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.62 ' HG3' ' CE3' ' A' ' 6' ' ' TRP 0.253 29.9 tttt -110.53 -138.39 0.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.255 7.7 tp10 . . . . . 0 N--CA 1.442 -0.841 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.441 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -145.41 -48.74 0.23 Allowed 'General case' 0 CA--C 1.56 1.352 0 O-C-N 127.826 3.204 . . . . 0.0 105.304 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 9.6 t0 -35.36 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 129.785 4.428 . . . . 0.0 117.878 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 153.13 175.56 24.68 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 115.413 -3.279 . . . . 0.0 105.297 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.285 3.6 p -90.78 176.8 6.51 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 113.274 -3.37 . . . . 0.0 103.844 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.585 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 28.4 m95 -147.21 160.37 42.55 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-O 112.592 -3.575 . . . . 0.0 112.435 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.5 mtmt 50.93 -178.89 0.02 OUTLIER 'General case' 0 C--O 1.195 -1.784 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 21' ' ' LEU 0.26 0.5 OUTLIER 28.33 36.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 3 CA-C-O 135.409 7.29 . . . . 0.0 119.675 174.899 . . . . . . . . 5 4 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.19 -53.18 15.32 Favored 'General case' 0 C--N 1.373 1.63 1 CA-C-N 107.873 -4.24 . . . . 0.0 103.792 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.0 103.44 15.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.188 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.21 113.0 25.65 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.074 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.86 44.91 0.83 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.49 -164.26 0.98 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 128.061 3.351 . . . . 0.0 105.009 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -92.68 19.94 6.94 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 111.567 -2.56 . . . . 0.0 110.833 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 t 67.45 101.82 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.719 1.247 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.29 155.59 18.53 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 115.861 -3.066 . . . . 0.0 107.559 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.83 -53.16 16.33 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -155.06 51.98 0.61 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 124.391 1.057 . . . . 0.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -106.83 21.04 18.15 Favored 'General case' 0 C--O 1.208 -1.091 0 O-C-N 128.504 3.627 . . . . 0.0 109.305 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -93.27 119.07 32.01 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 111.331 -2.668 . . . . 0.0 110.529 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.51 163.45 14.91 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 109.526 -3.488 . . . . 0.0 104.793 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER -171.72 150.54 2.71 Favored 'General case' 0 CA--C 1.563 1.464 1 O-C-N 133.302 6.626 . . . . 0.0 102.228 179.843 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.4 mt -115.32 157.1 24.3 Favored 'General case' 0 CA--C 1.565 1.546 4 O-C-N 132.916 6.385 . . . . 0.0 97.666 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 1.9 m 172.09 96.46 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.249 1 O-C-N 132.768 6.292 . . . . 0.0 102.745 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.92 HG22 ' CD1' ' A' ' 32' ' ' PHE . 3.0 mp -114.66 112.35 39.72 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 108.96 -3.746 . . . . 0.0 109.962 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 35.9 m -155.07 79.68 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 127.74 3.15 . . . . 0.0 108.44 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.6 mm-40 -88.08 -98.62 0.09 Allowed 'General case' 0 C--N 1.355 0.845 3 CA-C-N 105.865 -5.152 . . . . 0.0 111.634 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.88 -6.17 4.51 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 128.088 3.367 . . . . 0.0 106.47 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.31 -27.4 8.11 Favored Glycine 0 CA--C 1.546 1.969 1 N-CA-C 99.189 -5.565 . . . . 0.0 99.189 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -25.67 6.0 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 111.737 -3.983 . . . . 0.0 111.627 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 2.6 mttm -101.56 178.89 4.51 Favored 'General case' 0 C--O 1.25 1.085 1 N-CA-C 97.596 -4.964 . . . . 0.0 97.596 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -176.64 139.38 0.31 Allowed 'General case' 0 C--O 1.19 -2.076 1 N-CA-C 97.217 -5.105 . . . . 0.0 97.217 178.875 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.565 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -128.67 119.88 25.5 Favored 'General case' 0 C--O 1.249 1.028 3 O-C-N 136.446 8.591 . . . . 0.0 98.577 -179.957 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.364 1.2 t -84.6 128.41 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 1 N-CA-C 99.747 -4.168 . . . . 0.0 99.747 -179.944 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.295 5.3 tttm -67.72 -8.88 38.92 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 120.775 3.62 . . . . 0.0 120.775 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.339 3.9 tt0 -29.37 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 108.499 -3.955 . . . . 0.0 109.965 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -80.45 155.65 26.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 114.228 -2.989 . . . . 0.0 111.035 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.6 t -121.57 -151.82 0.49 Allowed 'General case' 0 N--CA 1.442 -0.827 0 O-C-N 127.527 3.017 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.13 -29.56 11.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 126.198 2.186 . . . . 0.0 108.937 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 10.2 m-85 -66.5 -60.49 2.69 Favored 'General case' 0 CA--C 1.551 1.013 1 O-C-N 130.654 4.971 . . . . 0.0 105.162 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.58 -163.28 1.71 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 128.972 3.92 . . . . 0.0 113.54 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.39 -16.46 52.14 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 121.431 1.923 . . . . 0.0 109.939 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' HB ' ' CZ ' ' A' ' 41' ' ' ARG . 8.8 tt 20.05 94.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.266 2 O-C-N 132.336 6.022 . . . . 0.0 111.972 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 152.1 22.0 Favored 'General case' 0 C--N 1.366 1.304 0 O-C-N 117.001 -3.562 . . . . 0.0 104.198 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -126.79 91.64 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.93 1 O-C-N 130.469 4.855 . . . . 0.0 103.707 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 ' OG1' ' A' ' 33' ' ' THR 0.29 0.7 OUTLIER -92.18 158.89 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 1 C-N-CA 111.052 -4.259 . . . . 0.0 115.764 -179.993 . . . . . . . . 5 4 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -154.66 -177.0 6.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 O-C-N 129.011 3.944 . . . . 0.0 111.303 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.571 ' HB3' HG21 ' A' ' 51' ' ' VAL 0.258 1.2 tt0 -130.22 31.54 4.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.267 3.48 . . . . 0.0 111.805 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.83 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 1 O-C-N 133.749 6.906 . . . . 0.0 113.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 86.51 52.14 3.28 Favored Glycine 0 CA--C 1.548 2.118 0 CA-C-O 113.797 -3.779 . . . . 0.0 104.085 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 48' ' ' GLU . 21.7 t -134.31 104.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 1 O-C-N 134.851 6.853 . . . . 0.0 113.531 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 145.57 33.63 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 110.45 -3.068 . . . . 0.0 109.563 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.58 124.01 7.72 Favored 'General case' 0 C--N 1.372 1.577 2 O-C-N 129.733 4.396 . . . . 0.0 116.131 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.6 73.53 4.36 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 121.75 41.27 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 127.564 3.04 . . . . 0.0 112.375 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -74.47 114.84 13.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 111.853 -3.939 . . . . 0.0 106.54 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.43 155.92 20.7 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 127.229 2.831 . . . . 0.0 112.408 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.41 22.93 3.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 115.721 -2.085 . . . . 0.0 114.026 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t70 39.14 38.7 0.34 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 128.957 3.911 . . . . 0.0 112.16 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.81 -58.03 0.01 OUTLIER Glycine 0 CA--C 1.543 1.786 0 N-CA-C 105.725 -2.95 . . . . 0.0 105.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.402 ' C ' ' HG2' ' A' ' 62' ' ' GLU . 1.1 p -77.07 149.48 35.77 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 127.8 2.706 . . . . 0.0 114.274 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HG2' ' C ' ' A' ' 61' ' ' THR . 2.9 mt-10 -143.31 66.24 1.31 Allowed 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.27 117.67 5.05 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 129.093 3.996 . . . . 0.0 107.255 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -123.57 109.55 13.92 Favored 'General case' 0 C--O 1.205 -1.283 0 O-C-N 126.404 2.315 . . . . 0.0 108.65 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 178.13 -146.11 7.31 Favored Glycine 0 N--CA 1.479 1.558 1 C-N-CA 113.838 -4.03 . . . . 0.0 103.727 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 66' ' ' THR 0.312 15.2 t -176.16 141.44 0.44 Allowed 'General case' 0 CA--C 1.486 -1.485 1 O-C-N 131.247 4.733 . . . . 0.0 119.58 -178.553 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.722 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.5 m95 -107.5 145.45 33.08 Favored 'General case' 0 C--O 1.195 -1.769 1 O-C-N 115.971 -4.206 . . . . 0.0 100.5 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.404 HG22 ' HA2' ' A' ' 50' ' ' GLY . 25.8 p -126.56 25.21 6.52 Favored 'General case' 0 N--CA 1.428 -1.526 2 O-C-N 135.278 7.861 . . . . 0.0 115.21 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 3.65 105.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.887 1 O-C-N 137.638 9.336 . . . . 0.0 108.611 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -114.0 -170.74 1.77 Allowed 'General case' 0 C--O 1.215 -0.713 1 O-C-N 129.625 4.328 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.41 105.83 0.81 Allowed Glycine 0 CA--C 1.541 1.707 0 O-C-N 127.354 2.909 . . . . 0.0 108.51 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 39.71 55.56 2.43 Favored 'General case' 0 C--O 1.238 0.491 1 O-C-N 131.496 4.88 . . . . 0.0 110.046 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -174.27 3.9 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 127.021 2.701 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 98' ' ' LEU . 1.1 mt -161.01 30.69 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 O-C-N 126.391 2.307 . . . . 0.0 115.507 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 t -59.27 137.14 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 2 O-C-N 131.24 5.338 . . . . 0.0 114.42 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 154.22 -139.94 7.14 Favored Glycine 0 C--O 1.197 -2.186 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 78' ' ' PHE 0.333 20.1 tttm -177.63 176.51 1.24 Allowed 'General case' 0 C--N 1.371 1.531 1 O-C-N 133.164 5.861 . . . . 0.0 110.145 -178.682 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 22.4 m-85 -176.06 172.62 2.36 Favored 'General case' 0 C--O 1.212 -0.92 2 O-C-N 134.178 7.174 . . . . 0.0 102.602 175.481 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' C ' ' A' ' 85' ' ' LYS 0.296 13.7 ttmt -160.22 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.825 1 CA-C-N 105.076 -5.511 . . . . 0.0 110.135 179.962 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.695 ' NE ' HD11 ' A' ' 87' ' ' LEU 0.272 5.9 ptt180 175.61 56.91 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 117.267 -1.349 . . . . 0.0 111.336 178.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 31.7 t -41.46 87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.558 2 O-C-N 134.769 7.543 . . . . 0.0 108.521 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 t70 170.31 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.107 1 O-C-N 130.597 4.935 . . . . 0.0 107.348 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 p30 175.93 -0.38 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 129.017 3.948 . . . . 0.0 115.377 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -101.93 -35.01 4.12 Favored Glycine 0 CA--C 1.54 1.649 1 C-N-CA 113.036 -4.411 . . . . 0.0 105.546 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.569 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 75.43 -174.76 0.12 Allowed 'General case' 0 CA--C 1.495 -1.145 1 O-C-N 131.292 4.76 . . . . 0.0 114.063 179.837 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.258 6.6 mt-10 -34.41 142.01 0.05 OUTLIER 'General case' 0 C--O 1.198 -1.623 1 O-C-N 130.077 4.611 . . . . 0.0 116.334 -177.297 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.695 HD11 ' NE ' ' A' ' 80' ' ' ARG . 40.4 mt -150.65 37.22 0.65 Allowed 'General case' 0 C--O 1.194 -1.829 1 O-C-N 132.969 6.418 . . . . 0.0 110.074 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 21.5 mt -62.27 152.39 6.92 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 3 O-C-N 130.053 4.596 . . . . 0.0 99.54 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' CH2' ' A' ' 67' ' ' TRP . . . -124.98 87.15 2.66 Favored 'General case' 0 C--O 1.197 -1.7 1 O-C-N 135.58 8.05 . . . . 0.0 110.363 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 90' ' ' VAL . 3.7 t -84.23 107.85 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 114.892 -2.723 . . . . 0.0 105.232 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD2' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -168.53 164.27 12.49 Favored 'General case' 0 C--O 1.194 -1.868 1 C-N-CA 111.097 -4.241 . . . . 0.0 115.717 -179.519 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -151.77 143.65 23.76 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 128.6 3.687 . . . . 0.0 104.088 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -58.35 81.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 1 O-C-N 133.176 6.548 . . . . 0.0 110.135 -179.985 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.62 -114.72 0.81 Allowed Glycine 0 CA--C 1.55 2.223 0 N-CA-C 104.528 -3.429 . . . . 0.0 104.528 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -113.86 24.74 11.8 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 109.688 -3.256 . . . . 0.0 108.893 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.572 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.91 165.21 32.61 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 110.963 -2.835 . . . . 0.0 106.756 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 74' ' ' LEU . 5.3 tt -110.48 121.23 44.8 Favored 'General case' 0 N--CA 1.447 -0.582 1 O-C-N 130.162 4.664 . . . . 0.0 109.826 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HB ' ' HD2' ' A' ' 91' ' ' ARG . 1.7 mt -71.11 -55.79 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 109.47 -3.513 . . . . 0.0 107.724 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' OE1' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER 73.65 105.68 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 1 O-C-N 132.27 5.981 . . . . 0.0 103.97 -179.915 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.21 91.03 3.48 Favored 'General case' 0 N--CA 1.424 -1.763 2 O-C-N 132.408 6.067 . . . . 0.0 113.141 179.671 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 50.4 m-85 -70.77 125.5 27.01 Favored 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 109.309 -4.956 . . . . 0.0 105.669 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.9 m -96.53 68.01 2.47 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 127.811 3.672 . . . . 0.0 105.982 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 2.0 t80 -65.06 156.68 30.7 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 109.803 -3.362 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 5.0 tp10 -47.76 104.55 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 112.848 -1.978 . . . . 0.0 115.681 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.8 83.78 Favored Glycine 0 C--N 1.347 1.178 0 C-N-CA 117.799 -2.143 . . . . 0.0 116.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.269 2.5 t -136.93 169.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -143.15 58.1 1.4 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.422 . . -98.42 152.49 19.44 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 114.658 -2.817 . . . . 0.0 111.287 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.667 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.2 OUTLIER -109.95 -163.21 0.84 Allowed 'General case' 0 N--CA 1.444 -0.747 1 O-C-N 134.029 7.081 . . . . 0.0 107.359 -179.771 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -57.63 0.74 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 110.469 -3.059 . . . . 0.0 105.801 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.284 4.5 mt 86.88 115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.027 1 O-C-N 129.386 4.179 . . . . 0.0 110.096 -179.847 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 9.1 m-85 -142.62 179.65 6.85 Favored 'General case' 0 N--CA 1.417 -2.081 1 O-C-N 130.091 4.619 . . . . 0.0 107.167 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.572 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -150.36 -160.92 1.24 Allowed 'General case' 0 C--O 1.196 -1.756 1 O-C-N 131.97 5.793 . . . . 0.0 111.836 179.501 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 11.7 tttt -123.17 152.61 41.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 111.812 -2.449 . . . . 0.0 112.549 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.419 -1.989 1 O-C-N 129.389 4.18 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 116.289 -1.815 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 168.01 -40.55 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.345 1 O-C-N 131.819 5.7 . . . . 0.0 103.51 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.95 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.777 1 O-C-N 131.027 5.204 . . . . 0.0 117.415 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.8 148.16 5.04 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 114.893 -3.17 . . . . 0.0 106.265 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.295 36.0 p -68.28 167.88 13.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 112.361 -3.735 . . . . 0.0 110.094 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 73.1 m95 -141.27 167.69 21.57 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-O 111.116 -4.278 . . . . 0.0 113.487 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 5.3 mtmt 36.85 171.84 0.0 OUTLIER 'General case' 0 C--O 1.19 -2.057 1 O-C-N 133.813 6.946 . . . . 0.0 119.182 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 21' ' ' LEU 0.287 0.9 OUTLIER -1.13 134.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.321 3 CA-C-N 105.262 -5.426 . . . . 0.0 119.331 174.941 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.95 -159.31 0.74 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 108.52 -3.946 . . . . 0.0 102.496 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.2 119.34 5.88 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-O 124.015 1.864 . . . . 0.0 111.41 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -150.94 73.85 1.13 Allowed 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.495 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.35 75.87 1.68 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.827 -1.533 . . . . 0.0 107.795 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.68 68.85 0.13 Allowed 'General case' 0 C--N 1.359 1.018 0 O-C-N 127.47 2.981 . . . . 0.0 106.603 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.22 54.03 10.92 Favored 'General case' 0 C--O 1.214 -0.814 1 CA-C-N 108.16 -4.109 . . . . 0.0 110.294 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.69 -172.46 0.19 Allowed 'General case' 0 C--N 1.347 0.498 0 O-C-N 126.641 2.463 . . . . 0.0 108.225 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.26 -92.14 0.09 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 117.512 -2.28 . . . . 0.0 113.008 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.02 133.59 54.1 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 116.151 -1.88 . . . . 0.0 106.431 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -88.81 90.47 8.43 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 126.951 2.657 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.74 36.09 0.7 Allowed 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.027 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 5.8 p-10 -86.19 172.92 10.16 Favored 'General case' 0 C--O 1.214 -0.784 1 O-C-N 131.987 5.804 . . . . 0.0 112.377 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -104.23 -165.05 1.11 Allowed 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 110.731 -2.941 . . . . 0.0 105.491 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.432 31.0 mttt 145.07 170.74 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.604 1 O-C-N 134.015 7.072 . . . . 0.0 101.018 -178.847 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 7.3 mt -141.83 -178.63 5.76 Favored 'General case' 0 CA--C 1.567 1.604 3 O-C-N 133.148 6.53 . . . . 0.0 96.985 177.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 25' ' ' ILE . 18.7 m -166.65 -90.04 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 128.418 3.574 . . . . 0.0 106.173 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 24' ' ' THR . 0.8 OUTLIER 70.72 130.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-N 109.752 -3.385 . . . . 0.0 109.316 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.4 m -168.27 73.99 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 113.185 -3.406 . . . . 0.0 103.583 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -37.38 138.96 0.28 Allowed 'General case' 0 N--CA 1.436 -1.131 2 O-C-N 133.483 6.74 . . . . 0.0 115.576 -179.923 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -92.9 0.36 Allowed 'General case' 0 C--N 1.35 0.618 1 O-C-N 131.017 5.198 . . . . 0.0 106.505 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.55 66.5 0.24 Allowed Glycine 0 CA--C 1.55 2.266 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 68.2 14.47 9.25 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -93.88 132.7 38.05 Favored 'General case' 0 CA--C 1.552 1.047 1 CA-C-O 111.213 -4.232 . . . . 0.0 100.827 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.693 ' CD1' HD23 ' A' ' 49' ' ' LEU . 13.0 m-85 -110.59 142.17 42.8 Favored 'General case' 0 C--O 1.191 -2.004 2 N-CA-C 96.858 -5.238 . . . . 0.0 96.858 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -130.91 108.44 9.83 Favored 'General case' 0 CA--C 1.496 -1.116 2 O-C-N 134.575 7.422 . . . . 0.0 100.744 -179.92 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 25' ' ' ILE 0.42 4.2 t -81.57 150.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 112.635 -3.626 . . . . 0.0 103.772 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.255 3.6 ttmt -98.99 36.88 1.61 Allowed 'General case' 0 N--CA 1.425 -1.711 1 CA-C-O 133.049 6.166 . . . . 0.0 116.949 179.792 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.335 28.1 tt0 -57.78 97.6 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 1 CA-C-N 107.455 -4.43 . . . . 0.0 107.512 -179.804 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.0 m -99.59 134.06 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.97 3.294 . . . . 0.0 106.767 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.23 -162.27 1.23 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 127.316 2.885 . . . . 0.0 112.807 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -57.46 -41.37 80.42 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -87.38 82.66 7.49 Favored 'General case' 0 N--CA 1.435 -1.198 2 O-C-N 131.35 5.406 . . . . 0.0 106.487 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER 35.14 -143.7 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 131.284 5.365 . . . . 0.0 114.878 -179.991 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 46.6 m-20 -77.29 -70.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 113.109 -3.436 . . . . 0.0 106.073 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.75 HG13 HD12 ' A' ' 57' ' ' LEU 0.25 0.2 OUTLIER 66.17 104.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 1 CA-C-O 132.302 5.81 . . . . 0.0 104.3 179.623 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.83 154.23 18.17 Favored 'General case' 0 C--N 1.372 1.586 0 CA-C-N 109.673 -3.421 . . . . 0.0 106.863 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 107.61 17.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 1 O-C-N 131.157 5.286 . . . . 0.0 102.498 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' OG1' ' A' ' 33' ' ' THR 0.374 9.9 p -112.23 154.03 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 114.049 -3.06 . . . . 0.0 113.422 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -163.73 -163.05 0.76 Allowed 'General case' 0 N--CA 1.442 -0.829 1 O-C-N 131.657 5.598 . . . . 0.0 114.602 -179.946 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -136.28 53.38 1.93 Allowed 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.355 2.284 . . . . 0.0 114.02 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD23 ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER 52.3 19.52 1.14 Allowed 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 128.701 3.751 . . . . 0.0 115.736 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.563 ' CA ' HG22 ' A' ' 68' ' ' THR . . . 143.55 71.75 0.02 OUTLIER Glycine 0 CA--C 1.546 1.978 0 N-CA-C 105.091 -3.203 . . . . 0.0 105.091 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.15 -49.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 130.159 4.094 . . . . 0.0 112.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.03 131.72 0.05 Allowed 'General case' 0 C--O 1.202 -1.441 1 O-C-N 129.426 4.204 . . . . 0.0 105.724 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -164.82 148.69 8.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 129.038 3.961 . . . . 0.0 117.09 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.54 115.77 30.92 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 100.468 -3.901 . . . . 0.0 100.468 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -139.23 128.14 23.57 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 127.972 3.295 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.49 112.6 15.71 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 115.417 -2.513 . . . . 0.0 105.692 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 43' ' ' ILE . 3.5 mm? -66.49 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 O-C-N 126.501 2.376 . . . . 0.0 111.386 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.44 -142.5 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.662 -1.161 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.03 -14.25 19.52 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 124.827 1.329 . . . . 0.0 111.669 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.47 74.36 0.34 Allowed Glycine 0 CA--C 1.562 3.007 0 O-C-N 128.591 3.682 . . . . 0.0 104.67 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.8 p -150.61 148.63 28.87 Favored 'General case' 0 N--CA 1.433 -1.28 1 O-C-N 131.985 5.167 . . . . 0.0 112.81 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -147.97 48.81 1.06 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 127.12 2.763 . . . . 0.0 108.721 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.05 166.21 14.24 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 113.549 -3.26 . . . . 0.0 107.514 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -161.92 118.32 2.07 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 110.302 -3.135 . . . . 0.0 104.439 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.24 -130.26 1.39 Allowed Glycine 0 CA--C 1.529 0.936 1 C-N-CA 110.782 -5.485 . . . . 0.0 108.401 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.595 ' C ' ' CG ' ' A' ' 67' ' ' TRP . 3.3 t 170.6 139.01 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.708 1 O-C-N 132.665 5.568 . . . . 0.0 110.472 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 78' ' ' PHE . 46.6 m95 -139.2 107.54 5.81 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 122.187 2.267 . . . . 0.0 106.753 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.563 HG22 ' CA ' ' A' ' 50' ' ' GLY . 43.0 p -103.49 74.8 1.28 Allowed 'General case' 0 N--CA 1.429 -1.513 2 O-C-N 131.441 5.463 . . . . 0.0 114.143 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.482 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -46.29 134.09 9.05 Favored 'General case' 0 C--O 1.215 -0.724 1 O-C-N 130.804 5.065 . . . . 0.0 105.352 179.867 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -136.98 66.67 1.46 Allowed 'General case' 0 C--N 1.347 0.46 1 O-C-N 131.131 5.269 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.79 84.19 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.167 0 O-C-N 125.68 1.863 . . . . 0.0 110.719 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 6.4 m-20 63.07 28.11 16.02 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 114.899 -2.477 . . . . 0.0 114.622 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -129.69 156.96 43.41 Favored 'General case' 0 N--CA 1.476 0.869 1 O-C-N 129.877 4.485 . . . . 0.0 107.694 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ARG . 7.9 mt -141.6 47.78 1.65 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 126.571 2.419 . . . . 0.0 116.877 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 t -68.66 147.65 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 1 CA-C-N 107.85 -4.25 . . . . 0.0 112.138 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.99 27.56 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HA ' ' HH2' ' A' ' 67' ' ' TRP 0.268 0.1 OUTLIER -174.53 128.55 0.33 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 111.951 -3.9 . . . . 0.0 117.676 -179.617 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 67' ' ' TRP . 25.6 m-85 -101.9 177.95 4.75 Favored 'General case' 0 C--O 1.204 -1.311 1 CA-C-O 129.288 4.375 . . . . 0.0 100.773 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.64 -129.89 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 1 CA-C-N 105.079 -5.509 . . . . 0.0 110.284 179.583 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 51.0 ttt180 168.65 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.685 0 O-C-N 128.138 3.399 . . . . 0.0 109.247 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.6 -1.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 1 O-C-N 131.93 5.768 . . . . 0.0 114.767 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.62 -26.79 12.66 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 128.493 3.621 . . . . 0.0 112.041 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.28 1.25 9.06 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 66.46 39.19 94.0 Favored Glycine 0 CA--C 1.558 2.749 1 N-CA-C 100.773 -4.931 . . . . 0.0 100.773 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.262 0.6 OUTLIER -74.44 -80.86 0.07 Allowed 'General case' 0 N--CA 1.411 -2.383 1 CA-C-N 106.145 -5.027 . . . . 0.0 120.994 -179.008 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER 78.61 101.87 0.07 Allowed 'General case' 0 CA--C 1.561 1.396 0 O-C-N 127.621 3.076 . . . . 0.0 109.489 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.76 48.57 2.15 Favored 'General case' 0 C--O 1.195 -1.779 1 O-C-N 133.636 6.835 . . . . 0.0 108.884 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 77' ' ' LYS . 57.0 mt -66.57 146.0 13.5 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.479 2 O-C-N 130.029 4.581 . . . . 0.0 103.937 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.9 105.61 15.23 Favored 'General case' 0 C--O 1.213 -0.827 1 O-C-N 137.751 9.407 . . . . 0.0 105.077 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 90' ' ' VAL . 4.0 t -101.85 100.43 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 128.917 3.886 . . . . 0.0 104.68 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -156.58 155.74 32.4 Favored 'General case' 0 C--O 1.19 -2.033 1 C-N-CA 110.615 -4.434 . . . . 0.0 113.756 179.76 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.5 108.34 3.34 Favored 'General case' 0 CA--C 1.558 1.279 2 CA-C-N 107.581 -4.372 . . . . 0.0 102.521 179.228 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.877 ' HB ' HD12 ' A' ' 98' ' ' LEU . 11.5 tt -42.66 109.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 1 O-C-N 132.986 6.428 . . . . 0.0 112.287 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.0 m -105.19 95.25 5.71 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 128.387 3.555 . . . . 0.0 115.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.0 -118.31 3.77 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 103.256 -3.937 . . . . 0.0 103.256 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.67 47.29 1.56 Allowed 'General case' 0 CA--C 1.552 1.029 1 O-C-N 130.18 4.106 . . . . 0.0 106.146 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.303 0.0 OUTLIER -177.3 110.93 0.08 Allowed 'General case' 0 C--O 1.204 -1.32 2 O-C-N 130.801 5.063 . . . . 0.0 108.358 179.801 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.877 HD12 ' HB ' ' A' ' 93' ' ' ILE . 3.0 tt -79.45 104.71 10.25 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 128.728 3.768 . . . . 0.0 108.815 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 26.1 mm -50.76 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.672 1 O-C-N 133.48 6.738 . . . . 0.0 108.434 -179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.565 ' CG ' HD23 ' A' ' 98' ' ' LEU . 23.2 mt-30 99.36 90.48 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 1 O-C-N 132.899 6.374 . . . . 0.0 103.915 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.8 m -102.64 96.75 7.09 Favored 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.683 6.864 . . . . 0.0 114.06 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 73.6 m-85 -67.78 132.85 48.19 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 112.605 -3.638 . . . . 0.0 105.213 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -107.86 94.8 5.27 Favored 'General case' 0 C--O 1.206 -1.198 1 O-C-N 132.129 5.893 . . . . 0.0 101.631 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 1.4 t80 -109.64 117.36 33.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 109.792 -3.367 . . . . 0.0 117.6 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 27.42 31.51 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.77 -6.37 6.16 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 116.718 -2.658 . . . . 0.0 114.353 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.4 t -120.03 145.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.979 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 70.89 0.73 Allowed 'General case' 0 C--N 1.359 1.011 1 O-C-N 130.87 5.106 . . . . 0.0 103.388 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.436 . . -90.86 119.13 30.81 Favored 'General case' 0 N--CA 1.41 -2.447 1 O-C-N 130.921 5.138 . . . . 0.0 116.267 179.907 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.4 163.08 14.85 Favored 'General case' 0 N--CA 1.415 -2.199 1 O-C-N 132.663 6.227 . . . . 0.0 106.924 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.27 99.53 4.56 Favored 'General case' 0 CA--C 1.556 1.202 3 O-C-N 130.195 4.684 . . . . 0.0 99.437 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -57.23 123.02 7.53 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 O-C-N 128.862 3.851 . . . . 0.0 111.194 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.771 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 14.2 m-30 -117.21 176.81 4.97 Favored 'General case' 0 N--CA 1.434 -1.24 2 O-C-N 132.544 6.152 . . . . 0.0 108.463 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 171.12 134.76 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.633 2 O-C-N 131.898 5.749 . . . . 0.0 113.843 -177.607 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 1.3 tttt -51.41 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.34 1 CA-C-O 128.649 4.071 . . . . 0.0 113.502 176.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.37 1.492 0 O-C-N 118.952 -2.342 . . . . 0.0 110.519 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.117 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 4.8 m-30 -111.93 11.49 20.69 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -50.3 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 127.737 3.148 . . . . 0.0 117.911 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.29 125.21 0.77 Allowed Glycine 0 C--N 1.353 1.488 1 C-N-CA 112.377 -4.725 . . . . 0.0 107.663 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.334 46.2 p -49.97 127.89 17.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 129.148 3.499 . . . . 0.0 110.123 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.324 55.7 m95 -100.58 161.47 13.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 128.565 3.666 . . . . 0.0 112.276 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.3 mtmt 50.99 -178.66 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.696 1 O-C-N 129.333 4.146 . . . . 0.0 117.325 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 21' ' ' LEU 0.326 0.9 OUTLIER 15.21 104.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.603 2 O-C-N 134.538 7.399 . . . . 0.0 113.753 174.979 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -128.9 31.86 4.86 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 110.834 -2.894 . . . . 0.0 106.105 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -63.34 124.26 20.81 Favored 'General case' 0 C--O 1.203 -1.346 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.771 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -50.03 136.76 18.34 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 127.032 2.708 . . . . 0.0 108.283 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -28.7 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.416 3.573 . . . . 0.0 112.863 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -91.31 127.56 36.79 Favored 'General case' 0 C--N 1.367 1.367 0 O-C-N 127.3 2.875 . . . . 0.0 106.187 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -116.28 81.74 1.66 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 128.315 3.51 . . . . 0.0 106.58 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 t -121.65 -81.94 0.64 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 125.686 1.866 . . . . 0.0 106.735 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.32 -88.39 0.45 Allowed Glycine 0 CA--C 1.533 1.178 0 O-C-N 128.606 3.691 . . . . 0.0 110.062 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 129.3 40.79 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 111.986 -2.107 . . . . 0.0 107.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -122.68 -44.1 2.23 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 117.097 -1.841 . . . . 0.0 110.318 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -81.0 107.27 13.67 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.865 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.55 ' HB3' HD23 ' A' ' 21' ' ' LEU . 3.3 m-20 -110.6 -87.6 0.52 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 127.822 3.201 . . . . 0.0 111.352 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -144.84 174.08 11.31 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 127.679 3.112 . . . . 0.0 105.736 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.377 0.0 OUTLIER 174.56 134.18 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.5 1 O-C-N 131.733 5.646 . . . . 0.0 102.694 179.689 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 13.2 mt -93.55 167.69 11.52 Favored 'General case' 0 CA--C 1.559 1.291 2 O-C-N 131.533 5.52 . . . . 0.0 100.33 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.9 m 176.7 79.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 1 O-C-N 132.518 6.136 . . . . 0.0 105.993 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 mp -90.11 144.07 9.89 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 110.293 -3.14 . . . . 0.0 109.188 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.7 m -162.48 82.29 0.53 Allowed 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 112.491 -3.683 . . . . 0.0 109.092 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.405 ' HG3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -51.65 148.05 5.85 Favored 'General case' 0 C--O 1.214 -0.797 2 O-C-N 130.373 4.795 . . . . 0.0 115.054 179.684 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -131.65 101.43 5.49 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 128.75 3.781 . . . . 0.0 103.76 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -104.08 2.26 Favored Glycine 0 CA--C 1.546 2.027 2 C-N-CA 110.909 -5.424 . . . . 0.0 99.934 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -131.36 14.21 5.06 Favored 'General case' 0 N--CA 1.435 -1.222 1 O-C-N 131.798 5.058 . . . . 0.0 109.241 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -82.8 155.29 24.27 Favored 'General case' 0 C--N 1.321 -0.662 1 N-CA-C 99.494 -4.261 . . . . 0.0 99.494 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 25' ' ' ILE . 9.3 t80 -155.67 106.76 2.52 Favored 'General case' 0 C--O 1.191 -1.995 2 N-CA-C 95.674 -5.676 . . . . 0.0 95.674 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.15 142.48 38.3 Favored 'General case' 0 N--CA 1.475 0.806 1 O-C-N 132.503 6.127 . . . . 0.0 102.797 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.356 24.7 t -111.48 140.04 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 1 O-C-N 129.144 4.027 . . . . 0.0 100.97 179.697 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB3' ' N ' ' A' ' 24' ' ' THR . 5.2 tttt -85.2 64.42 8.66 Favored 'General case' 0 CA--C 1.49 -1.355 1 CA-C-O 130.901 5.143 . . . . 0.0 115.029 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' OE1' HG23 ' A' ' 43' ' ' ILE . 9.9 tt0 -81.76 61.8 5.29 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 109.64 -3.436 . . . . 0.0 104.323 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.57 130.81 35.35 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 113.228 -3.389 . . . . 0.0 109.454 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -146.61 -158.79 0.94 Allowed 'General case' 0 C--N 1.368 1.394 0 O-C-N 125.87 1.981 . . . . 0.0 113.066 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -14.53 60.34 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.05 52.97 0.97 Allowed 'General case' 0 N--CA 1.424 -1.772 0 O-C-N 128.22 3.45 . . . . 0.0 107.349 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 72.9 -164.26 0.11 Allowed 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 127.637 3.086 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.504 ' C ' HG22 ' A' ' 43' ' ' ILE . 31.7 m-20 -81.85 -30.52 32.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 127.657 3.098 . . . . 0.0 107.127 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.691 HD11 HD22 ' A' ' 57' ' ' LEU . 3.8 tp 37.14 70.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.104 2 O-C-N 132.107 5.879 . . . . 0.0 110.444 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -66.07 114.79 5.48 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.711 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.96 95.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 2 O-C-N 131.657 5.598 . . . . 0.0 99.802 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.282 2.8 p -114.68 151.67 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 1 O-C-N 129.536 4.272 . . . . 0.0 116.086 -179.691 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 67' ' ' TRP . 3.4 p90 -174.17 -171.7 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 131.682 5.614 . . . . 0.0 111.7 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -124.8 76.47 1.52 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 128.201 3.438 . . . . 0.0 113.762 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 24.36 78.48 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.738 1 O-C-N 133.744 6.903 . . . . 0.0 116.294 -179.876 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.62 64.28 1.83 Allowed Glycine 0 CA--C 1.537 1.407 0 N-CA-C 105.714 -2.955 . . . . 0.0 105.714 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.24 -38.01 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 1 O-C-N 130.588 4.346 . . . . 0.0 111.209 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.89 143.84 0.06 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 109.025 -3.716 . . . . 0.0 110.644 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 28.5 p90 178.3 -178.33 0.26 Allowed 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 129.279 4.112 . . . . 0.0 116.184 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.7 14.11 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.91 131.59 24.11 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 115.749 -2.38 . . . . 0.0 111.259 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.3 122.91 28.56 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.691 HD22 HD11 ' A' ' 43' ' ' ILE . 94.8 mt -84.1 -62.12 1.64 Allowed 'General case' 0 C--O 1.247 0.968 1 O-C-N 130.547 4.905 . . . . 0.0 115.086 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -101.86 35.74 2.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 125.777 1.923 . . . . 0.0 111.383 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 68.25 26.28 6.98 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 126.9 2.625 . . . . 0.0 110.672 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.87 -60.78 0.04 OUTLIER Glycine 0 CA--C 1.557 2.712 1 CA-C-O 113.204 -4.109 . . . . 0.0 105.61 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 58' ' ' ALA . 8.8 m -5.25 -77.53 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 1 O-C-N 135.278 7.105 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 63' ' ' LEU . 5.6 tp10 74.86 122.97 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.497 1 O-C-N 129.321 4.138 . . . . 0.0 103.865 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -154.39 69.85 0.77 Allowed 'General case' 0 C--O 1.205 -1.287 0 CA-C-N 109.285 -3.598 . . . . 0.0 106.843 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -67.92 96.83 0.62 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 111.176 -2.738 . . . . 0.0 106.273 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -165.39 172.11 40.86 Favored Glycine 0 C--O 1.207 -1.579 1 C-N-CA 111.175 -5.298 . . . . 0.0 107.843 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -133.89 143.13 48.08 Favored 'General case' 0 CA--C 1.507 -0.706 1 O-C-N 134.863 6.86 . . . . 0.0 113.241 179.874 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.639 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 22.9 m95 -113.82 122.17 46.24 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 101.338 -3.579 . . . . 0.0 101.338 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 66' ' ' THR . 18.6 p -117.02 48.92 1.24 Allowed 'General case' 0 C--N 1.316 -0.848 2 O-C-N 135.59 8.056 . . . . 0.0 115.873 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.803 ' CB ' HD11 ' A' ' 49' ' ' LEU . 2.6 tmm? -30.84 133.09 0.08 Allowed 'General case' 0 C--O 1.216 -0.7 1 O-C-N 134.376 7.298 . . . . 0.0 108.472 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.03 76.36 1.56 Allowed 'General case' 0 N--CA 1.48 1.048 1 O-C-N 129.12 4.012 . . . . 0.0 108.296 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.95 -113.11 5.57 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.71 28.18 1.59 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 114.172 -2.823 . . . . 0.0 114.432 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.294 0.1 OUTLIER -130.21 154.61 47.38 Favored 'General case' 0 C--N 1.342 0.255 1 O-C-N 129.273 4.108 . . . . 0.0 112.843 -179.834 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.597 ' CD1' HD11 ' A' ' 98' ' ' LEU . 4.3 mt -131.11 70.36 1.47 Allowed 'General case' 0 C--O 1.211 -0.939 0 O-C-N 129.081 3.988 . . . . 0.0 111.46 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.71 123.53 43.87 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 2 O-C-N 131.076 5.235 . . . . 0.0 110.512 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.19 -166.84 39.72 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-N 108.428 -3.987 . . . . 0.0 103.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 4.9 tttm -178.02 133.69 0.15 Allowed 'General case' 0 C--O 1.203 -1.387 1 O-C-N 132.304 5.355 . . . . 0.0 112.453 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -128.95 164.18 23.72 Favored 'General case' 0 N--CA 1.48 1.069 2 O-C-N 131.561 5.538 . . . . 0.0 102.386 -179.434 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.0 OUTLIER -157.65 143.18 17.18 Favored 'General case' 0 N--CA 1.432 -1.347 1 CA-C-N 107.21 -4.541 . . . . 0.0 113.491 -178.901 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 85' ' ' LYS . 4.3 ptm180 -102.62 94.24 5.53 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 129.281 4.113 . . . . 0.0 109.185 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -33.46 -36.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.431 1 O-C-N 134.393 7.308 . . . . 0.0 112.114 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -38.96 -52.09 1.79 Allowed 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.99 5.181 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -121.76 5.23 9.99 Favored 'General case' 0 N--CA 1.422 -1.874 0 O-C-N 127.808 3.193 . . . . 0.0 118.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 75.43 36.01 45.69 Favored Glycine 0 CA--C 1.554 2.497 2 C-N-CA 112.019 -4.896 . . . . 0.0 100.866 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HG2' ' CG ' ' A' ' 80' ' ' ARG 0.274 14.3 tptp -76.94 -75.11 0.21 Allowed 'General case' 0 N--CA 1.422 -1.865 1 O-C-N 131.918 5.128 . . . . 0.0 120.088 -179.695 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 42.8 mt-10 84.4 88.95 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.499 1 O-C-N 129.766 4.416 . . . . 0.0 108.317 -178.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.94 56.05 0.65 Allowed 'General case' 0 C--O 1.196 -1.76 1 O-C-N 131.66 5.6 . . . . 0.0 111.031 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -67.93 157.99 5.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 108.895 -3.775 . . . . 0.0 102.9 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -129.35 74.12 1.56 Allowed 'General case' 0 C--O 1.213 -0.868 1 O-C-N 133.982 7.051 . . . . 0.0 109.425 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.56 133.48 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 1 O-C-N 129.41 4.194 . . . . 0.0 107.436 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -178.12 148.58 0.51 Allowed 'General case' 0 C--O 1.191 -1.997 0 O-C-N 128.479 3.612 . . . . 0.0 114.6 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 3.6 mt-10 -143.66 114.67 7.81 Favored 'General case' 0 CA--C 1.561 1.376 1 O-C-N 129.874 4.484 . . . . 0.0 107.327 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.864 ' CD1' HD12 ' A' ' 98' ' ' LEU . 2.6 mm -18.43 80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.243 1 O-C-N 134.499 7.374 . . . . 0.0 110.661 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.21 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.733 1 O-C-N 132.648 6.217 . . . . 0.0 115.305 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.95 -131.21 10.23 Favored Glycine 0 CA--C 1.553 2.406 1 N-CA-C 102.061 -4.416 . . . . 0.0 102.061 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.16 29.3 8.01 Favored 'General case' 0 C--N 1.361 1.09 1 CA-C-N 107.189 -4.505 . . . . 0.0 109.587 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.565 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -156.28 151.62 26.71 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 114.635 -2.602 . . . . 0.0 108.253 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 93' ' ' ILE . 2.5 tt -105.15 126.47 52.12 Favored 'General case' 0 N--CA 1.445 -0.705 1 O-C-N 132.215 5.947 . . . . 0.0 112.132 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -77.25 -82.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 1 CA-C-O 109.927 -4.844 . . . . 0.0 108.256 -179.994 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 99' ' ' ILE . 95.8 mt-30 103.43 111.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.35 1 O-C-N 133.363 6.664 . . . . 0.0 100.903 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -112.29 102.49 10.64 Favored 'General case' 0 N--CA 1.424 -1.74 1 O-C-N 130.464 4.853 . . . . 0.0 113.847 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -75.24 101.3 4.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 113.513 -3.275 . . . . 0.0 105.326 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -84.92 97.8 9.98 Favored 'General case' 0 C--O 1.217 -0.642 1 O-C-N 129.511 4.257 . . . . 0.0 104.211 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -120.18 119.3 32.85 Favored 'General case' 0 C--N 1.363 1.185 1 CA-C-N 108.182 -4.099 . . . . 0.0 117.517 -179.935 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 50.15 23.01 1.04 Allowed 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.8 -6.43 24.05 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 117.639 -2.22 . . . . 0.0 115.464 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 108' ' ' GLU 0.257 39.5 t -95.16 163.0 2.35 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 CA-C-N 113.039 -1.581 . . . . 0.0 111.013 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 107' ' ' VAL . 6.0 mt-10 -126.35 58.76 1.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 127.26 2.85 . . . . 0.0 106.647 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.508 . . -82.02 128.94 34.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.061 3.351 . . . . 0.0 112.11 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD2' HG21 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.12 171.86 11.99 Favored 'General case' 0 N--CA 1.418 -2.07 1 O-C-N 132.872 6.358 . . . . 0.0 106.912 179.836 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -134.11 133.52 41.19 Favored 'General case' 0 C--O 1.207 -1.173 2 O-C-N 130.501 4.876 . . . . 0.0 99.602 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 pt -85.52 85.04 2.23 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 1 O-C-N 130.376 4.798 . . . . 0.0 113.653 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -91.64 179.25 5.7 Favored 'General case' 0 N--CA 1.441 -0.924 1 O-C-N 132.395 6.059 . . . . 0.0 104.836 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -154.61 -163.23 1.54 Allowed 'General case' 0 C--O 1.198 -1.644 1 O-C-N 130.766 5.041 . . . . 0.0 111.652 179.992 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.63 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 74.5 tttt -118.76 -119.59 0.31 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 115' ' ' LYS . 1.3 tp10 . . . . . 0 CA--C 1.558 1.275 0 CA-C-O 117.429 -1.272 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.109 0.48 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.426 ' HZ ' HD11 ' A' ' 93' ' ' ILE . 1.8 m-30 -87.72 -5.2 58.78 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 127.275 2.859 . . . . 0.0 106.661 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -55.73 104.86 0.15 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 158.34 9.79 Favored Glycine 0 C--N 1.351 1.389 0 C-N-CA 114.15 -3.881 . . . . 0.0 104.488 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 58.1 p -78.72 163.42 25.43 Favored 'General case' 0 C--N 1.355 0.82 1 C-N-CA 110.566 -4.454 . . . . 0.0 110.307 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.553 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 23.0 m95 -132.81 162.27 31.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 112.319 -3.705 . . . . 0.0 111.043 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.8 OUTLIER 49.43 179.41 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 178.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 8' ' ' VAL 0.357 2.3 t -8.51 100.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.471 3 O-C-N 132.769 6.293 . . . . 0.0 115.265 174.96 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -161.76 97.45 1.06 Allowed 'General case' 0 C--N 1.362 1.136 0 CA-C-N 110.942 -2.844 . . . . 0.0 107.773 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -178.52 147.94 0.43 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.535 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 70.5 156.82 0.16 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 126.737 2.523 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -105.38 92.84 4.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 127.305 2.878 . . . . 0.0 107.378 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -92.77 134.06 35.42 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 127.54 3.025 . . . . 0.0 109.385 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 11.2 p90 -87.77 -10.93 49.57 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.171 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 3.9 p -162.23 142.4 9.97 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 116.997 -1.881 . . . . 0.0 106.509 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -126.36 18.88 6.42 Favored Glycine 0 C--O 1.207 -1.541 0 O-C-N 127.824 3.202 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . 64.02 18.15 11.04 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 111.707 -2.247 . . . . 0.0 106.754 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 18' ' ' HIS . 5.6 m170 58.13 58.53 3.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 126.454 2.346 . . . . 0.0 112.05 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.61 -54.82 2.47 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.875 3.234 . . . . 0.0 109.769 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 10.24 111.64 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 133.627 6.829 . . . . 0.0 115.376 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.93 140.76 36.46 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER -161.75 153.54 19.07 Favored 'General case' 0 C--O 1.2 -1.542 1 O-C-N 129.608 4.317 . . . . 0.0 104.354 -179.985 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD2' HG13 ' A' ' 34' ' ' VAL . 4.5 mt -114.01 175.88 5.28 Favored 'General case' 0 CA--C 1.565 1.53 3 O-C-N 134.57 7.419 . . . . 0.0 97.544 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.628 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.3 m -171.33 -79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 128.802 3.814 . . . . 0.0 104.939 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 24' ' ' THR . 0.9 OUTLIER 73.88 151.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-N 109.277 -3.601 . . . . 0.0 110.346 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.9 m -166.66 71.91 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -48.94 125.36 10.25 Favored 'General case' 0 C--O 1.205 -1.268 1 O-C-N 131.589 5.555 . . . . 0.0 114.376 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -88.64 -112.36 0.06 Allowed 'General case' 0 C--N 1.365 1.249 1 O-C-N 130.389 4.806 . . . . 0.0 103.299 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.77 100.82 1.02 Allowed Glycine 0 CA--C 1.564 3.136 2 N-CA-C 100.526 -5.03 . . . . 0.0 100.526 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 m120 56.04 43.58 26.85 Favored 'General case' 0 N--CA 1.424 -1.745 0 O-C-N 128.04 2.847 . . . . 0.0 109.158 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -155.6 116.88 3.94 Favored 'General case' 0 CA--C 1.548 0.88 2 N-CA-C 98.618 -4.586 . . . . 0.0 98.618 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -127.95 169.82 13.55 Favored 'General case' 0 C--O 1.198 -1.628 2 N-CA-C 97.978 -4.823 . . . . 0.0 97.978 179.868 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.78 132.53 29.04 Favored 'General case' 0 CA--C 1.494 -1.185 2 O-C-N 133.921 7.013 . . . . 0.0 99.643 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.597 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.364 2.2 t -91.5 134.68 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 -179.998 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -68.78 -10.7 58.13 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 108.535 -3.939 . . . . 0.0 119.201 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.44 ' CB ' HG12 ' A' ' 34' ' ' VAL 0.27 2.3 tp10 -33.82 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 109.919 -3.31 . . . . 0.0 110.262 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -81.57 132.6 35.31 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 116.463 -2.095 . . . . 0.0 108.073 -179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.63 -152.31 0.14 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 114.09 -3.044 . . . . 0.0 111.711 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.72 1.78 21.36 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 127.833 3.208 . . . . 0.0 108.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 82.8 m-85 -82.29 -56.58 3.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 109.451 -3.522 . . . . 0.0 105.424 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -175.09 -174.5 0.76 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 130.198 4.686 . . . . 0.0 112.334 -179.872 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.99 124.67 34.95 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.309 0.9 OUTLIER -142.09 106.66 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.039 2 CA-C-O 131.859 5.599 . . . . 0.0 109.483 -178.493 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 125.18 25.1 Favored 'General case' 0 C--N 1.373 1.587 1 CA-C-N 107.197 -4.547 . . . . 0.0 109.546 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.3 p -91.24 65.27 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.495 2 O-C-N 130.32 4.762 . . . . 0.0 100.128 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.08 161.11 5.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 1 C-N-CA 111.003 -4.279 . . . . 0.0 115.941 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CE1' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -174.77 -155.71 0.06 Allowed 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 128.1 3.375 . . . . 0.0 110.579 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.8 mt-10 -130.81 177.92 7.05 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 115.478 -2.201 . . . . 0.0 108.083 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 94.7 6.59 Favored 'General case' 0 C--O 1.214 -0.795 1 O-C-N 131.64 5.587 . . . . 0.0 109.804 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.99 53.17 1.95 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-O 114.04 -3.644 . . . . 0.0 104.868 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 25.5 t -141.44 123.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 1 O-C-N 130.714 4.42 . . . . 0.0 111.677 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.42 160.18 20.65 Favored 'General case' 0 C--N 1.356 0.883 1 O-C-N 130.053 4.595 . . . . 0.0 107.788 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 56.0 p90 -177.15 177.68 1.21 Allowed 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 130.676 4.985 . . . . 0.0 116.228 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.3 135.23 47.12 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.0 -154.1 0.6 Allowed 'General case' 0 C--O 1.204 -1.336 0 O-C-N 128.009 3.318 . . . . 0.0 113.745 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.27 89.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.52 HD12 HD22 ' A' ' 63' ' ' LEU . 10.3 mt -83.12 170.62 14.58 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.974 2.671 . . . . 0.0 110.508 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.47 -141.17 0.69 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 126.049 2.093 . . . . 0.0 113.521 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -26.06 60.46 Favored 'General case' 0 C--N 1.366 1.289 0 O-C-N 120.884 -1.135 . . . . 0.0 110.089 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.04 71.56 0.03 OUTLIER Glycine 0 CA--C 1.554 2.519 0 CA-C-O 116.337 -2.368 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 p -73.82 -134.06 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 1 O-C-N 132.636 5.551 . . . . 0.0 107.382 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -146.8 -61.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 112.38 -3.728 . . . . 0.0 104.022 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.52 HD22 HD12 ' A' ' 57' ' ' LEU . 1.8 mp 42.86 70.48 0.29 Allowed 'General case' 0 C--O 1.214 -0.809 1 O-C-N 131.047 5.217 . . . . 0.0 111.449 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.7 m -88.28 117.31 27.1 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.921 1.688 . . . . 0.0 108.936 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 176.62 -138.78 4.18 Favored Glycine 0 N--CA 1.473 1.106 1 C-N-CA 110.108 -5.806 . . . . 0.0 107.62 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.382 5.9 t -173.07 166.69 4.99 Favored 'General case' 0 N--CA 1.446 -0.665 1 O-C-N 130.667 4.393 . . . . 0.0 116.889 -179.122 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.569 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 2.6 m95 -122.37 145.94 47.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -136.31 32.42 2.84 Favored 'General case' 0 C--N 1.321 -0.652 2 O-C-N 135.099 7.749 . . . . 0.0 111.649 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 16.7 ttp -32.17 132.99 0.11 Allowed 'General case' 0 C--N 1.317 -0.84 2 O-C-N 134.909 7.63 . . . . 0.0 108.873 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.45 139.83 33.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 111.331 -2.668 . . . . 0.0 108.809 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 30.02 -98.67 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.816 1 O-C-N 133.086 6.491 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -119.35 56.78 0.91 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 108.813 -3.693 . . . . 0.0 112.337 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.4 mtpt -148.11 179.8 7.48 Favored 'General case' 0 C--O 1.249 1.069 1 O-C-N 129.335 4.147 . . . . 0.0 110.322 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.2 mt -147.13 46.14 1.16 Allowed 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 126.193 2.183 . . . . 0.0 112.755 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.63 130.16 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 1 O-C-N 129.294 4.121 . . . . 0.0 113.356 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.488 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 156.99 -142.49 8.73 Favored Glycine 0 CA--C 1.564 3.151 2 CA-C-N 106.647 -4.797 . . . . 0.0 103.917 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 170.59 168.69 0.07 Allowed 'General case' 0 N--CA 1.44 -0.942 1 O-C-N 133.789 6.229 . . . . 0.0 111.04 -179.289 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.599 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 11.9 m-85 -150.1 157.02 42.68 Favored 'General case' 0 C--O 1.197 -1.694 1 O-C-N 133.743 6.902 . . . . 0.0 101.615 176.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.946 ' HG2' HG13 ' A' ' 81' ' ' VAL . 4.2 ttpt -155.4 135.69 13.14 Favored 'General case' 0 N--CA 1.422 -1.835 1 CA-C-N 107.612 -4.358 . . . . 0.0 112.407 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.652 ' CD ' HD11 ' A' ' 87' ' ' LEU . 14.9 ptm180 -106.38 47.57 0.87 Allowed 'General case' 0 CA--C 1.557 1.237 0 O-C-N 125.906 2.004 . . . . 0.0 107.18 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.946 HG13 ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -6.16 -52.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.619 1 O-C-N 132.08 5.862 . . . . 0.0 115.658 -179.758 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 80' ' ' ARG . 2.1 t0 -39.23 -29.86 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 129.026 3.954 . . . . 0.0 113.059 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 174.79 -22.83 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.978 0 O-C-N 128.982 3.926 . . . . 0.0 114.132 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 80' ' ' ARG . . . -69.59 -52.18 22.13 Favored Glycine 0 CA--C 1.536 1.36 1 N-CA-C 101.826 -4.51 . . . . 0.0 101.826 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.03 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.939 2 O-C-N 132.015 5.185 . . . . 0.0 120.303 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 10.1 mt-10 74.48 62.03 0.07 Allowed 'General case' 0 N--CA 1.432 -1.366 1 O-C-N 130.226 4.704 . . . . 0.0 117.75 177.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' A' ' 80' ' ' ARG . 23.2 mt -97.7 61.53 1.6 Allowed 'General case' 0 C--O 1.199 -1.588 1 O-C-N 130.175 4.672 . . . . 0.0 108.8 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 77' ' ' LYS . 16.1 mt -69.98 -173.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 1 CA-C-N 107.226 -4.534 . . . . 0.0 104.487 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -153.28 54.12 0.75 Allowed 'General case' 0 C--O 1.196 -1.726 0 O-C-N 128.014 3.321 . . . . 0.0 105.449 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.9 t -57.66 113.12 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 1 O-C-N 131.014 5.196 . . . . 0.0 103.474 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.721 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -161.7 162.76 29.89 Favored 'General case' 0 C--O 1.189 -2.131 0 C-N-CA 113.599 -3.24 . . . . 0.0 113.27 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.721 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -162.76 100.78 1.01 Allowed 'General case' 0 N--CA 1.449 -0.522 2 O-C-N 131.187 5.304 . . . . 0.0 104.779 179.662 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 98' ' ' LEU . 1.8 mm 5.04 73.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.807 1 O-C-N 134.731 7.519 . . . . 0.0 111.453 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 t -15.21 -51.33 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.071 1 O-C-N 133.431 6.707 . . . . 0.0 117.092 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.17 -88.72 0.1 Allowed Glycine 0 CA--C 1.548 2.15 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -125.73 18.43 7.99 Favored 'General case' 0 CA--C 1.555 1.149 2 CA-C-N 105.785 -5.207 . . . . 0.0 103.52 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.618 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -153.49 168.79 24.97 Favored 'General case' 0 C--O 1.22 -0.486 0 O-C-N 127.892 3.245 . . . . 0.0 106.776 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -108.08 139.98 41.94 Favored 'General case' 0 N--CA 1.434 -1.27 1 O-C-N 130.525 4.891 . . . . 0.0 109.863 -179.885 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HB ' ' HD3' ' A' ' 91' ' ' ARG . 1.5 mt -102.96 -79.76 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.474 2 O-C-N 130.022 4.576 . . . . 0.0 105.639 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.522 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.6 mm100 105.52 82.27 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 1 O-C-N 132.776 6.298 . . . . 0.0 104.734 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.503 HG23 ' CG ' ' A' ' 110' ' ' LYS . 1.8 m -84.89 95.84 9.15 Favored 'General case' 0 N--CA 1.427 -1.619 2 O-C-N 130.983 5.177 . . . . 0.0 112.137 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -68.29 149.46 49.43 Favored 'General case' 0 N--CA 1.48 1.064 1 C-N-CA 110.094 -4.642 . . . . 0.0 105.085 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.3 m -118.53 72.0 0.86 Allowed 'General case' 0 C--O 1.206 -1.216 1 O-C-N 130.97 5.169 . . . . 0.0 107.75 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -88.55 108.68 19.54 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 109.118 -3.674 . . . . 0.0 110.372 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -17.25 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 126.96 2.663 . . . . 0.0 116.563 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.84 0.92 58.77 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 117.654 -2.213 . . . . 0.0 113.94 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.4 t -157.67 104.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -88.26 79.95 7.68 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-O 114.892 -2.48 . . . . 0.0 108.078 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.381 . . -93.91 148.47 22.11 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 129.41 4.194 . . . . 0.0 109.591 179.528 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' CG ' HG23 ' A' ' 101' ' ' THR . 50.8 mtmt -119.31 163.56 16.98 Favored 'General case' 0 N--CA 1.421 -1.912 1 O-C-N 133.393 6.683 . . . . 0.0 110.825 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.72 133.22 46.92 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 129.059 3.975 . . . . 0.0 101.152 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.59 114.16 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 O-C-N 127.367 2.917 . . . . 0.0 112.153 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 10.1 m-30 -129.25 174.2 9.81 Favored 'General case' 0 N--CA 1.422 -1.85 2 O-C-N 131.773 5.671 . . . . 0.0 104.251 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -163.74 -165.35 1.02 Allowed 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 132.728 6.267 . . . . 0.0 111.915 179.976 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.553 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 16.3 tttt -117.13 142.93 46.38 Favored 'General case' 0 N--CA 1.427 -1.624 0 O-C-N 119.123 -2.236 . . . . 0.0 111.279 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.243 0 O-C-N 126.94 2.65 . . . . 0.0 112.478 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 117.391 -1.29 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 2.1 m-30 -91.86 -22.64 19.98 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 128.727 3.767 . . . . 0.0 105.624 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.59 97.62 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.614 1 O-C-N 129.529 4.268 . . . . 0.0 115.795 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.17 142.7 3.46 Favored Glycine 0 N--CA 1.47 0.941 0 C-N-CA 114.295 -3.812 . . . . 0.0 105.949 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.319 60.2 p -67.41 164.2 19.16 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 115.558 -2.457 . . . . 0.0 107.537 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 71.1 m95 -141.19 135.34 30.68 Favored 'General case' 0 N--CA 1.411 -2.394 0 O-C-N 127.788 3.18 . . . . 0.0 113.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 26.5 mtmt 59.37 178.03 0.08 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.81 HG11 HD22 ' A' ' 21' ' ' LEU 0.26 1.5 t 16.87 99.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.64 3 O-C-N 135.122 7.764 . . . . 0.0 120.932 174.876 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -121.18 -47.91 2.24 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.615 -3.803 . . . . 0.0 108.38 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -31.28 84.62 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 125.138 2.399 . . . . 0.0 115.738 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -66.93 129.66 40.62 Favored 'General case' 0 C--N 1.37 1.491 0 CA-C-N 111.197 -2.729 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 21.79 3.91 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.446 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.7 t30 66.33 33.01 7.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 71.47 136.07 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.821 1 O-C-N 131.593 5.558 . . . . 0.0 108.769 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.87 9.14 6.89 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-N 113.055 -1.884 . . . . 0.0 108.793 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.45 -87.52 0.5 Allowed Glycine 0 CA--C 1.541 1.669 0 O-C-N 128.125 3.39 . . . . 0.0 112.668 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.62 31.14 0.23 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 117.216 -1.794 . . . . 0.0 108.979 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -120.11 156.76 30.38 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 126.019 2.074 . . . . 0.0 109.271 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 46.33 82.21 0.03 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 125.908 2.005 . . . . 0.0 113.941 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.651 ' C ' HD13 ' A' ' 21' ' ' LEU . 21.6 t30 -163.31 114.92 1.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.955 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.38 -97.78 0.06 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 113.477 -3.154 . . . . 0.0 106.244 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' H ' HD23 ' A' ' 21' ' ' LEU 0.362 1.3 mttp 83.12 155.99 0.11 Allowed 'General case' 0 C--O 1.198 -1.616 1 O-C-N 134.931 7.644 . . . . 0.0 101.555 -178.54 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 7.3 mt -118.14 174.02 6.45 Favored 'General case' 0 C--O 1.242 0.695 2 O-C-N 132.133 5.896 . . . . 0.0 99.275 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.3 m -156.06 -79.03 0.09 Allowed 'General case' 0 C--O 1.198 -1.633 0 O-C-N 127.615 3.072 . . . . 0.0 107.83 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.952 HG22 ' CD1' ' A' ' 32' ' ' PHE . 1.2 mp 62.08 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-N 109.401 -3.545 . . . . 0.0 114.702 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 m -145.68 78.57 1.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 116.239 -2.184 . . . . 0.0 106.954 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 18.0 mm-40 -91.21 -111.73 0.09 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 114.112 -3.035 . . . . 0.0 109.879 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -122.2 3.65 9.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.55 -16.0 55.36 Favored Glycine 0 CA--C 1.56 2.9 0 N-CA-C 104.289 -3.525 . . . . 0.0 104.289 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -115.81 -38.18 3.75 Favored 'General case' 0 N--CA 1.435 -1.182 1 O-C-N 131.078 4.634 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -102.38 -170.33 1.79 Allowed 'General case' 0 CA--C 1.551 0.996 1 N-CA-C 97.856 -4.868 . . . . 0.0 97.856 179.198 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.952 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER 179.68 126.29 0.07 Allowed 'General case' 0 C--O 1.195 -1.791 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 179.154 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.87 112.25 25.3 Favored 'General case' 0 C--O 1.252 1.197 3 O-C-N 132.585 6.178 . . . . 0.0 97.208 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.317 2.5 t -75.51 146.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 1 C-N-CA 111.026 -4.269 . . . . 0.0 105.152 179.799 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.263 2.4 ttmm -87.5 54.87 3.28 Favored 'General case' 0 C--O 1.195 -1.778 2 CA-C-O 128.523 4.011 . . . . 0.0 113.486 179.577 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.282 27.4 tt0 -72.68 68.55 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.854 -2.43 . . . . 0.0 107.668 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 132.87 36.64 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 116.341 -2.144 . . . . 0.0 108.088 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -137.13 -162.12 1.25 Allowed 'General case' 0 C--N 1.351 0.631 0 C-N-CA 114.126 -3.029 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.51 58.12 0.94 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 126.744 2.528 . . . . 0.0 106.659 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 15.9 m-85 -134.01 -71.81 0.5 Allowed 'General case' 0 C--N 1.358 0.962 1 CA-C-N 107.57 -4.377 . . . . 0.0 106.765 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -156.1 10.0 0.26 Allowed 'General case' 0 N--CA 1.428 -1.538 1 O-C-N 129.848 4.467 . . . . 0.0 116.206 179.691 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 75.63 8.41 3.73 Favored 'General case' 0 CA--C 1.548 0.897 1 O-C-N 129.407 4.192 . . . . 0.0 109.353 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.938 HD11 ' CD1' ' A' ' 57' ' ' LEU 0.336 0.7 OUTLIER -28.45 138.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.319 3 O-C-N 133.288 6.618 . . . . 0.0 110.615 178.741 . . . . . . . . 5 4 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.87 137.64 50.91 Favored 'General case' 0 C--N 1.373 1.601 1 CA-C-N 108.176 -4.102 . . . . 0.0 109.373 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.99 107.47 22.9 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.128 1 O-C-N 131.696 5.623 . . . . 0.0 104.2 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 47' ' ' PHE 0.319 2.8 p -110.02 168.47 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 2 O-C-N 130.196 4.685 . . . . 0.0 116.148 -179.752 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' N ' HG22 ' A' ' 46' ' ' VAL . 6.3 p90 -174.43 -177.93 1.31 Allowed 'General case' 0 N--CA 1.427 -1.59 1 O-C-N 131.601 5.563 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 2.7 tt0 -138.3 40.75 2.26 Favored 'General case' 0 N--CA 1.426 -1.644 0 O-C-N 127.007 2.692 . . . . 0.0 114.445 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.17 115.02 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.098 1 O-C-N 132.795 6.31 . . . . 0.0 115.855 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.44 44.88 94.64 Favored Glycine 0 CA--C 1.545 1.933 1 CA-C-O 112.673 -4.404 . . . . 0.0 104.367 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -115.12 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 1 O-C-N 133.672 6.16 . . . . 0.0 114.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 66' ' ' THR . 53.7 p-10 -79.27 151.9 30.86 Favored 'General case' 0 C--N 1.354 0.775 1 O-C-N 129.577 4.298 . . . . 0.0 111.624 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -174.55 -174.62 0.86 Allowed 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.39 4.181 . . . . 0.0 115.581 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.35 97.04 4.6 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -106.31 130.88 54.07 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 128.135 3.397 . . . . 0.0 113.025 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.1 t -91.99 71.09 5.52 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 112.599 -3.64 . . . . 0.0 106.002 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.938 ' CD1' HD11 ' A' ' 43' ' ' ILE . 27.2 tp -36.17 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 O-C-N 131.164 5.29 . . . . 0.0 112.997 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -88.07 -136.11 0.09 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 114.984 -2.436 . . . . 0.0 109.169 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.11 58.25 0.63 Allowed 'General case' 0 C--O 1.21 -0.987 0 O-C-N 127.249 2.843 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.03 -81.05 0.11 Allowed Glycine 0 CA--C 1.556 2.642 1 CA-C-O 112.499 -4.5 . . . . 0.0 104.116 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.844 HG21 HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER 23.02 -94.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.717 1 O-C-N 133.316 5.95 . . . . 0.0 109.398 -179.704 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 74.91 29.2 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 126.827 2.579 . . . . 0.0 108.743 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 61' ' ' THR . 7.2 mp -63.91 92.11 0.07 Allowed 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 128.868 3.855 . . . . 0.0 107.817 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 100.0 m -89.12 99.31 12.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.798 -2.91 . . . . 0.0 109.668 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -160.38 -152.72 6.66 Favored Glycine 0 CA--C 1.546 1.998 1 C-N-CA 113.635 -4.126 . . . . 0.0 105.843 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 66' ' ' THR . 6.0 t -163.5 118.48 1.64 Allowed 'General case' 0 CA--C 1.494 -1.179 1 O-C-N 131.184 4.696 . . . . 0.0 114.927 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.708 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m95 -96.31 124.74 40.41 Favored 'General case' 0 C--N 1.356 0.867 1 O-C-N 115.62 -4.425 . . . . 0.0 106.86 -179.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.51 94.88 5.07 Favored 'General case' 0 C--O 1.202 -1.402 2 O-C-N 135.106 7.754 . . . . 0.0 108.948 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.68 88.18 0.7 Allowed 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 109.943 -3.299 . . . . 0.0 103.965 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -94.93 81.82 3.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 126.422 2.327 . . . . 0.0 111.112 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.56 -92.85 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 O-C-N 128.647 3.717 . . . . 0.0 109.973 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -110.03 35.49 3.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.748 -2.726 . . . . 0.0 111.182 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 154.09 43.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 115.5 -2.48 . . . . 0.0 108.377 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.532 HD13 HH11 ' A' ' 91' ' ' ARG . 4.9 mt -134.8 37.32 3.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 127.605 3.066 . . . . 0.0 115.098 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.63 149.61 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 1 CA-C-N 107.879 -4.237 . . . . 0.0 115.598 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 155.75 -150.07 21.33 Favored Glycine 0 CA--C 1.551 2.301 1 N-CA-C 102.754 -4.138 . . . . 0.0 102.754 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 8.4 tttt 178.84 115.5 0.04 OUTLIER 'General case' 0 C--N 1.368 1.403 1 O-C-N 131.6 4.941 . . . . 0.0 114.311 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -120.25 145.32 47.15 Favored 'General case' 0 C--O 1.203 -1.383 1 CA-C-O 129.87 4.652 . . . . 0.0 102.309 179.802 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG2' ' C ' ' A' ' 85' ' ' LYS . 18.1 ttmt -138.52 147.62 43.33 Favored 'General case' 0 N--CA 1.425 -1.707 1 CA-C-N 105.991 -5.095 . . . . 0.0 115.103 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.656 ' CG ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -97.49 24.28 6.79 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 128.917 3.886 . . . . 0.0 111.908 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' CB ' ' HD2' ' A' ' 79' ' ' LYS . 1.4 m 1.73 -57.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.777 1 O-C-N 134.891 7.619 . . . . 0.0 114.807 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 t0 -45.34 -27.18 0.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 128.989 3.931 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.78 -7.96 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 C-N-CA 114.218 -2.993 . . . . 0.0 118.358 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.21 -46.34 2.22 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 105.212 -3.155 . . . . 0.0 105.212 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 90.04 -150.49 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 134.351 6.56 . . . . 0.0 113.896 179.844 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.492 ' HA ' ' HG3' ' A' ' 79' ' ' LYS 0.264 0.2 OUTLIER -63.58 133.44 53.76 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-O 112.77 -3.491 . . . . 0.0 114.965 -178.799 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.656 HD13 ' CG ' ' A' ' 80' ' ' ARG . 0.5 OUTLIER -137.24 49.21 2.03 Favored 'General case' 0 C--O 1.202 -1.412 1 O-C-N 137.99 9.556 . . . . 0.0 108.434 178.108 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.68 174.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.17 2 CA-C-N 107.153 -4.567 . . . . 0.0 104.235 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.99 55.15 1.72 Allowed 'General case' 0 N--CA 1.436 -1.132 1 O-C-N 130.856 5.098 . . . . 0.0 107.726 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.1 t -55.76 112.47 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 1 O-C-N 131.436 5.46 . . . . 0.0 100.865 178.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.754 ' HD3' HD21 ' A' ' 98' ' ' LEU . 5.5 ttm180 -151.89 160.08 43.63 Favored 'General case' 0 CA--C 1.495 -1.144 1 C-N-CA 109.468 -4.893 . . . . 0.0 113.472 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -160.87 136.38 7.96 Favored 'General case' 0 C--N 1.356 0.869 1 O-C-N 131.464 5.477 . . . . 0.0 109.369 -179.429 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 98' ' ' LEU . 4.4 mm -67.45 124.47 22.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 1 O-C-N 133.336 6.647 . . . . 0.0 110.354 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -77.22 -65.58 0.93 Allowed 'General case' 0 CA--C 1.503 -0.845 1 O-C-N 129.716 4.385 . . . . 0.0 113.171 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' OE2' ' A' ' 97' ' ' GLU . . . -174.44 78.05 0.08 OUTLIER Glycine 0 CA--C 1.554 2.482 0 C-N-CA 115.358 -3.306 . . . . 0.0 106.711 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 79.44 27.79 0.37 Allowed 'General case' 0 CA--C 1.551 0.981 1 CA-C-N 106.599 -4.801 . . . . 0.0 108.445 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.663 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.325 0.0 OUTLIER -168.8 142.74 3.05 Favored 'General case' 0 CA--C 1.564 1.516 1 O-C-N 130.731 5.019 . . . . 0.0 107.938 179.252 . . . . . . . . 5 4 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.894 HD12 ' CD1' ' A' ' 93' ' ' ILE . 3.8 tt -106.2 133.14 51.37 Favored 'General case' 0 N--CA 1.439 -1.0 2 O-C-N 135.206 7.817 . . . . 0.0 112.853 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 112' ' ' ILE . 3.3 mt -75.08 -66.86 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-O 111.99 -3.862 . . . . 0.0 105.479 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 73.95 92.95 0.08 Allowed 'General case' 0 C--O 1.201 -1.483 1 O-C-N 134.712 7.508 . . . . 0.0 101.631 -179.664 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -111.24 124.04 51.42 Favored 'General case' 0 N--CA 1.425 -1.699 1 CA-C-N 107.844 -4.253 . . . . 0.0 113.44 179.929 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -91.95 151.81 20.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 113.297 -3.24 . . . . 0.0 104.279 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 103' ' ' THR . 1.1 m -134.95 70.34 1.44 Allowed 'General case' 0 C--O 1.214 -0.807 1 O-C-N 131.843 5.714 . . . . 0.0 105.571 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -88.96 121.4 31.28 Favored 'General case' 0 CA--C 1.497 -1.064 1 CA-C-N 106.813 -4.721 . . . . 0.0 111.302 -179.898 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 5.9 mt-10 55.71 -85.31 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.441 0.696 . . . . 0.0 109.857 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -151.0 37.46 0.87 Allowed Glycine 0 C--N 1.363 2.05 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.696 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.4 t -136.68 149.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 116.685 -1.626 . . . . 0.0 114.767 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -124.46 104.3 8.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 128.954 3.909 . . . . 0.0 105.183 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 110' ' ' LYS 0.435 . . -100.11 -32.13 11.07 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 128.526 3.641 . . . . 0.0 113.588 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' CG ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER 46.73 -80.37 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.091 1 O-C-N 137.735 9.397 . . . . 0.0 111.462 179.961 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' ALA . 2.4 mtm180 77.34 88.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.42 1 N-CA-C 99.505 -4.258 . . . . 0.0 99.505 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 99' ' ' ILE . 3.7 pt -65.36 159.28 4.15 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 1 O-C-N 130.372 4.795 . . . . 0.0 114.077 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 22.0 m-85 -144.81 -148.44 0.24 Allowed 'General case' 0 N--CA 1.442 -0.848 1 O-C-N 130.858 5.099 . . . . 0.0 105.124 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.67 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -168.24 -141.33 0.04 OUTLIER 'General case' 0 C--O 1.196 -1.744 1 O-C-N 131.678 5.611 . . . . 0.0 112.139 -179.446 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 7.0 tttt -132.43 154.04 50.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 125.891 1.676 . . . . 0.0 110.804 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.196 179.569 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.978 ' CE1' HD11 ' A' ' 93' ' ' ILE . 23.1 m-85 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 103.735 -2.691 . . . . 0.0 103.735 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -148.96 62.72 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 115.791 -2.364 . . . . 0.0 114.913 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 176.78 21.13 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 115.192 -3.385 . . . . 0.0 107.449 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.274 16.9 p -72.84 168.47 18.8 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 128.253 2.972 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.599 ' CG ' ' HG3' ' A' ' 115' ' ' LYS 0.287 7.8 m95 -145.81 146.69 31.27 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 111.732 -3.985 . . . . 0.0 112.485 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.681 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 1.3 mtmt 61.49 -179.43 0.12 Allowed 'General case' 0 C--O 1.196 -1.752 1 O-C-N 133.297 6.623 . . . . 0.0 118.142 175.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 21' ' ' LEU 0.256 1.0 OUTLIER . . . . . 0 CA--C 1.482 -1.664 3 O-C-N 135.793 8.183 . . . . 0.0 119.938 174.897 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.725 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.314 0.4 OUTLIER 150.76 142.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.509 1 O-C-N 133.083 6.49 . . . . 0.0 104.805 179.935 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -110.84 165.77 11.57 Favored 'General case' 0 CA--C 1.561 1.399 1 O-C-N 133.098 6.499 . . . . 0.0 100.441 179.589 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.664 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 4.2 m 175.95 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 1 O-C-N 132.316 6.01 . . . . 0.0 107.123 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.768 HG12 HG22 ' A' ' 34' ' ' VAL . 2.6 mp -133.41 140.67 46.34 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 109.007 -3.724 . . . . 0.0 109.422 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 m -159.2 81.15 0.77 Allowed 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 113.214 -3.395 . . . . 0.0 107.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.27 151.41 1.45 Allowed 'General case' 0 N--CA 1.433 -1.289 1 O-C-N 132.849 6.343 . . . . 0.0 111.271 179.631 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.28 56.09 0.88 Allowed 'General case' 0 C--N 1.352 0.71 1 O-C-N 129.903 4.502 . . . . 0.0 106.873 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.77 87.36 0.61 Allowed Glycine 0 CA--C 1.547 2.031 2 C-N-CA 110.846 -5.454 . . . . 0.0 101.746 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 p30 34.13 55.13 0.61 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 133.029 5.782 . . . . 0.0 109.048 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 88.82 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 3 O-C-N 131.392 5.432 . . . . 0.0 96.533 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 69' ' ' MET . 21.7 p90 -121.82 131.19 53.92 Favored 'General case' 0 C--O 1.209 -1.056 2 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.84 156.36 22.13 Favored 'General case' 0 N--CA 1.478 0.934 4 O-C-N 136.984 8.928 . . . . 0.0 98.656 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 25' ' ' ILE 0.291 2.7 t -127.54 143.14 41.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 126.932 3.253 . . . . 0.0 104.425 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.2 tttm -93.12 77.65 4.61 Favored 'General case' 0 N--CA 1.421 -1.881 2 CA-C-O 133.808 6.527 . . . . 0.0 114.072 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -86.45 62.1 7.22 Favored 'General case' 0 N--CA 1.42 -1.974 1 CA-C-N 108.019 -4.173 . . . . 0.0 107.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -74.0 119.37 18.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 112.924 -3.51 . . . . 0.0 109.574 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.03 -142.02 0.16 Allowed 'General case' 0 C--N 1.353 0.724 0 C-N-CA 114.574 -2.85 . . . . 0.0 114.385 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -96.48 38.53 1.2 Allowed 'General case' 0 C--N 1.355 0.845 0 O-C-N 124.16 0.912 . . . . 0.0 111.07 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -152.42 54.63 0.8 Allowed 'General case' 0 C--O 1.2 -1.508 1 O-C-N 129.937 4.523 . . . . 0.0 105.182 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.26 -161.78 0.2 Allowed 'General case' 0 C--O 1.246 0.889 1 O-C-N 132.387 6.054 . . . . 0.0 110.621 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.63 -68.99 0.46 Allowed 'General case' 0 CA--C 1.548 0.892 1 C-N-CA 111.661 -4.016 . . . . 0.0 102.599 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER 67.14 134.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.776 2 CA-C-O 131.505 5.431 . . . . 0.0 107.79 179.886 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.38 165.17 18.87 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 110.027 -3.26 . . . . 0.0 108.787 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.91 101.15 7.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.091 1 O-C-N 132.234 5.959 . . . . 0.0 101.663 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 5.8 p -111.48 154.75 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 129.054 3.971 . . . . 0.0 112.867 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL 0.27 3.3 p90 170.5 -172.55 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 132.098 5.874 . . . . 0.0 110.739 -179.606 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 51' ' ' VAL . 19.4 mt-10 -115.29 81.32 1.56 Allowed 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 115.66 -2.416 . . . . 0.0 114.73 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 69' ' ' MET . 1.0 OUTLIER 48.73 -115.78 0.78 Allowed 'General case' 0 C--N 1.324 -0.524 1 O-C-N 129.573 4.295 . . . . 0.0 110.041 -179.987 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 49' ' ' LEU . . . -71.81 76.15 0.7 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 104.664 -3.374 . . . . 0.0 104.664 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' HD2' ' A' ' 53' ' ' PHE . 2.3 t -129.93 97.22 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 1 O-C-N 131.659 4.976 . . . . 0.0 111.014 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.75 157.37 36.59 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 128.129 3.393 . . . . 0.0 110.844 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 13.3 p90 172.33 159.98 0.11 Allowed 'General case' 0 C--N 1.373 1.605 1 O-C-N 131.072 5.233 . . . . 0.0 114.869 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' OE2' ' A' ' 62' ' ' GLU . . . -105.34 96.83 6.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 101.047 -3.686 . . . . 0.0 101.047 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.569 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -121.42 128.33 52.06 Favored 'General case' 0 C--O 1.209 -1.067 1 O-C-N 129.169 4.043 . . . . 0.0 114.665 -179.928 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.84 168.25 13.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 112.76 -3.576 . . . . 0.0 107.738 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.464 HD23 HG13 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.12 -41.85 0.38 Allowed 'General case' 0 CA--C 1.509 -0.597 1 O-C-N 131.32 5.387 . . . . 0.0 112.774 -179.957 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -123.62 45.42 2.46 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 125.065 1.478 . . . . 0.0 114.487 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 42.64 28.38 0.12 Allowed 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.9 41.4 0.06 OUTLIER Glycine 0 C--N 1.364 2.138 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.62 HG23 ' HB3' ' A' ' 58' ' ' ALA . 30.1 p -137.32 177.74 7.64 Favored 'General case' 0 C--N 1.315 -0.893 1 O-C-N 130.849 4.5 . . . . 0.0 112.054 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 5.5 tp10 -161.77 37.5 0.13 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 114.888 -2.725 . . . . 0.0 106.084 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.18 99.6 0.03 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-N 108.839 -3.8 . . . . 0.0 109.644 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -107.69 108.39 19.6 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 110.329 -3.123 . . . . 0.0 108.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.537 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -162.77 -161.09 11.79 Favored Glycine 0 C--O 1.21 -1.382 1 C-N-CA 110.93 -5.414 . . . . 0.0 107.57 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 66' ' ' THR . 9.9 t -154.19 99.36 2.22 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 129.004 3.414 . . . . 0.0 116.737 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.702 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 25.2 m95 -81.89 127.72 33.31 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 118.11 -2.869 . . . . 0.0 104.461 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.9 p -120.3 69.16 0.86 Allowed 'General case' 0 N--CA 1.433 -1.293 1 O-C-N 135.695 8.122 . . . . 0.0 110.647 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 59.6 ttp -43.7 118.53 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 1 O-C-N 131.712 5.632 . . . . 0.0 104.058 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -119.5 59.71 0.85 Allowed 'General case' 0 CA--C 1.506 -0.742 1 O-C-N 130.693 4.996 . . . . 0.0 110.509 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.86 -85.89 1.37 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 117.46 -2.305 . . . . 0.0 110.682 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.01 23.94 11.83 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 114.531 -2.652 . . . . 0.0 114.025 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.77 -172.36 2.51 Favored 'General case' 0 N--CA 1.476 0.866 1 O-C-N 130.172 4.67 . . . . 0.0 109.705 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 74' ' ' LEU . 1.1 mt -157.97 37.94 0.26 Allowed 'General case' 0 C--O 1.214 -0.766 0 O-C-N 126.641 2.463 . . . . 0.0 114.028 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -62.04 135.69 26.28 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 1 CA-C-N 106.905 -4.679 . . . . 0.0 114.841 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.472 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 159.24 -161.14 31.85 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 104.549 -3.42 . . . . 0.0 104.549 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -174.59 122.97 0.27 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 113.675 -3.21 . . . . 0.0 112.344 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -124.35 146.37 48.88 Favored 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.066 4.604 . . . . 0.0 102.039 179.913 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.718 ' CG ' ' C ' ' A' ' 85' ' ' LYS 0.348 16.9 ttmt -139.23 152.3 47.21 Favored 'General case' 0 N--CA 1.424 -1.735 1 CA-C-N 105.448 -5.342 . . . . 0.0 117.845 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.823 ' HG2' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -113.33 63.02 0.64 Allowed 'General case' 0 CA--C 1.558 1.284 0 O-C-N 126.246 2.216 . . . . 0.0 108.929 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 t -17.34 -44.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 131.949 5.781 . . . . 0.0 115.425 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 9.9 t0 -65.4 -3.42 4.24 Favored 'General case' 0 N--CA 1.436 -1.161 1 O-C-N 129.97 4.544 . . . . 0.0 113.773 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER 168.23 -30.41 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 115.705 -2.398 . . . . 0.0 114.688 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.568 ' HA3' ' HD3' ' A' ' 80' ' ' ARG . . . -88.64 -30.63 14.96 Favored Glycine 0 CA--C 1.56 2.844 1 C-N-CA 112.729 -4.557 . . . . 0.0 103.268 -179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.718 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 50.25 17.25 0.32 Allowed 'General case' 0 N--CA 1.441 -0.887 1 O-C-N 133.356 5.974 . . . . 0.0 118.896 178.69 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' C ' HD12 ' A' ' 87' ' ' LEU . 1.7 mt-10 161.06 116.22 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 1 O-C-N 129.459 4.224 . . . . 0.0 109.172 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' A' ' 80' ' ' ARG . 4.8 mp -152.76 58.95 0.8 Allowed 'General case' 0 C--O 1.207 -1.145 1 O-C-N 139.654 10.597 . . . . 0.0 112.301 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.5 mt -67.25 -177.49 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.235 1 CA-C-N 108.032 -4.167 . . . . 0.0 104.893 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.21 63.1 0.97 Allowed 'General case' 0 C--O 1.194 -1.82 0 O-C-N 128.425 3.578 . . . . 0.0 106.255 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -67.29 112.06 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 110.735 -2.939 . . . . 0.0 106.469 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD3' ' HB ' ' A' ' 99' ' ' ILE . 1.2 tpm_? -172.55 157.38 3.9 Favored 'General case' 0 C--O 1.191 -1.998 1 C-N-CA 110.738 -4.385 . . . . 0.0 116.779 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -137.21 148.17 46.34 Favored 'General case' 0 N--CA 1.439 -1.011 1 O-C-N 129.707 4.38 . . . . 0.0 104.971 179.522 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 98' ' ' LEU . 16.3 mm -55.55 96.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.913 1 O-C-N 131.632 5.582 . . . . 0.0 109.304 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 t -38.51 -57.17 1.19 Allowed 'General case' 0 CA--C 1.509 -0.619 1 O-C-N 130.885 5.116 . . . . 0.0 113.621 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.68 98.48 0.15 Allowed Glycine 0 CA--C 1.559 2.824 1 N-CA-C 103.051 -4.02 . . . . 0.0 103.051 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m120 79.48 15.43 0.94 Allowed 'General case' 0 CA--C 1.553 1.063 1 O-C-N 132.466 5.451 . . . . 0.0 108.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.286 0.1 OUTLIER 174.68 170.73 0.25 Allowed 'General case' 0 C--O 1.2 -1.533 0 O-C-N 127.256 2.847 . . . . 0.0 108.928 178.696 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 93' ' ' ILE . 16.5 tp -123.36 158.45 31.06 Favored 'General case' 0 N--CA 1.434 -1.237 2 O-C-N 132.475 6.109 . . . . 0.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 100' ' ' GLN 0.255 7.8 mt -110.01 -89.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.101 4.626 . . . . 0.0 103.807 179.835 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 99' ' ' ILE . 9.8 mm100 111.1 90.23 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.729 1 O-C-N 133.188 6.555 . . . . 0.0 105.473 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.1 m -87.71 92.45 9.11 Favored 'General case' 0 C--O 1.197 -1.7 2 O-C-N 132.623 6.202 . . . . 0.0 112.28 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -70.39 113.38 7.47 Favored 'General case' 0 C--O 1.211 -0.968 2 CA-C-N 107.073 -4.603 . . . . 0.0 106.192 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -88.64 116.1 26.65 Favored 'General case' 0 C--N 1.364 1.209 1 O-C-N 129.105 4.003 . . . . 0.0 102.419 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.1 t80 -131.52 118.13 19.73 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.888 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 36.06 30.87 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.25 -19.91 9.18 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.779 -2.153 . . . . 0.0 114.188 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -94.94 162.34 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 116.41 -1.757 . . . . 0.0 115.298 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.25 85.07 2.35 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 126.456 2.348 . . . . 0.0 105.288 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.438 . . -89.27 104.6 17.13 Favored 'General case' 0 C--O 1.2 -1.548 1 O-C-N 129.112 4.007 . . . . 0.0 110.507 179.959 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 101' ' ' THR . 7.3 mttp -97.84 134.57 40.81 Favored 'General case' 0 C--N 1.315 -0.9 1 O-C-N 135.3 7.875 . . . . 0.0 110.425 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 99' ' ' ILE . 8.8 mtt180 -99.28 141.21 32.34 Favored 'General case' 0 CA--C 1.562 1.411 1 N-CA-C 99.395 -4.298 . . . . 0.0 99.395 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.8 mt -112.94 105.84 19.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 1 O-C-N 130.175 4.672 . . . . 0.0 113.824 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 29.1 m-85 -137.88 -156.19 0.67 Allowed 'General case' 0 N--CA 1.436 -1.156 2 CA-C-N 108.124 -4.125 . . . . 0.0 104.993 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -169.82 -138.9 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.173 1 O-C-N 131.041 5.213 . . . . 0.0 110.483 -179.785 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.599 ' HG3' ' CG ' ' A' ' 6' ' ' TRP . 15.7 tttt -135.83 166.71 22.67 Favored 'General case' 0 C--O 1.202 -1.409 0 O-C-N 127.503 3.002 . . . . 0.0 109.434 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.434 -1.268 0 CA-C-N 113.579 -1.646 . . . . 0.0 106.699 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 CA--C 1.531 0.218 0 CA-C-O 124.006 1.86 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 9.8 p-10 -169.83 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 116.632 -2.027 . . . . 0.0 114.887 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.24 -147.02 4.87 Favored Glycine 0 N--CA 1.48 1.62 1 C-N-CA 111.067 -5.349 . . . . 0.0 103.502 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 24' ' ' THR 0.254 7.5 p -97.63 166.18 11.62 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 129.333 3.608 . . . . 0.0 104.266 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.26 10.4 m95 -141.61 169.91 16.71 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 113.058 -3.354 . . . . 0.0 112.07 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.737 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 51.5 179.06 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 178.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.258 0.5 OUTLIER . . . . . 0 CA--C 1.487 -1.454 3 CA-C-O 135.591 7.377 . . . . 0.0 120.263 175.015 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HG2' ' C ' ' A' ' 21' ' ' LEU 0.359 0.0 OUTLIER 171.13 165.91 0.08 Allowed 'General case' 0 CA--C 1.566 1.56 1 O-C-N 130.573 4.921 . . . . 0.0 104.268 179.805 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -131.93 151.48 51.69 Favored 'General case' 0 CA--C 1.558 1.26 4 O-C-N 134.494 7.371 . . . . 0.0 97.022 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.661 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.2 m 178.15 71.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 1 O-C-N 131.293 5.371 . . . . 0.0 104.215 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 34' ' ' VAL . 2.7 mp -86.37 157.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 109.87 -3.332 . . . . 0.0 108.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 27.9 m -172.77 77.3 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 128.056 3.347 . . . . 0.0 104.673 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -45.75 145.09 1.47 Allowed 'General case' 0 N--CA 1.449 -0.524 2 O-C-N 132.556 6.16 . . . . 0.0 112.032 179.925 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -105.0 -7.48 19.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.98 63.86 0.24 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 103.21 -3.956 . . . . 0.0 103.21 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 p30 105.52 -20.9 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.277 1 O-C-N 131.944 5.143 . . . . 0.0 111.559 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.67 84.69 7.46 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 129.091 3.994 . . . . 0.0 103.27 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 17.1 m-85 -91.76 129.44 37.73 Favored 'General case' 0 C--O 1.19 -2.056 1 N-CA-C 96.177 -5.49 . . . . 0.0 96.177 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 33' ' ' THR 0.255 0.4 OUTLIER -132.88 114.1 13.66 Favored 'General case' 0 N--CA 1.483 1.213 2 O-C-N 135.895 8.247 . . . . 0.0 97.454 -179.741 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.442 14.7 t -85.48 154.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 2 C-N-CA 109.64 -4.824 . . . . 0.0 102.935 -179.839 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.8 tttm -88.56 16.8 6.05 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 118.848 2.907 . . . . 0.0 118.848 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.596 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.327 26.3 mt-10 -44.25 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 109.624 -3.443 . . . . 0.0 107.934 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 46.0 m -100.08 141.74 32.5 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 125.764 1.915 . . . . 0.0 113.322 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.08 -151.3 0.48 Allowed 'General case' 0 C--N 1.352 0.696 0 O-C-N 128.231 3.457 . . . . 0.0 110.054 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -111.08 30.01 7.27 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 20.2 m-85 -110.6 -78.13 0.59 Allowed 'General case' 0 CA--C 1.55 0.956 2 O-C-N 130.448 4.843 . . . . 0.0 110.366 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 2.1 mpt_? -139.04 8.63 2.51 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.563 2.415 . . . . 0.0 112.391 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.1 18.97 2.39 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 127.2 2.813 . . . . 0.0 104.204 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' ILE 0.298 9.7 tt -35.71 101.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.722 3 O-C-N 132.218 5.949 . . . . 0.0 110.24 179.429 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.42 144.64 27.21 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 109.643 -3.435 . . . . 0.0 105.944 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.85 128.22 50.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 1 O-C-N 129.38 4.175 . . . . 0.0 101.344 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.345 14.0 p -138.85 159.42 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 115.912 -2.315 . . . . 0.0 112.945 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.3 OUTLIER 170.73 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.928 1 O-C-N 134.977 7.673 . . . . 0.0 111.193 179.959 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.71 76.9 1.46 Allowed 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 127.212 2.82 . . . . 0.0 110.175 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 38.87 -80.48 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.962 1 O-C-N 131.71 5.631 . . . . 0.0 115.813 179.692 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.63 72.88 2.75 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 53' ' ' PHE . 4.5 t -148.2 110.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.104 1 O-C-N 131.666 4.98 . . . . 0.0 116.958 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.08 163.04 15.66 Favored 'General case' 0 C--O 1.205 -1.257 1 O-C-N 129.87 4.481 . . . . 0.0 106.277 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.512 ' HD2' HG12 ' A' ' 51' ' ' VAL . 10.7 p90 178.38 167.24 0.82 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 112.36 -3.736 . . . . 0.0 114.495 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.69 83.92 1.93 Allowed 'General case' 0 CA--C 1.562 1.412 1 N-CA-C 100.104 -4.036 . . . . 0.0 100.104 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.469 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -93.65 150.07 20.71 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 129.049 3.968 . . . . 0.0 114.997 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 88.22 2.71 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 128.362 3.539 . . . . 0.0 105.144 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.6 mm? -62.38 -75.63 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 128.796 3.81 . . . . 0.0 112.455 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 43' ' ' ILE . . . -84.33 -138.98 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 114.797 -2.525 . . . . 0.0 109.045 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.75 6.68 23.79 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 127.26 2.85 . . . . 0.0 111.734 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 66.19 0.19 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-O 115.712 -2.716 . . . . 0.0 107.323 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.531 ' HB ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -123.14 -76.61 0.59 Allowed 'General case' 0 C--O 1.213 -0.863 1 O-C-N 130.786 4.463 . . . . 0.0 112.869 179.939 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER 65.03 32.47 10.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.632 1.208 . . . . 0.0 109.438 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 61' ' ' THR . 3.7 mp -71.35 84.06 0.79 Allowed 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 128.371 3.545 . . . . 0.0 108.334 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -72.28 115.73 11.87 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 77' ' ' LYS . . . -150.29 -155.36 6.82 Favored Glycine 0 C--O 1.199 -2.041 1 C-N-CA 110.423 -5.656 . . . . 0.0 107.801 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.653 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.28 1.1 t -179.73 130.17 0.1 Allowed 'General case' 0 CA--C 1.499 -0.994 1 O-C-N 134.394 6.585 . . . . 0.0 110.969 -177.391 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.675 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 71.7 m95 -140.86 113.12 7.92 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 118.307 -2.745 . . . . 0.0 106.509 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 p -96.57 54.83 1.38 Allowed 'General case' 0 N--CA 1.428 -1.528 2 O-C-N 132.16 5.912 . . . . 0.0 116.316 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.6 tpp -40.13 107.69 0.07 Allowed 'General case' 0 C--O 1.212 -0.908 1 O-C-N 134.398 7.311 . . . . 0.0 104.833 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -130.48 115.95 17.53 Favored 'General case' 0 C--O 1.21 -0.979 0 O-C-N 128.526 3.641 . . . . 0.0 106.85 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.89 -132.05 46.22 Favored Glycine 0 CA--C 1.55 2.225 0 C-N-CA 117.01 -2.519 . . . . 0.0 107.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 11.9 m120 -97.95 52.78 1.07 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 115.679 -2.105 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -132.99 171.65 13.68 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 125.108 1.505 . . . . 0.0 113.753 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.1 mt -153.11 46.06 0.67 Allowed 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.939 1.352 . . . . 0.0 113.146 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.4 134.12 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 110.27 -3.15 . . . . 0.0 115.679 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' CH2' ' A' ' 67' ' ' TRP . . . 157.87 -157.49 28.27 Favored Glycine 0 CA--C 1.554 2.495 1 N-CA-C 102.863 -4.095 . . . . 0.0 102.863 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.563 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.314 0.0 OUTLIER -173.14 131.6 0.49 Allowed 'General case' 0 C--N 1.363 1.153 0 O-C-N 129.326 3.603 . . . . 0.0 116.319 179.604 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.675 ' CE1' ' CZ2' ' A' ' 67' ' ' TRP . 1.2 m-85 -112.07 163.29 14.46 Favored 'General case' 0 C--O 1.193 -1.878 1 CA-C-O 129.117 4.294 . . . . 0.0 101.706 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 ttmt -171.2 146.69 2.41 Favored 'General case' 0 N--CA 1.441 -0.908 1 CA-C-N 104.39 -5.823 . . . . 0.0 117.087 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.418 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -94.91 104.81 16.7 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 115.041 -2.409 . . . . 0.0 107.287 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 35.6 m -78.5 76.38 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 1 O-C-N 131.53 5.519 . . . . 0.0 111.933 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.13 -47.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 O-C-N 129.095 3.997 . . . . 0.0 108.538 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -179.05 5.17 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 127.271 2.857 . . . . 0.0 116.408 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.17 -44.09 3.89 Favored Glycine 0 CA--C 1.545 1.947 1 N-CA-C 102.139 -4.384 . . . . 0.0 102.139 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 86.69 -156.92 0.01 OUTLIER 'General case' 0 C--O 1.252 1.227 1 O-C-N 132.357 5.386 . . . . 0.0 113.372 179.991 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.24 148.83 49.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.836 2.562 . . . . 0.0 117.425 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD11 ' CG ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -141.7 36.37 1.62 Allowed 'General case' 0 C--O 1.206 -1.21 1 O-C-N 132.619 6.199 . . . . 0.0 110.388 179.589 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.489 HD11 ' HD3' ' A' ' 77' ' ' LYS . 36.7 mt -53.65 163.95 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.558 1 CA-C-N 107.223 -4.535 . . . . 0.0 106.062 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.13 59.95 1.71 Allowed 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 128.585 3.678 . . . . 0.0 106.047 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.7 118.13 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 1 O-C-N 129.327 4.142 . . . . 0.0 104.057 179.866 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -178.74 160.82 1.2 Allowed 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 113.302 -3.359 . . . . 0.0 114.352 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HG3' ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -144.52 134.61 24.07 Favored 'General case' 0 N--CA 1.424 -1.748 2 O-C-N 132.583 6.177 . . . . 0.0 108.129 179.642 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.34 108.77 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 1 O-C-N 130.974 5.172 . . . . 0.0 110.085 179.909 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.99 91.05 3.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 126.895 2.622 . . . . 0.0 115.647 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.75 -122.42 6.59 Favored Glycine 0 C--O 1.208 -1.479 0 N-CA-C 103.692 -3.763 . . . . 0.0 103.692 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -130.96 53.51 1.97 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 109.157 -3.521 . . . . 0.0 106.012 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.272 0.2 OUTLIER 174.15 137.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 1 O-C-N 130.434 4.834 . . . . 0.0 108.837 179.957 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.683 HD23 ' HG2' ' A' ' 100' ' ' GLN . 2.5 tt -111.63 120.09 40.9 Favored 'General case' 0 C--O 1.203 -1.343 1 O-C-N 130.795 5.06 . . . . 0.0 109.067 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 100' ' ' GLN . 11.6 mt -54.07 -84.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.316 3 O-C-N 131.526 5.516 . . . . 0.0 108.852 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' HD23 ' A' ' 98' ' ' LEU . 12.0 mm-40 107.06 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.107 1 O-C-N 133.856 6.972 . . . . 0.0 104.039 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.482 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 18.5 m -96.48 84.34 3.68 Favored 'General case' 0 C--O 1.193 -1.892 2 O-C-N 133.571 6.794 . . . . 0.0 112.749 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.31 121.28 14.46 Favored 'General case' 0 C--O 1.218 -0.555 1 CA-C-N 107.862 -4.245 . . . . 0.0 106.871 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HD12 ' A' ' 88' ' ' ILE . 1.8 m -98.1 70.8 2.1 Favored 'General case' 0 C--N 1.36 1.061 1 O-C-N 130.704 5.002 . . . . 0.0 101.536 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -97.15 130.98 44.34 Favored 'General case' 0 C--N 1.362 1.127 1 CA-C-N 107.347 -4.479 . . . . 0.0 109.422 -179.994 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 34.8 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.12 31.68 25.14 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 114.941 -3.504 . . . . 0.0 116.229 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 104' ' ' TYR . 63.4 t -109.0 -49.12 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 117.934 -1.507 . . . . 0.0 110.83 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.482 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 8.1 tt0 79.07 31.83 0.28 Allowed 'General case' 0 C--N 1.35 0.604 0 O-C-N 127.431 2.957 . . . . 0.0 107.902 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.447 . . -62.42 166.71 4.85 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 113.296 -3.362 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 7.5 mttm -140.49 -48.45 0.43 Allowed 'General case' 0 N--CA 1.438 -1.043 1 O-C-N 131.909 5.756 . . . . 0.0 111.25 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.46 -158.38 0.19 Allowed 'General case' 0 C--O 1.202 -1.4 1 O-C-N 131.766 5.666 . . . . 0.0 104.446 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.78 115.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.47 1 C-N-CA 111.098 -4.241 . . . . 0.0 112.24 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 21.1 m-30 -109.97 174.34 5.91 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 131.102 5.251 . . . . 0.0 106.314 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.03 130.26 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.531 2 O-C-N 131.381 5.425 . . . . 0.0 114.109 -179.382 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.3 tttt -47.22 169.16 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 109.035 -3.712 . . . . 0.0 112.455 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.423 -1.805 0 CA-C-N 111.48 -2.6 . . . . 0.0 113.032 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 98' ' ' LEU . 75.4 m-85 . . . . . 0 CA--C 1.556 1.176 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -148.59 30.38 0.83 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 128.052 3.345 . . . . 0.0 117.324 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -151.53 8.0 Favored Glycine 0 C--N 1.349 1.293 2 C-N-CA 112.933 -4.46 . . . . 0.0 103.707 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.595 HG22 ' OG1' ' A' ' 24' ' ' THR 0.296 0.6 OUTLIER -89.85 -176.55 4.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 128.367 3.039 . . . . 0.0 105.627 179.616 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.334 19.1 m95 -162.63 153.17 16.83 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 113.147 -3.311 . . . . 0.0 113.581 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 15.2 mtmt 63.14 176.59 0.15 Allowed 'General case' 0 N--CA 1.426 -1.629 1 O-C-N 131.769 5.668 . . . . 0.0 119.086 176.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.255 0.5 OUTLIER . . . . . 0 CA--C 1.479 -1.786 3 CA-C-O 135.442 7.306 . . . . 0.0 120.869 174.88 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.035 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HG3' ' HD3' ' A' ' 35' ' ' LYS 0.447 0.0 OUTLIER 150.6 174.15 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.682 1 O-C-N 129.504 4.253 . . . . 0.0 102.383 -179.161 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HD11 ' A' ' 25' ' ' ILE . 2.6 mt -119.12 163.62 16.76 Favored 'General case' 0 CA--C 1.557 1.249 3 O-C-N 132.515 6.134 . . . . 0.0 98.742 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.9 m 179.85 96.03 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.238 1 O-C-N 133.902 7.001 . . . . 0.0 108.278 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.839 HD11 HD22 ' A' ' 23' ' ' LEU . 4.7 mp -117.28 140.47 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.193 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -164.78 84.84 0.41 Allowed 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 128.494 3.621 . . . . 0.0 107.539 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -46.06 138.36 5.23 Favored 'General case' 0 N--CA 1.438 -1.052 2 O-C-N 132.943 6.402 . . . . 0.0 110.019 179.482 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -89.47 4.58 48.66 Favored 'General case' 0 C--N 1.343 0.286 1 O-C-N 130.068 4.605 . . . . 0.0 107.457 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.21 -58.46 0.61 Allowed Glycine 0 CA--C 1.55 2.246 2 N-CA-C 100.826 -4.91 . . . . 0.0 100.826 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -10.46 4.0 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 108.785 -3.708 . . . . 0.0 109.062 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -91.45 169.52 10.71 Favored 'General case' 0 C--N 1.306 -1.308 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 25' ' ' ILE . 31.6 t80 -165.91 71.97 0.15 Allowed 'General case' 0 C--O 1.192 -1.942 1 N-CA-C 95.501 -5.74 . . . . 0.0 95.501 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -71.89 137.01 47.13 Favored 'General case' 0 CA--C 1.503 -0.856 2 O-C-N 133.717 6.886 . . . . 0.0 102.831 -179.883 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.372 0.5 OUTLIER -114.46 144.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 1 N-CA-C 99.774 -4.158 . . . . 0.0 99.774 179.248 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -101.55 58.79 0.86 Allowed 'General case' 0 N--CA 1.422 -1.858 1 CA-C-O 133.491 6.377 . . . . 0.0 117.924 -179.953 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.34 47.19 0.21 Allowed 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 108.92 -3.764 . . . . 0.0 110.151 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 30.8 t -58.05 138.04 56.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 116.017 -2.273 . . . . 0.0 108.343 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.54 127.91 0.14 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 114.737 -2.785 . . . . 0.0 114.746 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.05 -65.7 0.25 Allowed 'General case' 0 C--O 1.223 -0.298 0 O-C-N 128.972 3.92 . . . . 0.0 111.418 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 40.3 m-85 -120.55 102.16 8.25 Favored 'General case' 0 C--O 1.203 -1.393 0 O-C-N 127.861 3.226 . . . . 0.0 112.619 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.1 OUTLIER 61.47 -173.01 0.14 Allowed 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 126.722 2.513 . . . . 0.0 117.248 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -90.23 -20.4 23.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 126.671 2.482 . . . . 0.0 109.159 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 43' ' ' ILE 0.282 5.9 tp 6.84 77.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.427 2 O-C-N 133.312 6.633 . . . . 0.0 111.344 178.845 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.75 148.74 6.96 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 119.494 -2.004 . . . . 0.0 111.161 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.14 98.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 O-C-N 128.177 3.423 . . . . 0.0 104.267 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 47' ' ' PHE 0.285 8.1 p -106.64 164.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 113.662 -3.215 . . . . 0.0 116.072 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' N ' HG22 ' A' ' 46' ' ' VAL . 1.7 p90 -171.74 -161.79 0.2 Allowed 'General case' 0 N--CA 1.442 -0.862 1 O-C-N 129.976 4.547 . . . . 0.0 110.722 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -142.76 85.16 1.87 Allowed 'General case' 0 C--N 1.363 1.17 0 O-C-N 127.056 2.722 . . . . 0.0 115.373 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 18.22 94.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 131.261 5.351 . . . . 0.0 116.715 -179.941 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 92.41 46.72 3.44 Favored Glycine 0 C--O 1.207 -1.575 0 CA-C-O 114.209 -3.551 . . . . 0.0 104.95 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 t -134.89 118.53 25.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 1 O-C-N 130.315 4.185 . . . . 0.0 112.696 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.81 159.85 26.35 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 115.477 -2.489 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -173.23 165.57 4.84 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 130.625 4.953 . . . . 0.0 113.376 -179.822 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -125.57 89.98 3.13 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.13 144.57 28.12 Favored 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 116.082 -2.247 . . . . 0.0 113.341 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -106.51 71.38 0.86 Allowed 'General case' 0 CA--C 1.555 1.169 1 O-C-N 129.682 4.363 . . . . 0.0 103.018 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -38.06 -81.19 0.01 OUTLIER 'General case' 0 C--O 1.238 0.46 1 O-C-N 131.839 5.712 . . . . 0.0 114.239 -179.982 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.84 -101.45 0.03 OUTLIER 'General case' 0 C--O 1.247 0.972 0 CA-C-O 115.305 -2.284 . . . . 0.0 112.107 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.94 4.65 8.02 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 126.578 2.424 . . . . 0.0 111.844 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.59 53.65 0.03 OUTLIER Glycine 0 CA--C 1.549 2.203 0 CA-C-O 115.59 -2.784 . . . . 0.0 109.769 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 p -92.09 -64.93 1.05 Allowed 'General case' 0 CA--C 1.551 1.005 0 O-C-N 128.52 3.13 . . . . 0.0 107.352 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER 81.47 32.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.56 1 O-C-N 129.564 4.29 . . . . 0.0 111.076 177.619 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD23 ' CG ' ' A' ' 78' ' ' PHE . 2.7 mp -62.54 82.24 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.105 0 O-C-N 126.371 2.295 . . . . 0.0 110.807 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 62.3 m -69.15 117.47 10.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.78 -154.1 6.15 Favored Glycine 0 C--O 1.209 -1.434 1 C-N-CA 109.99 -5.862 . . . . 0.0 108.136 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.671 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 11.5 t 172.09 129.44 0.02 OUTLIER 'General case' 0 C--O 1.248 1.024 1 O-C-N 134.498 6.646 . . . . 0.0 111.861 -178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 69.9 m95 -136.76 128.76 29.41 Favored 'General case' 0 C--O 1.203 -1.359 1 O-C-N 116.194 -4.066 . . . . 0.0 106.283 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.456 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -111.42 31.85 5.81 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.432 4.832 . . . . 0.0 117.197 -177.988 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.73 ' CB ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 2.29 101.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.916 1 O-C-N 133.388 6.68 . . . . 0.0 109.611 179.377 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' ASN . 1.1 mm-40 -108.45 95.2 5.5 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 129.092 3.995 . . . . 0.0 112.171 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.32 -91.74 0.09 OUTLIER Glycine 0 C--N 1.353 1.51 1 O-C-N 129.55 4.281 . . . . 0.0 108.979 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -136.69 46.57 2.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 129.153 3.502 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.2 mtpt -129.33 163.04 26.58 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 128.843 3.84 . . . . 0.0 110.785 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 98' ' ' LEU . 8.2 mt -141.74 68.38 1.33 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 127.226 2.829 . . . . 0.0 112.186 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.49 83.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 2 O-C-N 131.044 5.215 . . . . 0.0 111.01 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 67' ' ' TRP . . . -150.57 -177.66 24.7 Favored Glycine 0 CA--C 1.555 2.575 2 CA-C-N 106.994 -4.639 . . . . 0.0 102.695 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.308 0.3 OUTLIER -155.14 168.69 26.2 Favored 'General case' 0 C--O 1.204 -1.32 1 O-C-N 132.758 5.623 . . . . 0.0 112.083 -179.733 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 m-85 -148.18 166.85 26.66 Favored 'General case' 0 C--O 1.19 -2.033 1 CA-C-O 128.943 4.211 . . . . 0.0 104.052 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 5.0 ttpt -173.14 132.81 0.51 Allowed 'General case' 0 N--CA 1.418 -2.059 1 CA-C-N 104.428 -5.805 . . . . 0.0 117.992 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -100.88 38.21 1.59 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 126.512 2.383 . . . . 0.0 114.281 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.606 HG22 ' N ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 7.02 -67.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.999 1 O-C-N 131.772 5.67 . . . . 0.0 115.041 179.832 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.606 ' N ' HG22 ' A' ' 81' ' ' VAL . 9.9 t0 -42.59 -26.01 0.11 Allowed 'General case' 0 N--CA 1.443 -0.808 1 O-C-N 130.248 4.717 . . . . 0.0 112.543 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.11 -16.45 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 113.954 -3.098 . . . . 0.0 117.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.446 ' HA3' ' HG3' ' A' ' 80' ' ' ARG . . . -97.79 -32.75 6.09 Favored Glycine 0 CA--C 1.548 2.147 1 C-N-CA 112.98 -4.438 . . . . 0.0 104.226 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.87 -157.85 0.06 Allowed 'General case' 0 C--O 1.25 1.089 1 O-C-N 131.672 4.983 . . . . 0.0 113.416 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.621 ' N ' ' HD3' ' A' ' 79' ' ' LYS 0.347 0.0 OUTLIER -61.88 133.46 55.46 Favored 'General case' 0 C--O 1.198 -1.638 1 O-C-N 129.534 4.271 . . . . 0.0 114.745 -177.598 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 80' ' ' ARG 0.255 2.4 mt -136.68 38.45 2.63 Favored 'General case' 0 C--O 1.208 -1.132 1 O-C-N 136.145 8.403 . . . . 0.0 109.641 -179.697 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 103' ' ' THR . 90.7 mt -61.83 163.5 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.707 1 CA-C-N 107.239 -4.528 . . . . 0.0 102.608 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.99 67.98 1.33 Allowed 'General case' 0 C--O 1.211 -0.939 1 O-C-N 134.47 7.356 . . . . 0.0 105.45 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.64 131.34 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-N 111.824 -2.444 . . . . 0.0 108.962 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -152.4 -158.25 0.88 Allowed 'General case' 0 N--CA 1.435 -1.209 1 C-N-CA 110.856 -4.338 . . . . 0.0 112.311 179.771 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 166.48 79.17 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.318 1 O-C-N 130.592 4.933 . . . . 0.0 105.265 -178.593 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 0.4 OUTLIER -24.08 92.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 1 O-C-N 132.383 6.052 . . . . 0.0 113.785 -179.419 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 p -53.07 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.102 1 O-C-N 129.261 4.101 . . . . 0.0 116.36 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -112.63 0.74 Allowed Glycine 0 CA--C 1.559 2.795 0 C-N-CA 115.633 -3.175 . . . . 0.0 106.46 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -117.38 46.19 1.76 Allowed 'General case' 0 C--N 1.362 1.133 1 CA-C-N 106.937 -4.632 . . . . 0.0 109.14 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.568 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -172.48 152.52 2.67 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 128.316 3.51 . . . . 0.0 106.863 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.552 HD22 ' HG2' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -104.32 107.37 18.25 Favored 'General case' 0 C--O 1.204 -1.306 2 O-C-N 132.321 6.013 . . . . 0.0 108.147 179.532 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -56.26 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.891 2 O-C-N 134.696 7.498 . . . . 0.0 103.287 -179.998 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.552 ' HG2' HD22 ' A' ' 98' ' ' LEU . 7.7 mm-40 99.45 98.1 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.079 1 O-C-N 130.257 4.723 . . . . 0.0 103.263 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.715 HG23 ' HG2' ' A' ' 110' ' ' LYS . 20.8 m -100.96 95.46 6.61 Favored 'General case' 0 C--O 1.195 -1.812 2 O-C-N 130.529 4.893 . . . . 0.0 111.236 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.2 m-85 -66.97 131.28 45.55 Favored 'General case' 0 C--O 1.202 -1.408 3 CA-C-N 106.411 -4.904 . . . . 0.0 106.481 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 88' ' ' ILE . 90.5 m -111.94 80.1 1.29 Allowed 'General case' 0 C--O 1.199 -1.553 1 O-C-N 131.824 5.702 . . . . 0.0 107.021 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -101.09 154.73 18.48 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 108.705 -3.862 . . . . 0.0 110.649 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.3 mm-40 -32.65 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.559 ' O ' HG13 ' A' ' 107' ' ' VAL . . . 88.88 10.15 67.19 Favored Glycine 0 C--N 1.357 1.727 0 C-N-CA 115.752 -3.118 . . . . 0.0 116.851 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -158.02 173.36 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 115.975 -1.964 . . . . 0.0 114.657 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.67 58.45 1.61 Allowed 'General case' 0 C--N 1.353 0.752 1 O-C-N 131.491 5.495 . . . . 0.0 107.067 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.321 . . -80.56 121.63 26.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 128.42 3.575 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG2' HG23 ' A' ' 101' ' ' THR . 11.4 mttt -104.28 179.61 4.22 Favored 'General case' 0 N--CA 1.426 -1.666 1 O-C-N 133.718 6.886 . . . . 0.0 108.536 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -159.14 135.82 9.38 Favored 'General case' 0 CA--C 1.562 1.406 2 O-C-N 130.131 4.644 . . . . 0.0 99.014 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 99' ' ' ILE . 1.2 pt -111.23 111.47 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 1 O-C-N 132.2 5.938 . . . . 0.0 114.039 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 93.0 m-85 -109.63 -142.18 0.38 Allowed 'General case' 0 CA--C 1.559 1.321 1 O-C-N 131.48 5.488 . . . . 0.0 101.901 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -149.94 0.06 Allowed 'General case' 0 C--O 1.205 -1.25 1 O-C-N 132.9 6.375 . . . . 0.0 111.417 179.56 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.674 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.2 tttt -131.63 -175.68 3.79 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 124.997 2.332 . . . . 0.0 112.616 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.204 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' HB2' ' NE2' ' A' ' 27' ' ' GLN . 1.4 m-85 . . . . . 0 CA--C 1.556 1.18 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -170.06 59.44 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 114.4 -2.92 . . . . 0.0 114.953 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 48.4 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 1 C-N-CA 111.366 -5.206 . . . . 0.0 107.24 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 34.8 p 59.22 162.85 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.814 1 O-C-N 132.269 5.334 . . . . 0.0 111.479 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.285 8.4 m95 -157.38 149.06 22.15 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 116.328 -1.796 . . . . 0.0 114.079 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 38.4 mtmt 59.71 178.96 0.09 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 21' ' ' LEU 0.257 0.5 OUTLIER . . . . . 0 CA--C 1.481 -1.674 3 O-C-N 134.061 7.101 . . . . 0.0 120.693 174.864 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 114.424 -2.703 . . . . 0.0 104.586 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.396 0.0 OUTLIER -147.12 140.2 25.23 Favored 'General case' 0 CA--C 1.566 1.569 1 O-C-N 131.029 5.205 . . . . 0.0 100.612 179.687 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.0 mt -98.4 164.39 12.3 Favored 'General case' 0 C--N 1.318 -0.799 2 O-C-N 133.072 6.482 . . . . 0.0 98.811 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.61 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 20.8 m 174.04 89.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 O-C-N 128.882 3.864 . . . . 0.0 104.155 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.829 HG21 ' CE1' ' A' ' 32' ' ' PHE 0.263 4.4 mp -111.05 152.86 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 108.533 -3.94 . . . . 0.0 110.809 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.0 m -162.34 80.22 0.52 Allowed 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 114.134 -3.026 . . . . 0.0 108.045 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.43 ' NE2' ' HB2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -52.35 124.0 12.24 Favored 'General case' 0 C--O 1.214 -0.814 2 O-C-N 132.996 6.435 . . . . 0.0 110.992 179.6 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -116.84 111.0 19.08 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 128.608 3.692 . . . . 0.0 103.229 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 -114.17 4.43 Favored Glycine 0 CA--C 1.546 2.026 1 N-CA-C 101.69 -4.564 . . . . 0.0 101.69 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 62.99 1.07 Allowed 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 127.338 2.434 . . . . 0.0 107.38 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.05 161.87 33.22 Favored 'General case' 0 C--N 1.306 -1.312 1 N-CA-C 98.936 -4.468 . . . . 0.0 98.936 -179.842 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.829 ' CE1' HG21 ' A' ' 25' ' ' ILE . 69.1 t80 -158.0 72.9 0.66 Allowed 'General case' 0 C--O 1.193 -1.918 1 N-CA-C 99.439 -4.282 . . . . 0.0 99.439 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -72.78 139.43 47.07 Favored 'General case' 0 CA--C 1.505 -0.761 2 O-C-N 131.784 5.677 . . . . 0.0 103.827 179.933 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.383 0.5 OUTLIER -120.13 137.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 128.782 3.802 . . . . 0.0 101.427 179.915 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 8.2 tttm -87.52 17.85 4.3 Favored 'General case' 0 N--CA 1.414 -2.228 1 N-CA-C 121.871 4.026 . . . . 0.0 121.871 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG2' HG12 ' A' ' 34' ' ' VAL . 7.3 pt-20 -49.68 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 124.727 2.204 . . . . 0.0 110.385 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.601 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 t -77.03 152.82 34.97 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 116.406 -2.117 . . . . 0.0 109.299 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.98 102.09 0.09 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 114.867 -2.733 . . . . 0.0 116.077 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 60.7 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 1 O-C-N 129.574 4.296 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 58' ' ' ALA . 1.1 m-85 -78.18 91.45 4.35 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 115.59 -2.444 . . . . 0.0 110.695 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.29 -160.76 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 129.198 4.061 . . . . 0.0 115.757 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -7.69 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 127.034 2.709 . . . . 0.0 108.205 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.8 tp 11.8 91.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.42 2 O-C-N 132.885 6.366 . . . . 0.0 111.909 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.63 123.35 17.66 Favored 'General case' 0 C--N 1.369 1.433 0 O-C-N 118.219 -2.8 . . . . 0.0 111.071 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' HE1' ' A' ' 47' ' ' PHE . 46.1 t -88.07 106.29 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 2 O-C-N 130.08 4.613 . . . . 0.0 100.014 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.312 10.7 p -118.0 153.51 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 O-C-N 127.444 2.965 . . . . 0.0 114.149 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HG12 ' A' ' 45' ' ' VAL . 2.2 p90 -179.32 -165.63 0.08 Allowed 'General case' 0 N--CA 1.429 -1.521 1 O-C-N 132.357 6.035 . . . . 0.0 111.132 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.75 73.53 1.41 Allowed 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 116.571 -2.052 . . . . 0.0 108.638 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.2 OUTLIER 69.59 -79.22 0.04 OUTLIER 'General case' 0 C--O 1.198 -1.615 2 O-C-N 132.499 6.125 . . . . 0.0 111.666 179.988 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.666 ' HA2' HG22 ' A' ' 68' ' ' THR . . . -127.91 84.09 0.33 Allowed Glycine 0 CA--C 1.537 1.437 0 N-CA-C 104.665 -3.374 . . . . 0.0 104.665 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.12 -40.74 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 O-C-N 131.341 4.789 . . . . 0.0 111.641 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.86 125.22 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.935 2 O-C-N 133.013 6.446 . . . . 0.0 108.368 179.906 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 3.3 p90 -167.25 140.6 3.55 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 112.311 -3.756 . . . . 0.0 115.37 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -90.76 151.21 21.3 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 100.846 -3.761 . . . . 0.0 100.846 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.472 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -170.51 135.1 1.16 Allowed 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 112.236 -3.786 . . . . 0.0 109.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 91.21 8.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 114.456 -2.688 . . . . 0.0 105.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 55' ' ' TYR . 10.5 mp -68.87 -96.11 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 O-C-N 129.544 4.277 . . . . 0.0 114.24 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 40' ' ' PHE . . . -46.66 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 126.587 2.429 . . . . 0.0 116.185 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.0 14.17 4.75 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 124.939 1.399 . . . . 0.0 112.739 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.66 58.68 0.09 OUTLIER Glycine 0 CA--C 1.544 1.858 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.82 ' HB ' HD13 ' A' ' 63' ' ' LEU . 71.7 p -67.3 -60.57 2.48 Favored 'General case' 0 N--CA 1.425 -1.722 1 O-C-N 131.755 5.032 . . . . 0.0 110.126 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 65.73 46.71 2.29 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 125.487 1.742 . . . . 0.0 108.532 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.82 HD13 ' HB ' ' A' ' 61' ' ' THR . 5.2 mp -99.84 84.12 2.85 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 127.66 3.1 . . . . 0.0 107.644 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 22.8 m -70.04 105.85 3.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 111.362 -2.654 . . . . 0.0 110.286 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -166.31 -156.42 9.48 Favored Glycine 0 CA--C 1.557 2.681 1 C-N-CA 111.954 -4.927 . . . . 0.0 104.314 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CE1' ' A' ' 78' ' ' PHE 0.26 8.8 t -161.27 135.54 7.02 Favored 'General case' 0 CA--C 1.491 -1.29 1 O-C-N 131.793 5.055 . . . . 0.0 114.481 179.525 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.744 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 9.4 m95 -115.03 97.66 6.35 Favored 'General case' 0 C--O 1.192 -1.96 0 O-C-N 117.839 -3.038 . . . . 0.0 104.553 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.666 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -101.16 97.36 7.9 Favored 'General case' 0 N--CA 1.447 -0.609 2 O-C-N 137.421 9.201 . . . . 0.0 114.879 179.952 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.596 ' HB3' HD21 ' A' ' 49' ' ' LEU . 3.6 ttp -56.69 109.53 0.64 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 128.974 3.922 . . . . 0.0 105.402 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 28.9 tt0 -101.68 65.12 1.01 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.158 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -105.78 0.79 Allowed Glycine 0 CA--C 1.551 2.327 0 O-C-N 128.817 3.823 . . . . 0.0 103.924 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.78 62.7 2.72 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 128.63 3.194 . . . . 0.0 109.041 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -172.23 179.14 2.67 Favored 'General case' 0 C--N 1.358 0.955 1 O-C-N 129.678 4.361 . . . . 0.0 109.95 179.934 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 74' ' ' LEU . 2.5 mt -157.6 74.54 0.75 Allowed 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 127.272 2.857 . . . . 0.0 112.191 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.58 134.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.037 -2.347 . . . . 0.0 116.036 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 173.78 -166.1 38.18 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 103.745 -3.742 . . . . 0.0 103.745 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 88' ' ' ILE 0.251 12.5 tttm 176.65 117.67 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.348 1 O-C-N 133.822 6.248 . . . . 0.0 113.345 179.997 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.744 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.1 OUTLIER -114.59 171.5 7.6 Favored 'General case' 0 C--O 1.192 -1.932 0 O-C-N 128.768 3.793 . . . . 0.0 101.335 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.338 0.0 OUTLIER -170.43 142.1 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 108.922 -3.763 . . . . 0.0 115.061 -179.001 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.513 ' CB ' ' HB3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.63 106.08 18.22 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 118.295 -1.362 . . . . 0.0 108.887 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.65 -16.82 17.59 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 1 O-C-N 130.777 5.048 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.04 -36.27 72.27 Favored 'General case' 0 C--O 1.252 1.206 0 O-C-N 129.091 3.994 . . . . 0.0 111.677 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -122.9 3.95 9.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 126.747 2.529 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 69.17 43.28 72.38 Favored Glycine 0 CA--C 1.558 2.746 2 N-CA-C 100.863 -4.895 . . . . 0.0 100.863 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -105.08 132.19 51.63 Favored 'General case' 0 N--CA 1.44 -0.946 2 CA-C-N 105.617 -5.291 . . . . 0.0 115.429 -179.539 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 6.2 mt-10 -110.16 139.6 45.14 Favored 'General case' 0 C--O 1.199 -1.554 0 CA-C-N 121.344 1.884 . . . . 0.0 107.844 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.7 45.44 2.81 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 133.031 6.457 . . . . 0.0 110.28 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 77' ' ' LYS . 96.9 mt -68.81 168.03 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.949 1 CA-C-N 107.929 -4.214 . . . . 0.0 103.592 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB3' ' CZ3' ' A' ' 67' ' ' TRP . . . -143.22 107.7 4.81 Favored 'General case' 0 C--O 1.195 -1.803 1 O-C-N 130.83 5.081 . . . . 0.0 105.587 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 t -110.87 106.95 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 128.645 3.716 . . . . 0.0 102.519 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -156.08 162.5 40.27 Favored 'General case' 0 C--O 1.189 -2.111 1 C-N-CA 110.411 -4.516 . . . . 0.0 116.136 -179.535 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.16 136.86 20.4 Favored 'General case' 0 N--CA 1.439 -1.015 2 O-C-N 132.84 6.337 . . . . 0.0 109.8 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.2 mm -47.55 124.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 1 O-C-N 131.891 5.744 . . . . 0.0 110.177 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -126.43 101.43 6.69 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 128.526 3.641 . . . . 0.0 117.297 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.94 39.05 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 59.32 44.15 15.73 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 111.637 -2.282 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.672 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.265 0.1 OUTLIER -158.71 157.64 32.16 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 114.621 -2.609 . . . . 0.0 108.309 179.063 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.469 ' CD2' ' HG2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -113.65 141.32 47.35 Favored 'General case' 0 C--O 1.208 -1.11 1 O-C-N 133.733 6.896 . . . . 0.0 109.187 179.894 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.29 5.0 mt -105.55 -46.35 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 1 O-C-N 129.302 4.126 . . . . 0.0 107.621 -179.863 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 63.2 100.5 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.142 1 O-C-N 129.58 4.3 . . . . 0.0 104.366 -179.367 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 m -98.55 96.76 8.19 Favored 'General case' 0 N--CA 1.427 -1.594 2 O-C-N 130.604 4.94 . . . . 0.0 111.949 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.28 126.15 28.86 Favored 'General case' 0 C--O 1.202 -1.438 1 CA-C-N 107.422 -4.445 . . . . 0.0 105.227 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -103.63 68.02 0.92 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -84.19 132.67 34.65 Favored 'General case' 0 CA--C 1.493 -1.213 1 CA-C-N 106.436 -4.893 . . . . 0.0 117.187 -179.63 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 44.58 31.72 0.66 Allowed 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.94 6.46 67.1 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.939 -2.077 . . . . 0.0 112.673 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.73 148.08 21.84 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-O 116.615 -1.66 . . . . 0.0 111.833 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -107.12 107.76 18.89 Favored 'General case' 0 C--N 1.371 1.517 1 O-C-N 129.116 4.01 . . . . 0.0 107.441 -179.671 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.429 . . -135.52 137.29 41.93 Favored 'General case' 0 N--CA 1.417 -2.093 1 O-C-N 130.053 4.596 . . . . 0.0 112.446 179.846 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 175.98 8.86 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 130.612 4.945 . . . . 0.0 110.479 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 37.9 mtt85 -141.24 130.36 23.39 Favored 'General case' 0 N--CA 1.48 1.059 2 O-C-N 129.861 4.476 . . . . 0.0 99.627 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 134.28 28.03 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 C-N-CA 114.359 -2.936 . . . . 0.0 112.84 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 2.6 m-85 -147.95 -157.13 0.78 Allowed 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 131.199 5.312 . . . . 0.0 107.37 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -166.94 -144.21 0.06 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 131.802 5.689 . . . . 0.0 112.061 -179.737 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 10.4 tttt -128.99 -171.74 2.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.462 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.21 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 O-C-N 127.163 2.789 . . . . 0.0 117.8 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 24' ' ' THR . . . 171.06 171.78 36.64 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 114.68 -3.628 . . . . 0.0 106.029 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -97.14 153.57 17.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 114.747 -2.781 . . . . 0.0 103.735 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.661 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 18.0 m95 -126.87 170.59 12.07 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 111.845 -3.931 . . . . 0.0 112.58 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.1 mtmt 43.58 -178.71 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.851 1 O-C-N 130.747 5.029 . . . . 0.0 117.366 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.277 1.2 t . . . . . 0 CA--C 1.484 -1.595 2 O-C-N 131.522 5.513 . . . . 0.0 118.013 174.982 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.565 1.526 0 CA-C-O 111.767 -3.968 . . . . 0.0 101.413 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 61.22 149.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 134.048 7.092 . . . . 0.0 105.825 179.224 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.534 HD11 HE21 ' A' ' 100' ' ' GLN . 5.6 mt -124.93 172.75 9.13 Favored 'General case' 0 N--CA 1.436 -1.146 3 CA-C-N 106.285 -4.961 . . . . 0.0 99.067 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 18.0 m -168.21 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 1 O-C-N 129.429 4.206 . . . . 0.0 108.553 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 2' ' ' PHE . 1.9 mp 72.14 137.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 109.202 -3.635 . . . . 0.0 109.557 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 m -170.11 73.56 0.07 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -52.35 145.29 11.37 Favored 'General case' 0 C--O 1.207 -1.177 2 O-C-N 133.307 6.63 . . . . 0.0 114.662 179.678 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.07 62.07 1.34 Allowed 'General case' 0 C--N 1.358 0.962 1 O-C-N 131.921 5.763 . . . . 0.0 104.361 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.45 57.01 0.81 Allowed Glycine 0 CA--C 1.552 2.357 1 C-N-CA 112.21 -4.805 . . . . 0.0 103.873 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 53.17 14.09 0.46 Allowed 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 112.733 -3.508 . . . . 0.0 110.6 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 84.27 5.77 Favored 'General case' 0 CA--C 1.55 0.976 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.601 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 6.3 m-85 -82.12 142.38 32.3 Favored 'General case' 0 CA--C 1.562 1.415 1 N-CA-C 96.646 -5.316 . . . . 0.0 96.646 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.83 112.99 15.36 Favored 'General case' 0 N--CA 1.482 1.155 3 O-C-N 137.527 9.267 . . . . 0.0 97.421 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 36' ' ' GLU 0.383 1.2 t -80.32 149.87 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 C-N-CA 111.01 -4.276 . . . . 0.0 104.764 179.934 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.286 0.7 OUTLIER -85.15 2.86 41.76 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 109.275 -3.602 . . . . 0.0 120.317 179.622 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -47.98 109.07 0.19 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.25 -3.159 . . . . 0.0 108.359 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -103.57 126.87 50.98 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 127.202 2.814 . . . . 0.0 107.595 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -152.46 -160.61 1.16 Allowed 'General case' 0 C--O 1.24 0.595 0 O-C-N 126.889 2.618 . . . . 0.0 112.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.25 -89.05 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.351 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.34 45.18 0.07 Allowed 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 113.732 -3.187 . . . . 0.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER 170.71 -164.35 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.959 1 O-C-N 133.573 6.796 . . . . 0.0 111.834 -179.912 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.48 121.12 44.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 1.9 tt -148.65 91.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.137 2 O-C-N 130.093 4.62 . . . . 0.0 109.378 -179.16 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.3 142.85 54.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 108.9 -3.773 . . . . 0.0 110.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 HD13 ' A' ' 57' ' ' LEU . 20.8 t -105.05 99.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.264 2 O-C-N 131.413 5.446 . . . . 0.0 99.876 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.338 3.6 p -101.56 168.07 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 112.393 -3.723 . . . . 0.0 115.656 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -164.85 163.13 21.18 Favored 'General case' 0 N--CA 1.434 -1.266 1 O-C-N 130.861 5.101 . . . . 0.0 112.583 -179.506 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.09 28.91 6.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 115.546 -2.462 . . . . 0.0 114.699 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 61.7 86.61 0.11 Allowed 'General case' 0 N--CA 1.441 -0.899 1 O-C-N 130.483 4.864 . . . . 0.0 115.811 179.931 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 76.24 75.0 0.9 Allowed Glycine 0 C--O 1.199 -2.046 0 N-CA-C 104.496 -3.441 . . . . 0.0 104.496 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.61 -42.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 1 O-C-N 130.678 4.399 . . . . 0.0 116.378 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.7 OUTLIER 78.44 126.85 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.132 1 O-C-N 129.408 4.193 . . . . 0.0 111.52 179.939 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -161.19 151.73 17.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 113.635 -3.226 . . . . 0.0 115.069 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.09 118.43 36.75 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 101.346 -3.575 . . . . 0.0 101.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.7 138.52 28.94 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 114.958 -2.697 . . . . 0.0 111.484 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.32 98.2 10.41 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 128.616 3.698 . . . . 0.0 106.822 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 10.4 mt -84.28 139.26 32.45 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 126.902 2.626 . . . . 0.0 112.378 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . 55.97 5.02 0.14 Allowed 'General case' 0 C--O 1.247 0.954 0 O-C-N 127.252 2.845 . . . . 0.0 114.842 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.21 -39.48 0.36 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.42 -40.71 7.23 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 115.336 -2.924 . . . . 0.0 107.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -79.11 150.73 31.7 Favored 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 130.208 4.123 . . . . 0.0 110.546 -179.88 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' HB2' HG12 ' A' ' 81' ' ' VAL . 17.7 mt-10 -153.49 68.26 0.78 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 113.278 -3.369 . . . . 0.0 106.418 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 87' ' ' LEU . 9.4 mp -79.17 131.15 36.11 Favored 'General case' 0 C--O 1.201 -1.459 2 CA-C-N 107.076 -4.602 . . . . 0.0 113.961 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.6 m -119.82 105.97 11.63 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . -168.4 -160.38 16.1 Favored Glycine 0 CA--C 1.542 1.723 1 C-N-CA 110.75 -5.5 . . . . 0.0 103.781 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 6.1 t -151.68 157.02 41.53 Favored 'General case' 0 N--CA 1.426 -1.639 1 O-C-N 133.35 5.971 . . . . 0.0 117.942 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 33.1 m95 -124.94 112.25 16.38 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 114.629 -2.605 . . . . 0.0 104.689 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 50' ' ' GLY . 9.1 p -107.14 52.68 0.71 Allowed 'General case' 0 N--CA 1.435 -1.192 1 O-C-N 135.51 8.006 . . . . 0.0 116.028 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.82 111.37 0.34 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 134.124 7.14 . . . . 0.0 104.153 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -90.1 -43.28 10.58 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 109.443 -3.526 . . . . 0.0 110.507 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.81 101.86 0.21 Allowed Glycine 0 CA--C 1.532 1.151 0 O-C-N 128.292 3.495 . . . . 0.0 105.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 73' ' ' LYS . 3.8 m-80 73.26 13.94 4.61 Favored 'General case' 0 N--CA 1.447 -0.595 1 O-C-N 130.683 4.402 . . . . 0.0 110.008 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 92' ' ' GLU 0.259 0.0 OUTLIER -124.06 -169.37 1.95 Allowed 'General case' 0 N--CA 1.471 0.609 1 O-C-N 129.642 4.339 . . . . 0.0 108.35 -179.72 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 91' ' ' ARG . 0.8 OUTLIER -169.31 43.65 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 128.506 3.629 . . . . 0.0 111.896 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 t -77.51 136.5 24.18 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 3 O-C-N 131.316 5.385 . . . . 0.0 113.24 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.53 -159.96 32.63 Favored Glycine 0 CA--C 1.556 2.655 1 N-CA-C 101.652 -4.579 . . . . 0.0 101.652 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.509 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 178.0 141.26 0.09 Allowed 'General case' 0 C--O 1.201 -1.484 1 O-C-N 130.918 4.54 . . . . 0.0 113.53 -179.449 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -131.18 178.5 6.65 Favored 'General case' 0 C--N 1.367 1.349 3 O-C-N 130.61 4.944 . . . . 0.0 105.694 -179.552 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.324 0.8 OUTLIER -163.74 131.24 3.44 Favored 'General case' 0 C--N 1.365 1.274 1 CA-C-N 106.257 -4.974 . . . . 0.0 113.64 179.906 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 72.7 ttt180 -85.92 94.87 9.29 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.32 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' GLU . 14.3 p -47.41 -26.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 O-C-N 133.175 6.547 . . . . 0.0 113.77 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.32 -0.712 1 O-C-N 130.121 4.638 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.82 -3.45 15.71 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 114.745 -2.782 . . . . 0.0 114.748 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.526 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 70.62 33.36 67.18 Favored Glycine 0 CA--C 1.557 2.674 2 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 3.9 tppt? -72.74 -78.26 0.09 Allowed 'General case' 0 N--CA 1.421 -1.904 1 CA-C-N 105.473 -5.364 . . . . 0.0 120.805 -178.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 52.8 mt-10 83.26 60.29 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.459 1 O-C-N 130.209 4.693 . . . . 0.0 107.906 -177.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 63' ' ' LEU . 5.2 tp -91.48 69.23 5.84 Favored 'General case' 0 CA--C 1.49 -1.341 1 O-C-N 135.009 7.693 . . . . 0.0 112.498 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.677 HD12 HG22 ' A' ' 103' ' ' THR 0.29 78.0 mt -76.81 -179.46 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 69.68 0.73 Allowed 'General case' 0 C--O 1.201 -1.469 0 O-C-N 128.627 3.705 . . . . 0.0 106.223 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.64 137.15 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 110.936 -2.847 . . . . 0.0 105.497 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.622 ' HG3' HD11 ' A' ' 98' ' ' LEU . 0.4 OUTLIER 179.51 162.48 0.89 Allowed 'General case' 0 N--CA 1.414 -2.272 1 C-N-CA 111.363 -4.135 . . . . 0.0 114.044 179.843 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -152.87 154.76 35.74 Favored 'General case' 0 N--CA 1.424 -1.746 1 O-C-N 131.441 5.463 . . . . 0.0 105.534 178.688 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.918 HD13 HD13 ' A' ' 98' ' ' LEU . 4.9 mm -56.09 91.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 1 O-C-N 132.365 6.041 . . . . 0.0 109.694 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB2' HG13 ' A' ' 99' ' ' ILE . 13.9 t -31.31 -59.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 1 O-C-N 133.002 6.439 . . . . 0.0 115.258 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.14 -83.14 0.12 Allowed Glycine 0 CA--C 1.556 2.634 0 N-CA-C 103.24 -3.944 . . . . 0.0 103.24 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.3 26.52 5.41 Favored 'General case' 0 CA--C 1.551 1.007 1 CA-C-N 107.123 -4.538 . . . . 0.0 105.193 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -164.44 163.08 22.32 Favored 'General case' 0 CA--C 1.563 1.45 1 O-C-N 133.049 6.468 . . . . 0.0 106.706 -179.881 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 93' ' ' ILE . 17.2 tp -115.89 136.53 52.95 Favored 'General case' 0 N--CA 1.437 -1.122 1 O-C-N 132.853 6.346 . . . . 0.0 110.484 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 ' HD2' ' A' ' 110' ' ' LYS 0.277 4.2 mt -85.28 -60.79 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 2 CA-C-O 110.796 -4.43 . . . . 0.0 106.102 -179.588 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.534 HE21 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER 86.09 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 1 O-C-N 134.064 7.103 . . . . 0.0 102.865 179.933 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -103.45 98.74 8.59 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.714 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.3 95.74 1.34 Allowed 'General case' 0 C--O 1.21 -1.022 2 CA-C-N 107.489 -4.414 . . . . 0.0 105.086 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.677 HG22 HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -64.1 132.69 51.25 Favored 'General case' 0 N--CA 1.48 1.032 1 O-C-N 129.541 4.276 . . . . 0.0 100.812 179.988 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -160.13 147.43 16.3 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 110.448 -3.069 . . . . 0.0 115.888 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 43.28 28.91 0.19 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.184 -2.28 . . . . 0.0 116.043 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 C--N 1.358 1.796 0 C-N-CA 117.066 -2.492 . . . . 0.0 116.328 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER -131.15 -159.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 118.801 -1.159 . . . . 0.0 112.765 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 107' ' ' VAL . 27.5 mt-10 -138.13 93.67 2.79 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 116.435 -2.106 . . . . 0.0 106.448 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.47 . . -105.13 150.39 25.08 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 125.954 2.034 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -147.78 177.59 9.19 Favored 'General case' 0 N--CA 1.427 -1.603 1 O-C-N 131.52 5.513 . . . . 0.0 110.75 -179.987 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -147.07 107.15 4.0 Favored 'General case' 0 CA--C 1.561 1.366 2 O-C-N 130.757 5.035 . . . . 0.0 99.834 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.31 132.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 O-C-N 128.872 3.857 . . . . 0.0 113.586 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.639 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 13.7 m-30 -140.15 175.73 9.35 Favored 'General case' 0 N--CA 1.423 -1.796 2 O-C-N 133.675 6.86 . . . . 0.0 104.083 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -159.95 -155.21 0.43 Allowed 'General case' 0 C--O 1.2 -1.52 1 O-C-N 131.367 5.417 . . . . 0.0 111.325 179.454 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.661 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.4 tttt -110.21 -173.04 2.16 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.747 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 109.422 -3.535 . . . . 0.0 111.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 104.381 -2.452 . . . . 0.0 104.381 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' THR 0.251 4.2 p-10 -33.1 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.7 1 O-C-N 130.493 4.871 . . . . 0.0 118.541 179.803 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.76 -176.29 43.65 Favored Glycine 0 C--N 1.355 1.594 1 C-N-CA 113.169 -4.348 . . . . 0.0 105.221 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 24' ' ' THR . 46.5 p -97.76 165.93 11.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 112.486 -3.685 . . . . 0.0 103.576 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.658 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 13.1 m95 -136.67 172.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 112.589 -3.576 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.651 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.6 mtmt 38.92 -178.64 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.505 4.878 . . . . 0.0 118.502 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.329 1.0 OUTLIER . . . . . 0 CA--C 1.493 -1.231 3 CA-C-N 105.319 -5.401 . . . . 0.0 118.794 174.915 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 21' ' ' LEU . 1.2 mp . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 113.604 -3.093 . . . . 0.0 102.909 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 37' ' ' SER 0.399 0.0 OUTLIER -150.29 168.62 23.53 Favored 'General case' 0 CA--C 1.566 1.586 1 O-C-N 131.682 5.614 . . . . 0.0 101.776 -179.912 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 7.0 mt -139.95 153.55 46.95 Favored 'General case' 0 CA--C 1.562 1.423 4 O-C-N 132.805 6.315 . . . . 0.0 97.233 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 40.7 m 175.84 77.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 1 O-C-N 131.169 5.293 . . . . 0.0 106.499 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.9 mp -89.13 157.48 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 C-N-CA 114.452 -2.899 . . . . 0.0 110.971 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 86.4 m -167.72 77.78 0.16 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 112.803 -3.559 . . . . 0.0 107.915 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.531 ' CA ' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -55.59 157.54 3.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 128.685 3.74 . . . . 0.0 115.555 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.8 61.56 1.67 Allowed 'General case' 0 C--N 1.356 0.87 0 O-C-N 128.787 3.804 . . . . 0.0 104.547 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.77 -95.39 0.43 Allowed Glycine 0 CA--C 1.555 2.566 2 O-C-N 130.551 4.907 . . . . 0.0 102.443 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -146.82 21.93 1.26 Allowed 'General case' 0 N--CA 1.415 -2.183 2 O-C-N 134.375 6.573 . . . . 0.0 106.392 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -125.46 126.39 44.85 Favored 'General case' 0 CA--C 1.552 1.02 1 O-C-N 129.729 4.393 . . . . 0.0 101.881 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.531 ' HB3' ' CA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -143.13 173.19 11.79 Favored 'General case' 0 C--O 1.193 -1.888 2 N-CA-C 96.162 -5.495 . . . . 0.0 96.162 179.736 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.07 124.66 20.85 Favored 'General case' 0 N--CA 1.473 0.708 2 O-C-N 137.945 9.528 . . . . 0.0 101.605 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.589 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.448 3.0 t -79.24 149.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 113.915 -3.114 . . . . 0.0 103.17 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.304 13.3 tttt -90.05 32.01 0.94 Allowed 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.438 27.8 tt0 -58.51 102.52 0.11 Allowed 'General case' 0 C--N 1.362 1.111 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.506 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 23.2 m -121.26 124.49 44.77 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 127.598 3.061 . . . . 0.0 112.147 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.529 ' CB ' ' HG ' ' A' ' 21' ' ' LEU . 1.5 t 159.34 -50.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 1 O-C-N 130.013 4.571 . . . . 0.0 115.317 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -38.8 -31.71 0.07 Allowed 'General case' 0 C--O 1.219 -0.545 0 O-C-N 128.416 3.572 . . . . 0.0 111.633 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.73 -48.85 0.06 Allowed 'General case' 0 C--N 1.356 0.876 1 C-N-CA 111.232 -4.187 . . . . 0.0 110.38 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.78 43.57 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.58 1.8 . . . . 0.0 114.953 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 84.47 6.18 0.59 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 128.891 3.87 . . . . 0.0 108.008 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 43' ' ' ILE 0.372 0.2 OUTLIER -25.69 92.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.069 3 O-C-N 133.55 6.781 . . . . 0.0 110.325 177.269 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.31 141.82 36.67 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 110.608 -2.996 . . . . 0.0 107.801 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.28 97.15 5.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 1 O-C-N 130.423 4.827 . . . . 0.0 103.86 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.308 1.2 p -95.47 155.64 3.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 C-N-CA 114.424 -2.91 . . . . 0.0 111.817 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.65 177.57 3.88 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 130.949 5.156 . . . . 0.0 111.8 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.19 78.37 1.83 Allowed 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 128.57 3.669 . . . . 0.0 116.144 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.1 OUTLIER 15.58 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.524 1 O-C-N 129.173 4.046 . . . . 0.0 117.204 -179.819 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 96.9 53.46 1.39 Allowed Glycine 0 C--O 1.197 -2.165 0 N-CA-C 105.236 -3.146 . . . . 0.0 105.236 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.62 111.38 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 1 O-C-N 130.611 4.359 . . . . 0.0 112.195 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.24 151.1 28.29 Favored 'General case' 0 N--CA 1.473 0.717 1 O-C-N 130.97 5.169 . . . . 0.0 109.727 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -172.19 113.94 0.31 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 112.217 -3.793 . . . . 0.0 116.86 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.89 53.12 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 101.114 -3.661 . . . . 0.0 101.114 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 57' ' ' LEU . 6.9 t80 -154.53 97.22 1.98 Allowed 'General case' 0 C--O 1.206 -1.212 0 C-N-CA 112.113 -3.835 . . . . 0.0 113.427 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.1 t -64.38 91.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.929 1 O-C-N 130.343 4.777 . . . . 0.0 104.202 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -54.96 -76.11 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 129.022 3.951 . . . . 0.0 111.841 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.71 26.26 0.5 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.02 -24.8 0.15 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -33.47 2.0 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-O 115.072 -3.071 . . . . 0.0 109.033 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.5 p -58.23 -172.38 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 1 O-C-N 130.064 4.038 . . . . 0.0 115.01 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -150.72 -60.86 0.19 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 117.109 -1.836 . . . . 0.0 107.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 mp 34.67 77.46 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.613 1 O-C-N 131.711 5.632 . . . . 0.0 113.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.0 m -87.69 99.66 12.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 112.169 -2.287 . . . . 0.0 107.988 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -159.38 -166.24 17.95 Favored Glycine 0 CA--C 1.536 1.401 1 C-N-CA 111.041 -5.361 . . . . 0.0 108.108 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 5.2 t -150.47 113.51 4.82 Favored 'General case' 0 N--CA 1.437 -1.122 2 O-C-N 132.376 5.397 . . . . 0.0 118.37 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.755 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 40.6 m95 -94.11 129.33 40.7 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 117.409 -3.307 . . . . 0.0 104.332 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.481 HG22 ' HA2' ' A' ' 50' ' ' GLY . 49.2 p -124.65 58.33 1.23 Allowed 'General case' 0 N--CA 1.433 -1.279 1 O-C-N 133.43 6.706 . . . . 0.0 116.301 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.775 ' HB3' HD21 ' A' ' 49' ' ' LEU 0.278 0.0 OUTLIER -42.26 112.43 0.34 Allowed 'General case' 0 N--CA 1.441 -0.896 1 O-C-N 131.116 5.26 . . . . 0.0 104.112 -179.923 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.43 -78.45 0.22 Allowed 'General case' 0 C--O 1.212 -0.903 0 O-C-N 127.975 3.297 . . . . 0.0 108.529 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.05 -76.47 0.06 OUTLIER Glycine 0 CA--C 1.555 2.544 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 37.34 4.11 Favored 'General case' 0 CA--C 1.537 0.45 1 O-C-N 130.09 4.053 . . . . 0.0 108.258 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -130.32 177.48 7.3 Favored 'General case' 0 C--N 1.362 1.126 1 O-C-N 129.249 4.093 . . . . 0.0 112.432 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.3 mt -149.71 46.29 0.94 Allowed 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.54 2.4 . . . . 0.0 113.285 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.82 130.36 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 2 O-C-N 131.015 5.197 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.16 -164.58 36.11 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 103.902 -3.679 . . . . 0.0 103.902 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.568 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -176.38 133.64 0.23 Allowed 'General case' 0 N--CA 1.423 -1.804 0 O-C-N 129.256 3.563 . . . . 0.0 114.149 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.6 OUTLIER -128.13 164.86 21.55 Favored 'General case' 0 C--O 1.203 -1.384 3 O-C-N 135.041 7.713 . . . . 0.0 105.272 179.765 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 85' ' ' LYS . 3.8 tmtt? -154.0 153.17 31.49 Favored 'General case' 0 N--CA 1.417 -2.106 1 CA-C-N 106.744 -4.753 . . . . 0.0 117.734 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 79' ' ' LYS . 44.0 ttt180 -104.13 85.84 2.46 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.942 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -42.68 -27.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 O-C-N 128.564 3.665 . . . . 0.0 113.338 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 30.9 t0 -72.99 0.55 10.99 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 128.787 3.804 . . . . 0.0 112.5 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER 102.09 12.0 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.284 1 O-C-N 132.772 6.295 . . . . 0.0 115.671 -179.489 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.03 -39.69 23.04 Favored Glycine 0 CA--C 1.559 2.788 2 C-N-CA 111.27 -5.252 . . . . 0.0 100.87 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 2.1 tttt 83.86 -178.95 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.655 2 O-C-N 134.558 6.681 . . . . 0.0 115.534 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' N ' ' HG2' ' A' ' 79' ' ' LYS 0.257 1.4 mt-10 -38.23 135.92 0.68 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 132.448 6.092 . . . . 0.0 116.586 -178.434 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 39.75 2.59 Favored 'General case' 0 C--O 1.197 -1.696 1 O-C-N 130.816 5.073 . . . . 0.0 110.251 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' A' ' 77' ' ' LYS . 82.8 mt -64.15 149.54 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.445 2 N-CA-C 98.907 -4.479 . . . . 0.0 98.907 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.57 76.8 1.29 Allowed 'General case' 0 C--N 1.315 -0.914 1 O-C-N 134.545 7.403 . . . . 0.0 106.843 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.9 121.67 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 128.564 3.665 . . . . 0.0 102.305 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CD ' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -162.52 157.05 21.7 Favored 'General case' 0 C--O 1.192 -1.953 1 C-N-CA 110.343 -4.543 . . . . 0.0 113.483 -179.71 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -157.29 127.96 6.55 Favored 'General case' 0 C--O 1.209 -1.045 1 O-C-N 130.281 4.738 . . . . 0.0 103.663 179.819 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.569 HD12 ' HG ' ' A' ' 98' ' ' LEU . 1.5 mm -38.0 120.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 1 O-C-N 130.787 5.054 . . . . 0.0 111.793 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 -66.58 0.57 Allowed 'General case' 0 C--O 1.248 0.975 1 O-C-N 129.273 4.108 . . . . 0.0 114.584 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -128.93 -88.92 0.57 Allowed Glycine 0 CA--C 1.547 2.07 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -130.39 44.77 2.91 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 128.985 3.403 . . . . 0.0 106.401 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.573 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.2 172.06 7.6 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.462 4.226 . . . . 0.0 109.298 -179.653 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 93' ' ' ILE . 1.9 mt -133.27 129.6 37.85 Favored 'General case' 0 C--O 1.205 -1.273 1 O-C-N 132.549 6.156 . . . . 0.0 112.16 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 34.4 mt -80.05 -82.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.932 2 O-C-N 129.796 4.435 . . . . 0.0 106.381 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 96.79 85.96 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 1 O-C-N 134.775 7.547 . . . . 0.0 105.026 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.6 m -82.57 92.26 7.08 Favored 'General case' 0 C--O 1.197 -1.688 2 O-C-N 131.18 5.3 . . . . 0.0 111.7 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 16.5 m-85 -68.54 126.5 29.86 Favored 'General case' 0 C--O 1.207 -1.138 2 C-N-CA 110.484 -4.486 . . . . 0.0 106.158 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.52 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 47.9 m -101.08 87.01 3.15 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-O 127.62 3.581 . . . . 0.0 101.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.524 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -109.85 128.17 55.16 Favored 'General case' 0 C--N 1.359 1.001 1 CA-C-N 107.485 -4.416 . . . . 0.0 115.877 -179.978 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 30.3 mt-10 50.41 20.75 0.72 Allowed 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 120.058 -1.651 . . . . 0.0 114.951 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.1 -9.33 54.49 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 117.925 -2.083 . . . . 0.0 114.739 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.739 HG12 ' HB2' ' A' ' 109' ' ' ALA . 21.4 t -100.85 113.5 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.04 91.37 3.09 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.739 ' HB2' HG12 ' A' ' 107' ' ' VAL 0.473 . . -125.77 122.54 36.52 Favored 'General case' 0 N--CA 1.414 -2.262 0 O-C-N 126.704 2.503 . . . . 0.0 116.25 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 101' ' ' THR . 22.9 mtmt -98.0 163.41 12.78 Favored 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 134.902 7.626 . . . . 0.0 108.893 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -107.85 -47.27 3.62 Favored 'General case' 0 CA--C 1.555 1.173 1 O-C-N 130.806 5.066 . . . . 0.0 105.276 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.302 11.6 mt 88.3 103.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 1 O-C-N 130.83 5.081 . . . . 0.0 109.283 179.992 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.651 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 16.8 m-85 -136.07 179.72 6.18 Favored 'General case' 0 N--CA 1.427 -1.601 1 O-C-N 132.695 6.247 . . . . 0.0 107.216 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.573 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -148.23 -152.48 0.44 Allowed 'General case' 0 C--O 1.203 -1.394 1 O-C-N 131.749 5.655 . . . . 0.0 112.369 179.125 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.6 tttt -115.55 -162.08 0.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 126.811 2.044 . . . . 0.0 111.575 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.431 -1.412 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.705 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 57.1 p30 -132.53 47.79 2.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.1 -171.68 38.67 Favored Glycine 0 N--CA 1.482 1.707 1 C-N-CA 110.731 -5.509 . . . . 0.0 105.446 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.371 4.4 p -82.85 -174.53 5.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 112.843 -3.543 . . . . 0.0 104.286 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 93' ' ' ILE 0.27 59.5 m95 -162.0 128.77 3.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 112.625 -3.56 . . . . 0.0 113.475 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.554 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 23.1 mtmt 73.91 177.4 0.24 Allowed 'General case' 0 C--O 1.193 -1.885 0 O-C-N 126.957 2.66 . . . . 0.0 117.229 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 CA--C 1.482 -1.638 3 O-C-N 136.592 8.682 . . . . 0.0 120.812 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.21 -1.001 0 N-CA-C 104.511 -2.404 . . . . 0.0 104.511 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.435 0.0 OUTLIER -152.83 142.66 22.07 Favored 'General case' 0 CA--C 1.565 1.556 1 O-C-N 129.226 4.079 . . . . 0.0 100.398 179.755 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 7.5 mt -101.16 175.97 5.41 Favored 'General case' 0 C--N 1.311 -1.107 2 O-C-N 132.704 6.252 . . . . 0.0 97.859 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 m 164.38 76.7 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 1 CA-C-O 128.53 4.014 . . . . 0.0 102.223 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 32' ' ' PHE . 3.3 mp -99.55 150.22 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 109.489 -3.505 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 6.2 m -170.79 75.62 0.07 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 113.531 -3.267 . . . . 0.0 102.669 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 2.7 pm0 -51.67 141.42 16.67 Favored 'General case' 0 C--O 1.212 -0.903 1 O-C-N 130.318 4.761 . . . . 0.0 115.862 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.2 pm0 -116.57 103.9 10.87 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 128.857 3.848 . . . . 0.0 103.17 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.61 -121.48 6.05 Favored Glycine 0 N--CA 1.482 1.738 2 N-CA-C 100.747 -4.941 . . . . 0.0 100.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 19.3 m120 -110.49 3.65 19.76 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 114.431 -2.699 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 16.9 mttt -81.36 141.14 34.28 Favored 'General case' 0 CA--C 1.544 0.718 1 N-CA-C 97.421 -5.029 . . . . 0.0 97.421 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -148.93 101.2 3.15 Favored 'General case' 0 C--O 1.194 -1.856 1 N-CA-C 96.048 -5.538 . . . . 0.0 96.048 -179.683 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -101.14 143.87 30.73 Favored 'General case' 0 N--CA 1.454 -0.264 3 O-C-N 134.461 7.351 . . . . 0.0 101.956 -179.718 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 32' ' ' PHE 0.333 1.3 t -111.75 149.5 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 2 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 179.718 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 3.0 tttm -87.32 45.02 1.23 Allowed 'General case' 0 C--O 1.195 -1.778 0 CA-C-O 126.585 3.088 . . . . 0.0 116.394 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 1.3 mm-40 -59.77 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.479 -2.146 . . . . 0.0 109.736 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 35' ' ' LYS . 4.3 t -97.2 117.65 31.87 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.485 2.366 . . . . 0.0 112.319 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.01 -156.45 0.57 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -78.4 -43.46 27.38 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 126.738 2.524 . . . . 0.0 108.763 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -45.58 -65.34 0.55 Allowed 'General case' 0 C--O 1.209 -1.04 1 O-C-N 132.341 6.026 . . . . 0.0 109.145 179.722 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -163.2 -163.39 0.84 Allowed 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 126.9 2.625 . . . . 0.0 111.135 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -16.08 57.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 114.546 -2.861 . . . . 0.0 104.748 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.598 HG13 HD22 ' A' ' 57' ' ' LEU 0.259 0.1 OUTLIER 11.59 68.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.335 3 O-C-N 133.146 6.529 . . . . 0.0 111.575 179.279 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 150.33 28.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.454 -3.521 . . . . 0.0 108.473 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 9.3 p -105.02 115.06 46.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.08 1 O-C-N 130.889 5.118 . . . . 0.0 104.126 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 47' ' ' PHE 0.256 9.7 p -131.05 161.65 40.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 C-N-CA 113.816 -3.154 . . . . 0.0 114.718 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 2.9 p90 177.09 -168.82 0.06 Allowed 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 109.35 -3.568 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.252 0.9 OUTLIER -126.18 82.75 2.1 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 128.704 3.752 . . . . 0.0 115.029 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 69' ' ' MET . 4.8 tp -0.83 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 1 O-C-N 133.614 6.821 . . . . 0.0 116.344 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 49' ' ' LEU . . . 96.4 36.14 5.23 Favored Glycine 0 C--O 1.204 -1.776 0 N-CA-C 104.048 -3.621 . . . . 0.0 104.048 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.81 114.71 22.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 1 O-C-N 130.486 4.286 . . . . 0.0 116.788 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.86 159.25 21.39 Favored 'General case' 0 CA--C 1.556 1.21 1 O-C-N 130.235 4.709 . . . . 0.0 107.882 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -172.83 164.4 5.15 Favored 'General case' 0 N--CA 1.439 -1.007 1 C-N-CA 111.318 -4.153 . . . . 0.0 113.271 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -127.9 80.88 1.99 Allowed 'General case' 0 CA--C 1.563 1.448 1 N-CA-C 100.149 -4.019 . . . . 0.0 100.149 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -102.48 126.19 49.44 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 127.976 3.297 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 t -78.9 171.45 15.17 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 112.209 -3.796 . . . . 0.0 106.643 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.598 HD22 HG13 ' A' ' 43' ' ' ILE . 5.8 mt -151.12 179.55 8.18 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 127.27 2.856 . . . . 0.0 109.514 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' ' 61' ' ' THR . . . 39.48 -98.97 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 O-C-N 128.527 3.642 . . . . 0.0 112.302 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.25 27.37 3.47 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 124.272 0.982 . . . . 0.0 112.87 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.24 71.07 0.29 Allowed Glycine 0 C--N 1.361 1.92 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 25.8 p -104.83 -47.84 3.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.326 1.45 . . . . 0.0 108.559 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.94 58.1 4.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 126.434 2.334 . . . . 0.0 109.743 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 87' ' ' LEU . 5.8 mp -84.26 76.06 10.14 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.466 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 68.8 m -52.07 119.63 4.54 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' C ' HG22 ' A' ' 66' ' ' THR . . . -143.69 -158.16 7.46 Favored Glycine 0 C--O 1.205 -1.671 1 C-N-CA 111.422 -5.18 . . . . 0.0 109.066 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.623 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.296 0.6 OUTLIER 172.78 124.12 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.886 2 O-C-N 132.5 5.471 . . . . 0.0 113.878 -178.413 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 68.2 m95 -133.83 134.1 42.41 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 119.494 -2.004 . . . . 0.0 106.635 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 2.3 p -118.27 36.33 4.41 Favored 'General case' 0 N--CA 1.424 -1.751 2 O-C-N 131.245 5.341 . . . . 0.0 116.677 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.551 ' CB ' HD22 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -8.17 87.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 1 O-C-N 136.392 8.557 . . . . 0.0 109.145 -179.988 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -168.05 1.58 Allowed 'General case' 0 C--N 1.356 0.885 1 CA-C-N 108.22 -4.082 . . . . 0.0 109.613 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.11 92.45 0.14 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 116.894 -2.574 . . . . 0.0 110.734 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 m120 54.42 44.09 29.4 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.074 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -132.42 173.64 11.08 Favored 'General case' 0 C--N 1.347 0.477 1 O-C-N 129.989 4.556 . . . . 0.0 108.576 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -148.81 58.26 1.05 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 128.245 3.466 . . . . 0.0 111.567 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.38 78.68 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.934 2 CA-C-O 129.475 4.464 . . . . 0.0 112.091 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -148.92 -167.32 13.74 Favored Glycine 0 CA--C 1.554 2.518 1 CA-C-N 106.304 -4.953 . . . . 0.0 104.35 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.566 ' HG3' ' N ' ' A' ' 78' ' ' PHE 0.265 0.7 OUTLIER -163.22 171.46 16.21 Favored 'General case' 0 C--N 1.37 1.477 2 O-C-N 131.483 4.873 . . . . 0.0 112.584 179.964 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 42.7 m-85 -149.72 151.88 34.38 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-O 127.738 3.637 . . . . 0.0 101.98 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.57 ' CE ' ' HA2' ' A' ' 84' ' ' GLY 0.29 0.0 OUTLIER -169.04 127.01 0.99 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 109.81 -3.359 . . . . 0.0 117.668 -179.75 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 69.7 mtt180 -76.6 113.02 13.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 126.588 2.43 . . . . 0.0 108.586 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.14 -24.94 25.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 1 O-C-N 131.478 5.486 . . . . 0.0 108.594 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -45.7 -51.65 12.12 Favored 'General case' 0 C--O 1.249 1.077 1 O-C-N 129.622 4.327 . . . . 0.0 112.294 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -141.93 3.97 1.65 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 113.496 -3.282 . . . . 0.0 117.621 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.57 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 98.01 36.3 4.77 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 3.2 tptm -70.96 -64.7 0.85 Allowed 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 120.131 3.382 . . . . 0.0 120.131 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 25.7 mt-10 71.14 87.99 0.11 Allowed 'General case' 0 C--O 1.199 -1.554 1 O-C-N 129.618 4.324 . . . . 0.0 110.926 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' CD2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -110.94 48.41 0.93 Allowed 'General case' 0 C--O 1.193 -1.893 1 O-C-N 132.349 6.031 . . . . 0.0 109.281 179.483 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.469 ' CG2' HG23 ' A' ' 90' ' ' VAL 0.268 98.4 mt -65.2 164.32 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.58 0 CA-C-N 108.582 -3.917 . . . . 0.0 105.675 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.5 71.95 1.39 Allowed 'General case' 0 C--O 1.201 -1.476 1 O-C-N 133.763 6.914 . . . . 0.0 105.309 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 88' ' ' ILE . 76.6 t -76.23 115.62 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 1 O-C-N 132.038 5.836 . . . . 0.0 105.614 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.482 ' CD ' ' HB ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -169.49 165.91 10.32 Favored 'General case' 0 C--O 1.187 -2.204 0 C-N-CA 114.669 -2.812 . . . . 0.0 114.714 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -156.91 118.84 3.84 Favored 'General case' 0 C--O 1.21 -1.005 1 O-C-N 130.479 4.862 . . . . 0.0 107.026 179.669 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.779 HD12 HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -42.61 144.99 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.54 1 O-C-N 133.013 6.445 . . . . 0.0 113.577 179.876 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 t -150.89 123.01 8.25 Favored 'General case' 0 CA--C 1.506 -0.717 1 O-C-N 129.75 4.406 . . . . 0.0 115.996 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.57 13.86 74.85 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 t30 57.47 58.73 3.64 Favored 'General case' 0 CA--C 1.563 1.476 1 O-C-N 131.884 5.108 . . . . 0.0 104.603 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.765 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.323 0.4 OUTLIER -178.41 100.21 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.588 1 O-C-N 132.116 5.885 . . . . 0.0 108.66 179.204 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 HD12 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.6 151.78 43.8 Favored 'General case' 0 N--CA 1.423 -1.783 1 O-C-N 130.423 4.827 . . . . 0.0 114.978 179.872 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLN . 26.9 mt -106.69 -106.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.337 3 O-C-N 133.447 6.717 . . . . 0.0 107.922 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.6 mt-30 116.21 93.17 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.519 2 O-C-N 135.261 7.85 . . . . 0.0 98.348 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 110' ' ' LYS . 1.3 m -72.39 -29.77 64.05 Favored 'General case' 0 N--CA 1.42 -1.944 1 O-C-N 133.333 6.646 . . . . 0.0 119.69 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 62.05 76.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 128.626 3.704 . . . . 0.0 105.74 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.6 m -76.35 78.4 3.1 Favored 'General case' 0 C--O 1.204 -1.325 0 O-C-N 128.439 3.587 . . . . 0.0 105.956 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.6 118.02 35.56 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 109.773 -3.376 . . . . 0.0 112.936 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 17.71 63.07 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.19 6.61 61.45 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 117.552 -2.261 . . . . 0.0 116.216 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.83 110.4 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 101' ' ' THR . 2.0 mt-10 -89.27 78.74 7.22 Favored 'General case' 0 C--N 1.363 1.173 0 O-C-N 128.246 3.466 . . . . 0.0 105.125 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.416 . . -86.57 86.2 7.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.319 2.887 . . . . 0.0 116.275 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HG2' HG23 ' A' ' 101' ' ' THR . 5.6 mtmp? -90.61 148.58 22.57 Favored 'General case' 0 N--CA 1.425 -1.683 1 O-C-N 130.042 4.589 . . . . 0.0 108.879 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 14.4 mmt180 -147.6 111.04 4.93 Favored 'General case' 0 CA--C 1.558 1.275 1 O-C-N 130.544 4.902 . . . . 0.0 101.31 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.55 128.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 1 O-C-N 130.908 5.13 . . . . 0.0 111.595 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 m-85 -131.22 -154.77 0.65 Allowed 'General case' 0 C--N 1.318 -0.776 1 O-C-N 131.727 5.642 . . . . 0.0 104.865 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.765 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.31 -138.0 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.595 1 O-C-N 131.336 5.398 . . . . 0.0 113.4 -177.627 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 3.1 tttt -137.34 158.53 44.22 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.417 -2.105 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.361 179.656 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 93' ' ' ILE . 9.9 m-85 . . . . . 0 CA--C 1.561 1.365 0 N-CA-C 104.543 -2.392 . . . . 0.0 104.543 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 1.5 m-20 -33.86 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.996 1 O-C-N 130.716 5.01 . . . . 0.0 118.465 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.24 27.09 0.03 OUTLIER Glycine 0 C--N 1.353 1.48 2 C-N-CA 110.485 -5.626 . . . . 0.0 109.683 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.26 157.21 0.16 Allowed 'General case' 0 C--O 1.248 0.983 0 O-C-N 127.696 2.645 . . . . 0.0 110.028 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 23' ' ' LEU 0.3 21.0 m95 -156.16 169.83 23.6 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 111.967 -3.873 . . . . 0.0 112.063 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 4.4 mtmt 44.72 -179.63 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.789 1 O-C-N 133.555 6.784 . . . . 0.0 118.34 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 21' ' ' LEU 0.271 0.4 OUTLIER . . . . . 0 CA--C 1.481 -1.706 3 CA-C-O 135.05 7.119 . . . . 0.0 120.848 174.852 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.642 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.381 0.0 OUTLIER -178.45 178.85 0.82 Allowed 'General case' 0 C--O 1.198 -1.653 1 O-C-N 132.456 6.097 . . . . 0.0 103.386 179.848 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 25' ' ' ILE . 4.0 mt -136.46 166.02 24.47 Favored 'General case' 0 CA--C 1.563 1.446 2 O-C-N 130.74 5.025 . . . . 0.0 97.504 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 86.3 m 175.67 73.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 1 O-C-N 129.715 4.385 . . . . 0.0 107.277 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 23' ' ' LEU . 3.7 mp -86.18 144.88 8.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 113.876 -3.13 . . . . 0.0 109.248 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.7 m -162.75 79.41 0.49 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 116.43 -2.108 . . . . 0.0 105.97 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -53.57 154.63 3.49 Favored 'General case' 0 N--CA 1.441 -0.892 2 O-C-N 132.031 5.832 . . . . 0.0 114.711 179.881 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -124.82 81.85 1.99 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.24 -87.45 1.56 Allowed Glycine 0 CA--C 1.558 2.766 1 N-CA-C 103.086 -4.006 . . . . 0.0 103.086 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -128.27 3.06 5.74 Favored 'General case' 0 N--CA 1.409 -2.506 2 O-C-N 133.212 5.889 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -79.79 160.3 26.21 Favored 'General case' 0 C--N 1.326 -0.432 2 N-CA-C 98.922 -4.473 . . . . 0.0 98.922 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HZ ' HD21 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -170.68 86.52 0.11 Allowed 'General case' 0 C--O 1.201 -1.465 2 N-CA-C 96.418 -5.401 . . . . 0.0 96.418 179.862 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.39 129.85 42.4 Favored 'General case' 0 CA--C 1.507 -0.702 2 O-C-N 132.829 6.331 . . . . 0.0 103.279 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG22 ' CE1' ' A' ' 32' ' ' PHE 0.323 69.3 t -102.29 134.32 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 1 N-CA-C 99.325 -4.324 . . . . 0.0 99.325 179.61 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -81.68 63.04 5.78 Favored 'General case' 0 CA--C 1.49 -1.361 1 CA-C-O 132.495 5.903 . . . . 0.0 116.233 -179.748 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.291 4.8 mt-10 -80.52 71.41 7.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 O-C-N 117.032 -3.543 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 m -77.31 126.48 30.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 112.454 -3.698 . . . . 0.0 107.058 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 -165.92 0.33 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 116.075 -2.25 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.678 HD21 HD23 ' A' ' 57' ' ' LEU . 76.9 m-20 69.38 -96.03 0.03 OUTLIER 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.031 0.832 . . . . 0.0 111.415 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -141.26 20.28 2.25 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 127.228 2.83 . . . . 0.0 111.468 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -176.71 -176.55 0.72 Allowed 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 127.595 3.06 . . . . 0.0 111.38 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 122.47 36.79 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.335 0.7 OUTLIER -140.98 146.48 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 2 O-C-N 131.091 5.244 . . . . 0.0 105.204 -179.32 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -116.66 173.62 6.52 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 110.26 -3.155 . . . . 0.0 108.571 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.19 91.41 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.328 1 O-C-N 131.561 5.538 . . . . 0.0 101.115 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -103.38 158.0 5.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 1 O-C-N 130.722 5.014 . . . . 0.0 112.685 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.0 p90 169.23 -158.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.738 1 O-C-N 133.462 6.726 . . . . 0.0 111.006 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 83.74 1.99 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 116.118 -2.233 . . . . 0.0 114.034 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 69' ' ' MET . 1.5 mp 43.44 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 1 O-C-N 130.96 5.163 . . . . 0.0 116.08 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.27 71.72 1.61 Allowed Glycine 0 C--O 1.203 -1.843 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.5 t -144.84 92.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 1 O-C-N 131.182 4.695 . . . . 0.0 112.363 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.32 147.17 34.35 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 113.531 -3.268 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -154.42 161.07 41.91 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 132.392 6.058 . . . . 0.0 115.896 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.71 109.79 20.18 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -179.78 4.54 Favored 'General case' 0 CA--C 1.509 -0.604 1 O-C-N 130.095 4.622 . . . . 0.0 110.294 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.88 99.05 3.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 114.542 -2.863 . . . . 0.0 105.311 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.678 HD23 HD21 ' A' ' 39' ' ' ASN . 0.8 OUTLIER -56.47 -74.02 0.05 Allowed 'General case' 0 C--O 1.247 0.936 0 O-C-N 126.769 2.543 . . . . 0.0 114.021 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 18.06 3.16 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 126.358 2.286 . . . . 0.0 115.232 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 73.3 0.49 3.68 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 126.417 2.323 . . . . 0.0 114.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.86 25.18 2.26 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 128.566 3.666 . . . . 0.0 108.161 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 p -118.37 170.87 8.56 Favored 'General case' 0 C--O 1.218 -0.567 1 O-C-N 130.479 4.282 . . . . 0.0 110.173 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -157.38 38.53 0.29 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 113.861 -3.136 . . . . 0.0 106.989 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.0 98.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 108.736 -3.847 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 64' ' ' THR . 2.9 m -99.53 101.6 12.88 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -168.21 -168.12 29.85 Favored Glycine 0 CA--C 1.541 1.702 1 C-N-CA 112.4 -4.714 . . . . 0.0 106.885 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.25 147.62 43.88 Favored 'General case' 0 CA--C 1.499 -0.998 1 O-C-N 133.709 6.182 . . . . 0.0 113.286 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 m95 -124.97 104.87 8.81 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.0 p -101.79 73.44 1.42 Allowed 'General case' 0 C--O 1.2 -1.548 1 O-C-N 134.437 7.335 . . . . 0.0 116.008 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.508 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.17 98.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 2 O-C-N 132.406 6.066 . . . . 0.0 103.813 179.891 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.11 -22.51 28.85 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 117.361 -1.736 . . . . 0.0 110.688 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.81 101.73 0.7 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 104.524 -3.43 . . . . 0.0 104.524 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 61.16 26.9 16.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 110.911 -2.645 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 4.1 mtpt -133.76 -170.7 2.55 Favored 'General case' 0 C--N 1.358 0.951 1 O-C-N 130.606 4.941 . . . . 0.0 111.393 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.665 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -165.76 39.17 0.06 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 114.682 -2.807 . . . . 0.0 112.683 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.98 146.66 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 110.228 -3.169 . . . . 0.0 116.002 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.17 -145.68 13.78 Favored Glycine 0 CA--C 1.559 2.813 1 N-CA-C 100.008 -5.237 . . . . 0.0 100.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.475 ' CB ' HG12 ' A' ' 88' ' ' ILE . 9.4 tttm 171.05 123.04 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 134.861 6.859 . . . . 0.0 114.049 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -113.04 166.53 11.33 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.664 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.276 16.1 ttmt -162.84 149.95 13.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 109.666 -3.425 . . . . 0.0 113.41 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.473 ' NE ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -98.98 72.48 1.91 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 117.242 -1.783 . . . . 0.0 106.306 178.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.4 t -29.74 -52.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 O-C-N 130.74 5.025 . . . . 0.0 115.351 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.55 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -52.66 -31.07 35.26 Favored 'General case' 0 N--CA 1.435 -1.197 1 O-C-N 129.322 4.139 . . . . 0.0 112.516 -179.219 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER 170.63 -3.31 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.243 4.09 . . . . 0.0 115.479 -178.83 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.451 ' HA3' ' CD ' ' A' ' 80' ' ' ARG . . . -91.0 -30.02 11.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 104.229 -3.548 . . . . 0.0 104.229 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 76.62 -169.69 0.07 Allowed 'General case' 0 N--CA 1.425 -1.686 1 O-C-N 132.377 5.398 . . . . 0.0 118.455 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.664 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 2.0 mp0 -45.45 139.27 3.8 Favored 'General case' 0 N--CA 1.429 -1.525 1 O-C-N 132.627 6.205 . . . . 0.0 116.111 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.473 HD11 ' NE ' ' A' ' 80' ' ' ARG . 30.3 mt -148.16 47.43 1.06 Allowed 'General case' 0 C--O 1.201 -1.487 1 O-C-N 137.151 9.032 . . . . 0.0 109.806 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' A' ' 77' ' ' LYS . 89.5 mt -64.72 172.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.123 1 CA-C-N 108.342 -4.027 . . . . 0.0 104.097 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.1 66.71 1.49 Allowed 'General case' 0 C--O 1.205 -1.265 1 O-C-N 130.824 5.077 . . . . 0.0 107.903 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.16 110.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 1 O-C-N 131.137 5.273 . . . . 0.0 102.129 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 1.1 tpm_? -164.5 156.41 16.11 Favored 'General case' 0 C--O 1.188 -2.161 1 C-N-CA 111.219 -4.192 . . . . 0.0 113.182 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.572 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 4.2 pt-20 -158.79 134.91 9.07 Favored 'General case' 0 N--CA 1.424 -1.728 2 O-C-N 129.975 4.547 . . . . 0.0 105.149 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.832 ' CD1' HD12 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -39.75 106.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.844 1 O-C-N 132.876 6.36 . . . . 0.0 111.01 179.89 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.11 67.11 Favored 'General case' 0 C--O 1.241 0.625 1 O-C-N 129.255 4.097 . . . . 0.0 114.355 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.46 96.23 0.1 Allowed Glycine 0 CA--C 1.545 1.964 0 C-N-CA 116.181 -2.914 . . . . 0.0 106.961 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 58.05 37.13 26.51 Favored 'General case' 0 N--CA 1.437 -1.121 2 CA-C-N 107.063 -4.569 . . . . 0.0 109.495 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 93' ' ' ILE 0.304 0.0 OUTLIER 179.44 179.46 0.47 Allowed 'General case' 0 CA--C 1.564 1.499 0 O-C-N 128.047 3.342 . . . . 0.0 106.579 179.403 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.832 HD12 ' CD1' ' A' ' 93' ' ' ILE . 8.1 tt -140.54 130.78 25.02 Favored 'General case' 0 C--O 1.211 -0.963 2 O-C-N 134.646 7.466 . . . . 0.0 109.349 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' GLN . 66.7 mt -76.13 -101.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.417 -2.111 1 O-C-N 130.046 4.591 . . . . 0.0 102.717 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.655 ' HG2' HD21 ' A' ' 98' ' ' LEU . 6.8 mt-30 130.34 75.1 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.486 1 O-C-N 131.801 5.688 . . . . 0.0 102.043 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m -81.27 93.34 6.51 Favored 'General case' 0 N--CA 1.428 -1.557 1 O-C-N 131.067 5.23 . . . . 0.0 112.006 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.37 125.1 25.39 Favored 'General case' 0 C--O 1.201 -1.465 2 CA-C-N 106.82 -4.718 . . . . 0.0 105.283 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 m -101.76 76.99 1.69 Allowed 'General case' 0 C--O 1.206 -1.236 1 O-C-N 130.613 4.945 . . . . 0.0 101.747 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.33 109.16 21.34 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 108.702 -3.863 . . . . 0.0 115.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 48.88 37.0 9.12 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.548 -2.114 . . . . 0.0 113.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.65 -12.39 61.21 Favored Glycine 0 C--N 1.346 1.094 1 C-N-CA 113.762 -4.066 . . . . 0.0 113.942 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.47 131.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 117.539 -1.22 . . . . 0.0 112.958 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -90.81 71.92 6.61 Favored 'General case' 0 C--N 1.358 0.936 1 O-C-N 129.359 4.162 . . . . 0.0 107.96 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.395 . . -89.97 103.84 16.46 Favored 'General case' 0 C--O 1.196 -1.723 0 C-N-CA 112.839 -3.545 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 145.14 30.93 Favored 'General case' 0 N--CA 1.417 -2.086 1 O-C-N 133.031 6.457 . . . . 0.0 110.475 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -128.7 119.25 24.28 Favored 'General case' 0 CA--C 1.559 1.311 2 O-C-N 132.029 5.83 . . . . 0.0 99.296 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 10.2 pt -79.22 137.08 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 1 O-C-N 130.11 4.631 . . . . 0.0 113.378 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.637 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.6 m-30 -125.68 -177.87 4.06 Favored 'General case' 0 N--CA 1.435 -1.196 2 O-C-N 135.94 8.275 . . . . 0.0 106.402 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 176.94 127.0 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.233 2 CA-C-O 131.872 5.606 . . . . 0.0 113.329 -179.405 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 10.2 ttmt -41.34 -62.92 0.77 Allowed 'General case' 0 C--O 1.203 -1.381 0 CA-C-O 128.166 3.841 . . . . 0.0 117.193 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.366 1.319 0 CA-C-N 109.363 -3.562 . . . . 0.0 113.171 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.43 98.24 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 O-C-N 127.61 3.069 . . . . 0.0 116.513 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 153.58 6.66 Favored Glycine 0 N--CA 1.464 0.52 0 C-N-CA 114.594 -3.67 . . . . 0.0 104.417 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 10.8 p -66.11 167.94 9.22 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 114.923 -2.711 . . . . 0.0 108.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.616 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.281 35.7 m95 -142.68 149.07 38.37 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 115.471 -2.204 . . . . 0.0 112.724 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 8.5 mtmt 56.7 -179.33 0.05 OUTLIER 'General case' 0 C--O 1.197 -1.663 1 O-C-N 129.488 4.242 . . . . 0.0 117.269 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.265 1.0 OUTLIER . . . . . 0 CA--C 1.485 -1.534 3 O-C-N 135.793 8.183 . . . . 0.0 120.086 174.769 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.371 0.0 OUTLIER -179.24 123.49 0.08 Allowed 'General case' 0 C--O 1.195 -1.787 0 O-C-N 128.878 3.861 . . . . 0.0 105.529 179.956 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 8.8 mt -87.91 162.0 17.15 Favored 'General case' 0 CA--C 1.552 1.036 2 O-C-N 129.862 4.476 . . . . 0.0 101.654 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 87.7 m -178.53 64.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.195 1 O-C-N 130.117 4.636 . . . . 0.0 105.439 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.4 mp -82.48 146.45 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 113.339 -3.344 . . . . 0.0 109.209 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -172.37 79.18 0.05 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 113.546 -3.261 . . . . 0.0 103.273 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -31.0 139.51 0.03 OUTLIER 'General case' 0 C--O 1.208 -1.099 2 O-C-N 134.834 7.584 . . . . 0.0 116.742 179.734 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -104.18 -99.61 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 128.815 3.822 . . . . 0.0 104.177 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.07 80.99 0.36 Allowed Glycine 0 CA--C 1.564 3.123 1 N-CA-C 99.699 -5.361 . . . . 0.0 99.699 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 68.66 28.33 5.71 Favored 'General case' 0 N--CA 1.433 -1.295 2 O-C-N 131.875 5.103 . . . . 0.0 106.646 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.5 ttpp -131.91 110.1 10.55 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 128.925 3.89 . . . . 0.0 101.315 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -101.36 166.37 10.78 Favored 'General case' 0 C--O 1.197 -1.687 2 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 -179.434 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 98.17 4.38 Favored 'General case' 0 N--CA 1.478 0.96 3 O-C-N 137.692 9.37 . . . . 0.0 97.356 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.409 0.9 OUTLIER -72.42 127.33 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 2 C-N-CA 109.643 -4.823 . . . . 0.0 98.984 179.705 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.429 25.1 tttt -76.18 8.43 3.3 Favored 'General case' 0 C--N 1.368 1.387 0 CA-C-N 109.978 -3.283 . . . . 0.0 119.581 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.421 2.6 mt-10 -47.76 106.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 111.038 -2.801 . . . . 0.0 103.502 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 p -138.36 145.84 41.57 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 128.282 3.489 . . . . 0.0 106.57 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.3 p -140.28 -175.25 4.19 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 116.217 -2.193 . . . . 0.0 112.373 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -15.98 60.81 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 127.408 2.943 . . . . 0.0 105.02 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -97.26 -109.8 0.16 Allowed 'General case' 0 N--CA 1.435 -1.215 1 CA-C-N 108.194 -4.093 . . . . 0.0 108.934 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.717 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -135.75 44.97 2.46 Favored 'General case' 0 CA--C 1.496 -1.114 1 O-C-N 129.161 4.038 . . . . 0.0 117.785 -179.076 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -72.62 -35.68 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.901 ' CG2' HD21 ' A' ' 57' ' ' LEU 0.267 5.1 tt 11.96 60.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 2 O-C-N 133.944 7.027 . . . . 0.0 112.036 178.318 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.93 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.831 -2.44 . . . . 0.0 111.436 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.31 50.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.275 3.0 p -61.53 167.22 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 O-C-N 129.065 3.978 . . . . 0.0 112.782 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -166.44 -157.1 0.26 Allowed 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.926 3.891 . . . . 0.0 111.064 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 1.2 mt-10 -138.42 52.79 1.81 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 126.472 2.357 . . . . 0.0 114.802 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 2.3 tp 18.11 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.533 1 CA-C-O 130.004 4.716 . . . . 0.0 117.461 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.32 51.4 8.62 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 103.375 -3.89 . . . . 0.0 103.375 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.52 121.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 1 O-C-N 134.53 6.664 . . . . 0.0 115.177 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.54 16.22 Favored 'General case' 0 C--O 1.21 -1.002 1 O-C-N 131.58 5.55 . . . . 0.0 110.167 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 9.5 p90 -176.99 169.47 2.37 Favored 'General case' 0 N--CA 1.421 -1.879 0 O-C-N 128.554 3.659 . . . . 0.0 114.457 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 136.67 52.77 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.23 101.62 4.06 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 128.923 3.889 . . . . 0.0 113.409 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 t -69.92 155.98 39.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 113.296 -3.361 . . . . 0.0 102.844 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.901 HD21 ' CG2' ' A' ' 43' ' ' ILE . 5.5 tp -147.21 -92.66 0.09 Allowed 'General case' 0 C--O 1.245 0.85 1 O-C-N 129.269 4.106 . . . . 0.0 110.745 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.717 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . . . -60.06 -5.45 1.03 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 112.921 -3.418 . . . . 0.0 115.999 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t70 106.49 -15.65 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.595 1 O-C-N 129.531 4.269 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.11 -55.6 0.26 Allowed Glycine 0 CA--C 1.558 2.74 0 N-CA-C 104.202 -3.559 . . . . 0.0 104.202 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 p -39.56 137.87 0.78 Allowed 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 128.968 3.393 . . . . 0.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.94 37.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 114.551 -2.86 . . . . 0.0 109.023 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' HD21 ' A' ' 87' ' ' LEU . 10.2 mp -42.02 97.91 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.687 1 O-C-N 130.658 4.974 . . . . 0.0 112.225 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.4 m -93.84 99.39 11.77 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 111.602 -2.544 . . . . 0.0 106.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.69 -175.71 34.0 Favored Glycine 0 C--O 1.201 -1.937 1 C-N-CA 111.617 -5.087 . . . . 0.0 108.556 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' THR . 15.0 t -140.85 143.81 34.97 Favored 'General case' 0 CA--C 1.5 -0.978 2 O-C-N 132.509 5.476 . . . . 0.0 111.883 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.691 ' CZ2' ' HB3' ' A' ' 89' ' ' ALA . 15.3 m95 -124.25 111.64 16.08 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -99.98 41.88 1.14 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 135.485 7.991 . . . . 0.0 113.613 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.431 ' HB2' HD13 ' A' ' 49' ' ' LEU . 4.6 tmm? -37.52 107.43 0.06 Allowed 'General case' 0 C--N 1.317 -0.806 1 O-C-N 134.434 7.334 . . . . 0.0 107.917 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -82.99 -74.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.305 0 O-C-N 129.055 3.972 . . . . 0.0 108.525 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.56 -79.85 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.117 1 O-C-N 129.435 4.21 . . . . 0.0 107.993 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.58 44.21 2.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 127.991 2.818 . . . . 0.0 108.865 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -141.08 178.73 7.18 Favored 'General case' 0 C--N 1.356 0.865 1 O-C-N 129.147 4.029 . . . . 0.0 112.451 -179.96 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 4.8 mt -148.28 91.87 1.96 Allowed 'General case' 0 C--N 1.321 -0.649 0 O-C-N 126.584 2.428 . . . . 0.0 110.596 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.28 119.68 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 O-C-N 128.321 3.513 . . . . 0.0 117.444 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.55 -141.33 5.82 Favored Glycine 0 CA--C 1.557 2.673 1 CA-C-N 108.082 -4.145 . . . . 0.0 103.772 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.474 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -178.79 131.68 0.12 Allowed 'General case' 0 C--O 1.204 -1.334 1 O-C-N 131.772 5.042 . . . . 0.0 113.966 -179.972 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.4 OUTLIER -127.13 167.9 15.38 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-O 127.417 3.484 . . . . 0.0 101.672 179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 6.8 ttmt -170.48 144.14 2.39 Favored 'General case' 0 N--CA 1.427 -1.617 1 CA-C-N 106.857 -4.702 . . . . 0.0 114.138 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 69.64 0.8 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 125.105 1.503 . . . . 0.0 107.175 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -31.64 -40.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.39 1 O-C-N 131.184 5.302 . . . . 0.0 115.472 -179.828 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.477 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 11.6 p-10 -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.442 -0.832 1 O-C-N 131.03 5.206 . . . . 0.0 112.549 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 172.08 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 O-C-N 128.903 3.877 . . . . 0.0 115.998 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.5 -34.38 6.08 Favored Glycine 0 CA--C 1.543 1.79 0 N-CA-C 104.092 -3.603 . . . . 0.0 104.092 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.492 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 78.0 -171.19 0.06 Allowed 'General case' 0 N--CA 1.436 -1.158 1 O-C-N 132.153 5.266 . . . . 0.0 117.272 -179.804 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 77.6 mt-10 -48.6 149.48 1.67 Allowed 'General case' 0 N--CA 1.432 -1.334 1 O-C-N 132.355 6.034 . . . . 0.0 113.456 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 63' ' ' LEU 0.257 0.1 OUTLIER -158.18 35.38 0.24 Allowed 'General case' 0 C--O 1.196 -1.751 1 O-C-N 135.255 7.847 . . . . 0.0 109.343 178.772 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' THR 0.251 42.7 mt -50.28 127.49 6.1 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.639 1 O-C-N 132.98 6.425 . . . . 0.0 100.479 -179.794 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -87.62 68.88 9.64 Favored 'General case' 0 C--O 1.205 -1.244 1 O-C-N 132.878 6.361 . . . . 0.0 110.958 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 t -66.92 108.36 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 1 C-N-CA 111.567 -4.053 . . . . 0.0 102.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 98' ' ' LEU . 8.9 ttm180 -139.05 168.73 19.19 Favored 'General case' 0 C--O 1.195 -1.778 0 O-C-N 128.479 3.612 . . . . 0.0 111.674 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.12 94.09 0.05 Allowed 'General case' 0 C--N 1.363 1.184 2 O-C-N 132.458 6.099 . . . . 0.0 108.438 179.829 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -28.28 105.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.749 1 O-C-N 133.424 6.702 . . . . 0.0 112.115 -179.938 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.9 m -94.55 130.73 40.85 Favored 'General case' 0 N--CA 1.439 -0.976 1 O-C-N 129.117 4.01 . . . . 0.0 113.541 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.1 -116.27 7.07 Favored Glycine 0 CA--C 1.561 2.91 1 N-CA-C 100.653 -4.979 . . . . 0.0 100.653 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.69 57.69 1.05 Allowed 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 129.609 3.77 . . . . 0.0 107.999 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.705 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.269 0.0 OUTLIER 176.77 115.55 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.53 1 O-C-N 130.694 4.996 . . . . 0.0 107.312 179.375 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 93' ' ' ILE . 1.5 tp -65.3 148.34 51.87 Favored 'General case' 0 N--CA 1.416 -2.158 2 O-C-N 133.366 6.667 . . . . 0.0 111.686 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.519 HG21 ' HD2' ' A' ' 110' ' ' LYS . 2.2 mt -130.27 128.92 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 3 O-C-N 131.6 5.563 . . . . 0.0 102.571 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' NE ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.75 129.09 54.33 Favored 'General case' 0 C--O 1.21 -1.003 1 O-C-N 135.395 7.935 . . . . 0.0 101.796 179.891 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 110' ' ' LYS . 68.6 p -82.34 -43.96 16.79 Favored 'General case' 0 N--CA 1.41 -2.467 2 O-C-N 131.184 5.303 . . . . 0.0 116.457 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 59.95 61.03 1.98 Allowed 'General case' 0 C--O 1.205 -1.281 1 O-C-N 129.331 4.144 . . . . 0.0 104.406 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' ILE . 54.7 m -55.2 101.85 0.06 Allowed 'General case' 0 N--CA 1.479 1.002 1 N-CA-C 100.119 -4.03 . . . . 0.0 100.119 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 113.1 20.86 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 109.165 -3.652 . . . . 0.0 110.561 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -4.79 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 107' ' ' VAL . . . 94.92 -3.8 67.64 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 116.618 -2.706 . . . . 0.0 112.536 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 106' ' ' GLY . 1.4 t -162.56 154.12 3.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -119.15 114.14 21.99 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 128.206 3.441 . . . . 0.0 102.334 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.378 . . -102.96 81.64 2.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 116.314 -2.155 . . . . 0.0 114.295 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD2' HG21 ' A' ' 99' ' ' ILE . 1.6 mtmm -72.25 150.72 43.39 Favored 'General case' 0 N--CA 1.435 -1.18 1 O-C-N 129.993 4.558 . . . . 0.0 108.859 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.8 mtp180 -131.91 -164.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 1 O-C-N 131.381 5.426 . . . . 0.0 103.234 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -162.0 79.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.044 1 C-N-CA 111.45 -4.1 . . . . 0.0 109.85 179.993 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.509 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 41.6 m-85 -100.2 -145.08 0.34 Allowed 'General case' 0 C--N 1.319 -0.757 1 O-C-N 130.552 4.907 . . . . 0.0 105.704 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.705 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.47 -154.45 0.16 Allowed 'General case' 0 C--O 1.197 -1.699 1 O-C-N 131.979 5.799 . . . . 0.0 111.462 -179.856 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 21.5 tttt -115.21 -141.71 0.38 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 111.842 -2.436 . . . . 0.0 111.605 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.222 -179.512 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 98' ' ' LEU . 98.3 m-85 . . . . . 0 CA--C 1.554 1.133 0 N-CA-C 101.753 -3.425 . . . . 0.0 101.753 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 24.4 p-10 -169.32 32.55 0.02 OUTLIER 'General case' 0 C--N 1.364 1.202 0 CA-C-N 110.137 -3.211 . . . . 0.0 115.914 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.53 159.62 21.18 Favored Glycine 0 C--N 1.346 1.105 1 C-N-CA 113.38 -4.248 . . . . 0.0 106.777 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -58.26 134.21 56.34 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 115.382 -2.527 . . . . 0.0 109.723 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.301 70.8 m95 -114.89 140.71 48.76 Favored 'General case' 0 N--CA 1.412 -2.342 1 CA-C-O 111.087 -4.292 . . . . 0.0 111.983 -179.807 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 11.4 mtmt 67.13 177.81 0.23 Allowed 'General case' 0 N--CA 1.424 -1.736 1 O-C-N 131.547 5.529 . . . . 0.0 118.164 176.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.486 -1.51 3 O-C-N 136.329 8.518 . . . . 0.0 120.802 174.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.437 0 CA-C-O 114.663 -2.589 . . . . 0.0 104.885 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.323 1.4 ptmt 163.52 150.39 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.466 1 O-C-N 134.967 7.667 . . . . 0.0 103.661 179.85 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 2.9 mt -114.04 176.35 5.08 Favored 'General case' 0 CA--C 1.56 1.354 2 O-C-N 131.778 5.673 . . . . 0.0 98.486 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.646 ' O ' HD12 ' A' ' 25' ' ' ILE . 77.8 m -162.03 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 128.729 3.768 . . . . 0.0 107.668 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.673 HG21 ' CE2' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 63.9 145.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-O 124.784 2.231 . . . . 0.0 115.947 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 169.27 67.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -26.15 124.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.28 2 O-C-N 135.804 8.19 . . . . 0.0 114.173 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -9.02 53.29 Favored 'General case' 0 N--CA 1.482 1.128 1 O-C-N 130.918 5.136 . . . . 0.0 106.371 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.87 -40.83 0.35 Allowed Glycine 0 CA--C 1.55 2.279 1 N-CA-C 102.171 -4.372 . . . . 0.0 102.171 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.79 -12.13 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.926 1 O-C-N 131.461 4.859 . . . . 0.0 112.817 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -78.95 120.21 23.22 Favored 'General case' 0 N--CA 1.48 1.062 1 N-CA-C 96.253 -5.462 . . . . 0.0 96.253 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.673 ' CE2' HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -126.45 105.33 8.69 Favored 'General case' 0 C--O 1.208 -1.118 1 N-CA-C 98.73 -4.545 . . . . 0.0 98.73 -179.263 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -109.21 127.07 53.93 Favored 'General case' 0 CA--C 1.492 -1.267 2 O-C-N 135.603 8.064 . . . . 0.0 104.435 -179.814 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.324 2.2 t -93.95 143.8 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-O 126.659 3.123 . . . . 0.0 103.248 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -86.59 70.03 10.4 Favored 'General case' 0 C--O 1.196 -1.718 2 CA-C-O 133.405 6.336 . . . . 0.0 112.902 179.114 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -78.34 44.8 0.52 Allowed 'General case' 0 N--CA 1.42 -1.95 1 CA-C-N 107.49 -4.414 . . . . 0.0 109.672 -179.697 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 t -67.78 119.81 13.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 114.023 -3.071 . . . . 0.0 104.803 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.32 100.07 0.94 Allowed 'General case' 0 C--O 1.244 0.791 0 O-C-N 127.442 2.964 . . . . 0.0 109.934 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 62.47 -173.32 0.15 Allowed 'General case' 0 C--N 1.361 1.094 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 12.6 m-85 57.2 -95.56 0.06 Allowed 'General case' 0 C--N 1.357 0.915 1 O-C-N 129.371 4.169 . . . . 0.0 106.667 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD2' ' HB3' ' A' ' 40' ' ' PHE 0.291 1.4 mpt_? -153.58 -161.5 1.27 Allowed 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 128.249 2.62 . . . . 0.0 111.316 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -103.91 98.93 8.7 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 128.022 3.326 . . . . 0.0 103.12 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.263 0.1 OUTLIER -131.17 151.02 35.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 2 CA-C-O 130.784 5.088 . . . . 0.0 110.051 -178.894 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.1 m-20 -117.67 173.18 6.88 Favored 'General case' 0 N--CA 1.427 -1.62 1 CA-C-N 107.189 -4.55 . . . . 0.0 109.588 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.03 105.86 19.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 1 O-C-N 132.825 6.328 . . . . 0.0 101.0 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.313 6.3 p -112.27 158.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 113.671 -3.212 . . . . 0.0 116.187 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.455 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.2 p90 -171.52 -132.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.647 1 O-C-N 131.761 5.663 . . . . 0.0 111.026 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.48 58.87 0.22 Allowed 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 112.924 -3.511 . . . . 0.0 114.898 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 31.53 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 127.345 2.903 . . . . 0.0 116.637 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 58.4 2.36 Favored Glycine 0 CA--C 1.547 2.09 1 N-CA-C 102.73 -4.148 . . . . 0.0 102.73 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -156.52 118.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.779 1 O-C-N 131.858 5.093 . . . . 0.0 113.43 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 1.0 OUTLIER -78.17 160.58 27.91 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 129.403 4.19 . . . . 0.0 107.625 179.723 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CE1' ' C ' ' A' ' 65' ' ' GLY . 15.2 p90 -175.85 149.2 0.91 Allowed 'General case' 0 C--N 1.36 1.048 2 O-C-N 132.328 6.018 . . . . 0.0 115.576 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -110.92 90.58 3.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 115.556 -2.164 . . . . 0.0 106.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.24 135.61 38.92 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 127.568 3.042 . . . . 0.0 111.897 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -96.43 85.08 3.83 Favored 'General case' 0 CA--C 1.551 1.007 1 O-C-N 130.857 5.098 . . . . 0.0 105.759 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' THR . 3.7 mp -71.05 -173.03 0.76 Allowed 'General case' 0 C--O 1.243 0.721 1 O-C-N 132.394 6.059 . . . . 0.0 110.264 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . 49.05 -146.86 0.32 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-O 115.033 -2.413 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.54 -6.09 55.17 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 128.027 3.329 . . . . 0.0 108.935 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.16 49.83 0.02 OUTLIER Glycine 0 CA--C 1.549 2.181 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.9 m -102.39 116.61 32.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 126.585 1.991 . . . . 0.0 109.18 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.5 119.21 36.8 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 115.574 -2.45 . . . . 0.0 109.115 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.14 60.82 1.38 Allowed 'General case' 0 C--O 1.202 -1.415 0 CA-C-N 110.726 -2.943 . . . . 0.0 107.215 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 54.4 m -41.7 117.03 0.86 Allowed 'General case' 0 N--CA 1.436 -1.142 1 O-C-N 129.23 4.081 . . . . 0.0 104.175 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.438 ' C ' ' CE1' ' A' ' 53' ' ' PHE . . . -149.1 -159.74 8.74 Favored Glycine 0 C--O 1.209 -1.436 1 C-N-CA 110.175 -5.774 . . . . 0.0 108.65 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 52' ' ' ASP 0.287 0.7 OUTLIER 175.25 130.94 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.136 2 O-C-N 131.992 5.172 . . . . 0.0 111.808 -178.252 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.75 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 33.4 m95 -136.31 121.01 18.43 Favored 'General case' 0 C--O 1.203 -1.351 0 O-C-N 119.044 -2.285 . . . . 0.0 106.46 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -98.76 22.49 9.99 Favored 'General case' 0 N--CA 1.426 -1.63 2 O-C-N 130.651 4.969 . . . . 0.0 116.988 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 4.22 88.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 1 O-C-N 136.567 8.667 . . . . 0.0 108.322 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -94.99 95.2 8.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 128.047 3.342 . . . . 0.0 111.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.45 -102.2 0.3 Allowed Glycine 0 CA--C 1.541 1.66 1 O-C-N 129.268 4.105 . . . . 0.0 105.565 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . 74.9 m-20 -120.24 53.37 1.09 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 115.31 -2.281 . . . . 0.0 113.103 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 2.4 mtpt -135.92 171.47 14.42 Favored 'General case' 0 C--N 1.343 0.308 1 O-C-N 130.978 5.174 . . . . 0.0 109.185 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -142.08 54.74 1.46 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 127.874 3.234 . . . . 0.0 111.797 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.88 102.0 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.862 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -171.33 -161.62 22.27 Favored Glycine 0 C--O 1.2 -2.021 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.288 0.0 OUTLIER -156.89 165.39 36.32 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 129.028 3.428 . . . . 0.0 113.713 -179.508 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.75 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 33.7 m-85 -145.54 153.84 41.54 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 101.248 -3.612 . . . . 0.0 101.248 176.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.325 0.0 OUTLIER -171.45 130.99 0.72 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 110.255 -3.157 . . . . 0.0 116.86 -179.633 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 85' ' ' LYS . 94.0 mtt180 -81.39 100.58 9.33 Favored 'General case' 0 N--CA 1.439 -0.989 1 O-C-N 129.374 4.171 . . . . 0.0 108.977 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.91 -26.85 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 1 O-C-N 132.208 5.943 . . . . 0.0 108.757 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -57.0 -39.52 74.85 Favored 'General case' 0 N--CA 1.442 -0.837 1 O-C-N 132.215 5.947 . . . . 0.0 110.466 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -126.15 -2.47 7.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 127.513 3.008 . . . . 0.0 117.073 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.503 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 77.61 38.01 29.17 Favored Glycine 0 C--O 1.2 -2.025 2 C-N-CA 112.224 -4.798 . . . . 0.0 101.889 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.26 15.4 tptp -81.05 -71.92 0.45 Allowed 'General case' 0 N--CA 1.424 -1.755 2 O-C-N 132.695 5.585 . . . . 0.0 120.935 -178.87 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 12.3 mm-40 73.93 108.38 0.07 Allowed 'General case' 0 N--CA 1.429 -1.506 1 O-C-N 129.206 4.067 . . . . 0.0 113.464 -178.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 63' ' ' LEU . 2.5 pt? -139.56 49.21 1.81 Allowed 'General case' 0 C--O 1.198 -1.635 1 O-C-N 132.255 5.972 . . . . 0.0 109.985 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 76' ' ' GLY 0.255 30.6 mt -61.99 139.71 20.36 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 1 CA-C-N 107.849 -4.251 . . . . 0.0 101.357 -179.812 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.68 97.83 7.61 Favored 'General case' 0 C--O 1.2 -1.54 1 O-C-N 134.73 7.519 . . . . 0.0 103.254 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 101' ' ' THR . 2.8 t -95.34 115.6 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 O-C-N 128.941 3.901 . . . . 0.0 110.541 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CG ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -163.72 -168.54 1.67 Allowed 'General case' 0 C--O 1.192 -1.94 0 C-N-CA 112.923 -3.511 . . . . 0.0 115.933 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.559 ' H ' ' CG ' ' A' ' 91' ' ' ARG 0.296 0.1 OUTLIER -177.12 110.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 1 O-C-N 130.419 4.824 . . . . 0.0 106.127 -179.535 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.6 HD11 ' H ' ' A' ' 97' ' ' GLU . 2.4 tp -33.25 98.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 1 O-C-N 133.46 6.725 . . . . 0.0 113.317 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -84.03 75.17 10.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 116.152 -2.219 . . . . 0.0 115.076 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.26 -123.41 5.94 Favored Glycine 0 CA--C 1.563 3.077 1 N-CA-C 102.585 -4.206 . . . . 0.0 102.585 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -130.52 44.25 2.99 Favored 'General case' 0 N--CA 1.437 -1.112 1 CA-C-N 108.055 -4.072 . . . . 0.0 106.073 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.694 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.278 0.0 OUTLIER -173.4 97.92 0.12 Allowed 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.416 4.823 . . . . 0.0 108.777 179.725 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 2' ' ' PHE . 3.2 tt -72.99 148.64 44.03 Favored 'General case' 0 N--CA 1.424 -1.727 1 O-C-N 130.321 4.763 . . . . 0.0 115.209 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.61 167.26 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 2 CA-C-N 106.345 -4.934 . . . . 0.0 103.429 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.25 98.93 0.83 Allowed 'General case' 0 C--O 1.204 -1.294 1 O-C-N 131.13 5.269 . . . . 0.0 103.895 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 90' ' ' VAL . 8.9 t -85.49 112.34 20.82 Favored 'General case' 0 N--CA 1.428 -1.574 2 O-C-N 131.177 5.298 . . . . 0.0 112.461 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.18 88.97 2.49 Favored 'General case' 0 C--O 1.208 -1.118 2 C-N-CA 110.772 -4.371 . . . . 0.0 105.773 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.8 m -65.4 93.72 0.15 Allowed 'General case' 0 C--O 1.209 -1.076 0 O-C-N 128.659 3.725 . . . . 0.0 101.37 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 1.8 t80 -110.57 114.5 27.96 Favored 'General case' 0 CA--C 1.498 -1.038 1 CA-C-N 107.512 -4.404 . . . . 0.0 111.426 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 47.45 17.59 0.08 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 112.428 -2.169 . . . . 0.0 116.547 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.31 16.91 19.36 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 116.306 -2.854 . . . . 0.0 114.59 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.15 -38.29 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 120.225 2.013 . . . . 0.0 113.357 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 68.16 97.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 1 O-C-N 130.071 4.607 . . . . 0.0 108.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.363 . . -132.07 113.64 13.59 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 128.398 3.561 . . . . 0.0 109.116 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -116.25 -174.34 2.53 Favored 'General case' 0 N--CA 1.421 -1.878 1 O-C-N 133.694 6.871 . . . . 0.0 111.381 -179.422 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -156.5 119.8 4.22 Favored 'General case' 0 C--O 1.204 -1.331 2 O-C-N 130.418 4.824 . . . . 0.0 101.511 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.06 125.36 45.63 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 O-C-N 127.763 3.164 . . . . 0.0 112.903 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 65.6 m-85 -120.58 -141.96 0.34 Allowed 'General case' 0 N--CA 1.446 -0.673 1 O-C-N 131.013 5.196 . . . . 0.0 104.949 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.694 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -164.16 -149.89 0.14 Allowed 'General case' 0 C--O 1.199 -1.579 1 O-C-N 131.538 5.524 . . . . 0.0 112.526 179.903 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.645 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 24.0 tttt -128.56 154.79 45.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 127.211 2.204 . . . . 0.0 111.185 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 N--CA 1.434 -1.228 0 O-C-N 127.767 3.167 . . . . 0.0 113.678 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.554 1.116 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -144.33 57.49 1.32 Allowed 'General case' 0 C--N 1.358 0.938 0 CA-C-N 110.126 -3.215 . . . . 0.0 111.192 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.429 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . -165.53 177.31 40.85 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 114.113 -3.899 . . . . 0.0 105.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.327 23.8 p -80.26 177.81 8.71 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 113.858 -3.137 . . . . 0.0 104.087 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.662 ' CE3' ' HG3' ' A' ' 115' ' ' LYS . 75.3 m95 -150.69 167.86 26.08 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 115.506 -2.187 . . . . 0.0 112.189 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 8.5 mtmt 51.03 179.19 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 O-C-N 127.83 3.207 . . . . 0.0 118.814 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.486 -1.512 3 O-C-N 133.492 6.745 . . . . 0.0 121.414 174.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 114.216 -2.802 . . . . 0.0 106.506 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.407 0.0 OUTLIER -179.14 175.45 0.96 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 133.237 6.586 . . . . 0.0 103.342 -179.7 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -136.96 157.55 46.49 Favored 'General case' 0 CA--C 1.565 1.547 3 O-C-N 133.895 6.997 . . . . 0.0 97.7 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 24' ' ' THR . 2.9 m 177.78 80.44 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 1 O-C-N 131.913 5.758 . . . . 0.0 106.514 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.703 HG22 ' HB2' ' A' ' 32' ' ' PHE . 2.2 mp -95.81 118.76 42.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 CA-C-N 109.451 -3.522 . . . . 0.0 109.079 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.5 m -172.63 68.62 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 128.895 3.872 . . . . 0.0 108.905 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.477 ' HB2' ' C ' ' A' ' 31' ' ' LYS 0.297 1.5 tp60 -73.89 -95.26 0.02 OUTLIER 'General case' 0 C--N 1.354 0.786 1 C-N-CA 110.74 -4.384 . . . . 0.0 115.504 -179.888 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 170.86 144.94 0.03 OUTLIER 'General case' 0 C--O 1.244 0.771 0 O-C-N 128.555 3.659 . . . . 0.0 106.427 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 30' ' ' ASN . . . 74.88 -97.32 1.0 Allowed Glycine 0 CA--C 1.559 2.792 3 O-C-N 130.902 5.127 . . . . 0.0 102.361 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 12.2 m120 -152.74 47.64 0.72 Allowed 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.62 6.129 . . . . 0.0 112.317 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 6.1 mttp -118.33 161.85 19.26 Favored 'General case' 0 CA--C 1.552 1.048 1 N-CA-C 96.579 -5.341 . . . . 0.0 96.579 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 25' ' ' ILE . 23.0 p90 -167.8 76.96 0.15 Allowed 'General case' 0 C--O 1.197 -1.706 2 C-N-CA 110.383 -4.527 . . . . 0.0 99.656 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 138.12 58.43 Favored 'General case' 0 CA--C 1.505 -0.755 2 O-C-N 130.907 5.129 . . . . 0.0 100.529 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.853 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 6.8 t -91.05 132.66 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 179.688 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.25 19.8 tttt -73.74 52.61 0.41 Allowed 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 126.732 3.158 . . . . 0.0 117.28 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.853 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.265 50.3 mt-10 -72.28 68.24 0.74 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.869 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -84.49 91.42 7.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 114.257 -2.977 . . . . 0.0 108.85 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 m -87.54 -178.78 6.2 Favored 'General case' 0 C--N 1.367 1.34 0 O-C-N 126.622 2.451 . . . . 0.0 116.549 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.6 -9.16 59.79 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 126.102 2.126 . . . . 0.0 108.351 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 19.7 m-85 -69.3 -55.32 10.82 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 113.341 -3.343 . . . . 0.0 106.978 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -158.95 6.63 0.11 Allowed 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 114.394 -2.717 . . . . 0.0 117.367 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.81 62.97 0.87 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 101.927 -3.361 . . . . 0.0 101.927 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 0.0 OUTLIER -134.88 113.47 16.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 3 CA-C-O 130.994 5.188 . . . . 0.0 111.249 -178.301 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.98 -172.95 4.21 Favored 'General case' 0 C--N 1.372 1.586 1 CA-C-N 107.259 -4.519 . . . . 0.0 109.59 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.26 118.36 31.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 O-C-N 128.839 3.837 . . . . 0.0 101.525 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.33 160.64 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 C-N-CA 113.035 -3.466 . . . . 0.0 111.758 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER 177.09 -176.89 0.15 Allowed 'General case' 0 N--CA 1.435 -1.183 1 O-C-N 129.818 4.449 . . . . 0.0 111.649 -179.819 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.315 3.7 tm-20 -141.97 86.51 1.99 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 114.676 -2.809 . . . . 0.0 113.388 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 36.87 91.64 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.282 1 O-C-N 131.236 5.335 . . . . 0.0 115.743 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.823 ' HA3' HG22 ' A' ' 68' ' ' THR . . . 57.46 65.22 3.71 Favored Glycine 0 C--O 1.203 -1.842 0 CA-C-O 114.248 -3.529 . . . . 0.0 105.713 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.23 -33.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 1 O-C-N 131.511 4.889 . . . . 0.0 113.637 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.8 126.02 0.03 OUTLIER 'General case' 0 C--O 1.2 -1.551 2 O-C-N 132.047 5.842 . . . . 0.0 108.368 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 9.6 p90 -173.7 149.33 1.59 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 112.5 -3.68 . . . . 0.0 117.479 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.56 138.44 40.91 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 100.698 -3.816 . . . . 0.0 100.698 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 56' ' ' SER . 4.4 t80 -150.78 26.96 0.73 Allowed 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 111.757 -3.977 . . . . 0.0 115.082 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 55' ' ' TYR . 7.4 t 23.52 78.68 0.02 OUTLIER 'General case' 0 C--O 1.249 1.061 1 O-C-N 134.693 7.496 . . . . 0.0 110.121 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.44 167.37 19.46 Favored 'General case' 0 C--N 1.317 -0.83 1 O-C-N 129.854 4.472 . . . . 0.0 114.991 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB3' HG23 ' A' ' 61' ' ' THR . . . 45.99 25.12 0.29 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 126.014 2.071 . . . . 0.0 115.388 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.74 42.13 19.18 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 126.926 2.641 . . . . 0.0 115.276 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.86 -48.3 0.06 OUTLIER Glycine 0 C--N 1.367 2.261 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 58' ' ' ALA . 3.5 p -63.61 173.61 1.63 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 127.72 2.659 . . . . 0.0 114.242 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -164.27 36.85 0.08 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 112.436 -3.706 . . . . 0.0 108.794 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 87' ' ' LEU . 8.0 mp -59.82 106.65 0.51 Allowed 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 126.558 2.411 . . . . 0.0 108.485 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.3 m -103.7 107.26 18.04 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 112.102 -2.317 . . . . 0.0 107.688 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -161.0 -163.35 13.88 Favored Glycine 0 C--O 1.203 -1.837 1 C-N-CA 111.16 -5.305 . . . . 0.0 107.499 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.441 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 1.5 t -142.33 114.67 8.37 Favored 'General case' 0 CA--C 1.495 -1.17 2 O-C-N 135.426 7.192 . . . . 0.0 118.735 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.719 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.5 m95 -99.54 112.58 24.77 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.823 HG22 ' HA3' ' A' ' 50' ' ' GLY . 73.7 p -106.03 66.26 0.71 Allowed 'General case' 0 N--CA 1.427 -1.594 1 O-C-N 132.618 6.199 . . . . 0.0 115.022 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -40.05 109.25 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 1 O-C-N 133.839 6.962 . . . . 0.0 103.207 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -66.89 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 127.563 3.04 . . . . 0.0 106.405 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.67 -63.06 0.04 OUTLIER Glycine 0 CA--C 1.556 2.654 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -140.38 16.94 2.39 Favored 'General case' 0 N--CA 1.444 -0.727 1 O-C-N 131.44 4.847 . . . . 0.0 108.647 179.543 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -99.4 176.71 5.42 Favored 'General case' 0 N--CA 1.476 0.826 1 O-C-N 131.307 5.379 . . . . 0.0 108.737 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.4 mt -148.17 45.16 1.07 Allowed 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 126.804 2.565 . . . . 0.0 111.951 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.68 137.75 23.05 Favored 'Isoleucine or valine' 0 C--N 1.364 1.227 1 CA-C-N 106.853 -4.703 . . . . 0.0 114.025 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.88 -149.65 20.5 Favored Glycine 0 CA--C 1.547 2.063 1 N-CA-C 100.649 -4.98 . . . . 0.0 100.649 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 176.5 137.82 0.06 Allowed 'General case' 0 C--O 1.208 -1.083 1 O-C-N 134.046 6.38 . . . . 0.0 112.632 -179.986 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.719 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -124.73 168.02 13.76 Favored 'General case' 0 C--O 1.195 -1.782 2 O-C-N 132.526 6.141 . . . . 0.0 104.814 179.783 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 86' ' ' GLU 0.28 0.0 OUTLIER -163.94 140.54 6.7 Favored 'General case' 0 N--CA 1.427 -1.609 1 CA-C-N 106.227 -4.988 . . . . 0.0 113.398 179.975 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.499 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 32.8 ttt180 -93.46 112.09 23.92 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 127.623 3.077 . . . . 0.0 107.164 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.02 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 1 O-C-N 130.714 5.009 . . . . 0.0 109.217 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.461 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . 32.6 m-20 -87.58 19.85 3.19 Favored 'General case' 0 N--CA 1.44 -0.957 1 O-C-N 134.024 7.078 . . . . 0.0 107.86 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.611 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 83.45 18.03 0.24 Allowed 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 128.502 3.626 . . . . 0.0 117.475 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 80' ' ' ARG . . . -82.49 -11.69 81.55 Favored Glycine 0 CA--C 1.562 2.993 1 C-N-CA 110.335 -5.698 . . . . 0.0 104.116 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 1.7 ttmm 41.55 82.83 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 2 O-C-N 132.672 5.572 . . . . 0.0 121.38 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 18.3 mt-10 82.79 71.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.667 1 O-C-N 129.754 4.409 . . . . 0.0 117.071 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 HD11 ' A' ' 63' ' ' LEU . 1.5 mp -99.83 64.58 1.27 Allowed 'General case' 0 C--O 1.197 -1.697 1 O-C-N 132.198 5.936 . . . . 0.0 113.646 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' A' ' 77' ' ' LYS 0.305 93.8 mt -77.84 -174.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 108.563 -3.926 . . . . 0.0 101.647 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.31 73.47 0.92 Allowed 'General case' 0 C--O 1.196 -1.745 0 O-C-N 128.051 3.345 . . . . 0.0 106.242 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 90' ' ' VAL . 2.4 t -61.87 110.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 110.597 -3.001 . . . . 0.0 105.427 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.686 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -162.82 162.67 26.63 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 111.854 -3.938 . . . . 0.0 113.438 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.686 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -153.69 121.05 5.82 Favored 'General case' 0 CA--C 1.543 0.679 2 CA-C-N 107.326 -4.488 . . . . 0.0 103.806 179.554 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 98' ' ' LEU 0.296 5.0 tt -48.4 108.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 1 O-C-N 131.265 5.353 . . . . 0.0 112.99 -179.766 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -74.74 69.33 1.79 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 130.025 4.578 . . . . 0.0 115.479 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.05 -113.4 2.63 Favored Glycine 0 CA--C 1.558 2.76 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -138.6 47.32 1.96 Allowed 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 129.461 3.683 . . . . 0.0 107.456 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.647 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 179.04 127.64 0.07 Allowed 'General case' 0 CA--C 1.56 1.354 0 O-C-N 128.577 3.673 . . . . 0.0 106.966 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 93' ' ' ILE . 11.9 tp -90.94 162.52 14.72 Favored 'General case' 0 C--O 1.206 -1.231 1 O-C-N 134.209 7.193 . . . . 0.0 111.863 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 110' ' ' LYS . 1.4 mp -107.77 -85.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 2 CA-C-O 110.707 -4.473 . . . . 0.0 103.294 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.3 mm-40 93.82 93.41 0.01 OUTLIER 'General case' 0 C--O 1.202 -1.415 1 O-C-N 133.593 6.808 . . . . 0.0 104.824 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.8 p -83.93 -166.37 1.39 Allowed 'General case' 0 N--CA 1.416 -2.174 1 O-C-N 129.273 4.108 . . . . 0.0 113.177 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -156.22 89.33 1.13 Allowed 'General case' 0 C--O 1.2 -1.552 1 C-N-CA 110.752 -4.379 . . . . 0.0 103.293 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.63 79.11 0.42 Allowed 'General case' 0 C--O 1.213 -0.835 1 O-C-N 129.804 4.44 . . . . 0.0 107.532 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -104.58 100.96 10.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 108.661 -3.881 . . . . 0.0 111.295 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 46.88 17.09 0.05 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.61 -18.57 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 116.388 -2.815 . . . . 0.0 116.41 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.12 142.5 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 119.72 1.76 . . . . 0.0 112.933 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -109.09 87.16 2.43 Favored 'General case' 0 C--N 1.364 1.238 1 O-C-N 129.3 4.125 . . . . 0.0 108.119 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.425 . . -106.71 142.41 36.39 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 116.109 -2.236 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.76 ' HB2' HG23 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -148.64 171.01 16.86 Favored 'General case' 0 N--CA 1.435 -1.184 1 O-C-N 130.875 5.109 . . . . 0.0 109.904 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.503 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -123.96 137.55 54.6 Favored 'General case' 0 CA--C 1.558 1.256 3 O-C-N 129.562 4.289 . . . . 0.0 99.921 179.541 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.09 110.0 15.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 C-N-CA 113.714 -3.194 . . . . 0.0 112.22 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 6.4 m-30 -108.56 175.43 5.47 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 128.84 3.838 . . . . 0.0 103.981 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.647 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.36 -159.19 0.31 Allowed 'General case' 0 C--O 1.198 -1.652 2 O-C-N 131.639 5.587 . . . . 0.0 111.616 179.404 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.662 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 21.6 tttt -112.59 -127.98 0.29 Allowed 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.782 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 . . . . . 0 CA--C 1.561 1.399 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -32.79 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 130.75 5.031 . . . . 0.0 118.294 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.79 -169.7 38.09 Favored Glycine 0 C--N 1.345 1.05 1 C-N-CA 112.006 -4.902 . . . . 0.0 105.496 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.309 0.4 OUTLIER -100.34 167.68 10.25 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 114.074 -3.051 . . . . 0.0 104.929 -179.964 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.656 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.264 34.4 m95 -143.21 140.15 30.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 O-C-N 128.672 3.733 . . . . 0.0 111.109 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' ' HD2' ' A' ' 114' ' ' LYS . 19.3 mtmt 58.2 178.58 0.06 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.306 0.6 OUTLIER . . . . . 0 CA--C 1.484 -1.588 3 O-C-N 136.404 8.565 . . . . 0.0 113.964 174.815 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.136 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.345 0.0 OUTLIER -159.94 149.79 18.27 Favored 'General case' 0 C--O 1.205 -1.259 1 O-C-N 130.856 5.098 . . . . 0.0 104.115 -179.811 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 6.6 mt -116.57 177.68 4.61 Favored 'General case' 0 CA--C 1.562 1.422 2 O-C-N 132.964 6.415 . . . . 0.0 97.937 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.526 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 21.9 m -167.91 -85.31 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 1 O-C-N 130.921 5.138 . . . . 0.0 106.508 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 72.68 162.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 109.163 -3.653 . . . . 0.0 108.853 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 27' ' ' GLN . 90.9 m -138.31 -48.93 0.54 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 112.781 -3.568 . . . . 0.0 108.661 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR 0.316 3.9 pt20 65.97 123.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.027 2 O-C-N 132.503 6.127 . . . . 0.0 115.778 178.762 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 7.1 tt0 -98.97 -130.81 0.22 Allowed 'General case' 0 C--O 1.248 1.022 0 O-C-N 128.795 3.81 . . . . 0.0 104.829 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.14 -53.43 3.91 Favored Glycine 0 CA--C 1.546 2.002 2 N-CA-C 99.594 -5.402 . . . . 0.0 99.594 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' N ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -136.17 75.81 1.57 Allowed 'General case' 0 N--CA 1.44 -0.956 1 CA-C-N 107.589 -4.305 . . . . 0.0 105.862 -179.9 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -168.28 102.88 0.44 Allowed 'General case' 0 C--O 1.246 0.917 1 C-N-CA 111.418 -4.113 . . . . 0.0 102.337 -179.893 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -140.09 165.25 27.87 Favored 'General case' 0 CA--C 1.562 1.426 1 N-CA-C 99.402 -4.295 . . . . 0.0 99.402 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.95 125.08 21.53 Favored 'General case' 0 N--CA 1.476 0.828 2 O-C-N 137.605 9.316 . . . . 0.0 101.468 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.404 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.352 1.1 t -84.89 132.77 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 112.932 -3.507 . . . . 0.0 103.585 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.308 0.3 OUTLIER -71.94 -0.83 12.44 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 109.361 -3.563 . . . . 0.0 118.875 179.789 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.368 1.0 OUTLIER -37.76 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.106 -2.77 . . . . 0.0 109.192 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -91.93 133.45 35.68 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 115.327 -2.549 . . . . 0.0 109.395 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p 177.02 -169.13 0.06 Allowed 'General case' 0 C--N 1.353 0.746 0 O-C-N 127.65 3.094 . . . . 0.0 112.958 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.08 -91.76 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.624 0 O-C-N 125.276 1.61 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -117.58 -36.54 3.67 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 128.254 3.471 . . . . 0.0 111.609 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -143.14 0.15 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 127.222 2.826 . . . . 0.0 115.228 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.7 -22.31 34.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 116.289 -2.164 . . . . 0.0 107.387 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.666 HG13 HD13 ' A' ' 57' ' ' LEU . 13.9 tt 25.28 69.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.223 2 O-C-N 132.349 6.03 . . . . 0.0 111.1 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 57' ' ' LEU . 11.4 p-10 -65.56 155.3 36.16 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 109.639 -3.437 . . . . 0.0 105.148 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 6.3 t -123.09 117.61 52.19 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 1 O-C-N 129.544 4.277 . . . . 0.0 101.462 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.271 0.3 OUTLIER -118.23 162.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 114.663 -2.815 . . . . 0.0 114.831 179.843 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -177.2 -159.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 130.095 4.622 . . . . 0.0 111.448 -179.961 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.1 49.5 1.85 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 117.757 -1.577 . . . . 0.0 114.582 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 39.52 98.37 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 127.778 3.656 . . . . 0.0 115.28 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.01 52.93 1.56 Allowed Glycine 0 CA--C 1.545 1.957 1 N-CA-C 101.563 -4.615 . . . . 0.0 101.563 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -147.3 122.02 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 1 O-C-N 132.184 5.285 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.52 153.16 22.05 Favored 'General case' 0 CA--C 1.558 1.252 1 O-C-N 130.423 4.827 . . . . 0.0 106.968 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -168.42 124.33 0.99 Allowed 'General case' 0 N--CA 1.426 -1.664 1 O-C-N 129.136 4.023 . . . . 0.0 118.566 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.05 118.78 26.66 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -142.59 135.74 28.5 Favored 'General case' 0 C--O 1.21 -0.999 0 O-C-N 127.573 3.046 . . . . 0.0 112.558 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.35 141.88 28.15 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 128.354 3.534 . . . . 0.0 106.883 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -133.17 -67.47 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 128.758 3.786 . . . . 0.0 114.365 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.23 24.16 4.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 116.848 -1.549 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.12 16.01 5.64 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 125.867 1.979 . . . . 0.0 114.489 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.01 56.36 0.12 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 104.813 -3.315 . . . . 0.0 104.813 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -127.97 -87.82 0.56 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 129.876 3.927 . . . . 0.0 110.393 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 69.76 15.22 8.04 Favored 'General case' 0 CA--C 1.517 -0.317 1 O-C-N 129.465 4.228 . . . . 0.0 109.656 179.927 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.453 HD13 HG22 ' A' ' 61' ' ' THR . 10.9 mp -58.5 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 124.374 2.035 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.0 m -85.95 113.35 21.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 77' ' ' LYS . . . -144.79 -155.47 6.47 Favored Glycine 0 C--O 1.209 -1.445 1 C-N-CA 111.673 -5.06 . . . . 0.0 109.213 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.629 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.27 8.8 t -179.78 135.96 0.12 Allowed 'General case' 0 CA--C 1.496 -1.131 2 O-C-N 133.524 6.073 . . . . 0.0 111.917 -178.154 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 67.7 m95 -141.45 119.63 12.13 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 116.692 -3.755 . . . . 0.0 106.209 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 1.1 p -106.43 34.72 3.25 Favored 'General case' 0 N--CA 1.434 -1.246 2 O-C-N 134.543 7.402 . . . . 0.0 116.154 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.469 ' N ' HD21 ' A' ' 49' ' ' LEU 0.264 4.3 ttm -17.66 84.56 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 1 O-C-N 136.57 8.669 . . . . 0.0 108.058 -179.92 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.72 94.54 9.42 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 128.046 3.341 . . . . 0.0 107.074 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.11 -132.04 36.25 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -85.43 60.66 6.38 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 109.075 -3.563 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 158.83 44.18 Favored 'General case' 0 C--N 1.359 1.015 1 O-C-N 129.297 4.123 . . . . 0.0 111.149 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 74' ' ' LEU . 13.0 mt -141.93 59.59 1.48 Allowed 'General case' 0 C--O 1.209 -1.047 0 O-C-N 128.269 3.481 . . . . 0.0 111.459 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.15 101.66 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 1 CA-C-N 107.531 -4.395 . . . . 0.0 115.601 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.81 -144.99 4.36 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 103.3 -3.92 . . . . 0.0 103.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.3 0.1 OUTLIER -176.89 165.21 2.42 Favored 'General case' 0 C--O 1.201 -1.457 2 O-C-N 131.36 4.8 . . . . 0.0 112.092 -179.767 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 19.9 m-85 -144.38 166.1 26.06 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.572 ' HE2' ' CG ' ' A' ' 86' ' ' GLU 0.283 0.0 OUTLIER -174.28 152.43 1.8 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 108.966 -3.743 . . . . 0.0 117.221 179.327 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HG3' ' CB ' ' A' ' 85' ' ' LYS . 5.8 ptm180 -104.11 78.29 1.5 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 126.299 2.25 . . . . 0.0 107.252 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.473 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 5.6 m -22.12 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 1 O-C-N 133.331 6.644 . . . . 0.0 114.047 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -41.88 -47.02 4.17 Favored 'General case' 0 N--CA 1.451 -0.425 1 O-C-N 134.751 7.532 . . . . 0.0 107.637 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -112.0 -0.28 15.78 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 128.544 3.653 . . . . 0.0 113.304 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.26 34.63 88.62 Favored Glycine 0 CA--C 1.559 2.782 1 N-CA-C 101.361 -4.696 . . . . 0.0 101.361 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -66.02 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 3 O-C-N 132.615 5.538 . . . . 0.0 118.264 179.983 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.572 ' CG ' ' HE2' ' A' ' 79' ' ' LYS . 46.3 mt-10 116.87 133.52 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 1 O-C-N 132.455 6.097 . . . . 0.0 109.136 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.64 42.4 0.48 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 133.289 6.618 . . . . 0.0 110.003 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 86' ' ' GLU 0.256 4.7 mt -67.71 171.52 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.591 1 O-C-N 131.42 5.45 . . . . 0.0 105.004 -179.567 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.68 73.95 1.25 Allowed 'General case' 0 C--O 1.219 -0.545 1 O-C-N 133.66 6.85 . . . . 0.0 107.592 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.69 125.71 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.581 ' HG2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -166.58 153.88 9.46 Favored 'General case' 0 C--O 1.191 -1.982 1 C-N-CA 110.407 -4.517 . . . . 0.0 115.405 179.83 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 4.5 mt-10 -149.04 113.61 5.32 Favored 'General case' 0 N--CA 1.433 -1.324 1 O-C-N 131.018 5.199 . . . . 0.0 107.095 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 98' ' ' LEU 0.26 0.1 OUTLIER -45.5 112.99 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.668 1 O-C-N 130.325 4.766 . . . . 0.0 109.296 179.823 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -67.72 -89.58 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.097 0 O-C-N 128.734 3.771 . . . . 0.0 116.89 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 97' ' ' GLU . . . -135.92 100.33 0.34 Allowed Glycine 0 C--O 1.206 -1.638 0 C-N-CA 115.464 -3.255 . . . . 0.0 107.662 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 52.51 22.73 2.25 Favored 'General case' 0 N--CA 1.443 -0.809 2 O-C-N 130.639 4.376 . . . . 0.0 109.663 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.296 0.0 OUTLIER -168.8 134.1 1.65 Allowed 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 127.581 3.051 . . . . 0.0 109.022 179.283 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 91' ' ' ARG . 2.6 tt -97.67 142.12 29.86 Favored 'General case' 0 N--CA 1.437 -1.095 1 O-C-N 133.598 6.811 . . . . 0.0 115.863 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 100' ' ' GLN . 29.0 mt -83.19 -84.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.518 0 O-C-N 128.945 3.903 . . . . 0.0 106.284 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.476 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.4 tt0 92.95 107.67 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.274 1 O-C-N 131.024 5.203 . . . . 0.0 100.833 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.518 HG21 ' OE2' ' A' ' 108' ' ' GLU . 17.2 p -77.76 -38.7 46.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 128.406 3.566 . . . . 0.0 119.462 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 61.81 53.04 3.26 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 111.569 -2.56 . . . . 0.0 105.583 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 m -52.42 117.18 2.67 Favored 'General case' 0 C--N 1.36 1.023 1 O-C-N 133.038 6.461 . . . . 0.0 100.625 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 5.7 t80 -144.58 138.04 27.18 Favored 'General case' 0 CA--C 1.49 -1.349 1 O-C-N 130.13 4.644 . . . . 0.0 112.604 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.51 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 1.0 OUTLIER 37.41 35.13 0.05 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.841 -1.981 . . . . 0.0 115.952 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.58 79.64 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 116.76 -2.638 . . . . 0.0 117.305 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.81 -19.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.518 ' OE2' HG21 ' A' ' 101' ' ' THR . 9.4 mt-10 66.48 173.08 0.24 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 128.33 3.519 . . . . 0.0 106.951 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.328 . . -174.8 81.43 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 117.234 -1.787 . . . . 0.0 114.166 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -95.5 120.86 36.48 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 129.729 4.393 . . . . 0.0 109.084 -179.931 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -92.85 -34.12 13.96 Favored 'General case' 0 CA--C 1.555 1.16 1 O-C-N 129.974 4.546 . . . . 0.0 104.164 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 83.5 118.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.126 1 O-C-N 130.25 4.719 . . . . 0.0 108.03 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 21' ' ' LEU . 37.0 m-85 -141.8 -146.67 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 1 O-C-N 129.549 4.28 . . . . 0.0 106.511 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -170.31 -145.31 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.024 1 O-C-N 131.104 5.253 . . . . 0.0 111.668 -179.739 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 17.4 tttt -129.03 -58.51 1.14 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.232 1.413 . . . . 0.0 111.979 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.411 -2.384 0 CA-C-N 111.027 -2.806 . . . . 0.0 113.837 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.588 ' HZ ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.267 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' ILE 0.252 5.0 p-10 -34.48 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.874 1 O-C-N 130.443 4.839 . . . . 0.0 117.735 179.493 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 169.57 -179.2 42.2 Favored Glycine 0 N--CA 1.477 1.43 1 C-N-CA 112.231 -4.795 . . . . 0.0 104.169 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 24' ' ' THR 0.305 3.3 p -88.4 173.08 8.92 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 113.712 -3.195 . . . . 0.0 108.168 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.633 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 64.6 m95 -152.14 117.69 5.35 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 89.3 171.58 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 22' ' ' LYS 0.274 0.5 OUTLIER . . . . . 0 CA--C 1.479 -1.775 3 CA-C-O 135.886 7.517 . . . . 0.0 120.305 174.864 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.424 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.321 7.9 mttt 147.09 141.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.53 2 O-C-N 132.914 6.384 . . . . 0.0 106.576 177.423 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 25' ' ' ILE . 5.9 mt -96.5 161.57 13.85 Favored 'General case' 0 CA--C 1.565 1.552 3 O-C-N 132.692 6.245 . . . . 0.0 96.686 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.561 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 2.7 m 172.09 83.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 1 O-C-N 129.308 4.13 . . . . 0.0 101.336 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.663 HG23 ' H ' ' A' ' 33' ' ' THR . 3.7 mp -106.13 116.34 49.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 108.688 -3.869 . . . . 0.0 112.833 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.9 m -162.14 77.2 0.49 Allowed 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 127.134 2.771 . . . . 0.0 108.506 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.618 ' HB2' ' C ' ' A' ' 31' ' ' LYS . 8.1 mm-40 -68.11 -93.07 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 1 C-N-CA 110.998 -4.281 . . . . 0.0 113.428 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -127.2 -7.86 5.9 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 113.396 -3.192 . . . . 0.0 106.725 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.82 -11.27 29.84 Favored Glycine 0 CA--C 1.538 1.493 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.9 -30.4 2.03 Favored 'General case' 0 N--CA 1.411 -2.418 1 CA-C-O 111.649 -4.024 . . . . 0.0 111.547 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.618 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 43.5 mttt -103.86 -165.94 1.21 Allowed 'General case' 0 C--O 1.246 0.897 1 N-CA-C 97.725 -4.917 . . . . 0.0 97.725 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.631 ' HD1' HG22 ' A' ' 25' ' ' ILE . 25.6 m-85 -167.86 156.63 9.38 Favored 'General case' 0 C--O 1.203 -1.389 1 N-CA-C 97.355 -5.054 . . . . 0.0 97.355 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.663 ' H ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -143.82 128.99 18.73 Favored 'General case' 0 N--CA 1.479 1.015 4 O-C-N 136.662 8.726 . . . . 0.0 98.079 179.836 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.431 4.0 t -88.15 121.46 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 1 N-CA-C 99.303 -4.332 . . . . 0.0 99.303 179.9 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.376 11.2 tttt -56.09 -18.99 11.29 Favored 'General case' 0 C--N 1.37 1.489 0 CA-C-N 110.281 -3.145 . . . . 0.0 119.252 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HB2' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER 3.58 67.87 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 109.774 -3.375 . . . . 0.0 111.342 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' HA ' ' A' ' 21' ' ' LEU . 19.1 m -70.45 127.9 34.33 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 116.816 -1.954 . . . . 0.0 113.071 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -126.38 -168.49 1.87 Allowed 'General case' 0 C--N 1.369 1.417 0 O-C-N 125.707 1.879 . . . . 0.0 112.263 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.25 -25.52 58.13 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 125.507 2.575 . . . . 0.0 104.722 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' O ' HD12 ' A' ' 43' ' ' ILE . 13.3 m-85 -90.32 69.24 7.02 Favored 'General case' 0 N--CA 1.437 -1.093 1 CA-C-N 106.653 -4.794 . . . . 0.0 107.143 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.93 177.58 0.1 Allowed 'General case' 0 N--CA 1.436 -1.172 1 O-C-N 129.328 4.142 . . . . 0.0 114.677 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 43' ' ' ILE . 12.7 m-80 -71.5 -44.62 64.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 111.776 -3.969 . . . . 0.0 102.539 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER 64.61 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.512 3 CA-C-O 130.08 4.752 . . . . 0.0 107.074 -179.798 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.02 138.4 42.17 Favored 'General case' 0 C--N 1.373 1.611 1 CA-C-N 106.395 -4.911 . . . . 0.0 108.26 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.36 86.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 1 N-CA-C 99.782 -4.155 . . . . 0.0 99.782 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.8 163.04 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 1 C-N-CA 111.003 -4.279 . . . . 0.0 113.311 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.8 p90 -161.94 149.68 14.58 Favored 'General case' 0 N--CA 1.433 -1.311 1 O-C-N 132.888 6.367 . . . . 0.0 111.06 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.02 51.55 1.83 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 113.056 -3.458 . . . . 0.0 115.554 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.711 HD21 ' CB ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 47.75 89.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 2 O-C-N 132.714 6.259 . . . . 0.0 114.585 -179.711 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.28 59.1 2.78 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.74 -32.2 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 1 O-C-N 133.915 6.303 . . . . 0.0 115.225 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.06 138.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 1 O-C-N 131.421 5.451 . . . . 0.0 109.049 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 p90 179.31 145.96 0.18 Allowed 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 108.668 -3.878 . . . . 0.0 116.505 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -109.45 137.31 47.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.474 -3.899 . . . . 0.0 100.474 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -147.69 100.79 3.27 Favored 'General case' 0 C--O 1.21 -1.001 1 O-C-N 129.295 4.122 . . . . 0.0 114.06 179.848 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 94.7 1.87 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 112.775 -3.57 . . . . 0.0 101.484 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' TYR . 5.7 tp -82.55 -86.35 0.1 Allowed 'General case' 0 CA--C 1.507 -0.709 1 O-C-N 131.735 5.647 . . . . 0.0 116.117 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -64.57 10.11 0.07 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 115.825 -2.036 . . . . 0.0 116.494 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 9.4 5.59 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 120.504 1.502 . . . . 0.0 111.122 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.09 46.26 0.27 Allowed Glycine 0 CA--C 1.548 2.128 0 N-CA-C 105.178 -3.169 . . . . 0.0 105.178 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HD13 ' A' ' 63' ' ' LEU . 1.7 p -126.59 -88.93 0.56 Allowed 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 132.155 5.268 . . . . 0.0 114.537 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 62.14 71.95 0.52 Allowed 'General case' 0 C--O 1.217 -0.654 0 O-C-N 127.595 3.06 . . . . 0.0 106.784 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.562 HD13 ' HB ' ' A' ' 61' ' ' THR . 11.1 mp -120.57 76.08 1.17 Allowed 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 128.518 3.636 . . . . 0.0 113.92 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 92.9 m -48.44 111.84 0.51 Allowed 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.89 -171.38 12.32 Favored Glycine 0 CA--C 1.538 1.469 2 C-N-CA 111.026 -5.368 . . . . 0.0 107.029 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.603 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 5.9 t 176.53 128.96 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.218 2 O-C-N 133.611 6.124 . . . . 0.0 111.368 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 52.1 m95 -137.73 117.83 13.48 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 117.174 -3.454 . . . . 0.0 106.347 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD22 ' A' ' 49' ' ' LEU . 6.9 p -96.6 33.64 1.79 Allowed 'General case' 0 N--CA 1.422 -1.87 2 O-C-N 130.703 5.002 . . . . 0.0 116.706 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.711 ' CB ' HD21 ' A' ' 49' ' ' LEU . 2.2 ttt -18.93 106.19 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.814 1 O-C-N 136.821 8.825 . . . . 0.0 107.523 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.22 -44.72 87.38 Favored 'General case' 0 CA--C 1.505 -0.786 1 O-C-N 129.684 4.365 . . . . 0.0 108.673 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.83 -39.35 0.18 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 110.46 -3.064 . . . . 0.0 107.492 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.7 p30 -142.07 30.53 1.61 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 129.795 3.879 . . . . 0.0 108.748 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 5.3 mttt -135.61 157.38 47.02 Favored 'General case' 0 N--CA 1.453 -0.315 1 O-C-N 131.032 5.207 . . . . 0.0 111.604 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 74' ' ' LEU . 7.3 mt -134.91 60.11 1.71 Allowed 'General case' 0 C--O 1.214 -0.775 0 O-C-N 127.879 3.237 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -85.31 93.27 3.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 1 CA-C-N 106.544 -4.843 . . . . 0.0 114.044 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -159.08 -156.64 8.14 Favored Glycine 0 C--O 1.207 -1.585 2 CA-C-N 107.599 -4.364 . . . . 0.0 102.955 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.331 21.8 ttpt -170.54 123.98 0.68 Allowed 'General case' 0 C--N 1.37 1.476 1 C-N-CA 108.813 -5.155 . . . . 0.0 112.779 179.934 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 28.0 m-85 -106.09 162.46 13.6 Favored 'General case' 0 C--O 1.2 -1.504 2 N-CA-C 99.831 -4.137 . . . . 0.0 99.831 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.2 OUTLIER -168.23 130.9 1.48 Allowed 'General case' 0 CA--C 1.495 -1.152 1 CA-C-N 105.594 -5.275 . . . . 0.0 113.737 -178.716 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 11.2 ttp180 -82.41 86.72 6.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 125.007 1.442 . . . . 0.0 110.775 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.39 -33.75 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 O-C-N 128.044 3.34 . . . . 0.0 110.274 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -56.91 -46.57 81.9 Favored 'General case' 0 C--O 1.248 1.002 1 O-C-N 132.36 6.038 . . . . 0.0 108.825 -179.754 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.34 -5.7 17.63 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 113.403 -3.319 . . . . 0.0 112.559 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.552 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 75.91 41.54 27.67 Favored Glycine 0 CA--C 1.557 2.677 2 C-N-CA 110.843 -5.456 . . . . 0.0 100.485 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 8.6 tppt? -81.75 -81.44 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 2 CA-C-N 105.75 -5.225 . . . . 0.0 121.239 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 7.0 mm-40 91.04 121.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.576 4.922 . . . . 0.0 108.084 -177.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 63' ' ' LEU . 1.4 pt? -153.45 48.48 0.68 Allowed 'General case' 0 C--O 1.194 -1.836 1 O-C-N 132.435 6.084 . . . . 0.0 110.292 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.712 HG22 HG23 ' A' ' 90' ' ' VAL . 30.8 mt -52.33 141.99 5.5 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.552 2 O-C-N 130.248 4.717 . . . . 0.0 104.87 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.65 59.03 0.7 Allowed 'General case' 0 C--O 1.213 -0.832 1 O-C-N 130.75 5.032 . . . . 0.0 105.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 88' ' ' ILE . 13.3 t -64.02 102.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 O-C-N 127.848 3.218 . . . . 0.0 110.842 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.575 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -140.63 -174.03 3.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 115.408 -2.517 . . . . 0.0 110.554 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 91' ' ' ARG 0.299 0.0 OUTLIER 176.9 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 132.386 6.054 . . . . 0.0 105.822 -178.858 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -39.86 100.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.05 1 O-C-N 131.673 5.608 . . . . 0.0 110.001 179.247 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 m -85.59 -69.07 0.68 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 108.838 -3.801 . . . . 0.0 117.723 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.06 -106.44 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 CA-C-O 126.279 3.155 . . . . 0.0 105.705 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.33 52.61 1.55 Allowed 'General case' 0 CA--C 1.54 0.586 1 CA-C-N 108.009 -4.095 . . . . 0.0 105.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.88 ' O ' HD13 ' A' ' 93' ' ' ILE 0.318 0.0 OUTLIER -159.81 -118.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 1 O-C-N 130.399 4.812 . . . . 0.0 106.272 179.546 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 100' ' ' GLN . 9.9 tt 155.88 103.56 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.196 1 O-C-N 129.849 4.468 . . . . 0.0 109.442 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -48.49 -72.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.41 -2.472 1 O-C-N 130.903 5.127 . . . . 0.0 107.483 -179.876 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.721 ' HB2' HD21 ' A' ' 98' ' ' LEU . 7.6 tp60 79.06 100.71 0.06 Allowed 'General case' 0 CA--C 1.562 1.428 1 O-C-N 134.737 7.523 . . . . 0.0 100.428 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.031 HG23 ' HG3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -105.94 119.77 40.04 Favored 'General case' 0 N--CA 1.411 -2.41 2 O-C-N 134.04 7.088 . . . . 0.0 114.346 179.752 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.66 81.93 8.65 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ILE . 1.5 m -65.94 98.65 0.43 Allowed 'General case' 0 C--N 1.361 1.067 1 O-C-N 132.359 6.037 . . . . 0.0 101.332 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -107.62 120.29 41.8 Favored 'General case' 0 N--CA 1.435 -1.19 2 O-C-N 129.718 4.386 . . . . 0.0 113.359 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 4.88 64.65 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 126.937 2.648 . . . . 0.0 117.601 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.89 13.29 29.88 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 118.39 -1.862 . . . . 0.0 116.347 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.61 148.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-O 116.618 -1.658 . . . . 0.0 115.197 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -117.59 67.46 0.75 Allowed 'General case' 0 C--N 1.362 1.129 1 O-C-N 129.724 4.39 . . . . 0.0 106.586 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.411 . . -99.94 97.16 8.07 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 127.672 3.108 . . . . 0.0 111.582 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 1.031 ' HG3' HG23 ' A' ' 101' ' ' THR . 2.1 mtmt -89.98 176.51 6.77 Favored 'General case' 0 N--CA 1.419 -1.982 2 O-C-N 135.117 7.76 . . . . 0.0 110.074 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -135.24 117.32 15.38 Favored 'General case' 0 CA--C 1.561 1.39 3 O-C-N 131.975 5.797 . . . . 0.0 98.991 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.14 126.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 1 O-C-N 129.495 4.247 . . . . 0.0 112.468 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 31.1 m-85 -140.19 -149.24 0.27 Allowed 'General case' 0 N--CA 1.445 -0.72 1 O-C-N 129.851 4.469 . . . . 0.0 107.858 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.18 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 1 O-C-N 131.114 5.259 . . . . 0.0 112.257 -179.147 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.633 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 28.3 tttt -123.04 -130.53 0.27 Allowed 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.721 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.264 0.3 OUTLIER . . . . . 0 C--O 1.21 -0.985 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.966 0 CA-C-O 116.974 -1.489 . . . . 0.0 107.897 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.36 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 128.827 3.83 . . . . 0.0 116.8 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.97 176.35 36.56 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 114.853 -3.546 . . . . 0.0 105.79 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.538 HG22 ' OG1' ' A' ' 24' ' ' THR 0.392 0.2 OUTLIER -93.01 160.89 14.67 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 111.898 -3.921 . . . . 0.0 109.747 -179.605 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.643 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 12.8 m95 -127.61 161.29 29.19 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-O 113.033 -3.365 . . . . 0.0 111.095 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 10.6 mtmt 46.41 -179.59 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 8' ' ' VAL 0.328 0.9 OUTLIER . . . . . 0 CA--C 1.487 -1.458 3 CA-C-O 133.024 6.154 . . . . 0.0 119.239 174.984 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.997 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.395 0.0 OUTLIER -174.86 134.55 0.36 Allowed 'General case' 0 CA--C 1.566 1.569 1 O-C-N 132.379 6.049 . . . . 0.0 103.891 -179.962 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 9.1 mt -97.29 158.22 15.57 Favored 'General case' 0 CA--C 1.555 1.147 3 O-C-N 130.705 5.003 . . . . 0.0 97.801 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.4 m 173.18 94.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 2 CA-C-O 130.402 4.906 . . . . 0.0 102.455 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 32' ' ' PHE . 3.5 mp -106.89 138.41 32.82 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 109.429 -3.532 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -174.56 73.0 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.168 2.792 . . . . 0.0 108.468 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.7 mm-40 -92.17 -95.0 0.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 113.367 -3.333 . . . . 0.0 112.295 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.47 1.82 0.53 Allowed 'General case' 0 C--O 1.251 1.138 0 O-C-N 127.982 3.302 . . . . 0.0 107.797 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.89 -33.15 5.76 Favored Glycine 0 CA--C 1.539 1.558 1 N-CA-C 101.552 -4.619 . . . . 0.0 101.552 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -98.48 -36.99 9.76 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-O 112.723 -3.513 . . . . 0.0 112.188 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' GLN . 72.5 mttt -111.37 173.92 6.11 Favored 'General case' 0 C--O 1.247 0.923 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.815 ' HD2' HG21 ' A' ' 25' ' ' ILE 0.265 2.0 p90 -167.8 68.66 0.08 Allowed 'General case' 0 C--O 1.187 -2.222 1 C-N-CA 110.836 -4.346 . . . . 0.0 100.757 178.638 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.01 123.3 13.13 Favored 'General case' 0 CA--C 1.502 -0.894 2 CA-C-N 105.777 -5.192 . . . . 0.0 103.947 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.413 0.5 OUTLIER -91.41 142.74 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 101.584 -3.487 . . . . 0.0 101.584 -179.753 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.279 6.2 tttt -77.68 1.54 19.58 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 110.629 -2.987 . . . . 0.0 118.603 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 34' ' ' VAL 0.252 0.0 OUTLIER -36.43 99.42 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 110.597 -3.002 . . . . 0.0 109.516 -179.962 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.49 164.43 12.22 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 128.29 3.494 . . . . 0.0 110.095 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -171.19 3.04 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 125.237 1.586 . . . . 0.0 112.694 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -76.05 -7.75 55.4 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.962 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 33.9 m-85 -80.94 -71.66 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.18 -2.736 . . . . 0.0 110.396 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -150.78 -172.31 4.16 Favored 'General case' 0 N--CA 1.433 -1.286 1 O-C-N 131.891 5.744 . . . . 0.0 112.443 179.871 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -23.46 59.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 113.753 -3.179 . . . . 0.0 104.25 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 57' ' ' LEU . 7.4 tp 28.18 80.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.122 2 O-C-N 132.839 6.337 . . . . 0.0 110.676 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.35 120.52 21.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 109.701 -3.408 . . . . 0.0 105.828 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 57' ' ' LEU . 98.2 t -91.12 97.9 7.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 1 O-C-N 132.254 5.971 . . . . 0.0 102.779 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.316 8.9 p -99.98 158.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 1 O-C-N 129.161 4.038 . . . . 0.0 115.226 -179.967 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -178.8 -160.45 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 129.543 4.277 . . . . 0.0 112.055 -179.64 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' CG ' ' HG2' ' A' ' 31' ' ' LYS 0.294 22.9 mt-10 -142.77 63.03 1.4 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.278 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 69' ' ' MET . 19.5 mt 54.15 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.217 0 O-C-N 128.159 3.412 . . . . 0.0 114.626 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.52 82.44 0.94 Allowed Glycine 0 C--O 1.197 -2.2 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.95 111.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 O-C-N 132.747 5.616 . . . . 0.0 112.897 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 6.5 t70 -91.87 163.34 14.07 Favored 'General case' 0 C--N 1.365 1.266 1 O-C-N 129.35 4.156 . . . . 0.0 106.797 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -173.32 143.64 1.11 Allowed 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 114.003 -3.079 . . . . 0.0 116.209 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.52 91.02 4.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.68 147.57 28.37 Favored 'General case' 0 C--O 1.208 -1.094 1 O-C-N 130.192 4.682 . . . . 0.0 112.772 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.61 92.98 4.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 128.16 3.413 . . . . 0.0 103.539 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.68 HD11 HG22 ' A' ' 45' ' ' VAL . 2.7 tp -47.36 -86.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 1 O-C-N 130.75 5.031 . . . . 0.0 109.998 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 -135.85 0.02 OUTLIER 'General case' 0 C--O 1.248 1.001 0 C-N-CA 116.875 -1.93 . . . . 0.0 109.723 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.46 -37.02 82.3 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.521 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.77 -81.71 0.82 Allowed Glycine 0 CA--C 1.545 1.909 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HD13 ' A' ' 63' ' ' LEU . 1.4 m 35.7 77.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 1 O-C-N 131.089 4.641 . . . . 0.0 113.426 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 63' ' ' LEU . 1.9 tm-20 -81.99 139.93 34.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 115.31 -2.556 . . . . 0.0 104.36 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -155.73 44.21 0.44 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 129.264 4.102 . . . . 0.0 111.695 -179.719 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -43.03 106.71 0.07 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 111.866 -2.424 . . . . 0.0 109.525 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -173.48 -161.98 24.63 Favored Glycine 0 N--CA 1.479 1.502 1 C-N-CA 111.133 -5.317 . . . . 0.0 107.474 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.49 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 8.3 t -154.36 142.04 19.92 Favored 'General case' 0 C--O 1.247 0.953 0 O-C-N 129.45 3.677 . . . . 0.0 116.585 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.732 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 6.1 m95 -122.28 96.76 5.17 Favored 'General case' 0 C--O 1.196 -1.713 0 CA-C-O 113.192 -3.289 . . . . 0.0 102.595 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -105.72 75.58 1.14 Allowed 'General case' 0 N--CA 1.438 -1.058 2 O-C-N 139.426 10.454 . . . . 0.0 114.404 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.77 ' HB3' HD22 ' A' ' 49' ' ' LEU 0.262 30.7 ttp -46.33 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 2 O-C-N 132.991 6.432 . . . . 0.0 103.778 179.963 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.74 -46.52 90.12 Favored 'General case' 0 C--O 1.211 -0.948 1 O-C-N 132.094 5.871 . . . . 0.0 104.831 -179.874 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.17 -76.83 0.04 OUTLIER Glycine 0 CA--C 1.549 2.17 0 N-CA-C 105.326 -3.11 . . . . 0.0 105.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -114.34 9.98 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.166 2.921 . . . . 0.0 107.89 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HB3' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.28 -178.97 3.8 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 128.945 3.903 . . . . 0.0 108.32 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.751 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.2 mt -152.69 43.06 0.64 Allowed 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 126.853 2.596 . . . . 0.0 112.772 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 73' ' ' LYS . 15.3 t -69.52 140.1 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 1 CA-C-N 107.85 -4.25 . . . . 0.0 117.525 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.8 -142.24 7.55 Favored Glycine 0 CA--C 1.547 2.059 3 CA-C-N 107.232 -4.531 . . . . 0.0 102.545 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' CB ' HG12 ' A' ' 88' ' ' ILE 0.369 8.0 tttt 175.71 125.29 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.408 1 O-C-N 132.135 5.256 . . . . 0.0 112.517 -179.75 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.732 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -123.0 156.37 34.93 Favored 'General case' 0 C--O 1.204 -1.325 3 O-C-N 130.323 4.764 . . . . 0.0 102.073 -179.151 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CE ' ' HB2' ' A' ' 86' ' ' GLU 0.335 0.0 OUTLIER -160.68 152.03 19.25 Favored 'General case' 0 N--CA 1.424 -1.766 1 CA-C-N 107.282 -4.508 . . . . 0.0 114.664 179.989 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -105.14 99.59 9.2 Favored 'General case' 0 CA--C 1.556 1.173 0 O-C-N 128.65 3.719 . . . . 0.0 108.344 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -43.46 -29.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 1 O-C-N 129.886 4.491 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -39.75 -56.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.505 1 O-C-N 133.537 6.773 . . . . 0.0 105.444 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -122.43 8.56 9.62 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 129.069 3.981 . . . . 0.0 113.438 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.78 50.84 56.43 Favored Glycine 0 CA--C 1.55 2.26 1 N-CA-C 101.83 -4.508 . . . . 0.0 101.83 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' NZ ' ' NE ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -82.78 -64.14 1.23 Allowed 'General case' 0 N--CA 1.413 -2.284 1 O-C-N 131.813 5.067 . . . . 0.0 120.188 -179.355 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.605 ' OE2' HG22 ' A' ' 103' ' ' THR . 0.6 OUTLIER 81.35 137.66 0.06 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 131.953 5.783 . . . . 0.0 113.415 -177.656 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 87' ' ' LEU 0.314 0.2 OUTLIER -155.88 34.96 0.35 Allowed 'General case' 0 C--O 1.201 -1.481 1 O-C-N 133.542 6.776 . . . . 0.0 113.02 177.979 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 103' ' ' THR . 75.6 mt -46.54 114.71 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.562 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.584 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 69.7 10.67 Favored 'General case' 0 C--O 1.196 -1.758 1 O-C-N 130.659 4.974 . . . . 0.0 106.611 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.54 127.23 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 1 O-C-N 133.109 6.506 . . . . 0.0 100.916 178.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.893 ' CD ' HD21 ' A' ' 98' ' ' LEU . 2.3 ttp180 -158.17 161.75 37.88 Favored 'General case' 0 C--O 1.191 -2.02 1 C-N-CA 109.702 -4.799 . . . . 0.0 112.876 -177.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.6 145.99 2.11 Favored 'General case' 0 C--N 1.35 0.593 1 O-C-N 131.274 5.359 . . . . 0.0 106.411 179.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 98' ' ' LEU . 1.1 mm -53.68 111.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 1 O-C-N 130.141 4.651 . . . . 0.0 110.695 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.6 ' CB ' HD13 ' A' ' 99' ' ' ILE . 1.5 t -51.97 -61.46 2.25 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 128.253 3.47 . . . . 0.0 116.025 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.48 -94.73 0.12 Allowed Glycine 0 C--O 1.206 -1.626 1 N-CA-C 102.987 -4.045 . . . . 0.0 102.987 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -102.35 32.85 3.36 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 111.027 -2.586 . . . . 0.0 107.905 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.84 175.05 0.87 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 128.669 3.731 . . . . 0.0 105.217 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 ' CD ' ' A' ' 91' ' ' ARG . 1.3 tt -109.41 157.48 18.88 Favored 'General case' 0 C--O 1.201 -1.457 1 O-C-N 132.326 6.016 . . . . 0.0 110.034 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.717 HG22 ' N ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -116.09 -62.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 1 O-C-N 129.433 4.208 . . . . 0.0 109.608 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.717 ' N ' HG22 ' A' ' 99' ' ' ILE . 23.7 mt-30 83.09 134.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.469 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.0 m -141.88 101.15 3.89 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.989 5.18 . . . . 0.0 112.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -88.49 95.33 10.18 Favored 'General case' 0 C--O 1.203 -1.348 1 O-C-N 129.673 4.358 . . . . 0.0 107.205 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.605 HG22 ' OE2' ' A' ' 86' ' ' GLU . 2.5 m -62.32 120.03 10.2 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 178.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -170.14 119.68 0.6 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 110.946 -2.843 . . . . 0.0 113.386 -179.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 107' ' ' VAL . 5.8 mt-10 40.66 -81.16 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.635 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.497 ' C ' HG23 ' A' ' 107' ' ' VAL . . . -61.01 -18.52 54.81 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.941 -3.028 . . . . 0.0 110.94 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 105' ' ' GLU . 2.2 t 68.22 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 46.18 79.86 0.05 Allowed 'General case' 0 C--N 1.358 0.946 1 O-C-N 129.354 4.159 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.346 . . -117.99 74.64 0.95 Allowed 'General case' 0 C--O 1.199 -1.568 0 O-C-N 126.595 2.434 . . . . 0.0 108.585 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -84.04 153.09 24.02 Favored 'General case' 0 N--CA 1.416 -2.153 1 O-C-N 131.64 5.588 . . . . 0.0 111.665 -179.104 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -120.64 -179.88 4.12 Favored 'General case' 0 CA--C 1.558 1.274 1 CA-C-N 107.964 -4.198 . . . . 0.0 104.758 -179.895 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.461 HD12 ' C ' ' A' ' 111' ' ' ARG . 1.8 mp -131.08 108.45 15.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 1 O-C-N 129.498 4.249 . . . . 0.0 112.933 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.707 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -119.69 179.66 4.16 Favored 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.951 5.157 . . . . 0.0 106.676 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.7 126.02 0.08 Allowed 'General case' 0 N--CA 1.429 -1.477 2 O-C-N 132.3 6.0 . . . . 0.0 113.577 -179.758 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 18.0 tttt -38.09 -57.07 1.1 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 110.014 -3.266 . . . . 0.0 116.463 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.423 -1.797 0 O-C-N 127.902 3.251 . . . . 0.0 111.371 179.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.432 ' HE1' HG21 ' A' ' 93' ' ' ILE . 2.6 m-85 . . . . . 0 CA--C 1.56 1.357 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -40.93 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.418 -2.035 1 O-C-N 129.633 4.333 . . . . 0.0 116.472 -179.897 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' PHE . . . 164.46 147.43 5.1 Favored Glycine 0 C--N 1.339 0.701 1 C-N-CA 112.22 -4.8 . . . . 0.0 106.612 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 11.1 p -61.46 166.2 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 115.729 -2.389 . . . . 0.0 108.564 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 115' ' ' LYS 0.25 73.4 m95 -139.46 158.74 43.63 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 111.758 -3.972 . . . . 0.0 110.43 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 11.4 mtmt 51.02 -178.25 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.837 0 O-C-N 128.571 3.67 . . . . 0.0 117.141 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 21' ' ' LEU 0.308 1.2 t . . . . . 0 CA--C 1.485 -1.534 3 O-C-N 134.303 7.252 . . . . 0.0 114.78 174.931 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.401 0.0 OUTLIER 167.98 153.97 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.626 1 O-C-N 132.317 6.01 . . . . 0.0 100.668 -179.66 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD23 ' C ' ' A' ' 35' ' ' LYS . 8.0 mt -112.59 170.33 8.26 Favored 'General case' 0 CA--C 1.551 0.99 1 O-C-N 133.266 6.604 . . . . 0.0 101.028 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 25' ' ' ILE . 1.6 m -156.14 -81.6 0.07 Allowed 'General case' 0 C--O 1.199 -1.577 1 O-C-N 130.218 4.699 . . . . 0.0 106.264 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.626 ' N ' HG22 ' A' ' 24' ' ' THR . 2.6 mp 70.91 129.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.385 0 CA-C-N 109.142 -3.663 . . . . 0.0 109.733 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.0 m -162.55 80.19 0.51 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.1 148.34 36.23 Favored 'General case' 0 C--N 1.357 0.918 1 CA-C-N 106.08 -5.055 . . . . 0.0 115.246 -179.953 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.83 86.42 2.5 Favored 'General case' 0 CA--C 1.555 1.155 0 O-C-N 128.29 3.494 . . . . 0.0 103.412 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.13 -128.91 8.7 Favored Glycine 0 CA--C 1.552 2.365 2 C-N-CA 110.839 -5.458 . . . . 0.0 102.821 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.56 55.95 0.98 Allowed 'General case' 0 N--CA 1.437 -1.111 1 O-C-N 131.083 4.637 . . . . 0.0 109.252 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -146.84 122.56 10.54 Favored 'General case' 0 CA--C 1.552 1.041 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 49' ' ' LEU . 3.8 m-85 -119.48 171.09 8.59 Favored 'General case' 0 C--O 1.211 -0.933 2 O-C-N 130.111 4.632 . . . . 0.0 99.061 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -158.68 127.88 5.57 Favored 'General case' 0 C--O 1.249 1.058 3 O-C-N 136.284 8.49 . . . . 0.0 98.674 179.814 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 2.4 t -101.56 146.89 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' C ' HD23 ' A' ' 23' ' ' LEU 0.27 12.7 ttmt -91.67 48.57 1.47 Allowed 'General case' 0 C--O 1.195 -1.791 0 CA-C-O 127.491 3.52 . . . . 0.0 115.145 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.284 7.3 mt-10 -69.01 88.53 0.4 Allowed 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 m -86.61 128.02 34.96 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 127.222 2.826 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.6 -161.98 0.92 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 114.683 -2.807 . . . . 0.0 115.128 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -96.26 -7.21 36.1 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 111.961 -2.382 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -92.28 -65.9 0.97 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 114.572 -2.851 . . . . 0.0 107.265 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HD3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -141.98 -155.69 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 128.654 3.721 . . . . 0.0 110.616 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -75.66 -67.44 0.67 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 112.263 -3.775 . . . . 0.0 103.604 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD12 ' HD3' ' A' ' 41' ' ' ARG 0.251 0.4 OUTLIER 72.42 75.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.422 2 CA-C-O 134.919 7.057 . . . . 0.0 105.52 179.76 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.05 151.84 23.38 Favored 'General case' 0 C--N 1.373 1.619 1 CA-C-N 107.182 -4.554 . . . . 0.0 105.558 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.39 117.23 53.33 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 1 O-C-N 131.104 5.253 . . . . 0.0 102.734 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.325 9.4 p -115.11 155.42 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 115.798 -2.361 . . . . 0.0 110.977 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 67' ' ' TRP . 0.3 OUTLIER -166.79 177.88 6.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 127.667 3.104 . . . . 0.0 111.442 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -119.35 67.5 0.8 Allowed 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 115.326 -2.55 . . . . 0.0 115.169 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 32' ' ' PHE . 11.2 tp 23.32 75.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.812 1 O-C-N 130.148 4.655 . . . . 0.0 116.237 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.87 57.56 0.49 Allowed Glycine 0 CA--C 1.561 2.911 1 CA-C-O 112.545 -4.475 . . . . 0.0 104.452 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -150.67 120.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 O-C-N 134.662 6.742 . . . . 0.0 114.932 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 3.9 p30 -83.82 151.99 24.86 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 128.065 3.353 . . . . 0.0 107.913 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 21.4 p90 -173.66 162.71 4.16 Favored 'General case' 0 C--N 1.37 1.492 1 O-C-N 131.74 5.65 . . . . 0.0 115.006 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.68 141.41 37.17 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -154.19 102.97 2.5 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 116.732 -1.987 . . . . 0.0 109.683 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.67 95.17 2.8 Favored 'General case' 0 CA--C 1.539 0.519 1 O-C-N 129.106 4.004 . . . . 0.0 104.066 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.13 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 1 O-C-N 132.56 6.163 . . . . 0.0 109.773 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -70.72 177.05 3.75 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 116.584 -2.046 . . . . 0.0 109.812 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.38 66.26 4.79 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 128.543 3.652 . . . . 0.0 111.607 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.23 -38.43 0.17 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 115.243 -2.976 . . . . 0.0 108.378 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 58' ' ' ALA . 28.4 p -52.79 166.54 0.2 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 129.336 3.61 . . . . 0.0 114.021 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -165.02 49.14 0.1 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 125.413 2.53 . . . . 0.0 107.906 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 HD23 ' A' ' 87' ' ' LEU . 8.4 mp -69.37 125.72 27.56 Favored 'General case' 0 C--N 1.367 1.347 0 CA-C-N 110.237 -3.165 . . . . 0.0 107.994 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 m -126.82 98.75 5.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.44 -164.9 18.45 Favored Glycine 0 N--CA 1.478 1.449 1 C-N-CA 111.917 -4.944 . . . . 0.0 104.475 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.8 t -140.56 150.67 43.95 Favored 'General case' 0 N--CA 1.428 -1.56 1 O-C-N 131.073 4.631 . . . . 0.0 116.585 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.582 ' HB2' ' CD2' ' A' ' 47' ' ' PHE . 9.0 m95 -129.43 122.89 30.3 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-O 115.476 -2.202 . . . . 0.0 105.474 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.61 97.51 4.09 Favored 'General case' 0 C--O 1.203 -1.375 1 O-C-N 136.059 8.349 . . . . 0.0 110.626 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.572 ' HG2' ' CE2' ' A' ' 32' ' ' PHE 0.254 9.2 tpp -74.24 137.98 43.36 Favored 'General case' 0 CA--C 1.512 -0.49 1 O-C-N 132.181 5.926 . . . . 0.0 105.756 179.963 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -141.28 120.64 13.11 Favored 'General case' 0 C--O 1.218 -0.576 1 O-C-N 129.178 4.049 . . . . 0.0 105.427 -179.921 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.44 -98.11 0.02 OUTLIER Glycine 0 CA--C 1.557 2.682 1 O-C-N 129.521 4.263 . . . . 0.0 106.55 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 51.14 1.82 Allowed 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 129.703 3.825 . . . . 0.0 109.87 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 70' ' ' GLU . 1.5 mtpt -137.35 160.14 39.93 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 128.409 3.568 . . . . 0.0 108.65 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.6 mt -144.23 64.72 1.3 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.57 147.0 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 CA-C-O 129.778 4.608 . . . . 0.0 115.577 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.19 -147.3 15.71 Favored Glycine 0 CA--C 1.563 3.063 1 CA-C-N 107.183 -4.553 . . . . 0.0 103.641 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 163.73 139.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.651 1 O-C-N 134.045 6.38 . . . . 0.0 112.86 -179.835 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.61 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 5.5 m-85 -123.52 -169.49 1.95 Allowed 'General case' 0 C--O 1.204 -1.339 2 O-C-N 134.324 7.265 . . . . 0.0 104.648 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.671 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.316 0.0 OUTLIER -169.96 -145.68 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 109.801 -3.363 . . . . 0.0 115.162 -179.281 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 47.0 ttt180 -168.12 90.29 0.29 Allowed 'General case' 0 C--N 1.352 0.679 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.884 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -32.51 -33.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 127.621 3.076 . . . . 0.0 113.014 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 81' ' ' VAL . 1.2 t70 -53.44 -49.5 67.23 Favored 'General case' 0 CA--C 1.508 -0.636 1 O-C-N 129.727 4.392 . . . . 0.0 111.894 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.1 19.08 2.98 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-O 113.66 -3.067 . . . . 0.0 117.908 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 63.15 55.28 27.14 Favored Glycine 0 C--O 1.2 -1.976 1 N-CA-C 102.435 -4.266 . . . . 0.0 102.435 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 6.9 tppt? -80.94 -81.82 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 2 O-C-N 132.131 5.253 . . . . 0.0 118.603 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 78.2 mt-10 86.95 97.62 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.637 1 O-C-N 131.036 5.21 . . . . 0.0 109.832 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 HD21 ' A' ' 63' ' ' LEU . 12.9 tp -124.08 53.38 1.41 Allowed 'General case' 0 C--O 1.201 -1.478 1 O-C-N 138.185 9.678 . . . . 0.0 108.607 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 77' ' ' LYS . 25.5 mt -78.61 -178.0 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.176 2 CA-C-N 107.247 -4.524 . . . . 0.0 103.691 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.54 88.94 0.66 Allowed 'General case' 0 C--O 1.195 -1.794 1 O-C-N 131.804 5.69 . . . . 0.0 108.732 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.65 121.0 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 O-C-N 126.396 2.31 . . . . 0.0 107.583 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.3 tpt180 -170.63 163.04 8.11 Favored 'General case' 0 C--O 1.186 -2.243 0 C-N-CA 111.892 -3.923 . . . . 0.0 112.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -150.87 132.22 14.6 Favored 'General case' 0 N--CA 1.426 -1.626 1 O-C-N 132.035 5.835 . . . . 0.0 107.086 179.226 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -48.18 129.28 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 1 O-C-N 132.509 6.131 . . . . 0.0 109.149 179.976 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.9 p -78.92 -67.98 0.7 Allowed 'General case' 0 C--O 1.247 0.94 0 O-C-N 127.654 3.096 . . . . 0.0 116.13 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.17 -66.92 0.33 Allowed Glycine 0 CA--C 1.545 1.95 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.34 27.73 1.24 Allowed 'General case' 0 C--N 1.35 0.619 0 CA-C-N 110.501 -2.85 . . . . 0.0 107.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.73 119.28 2.9 Favored 'General case' 0 N--CA 1.433 -1.289 0 O-C-N 128.356 3.535 . . . . 0.0 109.642 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 121.67 28.62 Favored 'General case' 0 CA--C 1.557 1.231 1 O-C-N 129.771 4.42 . . . . 0.0 108.688 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' CG2' ' HB2' ' A' ' 110' ' ' LYS . 30.9 mt -74.04 -80.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.491 2 CA-C-O 111.285 -4.198 . . . . 0.0 108.206 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' N ' HG22 ' A' ' 99' ' ' ILE . 5.3 mt-30 99.75 112.6 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.394 2 O-C-N 136.054 8.346 . . . . 0.0 98.127 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 110' ' ' LYS . 30.9 p -82.95 -32.07 27.33 Favored 'General case' 0 N--CA 1.404 -2.74 1 O-C-N 130.306 4.754 . . . . 0.0 119.906 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 104' ' ' TYR . 62.9 m-85 60.24 70.22 0.64 Allowed 'General case' 0 CA--C 1.565 1.538 0 O-C-N 128.973 3.921 . . . . 0.0 103.558 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.6 m -69.22 73.7 0.32 Allowed 'General case' 0 C--O 1.215 -0.712 1 O-C-N 132.169 5.918 . . . . 0.0 106.206 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' TYR . 3.3 t80 -88.85 116.74 27.34 Favored 'General case' 0 CA--C 1.495 -1.144 1 CA-C-N 108.261 -4.063 . . . . 0.0 112.863 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 61.0 46.04 8.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 112.817 -1.992 . . . . 0.0 112.708 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.82 4.12 57.44 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-O 124.769 2.316 . . . . 0.0 117.528 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.15 137.2 53.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 119.558 -2.143 . . . . 0.0 115.051 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.93 132.17 43.12 Favored 'General case' 0 C--N 1.366 1.3 1 O-C-N 129.206 4.066 . . . . 0.0 105.661 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.354 . . -138.85 44.0 2.07 Favored 'General case' 0 N--CA 1.424 -1.764 0 O-C-N 128.368 3.542 . . . . 0.0 112.783 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 2.7 pttp -74.73 168.99 18.76 Favored 'General case' 0 N--CA 1.419 -1.989 1 O-C-N 133.308 6.63 . . . . 0.0 109.047 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -145.45 -90.62 0.1 Allowed 'General case' 0 CA--C 1.556 1.208 1 O-C-N 129.292 4.12 . . . . 0.0 100.632 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -174.63 179.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 111.377 -2.647 . . . . 0.0 108.974 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.517 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 8.8 m-85 166.49 178.55 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 1 O-C-N 136.157 8.411 . . . . 0.0 104.926 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.72 -154.17 0.33 Allowed 'General case' 0 C--O 1.198 -1.607 1 O-C-N 131.795 5.684 . . . . 0.0 111.515 178.683 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.62 ' HG3' ' CE3' ' A' ' 6' ' ' TRP 0.253 29.9 tttt -110.53 -138.39 0.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.255 7.7 tp10 . . . . . 0 N--CA 1.442 -0.841 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.441 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 . . . . . 0 CA--C 1.56 1.352 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 9.6 t0 -35.36 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 129.785 4.428 . . . . 0.0 117.878 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 153.13 175.56 24.68 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 115.413 -3.279 . . . . 0.0 105.297 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.285 3.6 p -90.78 176.8 6.51 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 113.274 -3.37 . . . . 0.0 103.844 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.585 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 28.4 m95 -147.21 160.37 42.55 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-O 112.592 -3.575 . . . . 0.0 112.435 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.5 mtmt 50.93 -178.89 0.02 OUTLIER 'General case' 0 C--O 1.195 -1.784 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 21' ' ' LEU 0.26 0.5 OUTLIER . . . . . 0 CA--C 1.483 -1.627 3 CA-C-O 135.409 7.29 . . . . 0.0 119.675 174.899 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.445 0 CA-C-O 114.266 -2.778 . . . . 0.0 104.793 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER -171.72 150.54 2.71 Favored 'General case' 0 CA--C 1.563 1.464 1 O-C-N 133.302 6.626 . . . . 0.0 102.228 179.843 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.4 mt -115.32 157.1 24.3 Favored 'General case' 0 CA--C 1.565 1.546 4 O-C-N 132.916 6.385 . . . . 0.0 97.666 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 1.9 m 172.09 96.46 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.249 1 O-C-N 132.768 6.292 . . . . 0.0 102.745 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.92 HG22 ' CD1' ' A' ' 32' ' ' PHE . 3.0 mp -114.66 112.35 39.72 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 108.96 -3.746 . . . . 0.0 109.962 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 35.9 m -155.07 79.68 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 127.74 3.15 . . . . 0.0 108.44 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.6 mm-40 -88.08 -98.62 0.09 Allowed 'General case' 0 C--N 1.355 0.845 3 CA-C-N 105.865 -5.152 . . . . 0.0 111.634 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.88 -6.17 4.51 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 128.088 3.367 . . . . 0.0 106.47 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.31 -27.4 8.11 Favored Glycine 0 CA--C 1.546 1.969 1 N-CA-C 99.189 -5.565 . . . . 0.0 99.189 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -25.67 6.0 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 111.737 -3.983 . . . . 0.0 111.627 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 2.6 mttm -101.56 178.89 4.51 Favored 'General case' 0 C--O 1.25 1.085 1 N-CA-C 97.596 -4.964 . . . . 0.0 97.596 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -176.64 139.38 0.31 Allowed 'General case' 0 C--O 1.19 -2.076 1 N-CA-C 97.217 -5.105 . . . . 0.0 97.217 178.875 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.565 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -128.67 119.88 25.5 Favored 'General case' 0 C--O 1.249 1.028 3 O-C-N 136.446 8.591 . . . . 0.0 98.577 -179.957 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.364 1.2 t -84.6 128.41 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 1 N-CA-C 99.747 -4.168 . . . . 0.0 99.747 -179.944 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.295 5.3 tttm -67.72 -8.88 38.92 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 120.775 3.62 . . . . 0.0 120.775 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.339 3.9 tt0 -29.37 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 108.499 -3.955 . . . . 0.0 109.965 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -80.45 155.65 26.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 114.228 -2.989 . . . . 0.0 111.035 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.6 t -121.57 -151.82 0.49 Allowed 'General case' 0 N--CA 1.442 -0.827 0 O-C-N 127.527 3.017 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.13 -29.56 11.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 126.198 2.186 . . . . 0.0 108.937 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 10.2 m-85 -66.5 -60.49 2.69 Favored 'General case' 0 CA--C 1.551 1.013 1 O-C-N 130.654 4.971 . . . . 0.0 105.162 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.58 -163.28 1.71 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 128.972 3.92 . . . . 0.0 113.54 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.39 -16.46 52.14 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 121.431 1.923 . . . . 0.0 109.939 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' HB ' ' CZ ' ' A' ' 41' ' ' ARG . 8.8 tt 20.05 94.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.266 2 O-C-N 132.336 6.022 . . . . 0.0 111.972 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 152.1 22.0 Favored 'General case' 0 C--N 1.366 1.304 0 O-C-N 117.001 -3.562 . . . . 0.0 104.198 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -126.79 91.64 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.93 1 O-C-N 130.469 4.855 . . . . 0.0 103.707 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 ' OG1' ' A' ' 33' ' ' THR 0.29 0.7 OUTLIER -92.18 158.89 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 1 C-N-CA 111.052 -4.259 . . . . 0.0 115.764 -179.993 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -154.66 -177.0 6.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 O-C-N 129.011 3.944 . . . . 0.0 111.303 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.571 ' HB3' HG21 ' A' ' 51' ' ' VAL 0.258 1.2 tt0 -130.22 31.54 4.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.267 3.48 . . . . 0.0 111.805 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.83 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 1 O-C-N 133.749 6.906 . . . . 0.0 113.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 86.51 52.14 3.28 Favored Glycine 0 CA--C 1.548 2.118 0 CA-C-O 113.797 -3.779 . . . . 0.0 104.085 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 48' ' ' GLU . 21.7 t -134.31 104.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 1 O-C-N 134.851 6.853 . . . . 0.0 113.531 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 145.57 33.63 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 110.45 -3.068 . . . . 0.0 109.563 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.58 124.01 7.72 Favored 'General case' 0 C--N 1.372 1.577 2 O-C-N 129.733 4.396 . . . . 0.0 116.131 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.6 73.53 4.36 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 121.75 41.27 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 127.564 3.04 . . . . 0.0 112.375 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -74.47 114.84 13.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 111.853 -3.939 . . . . 0.0 106.54 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.43 155.92 20.7 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 127.229 2.831 . . . . 0.0 112.408 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.41 22.93 3.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 115.721 -2.085 . . . . 0.0 114.026 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t70 39.14 38.7 0.34 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 128.957 3.911 . . . . 0.0 112.16 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.81 -58.03 0.01 OUTLIER Glycine 0 CA--C 1.543 1.786 0 N-CA-C 105.725 -2.95 . . . . 0.0 105.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.402 ' C ' ' HG2' ' A' ' 62' ' ' GLU . 1.1 p -77.07 149.48 35.77 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 127.8 2.706 . . . . 0.0 114.274 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HG2' ' C ' ' A' ' 61' ' ' THR . 2.9 mt-10 -143.31 66.24 1.31 Allowed 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.27 117.67 5.05 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 129.093 3.996 . . . . 0.0 107.255 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -123.57 109.55 13.92 Favored 'General case' 0 C--O 1.205 -1.283 0 O-C-N 126.404 2.315 . . . . 0.0 108.65 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 178.13 -146.11 7.31 Favored Glycine 0 N--CA 1.479 1.558 1 C-N-CA 113.838 -4.03 . . . . 0.0 103.727 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 66' ' ' THR 0.312 15.2 t -176.16 141.44 0.44 Allowed 'General case' 0 CA--C 1.486 -1.485 1 O-C-N 131.247 4.733 . . . . 0.0 119.58 -178.553 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.722 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.5 m95 -107.5 145.45 33.08 Favored 'General case' 0 C--O 1.195 -1.769 1 O-C-N 115.971 -4.206 . . . . 0.0 100.5 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.404 HG22 ' HA2' ' A' ' 50' ' ' GLY . 25.8 p -126.56 25.21 6.52 Favored 'General case' 0 N--CA 1.428 -1.526 2 O-C-N 135.278 7.861 . . . . 0.0 115.21 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 3.65 105.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.887 1 O-C-N 137.638 9.336 . . . . 0.0 108.611 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -114.0 -170.74 1.77 Allowed 'General case' 0 C--O 1.215 -0.713 1 O-C-N 129.625 4.328 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.41 105.83 0.81 Allowed Glycine 0 CA--C 1.541 1.707 0 O-C-N 127.354 2.909 . . . . 0.0 108.51 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 39.71 55.56 2.43 Favored 'General case' 0 C--O 1.238 0.491 1 O-C-N 131.496 4.88 . . . . 0.0 110.046 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -174.27 3.9 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 127.021 2.701 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 98' ' ' LEU . 1.1 mt -161.01 30.69 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 O-C-N 126.391 2.307 . . . . 0.0 115.507 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 t -59.27 137.14 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 2 O-C-N 131.24 5.338 . . . . 0.0 114.42 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 154.22 -139.94 7.14 Favored Glycine 0 C--O 1.197 -2.186 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 78' ' ' PHE 0.333 20.1 tttm -177.63 176.51 1.24 Allowed 'General case' 0 C--N 1.371 1.531 1 O-C-N 133.164 5.861 . . . . 0.0 110.145 -178.682 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 22.4 m-85 -176.06 172.62 2.36 Favored 'General case' 0 C--O 1.212 -0.92 2 O-C-N 134.178 7.174 . . . . 0.0 102.602 175.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' C ' ' A' ' 85' ' ' LYS 0.296 13.7 ttmt -160.22 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.825 1 CA-C-N 105.076 -5.511 . . . . 0.0 110.135 179.962 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.695 ' NE ' HD11 ' A' ' 87' ' ' LEU 0.272 5.9 ptt180 175.61 56.91 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 117.267 -1.349 . . . . 0.0 111.336 178.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 31.7 t -41.46 87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.558 2 O-C-N 134.769 7.543 . . . . 0.0 108.521 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 t70 170.31 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.107 1 O-C-N 130.597 4.935 . . . . 0.0 107.348 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.93 -0.38 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 129.017 3.948 . . . . 0.0 115.377 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -101.93 -35.01 4.12 Favored Glycine 0 CA--C 1.54 1.649 1 C-N-CA 113.036 -4.411 . . . . 0.0 105.546 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.569 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 75.43 -174.76 0.12 Allowed 'General case' 0 CA--C 1.495 -1.145 1 O-C-N 131.292 4.76 . . . . 0.0 114.063 179.837 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.258 6.6 mt-10 -34.41 142.01 0.05 OUTLIER 'General case' 0 C--O 1.198 -1.623 1 O-C-N 130.077 4.611 . . . . 0.0 116.334 -177.297 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.695 HD11 ' NE ' ' A' ' 80' ' ' ARG . 40.4 mt -150.65 37.22 0.65 Allowed 'General case' 0 C--O 1.194 -1.829 1 O-C-N 132.969 6.418 . . . . 0.0 110.074 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 21.5 mt -62.27 152.39 6.92 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 3 O-C-N 130.053 4.596 . . . . 0.0 99.54 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.657 ' HB1' HE22 ' A' ' 100' ' ' GLN . . . -124.98 87.15 2.66 Favored 'General case' 0 C--O 1.197 -1.7 1 O-C-N 135.58 8.05 . . . . 0.0 110.363 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 90' ' ' VAL . 3.7 t -84.23 107.85 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 114.892 -2.723 . . . . 0.0 105.232 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD2' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -168.53 164.27 12.49 Favored 'General case' 0 C--O 1.194 -1.868 1 C-N-CA 111.097 -4.241 . . . . 0.0 115.717 -179.519 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -151.77 143.65 23.76 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 128.6 3.687 . . . . 0.0 104.088 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -58.35 81.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 1 O-C-N 133.176 6.548 . . . . 0.0 110.135 -179.985 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.62 -114.72 0.81 Allowed Glycine 0 CA--C 1.55 2.223 0 N-CA-C 104.528 -3.429 . . . . 0.0 104.528 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -113.86 24.74 11.8 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 109.688 -3.256 . . . . 0.0 108.893 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.572 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.91 165.21 32.61 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 110.963 -2.835 . . . . 0.0 106.756 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 74' ' ' LEU . 5.3 tt -110.48 121.23 44.8 Favored 'General case' 0 N--CA 1.447 -0.582 1 O-C-N 130.162 4.664 . . . . 0.0 109.826 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HB ' ' HD2' ' A' ' 91' ' ' ARG . 1.7 mt -71.11 -55.79 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 109.47 -3.513 . . . . 0.0 107.724 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.657 HE22 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER 73.65 105.68 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 1 O-C-N 132.27 5.981 . . . . 0.0 103.97 -179.915 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.21 91.03 3.48 Favored 'General case' 0 N--CA 1.424 -1.763 2 O-C-N 132.408 6.067 . . . . 0.0 113.141 179.671 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 50.4 m-85 -70.77 125.5 27.01 Favored 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 109.309 -4.956 . . . . 0.0 105.669 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.9 m -96.53 68.01 2.47 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 127.811 3.672 . . . . 0.0 105.982 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 2.0 t80 -65.06 156.68 30.7 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 109.803 -3.362 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 5.0 tp10 -47.76 104.55 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 112.848 -1.978 . . . . 0.0 115.681 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.8 83.78 Favored Glycine 0 C--N 1.347 1.178 0 C-N-CA 117.799 -2.143 . . . . 0.0 116.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.269 2.5 t -136.93 169.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -143.15 58.1 1.4 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.422 . . -98.42 152.49 19.44 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 114.658 -2.817 . . . . 0.0 111.287 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.667 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.2 OUTLIER -109.95 -163.21 0.84 Allowed 'General case' 0 N--CA 1.444 -0.747 1 O-C-N 134.029 7.081 . . . . 0.0 107.359 -179.771 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -57.63 0.74 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 110.469 -3.059 . . . . 0.0 105.801 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.284 4.5 mt 86.88 115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.027 1 O-C-N 129.386 4.179 . . . . 0.0 110.096 -179.847 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 9.1 m-85 -142.62 179.65 6.85 Favored 'General case' 0 N--CA 1.417 -2.081 1 O-C-N 130.091 4.619 . . . . 0.0 107.167 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.572 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -150.36 -160.92 1.24 Allowed 'General case' 0 C--O 1.196 -1.756 1 O-C-N 131.97 5.793 . . . . 0.0 111.836 179.501 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 11.7 tttt -123.17 152.61 41.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 111.812 -2.449 . . . . 0.0 112.549 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.419 -1.989 1 O-C-N 129.389 4.18 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.56 1.345 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.95 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.777 1 O-C-N 131.027 5.204 . . . . 0.0 117.415 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.8 148.16 5.04 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 114.893 -3.17 . . . . 0.0 106.265 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.295 36.0 p -68.28 167.88 13.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 112.361 -3.735 . . . . 0.0 110.094 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 73.1 m95 -141.27 167.69 21.57 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-O 111.116 -4.278 . . . . 0.0 113.487 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 5.3 mtmt 36.85 171.84 0.0 OUTLIER 'General case' 0 C--O 1.19 -2.057 1 O-C-N 133.813 6.946 . . . . 0.0 119.182 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.287 0.9 OUTLIER . . . . . 0 CA--C 1.491 -1.321 3 CA-C-N 105.262 -5.426 . . . . 0.0 119.331 174.941 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.566 1.589 0 CA-C-O 114.107 -2.854 . . . . 0.0 105.491 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.432 31.0 mttt 145.07 170.74 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.604 1 O-C-N 134.015 7.072 . . . . 0.0 101.018 -178.847 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 7.3 mt -141.83 -178.63 5.76 Favored 'General case' 0 CA--C 1.567 1.604 3 O-C-N 133.148 6.53 . . . . 0.0 96.985 177.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 25' ' ' ILE . 18.7 m -166.65 -90.04 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 128.418 3.574 . . . . 0.0 106.173 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 24' ' ' THR . 0.8 OUTLIER 70.72 130.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-N 109.752 -3.385 . . . . 0.0 109.316 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.4 m -168.27 73.99 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 113.185 -3.406 . . . . 0.0 103.583 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -37.38 138.96 0.28 Allowed 'General case' 0 N--CA 1.436 -1.131 2 O-C-N 133.483 6.74 . . . . 0.0 115.576 -179.923 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -92.9 0.36 Allowed 'General case' 0 C--N 1.35 0.618 1 O-C-N 131.017 5.198 . . . . 0.0 106.505 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.55 66.5 0.24 Allowed Glycine 0 CA--C 1.55 2.266 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 68.2 14.47 9.25 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -93.88 132.7 38.05 Favored 'General case' 0 CA--C 1.552 1.047 1 CA-C-O 111.213 -4.232 . . . . 0.0 100.827 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.693 ' CD1' HD23 ' A' ' 49' ' ' LEU . 13.0 m-85 -110.59 142.17 42.8 Favored 'General case' 0 C--O 1.191 -2.004 2 N-CA-C 96.858 -5.238 . . . . 0.0 96.858 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -130.91 108.44 9.83 Favored 'General case' 0 CA--C 1.496 -1.116 2 O-C-N 134.575 7.422 . . . . 0.0 100.744 -179.92 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 25' ' ' ILE 0.42 4.2 t -81.57 150.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 112.635 -3.626 . . . . 0.0 103.772 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.255 3.6 ttmt -98.99 36.88 1.61 Allowed 'General case' 0 N--CA 1.425 -1.711 1 CA-C-O 133.049 6.166 . . . . 0.0 116.949 179.792 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.335 28.1 tt0 -57.78 97.6 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 1 CA-C-N 107.455 -4.43 . . . . 0.0 107.512 -179.804 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.0 m -99.59 134.06 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.97 3.294 . . . . 0.0 106.767 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.23 -162.27 1.23 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 127.316 2.885 . . . . 0.0 112.807 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -57.46 -41.37 80.42 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -87.38 82.66 7.49 Favored 'General case' 0 N--CA 1.435 -1.198 2 O-C-N 131.35 5.406 . . . . 0.0 106.487 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER 35.14 -143.7 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 131.284 5.365 . . . . 0.0 114.878 -179.991 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 46.6 m-20 -77.29 -70.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 113.109 -3.436 . . . . 0.0 106.073 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.75 HG13 HD12 ' A' ' 57' ' ' LEU 0.25 0.2 OUTLIER 66.17 104.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 1 CA-C-O 132.302 5.81 . . . . 0.0 104.3 179.623 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.83 154.23 18.17 Favored 'General case' 0 C--N 1.372 1.586 0 CA-C-N 109.673 -3.421 . . . . 0.0 106.863 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 107.61 17.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 1 O-C-N 131.157 5.286 . . . . 0.0 102.498 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' OG1' ' A' ' 33' ' ' THR 0.374 9.9 p -112.23 154.03 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 114.049 -3.06 . . . . 0.0 113.422 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -163.73 -163.05 0.76 Allowed 'General case' 0 N--CA 1.442 -0.829 1 O-C-N 131.657 5.598 . . . . 0.0 114.602 -179.946 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -136.28 53.38 1.93 Allowed 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.355 2.284 . . . . 0.0 114.02 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD23 ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER 52.3 19.52 1.14 Allowed 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 128.701 3.751 . . . . 0.0 115.736 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.563 ' CA ' HG22 ' A' ' 68' ' ' THR . . . 143.55 71.75 0.02 OUTLIER Glycine 0 CA--C 1.546 1.978 0 N-CA-C 105.091 -3.203 . . . . 0.0 105.091 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.15 -49.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 130.159 4.094 . . . . 0.0 112.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.03 131.72 0.05 Allowed 'General case' 0 C--O 1.202 -1.441 1 O-C-N 129.426 4.204 . . . . 0.0 105.724 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -164.82 148.69 8.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 129.038 3.961 . . . . 0.0 117.09 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.54 115.77 30.92 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 100.468 -3.901 . . . . 0.0 100.468 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -139.23 128.14 23.57 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 127.972 3.295 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.49 112.6 15.71 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 115.417 -2.513 . . . . 0.0 105.692 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 43' ' ' ILE . 3.5 mm? -66.49 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 O-C-N 126.501 2.376 . . . . 0.0 111.386 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.44 -142.5 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.662 -1.161 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.03 -14.25 19.52 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 124.827 1.329 . . . . 0.0 111.669 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.47 74.36 0.34 Allowed Glycine 0 CA--C 1.562 3.007 0 O-C-N 128.591 3.682 . . . . 0.0 104.67 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.8 p -150.61 148.63 28.87 Favored 'General case' 0 N--CA 1.433 -1.28 1 O-C-N 131.985 5.167 . . . . 0.0 112.81 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -147.97 48.81 1.06 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 127.12 2.763 . . . . 0.0 108.721 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.05 166.21 14.24 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 113.549 -3.26 . . . . 0.0 107.514 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -161.92 118.32 2.07 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 110.302 -3.135 . . . . 0.0 104.439 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.24 -130.26 1.39 Allowed Glycine 0 CA--C 1.529 0.936 1 C-N-CA 110.782 -5.485 . . . . 0.0 108.401 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.595 ' C ' ' CG ' ' A' ' 67' ' ' TRP . 3.3 t 170.6 139.01 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.708 1 O-C-N 132.665 5.568 . . . . 0.0 110.472 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 78' ' ' PHE . 46.6 m95 -139.2 107.54 5.81 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 122.187 2.267 . . . . 0.0 106.753 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.563 HG22 ' CA ' ' A' ' 50' ' ' GLY . 43.0 p -103.49 74.8 1.28 Allowed 'General case' 0 N--CA 1.429 -1.513 2 O-C-N 131.441 5.463 . . . . 0.0 114.143 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.482 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -46.29 134.09 9.05 Favored 'General case' 0 C--O 1.215 -0.724 1 O-C-N 130.804 5.065 . . . . 0.0 105.352 179.867 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -136.98 66.67 1.46 Allowed 'General case' 0 C--N 1.347 0.46 1 O-C-N 131.131 5.269 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.79 84.19 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.167 0 O-C-N 125.68 1.863 . . . . 0.0 110.719 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 6.4 m-20 63.07 28.11 16.02 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 114.899 -2.477 . . . . 0.0 114.622 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -129.69 156.96 43.41 Favored 'General case' 0 N--CA 1.476 0.869 1 O-C-N 129.877 4.485 . . . . 0.0 107.694 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ARG . 7.9 mt -141.6 47.78 1.65 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 126.571 2.419 . . . . 0.0 116.877 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 t -68.66 147.65 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 1 CA-C-N 107.85 -4.25 . . . . 0.0 112.138 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.99 27.56 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HA ' ' HH2' ' A' ' 67' ' ' TRP 0.268 0.1 OUTLIER -174.53 128.55 0.33 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 111.951 -3.9 . . . . 0.0 117.676 -179.617 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 67' ' ' TRP . 25.6 m-85 -101.9 177.95 4.75 Favored 'General case' 0 C--O 1.204 -1.311 1 CA-C-O 129.288 4.375 . . . . 0.0 100.773 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.64 -129.89 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 1 CA-C-N 105.079 -5.509 . . . . 0.0 110.284 179.583 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 51.0 ttt180 168.65 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.685 0 O-C-N 128.138 3.399 . . . . 0.0 109.247 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.6 -1.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 1 O-C-N 131.93 5.768 . . . . 0.0 114.767 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.62 -26.79 12.66 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 128.493 3.621 . . . . 0.0 112.041 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.28 1.25 9.06 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.445 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 66.46 39.19 94.0 Favored Glycine 0 CA--C 1.558 2.749 1 N-CA-C 100.773 -4.931 . . . . 0.0 100.773 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.262 0.6 OUTLIER -74.44 -80.86 0.07 Allowed 'General case' 0 N--CA 1.411 -2.383 1 CA-C-N 106.145 -5.027 . . . . 0.0 120.994 -179.008 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER 78.61 101.87 0.07 Allowed 'General case' 0 CA--C 1.561 1.396 0 O-C-N 127.621 3.076 . . . . 0.0 109.489 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.76 48.57 2.15 Favored 'General case' 0 C--O 1.195 -1.779 1 O-C-N 133.636 6.835 . . . . 0.0 108.884 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 77' ' ' LYS . 57.0 mt -66.57 146.0 13.5 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.479 2 O-C-N 130.029 4.581 . . . . 0.0 103.937 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.9 105.61 15.23 Favored 'General case' 0 C--O 1.213 -0.827 1 O-C-N 137.751 9.407 . . . . 0.0 105.077 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 90' ' ' VAL . 4.0 t -101.85 100.43 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 128.917 3.886 . . . . 0.0 104.68 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -156.58 155.74 32.4 Favored 'General case' 0 C--O 1.19 -2.033 1 C-N-CA 110.615 -4.434 . . . . 0.0 113.756 179.76 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.5 108.34 3.34 Favored 'General case' 0 CA--C 1.558 1.279 2 CA-C-N 107.581 -4.372 . . . . 0.0 102.521 179.228 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.877 ' HB ' HD12 ' A' ' 98' ' ' LEU . 11.5 tt -42.66 109.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 1 O-C-N 132.986 6.428 . . . . 0.0 112.287 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.0 m -105.19 95.25 5.71 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 128.387 3.555 . . . . 0.0 115.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.0 -118.31 3.77 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 103.256 -3.937 . . . . 0.0 103.256 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.67 47.29 1.56 Allowed 'General case' 0 CA--C 1.552 1.029 1 O-C-N 130.18 4.106 . . . . 0.0 106.146 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.303 0.0 OUTLIER -177.3 110.93 0.08 Allowed 'General case' 0 C--O 1.204 -1.32 2 O-C-N 130.801 5.063 . . . . 0.0 108.358 179.801 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.877 HD12 ' HB ' ' A' ' 93' ' ' ILE . 3.0 tt -79.45 104.71 10.25 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 128.728 3.768 . . . . 0.0 108.815 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 26.1 mm -50.76 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.672 1 O-C-N 133.48 6.738 . . . . 0.0 108.434 -179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.565 ' CG ' HD23 ' A' ' 98' ' ' LEU . 23.2 mt-30 99.36 90.48 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 1 O-C-N 132.899 6.374 . . . . 0.0 103.915 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.8 m -102.64 96.75 7.09 Favored 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.683 6.864 . . . . 0.0 114.06 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 73.6 m-85 -67.78 132.85 48.19 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 112.605 -3.638 . . . . 0.0 105.213 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -107.86 94.8 5.27 Favored 'General case' 0 C--O 1.206 -1.198 1 O-C-N 132.129 5.893 . . . . 0.0 101.631 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 1.4 t80 -109.64 117.36 33.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 109.792 -3.367 . . . . 0.0 117.6 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 27.42 31.51 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.77 -6.37 6.16 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 116.718 -2.658 . . . . 0.0 114.353 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.4 t -120.03 145.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.979 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 70.89 0.73 Allowed 'General case' 0 C--N 1.359 1.011 1 O-C-N 130.87 5.106 . . . . 0.0 103.388 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.436 . . -90.86 119.13 30.81 Favored 'General case' 0 N--CA 1.41 -2.447 1 O-C-N 130.921 5.138 . . . . 0.0 116.267 179.907 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.4 163.08 14.85 Favored 'General case' 0 N--CA 1.415 -2.199 1 O-C-N 132.663 6.227 . . . . 0.0 106.924 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.27 99.53 4.56 Favored 'General case' 0 CA--C 1.556 1.202 3 O-C-N 130.195 4.684 . . . . 0.0 99.437 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -57.23 123.02 7.53 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 O-C-N 128.862 3.851 . . . . 0.0 111.194 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.771 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 14.2 m-30 -117.21 176.81 4.97 Favored 'General case' 0 N--CA 1.434 -1.24 2 O-C-N 132.544 6.152 . . . . 0.0 108.463 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 171.12 134.76 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.633 2 O-C-N 131.898 5.749 . . . . 0.0 113.843 -177.607 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 1.3 tttt -51.41 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.34 1 CA-C-O 128.649 4.071 . . . . 0.0 113.502 176.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.37 1.492 0 O-C-N 118.952 -2.342 . . . . 0.0 110.519 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 4.8 m-30 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -50.3 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 127.737 3.148 . . . . 0.0 117.911 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.29 125.21 0.77 Allowed Glycine 0 C--N 1.353 1.488 1 C-N-CA 112.377 -4.725 . . . . 0.0 107.663 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.334 46.2 p -49.97 127.89 17.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 129.148 3.499 . . . . 0.0 110.123 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.324 55.7 m95 -100.58 161.47 13.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 128.565 3.666 . . . . 0.0 112.276 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.3 mtmt 50.99 -178.66 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.696 1 O-C-N 129.333 4.146 . . . . 0.0 117.325 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 21' ' ' LEU 0.326 0.9 OUTLIER . . . . . 0 CA--C 1.483 -1.603 2 O-C-N 134.538 7.399 . . . . 0.0 113.753 174.979 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.403 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.377 0.0 OUTLIER 174.56 134.18 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.5 1 O-C-N 131.733 5.646 . . . . 0.0 102.694 179.689 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 13.2 mt -93.55 167.69 11.52 Favored 'General case' 0 CA--C 1.559 1.291 2 O-C-N 131.533 5.52 . . . . 0.0 100.33 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.9 m 176.7 79.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 1 O-C-N 132.518 6.136 . . . . 0.0 105.993 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 mp -90.11 144.07 9.89 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 110.293 -3.14 . . . . 0.0 109.188 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.7 m -162.48 82.29 0.53 Allowed 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 112.491 -3.683 . . . . 0.0 109.092 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.411 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -51.65 148.05 5.85 Favored 'General case' 0 C--O 1.214 -0.797 2 O-C-N 130.373 4.795 . . . . 0.0 115.054 179.684 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -131.65 101.43 5.49 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 128.75 3.781 . . . . 0.0 103.76 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -104.08 2.26 Favored Glycine 0 CA--C 1.546 2.027 2 C-N-CA 110.909 -5.424 . . . . 0.0 99.934 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -131.36 14.21 5.06 Favored 'General case' 0 N--CA 1.435 -1.222 1 O-C-N 131.798 5.058 . . . . 0.0 109.241 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -82.8 155.29 24.27 Favored 'General case' 0 C--N 1.321 -0.662 1 N-CA-C 99.494 -4.261 . . . . 0.0 99.494 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 25' ' ' ILE . 9.3 t80 -155.67 106.76 2.52 Favored 'General case' 0 C--O 1.191 -1.995 2 N-CA-C 95.674 -5.676 . . . . 0.0 95.674 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.15 142.48 38.3 Favored 'General case' 0 N--CA 1.475 0.806 1 O-C-N 132.503 6.127 . . . . 0.0 102.797 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.356 24.7 t -111.48 140.04 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 1 O-C-N 129.144 4.027 . . . . 0.0 100.97 179.697 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB3' ' N ' ' A' ' 24' ' ' THR . 5.2 tttt -85.2 64.42 8.66 Favored 'General case' 0 CA--C 1.49 -1.355 1 CA-C-O 130.901 5.143 . . . . 0.0 115.029 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' OE1' HG23 ' A' ' 43' ' ' ILE . 9.9 tt0 -81.76 61.8 5.29 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 109.64 -3.436 . . . . 0.0 104.323 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.57 130.81 35.35 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 113.228 -3.389 . . . . 0.0 109.454 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -146.61 -158.79 0.94 Allowed 'General case' 0 C--N 1.368 1.394 0 O-C-N 125.87 1.981 . . . . 0.0 113.066 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -14.53 60.34 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.05 52.97 0.97 Allowed 'General case' 0 N--CA 1.424 -1.772 0 O-C-N 128.22 3.45 . . . . 0.0 107.349 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 72.9 -164.26 0.11 Allowed 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 127.637 3.086 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.504 ' C ' HG22 ' A' ' 43' ' ' ILE . 31.7 m-20 -81.85 -30.52 32.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 127.657 3.098 . . . . 0.0 107.127 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.691 HD11 HD22 ' A' ' 57' ' ' LEU . 3.8 tp 37.14 70.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.104 2 O-C-N 132.107 5.879 . . . . 0.0 110.444 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -66.07 114.79 5.48 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.711 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.96 95.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 2 O-C-N 131.657 5.598 . . . . 0.0 99.802 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.282 2.8 p -114.68 151.67 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 1 O-C-N 129.536 4.272 . . . . 0.0 116.086 -179.691 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 67' ' ' TRP . 3.4 p90 -174.17 -171.7 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 131.682 5.614 . . . . 0.0 111.7 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -124.8 76.47 1.52 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 128.201 3.438 . . . . 0.0 113.762 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 24.36 78.48 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.738 1 O-C-N 133.744 6.903 . . . . 0.0 116.294 -179.876 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.62 64.28 1.83 Allowed Glycine 0 CA--C 1.537 1.407 0 N-CA-C 105.714 -2.955 . . . . 0.0 105.714 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.24 -38.01 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 1 O-C-N 130.588 4.346 . . . . 0.0 111.209 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.89 143.84 0.06 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 109.025 -3.716 . . . . 0.0 110.644 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 28.5 p90 178.3 -178.33 0.26 Allowed 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 129.279 4.112 . . . . 0.0 116.184 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.7 14.11 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.91 131.59 24.11 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 115.749 -2.38 . . . . 0.0 111.259 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.3 122.91 28.56 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.691 HD22 HD11 ' A' ' 43' ' ' ILE . 94.8 mt -84.1 -62.12 1.64 Allowed 'General case' 0 C--O 1.247 0.968 1 O-C-N 130.547 4.905 . . . . 0.0 115.086 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -101.86 35.74 2.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 125.777 1.923 . . . . 0.0 111.383 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 68.25 26.28 6.98 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 126.9 2.625 . . . . 0.0 110.672 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.87 -60.78 0.04 OUTLIER Glycine 0 CA--C 1.557 2.712 1 CA-C-O 113.204 -4.109 . . . . 0.0 105.61 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 58' ' ' ALA . 8.8 m -5.25 -77.53 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 1 O-C-N 135.278 7.105 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 63' ' ' LEU . 5.6 tp10 74.86 122.97 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.497 1 O-C-N 129.321 4.138 . . . . 0.0 103.865 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -154.39 69.85 0.77 Allowed 'General case' 0 C--O 1.205 -1.287 0 CA-C-N 109.285 -3.598 . . . . 0.0 106.843 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -67.92 96.83 0.62 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 111.176 -2.738 . . . . 0.0 106.273 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -165.39 172.11 40.86 Favored Glycine 0 C--O 1.207 -1.579 1 C-N-CA 111.175 -5.298 . . . . 0.0 107.843 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -133.89 143.13 48.08 Favored 'General case' 0 CA--C 1.507 -0.706 1 O-C-N 134.863 6.86 . . . . 0.0 113.241 179.874 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.639 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 22.9 m95 -113.82 122.17 46.24 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 101.338 -3.579 . . . . 0.0 101.338 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 66' ' ' THR . 18.6 p -117.02 48.92 1.24 Allowed 'General case' 0 C--N 1.316 -0.848 2 O-C-N 135.59 8.056 . . . . 0.0 115.873 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.803 ' CB ' HD11 ' A' ' 49' ' ' LEU . 2.6 tmm? -30.84 133.09 0.08 Allowed 'General case' 0 C--O 1.216 -0.7 1 O-C-N 134.376 7.298 . . . . 0.0 108.472 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.03 76.36 1.56 Allowed 'General case' 0 N--CA 1.48 1.048 1 O-C-N 129.12 4.012 . . . . 0.0 108.296 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.95 -113.11 5.57 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.71 28.18 1.59 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 114.172 -2.823 . . . . 0.0 114.432 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.294 0.1 OUTLIER -130.21 154.61 47.38 Favored 'General case' 0 C--N 1.342 0.255 1 O-C-N 129.273 4.108 . . . . 0.0 112.843 -179.834 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.597 ' CD1' HD11 ' A' ' 98' ' ' LEU . 4.3 mt -131.11 70.36 1.47 Allowed 'General case' 0 C--O 1.211 -0.939 0 O-C-N 129.081 3.988 . . . . 0.0 111.46 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.71 123.53 43.87 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 2 O-C-N 131.076 5.235 . . . . 0.0 110.512 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.19 -166.84 39.72 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-N 108.428 -3.987 . . . . 0.0 103.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 4.9 tttm -178.02 133.69 0.15 Allowed 'General case' 0 C--O 1.203 -1.387 1 O-C-N 132.304 5.355 . . . . 0.0 112.453 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -128.95 164.18 23.72 Favored 'General case' 0 N--CA 1.48 1.069 2 O-C-N 131.561 5.538 . . . . 0.0 102.386 -179.434 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.0 OUTLIER -157.65 143.18 17.18 Favored 'General case' 0 N--CA 1.432 -1.347 1 CA-C-N 107.21 -4.541 . . . . 0.0 113.491 -178.901 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 85' ' ' LYS . 4.3 ptm180 -102.62 94.24 5.53 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 129.281 4.113 . . . . 0.0 109.185 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -33.46 -36.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.431 1 O-C-N 134.393 7.308 . . . . 0.0 112.114 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -38.96 -52.09 1.79 Allowed 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.99 5.181 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -121.76 5.23 9.99 Favored 'General case' 0 N--CA 1.422 -1.874 0 O-C-N 127.808 3.193 . . . . 0.0 118.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.513 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 75.43 36.01 45.69 Favored Glycine 0 CA--C 1.554 2.497 2 C-N-CA 112.019 -4.896 . . . . 0.0 100.866 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HG2' ' CG ' ' A' ' 80' ' ' ARG 0.274 14.3 tptp -76.94 -75.11 0.21 Allowed 'General case' 0 N--CA 1.422 -1.865 1 O-C-N 131.918 5.128 . . . . 0.0 120.088 -179.695 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 42.8 mt-10 84.4 88.95 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.499 1 O-C-N 129.766 4.416 . . . . 0.0 108.317 -178.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.94 56.05 0.65 Allowed 'General case' 0 C--O 1.196 -1.76 1 O-C-N 131.66 5.6 . . . . 0.0 111.031 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -67.93 157.99 5.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 108.895 -3.775 . . . . 0.0 102.9 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -129.35 74.12 1.56 Allowed 'General case' 0 C--O 1.213 -0.868 1 O-C-N 133.982 7.051 . . . . 0.0 109.425 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.56 133.48 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 1 O-C-N 129.41 4.194 . . . . 0.0 107.436 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -178.12 148.58 0.51 Allowed 'General case' 0 C--O 1.191 -1.997 0 O-C-N 128.479 3.612 . . . . 0.0 114.6 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 3.6 mt-10 -143.66 114.67 7.81 Favored 'General case' 0 CA--C 1.561 1.376 1 O-C-N 129.874 4.484 . . . . 0.0 107.327 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.864 ' CD1' HD12 ' A' ' 98' ' ' LEU . 2.6 mm -18.43 80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.243 1 O-C-N 134.499 7.374 . . . . 0.0 110.661 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.21 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.733 1 O-C-N 132.648 6.217 . . . . 0.0 115.305 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.95 -131.21 10.23 Favored Glycine 0 CA--C 1.553 2.406 1 N-CA-C 102.061 -4.416 . . . . 0.0 102.061 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.16 29.3 8.01 Favored 'General case' 0 C--N 1.361 1.09 1 CA-C-N 107.189 -4.505 . . . . 0.0 109.587 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.565 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -156.28 151.62 26.71 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 114.635 -2.602 . . . . 0.0 108.253 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 93' ' ' ILE . 2.5 tt -105.15 126.47 52.12 Favored 'General case' 0 N--CA 1.445 -0.705 1 O-C-N 132.215 5.947 . . . . 0.0 112.132 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -77.25 -82.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 1 CA-C-O 109.927 -4.844 . . . . 0.0 108.256 -179.994 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 99' ' ' ILE . 95.8 mt-30 103.43 111.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.35 1 O-C-N 133.363 6.664 . . . . 0.0 100.903 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -112.29 102.49 10.64 Favored 'General case' 0 N--CA 1.424 -1.74 1 O-C-N 130.464 4.853 . . . . 0.0 113.847 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -75.24 101.3 4.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 113.513 -3.275 . . . . 0.0 105.326 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -84.92 97.8 9.98 Favored 'General case' 0 C--O 1.217 -0.642 1 O-C-N 129.511 4.257 . . . . 0.0 104.211 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -120.18 119.3 32.85 Favored 'General case' 0 C--N 1.363 1.185 1 CA-C-N 108.182 -4.099 . . . . 0.0 117.517 -179.935 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 50.15 23.01 1.04 Allowed 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.8 -6.43 24.05 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 117.639 -2.22 . . . . 0.0 115.464 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 108' ' ' GLU 0.257 39.5 t -95.16 163.0 2.35 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 CA-C-N 113.039 -1.581 . . . . 0.0 111.013 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 107' ' ' VAL . 6.0 mt-10 -126.35 58.76 1.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 127.26 2.85 . . . . 0.0 106.647 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.508 . . -82.02 128.94 34.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.061 3.351 . . . . 0.0 112.11 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD2' HG21 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.12 171.86 11.99 Favored 'General case' 0 N--CA 1.418 -2.07 1 O-C-N 132.872 6.358 . . . . 0.0 106.912 179.836 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -134.11 133.52 41.19 Favored 'General case' 0 C--O 1.207 -1.173 2 O-C-N 130.501 4.876 . . . . 0.0 99.602 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 pt -85.52 85.04 2.23 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 1 O-C-N 130.376 4.798 . . . . 0.0 113.653 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -91.64 179.25 5.7 Favored 'General case' 0 N--CA 1.441 -0.924 1 O-C-N 132.395 6.059 . . . . 0.0 104.836 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -154.61 -163.23 1.54 Allowed 'General case' 0 C--O 1.198 -1.644 1 O-C-N 130.766 5.041 . . . . 0.0 111.652 179.992 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.63 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 74.5 tttt -118.76 -119.59 0.31 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 115' ' ' LYS . 1.3 tp10 . . . . . 0 CA--C 1.558 1.275 0 CA-C-O 117.429 -1.272 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.426 ' HZ ' HD11 ' A' ' 93' ' ' ILE . 1.8 m-30 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -55.73 104.86 0.15 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 158.34 9.79 Favored Glycine 0 C--N 1.351 1.389 0 C-N-CA 114.15 -3.881 . . . . 0.0 104.488 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 58.1 p -78.72 163.42 25.43 Favored 'General case' 0 C--N 1.355 0.82 1 C-N-CA 110.566 -4.454 . . . . 0.0 110.307 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.553 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 23.0 m95 -132.81 162.27 31.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 112.319 -3.705 . . . . 0.0 111.043 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.8 OUTLIER 49.43 179.41 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 178.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 8' ' ' VAL 0.357 2.3 t . . . . . 0 CA--C 1.487 -1.471 3 O-C-N 132.769 6.293 . . . . 0.0 115.265 174.96 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.249 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER -161.75 153.54 19.07 Favored 'General case' 0 C--O 1.2 -1.542 1 O-C-N 129.608 4.317 . . . . 0.0 104.354 -179.985 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD2' HG13 ' A' ' 34' ' ' VAL . 4.5 mt -114.01 175.88 5.28 Favored 'General case' 0 CA--C 1.565 1.53 3 O-C-N 134.57 7.419 . . . . 0.0 97.544 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.628 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.3 m -171.33 -79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 128.802 3.814 . . . . 0.0 104.939 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 24' ' ' THR . 0.9 OUTLIER 73.88 151.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-N 109.277 -3.601 . . . . 0.0 110.346 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.9 m -166.66 71.91 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -48.94 125.36 10.25 Favored 'General case' 0 C--O 1.205 -1.268 1 O-C-N 131.589 5.555 . . . . 0.0 114.376 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -88.64 -112.36 0.06 Allowed 'General case' 0 C--N 1.365 1.249 1 O-C-N 130.389 4.806 . . . . 0.0 103.299 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.77 100.82 1.02 Allowed Glycine 0 CA--C 1.564 3.136 2 N-CA-C 100.526 -5.03 . . . . 0.0 100.526 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 m120 56.04 43.58 26.85 Favored 'General case' 0 N--CA 1.424 -1.745 0 O-C-N 128.04 2.847 . . . . 0.0 109.158 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -155.6 116.88 3.94 Favored 'General case' 0 CA--C 1.548 0.88 2 N-CA-C 98.618 -4.586 . . . . 0.0 98.618 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -127.95 169.82 13.55 Favored 'General case' 0 C--O 1.198 -1.628 2 N-CA-C 97.978 -4.823 . . . . 0.0 97.978 179.868 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.78 132.53 29.04 Favored 'General case' 0 CA--C 1.494 -1.185 2 O-C-N 133.921 7.013 . . . . 0.0 99.643 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.597 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.364 2.2 t -91.5 134.68 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 -179.998 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -68.78 -10.7 58.13 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 108.535 -3.939 . . . . 0.0 119.201 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.44 ' CB ' HG12 ' A' ' 34' ' ' VAL 0.27 2.3 tp10 -33.82 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 109.919 -3.31 . . . . 0.0 110.262 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -81.57 132.6 35.31 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 116.463 -2.095 . . . . 0.0 108.073 -179.27 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.63 -152.31 0.14 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 114.09 -3.044 . . . . 0.0 111.711 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.72 1.78 21.36 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 127.833 3.208 . . . . 0.0 108.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 82.8 m-85 -82.29 -56.58 3.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 109.451 -3.522 . . . . 0.0 105.424 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -175.09 -174.5 0.76 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 130.198 4.686 . . . . 0.0 112.334 -179.872 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.99 124.67 34.95 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.309 0.9 OUTLIER -142.09 106.66 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.039 2 CA-C-O 131.859 5.599 . . . . 0.0 109.483 -178.493 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 125.18 25.1 Favored 'General case' 0 C--N 1.373 1.587 1 CA-C-N 107.197 -4.547 . . . . 0.0 109.546 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.3 p -91.24 65.27 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.495 2 O-C-N 130.32 4.762 . . . . 0.0 100.128 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.08 161.11 5.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 1 C-N-CA 111.003 -4.279 . . . . 0.0 115.941 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CE1' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -174.77 -155.71 0.06 Allowed 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 128.1 3.375 . . . . 0.0 110.579 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.8 mt-10 -130.81 177.92 7.05 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 115.478 -2.201 . . . . 0.0 108.083 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 94.7 6.59 Favored 'General case' 0 C--O 1.214 -0.795 1 O-C-N 131.64 5.587 . . . . 0.0 109.804 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.99 53.17 1.95 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-O 114.04 -3.644 . . . . 0.0 104.868 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 25.5 t -141.44 123.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 1 O-C-N 130.714 4.42 . . . . 0.0 111.677 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.42 160.18 20.65 Favored 'General case' 0 C--N 1.356 0.883 1 O-C-N 130.053 4.595 . . . . 0.0 107.788 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 56.0 p90 -177.15 177.68 1.21 Allowed 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 130.676 4.985 . . . . 0.0 116.228 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.3 135.23 47.12 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.0 -154.1 0.6 Allowed 'General case' 0 C--O 1.204 -1.336 0 O-C-N 128.009 3.318 . . . . 0.0 113.745 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.27 89.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.52 HD12 HD22 ' A' ' 63' ' ' LEU . 10.3 mt -83.12 170.62 14.58 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.974 2.671 . . . . 0.0 110.508 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.47 -141.17 0.69 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 126.049 2.093 . . . . 0.0 113.521 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -26.06 60.46 Favored 'General case' 0 C--N 1.366 1.289 0 O-C-N 120.884 -1.135 . . . . 0.0 110.089 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.04 71.56 0.03 OUTLIER Glycine 0 CA--C 1.554 2.519 0 CA-C-O 116.337 -2.368 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 p -73.82 -134.06 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 1 O-C-N 132.636 5.551 . . . . 0.0 107.382 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -146.8 -61.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 112.38 -3.728 . . . . 0.0 104.022 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.52 HD22 HD12 ' A' ' 57' ' ' LEU . 1.8 mp 42.86 70.48 0.29 Allowed 'General case' 0 C--O 1.214 -0.809 1 O-C-N 131.047 5.217 . . . . 0.0 111.449 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.7 m -88.28 117.31 27.1 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.921 1.688 . . . . 0.0 108.936 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 176.62 -138.78 4.18 Favored Glycine 0 N--CA 1.473 1.106 1 C-N-CA 110.108 -5.806 . . . . 0.0 107.62 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.382 5.9 t -173.07 166.69 4.99 Favored 'General case' 0 N--CA 1.446 -0.665 1 O-C-N 130.667 4.393 . . . . 0.0 116.889 -179.122 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.569 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 2.6 m95 -122.37 145.94 47.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -136.31 32.42 2.84 Favored 'General case' 0 C--N 1.321 -0.652 2 O-C-N 135.099 7.749 . . . . 0.0 111.649 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 16.7 ttp -32.17 132.99 0.11 Allowed 'General case' 0 C--N 1.317 -0.84 2 O-C-N 134.909 7.63 . . . . 0.0 108.873 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.45 139.83 33.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 111.331 -2.668 . . . . 0.0 108.809 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 30.02 -98.67 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.816 1 O-C-N 133.086 6.491 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -119.35 56.78 0.91 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 108.813 -3.693 . . . . 0.0 112.337 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.4 mtpt -148.11 179.8 7.48 Favored 'General case' 0 C--O 1.249 1.069 1 O-C-N 129.335 4.147 . . . . 0.0 110.322 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.2 mt -147.13 46.14 1.16 Allowed 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 126.193 2.183 . . . . 0.0 112.755 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.63 130.16 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 1 O-C-N 129.294 4.121 . . . . 0.0 113.356 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.488 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 156.99 -142.49 8.73 Favored Glycine 0 CA--C 1.564 3.151 2 CA-C-N 106.647 -4.797 . . . . 0.0 103.917 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 170.59 168.69 0.07 Allowed 'General case' 0 N--CA 1.44 -0.942 1 O-C-N 133.789 6.229 . . . . 0.0 111.04 -179.289 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.599 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 11.9 m-85 -150.1 157.02 42.68 Favored 'General case' 0 C--O 1.197 -1.694 1 O-C-N 133.743 6.902 . . . . 0.0 101.615 176.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.946 ' HG2' HG13 ' A' ' 81' ' ' VAL . 4.2 ttpt -155.4 135.69 13.14 Favored 'General case' 0 N--CA 1.422 -1.835 1 CA-C-N 107.612 -4.358 . . . . 0.0 112.407 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.652 ' CD ' HD11 ' A' ' 87' ' ' LEU . 14.9 ptm180 -106.38 47.57 0.87 Allowed 'General case' 0 CA--C 1.557 1.237 0 O-C-N 125.906 2.004 . . . . 0.0 107.18 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.946 HG13 ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -6.16 -52.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.619 1 O-C-N 132.08 5.862 . . . . 0.0 115.658 -179.758 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 80' ' ' ARG . 2.1 t0 -39.23 -29.86 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 129.026 3.954 . . . . 0.0 113.059 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 174.79 -22.83 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.978 0 O-C-N 128.982 3.926 . . . . 0.0 114.132 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 80' ' ' ARG . . . -69.59 -52.18 22.13 Favored Glycine 0 CA--C 1.536 1.36 1 N-CA-C 101.826 -4.51 . . . . 0.0 101.826 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.03 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.939 2 O-C-N 132.015 5.185 . . . . 0.0 120.303 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 10.1 mt-10 74.48 62.03 0.07 Allowed 'General case' 0 N--CA 1.432 -1.366 1 O-C-N 130.226 4.704 . . . . 0.0 117.75 177.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' A' ' 80' ' ' ARG . 23.2 mt -97.7 61.53 1.6 Allowed 'General case' 0 C--O 1.199 -1.588 1 O-C-N 130.175 4.672 . . . . 0.0 108.8 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 77' ' ' LYS . 16.1 mt -69.98 -173.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 1 CA-C-N 107.226 -4.534 . . . . 0.0 104.487 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -153.28 54.12 0.75 Allowed 'General case' 0 C--O 1.196 -1.726 0 O-C-N 128.014 3.321 . . . . 0.0 105.449 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.9 t -57.66 113.12 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 1 O-C-N 131.014 5.196 . . . . 0.0 103.474 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.721 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -161.7 162.76 29.89 Favored 'General case' 0 C--O 1.189 -2.131 0 C-N-CA 113.599 -3.24 . . . . 0.0 113.27 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.721 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -162.76 100.78 1.01 Allowed 'General case' 0 N--CA 1.449 -0.522 2 O-C-N 131.187 5.304 . . . . 0.0 104.779 179.662 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 98' ' ' LEU . 1.8 mm 5.04 73.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.807 1 O-C-N 134.731 7.519 . . . . 0.0 111.453 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 t -15.21 -51.33 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.071 1 O-C-N 133.431 6.707 . . . . 0.0 117.092 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.17 -88.72 0.1 Allowed Glycine 0 CA--C 1.548 2.15 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -125.73 18.43 7.99 Favored 'General case' 0 CA--C 1.555 1.149 2 CA-C-N 105.785 -5.207 . . . . 0.0 103.52 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.618 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -153.49 168.79 24.97 Favored 'General case' 0 C--O 1.22 -0.486 0 O-C-N 127.892 3.245 . . . . 0.0 106.776 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -108.08 139.98 41.94 Favored 'General case' 0 N--CA 1.434 -1.27 1 O-C-N 130.525 4.891 . . . . 0.0 109.863 -179.885 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HB ' ' HD3' ' A' ' 91' ' ' ARG . 1.5 mt -102.96 -79.76 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.474 2 O-C-N 130.022 4.576 . . . . 0.0 105.639 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.522 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.6 mm100 105.52 82.27 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 1 O-C-N 132.776 6.298 . . . . 0.0 104.734 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.503 HG23 ' CG ' ' A' ' 110' ' ' LYS . 1.8 m -84.89 95.84 9.15 Favored 'General case' 0 N--CA 1.427 -1.619 2 O-C-N 130.983 5.177 . . . . 0.0 112.137 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -68.29 149.46 49.43 Favored 'General case' 0 N--CA 1.48 1.064 1 C-N-CA 110.094 -4.642 . . . . 0.0 105.085 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.3 m -118.53 72.0 0.86 Allowed 'General case' 0 C--O 1.206 -1.216 1 O-C-N 130.97 5.169 . . . . 0.0 107.75 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -88.55 108.68 19.54 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 109.118 -3.674 . . . . 0.0 110.372 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -17.25 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 126.96 2.663 . . . . 0.0 116.563 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.84 0.92 58.77 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 117.654 -2.213 . . . . 0.0 113.94 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.4 t -157.67 104.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -88.26 79.95 7.68 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-O 114.892 -2.48 . . . . 0.0 108.078 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.381 . . -93.91 148.47 22.11 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 129.41 4.194 . . . . 0.0 109.591 179.528 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' CG ' HG23 ' A' ' 101' ' ' THR . 50.8 mtmt -119.31 163.56 16.98 Favored 'General case' 0 N--CA 1.421 -1.912 1 O-C-N 133.393 6.683 . . . . 0.0 110.825 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.72 133.22 46.92 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 129.059 3.975 . . . . 0.0 101.152 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.59 114.16 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 O-C-N 127.367 2.917 . . . . 0.0 112.153 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 10.1 m-30 -129.25 174.2 9.81 Favored 'General case' 0 N--CA 1.422 -1.85 2 O-C-N 131.773 5.671 . . . . 0.0 104.251 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -163.74 -165.35 1.02 Allowed 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 132.728 6.267 . . . . 0.0 111.915 179.976 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.553 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 16.3 tttt -117.13 142.93 46.38 Favored 'General case' 0 N--CA 1.427 -1.624 0 O-C-N 119.123 -2.236 . . . . 0.0 111.279 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.243 0 O-C-N 126.94 2.65 . . . . 0.0 112.478 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 2.1 m-30 . . . . . 0 CA--C 1.559 1.296 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.59 97.62 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.614 1 O-C-N 129.529 4.268 . . . . 0.0 115.795 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.17 142.7 3.46 Favored Glycine 0 N--CA 1.47 0.941 0 C-N-CA 114.295 -3.812 . . . . 0.0 105.949 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.319 60.2 p -67.41 164.2 19.16 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 115.558 -2.457 . . . . 0.0 107.537 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 71.1 m95 -141.19 135.34 30.68 Favored 'General case' 0 N--CA 1.411 -2.394 0 O-C-N 127.788 3.18 . . . . 0.0 113.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 26.5 mtmt 59.37 178.03 0.08 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.81 HG11 HD22 ' A' ' 21' ' ' LEU 0.26 1.5 t . . . . . 0 CA--C 1.482 -1.64 3 O-C-N 135.122 7.764 . . . . 0.0 120.932 174.876 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.558 1.281 0 CA-C-O 113.477 -3.154 . . . . 0.0 106.244 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' H ' HD23 ' A' ' 21' ' ' LEU 0.362 1.3 mttp 83.12 155.99 0.11 Allowed 'General case' 0 C--O 1.198 -1.616 1 O-C-N 134.931 7.644 . . . . 0.0 101.555 -178.54 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 7.3 mt -118.14 174.02 6.45 Favored 'General case' 0 C--O 1.242 0.695 2 O-C-N 132.133 5.896 . . . . 0.0 99.275 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.3 m -156.06 -79.03 0.09 Allowed 'General case' 0 C--O 1.198 -1.633 0 O-C-N 127.615 3.072 . . . . 0.0 107.83 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.952 HG22 ' CD1' ' A' ' 32' ' ' PHE . 1.2 mp 62.08 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-N 109.401 -3.545 . . . . 0.0 114.702 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 m -145.68 78.57 1.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 116.239 -2.184 . . . . 0.0 106.954 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 18.0 mm-40 -91.21 -111.73 0.09 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 114.112 -3.035 . . . . 0.0 109.879 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -122.2 3.65 9.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.55 -16.0 55.36 Favored Glycine 0 CA--C 1.56 2.9 0 N-CA-C 104.289 -3.525 . . . . 0.0 104.289 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -115.81 -38.18 3.75 Favored 'General case' 0 N--CA 1.435 -1.182 1 O-C-N 131.078 4.634 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -102.38 -170.33 1.79 Allowed 'General case' 0 CA--C 1.551 0.996 1 N-CA-C 97.856 -4.868 . . . . 0.0 97.856 179.198 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.952 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER 179.68 126.29 0.07 Allowed 'General case' 0 C--O 1.195 -1.791 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 179.154 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.87 112.25 25.3 Favored 'General case' 0 C--O 1.252 1.197 3 O-C-N 132.585 6.178 . . . . 0.0 97.208 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.317 2.5 t -75.51 146.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 1 C-N-CA 111.026 -4.269 . . . . 0.0 105.152 179.799 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.263 2.4 ttmm -87.5 54.87 3.28 Favored 'General case' 0 C--O 1.195 -1.778 2 CA-C-O 128.523 4.011 . . . . 0.0 113.486 179.577 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.282 27.4 tt0 -72.68 68.55 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.854 -2.43 . . . . 0.0 107.668 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 132.87 36.64 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 116.341 -2.144 . . . . 0.0 108.088 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -137.13 -162.12 1.25 Allowed 'General case' 0 C--N 1.351 0.631 0 C-N-CA 114.126 -3.029 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.51 58.12 0.94 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 126.744 2.528 . . . . 0.0 106.659 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 15.9 m-85 -134.01 -71.81 0.5 Allowed 'General case' 0 C--N 1.358 0.962 1 CA-C-N 107.57 -4.377 . . . . 0.0 106.765 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -156.1 10.0 0.26 Allowed 'General case' 0 N--CA 1.428 -1.538 1 O-C-N 129.848 4.467 . . . . 0.0 116.206 179.691 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 75.63 8.41 3.73 Favored 'General case' 0 CA--C 1.548 0.897 1 O-C-N 129.407 4.192 . . . . 0.0 109.353 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.938 HD11 ' CD1' ' A' ' 57' ' ' LEU 0.336 0.7 OUTLIER -28.45 138.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.319 3 O-C-N 133.288 6.618 . . . . 0.0 110.615 178.741 . . . . . . . . 5 4 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.87 137.64 50.91 Favored 'General case' 0 C--N 1.373 1.601 1 CA-C-N 108.176 -4.102 . . . . 0.0 109.373 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.99 107.47 22.9 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.128 1 O-C-N 131.696 5.623 . . . . 0.0 104.2 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 47' ' ' PHE 0.319 2.8 p -110.02 168.47 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 2 O-C-N 130.196 4.685 . . . . 0.0 116.148 -179.752 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' N ' HG22 ' A' ' 46' ' ' VAL . 6.3 p90 -174.43 -177.93 1.31 Allowed 'General case' 0 N--CA 1.427 -1.59 1 O-C-N 131.601 5.563 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 2.7 tt0 -138.3 40.75 2.26 Favored 'General case' 0 N--CA 1.426 -1.644 0 O-C-N 127.007 2.692 . . . . 0.0 114.445 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.17 115.02 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.098 1 O-C-N 132.795 6.31 . . . . 0.0 115.855 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.44 44.88 94.64 Favored Glycine 0 CA--C 1.545 1.933 1 CA-C-O 112.673 -4.404 . . . . 0.0 104.367 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -115.12 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 1 O-C-N 133.672 6.16 . . . . 0.0 114.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 66' ' ' THR . 53.7 p-10 -79.27 151.9 30.86 Favored 'General case' 0 C--N 1.354 0.775 1 O-C-N 129.577 4.298 . . . . 0.0 111.624 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -174.55 -174.62 0.86 Allowed 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.39 4.181 . . . . 0.0 115.581 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.35 97.04 4.6 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -106.31 130.88 54.07 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 128.135 3.397 . . . . 0.0 113.025 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.1 t -91.99 71.09 5.52 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 112.599 -3.64 . . . . 0.0 106.002 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.938 ' CD1' HD11 ' A' ' 43' ' ' ILE . 27.2 tp -36.17 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 O-C-N 131.164 5.29 . . . . 0.0 112.997 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -88.07 -136.11 0.09 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 114.984 -2.436 . . . . 0.0 109.169 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.11 58.25 0.63 Allowed 'General case' 0 C--O 1.21 -0.987 0 O-C-N 127.249 2.843 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.03 -81.05 0.11 Allowed Glycine 0 CA--C 1.556 2.642 1 CA-C-O 112.499 -4.5 . . . . 0.0 104.116 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.844 HG21 HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER 23.02 -94.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.717 1 O-C-N 133.316 5.95 . . . . 0.0 109.398 -179.704 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 74.91 29.2 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 126.827 2.579 . . . . 0.0 108.743 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 61' ' ' THR . 7.2 mp -63.91 92.11 0.07 Allowed 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 128.868 3.855 . . . . 0.0 107.817 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 100.0 m -89.12 99.31 12.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.798 -2.91 . . . . 0.0 109.668 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -160.38 -152.72 6.66 Favored Glycine 0 CA--C 1.546 1.998 1 C-N-CA 113.635 -4.126 . . . . 0.0 105.843 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 66' ' ' THR . 6.0 t -163.5 118.48 1.64 Allowed 'General case' 0 CA--C 1.494 -1.179 1 O-C-N 131.184 4.696 . . . . 0.0 114.927 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.708 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m95 -96.31 124.74 40.41 Favored 'General case' 0 C--N 1.356 0.867 1 O-C-N 115.62 -4.425 . . . . 0.0 106.86 -179.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.51 94.88 5.07 Favored 'General case' 0 C--O 1.202 -1.402 2 O-C-N 135.106 7.754 . . . . 0.0 108.948 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.68 88.18 0.7 Allowed 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 109.943 -3.299 . . . . 0.0 103.965 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -94.93 81.82 3.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 126.422 2.327 . . . . 0.0 111.112 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.56 -92.85 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 O-C-N 128.647 3.717 . . . . 0.0 109.973 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -110.03 35.49 3.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.748 -2.726 . . . . 0.0 111.182 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 154.09 43.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 115.5 -2.48 . . . . 0.0 108.377 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.532 HD13 HH11 ' A' ' 91' ' ' ARG . 4.9 mt -134.8 37.32 3.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 127.605 3.066 . . . . 0.0 115.098 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.63 149.61 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 1 CA-C-N 107.879 -4.237 . . . . 0.0 115.598 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 155.75 -150.07 21.33 Favored Glycine 0 CA--C 1.551 2.301 1 N-CA-C 102.754 -4.138 . . . . 0.0 102.754 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 8.4 tttt 178.84 115.5 0.04 OUTLIER 'General case' 0 C--N 1.368 1.403 1 O-C-N 131.6 4.941 . . . . 0.0 114.311 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -120.25 145.32 47.15 Favored 'General case' 0 C--O 1.203 -1.383 1 CA-C-O 129.87 4.652 . . . . 0.0 102.309 179.802 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG2' ' C ' ' A' ' 85' ' ' LYS . 18.1 ttmt -138.52 147.62 43.33 Favored 'General case' 0 N--CA 1.425 -1.707 1 CA-C-N 105.991 -5.095 . . . . 0.0 115.103 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.656 ' CG ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -97.49 24.28 6.79 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 128.917 3.886 . . . . 0.0 111.908 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.464 ' CB ' ' HD2' ' A' ' 79' ' ' LYS . 1.4 m 1.73 -57.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.777 1 O-C-N 134.891 7.619 . . . . 0.0 114.807 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 t0 -45.34 -27.18 0.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 128.989 3.931 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.78 -7.96 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 C-N-CA 114.218 -2.993 . . . . 0.0 118.358 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.21 -46.34 2.22 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 105.212 -3.155 . . . . 0.0 105.212 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 90.04 -150.49 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 134.351 6.56 . . . . 0.0 113.896 179.844 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.492 ' HA ' ' HG3' ' A' ' 79' ' ' LYS 0.264 0.2 OUTLIER -63.58 133.44 53.76 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-O 112.77 -3.491 . . . . 0.0 114.965 -178.799 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.656 HD13 ' CG ' ' A' ' 80' ' ' ARG . 0.5 OUTLIER -137.24 49.21 2.03 Favored 'General case' 0 C--O 1.202 -1.412 1 O-C-N 137.99 9.556 . . . . 0.0 108.434 178.108 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.68 174.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.17 2 CA-C-N 107.153 -4.567 . . . . 0.0 104.235 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.99 55.15 1.72 Allowed 'General case' 0 N--CA 1.436 -1.132 1 O-C-N 130.856 5.098 . . . . 0.0 107.726 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.1 t -55.76 112.47 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 1 O-C-N 131.436 5.46 . . . . 0.0 100.865 178.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.754 ' HD3' HD21 ' A' ' 98' ' ' LEU . 5.5 ttm180 -151.89 160.08 43.63 Favored 'General case' 0 CA--C 1.495 -1.144 1 C-N-CA 109.468 -4.893 . . . . 0.0 113.472 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -160.87 136.38 7.96 Favored 'General case' 0 C--N 1.356 0.869 1 O-C-N 131.464 5.477 . . . . 0.0 109.369 -179.429 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 98' ' ' LEU . 4.4 mm -67.45 124.47 22.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 1 O-C-N 133.336 6.647 . . . . 0.0 110.354 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -77.22 -65.58 0.93 Allowed 'General case' 0 CA--C 1.503 -0.845 1 O-C-N 129.716 4.385 . . . . 0.0 113.171 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' OE2' ' A' ' 97' ' ' GLU . . . -174.44 78.05 0.08 OUTLIER Glycine 0 CA--C 1.554 2.482 0 C-N-CA 115.358 -3.306 . . . . 0.0 106.711 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 79.44 27.79 0.37 Allowed 'General case' 0 CA--C 1.551 0.981 1 CA-C-N 106.599 -4.801 . . . . 0.0 108.445 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.663 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.325 0.0 OUTLIER -168.8 142.74 3.05 Favored 'General case' 0 CA--C 1.564 1.516 1 O-C-N 130.731 5.019 . . . . 0.0 107.938 179.252 . . . . . . . . 5 4 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.894 HD12 ' CD1' ' A' ' 93' ' ' ILE . 3.8 tt -106.2 133.14 51.37 Favored 'General case' 0 N--CA 1.439 -1.0 2 O-C-N 135.206 7.817 . . . . 0.0 112.853 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 112' ' ' ILE . 3.3 mt -75.08 -66.86 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-O 111.99 -3.862 . . . . 0.0 105.479 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 73.95 92.95 0.08 Allowed 'General case' 0 C--O 1.201 -1.483 1 O-C-N 134.712 7.508 . . . . 0.0 101.631 -179.664 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -111.24 124.04 51.42 Favored 'General case' 0 N--CA 1.425 -1.699 1 CA-C-N 107.844 -4.253 . . . . 0.0 113.44 179.929 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -91.95 151.81 20.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 113.297 -3.24 . . . . 0.0 104.279 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 103' ' ' THR . 1.1 m -134.95 70.34 1.44 Allowed 'General case' 0 C--O 1.214 -0.807 1 O-C-N 131.843 5.714 . . . . 0.0 105.571 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -88.96 121.4 31.28 Favored 'General case' 0 CA--C 1.497 -1.064 1 CA-C-N 106.813 -4.721 . . . . 0.0 111.302 -179.898 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 5.9 mt-10 55.71 -85.31 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.441 0.696 . . . . 0.0 109.857 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -151.0 37.46 0.87 Allowed Glycine 0 C--N 1.363 2.05 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.696 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.4 t -136.68 149.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 116.685 -1.626 . . . . 0.0 114.767 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -124.46 104.3 8.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 128.954 3.909 . . . . 0.0 105.183 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 110' ' ' LYS 0.435 . . -100.11 -32.13 11.07 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 128.526 3.641 . . . . 0.0 113.588 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' CG ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER 46.73 -80.37 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.091 1 O-C-N 137.735 9.397 . . . . 0.0 111.462 179.961 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' ALA . 2.4 mtm180 77.34 88.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.42 1 N-CA-C 99.505 -4.258 . . . . 0.0 99.505 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 99' ' ' ILE . 3.7 pt -65.36 159.28 4.15 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 1 O-C-N 130.372 4.795 . . . . 0.0 114.077 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 22.0 m-85 -144.81 -148.44 0.24 Allowed 'General case' 0 N--CA 1.442 -0.848 1 O-C-N 130.858 5.099 . . . . 0.0 105.124 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.67 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -168.24 -141.33 0.04 OUTLIER 'General case' 0 C--O 1.196 -1.744 1 O-C-N 131.678 5.611 . . . . 0.0 112.139 -179.446 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 7.0 tttt -132.43 154.04 50.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 125.891 1.676 . . . . 0.0 110.804 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.196 179.569 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.978 ' CE1' HD11 ' A' ' 93' ' ' ILE . 23.1 m-85 62.04 51.18 3.74 Favored 'General case' 0 N--CA 1.469 0.477 1 O-C-N 131.676 5.61 . . . . 0.0 103.735 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -148.96 62.72 1.05 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 115.791 -2.364 . . . . 0.0 114.913 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 176.78 21.13 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 115.192 -3.385 . . . . 0.0 107.449 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.274 16.9 p -72.84 168.47 18.8 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 128.253 2.972 . . . . 0.0 109.16 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.599 ' CG ' ' HG3' ' A' ' 115' ' ' LYS 0.287 7.8 m95 -145.81 146.69 31.27 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 111.732 -3.985 . . . . 0.0 112.485 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.681 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 1.3 mtmt 61.49 -179.43 0.12 Allowed 'General case' 0 C--O 1.196 -1.752 1 O-C-N 133.297 6.623 . . . . 0.0 118.142 175.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.725 HG11 ' O ' ' A' ' 21' ' ' LEU 0.256 1.0 OUTLIER 29.56 133.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.664 3 O-C-N 135.793 8.183 . . . . 0.0 119.938 174.897 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -174.56 81.49 0.03 OUTLIER 'General case' 0 C--N 1.367 1.364 0 CA-C-N 110.598 -3.001 . . . . 0.0 108.303 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -90.82 92.63 8.88 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 123.016 1.388 . . . . 0.0 111.356 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 52.97 -160.68 0.12 Allowed 'General case' 0 C--N 1.363 1.196 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.308 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.4 -34.22 77.67 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.928 1.393 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.9 t30 75.73 137.23 0.06 Allowed 'General case' 0 C--N 1.36 1.046 0 O-C-N 129.002 3.939 . . . . 0.0 108.151 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -101.89 -155.85 0.54 Allowed 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 109.848 -3.342 . . . . 0.0 108.7 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -86.54 -158.88 0.44 Allowed 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 114.626 -2.83 . . . . 0.0 110.602 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . 103.96 -58.99 0.5 Allowed Glycine 0 CA--C 1.542 1.778 0 C-N-CA 117.92 -2.086 . . . . 0.0 113.301 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . 71.89 85.5 0.12 Allowed 'General case' 0 C--O 1.248 0.975 0 O-C-N 126.589 1.994 . . . . 0.0 106.197 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -129.46 131.81 46.79 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 116.189 -1.862 . . . . 0.0 111.704 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 17.43 61.42 0.01 OUTLIER 'General case' 0 C--O 1.199 -1.598 1 O-C-N 131.29 5.369 . . . . 0.0 113.814 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 97.36 8.23 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 110.714 -2.948 . . . . 0.0 111.594 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.725 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -81.32 -173.26 4.24 Favored 'General case' 0 CA--C 1.55 0.972 1 CA-C-N 107.453 -4.43 . . . . 0.0 103.178 -179.995 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.314 0.4 OUTLIER 150.76 142.19 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.509 1 O-C-N 133.083 6.49 . . . . 0.0 104.805 179.935 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD22 HD11 ' A' ' 25' ' ' ILE . 0.8 OUTLIER -110.84 165.77 11.57 Favored 'General case' 0 CA--C 1.561 1.399 1 O-C-N 133.098 6.499 . . . . 0.0 100.441 179.589 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.664 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 4.2 m 175.95 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 1 O-C-N 132.316 6.01 . . . . 0.0 107.123 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.768 HG12 HG22 ' A' ' 34' ' ' VAL . 2.6 mp -133.41 140.67 46.34 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 109.007 -3.724 . . . . 0.0 109.422 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.0 m -159.2 81.15 0.77 Allowed 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 113.214 -3.395 . . . . 0.0 107.855 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.53 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.27 151.41 1.45 Allowed 'General case' 0 N--CA 1.433 -1.289 1 O-C-N 132.849 6.343 . . . . 0.0 111.271 179.631 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.28 56.09 0.88 Allowed 'General case' 0 C--N 1.352 0.71 1 O-C-N 129.903 4.502 . . . . 0.0 106.873 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.77 87.36 0.61 Allowed Glycine 0 CA--C 1.547 2.031 2 C-N-CA 110.846 -5.454 . . . . 0.0 101.746 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 p30 34.13 55.13 0.61 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 133.029 5.782 . . . . 0.0 109.048 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 88.82 1.3 Allowed 'General case' 0 C--N 1.307 -1.278 3 O-C-N 131.392 5.432 . . . . 0.0 96.533 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 69' ' ' MET . 21.7 p90 -121.82 131.19 53.92 Favored 'General case' 0 C--O 1.209 -1.056 2 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.84 156.36 22.13 Favored 'General case' 0 N--CA 1.478 0.934 4 O-C-N 136.984 8.928 . . . . 0.0 98.656 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 25' ' ' ILE 0.291 2.7 t -127.54 143.14 41.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 126.932 3.253 . . . . 0.0 104.425 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.2 tttm -93.12 77.65 4.61 Favored 'General case' 0 N--CA 1.421 -1.881 2 CA-C-O 133.808 6.527 . . . . 0.0 114.072 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -86.45 62.1 7.22 Favored 'General case' 0 N--CA 1.42 -1.974 1 CA-C-N 108.019 -4.173 . . . . 0.0 107.759 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -74.0 119.37 18.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 112.924 -3.51 . . . . 0.0 109.574 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.03 -142.02 0.16 Allowed 'General case' 0 C--N 1.353 0.724 0 C-N-CA 114.574 -2.85 . . . . 0.0 114.385 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -96.48 38.53 1.2 Allowed 'General case' 0 C--N 1.355 0.845 0 O-C-N 124.16 0.912 . . . . 0.0 111.07 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -152.42 54.63 0.8 Allowed 'General case' 0 C--O 1.2 -1.508 1 O-C-N 129.937 4.523 . . . . 0.0 105.182 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 68.26 -161.78 0.2 Allowed 'General case' 0 C--O 1.246 0.889 1 O-C-N 132.387 6.054 . . . . 0.0 110.621 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -73.63 -68.99 0.46 Allowed 'General case' 0 CA--C 1.548 0.892 1 C-N-CA 111.661 -4.016 . . . . 0.0 102.599 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER 67.14 134.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.776 2 CA-C-O 131.505 5.431 . . . . 0.0 107.79 179.886 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.38 165.17 18.87 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 110.027 -3.26 . . . . 0.0 108.787 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.91 101.15 7.26 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.091 1 O-C-N 132.234 5.959 . . . . 0.0 101.663 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 5.8 p -111.48 154.75 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 O-C-N 129.054 3.971 . . . . 0.0 112.867 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 46' ' ' VAL 0.27 3.3 p90 170.5 -172.55 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 132.098 5.874 . . . . 0.0 110.739 -179.606 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' HB2' HG21 ' A' ' 51' ' ' VAL . 19.4 mt-10 -115.29 81.32 1.56 Allowed 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 115.66 -2.416 . . . . 0.0 114.73 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 69' ' ' MET . 1.0 OUTLIER 48.73 -115.78 0.78 Allowed 'General case' 0 C--N 1.324 -0.524 1 O-C-N 129.573 4.295 . . . . 0.0 110.041 -179.987 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 49' ' ' LEU . . . -71.81 76.15 0.7 Allowed Glycine 0 N--CA 1.48 1.567 0 N-CA-C 104.664 -3.374 . . . . 0.0 104.664 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' HD2' ' A' ' 53' ' ' PHE . 2.3 t -129.93 97.22 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 1 O-C-N 131.659 4.976 . . . . 0.0 111.014 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -73.75 157.37 36.59 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 128.129 3.393 . . . . 0.0 110.844 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 13.3 p90 172.33 159.98 0.11 Allowed 'General case' 0 C--N 1.373 1.605 1 O-C-N 131.072 5.233 . . . . 0.0 114.869 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' OE2' ' A' ' 62' ' ' GLU . . . -105.34 96.83 6.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 101.047 -3.686 . . . . 0.0 101.047 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.569 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -121.42 128.33 52.06 Favored 'General case' 0 C--O 1.209 -1.067 1 O-C-N 129.169 4.043 . . . . 0.0 114.665 -179.928 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.84 168.25 13.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 112.76 -3.576 . . . . 0.0 107.738 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.464 HD23 HG13 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.12 -41.85 0.38 Allowed 'General case' 0 CA--C 1.509 -0.597 1 O-C-N 131.32 5.387 . . . . 0.0 112.774 -179.957 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -123.62 45.42 2.46 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 125.065 1.478 . . . . 0.0 114.487 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.5 p30 42.64 28.38 0.12 Allowed 'General case' 0 C--O 1.211 -0.925 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.9 41.4 0.06 OUTLIER Glycine 0 C--N 1.364 2.138 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.62 HG23 ' HB3' ' A' ' 58' ' ' ALA . 30.1 p -137.32 177.74 7.64 Favored 'General case' 0 C--N 1.315 -0.893 1 O-C-N 130.849 4.5 . . . . 0.0 112.054 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 5.5 tp10 -161.77 37.5 0.13 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 114.888 -2.725 . . . . 0.0 106.084 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.18 99.6 0.03 OUTLIER 'General case' 0 C--N 1.361 1.073 0 CA-C-N 108.839 -3.8 . . . . 0.0 109.644 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -107.69 108.39 19.6 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 110.329 -3.123 . . . . 0.0 108.18 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.537 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -162.77 -161.09 11.79 Favored Glycine 0 C--O 1.21 -1.382 1 C-N-CA 110.93 -5.414 . . . . 0.0 107.57 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 66' ' ' THR . 9.9 t -154.19 99.36 2.22 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 129.004 3.414 . . . . 0.0 116.737 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.702 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 25.2 m95 -81.89 127.72 33.31 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 118.11 -2.869 . . . . 0.0 104.461 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.9 p -120.3 69.16 0.86 Allowed 'General case' 0 N--CA 1.433 -1.293 1 O-C-N 135.695 8.122 . . . . 0.0 110.647 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.534 ' HB2' ' CE2' ' A' ' 32' ' ' PHE . 59.6 ttp -43.7 118.53 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 1 O-C-N 131.712 5.632 . . . . 0.0 104.058 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -119.5 59.71 0.85 Allowed 'General case' 0 CA--C 1.506 -0.742 1 O-C-N 130.693 4.996 . . . . 0.0 110.509 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.86 -85.89 1.37 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 117.46 -2.305 . . . . 0.0 110.682 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.01 23.94 11.83 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 114.531 -2.652 . . . . 0.0 114.025 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.77 -172.36 2.51 Favored 'General case' 0 N--CA 1.476 0.866 1 O-C-N 130.172 4.67 . . . . 0.0 109.705 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 74' ' ' LEU . 1.1 mt -157.97 37.94 0.26 Allowed 'General case' 0 C--O 1.214 -0.766 0 O-C-N 126.641 2.463 . . . . 0.0 114.028 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -62.04 135.69 26.28 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 1 CA-C-N 106.905 -4.679 . . . . 0.0 114.841 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.472 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 159.24 -161.14 31.85 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 104.549 -3.42 . . . . 0.0 104.549 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -174.59 122.97 0.27 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 113.675 -3.21 . . . . 0.0 112.344 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -124.35 146.37 48.88 Favored 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.066 4.604 . . . . 0.0 102.039 179.913 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.718 ' CG ' ' C ' ' A' ' 85' ' ' LYS 0.348 16.9 ttmt -139.23 152.3 47.21 Favored 'General case' 0 N--CA 1.424 -1.735 1 CA-C-N 105.448 -5.342 . . . . 0.0 117.845 -179.512 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.823 ' HG2' HD13 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -113.33 63.02 0.64 Allowed 'General case' 0 CA--C 1.558 1.284 0 O-C-N 126.246 2.216 . . . . 0.0 108.929 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 t -17.34 -44.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 131.949 5.781 . . . . 0.0 115.425 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 9.9 t0 -65.4 -3.42 4.24 Favored 'General case' 0 N--CA 1.436 -1.161 1 O-C-N 129.97 4.544 . . . . 0.0 113.773 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER 168.23 -30.41 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 115.705 -2.398 . . . . 0.0 114.688 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.568 ' HA3' ' HD3' ' A' ' 80' ' ' ARG . . . -88.64 -30.63 14.96 Favored Glycine 0 CA--C 1.56 2.844 1 C-N-CA 112.729 -4.557 . . . . 0.0 103.268 -179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.718 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 50.25 17.25 0.32 Allowed 'General case' 0 N--CA 1.441 -0.887 1 O-C-N 133.356 5.974 . . . . 0.0 118.896 178.69 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' C ' HD12 ' A' ' 87' ' ' LEU . 1.7 mt-10 161.06 116.22 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 1 O-C-N 129.459 4.224 . . . . 0.0 109.172 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' A' ' 80' ' ' ARG . 4.8 mp -152.76 58.95 0.8 Allowed 'General case' 0 C--O 1.207 -1.145 1 O-C-N 139.654 10.597 . . . . 0.0 112.301 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 92.5 mt -67.25 -177.49 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.235 1 CA-C-N 108.032 -4.167 . . . . 0.0 104.893 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.21 63.1 0.97 Allowed 'General case' 0 C--O 1.194 -1.82 0 O-C-N 128.425 3.578 . . . . 0.0 106.255 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -67.29 112.06 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 110.735 -2.939 . . . . 0.0 106.469 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD3' ' HB ' ' A' ' 99' ' ' ILE . 1.2 tpm_? -172.55 157.38 3.9 Favored 'General case' 0 C--O 1.191 -1.998 1 C-N-CA 110.738 -4.385 . . . . 0.0 116.779 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -137.21 148.17 46.34 Favored 'General case' 0 N--CA 1.439 -1.011 1 O-C-N 129.707 4.38 . . . . 0.0 104.971 179.522 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 98' ' ' LEU . 16.3 mm -55.55 96.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.913 1 O-C-N 131.632 5.582 . . . . 0.0 109.304 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.9 t -38.51 -57.17 1.19 Allowed 'General case' 0 CA--C 1.509 -0.619 1 O-C-N 130.885 5.116 . . . . 0.0 113.621 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.68 98.48 0.15 Allowed Glycine 0 CA--C 1.559 2.824 1 N-CA-C 103.051 -4.02 . . . . 0.0 103.051 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 m120 79.48 15.43 0.94 Allowed 'General case' 0 CA--C 1.553 1.063 1 O-C-N 132.466 5.451 . . . . 0.0 108.757 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.286 0.1 OUTLIER 174.68 170.73 0.25 Allowed 'General case' 0 C--O 1.2 -1.533 0 O-C-N 127.256 2.847 . . . . 0.0 108.928 178.696 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 93' ' ' ILE . 16.5 tp -123.36 158.45 31.06 Favored 'General case' 0 N--CA 1.434 -1.237 2 O-C-N 132.475 6.109 . . . . 0.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 100' ' ' GLN 0.255 7.8 mt -110.01 -89.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.101 4.626 . . . . 0.0 103.807 179.835 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 99' ' ' ILE . 9.8 mm100 111.1 90.23 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.729 1 O-C-N 133.188 6.555 . . . . 0.0 105.473 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.1 m -87.71 92.45 9.11 Favored 'General case' 0 C--O 1.197 -1.7 2 O-C-N 132.623 6.202 . . . . 0.0 112.28 179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -70.39 113.38 7.47 Favored 'General case' 0 C--O 1.211 -0.968 2 CA-C-N 107.073 -4.603 . . . . 0.0 106.192 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -88.64 116.1 26.65 Favored 'General case' 0 C--N 1.364 1.209 1 O-C-N 129.105 4.003 . . . . 0.0 102.419 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.1 t80 -131.52 118.13 19.73 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 109.867 -3.333 . . . . 0.0 113.888 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 36.06 30.87 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.25 -19.91 9.18 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 117.779 -2.153 . . . . 0.0 114.188 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -94.94 162.34 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 CA-C-O 116.41 -1.757 . . . . 0.0 115.298 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.25 85.07 2.35 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 126.456 2.348 . . . . 0.0 105.288 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.438 . . -89.27 104.6 17.13 Favored 'General case' 0 C--O 1.2 -1.548 1 O-C-N 129.112 4.007 . . . . 0.0 110.507 179.959 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 101' ' ' THR . 7.3 mttp -97.84 134.57 40.81 Favored 'General case' 0 C--N 1.315 -0.9 1 O-C-N 135.3 7.875 . . . . 0.0 110.425 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 99' ' ' ILE . 8.8 mtt180 -99.28 141.21 32.34 Favored 'General case' 0 CA--C 1.562 1.411 1 N-CA-C 99.395 -4.298 . . . . 0.0 99.395 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.8 mt -112.94 105.84 19.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 1 O-C-N 130.175 4.672 . . . . 0.0 113.824 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.681 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 29.1 m-85 -137.88 -156.19 0.67 Allowed 'General case' 0 N--CA 1.436 -1.156 2 CA-C-N 108.124 -4.125 . . . . 0.0 104.993 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -169.82 -138.9 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.173 1 O-C-N 131.041 5.213 . . . . 0.0 110.483 -179.785 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.599 ' HG3' ' CG ' ' A' ' 6' ' ' TRP . 15.7 tttt -135.83 166.71 22.67 Favored 'General case' 0 C--O 1.202 -1.409 0 O-C-N 127.503 3.002 . . . . 0.0 109.434 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.434 -1.268 0 CA-C-N 113.579 -1.646 . . . . 0.0 106.699 179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.604 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.029 0.442 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.34 71.94 5.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 116.659 -2.016 . . . . 0.0 108.384 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 9.8 p-10 -169.83 29.29 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.579 0 C-N-CA 116.632 -2.027 . . . . 0.0 114.887 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.24 -147.02 4.87 Favored Glycine 0 N--CA 1.48 1.62 1 C-N-CA 111.067 -5.349 . . . . 0.0 103.502 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.49 ' HA ' ' CB ' ' A' ' 24' ' ' THR 0.254 7.5 p -97.63 166.18 11.62 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 129.333 3.608 . . . . 0.0 104.266 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.26 10.4 m95 -141.61 169.91 16.71 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 113.058 -3.354 . . . . 0.0 112.07 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.737 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 51.5 179.06 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 178.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.258 0.5 OUTLIER 22.75 146.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.454 3 CA-C-O 135.591 7.377 . . . . 0.0 120.263 175.015 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -104.7 -126.04 0.23 Allowed 'General case' 0 C--N 1.372 1.571 1 CA-C-N 107.479 -4.419 . . . . 0.0 102.483 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 33.47 79.24 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.672 0 O-C-N 126.229 2.206 . . . . 0.0 115.641 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 13' ' ' ASN . 1.7 m120 -64.1 174.68 1.47 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 116.266 -2.174 . . . . 0.0 111.585 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.61 79.79 0.01 OUTLIER 'General case' 0 C--O 1.242 0.704 0 O-C-N 126.668 2.48 . . . . 0.0 112.029 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' ASN . 5.3 t30 -154.13 45.39 0.58 Allowed 'General case' 0 C--N 1.346 0.427 0 CA-C-O 123.436 1.589 . . . . 0.0 107.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.556 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -141.49 110.1 6.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-N 112.038 -2.346 . . . . 0.0 107.546 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.6 t -89.39 136.5 32.99 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 127.534 3.022 . . . . 0.0 108.755 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.48 27.01 73.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 114.44 -3.743 . . . . 0.0 113.247 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 14' ' ' TYR . . . -81.22 118.31 22.47 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 127.843 2.731 . . . . 0.0 109.175 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -102.3 35.98 2.26 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 125.173 1.546 . . . . 0.0 113.483 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -168.98 108.28 0.46 Allowed 'General case' 0 C--O 1.209 -1.072 0 O-C-N 124.821 1.326 . . . . 0.0 111.389 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -164.3 135.67 4.47 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 127.203 2.815 . . . . 0.0 110.174 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.609 HD12 ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -144.25 -173.15 3.94 Favored 'General case' 0 CA--C 1.552 1.034 0 O-C-N 129.056 3.972 . . . . 0.0 102.576 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' HG2' ' C ' ' A' ' 21' ' ' LEU 0.359 0.0 OUTLIER 171.13 165.91 0.08 Allowed 'General case' 0 CA--C 1.566 1.56 1 O-C-N 130.573 4.921 . . . . 0.0 104.268 179.805 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -131.93 151.48 51.69 Favored 'General case' 0 CA--C 1.558 1.26 4 O-C-N 134.494 7.371 . . . . 0.0 97.022 178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.661 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.2 m 178.15 71.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 1 O-C-N 131.293 5.371 . . . . 0.0 104.215 -179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 34' ' ' VAL . 2.7 mp -86.37 157.99 3.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 109.87 -3.332 . . . . 0.0 108.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 27.9 m -172.77 77.3 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 O-C-N 128.056 3.347 . . . . 0.0 104.673 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -45.75 145.09 1.47 Allowed 'General case' 0 N--CA 1.449 -0.524 2 O-C-N 132.556 6.16 . . . . 0.0 112.032 179.925 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 0.0 OUTLIER -105.0 -7.48 19.21 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.98 63.86 0.24 Allowed Glycine 0 CA--C 1.556 2.633 0 N-CA-C 103.21 -3.956 . . . . 0.0 103.21 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.1 p30 105.52 -20.9 0.01 OUTLIER 'General case' 0 N--CA 1.413 -2.277 1 O-C-N 131.944 5.143 . . . . 0.0 111.559 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.67 84.69 7.46 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 129.091 3.994 . . . . 0.0 103.27 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 17.1 m-85 -91.76 129.44 37.73 Favored 'General case' 0 C--O 1.19 -2.056 1 N-CA-C 96.177 -5.49 . . . . 0.0 96.177 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 33' ' ' THR 0.255 0.4 OUTLIER -132.88 114.1 13.66 Favored 'General case' 0 N--CA 1.483 1.213 2 O-C-N 135.895 8.247 . . . . 0.0 97.454 -179.741 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.442 14.7 t -85.48 154.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 2 C-N-CA 109.64 -4.824 . . . . 0.0 102.935 -179.839 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' HB3' ' N ' ' A' ' 24' ' ' THR . 2.8 tttm -88.56 16.8 6.05 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 118.848 2.907 . . . . 0.0 118.848 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.596 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.327 26.3 mt-10 -44.25 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 109.624 -3.443 . . . . 0.0 107.934 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 46.0 m -100.08 141.74 32.5 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 125.764 1.915 . . . . 0.0 113.322 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.08 -151.3 0.48 Allowed 'General case' 0 C--N 1.352 0.696 0 O-C-N 128.231 3.457 . . . . 0.0 110.054 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -111.08 30.01 7.27 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.541 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 20.2 m-85 -110.6 -78.13 0.59 Allowed 'General case' 0 CA--C 1.55 0.956 2 O-C-N 130.448 4.843 . . . . 0.0 110.366 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 2.1 mpt_? -139.04 8.63 2.51 Favored 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 126.563 2.415 . . . . 0.0 112.391 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 75.1 18.97 2.39 Favored 'General case' 0 N--CA 1.437 -1.105 0 O-C-N 127.2 2.813 . . . . 0.0 104.204 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 43' ' ' ILE 0.298 9.7 tt -35.71 101.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.722 3 O-C-N 132.218 5.949 . . . . 0.0 110.24 179.429 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.42 144.64 27.21 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 109.643 -3.435 . . . . 0.0 105.944 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.85 128.22 50.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 1 O-C-N 129.38 4.175 . . . . 0.0 101.344 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.345 14.0 p -138.85 159.42 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 115.912 -2.315 . . . . 0.0 112.945 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . 0.261 0.3 OUTLIER 170.73 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.928 1 O-C-N 134.977 7.673 . . . . 0.0 111.193 179.959 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.71 76.9 1.46 Allowed 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 127.212 2.82 . . . . 0.0 110.175 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 68' ' ' THR . 0.1 OUTLIER 38.87 -80.48 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.962 1 O-C-N 131.71 5.631 . . . . 0.0 115.813 179.692 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.63 72.88 2.75 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 105.559 -3.016 . . . . 0.0 105.559 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 53' ' ' PHE . 4.5 t -148.2 110.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.104 1 O-C-N 131.666 4.98 . . . . 0.0 116.958 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.08 163.04 15.66 Favored 'General case' 0 C--O 1.205 -1.257 1 O-C-N 129.87 4.481 . . . . 0.0 106.277 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.512 ' HD2' HG12 ' A' ' 51' ' ' VAL . 10.7 p90 178.38 167.24 0.82 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 112.36 -3.736 . . . . 0.0 114.495 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.69 83.92 1.93 Allowed 'General case' 0 CA--C 1.562 1.412 1 N-CA-C 100.104 -4.036 . . . . 0.0 100.104 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.469 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -93.65 150.07 20.71 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 129.049 3.968 . . . . 0.0 114.997 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 88.22 2.71 Favored 'General case' 0 CA--C 1.558 1.266 0 O-C-N 128.362 3.539 . . . . 0.0 105.144 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.6 mm? -62.38 -75.63 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 128.796 3.81 . . . . 0.0 112.455 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 43' ' ' ILE . . . -84.33 -138.98 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 114.797 -2.525 . . . . 0.0 109.045 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.75 6.68 23.79 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 127.26 2.85 . . . . 0.0 111.734 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.3 66.19 0.19 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-O 115.712 -2.716 . . . . 0.0 107.323 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.531 ' HB ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -123.14 -76.61 0.59 Allowed 'General case' 0 C--O 1.213 -0.863 1 O-C-N 130.786 4.463 . . . . 0.0 112.869 179.939 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER 65.03 32.47 10.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.632 1.208 . . . . 0.0 109.438 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 61' ' ' THR . 3.7 mp -71.35 84.06 0.79 Allowed 'General case' 0 N--CA 1.422 -1.844 0 O-C-N 128.371 3.545 . . . . 0.0 108.334 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -72.28 115.73 11.87 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 77' ' ' LYS . . . -150.29 -155.36 6.82 Favored Glycine 0 C--O 1.199 -2.041 1 C-N-CA 110.423 -5.656 . . . . 0.0 107.801 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.653 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.28 1.1 t -179.73 130.17 0.1 Allowed 'General case' 0 CA--C 1.499 -0.994 1 O-C-N 134.394 6.585 . . . . 0.0 110.969 -177.391 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.675 ' CZ2' ' CE1' ' A' ' 78' ' ' PHE . 71.7 m95 -140.86 113.12 7.92 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 118.307 -2.745 . . . . 0.0 106.509 -176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.515 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 p -96.57 54.83 1.38 Allowed 'General case' 0 N--CA 1.428 -1.528 2 O-C-N 132.16 5.912 . . . . 0.0 116.316 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.6 tpp -40.13 107.69 0.07 Allowed 'General case' 0 C--O 1.212 -0.908 1 O-C-N 134.398 7.311 . . . . 0.0 104.833 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -130.48 115.95 17.53 Favored 'General case' 0 C--O 1.21 -0.979 0 O-C-N 128.526 3.641 . . . . 0.0 106.85 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.89 -132.05 46.22 Favored Glycine 0 CA--C 1.55 2.225 0 C-N-CA 117.01 -2.519 . . . . 0.0 107.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 11.9 m120 -97.95 52.78 1.07 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 115.679 -2.105 . . . . 0.0 110.32 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -132.99 171.65 13.68 Favored 'General case' 0 CA--C 1.502 -0.895 0 O-C-N 125.108 1.505 . . . . 0.0 113.753 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.1 mt -153.11 46.06 0.67 Allowed 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 122.939 1.352 . . . . 0.0 113.146 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.4 134.12 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 CA-C-N 110.27 -3.15 . . . . 0.0 115.679 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' C ' ' CH2' ' A' ' 67' ' ' TRP . . . 157.87 -157.49 28.27 Favored Glycine 0 CA--C 1.554 2.495 1 N-CA-C 102.863 -4.095 . . . . 0.0 102.863 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.563 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.314 0.0 OUTLIER -173.14 131.6 0.49 Allowed 'General case' 0 C--N 1.363 1.153 0 O-C-N 129.326 3.603 . . . . 0.0 116.319 179.604 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.675 ' CE1' ' CZ2' ' A' ' 67' ' ' TRP . 1.2 m-85 -112.07 163.29 14.46 Favored 'General case' 0 C--O 1.193 -1.878 1 CA-C-O 129.117 4.294 . . . . 0.0 101.706 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.549 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 ttmt -171.2 146.69 2.41 Favored 'General case' 0 N--CA 1.441 -0.908 1 CA-C-N 104.39 -5.823 . . . . 0.0 117.087 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.418 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -94.91 104.81 16.7 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 115.041 -2.409 . . . . 0.0 107.287 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 35.6 m -78.5 76.38 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.101 1 O-C-N 131.53 5.519 . . . . 0.0 111.933 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.13 -47.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 O-C-N 129.095 3.997 . . . . 0.0 108.538 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -179.05 5.17 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 127.271 2.857 . . . . 0.0 116.408 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.17 -44.09 3.89 Favored Glycine 0 CA--C 1.545 1.947 1 N-CA-C 102.139 -4.384 . . . . 0.0 102.139 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' C ' ' CG ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 86.69 -156.92 0.01 OUTLIER 'General case' 0 C--O 1.252 1.227 1 O-C-N 132.357 5.386 . . . . 0.0 113.372 179.991 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -64.24 148.83 49.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.836 2.562 . . . . 0.0 117.425 -177.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD11 ' CG ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -141.7 36.37 1.62 Allowed 'General case' 0 C--O 1.206 -1.21 1 O-C-N 132.619 6.199 . . . . 0.0 110.388 179.589 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.489 HD11 ' HD3' ' A' ' 77' ' ' LYS . 36.7 mt -53.65 163.95 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.558 1 CA-C-N 107.223 -4.535 . . . . 0.0 106.062 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.13 59.95 1.71 Allowed 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 128.585 3.678 . . . . 0.0 106.047 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.7 118.13 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 1 O-C-N 129.327 4.142 . . . . 0.0 104.057 179.866 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 92' ' ' GLU . 0.1 OUTLIER -178.74 160.82 1.2 Allowed 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 113.302 -3.359 . . . . 0.0 114.352 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.489 ' HG3' ' CZ ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -144.52 134.61 24.07 Favored 'General case' 0 N--CA 1.424 -1.748 2 O-C-N 132.583 6.177 . . . . 0.0 108.129 179.642 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.34 108.77 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 1 O-C-N 130.974 5.172 . . . . 0.0 110.085 179.909 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.99 91.05 3.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 126.895 2.622 . . . . 0.0 115.647 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.75 -122.42 6.59 Favored Glycine 0 C--O 1.208 -1.479 0 N-CA-C 103.692 -3.763 . . . . 0.0 103.692 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -130.96 53.51 1.97 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 109.157 -3.521 . . . . 0.0 106.012 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.272 0.2 OUTLIER 174.15 137.22 0.04 OUTLIER 'General case' 0 CA--C 1.562 1.413 1 O-C-N 130.434 4.834 . . . . 0.0 108.837 179.957 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.683 HD23 ' HG2' ' A' ' 100' ' ' GLN . 2.5 tt -111.63 120.09 40.9 Favored 'General case' 0 C--O 1.203 -1.343 1 O-C-N 130.795 5.06 . . . . 0.0 109.067 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.651 HG22 ' N ' ' A' ' 100' ' ' GLN . 11.6 mt -54.07 -84.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.413 -2.316 3 O-C-N 131.526 5.516 . . . . 0.0 108.852 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.683 ' HG2' HD23 ' A' ' 98' ' ' LEU . 12.0 mm-40 107.06 90.07 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.107 1 O-C-N 133.856 6.972 . . . . 0.0 104.039 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.482 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 18.5 m -96.48 84.34 3.68 Favored 'General case' 0 C--O 1.193 -1.892 2 O-C-N 133.571 6.794 . . . . 0.0 112.749 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.31 121.28 14.46 Favored 'General case' 0 C--O 1.218 -0.555 1 CA-C-N 107.862 -4.245 . . . . 0.0 106.871 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.444 ' O ' HD12 ' A' ' 88' ' ' ILE . 1.8 m -98.1 70.8 2.1 Favored 'General case' 0 C--N 1.36 1.061 1 O-C-N 130.704 5.002 . . . . 0.0 101.536 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -97.15 130.98 44.34 Favored 'General case' 0 C--N 1.362 1.127 1 CA-C-N 107.347 -4.479 . . . . 0.0 109.422 -179.994 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 34.8 28.98 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 117.194 2.294 . . . . 0.0 117.194 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.12 31.68 25.14 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 114.941 -3.504 . . . . 0.0 116.229 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 104' ' ' TYR . 63.4 t -109.0 -49.12 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 117.934 -1.507 . . . . 0.0 110.83 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.482 ' HG2' ' CG2' ' A' ' 101' ' ' THR . 8.1 tt0 79.07 31.83 0.28 Allowed 'General case' 0 C--N 1.35 0.604 0 O-C-N 127.431 2.957 . . . . 0.0 107.902 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.447 . . -62.42 166.71 4.85 Favored 'General case' 0 C--N 1.372 1.553 0 C-N-CA 113.296 -3.362 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 7.5 mttm -140.49 -48.45 0.43 Allowed 'General case' 0 N--CA 1.438 -1.043 1 O-C-N 131.909 5.756 . . . . 0.0 111.25 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.46 -158.38 0.19 Allowed 'General case' 0 C--O 1.202 -1.4 1 O-C-N 131.766 5.666 . . . . 0.0 104.446 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -162.78 115.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.47 1 C-N-CA 111.098 -4.241 . . . . 0.0 112.24 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 21.1 m-30 -109.97 174.34 5.91 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 131.102 5.251 . . . . 0.0 106.314 179.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.55 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 176.03 130.26 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.531 2 O-C-N 131.381 5.425 . . . . 0.0 114.109 -179.382 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 3.3 tttt -47.22 169.16 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 109.035 -3.712 . . . . 0.0 112.455 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 N--CA 1.423 -1.805 0 CA-C-N 111.48 -2.6 . . . . 0.0 113.032 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.021 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 98' ' ' LEU . 75.4 m-85 55.4 73.79 0.4 Allowed 'General case' 0 CA--C 1.556 1.176 1 O-C-N 129.507 4.254 . . . . 0.0 106.079 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -148.59 30.38 0.83 Allowed 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 128.052 3.345 . . . . 0.0 117.324 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -151.53 8.0 Favored Glycine 0 C--N 1.349 1.293 2 C-N-CA 112.933 -4.46 . . . . 0.0 103.707 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.595 HG22 ' OG1' ' A' ' 24' ' ' THR 0.296 0.6 OUTLIER -89.85 -176.55 4.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 128.367 3.039 . . . . 0.0 105.627 179.616 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.334 19.1 m95 -162.63 153.17 16.83 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-O 113.147 -3.311 . . . . 0.0 113.581 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 15.2 mtmt 63.14 176.59 0.15 Allowed 'General case' 0 N--CA 1.426 -1.629 1 O-C-N 131.769 5.668 . . . . 0.0 119.086 176.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.255 0.5 OUTLIER 55.82 102.71 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.479 -1.786 3 CA-C-O 135.442 7.306 . . . . 0.0 120.869 174.88 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.41 138.92 43.73 Favored 'General case' 0 C--N 1.375 1.713 1 CA-C-N 107.631 -4.349 . . . . 0.0 103.626 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? 58.13 65.5 1.28 Allowed 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.324 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -44.88 137.9 3.83 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 110.833 -2.894 . . . . 0.0 112.781 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -99.08 93.7 6.12 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.896 2.622 . . . . 0.0 107.68 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.29 42.71 1.27 Allowed 'General case' 0 C--N 1.356 0.868 0 O-C-N 127.631 3.082 . . . . 0.0 106.054 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -127.22 35.06 4.62 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 126.314 2.259 . . . . 0.0 109.683 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -135.3 174.71 10.31 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 127.977 3.298 . . . . 0.0 106.813 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.41 67.1 0.45 Allowed Glycine 0 CA--C 1.552 2.38 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.22 80.15 0.1 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.456 -1.872 . . . . 0.0 108.52 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -81.56 101.92 10.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.628 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.44 -42.05 0.16 Allowed 'General case' 0 C--N 1.354 0.797 0 O-C-N 127.379 2.924 . . . . 0.0 113.324 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.43 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 70.99 162.28 0.24 Allowed 'General case' 0 C--N 1.358 0.96 0 O-C-N 125.111 1.507 . . . . 0.0 108.098 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -157.61 -163.93 1.45 Allowed 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 110.523 -3.035 . . . . 0.0 106.293 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HG3' ' HD3' ' A' ' 35' ' ' LYS 0.447 0.0 OUTLIER 150.6 174.15 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.682 1 O-C-N 129.504 4.253 . . . . 0.0 102.383 -179.161 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HD11 ' A' ' 25' ' ' ILE . 2.6 mt -119.12 163.62 16.76 Favored 'General case' 0 CA--C 1.557 1.249 3 O-C-N 132.515 6.134 . . . . 0.0 98.742 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.595 ' OG1' HG22 ' A' ' 5' ' ' THR . 52.9 m 179.85 96.03 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.238 1 O-C-N 133.902 7.001 . . . . 0.0 108.278 -179.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.839 HD11 HD22 ' A' ' 23' ' ' LEU . 4.7 mp -117.28 140.47 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.193 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -164.78 84.84 0.41 Allowed 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 128.494 3.621 . . . . 0.0 107.539 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -46.06 138.36 5.23 Favored 'General case' 0 N--CA 1.438 -1.052 2 O-C-N 132.943 6.402 . . . . 0.0 110.019 179.482 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -89.47 4.58 48.66 Favored 'General case' 0 C--N 1.343 0.286 1 O-C-N 130.068 4.605 . . . . 0.0 107.457 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.21 -58.46 0.61 Allowed Glycine 0 CA--C 1.55 2.246 2 N-CA-C 100.826 -4.91 . . . . 0.0 100.826 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.61 -10.46 4.0 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 108.785 -3.708 . . . . 0.0 109.062 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -91.45 169.52 10.71 Favored 'General case' 0 C--N 1.306 -1.308 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.824 ' CE1' HG21 ' A' ' 25' ' ' ILE . 31.6 t80 -165.91 71.97 0.15 Allowed 'General case' 0 C--O 1.192 -1.942 1 N-CA-C 95.501 -5.74 . . . . 0.0 95.501 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -71.89 137.01 47.13 Favored 'General case' 0 CA--C 1.503 -0.856 2 O-C-N 133.717 6.886 . . . . 0.0 102.831 -179.883 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.372 0.5 OUTLIER -114.46 144.34 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 1 N-CA-C 99.774 -4.158 . . . . 0.0 99.774 179.248 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -101.55 58.79 0.86 Allowed 'General case' 0 N--CA 1.422 -1.858 1 CA-C-O 133.491 6.377 . . . . 0.0 117.924 -179.953 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -73.34 47.19 0.21 Allowed 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 108.92 -3.764 . . . . 0.0 110.151 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 30.8 t -58.05 138.04 56.35 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 116.017 -2.273 . . . . 0.0 108.343 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.54 127.91 0.14 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 114.737 -2.785 . . . . 0.0 114.746 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.05 -65.7 0.25 Allowed 'General case' 0 C--O 1.223 -0.298 0 O-C-N 128.972 3.92 . . . . 0.0 111.418 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 40.3 m-85 -120.55 102.16 8.25 Favored 'General case' 0 C--O 1.203 -1.393 0 O-C-N 127.861 3.226 . . . . 0.0 112.619 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.1 OUTLIER 61.47 -173.01 0.14 Allowed 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 126.722 2.513 . . . . 0.0 117.248 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -90.23 -20.4 23.04 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 126.671 2.482 . . . . 0.0 109.159 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 43' ' ' ILE 0.282 5.9 tp 6.84 77.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.427 2 O-C-N 133.312 6.633 . . . . 0.0 111.344 178.845 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.75 148.74 6.96 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 119.494 -2.004 . . . . 0.0 111.161 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.9 t -110.14 98.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 O-C-N 128.177 3.423 . . . . 0.0 104.267 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.578 HG22 ' N ' ' A' ' 47' ' ' PHE 0.285 8.1 p -106.64 164.62 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 113.662 -3.215 . . . . 0.0 116.072 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' N ' HG22 ' A' ' 46' ' ' VAL . 1.7 p90 -171.74 -161.79 0.2 Allowed 'General case' 0 N--CA 1.442 -0.862 1 O-C-N 129.976 4.547 . . . . 0.0 110.722 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -142.76 85.16 1.87 Allowed 'General case' 0 C--N 1.363 1.17 0 O-C-N 127.056 2.722 . . . . 0.0 115.373 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.73 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 18.22 94.76 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 131.261 5.351 . . . . 0.0 116.715 -179.941 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 92.41 46.72 3.44 Favored Glycine 0 C--O 1.207 -1.575 0 CA-C-O 114.209 -3.551 . . . . 0.0 104.95 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 t -134.89 118.53 25.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 1 O-C-N 130.315 4.185 . . . . 0.0 112.696 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.81 159.85 26.35 Favored 'General case' 0 C--O 1.209 -1.05 0 C-N-CA 115.477 -2.489 . . . . 0.0 109.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -173.23 165.57 4.84 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 130.625 4.953 . . . . 0.0 113.376 -179.822 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -125.57 89.98 3.13 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -85.13 144.57 28.12 Favored 'General case' 0 C--O 1.209 -1.048 0 C-N-CA 116.082 -2.247 . . . . 0.0 113.341 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -106.51 71.38 0.86 Allowed 'General case' 0 CA--C 1.555 1.169 1 O-C-N 129.682 4.363 . . . . 0.0 103.018 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -38.06 -81.19 0.01 OUTLIER 'General case' 0 C--O 1.238 0.46 1 O-C-N 131.839 5.712 . . . . 0.0 114.239 -179.982 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.84 -101.45 0.03 OUTLIER 'General case' 0 C--O 1.247 0.972 0 CA-C-O 115.305 -2.284 . . . . 0.0 112.107 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.94 4.65 8.02 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 126.578 2.424 . . . . 0.0 111.844 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.59 53.65 0.03 OUTLIER Glycine 0 CA--C 1.549 2.203 0 CA-C-O 115.59 -2.784 . . . . 0.0 109.769 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.1 p -92.09 -64.93 1.05 Allowed 'General case' 0 CA--C 1.551 1.005 0 O-C-N 128.52 3.13 . . . . 0.0 107.352 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER 81.47 32.99 0.11 Allowed 'General case' 0 N--CA 1.448 -0.56 1 O-C-N 129.564 4.29 . . . . 0.0 111.076 177.619 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD23 ' CG ' ' A' ' 78' ' ' PHE . 2.7 mp -62.54 82.24 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.105 0 O-C-N 126.371 2.295 . . . . 0.0 110.807 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 62.3 m -69.15 117.47 10.83 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.78 -154.1 6.15 Favored Glycine 0 C--O 1.209 -1.434 1 C-N-CA 109.99 -5.862 . . . . 0.0 108.136 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.671 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 11.5 t 172.09 129.44 0.02 OUTLIER 'General case' 0 C--O 1.248 1.024 1 O-C-N 134.498 6.646 . . . . 0.0 111.861 -178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 69.9 m95 -136.76 128.76 29.41 Favored 'General case' 0 C--O 1.203 -1.359 1 O-C-N 116.194 -4.066 . . . . 0.0 106.283 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.456 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -111.42 31.85 5.81 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.432 4.832 . . . . 0.0 117.197 -177.988 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.73 ' CB ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 2.29 101.18 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.916 1 O-C-N 133.388 6.68 . . . . 0.0 109.611 179.377 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 72' ' ' ASN . 1.1 mm-40 -108.45 95.2 5.5 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 129.092 3.995 . . . . 0.0 112.171 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.32 -91.74 0.09 OUTLIER Glycine 0 C--N 1.353 1.51 1 O-C-N 129.55 4.281 . . . . 0.0 108.979 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -136.69 46.57 2.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 129.153 3.502 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 5.2 mtpt -129.33 163.04 26.58 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 128.843 3.84 . . . . 0.0 110.785 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.452 HD12 HD11 ' A' ' 98' ' ' LEU . 8.2 mt -141.74 68.38 1.33 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 127.226 2.829 . . . . 0.0 112.186 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.5 t -92.49 83.15 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.124 2 O-C-N 131.044 5.215 . . . . 0.0 111.01 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 67' ' ' TRP . . . -150.57 -177.66 24.7 Favored Glycine 0 CA--C 1.555 2.575 2 CA-C-N 106.994 -4.639 . . . . 0.0 102.695 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' N ' ' CZ2' ' A' ' 67' ' ' TRP 0.308 0.3 OUTLIER -155.14 168.69 26.2 Favored 'General case' 0 C--O 1.204 -1.32 1 O-C-N 132.758 5.623 . . . . 0.0 112.083 -179.733 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 m-85 -148.18 166.85 26.66 Favored 'General case' 0 C--O 1.19 -2.033 1 CA-C-O 128.943 4.211 . . . . 0.0 104.052 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLU . 5.0 ttpt -173.14 132.81 0.51 Allowed 'General case' 0 N--CA 1.418 -2.059 1 CA-C-N 104.428 -5.805 . . . . 0.0 117.992 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -100.88 38.21 1.59 Allowed 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 126.512 2.383 . . . . 0.0 114.281 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.606 HG22 ' N ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 7.02 -67.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.999 1 O-C-N 131.772 5.67 . . . . 0.0 115.041 179.832 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.606 ' N ' HG22 ' A' ' 81' ' ' VAL . 9.9 t0 -42.59 -26.01 0.11 Allowed 'General case' 0 N--CA 1.443 -0.808 1 O-C-N 130.248 4.717 . . . . 0.0 112.543 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -176.11 -16.45 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 113.954 -3.098 . . . . 0.0 117.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' HA3' ' HG3' ' A' ' 80' ' ' ARG . . . -97.79 -32.75 6.09 Favored Glycine 0 CA--C 1.548 2.147 1 C-N-CA 112.98 -4.438 . . . . 0.0 104.226 -178.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.87 -157.85 0.06 Allowed 'General case' 0 C--O 1.25 1.089 1 O-C-N 131.672 4.983 . . . . 0.0 113.416 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.621 ' N ' ' HD3' ' A' ' 79' ' ' LYS 0.347 0.0 OUTLIER -61.88 133.46 55.46 Favored 'General case' 0 C--O 1.198 -1.638 1 O-C-N 129.534 4.271 . . . . 0.0 114.745 -177.598 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.478 HD12 ' HG2' ' A' ' 80' ' ' ARG 0.255 2.4 mt -136.68 38.45 2.63 Favored 'General case' 0 C--O 1.208 -1.132 1 O-C-N 136.145 8.403 . . . . 0.0 109.641 -179.697 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 103' ' ' THR . 90.7 mt -61.83 163.5 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.707 1 CA-C-N 107.239 -4.528 . . . . 0.0 102.608 179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.99 67.98 1.33 Allowed 'General case' 0 C--O 1.211 -0.939 1 O-C-N 134.47 7.356 . . . . 0.0 105.45 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -67.64 131.34 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-N 111.824 -2.444 . . . . 0.0 108.962 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.484 ' HD3' ' HG3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -152.4 -158.25 0.88 Allowed 'General case' 0 N--CA 1.435 -1.209 1 C-N-CA 110.856 -4.338 . . . . 0.0 112.311 179.771 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' HG3' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 166.48 79.17 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.318 1 O-C-N 130.592 4.933 . . . . 0.0 105.265 -178.593 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 0.4 OUTLIER -24.08 92.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.962 1 O-C-N 132.383 6.052 . . . . 0.0 113.785 -179.419 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 p -53.07 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.102 1 O-C-N 129.261 4.101 . . . . 0.0 116.36 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -112.63 0.74 Allowed Glycine 0 CA--C 1.559 2.795 0 C-N-CA 115.633 -3.175 . . . . 0.0 106.46 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -117.38 46.19 1.76 Allowed 'General case' 0 C--N 1.362 1.133 1 CA-C-N 106.937 -4.632 . . . . 0.0 109.14 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.568 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -172.48 152.52 2.67 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 128.316 3.51 . . . . 0.0 106.863 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD22 ' HG2' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -104.32 107.37 18.25 Favored 'General case' 0 C--O 1.204 -1.306 2 O-C-N 132.321 6.013 . . . . 0.0 108.147 179.532 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.747 HG12 HG22 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -56.26 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.891 2 O-C-N 134.696 7.498 . . . . 0.0 103.287 -179.998 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.552 ' HG2' HD22 ' A' ' 98' ' ' LEU . 7.7 mm-40 99.45 98.1 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.079 1 O-C-N 130.257 4.723 . . . . 0.0 103.263 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.715 HG23 ' HG2' ' A' ' 110' ' ' LYS . 20.8 m -100.96 95.46 6.61 Favored 'General case' 0 C--O 1.195 -1.812 2 O-C-N 130.529 4.893 . . . . 0.0 111.236 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 82.2 m-85 -66.97 131.28 45.55 Favored 'General case' 0 C--O 1.202 -1.408 3 CA-C-N 106.411 -4.904 . . . . 0.0 106.481 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 88' ' ' ILE . 90.5 m -111.94 80.1 1.29 Allowed 'General case' 0 C--O 1.199 -1.553 1 O-C-N 131.824 5.702 . . . . 0.0 107.021 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -101.09 154.73 18.48 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 108.705 -3.862 . . . . 0.0 110.649 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 14.3 mm-40 -32.65 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.559 ' O ' HG13 ' A' ' 107' ' ' VAL . . . 88.88 10.15 67.19 Favored Glycine 0 C--N 1.357 1.727 0 C-N-CA 115.752 -3.118 . . . . 0.0 116.851 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -158.02 173.36 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 CA-C-O 115.975 -1.964 . . . . 0.0 114.657 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.67 58.45 1.61 Allowed 'General case' 0 C--N 1.353 0.752 1 O-C-N 131.491 5.495 . . . . 0.0 107.067 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.321 . . -80.56 121.63 26.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 O-C-N 128.42 3.575 . . . . 0.0 111.059 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG2' HG23 ' A' ' 101' ' ' THR . 11.4 mttt -104.28 179.61 4.22 Favored 'General case' 0 N--CA 1.426 -1.666 1 O-C-N 133.718 6.886 . . . . 0.0 108.536 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -159.14 135.82 9.38 Favored 'General case' 0 CA--C 1.562 1.406 2 O-C-N 130.131 4.644 . . . . 0.0 99.014 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.747 HG22 HG12 ' A' ' 99' ' ' ILE . 1.2 pt -111.23 111.47 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 1 O-C-N 132.2 5.938 . . . . 0.0 114.039 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.524 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 93.0 m-85 -109.63 -142.18 0.38 Allowed 'General case' 0 CA--C 1.559 1.321 1 O-C-N 131.48 5.488 . . . . 0.0 101.901 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.51 -149.94 0.06 Allowed 'General case' 0 C--O 1.205 -1.25 1 O-C-N 132.9 6.375 . . . . 0.0 111.417 179.56 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.674 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.2 tttt -131.63 -175.68 3.79 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-O 124.997 2.332 . . . . 0.0 112.616 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.204 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 122.098 0.952 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' HB2' ' NE2' ' A' ' 27' ' ' GLN . 1.4 m-85 -169.72 79.24 0.11 Allowed 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 110.203 -3.18 . . . . 0.0 103.733 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -170.06 59.44 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.959 0 C-N-CA 114.4 -2.92 . . . . 0.0 114.953 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.19 48.4 0.03 OUTLIER Glycine 0 CA--C 1.53 0.978 1 C-N-CA 111.366 -5.206 . . . . 0.0 107.24 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 34.8 p 59.22 162.85 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.814 1 O-C-N 132.269 5.334 . . . . 0.0 111.479 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.285 8.4 m95 -157.38 149.06 22.15 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 116.328 -1.796 . . . . 0.0 114.079 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HD2' ' HB3' ' A' ' 113' ' ' PHE . 38.4 mtmt 59.71 178.96 0.09 Allowed 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 21' ' ' LEU 0.257 0.5 OUTLIER 39.07 148.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.481 -1.674 3 O-C-N 134.061 7.101 . . . . 0.0 120.693 174.864 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.33 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 CA-C-N 107.644 -4.343 . . . . 0.0 108.141 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -43.1 132.64 4.08 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.9 152.01 11.02 Favored 'General case' 0 C--O 1.206 -1.188 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.812 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.83 -159.11 0.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -84.52 70.95 10.78 Favored 'General case' 0 CA--C 1.541 0.625 1 O-C-N 129.6 4.313 . . . . 0.0 102.688 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.36 167.68 0.31 Allowed 'General case' 0 C--O 1.215 -0.732 0 O-C-N 128.508 3.63 . . . . 0.0 105.283 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 t 65.91 -153.38 0.25 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.63 153.72 5.95 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 127.665 3.103 . . . . 0.0 112.36 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.56 53.2 0.75 Allowed 'General case' 0 C--O 1.242 0.692 0 CA-C-N 112.05 -2.075 . . . . 0.0 107.468 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -158.66 136.86 10.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 126.142 2.151 . . . . 0.0 111.529 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.47 94.17 9.33 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 116.166 -1.873 . . . . 0.0 109.617 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.761 ' C ' HD23 ' A' ' 21' ' ' LEU . 25.5 p-10 -108.21 161.76 14.69 Favored 'General case' 0 CA--C 1.561 1.403 1 O-C-N 130.153 4.658 . . . . 0.0 113.193 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -146.66 -178.72 6.33 Favored 'General case' 0 CA--C 1.553 1.088 1 O-C-N 129.511 4.257 . . . . 0.0 104.586 -179.976 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.396 0.0 OUTLIER -147.12 140.2 25.23 Favored 'General case' 0 CA--C 1.566 1.569 1 O-C-N 131.029 5.205 . . . . 0.0 100.612 179.687 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.0 mt -98.4 164.39 12.3 Favored 'General case' 0 C--N 1.318 -0.799 2 O-C-N 133.072 6.482 . . . . 0.0 98.811 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.61 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 20.8 m 174.04 89.22 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 O-C-N 128.882 3.864 . . . . 0.0 104.155 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.829 HG21 ' CE1' ' A' ' 32' ' ' PHE 0.263 4.4 mp -111.05 152.86 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 108.533 -3.94 . . . . 0.0 110.809 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.0 m -162.34 80.22 0.52 Allowed 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 114.134 -3.026 . . . . 0.0 108.045 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.43 ' NE2' ' HB2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -52.35 124.0 12.24 Favored 'General case' 0 C--O 1.214 -0.814 2 O-C-N 132.996 6.435 . . . . 0.0 110.992 179.6 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -116.84 111.0 19.08 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 128.608 3.692 . . . . 0.0 103.229 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 -114.17 4.43 Favored Glycine 0 CA--C 1.546 2.026 1 N-CA-C 101.69 -4.564 . . . . 0.0 101.69 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 62.99 1.07 Allowed 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 127.338 2.434 . . . . 0.0 107.38 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -133.05 161.87 33.22 Favored 'General case' 0 C--N 1.306 -1.312 1 N-CA-C 98.936 -4.468 . . . . 0.0 98.936 -179.842 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.829 ' CE1' HG21 ' A' ' 25' ' ' ILE . 69.1 t80 -158.0 72.9 0.66 Allowed 'General case' 0 C--O 1.193 -1.918 1 N-CA-C 99.439 -4.282 . . . . 0.0 99.439 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -72.78 139.43 47.07 Favored 'General case' 0 CA--C 1.505 -0.761 2 O-C-N 131.784 5.677 . . . . 0.0 103.827 179.933 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.383 0.5 OUTLIER -120.13 137.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 128.782 3.802 . . . . 0.0 101.427 179.915 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 8.2 tttm -87.52 17.85 4.3 Favored 'General case' 0 N--CA 1.414 -2.228 1 N-CA-C 121.871 4.026 . . . . 0.0 121.871 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.53 ' HG2' HG12 ' A' ' 34' ' ' VAL . 7.3 pt-20 -49.68 91.99 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 124.727 2.204 . . . . 0.0 110.385 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.601 ' O ' HD13 ' A' ' 21' ' ' LEU . 2.0 t -77.03 152.82 34.97 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 116.406 -2.117 . . . . 0.0 109.299 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.98 102.09 0.09 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 114.867 -2.733 . . . . 0.0 116.077 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 60.7 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 1 O-C-N 129.574 4.296 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 58' ' ' ALA . 1.1 m-85 -78.18 91.45 4.35 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 115.59 -2.444 . . . . 0.0 110.695 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.29 -160.76 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 129.198 4.061 . . . . 0.0 115.757 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.77 -7.69 45.83 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 127.034 2.709 . . . . 0.0 108.205 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.8 tp 11.8 91.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.42 2 O-C-N 132.885 6.366 . . . . 0.0 111.909 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.63 123.35 17.66 Favored 'General case' 0 C--N 1.369 1.433 0 O-C-N 118.219 -2.8 . . . . 0.0 111.071 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG12 ' HE1' ' A' ' 47' ' ' PHE . 46.1 t -88.07 106.29 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 2 O-C-N 130.08 4.613 . . . . 0.0 100.014 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.312 10.7 p -118.0 153.51 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 O-C-N 127.444 2.965 . . . . 0.0 114.149 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HE1' HG12 ' A' ' 45' ' ' VAL . 2.2 p90 -179.32 -165.63 0.08 Allowed 'General case' 0 N--CA 1.429 -1.521 1 O-C-N 132.357 6.035 . . . . 0.0 111.132 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.75 73.53 1.41 Allowed 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 116.571 -2.052 . . . . 0.0 108.638 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.2 OUTLIER 69.59 -79.22 0.04 OUTLIER 'General case' 0 C--O 1.198 -1.615 2 O-C-N 132.499 6.125 . . . . 0.0 111.666 179.988 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.666 ' HA2' HG22 ' A' ' 68' ' ' THR . . . -127.91 84.09 0.33 Allowed Glycine 0 CA--C 1.537 1.437 0 N-CA-C 104.665 -3.374 . . . . 0.0 104.665 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.12 -40.74 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 O-C-N 131.341 4.789 . . . . 0.0 111.641 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.86 125.22 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.935 2 O-C-N 133.013 6.446 . . . . 0.0 108.368 179.906 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 3.3 p90 -167.25 140.6 3.55 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 112.311 -3.756 . . . . 0.0 115.37 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -90.76 151.21 21.3 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 100.846 -3.761 . . . . 0.0 100.846 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.472 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -170.51 135.1 1.16 Allowed 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 112.236 -3.786 . . . . 0.0 109.956 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 91.21 8.23 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 114.456 -2.688 . . . . 0.0 105.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 55' ' ' TYR . 10.5 mp -68.87 -96.11 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 1 O-C-N 129.544 4.277 . . . . 0.0 114.24 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 40' ' ' PHE . . . -46.66 -83.28 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 126.587 2.429 . . . . 0.0 116.185 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -132.0 14.17 4.75 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 124.939 1.399 . . . . 0.0 112.739 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.66 58.68 0.09 OUTLIER Glycine 0 CA--C 1.544 1.858 0 N-CA-C 105.544 -3.022 . . . . 0.0 105.544 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.82 ' HB ' HD13 ' A' ' 63' ' ' LEU . 71.7 p -67.3 -60.57 2.48 Favored 'General case' 0 N--CA 1.425 -1.722 1 O-C-N 131.755 5.032 . . . . 0.0 110.126 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 65.73 46.71 2.29 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 125.487 1.742 . . . . 0.0 108.532 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.82 HD13 ' HB ' ' A' ' 61' ' ' THR . 5.2 mp -99.84 84.12 2.85 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 127.66 3.1 . . . . 0.0 107.644 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 22.8 m -70.04 105.85 3.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 111.362 -2.654 . . . . 0.0 110.286 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -166.31 -156.42 9.48 Favored Glycine 0 CA--C 1.557 2.681 1 C-N-CA 111.954 -4.927 . . . . 0.0 104.314 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CE1' ' A' ' 78' ' ' PHE 0.26 8.8 t -161.27 135.54 7.02 Favored 'General case' 0 CA--C 1.491 -1.29 1 O-C-N 131.793 5.055 . . . . 0.0 114.481 179.525 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.744 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 9.4 m95 -115.03 97.66 6.35 Favored 'General case' 0 C--O 1.192 -1.96 0 O-C-N 117.839 -3.038 . . . . 0.0 104.553 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.666 HG22 ' HA2' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -101.16 97.36 7.9 Favored 'General case' 0 N--CA 1.447 -0.609 2 O-C-N 137.421 9.201 . . . . 0.0 114.879 179.952 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.596 ' HB3' HD21 ' A' ' 49' ' ' LEU . 3.6 ttp -56.69 109.53 0.64 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 128.974 3.922 . . . . 0.0 105.402 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 73' ' ' LYS . 28.9 tt0 -101.68 65.12 1.01 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.158 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.33 -105.78 0.79 Allowed Glycine 0 CA--C 1.551 2.327 0 O-C-N 128.817 3.823 . . . . 0.0 103.924 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.78 62.7 2.72 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 128.63 3.194 . . . . 0.0 109.041 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -172.23 179.14 2.67 Favored 'General case' 0 C--N 1.358 0.955 1 O-C-N 129.678 4.361 . . . . 0.0 109.95 179.934 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 74' ' ' LEU . 2.5 mt -157.6 74.54 0.75 Allowed 'General case' 0 CA--C 1.485 -1.536 0 O-C-N 127.272 2.857 . . . . 0.0 112.191 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.58 134.03 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.037 -2.347 . . . . 0.0 116.036 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 173.78 -166.1 38.18 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 103.745 -3.742 . . . . 0.0 103.745 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 88' ' ' ILE 0.251 12.5 tttm 176.65 117.67 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.348 1 O-C-N 133.822 6.248 . . . . 0.0 113.345 179.997 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.744 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.1 OUTLIER -114.59 171.5 7.6 Favored 'General case' 0 C--O 1.192 -1.932 0 O-C-N 128.768 3.793 . . . . 0.0 101.335 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.338 0.0 OUTLIER -170.43 142.1 2.07 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 108.922 -3.763 . . . . 0.0 115.061 -179.001 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.513 ' CB ' ' HB3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -91.63 106.08 18.22 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 118.295 -1.362 . . . . 0.0 108.887 179.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -62.65 -16.82 17.59 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 1 O-C-N 130.777 5.048 . . . . 0.0 109.674 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.04 -36.27 72.27 Favored 'General case' 0 C--O 1.252 1.206 0 O-C-N 129.091 3.994 . . . . 0.0 111.677 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -122.9 3.95 9.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 126.747 2.529 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 69.17 43.28 72.38 Favored Glycine 0 CA--C 1.558 2.746 2 N-CA-C 100.863 -4.895 . . . . 0.0 100.863 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -105.08 132.19 51.63 Favored 'General case' 0 N--CA 1.44 -0.946 2 CA-C-N 105.617 -5.291 . . . . 0.0 115.429 -179.539 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 6.2 mt-10 -110.16 139.6 45.14 Favored 'General case' 0 C--O 1.199 -1.554 0 CA-C-N 121.344 1.884 . . . . 0.0 107.844 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.7 45.44 2.81 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 133.031 6.457 . . . . 0.0 110.28 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 77' ' ' LYS . 96.9 mt -68.81 168.03 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.949 1 CA-C-N 107.929 -4.214 . . . . 0.0 103.592 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB3' ' CZ3' ' A' ' 67' ' ' TRP . . . -143.22 107.7 4.81 Favored 'General case' 0 C--O 1.195 -1.803 1 O-C-N 130.83 5.081 . . . . 0.0 105.587 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 t -110.87 106.95 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 O-C-N 128.645 3.716 . . . . 0.0 102.519 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -156.08 162.5 40.27 Favored 'General case' 0 C--O 1.189 -2.111 1 C-N-CA 110.411 -4.516 . . . . 0.0 116.136 -179.535 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.16 136.86 20.4 Favored 'General case' 0 N--CA 1.439 -1.015 2 O-C-N 132.84 6.337 . . . . 0.0 109.8 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.2 mm -47.55 124.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 1 O-C-N 131.891 5.744 . . . . 0.0 110.177 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 p -126.43 101.43 6.69 Favored 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 128.526 3.641 . . . . 0.0 117.297 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.94 39.05 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 107.212 -2.355 . . . . 0.0 107.212 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 59.32 44.15 15.73 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 111.637 -2.282 . . . . 0.0 110.593 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.672 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.265 0.1 OUTLIER -158.71 157.64 32.16 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 114.621 -2.609 . . . . 0.0 108.309 179.063 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.469 ' CD2' ' HG2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -113.65 141.32 47.35 Favored 'General case' 0 C--O 1.208 -1.11 1 O-C-N 133.733 6.896 . . . . 0.0 109.187 179.894 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.29 5.0 mt -105.55 -46.35 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 1 O-C-N 129.302 4.126 . . . . 0.0 107.621 -179.863 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HG2' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 63.2 100.5 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.142 1 O-C-N 129.58 4.3 . . . . 0.0 104.366 -179.367 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 m -98.55 96.76 8.19 Favored 'General case' 0 N--CA 1.427 -1.594 2 O-C-N 130.604 4.94 . . . . 0.0 111.949 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -71.28 126.15 28.86 Favored 'General case' 0 C--O 1.202 -1.438 1 CA-C-N 107.422 -4.445 . . . . 0.0 105.227 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.7 m -103.63 68.02 0.92 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 100.75 -3.796 . . . . 0.0 100.75 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -84.19 132.67 34.65 Favored 'General case' 0 CA--C 1.493 -1.213 1 CA-C-N 106.436 -4.893 . . . . 0.0 117.187 -179.63 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 44.58 31.72 0.66 Allowed 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.94 6.46 67.1 Favored Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 117.939 -2.077 . . . . 0.0 112.673 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.73 148.08 21.84 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 CA-C-O 116.615 -1.66 . . . . 0.0 111.833 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -107.12 107.76 18.89 Favored 'General case' 0 C--N 1.371 1.517 1 O-C-N 129.116 4.01 . . . . 0.0 107.441 -179.671 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.429 . . -135.52 137.29 41.93 Favored 'General case' 0 N--CA 1.417 -2.093 1 O-C-N 130.053 4.596 . . . . 0.0 112.446 179.846 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 175.98 8.86 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 130.612 4.945 . . . . 0.0 110.479 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . 37.9 mtt85 -141.24 130.36 23.39 Favored 'General case' 0 N--CA 1.48 1.059 2 O-C-N 129.861 4.476 . . . . 0.0 99.627 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 134.28 28.03 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.24 0 C-N-CA 114.359 -2.936 . . . . 0.0 112.84 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HD2' ' A' ' 7' ' ' LYS . 2.6 m-85 -147.95 -157.13 0.78 Allowed 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 131.199 5.312 . . . . 0.0 107.37 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.672 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -166.94 -144.21 0.06 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 131.802 5.689 . . . . 0.0 112.061 -179.737 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 10.4 tttt -128.99 -171.74 2.55 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.816 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -104.15 -31.35 9.68 Favored 'General case' 0 C--O 1.22 -0.462 1 O-C-N 130.221 4.701 . . . . 0.0 108.086 -179.831 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.21 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.822 0 O-C-N 127.163 2.789 . . . . 0.0 117.8 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 24' ' ' THR . . . 171.06 171.78 36.64 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 114.68 -3.628 . . . . 0.0 106.029 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -97.14 153.57 17.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 114.747 -2.781 . . . . 0.0 103.735 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.661 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 18.0 m95 -126.87 170.59 12.07 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 111.845 -3.931 . . . . 0.0 112.58 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.1 mtmt 43.58 -178.71 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.851 1 O-C-N 130.747 5.029 . . . . 0.0 117.366 179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.277 1.2 t 26.51 114.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.595 2 O-C-N 131.522 5.513 . . . . 0.0 118.013 174.982 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.32 121.35 40.19 Favored 'General case' 0 C--N 1.373 1.588 0 O-C-N 118.577 -2.577 . . . . 0.0 110.345 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 56.85 -174.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.32 -64.03 0.22 Allowed 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.432 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 64.36 20.45 12.17 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 127.715 3.134 . . . . 0.0 110.782 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 p30 31.67 55.02 0.28 Allowed 'General case' 0 N--CA 1.452 -0.353 1 O-C-N 130.621 4.95 . . . . 0.0 109.133 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.47 -16.32 14.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 110.859 -2.882 . . . . 0.0 112.863 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 85.5 p -131.67 133.2 44.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.72 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.03 142.43 7.68 Favored Glycine 0 CA--C 1.543 1.844 0 O-C-N 128.308 3.505 . . . . 0.0 109.591 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.57 101.21 0.05 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 129.021 3.424 . . . . 0.0 107.54 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -43.1 -51.55 5.81 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 128.681 3.738 . . . . 0.0 108.747 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 54.37 86.62 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 112.389 -2.187 . . . . 0.0 113.019 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' LYS . 3.0 m-20 -85.11 -57.9 2.9 Favored 'General case' 0 CA--C 1.561 1.404 0 O-C-N 127.67 3.106 . . . . 0.0 108.976 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 53.76 -89.76 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.526 1 O-C-N 130.667 4.979 . . . . 0.0 101.413 179.946 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 61.22 149.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 134.048 7.092 . . . . 0.0 105.825 179.224 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.534 HD11 HE21 ' A' ' 100' ' ' GLN . 5.6 mt -124.93 172.75 9.13 Favored 'General case' 0 N--CA 1.436 -1.146 3 CA-C-N 106.285 -4.961 . . . . 0.0 99.067 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 18.0 m -168.21 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 1 O-C-N 129.429 4.206 . . . . 0.0 108.553 -179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 2' ' ' PHE . 1.9 mp 72.14 137.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 109.202 -3.635 . . . . 0.0 109.557 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 m -170.11 73.56 0.07 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HG3' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -52.35 145.29 11.37 Favored 'General case' 0 C--O 1.207 -1.177 2 O-C-N 133.307 6.63 . . . . 0.0 114.662 179.678 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -127.07 62.07 1.34 Allowed 'General case' 0 C--N 1.358 0.962 1 O-C-N 131.921 5.763 . . . . 0.0 104.361 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.45 57.01 0.81 Allowed Glycine 0 CA--C 1.552 2.357 1 C-N-CA 112.21 -4.805 . . . . 0.0 103.873 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 53.17 14.09 0.46 Allowed 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 112.733 -3.508 . . . . 0.0 110.6 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 84.27 5.77 Favored 'General case' 0 CA--C 1.55 0.976 1 N-CA-C 98.671 -4.566 . . . . 0.0 98.671 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.601 ' HB2' ' CE2' ' A' ' 47' ' ' PHE . 6.3 m-85 -82.12 142.38 32.3 Favored 'General case' 0 CA--C 1.562 1.415 1 N-CA-C 96.646 -5.316 . . . . 0.0 96.646 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.83 112.99 15.36 Favored 'General case' 0 N--CA 1.482 1.155 3 O-C-N 137.527 9.267 . . . . 0.0 97.421 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 36' ' ' GLU 0.383 1.2 t -80.32 149.87 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 1 C-N-CA 111.01 -4.276 . . . . 0.0 104.764 179.934 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.286 0.7 OUTLIER -85.15 2.86 41.76 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 109.275 -3.602 . . . . 0.0 120.317 179.622 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -47.98 109.07 0.19 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 110.25 -3.159 . . . . 0.0 108.359 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -103.57 126.87 50.98 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 127.202 2.814 . . . . 0.0 107.595 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -152.46 -160.61 1.16 Allowed 'General case' 0 C--O 1.24 0.595 0 O-C-N 126.889 2.618 . . . . 0.0 112.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.25 -89.05 0.03 OUTLIER 'General case' 0 C--O 1.203 -1.385 0 CA-C-N 112.226 -2.261 . . . . 0.0 107.351 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.34 45.18 0.07 Allowed 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 113.732 -3.187 . . . . 0.0 108.973 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER 170.71 -164.35 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.959 1 O-C-N 133.573 6.796 . . . . 0.0 111.834 -179.912 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.48 121.12 44.31 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 1.9 tt -148.65 91.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.137 2 O-C-N 130.093 4.62 . . . . 0.0 109.378 -179.16 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.3 142.85 54.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 108.9 -3.773 . . . . 0.0 110.182 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 HD13 ' A' ' 57' ' ' LEU . 20.8 t -105.05 99.19 7.94 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.264 2 O-C-N 131.413 5.446 . . . . 0.0 99.876 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.338 3.6 p -101.56 168.07 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 112.393 -3.723 . . . . 0.0 115.656 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.8 OUTLIER -164.85 163.13 21.18 Favored 'General case' 0 N--CA 1.434 -1.266 1 O-C-N 130.861 5.101 . . . . 0.0 112.583 -179.506 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.09 28.91 6.33 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 115.546 -2.462 . . . . 0.0 114.699 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 0.8 OUTLIER 61.7 86.61 0.11 Allowed 'General case' 0 N--CA 1.441 -0.899 1 O-C-N 130.483 4.864 . . . . 0.0 115.811 179.931 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 76.24 75.0 0.9 Allowed Glycine 0 C--O 1.199 -2.046 0 N-CA-C 104.496 -3.441 . . . . 0.0 104.496 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.61 -42.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.62 1 O-C-N 130.678 4.399 . . . . 0.0 116.378 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 0.7 OUTLIER 78.44 126.85 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.132 1 O-C-N 129.408 4.193 . . . . 0.0 111.52 179.939 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -161.19 151.73 17.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 113.635 -3.226 . . . . 0.0 115.069 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -109.09 118.43 36.75 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 101.346 -3.575 . . . . 0.0 101.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.7 138.52 28.94 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 114.958 -2.697 . . . . 0.0 111.484 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.32 98.2 10.41 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 128.616 3.698 . . . . 0.0 106.822 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 10.4 mt -84.28 139.26 32.45 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 126.902 2.626 . . . . 0.0 112.378 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 57' ' ' LEU . . . 55.97 5.02 0.14 Allowed 'General case' 0 C--O 1.247 0.954 0 O-C-N 127.252 2.845 . . . . 0.0 114.842 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.21 -39.48 0.36 Allowed 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.42 -40.71 7.23 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 115.336 -2.924 . . . . 0.0 107.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -79.11 150.73 31.7 Favored 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 130.208 4.123 . . . . 0.0 110.546 -179.88 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' HB2' HG12 ' A' ' 81' ' ' VAL . 17.7 mt-10 -153.49 68.26 0.78 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 113.278 -3.369 . . . . 0.0 106.418 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 HD23 ' A' ' 87' ' ' LEU . 9.4 mp -79.17 131.15 36.11 Favored 'General case' 0 C--O 1.201 -1.459 2 CA-C-N 107.076 -4.602 . . . . 0.0 113.961 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.6 m -119.82 105.97 11.63 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . -168.4 -160.38 16.1 Favored Glycine 0 CA--C 1.542 1.723 1 C-N-CA 110.75 -5.5 . . . . 0.0 103.781 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.526 ' N ' ' CZ ' ' A' ' 78' ' ' PHE . 6.1 t -151.68 157.02 41.53 Favored 'General case' 0 N--CA 1.426 -1.639 1 O-C-N 133.35 5.971 . . . . 0.0 117.942 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 33.1 m95 -124.94 112.25 16.38 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 114.629 -2.605 . . . . 0.0 104.689 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.479 HG22 ' HA2' ' A' ' 50' ' ' GLY . 9.1 p -107.14 52.68 0.71 Allowed 'General case' 0 N--CA 1.435 -1.192 1 O-C-N 135.51 8.006 . . . . 0.0 116.028 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.82 111.37 0.34 Allowed 'General case' 0 C--O 1.214 -0.79 1 O-C-N 134.124 7.14 . . . . 0.0 104.153 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -90.1 -43.28 10.58 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 109.443 -3.526 . . . . 0.0 110.507 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.81 101.86 0.21 Allowed Glycine 0 CA--C 1.532 1.151 0 O-C-N 128.292 3.495 . . . . 0.0 105.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 73' ' ' LYS . 3.8 m-80 73.26 13.94 4.61 Favored 'General case' 0 N--CA 1.447 -0.595 1 O-C-N 130.683 4.402 . . . . 0.0 110.008 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 92' ' ' GLU 0.259 0.0 OUTLIER -124.06 -169.37 1.95 Allowed 'General case' 0 N--CA 1.471 0.609 1 O-C-N 129.642 4.339 . . . . 0.0 108.35 -179.72 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 91' ' ' ARG . 0.8 OUTLIER -169.31 43.65 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 128.506 3.629 . . . . 0.0 111.896 -179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.3 t -77.51 136.5 24.18 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.147 3 O-C-N 131.316 5.385 . . . . 0.0 113.24 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.53 -159.96 32.63 Favored Glycine 0 CA--C 1.556 2.655 1 N-CA-C 101.652 -4.579 . . . . 0.0 101.652 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.509 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 178.0 141.26 0.09 Allowed 'General case' 0 C--O 1.201 -1.484 1 O-C-N 130.918 4.54 . . . . 0.0 113.53 -179.449 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -131.18 178.5 6.65 Favored 'General case' 0 C--N 1.367 1.349 3 O-C-N 130.61 4.944 . . . . 0.0 105.694 -179.552 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.324 0.8 OUTLIER -163.74 131.24 3.44 Favored 'General case' 0 C--N 1.365 1.274 1 CA-C-N 106.257 -4.974 . . . . 0.0 113.64 179.906 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 72.7 ttt180 -85.92 94.87 9.29 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.32 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' GLU . 14.3 p -47.41 -26.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 1 O-C-N 133.175 6.547 . . . . 0.0 113.77 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.14 -37.99 84.77 Favored 'General case' 0 C--N 1.32 -0.712 1 O-C-N 130.121 4.638 . . . . 0.0 110.859 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -110.82 -3.45 15.71 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 114.745 -2.782 . . . . 0.0 114.748 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.526 ' CA ' ' HE2' ' A' ' 79' ' ' LYS . . . 70.62 33.36 67.18 Favored Glycine 0 CA--C 1.557 2.674 2 N-CA-C 100.435 -5.066 . . . . 0.0 100.435 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 3.9 tppt? -72.74 -78.26 0.09 Allowed 'General case' 0 N--CA 1.421 -1.904 1 CA-C-N 105.473 -5.364 . . . . 0.0 120.805 -178.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.659 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 52.8 mt-10 83.26 60.29 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.459 1 O-C-N 130.209 4.693 . . . . 0.0 107.906 -177.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.782 HD23 HD21 ' A' ' 63' ' ' LEU . 5.2 tp -91.48 69.23 5.84 Favored 'General case' 0 CA--C 1.49 -1.341 1 O-C-N 135.009 7.693 . . . . 0.0 112.498 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.677 HD12 HG22 ' A' ' 103' ' ' THR 0.29 78.0 mt -76.81 -179.46 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 69.68 0.73 Allowed 'General case' 0 C--O 1.201 -1.469 0 O-C-N 128.627 3.705 . . . . 0.0 106.223 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.64 137.15 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 110.936 -2.847 . . . . 0.0 105.497 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.622 ' HG3' HD11 ' A' ' 98' ' ' LEU . 0.4 OUTLIER 179.51 162.48 0.89 Allowed 'General case' 0 N--CA 1.414 -2.272 1 C-N-CA 111.363 -4.135 . . . . 0.0 114.044 179.843 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -152.87 154.76 35.74 Favored 'General case' 0 N--CA 1.424 -1.746 1 O-C-N 131.441 5.463 . . . . 0.0 105.534 178.688 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.918 HD13 HD13 ' A' ' 98' ' ' LEU . 4.9 mm -56.09 91.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 1 O-C-N 132.365 6.041 . . . . 0.0 109.694 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.414 ' HB2' HG13 ' A' ' 99' ' ' ILE . 13.9 t -31.31 -59.35 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 1 O-C-N 133.002 6.439 . . . . 0.0 115.258 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -137.14 -83.14 0.12 Allowed Glycine 0 CA--C 1.556 2.634 0 N-CA-C 103.24 -3.944 . . . . 0.0 103.24 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.3 26.52 5.41 Favored 'General case' 0 CA--C 1.551 1.007 1 CA-C-N 107.123 -4.538 . . . . 0.0 105.193 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -164.44 163.08 22.32 Favored 'General case' 0 CA--C 1.563 1.45 1 O-C-N 133.049 6.468 . . . . 0.0 106.706 -179.881 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.918 HD13 HD13 ' A' ' 93' ' ' ILE . 17.2 tp -115.89 136.53 52.95 Favored 'General case' 0 N--CA 1.437 -1.122 1 O-C-N 132.853 6.346 . . . . 0.0 110.484 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 ' HD2' ' A' ' 110' ' ' LYS 0.277 4.2 mt -85.28 -60.79 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 2 CA-C-O 110.796 -4.43 . . . . 0.0 106.102 -179.588 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.534 HE21 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER 86.09 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 1 O-C-N 134.064 7.103 . . . . 0.0 102.865 179.933 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.569 HG23 ' HB3' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -103.45 98.74 8.59 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 110.835 -2.893 . . . . 0.0 112.714 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.3 95.74 1.34 Allowed 'General case' 0 C--O 1.21 -1.022 2 CA-C-N 107.489 -4.414 . . . . 0.0 105.086 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.677 HG22 HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -64.1 132.69 51.25 Favored 'General case' 0 N--CA 1.48 1.032 1 O-C-N 129.541 4.276 . . . . 0.0 100.812 179.988 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -160.13 147.43 16.3 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 110.448 -3.069 . . . . 0.0 115.888 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 43.28 28.91 0.19 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.184 -2.28 . . . . 0.0 116.043 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.55 7.93 57.65 Favored Glycine 0 C--N 1.358 1.796 0 C-N-CA 117.066 -2.492 . . . . 0.0 116.328 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER -131.15 -159.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 118.801 -1.159 . . . . 0.0 112.765 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 107' ' ' VAL . 27.5 mt-10 -138.13 93.67 2.79 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 116.435 -2.106 . . . . 0.0 106.448 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.47 . . -105.13 150.39 25.08 Favored 'General case' 0 N--CA 1.413 -2.302 0 O-C-N 125.954 2.034 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -147.78 177.59 9.19 Favored 'General case' 0 N--CA 1.427 -1.603 1 O-C-N 131.52 5.513 . . . . 0.0 110.75 -179.987 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -147.07 107.15 4.0 Favored 'General case' 0 CA--C 1.561 1.366 2 O-C-N 130.757 5.035 . . . . 0.0 99.834 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.31 132.9 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 O-C-N 128.872 3.857 . . . . 0.0 113.586 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.639 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 13.7 m-30 -140.15 175.73 9.35 Favored 'General case' 0 N--CA 1.423 -1.796 2 O-C-N 133.675 6.86 . . . . 0.0 104.083 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -159.95 -155.21 0.43 Allowed 'General case' 0 C--O 1.2 -1.52 1 O-C-N 131.367 5.417 . . . . 0.0 111.325 179.454 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.661 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.4 tttt -110.21 -173.04 2.16 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 112.961 -1.927 . . . . 0.0 111.747 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.671 0 CA-C-N 109.422 -3.535 . . . . 0.0 111.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.54 -60.77 0.17 Allowed 'General case' 0 C--N 1.358 0.955 0 O-C-N 128.2 3.438 . . . . 0.0 104.381 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 26' ' ' THR 0.251 4.2 p-10 -33.1 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.425 -1.7 1 O-C-N 130.493 4.871 . . . . 0.0 118.541 179.803 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.76 -176.29 43.65 Favored Glycine 0 C--N 1.355 1.594 1 C-N-CA 113.169 -4.348 . . . . 0.0 105.221 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' CB ' ' A' ' 24' ' ' THR . 46.5 p -97.76 165.93 11.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 112.486 -3.685 . . . . 0.0 103.576 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.658 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 13.1 m95 -136.67 172.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 112.589 -3.576 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.651 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 7.6 mtmt 38.92 -178.64 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.884 1 O-C-N 130.505 4.878 . . . . 0.0 118.502 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 10' ' ' ARG 0.329 1.0 OUTLIER -2.86 125.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.231 3 CA-C-N 105.319 -5.401 . . . . 0.0 118.794 174.915 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.97 -45.78 13.7 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 110.272 -3.149 . . . . 0.0 104.883 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 8' ' ' VAL . 38.7 ttt180 54.51 106.63 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.49 3.043 . . . . 0.0 115.355 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -67.47 -13.34 61.95 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 113.31 -1.768 . . . . 0.0 110.252 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 63.65 97.17 0.04 OUTLIER 'General case' 0 C--O 1.237 0.429 0 O-C-N 127.859 3.225 . . . . 0.0 107.114 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.14 128.85 14.21 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.38 139.2 51.85 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 127.541 3.026 . . . . 0.0 108.349 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -157.92 -162.03 1.1 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 116.461 -2.095 . . . . 0.0 105.598 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.07 -82.78 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 O-C-N 127.004 2.69 . . . . 0.0 109.701 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.35 116.97 9.2 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.38 118.55 31.47 Favored 'General case' 0 C--N 1.356 0.874 0 CA-C-O 117.996 -1.002 . . . . 0.0 108.851 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -104.68 90.43 3.49 Favored 'General case' 0 C--O 1.204 -1.305 0 O-C-N 127.483 2.989 . . . . 0.0 111.945 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB2' ' HD2' ' A' ' 10' ' ' ARG . 4.1 m120 -132.66 125.72 30.97 Favored 'General case' 0 CA--C 1.547 0.853 1 O-C-N 133.094 6.496 . . . . 0.0 110.681 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 21' ' ' LEU . 1.2 mp -112.21 -172.12 1.98 Allowed 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 113.604 -3.093 . . . . 0.0 102.909 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 37' ' ' SER 0.399 0.0 OUTLIER -150.29 168.62 23.53 Favored 'General case' 0 CA--C 1.566 1.586 1 O-C-N 131.682 5.614 . . . . 0.0 101.776 -179.912 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 7.0 mt -139.95 153.55 46.95 Favored 'General case' 0 CA--C 1.562 1.423 4 O-C-N 132.805 6.315 . . . . 0.0 97.233 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 40.7 m 175.84 77.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.596 1 O-C-N 131.169 5.293 . . . . 0.0 106.499 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 34' ' ' VAL . 3.9 mp -89.13 157.48 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 C-N-CA 114.452 -2.899 . . . . 0.0 110.971 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 86.4 m -167.72 77.78 0.16 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 112.803 -3.559 . . . . 0.0 107.915 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.531 ' CA ' ' HB3' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -55.59 157.54 3.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 128.685 3.74 . . . . 0.0 115.555 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -134.8 61.56 1.67 Allowed 'General case' 0 C--N 1.356 0.87 0 O-C-N 128.787 3.804 . . . . 0.0 104.547 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.77 -95.39 0.43 Allowed Glycine 0 CA--C 1.555 2.566 2 O-C-N 130.551 4.907 . . . . 0.0 102.443 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -146.82 21.93 1.26 Allowed 'General case' 0 N--CA 1.415 -2.183 2 O-C-N 134.375 6.573 . . . . 0.0 106.392 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -125.46 126.39 44.85 Favored 'General case' 0 CA--C 1.552 1.02 1 O-C-N 129.729 4.393 . . . . 0.0 101.881 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.531 ' HB3' ' CA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -143.13 173.19 11.79 Favored 'General case' 0 C--O 1.193 -1.888 2 N-CA-C 96.162 -5.495 . . . . 0.0 96.162 179.736 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.07 124.66 20.85 Favored 'General case' 0 N--CA 1.473 0.708 2 O-C-N 137.945 9.528 . . . . 0.0 101.605 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.589 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.448 3.0 t -79.24 149.57 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 113.915 -3.114 . . . . 0.0 103.17 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 24' ' ' THR 0.304 13.3 tttt -90.05 32.01 0.94 Allowed 'General case' 0 C--O 1.205 -1.277 0 N-CA-C 118.277 2.695 . . . . 0.0 118.277 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.438 27.8 tt0 -58.51 102.52 0.11 Allowed 'General case' 0 C--N 1.362 1.111 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.506 ' CB ' ' HA ' ' A' ' 42' ' ' ASN . 23.2 m -121.26 124.49 44.77 Favored 'General case' 0 C--N 1.347 0.492 0 O-C-N 127.598 3.061 . . . . 0.0 112.147 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.529 ' CB ' ' HG ' ' A' ' 21' ' ' LEU . 1.5 t 159.34 -50.0 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.8 1 O-C-N 130.013 4.571 . . . . 0.0 115.317 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -38.8 -31.71 0.07 Allowed 'General case' 0 C--O 1.219 -0.545 0 O-C-N 128.416 3.572 . . . . 0.0 111.633 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.73 -48.85 0.06 Allowed 'General case' 0 C--N 1.356 0.876 1 C-N-CA 111.232 -4.187 . . . . 0.0 110.38 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.78 43.57 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.58 1.8 . . . . 0.0 114.953 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 37' ' ' SER . 0.0 OUTLIER 84.47 6.18 0.59 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 128.891 3.87 . . . . 0.0 108.008 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 43' ' ' ILE 0.372 0.2 OUTLIER -25.69 92.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.069 3 O-C-N 133.55 6.781 . . . . 0.0 110.325 177.269 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.31 141.82 36.67 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 110.608 -2.996 . . . . 0.0 107.801 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.28 97.15 5.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 1 O-C-N 130.423 4.827 . . . . 0.0 103.86 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.308 1.2 p -95.47 155.64 3.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 C-N-CA 114.424 -2.91 . . . . 0.0 111.817 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.65 177.57 3.88 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 130.949 5.156 . . . . 0.0 111.8 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.19 78.37 1.83 Allowed 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 128.57 3.669 . . . . 0.0 116.144 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.775 HD21 ' HB3' ' A' ' 69' ' ' MET . 0.1 OUTLIER 15.58 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.524 1 O-C-N 129.173 4.046 . . . . 0.0 117.204 -179.819 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 96.9 53.46 1.39 Allowed Glycine 0 C--O 1.197 -2.165 0 N-CA-C 105.236 -3.146 . . . . 0.0 105.236 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.62 111.38 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 1 O-C-N 130.611 4.359 . . . . 0.0 112.195 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.24 151.1 28.29 Favored 'General case' 0 N--CA 1.473 0.717 1 O-C-N 130.97 5.169 . . . . 0.0 109.727 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 0.3 OUTLIER -172.19 113.94 0.31 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 112.217 -3.793 . . . . 0.0 116.86 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 134.89 53.12 Favored 'General case' 0 CA--C 1.558 1.272 0 N-CA-C 101.114 -3.661 . . . . 0.0 101.114 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 57' ' ' LEU . 6.9 t80 -154.53 97.22 1.98 Allowed 'General case' 0 C--O 1.206 -1.212 0 C-N-CA 112.113 -3.835 . . . . 0.0 113.427 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.1 t -64.38 91.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.929 1 O-C-N 130.343 4.777 . . . . 0.0 104.202 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -54.96 -76.11 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 129.022 3.951 . . . . 0.0 111.841 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.71 26.26 0.5 Allowed 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 84.02 -24.8 0.15 Allowed 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -33.47 2.0 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-O 115.072 -3.071 . . . . 0.0 109.033 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.5 p -58.23 -172.38 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.061 1 O-C-N 130.064 4.038 . . . . 0.0 115.01 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -150.72 -60.86 0.19 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 117.109 -1.836 . . . . 0.0 107.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 mp 34.67 77.46 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.613 1 O-C-N 131.711 5.632 . . . . 0.0 113.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.0 m -87.69 99.66 12.24 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 112.169 -2.287 . . . . 0.0 107.988 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.551 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -159.38 -166.24 17.95 Favored Glycine 0 CA--C 1.536 1.401 1 C-N-CA 111.041 -5.361 . . . . 0.0 108.108 -179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 66' ' ' THR . 5.2 t -150.47 113.51 4.82 Favored 'General case' 0 N--CA 1.437 -1.122 2 O-C-N 132.376 5.397 . . . . 0.0 118.37 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.755 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 40.6 m95 -94.11 129.33 40.7 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 117.409 -3.307 . . . . 0.0 104.332 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.481 HG22 ' HA2' ' A' ' 50' ' ' GLY . 49.2 p -124.65 58.33 1.23 Allowed 'General case' 0 N--CA 1.433 -1.279 1 O-C-N 133.43 6.706 . . . . 0.0 116.301 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.775 ' HB3' HD21 ' A' ' 49' ' ' LEU 0.278 0.0 OUTLIER -42.26 112.43 0.34 Allowed 'General case' 0 N--CA 1.441 -0.896 1 O-C-N 131.116 5.26 . . . . 0.0 104.112 -179.923 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -83.43 -78.45 0.22 Allowed 'General case' 0 C--O 1.212 -0.903 0 O-C-N 127.975 3.297 . . . . 0.0 108.529 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.05 -76.47 0.06 OUTLIER Glycine 0 CA--C 1.555 2.544 0 N-CA-C 104.11 -3.596 . . . . 0.0 104.11 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.76 37.34 4.11 Favored 'General case' 0 CA--C 1.537 0.45 1 O-C-N 130.09 4.053 . . . . 0.0 108.258 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -130.32 177.48 7.3 Favored 'General case' 0 C--N 1.362 1.126 1 O-C-N 129.249 4.093 . . . . 0.0 112.432 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 91' ' ' ARG . 2.3 mt -149.71 46.29 0.94 Allowed 'General case' 0 CA--C 1.5 -0.955 0 O-C-N 126.54 2.4 . . . . 0.0 113.285 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.82 130.36 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.068 2 O-C-N 131.015 5.197 . . . . 0.0 112.213 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.16 -164.58 36.11 Favored Glycine 0 CA--C 1.546 1.989 0 N-CA-C 103.902 -3.679 . . . . 0.0 103.902 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.568 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -176.38 133.64 0.23 Allowed 'General case' 0 N--CA 1.423 -1.804 0 O-C-N 129.256 3.563 . . . . 0.0 114.149 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.6 OUTLIER -128.13 164.86 21.55 Favored 'General case' 0 C--O 1.203 -1.384 3 O-C-N 135.041 7.713 . . . . 0.0 105.272 179.765 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HE2' ' HG3' ' A' ' 85' ' ' LYS . 3.8 tmtt? -154.0 153.17 31.49 Favored 'General case' 0 N--CA 1.417 -2.106 1 CA-C-N 106.744 -4.753 . . . . 0.0 117.734 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 79' ' ' LYS . 44.0 ttt180 -104.13 85.84 2.46 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.942 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -42.68 -27.24 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 O-C-N 128.564 3.665 . . . . 0.0 113.338 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 30.9 t0 -72.99 0.55 10.99 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 128.787 3.804 . . . . 0.0 112.5 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER 102.09 12.0 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.284 1 O-C-N 132.772 6.295 . . . . 0.0 115.671 -179.489 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.03 -39.69 23.04 Favored Glycine 0 CA--C 1.559 2.788 2 C-N-CA 111.27 -5.252 . . . . 0.0 100.87 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 2.1 tttt 83.86 -178.95 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.655 2 O-C-N 134.558 6.681 . . . . 0.0 115.534 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' N ' ' HG2' ' A' ' 79' ' ' LYS 0.257 1.4 mt-10 -38.23 135.92 0.68 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 132.448 6.092 . . . . 0.0 116.586 -178.434 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 39.75 2.59 Favored 'General case' 0 C--O 1.197 -1.696 1 O-C-N 130.816 5.073 . . . . 0.0 110.251 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' A' ' 77' ' ' LYS . 82.8 mt -64.15 149.54 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.445 2 N-CA-C 98.907 -4.479 . . . . 0.0 98.907 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.57 76.8 1.29 Allowed 'General case' 0 C--N 1.315 -0.914 1 O-C-N 134.545 7.403 . . . . 0.0 106.843 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -65.9 121.67 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 O-C-N 128.564 3.665 . . . . 0.0 102.305 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CD ' ' CD2' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -162.52 157.05 21.7 Favored 'General case' 0 C--O 1.192 -1.953 1 C-N-CA 110.343 -4.543 . . . . 0.0 113.483 -179.71 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -157.29 127.96 6.55 Favored 'General case' 0 C--O 1.209 -1.045 1 O-C-N 130.281 4.738 . . . . 0.0 103.663 179.819 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.569 HD12 ' HG ' ' A' ' 98' ' ' LEU . 1.5 mm -38.0 120.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 1 O-C-N 130.787 5.054 . . . . 0.0 111.793 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.97 -66.58 0.57 Allowed 'General case' 0 C--O 1.248 0.975 1 O-C-N 129.273 4.108 . . . . 0.0 114.584 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -128.93 -88.92 0.57 Allowed Glycine 0 CA--C 1.547 2.07 0 N-CA-C 105.282 -3.127 . . . . 0.0 105.282 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -130.39 44.77 2.91 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 128.985 3.403 . . . . 0.0 106.401 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.573 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -169.2 172.06 7.6 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.462 4.226 . . . . 0.0 109.298 -179.653 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 93' ' ' ILE . 1.9 mt -133.27 129.6 37.85 Favored 'General case' 0 C--O 1.205 -1.273 1 O-C-N 132.549 6.156 . . . . 0.0 112.16 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 34.4 mt -80.05 -82.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.42 -1.932 2 O-C-N 129.796 4.435 . . . . 0.0 106.381 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 96.79 85.96 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 1 O-C-N 134.775 7.547 . . . . 0.0 105.026 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 110' ' ' LYS . 4.6 m -82.57 92.26 7.08 Favored 'General case' 0 C--O 1.197 -1.688 2 O-C-N 131.18 5.3 . . . . 0.0 111.7 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 16.5 m-85 -68.54 126.5 29.86 Favored 'General case' 0 C--O 1.207 -1.138 2 C-N-CA 110.484 -4.486 . . . . 0.0 106.158 -178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.52 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 47.9 m -101.08 87.01 3.15 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-O 127.62 3.581 . . . . 0.0 101.716 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.524 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.7 OUTLIER -109.85 128.17 55.16 Favored 'General case' 0 C--N 1.359 1.001 1 CA-C-N 107.485 -4.416 . . . . 0.0 115.877 -179.978 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 30.3 mt-10 50.41 20.75 0.72 Allowed 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 120.058 -1.651 . . . . 0.0 114.951 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.1 -9.33 54.49 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 117.925 -2.083 . . . . 0.0 114.739 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.739 HG12 ' HB2' ' A' ' 109' ' ' ALA . 21.4 t -100.85 113.5 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.04 91.37 3.09 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.739 ' HB2' HG12 ' A' ' 107' ' ' VAL 0.473 . . -125.77 122.54 36.52 Favored 'General case' 0 N--CA 1.414 -2.262 0 O-C-N 126.704 2.503 . . . . 0.0 116.25 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 101' ' ' THR . 22.9 mtmt -98.0 163.41 12.78 Favored 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 134.902 7.626 . . . . 0.0 108.893 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -107.85 -47.27 3.62 Favored 'General case' 0 CA--C 1.555 1.173 1 O-C-N 130.806 5.066 . . . . 0.0 105.276 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.302 11.6 mt 88.3 103.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.977 1 O-C-N 130.83 5.081 . . . . 0.0 109.283 179.992 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.651 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 16.8 m-85 -136.07 179.72 6.18 Favored 'General case' 0 N--CA 1.427 -1.601 1 O-C-N 132.695 6.247 . . . . 0.0 107.216 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.573 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -148.23 -152.48 0.44 Allowed 'General case' 0 C--O 1.203 -1.394 1 O-C-N 131.749 5.655 . . . . 0.0 112.369 179.125 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 8.6 tttt -115.55 -162.08 0.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 126.811 2.044 . . . . 0.0 111.575 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.431 -1.412 0 CA-C-N 112.983 -1.917 . . . . 0.0 112.705 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 118.335 -0.84 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 53.62 33.98 17.66 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 128.772 3.795 . . . . 0.0 105.448 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 57.1 p30 -132.53 47.79 2.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.1 -171.68 38.67 Favored Glycine 0 N--CA 1.482 1.707 1 C-N-CA 110.731 -5.509 . . . . 0.0 105.446 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.371 4.4 p -82.85 -174.53 5.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 112.843 -3.543 . . . . 0.0 104.286 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.674 ' CZ3' HD11 ' A' ' 93' ' ' ILE 0.27 59.5 m95 -162.0 128.77 3.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 112.625 -3.56 . . . . 0.0 113.475 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.554 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 23.1 mtmt 73.91 177.4 0.24 Allowed 'General case' 0 C--O 1.193 -1.885 0 O-C-N 126.957 2.66 . . . . 0.0 117.229 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 t 32.05 118.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.638 3 O-C-N 136.592 8.682 . . . . 0.0 120.812 174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -151.61 -171.33 3.9 Favored 'General case' 0 N--CA 1.421 -1.875 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.202 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.98 96.27 4.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.813 -1.54 . . . . 0.0 111.944 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.93 -19.4 7.27 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.182 0.927 . . . . 0.0 112.017 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 64.37 -93.7 0.04 OUTLIER 'General case' 0 C--O 1.245 0.824 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 4.0 m120 53.19 -95.1 0.04 OUTLIER 'General case' 0 C--N 1.351 0.652 0 O-C-N 126.392 2.308 . . . . 0.0 106.885 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' A' ' 13' ' ' ASN . 1.6 p90 -148.9 95.71 2.45 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 112.704 -2.044 . . . . 0.0 108.226 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.4 p -165.2 156.83 14.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 114.054 -3.058 . . . . 0.0 107.739 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.38 62.05 0.01 OUTLIER Glycine 0 C--O 1.208 -1.514 0 C-N-CA 118.66 -1.733 . . . . 0.0 109.731 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.39 -86.4 0.08 Allowed 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 112.846 -1.677 . . . . 0.0 107.171 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -151.5 63.47 0.88 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 128.152 3.408 . . . . 0.0 112.605 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.82 76.22 1.53 Allowed 'General case' 0 C--N 1.365 1.268 0 O-C-N 125.262 1.601 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -122.21 23.38 9.85 Favored 'General case' 0 CA--C 1.554 1.096 1 O-C-N 130.441 4.838 . . . . 0.0 111.35 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.8 153.62 42.58 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-N 108.892 -3.776 . . . . 0.0 104.511 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.435 0.0 OUTLIER -152.83 142.66 22.07 Favored 'General case' 0 CA--C 1.565 1.556 1 O-C-N 129.226 4.079 . . . . 0.0 100.398 179.755 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 7.5 mt -101.16 175.97 5.41 Favored 'General case' 0 C--N 1.311 -1.107 2 O-C-N 132.704 6.252 . . . . 0.0 97.859 178.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 m 164.38 76.7 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 1 CA-C-O 128.53 4.014 . . . . 0.0 102.223 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.763 HG21 ' CE2' ' A' ' 32' ' ' PHE . 3.3 mp -99.55 150.22 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 109.489 -3.505 . . . . 0.0 109.688 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 6.2 m -170.79 75.62 0.07 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 113.531 -3.267 . . . . 0.0 102.669 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 2.7 pm0 -51.67 141.42 16.67 Favored 'General case' 0 C--O 1.212 -0.903 1 O-C-N 130.318 4.761 . . . . 0.0 115.862 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 31' ' ' LYS . 1.2 pm0 -116.57 103.9 10.87 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 128.857 3.848 . . . . 0.0 103.17 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.61 -121.48 6.05 Favored Glycine 0 N--CA 1.482 1.738 2 N-CA-C 100.747 -4.941 . . . . 0.0 100.747 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 19.3 m120 -110.49 3.65 19.76 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 114.431 -2.699 . . . . 0.0 109.481 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 28' ' ' GLU . 16.9 mttt -81.36 141.14 34.28 Favored 'General case' 0 CA--C 1.544 0.718 1 N-CA-C 97.421 -5.029 . . . . 0.0 97.421 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.763 ' CE2' HG21 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -148.93 101.2 3.15 Favored 'General case' 0 C--O 1.194 -1.856 1 N-CA-C 96.048 -5.538 . . . . 0.0 96.048 -179.683 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.6 OUTLIER -101.14 143.87 30.73 Favored 'General case' 0 N--CA 1.454 -0.264 3 O-C-N 134.461 7.351 . . . . 0.0 101.956 -179.718 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.676 HG23 ' CE1' ' A' ' 32' ' ' PHE 0.333 1.3 t -111.75 149.5 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 2 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 179.718 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 3.0 tttm -87.32 45.02 1.23 Allowed 'General case' 0 C--O 1.195 -1.778 0 CA-C-O 126.585 3.088 . . . . 0.0 116.394 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.292 1.3 mm-40 -59.77 85.46 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.479 -2.146 . . . . 0.0 109.736 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 35' ' ' LYS . 4.3 t -97.2 117.65 31.87 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 126.485 2.366 . . . . 0.0 112.319 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.01 -156.45 0.57 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 118.259 -1.376 . . . . 0.0 110.636 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -78.4 -43.46 27.38 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 126.738 2.524 . . . . 0.0 108.763 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -45.58 -65.34 0.55 Allowed 'General case' 0 C--O 1.209 -1.04 1 O-C-N 132.341 6.026 . . . . 0.0 109.145 179.722 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -163.2 -163.39 0.84 Allowed 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 126.9 2.625 . . . . 0.0 111.135 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -16.08 57.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 114.546 -2.861 . . . . 0.0 104.748 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.598 HG13 HD22 ' A' ' 57' ' ' LEU 0.259 0.1 OUTLIER 11.59 68.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.335 3 O-C-N 133.146 6.529 . . . . 0.0 111.575 179.279 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 150.33 28.89 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 109.454 -3.521 . . . . 0.0 108.473 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 9.3 p -105.02 115.06 46.16 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.08 1 O-C-N 130.889 5.118 . . . . 0.0 104.126 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 47' ' ' PHE 0.256 9.7 p -131.05 161.65 40.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 C-N-CA 113.816 -3.154 . . . . 0.0 114.718 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 2.9 p90 177.09 -168.82 0.06 Allowed 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 109.35 -3.568 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.252 0.9 OUTLIER -126.18 82.75 2.1 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 128.704 3.752 . . . . 0.0 115.029 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 69' ' ' MET . 4.8 tp -0.83 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 1 O-C-N 133.614 6.821 . . . . 0.0 116.344 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 49' ' ' LEU . . . 96.4 36.14 5.23 Favored Glycine 0 C--O 1.204 -1.776 0 N-CA-C 104.048 -3.621 . . . . 0.0 104.048 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.81 114.71 22.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 1 O-C-N 130.486 4.286 . . . . 0.0 116.788 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.86 159.25 21.39 Favored 'General case' 0 CA--C 1.556 1.21 1 O-C-N 130.235 4.709 . . . . 0.0 107.882 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -172.83 164.4 5.15 Favored 'General case' 0 N--CA 1.439 -1.007 1 C-N-CA 111.318 -4.153 . . . . 0.0 113.271 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -127.9 80.88 1.99 Allowed 'General case' 0 CA--C 1.563 1.448 1 N-CA-C 100.149 -4.019 . . . . 0.0 100.149 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -102.48 126.19 49.44 Favored 'General case' 0 C--O 1.211 -0.93 0 O-C-N 127.976 3.297 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 t -78.9 171.45 15.17 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 112.209 -3.796 . . . . 0.0 106.643 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.598 HD22 HG13 ' A' ' 43' ' ' ILE . 5.8 mt -151.12 179.55 8.18 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 127.27 2.856 . . . . 0.0 109.514 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB3' ' CG2' ' A' ' 61' ' ' THR . . . 39.48 -98.97 0.02 OUTLIER 'General case' 0 C--O 1.248 1.018 0 O-C-N 128.527 3.642 . . . . 0.0 112.302 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.25 27.37 3.47 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 124.272 0.982 . . . . 0.0 112.87 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.24 71.07 0.29 Allowed Glycine 0 C--N 1.361 1.92 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.521 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 25.8 p -104.83 -47.84 3.93 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.326 1.45 . . . . 0.0 108.559 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.94 58.1 4.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 126.434 2.334 . . . . 0.0 109.743 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 ' CD2' ' A' ' 87' ' ' LEU . 5.8 mp -84.26 76.06 10.14 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.466 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 68.8 m -52.07 119.63 4.54 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' C ' HG22 ' A' ' 66' ' ' THR . . . -143.69 -158.16 7.46 Favored Glycine 0 C--O 1.205 -1.671 1 C-N-CA 111.422 -5.18 . . . . 0.0 109.066 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.623 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.296 0.6 OUTLIER 172.78 124.12 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.886 2 O-C-N 132.5 5.471 . . . . 0.0 113.878 -178.413 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 68.2 m95 -133.83 134.1 42.41 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 119.494 -2.004 . . . . 0.0 106.635 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 2.3 p -118.27 36.33 4.41 Favored 'General case' 0 N--CA 1.424 -1.751 2 O-C-N 131.245 5.341 . . . . 0.0 116.677 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.551 ' CB ' HD22 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -8.17 87.27 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 1 O-C-N 136.392 8.557 . . . . 0.0 109.145 -179.988 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 -168.05 1.58 Allowed 'General case' 0 C--N 1.356 0.885 1 CA-C-N 108.22 -4.082 . . . . 0.0 109.613 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.11 92.45 0.14 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 116.894 -2.574 . . . . 0.0 110.734 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 m120 54.42 44.09 29.4 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.074 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -132.42 173.64 11.08 Favored 'General case' 0 C--N 1.347 0.477 1 O-C-N 129.989 4.556 . . . . 0.0 108.576 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.1 mt -148.81 58.26 1.05 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 128.245 3.466 . . . . 0.0 111.567 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.38 78.68 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.934 2 CA-C-O 129.475 4.464 . . . . 0.0 112.091 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' HA3' ' CE3' ' A' ' 67' ' ' TRP . . . -148.92 -167.32 13.74 Favored Glycine 0 CA--C 1.554 2.518 1 CA-C-N 106.304 -4.953 . . . . 0.0 104.35 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.566 ' HG3' ' N ' ' A' ' 78' ' ' PHE 0.265 0.7 OUTLIER -163.22 171.46 16.21 Favored 'General case' 0 C--N 1.37 1.477 2 O-C-N 131.483 4.873 . . . . 0.0 112.584 179.964 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 42.7 m-85 -149.72 151.88 34.38 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-O 127.738 3.637 . . . . 0.0 101.98 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.57 ' CE ' ' HA2' ' A' ' 84' ' ' GLY 0.29 0.0 OUTLIER -169.04 127.01 0.99 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 109.81 -3.359 . . . . 0.0 117.668 -179.75 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 69.7 mtt180 -76.6 113.02 13.77 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 126.588 2.43 . . . . 0.0 108.586 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -58.14 -24.94 25.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.267 1 O-C-N 131.478 5.486 . . . . 0.0 108.594 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -45.7 -51.65 12.12 Favored 'General case' 0 C--O 1.249 1.077 1 O-C-N 129.622 4.327 . . . . 0.0 112.294 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -141.93 3.97 1.65 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 113.496 -3.282 . . . . 0.0 117.621 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.57 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 98.01 36.3 4.77 Favored Glycine 0 CA--C 1.539 1.558 0 N-CA-C 104.556 -3.418 . . . . 0.0 104.556 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 3.2 tptm -70.96 -64.7 0.85 Allowed 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 120.131 3.382 . . . . 0.0 120.131 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 25.7 mt-10 71.14 87.99 0.11 Allowed 'General case' 0 C--O 1.199 -1.554 1 O-C-N 129.618 4.324 . . . . 0.0 110.926 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' CD2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -110.94 48.41 0.93 Allowed 'General case' 0 C--O 1.193 -1.893 1 O-C-N 132.349 6.031 . . . . 0.0 109.281 179.483 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.469 ' CG2' HG23 ' A' ' 90' ' ' VAL 0.268 98.4 mt -65.2 164.32 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.58 0 CA-C-N 108.582 -3.917 . . . . 0.0 105.675 -179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.5 71.95 1.39 Allowed 'General case' 0 C--O 1.201 -1.476 1 O-C-N 133.763 6.914 . . . . 0.0 105.309 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 88' ' ' ILE . 76.6 t -76.23 115.62 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 1 O-C-N 132.038 5.836 . . . . 0.0 105.614 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.482 ' CD ' ' HB ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -169.49 165.91 10.32 Favored 'General case' 0 C--O 1.187 -2.204 0 C-N-CA 114.669 -2.812 . . . . 0.0 114.714 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -156.91 118.84 3.84 Favored 'General case' 0 C--O 1.21 -1.005 1 O-C-N 130.479 4.862 . . . . 0.0 107.026 179.669 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.779 HD12 HD12 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -42.61 144.99 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.54 1 O-C-N 133.013 6.445 . . . . 0.0 113.577 179.876 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 t -150.89 123.01 8.25 Favored 'General case' 0 CA--C 1.506 -0.717 1 O-C-N 129.75 4.406 . . . . 0.0 115.996 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.57 13.86 74.85 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 t30 57.47 58.73 3.64 Favored 'General case' 0 CA--C 1.563 1.476 1 O-C-N 131.884 5.108 . . . . 0.0 104.603 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.765 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.323 0.4 OUTLIER -178.41 100.21 0.04 OUTLIER 'General case' 0 C--O 1.199 -1.588 1 O-C-N 132.116 5.885 . . . . 0.0 108.66 179.204 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 HD12 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.6 151.78 43.8 Favored 'General case' 0 N--CA 1.423 -1.783 1 O-C-N 130.423 4.827 . . . . 0.0 114.978 179.872 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLN . 26.9 mt -106.69 -106.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.412 -2.337 3 O-C-N 133.447 6.717 . . . . 0.0 107.922 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.6 mt-30 116.21 93.17 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.519 2 O-C-N 135.261 7.85 . . . . 0.0 98.348 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.654 HG23 ' HG2' ' A' ' 110' ' ' LYS . 1.3 m -72.39 -29.77 64.05 Favored 'General case' 0 N--CA 1.42 -1.944 1 O-C-N 133.333 6.646 . . . . 0.0 119.69 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 62.05 76.8 0.35 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 128.626 3.704 . . . . 0.0 105.74 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.6 m -76.35 78.4 3.1 Favored 'General case' 0 C--O 1.204 -1.325 0 O-C-N 128.439 3.587 . . . . 0.0 105.956 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.6 118.02 35.56 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 109.773 -3.376 . . . . 0.0 112.936 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 17.71 63.07 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.19 6.61 61.45 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 117.552 -2.261 . . . . 0.0 116.216 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.83 110.4 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.519 ' HG2' HG21 ' A' ' 101' ' ' THR . 2.0 mt-10 -89.27 78.74 7.22 Favored 'General case' 0 C--N 1.363 1.173 0 O-C-N 128.246 3.466 . . . . 0.0 105.125 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.416 . . -86.57 86.2 7.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.319 2.887 . . . . 0.0 116.275 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.654 ' HG2' HG23 ' A' ' 101' ' ' THR . 5.6 mtmp? -90.61 148.58 22.57 Favored 'General case' 0 N--CA 1.425 -1.683 1 O-C-N 130.042 4.589 . . . . 0.0 108.879 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 111' ' ' ARG . 14.4 mmt180 -147.6 111.04 4.93 Favored 'General case' 0 CA--C 1.558 1.275 1 O-C-N 130.544 4.902 . . . . 0.0 101.31 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.55 128.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 1 O-C-N 130.908 5.13 . . . . 0.0 111.595 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.554 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 m-85 -131.22 -154.77 0.65 Allowed 'General case' 0 C--N 1.318 -0.776 1 O-C-N 131.727 5.642 . . . . 0.0 104.865 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.765 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -168.31 -138.0 0.02 OUTLIER 'General case' 0 C--O 1.199 -1.595 1 O-C-N 131.336 5.398 . . . . 0.0 113.4 -177.627 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 3.1 tttt -137.34 158.53 44.22 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.417 -2.105 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.361 179.656 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 93' ' ' ILE . 9.9 m-85 -140.81 -70.8 0.37 Allowed 'General case' 0 CA--C 1.561 1.365 1 O-C-N 130.336 4.772 . . . . 0.0 104.543 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 1.5 m-20 -33.86 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.996 1 O-C-N 130.716 5.01 . . . . 0.0 118.465 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.24 27.09 0.03 OUTLIER Glycine 0 C--N 1.353 1.48 2 C-N-CA 110.485 -5.626 . . . . 0.0 109.683 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.26 157.21 0.16 Allowed 'General case' 0 C--O 1.248 0.983 0 O-C-N 127.696 2.645 . . . . 0.0 110.028 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 23' ' ' LEU 0.3 21.0 m95 -156.16 169.83 23.6 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 111.967 -3.873 . . . . 0.0 112.063 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.637 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 4.4 mtmt 44.72 -179.63 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.789 1 O-C-N 133.555 6.784 . . . . 0.0 118.34 178.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 21' ' ' LEU 0.271 0.4 OUTLIER 40.33 51.27 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.481 -1.706 3 CA-C-O 135.05 7.119 . . . . 0.0 120.848 174.852 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.15 -59.83 0.82 Allowed 'General case' 0 C--N 1.367 1.343 0 CA-C-N 108.455 -3.975 . . . . 0.0 103.151 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -90.05 140.25 29.83 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.033 0.921 . . . . 0.0 111.831 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.71 -21.84 0.28 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-N 112.922 -1.945 . . . . 0.0 114.338 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 61.05 41.39 13.92 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 116.332 -1.794 . . . . 0.0 110.627 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.07 111.55 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.955 1 O-C-N 129.958 4.536 . . . . 0.0 109.449 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -50.6 -45.05 57.18 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 110.391 -3.095 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.4 m -92.31 123.11 35.4 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 115.11 -2.636 . . . . 0.0 107.693 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.1 98.14 2.34 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 127.27 2.856 . . . . 0.0 107.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.36 -75.32 0.08 Allowed 'General case' 0 C--N 1.361 1.069 0 CA-C-N 111.003 -2.599 . . . . 0.0 104.587 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -80.69 153.87 27.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 126.246 2.216 . . . . 0.0 107.575 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.42 36.31 0.65 Allowed 'General case' 0 C--O 1.207 -1.139 0 O-C-N 125.868 1.98 . . . . 0.0 110.803 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.411 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 24.2 t-20 -161.16 87.12 0.71 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 128.801 3.813 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.642 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -170.63 170.59 6.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.381 0.0 OUTLIER -178.45 178.85 0.82 Allowed 'General case' 0 C--O 1.198 -1.653 1 O-C-N 132.456 6.097 . . . . 0.0 103.386 179.848 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD22 HD11 ' A' ' 25' ' ' ILE . 4.0 mt -136.46 166.02 24.47 Favored 'General case' 0 CA--C 1.563 1.446 2 O-C-N 130.74 5.025 . . . . 0.0 97.504 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 35' ' ' LYS . 86.3 m 175.67 73.05 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 1 O-C-N 129.715 4.385 . . . . 0.0 107.277 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.588 HD11 HD22 ' A' ' 23' ' ' LEU . 3.7 mp -86.18 144.88 8.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 113.876 -3.13 . . . . 0.0 109.248 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 90.7 m -162.75 79.41 0.49 Allowed 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 116.43 -2.108 . . . . 0.0 105.97 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -53.57 154.63 3.49 Favored 'General case' 0 N--CA 1.441 -0.892 2 O-C-N 132.031 5.832 . . . . 0.0 114.711 179.881 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -124.82 81.85 1.99 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.24 -87.45 1.56 Allowed Glycine 0 CA--C 1.558 2.766 1 N-CA-C 103.086 -4.006 . . . . 0.0 103.086 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -128.27 3.06 5.74 Favored 'General case' 0 N--CA 1.409 -2.506 2 O-C-N 133.212 5.889 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -79.79 160.3 26.21 Favored 'General case' 0 C--N 1.326 -0.432 2 N-CA-C 98.922 -4.473 . . . . 0.0 98.922 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.665 ' HZ ' HD21 ' A' ' 74' ' ' LEU . 0.5 OUTLIER -170.68 86.52 0.11 Allowed 'General case' 0 C--O 1.201 -1.465 2 N-CA-C 96.418 -5.401 . . . . 0.0 96.418 179.862 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.39 129.85 42.4 Favored 'General case' 0 CA--C 1.507 -0.702 2 O-C-N 132.829 6.331 . . . . 0.0 103.279 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG22 ' CE1' ' A' ' 32' ' ' PHE 0.323 69.3 t -102.29 134.32 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 1 N-CA-C 99.325 -4.324 . . . . 0.0 99.325 179.61 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HD2' ' HB ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -81.68 63.04 5.78 Favored 'General case' 0 CA--C 1.49 -1.361 1 CA-C-O 132.495 5.903 . . . . 0.0 116.233 -179.748 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.291 4.8 mt-10 -80.52 71.41 7.37 Favored 'General case' 0 N--CA 1.421 -1.918 0 O-C-N 117.032 -3.543 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 m -77.31 126.48 30.99 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 112.454 -3.698 . . . . 0.0 107.058 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 -165.92 0.33 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 116.075 -2.25 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.678 HD21 HD23 ' A' ' 57' ' ' LEU . 76.9 m-20 69.38 -96.03 0.03 OUTLIER 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.031 0.832 . . . . 0.0 111.415 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -141.26 20.28 2.25 Favored 'General case' 0 C--O 1.215 -0.73 0 O-C-N 127.228 2.83 . . . . 0.0 111.468 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -176.71 -176.55 0.72 Allowed 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 127.595 3.06 . . . . 0.0 111.38 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.23 122.47 36.79 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 101.949 -3.352 . . . . 0.0 101.949 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.335 0.7 OUTLIER -140.98 146.48 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 2 O-C-N 131.091 5.244 . . . . 0.0 105.204 -179.32 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -116.66 173.62 6.52 Favored 'General case' 0 C--N 1.36 1.047 0 CA-C-N 110.26 -3.155 . . . . 0.0 108.571 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.19 91.41 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.328 1 O-C-N 131.561 5.538 . . . . 0.0 101.115 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -103.38 158.0 5.01 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 1 O-C-N 130.722 5.014 . . . . 0.0 112.685 -179.904 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.0 p90 169.23 -158.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.738 1 O-C-N 133.462 6.726 . . . . 0.0 111.006 -179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 83.74 1.99 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 116.118 -2.233 . . . . 0.0 114.034 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 69' ' ' MET . 1.5 mp 43.44 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.751 1 O-C-N 130.96 5.163 . . . . 0.0 116.08 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.27 71.72 1.61 Allowed Glycine 0 C--O 1.203 -1.843 0 N-CA-C 104.195 -3.562 . . . . 0.0 104.195 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.5 t -144.84 92.85 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.785 1 O-C-N 131.182 4.695 . . . . 0.0 112.363 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.32 147.17 34.35 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 113.531 -3.268 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -154.42 161.07 41.91 Favored 'General case' 0 N--CA 1.425 -1.699 1 O-C-N 132.392 6.058 . . . . 0.0 115.896 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.71 109.79 20.18 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 101.674 -3.454 . . . . 0.0 101.674 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.0 -179.78 4.54 Favored 'General case' 0 CA--C 1.509 -0.604 1 O-C-N 130.095 4.622 . . . . 0.0 110.294 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.88 99.05 3.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 114.542 -2.863 . . . . 0.0 105.311 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.678 HD23 HD21 ' A' ' 39' ' ' ASN . 0.8 OUTLIER -56.47 -74.02 0.05 Allowed 'General case' 0 C--O 1.247 0.936 0 O-C-N 126.769 2.543 . . . . 0.0 114.021 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.9 18.06 3.16 Favored 'General case' 0 C--O 1.246 0.871 0 O-C-N 126.358 2.286 . . . . 0.0 115.232 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 73.3 0.49 3.68 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 126.417 2.323 . . . . 0.0 114.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.86 25.18 2.26 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 128.566 3.666 . . . . 0.0 108.161 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 p -118.37 170.87 8.56 Favored 'General case' 0 C--O 1.218 -0.567 1 O-C-N 130.479 4.282 . . . . 0.0 110.173 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -157.38 38.53 0.29 Allowed 'General case' 0 C--N 1.345 0.398 0 C-N-CA 113.861 -3.136 . . . . 0.0 106.989 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.0 98.91 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 108.736 -3.847 . . . . 0.0 108.904 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 64' ' ' THR . 2.9 m -99.53 101.6 12.88 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -168.21 -168.12 29.85 Favored Glycine 0 CA--C 1.541 1.702 1 C-N-CA 112.4 -4.714 . . . . 0.0 106.885 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.25 147.62 43.88 Favored 'General case' 0 CA--C 1.499 -0.998 1 O-C-N 133.709 6.182 . . . . 0.0 113.286 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 m95 -124.97 104.87 8.81 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.0 p -101.79 73.44 1.42 Allowed 'General case' 0 C--O 1.2 -1.548 1 O-C-N 134.437 7.335 . . . . 0.0 116.008 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.508 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -49.17 98.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 2 O-C-N 132.406 6.066 . . . . 0.0 103.813 179.891 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -85.11 -22.51 28.85 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 117.361 -1.736 . . . . 0.0 110.688 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.81 101.73 0.7 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 104.524 -3.43 . . . . 0.0 104.524 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 61.16 26.9 16.74 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 110.911 -2.645 . . . . 0.0 110.96 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 4.1 mtpt -133.76 -170.7 2.55 Favored 'General case' 0 C--N 1.358 0.951 1 O-C-N 130.606 4.941 . . . . 0.0 111.393 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.665 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -165.76 39.17 0.06 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 114.682 -2.807 . . . . 0.0 112.683 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.98 146.66 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 110.228 -3.169 . . . . 0.0 116.002 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.17 -145.68 13.78 Favored Glycine 0 CA--C 1.559 2.813 1 N-CA-C 100.008 -5.237 . . . . 0.0 100.008 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.475 ' CB ' HG12 ' A' ' 88' ' ' ILE . 9.4 tttm 171.05 123.04 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 134.861 6.859 . . . . 0.0 114.049 -179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -113.04 166.53 11.33 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.664 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.276 16.1 ttmt -162.84 149.95 13.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 109.666 -3.425 . . . . 0.0 113.41 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.473 ' NE ' HD11 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -98.98 72.48 1.91 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 117.242 -1.783 . . . . 0.0 106.306 178.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.4 t -29.74 -52.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 O-C-N 130.74 5.025 . . . . 0.0 115.351 -179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.55 ' N ' HG12 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -52.66 -31.07 35.26 Favored 'General case' 0 N--CA 1.435 -1.197 1 O-C-N 129.322 4.139 . . . . 0.0 112.516 -179.219 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER 170.63 -3.31 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.243 4.09 . . . . 0.0 115.479 -178.83 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' HA3' ' CD ' ' A' ' 80' ' ' ARG . . . -91.0 -30.02 11.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 104.229 -3.548 . . . . 0.0 104.229 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 76.62 -169.69 0.07 Allowed 'General case' 0 N--CA 1.425 -1.686 1 O-C-N 132.377 5.398 . . . . 0.0 118.455 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.664 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 2.0 mp0 -45.45 139.27 3.8 Favored 'General case' 0 N--CA 1.429 -1.525 1 O-C-N 132.627 6.205 . . . . 0.0 116.111 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.473 HD11 ' NE ' ' A' ' 80' ' ' ARG . 30.3 mt -148.16 47.43 1.06 Allowed 'General case' 0 C--O 1.201 -1.487 1 O-C-N 137.151 9.032 . . . . 0.0 109.806 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' A' ' 77' ' ' LYS . 89.5 mt -64.72 172.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.123 1 CA-C-N 108.342 -4.027 . . . . 0.0 104.097 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.1 66.71 1.49 Allowed 'General case' 0 C--O 1.205 -1.265 1 O-C-N 130.824 5.077 . . . . 0.0 107.903 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.16 110.49 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 1 O-C-N 131.137 5.273 . . . . 0.0 102.129 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HG3' ' N ' ' A' ' 92' ' ' GLU . 1.1 tpm_? -164.5 156.41 16.11 Favored 'General case' 0 C--O 1.188 -2.161 1 C-N-CA 111.219 -4.192 . . . . 0.0 113.182 -179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.572 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 4.2 pt-20 -158.79 134.91 9.07 Favored 'General case' 0 N--CA 1.424 -1.728 2 O-C-N 129.975 4.547 . . . . 0.0 105.149 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.832 ' CD1' HD12 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -39.75 106.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.844 1 O-C-N 132.876 6.36 . . . . 0.0 111.01 179.89 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.11 67.11 Favored 'General case' 0 C--O 1.241 0.625 1 O-C-N 129.255 4.097 . . . . 0.0 114.355 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.46 96.23 0.1 Allowed Glycine 0 CA--C 1.545 1.964 0 C-N-CA 116.181 -2.914 . . . . 0.0 106.961 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 58.05 37.13 26.51 Favored 'General case' 0 N--CA 1.437 -1.121 2 CA-C-N 107.063 -4.569 . . . . 0.0 109.495 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 93' ' ' ILE 0.304 0.0 OUTLIER 179.44 179.46 0.47 Allowed 'General case' 0 CA--C 1.564 1.499 0 O-C-N 128.047 3.342 . . . . 0.0 106.579 179.403 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.832 HD12 ' CD1' ' A' ' 93' ' ' ILE . 8.1 tt -140.54 130.78 25.02 Favored 'General case' 0 C--O 1.211 -0.963 2 O-C-N 134.646 7.466 . . . . 0.0 109.349 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' GLN . 66.7 mt -76.13 -101.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.417 -2.111 1 O-C-N 130.046 4.591 . . . . 0.0 102.717 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.655 ' HG2' HD21 ' A' ' 98' ' ' LEU . 6.8 mt-30 130.34 75.1 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.486 1 O-C-N 131.801 5.688 . . . . 0.0 102.043 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 m -81.27 93.34 6.51 Favored 'General case' 0 N--CA 1.428 -1.557 1 O-C-N 131.067 5.23 . . . . 0.0 112.006 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -68.37 125.1 25.39 Favored 'General case' 0 C--O 1.201 -1.465 2 CA-C-N 106.82 -4.718 . . . . 0.0 105.283 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 88' ' ' ILE . 17.1 m -101.76 76.99 1.69 Allowed 'General case' 0 C--O 1.206 -1.236 1 O-C-N 130.613 4.945 . . . . 0.0 101.747 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.33 109.16 21.34 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-N 108.702 -3.863 . . . . 0.0 115.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 48.88 37.0 9.12 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 112.548 -2.114 . . . . 0.0 113.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 99.65 -12.39 61.21 Favored Glycine 0 C--N 1.346 1.094 1 C-N-CA 113.762 -4.066 . . . . 0.0 113.942 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.47 131.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 117.539 -1.22 . . . . 0.0 112.958 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -90.81 71.92 6.61 Favored 'General case' 0 C--N 1.358 0.936 1 O-C-N 129.359 4.162 . . . . 0.0 107.96 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.395 . . -89.97 103.84 16.46 Favored 'General case' 0 C--O 1.196 -1.723 0 C-N-CA 112.839 -3.545 . . . . 0.0 111.044 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 145.14 30.93 Favored 'General case' 0 N--CA 1.417 -2.086 1 O-C-N 133.031 6.457 . . . . 0.0 110.475 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -128.7 119.25 24.28 Favored 'General case' 0 CA--C 1.559 1.311 2 O-C-N 132.029 5.83 . . . . 0.0 99.296 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 10.2 pt -79.22 137.08 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 1 O-C-N 130.11 4.631 . . . . 0.0 113.378 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.637 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.6 m-30 -125.68 -177.87 4.06 Favored 'General case' 0 N--CA 1.435 -1.196 2 O-C-N 135.94 8.275 . . . . 0.0 106.402 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 176.94 127.0 0.04 OUTLIER 'General case' 0 C--O 1.206 -1.233 2 CA-C-O 131.872 5.606 . . . . 0.0 113.329 -179.405 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 10.2 ttmt -41.34 -62.92 0.77 Allowed 'General case' 0 C--O 1.203 -1.381 0 CA-C-O 128.166 3.841 . . . . 0.0 117.193 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.366 1.319 0 CA-C-N 109.363 -3.562 . . . . 0.0 113.171 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.137 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.23 -42.72 83.56 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 127.312 2.882 . . . . 0.0 105.178 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.43 98.24 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 O-C-N 127.61 3.069 . . . . 0.0 116.513 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 153.58 6.66 Favored Glycine 0 N--CA 1.464 0.52 0 C-N-CA 114.594 -3.67 . . . . 0.0 104.417 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 10.8 p -66.11 167.94 9.22 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 114.923 -2.711 . . . . 0.0 108.629 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.616 ' CD2' ' HG3' ' A' ' 115' ' ' LYS 0.281 35.7 m95 -142.68 149.07 38.37 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-O 115.471 -2.204 . . . . 0.0 112.724 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 8.5 mtmt 56.7 -179.33 0.05 OUTLIER 'General case' 0 C--O 1.197 -1.663 1 O-C-N 129.488 4.242 . . . . 0.0 117.269 177.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.265 1.0 OUTLIER 33.4 141.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.534 3 O-C-N 135.793 8.183 . . . . 0.0 120.086 174.769 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -169.61 50.48 0.03 OUTLIER 'General case' 0 C--N 1.374 1.664 0 O-C-N 117.312 -3.367 . . . . 0.0 107.659 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 -137.25 150.4 47.81 Favored 'General case' 0 C--O 1.21 -1.021 0 O-C-N 120.695 -1.253 . . . . 0.0 114.17 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -115.74 94.15 4.56 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 125.682 1.864 . . . . 0.0 108.311 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.31 -64.18 1.19 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -144.98 165.08 29.18 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 127.297 2.873 . . . . 0.0 107.883 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 66.29 152.98 0.07 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 108.419 -3.991 . . . . 0.0 109.454 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 p -157.99 30.29 0.26 Allowed 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.1 31.19 5.39 Favored Glycine 0 CA--C 1.55 2.255 0 O-C-N 126.42 2.325 . . . . 0.0 112.681 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.8 -104.47 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 111.281 -2.46 . . . . 0.0 109.793 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -153.78 -170.37 3.56 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.78 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.62 -169.6 0.04 OUTLIER 'General case' 0 C--O 1.201 -1.481 0 C-N-CA 117.566 -1.654 . . . . 0.0 111.013 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -93.26 -124.1 0.09 Allowed 'General case' 0 C--N 1.352 0.705 0 O-C-N 126.375 2.297 . . . . 0.0 113.956 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 155.02 22.67 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 101.565 -3.494 . . . . 0.0 101.565 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.371 0.0 OUTLIER -179.24 123.49 0.08 Allowed 'General case' 0 C--O 1.195 -1.787 0 O-C-N 128.878 3.861 . . . . 0.0 105.529 179.956 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 8.8 mt -87.91 162.0 17.15 Favored 'General case' 0 CA--C 1.552 1.036 2 O-C-N 129.862 4.476 . . . . 0.0 101.654 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 87.7 m -178.53 64.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.195 1 O-C-N 130.117 4.636 . . . . 0.0 105.439 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.428 ' H ' HD12 ' A' ' 25' ' ' ILE . 3.4 mp -82.48 146.45 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 113.339 -3.344 . . . . 0.0 109.209 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.5 m -172.37 79.18 0.05 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 113.546 -3.261 . . . . 0.0 103.273 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.513 ' HB3' ' CE1' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -31.0 139.51 0.03 OUTLIER 'General case' 0 C--O 1.208 -1.099 2 O-C-N 134.834 7.584 . . . . 0.0 116.742 179.734 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -104.18 -99.61 0.31 Allowed 'General case' 0 CA--C 1.546 0.822 0 O-C-N 128.815 3.822 . . . . 0.0 104.177 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.07 80.99 0.36 Allowed Glycine 0 CA--C 1.564 3.123 1 N-CA-C 99.699 -5.361 . . . . 0.0 99.699 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 68.66 28.33 5.71 Favored 'General case' 0 N--CA 1.433 -1.295 2 O-C-N 131.875 5.103 . . . . 0.0 106.646 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 8.5 ttpp -131.91 110.1 10.55 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 128.925 3.89 . . . . 0.0 101.315 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -101.36 166.37 10.78 Favored 'General case' 0 C--O 1.197 -1.687 2 N-CA-C 95.269 -5.826 . . . . 0.0 95.269 -179.434 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 98.17 4.38 Favored 'General case' 0 N--CA 1.478 0.96 3 O-C-N 137.692 9.37 . . . . 0.0 97.356 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.409 0.9 OUTLIER -72.42 127.33 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 2 C-N-CA 109.643 -4.823 . . . . 0.0 98.984 179.705 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.429 25.1 tttt -76.18 8.43 3.3 Favored 'General case' 0 C--N 1.368 1.387 0 CA-C-N 109.978 -3.283 . . . . 0.0 119.581 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.421 2.6 mt-10 -47.76 106.54 0.09 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 111.038 -2.801 . . . . 0.0 103.502 179.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.1 p -138.36 145.84 41.57 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 128.282 3.489 . . . . 0.0 106.57 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.3 p -140.28 -175.25 4.19 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 116.217 -2.193 . . . . 0.0 112.373 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -15.98 60.81 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 127.408 2.943 . . . . 0.0 105.02 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -97.26 -109.8 0.16 Allowed 'General case' 0 N--CA 1.435 -1.215 1 CA-C-N 108.194 -4.093 . . . . 0.0 108.934 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.717 ' HG2' ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -135.75 44.97 2.46 Favored 'General case' 0 CA--C 1.496 -1.114 1 O-C-N 129.161 4.038 . . . . 0.0 117.785 -179.076 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -72.62 -35.68 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.901 ' CG2' HD21 ' A' ' 57' ' ' LEU 0.267 5.1 tt 11.96 60.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.602 2 O-C-N 133.944 7.027 . . . . 0.0 112.036 178.318 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.93 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.831 -2.44 . . . . 0.0 111.436 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.31 50.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 N-CA-C 100.5 -3.889 . . . . 0.0 100.5 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.275 3.0 p -61.53 167.22 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 O-C-N 129.065 3.978 . . . . 0.0 112.782 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -166.44 -157.1 0.26 Allowed 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.926 3.891 . . . . 0.0 111.064 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 1.2 mt-10 -138.42 52.79 1.81 Allowed 'General case' 0 C--N 1.359 0.979 0 O-C-N 126.472 2.357 . . . . 0.0 114.802 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 2.3 tp 18.11 113.81 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.533 1 CA-C-O 130.004 4.716 . . . . 0.0 117.461 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.32 51.4 8.62 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 103.375 -3.89 . . . . 0.0 103.375 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.52 121.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 1 O-C-N 134.53 6.664 . . . . 0.0 115.177 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.54 16.22 Favored 'General case' 0 C--O 1.21 -1.002 1 O-C-N 131.58 5.55 . . . . 0.0 110.167 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 47' ' ' PHE . 9.5 p90 -176.99 169.47 2.37 Favored 'General case' 0 N--CA 1.421 -1.879 0 O-C-N 128.554 3.659 . . . . 0.0 114.457 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 136.67 52.77 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 101.247 -3.612 . . . . 0.0 101.247 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.23 101.62 4.06 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 128.923 3.889 . . . . 0.0 113.409 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 t -69.92 155.98 39.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 113.296 -3.361 . . . . 0.0 102.844 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.901 HD21 ' CG2' ' A' ' 43' ' ' ILE . 5.5 tp -147.21 -92.66 0.09 Allowed 'General case' 0 C--O 1.245 0.85 1 O-C-N 129.269 4.106 . . . . 0.0 110.745 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.717 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . . . -60.06 -5.45 1.03 Allowed 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 112.921 -3.418 . . . . 0.0 115.999 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t70 106.49 -15.65 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.595 1 O-C-N 129.531 4.269 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.11 -55.6 0.26 Allowed Glycine 0 CA--C 1.558 2.74 0 N-CA-C 104.202 -3.559 . . . . 0.0 104.202 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.8 p -39.56 137.87 0.78 Allowed 'General case' 0 N--CA 1.432 -1.374 0 O-C-N 128.968 3.393 . . . . 0.0 110.249 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.94 37.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 114.551 -2.86 . . . . 0.0 109.023 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HG ' HD21 ' A' ' 87' ' ' LEU . 10.2 mp -42.02 97.91 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.687 1 O-C-N 130.658 4.974 . . . . 0.0 112.225 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.4 m -93.84 99.39 11.77 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 111.602 -2.544 . . . . 0.0 106.388 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.69 -175.71 34.0 Favored Glycine 0 C--O 1.201 -1.937 1 C-N-CA 111.617 -5.087 . . . . 0.0 108.556 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' THR . 15.0 t -140.85 143.81 34.97 Favored 'General case' 0 CA--C 1.5 -0.978 2 O-C-N 132.509 5.476 . . . . 0.0 111.883 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.691 ' CZ2' ' HB3' ' A' ' 89' ' ' ALA . 15.3 m95 -124.25 111.64 16.08 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 p -99.98 41.88 1.14 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 135.485 7.991 . . . . 0.0 113.613 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.431 ' HB2' HD13 ' A' ' 49' ' ' LEU . 4.6 tmm? -37.52 107.43 0.06 Allowed 'General case' 0 C--N 1.317 -0.806 1 O-C-N 134.434 7.334 . . . . 0.0 107.917 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -82.99 -74.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.305 0 O-C-N 129.055 3.972 . . . . 0.0 108.525 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.56 -79.85 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.117 1 O-C-N 129.435 4.21 . . . . 0.0 107.993 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -117.58 44.21 2.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 127.991 2.818 . . . . 0.0 108.865 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -141.08 178.73 7.18 Favored 'General case' 0 C--N 1.356 0.865 1 O-C-N 129.147 4.029 . . . . 0.0 112.451 -179.96 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 4.8 mt -148.28 91.87 1.96 Allowed 'General case' 0 C--N 1.321 -0.649 0 O-C-N 126.584 2.428 . . . . 0.0 110.596 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.28 119.68 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 O-C-N 128.321 3.513 . . . . 0.0 117.444 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.55 -141.33 5.82 Favored Glycine 0 CA--C 1.557 2.673 1 CA-C-N 108.082 -4.145 . . . . 0.0 103.772 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -178.79 131.68 0.12 Allowed 'General case' 0 C--O 1.204 -1.334 1 O-C-N 131.772 5.042 . . . . 0.0 113.966 -179.972 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.616 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.4 OUTLIER -127.13 167.9 15.38 Favored 'General case' 0 C--O 1.204 -1.293 0 CA-C-O 127.417 3.484 . . . . 0.0 101.672 179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 6.8 ttmt -170.48 144.14 2.39 Favored 'General case' 0 N--CA 1.427 -1.617 1 CA-C-N 106.857 -4.702 . . . . 0.0 114.138 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 69.64 0.8 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 125.105 1.503 . . . . 0.0 107.175 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -31.64 -40.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.39 1 O-C-N 131.184 5.302 . . . . 0.0 115.472 -179.828 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.477 ' N ' ' CG1' ' A' ' 81' ' ' VAL . 11.6 p-10 -56.73 -28.68 61.49 Favored 'General case' 0 N--CA 1.442 -0.832 1 O-C-N 131.03 5.206 . . . . 0.0 112.549 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 172.08 -7.49 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 O-C-N 128.903 3.877 . . . . 0.0 115.998 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.5 -34.38 6.08 Favored Glycine 0 CA--C 1.543 1.79 0 N-CA-C 104.092 -3.603 . . . . 0.0 104.092 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.492 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 78.0 -171.19 0.06 Allowed 'General case' 0 N--CA 1.436 -1.158 1 O-C-N 132.153 5.266 . . . . 0.0 117.272 -179.804 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 77.6 mt-10 -48.6 149.48 1.67 Allowed 'General case' 0 N--CA 1.432 -1.334 1 O-C-N 132.355 6.034 . . . . 0.0 113.456 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.499 HD21 ' HG ' ' A' ' 63' ' ' LEU 0.257 0.1 OUTLIER -158.18 35.38 0.24 Allowed 'General case' 0 C--O 1.196 -1.751 1 O-C-N 135.255 7.847 . . . . 0.0 109.343 178.772 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' A' ' 103' ' ' THR 0.251 42.7 mt -50.28 127.49 6.1 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.639 1 O-C-N 132.98 6.425 . . . . 0.0 100.479 -179.794 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -87.62 68.88 9.64 Favored 'General case' 0 C--O 1.205 -1.244 1 O-C-N 132.878 6.361 . . . . 0.0 110.958 -179.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.7 t -66.92 108.36 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 1 C-N-CA 111.567 -4.053 . . . . 0.0 102.843 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' HD2' HD21 ' A' ' 98' ' ' LEU . 8.9 ttm180 -139.05 168.73 19.19 Favored 'General case' 0 C--O 1.195 -1.778 0 O-C-N 128.479 3.612 . . . . 0.0 111.674 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -176.12 94.09 0.05 Allowed 'General case' 0 C--N 1.363 1.184 2 O-C-N 132.458 6.099 . . . . 0.0 108.438 179.829 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -28.28 105.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.749 1 O-C-N 133.424 6.702 . . . . 0.0 112.115 -179.938 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.9 m -94.55 130.73 40.85 Favored 'General case' 0 N--CA 1.439 -0.976 1 O-C-N 129.117 4.01 . . . . 0.0 113.541 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.1 -116.27 7.07 Favored Glycine 0 CA--C 1.561 2.91 1 N-CA-C 100.653 -4.979 . . . . 0.0 100.653 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.69 57.69 1.05 Allowed 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 129.609 3.77 . . . . 0.0 107.999 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.705 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.269 0.0 OUTLIER 176.77 115.55 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.53 1 O-C-N 130.694 4.996 . . . . 0.0 107.312 179.375 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 93' ' ' ILE . 1.5 tp -65.3 148.34 51.87 Favored 'General case' 0 N--CA 1.416 -2.158 2 O-C-N 133.366 6.667 . . . . 0.0 111.686 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.519 HG21 ' HD2' ' A' ' 110' ' ' LYS . 2.2 mt -130.27 128.92 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 3 O-C-N 131.6 5.563 . . . . 0.0 102.571 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' NE ' ' A' ' 91' ' ' ARG . 0.7 OUTLIER -119.75 129.09 54.33 Favored 'General case' 0 C--O 1.21 -1.003 1 O-C-N 135.395 7.935 . . . . 0.0 101.796 179.891 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HG2' ' A' ' 110' ' ' LYS . 68.6 p -82.34 -43.96 16.79 Favored 'General case' 0 N--CA 1.41 -2.467 2 O-C-N 131.184 5.303 . . . . 0.0 116.457 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 59.95 61.03 1.98 Allowed 'General case' 0 C--O 1.205 -1.281 1 O-C-N 129.331 4.144 . . . . 0.0 104.406 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 88' ' ' ILE . 54.7 m -55.2 101.85 0.06 Allowed 'General case' 0 N--CA 1.479 1.002 1 N-CA-C 100.119 -4.03 . . . . 0.0 100.119 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.41 113.1 20.86 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 109.165 -3.652 . . . . 0.0 110.561 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -4.79 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HG23 ' A' ' 107' ' ' VAL . . . 94.92 -3.8 67.64 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 116.618 -2.706 . . . . 0.0 112.536 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 106' ' ' GLY . 1.4 t -162.56 154.12 3.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -119.15 114.14 21.99 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 128.206 3.441 . . . . 0.0 102.334 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.378 . . -102.96 81.64 2.01 Favored 'General case' 0 N--CA 1.411 -2.382 0 C-N-CA 116.314 -2.155 . . . . 0.0 114.295 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HD2' HG21 ' A' ' 99' ' ' ILE . 1.6 mtmm -72.25 150.72 43.39 Favored 'General case' 0 N--CA 1.435 -1.18 1 O-C-N 129.993 4.558 . . . . 0.0 108.859 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 112' ' ' ILE . 5.8 mtp180 -131.91 -164.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 1 O-C-N 131.381 5.426 . . . . 0.0 103.234 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -162.0 79.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.044 1 C-N-CA 111.45 -4.1 . . . . 0.0 109.85 179.993 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.509 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 41.6 m-85 -100.2 -145.08 0.34 Allowed 'General case' 0 C--N 1.319 -0.757 1 O-C-N 130.552 4.907 . . . . 0.0 105.704 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.705 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.47 -154.45 0.16 Allowed 'General case' 0 C--O 1.197 -1.699 1 O-C-N 131.979 5.799 . . . . 0.0 111.462 -179.856 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.616 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 21.5 tttt -115.21 -141.71 0.38 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 111.842 -2.436 . . . . 0.0 111.605 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 N--CA 1.439 -1.0 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.222 -179.512 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.162 0 CA-C-O 116.222 -1.847 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 98' ' ' LEU . 98.3 m-85 54.01 81.97 0.09 Allowed 'General case' 0 CA--C 1.554 1.133 1 O-C-N 133.744 6.903 . . . . 0.0 101.753 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 24.4 p-10 -169.32 32.55 0.02 OUTLIER 'General case' 0 C--N 1.364 1.202 0 CA-C-N 110.137 -3.211 . . . . 0.0 115.914 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.53 159.62 21.18 Favored Glycine 0 C--N 1.346 1.105 1 C-N-CA 113.38 -4.248 . . . . 0.0 106.777 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 0.2 OUTLIER -58.26 134.21 56.34 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 115.382 -2.527 . . . . 0.0 109.723 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.645 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.301 70.8 m95 -114.89 140.71 48.76 Favored 'General case' 0 N--CA 1.412 -2.342 1 CA-C-O 111.087 -4.292 . . . . 0.0 111.983 -179.807 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 11.4 mtmt 67.13 177.81 0.23 Allowed 'General case' 0 N--CA 1.424 -1.736 1 O-C-N 131.547 5.529 . . . . 0.0 118.164 176.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER 41.79 149.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.51 3 O-C-N 136.329 8.518 . . . . 0.0 120.802 174.893 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.52 35.69 0.01 OUTLIER 'General case' 0 C--N 1.37 1.496 1 CA-C-N 108.144 -4.116 . . . . 0.0 105.42 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -122.96 72.85 1.11 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 123.238 1.494 . . . . 0.0 114.269 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -171.04 120.69 0.53 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 112.696 -2.047 . . . . 0.0 112.931 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.21 -41.33 1.26 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 116.469 -1.729 . . . . 0.0 109.081 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.463 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 2.0 p30 -115.81 14.21 16.25 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 128.084 3.365 . . . . 0.0 106.328 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 2.4 m-85 46.37 61.6 2.67 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 127.832 3.208 . . . . 0.0 111.262 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -81.27 138.46 35.73 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 116.741 -1.983 . . . . 0.0 107.004 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.34 -132.75 5.63 Favored Glycine 0 C--O 1.207 -1.561 0 O-C-N 126.067 2.104 . . . . 0.0 112.297 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.82 -51.54 3.85 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 110.728 -2.736 . . . . 0.0 106.305 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -98.59 0.06 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.404 -1.284 . . . . 0.0 108.649 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -124.79 139.47 53.82 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 127.062 2.726 . . . . 0.0 108.298 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -58.69 174.16 0.35 Allowed 'General case' 0 CA--C 1.561 1.399 1 O-C-N 129.287 4.117 . . . . 0.0 110.308 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -83.44 -175.46 5.84 Favored 'General case' 0 CA--C 1.562 1.437 0 CA-C-N 110.394 -3.094 . . . . 0.0 104.885 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.323 1.4 ptmt 163.52 150.39 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.466 1 O-C-N 134.967 7.667 . . . . 0.0 103.661 179.85 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 2.9 mt -114.04 176.35 5.08 Favored 'General case' 0 CA--C 1.56 1.354 2 O-C-N 131.778 5.673 . . . . 0.0 98.486 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.646 ' O ' HD12 ' A' ' 25' ' ' ILE . 77.8 m -162.03 -97.28 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 128.729 3.768 . . . . 0.0 107.668 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.673 HG21 ' CE2' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 63.9 145.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-O 124.784 2.231 . . . . 0.0 115.947 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 169.27 67.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -26.15 124.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.28 2 O-C-N 135.804 8.19 . . . . 0.0 114.173 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 -9.02 53.29 Favored 'General case' 0 N--CA 1.482 1.128 1 O-C-N 130.918 5.136 . . . . 0.0 106.371 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 162.87 -40.83 0.35 Allowed Glycine 0 CA--C 1.55 2.279 1 N-CA-C 102.171 -4.372 . . . . 0.0 102.171 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.79 -12.13 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.926 1 O-C-N 131.461 4.859 . . . . 0.0 112.817 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -78.95 120.21 23.22 Favored 'General case' 0 N--CA 1.48 1.062 1 N-CA-C 96.253 -5.462 . . . . 0.0 96.253 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.673 ' CE2' HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -126.45 105.33 8.69 Favored 'General case' 0 C--O 1.208 -1.118 1 N-CA-C 98.73 -4.545 . . . . 0.0 98.73 -179.263 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -109.21 127.07 53.93 Favored 'General case' 0 CA--C 1.492 -1.267 2 O-C-N 135.603 8.064 . . . . 0.0 104.435 -179.814 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HG2' ' A' ' 36' ' ' GLU 0.324 2.2 t -93.95 143.8 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 CA-C-O 126.659 3.123 . . . . 0.0 103.248 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.552 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -86.59 70.03 10.4 Favored 'General case' 0 C--O 1.196 -1.718 2 CA-C-O 133.405 6.336 . . . . 0.0 112.902 179.114 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HG2' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -78.34 44.8 0.52 Allowed 'General case' 0 N--CA 1.42 -1.95 1 CA-C-N 107.49 -4.414 . . . . 0.0 109.672 -179.697 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 t -67.78 119.81 13.09 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 114.023 -3.071 . . . . 0.0 104.803 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.32 100.07 0.94 Allowed 'General case' 0 C--O 1.244 0.791 0 O-C-N 127.442 2.964 . . . . 0.0 109.934 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 62.47 -173.32 0.15 Allowed 'General case' 0 C--N 1.361 1.094 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 12.6 m-85 57.2 -95.56 0.06 Allowed 'General case' 0 C--N 1.357 0.915 1 O-C-N 129.371 4.169 . . . . 0.0 106.667 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD2' ' HB3' ' A' ' 40' ' ' PHE 0.291 1.4 mpt_? -153.58 -161.5 1.27 Allowed 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 128.249 2.62 . . . . 0.0 111.316 179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -103.91 98.93 8.7 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 128.022 3.326 . . . . 0.0 103.12 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.263 0.1 OUTLIER -131.17 151.02 35.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 2 CA-C-O 130.784 5.088 . . . . 0.0 110.051 -178.894 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 33' ' ' THR . 1.1 m-20 -117.67 173.18 6.88 Favored 'General case' 0 N--CA 1.427 -1.62 1 CA-C-N 107.189 -4.55 . . . . 0.0 109.588 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 m -116.03 105.86 19.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 1 O-C-N 132.825 6.328 . . . . 0.0 101.0 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.313 6.3 p -112.27 158.92 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 113.671 -3.212 . . . . 0.0 116.187 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.455 ' CD2' ' C ' ' A' ' 46' ' ' VAL . 5.2 p90 -171.52 -132.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.647 1 O-C-N 131.761 5.663 . . . . 0.0 111.026 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -162.48 58.87 0.22 Allowed 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 112.924 -3.511 . . . . 0.0 114.898 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 32' ' ' PHE . 0.2 OUTLIER 31.53 101.87 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 127.345 2.903 . . . . 0.0 116.637 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.91 58.4 2.36 Favored Glycine 0 CA--C 1.547 2.09 1 N-CA-C 102.73 -4.148 . . . . 0.0 102.73 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.4 t -156.52 118.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.779 1 O-C-N 131.858 5.093 . . . . 0.0 113.43 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.539 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 1.0 OUTLIER -78.17 160.58 27.91 Favored 'General case' 0 C--O 1.206 -1.203 1 O-C-N 129.403 4.19 . . . . 0.0 107.625 179.723 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CE1' ' C ' ' A' ' 65' ' ' GLY . 15.2 p90 -175.85 149.2 0.91 Allowed 'General case' 0 C--N 1.36 1.048 2 O-C-N 132.328 6.018 . . . . 0.0 115.576 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -110.92 90.58 3.37 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 115.556 -2.164 . . . . 0.0 106.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.24 135.61 38.92 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 127.568 3.042 . . . . 0.0 111.897 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -96.43 85.08 3.83 Favored 'General case' 0 CA--C 1.551 1.007 1 O-C-N 130.857 5.098 . . . . 0.0 105.759 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' THR . 3.7 mp -71.05 -173.03 0.76 Allowed 'General case' 0 C--O 1.243 0.721 1 O-C-N 132.394 6.059 . . . . 0.0 110.264 179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . 49.05 -146.86 0.32 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-O 115.033 -2.413 . . . . 0.0 111.178 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -90.54 -6.09 55.17 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 128.027 3.329 . . . . 0.0 108.935 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.16 49.83 0.02 OUTLIER Glycine 0 CA--C 1.549 2.181 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.9 m -102.39 116.61 32.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 126.585 1.991 . . . . 0.0 109.18 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.5 119.21 36.8 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 115.574 -2.45 . . . . 0.0 109.115 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -127.14 60.82 1.38 Allowed 'General case' 0 C--O 1.202 -1.415 0 CA-C-N 110.726 -2.943 . . . . 0.0 107.215 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 54.4 m -41.7 117.03 0.86 Allowed 'General case' 0 N--CA 1.436 -1.142 1 O-C-N 129.23 4.081 . . . . 0.0 104.175 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.438 ' C ' ' CE1' ' A' ' 53' ' ' PHE . . . -149.1 -159.74 8.74 Favored Glycine 0 C--O 1.209 -1.436 1 C-N-CA 110.175 -5.774 . . . . 0.0 108.65 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.539 ' HB ' ' HA ' ' A' ' 52' ' ' ASP 0.287 0.7 OUTLIER 175.25 130.94 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.136 2 O-C-N 131.992 5.172 . . . . 0.0 111.808 -178.252 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.75 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 33.4 m95 -136.31 121.01 18.43 Favored 'General case' 0 C--O 1.203 -1.351 0 O-C-N 119.044 -2.285 . . . . 0.0 106.46 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.5 p -98.76 22.49 9.99 Favored 'General case' 0 N--CA 1.426 -1.63 2 O-C-N 130.651 4.969 . . . . 0.0 116.988 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 4.22 88.23 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.984 1 O-C-N 136.567 8.667 . . . . 0.0 108.322 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -94.99 95.2 8.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 128.047 3.342 . . . . 0.0 111.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.45 -102.2 0.3 Allowed Glycine 0 CA--C 1.541 1.66 1 O-C-N 129.268 4.105 . . . . 0.0 105.565 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . 74.9 m-20 -120.24 53.37 1.09 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 115.31 -2.281 . . . . 0.0 113.103 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . 2.4 mtpt -135.92 171.47 14.42 Favored 'General case' 0 C--N 1.343 0.308 1 O-C-N 130.978 5.174 . . . . 0.0 109.185 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -142.08 54.74 1.46 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 127.874 3.234 . . . . 0.0 111.797 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.88 102.0 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.862 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -171.33 -161.62 22.27 Favored Glycine 0 C--O 1.2 -2.021 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.288 0.0 OUTLIER -156.89 165.39 36.32 Favored 'General case' 0 C--N 1.368 1.408 0 O-C-N 129.028 3.428 . . . . 0.0 113.713 -179.508 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.75 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 33.7 m-85 -145.54 153.84 41.54 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 101.248 -3.612 . . . . 0.0 101.248 176.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.325 0.0 OUTLIER -171.45 130.99 0.72 Allowed 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 110.255 -3.157 . . . . 0.0 116.86 -179.633 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.502 ' HB2' ' CB ' ' A' ' 85' ' ' LYS . 94.0 mtt180 -81.39 100.58 9.33 Favored 'General case' 0 N--CA 1.439 -0.989 1 O-C-N 129.374 4.171 . . . . 0.0 108.977 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.91 -26.85 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 1 O-C-N 132.208 5.943 . . . . 0.0 108.757 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -57.0 -39.52 74.85 Favored 'General case' 0 N--CA 1.442 -0.837 1 O-C-N 132.215 5.947 . . . . 0.0 110.466 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -126.15 -2.47 7.0 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 127.513 3.008 . . . . 0.0 117.073 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.503 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 77.61 38.01 29.17 Favored Glycine 0 C--O 1.2 -2.025 2 C-N-CA 112.224 -4.798 . . . . 0.0 101.889 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.26 15.4 tptp -81.05 -71.92 0.45 Allowed 'General case' 0 N--CA 1.424 -1.755 2 O-C-N 132.695 5.585 . . . . 0.0 120.935 -178.87 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 12.3 mm-40 73.93 108.38 0.07 Allowed 'General case' 0 N--CA 1.429 -1.506 1 O-C-N 129.206 4.067 . . . . 0.0 113.464 -178.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 63' ' ' LEU . 2.5 pt? -139.56 49.21 1.81 Allowed 'General case' 0 C--O 1.198 -1.635 1 O-C-N 132.255 5.972 . . . . 0.0 109.985 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 76' ' ' GLY 0.255 30.6 mt -61.99 139.71 20.36 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.317 1 CA-C-N 107.849 -4.251 . . . . 0.0 101.357 -179.812 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.68 97.83 7.61 Favored 'General case' 0 C--O 1.2 -1.54 1 O-C-N 134.73 7.519 . . . . 0.0 103.254 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 101' ' ' THR . 2.8 t -95.34 115.6 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 O-C-N 128.941 3.901 . . . . 0.0 110.541 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.559 ' CG ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -163.72 -168.54 1.67 Allowed 'General case' 0 C--O 1.192 -1.94 0 C-N-CA 112.923 -3.511 . . . . 0.0 115.933 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.559 ' H ' ' CG ' ' A' ' 91' ' ' ARG 0.296 0.1 OUTLIER -177.12 110.93 0.08 Allowed 'General case' 0 CA--C 1.546 0.812 1 O-C-N 130.419 4.824 . . . . 0.0 106.127 -179.535 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.6 HD11 ' H ' ' A' ' 97' ' ' GLU . 2.4 tp -33.25 98.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 1 O-C-N 133.46 6.725 . . . . 0.0 113.317 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -84.03 75.17 10.17 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 116.152 -2.219 . . . . 0.0 115.076 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 115.26 -123.41 5.94 Favored Glycine 0 CA--C 1.563 3.077 1 N-CA-C 102.585 -4.206 . . . . 0.0 102.585 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -130.52 44.25 2.99 Favored 'General case' 0 N--CA 1.437 -1.112 1 CA-C-N 108.055 -4.072 . . . . 0.0 106.073 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.694 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.278 0.0 OUTLIER -173.4 97.92 0.12 Allowed 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.416 4.823 . . . . 0.0 108.777 179.725 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 2' ' ' PHE . 3.2 tt -72.99 148.64 44.03 Favored 'General case' 0 N--CA 1.424 -1.727 1 O-C-N 130.321 4.763 . . . . 0.0 115.209 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.61 167.26 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 2 CA-C-N 106.345 -4.934 . . . . 0.0 103.429 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.25 98.93 0.83 Allowed 'General case' 0 C--O 1.204 -1.294 1 O-C-N 131.13 5.269 . . . . 0.0 103.895 179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 90' ' ' VAL . 8.9 t -85.49 112.34 20.82 Favored 'General case' 0 N--CA 1.428 -1.574 2 O-C-N 131.177 5.298 . . . . 0.0 112.461 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.18 88.97 2.49 Favored 'General case' 0 C--O 1.208 -1.118 2 C-N-CA 110.772 -4.371 . . . . 0.0 105.773 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.8 m -65.4 93.72 0.15 Allowed 'General case' 0 C--O 1.209 -1.076 0 O-C-N 128.659 3.725 . . . . 0.0 101.37 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' C ' ' CD1' ' A' ' 104' ' ' TYR . 1.8 t80 -110.57 114.5 27.96 Favored 'General case' 0 CA--C 1.498 -1.038 1 CA-C-N 107.512 -4.404 . . . . 0.0 111.426 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 47.45 17.59 0.08 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 112.428 -2.169 . . . . 0.0 116.547 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.31 16.91 19.36 Favored Glycine 0 C--N 1.361 1.947 0 C-N-CA 116.306 -2.854 . . . . 0.0 114.59 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.15 -38.29 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-N 120.225 2.013 . . . . 0.0 113.357 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 68.16 97.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.427 1 O-C-N 130.071 4.607 . . . . 0.0 108.151 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.363 . . -132.07 113.64 13.59 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 128.398 3.561 . . . . 0.0 109.116 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HG2' ' HB ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -116.25 -174.34 2.53 Favored 'General case' 0 N--CA 1.421 -1.878 1 O-C-N 133.694 6.871 . . . . 0.0 111.381 -179.422 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -156.5 119.8 4.22 Favored 'General case' 0 C--O 1.204 -1.331 2 O-C-N 130.418 4.824 . . . . 0.0 101.511 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -93.06 125.36 45.63 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 O-C-N 127.763 3.164 . . . . 0.0 112.903 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.503 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 65.6 m-85 -120.58 -141.96 0.34 Allowed 'General case' 0 N--CA 1.446 -0.673 1 O-C-N 131.013 5.196 . . . . 0.0 104.949 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.694 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -164.16 -149.89 0.14 Allowed 'General case' 0 C--O 1.199 -1.579 1 O-C-N 131.538 5.524 . . . . 0.0 112.526 179.903 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.645 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 24.0 tttt -128.56 154.79 45.81 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 127.211 2.204 . . . . 0.0 111.185 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 N--CA 1.434 -1.228 0 O-C-N 127.767 3.167 . . . . 0.0 113.678 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.195 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -118.17 61.51 0.77 Allowed 'General case' 0 CA--C 1.554 1.116 1 O-C-N 129.9 4.5 . . . . 0.0 102.752 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -144.33 57.49 1.32 Allowed 'General case' 0 C--N 1.358 0.938 0 CA-C-N 110.126 -3.215 . . . . 0.0 111.192 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.429 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . -165.53 177.31 40.85 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 114.113 -3.899 . . . . 0.0 105.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.327 23.8 p -80.26 177.81 8.71 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 113.858 -3.137 . . . . 0.0 104.087 179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.662 ' CE3' ' HG3' ' A' ' 115' ' ' LYS . 75.3 m95 -150.69 167.86 26.08 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 115.506 -2.187 . . . . 0.0 112.189 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.613 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 8.5 mtmt 51.03 179.19 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 O-C-N 127.83 3.207 . . . . 0.0 118.814 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 32.22 112.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.486 -1.512 3 O-C-N 133.492 6.745 . . . . 0.0 121.414 174.879 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -140.37 -148.81 0.26 Allowed 'General case' 0 N--CA 1.425 -1.723 1 CA-C-N 107.535 -4.393 . . . . 0.0 103.721 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -97.53 54.01 1.17 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 123.145 1.45 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -98.97 152.44 19.8 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.986 -1.086 . . . . 0.0 113.29 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -151.53 89.11 1.46 Allowed 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 111.498 -2.592 . . . . 0.0 105.73 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -89.74 -12.27 39.85 Favored 'General case' 0 C--N 1.362 1.109 0 O-C-N 125.38 1.675 . . . . 0.0 109.277 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.46 -92.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 O-C-N 126.4 2.312 . . . . 0.0 112.116 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -179.52 -171.62 0.2 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 124.61 2.147 . . . . 0.0 107.041 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 41.62 4.89 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 111.349 -2.66 . . . . 0.0 110.779 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 131.49 47.64 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -156.27 -44.87 0.07 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 117.367 -1.302 . . . . 0.0 110.595 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.08 170.05 13.37 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 126.416 2.322 . . . . 0.0 112.082 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -133.11 115.72 15.43 Favored 'General case' 0 CA--C 1.538 0.495 1 O-C-N 129.846 4.466 . . . . 0.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -130.95 -164.03 1.39 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 114.216 -2.802 . . . . 0.0 106.506 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.407 0.0 OUTLIER -179.14 175.45 0.96 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 133.237 6.586 . . . . 0.0 103.342 -179.7 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.2 mt -136.96 157.55 46.49 Favored 'General case' 0 CA--C 1.565 1.547 3 O-C-N 133.895 6.997 . . . . 0.0 97.7 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 24' ' ' THR . 2.9 m 177.78 80.44 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.528 1 O-C-N 131.913 5.758 . . . . 0.0 106.514 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.703 HG22 ' HB2' ' A' ' 32' ' ' PHE . 2.2 mp -95.81 118.76 42.78 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.02 0 CA-C-N 109.451 -3.522 . . . . 0.0 109.079 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.5 m -172.63 68.62 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 128.895 3.872 . . . . 0.0 108.905 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' HB2' ' C ' ' A' ' 31' ' ' LYS 0.297 1.5 tp60 -73.89 -95.26 0.02 OUTLIER 'General case' 0 C--N 1.354 0.786 1 C-N-CA 110.74 -4.384 . . . . 0.0 115.504 -179.888 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 170.86 144.94 0.03 OUTLIER 'General case' 0 C--O 1.244 0.771 0 O-C-N 128.555 3.659 . . . . 0.0 106.427 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 30' ' ' ASN . . . 74.88 -97.32 1.0 Allowed Glycine 0 CA--C 1.559 2.792 3 O-C-N 130.902 5.127 . . . . 0.0 102.361 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 12.2 m120 -152.74 47.64 0.72 Allowed 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.62 6.129 . . . . 0.0 112.317 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 6.1 mttp -118.33 161.85 19.26 Favored 'General case' 0 CA--C 1.552 1.048 1 N-CA-C 96.579 -5.341 . . . . 0.0 96.579 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 25' ' ' ILE . 23.0 p90 -167.8 76.96 0.15 Allowed 'General case' 0 C--O 1.197 -1.706 2 C-N-CA 110.383 -4.527 . . . . 0.0 99.656 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 138.12 58.43 Favored 'General case' 0 CA--C 1.505 -0.755 2 O-C-N 130.907 5.129 . . . . 0.0 100.529 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.853 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 6.8 t -91.05 132.66 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 99.098 -4.408 . . . . 0.0 99.098 179.688 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.25 19.8 tttt -73.74 52.61 0.41 Allowed 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 126.732 3.158 . . . . 0.0 117.28 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.853 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.265 50.3 mt-10 -72.28 68.24 0.74 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.869 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -84.49 91.42 7.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 114.257 -2.977 . . . . 0.0 108.85 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 m -87.54 -178.78 6.2 Favored 'General case' 0 C--N 1.367 1.34 0 O-C-N 126.622 2.451 . . . . 0.0 116.549 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.6 -9.16 59.79 Favored 'General case' 0 C--O 1.213 -0.818 0 O-C-N 126.102 2.126 . . . . 0.0 108.351 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.452 ' CB ' ' HD2' ' A' ' 41' ' ' ARG . 19.7 m-85 -69.3 -55.32 10.82 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 113.341 -3.343 . . . . 0.0 106.978 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HD2' ' CB ' ' A' ' 40' ' ' PHE . 0.1 OUTLIER -158.95 6.63 0.11 Allowed 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 114.394 -2.717 . . . . 0.0 117.367 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.81 62.97 0.87 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 101.927 -3.361 . . . . 0.0 101.927 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 0.0 OUTLIER -134.88 113.47 16.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 3 CA-C-O 130.994 5.188 . . . . 0.0 111.249 -178.301 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.98 -172.95 4.21 Favored 'General case' 0 C--N 1.372 1.586 1 CA-C-N 107.259 -4.519 . . . . 0.0 109.59 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -133.26 118.36 31.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 O-C-N 128.839 3.837 . . . . 0.0 101.525 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -106.33 160.64 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 C-N-CA 113.035 -3.466 . . . . 0.0 111.758 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER 177.09 -176.89 0.15 Allowed 'General case' 0 N--CA 1.435 -1.183 1 O-C-N 129.818 4.449 . . . . 0.0 111.649 -179.819 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.315 3.7 tm-20 -141.97 86.51 1.99 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 114.676 -2.809 . . . . 0.0 113.388 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 36.87 91.64 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.282 1 O-C-N 131.236 5.335 . . . . 0.0 115.743 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.823 ' HA3' HG22 ' A' ' 68' ' ' THR . . . 57.46 65.22 3.71 Favored Glycine 0 C--O 1.203 -1.842 0 CA-C-O 114.248 -3.529 . . . . 0.0 105.713 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.23 -33.1 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 1 O-C-N 131.511 4.889 . . . . 0.0 113.637 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.8 126.02 0.03 OUTLIER 'General case' 0 C--O 1.2 -1.551 2 O-C-N 132.047 5.842 . . . . 0.0 108.368 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 9.6 p90 -173.7 149.33 1.59 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 112.5 -3.68 . . . . 0.0 117.479 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.56 138.44 40.91 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 100.698 -3.816 . . . . 0.0 100.698 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 56' ' ' SER . 4.4 t80 -150.78 26.96 0.73 Allowed 'General case' 0 C--O 1.198 -1.613 0 C-N-CA 111.757 -3.977 . . . . 0.0 115.082 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 55' ' ' TYR . 7.4 t 23.52 78.68 0.02 OUTLIER 'General case' 0 C--O 1.249 1.061 1 O-C-N 134.693 7.496 . . . . 0.0 110.121 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.44 167.37 19.46 Favored 'General case' 0 C--N 1.317 -0.83 1 O-C-N 129.854 4.472 . . . . 0.0 114.991 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB3' HG23 ' A' ' 61' ' ' THR . . . 45.99 25.12 0.29 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 126.014 2.071 . . . . 0.0 115.388 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.74 42.13 19.18 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 126.926 2.641 . . . . 0.0 115.276 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.86 -48.3 0.06 OUTLIER Glycine 0 C--N 1.367 2.261 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 58' ' ' ALA . 3.5 p -63.61 173.61 1.63 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 127.72 2.659 . . . . 0.0 114.242 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -164.27 36.85 0.08 Allowed 'General case' 0 C--N 1.352 0.677 0 C-N-CA 112.436 -3.706 . . . . 0.0 108.794 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD11 HD13 ' A' ' 87' ' ' LEU . 8.0 mp -59.82 106.65 0.51 Allowed 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 126.558 2.411 . . . . 0.0 108.485 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.3 m -103.7 107.26 18.04 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 112.102 -2.317 . . . . 0.0 107.688 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -161.0 -163.35 13.88 Favored Glycine 0 C--O 1.203 -1.837 1 C-N-CA 111.16 -5.305 . . . . 0.0 107.499 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.441 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 1.5 t -142.33 114.67 8.37 Favored 'General case' 0 CA--C 1.495 -1.17 2 O-C-N 135.426 7.192 . . . . 0.0 118.735 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.719 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 15.5 m95 -99.54 112.58 24.77 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.823 HG22 ' HA3' ' A' ' 50' ' ' GLY . 73.7 p -106.03 66.26 0.71 Allowed 'General case' 0 N--CA 1.427 -1.594 1 O-C-N 132.618 6.199 . . . . 0.0 115.022 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.7 tmm? -40.05 109.25 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 1 O-C-N 133.839 6.962 . . . . 0.0 103.207 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -66.89 0.83 Allowed 'General case' 0 N--CA 1.478 0.937 0 O-C-N 127.563 3.04 . . . . 0.0 106.405 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.67 -63.06 0.04 OUTLIER Glycine 0 CA--C 1.556 2.654 0 N-CA-C 103.785 -3.726 . . . . 0.0 103.785 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 0.4 OUTLIER -140.38 16.94 2.39 Favored 'General case' 0 N--CA 1.444 -0.727 1 O-C-N 131.44 4.847 . . . . 0.0 108.647 179.543 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HG3' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -99.4 176.71 5.42 Favored 'General case' 0 N--CA 1.476 0.826 1 O-C-N 131.307 5.379 . . . . 0.0 108.737 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 74' ' ' LEU . 4.4 mt -148.17 45.16 1.07 Allowed 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 126.804 2.565 . . . . 0.0 111.951 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.68 137.75 23.05 Favored 'Isoleucine or valine' 0 C--N 1.364 1.227 1 CA-C-N 106.853 -4.703 . . . . 0.0 114.025 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.88 -149.65 20.5 Favored Glycine 0 CA--C 1.547 2.063 1 N-CA-C 100.649 -4.98 . . . . 0.0 100.649 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HG3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER 176.5 137.82 0.06 Allowed 'General case' 0 C--O 1.208 -1.083 1 O-C-N 134.046 6.38 . . . . 0.0 112.632 -179.986 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.719 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -124.73 168.02 13.76 Favored 'General case' 0 C--O 1.195 -1.782 2 O-C-N 132.526 6.141 . . . . 0.0 104.814 179.783 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 86' ' ' GLU 0.28 0.0 OUTLIER -163.94 140.54 6.7 Favored 'General case' 0 N--CA 1.427 -1.609 1 CA-C-N 106.227 -4.988 . . . . 0.0 113.398 179.975 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.499 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 32.8 ttt180 -93.46 112.09 23.92 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 127.623 3.077 . . . . 0.0 107.164 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.02 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 1 O-C-N 130.714 5.009 . . . . 0.0 109.217 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' HB2' ' CG ' ' A' ' 80' ' ' ARG . 32.6 m-20 -87.58 19.85 3.19 Favored 'General case' 0 N--CA 1.44 -0.957 1 O-C-N 134.024 7.078 . . . . 0.0 107.86 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.611 ' N ' ' ND2' ' A' ' 83' ' ' ASN . 0.2 OUTLIER 83.45 18.03 0.24 Allowed 'General case' 0 CA--C 1.504 -0.817 0 O-C-N 128.502 3.626 . . . . 0.0 117.475 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 80' ' ' ARG . . . -82.49 -11.69 81.55 Favored Glycine 0 CA--C 1.562 2.993 1 C-N-CA 110.335 -5.698 . . . . 0.0 104.116 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HG3' ' HE2' ' A' ' 79' ' ' LYS . 1.7 ttmm 41.55 82.83 0.02 OUTLIER 'General case' 0 N--CA 1.418 -2.06 2 O-C-N 132.672 5.572 . . . . 0.0 121.38 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 18.3 mt-10 82.79 71.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.667 1 O-C-N 129.754 4.409 . . . . 0.0 117.071 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.685 HD13 HD11 ' A' ' 63' ' ' LEU . 1.5 mp -99.83 64.58 1.27 Allowed 'General case' 0 C--O 1.197 -1.697 1 O-C-N 132.198 5.936 . . . . 0.0 113.646 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' A' ' 77' ' ' LYS 0.305 93.8 mt -77.84 -174.89 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 108.563 -3.926 . . . . 0.0 101.647 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.31 73.47 0.92 Allowed 'General case' 0 C--O 1.196 -1.745 0 O-C-N 128.051 3.345 . . . . 0.0 106.242 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 90' ' ' VAL . 2.4 t -61.87 110.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.749 0 CA-C-N 110.597 -3.001 . . . . 0.0 105.427 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.686 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -162.82 162.67 26.63 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 111.854 -3.938 . . . . 0.0 113.438 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.686 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.2 OUTLIER -153.69 121.05 5.82 Favored 'General case' 0 CA--C 1.543 0.679 2 CA-C-N 107.326 -4.488 . . . . 0.0 103.806 179.554 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 98' ' ' LEU 0.296 5.0 tt -48.4 108.26 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.452 1 O-C-N 131.265 5.353 . . . . 0.0 112.99 -179.766 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -74.74 69.33 1.79 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 130.025 4.578 . . . . 0.0 115.479 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.05 -113.4 2.63 Favored Glycine 0 CA--C 1.558 2.76 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -138.6 47.32 1.96 Allowed 'General case' 0 N--CA 1.435 -1.203 0 O-C-N 129.461 3.683 . . . . 0.0 107.456 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.647 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 179.04 127.64 0.07 Allowed 'General case' 0 CA--C 1.56 1.354 0 O-C-N 128.577 3.673 . . . . 0.0 106.966 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 93' ' ' ILE . 11.9 tp -90.94 162.52 14.72 Favored 'General case' 0 C--O 1.206 -1.231 1 O-C-N 134.209 7.193 . . . . 0.0 111.863 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.76 HG23 ' HB2' ' A' ' 110' ' ' LYS . 1.4 mp -107.77 -85.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 2 CA-C-O 110.707 -4.473 . . . . 0.0 103.294 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.617 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.3 mm-40 93.82 93.41 0.01 OUTLIER 'General case' 0 C--O 1.202 -1.415 1 O-C-N 133.593 6.808 . . . . 0.0 104.824 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.8 p -83.93 -166.37 1.39 Allowed 'General case' 0 N--CA 1.416 -2.174 1 O-C-N 129.273 4.108 . . . . 0.0 113.177 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -156.22 89.33 1.13 Allowed 'General case' 0 C--O 1.2 -1.552 1 C-N-CA 110.752 -4.379 . . . . 0.0 103.293 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.63 79.11 0.42 Allowed 'General case' 0 C--O 1.213 -0.835 1 O-C-N 129.804 4.44 . . . . 0.0 107.532 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.8 OUTLIER -104.58 100.96 10.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 108.661 -3.881 . . . . 0.0 111.295 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 46.88 17.09 0.05 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.61 -18.57 4.59 Favored Glycine 0 C--N 1.344 1.01 0 C-N-CA 116.388 -2.815 . . . . 0.0 116.41 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.12 142.5 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 119.72 1.76 . . . . 0.0 112.933 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -109.09 87.16 2.43 Favored 'General case' 0 C--N 1.364 1.238 1 O-C-N 129.3 4.125 . . . . 0.0 108.119 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.425 . . -106.71 142.41 36.39 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 116.109 -2.236 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.76 ' HB2' HG23 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -148.64 171.01 16.86 Favored 'General case' 0 N--CA 1.435 -1.184 1 O-C-N 130.875 5.109 . . . . 0.0 109.904 -179.95 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.503 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -123.96 137.55 54.6 Favored 'General case' 0 CA--C 1.558 1.256 3 O-C-N 129.562 4.289 . . . . 0.0 99.921 179.541 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.09 110.0 15.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 C-N-CA 113.714 -3.194 . . . . 0.0 112.22 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 6.4 m-30 -108.56 175.43 5.47 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 128.84 3.838 . . . . 0.0 103.981 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.647 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -167.36 -159.19 0.31 Allowed 'General case' 0 C--O 1.198 -1.652 2 O-C-N 131.639 5.587 . . . . 0.0 111.616 179.404 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.662 ' HG3' ' CE3' ' A' ' 6' ' ' TRP . 21.6 tttt -112.59 -127.98 0.29 Allowed 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.782 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.902 0 CA-C-O 121.952 0.882 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -103.3 -33.73 9.03 Favored 'General case' 0 CA--C 1.561 1.399 0 CA-C-N 111.029 -2.805 . . . . 0.0 107.126 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -32.79 92.3 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 130.75 5.031 . . . . 0.0 118.294 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.79 -169.7 38.09 Favored Glycine 0 C--N 1.345 1.05 1 C-N-CA 112.006 -4.902 . . . . 0.0 105.496 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.309 0.4 OUTLIER -100.34 167.68 10.25 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 114.074 -3.051 . . . . 0.0 104.929 -179.964 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.656 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.264 34.4 m95 -143.21 140.15 30.6 Favored 'General case' 0 N--CA 1.42 -1.963 0 O-C-N 128.672 3.733 . . . . 0.0 111.109 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG2' ' HD2' ' A' ' 114' ' ' LYS . 19.3 mtmt 58.2 178.58 0.06 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 117.403 2.371 . . . . 0.0 117.403 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . 0.306 0.6 OUTLIER 35.44 92.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.484 -1.588 3 O-C-N 136.404 8.565 . . . . 0.0 113.964 174.815 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -139.74 29.14 2.13 Favored 'General case' 0 C--N 1.375 1.684 1 CA-C-N 107.717 -4.31 . . . . 0.0 108.59 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -142.84 -175.74 4.62 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 118.424 -1.31 . . . . 0.0 111.848 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 65.53 102.23 0.04 OUTLIER 'General case' 0 C--N 1.363 1.186 0 CA-C-N 113.168 -1.833 . . . . 0.0 111.366 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -121.96 150.82 41.49 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 128.141 3.401 . . . . 0.0 107.598 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.08 59.03 0.86 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 128.518 3.636 . . . . 0.0 104.285 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -115.52 122.02 44.45 Favored 'General case' 0 N--CA 1.443 -0.82 2 O-C-N 129.435 4.209 . . . . 0.0 107.26 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.13 24.24 3.54 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.46 54.62 0.67 Allowed Glycine 0 CA--C 1.55 2.264 0 O-C-N 128.288 3.492 . . . . 0.0 111.325 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.23 -177.04 2.38 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 110.145 -3.027 . . . . 0.0 106.202 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -168.72 -40.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.805 0.812 . . . . 0.0 111.742 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -83.82 118.33 23.88 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 113.45 -1.705 . . . . 0.0 111.548 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -119.89 165.67 14.31 Favored 'General case' 0 C--N 1.362 1.112 1 O-C-N 130.5 4.875 . . . . 0.0 111.838 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -144.07 139.93 29.2 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 127.206 2.816 . . . . 0.0 105.417 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.345 0.0 OUTLIER -159.94 149.79 18.27 Favored 'General case' 0 C--O 1.205 -1.259 1 O-C-N 130.856 5.098 . . . . 0.0 104.115 -179.811 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 6.6 mt -116.57 177.68 4.61 Favored 'General case' 0 CA--C 1.562 1.422 2 O-C-N 132.964 6.415 . . . . 0.0 97.937 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.526 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 21.9 m -167.91 -85.31 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 1 O-C-N 130.921 5.138 . . . . 0.0 106.508 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 72.68 162.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 109.163 -3.653 . . . . 0.0 108.853 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 27' ' ' GLN . 90.9 m -138.31 -48.93 0.54 Allowed 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 112.781 -3.568 . . . . 0.0 108.661 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR 0.316 3.9 pt20 65.97 123.07 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.027 2 O-C-N 132.503 6.127 . . . . 0.0 115.778 178.762 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 31' ' ' LYS . 7.1 tt0 -98.97 -130.81 0.22 Allowed 'General case' 0 C--O 1.248 1.022 0 O-C-N 128.795 3.81 . . . . 0.0 104.829 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.14 -53.43 3.91 Favored Glycine 0 CA--C 1.546 2.002 2 N-CA-C 99.594 -5.402 . . . . 0.0 99.594 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' N ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -136.17 75.81 1.57 Allowed 'General case' 0 N--CA 1.44 -0.956 1 CA-C-N 107.589 -4.305 . . . . 0.0 105.862 -179.9 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 28' ' ' GLU . 0.4 OUTLIER -168.28 102.88 0.44 Allowed 'General case' 0 C--O 1.246 0.917 1 C-N-CA 111.418 -4.113 . . . . 0.0 102.337 -179.893 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -140.09 165.25 27.87 Favored 'General case' 0 CA--C 1.562 1.426 1 N-CA-C 99.402 -4.295 . . . . 0.0 99.402 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.95 125.08 21.53 Favored 'General case' 0 N--CA 1.476 0.828 2 O-C-N 137.605 9.316 . . . . 0.0 101.468 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.404 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.352 1.1 t -84.89 132.77 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 112.932 -3.507 . . . . 0.0 103.585 -179.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.308 0.3 OUTLIER -71.94 -0.83 12.44 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 109.361 -3.563 . . . . 0.0 118.875 179.789 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.368 1.0 OUTLIER -37.76 91.19 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.106 -2.77 . . . . 0.0 109.192 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -91.93 133.45 35.68 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 115.327 -2.549 . . . . 0.0 109.395 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p 177.02 -169.13 0.06 Allowed 'General case' 0 C--N 1.353 0.746 0 O-C-N 127.65 3.094 . . . . 0.0 112.958 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.08 -91.76 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.624 0 O-C-N 125.276 1.61 . . . . 0.0 110.415 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -117.58 -36.54 3.67 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 128.254 3.471 . . . . 0.0 111.609 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -143.14 0.15 Allowed 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 127.222 2.826 . . . . 0.0 115.228 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.7 -22.31 34.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 116.289 -2.164 . . . . 0.0 107.387 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.666 HG13 HD13 ' A' ' 57' ' ' LEU . 13.9 tt 25.28 69.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.223 2 O-C-N 132.349 6.03 . . . . 0.0 111.1 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 57' ' ' LEU . 11.4 p-10 -65.56 155.3 36.16 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 109.639 -3.437 . . . . 0.0 105.148 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 78' ' ' PHE . 6.3 t -123.09 117.61 52.19 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 1 O-C-N 129.544 4.277 . . . . 0.0 101.462 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.271 0.3 OUTLIER -118.23 162.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 C-N-CA 114.663 -2.815 . . . . 0.0 114.831 179.843 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -177.2 -159.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.211 1 O-C-N 130.095 4.622 . . . . 0.0 111.448 -179.961 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -139.1 49.5 1.85 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 117.757 -1.577 . . . . 0.0 114.582 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 39.52 98.37 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 127.778 3.656 . . . . 0.0 115.28 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.01 52.93 1.56 Allowed Glycine 0 CA--C 1.545 1.957 1 N-CA-C 101.563 -4.615 . . . . 0.0 101.563 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -147.3 122.02 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 1 O-C-N 132.184 5.285 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.52 153.16 22.05 Favored 'General case' 0 CA--C 1.558 1.252 1 O-C-N 130.423 4.827 . . . . 0.0 106.968 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 2.6 p90 -168.42 124.33 0.99 Allowed 'General case' 0 N--CA 1.426 -1.664 1 O-C-N 129.136 4.023 . . . . 0.0 118.566 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.05 118.78 26.66 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 101.667 -3.457 . . . . 0.0 101.667 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -142.59 135.74 28.5 Favored 'General case' 0 C--O 1.21 -0.999 0 O-C-N 127.573 3.046 . . . . 0.0 112.558 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.35 141.88 28.15 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 128.354 3.534 . . . . 0.0 106.883 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -133.17 -67.47 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 O-C-N 128.758 3.786 . . . . 0.0 114.365 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.23 24.16 4.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 116.848 -1.549 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 60.12 16.01 5.64 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 125.867 1.979 . . . . 0.0 114.489 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.01 56.36 0.12 Allowed Glycine 0 CA--C 1.539 1.555 0 N-CA-C 104.813 -3.315 . . . . 0.0 104.813 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -127.97 -87.82 0.56 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 129.876 3.927 . . . . 0.0 110.393 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 81' ' ' VAL . 0.0 OUTLIER 69.76 15.22 8.04 Favored 'General case' 0 CA--C 1.517 -0.317 1 O-C-N 129.465 4.228 . . . . 0.0 109.656 179.927 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.453 HD13 HG22 ' A' ' 61' ' ' THR . 10.9 mp -58.5 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 124.374 2.035 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.0 m -85.95 113.35 21.99 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 77' ' ' LYS . . . -144.79 -155.47 6.47 Favored Glycine 0 C--O 1.209 -1.445 1 C-N-CA 111.673 -5.06 . . . . 0.0 109.213 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.629 ' C ' ' CD1' ' A' ' 67' ' ' TRP 0.27 8.8 t -179.78 135.96 0.12 Allowed 'General case' 0 CA--C 1.496 -1.131 2 O-C-N 133.524 6.073 . . . . 0.0 111.917 -178.154 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 67.7 m95 -141.45 119.63 12.13 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 116.692 -3.755 . . . . 0.0 106.209 -178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . 1.1 p -106.43 34.72 3.25 Favored 'General case' 0 N--CA 1.434 -1.246 2 O-C-N 134.543 7.402 . . . . 0.0 116.154 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.469 ' N ' HD21 ' A' ' 49' ' ' LEU 0.264 4.3 ttm -17.66 84.56 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 1 O-C-N 136.57 8.669 . . . . 0.0 108.058 -179.92 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.72 94.54 9.42 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 128.046 3.341 . . . . 0.0 107.074 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.11 -132.04 36.25 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 105.005 -3.238 . . . . 0.0 105.005 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -85.43 60.66 6.38 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 109.075 -3.563 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 158.83 44.18 Favored 'General case' 0 C--N 1.359 1.015 1 O-C-N 129.297 4.123 . . . . 0.0 111.149 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 74' ' ' LEU . 13.0 mt -141.93 59.59 1.48 Allowed 'General case' 0 C--O 1.209 -1.047 0 O-C-N 128.269 3.481 . . . . 0.0 111.459 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.5 t -90.15 101.66 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 1 CA-C-N 107.531 -4.395 . . . . 0.0 115.601 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.81 -144.99 4.36 Favored Glycine 0 CA--C 1.537 1.429 0 N-CA-C 103.3 -3.92 . . . . 0.0 103.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.519 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.3 0.1 OUTLIER -176.89 165.21 2.42 Favored 'General case' 0 C--O 1.201 -1.457 2 O-C-N 131.36 4.8 . . . . 0.0 112.092 -179.767 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 19.9 m-85 -144.38 166.1 26.06 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.572 ' HE2' ' CG ' ' A' ' 86' ' ' GLU 0.283 0.0 OUTLIER -174.28 152.43 1.8 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 108.966 -3.743 . . . . 0.0 117.221 179.327 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HG3' ' CB ' ' A' ' 85' ' ' LYS . 5.8 ptm180 -104.11 78.29 1.5 Allowed 'General case' 0 CA--C 1.557 1.227 0 O-C-N 126.299 2.25 . . . . 0.0 107.252 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.473 ' CG2' ' HG2' ' A' ' 62' ' ' GLU . 5.6 m -22.12 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 1 O-C-N 133.331 6.644 . . . . 0.0 114.047 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -41.88 -47.02 4.17 Favored 'General case' 0 N--CA 1.451 -0.425 1 O-C-N 134.751 7.532 . . . . 0.0 107.637 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -112.0 -0.28 15.78 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 128.544 3.653 . . . . 0.0 113.304 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.26 34.63 88.62 Favored Glycine 0 CA--C 1.559 2.782 1 N-CA-C 101.361 -4.696 . . . . 0.0 101.361 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.549 ' CG ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -66.02 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.203 3 O-C-N 132.615 5.538 . . . . 0.0 118.264 179.983 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.572 ' CG ' ' HE2' ' A' ' 79' ' ' LYS . 46.3 mt-10 116.87 133.52 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 1 O-C-N 132.455 6.097 . . . . 0.0 109.136 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.64 42.4 0.48 Allowed 'General case' 0 C--O 1.201 -1.479 1 O-C-N 133.289 6.618 . . . . 0.0 110.003 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 86' ' ' GLU 0.256 4.7 mt -67.71 171.52 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.591 1 O-C-N 131.42 5.45 . . . . 0.0 105.004 -179.567 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.68 73.95 1.25 Allowed 'General case' 0 C--O 1.219 -0.545 1 O-C-N 133.66 6.85 . . . . 0.0 107.592 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 t -63.69 125.71 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.581 ' HG2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -166.58 153.88 9.46 Favored 'General case' 0 C--O 1.191 -1.982 1 C-N-CA 110.407 -4.517 . . . . 0.0 115.405 179.83 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 4.5 mt-10 -149.04 113.61 5.32 Favored 'General case' 0 N--CA 1.433 -1.324 1 O-C-N 131.018 5.199 . . . . 0.0 107.095 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 98' ' ' LEU 0.26 0.1 OUTLIER -45.5 112.99 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.668 1 O-C-N 130.325 4.766 . . . . 0.0 109.296 179.823 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -67.72 -89.58 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.097 0 O-C-N 128.734 3.771 . . . . 0.0 116.89 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 97' ' ' GLU . . . -135.92 100.33 0.34 Allowed Glycine 0 C--O 1.206 -1.638 0 C-N-CA 115.464 -3.255 . . . . 0.0 107.662 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 52.51 22.73 2.25 Favored 'General case' 0 N--CA 1.443 -0.809 2 O-C-N 130.639 4.376 . . . . 0.0 109.663 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.681 ' HB2' ' HA ' ' A' ' 114' ' ' LYS 0.296 0.0 OUTLIER -168.8 134.1 1.65 Allowed 'General case' 0 N--CA 1.426 -1.651 0 O-C-N 127.581 3.051 . . . . 0.0 109.022 179.283 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.581 HD21 ' HG2' ' A' ' 91' ' ' ARG . 2.6 tt -97.67 142.12 29.86 Favored 'General case' 0 N--CA 1.437 -1.095 1 O-C-N 133.598 6.811 . . . . 0.0 115.863 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.476 HG22 ' N ' ' A' ' 100' ' ' GLN . 29.0 mt -83.19 -84.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.518 0 O-C-N 128.945 3.903 . . . . 0.0 106.284 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.476 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.4 tt0 92.95 107.67 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.274 1 O-C-N 131.024 5.203 . . . . 0.0 100.833 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.518 HG21 ' OE2' ' A' ' 108' ' ' GLU . 17.2 p -77.76 -38.7 46.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 128.406 3.566 . . . . 0.0 119.462 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 61.81 53.04 3.26 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 111.569 -2.56 . . . . 0.0 105.583 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 m -52.42 117.18 2.67 Favored 'General case' 0 C--N 1.36 1.023 1 O-C-N 133.038 6.461 . . . . 0.0 100.625 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.51 ' CD1' ' HB2' ' A' ' 105' ' ' GLU . 5.7 t80 -144.58 138.04 27.18 Favored 'General case' 0 CA--C 1.49 -1.349 1 O-C-N 130.13 4.644 . . . . 0.0 112.604 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.51 ' HB2' ' CD1' ' A' ' 104' ' ' TYR . 1.0 OUTLIER 37.41 35.13 0.05 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.841 -1.981 . . . . 0.0 115.952 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.58 79.64 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 116.76 -2.638 . . . . 0.0 117.305 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.81 -19.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.518 ' OE2' HG21 ' A' ' 101' ' ' THR . 9.4 mt-10 66.48 173.08 0.24 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 128.33 3.519 . . . . 0.0 106.951 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.328 . . -174.8 81.43 0.03 OUTLIER 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 117.234 -1.787 . . . . 0.0 114.166 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -95.5 120.86 36.48 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 129.729 4.393 . . . . 0.0 109.084 -179.931 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -92.85 -34.12 13.96 Favored 'General case' 0 CA--C 1.555 1.16 1 O-C-N 129.974 4.546 . . . . 0.0 104.164 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER 83.5 118.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.126 1 O-C-N 130.25 4.719 . . . . 0.0 108.03 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 21' ' ' LEU . 37.0 m-85 -141.8 -146.67 0.2 Allowed 'General case' 0 CA--C 1.55 0.943 1 O-C-N 129.549 4.28 . . . . 0.0 106.511 179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -170.31 -145.31 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.024 1 O-C-N 131.104 5.253 . . . . 0.0 111.668 -179.739 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 17.4 tttt -129.03 -58.51 1.14 Allowed 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 125.232 1.413 . . . . 0.0 111.979 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 N--CA 1.411 -2.384 0 CA-C-N 111.027 -2.806 . . . . 0.0 113.837 -179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.588 ' HZ ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER 159.97 -36.49 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.267 0 O-C-N 128.363 3.539 . . . . 0.0 105.051 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 25' ' ' ILE 0.252 5.0 p-10 -34.48 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.422 -1.874 1 O-C-N 130.443 4.839 . . . . 0.0 117.735 179.493 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 169.57 -179.2 42.2 Favored Glycine 0 N--CA 1.477 1.43 1 C-N-CA 112.231 -4.795 . . . . 0.0 104.169 -179.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 24' ' ' THR 0.305 3.3 p -88.4 173.08 8.92 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 113.712 -3.195 . . . . 0.0 108.168 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.633 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 64.6 m95 -152.14 117.69 5.35 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 1.3 mtmt 89.3 171.58 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 22' ' ' LYS 0.274 0.5 OUTLIER 47.77 92.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.479 -1.775 3 CA-C-O 135.886 7.517 . . . . 0.0 120.305 174.864 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.37 -153.36 0.04 OUTLIER 'General case' 0 C--N 1.373 1.599 1 CA-C-N 107.656 -4.338 . . . . 0.0 108.352 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.14 154.41 40.08 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 119.69 -1.881 . . . . 0.0 111.996 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -96.9 -38.44 9.83 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 126.533 2.396 . . . . 0.0 111.459 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.63 -167.33 1.36 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 117.092 -1.432 . . . . 0.0 108.841 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -117.33 52.74 0.95 Allowed 'General case' 0 C--O 1.215 -0.739 1 O-C-N 130.222 4.702 . . . . 0.0 107.168 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' CG ' ' N ' ' A' ' 15' ' ' SER . 36.7 t80 -169.43 160.08 9.02 Favored 'General case' 0 C--O 1.217 -0.627 1 CA-C-N 108.355 -4.021 . . . . 0.0 106.477 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -133.56 125.45 28.86 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 117.408 -1.717 . . . . 0.0 108.279 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.8 -95.68 2.07 Favored Glycine 0 CA--C 1.547 2.075 0 O-C-N 127.058 2.724 . . . . 0.0 111.595 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.55 136.3 37.49 Favored 'General case' 0 C--N 1.361 1.074 0 CA-C-N 111.213 -2.493 . . . . 0.0 105.86 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -153.6 176.27 12.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 125.368 1.668 . . . . 0.0 109.063 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.84 76.43 0.8 Allowed 'General case' 0 C--O 1.207 -1.154 0 O-C-N 128.762 3.789 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -104.44 -155.41 0.53 Allowed 'General case' 0 C--N 1.357 0.91 1 O-C-N 129.543 4.277 . . . . 0.0 109.307 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.702 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -103.06 -169.87 1.71 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.321 7.9 mttt 147.09 141.28 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.53 2 O-C-N 132.914 6.384 . . . . 0.0 106.576 177.423 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.614 HD22 HD11 ' A' ' 25' ' ' ILE . 5.9 mt -96.5 161.57 13.85 Favored 'General case' 0 CA--C 1.565 1.552 3 O-C-N 132.692 6.245 . . . . 0.0 96.686 178.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.561 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 2.7 m 172.09 83.89 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 1 O-C-N 129.308 4.13 . . . . 0.0 101.336 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.663 HG23 ' H ' ' A' ' 33' ' ' THR . 3.7 mp -106.13 116.34 49.69 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 108.688 -3.869 . . . . 0.0 112.833 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 2.9 m -162.14 77.2 0.49 Allowed 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 127.134 2.771 . . . . 0.0 108.506 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.618 ' HB2' ' C ' ' A' ' 31' ' ' LYS . 8.1 mm-40 -68.11 -93.07 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 1 C-N-CA 110.998 -4.281 . . . . 0.0 113.428 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -127.2 -7.86 5.9 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 113.396 -3.192 . . . . 0.0 106.725 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.82 -11.27 29.84 Favored Glycine 0 CA--C 1.538 1.493 1 N-CA-C 100.181 -5.168 . . . . 0.0 100.181 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.9 -30.4 2.03 Favored 'General case' 0 N--CA 1.411 -2.418 1 CA-C-O 111.649 -4.024 . . . . 0.0 111.547 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.618 ' C ' ' HB2' ' A' ' 27' ' ' GLN . 43.5 mttt -103.86 -165.94 1.21 Allowed 'General case' 0 C--O 1.246 0.897 1 N-CA-C 97.725 -4.917 . . . . 0.0 97.725 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.631 ' HD1' HG22 ' A' ' 25' ' ' ILE . 25.6 m-85 -167.86 156.63 9.38 Favored 'General case' 0 C--O 1.203 -1.389 1 N-CA-C 97.355 -5.054 . . . . 0.0 97.355 179.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.663 ' H ' HG23 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -143.82 128.99 18.73 Favored 'General case' 0 N--CA 1.479 1.015 4 O-C-N 136.662 8.726 . . . . 0.0 98.079 179.836 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.431 4.0 t -88.15 121.46 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 1 N-CA-C 99.303 -4.332 . . . . 0.0 99.303 179.9 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.376 11.2 tttt -56.09 -18.99 11.29 Favored 'General case' 0 C--N 1.37 1.489 0 CA-C-N 110.281 -3.145 . . . . 0.0 119.252 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HB2' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER 3.58 67.87 0.0 OUTLIER 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 109.774 -3.375 . . . . 0.0 111.342 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.479 ' CB ' ' HA ' ' A' ' 21' ' ' LEU . 19.1 m -70.45 127.9 34.33 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 116.816 -1.954 . . . . 0.0 113.071 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -126.38 -168.49 1.87 Allowed 'General case' 0 C--N 1.369 1.417 0 O-C-N 125.707 1.879 . . . . 0.0 112.263 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -75.25 -25.52 58.13 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 125.507 2.575 . . . . 0.0 104.722 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' O ' HD12 ' A' ' 43' ' ' ILE . 13.3 m-85 -90.32 69.24 7.02 Favored 'General case' 0 N--CA 1.437 -1.093 1 CA-C-N 106.653 -4.794 . . . . 0.0 107.143 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.93 177.58 0.1 Allowed 'General case' 0 N--CA 1.436 -1.172 1 O-C-N 129.328 4.142 . . . . 0.0 114.677 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 43' ' ' ILE . 12.7 m-80 -71.5 -44.62 64.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 111.776 -3.969 . . . . 0.0 102.539 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER 64.61 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.512 3 CA-C-O 130.08 4.752 . . . . 0.0 107.074 -179.798 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.02 138.4 42.17 Favored 'General case' 0 C--N 1.373 1.611 1 CA-C-N 106.395 -4.911 . . . . 0.0 108.26 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -125.36 86.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 1 N-CA-C 99.782 -4.155 . . . . 0.0 99.782 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.8 163.04 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 1 C-N-CA 111.003 -4.279 . . . . 0.0 113.311 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 47' ' ' PHE . 2.8 p90 -161.94 149.68 14.58 Favored 'General case' 0 N--CA 1.433 -1.311 1 O-C-N 132.888 6.367 . . . . 0.0 111.06 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.02 51.55 1.83 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 113.056 -3.458 . . . . 0.0 115.554 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.711 HD21 ' CB ' ' A' ' 69' ' ' MET . 0.0 OUTLIER 47.75 89.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.399 2 O-C-N 132.714 6.259 . . . . 0.0 114.585 -179.711 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.28 59.1 2.78 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.74 -32.2 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 1 O-C-N 133.915 6.303 . . . . 0.0 115.225 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 71.06 138.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.892 1 O-C-N 131.421 5.451 . . . . 0.0 109.049 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.3 p90 179.31 145.96 0.18 Allowed 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 108.668 -3.878 . . . . 0.0 116.505 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' THR . . . -109.45 137.31 47.49 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 100.474 -3.899 . . . . 0.0 100.474 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -147.69 100.79 3.27 Favored 'General case' 0 C--O 1.21 -1.001 1 O-C-N 129.295 4.122 . . . . 0.0 114.06 179.848 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 94.7 1.87 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 112.775 -3.57 . . . . 0.0 101.484 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' TYR . 5.7 tp -82.55 -86.35 0.1 Allowed 'General case' 0 CA--C 1.507 -0.709 1 O-C-N 131.735 5.647 . . . . 0.0 116.117 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -64.57 10.11 0.07 Allowed 'General case' 0 C--O 1.246 0.881 0 CA-C-O 115.825 -2.036 . . . . 0.0 116.494 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 9.4 5.59 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 120.504 1.502 . . . . 0.0 111.122 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.09 46.26 0.27 Allowed Glycine 0 CA--C 1.548 2.128 0 N-CA-C 105.178 -3.169 . . . . 0.0 105.178 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.562 ' HB ' HD13 ' A' ' 63' ' ' LEU . 1.7 p -126.59 -88.93 0.56 Allowed 'General case' 0 N--CA 1.445 -0.708 1 O-C-N 132.155 5.268 . . . . 0.0 114.537 179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 62.14 71.95 0.52 Allowed 'General case' 0 C--O 1.217 -0.654 0 O-C-N 127.595 3.06 . . . . 0.0 106.784 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.562 HD13 ' HB ' ' A' ' 61' ' ' THR . 11.1 mp -120.57 76.08 1.17 Allowed 'General case' 0 N--CA 1.423 -1.818 0 O-C-N 128.518 3.636 . . . . 0.0 113.92 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 92.9 m -48.44 111.84 0.51 Allowed 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.89 -171.38 12.32 Favored Glycine 0 CA--C 1.538 1.469 2 C-N-CA 111.026 -5.368 . . . . 0.0 107.029 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.603 ' C ' ' CD1' ' A' ' 67' ' ' TRP . 5.9 t 176.53 128.96 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.218 2 O-C-N 133.611 6.124 . . . . 0.0 111.368 -178.154 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.701 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 52.1 m95 -137.73 117.83 13.48 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 117.174 -3.454 . . . . 0.0 106.347 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.465 ' HA ' HD22 ' A' ' 49' ' ' LEU . 6.9 p -96.6 33.64 1.79 Allowed 'General case' 0 N--CA 1.422 -1.87 2 O-C-N 130.703 5.002 . . . . 0.0 116.706 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.711 ' CB ' HD21 ' A' ' 49' ' ' LEU . 2.2 ttt -18.93 106.19 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.814 1 O-C-N 136.821 8.825 . . . . 0.0 107.523 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -65.22 -44.72 87.38 Favored 'General case' 0 CA--C 1.505 -0.786 1 O-C-N 129.684 4.365 . . . . 0.0 108.673 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.83 -39.35 0.18 Allowed Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 110.46 -3.064 . . . . 0.0 107.492 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 1.7 p30 -142.07 30.53 1.61 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 129.795 3.879 . . . . 0.0 108.748 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 5.3 mttt -135.61 157.38 47.02 Favored 'General case' 0 N--CA 1.453 -0.315 1 O-C-N 131.032 5.207 . . . . 0.0 111.604 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 74' ' ' LEU . 7.3 mt -134.91 60.11 1.71 Allowed 'General case' 0 C--O 1.214 -0.775 0 O-C-N 127.879 3.237 . . . . 0.0 110.852 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.2 t -85.31 93.27 3.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 1 CA-C-N 106.544 -4.843 . . . . 0.0 114.044 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 88' ' ' ILE . . . -159.08 -156.64 8.14 Favored Glycine 0 C--O 1.207 -1.585 2 CA-C-N 107.599 -4.364 . . . . 0.0 102.955 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' N ' ' CH2' ' A' ' 67' ' ' TRP 0.331 21.8 ttpt -170.54 123.98 0.68 Allowed 'General case' 0 C--N 1.37 1.476 1 C-N-CA 108.813 -5.155 . . . . 0.0 112.779 179.934 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.701 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 28.0 m-85 -106.09 162.46 13.6 Favored 'General case' 0 C--O 1.2 -1.504 2 N-CA-C 99.831 -4.137 . . . . 0.0 99.831 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.2 OUTLIER -168.23 130.9 1.48 Allowed 'General case' 0 CA--C 1.495 -1.152 1 CA-C-N 105.594 -5.275 . . . . 0.0 113.737 -178.716 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 11.2 ttp180 -82.41 86.72 6.68 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 125.007 1.442 . . . . 0.0 110.775 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.6 t -42.39 -33.75 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 O-C-N 128.044 3.34 . . . . 0.0 110.274 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -56.91 -46.57 81.9 Favored 'General case' 0 C--O 1.248 1.002 1 O-C-N 132.36 6.038 . . . . 0.0 108.825 -179.754 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -107.34 -5.7 17.63 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 113.403 -3.319 . . . . 0.0 112.559 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.552 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 75.91 41.54 27.67 Favored Glycine 0 CA--C 1.557 2.677 2 C-N-CA 110.843 -5.456 . . . . 0.0 100.485 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 8.6 tppt? -81.75 -81.44 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 2 CA-C-N 105.75 -5.225 . . . . 0.0 121.239 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 7.0 mm-40 91.04 121.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.462 1 O-C-N 130.576 4.922 . . . . 0.0 108.084 -177.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 63' ' ' LEU . 1.4 pt? -153.45 48.48 0.68 Allowed 'General case' 0 C--O 1.194 -1.836 1 O-C-N 132.435 6.084 . . . . 0.0 110.292 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.712 HG22 HG23 ' A' ' 90' ' ' VAL . 30.8 mt -52.33 141.99 5.5 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.552 2 O-C-N 130.248 4.717 . . . . 0.0 104.87 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.65 59.03 0.7 Allowed 'General case' 0 C--O 1.213 -0.832 1 O-C-N 130.75 5.032 . . . . 0.0 105.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.712 HG23 HG22 ' A' ' 88' ' ' ILE . 13.3 t -64.02 102.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.385 0 O-C-N 127.848 3.218 . . . . 0.0 110.842 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.575 ' CD ' ' H ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -140.63 -174.03 3.85 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 115.408 -2.517 . . . . 0.0 110.554 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 91' ' ' ARG 0.299 0.0 OUTLIER 176.9 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 132.386 6.054 . . . . 0.0 105.822 -178.858 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -39.86 100.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.05 1 O-C-N 131.673 5.608 . . . . 0.0 110.001 179.247 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.1 m -85.59 -69.07 0.68 Allowed 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 108.838 -3.801 . . . . 0.0 117.723 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.06 -106.44 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 CA-C-O 126.279 3.155 . . . . 0.0 105.705 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -141.33 52.61 1.55 Allowed 'General case' 0 CA--C 1.54 0.586 1 CA-C-N 108.009 -4.095 . . . . 0.0 105.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.88 ' O ' HD13 ' A' ' 93' ' ' ILE 0.318 0.0 OUTLIER -159.81 -118.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 1 O-C-N 130.399 4.812 . . . . 0.0 106.272 179.546 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 100' ' ' GLN . 9.9 tt 155.88 103.56 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.196 1 O-C-N 129.849 4.468 . . . . 0.0 109.442 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.71 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.8 OUTLIER -48.49 -72.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.41 -2.472 1 O-C-N 130.903 5.127 . . . . 0.0 107.483 -179.876 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.721 ' HB2' HD21 ' A' ' 98' ' ' LEU . 7.6 tp60 79.06 100.71 0.06 Allowed 'General case' 0 CA--C 1.562 1.428 1 O-C-N 134.737 7.523 . . . . 0.0 100.428 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.031 HG23 ' HG3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -105.94 119.77 40.04 Favored 'General case' 0 N--CA 1.411 -2.41 2 O-C-N 134.04 7.088 . . . . 0.0 114.346 179.752 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.66 81.93 8.65 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 101.336 -3.579 . . . . 0.0 101.336 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ILE . 1.5 m -65.94 98.65 0.43 Allowed 'General case' 0 C--N 1.361 1.067 1 O-C-N 132.359 6.037 . . . . 0.0 101.332 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -107.62 120.29 41.8 Favored 'General case' 0 N--CA 1.435 -1.19 2 O-C-N 129.718 4.386 . . . . 0.0 113.359 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 4.88 64.65 0.0 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 126.937 2.648 . . . . 0.0 117.601 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.89 13.29 29.88 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 118.39 -1.862 . . . . 0.0 116.347 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.61 148.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-O 116.618 -1.658 . . . . 0.0 115.197 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -117.59 67.46 0.75 Allowed 'General case' 0 C--N 1.362 1.129 1 O-C-N 129.724 4.39 . . . . 0.0 106.586 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.411 . . -99.94 97.16 8.07 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 127.672 3.108 . . . . 0.0 111.582 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 1.031 ' HG3' HG23 ' A' ' 101' ' ' THR . 2.1 mtmt -89.98 176.51 6.77 Favored 'General case' 0 N--CA 1.419 -1.982 2 O-C-N 135.117 7.76 . . . . 0.0 110.074 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -135.24 117.32 15.38 Favored 'General case' 0 CA--C 1.561 1.39 3 O-C-N 131.975 5.797 . . . . 0.0 98.991 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.14 126.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 1 O-C-N 129.495 4.247 . . . . 0.0 112.468 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.6 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 31.1 m-85 -140.19 -149.24 0.27 Allowed 'General case' 0 N--CA 1.445 -0.72 1 O-C-N 129.851 4.469 . . . . 0.0 107.858 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -171.18 -141.53 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 1 O-C-N 131.114 5.259 . . . . 0.0 112.257 -179.147 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.633 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 28.3 tttt -123.04 -130.53 0.27 Allowed 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 113.459 -1.701 . . . . 0.0 111.721 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.264 0.3 OUTLIER . . . . . 0 C--O 1.21 -0.985 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.069 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -31.71 14.85 Favored 'General case' 0 CA--C 1.55 0.966 1 O-C-N 129.331 4.145 . . . . 0.0 107.897 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.36 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.57 0 O-C-N 128.827 3.83 . . . . 0.0 116.8 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.97 176.35 36.56 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 114.853 -3.546 . . . . 0.0 105.79 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.538 HG22 ' OG1' ' A' ' 24' ' ' THR 0.392 0.2 OUTLIER -93.01 160.89 14.67 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 111.898 -3.921 . . . . 0.0 109.747 -179.605 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.643 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 12.8 m95 -127.61 161.29 29.19 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-O 113.033 -3.365 . . . . 0.0 111.095 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 10.6 mtmt 46.41 -179.59 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 8' ' ' VAL 0.328 0.9 OUTLIER 1.09 117.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.458 3 CA-C-O 133.024 6.154 . . . . 0.0 119.239 174.984 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -145.38 35.55 1.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.941 -3.754 . . . . 0.0 109.427 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -171.75 0.71 Allowed 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.857 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.73 -147.76 0.02 OUTLIER 'General case' 0 C--N 1.365 1.249 0 O-C-N 124.923 1.389 . . . . 0.0 107.677 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 70.48 120.18 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 O-C-N 125.231 1.582 . . . . 0.0 110.345 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -111.65 -60.95 1.78 Allowed 'General case' 0 C--N 1.349 0.565 0 CA-C-O 126.564 3.078 . . . . 0.0 108.061 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.97 160.37 30.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 110.531 -3.031 . . . . 0.0 110.729 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 t 59.87 30.85 20.37 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 126.129 2.143 . . . . 0.0 107.323 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 17' ' ' ALA . . . -92.32 -63.57 1.13 Allowed Glycine 0 C--N 1.347 1.156 0 O-C-N 124.904 1.378 . . . . 0.0 111.981 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 16' ' ' GLY . . . 173.9 -63.12 0.01 OUTLIER 'General case' 0 C--O 1.247 0.966 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.56 134.76 0.14 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.09 -172.22 2.51 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 127.026 2.704 . . . . 0.0 110.53 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.696 ' C ' HD23 ' A' ' 21' ' ' LEU . 20.2 m120 -120.97 -110.73 0.33 Allowed 'General case' 0 C--O 1.217 -0.626 0 O-C-N 128.617 3.698 . . . . 0.0 112.213 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -139.72 -169.3 2.68 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.395 0.0 OUTLIER -174.86 134.55 0.36 Allowed 'General case' 0 CA--C 1.566 1.569 1 O-C-N 132.379 6.049 . . . . 0.0 103.891 -179.962 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' C ' ' HB3' ' A' ' 35' ' ' LYS . 9.1 mt -97.29 158.22 15.57 Favored 'General case' 0 CA--C 1.555 1.147 3 O-C-N 130.705 5.003 . . . . 0.0 97.801 179.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 35' ' ' LYS . 1.4 m 173.18 94.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 2 CA-C-O 130.402 4.906 . . . . 0.0 102.455 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 32' ' ' PHE . 3.5 mp -106.89 138.41 32.82 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 109.429 -3.532 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -174.56 73.0 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.168 2.792 . . . . 0.0 108.468 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 3.7 mm-40 -92.17 -95.0 0.14 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 113.367 -3.333 . . . . 0.0 112.295 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.47 1.82 0.53 Allowed 'General case' 0 C--O 1.251 1.138 0 O-C-N 127.982 3.302 . . . . 0.0 107.797 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.89 -33.15 5.76 Favored Glycine 0 CA--C 1.539 1.558 1 N-CA-C 101.552 -4.619 . . . . 0.0 101.552 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -98.48 -36.99 9.76 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-O 112.723 -3.513 . . . . 0.0 112.188 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' GLN . 72.5 mttt -111.37 173.92 6.11 Favored 'General case' 0 C--O 1.247 0.923 1 N-CA-C 99.679 -4.193 . . . . 0.0 99.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.815 ' HD2' HG21 ' A' ' 25' ' ' ILE 0.265 2.0 p90 -167.8 68.66 0.08 Allowed 'General case' 0 C--O 1.187 -2.222 1 C-N-CA 110.836 -4.346 . . . . 0.0 100.757 178.638 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.01 123.3 13.13 Favored 'General case' 0 CA--C 1.502 -0.894 2 CA-C-N 105.777 -5.192 . . . . 0.0 103.947 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.413 0.5 OUTLIER -91.41 142.74 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 101.584 -3.487 . . . . 0.0 101.584 -179.753 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CD ' ' HB ' ' A' ' 24' ' ' THR 0.279 6.2 tttt -77.68 1.54 19.58 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 110.629 -2.987 . . . . 0.0 118.603 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' HB2' HG13 ' A' ' 34' ' ' VAL 0.252 0.0 OUTLIER -36.43 99.42 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 110.597 -3.002 . . . . 0.0 109.516 -179.962 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -107.49 164.43 12.22 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 128.29 3.494 . . . . 0.0 110.095 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.03 -171.19 3.04 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 125.237 1.586 . . . . 0.0 112.694 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -76.05 -7.75 55.4 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.962 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 33.9 m-85 -80.94 -71.66 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.18 -2.736 . . . . 0.0 110.396 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.427 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -150.78 -172.31 4.16 Favored 'General case' 0 N--CA 1.433 -1.286 1 O-C-N 131.891 5.744 . . . . 0.0 112.443 179.871 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -23.46 59.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 113.753 -3.179 . . . . 0.0 104.25 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 57' ' ' LEU . 7.4 tp 28.18 80.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.122 2 O-C-N 132.839 6.337 . . . . 0.0 110.676 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -76.35 120.52 21.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 109.701 -3.408 . . . . 0.0 105.828 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 57' ' ' LEU . 98.2 t -91.12 97.9 7.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 1 O-C-N 132.254 5.971 . . . . 0.0 102.779 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CG ' ' A' ' 47' ' ' PHE 0.316 8.9 p -99.98 158.43 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 1 O-C-N 129.161 4.038 . . . . 0.0 115.226 -179.967 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' CG ' ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -178.8 -160.45 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 129.543 4.277 . . . . 0.0 112.055 -179.64 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' CG ' ' HG2' ' A' ' 31' ' ' LYS 0.294 22.9 mt-10 -142.77 63.03 1.4 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 118.097 -1.441 . . . . 0.0 112.278 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' HB3' ' A' ' 69' ' ' MET . 19.5 mt 54.15 -82.46 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.217 0 O-C-N 128.159 3.412 . . . . 0.0 114.626 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.52 82.44 0.94 Allowed Glycine 0 C--O 1.197 -2.2 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.95 111.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 O-C-N 132.747 5.616 . . . . 0.0 112.897 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 6.5 t70 -91.87 163.34 14.07 Favored 'General case' 0 C--N 1.365 1.266 1 O-C-N 129.35 4.156 . . . . 0.0 106.797 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -173.32 143.64 1.11 Allowed 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 114.003 -3.079 . . . . 0.0 116.209 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.52 91.02 4.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -105.68 147.57 28.37 Favored 'General case' 0 C--O 1.208 -1.094 1 O-C-N 130.192 4.682 . . . . 0.0 112.772 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.61 92.98 4.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 128.16 3.413 . . . . 0.0 103.539 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.68 HD11 HG22 ' A' ' 45' ' ' VAL . 2.7 tp -47.36 -86.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 1 O-C-N 130.75 5.031 . . . . 0.0 109.998 -179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 -135.85 0.02 OUTLIER 'General case' 0 C--O 1.248 1.001 0 C-N-CA 116.875 -1.93 . . . . 0.0 109.723 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -67.46 -37.02 82.3 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.521 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -117.77 -81.71 0.82 Allowed Glycine 0 CA--C 1.545 1.909 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.687 HG22 HD13 ' A' ' 63' ' ' LEU . 1.4 m 35.7 77.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 1 O-C-N 131.089 4.641 . . . . 0.0 113.426 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 63' ' ' LEU . 1.9 tm-20 -81.99 139.93 34.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 115.31 -2.556 . . . . 0.0 104.36 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -155.73 44.21 0.44 Allowed 'General case' 0 C--O 1.204 -1.29 1 O-C-N 129.264 4.102 . . . . 0.0 111.695 -179.719 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -43.03 106.71 0.07 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 111.866 -2.424 . . . . 0.0 109.525 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -173.48 -161.98 24.63 Favored Glycine 0 N--CA 1.479 1.502 1 C-N-CA 111.133 -5.317 . . . . 0.0 107.474 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.49 ' N ' ' CE1' ' A' ' 78' ' ' PHE . 8.3 t -154.36 142.04 19.92 Favored 'General case' 0 C--O 1.247 0.953 0 O-C-N 129.45 3.677 . . . . 0.0 116.585 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.732 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 6.1 m95 -122.28 96.76 5.17 Favored 'General case' 0 C--O 1.196 -1.713 0 CA-C-O 113.192 -3.289 . . . . 0.0 102.595 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -105.72 75.58 1.14 Allowed 'General case' 0 N--CA 1.438 -1.058 2 O-C-N 139.426 10.454 . . . . 0.0 114.404 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.77 ' HB3' HD22 ' A' ' 49' ' ' LEU 0.262 30.7 ttp -46.33 100.4 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 2 O-C-N 132.991 6.432 . . . . 0.0 103.778 179.963 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.74 -46.52 90.12 Favored 'General case' 0 C--O 1.211 -0.948 1 O-C-N 132.094 5.871 . . . . 0.0 104.831 -179.874 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.17 -76.83 0.04 OUTLIER Glycine 0 CA--C 1.549 2.17 0 N-CA-C 105.326 -3.11 . . . . 0.0 105.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -114.34 9.98 17.02 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.166 2.921 . . . . 0.0 107.89 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.419 ' HB3' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -105.28 -178.97 3.8 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 128.945 3.903 . . . . 0.0 108.32 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.751 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 1.2 mt -152.69 43.06 0.64 Allowed 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 126.853 2.596 . . . . 0.0 112.772 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 73' ' ' LYS . 15.3 t -69.52 140.1 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.147 1 CA-C-N 107.85 -4.25 . . . . 0.0 117.525 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.8 -142.24 7.55 Favored Glycine 0 CA--C 1.547 2.059 3 CA-C-N 107.232 -4.531 . . . . 0.0 102.545 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' CB ' HG12 ' A' ' 88' ' ' ILE 0.369 8.0 tttt 175.71 125.29 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.408 1 O-C-N 132.135 5.256 . . . . 0.0 112.517 -179.75 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.732 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -123.0 156.37 34.93 Favored 'General case' 0 C--O 1.204 -1.325 3 O-C-N 130.323 4.764 . . . . 0.0 102.073 -179.151 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CE ' ' HB2' ' A' ' 86' ' ' GLU 0.335 0.0 OUTLIER -160.68 152.03 19.25 Favored 'General case' 0 N--CA 1.424 -1.766 1 CA-C-N 107.282 -4.508 . . . . 0.0 114.664 179.989 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -105.14 99.59 9.2 Favored 'General case' 0 CA--C 1.556 1.173 0 O-C-N 128.65 3.719 . . . . 0.0 108.344 179.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.3 t -43.46 -29.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 1 O-C-N 129.886 4.491 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -39.75 -56.06 1.81 Allowed 'General case' 0 C--N 1.324 -0.505 1 O-C-N 133.537 6.773 . . . . 0.0 105.444 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -122.43 8.56 9.62 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 129.069 3.981 . . . . 0.0 113.438 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.78 50.84 56.43 Favored Glycine 0 CA--C 1.55 2.26 1 N-CA-C 101.83 -4.508 . . . . 0.0 101.83 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' NZ ' ' NE ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -82.78 -64.14 1.23 Allowed 'General case' 0 N--CA 1.413 -2.284 1 O-C-N 131.813 5.067 . . . . 0.0 120.188 -179.355 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.605 ' OE2' HG22 ' A' ' 103' ' ' THR . 0.6 OUTLIER 81.35 137.66 0.06 Allowed 'General case' 0 C--O 1.198 -1.608 1 O-C-N 131.953 5.783 . . . . 0.0 113.415 -177.656 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 87' ' ' LEU 0.314 0.2 OUTLIER -155.88 34.96 0.35 Allowed 'General case' 0 C--O 1.201 -1.481 1 O-C-N 133.542 6.776 . . . . 0.0 113.02 177.979 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 103' ' ' THR . 75.6 mt -46.54 114.71 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.199 -1.562 1 CA-C-N 108.075 -4.148 . . . . 0.0 104.584 179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 69.7 10.67 Favored 'General case' 0 C--O 1.196 -1.758 1 O-C-N 130.659 4.974 . . . . 0.0 106.611 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.54 127.23 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 1 O-C-N 133.109 6.506 . . . . 0.0 100.916 178.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.893 ' CD ' HD21 ' A' ' 98' ' ' LEU . 2.3 ttp180 -158.17 161.75 37.88 Favored 'General case' 0 C--O 1.191 -2.02 1 C-N-CA 109.702 -4.799 . . . . 0.0 112.876 -177.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.6 145.99 2.11 Favored 'General case' 0 C--N 1.35 0.593 1 O-C-N 131.274 5.359 . . . . 0.0 106.411 179.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 98' ' ' LEU . 1.1 mm -53.68 111.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 1 O-C-N 130.141 4.651 . . . . 0.0 110.695 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.6 ' CB ' HD13 ' A' ' 99' ' ' ILE . 1.5 t -51.97 -61.46 2.25 Favored 'General case' 0 C--O 1.248 0.989 0 O-C-N 128.253 3.47 . . . . 0.0 116.025 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.48 -94.73 0.12 Allowed Glycine 0 C--O 1.206 -1.626 1 N-CA-C 102.987 -4.045 . . . . 0.0 102.987 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -102.35 32.85 3.36 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 111.027 -2.586 . . . . 0.0 107.905 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.84 175.05 0.87 Allowed 'General case' 0 CA--C 1.561 1.388 0 O-C-N 128.669 3.731 . . . . 0.0 105.217 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.893 HD21 ' CD ' ' A' ' 91' ' ' ARG . 1.3 tt -109.41 157.48 18.88 Favored 'General case' 0 C--O 1.201 -1.457 1 O-C-N 132.326 6.016 . . . . 0.0 110.034 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.717 HG22 ' N ' ' A' ' 100' ' ' GLN . 1.0 OUTLIER -116.09 -62.97 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 1 O-C-N 129.433 4.208 . . . . 0.0 109.608 -179.734 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.717 ' N ' HG22 ' A' ' 99' ' ' ILE . 23.7 mt-30 83.09 134.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.469 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 28.0 m -141.88 101.15 3.89 Favored 'General case' 0 N--CA 1.423 -1.785 1 O-C-N 130.989 5.18 . . . . 0.0 112.644 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -88.49 95.33 10.18 Favored 'General case' 0 C--O 1.203 -1.348 1 O-C-N 129.673 4.358 . . . . 0.0 107.205 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.605 HG22 ' OE2' ' A' ' 86' ' ' GLU . 2.5 m -62.32 120.03 10.2 Favored 'General case' 0 N--CA 1.481 1.077 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 178.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.503 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -170.14 119.68 0.6 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 110.946 -2.843 . . . . 0.0 113.386 -179.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 107' ' ' VAL . 5.8 mt-10 40.66 -81.16 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 112.763 -2.017 . . . . 0.0 111.635 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.497 ' C ' HG23 ' A' ' 107' ' ' VAL . . . -61.01 -18.52 54.81 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.941 -3.028 . . . . 0.0 110.94 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 105' ' ' GLU . 2.2 t 68.22 149.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 46.18 79.86 0.05 Allowed 'General case' 0 C--N 1.358 0.946 1 O-C-N 129.354 4.159 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.346 . . -117.99 74.64 0.95 Allowed 'General case' 0 C--O 1.199 -1.568 0 O-C-N 126.595 2.434 . . . . 0.0 108.585 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 99' ' ' ILE . 0.2 OUTLIER -84.04 153.09 24.02 Favored 'General case' 0 N--CA 1.416 -2.153 1 O-C-N 131.64 5.588 . . . . 0.0 111.665 -179.104 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -120.64 -179.88 4.12 Favored 'General case' 0 CA--C 1.558 1.274 1 CA-C-N 107.964 -4.198 . . . . 0.0 104.758 -179.895 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.461 HD12 ' C ' ' A' ' 111' ' ' ARG . 1.8 mp -131.08 108.45 15.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 1 O-C-N 129.498 4.249 . . . . 0.0 112.933 -179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.707 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -119.69 179.66 4.16 Favored 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.951 5.157 . . . . 0.0 106.676 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.604 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.7 126.02 0.08 Allowed 'General case' 0 N--CA 1.429 -1.477 2 O-C-N 132.3 6.0 . . . . 0.0 113.577 -179.758 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.643 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 18.0 tttt -38.09 -57.07 1.1 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 110.014 -3.266 . . . . 0.0 116.463 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.423 -1.797 0 O-C-N 127.902 3.251 . . . . 0.0 111.371 179.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.135 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.904 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.432 ' HE1' HG21 ' A' ' 93' ' ' ILE . 2.6 m-85 -76.87 -32.87 57.78 Favored 'General case' 0 CA--C 1.56 1.357 1 O-C-N 131.012 5.195 . . . . 0.0 105.929 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -40.93 88.74 0.0 OUTLIER 'General case' 0 N--CA 1.418 -2.035 1 O-C-N 129.633 4.333 . . . . 0.0 116.472 -179.897 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' PHE . . . 164.46 147.43 5.1 Favored Glycine 0 C--N 1.339 0.701 1 C-N-CA 112.22 -4.8 . . . . 0.0 106.612 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 11.1 p -61.46 166.2 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 115.729 -2.389 . . . . 0.0 108.564 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.62 ' CE3' ' HG3' ' A' ' 115' ' ' LYS 0.25 73.4 m95 -139.46 158.74 43.63 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 111.758 -3.972 . . . . 0.0 110.43 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' CD ' ' HB3' ' A' ' 113' ' ' PHE . 11.4 mtmt 51.02 -178.25 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.837 0 O-C-N 128.571 3.67 . . . . 0.0 117.141 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG11 ' O ' ' A' ' 21' ' ' LEU 0.308 1.2 t 21.77 112.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.485 -1.534 3 O-C-N 134.303 7.252 . . . . 0.0 114.78 174.931 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.16 75.92 2.62 Favored 'General case' 0 C--N 1.368 1.412 1 O-C-N 116.047 -4.158 . . . . 0.0 110.035 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -169.04 77.69 0.11 Allowed 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.993 -1.067 . . . . 0.0 111.57 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.406 ' C ' ' HG3' ' A' ' 12' ' ' GLU . 3.5 p-10 -121.2 -18.8 7.31 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 115.914 -1.994 . . . . 0.0 113.371 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 11' ' ' ASN . 0.8 OUTLIER 36.35 75.35 0.06 Allowed 'General case' 0 C--O 1.245 0.833 0 O-C-N 127.775 3.172 . . . . 0.0 112.205 179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.41 -161.76 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 O-C-N 128.138 3.399 . . . . 0.0 108.538 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -86.92 85.87 7.29 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.706 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.1 22.89 0.25 Allowed 'General case' 0 C--N 1.363 1.168 0 C-N-CA 115.494 -2.482 . . . . 0.0 109.923 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.03 146.18 18.3 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.16 -42.94 2.45 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 116.445 -1.74 . . . . 0.0 108.897 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.26 -66.91 0.87 Allowed 'General case' 0 C--N 1.356 0.875 0 O-C-N 124.726 1.266 . . . . 0.0 111.65 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 63.26 -179.47 0.15 Allowed 'General case' 0 C--O 1.221 -0.433 0 O-C-N 127.918 3.261 . . . . 0.0 110.521 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -98.42 -74.62 0.58 Allowed 'General case' 0 C--N 1.367 1.363 0 O-C-N 126.031 2.082 . . . . 0.0 112.098 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' O ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -167.65 170.68 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.401 0.0 OUTLIER 167.98 153.97 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.626 1 O-C-N 132.317 6.01 . . . . 0.0 100.668 -179.66 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD23 ' C ' ' A' ' 35' ' ' LYS . 8.0 mt -112.59 170.33 8.26 Favored 'General case' 0 CA--C 1.551 0.99 1 O-C-N 133.266 6.604 . . . . 0.0 101.028 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 25' ' ' ILE . 1.6 m -156.14 -81.6 0.07 Allowed 'General case' 0 C--O 1.199 -1.577 1 O-C-N 130.218 4.699 . . . . 0.0 106.264 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.626 ' N ' HG22 ' A' ' 24' ' ' THR . 2.6 mp 70.91 129.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.203 -1.385 0 CA-C-N 109.142 -3.663 . . . . 0.0 109.733 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.0 m -162.55 80.19 0.51 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -60.1 148.34 36.23 Favored 'General case' 0 C--N 1.357 0.918 1 CA-C-N 106.08 -5.055 . . . . 0.0 115.246 -179.953 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.83 86.42 2.5 Favored 'General case' 0 CA--C 1.555 1.155 0 O-C-N 128.29 3.494 . . . . 0.0 103.412 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.13 -128.91 8.7 Favored Glycine 0 CA--C 1.552 2.365 2 C-N-CA 110.839 -5.458 . . . . 0.0 102.821 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -99.56 55.95 0.98 Allowed 'General case' 0 N--CA 1.437 -1.111 1 O-C-N 131.083 4.637 . . . . 0.0 109.252 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -146.84 122.56 10.54 Favored 'General case' 0 CA--C 1.552 1.041 1 N-CA-C 96.425 -5.398 . . . . 0.0 96.425 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.582 ' CE1' HD22 ' A' ' 49' ' ' LEU . 3.8 m-85 -119.48 171.09 8.59 Favored 'General case' 0 C--O 1.211 -0.933 2 O-C-N 130.111 4.632 . . . . 0.0 99.061 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -158.68 127.88 5.57 Favored 'General case' 0 C--O 1.249 1.058 3 O-C-N 136.284 8.49 . . . . 0.0 98.674 179.814 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 36' ' ' GLU 0.369 2.4 t -101.56 146.89 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 102.342 -3.207 . . . . 0.0 102.342 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' C ' HD23 ' A' ' 23' ' ' LEU 0.27 12.7 ttmt -91.67 48.57 1.47 Allowed 'General case' 0 C--O 1.195 -1.791 0 CA-C-O 127.491 3.52 . . . . 0.0 115.145 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 34' ' ' VAL 0.284 7.3 mt-10 -69.01 88.53 0.4 Allowed 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 35' ' ' LYS . 2.0 m -86.61 128.02 34.96 Favored 'General case' 0 C--O 1.215 -0.717 0 O-C-N 127.222 2.826 . . . . 0.0 110.882 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.6 -161.98 0.92 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 114.683 -2.807 . . . . 0.0 115.128 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -96.26 -7.21 36.1 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 111.961 -2.382 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -92.28 -65.9 0.97 Allowed 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 114.572 -2.851 . . . . 0.0 107.265 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HD3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -141.98 -155.69 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 128.654 3.721 . . . . 0.0 110.616 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -75.66 -67.44 0.67 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 112.263 -3.775 . . . . 0.0 103.604 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD12 ' HD3' ' A' ' 41' ' ' ARG 0.251 0.4 OUTLIER 72.42 75.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.422 2 CA-C-O 134.919 7.057 . . . . 0.0 105.52 179.76 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.05 151.84 23.38 Favored 'General case' 0 C--N 1.373 1.619 1 CA-C-N 107.182 -4.554 . . . . 0.0 105.558 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.39 117.23 53.33 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 1 O-C-N 131.104 5.253 . . . . 0.0 102.734 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' PHE 0.325 9.4 p -115.11 155.42 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 115.798 -2.361 . . . . 0.0 110.977 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 67' ' ' TRP . 0.3 OUTLIER -166.79 177.88 6.21 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 127.667 3.104 . . . . 0.0 111.442 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -119.35 67.5 0.8 Allowed 'General case' 0 N--CA 1.423 -1.82 0 C-N-CA 115.326 -2.55 . . . . 0.0 115.169 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 32' ' ' PHE . 11.2 tp 23.32 75.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.812 1 O-C-N 130.148 4.655 . . . . 0.0 116.237 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.87 57.56 0.49 Allowed Glycine 0 CA--C 1.561 2.911 1 CA-C-O 112.545 -4.475 . . . . 0.0 104.452 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -150.67 120.83 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 1 O-C-N 134.662 6.742 . . . . 0.0 114.932 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' HA ' ' HB ' ' A' ' 66' ' ' THR . 3.9 p30 -83.82 151.99 24.86 Favored 'General case' 0 C--O 1.207 -1.144 0 O-C-N 128.065 3.353 . . . . 0.0 107.913 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 55' ' ' TYR . 21.4 p90 -173.66 162.71 4.16 Favored 'General case' 0 C--N 1.37 1.492 1 O-C-N 131.74 5.65 . . . . 0.0 115.006 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.68 141.41 37.17 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -154.19 102.97 2.5 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 116.732 -1.987 . . . . 0.0 109.683 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.67 95.17 2.8 Favored 'General case' 0 CA--C 1.539 0.519 1 O-C-N 129.106 4.004 . . . . 0.0 104.066 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.13 -90.21 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 1 O-C-N 132.56 6.163 . . . . 0.0 109.773 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB3' HG23 ' A' ' 61' ' ' THR . . . -70.72 177.05 3.75 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 116.584 -2.046 . . . . 0.0 109.812 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.38 66.26 4.79 Favored 'General case' 0 C--O 1.21 -0.975 0 O-C-N 128.543 3.652 . . . . 0.0 111.607 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.23 -38.43 0.17 Allowed Glycine 0 CA--C 1.54 1.598 0 CA-C-O 115.243 -2.976 . . . . 0.0 108.378 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 58' ' ' ALA . 28.4 p -52.79 166.54 0.2 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 129.336 3.61 . . . . 0.0 114.021 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -165.02 49.14 0.1 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 125.413 2.53 . . . . 0.0 107.906 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 HD23 ' A' ' 87' ' ' LEU . 8.4 mp -69.37 125.72 27.56 Favored 'General case' 0 C--N 1.367 1.347 0 CA-C-N 110.237 -3.165 . . . . 0.0 107.994 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 m -126.82 98.75 5.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -162.44 -164.9 18.45 Favored Glycine 0 N--CA 1.478 1.449 1 C-N-CA 111.917 -4.944 . . . . 0.0 104.475 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.8 t -140.56 150.67 43.95 Favored 'General case' 0 N--CA 1.428 -1.56 1 O-C-N 131.073 4.631 . . . . 0.0 116.585 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.582 ' HB2' ' CD2' ' A' ' 47' ' ' PHE . 9.0 m95 -129.43 122.89 30.3 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-O 115.476 -2.202 . . . . 0.0 105.474 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.61 97.51 4.09 Favored 'General case' 0 C--O 1.203 -1.375 1 O-C-N 136.059 8.349 . . . . 0.0 110.626 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.572 ' HG2' ' CE2' ' A' ' 32' ' ' PHE 0.254 9.2 tpp -74.24 137.98 43.36 Favored 'General case' 0 CA--C 1.512 -0.49 1 O-C-N 132.181 5.926 . . . . 0.0 105.756 179.963 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -141.28 120.64 13.11 Favored 'General case' 0 C--O 1.218 -0.576 1 O-C-N 129.178 4.049 . . . . 0.0 105.427 -179.921 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.44 -98.11 0.02 OUTLIER Glycine 0 CA--C 1.557 2.682 1 O-C-N 129.521 4.263 . . . . 0.0 106.55 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.23 51.14 1.82 Allowed 'General case' 0 N--CA 1.439 -1.005 0 O-C-N 129.703 3.825 . . . . 0.0 109.87 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 70' ' ' GLU . 1.5 mtpt -137.35 160.14 39.93 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 128.409 3.568 . . . . 0.0 108.65 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.6 mt -144.23 64.72 1.3 Allowed 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.57 147.0 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 CA-C-O 129.778 4.608 . . . . 0.0 115.577 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.19 -147.3 15.71 Favored Glycine 0 CA--C 1.563 3.063 1 CA-C-N 107.183 -4.553 . . . . 0.0 103.641 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 163.73 139.13 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.651 1 O-C-N 134.045 6.38 . . . . 0.0 112.86 -179.835 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.61 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 5.5 m-85 -123.52 -169.49 1.95 Allowed 'General case' 0 C--O 1.204 -1.339 2 O-C-N 134.324 7.265 . . . . 0.0 104.648 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.671 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.316 0.0 OUTLIER -169.96 -145.68 0.05 OUTLIER 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 109.801 -3.363 . . . . 0.0 115.162 -179.281 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HB3' ' CB ' ' A' ' 85' ' ' LYS . 47.0 ttt180 -168.12 90.29 0.29 Allowed 'General case' 0 C--N 1.352 0.679 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.884 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -32.51 -33.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 127.621 3.076 . . . . 0.0 113.014 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 81' ' ' VAL . 1.2 t70 -53.44 -49.5 67.23 Favored 'General case' 0 CA--C 1.508 -0.636 1 O-C-N 129.727 4.392 . . . . 0.0 111.894 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.1 19.08 2.98 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-O 113.66 -3.067 . . . . 0.0 117.908 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 63.15 55.28 27.14 Favored Glycine 0 C--O 1.2 -1.976 1 N-CA-C 102.435 -4.266 . . . . 0.0 102.435 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 80' ' ' ARG . 6.9 tppt? -80.94 -81.82 0.13 Allowed 'General case' 0 N--CA 1.427 -1.58 2 O-C-N 132.131 5.253 . . . . 0.0 118.603 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 78.2 mt-10 86.95 97.62 0.03 OUTLIER 'General case' 0 C--O 1.198 -1.637 1 O-C-N 131.036 5.21 . . . . 0.0 109.832 -179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 HD21 ' A' ' 63' ' ' LEU . 12.9 tp -124.08 53.38 1.41 Allowed 'General case' 0 C--O 1.201 -1.478 1 O-C-N 138.185 9.678 . . . . 0.0 108.607 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 77' ' ' LYS . 25.5 mt -78.61 -178.0 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.176 2 CA-C-N 107.247 -4.524 . . . . 0.0 103.691 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.54 88.94 0.66 Allowed 'General case' 0 C--O 1.195 -1.794 1 O-C-N 131.804 5.69 . . . . 0.0 108.732 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.65 121.0 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 O-C-N 126.396 2.31 . . . . 0.0 107.583 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.3 tpt180 -170.63 163.04 8.11 Favored 'General case' 0 C--O 1.186 -2.243 0 C-N-CA 111.892 -3.923 . . . . 0.0 112.973 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -150.87 132.22 14.6 Favored 'General case' 0 N--CA 1.426 -1.626 1 O-C-N 132.035 5.835 . . . . 0.0 107.086 179.226 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -48.18 129.28 4.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 1 O-C-N 132.509 6.131 . . . . 0.0 109.149 179.976 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.9 p -78.92 -67.98 0.7 Allowed 'General case' 0 C--O 1.247 0.94 0 O-C-N 127.654 3.096 . . . . 0.0 116.13 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -118.17 -66.92 0.33 Allowed Glycine 0 CA--C 1.545 1.95 0 N-CA-C 105.199 -3.16 . . . . 0.0 105.199 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.34 27.73 1.24 Allowed 'General case' 0 C--N 1.35 0.619 0 CA-C-N 110.501 -2.85 . . . . 0.0 107.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.636 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.73 119.28 2.9 Favored 'General case' 0 N--CA 1.433 -1.289 0 O-C-N 128.356 3.535 . . . . 0.0 109.642 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 121.67 28.62 Favored 'General case' 0 CA--C 1.557 1.231 1 O-C-N 129.771 4.42 . . . . 0.0 108.688 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' CG2' ' HB2' ' A' ' 110' ' ' LYS . 30.9 mt -74.04 -80.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.491 2 CA-C-O 111.285 -4.198 . . . . 0.0 108.206 -179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' N ' HG22 ' A' ' 99' ' ' ILE . 5.3 mt-30 99.75 112.6 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.394 2 O-C-N 136.054 8.346 . . . . 0.0 98.127 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 110' ' ' LYS . 30.9 p -82.95 -32.07 27.33 Favored 'General case' 0 N--CA 1.404 -2.74 1 O-C-N 130.306 4.754 . . . . 0.0 119.906 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 104' ' ' TYR . 62.9 m-85 60.24 70.22 0.64 Allowed 'General case' 0 CA--C 1.565 1.538 0 O-C-N 128.973 3.921 . . . . 0.0 103.558 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.6 m -69.22 73.7 0.32 Allowed 'General case' 0 C--O 1.215 -0.712 1 O-C-N 132.169 5.918 . . . . 0.0 106.206 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' TYR . 3.3 t80 -88.85 116.74 27.34 Favored 'General case' 0 CA--C 1.495 -1.144 1 CA-C-N 108.261 -4.063 . . . . 0.0 112.863 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 61.0 46.04 8.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 112.817 -1.992 . . . . 0.0 112.708 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.82 4.12 57.44 Favored Glycine 0 N--CA 1.432 -1.62 0 CA-C-O 124.769 2.316 . . . . 0.0 117.528 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.5 t -119.15 137.2 53.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 O-C-N 119.558 -2.143 . . . . 0.0 115.051 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.93 132.17 43.12 Favored 'General case' 0 C--N 1.366 1.3 1 O-C-N 129.206 4.066 . . . . 0.0 105.661 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.354 . . -138.85 44.0 2.07 Favored 'General case' 0 N--CA 1.424 -1.764 0 O-C-N 128.368 3.542 . . . . 0.0 112.783 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 2.7 pttp -74.73 168.99 18.76 Favored 'General case' 0 N--CA 1.419 -1.989 1 O-C-N 133.308 6.63 . . . . 0.0 109.047 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -145.45 -90.62 0.1 Allowed 'General case' 0 CA--C 1.556 1.208 1 O-C-N 129.292 4.12 . . . . 0.0 100.632 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -174.63 179.54 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 111.377 -2.647 . . . . 0.0 108.974 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.517 ' HB3' ' CD ' ' A' ' 7' ' ' LYS . 8.8 m-85 166.49 178.55 0.02 OUTLIER 'General case' 0 N--CA 1.422 -1.848 1 O-C-N 136.157 8.411 . . . . 0.0 104.926 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.636 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -161.72 -154.17 0.33 Allowed 'General case' 0 C--O 1.198 -1.607 1 O-C-N 131.795 5.684 . . . . 0.0 111.515 178.683 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.62 ' HG3' ' CE3' ' A' ' 6' ' ' TRP 0.253 29.9 tttt -110.53 -138.39 0.38 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . 0.255 7.7 tp10 . . . . . 0 N--CA 1.442 -0.841 0 CA-C-N 113.662 -1.608 . . . . 0.0 112.441 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -145.41 -48.74 0.23 Allowed 'General case' 0 CA--C 1.56 1.352 0 O-C-N 127.826 3.204 . . . . 0.0 105.304 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 9.6 t0 -35.36 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 129.785 4.428 . . . . 0.0 117.878 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' N ' ' OG1' ' A' ' 26' ' ' THR . . . 153.13 175.56 24.68 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 115.413 -3.279 . . . . 0.0 105.297 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.285 3.6 p -90.78 176.8 6.51 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 113.274 -3.37 . . . . 0.0 103.844 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.585 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 28.4 m95 -147.21 160.37 42.55 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-O 112.592 -3.575 . . . . 0.0 112.435 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.5 mtmt 50.93 -178.89 0.02 OUTLIER 'General case' 0 C--O 1.195 -1.784 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 21' ' ' LEU 0.26 0.5 OUTLIER 28.33 36.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 3 CA-C-O 135.409 7.29 . . . . 0.0 119.675 174.899 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -71.19 -53.18 15.32 Favored 'General case' 0 C--N 1.373 1.63 1 CA-C-N 107.873 -4.24 . . . . 0.0 103.792 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.0 103.44 15.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.188 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.21 113.0 25.65 Favored 'General case' 0 C--N 1.36 1.037 0 CA-C-N 113.76 -1.564 . . . . 0.0 114.074 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.86 44.91 0.83 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.49 -164.26 0.98 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 128.061 3.351 . . . . 0.0 105.009 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -92.68 19.94 6.94 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 111.567 -2.56 . . . . 0.0 110.833 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 t 67.45 101.82 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.719 1.247 . . . . 0.0 110.989 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.29 155.59 18.53 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 115.861 -3.066 . . . . 0.0 107.559 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.83 -53.16 16.33 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -155.06 51.98 0.61 Allowed 'General case' 0 C--O 1.243 0.741 0 O-C-N 124.391 1.057 . . . . 0.0 110.627 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -106.83 21.04 18.15 Favored 'General case' 0 C--O 1.208 -1.091 0 O-C-N 128.504 3.627 . . . . 0.0 109.305 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -93.27 119.07 32.01 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 111.331 -2.668 . . . . 0.0 110.529 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.51 163.45 14.91 Favored 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 109.526 -3.488 . . . . 0.0 104.793 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.382 0.0 OUTLIER -171.72 150.54 2.71 Favored 'General case' 0 CA--C 1.563 1.464 1 O-C-N 133.302 6.626 . . . . 0.0 102.228 179.843 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 6' ' ' TRP . 5.4 mt -115.32 157.1 24.3 Favored 'General case' 0 CA--C 1.565 1.546 4 O-C-N 132.916 6.385 . . . . 0.0 97.666 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 35' ' ' LYS . 1.9 m 172.09 96.46 0.01 OUTLIER 'General case' 0 C--O 1.205 -1.249 1 O-C-N 132.768 6.292 . . . . 0.0 102.745 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.92 HG22 ' CD1' ' A' ' 32' ' ' PHE . 3.0 mp -114.66 112.35 39.72 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-N 108.96 -3.746 . . . . 0.0 109.962 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 4' ' ' GLY . 35.9 m -155.07 79.68 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 127.74 3.15 . . . . 0.0 108.44 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.6 mm-40 -88.08 -98.62 0.09 Allowed 'General case' 0 C--N 1.355 0.845 3 CA-C-N 105.865 -5.152 . . . . 0.0 111.634 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.88 -6.17 4.51 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 128.088 3.367 . . . . 0.0 106.47 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.31 -27.4 8.11 Favored Glycine 0 CA--C 1.546 1.969 1 N-CA-C 99.189 -5.565 . . . . 0.0 99.189 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.41 -25.67 6.0 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 111.737 -3.983 . . . . 0.0 111.627 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 2.6 mttm -101.56 178.89 4.51 Favored 'General case' 0 C--O 1.25 1.085 1 N-CA-C 97.596 -4.964 . . . . 0.0 97.596 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -176.64 139.38 0.31 Allowed 'General case' 0 C--O 1.19 -2.076 1 N-CA-C 97.217 -5.105 . . . . 0.0 97.217 178.875 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.565 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -128.67 119.88 25.5 Favored 'General case' 0 C--O 1.249 1.028 3 O-C-N 136.446 8.591 . . . . 0.0 98.577 -179.957 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 36' ' ' GLU 0.364 1.2 t -84.6 128.41 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 1 N-CA-C 99.747 -4.168 . . . . 0.0 99.747 -179.944 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' CB ' ' HB ' ' A' ' 24' ' ' THR 0.295 5.3 tttm -67.72 -8.88 38.92 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 120.775 3.62 . . . . 0.0 120.775 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 34' ' ' VAL 0.339 3.9 tt0 -29.37 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 108.499 -3.955 . . . . 0.0 109.965 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -80.45 155.65 26.98 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 114.228 -2.989 . . . . 0.0 111.035 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.6 t -121.57 -151.82 0.49 Allowed 'General case' 0 N--CA 1.442 -0.827 0 O-C-N 127.527 3.017 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -102.13 -29.56 11.67 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 126.198 2.186 . . . . 0.0 108.937 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 10.2 m-85 -66.5 -60.49 2.69 Favored 'General case' 0 CA--C 1.551 1.013 1 O-C-N 130.654 4.971 . . . . 0.0 105.162 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CZ ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -151.58 -163.28 1.71 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 128.972 3.92 . . . . 0.0 113.54 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.39 -16.46 52.14 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 121.431 1.923 . . . . 0.0 109.939 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' HB ' ' CZ ' ' A' ' 41' ' ' ARG . 8.8 tt 20.05 94.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.266 2 O-C-N 132.336 6.022 . . . . 0.0 111.972 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 152.1 22.0 Favored 'General case' 0 C--N 1.366 1.304 0 O-C-N 117.001 -3.562 . . . . 0.0 104.198 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -126.79 91.64 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.93 1 O-C-N 130.469 4.855 . . . . 0.0 103.707 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 ' OG1' ' A' ' 33' ' ' THR 0.29 0.7 OUTLIER -92.18 158.89 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 1 C-N-CA 111.052 -4.259 . . . . 0.0 115.764 -179.993 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 32' ' ' PHE . 0.9 OUTLIER -154.66 -177.0 6.19 Favored 'General case' 0 N--CA 1.437 -1.11 0 O-C-N 129.011 3.944 . . . . 0.0 111.303 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.571 ' HB3' HG21 ' A' ' 51' ' ' VAL 0.258 1.2 tt0 -130.22 31.54 4.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.267 3.48 . . . . 0.0 111.805 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.9 mp 57.83 99.43 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.585 1 O-C-N 133.749 6.906 . . . . 0.0 113.337 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 86.51 52.14 3.28 Favored Glycine 0 CA--C 1.548 2.118 0 CA-C-O 113.797 -3.779 . . . . 0.0 104.085 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 48' ' ' GLU . 21.7 t -134.31 104.79 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 1 O-C-N 134.851 6.853 . . . . 0.0 113.531 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 145.57 33.63 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 110.45 -3.068 . . . . 0.0 109.563 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.58 124.01 7.72 Favored 'General case' 0 C--N 1.372 1.577 2 O-C-N 129.733 4.396 . . . . 0.0 116.131 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.6 73.53 4.36 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.92 121.75 41.27 Favored 'General case' 0 C--O 1.225 -0.203 0 O-C-N 127.564 3.04 . . . . 0.0 112.375 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -74.47 114.84 13.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 111.853 -3.939 . . . . 0.0 106.54 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mp -109.43 155.92 20.7 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 127.229 2.831 . . . . 0.0 112.408 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 53.41 22.93 3.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 115.721 -2.085 . . . . 0.0 114.026 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.2 t70 39.14 38.7 0.34 Allowed 'General case' 0 C--N 1.355 0.831 0 O-C-N 128.957 3.911 . . . . 0.0 112.16 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.81 -58.03 0.01 OUTLIER Glycine 0 CA--C 1.543 1.786 0 N-CA-C 105.725 -2.95 . . . . 0.0 105.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.402 ' C ' ' HG2' ' A' ' 62' ' ' GLU . 1.1 p -77.07 149.48 35.77 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 127.8 2.706 . . . . 0.0 114.274 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HG2' ' C ' ' A' ' 61' ' ' THR . 2.9 mt-10 -143.31 66.24 1.31 Allowed 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.27 117.67 5.05 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 129.093 3.996 . . . . 0.0 107.255 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -123.57 109.55 13.92 Favored 'General case' 0 C--O 1.205 -1.283 0 O-C-N 126.404 2.315 . . . . 0.0 108.65 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 178.13 -146.11 7.31 Favored Glycine 0 N--CA 1.479 1.558 1 C-N-CA 113.838 -4.03 . . . . 0.0 103.727 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 66' ' ' THR 0.312 15.2 t -176.16 141.44 0.44 Allowed 'General case' 0 CA--C 1.486 -1.485 1 O-C-N 131.247 4.733 . . . . 0.0 119.58 -178.553 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.722 ' CZ2' ' CE2' ' A' ' 78' ' ' PHE . 10.5 m95 -107.5 145.45 33.08 Favored 'General case' 0 C--O 1.195 -1.769 1 O-C-N 115.971 -4.206 . . . . 0.0 100.5 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.404 HG22 ' HA2' ' A' ' 50' ' ' GLY . 25.8 p -126.56 25.21 6.52 Favored 'General case' 0 N--CA 1.428 -1.526 2 O-C-N 135.278 7.861 . . . . 0.0 115.21 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 3.65 105.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.887 1 O-C-N 137.638 9.336 . . . . 0.0 108.611 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -114.0 -170.74 1.77 Allowed 'General case' 0 C--O 1.215 -0.713 1 O-C-N 129.625 4.328 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.41 105.83 0.81 Allowed Glycine 0 CA--C 1.541 1.707 0 O-C-N 127.354 2.909 . . . . 0.0 108.51 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 39.71 55.56 2.43 Favored 'General case' 0 C--O 1.238 0.491 1 O-C-N 131.496 4.88 . . . . 0.0 110.046 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -174.27 3.9 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 127.021 2.701 . . . . 0.0 109.772 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 98' ' ' LEU . 1.1 mt -161.01 30.69 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 O-C-N 126.391 2.307 . . . . 0.0 115.507 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 t -59.27 137.14 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 2 O-C-N 131.24 5.338 . . . . 0.0 114.42 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 154.22 -139.94 7.14 Favored Glycine 0 C--O 1.197 -2.186 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 78' ' ' PHE 0.333 20.1 tttm -177.63 176.51 1.24 Allowed 'General case' 0 C--N 1.371 1.531 1 O-C-N 133.164 5.861 . . . . 0.0 110.145 -178.682 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.722 ' CE2' ' CZ2' ' A' ' 67' ' ' TRP . 22.4 m-85 -176.06 172.62 2.36 Favored 'General case' 0 C--O 1.212 -0.92 2 O-C-N 134.178 7.174 . . . . 0.0 102.602 175.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' C ' ' A' ' 85' ' ' LYS 0.296 13.7 ttmt -160.22 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.825 1 CA-C-N 105.076 -5.511 . . . . 0.0 110.135 179.962 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.695 ' NE ' HD11 ' A' ' 87' ' ' LEU 0.272 5.9 ptt180 175.61 56.91 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 117.267 -1.349 . . . . 0.0 111.336 178.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 81' ' ' VAL . 31.7 t -41.46 87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.558 2 O-C-N 134.769 7.543 . . . . 0.0 108.521 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 t70 170.31 -42.07 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.107 1 O-C-N 130.597 4.935 . . . . 0.0 107.348 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.93 -0.38 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 129.017 3.948 . . . . 0.0 115.377 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' CA ' ' HG3' ' A' ' 80' ' ' ARG . . . -101.93 -35.01 4.12 Favored Glycine 0 CA--C 1.54 1.649 1 C-N-CA 113.036 -4.411 . . . . 0.0 105.546 -179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.569 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 75.43 -174.76 0.12 Allowed 'General case' 0 CA--C 1.495 -1.145 1 O-C-N 131.292 4.76 . . . . 0.0 114.063 179.837 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 79' ' ' LYS 0.258 6.6 mt-10 -34.41 142.01 0.05 OUTLIER 'General case' 0 C--O 1.198 -1.623 1 O-C-N 130.077 4.611 . . . . 0.0 116.334 -177.297 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.695 HD11 ' NE ' ' A' ' 80' ' ' ARG . 40.4 mt -150.65 37.22 0.65 Allowed 'General case' 0 C--O 1.194 -1.829 1 O-C-N 132.969 6.418 . . . . 0.0 110.074 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 21.5 mt -62.27 152.39 6.92 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 3 O-C-N 130.053 4.596 . . . . 0.0 99.54 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.657 ' HB1' HE22 ' A' ' 100' ' ' GLN . . . -124.98 87.15 2.66 Favored 'General case' 0 C--O 1.197 -1.7 1 O-C-N 135.58 8.05 . . . . 0.0 110.363 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 90' ' ' VAL . 3.7 t -84.23 107.85 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 114.892 -2.723 . . . . 0.0 105.232 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.509 ' HD2' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -168.53 164.27 12.49 Favored 'General case' 0 C--O 1.194 -1.868 1 C-N-CA 111.097 -4.241 . . . . 0.0 115.717 -179.519 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.5 ' N ' ' HG3' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -151.77 143.65 23.76 Favored 'General case' 0 N--CA 1.427 -1.599 0 O-C-N 128.6 3.687 . . . . 0.0 104.088 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -58.35 81.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 1 O-C-N 133.176 6.548 . . . . 0.0 110.135 -179.985 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.62 -76.27 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.62 -114.72 0.81 Allowed Glycine 0 CA--C 1.55 2.223 0 N-CA-C 104.528 -3.429 . . . . 0.0 104.528 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -113.86 24.74 11.8 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 109.688 -3.256 . . . . 0.0 108.893 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.572 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -159.91 165.21 32.61 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 110.963 -2.835 . . . . 0.0 106.756 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 HD12 ' A' ' 74' ' ' LEU . 5.3 tt -110.48 121.23 44.8 Favored 'General case' 0 N--CA 1.447 -0.582 1 O-C-N 130.162 4.664 . . . . 0.0 109.826 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HB ' ' HD2' ' A' ' 91' ' ' ARG . 1.7 mt -71.11 -55.79 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 109.47 -3.513 . . . . 0.0 107.724 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.657 HE22 ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER 73.65 105.68 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 1 O-C-N 132.27 5.981 . . . . 0.0 103.97 -179.915 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.21 91.03 3.48 Favored 'General case' 0 N--CA 1.424 -1.763 2 O-C-N 132.408 6.067 . . . . 0.0 113.141 179.671 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 50.4 m-85 -70.77 125.5 27.01 Favored 'General case' 0 N--CA 1.479 0.988 1 C-N-CA 109.309 -4.956 . . . . 0.0 105.669 -179.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 88' ' ' ILE . 2.9 m -96.53 68.01 2.47 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 127.811 3.672 . . . . 0.0 105.982 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 105' ' ' GLU . 2.0 t80 -65.06 156.68 30.7 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 109.803 -3.362 . . . . 0.0 111.0 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 104' ' ' TYR . 5.0 tp10 -47.76 104.55 0.06 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 112.848 -1.978 . . . . 0.0 115.681 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.24 1.8 83.78 Favored Glycine 0 C--N 1.347 1.178 0 C-N-CA 117.799 -2.143 . . . . 0.0 116.858 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . 0.269 2.5 t -136.93 169.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -143.15 58.1 1.4 Allowed 'General case' 0 C--N 1.359 1.006 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.422 . . -98.42 152.49 19.44 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 114.658 -2.817 . . . . 0.0 111.287 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.667 ' HG2' HG23 ' A' ' 101' ' ' THR . 0.2 OUTLIER -109.95 -163.21 0.84 Allowed 'General case' 0 N--CA 1.444 -0.747 1 O-C-N 134.029 7.081 . . . . 0.0 107.359 -179.771 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -57.63 0.74 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 110.469 -3.059 . . . . 0.0 105.801 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . 0.284 4.5 mt 86.88 115.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.027 1 O-C-N 129.386 4.179 . . . . 0.0 110.096 -179.847 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 9.1 m-85 -142.62 179.65 6.85 Favored 'General case' 0 N--CA 1.417 -2.081 1 O-C-N 130.091 4.619 . . . . 0.0 107.167 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.572 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -150.36 -160.92 1.24 Allowed 'General case' 0 C--O 1.196 -1.756 1 O-C-N 131.97 5.793 . . . . 0.0 111.836 179.501 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 11.7 tttt -123.17 152.61 41.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 111.812 -2.449 . . . . 0.0 112.549 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.419 -1.989 1 O-C-N 129.389 4.18 . . . . 0.0 113.168 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 116.289 -1.815 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 168.01 -40.55 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.345 1 O-C-N 131.819 5.7 . . . . 0.0 103.51 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -30.95 98.79 0.01 OUTLIER 'General case' 0 N--CA 1.423 -1.777 1 O-C-N 131.027 5.204 . . . . 0.0 117.415 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.8 148.16 5.04 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 114.893 -3.17 . . . . 0.0 106.265 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.295 36.0 p -68.28 167.88 13.53 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 112.361 -3.735 . . . . 0.0 110.094 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.625 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 73.1 m95 -141.27 167.69 21.57 Favored 'General case' 0 N--CA 1.413 -2.312 1 CA-C-O 111.116 -4.278 . . . . 0.0 113.487 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 5.3 mtmt 36.85 171.84 0.0 OUTLIER 'General case' 0 C--O 1.19 -2.057 1 O-C-N 133.813 6.946 . . . . 0.0 119.182 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 21' ' ' LEU 0.287 0.9 OUTLIER -1.13 134.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.321 3 CA-C-N 105.262 -5.426 . . . . 0.0 119.331 174.941 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.95 -159.31 0.74 Allowed 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 108.52 -3.946 . . . . 0.0 102.496 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.2 119.34 5.88 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-O 124.015 1.864 . . . . 0.0 111.41 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -150.94 73.85 1.13 Allowed 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.495 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.35 75.87 1.68 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.827 -1.533 . . . . 0.0 107.795 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.68 68.85 0.13 Allowed 'General case' 0 C--N 1.359 1.018 0 O-C-N 127.47 2.981 . . . . 0.0 106.603 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.22 54.03 10.92 Favored 'General case' 0 C--O 1.214 -0.814 1 CA-C-N 108.16 -4.109 . . . . 0.0 110.294 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.69 -172.46 0.19 Allowed 'General case' 0 C--N 1.347 0.498 0 O-C-N 126.641 2.463 . . . . 0.0 108.225 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.26 -92.14 0.09 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 117.512 -2.28 . . . . 0.0 113.008 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.02 133.59 54.1 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 116.151 -1.88 . . . . 0.0 106.431 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -88.81 90.47 8.43 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 126.951 2.657 . . . . 0.0 110.495 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -149.74 36.09 0.7 Allowed 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.027 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 5.8 p-10 -86.19 172.92 10.16 Favored 'General case' 0 C--O 1.214 -0.784 1 O-C-N 131.987 5.804 . . . . 0.0 112.377 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -104.23 -165.05 1.11 Allowed 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 110.731 -2.941 . . . . 0.0 105.491 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.432 31.0 mttt 145.07 170.74 0.0 OUTLIER 'General case' 0 N--CA 1.427 -1.604 1 O-C-N 134.015 7.072 . . . . 0.0 101.018 -178.847 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 7.3 mt -141.83 -178.63 5.76 Favored 'General case' 0 CA--C 1.567 1.604 3 O-C-N 133.148 6.53 . . . . 0.0 96.985 177.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 25' ' ' ILE . 18.7 m -166.65 -90.04 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 128.418 3.574 . . . . 0.0 106.173 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 24' ' ' THR . 0.8 OUTLIER 70.72 130.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.202 -1.42 0 CA-C-N 109.752 -3.385 . . . . 0.0 109.316 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.4 m -168.27 73.99 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 113.185 -3.406 . . . . 0.0 103.583 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -37.38 138.96 0.28 Allowed 'General case' 0 N--CA 1.436 -1.131 2 O-C-N 133.483 6.74 . . . . 0.0 115.576 -179.923 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.9 -92.9 0.36 Allowed 'General case' 0 C--N 1.35 0.618 1 O-C-N 131.017 5.198 . . . . 0.0 106.505 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.55 66.5 0.24 Allowed Glycine 0 CA--C 1.55 2.266 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 68.2 14.47 9.25 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -93.88 132.7 38.05 Favored 'General case' 0 CA--C 1.552 1.047 1 CA-C-O 111.213 -4.232 . . . . 0.0 100.827 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.693 ' CD1' HD23 ' A' ' 49' ' ' LEU . 13.0 m-85 -110.59 142.17 42.8 Favored 'General case' 0 C--O 1.191 -2.004 2 N-CA-C 96.858 -5.238 . . . . 0.0 96.858 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -130.91 108.44 9.83 Favored 'General case' 0 CA--C 1.496 -1.116 2 O-C-N 134.575 7.422 . . . . 0.0 100.744 -179.92 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 25' ' ' ILE 0.42 4.2 t -81.57 150.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 112.635 -3.626 . . . . 0.0 103.772 -179.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.255 3.6 ttmt -98.99 36.88 1.61 Allowed 'General case' 0 N--CA 1.425 -1.711 1 CA-C-O 133.049 6.166 . . . . 0.0 116.949 179.792 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.335 28.1 tt0 -57.78 97.6 0.03 OUTLIER 'General case' 0 C--N 1.369 1.431 1 CA-C-N 107.455 -4.43 . . . . 0.0 107.512 -179.804 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.0 m -99.59 134.06 43.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.97 3.294 . . . . 0.0 106.767 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.23 -162.27 1.23 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 127.316 2.885 . . . . 0.0 112.807 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -57.46 -41.37 80.42 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -87.38 82.66 7.49 Favored 'General case' 0 N--CA 1.435 -1.198 2 O-C-N 131.35 5.406 . . . . 0.0 106.487 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HG2' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER 35.14 -143.7 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 131.284 5.365 . . . . 0.0 114.878 -179.991 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 46.6 m-20 -77.29 -70.39 0.47 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 113.109 -3.436 . . . . 0.0 106.073 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.75 HG13 HD12 ' A' ' 57' ' ' LEU 0.25 0.2 OUTLIER 66.17 104.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 1 CA-C-O 132.302 5.81 . . . . 0.0 104.3 179.623 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.83 154.23 18.17 Favored 'General case' 0 C--N 1.372 1.586 0 CA-C-N 109.673 -3.421 . . . . 0.0 106.863 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 107.61 17.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.065 1 O-C-N 131.157 5.286 . . . . 0.0 102.498 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' OG1' ' A' ' 33' ' ' THR 0.374 9.9 p -112.23 154.03 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 114.049 -3.06 . . . . 0.0 113.422 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -163.73 -163.05 0.76 Allowed 'General case' 0 N--CA 1.442 -0.829 1 O-C-N 131.657 5.598 . . . . 0.0 114.602 -179.946 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -136.28 53.38 1.93 Allowed 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 126.355 2.284 . . . . 0.0 114.02 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD23 ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER 52.3 19.52 1.14 Allowed 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 128.701 3.751 . . . . 0.0 115.736 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.563 ' CA ' HG22 ' A' ' 68' ' ' THR . . . 143.55 71.75 0.02 OUTLIER Glycine 0 CA--C 1.546 1.978 0 N-CA-C 105.091 -3.203 . . . . 0.0 105.091 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 t -122.15 -49.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 130.159 4.094 . . . . 0.0 112.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 78.03 131.72 0.05 Allowed 'General case' 0 C--O 1.202 -1.441 1 O-C-N 129.426 4.204 . . . . 0.0 105.724 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -164.82 148.69 8.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 129.038 3.961 . . . . 0.0 117.09 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.54 115.77 30.92 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 100.468 -3.901 . . . . 0.0 100.468 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -139.23 128.14 23.57 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 127.972 3.295 . . . . 0.0 110.378 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.49 112.6 15.71 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 115.417 -2.513 . . . . 0.0 105.692 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.75 HD12 HG13 ' A' ' 43' ' ' ILE . 3.5 mm? -66.49 -86.6 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 O-C-N 126.501 2.376 . . . . 0.0 111.386 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.44 -142.5 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 117.662 -1.161 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.03 -14.25 19.52 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 124.827 1.329 . . . . 0.0 111.669 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -142.47 74.36 0.34 Allowed Glycine 0 CA--C 1.562 3.007 0 O-C-N 128.591 3.682 . . . . 0.0 104.67 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.8 p -150.61 148.63 28.87 Favored 'General case' 0 N--CA 1.433 -1.28 1 O-C-N 131.985 5.167 . . . . 0.0 112.81 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -147.97 48.81 1.06 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 127.12 2.763 . . . . 0.0 108.721 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.05 166.21 14.24 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 113.549 -3.26 . . . . 0.0 107.514 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -161.92 118.32 2.07 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 110.302 -3.135 . . . . 0.0 104.439 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.24 -130.26 1.39 Allowed Glycine 0 CA--C 1.529 0.936 1 C-N-CA 110.782 -5.485 . . . . 0.0 108.401 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.595 ' C ' ' CG ' ' A' ' 67' ' ' TRP . 3.3 t 170.6 139.01 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.708 1 O-C-N 132.665 5.568 . . . . 0.0 110.472 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 78' ' ' PHE . 46.6 m95 -139.2 107.54 5.81 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 122.187 2.267 . . . . 0.0 106.753 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.563 HG22 ' CA ' ' A' ' 50' ' ' GLY . 43.0 p -103.49 74.8 1.28 Allowed 'General case' 0 N--CA 1.429 -1.513 2 O-C-N 131.441 5.463 . . . . 0.0 114.143 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.482 ' HB3' HD21 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -46.29 134.09 9.05 Favored 'General case' 0 C--O 1.215 -0.724 1 O-C-N 130.804 5.065 . . . . 0.0 105.352 179.867 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -136.98 66.67 1.46 Allowed 'General case' 0 C--N 1.347 0.46 1 O-C-N 131.131 5.269 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.79 84.19 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.167 0 O-C-N 125.68 1.863 . . . . 0.0 110.719 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' GLU . 6.4 m-20 63.07 28.11 16.02 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 114.899 -2.477 . . . . 0.0 114.622 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -129.69 156.96 43.41 Favored 'General case' 0 N--CA 1.476 0.869 1 O-C-N 129.877 4.485 . . . . 0.0 107.694 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 91' ' ' ARG . 7.9 mt -141.6 47.78 1.65 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 126.571 2.419 . . . . 0.0 116.877 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.9 t -68.66 147.65 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 1 CA-C-N 107.85 -4.25 . . . . 0.0 112.138 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.99 27.56 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 104.138 -3.585 . . . . 0.0 104.138 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HA ' ' HH2' ' A' ' 67' ' ' TRP 0.268 0.1 OUTLIER -174.53 128.55 0.33 Allowed 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 111.951 -3.9 . . . . 0.0 117.676 -179.617 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 67' ' ' TRP . 25.6 m-85 -101.9 177.95 4.75 Favored 'General case' 0 C--O 1.204 -1.311 1 CA-C-O 129.288 4.375 . . . . 0.0 100.773 178.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HG2' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -160.64 -129.89 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.538 1 CA-C-N 105.079 -5.509 . . . . 0.0 110.284 179.583 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 85' ' ' LYS . 51.0 ttt180 168.65 103.9 0.01 OUTLIER 'General case' 0 N--CA 1.425 -1.685 0 O-C-N 128.138 3.399 . . . . 0.0 109.247 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.6 -1.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 1 O-C-N 131.93 5.768 . . . . 0.0 114.767 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.62 -26.79 12.66 Favored 'General case' 0 C--O 1.247 0.923 0 O-C-N 128.493 3.621 . . . . 0.0 112.041 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -123.28 1.25 9.06 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 118.808 2.892 . . . . 0.0 118.808 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.445 ' HA2' ' NZ ' ' A' ' 79' ' ' LYS . . . 66.46 39.19 94.0 Favored Glycine 0 CA--C 1.558 2.749 1 N-CA-C 100.773 -4.931 . . . . 0.0 100.773 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 86' ' ' GLU 0.262 0.6 OUTLIER -74.44 -80.86 0.07 Allowed 'General case' 0 N--CA 1.411 -2.383 1 CA-C-N 106.145 -5.027 . . . . 0.0 120.994 -179.008 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER 78.61 101.87 0.07 Allowed 'General case' 0 CA--C 1.561 1.396 0 O-C-N 127.621 3.076 . . . . 0.0 109.489 -178.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.76 48.57 2.15 Favored 'General case' 0 C--O 1.195 -1.779 1 O-C-N 133.636 6.835 . . . . 0.0 108.884 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 77' ' ' LYS . 57.0 mt -66.57 146.0 13.5 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.479 2 O-C-N 130.029 4.581 . . . . 0.0 103.937 -179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.9 105.61 15.23 Favored 'General case' 0 C--O 1.213 -0.827 1 O-C-N 137.751 9.407 . . . . 0.0 105.077 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 90' ' ' VAL . 4.0 t -101.85 100.43 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 128.917 3.886 . . . . 0.0 104.68 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.495 ' CZ ' ' HB ' ' A' ' 99' ' ' ILE . 0.0 OUTLIER -156.58 155.74 32.4 Favored 'General case' 0 C--O 1.19 -2.033 1 C-N-CA 110.615 -4.434 . . . . 0.0 113.756 179.76 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -152.5 108.34 3.34 Favored 'General case' 0 CA--C 1.558 1.279 2 CA-C-N 107.581 -4.372 . . . . 0.0 102.521 179.228 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.877 ' HB ' HD12 ' A' ' 98' ' ' LEU . 11.5 tt -42.66 109.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 1 O-C-N 132.986 6.428 . . . . 0.0 112.287 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.0 m -105.19 95.25 5.71 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 128.387 3.555 . . . . 0.0 115.241 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.0 -118.31 3.77 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 103.256 -3.937 . . . . 0.0 103.256 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.67 47.29 1.56 Allowed 'General case' 0 CA--C 1.552 1.029 1 O-C-N 130.18 4.106 . . . . 0.0 106.146 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.525 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.303 0.0 OUTLIER -177.3 110.93 0.08 Allowed 'General case' 0 C--O 1.204 -1.32 2 O-C-N 130.801 5.063 . . . . 0.0 108.358 179.801 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.877 HD12 ' HB ' ' A' ' 93' ' ' ILE . 3.0 tt -79.45 104.71 10.25 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 128.728 3.768 . . . . 0.0 108.815 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.495 ' HB ' ' CZ ' ' A' ' 91' ' ' ARG . 26.1 mm -50.76 -86.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.672 1 O-C-N 133.48 6.738 . . . . 0.0 108.434 -179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.565 ' CG ' HD23 ' A' ' 98' ' ' LEU . 23.2 mt-30 99.36 90.48 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.367 1 O-C-N 132.899 6.374 . . . . 0.0 103.915 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.8 m -102.64 96.75 7.09 Favored 'General case' 0 N--CA 1.413 -2.31 1 O-C-N 133.683 6.864 . . . . 0.0 114.06 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 73.6 m-85 -67.78 132.85 48.19 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 112.605 -3.638 . . . . 0.0 105.213 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 m -107.86 94.8 5.27 Favored 'General case' 0 C--O 1.206 -1.198 1 O-C-N 132.129 5.893 . . . . 0.0 101.631 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 1.4 t80 -109.64 117.36 33.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-N 109.792 -3.367 . . . . 0.0 117.6 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 27.42 31.51 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.77 -6.37 6.16 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 116.718 -2.658 . . . . 0.0 114.353 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.4 t -120.03 145.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 117.059 -1.448 . . . . 0.0 110.979 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 70.89 0.73 Allowed 'General case' 0 C--N 1.359 1.011 1 O-C-N 130.87 5.106 . . . . 0.0 103.388 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.436 . . -90.86 119.13 30.81 Favored 'General case' 0 N--CA 1.41 -2.447 1 O-C-N 130.921 5.138 . . . . 0.0 116.267 179.907 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.4 163.08 14.85 Favored 'General case' 0 N--CA 1.415 -2.199 1 O-C-N 132.663 6.227 . . . . 0.0 106.924 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.27 99.53 4.56 Favored 'General case' 0 CA--C 1.556 1.202 3 O-C-N 130.195 4.684 . . . . 0.0 99.437 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -57.23 123.02 7.53 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 O-C-N 128.862 3.851 . . . . 0.0 111.194 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.771 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 14.2 m-30 -117.21 176.81 4.97 Favored 'General case' 0 N--CA 1.434 -1.24 2 O-C-N 132.544 6.152 . . . . 0.0 108.463 -179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.59 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER 171.12 134.76 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.633 2 O-C-N 131.898 5.749 . . . . 0.0 113.843 -177.607 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 1.3 tttt -51.41 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.34 1 CA-C-O 128.649 4.071 . . . . 0.0 113.502 176.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.37 1.492 0 O-C-N 118.952 -2.342 . . . . 0.0 110.519 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.117 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 4.8 m-30 -111.93 11.49 20.69 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -50.3 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.232 0 O-C-N 127.737 3.148 . . . . 0.0 117.911 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.29 125.21 0.77 Allowed Glycine 0 C--N 1.353 1.488 1 C-N-CA 112.377 -4.725 . . . . 0.0 107.663 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.334 46.2 p -49.97 127.89 17.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 129.148 3.499 . . . . 0.0 110.123 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.63 ' CE3' ' HB2' ' A' ' 115' ' ' LYS 0.324 55.7 m95 -100.58 161.47 13.58 Favored 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 128.565 3.666 . . . . 0.0 112.276 179.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 2.3 mtmt 50.99 -178.66 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.696 1 O-C-N 129.333 4.146 . . . . 0.0 117.325 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 21' ' ' LEU 0.326 0.9 OUTLIER 15.21 104.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.603 2 O-C-N 134.538 7.399 . . . . 0.0 113.753 174.979 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -128.9 31.86 4.86 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 110.834 -2.894 . . . . 0.0 106.105 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -63.34 124.26 20.81 Favored 'General case' 0 C--O 1.203 -1.346 0 C-N-CA 117.515 -1.674 . . . . 0.0 112.771 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -50.03 136.76 18.34 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 127.032 2.708 . . . . 0.0 108.283 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -28.7 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.416 3.573 . . . . 0.0 112.863 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -91.31 127.56 36.79 Favored 'General case' 0 C--N 1.367 1.367 0 O-C-N 127.3 2.875 . . . . 0.0 106.187 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -116.28 81.74 1.66 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 128.315 3.51 . . . . 0.0 106.58 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.1 t -121.65 -81.94 0.64 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 125.686 1.866 . . . . 0.0 106.735 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.32 -88.39 0.45 Allowed Glycine 0 CA--C 1.533 1.178 0 O-C-N 128.606 3.691 . . . . 0.0 110.062 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.15 129.3 40.79 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-N 111.986 -2.107 . . . . 0.0 107.234 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -122.68 -44.1 2.23 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 117.097 -1.841 . . . . 0.0 110.318 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -81.0 107.27 13.67 Favored 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 117.421 -1.712 . . . . 0.0 109.865 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.55 ' HB3' HD23 ' A' ' 21' ' ' LEU . 3.3 m-20 -110.6 -87.6 0.52 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 127.822 3.201 . . . . 0.0 111.352 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.572 HD23 ' N ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -144.84 174.08 11.31 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 127.679 3.112 . . . . 0.0 105.736 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 7' ' ' LYS 0.377 0.0 OUTLIER 174.56 134.18 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.5 1 O-C-N 131.733 5.646 . . . . 0.0 102.694 179.689 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 6' ' ' TRP . 13.2 mt -93.55 167.69 11.52 Favored 'General case' 0 CA--C 1.559 1.291 2 O-C-N 131.533 5.52 . . . . 0.0 100.33 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HB3' ' A' ' 35' ' ' LYS . 3.9 m 176.7 79.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 1 O-C-N 132.518 6.136 . . . . 0.0 105.993 -179.404 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 ' CZ ' ' A' ' 32' ' ' PHE . 3.6 mp -90.11 144.07 9.89 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 110.293 -3.14 . . . . 0.0 109.188 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.7 m -162.48 82.29 0.53 Allowed 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 112.491 -3.683 . . . . 0.0 109.092 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.411 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -51.65 148.05 5.85 Favored 'General case' 0 C--O 1.214 -0.797 2 O-C-N 130.373 4.795 . . . . 0.0 115.054 179.684 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -131.65 101.43 5.49 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 128.75 3.781 . . . . 0.0 103.76 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.68 -104.08 2.26 Favored Glycine 0 CA--C 1.546 2.027 2 C-N-CA 110.909 -5.424 . . . . 0.0 99.934 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -131.36 14.21 5.06 Favored 'General case' 0 N--CA 1.435 -1.222 1 O-C-N 131.798 5.058 . . . . 0.0 109.241 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -82.8 155.29 24.27 Favored 'General case' 0 C--N 1.321 -0.662 1 N-CA-C 99.494 -4.261 . . . . 0.0 99.494 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 25' ' ' ILE . 9.3 t80 -155.67 106.76 2.52 Favored 'General case' 0 C--O 1.191 -1.995 2 N-CA-C 95.674 -5.676 . . . . 0.0 95.674 -179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.15 142.48 38.3 Favored 'General case' 0 N--CA 1.475 0.806 1 O-C-N 132.503 6.127 . . . . 0.0 102.797 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 25' ' ' ILE 0.356 24.7 t -111.48 140.04 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 1 O-C-N 129.144 4.027 . . . . 0.0 100.97 179.697 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.576 ' HB3' ' N ' ' A' ' 24' ' ' THR . 5.2 tttt -85.2 64.42 8.66 Favored 'General case' 0 CA--C 1.49 -1.355 1 CA-C-O 130.901 5.143 . . . . 0.0 115.029 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' OE1' HG23 ' A' ' 43' ' ' ILE . 9.9 tt0 -81.76 61.8 5.29 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 109.64 -3.436 . . . . 0.0 104.323 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.57 130.81 35.35 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 113.228 -3.389 . . . . 0.0 109.454 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 t -146.61 -158.79 0.94 Allowed 'General case' 0 C--N 1.368 1.394 0 O-C-N 125.87 1.981 . . . . 0.0 113.066 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -14.53 60.34 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.05 52.97 0.97 Allowed 'General case' 0 N--CA 1.424 -1.772 0 O-C-N 128.22 3.45 . . . . 0.0 107.349 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 72.9 -164.26 0.11 Allowed 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 127.637 3.086 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.504 ' C ' HG22 ' A' ' 43' ' ' ILE . 31.7 m-20 -81.85 -30.52 32.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 O-C-N 127.657 3.098 . . . . 0.0 107.127 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.691 HD11 HD22 ' A' ' 57' ' ' LEU . 3.8 tp 37.14 70.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.208 -1.104 2 O-C-N 132.107 5.879 . . . . 0.0 110.444 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -66.07 114.79 5.48 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.711 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.96 95.81 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 2 O-C-N 131.657 5.598 . . . . 0.0 99.802 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' C ' ' CD2' ' A' ' 47' ' ' PHE 0.282 2.8 p -114.68 151.67 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 1 O-C-N 129.536 4.272 . . . . 0.0 116.086 -179.691 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 67' ' ' TRP . 3.4 p90 -174.17 -171.7 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 131.682 5.614 . . . . 0.0 111.7 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -124.8 76.47 1.52 Allowed 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 128.201 3.438 . . . . 0.0 113.762 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 69' ' ' MET . 0.1 OUTLIER 24.36 78.48 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.738 1 O-C-N 133.744 6.903 . . . . 0.0 116.294 -179.876 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.62 64.28 1.83 Allowed Glycine 0 CA--C 1.537 1.407 0 N-CA-C 105.714 -2.955 . . . . 0.0 105.714 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.24 -38.01 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 1 O-C-N 130.588 4.346 . . . . 0.0 111.209 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER 71.89 143.84 0.06 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 109.025 -3.716 . . . . 0.0 110.644 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 52' ' ' ASP . 28.5 p90 178.3 -178.33 0.26 Allowed 'General case' 0 N--CA 1.434 -1.245 1 O-C-N 129.279 4.112 . . . . 0.0 116.184 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.87 116.7 14.11 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.91 131.59 24.11 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 115.749 -2.38 . . . . 0.0 111.259 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.3 122.91 28.56 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 102.883 -3.006 . . . . 0.0 102.883 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.691 HD22 HD11 ' A' ' 43' ' ' ILE . 94.8 mt -84.1 -62.12 1.64 Allowed 'General case' 0 C--O 1.247 0.968 1 O-C-N 130.547 4.905 . . . . 0.0 115.086 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 61' ' ' THR . . . -101.86 35.74 2.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 125.777 1.923 . . . . 0.0 111.383 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 68.25 26.28 6.98 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 126.9 2.625 . . . . 0.0 110.672 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.87 -60.78 0.04 OUTLIER Glycine 0 CA--C 1.557 2.712 1 CA-C-O 113.204 -4.109 . . . . 0.0 105.61 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 58' ' ' ALA . 8.8 m -5.25 -77.53 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 1 O-C-N 135.278 7.105 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 63' ' ' LEU . 5.6 tp10 74.86 122.97 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.497 1 O-C-N 129.321 4.138 . . . . 0.0 103.865 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -154.39 69.85 0.77 Allowed 'General case' 0 C--O 1.205 -1.287 0 CA-C-N 109.285 -3.598 . . . . 0.0 106.843 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -67.92 96.83 0.62 Allowed 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 111.176 -2.738 . . . . 0.0 106.273 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 78' ' ' PHE . . . -165.39 172.11 40.86 Favored Glycine 0 C--O 1.207 -1.579 1 C-N-CA 111.175 -5.298 . . . . 0.0 107.843 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -133.89 143.13 48.08 Favored 'General case' 0 CA--C 1.507 -0.706 1 O-C-N 134.863 6.86 . . . . 0.0 113.241 179.874 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.639 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 22.9 m95 -113.82 122.17 46.24 Favored 'General case' 0 C--O 1.204 -1.291 0 N-CA-C 101.338 -3.579 . . . . 0.0 101.338 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.541 HG23 HG23 ' A' ' 66' ' ' THR . 18.6 p -117.02 48.92 1.24 Allowed 'General case' 0 C--N 1.316 -0.848 2 O-C-N 135.59 8.056 . . . . 0.0 115.873 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.803 ' CB ' HD11 ' A' ' 49' ' ' LEU . 2.6 tmm? -30.84 133.09 0.08 Allowed 'General case' 0 C--O 1.216 -0.7 1 O-C-N 134.376 7.298 . . . . 0.0 108.472 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.03 76.36 1.56 Allowed 'General case' 0 N--CA 1.48 1.048 1 O-C-N 129.12 4.012 . . . . 0.0 108.296 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.95 -113.11 5.57 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 106.397 -2.681 . . . . 0.0 106.397 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.71 28.18 1.59 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 114.172 -2.823 . . . . 0.0 114.432 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.294 0.1 OUTLIER -130.21 154.61 47.38 Favored 'General case' 0 C--N 1.342 0.255 1 O-C-N 129.273 4.108 . . . . 0.0 112.843 -179.834 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.597 ' CD1' HD11 ' A' ' 98' ' ' LEU . 4.3 mt -131.11 70.36 1.47 Allowed 'General case' 0 C--O 1.211 -0.939 0 O-C-N 129.081 3.988 . . . . 0.0 111.46 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.9 t -91.71 123.53 43.87 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 2 O-C-N 131.076 5.235 . . . . 0.0 110.512 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.19 -166.84 39.72 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-N 108.428 -3.987 . . . . 0.0 103.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 78' ' ' PHE . 4.9 tttm -178.02 133.69 0.15 Allowed 'General case' 0 C--O 1.203 -1.387 1 O-C-N 132.304 5.355 . . . . 0.0 112.453 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -128.95 164.18 23.72 Favored 'General case' 0 N--CA 1.48 1.069 2 O-C-N 131.561 5.538 . . . . 0.0 102.386 -179.434 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' ' HA ' ' A' ' 86' ' ' GLU 0.366 0.0 OUTLIER -157.65 143.18 17.18 Favored 'General case' 0 N--CA 1.432 -1.347 1 CA-C-N 107.21 -4.541 . . . . 0.0 113.491 -178.901 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 85' ' ' LYS . 4.3 ptm180 -102.62 94.24 5.53 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 129.281 4.113 . . . . 0.0 109.185 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -33.46 -36.85 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.431 1 O-C-N 134.393 7.308 . . . . 0.0 112.114 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -38.96 -52.09 1.79 Allowed 'General case' 0 N--CA 1.438 -1.045 1 O-C-N 130.99 5.181 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -121.76 5.23 9.99 Favored 'General case' 0 N--CA 1.422 -1.874 0 O-C-N 127.808 3.193 . . . . 0.0 118.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' HA2' ' CE ' ' A' ' 79' ' ' LYS . . . 75.43 36.01 45.69 Favored Glycine 0 CA--C 1.554 2.497 2 C-N-CA 112.019 -4.896 . . . . 0.0 100.866 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HG2' ' CG ' ' A' ' 80' ' ' ARG 0.274 14.3 tptp -76.94 -75.11 0.21 Allowed 'General case' 0 N--CA 1.422 -1.865 1 O-C-N 131.918 5.128 . . . . 0.0 120.088 -179.695 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.611 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 42.8 mt-10 84.4 88.95 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.499 1 O-C-N 129.766 4.416 . . . . 0.0 108.317 -178.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.94 56.05 0.65 Allowed 'General case' 0 C--O 1.196 -1.76 1 O-C-N 131.66 5.6 . . . . 0.0 111.031 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -67.93 157.99 5.93 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.565 0 CA-C-N 108.895 -3.775 . . . . 0.0 102.9 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -129.35 74.12 1.56 Allowed 'General case' 0 C--O 1.213 -0.868 1 O-C-N 133.982 7.051 . . . . 0.0 109.425 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.56 133.48 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 1 O-C-N 129.41 4.194 . . . . 0.0 107.436 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -178.12 148.58 0.51 Allowed 'General case' 0 C--O 1.191 -1.997 0 O-C-N 128.479 3.612 . . . . 0.0 114.6 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' A' ' 91' ' ' ARG . 3.6 mt-10 -143.66 114.67 7.81 Favored 'General case' 0 CA--C 1.561 1.376 1 O-C-N 129.874 4.484 . . . . 0.0 107.327 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.864 ' CD1' HD12 ' A' ' 98' ' ' LEU . 2.6 mm -18.43 80.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.243 1 O-C-N 134.499 7.374 . . . . 0.0 110.661 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.21 71.89 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.733 1 O-C-N 132.648 6.217 . . . . 0.0 115.305 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.95 -131.21 10.23 Favored Glycine 0 CA--C 1.553 2.406 1 N-CA-C 102.061 -4.416 . . . . 0.0 102.061 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -112.16 29.3 8.01 Favored 'General case' 0 C--N 1.361 1.09 1 CA-C-N 107.189 -4.505 . . . . 0.0 109.587 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.565 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -156.28 151.62 26.71 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 114.635 -2.602 . . . . 0.0 108.253 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.864 HD12 ' CD1' ' A' ' 93' ' ' ILE . 2.5 tt -105.15 126.47 52.12 Favored 'General case' 0 N--CA 1.445 -0.705 1 O-C-N 132.215 5.947 . . . . 0.0 112.132 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.699 HG22 ' N ' ' A' ' 100' ' ' GLN . 0.5 OUTLIER -77.25 -82.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.074 1 CA-C-O 109.927 -4.844 . . . . 0.0 108.256 -179.994 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 99' ' ' ILE . 95.8 mt-30 103.43 111.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.35 1 O-C-N 133.363 6.664 . . . . 0.0 100.903 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.4 m -112.29 102.49 10.64 Favored 'General case' 0 N--CA 1.424 -1.74 1 O-C-N 130.464 4.853 . . . . 0.0 113.847 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -75.24 101.3 4.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 113.513 -3.275 . . . . 0.0 105.326 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.7 m -84.92 97.8 9.98 Favored 'General case' 0 C--O 1.217 -0.642 1 O-C-N 129.511 4.257 . . . . 0.0 104.211 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -120.18 119.3 32.85 Favored 'General case' 0 C--N 1.363 1.185 1 CA-C-N 108.182 -4.099 . . . . 0.0 117.517 -179.935 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 50.15 23.01 1.04 Allowed 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.8 -6.43 24.05 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 117.639 -2.22 . . . . 0.0 115.464 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 108' ' ' GLU 0.257 39.5 t -95.16 163.0 2.35 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 CA-C-N 113.039 -1.581 . . . . 0.0 111.013 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 107' ' ' VAL . 6.0 mt-10 -126.35 58.76 1.36 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 127.26 2.85 . . . . 0.0 106.647 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.508 . . -82.02 128.94 34.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.061 3.351 . . . . 0.0 112.11 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD2' HG21 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.12 171.86 11.99 Favored 'General case' 0 N--CA 1.418 -2.07 1 O-C-N 132.872 6.358 . . . . 0.0 106.912 179.836 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -134.11 133.52 41.19 Favored 'General case' 0 C--O 1.207 -1.173 2 O-C-N 130.501 4.876 . . . . 0.0 99.602 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 pt -85.52 85.04 2.23 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 1 O-C-N 130.376 4.798 . . . . 0.0 113.653 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 12.7 m-30 -91.64 179.25 5.7 Favored 'General case' 0 N--CA 1.441 -0.924 1 O-C-N 132.395 6.059 . . . . 0.0 104.836 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.565 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -154.61 -163.23 1.54 Allowed 'General case' 0 C--O 1.198 -1.644 1 O-C-N 130.766 5.041 . . . . 0.0 111.652 179.992 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.63 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 74.5 tttt -118.76 -119.59 0.31 Allowed 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 115' ' ' LYS . 1.3 tp10 . . . . . 0 CA--C 1.558 1.275 0 CA-C-O 117.429 -1.272 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.109 0.48 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.426 ' HZ ' HD11 ' A' ' 93' ' ' ILE . 1.8 m-30 -87.72 -5.2 58.78 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 127.275 2.859 . . . . 0.0 106.661 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -55.73 104.86 0.15 Allowed 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 117.076 2.251 . . . . 0.0 117.076 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.37 158.34 9.79 Favored Glycine 0 C--N 1.351 1.389 0 C-N-CA 114.15 -3.881 . . . . 0.0 104.488 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 58.1 p -78.72 163.42 25.43 Favored 'General case' 0 C--N 1.355 0.82 1 C-N-CA 110.566 -4.454 . . . . 0.0 110.307 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.553 ' CD2' ' HG3' ' A' ' 115' ' ' LYS . 23.0 m95 -132.81 162.27 31.95 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 112.319 -3.705 . . . . 0.0 111.043 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 113' ' ' PHE . 0.8 OUTLIER 49.43 179.41 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.687 0 N-CA-C 117.886 2.55 . . . . 0.0 117.886 178.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 8' ' ' VAL 0.357 2.3 t -8.51 100.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.487 -1.471 3 O-C-N 132.769 6.293 . . . . 0.0 115.265 174.96 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -161.76 97.45 1.06 Allowed 'General case' 0 C--N 1.362 1.136 0 CA-C-N 110.942 -2.844 . . . . 0.0 107.773 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -178.52 147.94 0.43 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.535 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 70.5 156.82 0.16 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 126.737 2.523 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -105.38 92.84 4.37 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 127.305 2.878 . . . . 0.0 107.378 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -92.77 134.06 35.42 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 127.54 3.025 . . . . 0.0 109.385 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 15' ' ' SER . 11.2 p90 -87.77 -10.93 49.57 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 112.479 -2.146 . . . . 0.0 106.171 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 3.9 p -162.23 142.4 9.97 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 116.997 -1.881 . . . . 0.0 106.509 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 17' ' ' ALA . . . -126.36 18.88 6.42 Favored Glycine 0 C--O 1.207 -1.541 0 O-C-N 127.824 3.202 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . 64.02 18.15 11.04 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 111.707 -2.247 . . . . 0.0 106.754 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' A' ' 18' ' ' HIS . 5.6 m170 58.13 58.53 3.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 126.454 2.346 . . . . 0.0 112.05 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.61 -54.82 2.47 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 127.875 3.234 . . . . 0.0 109.769 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 p30 10.24 111.64 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.97 1 O-C-N 133.627 6.829 . . . . 0.0 115.376 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.93 140.76 36.46 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 102.15 -3.278 . . . . 0.0 102.15 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . 0.368 0.0 OUTLIER -161.75 153.54 19.07 Favored 'General case' 0 C--O 1.2 -1.542 1 O-C-N 129.608 4.317 . . . . 0.0 104.354 -179.985 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD2' HG13 ' A' ' 34' ' ' VAL . 4.5 mt -114.01 175.88 5.28 Favored 'General case' 0 CA--C 1.565 1.53 3 O-C-N 134.57 7.419 . . . . 0.0 97.544 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.628 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.3 m -171.33 -79.07 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 128.802 3.814 . . . . 0.0 104.939 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 24' ' ' THR . 0.9 OUTLIER 73.88 151.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-N 109.277 -3.601 . . . . 0.0 110.346 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.9 m -166.66 71.91 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -48.94 125.36 10.25 Favored 'General case' 0 C--O 1.205 -1.268 1 O-C-N 131.589 5.555 . . . . 0.0 114.376 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -88.64 -112.36 0.06 Allowed 'General case' 0 C--N 1.365 1.249 1 O-C-N 130.389 4.806 . . . . 0.0 103.299 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.77 100.82 1.02 Allowed Glycine 0 CA--C 1.564 3.136 2 N-CA-C 100.526 -5.03 . . . . 0.0 100.526 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.7 m120 56.04 43.58 26.85 Favored 'General case' 0 N--CA 1.424 -1.745 0 O-C-N 128.04 2.847 . . . . 0.0 109.158 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -155.6 116.88 3.94 Favored 'General case' 0 CA--C 1.548 0.88 2 N-CA-C 98.618 -4.586 . . . . 0.0 98.618 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -127.95 169.82 13.55 Favored 'General case' 0 C--O 1.198 -1.628 2 N-CA-C 97.978 -4.823 . . . . 0.0 97.978 179.868 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.78 132.53 29.04 Favored 'General case' 0 CA--C 1.494 -1.185 2 O-C-N 133.921 7.013 . . . . 0.0 99.643 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.597 HG13 ' CD2' ' A' ' 23' ' ' LEU 0.364 2.2 t -91.5 134.68 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 1 N-CA-C 99.754 -4.165 . . . . 0.0 99.754 -179.998 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB3' ' N ' ' A' ' 24' ' ' THR . 0.0 OUTLIER -68.78 -10.7 58.13 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 108.535 -3.939 . . . . 0.0 119.201 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.44 ' CB ' HG12 ' A' ' 34' ' ' VAL 0.27 2.3 tp10 -33.82 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 109.919 -3.31 . . . . 0.0 110.262 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -81.57 132.6 35.31 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 116.463 -2.095 . . . . 0.0 108.073 -179.27 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.63 -152.31 0.14 Allowed 'General case' 0 C--N 1.353 0.736 0 C-N-CA 114.09 -3.044 . . . . 0.0 111.711 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -108.72 1.78 21.36 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 127.833 3.208 . . . . 0.0 108.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 82.8 m-85 -82.29 -56.58 3.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 109.451 -3.522 . . . . 0.0 105.424 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -175.09 -174.5 0.76 Allowed 'General case' 0 N--CA 1.436 -1.128 1 O-C-N 130.198 4.686 . . . . 0.0 112.334 -179.872 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.99 124.67 34.95 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.309 0.9 OUTLIER -142.09 106.66 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.039 2 CA-C-O 131.859 5.599 . . . . 0.0 109.483 -178.493 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 125.18 25.1 Favored 'General case' 0 C--N 1.373 1.587 1 CA-C-N 107.197 -4.547 . . . . 0.0 109.546 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.3 p -91.24 65.27 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.495 2 O-C-N 130.32 4.762 . . . . 0.0 100.128 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.08 161.11 5.04 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 1 C-N-CA 111.003 -4.279 . . . . 0.0 115.941 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' CE1' ' CE2' ' A' ' 32' ' ' PHE . 0.5 OUTLIER -174.77 -155.71 0.06 Allowed 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 128.1 3.375 . . . . 0.0 110.579 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . 2.8 mt-10 -130.81 177.92 7.05 Favored 'General case' 0 CA--C 1.561 1.385 0 CA-C-O 115.478 -2.201 . . . . 0.0 108.083 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 94.7 6.59 Favored 'General case' 0 C--O 1.214 -0.795 1 O-C-N 131.64 5.587 . . . . 0.0 109.804 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.99 53.17 1.95 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-O 114.04 -3.644 . . . . 0.0 104.868 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 48' ' ' GLU . 25.5 t -141.44 123.91 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 1 O-C-N 130.714 4.42 . . . . 0.0 111.677 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.42 160.18 20.65 Favored 'General case' 0 C--N 1.356 0.883 1 O-C-N 130.053 4.595 . . . . 0.0 107.788 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 56.0 p90 -177.15 177.68 1.21 Allowed 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 130.676 4.985 . . . . 0.0 116.228 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.3 135.23 47.12 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 101.839 -3.393 . . . . 0.0 101.839 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.0 -154.1 0.6 Allowed 'General case' 0 C--O 1.204 -1.336 0 O-C-N 128.009 3.318 . . . . 0.0 113.745 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.27 89.59 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.52 HD12 HD22 ' A' ' 63' ' ' LEU . 10.3 mt -83.12 170.62 14.58 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.974 2.671 . . . . 0.0 110.508 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 49.47 -141.17 0.69 Allowed 'General case' 0 C--O 1.248 0.999 0 O-C-N 126.049 2.093 . . . . 0.0 113.521 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.38 -26.06 60.46 Favored 'General case' 0 C--N 1.366 1.289 0 O-C-N 120.884 -1.135 . . . . 0.0 110.089 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 142.04 71.56 0.03 OUTLIER Glycine 0 CA--C 1.554 2.519 0 CA-C-O 116.337 -2.368 . . . . 0.0 109.751 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 p -73.82 -134.06 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 1 O-C-N 132.636 5.551 . . . . 0.0 107.382 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -146.8 -61.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 112.38 -3.728 . . . . 0.0 104.022 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.52 HD22 HD12 ' A' ' 57' ' ' LEU . 1.8 mp 42.86 70.48 0.29 Allowed 'General case' 0 C--O 1.214 -0.809 1 O-C-N 131.047 5.217 . . . . 0.0 111.449 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.7 m -88.28 117.31 27.1 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.921 1.688 . . . . 0.0 108.936 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 77' ' ' LYS . . . 176.62 -138.78 4.18 Favored Glycine 0 N--CA 1.473 1.106 1 C-N-CA 110.108 -5.806 . . . . 0.0 107.62 179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.382 5.9 t -173.07 166.69 4.99 Favored 'General case' 0 N--CA 1.446 -0.665 1 O-C-N 130.667 4.393 . . . . 0.0 116.889 -179.122 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.569 ' HA ' ' CE3' ' A' ' 67' ' ' TRP . 2.6 m95 -122.37 145.94 47.8 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -136.31 32.42 2.84 Favored 'General case' 0 C--N 1.321 -0.652 2 O-C-N 135.099 7.749 . . . . 0.0 111.649 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 16.7 ttp -32.17 132.99 0.11 Allowed 'General case' 0 C--N 1.317 -0.84 2 O-C-N 134.909 7.63 . . . . 0.0 108.873 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -141.45 139.83 33.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 111.331 -2.668 . . . . 0.0 108.809 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 30.02 -98.67 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.816 1 O-C-N 133.086 6.491 . . . . 0.0 111.241 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -119.35 56.78 0.91 Allowed 'General case' 0 C--N 1.35 0.616 0 CA-C-N 108.813 -3.693 . . . . 0.0 112.337 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.4 mtpt -148.11 179.8 7.48 Favored 'General case' 0 C--O 1.249 1.069 1 O-C-N 129.335 4.147 . . . . 0.0 110.322 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ARG . 4.2 mt -147.13 46.14 1.16 Allowed 'General case' 0 CA--C 1.497 -1.092 0 O-C-N 126.193 2.183 . . . . 0.0 112.755 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.63 130.16 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 1 O-C-N 129.294 4.121 . . . . 0.0 113.356 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.488 ' C ' ' CZ3' ' A' ' 67' ' ' TRP . . . 156.99 -142.49 8.73 Favored Glycine 0 CA--C 1.564 3.151 2 CA-C-N 106.647 -4.797 . . . . 0.0 103.917 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER 170.59 168.69 0.07 Allowed 'General case' 0 N--CA 1.44 -0.942 1 O-C-N 133.789 6.229 . . . . 0.0 111.04 -179.289 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.599 ' N ' ' HG2' ' A' ' 77' ' ' LYS . 11.9 m-85 -150.1 157.02 42.68 Favored 'General case' 0 C--O 1.197 -1.694 1 O-C-N 133.743 6.902 . . . . 0.0 101.615 176.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.946 ' HG2' HG13 ' A' ' 81' ' ' VAL . 4.2 ttpt -155.4 135.69 13.14 Favored 'General case' 0 N--CA 1.422 -1.835 1 CA-C-N 107.612 -4.358 . . . . 0.0 112.407 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.652 ' CD ' HD11 ' A' ' 87' ' ' LEU . 14.9 ptm180 -106.38 47.57 0.87 Allowed 'General case' 0 CA--C 1.557 1.237 0 O-C-N 125.906 2.004 . . . . 0.0 107.18 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.946 HG13 ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -6.16 -52.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.619 1 O-C-N 132.08 5.862 . . . . 0.0 115.658 -179.758 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 80' ' ' ARG . 2.1 t0 -39.23 -29.86 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 129.026 3.954 . . . . 0.0 113.059 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER 174.79 -22.83 0.0 OUTLIER 'General case' 0 N--CA 1.419 -1.978 0 O-C-N 128.982 3.926 . . . . 0.0 114.132 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 80' ' ' ARG . . . -69.59 -52.18 22.13 Favored Glycine 0 CA--C 1.536 1.36 1 N-CA-C 101.826 -4.51 . . . . 0.0 101.826 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.03 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.939 2 O-C-N 132.015 5.185 . . . . 0.0 120.303 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 10.1 mt-10 74.48 62.03 0.07 Allowed 'General case' 0 N--CA 1.432 -1.366 1 O-C-N 130.226 4.704 . . . . 0.0 117.75 177.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.652 HD11 ' CD ' ' A' ' 80' ' ' ARG . 23.2 mt -97.7 61.53 1.6 Allowed 'General case' 0 C--O 1.199 -1.588 1 O-C-N 130.175 4.672 . . . . 0.0 108.8 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 77' ' ' LYS . 16.1 mt -69.98 -173.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 1 CA-C-N 107.226 -4.534 . . . . 0.0 104.487 -179.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 67' ' ' TRP . . . -153.28 54.12 0.75 Allowed 'General case' 0 C--O 1.196 -1.726 0 O-C-N 128.014 3.321 . . . . 0.0 105.449 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.9 t -57.66 113.12 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.645 1 O-C-N 131.014 5.196 . . . . 0.0 103.474 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.721 ' NE ' ' H ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -161.7 162.76 29.89 Favored 'General case' 0 C--O 1.189 -2.131 0 C-N-CA 113.599 -3.24 . . . . 0.0 113.27 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.721 ' H ' ' NE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -162.76 100.78 1.01 Allowed 'General case' 0 N--CA 1.449 -0.522 2 O-C-N 131.187 5.304 . . . . 0.0 104.779 179.662 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 98' ' ' LEU . 1.8 mm 5.04 73.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.807 1 O-C-N 134.731 7.519 . . . . 0.0 111.453 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 t -15.21 -51.33 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.071 1 O-C-N 133.431 6.707 . . . . 0.0 117.092 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.17 -88.72 0.1 Allowed Glycine 0 CA--C 1.548 2.15 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -125.73 18.43 7.99 Favored 'General case' 0 CA--C 1.555 1.149 2 CA-C-N 105.785 -5.207 . . . . 0.0 103.52 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.618 ' CB ' ' HA ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -153.49 168.79 24.97 Favored 'General case' 0 C--O 1.22 -0.486 0 O-C-N 127.892 3.245 . . . . 0.0 106.776 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.52 HD12 HD12 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -108.08 139.98 41.94 Favored 'General case' 0 N--CA 1.434 -1.27 1 O-C-N 130.525 4.891 . . . . 0.0 109.863 -179.885 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' HB ' ' HD3' ' A' ' 91' ' ' ARG . 1.5 mt -102.96 -79.76 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.474 2 O-C-N 130.022 4.576 . . . . 0.0 105.639 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.522 ' N ' HG22 ' A' ' 99' ' ' ILE . 2.6 mm100 105.52 82.27 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 1 O-C-N 132.776 6.298 . . . . 0.0 104.734 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.503 HG23 ' CG ' ' A' ' 110' ' ' LYS . 1.8 m -84.89 95.84 9.15 Favored 'General case' 0 N--CA 1.427 -1.619 2 O-C-N 130.983 5.177 . . . . 0.0 112.137 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -68.29 149.46 49.43 Favored 'General case' 0 N--CA 1.48 1.064 1 C-N-CA 110.094 -4.642 . . . . 0.0 105.085 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.3 m -118.53 72.0 0.86 Allowed 'General case' 0 C--O 1.206 -1.216 1 O-C-N 130.97 5.169 . . . . 0.0 107.75 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -88.55 108.68 19.54 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 109.118 -3.674 . . . . 0.0 110.372 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -17.25 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 126.96 2.663 . . . . 0.0 116.563 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.84 0.92 58.77 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 117.654 -2.213 . . . . 0.0 113.94 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.4 t -157.67 104.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -88.26 79.95 7.68 Favored 'General case' 0 C--N 1.368 1.407 0 CA-C-O 114.892 -2.48 . . . . 0.0 108.078 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . 0.381 . . -93.91 148.47 22.11 Favored 'General case' 0 N--CA 1.433 -1.298 1 O-C-N 129.41 4.194 . . . . 0.0 109.591 179.528 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' CG ' HG23 ' A' ' 101' ' ' THR . 50.8 mtmt -119.31 163.56 16.98 Favored 'General case' 0 N--CA 1.421 -1.912 1 O-C-N 133.393 6.683 . . . . 0.0 110.825 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.72 133.22 46.92 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 129.059 3.975 . . . . 0.0 101.152 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.6 mp -94.59 114.16 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 O-C-N 127.367 2.917 . . . . 0.0 112.153 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 10.1 m-30 -129.25 174.2 9.81 Favored 'General case' 0 N--CA 1.422 -1.85 2 O-C-N 131.773 5.671 . . . . 0.0 104.251 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.618 ' HA ' ' CB ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -163.74 -165.35 1.02 Allowed 'General case' 0 N--CA 1.441 -0.902 1 O-C-N 132.728 6.267 . . . . 0.0 111.915 179.976 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.553 ' HG3' ' CD2' ' A' ' 6' ' ' TRP . 16.3 tttt -117.13 142.93 46.38 Favored 'General case' 0 N--CA 1.427 -1.624 0 O-C-N 119.123 -2.236 . . . . 0.0 111.279 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.243 0 O-C-N 126.94 2.65 . . . . 0.0 112.478 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 117.391 -1.29 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 93' ' ' ILE . 2.1 m-30 -91.86 -22.64 19.98 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 128.727 3.767 . . . . 0.0 105.624 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -40.59 97.62 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.614 1 O-C-N 129.529 4.268 . . . . 0.0 115.795 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.17 142.7 3.46 Favored Glycine 0 N--CA 1.47 0.941 0 C-N-CA 114.295 -3.812 . . . . 0.0 105.949 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' THR 0.319 60.2 p -67.41 164.2 19.16 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 115.558 -2.457 . . . . 0.0 107.537 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.618 ' CE3' ' HB2' ' A' ' 115' ' ' LYS . 71.1 m95 -141.19 135.34 30.68 Favored 'General case' 0 N--CA 1.411 -2.394 0 O-C-N 127.788 3.18 . . . . 0.0 113.599 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HD2' ' CB ' ' A' ' 113' ' ' PHE . 26.5 mtmt 59.37 178.03 0.08 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 118.035 2.606 . . . . 0.0 118.035 175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.81 HG11 HD22 ' A' ' 21' ' ' LEU 0.26 1.5 t 16.87 99.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.482 -1.64 3 O-C-N 135.122 7.764 . . . . 0.0 120.932 174.876 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -121.18 -47.91 2.24 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 116.615 -3.803 . . . . 0.0 108.38 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -31.28 84.62 0.0 OUTLIER 'General case' 0 C--O 1.207 -1.159 0 CA-C-O 125.138 2.399 . . . . 0.0 115.738 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -66.93 129.66 40.62 Favored 'General case' 0 C--N 1.37 1.491 0 CA-C-N 111.197 -2.729 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.78 21.79 3.91 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.446 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 66.33 33.01 7.34 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 71.47 136.07 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.821 1 O-C-N 131.593 5.558 . . . . 0.0 108.769 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.87 9.14 6.89 Favored 'General case' 0 C--N 1.364 1.217 0 CA-C-N 113.055 -1.884 . . . . 0.0 108.793 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.45 -87.52 0.5 Allowed Glycine 0 CA--C 1.541 1.669 0 O-C-N 128.125 3.39 . . . . 0.0 112.668 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -158.62 31.14 0.23 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 117.216 -1.794 . . . . 0.0 108.979 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -120.11 156.76 30.38 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 126.019 2.074 . . . . 0.0 109.271 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 46.33 82.21 0.03 OUTLIER 'General case' 0 C--N 1.345 0.401 0 O-C-N 125.908 2.005 . . . . 0.0 113.941 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.651 ' C ' HD13 ' A' ' 21' ' ' LEU . 21.6 t30 -163.31 114.92 1.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.955 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -151.38 -97.78 0.06 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 113.477 -3.154 . . . . 0.0 106.244 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' H ' HD23 ' A' ' 21' ' ' LEU 0.362 1.3 mttp 83.12 155.99 0.11 Allowed 'General case' 0 C--O 1.198 -1.616 1 O-C-N 134.931 7.644 . . . . 0.0 101.555 -178.54 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 7.3 mt -118.14 174.02 6.45 Favored 'General case' 0 C--O 1.242 0.695 2 O-C-N 132.133 5.896 . . . . 0.0 99.275 179.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.3 m -156.06 -79.03 0.09 Allowed 'General case' 0 C--O 1.198 -1.633 0 O-C-N 127.615 3.072 . . . . 0.0 107.83 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.952 HG22 ' CD1' ' A' ' 32' ' ' PHE . 1.2 mp 62.08 99.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 CA-C-N 109.401 -3.545 . . . . 0.0 114.702 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.2 m -145.68 78.57 1.54 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 116.239 -2.184 . . . . 0.0 106.954 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' A' ' 32' ' ' PHE . 18.0 mm-40 -91.21 -111.73 0.09 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 114.112 -3.035 . . . . 0.0 109.879 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -122.2 3.65 9.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 101.844 -3.391 . . . . 0.0 101.844 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.55 -16.0 55.36 Favored Glycine 0 CA--C 1.56 2.9 0 N-CA-C 104.289 -3.525 . . . . 0.0 104.289 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -115.81 -38.18 3.75 Favored 'General case' 0 N--CA 1.435 -1.182 1 O-C-N 131.078 4.634 . . . . 0.0 109.843 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -102.38 -170.33 1.79 Allowed 'General case' 0 CA--C 1.551 0.996 1 N-CA-C 97.856 -4.868 . . . . 0.0 97.856 179.198 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.952 ' CD1' HG22 ' A' ' 25' ' ' ILE . 0.7 OUTLIER 179.68 126.29 0.07 Allowed 'General case' 0 C--O 1.195 -1.791 1 N-CA-C 97.048 -5.167 . . . . 0.0 97.048 179.154 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.87 112.25 25.3 Favored 'General case' 0 C--O 1.252 1.197 3 O-C-N 132.585 6.178 . . . . 0.0 97.208 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . 0.317 2.5 t -75.51 146.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 1 C-N-CA 111.026 -4.269 . . . . 0.0 105.152 179.799 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' N ' ' A' ' 24' ' ' THR 0.263 2.4 ttmm -87.5 54.87 3.28 Favored 'General case' 0 C--O 1.195 -1.778 2 CA-C-O 128.523 4.011 . . . . 0.0 113.486 179.577 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.282 27.4 tt0 -72.68 68.55 0.85 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 111.854 -2.43 . . . . 0.0 107.668 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 132.87 36.64 Favored 'General case' 0 C--O 1.216 -0.706 0 C-N-CA 116.341 -2.144 . . . . 0.0 108.088 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.3 m -137.13 -162.12 1.25 Allowed 'General case' 0 C--N 1.351 0.631 0 C-N-CA 114.126 -3.029 . . . . 0.0 110.19 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.51 58.12 0.94 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 126.744 2.528 . . . . 0.0 106.659 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 15.9 m-85 -134.01 -71.81 0.5 Allowed 'General case' 0 C--N 1.358 0.962 1 CA-C-N 107.57 -4.377 . . . . 0.0 106.765 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -156.1 10.0 0.26 Allowed 'General case' 0 N--CA 1.428 -1.538 1 O-C-N 129.848 4.467 . . . . 0.0 116.206 179.691 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 75.63 8.41 3.73 Favored 'General case' 0 CA--C 1.548 0.897 1 O-C-N 129.407 4.192 . . . . 0.0 109.353 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.938 HD11 ' CD1' ' A' ' 57' ' ' LEU 0.336 0.7 OUTLIER -28.45 138.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.204 -1.319 3 O-C-N 133.288 6.618 . . . . 0.0 110.615 178.741 . . . . . . . . 5 4 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.87 137.64 50.91 Favored 'General case' 0 C--N 1.373 1.601 1 CA-C-N 108.176 -4.102 . . . . 0.0 109.373 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.99 107.47 22.9 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.128 1 O-C-N 131.696 5.623 . . . . 0.0 104.2 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 47' ' ' PHE 0.319 2.8 p -110.02 168.47 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 2 O-C-N 130.196 4.685 . . . . 0.0 116.148 -179.752 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' N ' HG22 ' A' ' 46' ' ' VAL . 6.3 p90 -174.43 -177.93 1.31 Allowed 'General case' 0 N--CA 1.427 -1.59 1 O-C-N 131.601 5.563 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 2.7 tt0 -138.3 40.75 2.26 Favored 'General case' 0 N--CA 1.426 -1.644 0 O-C-N 127.007 2.692 . . . . 0.0 114.445 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.17 115.02 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.098 1 O-C-N 132.795 6.31 . . . . 0.0 115.855 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.44 44.88 94.64 Favored Glycine 0 CA--C 1.545 1.933 1 CA-C-O 112.673 -4.404 . . . . 0.0 104.367 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.9 t -115.12 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 1 O-C-N 133.672 6.16 . . . . 0.0 114.882 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB3' ' HB ' ' A' ' 66' ' ' THR . 53.7 p-10 -79.27 151.9 30.86 Favored 'General case' 0 C--N 1.354 0.775 1 O-C-N 129.577 4.298 . . . . 0.0 111.624 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -174.55 -174.62 0.86 Allowed 'General case' 0 N--CA 1.426 -1.648 1 O-C-N 129.39 4.181 . . . . 0.0 115.581 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.35 97.04 4.6 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 102.072 -3.307 . . . . 0.0 102.072 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -106.31 130.88 54.07 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 128.135 3.397 . . . . 0.0 113.025 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.1 t -91.99 71.09 5.52 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 112.599 -3.64 . . . . 0.0 106.002 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.938 ' CD1' HD11 ' A' ' 43' ' ' ILE . 27.2 tp -36.17 -85.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 O-C-N 131.164 5.29 . . . . 0.0 112.997 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -88.07 -136.11 0.09 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 114.984 -2.436 . . . . 0.0 109.169 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.11 58.25 0.63 Allowed 'General case' 0 C--O 1.21 -0.987 0 O-C-N 127.249 2.843 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.03 -81.05 0.11 Allowed Glycine 0 CA--C 1.556 2.642 1 CA-C-O 112.499 -4.5 . . . . 0.0 104.116 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.844 HG21 HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER 23.02 -94.2 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.717 1 O-C-N 133.316 5.95 . . . . 0.0 109.398 -179.704 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 74.91 29.2 1.03 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 126.827 2.579 . . . . 0.0 108.743 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD13 HG22 ' A' ' 61' ' ' THR . 7.2 mp -63.91 92.11 0.07 Allowed 'General case' 0 N--CA 1.428 -1.538 0 O-C-N 128.868 3.855 . . . . 0.0 107.817 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 100.0 m -89.12 99.31 12.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.798 -2.91 . . . . 0.0 109.668 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 78' ' ' PHE . . . -160.38 -152.72 6.66 Favored Glycine 0 CA--C 1.546 1.998 1 C-N-CA 113.635 -4.126 . . . . 0.0 105.843 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 66' ' ' THR . 6.0 t -163.5 118.48 1.64 Allowed 'General case' 0 CA--C 1.494 -1.179 1 O-C-N 131.184 4.696 . . . . 0.0 114.927 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.708 ' CE2' ' CE1' ' A' ' 78' ' ' PHE . 16.8 m95 -96.31 124.74 40.41 Favored 'General case' 0 C--N 1.356 0.867 1 O-C-N 115.62 -4.425 . . . . 0.0 106.86 -179.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.51 94.88 5.07 Favored 'General case' 0 C--O 1.202 -1.402 2 O-C-N 135.106 7.754 . . . . 0.0 108.948 179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.68 88.18 0.7 Allowed 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 109.943 -3.299 . . . . 0.0 103.965 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -94.93 81.82 3.78 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 126.422 2.327 . . . . 0.0 111.112 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.56 -92.85 0.09 OUTLIER Glycine 0 CA--C 1.527 0.823 0 O-C-N 128.647 3.717 . . . . 0.0 109.973 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -110.03 35.49 3.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.748 -2.726 . . . . 0.0 111.182 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.16 154.09 43.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 115.5 -2.48 . . . . 0.0 108.377 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.532 HD13 HH11 ' A' ' 91' ' ' ARG . 4.9 mt -134.8 37.32 3.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 127.605 3.066 . . . . 0.0 115.098 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.63 149.61 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 1 CA-C-N 107.879 -4.237 . . . . 0.0 115.598 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 66' ' ' THR . . . 155.75 -150.07 21.33 Favored Glycine 0 CA--C 1.551 2.301 1 N-CA-C 102.754 -4.138 . . . . 0.0 102.754 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 8.4 tttt 178.84 115.5 0.04 OUTLIER 'General case' 0 C--N 1.368 1.403 1 O-C-N 131.6 4.941 . . . . 0.0 114.311 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.708 ' CE1' ' CE2' ' A' ' 67' ' ' TRP . 0.0 OUTLIER -120.25 145.32 47.15 Favored 'General case' 0 C--O 1.203 -1.383 1 CA-C-O 129.87 4.652 . . . . 0.0 102.309 179.802 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' HG2' ' C ' ' A' ' 85' ' ' LYS . 18.1 ttmt -138.52 147.62 43.33 Favored 'General case' 0 N--CA 1.425 -1.707 1 CA-C-N 105.991 -5.095 . . . . 0.0 115.103 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.656 ' CG ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -97.49 24.28 6.79 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 128.917 3.886 . . . . 0.0 111.908 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.464 ' CB ' ' HD2' ' A' ' 79' ' ' LYS . 1.4 m 1.73 -57.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.777 1 O-C-N 134.891 7.619 . . . . 0.0 114.807 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.462 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 43.5 t0 -45.34 -27.18 0.63 Allowed 'General case' 0 C--N 1.319 -0.759 0 O-C-N 128.989 3.931 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -178.78 -7.96 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 0 C-N-CA 114.218 -2.993 . . . . 0.0 118.358 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.21 -46.34 2.22 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 105.212 -3.155 . . . . 0.0 105.212 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' C ' ' HG2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 90.04 -150.49 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 134.351 6.56 . . . . 0.0 113.896 179.844 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.492 ' HA ' ' HG3' ' A' ' 79' ' ' LYS 0.264 0.2 OUTLIER -63.58 133.44 53.76 Favored 'General case' 0 C--O 1.198 -1.65 0 CA-C-O 112.77 -3.491 . . . . 0.0 114.965 -178.799 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.656 HD13 ' CG ' ' A' ' 80' ' ' ARG . 0.5 OUTLIER -137.24 49.21 2.03 Favored 'General case' 0 C--O 1.202 -1.412 1 O-C-N 137.99 9.556 . . . . 0.0 108.434 178.108 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.68 174.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.17 2 CA-C-N 107.153 -4.567 . . . . 0.0 104.235 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.99 55.15 1.72 Allowed 'General case' 0 N--CA 1.436 -1.132 1 O-C-N 130.856 5.098 . . . . 0.0 107.726 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.1 t -55.76 112.47 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 1 O-C-N 131.436 5.46 . . . . 0.0 100.865 178.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.754 ' HD3' HD21 ' A' ' 98' ' ' LEU . 5.5 ttm180 -151.89 160.08 43.63 Favored 'General case' 0 CA--C 1.495 -1.144 1 C-N-CA 109.468 -4.893 . . . . 0.0 113.472 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' N ' ' HG2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -160.87 136.38 7.96 Favored 'General case' 0 C--N 1.356 0.869 1 O-C-N 131.464 5.477 . . . . 0.0 109.369 -179.429 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.894 ' CD1' HD12 ' A' ' 98' ' ' LEU . 4.4 mm -67.45 124.47 22.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 1 O-C-N 133.336 6.647 . . . . 0.0 110.354 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -77.22 -65.58 0.93 Allowed 'General case' 0 CA--C 1.503 -0.845 1 O-C-N 129.716 4.385 . . . . 0.0 113.171 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' N ' ' OE2' ' A' ' 97' ' ' GLU . . . -174.44 78.05 0.08 OUTLIER Glycine 0 CA--C 1.554 2.482 0 C-N-CA 115.358 -3.306 . . . . 0.0 106.711 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.4 t30 79.44 27.79 0.37 Allowed 'General case' 0 CA--C 1.551 0.981 1 CA-C-N 106.599 -4.801 . . . . 0.0 108.445 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.663 ' CB ' ' HA ' ' A' ' 114' ' ' LYS 0.325 0.0 OUTLIER -168.8 142.74 3.05 Favored 'General case' 0 CA--C 1.564 1.516 1 O-C-N 130.731 5.019 . . . . 0.0 107.938 179.252 . . . . . . . . 5 4 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.894 HD12 ' CD1' ' A' ' 93' ' ' ILE . 3.8 tt -106.2 133.14 51.37 Favored 'General case' 0 N--CA 1.439 -1.0 2 O-C-N 135.206 7.817 . . . . 0.0 112.853 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 112' ' ' ILE . 3.3 mt -75.08 -66.86 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-O 111.99 -3.862 . . . . 0.0 105.479 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 73.95 92.95 0.08 Allowed 'General case' 0 C--O 1.201 -1.483 1 O-C-N 134.712 7.508 . . . . 0.0 101.631 -179.664 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.519 HG23 ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -111.24 124.04 51.42 Favored 'General case' 0 N--CA 1.425 -1.699 1 CA-C-N 107.844 -4.253 . . . . 0.0 113.44 179.929 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -91.95 151.81 20.33 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-O 113.297 -3.24 . . . . 0.0 104.279 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 103' ' ' THR . 1.1 m -134.95 70.34 1.44 Allowed 'General case' 0 C--O 1.214 -0.807 1 O-C-N 131.843 5.714 . . . . 0.0 105.571 -179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -88.96 121.4 31.28 Favored 'General case' 0 CA--C 1.497 -1.064 1 CA-C-N 106.813 -4.721 . . . . 0.0 111.302 -179.898 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 104' ' ' TYR . 5.9 mt-10 55.71 -85.31 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.441 0.696 . . . . 0.0 109.857 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 104' ' ' TYR . . . -151.0 37.46 0.87 Allowed Glycine 0 C--N 1.363 2.05 0 C-N-CA 117.295 -2.383 . . . . 0.0 114.696 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.4 t -136.68 149.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 116.685 -1.626 . . . . 0.0 114.767 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -124.46 104.3 8.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 128.954 3.909 . . . . 0.0 105.183 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 110' ' ' LYS 0.435 . . -100.11 -32.13 11.07 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 128.526 3.641 . . . . 0.0 113.588 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' CG ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER 46.73 -80.37 0.0 OUTLIER 'General case' 0 N--CA 1.417 -2.091 1 O-C-N 137.735 9.397 . . . . 0.0 111.462 179.961 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' ALA . 2.4 mtm180 77.34 88.35 0.07 Allowed 'General case' 0 C--O 1.202 -1.42 1 N-CA-C 99.505 -4.258 . . . . 0.0 99.505 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 99' ' ' ILE . 3.7 pt -65.36 159.28 4.15 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.234 1 O-C-N 130.372 4.795 . . . . 0.0 114.077 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.499 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 22.0 m-85 -144.81 -148.44 0.24 Allowed 'General case' 0 N--CA 1.442 -0.848 1 O-C-N 130.858 5.099 . . . . 0.0 105.124 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.67 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -168.24 -141.33 0.04 OUTLIER 'General case' 0 C--O 1.196 -1.744 1 O-C-N 131.678 5.611 . . . . 0.0 112.139 -179.446 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 7.0 tttt -132.43 154.04 50.24 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 125.891 1.676 . . . . 0.0 110.804 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.196 179.569 . . . . . . . . 0 0 . 1 stop_ save_